<SEC-DOCUMENT>0000927653-22-000051.txt : 20220509
<SEC-HEADER>0000927653-22-000051.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509081536
ACCESSION NUMBER:		0000927653-22-000051
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		144
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		22903332

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mck-20220331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:eedc7054-d2b4-49fb-b502-fc8a725b4aca,g:dd1fa40e-8b61-4831-9194-c55f1729d4f8,d:4b4e3b23ed904498bf3396ff0593cb05--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:mck="http://mckesson123.com/20220331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV8zLTItMS0xLTY3NTEy_e444f33a-b7fa-4d95-ab10-1d29f0aff172">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV80LTItMS0xLTY3NTEy_4fb4110c-37e7-4fe0-bae9-dc04cba116ce">03-31</ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV80LTItMS0xLTY3NTEy_88006d8d-10eb-40d4-8c70-d3c31bf331f1">2022-03-31</ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV81LTItMS0xLTY3NTEy_ef86f3a6-4c96-4d8f-a152-ad0822c1f61c">FY</ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV82LTItMS0xLTY3NTEy_3819a34a-a937-4719-85dd-b6b32421ea54">2022</ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV83LTItMS0xLTY3NTEy_bc83a56b-7ab0-476d-8cd4-e739a9b06553">false</ix:nonNumeric><ix:nonNumeric contextRef="i975f1db8bccf423181a945e065415fff_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i92ca8c27ec4649008fa3211cb422f720_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i430c0a72e23b438a8649c6275316dac5_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="id75ca3120774435ca04f05387924ec80_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODE_2c540d8b-dc0c-4d2c-842e-9bfd3840f523">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i95419da414bb4ab191a0c6bdfc3acda0_I20220331" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i0352fcb39b434a9cbd835b33a19c1e6d_D20210401-20220331" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDA_c483e2c9-dff3-4b92-bc09-7d0567550317">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i7a8333254bac48c78da787f6e428f9aa_D20210401-20220331" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTI_c01062b2-22fa-48c8-ab15-ad2d5e0ffc41">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3.125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e45aeb91b9541c99e6059f70915b672_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i67fe817fe4174122acfb22089bd77bb2_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3deea6c14b24c35a88fb4f3b5239602_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b21cbe51124474092ab038b1d408bb7_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785292e3540b46a8b3ab968c6707dd77_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a6c8a7f661b462f9ac6296df77d8e06_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cd9f0cb497242a6826289cfb5fdad80_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide9952cef22a4bc8b524552d5f4a71b9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4592918a3c14823acad8256f0ddfbde_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3028b894dc5241e6bdae80eea3de8d1f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8428ec3a9cbb437d8aa822268f3ae46f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia689b4eec1084768aaebdb4bc5f99af7_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7820f8179cd488caae5ec4d8b342012_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa23c711f267453f9563f59bc7ef048a_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b01dc80a44246cd9ff31ee62f1cf4f5_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f39b2ee8ba4ad9b6df061b0133c8c6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i180ef1abd93241dd9b099926ef64a73e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a7555c1d0ba47188d1bf7a199033063_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95e07416b7c42009dca3b45fcac417f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aec4e5c4fc44a31a9df1e4f8d8962c9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5103e93a3d4aa2b15d717f1d91a04d_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e972d123eb647c8a45d52545e29ad97_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64627de0752a4f38a0331018368b8865_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3440078a7adb46d7b5f9accf550ba77b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b02a4b752d74cfd80393765ca780d97_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f88e128a22f4b15be314f3dd2e0d53d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i883cca538ace48298886a121db79175e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic641abc11fc64b27871a5f1b878bbdb6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f0aa9722f4476ca58477e03a36b9f4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb569322fd7143f1924eb4050fec05d0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2cdad70673142c9a93a6bbb19838852_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i201940e73632457882da553cf6462766_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8791362274e94d518929bbd7ee69eced_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf764aa2c30f43d08cdd30a5094d5c77_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic31e30cd614c468c88d7a33e3c01b62c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d61cae07b149f28ab844297d0650dd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305e3fcf99604bad83df1de067162bda_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1eb7d3437fe498bba552eae2bce578c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9378e02396964f6fa338e061f8c72449_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib551700663cc480187b2925365dc76f3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210241066bf44247a7e0bfd8995df0e5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc9248dc9c64dae83ba79637793aab6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57057534f4b548078330647f41d65cd9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973951133a204d4eb8580125b92aed26_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461023189d294286a463ef01b45de63d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5b27e96a471495799b6dd0a225ad062_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic951943367684ce392dcd7a2919ab132_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b967dacd7747f1897007bd0e7d2096_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c4849bc12314eb6878d6ecc627ba11c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f038c81a5a4b8198d4c97be9e3cfa7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3764f741fee2439f932384b08f26eaf2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dec5df30de44f7a83e4f2ce0278a9d7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcca99ee396c495597323a1f0cfd1b93_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i199433cd82524872a587c50f96b8c524_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie685032700114a648030b37f3029390e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a83e66e4b34cfcbbd7fafb3e2d383e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8062dd2444549b5b588b1c34805e71c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1996a48e50224bb9a7a3ef02f89a15be_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b963f2005d473788cd329e855eb9f8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e04acff1af415fb304c565efd6376b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c565412e4c44e6090973b99e12490b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52cdcc95103d4a2b933719ac01f8cec5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="ia875aad6cce743958618a33cce559dc9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef844e82df1453ebb9d87c78078c9bb_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0ca5a3c42a474837ad3c8ddb0bd7ed5d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i497343cb5b494f24aff9bdc1fea240b3_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1927407de0374cf69e8f7b4d87b815fc_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4813acb64c45d2b97a2771fc585000_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica1b10d592e944029941c3362d1e7d7f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2a1aaa4aa14613b98b19f05c608e54_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3520428561d84269863983bba1a927e7_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4995096937474d1bafc21c7eb57b994e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id81d0417806f4bd2852861c9771dece6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bbfc4c323144cdbacc148f6e3af2eae_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975f1db8bccf423181a945e065415fff_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f482d9a485949708d2fb871130187fd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ca8c27ec4649008fa3211cb422f720_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07fbf9f75177477d9f3069a6a3ca5aa5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3d97d7bd9041e6a3021f9f3286582a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:RealPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i430c0a72e23b438a8649c6275316dac5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i866185886e394d17bb4c613ad5943f58_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96172b3b6b994d48bf70c6de9f508828_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6056d0a51a7f4646bfa84408265c81c0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e41ae776e234aad99573060abfa3d60_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e210e8bb0d04564b3c8c5efbc105415_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic483b5ea8e204c8a81418d102f77e31e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24fc415a058448cabaac1543f414ee42_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5fc2a45b1fb4a57a52e375ee61e2e18_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf194e10ae1d4f91ab6ebadc346e333c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36ffbe522794177a4a329b2f1eb434e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8727a45639054efb97996743cbbaa5c5_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafca086d825c49179df146b9365fef4a_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cb26398b07540459c29d095fcbe163a_I20210705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i148d988b662042b2a7deeb2a40ab602b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e231614cf344e4b636aecd2998ddde_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0254ffce6f4249b8b5901d3add0491_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i03a43c3fab9f446eb0a8de876cfc5913_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78ccaa920a9a4c73a30399adf8117855_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72fd68575bf94328b58c74040ee351f4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0adedf0f78e24ba5b61ec3c4ef5b7cbf_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d3e091542c4331aa802c94a7053cc5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i805540d4c73c4b6387871c54c384fbbf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd8b5bc85ab463b9b570056218ced7a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3680721de0643ebb55f9f02576ae3ff_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f12825bbb7d4be19f89e6a7c0f56679_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb3e221693840dbb9ad1863bc6749ce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee10d37e08c43bb976ba37d004b5745_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00ccbaf67b84520a82cd5bc577ccbf8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33304856ba67431dbe134e6a3ab5f8b0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a27f3b5cf9d4d86a3c7d1030055337c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86e51851e38343d889528a7d74ce170b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id91a5fa4a09149dda8dc0d199e094ffe_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41c0c862a7ce4612a21718defa31e238_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69ad3377d9084d09824adc34ca4401cc_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1238be9949344a4ca03b1fd2035c6266_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i735f207277504040936a46b7a21dbc2a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44ae2fd5d4d84827a40c6ccf806b3215_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7657b4a360fd42b382531c0ba2049a37_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i819b3e5a18554614be6da3dc30c8c20e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf37a2aea301469bbf8c95c1cb87dea0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38e69dbb765c4cbba679db0d75d4e24d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3836c14e169d426385529b1516d34376_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbae9d0f6df24779a201d5522b29b806_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5920306c6c74407aa3c61813edac174_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75859372620f4bba9fcc690a92937930_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe8302f1495433a8b56aac54216c93a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60fde2da64904433badd4e9125f5242e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i085f9b77e2ff45639871e3f6c4e87e81_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i136fbfde3b204ba88d3ef047c523f6d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e33cbb297240f8b26bda1df5bbbe78_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3be7b53b364d71925dd6edb5685f60_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c6852c1f9a6482689173337df8e42e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70f13591242b45b99e2c1c5db5996175_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea0833513a6441c390d86adb1976e862_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie75d55168ab54f22bd06fbcb372e660d_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i014202a1f605442dbab72a51287eee8c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850442d9feb244c1b8d54049ca967bf7_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5602bb7b6c1f4462ad47f96096815f13_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia25cf3b3c2cb43a3a841dfd73d6b05a3_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i957db9ee8dda4a86a6807315859b7837_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dea9ba882cb4ed59e73b4c472a99efc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4acf39f6c45042d9825177088805f18a_I20200310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1946db5930c242abbc59691266086fb6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd842111f74444da1462dfb1b854980_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3109ad9f81eb416ab0a243bace22e406_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefb5b025ddcb4d33a1880e89a1d2abc9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372b78f92945468a8ee64d9a3cfcac2a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i713d743d96654a20823b67a74fa07746_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i396a3d47aa6b4128922f47705dca2702_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70f4f23e9a04a66a4f3946139215e69_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83619a483e764d0bbec67a9c3cdbc05f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70fb53d969384de7892c6e9555726ec2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad2eb9cc2d54973b510383cde197e58_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf75a56d89594901b67572ed9c73d754_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i155ee628098a42bdba6bed51090a2fd6_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6991844f2274f7e8df965bf0500c897_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12086cb093c648ecb1b3b14a73e46526_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a23fb1c43dd4a25ae7f616ad567c312_I20130731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cbf7bb534a14e729833a52263987ab2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75ca3120774435ca04f05387924ec80_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7175fa977964dc5b6050bcf39c64b38_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9985842113274b9bb12a6616b9b70bf2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica790b51350c436380a7c20f7ab4a955_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada693d5d07f484eb5f7830f874b2439_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f34988e21e446d58a56961047fed59c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5991194f40e4d9fb3ea2ad222435266_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dd23280ebc846d8b2d4860031a724c2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57920885a3494e0ca6394523c80f50e3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18638b28013f47cc83d0371a8132d139_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice1ca3402501452f8282a882c66a1a41_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b903eb87c2421eb495ac4394329d5d_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i167f7828260e4a198813c305f400a996_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:SettlementofExecutiveRetirementBenefitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e8b5cec568422ebcfc63feb76be4b7_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63827a6bb93940659eeb1ad9423601f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e32a1fbc82b4b00bc1a50e31b77e798_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fec03c76dc94380a58e045d8dc7b5dc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7a390cba074697a32fefbb6fab99ca_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0ac656b00974ec2a54cd2ed0080a826_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id468ab83e79c4da3bdeb27a9b9e7e51f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if89d7ba5882b4f0fa002ab7806455632_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb72716661344f2b3ed64c31036af17_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb22ce88060842ff860b7a4f6f4d8c8d_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id49f95b8b84d4733a35b6f6d7352eb6b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fb979952704eaeb0354680a480489e_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdac5b94f2184c3a99658bd787744bdf_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74517685e93241df8e4050dd6818b8c2_D20180919-20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-19</xbrli:startDate><xbrli:endDate>2018-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55a461c58734092bdfe4dbc17c833c2_I20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314553b738ee43fc96f6e068ba26aa3c_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbf87d883a1e46a99b0a0ea932dfd523_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369ed3d532394663ba99e0e952d94674_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2d296e2c5c427f97b8588765fa3178_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc4df20c07240af91fdfc7690f7f39a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a5f885d18c04e07bd8c41ef8f1ce99b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac41f1025f14743bb7d39f341e23ed7_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb2e420d55e43d0aa913ab1b22cbcaa_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcdc1a443e549bdae94a956c44c8a5e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ae40923a8c44fae93e93658b71a6fbe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2605ebb23764962bfd89d4578016d5b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if31e8179749841c8870313f7d3ba430c_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc5e78fe538f4bacbd70c847c9f29b70_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95419da414bb4ab191a0c6bdfc3acda0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6fbd33f726e47aba5491ae5385fa919_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082e438b9e624b688d526df079a96fae_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc65fc10a6f46eb873730b43c245ffd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab6ade13b6047f2bc574352c680315a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee45133724c4e4d9e9cc8e6880430af_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i558a4f91a45148328e79fe9c105520e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3167c8a2454bfc8d55421585d3d985_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15b55a2e948f4b24a3b527c5ac723106_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2898617ea052451ab1b166e16ad0bff1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1778f09368dd4bde9d01e3bceccc0de4_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8bec42efc82456886f328dfaa5e4c78_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57b1f3f32ffc4e6ca7fc465f2efcfa9c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89602a22aafc4c248462dc75c787e1db_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65c2a80c51924ffea392e70a7d81af35_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17f9f344cd2424186b1efb969df180c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i480ab7e945d745479b45988a832ff1ef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d68a928d7824033ace17d52e23a8dca_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c222358c854868933a4aec3f197b82_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if320149638f44877bc4627df44ee32f0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68562b53b58b4e4eb84618514db2cb80_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bf05e148e384ae29d92e24fc00c4fef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b1d9b80a624667a047ec06a972915f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987e27c5d1bf40c783eef89efb6f9d6e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97df16e5800541ca9604a3cf83a192c2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b657fb07354a6c983690d6eee84e3a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if68227cf6cac4d3d86ed24a1337b11f2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260b94765bd84eba92c24f9d3b5ece7a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b800d5a4ed46c98d60b8f90472d8b0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8bd56dac64452db5d3474b91e08366_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie64c7a9ecd8140eab1897947f3348779_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanAssetsHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5e289f8bb94f8ba82cd55b25264f93_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38191160842b4d688580a4d3c249f8c9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75f9b3f6ce4a48629e8939f2036c9a7e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaebf771578eb4688a13cafab7d91e267_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id41b46d826cf480a9d07b02c6f0fa4b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b257ef2e3f049e28d8f48078592b92a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff19ad24fcaa4efe8adbe9568e74156a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5269554a47894df4b123574f180fa7bf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4492282a1a93402a8f44df990dd74728_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdebf42f817b45e8837663f7bac80ed5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02dc743ac553435dba404f92c86d8691_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70b14d9641344a939e986c99e6567d70_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6b3ed5f2ea54176814a8708c6499848_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd84b2361824bb0bc00064d18891fb0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91a13fda196843f6b109d769cfe0751d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18046743a1974c45821697aea7b0f77f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i776610a612354ff280ad9f037198c296_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8410975cba024c78bef5a76f712f7294_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9099b942bd1b45f78fdeefc39837a3ce_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied357647ec7743bea35135bd6969080e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74426e55813a40cc92bc89945e9dd130_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29908212c93c4b2cba4a35c49394c7b5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a43cf31de784042b8d27a08355df15f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie471ed607d464069b849582cde89f693_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03e6233f5e8548d5a04aac3f11cb0d2f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3995850cc8f4cf0bfa3483d28ead8fa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8b875fcead64ab181ee711d77c92192_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd452d00a734f2699190045314018e3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a54c5deff6741e68bb12b5a3eadc2e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a3dbeaa252741fa82864c3f88132372_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b2810c0aee413597e8c1646426d086_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6d4f12944242709bef7d5e0584395f_D20210812-20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3cf2b7fbad458882870ec7a0921f35_I20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c1af6fdd3b44f1934218a6f196c0a9_D20201203-20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-03</xbrli:startDate><xbrli:endDate>2020-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f2539eb1dc470b917574e5cba645f8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if911145c95344b73b7494ae283e29168_I20210717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b43789844d4108be63a4a1dd1280fe_I20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97437c473f7b4c27959c7f3f98f911fe_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae64a0ee64e4ca28a9e634159013ab3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb94ab329074f2382e57702aeb12464_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c2711a4ba7d4daeb3142e521b8d969d_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i404ec63c736d4d128bee727971bdc191_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa0c457401141829a63813967411389_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7700fd1bf3b64d08ab4b2725bcf11c2f_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib46cc219b945454c99153f6a6c005bc1_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if28ea4a9885e4a2aaccecc13941b21fc_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40b1e6ac876c4f44be5287989b81b43c_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2f0e560d0dd48aaa9c9a66d529db5b7_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i815ce043efb54a79a003ee84bccbc673_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e0a17bd91147bba817806801ea38d9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d7edea6bbe944938cf631118e7e0c24_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i786695c3c8824251b74d57413f2ab330_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96bdc5d0996443d4bc99773608909bc1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c239f7cb9ba4f119b5f6aac4be47c6f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f981237ad304136b3c2ae388a494f17_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae704fbe3b04d318f47ec250c37e298_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d8d6b46e9d4decbb6a76ffd434ad18_D20190401-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c59a4ea805b47c08a95056ceb9c564e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad7a2e6922f64cf3808e830fd554c3ff_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb808ca7946448095716d3e591aec2f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id447a2bd767645c7a12007233124425f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d2b3d87c4114cc6b082a6eb3df4484b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8a6c7fc82394698afcdf83d11179f9a_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="participant"><xbrli:measure>mck:participant</xbrli:measure></xbrli:unit><xbrli:context id="ib56e9807d14242ab8a66d9df9e68b070_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f41e21247ae4a519309d2ad4bff9441_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83736112ca9462697b6ec54e87de910_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2f3b3bb37649189b90084615b5a308_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2faa1d1ed13a446eb975b380912a3068_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec0851116374d82b9e49426d73763b6_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c424200871342f38c9f8485d07949ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a003a64326a491fb3ed09f382ba84b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d6f450ac22e49d6bf0df50d025ae906_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60c1e60e920e4d629a84b4eff86bead7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i493c2820033f44e2891698cc75e5d9f0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ce3eddb5fc4a9387c2b4a7e93476dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226a25479b7c46bf9d8ddd2a5bfcf119_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1718647e98904b358ee1e9de9b292eb9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0132582b984b76ae285cf19ed5c7f6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2728f1fd9955493099bbd68893348eff_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24a302cc95448b6895bf70aef816116_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief082c01cc5e412cb6ff4de8ad61ca8d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f84586bbdc64b9db37cbe7a0a6e91a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24a81b323f944750ad86fa66047de210_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c57f6243c3043139895c497e5082a6c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1feb4c8ee03c4ea8b76a8dec194384a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice1db9b721a84b9a962dd773d56f5625_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42493a65e37c41cd84bfc0a43dfbfcfd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67a195a2dbc24ab0b3916b6c936b0a81_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i802adc56f209414fa2679958ea52481f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2fc5f76445f4ccb949607a1612c1efb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie231571b70294eae9fa4e83ed3eeca65_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a4ddf8d6704a26b6c3d695218fd03f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief335562064c476d87395446c7085794_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic376ec9b950641b1af873ef2748b3c7c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b45db4fc0e645fb81133a5906dbd495_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9f160bc0e164814a7383b997da65a5c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd0a0364703401aba0fda8a20e2d103_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd6515ad0894db092afa7fcc8fbef3c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1498edc5a78e460cb75dd394ce55f4bc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a450f02f814c13ad2c3e1a67df52db_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf3513bbbfa54d83b35c2db60004594d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98369f24f8ab4c2eb5f3e9a7ec1b1865_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d18f2d389c34f889fe5b27bea6dedca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e2be2f8d0b46c798249db103676c1e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06830bb28fe54b568fbb0beb096d29c6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e437bd0e8ac42d1922f9d4c9b56a9e9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb6959cf5a342729ed17f01d0dd71ad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25303d6a03249938b42bc7d3c1357bc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82602c6601f4f45a4a7369ec1b8bf35_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ea8b4f7ef14653a641e807f4cd138a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69cf84e558644557a7de95ff69e39200_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i549bcf1376444c1c96c41b62e0f53c13_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7992105cb65e4456891d27cc92f31f82_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6750d94d7246455fa05c465a0a2ce518_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb4cdf5216e54e7d8f62bf705dc2eb7b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3e73ea452a64d409c6a0144d7c8f775_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i789450adbe47425287cf59d8f464ddd4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib64b7c133d6d4fe4aacc658b24720e06_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e7cc563acc44759bce119f8ce36a604_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ebb6ae9dcdc495b9cc3c87d23f6cbec_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c239fdb13f450da87c6daa53922d8d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c306b0e9f2f4c79a4da4e3080b6d89e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21c7e2a081d5465796f47bd8606c00e9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5164fe963e2645c899da80d46fd4ae97_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7649f7142e4c4b9a4814ec21eff4cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5572d95dce3c4525ac5872c923be80d8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife0b53acf3404eb896235616da3a2829_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7038af880144a7ea84a73759de44134_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9233f3fb62d4e2288e4195f2496e9d8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i198ca18f282b482093bc4dbc11845c9f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53073f5452fd4d48a40ef1c67e4481ab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7d7e52a71c45f191cff470e5e58900_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3049d1d278b041b182572ae407160d16_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd607e6a67e34b6a80181cb19f672808_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35d3c0a9434f43f4a185b11c84d8c084_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2db81a22674f35a3dca780612fa224_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a29ea5f47374404ba20c59dc7af27a8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i088530175de844cdb1ff52c1bae2e520_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec69e1f822ee4fbca88f48124ec26c7c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i780bb7e3c18c4e2da57a59b5e8a82b8d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a603bd1125146b48426fed799546156_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7187fc49e8d94a85b667b111d6e5dc69_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04278e26dd54ce48826dbc56cb31d0c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee7ff1a301f4f4badf6de78d85f9ee7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65b4babfea54b92be6fb935a4313666_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a44775f82674797bf85d3b9a8a5ab4f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib359c5a79d704e0ebf9e432707a3b141_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bc4364d89ca4d929d7940909184939c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i294bbf493f9b404bbff0579c52891b4a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04db204508bd48ea9785a68185baa374_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe2c94dcf99244b7b82fca2d408a16a4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad63af957fc64549aee083f9cdee9453_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac275e02b8b48a39ec49c6224a2a136_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:FirstPartOfPayContributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i195f1f7208864f679b4d15f3687a5587_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:SecondPartOfPayContributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81e084748f994c2b9dee394b47094c3f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8cbf8941d6b49f7a3fd6216544852e1_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a78699f72e4caaa49cdae2c1264ff9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5c091f35bda4066898f44d7a15e739b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a2bce002414557a29e4f5c83a868f2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a394ed33cbc477aace60da23a0ce725_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a9c80472fe146588b6eac8a58404290_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24fdde78e96442cbafbef0fa22f902e4_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf83c6faa1c2418c96f6ef2cef6c1bcb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="i808f703176d2404abd9b7793bf0a6599_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07635e9764bd408087acfd4f78ea3577_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c98cdf793bc4ce48f4a0004d0a47ebc_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b34b6e8ced4d97b4d47ddb2965e898_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaa55b6bf9f44cd1a8a25b42288d0593_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f9cac9e86284785ab4d70600ae33ad6_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb5afe9d8f741d98516f86630f9a369_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca4b4a7511f40e5a9d3ef22dada90c7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d147eb37a56481b848433e3e940585d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c39129d8ab4c4b9955fcd9310ac053_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e32714cfa934a93b4e7c425d1d050de_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137f365a182943e796f2e1d55d814426_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fb91758a04f4bacb9905307ab195623_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4542a21b25d543c4acc0fa4436d289e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i012c7ab6d6f04da38da0d95109115f5c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i024aefa502ee40d6b34f7f8368e3b55c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff333b050afd48d9b90c24d10c24348a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c57740209a940fa8dafc8433670f167_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i309ac7f13b444d0db3954863ad6e761c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i719adfe70a964eb882c96f1004d74bf8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c355ddfeccf45afb84fc6d09c4cd44e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e46135b9e374ad194e91da1167d2848_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fa2453674034bfe8272f5598f29c014_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f221a3ec78445e79e65fa93472e8585_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e26180f2064b60a601613f3b0d3643_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0af94175dd994714a8a7faae0f0e5212_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb892ad00ab49ed8566342454fa928c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4989346074144770b6adc1234e579021_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70cd65a985648138af1f3c043a64290_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if507dc7fc59b47fea1f9ddc4fc902174_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbe2788b715640b4b52cee7ba7637f83_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3508fc7db8ac40f1a7ea81409ab7678f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8840acf2e77d44af9a2a8cb81017cda9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i374b081d61104014bfe452acfb9cbcf4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3cb819d9d034281bc184dd6e2359115_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe727da0df047e9a85ea9962c4b400d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9ec224cf4764392959e53320ef9a081_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407dcd9fcbb146db960f9ded6cee8015_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d3f99f4a8e4b5aba1d005bdf779310_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0352fcb39b434a9cbd835b33a19c1e6d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98c151bfae0f42a4b2ce4521c05e9acf_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a8333254bac48c78da787f6e428f9aa_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe76b97b0b24598b07f33f5ca016907_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77cf6c86ae8c46a682b412b3e0abac24_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2934427a7be2467d8b52f822c45c8593_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f79f2c96f24d718707c887c792a696_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f60f777e8754ae3b0d798ac833ac49f_I20220225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mck:product</xbrli:measure></xbrli:unit><xbrli:context id="i8ee8208665914ed2bf9222d6977c182f_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7c4180c7d349cdad921bd625aef19c_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5f3b6a5a5224458ab102b9be37642c2_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ef52d9fd4b04fa4ade734933f7afdc0_I20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-02</xbrli:startDate><xbrli:endDate>2022-04-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>mck:installment</xbrli:measure></xbrli:unit><xbrli:context id="i83583bb4d9614c5fa83041c913ae479e_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97b0337408f4e61a2e9c5103e016421_I20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e30da8843dc43c9ad33ff55a33b1d77_D20220503-20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4662a32533444a67872a829f9f186342_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1ba0d32bc5422d928acee1595764cd_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3baef44f3b9f46039f19cbc1c9ac553f_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0753823b559c4b249d5e8a0ea960fe6e_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b2d108c832a4b15b42ef645fcac9c15_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic52a333760c648e4b96056ff25230e21_I20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c16ab737af40eb8c59705ef1b73c45_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272671062b484a64b905316d40d3ac81_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eeabc6ce6174d6d914bf4b541540d89_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71cd8720173a496486279e0544a6abce_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7cf3ce788524e9fb74bf1ade9cde623_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12913f42c838424a97ff6d451699968c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i4f2b5de2b7964c299fe4538bbce99201_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1569fe7f254494bbcf927a0376e97c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2743565c13d0440d9c782b3823bb2dbc_D20190225-20190225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-25</xbrli:startDate><xbrli:endDate>2019-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987dad20a95b4cbdb8b7627a6eaa19cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>mck:complaint</xbrli:measure></xbrli:unit><xbrli:context id="i9fa583f3ec4d43c39a9e06debe72ee55_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="relator"><xbrli:measure>mck:relator</xbrli:measure></xbrli:unit><xbrli:context id="i66664fd861c54faf85787d6861f4bd01_I20201023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a7e381cd664bfead2365a491df4db8_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i349cf2789de1486e908e9763803d4227_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14a8cc9bca31458291c36a5f215ed0bb_I20190813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="faxnumber"><xbrli:measure>mck:faxNumber</xbrli:measure></xbrli:unit><xbrli:unit id="fax"><xbrli:measure>mck:fax</xbrli:measure></xbrli:unit><xbrli:context id="ia7b18f283c214a63941ca5f3aa2f1ba3_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1141187871d64de6b18824ede60c2f14_D20130416-20130416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-04-16</xbrli:startDate><xbrli:endDate>2013-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:unit id="defendant"><xbrli:measure>mck:defendant</xbrli:measure></xbrli:unit><xbrli:context id="i14ac6ad34bca4c4691038eca05b20788_D20180403-20180403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-03</xbrli:startDate><xbrli:endDate>2018-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272a1d83ed104933bc5777159d6a279b_I20180403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="city"><xbrli:measure>mck:city</xbrli:measure></xbrli:unit><xbrli:context id="i3ca99d687e7a44bf9addf006fbd8fc6c_I20181212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="officer"><xbrli:measure>mck:officer</xbrli:measure></xbrli:unit><xbrli:context id="i7c871b75f43643cab2812bfd524754ec_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ad0b32109f349168507a51c296e9f4a_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e8e9b14a1e24dbd9dd4da9e2e12f251_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ConsolidatedActionsvSureScriptsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85d07627aee4db8896b725c019fcc18_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72b34df8ae41427db43c35ab86ae900b_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="softwareproduct"><xbrli:measure>mck:softwareProduct</xbrli:measure></xbrli:unit><xbrli:context id="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0191e84fbf046f1bf6fa863cb4e56bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>mck:site</xbrli:measure></xbrli:unit><xbrli:context id="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="ic33eab4418d04068bfb2c3d091c51f4a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6786f86e4c4e6d8af02b607fd8f48b_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c08dc9e360548f496960579d4795f54_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c6e70168da414cb0ac4e9c64318d06_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5d39fcc93f468db79dbc8f03cfc331_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b7452f966eb4322aa52d896f745263f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38e0059bd2b14949ab11b259c08962df_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8ce6232f2024c3c85f71080415b78ce_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e181f7f03474d17a658711503e83555_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af057e14a6c4a569ffbf7f13a871e72_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c6f6a5ff29462b9d28c777bd2bd274_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ad4ab28ad0e4703b8f21cbc668994aa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa805c2e2cb74e2fb138905ae2d6aeb5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341fc51538c24926bae5c478238735ef_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85cd2ff97d53454f89e0a9769c6b9cdc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a18c76ff5b34fad9b94fc6bc03eeab7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec5e0ac198fc4744ac896c1d7596fdf5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icda474b56c3e4aa1a24ed971c975e0f8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd07866af62b438392a2793d370d5438_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5deabb24d12941e896a4e688121d8f30_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9922f80e4f24738b404cca8c87f73bd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fff78ca4ca84ca68f9917ec5e4784fe_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93e1536edc94513a25b75692a412434_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073988a4a0ef43228b2f01d389f330b2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbf8232e206747f2be913302ec5dbaaf_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia70ab04be4fc4669bf6269d283c9c79e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91df3cbe60584b50a204d33eeeed8980_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9c8554b2fb4c5fbdc95411f1908eac_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2b0cbe0ef24d20b15b7f972083020e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i887ec05b39874d2c8d43dc5b0c6812aa_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df6b8d2453344e9a3d64c0a536c0e26_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0992fb1791f946ecaadfede91d31d6cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:context id="i5cf29ddb5c8f42deb929d1d83dbc572f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e9915b20bd46ef92252fc1f54b6842_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4014e9c3176b42c78989359017baa154_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7babc476db874b4b8550fefdfe333525_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b1bc5bf2b154cf2933d838b8ed000b3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c2308bff3d84467bbd32719c1b729f3_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4306427a0c8f4e4f9a6abfe8b834d477_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf1fc43ee8743cc841ae8e190b19f5e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d32ea0d7121424d8050da60bae6313b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02266411b5ae476685c7f46474a2bc26_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a61358af12d408d98a32edf22828df2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57862e2d41134adab208bb4e37e2f526_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i421693f2ac6f4634892f8037573c7473_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98dde87c16b848c5b435a117b3bcaa0b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia363f8f9a4de48ca805cfea21f6c1846_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38c0b8cc6cdd4e5a87c08c8347fa83db_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb4a025d54cc4e119f9bdcce62a65384_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4f92dd395054c9e87369fe7c7e30c52_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3667722556cc48a986ac133abdb684ef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ded543679294c96804c2f7f25ea7ef1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40175ec1fccc491fb2cbcd0cf1e19dc5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41829b0d50c84e67810fffe88435a9df_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0016a42d06144f0083c43e8c3861007f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief597acca9b943b499ca2cd3b523d72a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i985cb718c86e4ef0866b20d0c5f9ba59_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f4961dbfe344bc8e2f41bae9d5131f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedade147b8b646c8b00bbb5188244496_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c1bd212c45448698e1854f6e5f1080_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48eb2bbbe76d4424947b05d6ff6b3111_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if99beb6352cf47479de57c9883cab9b5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f4dc77fae347c3949ca450f0bd6c27_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib560e861e6d44cc1bc5d64c84ed65be5_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14b84c6208fd487782c55ab942c054c2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13224b1cb34e43ea9f7419286f4e4d8a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32eb06e34414e3699858d846e951a74_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_1"></div><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgw_3452fba0-26e0-4cc7-a442-ff94dfecf3da">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:472.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6ZmQyOWVjOTlmMDY1NDRmNGFkOTJjZjYzNWY0MWNkOWQvdGFibGVyYW5nZTpmZDI5ZWM5OWYwNjU0NGY0YWQ5MmNmNjM1ZjQxY2Q5ZF8wLTAtMS0xLTY3NTEy_64e0d364-0ba7-4430-a387-5c2ff97538ab">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended March 31, 2022</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:472.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6NjNhYTNkZGQ3ZTNiNDllN2EyNjc5ZGEwODAyMTRiZTEvdGFibGVyYW5nZTo2M2FhM2RkZDdlM2I0OWU3YTI2NzlkYTA4MDIxNGJlMV8wLTAtMS0xLTY3NTEy_64f8a5fc-1660-454b-b2dc-bc866543a132">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTkx_781f42d9-6045-422f-82f7-76b6880851f1">1-13252</ix:nonNumeric></span></div><div style="text-align:center"><img src="mck-20220331_g1.jpg" alt="mck-20220331_g1.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgy_2de66835-c278-4759-b3d7-9d17b2ac4d71">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.898%"><tr><td style="width:1.0%"></td><td style="width:50.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6NDFlNTllZGFlMmU0NDAxY2I3YTFkOGI5NjgyMjg4NjQvdGFibGVyYW5nZTo0MWU1OWVkYWUyZTQ0MDFjYjdhMWQ4Yjk2ODIyODg2NF8wLTAtMS0xLTY3NTEy_165aac78-846a-41fb-8981-6936348dab1d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6NDFlNTllZGFlMmU0NDAxY2I3YTFkOGI5NjgyMjg4NjQvdGFibGVyYW5nZTo0MWU1OWVkYWUyZTQ0MDFjYjdhMWQ4Yjk2ODIyODg2NF8wLTItMS0xLTY3NTEy_c26217d9-6d7e-4997-abec-6762e2cc8c07">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTky_61c840c2-a142-4b1c-b969-51ffe9e08885">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTkz_166632e9-6960-4be4-b7eb-17ca45b65aeb">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTk0_cefe9836-d3ca-4639-9d01-409581634d2c">TX</ix:nonNumeric> <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg2_c0dbbdc5-8103-480a-8df2-a34b6fc0d497">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg3_3d3bf180-c289-4186-bfa8-8a18808d7074">972</ix:nonNumeric>) <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgz_849606aa-b5a0-4b9a-87ba-0308cee47bef">446-4800</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8xLTAtMS0xLTY3NTEy_65bf1773-e530-443a-8315-06e4259acd3b">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8xLTEtMS0xLTY3NTEy_c0f27736-5048-437b-923d-cf4df0b7833e">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8xLTItMS0xLTY3NTEy_5aaed74e-e153-485f-90c1-d37f85672b93">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8zLTAtMS0xLTY3NTEy_bceaba6c-9529-476d-b106-b456cb129aa1">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8zLTEtMS0xLTY3NTEy_213de9d0-9ebf-4833-be48-19b5020b2465">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8zLTItMS0xLTY3NTEy_2a38097e-e7d1-42a1-ba00-aca8137ac02b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF80LTAtMS0xLTY3NTEy_f3b9cd6e-bc86-489b-9c37-4589a12dba52">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF80LTEtMS0xLTY3NTEy_b05c00a6-420c-44d8-9b5d-b282109ab105">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF80LTItMS0xLTY3NTEy_9f08e4e6-5c4f-4ee3-a0f4-4ef9b2e0fe60">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF81LTAtMS0xLTY3NTEy_97b7b546-7457-42b9-a40e-1fc9513dc132">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF81LTEtMS0xLTY3NTEy_75d3421b-b607-49e6-bb29-b84a0a890e4a">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF81LTItMS0xLTY3NTEy_60586485-a18a-4e7f-967e-f010cc645c21">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities&#160;Act.&#160; <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgx_8ab2d9a7-e963-4476-952a-a6cc94f13a91">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the&#160;Act.&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg4_c94fde65-b260-4799-80eb-193375cf429c">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg5_14fe1338-927f-4165-abba-612406e815ae">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg0_cd4b31bd-5105-4ad1-9c38-c2a94260c73a">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:199.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:195.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6OTQzZDNlYTc1NzAwNDI5Yzk5MTZkNmUzNTMwYjQ0N2MvdGFibGVyYW5nZTo5NDNkM2VhNzU3MDA0MjljOTkxNmQ2ZTM1MzBiNDQ3Y18wLTAtMS0xLTY3NTEy_48e02f68-489e-4a1f-b22b-85edf9605e0b">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6OTQzZDNlYTc1NzAwNDI5Yzk5MTZkNmUzNTMwYjQ0N2MvdGFibGVyYW5nZTo5NDNkM2VhNzU3MDA0MjljOTkxNmQ2ZTM1MzBiNDQ3Y18xLTYtMS0xLTY3NTEy_9dd0a7d4-ea0a-4159-9dbf-31c193acb4e1">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6OTQzZDNlYTc1NzAwNDI5Yzk5MTZkNmUzNTMwYjQ0N2MvdGFibGVyYW5nZTo5NDNkM2VhNzU3MDA0MjljOTkxNmQ2ZTM1MzBiNDQ3Y18yLTYtMS0xLTY3NTEy_50556989-4979-4220-a572-d39f56a0aa47">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg1_8de452cc-d218-4be1-9030-8798524e1634">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTk1_b8de0133-ec03-42f9-ad11-ccfe68c3d250">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the closing price as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter, September 30, 2021, was approximately $<ix:nonFraction unitRef="usd" contextRef="i7e45aeb91b9541c99e6059f70915b672_I20210930" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8xNjQ5MjY3NDQ1MjE5_adbe7b67-77fc-422a-9d99-9c44848428a4">30.4</ix:nonFraction> billion.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares of common stock outstanding on April 29, 2022: <ix:nonFraction unitRef="shares" contextRef="i67fe817fe4174122acfb22089bd77bb2_I20220429" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8xNjQ5MjY3NDQ1MjI5_d7d62342-a579-4ac4-96cc-2d7cbadb0c30">145,365,324</ix:nonFraction></span></div><div style="margin-bottom:2pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTkw_210faaad-e2ef-4e4f-9b12-6462feac8715" continuedAt="i045d5e0488ad42c484d355335ba7c94c" escape="true">DOCUMENTS INCORPORATED BY REFERENCE</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i045d5e0488ad42c484d355335ba7c94c">Portions of the registrant&#8217;s Proxy Statement for its 2022 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</ix:continuation></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_13">3</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_16">14</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_19">26</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_22">26</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_25">26</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_28">27</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_31">Information about our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_31">28</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_34">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_37">Market for the Registrant's Common Equity, Related Stockholder Matters</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_37">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_37"> and </a></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_37">Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_37">29</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_40">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_40">31</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">32</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_79">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_79">61</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">63</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_178">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_178">137</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_181">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_181">137</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_184">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_184">137</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_1968">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_1968">137</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_187">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_190">Directors, Executive Officers</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_190">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_190"> and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_190">137</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_193">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_193">138</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_196">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_196">138</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_199">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_199">140</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_202">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_202">140</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_205">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_208">Exhibits and Financial Statement Schedule</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_208">141</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_217">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_217">147</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_220">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_220">148</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_10"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_13"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Business.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (&#8220;McKesson,&#8221; the &#8220;Company,&#8221; or &#8220;we,&#8221; and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this document to a particular year refers to the Company&#8217;s fiscal year. The Company was incorporated on July 7, 1994 in the State of Delaware.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), are available free of charge on the Company&#8217;s website (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.mckesson.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the &#8220;Investors &#8212; Financials &#8212; SEC Filings&#8221; caption) as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission (&#8220;SEC&#8221; or the &#8220;Commission&#8221;). The content on any website referred to in this Annual Report on Form 10-K (&#8220;Annual Report&#8221;) is not incorporated by reference into this report, unless expressly noted otherwise. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers, including the Company, that file electronically with the SEC. The address of the website is </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company operates its business in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter (&#8220;OTC&#8221;) pharmaceutical drugs, and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Prescription Technology Solutions segment serves our biopharma and life sciences partners and patients. RxTS addresses medication challenges for patients throughout their journeys by working across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions as well as dispensing support services, third-party logistics and wholesale distribution support designed to benefit stakeholders. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. We offer more than 285,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the United States (&#8220;U.S.&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our International segment provides distribution and services to wholesale, institutional, and retail customers in 11 European countries and Canada where we own, partner or franchise with retail pharmacies, and support better, safer patient care by delivering vital medicines, supplies, and information technology solutions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Pharmaceutical Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and OTC pharmaceutical drugs along with other healthcare-related products to customers. This business provides solutions and services to pharmacies, hospitals, oncology and other specialty practices, pharmaceutical manufacturers, biopharma partners, physicians, payers, and patients throughout the U.S. and Puerto Rico. We also source generic pharmaceutical drugs through our ClarusONE Sourcing Services LLP joint venture with Walmart (&#8220;ClarusONE&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment operates and serves customers through a network of 29 distribution centers, including two strategic redistribution centers. We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability. For example, we offer McKesson Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality. We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maximize distribution efficiency and effectiveness, we follow the Six Sigma methodology, which is an analytical approach that emphasizes setting high-quality objectives, collecting data, and analyzing results to a fine degree in order to improve processes, reduce costs, and enhance service accuracy and safety. We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals. We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four primary customer pharmaceutical distribution channels: (i) retail national accounts, which include national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers, (ii) community pharmacies and health (formerly described as independent, small, and medium chain retail pharmacies), (iii) institutional healthcare providers such as hospitals, health systems, integrated delivery networks, and long-term care providers, and (iv) oncology, biopharma, and other specialty partners.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail National Accounts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide business solutions that help retail national account customers increase revenues and profitability. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Central Fill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Prescription refill service that enables pharmacies to more quickly refill prescriptions remotely, more accurately, and at a lower cost, while reducing inventory levels and improving customer service.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strategic Redistribution Centers - Two facilities totaling over 740,000 square feet that offer access to inventory for single source warehouse purchasing, including pharmaceuticals and biologics. These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson SynerGx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Generic pharmaceutical purchasing program and inventory management that helps pharmacies maximize their cost savings with a broad selection of generic drugs, competitive pricing, and one-stop shopping.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inventory Management - An integrated solution comprising forecasting software and automated replenishment technologies that reduce inventory-carrying costs.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ExpressRx Track&#8482; - Pharmacy automation solution featuring state-of-the-art robotics, upgraded imaging, and expanded vial capabilities, and industry-leading speed and accuracy in a small footprint. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Community Pharmacy and Health: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide managed care contracting, branding and advertising, merchandising, purchasing, operational efficiency, and automation that help community pharmacists focus on patient care while improving profitability. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - A national network of approximately 4,700 independently-owned pharmacies and one of the industry&#8217;s most comprehensive pharmacy franchise programs. Health Mart provides franchisees support for managed care contracting, branding and local marketing solutions, the Health Mart private label line of products, merchandising solutions, and programs for enhanced patient support.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart Atlas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Comprehensive managed care and reconciliation assistance services that help community pharmacies save time, access competitive reimbursement rates, and improve cash flow.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Reimbursement Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;MRA&#8221;) - MRA is one of the industry&#8217;s most comprehensive reimbursement optimization packages, comprising financial services (automated claim resubmission), analytic services, and customer care.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson OneStop Generics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Generic pharmaceutical purchasing program that helps pharmacies maximize their cost savings with a broad selection of generic drugs, competitive pricing, and one-stop shopping.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart and Sunmark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Complete line of products that provide community pharmacies with value-priced alternatives to national brands.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FrontEdge&#8482; - Strategic planning, merchandising, and price maintenance program that helps community pharmacies maximize store profitability.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson RxOwnership Program - Assist independent pharmacist owners with the opportunity to remain independent via succession planning and business operation loans.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart Digital Portfolio - Introducing an enhanced online experience for pharmacies and patients.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Institutional Healthcare Providers:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At McKesson, we are relentless in our pursuit of opportunities to achieve operational efficiency, reduce waste, and improve the financial performance of our customers so they can achieve more of their goals today and into the future. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">RxO Advisory Services &#8211; A suite of supply chain management, pharmacy optimization, and 340B program advisory services.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Plasma and Biologics &#8211; A robust portfolio of plasma-derivatives and biologic products.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Outpatient and Specialty Pharmacy &#8211; A portfolio of services and solutions customized to each customer&#8217;s business and clinical strategy.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contracting and Contract/Purchasing Optimization &#8211; Solutions across generics, specialty, branded products, biosimilars, and 340B products, for inpatient and outpatient settings. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Supply Assurance &#8211; Solutions and strategies to enhance product availability and proactively manage inventory of critical items. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patient Assistance Solutions &#8211; Solutions and resources for patient financial assistance and community benefit programs. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology, Biopharma, and Other Specialty Partners:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment provides a range of solutions to oncology and other specialty practices and offers community specialists (oncologists, rheumatologists, ophthalmologists, urologists, neurologists, and other specialists) an extensive set of customizable products and services designed to strengthen core practice operations, enhance value-based care delivery, and expand their service offering to patients. Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs. Services in provider solutions include specialty drug distribution, group purchasing organizations (&#8220;GPO&#8221;) like Onmark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention&#8217;s (&#8220;CDC&#8221;) Vaccines for Children program. Additionally, to support the U.S. efforts to fight the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), this segment has been distributing certain COVID-19 vaccines since December 2020 at the direction of the U.S. government. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This business provides a variety of solutions, including practice operations, healthcare information technology, revenue cycle management and managed care contracting solutions, evidence-based guidelines, and quality measurements to support U.S. Oncology Network (&#8220;USON&#8221;), one of the nation&#8217;s largest networks of physician-led, integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. We also support U.S. Oncology Research, one of the nation&#8217;s largest research networks, specializing in oncology clinical trials.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment includes our Ontada business, providing software to support the clinical, financial, and operational needs of our oncology practice partners. Ontada also partners with oncology providers and biopharma partners to perform real-world evidence studies, retrospective research, and to provide clinical data insights, advisory solutions and education opportunities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment also offers solutions which enable its customers to drive greater efficiencies in their day to day operations, effectively managing their inventories and complying with complex government regulations. Solutions include McKesson Pharmacy Systems, MacroHelix, and Supply Logix, all of which provide innovative software technology and services that support retail pharmacies and hospitals.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we discuss specialty products or services, we consider the following factors: diseases requiring complex treatment regimens such as cancer and rheumatoid arthritis; plasma and biologics products; ongoing clinical monitoring requirements, high-cost, special handling, storage, and delivery requirements and, in some cases, exclusive distribution arrangements. Our use of the term &#8220;specialty&#8221; may not be comparable to that used by other industry participants, including our competitors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prescription Technology Solutions Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Prescription Technology Solutions segment works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver medication access and adherence solutions that support patients from first prescription fill to ongoing therapy, regardless of their insurance coverage. RxTS has connections with most electronic health record systems, over 50,000 pharmacies, more than 750,000 providers, most payers and pharmacy benefit managers, and over 650 biopharma brands representing most therapeutic areas. Through its industry connections and ability to navigate the healthcare ecosystem, RxTS accelerates innovative solutions created to benefit healthcare stakeholders. Its comprehensive solution suites span across the entire patient journey, including medication access and affordability, prescription decision support and dispensing support services, as well as third-party logistics and wholesale distribution support, to help increase speed to therapy, reduce prescription abandonment, and support improved health outcomes for the patient. In the past year, RxTS helped patients save more than $6 billion on brand and specialty medications, helped to prevent more than 9 million prescriptions from being abandoned due to affordability challenges, and helped patients access their medicine more than 67 million times.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical-Surgical Solutions Segment: </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment delivers medical-supply distribution, logistics, biomedical maintenance, and other services to healthcare providers across the alternate-site spectrum. Our more than 275,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and home health agencies. We partner with manufacturers and channel partners to support our key target end-markets, including primary care, extended care, government, and other markets. We distribute medical-surgical supplies (such as gloves, needles, syringes, and wound care products), infusion pumps, laboratory equipment, and pharmaceuticals. Through a network of distribution centers within the U.S., we offer more than 285,000 products from national brand manufacturers and McKesson&#8217;s own brand of high-quality products. Through the right mix of products and services, we help improve efficiencies, profitability, and compliance. We also never lose focus on helping customers improve patient and business outcomes. We develop customized plans to address the product, operational, and clinical support needs of our customers, including tackling inventory management, reducing administrative burdens, and training and educating clinical staff. We deliver for our customers, so they can deliver and care for their patients. Additionally, under contracts with the Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer, Inc., McKesson&#8217;s Medical-Surgical business leverages its expertise to manage the assembly, storage, and distribution of supply kits needed to administer COVID-19 vaccines, as well as some of the sourcing of those supplies. The kits are produced and distributed at the direction of HHS to support the administration of all COVID-19 vaccines approved in the U.S. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our International segment provides distribution and services to wholesale, institutional, and retail customers in 11 European countries where we own, partner, or franchise with retail pharmacies and operate through two businesses: Pharmaceutical Distribution and Retail Pharmacy. Our operations in Canada support better, safer patient care by delivering vital medicines, supplies, and information technology solutions to customers, and through several retail health and wellness brands, across Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our European Pharmaceutical Distribution business delivers pharmaceutical and other healthcare-related products to pharmacies across Europe. This business functions as a vital link, using technology-enabled management systems at our regional wholesale branches to connect manufacturers to retail pharmacies, supplying medicines and other products sold in pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our European Retail Pharmacy business serves patients and consumers in European countries directly through approximately 2,000 of our own pharmacies and 4,800 participant pharmacies operating under brand partnership arrangements. This business provides customers with traditional prescription pharmaceuticals, non-prescription products, and medical services, as well as e-commerce operating under the Lloyds pharmacy branding in Belgium, Ireland, and Italy. In addition, we partner with independent pharmacies under local banner programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022, we announced our intention to exit our businesses in Europe. We entered into an agreement to sell certain of our businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;). We also completed the sale of our Austrian business. On April 6, 2022, we completed the sale of our retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;). Of the owned and banner pharmacies referenced above, all except for approximately 300 owned and 100 partner pharmacies are included within these disposal groups. In executing our strategy to exit Europe, we continue to evaluate suitable exit alternatives for our remaining businesses in Norway and Denmark. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for additional information on our European divestiture activities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada is one of the largest pharmaceutical wholesale and retail distributors in Canada. The wholesale business delivers products to retail pharmacies, hospitals, long-term care centers, clinics and institutions in Canada through a national network of distribution centers and provides logistics and distribution services for manufacturers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond wholesale pharmaceutical logistics and distribution, McKesson Canada provides automation and technology solutions to its retail and hospital customers. Additionally, McKesson Canada provides comprehensive specialty health services to Canadians, including a national network of specialty pharmacies, personalized patient care and support programs, and INVIVA, Canada&#8217;s first and largest accredited network of private infusion clinics. McKesson Canada also owns and operates PDCI, Canada&#8217;s leading market access consultancy, supporting manufacturers as they introduce new products into the Canadian market.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Canada retail business includes over 2,700 banner pharmacies under the IDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Guardian</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, The Medicine Shoppe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Remedy&#8217;sRx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Proxim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Uniprix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> banners, and approximately 400 owned pharmacies under the Rexall</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels. McKesson Canada also owns and operates Well.ca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a leading Canadian online health and wellness retailer.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change Healthcare: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity ownership interest in the Change Healthcare JV, a joint venture, was accounted for using the equity method of accounting. The Change Healthcare JV provided software and analytics, network solutions, and technology-enabled services that deliver wide-ranging financial, operational, and clinical benefits to payers, providers and consumers. On March&#160;10, 2020, we completed the separation of our interest in the Change Healthcare JV through a split-off transaction. This transaction reduced our investment in the Change Healthcare JV to zero. Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information related to this transaction.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring, Business Combinations, Investments, and Divestitures </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have undertaken additional strategic initiatives in recent years designed to further focus on our core healthcare businesses and enhance our competitive position. These initiatives are detailed in Financial Notes 2, 3, and 4, &#8220;Held for Sale,&#8221; &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; and &#8220;Business Acquisitions and Divestitures,&#8221; respectively, to the consolidated financial statements included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in highly competitive environments, primarily in North America and Europe. In recent years, the healthcare industry has been subject to increasing consolidation. In the pharmaceutical distribution environment in which our U.S. Pharmaceutical and International segments operate, we face strong competition from international, national, regional, and local full-line, short-line, and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations. We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc. Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local retailers, including chain and independent pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our RxTS business experiences substantial competition from many companies, including other biopharma services companies, software services firms, consulting firms, shared service vendors, and internet-based companies with technology applicable to the healthcare industry. Competition in this business varies in size from large to small companies, in geographical coverage, and in scope and breadth of products and services offered.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, home health care agencies, and other alternative sites with competition from a wide range of national and regional medical supply and equipment distributors throughout the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we compete with other service providers and healthcare manufacturers, as well as other potential customers of our businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses. We believe that our scale and diversity of product and service offerings are our primary competitive advantages. In all areas, key competitive factors include price, quality of service, breadth of product lines, innovation and, in some cases, convenience to the customer. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents, Trademarks, Copyrights, and Licenses</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson and its subsidiaries hold patents, copyrights, trademarks, and trade secrets related to McKesson products and services. We pursue patent protection for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous. Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide. In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, in the aggregate, McKesson&#8217;s confidential information, patents, copyrights, trademarks, and intellectual property licenses are important to its operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same. We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers. We periodically receive notices alleging that our products or services infringe on third-party patents and other intellectual property rights. These claims may result in McKesson entering settlement agreements, paying damages, discontinuing use or sale of accused products, or ceasing other activities. While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson&#8217;s products or services. While it may be necessary in the future to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice, such licenses generally can be obtained on commercially reasonable terms. We believe our operations as well as our products and services are not materially dependent on any single license or other agreement with any third party.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our vision for a healthier world begins with our employees, who bring our mission to life every day. We deliver programs that focus on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential. At March 31, 2022, we had approximately 75,000 employees worldwide, including 17,000 part-time employees, as well as 33,000 employees in the U.S. and 13,000 employees in Canada. We also supplement our work force with contractors and/or consultants for certain business projects, processes, and/or operations as demand requires, including for programs such as the COVID-19 vaccine distribution and related ancillary supply kit programs. During 2022, we entered into an agreement to sell the E.U. disposal group which is expected to close within the second half of fiscal year 2023 and completed the sale of our Austrian business. On April 6, 2022, we completed the sale of the U.K. disposal group. At March 31, 2022, we had approximately 29,000 employees in Europe, including 11,000 part-time employees, the majority of whom we expect will be transferred with the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for additional information on our European divestiture activities. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity, and Inclusion (&#8220;DEI&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are committed to making the principles of DEI integral to everything we do because we believe building a healthier future is everyone&#8217;s business. We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion and belonging as an important element that drives long-term shareholder value. We have 10 employee resource groups (&#8220;ERGs&#8221;) that are voluntary, employee-led, company-sponsored groups that focus on making a difference among our U.S. employees. ERGs can help employees make authentic connections, showcase leadership skills, and create a positive impact.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, women and people of color represented the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">McKesson<br/> Overall</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">McKesson </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leadership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Metric </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">People of Color </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) (5)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The data for our metrics is derived from our voluntary self-identification process as of March 31, 2022 and therefore represents our best estimate at this time. For fiscal year 2021, our metrics did not include our employees related to USON as the data was not available. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents our leadership at the vice president level and above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents worldwide employees. In North America, women represent 60% of &#8220;McKesson Overall&#8221; and 48% of &#8220;McKesson Leadership.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents U.S. employees only because the data for Canada and Europe is not available.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">People of Color includes the following races and ethnicities: American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian or Other Pacific Islander, or Two or More Races.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Culture and Leadership:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> What sets McKesson apart as an exceptional place is our people. Our employees understand that together, unified by our global I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CARE and ILEAD principles, we fulfill our mission of improving care in every setting. Our I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company. ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition of and shared commitment to leadership. By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health &#8211; for our company, our customers, and the patients they serve &#8211; for years to come. We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments. These values and behaviors help make McKesson unique.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Employees: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support employee growth and development, we provide regular feedback and training, and work to create and maintain an inclusive environment where everyone can bring their authentic self to work and know they are appreciated, with their perspectives heard and considered. Through training, we encourage leaders to embrace diverse perspectives and lead inclusively. Employee development programs include training, coaching, and 360-degree assessments, which can support the careers of future leaders and their teams. We offer financial assistance programs for higher education opportunities that support employees&#8217; career growth at the company. To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal equity, market competitiveness, and pay for performance. We operate in several countries and our benefits offerings vary accordingly. We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other offerings, when possible. We seek employee feedback through an annual employee opinion survey, which assesses our employees&#8217; levels of engagement, commitment, and overall satisfaction using industry benchmarks, and we then design action plans to improve those metrics.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As broader U.S. labor markets continue to be challenging and evolving, we continue our dedication to recruiting and retaining qualified employees across the organization. During 2022, we committed to increasing base pay and providing long-term incentive awards for certain markets and job classes as necessary to retain top talent. We also made investments in our talent acquisition team by adding recruiters, systems, and process improvements to strengthen our ability to attract employees and reduce the lead time to fill open positions as well as improve our employee value proposition. In response to the COVID-19 pandemic, we offer medical benefits covering COVID-19 related visits, testing (including over-the-counter tests), treatment and vaccines, telehealth options, and emergency paid time off (&#8220;PTO&#8221;). During the first quarter of 2022, we approved changes to our real estate strategy to increase efficiencies and support flexibility for our employees, as discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report. Our North American future of work approach is based on four pillars: best talent and co-location, flexibility, mobility, and a partial remote work model for certain employees.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Safety:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our security and safety departments employ systems designed to continually monitor our facilities and work environment to help identify and prevent or mitigate any potential risks. This includes having procedures in place and investing in equipment for both physical and electronic security. We routinely assess facilities to closely monitor adherence to established security and safety standards. If we identify a vulnerability, it is documented, and the facility prepares an action plan. Our employees receive specialized training related to their role, work setting, and equipment used in their work environment. As our processes evolve, we update relevant safety training modules, which may include new employee training programs. In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees, customers, patients, and communities while also safeguarding the healthcare supply chain. The various responses we put in place to mitigate the impact of COVID-19 on our business operations, including telecommuting and work-from-home policies, restricted travel, and enhanced safety measures, are intended to limit employee exposure to the virus that causes COVID-19 as they perform their jobs while also providing employee support programs and a sense of belonging. During 2022, we implemented COVID-19 vaccination protocols designed to be consistent with federal, state, and local laws and with customer requirements for our U.S. and Canada employees. For additional information on our response to COVID-19 in the workplace, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson, generally and in many of the highly regulated industries in which it operates, is subject to oversight by various federal, state, and local governmental entities in the U.S. and elsewhere. The Company incurs significant expense and makes large investments to enable it to comply with regulations and guidance promulgated by those governmental entities. A failure, or alleged failure, by the Company to comply with statutes, regulations, or other laws could have a material adverse impact to the Company&#8217;s business operations, reputation, results of operations, and financial and competitive position.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controlled Substances:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are subject to the operating and security standards of the U.S. Drug Enforcement Administration (&#8220;DEA&#8221;), the U.S. Food and Drug Administration (&#8220;FDA&#8221;), HHS, the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), various state boards of pharmacy, state health departments, and comparable agencies in the U.S. and other countries. We maintain extensive controlled substance monitoring and reporting programs at considerable expense in order to help us meet those standards. We have incurred monetary penalties and licensing sanctions pursuant to these requirements and future allegations of noncompliance could result in our inability to obtain, maintain, or renew permits, licenses, or other regulatory approvals needed for the operation of our businesses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company is a defendant in many litigation matters alleging claims related to its distribution of controlled substances (opioids), including claims about regulatory compliance. On February 25, 2022, the Company and two other U.S. pharmaceutical distribution companies (collectively, "Distributors") determined that there is sufficient State and subdivision participation to proceed with an agreement to settle a substantial majority of opioids-related lawsuits filed against the Distributors by U.S. states, territories, and local governmental entities. The Company incurs and expects to continue to incur significant expense in order to resolve those and other opioids-related matters. As part of that resolution, the Company will bear a portion of the expense to establish and maintain a clearinghouse for data related to distribution of controlled substance. For more information about those litigation matters, refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Contracts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with government entities typically are subject to procurement laws that include socio-economic, employment practices, environmental protection, recordkeeping and accounting, and other requirements. These statutory and regulatory requirements complicate our business and increase our compliance burden. We are subject to audits, investigations and oversight proceedings about our compliance with contractual and legal requirements. If we fail to comply with these requirements, or we fail an audit, we may be subject to sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local governmental entities in the U.S. and elsewhere continue to strengthen their position and scrutiny of practices that may indicate fraud, waste, and abuse affecting government healthcare programs such as Medicare and Medicaid. Our relationships with pharmaceutical and medical surgical product manufacturers, healthcare providers, and other companies and individuals, as well as our provision of products and services to government entities, subject our business to statutes, regulations, and government guidance that are intended to prevent fraud and abuse. Many of these laws are vague or indefinite and have not been interpreted by the courts and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations at added expense. Failure to comply with these laws, including the federal Anti-Kickback Statute, could subject us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and other federal and state healthcare programs, or pursue government contracts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Patient Protection and Affordable Care Act (&#8220;ACA&#8221;) significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. There are also further efforts to broaden healthcare coverage. U.S. lawmakers also have explored proposals to reduce drug prices, including requiring greater price transparency, authorizing the federal government to negotiate prices for some drugs covered under the Medicare program, and drug importation measures. Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs. For example, provincial governments have taken steps to reduce consumer prices for generic pharmaceuticals and, in some provinces, change professional allowances paid to pharmacists by generic manufacturers. Many European governments provide or subsidize healthcare to consumers and patients by regulating pharmaceutical prices, patient eligibility, or reimbursement levels to control government healthcare system costs. European governments are continuously reviewing measures to support the reduction of public healthcare spending. Such measures can exert pressure on pricing frameworks and reimbursement timelines for pharmaceuticals, which in turn may impact customer behavior. There is substantial uncertainty about the likelihood and timing of any healthcare policy reform as each E.U. country operates in a separate healthcare environment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the CMS issued a final rule pertaining to &#8220;Best Price&#8221; reporting requirements under the Medicaid Drug Rebate Program. Among other things, that rule may impact drug pricing and solutions to help patients afford their medications. This rule is subject to ongoing litigation. Unless the legal challenge to the rule is successful, the rule will likely become effective on January 1, 2023. There is substantial uncertainly about the likelihood, timing, and ultimate resolutions of these lawsuits.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, there have been increasing efforts by governments to regulate the pharmaceutical drug supply chain in order to prevent the introduction of counterfeit, stolen, contaminated, or otherwise harmful drugs into the pharmaceutical distribution system, otherwise known as pedigree tracking. For example, the U.S. Drug Quality and Security Act of 2013 (&#8220;DQSA&#8221;) requires us to participate in a federal prescription drug track and trace system that preempts state drug pedigree requirements, and the U.S. Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs. We also have record-keeping and other obligations under the E.U. Falsified Medicines Directive. Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Security and Privacy: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction. For example, under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) we must maintain administrative, physical, and technological safeguards to protect individually identifiable health information (&#8220;protected health information&#8221;) and ensure the confidentiality, integrity, and availability of electronic protected health information. We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (&#8220;GDPR&#8221;) in the European Union, the Personal Information Protection and Electronic Documents Act (&#8220;PIPEDA&#8221;) in Canada, and an expanding list of comprehensive state privacy laws in the United States, including the California Consumer Protection Act (&#8220;CCPA&#8221;). Some privacy laws prohibit the transfer of personal information to certain other jurisdictions or otherwise limit our use of data. Many of these laws also require us to provide access or other data rights (modification, deletion, portability, etc.) to consumers&#8217; and patients&#8217; individual personal data records within specified periods of time. Laws such as the federal Cyber Incident Reporting for Critical Infrastructure Act of 2022 may require us to provide notifications of significant data privacy breaches or cybersecurity incidents before our investigations are complete. We are subject to privacy and data protection compliance audits or investigations by various government agencies. Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, reputational impacts, and other costs. We also have contractual obligations that might be breached if we fail to comply with privacy and data security laws. Our efforts to comply with privacy and data security laws complicate our operations and add to our costs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to many environmental and hazardous materials regulations, including those relating to radiation-emitting equipment operated at U.S. Oncology Network practices. Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites, as discussed in more detail below. We could incur substantial costs, including cleanup costs, fines and civil or criminal sanctions, and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental laws. We are committed to maintaining compliance with all environmental laws applicable to our operations, products, and services and to reducing our environmental impact across all aspects of our business. We meet this commitment through an environmental strategy and sustainability program.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations. Agreements with the Environmental Protection Agency and certain states may require environmental assessments and cleanups at several closed sites. These matters are described further in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability for environmental remediation and other environmental costs is accrued when the Company considers it probable and can reasonably estimate the costs. Environmental costs and accruals, including that related to our legacy chemical distribution operations, are not material to our operations or financial position. Other than the expected expenditures that may be required in connection with our legacy chemical distribution operations, we do not anticipate making substantial capital expenditures either for environmental issues or to comply with environmental laws, regulations, or government guidance in the future.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Climate Change Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governments in the U.S. and abroad are considering new or expanded laws to address climate change. Such laws may include limitations on greenhouse gas (&#8220;GHG&#8221;) emissions, mandates that companies implement processes to monitor and disclose climate-related matters, additional taxes or offset charges on specified energy sources, and other requirements. Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions. New or expanded climate-related laws could impose costs on us, including capital expenditures to develop data gathering and reporting systems. Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures or our results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information about the Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During 2022, sales to our ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;) accounted for approximately 52% of our total consolidated revenues. Sales to our largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of our total consolidated revenues in 2022. In May 2019, we extended our pharmaceutical distribution relationship with CVS to June 2023. Our ten largest customers comprised approximately 43%, and CVS was approximately 28%, of total trade accounts receivable at March 31, 2022. We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. Substantially all of these revenues and accounts receivable are included in our U.S. Pharmaceutical segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Suppliers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than our largest supplier at 9% of our purchases in 2022. The loss of a supplier could adversely affect our business if alternate sources of supply are unavailable. We believe that our relationships with our suppliers are generally sound. The ten largest suppliers in 2022 accounted for approximately 55% of our purchases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our distribution arrangements with manufacturers provide us compensation based on a percentage of our purchases. In addition, we have certain distribution arrangements with pharmaceutical manufacturers that include an inflation-based compensation component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices. For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses were $70&#160;million, $74&#160;million, and $96&#160;million during 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Information About Foreign and Domestic Operations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain financial information relating to foreign and domestic operations is discussed in Financial Note 21, &#8220;Segments of Business,&#8221; to the consolidated financial statements included in this Annual Report as well as in &#8220;Foreign Operations&#8221; in Item 7 of Part II of this Annual Report. See &#8220;Risk Factors&#8221; in Item 1A of Part I below for information regarding risks associated with our foreign operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II of this report and the &#8220;Risk Factors&#8221; in Item 1A of Part I of this report, contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 (&#8220;Securities Act&#8221;) and section 21E of the Securities Exchange Act of 1934, as amended. Some of these statements can be identified by use of forward-looking words such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; or &#8220;estimates,&#8221; or the negative of these words, or other comparable terminology. The discussion of financial trends, strategy, plans, or intentions may also include forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under &#8220;Risk Factors&#8221; and in our publicly available SEC filings and press releases. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_16"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below identifies certain representative risks that might cause our actual business results to materially differ from our estimates. It is not practical to identify or describe all risks and uncertainties that might materially impact our business operations, reputation, financial position, or results of operations. Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial. This is not a complete statement of all potential risks and uncertainties.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation and Regulatory Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience costly and disruptive legal disputes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely named as a defendant in litigation or regulatory proceedings and other legal disputes, which may include asserted class action litigation, such as those described in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this Annual Report. Regulatory proceedings involve allegations such as false claims, healthcare fraud and abuse, and antitrust violations. Civil litigation proceedings involve commercial, employment, environmental, intellectual property, tort, and other claims. Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management and disruptive to normal business operations. The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter ultimately is favorably resolved. The outcome of legal disputes is difficult to predict. Outcomes can occur that are not justified by the evidence or existing law. Outcomes include monetary damages, penalties and fines, and injunctive or other relief that requires us to change our business operations and incur significant expense. Accordingly, legal disputes might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience losses not covered by insurance or indemnification.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to risks that are inherent in the distribution, manufacturing, dispensing and administration of pharmaceuticals and medical-surgical supplies, the provision of ancillary services, the conduct of our payer businesses and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans. For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs, and expiration of drugs. Although we seek to maintain adequate insurance coverage, such as property insurance for inventory and professional and general liability insurance, coverages on acceptable terms might be unavailable, or coverages might not cover our losses. We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability. Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience costly legal disputes, government actions, and adverse publicity regarding our role in distributing controlled substances such as opioids.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in many litigation matters alleging claims related to the distribution of controlled substances (opioids), as described in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this Annual Report. We regularly are named as a defendant in similar, new cases. The plaintiffs in those cases include governmental entities (such as states, provinces, counties, and municipalities) as well as businesses, groups and individuals. The cases allege violations of controlled substance laws and other laws, and they make common law claims such as negligence and public nuisance. Many of these cases raise novel theories of liability. Any proceedings can have unexpected outcomes that are not justified by evidence or existing law. Legal proceedings such as these often involve significant expense, management time and distraction, and risk of loss that can be difficult to predict or quantify. It is not uncommon for claims to be resolved over many years. Outcomes include monetary damages, penalties and fines, and injunctive or other relief that requires us to change our business operations and incur significant expense. Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome. Not all proceedings, however, are resolved by settlement. Our reputation has been and may continue to be impacted by publicity regarding the litigation and related allegations. The adverse outcome of legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience increased costs to distribute controlled substances such as opioids.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict. For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation. Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive, complex and challenging healthcare and other laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our industry is highly regulated, and further regulation of our distribution businesses and technology products and services could impose increased costs, negatively impact our profit margins and the profit margins of our customers, delay the introduction or implementation of our new products, or otherwise negatively impact our business and expose the Company to litigation and regulatory investigations. For example, we are subject to many environmental and hazardous materials regulations, including those relating to radiation-emitting equipment operated at U.S. Oncology Network practices. Additionally, we are subject to various routine agency and ad hoc inspections by government agencies to determine compliance with various statutes and regulations. Any noncompliance by us with applicable laws or the failure to maintain, renew or obtain necessary permits and licenses could lead to enforcement actions or litigation and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to extensive and frequently changing laws relating to healthcare fraud, waste and abuse.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, and local governmental entities in the U.S. and elsewhere continue to strengthen their position and scrutiny over practices that may indicate fraud, waste and abuse affecting government healthcare programs such as Medicare and Medicaid. Our relationships with companies and individuals including pharmaceutical and medical surgical product manufacturers and healthcare providers, as well as our provision of products and services to government entities, subject our business to statutes, regulations, or government guidance that are intended to prevent fraud, waste, and abuse. Among other things, those laws: (1) prohibit persons from soliciting, offering, receiving, or paying any remuneration in order to induce the referral of a patient for treatment or to induce the ordering or purchasing of items or services that are in any way paid for by Medicare, Medicaid, or other government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such as Medicare and Medicaid. Many of these laws, including those relating to marketing incentives, are vague or indefinite and have not been interpreted by the courts, regulators, or enforcing agencies. Those laws may be interpreted or applied in a manner that could require us to make changes in our operations at added expense. Failures to comply with those laws exposes us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties. Such failures might result in the loss of licenses or our ability to participate in Medicare, Medicaid or other federal and state healthcare programs. These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might lose our ability to purchase, compound, store or distribute pharmaceuticals and controlled substances.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the operating and security standards of the DEA, the FDA, various state boards of pharmacy, state health departments, the CMS, and other comparable agencies. Certain of our businesses may be required to register for permits and/or licenses with, and comply with operating and security standards of, the DEA, FDA, CMS, various state boards of pharmacy, state health departments and/or comparable state agencies as well as foreign agencies and certain accrediting bodies, depending upon the type of operations and location of product development, manufacture, distribution, and sale. For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards, and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances. Noncompliance with these requirements results in monetary penalties and/or licensing sanctions. If we are not able to obtain, maintain, or renew permits, licenses, or other regulatory approvals needed for the operation of our businesses, it might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy and data protection laws increase our compliance burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction. For example, under HIPAA we must maintain administrative, physical, and technological safeguards for protected health information and ensure the confidentiality, integrity, and availability of electronic protected health information. We are subject to significant compliance obligations under privacy laws such as the GDPR in the E.U., the PIPEDA in Canada, and an expanding list of comprehensive state privacy laws in the United States, including the CCPA in California. Some privacy laws prohibit the transfer of personal information to certain other jurisdictions or otherwise limit our use of data. Many of these laws also require us to provide access or other data rights (modification, deletion, portability, etc.) to consumers&#8217; and patients&#8217; individual personal data records within specified periods of time. Laws such as the federal Cyber Incident Reporting for Critical Infrastructure Act of 2022 may require us to provide notifications of significant data privacy breaches or cybersecurity incidents before our investigations are complete. We are subject to privacy and data protection compliance audits or investigations by various government agencies. Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, reputational impacts, and other costs. We also have contractual obligations that might be breached if we fail to comply with privacy and data security laws. Our efforts to comply with privacy laws complicates our operations and adds to our costs. A significant privacy breach or failure to comply with privacy and data security laws might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-bribery and anti-corruption laws increase our compliance burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws prohibiting improper payments and bribery, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar regulations in other jurisdictions. The U.K. Bribery Act, for example, prohibits both domestic and international bribery, as well as bribery across both private and public sectors. An organization that fails to prevent bribery committed by anyone associated with the organization can be charged under the U.K. Bribery Act unless the organization can establish the defense of having implemented adequate procedures to prevent bribery. Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, business operations and our financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company and Operational Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might record significant charges from impairment to goodwill, intangibles and other assets or investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required under U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) to test our goodwill for impairment annually or more frequently if indicators for potential impairment exist. Indicators that are considered include significant changes in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends, or a significant decline in the Company&#8217;s stock price and/or market capitalization for a sustained period of time. In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable. Factors that may be considered a change in circumstances indicating that the carrying value of our intangible and other long-lived assets may not be recoverable include slower growth rates, the loss of a significant customer, burdensome new laws or divestiture of a business or asset for less than its carrying value. There are inherent uncertainties in management&#8217;s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible, and other long-lived assets. Any material changes in key assumptions, including failure to meet business plans, negative changes in government reimbursement rates, a deterioration in the U.S. and global financial markets, an increase in interest rate or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may decrease the projected cash flows or increase the discount rates and could potentially result in an impairment charge. For example, the COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments and assumptions used in our forecasts and impairment assessments. We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, our external service providers, and other third parties with which we do business use technology and systems to perform our business operations, such as the secure electronic transmission, processing, storage and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company and workforce. Despite physical, technical, and administrative security measures, technology systems and operations of the Company and third parties with which we do business are subject to cyberattacks and cybersecurity incidents. Cybersecurity incidents include unauthorized occurrences on or conducted through our information systems, such as tampering, malware insertion, ransomware attacks, or other system integrity events. The risk of cyberattacks increases from time to time due to a variety of internal and external factors, including during political conflicts or unrest. A cybersecurity incident might involve a material data breach or other material impact to the confidentiality, integrity, availability, and operations of our technology systems or data, which might result in injury to patients or consumers, litigation or regulatory action, disruption of our business operations, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business, reputation, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience significant problems with information systems or networks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on sophisticated information systems and networks to perform our business operations, such as to obtain, rapidly process, analyze, and manage data that facilitate the purchase and distribution of thousands of inventory items from distribution centers. We provide remote services that involve hosting customer data and operating software on our own or third-party systems. Our customers rely on their ability to access and use these the systems and their data as needed. The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, software and hardware failures and cybersecurity incidents. If those information systems or networks suffer errors, interruptions, or become unavailable, or if the timely delivery of medical care or other customer business requirements are impaired by data access, network, or systems problems, we might experience injury to patients or consumers, litigation or regulatory action, disruption of our business operations, loss of customers or revenue, and increased expense. Any such problems might have a materially adverse impact on our business, reputation, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products or services might not conform to specifications or perform as we intend.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market. Healthcare professionals delivering patient care tend to have heightened sensitivity to system and software errors. If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients. Errors or failures might damage our reputation and negatively affect future sales. A failure of a system or software to conform to specifications might constitute a breach of warranty that could result in repair costs, contract termination, refunds of amounts previously paid, or claims for damages. Any of these types of errors or failures might have a materially adverse impact on our reputation, business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might not realize expected benefits from business process initiatives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may implement restructuring, cost reduction or other business process initiatives that might result in extraordinary charges and expenses, failures to achieve our desired objectives, or unintended consequences such as distraction of our management and employees, business disruption, attrition beyond any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be unable to successfully complete or integrate acquisitions or other business combinations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business. To fund acquisitions, we may require financing that may not be available on acceptable terms. We may not receive regulatory approvals needed to complete proposed transactions, or such approvals may be subject to delays or conditions that reduce transaction benefits. Achieving the desired outcomes of business combinations involves significant risks including: diverting management&#8217;s attention from other business operations; challenges with assimilating the acquired businesses, such as integration of operations and systems; failure or delay in realizing operating synergies; difficulty retaining key acquired company personnel; unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business. Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive forum provisions in our Bylaws could limit our stockholders&#8217; ability to choose their preferred judicial forum for disputes with us or our directors, officers or employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Court of Chancery of the State of Delaware or the United States District Court for the District of Delaware if the Court of Chancery does not have or declines to accept jurisdiction (collectively, &#8220;Delaware Courts&#8221;). Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action. These provisions of the bylaws are not a waiver of, and do not relieve anyone of duties to comply with, federal securities laws including those specifying the exclusive jurisdiction of federal courts under the Exchange Act and concurrent jurisdiction of federal and state courts under the Securities Act. To the extent that these provisions of the bylaws limit a current or former stockholder&#8217;s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses and might result in outcomes unfavorable to current or former stockholders. A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by delays or other difficulties with divestitures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our intention to exit our businesses in Europe. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying consolidated financial statements included in this Annual Report for information on our European divestiture activities. When we decide to sell assets or a business, we may encounter difficulty in finding buyers or exit strategies on acceptable terms or in a timely manner, which could delay the achievement of our strategic objectives. After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected. We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture. We might have financial exposure in a divested business, such as through minority equity ownership, financial or performance guarantees, indemnities or other obligations, such that conditions outside of our control might negate the expected benefits of the disposition. Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might not realize the expected tax treatment from our split-off of Change Healthcare.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed a separation of its interest in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;). The divestiture was effected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (the &#8220;Exchange Offer&#8221;), followed by a merger of SpinCo with and into Change Healthcare Inc. (&#8220;Change&#8221;), with Change surviving the merger (the &#8220;Merger&#8221; and, together with the Exchange Offer, the &#8220;Transactions&#8221;). The Company received an opinion from outside legal counsel to the effect that the Transactions qualified as generally tax-free transactions to the Company and its shareholders for U.S. federal income tax purposes. An opinion of legal counsel is not binding on the Internal Revenue Service (the &#8220;IRS&#8221;) or the courts, and the IRS or the courts may not agree with the intended tax-free treatment of the Transactions. In addition, the opinion could not be relied upon if certain assumptions, representations, and undertakings upon which the opinion was based are materially inaccurate or incomplete, or are violated in any material respect. If the intended tax-free treatment of the Transactions is not sustained, the Company and its stockholders who participated in the Transactions may be required to pay substantial U.S. federal income taxes. In connection with the Transactions, the Company, SpinCo, Change, and the Change Healthcare JV entered into the Tax Matters Agreement, which governs their respective rights, responsibilities, and obligations with respect to tax liabilities and benefits, tax attributes, tax contests, and other tax sharing regarding U.S. federal, state, and local, and non-U.S. taxes, other tax matters, and related tax returns. Under the Tax Matters Agreement, Change is required to indemnify the Company if the Transactions become taxable as a result of certain actions by Change or SpinCo, or as a result of certain changes in ownership of the stock of Change after the Merger. If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by outsourcing or similar third-party relationships.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to perform certain business and administrative functions for us. We might not adequately develop, implement and monitor these outsourced service providers, and we might not realize expected cost savings or other benefits. Third-party services providers might fail to perform as anticipated, or we might experience unanticipated operational difficulties, compliance requirements or increased costs related to outsourced services. For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in achieving our strategic growth objectives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy to become a diversified healthcare services company includes investing to build an integrated oncology service business and expand our biopharma services business. Our ability to grow those businesses will depend on our: hiring and retaining talented individuals with necessary knowledge and skills; acquiring, developing, and implementing new technologies and capabilities; forming and expanding business relationships; and successfully competing against providers of similar services. Some competitors have more experience than we do in enabling technologies such as data analytics. We may not achieve our desired return on our investments through our growth strategies. If we fail to achieve acceptable sales and profitability in our strategic growth areas, it might have a materially adverse impact on our business prospects and our financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy included expanding our retail pharmacy operations. Our retail pharmacy operations involve numerous risks, such as the following ones. We might encounter difficulties attracting and retaining customers to our retail locations due to their unfamiliarity with our brands or our inexperience with local market preferences. Competition from our retail pharmacy operations might strain relationships with our retail pharmacy customers. Consolidation of retail pharmacies with third-party payers, expansion of large retail pharmacy networks, reductions in reimbursement rates, shifts in the mix of branded and generic pharmaceutical sales, and exclusion from preferred pharmacy networks can impair our retail pharmacy sales and profitability. Failure to maintain profitable retail pharmacy operations may result in significant costs, including those associated with site closures and reductions in workforce. We incur long-lived asset impairments related to our retail pharmacy networks. If our retail pharmacy operations fail to achieve, or are unable to sustain, acceptable net sales and profitability levels, it might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be harmed by large customer purchase reductions, payment defaults or contract non-renewal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our revenue from, and have a significant portion of our accounts receivable with, a small number of customers. At March 31, 2022, sales to our largest customer represented approximately 21% of our consolidated revenues and approximately 28% of our trade receivables, and those of our ten largest customers combined accounted for approximately 52% of our consolidated revenues and approximately 43% of our trade receivables. A material default in payment, reduction in purchases, or the loss of business from a large customer might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our contracts with government entities involve future funding and compliance risks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with government entities are subject to risks such as lack of funding and compliance with unique requirements. For example, government contract purchase obligations are typically subject to the availability of funding, which may be eliminated or reduced. In addition, the future volume of products or services purchased by a government customer is often uncertain. Our government contracts might not be renewed or might be terminated for convenience with little prior notice. Government contracts typically expose us to higher potential liability than do other types of contracts. In addition, government contracts typically are subject to procurement laws that include socio-economic, employment practices, environmental protection, recordkeeping and accounting and other requirements. For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations. We are subject to government audits, investigations and oversight proceedings. Government agencies routinely review and audit government contractors to determine whether they are complying with contractual and legal requirements. If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts and suspension or debarment from government contract work. These requirements complicate our business and increase our compliance burden. The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate as a distributor in government-sponsored vaccination programs, such as the U.S. government&#8217;s COVID-19 distribution program (&#8220;Federal COVID-19 Response&#8221;). We also provide supplies used for vaccine administration in the Federal COVID-19 Response. Our participation in such programs exposes us to various uncertainties. For example, the novel nature and rapid mutation of the SARS-CoV&#8209;2 virus, the changing distribution scope of COVID-19 vaccines, supply chain stability, inflation, and the effectiveness of other COVID-19 transmission mitigation measures introduce uncertainty about what volumes of vaccines and related supplies may be distributed by us, the safety and efficacy of newly developed vaccines, and the cost of distribution. Because of such uncertainties, our operating results may be subject to variability. Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges. Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business. Because of these risks and uncertainties our operating results may be materially higher or lower than our projections.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We might be harmed by changes in our relationships or contracts with suppliers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to structure our pharmaceutical distribution agreements with manufacturers to ensure that we are appropriately and predictably compensated for the services we provide. Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our compensation, and we cannot control the frequency or magnitude of pharmaceutical price changes. We might be unable to renew pharmaceutical distribution agreements with manufacturers in a timely and favorable manner. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might infringe intellectual property rights or our intellectual property protections might be inadequate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our products and services do not infringe the proprietary rights of third parties, but third parties have asserted infringement claims against us and may do so in the future. If a court were to hold that we infringed other&#8217;s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions. We rely on trade secret, patent, copyright, and trademark laws, nondisclosure obligations, and other contractual provisions and technical measures to protect our proprietary rights in our products and solutions. We might initiate costly and time-consuming litigation to protect our trade secrets, to enforce our patent, copyright and trademark rights and to determine the scope and validity of the proprietary rights of others. Our intellectual property protection efforts might be inadequate to protect our rights. Our competitors might develop non-infringing products or services equivalent or superior to ours. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of third-party data is subject to limitations that could impede the growth of our data services business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to structure our diligence processes to satisfy contractual and other operative data usage rights and limitations associated with customer, partner, and other third-party data flowing through our businesses. These rights and limitations can apply to both confidential commercial data and personal data provided to us by these customers, partners, and other third parties. Failure to satisfy these data usage rights and limitations can lead to contractual breach and other legal claims or reputational impacts. If a court were to hold that we violated these contractual rights, we might be required to pay substantial damages; we may need to stop using, sharing, and/or selling certain products and services; or we could incur other financial, legal, and/or reputational consequences. In addition, in order to reach our data strategy growth objectives, we might be unable to obtain at an acceptable cost the data usage rights needed to advance such goals. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be unable to successfully recruit and retain qualified employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract, engage, develop, and retain qualified and experienced employees, including key executives and other talent, is essential for us to meet our objectives. We compete with many other businesses to attract and retain employees. Competition among potential employers results in increased salaries, benefits, or other employee-related costs, or in our failure to recruit and retain employees. We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles. Employees might not successfully transition into new roles. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry and Economic Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems. The healthcare industry and related government programs are changing. Some of these changes increase our risks and create uncertainties for our business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, some changes in reimbursement methodologies (including government rates) for pharmaceuticals, medical treatments, and related services reduce profit margins for us and our customers and impose new legal requirements on healthcare providers. Those changes have included cuts in Medicare and Medicaid reimbursement levels, changes in the basis for payments, shifting away from fee-for-service and towards value-based payments and risk-sharing models, and increases in the use of managed care.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the ACA significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. There have been continued efforts to challenge the ACA. There are also efforts to broaden healthcare coverage. U.S. lawmakers also have explored proposals to reduce drug prices, including requiring greater price transparency, enabling Medicare to directly negotiate drug prices, and drug importation measures. These proposals might result in significant changes in the pharmaceutical value chain as manufacturers, pharmacy benefit managers, managed care organizations, and other industry stakeholders look to implement new transactional flows and adapt their business models.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private challenges to government healthcare policy may also have significant impacts on our business. For example, over a dozen pharmaceutical manufacturers have unilaterally restricted sales under the 340B drug pricing program to contract pharmacies. The 340B drug pricing program requires manufacturers to offer discounts on certain drugs purchased by &#8220;covered entities,&#8221; which include safety-net providers. The HRSA has taken the position that a covered entity may dispense such discounted drugs through multiple contract pharmacies. Starting in 2020, some manufacturers began to restrict such practices. A number of manufacturers and the HHS continue to litigate these issues. So far, lower courts have rendered somewhat conflicting opinions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs. For example, provincial governments have taken steps to reduce consumer prices for generic pharmaceuticals and, in some provinces, change professional allowances paid to pharmacists by generic manufacturers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many European governments provide or subsidize healthcare to consumers and patients by regulating pharmaceutical prices, patient eligibility, or reimbursement levels to control government healthcare system costs. European governments are continuously reviewing measures to support the reduction of public healthcare spending. Such measures can exert pressure on pricing frameworks and reimbursement timelines for pharmaceuticals, which in turn may impact customer behavior. There is substantial uncertainty about the likelihood and timing of any healthcare policy reform as each E.U. country operates in a separate healthcare environment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there is substantial uncertainty about the likelihood, timing, and results of these health reform efforts, their implementation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by competition and industry consolidation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses face a highly competitive global environment with strong competition from international, national, regional and local full-line, short-line, and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations. In addition, our businesses face competition from various other service providers and from pharmaceutical and other healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses. Due to consolidation, a few large suppliers control a significant share of the pharmaceuticals market. This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers. Many of our customers, including healthcare organizations, have consolidated and have greater power to negotiate favorable prices. Consolidation by our customers, suppliers and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin. Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants. These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by changes or disruptions in product supply.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our supply arrangements might be interrupted or adversely affected by a variety of causes over which we have no control, such as export controls or trade sanctions, labor disputes, unavailability of key manufacturing sites, inability to procure raw materials, quality control concerns, ethical sourcing issues, supplier&#8217;s financial distress, natural disasters, civil unrest or acts of war, the impact of epidemics or pandemics, such as COVID-19, and other general supply constraints. Our inventory might be requisitioned, diverted, or allocated by government order such as under emergency, disaster, and civil defense declarations. The FDA banned certain manufacturers from selling raw materials and drug ingredients in the U.S. due to quality issues. For example, government actions in response to the COVID-19 pandemic affect our supply allocation, and those and our own allocation decisions can impact our customer relationships. Changes in the healthcare industry&#8217;s or our suppliers&#8217; pricing, selling, inventory, distribution, or supply policies or practices could significantly reduce our revenues and net income. We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals. Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted as a result of our distribution of generic pharmaceuticals.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our generic pharmaceuticals distribution business is subject to pricing risks. We might be adversely impacted if our ClarusONE joint venture is unsuccessful or experiences margins declines. Generic drug manufacturers often offer a generic version of branded pharmaceuticals while they challenge the validity or enforceability branded pharmaceutical patents. The patent holder might assert infringement claims against us for distributing those generic versions and the generic drug manufactures may not fully indemnify us against such claims. These risks, as well as changes in the availability, pricing volatility, reimbursement rates for generic drugs, or significant changes in the nature, frequency or magnitude of generic pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by inflation, an economic slowdown, or recession.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflationary conditions result in increased costs and decreased levels of consumer commercial spending and, to the extent we are not able to offset such cost increases from our suppliers, increase the costs which we incur to purchase inventories and services. Inflationary pressure is increased by supply chain disruptions and reduced availability of key commodities. Cost inflation during 2022 generally increased our transportation, operational, and other administrative costs associated with our normal business operations. An economic slowdown or recession could reduce the prices our customers are able or willing to pay for our products and services and reduce the volume of their purchases. Recessionary pressure may be increased by the COVID-19 pandemic and regional political and military conflicts. Any economic slowdown or recession and the impact of inflation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption or other changes in capital and credit markets might impede access to credit and increase borrowing costs for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volatility and disruption in global capital and credit markets, including the bankruptcy or restructuring of certain financial institutions, reduced lending activity by financial institutions, or decreased liquidity and increased costs in the commercial paper market, might adversely affect our borrowing ability and cost of borrowing. We generally sell our products and services under short-term unsecured credit arrangements. An adverse change in general economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us. Suppliers might increase their prices, reduce their output or change their terms of sale due to limited availability of credit. Suppliers might be unable to make payments due to us for fees, returned products, or incentives. These risks are increased by the COVID-19 pandemic and regional political and military conflicts. Interest rate increases or changes in capital market conditions might impede our or our customers&#8217; or suppliers&#8217; ability or cost to obtain credit. Any of these risks might have a material adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulties in sourcing or selling products due to a variety of causes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We might experience difficulties and delays in sourcing and selling products due to a variety of causes, such as: difficulties in complying with the legal requirements for export or import of pharmaceuticals or components; suppliers&#8217; failure to satisfy production demand; manufacturing or supply problems such as inadequate resources; and real or perceived quality issues. Difficulties in product manufacturing or access to raw materials could result in supplier production shutdowns, product shortages and other supply disruptions. The FDA banned certain manufacturers from selling raw materials and drug ingredients in the U.S. due to quality issues. The COVID-19 pandemic adversely affects the availability of some products, resulting in product allocation and delivery delays. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by tax legislation or challenges to our tax positions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the tax laws in the U.S. at the federal, state, and local government levels and to the tax laws of many other jurisdictions in which we operate or sell products or services. Tax laws might change in ways that adversely affect our tax positions, effective tax rate, and cash flow. The tax laws are extremely complex and subject to varying interpretations. We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us. Our tax reporting positions might be challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts. Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals. Any of these risks might have a materially adverse impact on our business operations, our cash flows, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by fluctuations in foreign currency exchange rates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business in various currencies, including the U.S. dollar, euro, British pound sterling and Canadian dollar. Changes in foreign currency exchange rates could reduce our revenues, increase our costs, or otherwise adversely affect our financial results reported in U.S. dollars. For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar. We also have currency exchange risk due to intercompany loans denominated in various currencies. The COVID-19 pandemic and regional political and military conflict have affected and might increase currency exchange rate volatility. We may from time to time enter into foreign currency contracts, foreign currency borrowings or other techniques intended to hedge a portion of our foreign currency exchange rate risks. These hedging activities may not completely offset the adverse financial effects of unfavorable movements in foreign currency exchange rates during the time the hedges are in place. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events, and other catastrophic events.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We might be adversely affected by events outside of our control, including: widespread public health issues, such as epidemic or pandemic infectious diseases; natural disasters such as earthquakes, floods, or severe weather; political events such as terrorism, military conflicts, and trade wars; and other catastrophic events. These events can disrupt operations for us, our suppliers, our vendors, and our customers. They might affect consumer confidence levels and spending or the availability of certain goods or commodities. For example, in February 2022, the Russian Federation began conducting military operations against Ukraine, resulting in global economic uncertainty and increased cost of various commodities. As another example, the COVID-19 pandemic affects product manufacturing, supply, and transport availability and cost in unpredictable ways that depend on highly uncertain future developments. In response to these types of events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by global climate change or by legal, regulatory, or market responses to such change.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-term effects of climate change are difficult to predict and may be widespread. The impacts may include physical risks (such as rising sea levels or frequency and severity of extreme weather conditions), social and human effects (such as population dislocations or harm to health and well-being), compliance costs and transition risks (such as regulatory or technology changes), and other adverse effects. The effects could impair, for example, the availability and cost of certain products, commodities, and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require. We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory due to unusual ambient temperatures, and business interruption due to weather events that may be attributable to climate change. These events and impacts could materially adversely affect our business operations, financial position, or results of operation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by changes in accounting standards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are subject to the application of U.S. GAAP, which periodically is revised or reinterpreted. From time to time, we are required to adopt new or revised accounting standards issued by recognized authoritative bodies, including the Financial Accounting Standards Board (&#8220;FASB&#8221;) and the SEC. It is possible that future accounting standards may require changes to the accounting treatment in our consolidated financial statements and may require us to make significant changes to our financial systems. Such changes might have a materially adverse impact on our financial position or results of operations.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_19"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_22"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the nature of our principal businesses, our plant, warehousing, retail pharmacies, office, and other facilities are operated in widely dispersed locations, primarily throughout North America and Europe. Retail pharmacies and most warehouses are typically owned or leased on a long-term basis. We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels. Information as to material lease commitments is included in Financial Note 10, &#8220;Leases,&#8221; to the consolidated financial statements included in this Annual Report. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intention to exit our businesses in Europe. As of March 31, 2022, the majority of our properties in Europe are expected to be divested and are classified as</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets held for sale in the Company&#8217;s Consolidated Balance Sheet, as discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of our office space in North America. Where we ceased using office space, we exited the portion of the facility no longer used. We also retained and repurposed certain other office locations. This initiative was substantially completed in 2022. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for further details</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_25"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Legal Proceedings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain legal proceedings in which we are involved are discussed in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report. Disclosure of an environmental proceeding with a governmental agency is generally included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_28"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_31"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding the executive officers of the Company, including their principal occupations during the past five years.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships between any of the executive officers or directors of the Company. The term of office of each executive officer expires at the first meeting of the Board of Directors (&#8220;Board&#8221;) following the annual meeting of shareholders, or until their successors are elected and have qualified, or until death, resignation, or removal, whichever is sooner.</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Position with Registrant and Business Experience</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and a director since April 2019; President and Chief Operating Officer from August 2018 to March 2019; Chairman of the Management Board of McKesson Europe AG from 2017 to 2018; President and Chief Operating Officer, McKesson Europe from 2016 to 2017; President of North America Distribution and Services from 2015 to 2016; and Executive Vice President, Corporate Strategy and Business Development from 2012 to 2015.&#160;Service with the Company - 25 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Britt J. Vitalone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer since January 2018; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical from July 2014 to December 2017; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical and Specialty Health from October 2017 to December 2017; Senior Vice President of Corporate Finance and M&amp;A Finance from March 2012 to June 2014.&#160;Service with the Company - 16 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tracy L. Faber</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Human Resources Officer since October 2019. Previously, Senior Vice President of Human Resources. Service with the Company - 11 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nancy Flores</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Information Officer and Chief Technology Officer since January 2020. Chief Information Officer, Johnson Controls from 2018 to July 2019. Corporate Officer and Vice President of Business and Technology Services, Abbott Laboratories from 1996 to 2018. Service with the Company - 2 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas L. Rodgers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Strategy and Business Development Officer since June 2020. Previously, Senior Vice President and Managing Director of McKesson Ventures from 2014 to 2020. Service with the Company - 8 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lori A. Schechter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer and General Counsel since June 2014. Associate General Counsel from January 2012 to June 2014. Litigation Partner, Morrison &amp; Foerster LLP from 1995 to December 2011. Service with the Company - 10&#160;years.</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_34"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_37"></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal market on which our common stock is traded is the New York Stock Exchange (&#8220;NYSE&#8221;) under the trading symbol of &#8220;MCK.&#8221;</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holders: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, there were 4,636 holders of record of our common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In July 2021, our quarterly dividend was raised from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board.&#160;We declared regular cash dividends of $1.83, $1.67, and $1.62 per share for the years ended March 31, 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Information relating to this item is provided under Part III, Item 12, to this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. During the last three years, our share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2019 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to our split-off of the Change Healthcare JV as described in Financial Note 19, &#8220;Stockholders' Equity (Deficit)&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8 million was accrued within &#8220;Other accrued liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our share repurchases during the fourth quarter of 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022 - January 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2022 - February 28, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022 - March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Price Performance Graph*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The following graph compares the cumulative total stockholder return on our common stock for the periods indicated with the Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) 500 Index and the S&amp;P 500 Health Care Index. The S&amp;P 500 Health Care Index was selected as a comparator because it is generally available to investors and broadly used by other companies in the same industry.</span></div><div style="text-align:center"><img src="mck-20220331_g2.jpg" alt="mck-20220331_g2.jpg" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.27&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.84&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.55&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.62&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Assumes $100 invested in McKesson Common Stock and in each index on March 31, 2017 and that all dividends are reinvested.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_40"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Reserved.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_46"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_1987">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_1987">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_1999">Overview of Our Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_1999">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_2006">Executive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_2006">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_2013">Trends and Uncertainties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_2013">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_2020">Overview of Consolidated Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_2020">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_49">Overview of Segment Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_49">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_58">Foreign Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_58">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_61">Business Combinations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_61">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_64">Fiscal 2023 Outlook</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_64">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_67">Critical Accounting Policies and Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_67">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_70">Financial Condition, Liquidity, and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_70">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_73">Related Party Balances and Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_73">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_76">New Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_76">61</a></span></div></td></tr></table></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_1987"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K (&#8220;Annual Report&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Financial Review within this Form 10-K generally discusses 2022 and 2021 results and year-over-year comparisons between 2022 and 2021. For a discussion on our year-over-year comparisons between 2021 and 2020, refer to our Annual Report on Form 10-K for the year ended March 31, 2021, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of Part II, previously filed with the Securities and Exchange Commission on May&#160;12, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See Item 1 - Business - Forward-Looking Statements in Part I of this Annual Report for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report for a list of certain risk factors applicable to our business, financial condition, and results of operations. </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_1999"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments. Refer to Financial Note 21, &#8220;Segments of Business,&#8221; to the consolidated financial statements included in this Annual Report for further information regarding our reportable segments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a reportable segment that distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a reportable segment that combines automation and our ability to navigate the healthcare ecosystem to connect pharmacies, providers, payers, and biopharma companies to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;).</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. During 2022, we entered into agreements to sell certain of our businesses in the European Union (&#8220;E.U.&#8221;) and our retail and distribution businesses in the United Kingdom (&#8220;U.K.&#8221;), as well as completed the sale of our Austrian business. These divestitures are further described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestiture Activities&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, we entered into an agreement to sell certain of our businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2 billion (or, approximately $1.4 billion) adjusted for certain items, including cash, net debt and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. We recorded charges of $438 million for the year ended March 31, 2022 in total operating expenses to remeasure the E.U. disposal group to fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. The remeasurement adjustment includes a $151 million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The transaction is anticipated to close within the second half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2021, we announced an agreement to sell our retail and distribution businesses in the U.K. (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited. In April 2022, we entered into an amendment to the agreement for a purchase price of &#163;110&#160;million (or, approximately $144&#160;million), including certain adjustments. We recorded charges of $1.2&#160;billion for the year ended March 31, 2022 in total operating expenses to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustment includes a $734&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The transaction closed on April 6, 2022, and at closing the buyer assumed and repaid a note payable to us of approximately $118&#160;million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, we completed the sale of our Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#8364;244&#160;million (or, approximately $276&#160;million), including certain adjustments. We divested net assets of the Austrian business of $272 million, primarily within the International segment, and the buyer assumed a note payable to us of approximately $63 million which was paid to us in the fourth quarter of 2022. We recorded a charge of $32&#160;million for the year ended March 31, 2022 in total operating expenses to remeasure the Austrian business to fair value less costs to sell.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, we sold our 30% interest in the German pharmaceutical wholesale joint venture to Walgreens Boots Alliance (&#8220;WBA&#8221;). We recognized a $42 million gain within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2022 related to this sale.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, we had $4.5 billion of assets and $4.7 billion of liabilities classified as &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale,&#8221; respectively, in the Consolidated Balance Sheet primarily related to the European divestiture activities described above. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_2006"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the year ended March 31, 2022. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The pandemic disease caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;) impacted our results of operations for the year ended March 31, 2022. As previously disclosed in our 2021 Annual Report, pharmaceutical distribution volumes decreased across the enterprise during the first quarter of 2021 as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government-mandated business shutdowns and shelter-in-place orders, following the onset of the pandemic. The recovery from the pandemic is favorably reflected in our results when comparing 2022 versus 2021. We also had favorable contributions from our COVID-19 vaccine and related ancillary supply kit distribution programs during 2022;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2021, we began distributing certain COVID-19 vaccines under the direction of the Centers for Disease Control and Prevention (&#8220;CDC&#8221;). Since 2021 and through the end of 2022, we distributed over 380 million COVID-19 vaccine doses to administration sites all across the U.S. and in support of the U.S. government&#8217;s international donation mission. For a more in-depth discussion of how COVID-19 impacted our business, operations, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Revenues of $264 billion, reflects an 11% increase from the prior year primarily driven by market growth in our U.S. Pharmaceutical segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit increased 8% from the prior year primarily driven by improvements in primary care patient visits and the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment as well as growth of specialty pharmaceuticals and the contribution from our COVID-19 vaccination distribution program in our U.S. Pharmaceutical segment; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses in 2022 includes fair value remeasurement charges related to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestiture Activities&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discussed above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Other income, net in 2022 includes net gains of $98&#160;million related to our McKesson Ventures equity investments and $42 million related to the gain on sale of our 30% interest in the German pharmaceutical wholesale joint venture with WBA;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 23, 2021, we completed a cash tender offer and paid an aggregate consideration of $1.1&#160;billion to redeem certain notes with a principal amount of $922&#160;million. As a result of the redemption, we incurred a loss on debt extinguishment in the second quarter of 2022 of $191 million, consisting of the premiums paid and a portion of the write-off of unamortized debt issuance costs in an amount proportional to the principal amount of debt retired. Refer to Financial Note 12, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report for more information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted earnings per common share from continuing operations attributable to McKesson Corporation in 2022 of $7.23 reflects the aforementioned items, net of any respective tax impacts, discrete tax items recognized, and a lower share count compared to the prior year due to the cumulative effect of share repurchases;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We paid $1.0 billion to purchase 34.5&#160;million shares of McKesson Europe in 2022 through exercises of a put right by the noncontrolling shareholders pursuant to the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;); </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 17, 2021, we redeemed our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709&#160;million) prior to the maturity date of August 17, 2021. The notes were redeemed using cash on hand. On August 12, 2021, we also completed a public offering of 1.30% notes due August 15, 2026 with a principal amount of $500&#160;million for proceeds received, net of discounts and offering expenses, of $495&#160;million. We utilized the net proceeds from this note for general corporate purposes;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">We returned $3.8 billion of cash to shareholders through $3.5 billion of common stock repurchases and $277 million of dividend payments during 2022. On July 23, 2021, we raised our quarterly dividend from $0.42 to $0.47 per common share; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2021, we announced that our Board of Directors (the &#8220;Board&#8221;) approved an increase of $4.0&#160;billion for the authorized repurchases of our common stock.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_2013"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Impact of Inflationary and Global Events</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and results of operations, financial condition, and liquidity are impacted by broad economic conditions including inflation, increased competition for talent, and disruption of the supply chain, as well as by political or civil unrest or military action, including the conflict between Russia and Ukraine. Cost inflation during 2022 generally affects us by increasing transportation, operational, and other administrative costs associated with our normal business operations which we might not be able to fully pass along to our customers. Although, it is difficult to predict the impact that these factors may have on our business in the future, they did not have a material effect on our results of operations, financial condition, or liquidity for the year ended March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">COVID-19 </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SARS-CoV-2 novel strain of coronavirus, which causes the infectious disease known as COVID-19, continues to evolve since it was declared a global pandemic on March 11, 2020 by the World Health Organization. We continue to evaluate the nature and extent of the ongoing impacts COVID-19 has on our business, operations, and financial results. The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risks and Forward-Looking Information&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response to COVID-19 in the Workplace</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to continuing to supply our customers and protect the safety of our employees. The various responses we put in place to mitigate the impact of COVID-19 on our business operations include telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures. During the first quarter of 2022, we approved changes to our real estate strategy to increase efficiencies and support flexibility for our employees, including a partial remote work model for certain employees as further discussed in this Financial Review and in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report. During the third quarter of 2022, we continued to refine our policies and apply safety measures in the workplace as recommended by the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) as COVID-19 cases increased across North America and Europe driven by the highly contagious Omicron variant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we continued COVID-19 vaccination protocols for our U.S. and Canada employees, which are designed to be consistent with federal, state, and local laws and with customer requirements and to protect the safety of our employees, customers, patients, and communities while also safeguarding the healthcare supply chain. In Europe, we followed applicable government guidelines. We continue to monitor all of these changing laws, requirements and guidelines. We have not observed a material increase in employee turnover as a result of COVID-19 vaccination protocols; however, we are unable to predict whether such protocols will have a material impact on our workforce in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a diversified healthcare services leader, we remain well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including PPE, and medicine reach our customers and patients. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through a contract with the CDC, we continue to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines. We began distributing certain COVID-19 vaccines in December 2020. In the first quarter of 2022, McKesson began supporting the U.S. government&#8217;s commitment to donate COVID-19 vaccines worldwide. For this initiative, we are responsible for picking and packing the COVID-19 vaccines into temperature-controlled coolers and preparing them for pickup by an international partner. We do not manage the actual shipments of the vaccines to other countries. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. We also continue to manage the assembly, storage, and distribution of ancillary supply kits needed to administer COVID-19 vaccines, including sourcing some of those supplies, through agreements with both the Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer, Inc. The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment. The future financial impact of the arrangements with the CDC and HHS depend on numerous uncertainties, which are described in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Risks and Forward-Looking Information&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada and McKesson Europe are playing a role by supporting governments and public health entities through distributing COVID-19 vaccines and administering them in pharmacies. Additionally, McKesson Canada and McKesson Europe are distributing COVID-19 tests and certain PPE.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the onset of the COVID-19 pandemic late in our fourth quarter of 2020, we had higher pharmaceutical distribution volumes and increased retail pharmacy foot traffic as our customers increased supplies on hand in March. During 2021, pharmaceutical distribution volumes decreased as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government-mandated business shutdowns and shelter-in-place orders. We also had a decrease in demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors&#8217; offices, which was partially offset by demand for PPE and COVID-19 tests. Additionally, the decreased traffic in doctors&#8217; offices and general shelter-in-place guidance by governmental authorities negatively impacted retail pharmacy foot traffic in both Europe and Canada. This drove favorability in our results when comparing 2022 versus 2021, particularly during the first quarter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have observed improvements in prescription volumes and primary care patient visits during 2022 compared to the prior year period; however, the recovery of COVID-19 continues to be non-linear and impacted by virus variants such as Omicron and ongoing fluctuations in case levels. During the year ended March 31, 2022, the U.S. distribution of COVID-19 vaccines and related ancillary kits favorably impacted our results. We recognized higher sales for COVID-19 tests primarily due to limited product availability in the first quarter of 2021 and increased demand during 2022 corresponding with the spike in positive COVID-19 cases as a result of the Delta and Omicron variants.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Supply Chain </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to monitor and address the COVID-19 pandemic impacts on our supply chain. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they are impacted by the COVID-19 pandemic, we are proactively working with manufacturers, industry partners, and government agencies to meet the needs of our customers during the pandemic. Overall, during 2022 we had an increase in supply chain costs primarily related to transportation and labor; however, this did not materially impact our results of operations for the year ended March 31, 2022. In our Medical-Surgical Solutions segment, we have observed certain supply chain disruptions for COVID-19 tests, which poses a potential risk for supply availability to meet the future demand. As potential shortages or disruptions of any products are identified we address supply continuity, which includes securing additional products when available, sourcing back-up products when needed, and following allocation procedures to maintain and protect supply as much as possible. We utilize business continuity action planning to maintain and protect operations across all locations and facilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March 31, 2022, COVID-19 tests and the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately $1.8 billion, or 16% to segment revenues, and including total inventory charges as further described below, increased our segment operating profit by approximately $208 million, or 22%.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment contributed less than 10% to segment operating profit during the year ended March 31, 2022. The financial impact from our COVID-19 response efforts in the International segment during 2022 was not material to our consolidated results, but contributed to year over year favorability in segment operating results. During the year ended March 31, 2021, particularly during the first quarter, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income (loss) from continuing operations before income taxes. The recovery of prescription volume trends and patient care visits, which are also described in more detail above in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends in our Business&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, had a favorable impact year over year across our businesses when comparing 2022 versus 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels. That inventory valuation, if not supported by market resale prices, may be written down to net realizable value. We may also write-off inventory due to decreased customer demand and excess inventory. During the year ended March 31, 2022, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. Of this amount, we recorded $147 million in cost of sales driven by the intent of management not to sell certain excess PPE inventory, which required an inventory write-down to zero, and instead direct it to charitable organizations or otherwise dispose. We recorded $8 million in total operating expenses for excess inventory which had already been committed for donation at the time of the charge and subsequently was delivered during 2022. In addition, $9 million of inventory charges were recorded in cost of sales for PPE and other related products that management intends to sell. Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods of other PPE and related product categories, we are taking measures to mitigate such risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, these COVID-19 related items had a net favorable impact on consolidated income from continuing operations before income taxes for the year ended March 31, 2022 compared to the prior year period. Impacts to future periods due to COVID-19 may differ based on future developments, which is described in our &#8220;Risks and Forward-Looking Information&#8221; section below.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, we maintained appropriate labor and overall vendor supply levels and experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. We continue to monitor the COVID-19 situation closely and engage with manufacturers, industry partners, and government agencies to anticipate shortages and respond to demand for certain medications and therapies. We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses. We remain well-capitalized with access to liquidity from our revolving credit facility. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. At March 31, 2022, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Forward-Looking Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We still face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity. The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the COVID-19 pandemic; potential seasonality of viral outbreaks; impacts of additional variants of the SARS-Cov-2 virus; the amount of COVID-19 vaccines and ancillary supply kits that we are contracted to distribute; the effectiveness of COVID-19 vaccines and governmental measures designed to mitigate the spread of the virus; the effectiveness of treatments of infected individuals; commercialization of COVID-19 vaccines; competition in COVID-19 vaccine distribution; and changes or disruptions in product supply. We have experienced and may experience difficulties in sourcing products and changes in pricing due to the effects of the COVID-19 pandemic on supply chains. Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when COVID-19 may no longer significantly impact our ability to forecast future financial performance remain challenging. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the COVID-19 pandemic on industry and economic trends as well as on our business strategy and internal forecasts. Material changes to key assumptions and estimates can decrease the projected cash flows or increase the discount rates and have resulted in impairment charges of certain long-lived assets and could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of this Annual Report for a disclosure of risk factors related to COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in many legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. The plaintiffs in these actions have included state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, the Company and two other United States pharmaceutical distribution companies (collectively, "Distributors") determined that there is sufficient State and subdivision participation to proceed with an agreement ("Settlement") to settle a substantial majority of opioids-related lawsuits filed against the Distributors by U.S. states, territories and local governmental entities. Under the Settlement, 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, "Settling Governmental Entities"), have agreed to join the Settlement. The Settlement became effective on April 2, 2022. If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. Under the Settlement, a minimum of 85% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement only addresses the claims of attorneys general of U.S. states and territories and political subdivisions in participating states and territories. The terms under which the Distributors previously agreed to settle opioids claims of the states of New York, Ohio, Rhode Island, Florida and Texas, and each of their participating subdivisions, will become part of the Settlement. The previously disclosed agreement for the Distributors to settle opioids claims of the attorney general of West Virginia will remain a separate settlement arrangement that is not part of the Settlement. Governmental entities not participating in the Settlement may continue to pursue their claims. The states of Alabama, Oklahoma and Washington chose not to participate in the Settlement. We have reached separate agreements in principle with the attorneys general of Alabama and Washington to settle the claims of those states and their subdivisions. The Distributors previously settled with the Cherokee Nation and reached a separate agreement in principle to settle the claims of the remaining federally recognized Native American Tribes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a charge of $8.1 billion during the year ended March 31, 2021 related to our estimated liability to U.S. governmental entities, including those expected to participate in the Settlement, the states and subdivisions that were not expected to participate or were not eligible, and the Native American tribes. In connection with the Settlement and other opioid-related settlement accruals described above, we recorded additional charges of $274&#160;million during the year ended March 31, 2022 within &#8220;Claims and litigation charges, net&#8221; in our Consolidated Statement of Operations. Our total estimated liability for opioid-related claims was $8.3 billion as of March 31, 2022, of which $1.0 billion was included in &#8220;Other accrued liabilities&#8221; for the amount estimated to be paid prior to March 31, 2023, and the remaining liability was included in &#8220;Long-term litigation liabilities&#8221; in our Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with ongoing opioid-related litigation matters, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty, the amount of any ultimate loss may differ materially from the amount accrued. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the Settlement, we also continue to prepare for trial in pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report on Form 10&#8209;K for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_2020"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,340)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the years ended March 31, 2022 and 2021 compared to the respective prior years primarily due to market growth, including expanded business with existing customers within our U.S. Pharmaceutical segment. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the year ended March 31, 2022 compared to the prior year primarily in our Medical-Surgical Solutions segment driven by improvements in patient care visits in our primary care business, the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines, partially offset by the unfavorable impact from PPE and other related products largely due to inventory charges. Gross profit was favorably impacted by growth of specialty pharmaceuticals and the contribution from our vaccine distribution programs in our U.S. Pharmaceutical segment. Gross profit was also driven by increased volume with new and existing customers in our RxTS segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the years ended March 31, 2022 and 2021, included LIFO inventory credits of $23&#160;million and $38&#160;million, respectively. The lower LIFO credits in 2022 compared to 2021 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Estimates&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section included in this Financial Review for further information. Gross profit for the years ended March 31, 2022 and 2021 also included net cash proceeds received of $46&#160;million and $181&#160;million, respectively, representing our share of antitrust legal settlements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary and description of the components of our total operating expenses for the years ended March 31, 2022 and 2021 is as follows:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, administrative expenses, remeasurement charges to the lower of carrying value or fair value less costs to sell, and other general charges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Goodwill impairments charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist. The resulting goodwill impairment charges are reflected within this line item. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restructuring charges that are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses and total operating expenses as a percentage of revenues decreased for the year ended March 31, 2022 compared to the prior year. Total operating expenses for the years ended March 31, 2022 and 2021 were affected by the following significant items:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes charges totaling $1.2&#160;billion to remeasure our U.K. disposal group to fair value less costs to sell. The remeasurement adjustment includes a $734&#160;million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. Of the total charges recorded during the period, $1.1&#160;billion are included within our International segment and $42&#160;million are included within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes charges of $438 million to remeasure assets and liabilities of our E.U. disposal group held for sale to fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. The remeasurement adjustment includes a $151 million loss related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. Of the total charges recorded during the period, $383 million are included within our International segment and $55 million are included within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects a cost reduction of $142&#160;million related to the cessation of depreciation and amortization of long-lived assets and operating lease right-of-use assets classified as held for sale for our European divestiture disposal groups;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes opioid-related costs of $130 million primarily related to litigation expenses;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes a gain of $59 million related to the sale of our Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A when compared to the same prior year period also includes increased employee-related and transportation costs across our businesses, partially offset by lower operating expenses due to the contribution of a majority of our German pharmaceutical business to a joint venture with WBA in the third quarter of 2021;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net includes a charge of $274 million related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Restructuring, impairment, and related charges, net includes charges related to Corporate expenses, net, as well as our International segment. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives and Long-Lived Asset Impairments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sections below as well as Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for more information; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG&amp;A includes opioid-related costs of $153&#160;million, primarily related to litigation expenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects cost savings of $95&#160;million on travel and entertainment due to travel and meeting restrictions associated with COVID-19;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects charges of $58&#160;million to remeasure assets and liabilities held for sale to fair value less costs to sell related to the completed contribution of the majority of our German pharmaceutical wholesale business to create a joint venture with WBA in which we held a 30% ownership interest within our International segment. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for more information;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes a charge of $50&#160;million related to our estimated liability under the State of New York Opioid Stewardship Act (&#8220;OSA&#8221;);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A also includes lower operating expenses due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA and a divestiture in our Medical-Surgical Solutions segment that closed in 2020; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Claims and litigation charges, net includes a charge of $8.1 billion related to our estimated liability for opioid-related claims;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Claims and litigation charges, net includes a net gain of $131&#160;million reflecting insurance proceeds received, net of attorneys' fees and expenses awarded to plaintiffs' counsel, in connection with the previously reported $175 million settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill impairment charges of $69&#160;million were recorded in connection with our segment realignment that commenced in the second quarter of 2021. Refer to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;Goodwill Impairment&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below for further details;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Restructuring, impairment, and related charges, net includes long-lived asset impairment charges of $115&#160;million primarily related to our retail pharmacy businesses in Canada and Europe within our International segment, and the remaining $219&#160;million primarily represents costs associated with our operating model and cost optimization efforts in our corporate headquarters and International segment. In addition, certain charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in our Consolidated Statements of Operations and were not material for the year ended March 31, 2021; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Overview of Our Business&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, our operating structure was realigned commencing in the second quarter of 2021 into four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. The segment realignment resulted in changes in multiple reporting units across the Company. As a result, we were required to perform a goodwill impairment test for these reporting units and recorded a goodwill impairment charge in our Europe Retail Pharmacy reporting unit of $69&#160;million during the second quarter of 2021. At March 31, 2022, the balance of goodwill for our reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of our reporting units in Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed in 2022 and 2021 did not indicate any impairment of goodwill. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment, where the risk of material goodwill impairment is higher than other reporting units. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Estimates&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Financial Review for further information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of our office space in North America. Where we ceased using office space, we exited the portion of the facility no longer used. We also retained and repurposed certain other office locations. We recorded charges of $124 million for the year ended March 31, 2022 primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we committed to an initiative within the U.K., which is included in our International segment, to further drive transformational changes in technologies and business processes, operational efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for 2022, and were $57 million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in 2022 and remaining costs we expect to record under this initiative are not material.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, we recognized charges totaling $36 million to impair certain long-lived assets within our International segment related to our operations in Denmark and our retail pharmacy businesses in Canada. Restructuring, impairment, and related charges, net for the year ended 2021 includes long-lived asset impairment charges of $115 million primarily related to our retail pharmacy businesses in Canada and Europe within our International segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3 , &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the years ended March 31, 2022 and 2021 includes net gains recognized from our equity investments of $98&#160;million and $133&#160;million, respectively. This primarily reflects mark-to-market gains on our investments in certain U.S. growth stage companies in the healthcare industry and realized gains on the exit of some of these investments as further described in Financial Note 16, &#8220;Fair Value Measurements,&#8221; to the consolidated financial statements included in this Annual Report. In future periods, fair value adjustments recognized in our operating results for these types of investments may be adversely impacted by market volatility. Other income, net for the year ended March 31, 2022 also includes a gain of $42 million related to the sale of our 30% interest in the German pharmaceutical wholesale joint venture with WBA.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on Debt Extinguishment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on debt extinguishment recorded for the year ended March 31, 2022 of $191&#160;million includes premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred of $9&#160;million, and was driven by our July 2021 tender offer to redeem a portion of our existing debt. Refer to Financial Note 12, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased in 2022 compared to the prior year primarily due to the repayment of $1.0 billion of long-term debt in the third quarter of 2021 and our tender offer activity in the second quarter of 2022. Interest expense fluctuates based on timing, amounts and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax (Benefit) Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax (benefit) expense of $636 million and ($695 million) for the years ended March 31, 2022 and 2021, respectively. Our reported income tax (benefit) expense rates were 33.0% and (13.8%) in 2022 and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in our reported income tax rates are primarily due to non-cash charges related to remeasuring the value of certain of our European businesses to fair value less costs to sell, the impact of opioid-related claims, and changes in our mix of earnings between various taxing jurisdictions. Refer to Financial Note 7, &#8220;Income Taxes,&#8221; to the consolidated financial statements included in this Annual Report for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported income tax rate for 2021 was impacted by the charge for opioid-related claims of $8.1 billion ($6.8 billion after-tax). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties. Although our major taxing jurisdictions include the U.S., Canada, and the U.K., we are subject to income taxes in numerous foreign jurisdictions. Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We believe that we have made adequate provision for all income tax uncertainties. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss from Discontinued Operations, Net of Tax </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from discontinued operations, net of tax, was $5 million and $1 million and for the years ended March 31, 2022 and 2021, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe AG (&#8220;McKesson Europe&#8221;) share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under the Domination Agreement.&#160;Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Redeemable noncontrolling interests are presented outside of McKesson Corporation stockholders&#8217; deficit in our consolidated balance sheet. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 8, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the consolidated financial statements included in this Annual Report for additional information on changes to our redeemable and noncontrolling interests that occurred during the first quarter of 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to McKesson Corporation </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to McKesson Corporation was $1.1 billion and $(4.5) billion for the years ended March 31, 2022 and 2021, respectively. Diluted earnings (loss) per common share attributable to McKesson Corporation was $7.23 and $(28.26) for the years ended March 31, 2022 and 2021, respectively. Net loss per diluted share for the year ended March 31, 2021 is calculated by excluding dilutive securities from the denominator due to their antidilutive effects. Additionally, our 2022 and 2021 diluted earnings (loss) per share reflect the cumulative effects of share repurchases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (loss) per common share was calculated based on a weighted-average number of shares outstanding of 154.1 million and 160.6 million for the years ended March 31, 2022 and 2021, respectively. Weighted-average diluted common shares outstanding is impacted by the exercise and settlement of share-based awards and the cumulative effect of share repurchases.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.992%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in revenues for each of our segments for the year ended March 31, 2022 compared to the prior year consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.992%"><tr><td style="width:1.0%"></td><td style="width:79.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.637%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to pharmacies and institutional healthcare providers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to specialty practices and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in U.S. Pharmaceutical revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in Prescription Technology Solutions revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to primary care customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to extended care customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in Medical-Surgical Solutions revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales in Europe, excluding FX impact</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales in Canada, excluding FX impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact from FX</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in International revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in revenues</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,738&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FX - foreign currency exchange fluctuations. We calculate the impact from FX by converting current year period results of our operations in foreign countries, which are recorded in local currencies, into U.S. dollars by applying the average foreign currency exchange rates of the comparable prior year period.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the results for the distribution of COVID-19 vaccines.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the results for the kitting and distribution of ancillary supply kits needed to administer COVID-19 vaccines.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the year ended March 31, 2022 increased 12% compared to the prior year primarily due to market growth, including growth in specialty pharmaceuticals, branded pharmaceutical price increases, and higher volumes from retail national account customers, partially offset by branded to generic drug conversions. Revenues for this segment were also favorable year over year driven by the recovery of prescription volumes from the prior year impact of COVID-19, including increased customer demand for pharmaceuticals in retail pharmacies and institutional healthcare providers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the year ended March 31, 2022 increased 34% compared to the prior year primarily due to increased volume with new and existing customers primarily in our third-party logistics and wholesale distribution services.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the year ended March 31, 2022 increased 15% compared to the prior year largely in our primary care business driven by improvements in patient care visits. Revenues for this segment were also favorably impacted by the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the year ended March 31, 2022 increased 1% compared to the prior year. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 2% largely due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA. This was partially offset by favorability year over year due to the recovery of volumes from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses across the segment as well as sales to new customers in our Canadian business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_55"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.66)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for our reportable segments. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes cash receipts of our share of antitrust legal settlements of $46 million and $181 million for the years ended March 31, 2022 and 2021, respectively. Operating profit includes a charge of $50&#160;million for the year ended March 31, 2021 related to our estimated liability under the OSA.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the years ended March 31, 2022 and 2021 includes charges totaling $164&#160;million and $136&#160;million, respectively, on certain PPE and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for our International segment for the year ended March 31, 2022 includes charges of $1.1 billion to remeasure our U.K. disposal group held for sale to fair value less costs to sell. Operating loss for the year ended March 31, 2022 includes charges of $383 million to remeasure our E.U. disposal group held for sale to fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. Operating loss for the year ended March 31, 2022 also includes a gain of $59 million related to the sale of our Canadian health benefit claims management and plan administrative services business as well as a gain of $42 million related to the sale to WBA of our 30% interest in the German pharmaceutical wholesale joint venture to WBA. Operating loss for the year ended March 31, 2021 includes charges of $58&#160;million to remeasure to fair value the assets and liabilities of our German pharmaceutical wholesale business which was contributed to a joint venture. Operating loss for the year ended March 31, 2021 includes long-lived asset impairment charges of $115 million primarily related to our retail pharmacy businesses in Canada and Europe. Operating loss for the year ended March 31, 2021 includes a goodwill impairment charge of $69 million related to our European retail business.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the year ended March 31, 2022 includes charges of $55 million primarily related to the effect of accumulated other comprehensive loss components from our E.U. disposal group. Corporate expenses, net for the year ended March 31, 2022 includes charges of $42 million primarily related to the effect of accumulated other comprehensive loss components from our U.K. disposal group. Corporate expenses, net includes net gains from our equity investments of $98 million and $133 million for the years ended March 31, 2022 and 2021, respectively. Corporate expenses, net includes charges of $274 million and $8.1 billion for the years ended March 31, 2022 and 2021, respectively, related to our estimated liability for opioid-related claims. Corporate expenses, net includes $130 million and $153 million for the years ended March 31, 2022 and 2021, respectively, of opioid-related costs, primarily litigation expenses. Corporate expenses, net for the year ended March 31, 2021 includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the year ended March 31, 2022 consists of a charge of $191 million on debt extinguishment related to our July 2021 tender offer to redeem a portion of our existing debt.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March 31, 2022 compared to the prior year primarily due to growth in specialty pharmaceuticals and the contribution from our COVID-19 vaccine distribution program. Operating profit was unfavorably impacted by a decrease in net cash proceeds received of $135 million representing our share of antitrust legal settlements, an increase in operating expenses, and product mix and volume.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March 31, 2022 compared to prior year primarily driven by increased volumes with new and existing customers due to growth in our access and adherence solutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March 31, 2022 compared to prior year primarily due to favorability in our primary care business from improvements in patient care visits, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines. This increase was partially offset by inventory charges on certain PPE and other related products, and an increase in employee-related expenses to support business growth. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss increased for the year ended March 31, 2022 compared to the prior year primarily due to fair value remeasurement charges related to our E.U. disposal group and our U.K. disposal group, partially offset by the cessation of depreciation and amortization expenses, a prior year goodwill impairment charge related to our European retail business and a gain recognized related to the sale of our Canadian health benefit claims management and plan administrative services business. This segment also observed favorability year over year due to the distribution of COVID-19 vaccines, COVID-19 tests, and PPE, as well as volume recovery from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses across the segment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 vs. 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net decreased for the year ended March 31, 2022 compared to the prior year due to a charge of $8.1 billion recorded in 2021 related to our estimated liability for opioid-related claims. The decrease in Corporate expenses, net was partially offset by $274 million recorded in 2022 related to our estimated liability for opioid-related claims, a net gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$131 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> recognized in 2021 in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program, and fair value remeasurement charges related to our E.U. disposal group and our U.K. disposal group. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_58"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOREIGN OPERATIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign operations represented approximately 14% and 15% of our consolidated revenues in 2022 and 2021, respectively. Foreign operations are subject to certain risks, including currency fluctuations. Refer to Item 1A - Risk Factors in Part I of this Annual Report for a risk factor related to fluctuations in foreign currency exchange rates. We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate. We conduct our business worldwide in local currencies including Euro, British pound sterling, and Canadian dollar. As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.&#160;In discussing our operating results, we may use the term &#8220;foreign currency exchange fluctuations,&#8221; which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar. We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.&#160;In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S. dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our intention to exit our businesses in Europe. In 2022, we entered into agreements to sell the E.U. disposal group and U.K. disposal group and completed the previously announced sale of our Austrian business. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for more information on these European divestitures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information regarding our foreign operations is also included in Financial Note 21, &#8220;Segments of Business,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_61"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS COMBINATIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_64"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FISCAL 2023 OUTLOOK</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company&#8217;s fiscal 2023 outlook is contained in the release of our fourth quarter fiscal 2022 financial results included as an exhibit to our Form 8-K furnished to the SEC on May&#160;5, 2022, which is not incorporated by reference into this Annual Report. That Form 8-K should be read in conjunction with the forward-looking statements in the "Trends and Uncertainties" section of this Financial Review, as well as the cautionary statements in Item 1, "Business - Forward-Looking Statements," and Item 1A, "Risk Factors," in Part I of this Annual Report.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_67"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider an accounting estimate to be critical if the estimate requires us to make assumptions about matters based upon past experience and management&#8217;s judgment that were uncertain at the time the accounting estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations. Below are the estimates that we believe are critical to the understanding of our operating results and financial condition. Other accounting policies are described in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements included in this Annual Report. Because of the uncertainty inherent in such estimates, actual results may differ from these estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our receivables primarily consist of short-term trade accounts receivable from customers that result from the sale of goods and services. We also provide other customer financing arrangements to customers who purchase our products and services. Other customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories. We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans. We estimate the receivables for which we do not expect full collection based on historical collection rates and specific knowledge regarding the current creditworthiness of our customers and record an allowance in our consolidated financial statements for these amounts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers historical experience, the current economic environment, customer credit ratings or bankruptcies, legal disputes, and reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 52% of total consolidated revenues in 2022 and comprised approximately 43% of total trade accounts receivable at March 31, 2022. Sales to our largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of our total consolidated revenues in 2022 and comprised approximately 28% of total trade accounts receivable at March 31, 2022. As a result, our sales and credit concentration is significant. We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve methodologies are assessed annually based on historical losses and economic, business, and market trends. In addition, reserves are reviewed quarterly and updated if unusual circumstances or trends are present. We believe the reserves maintained and expenses recorded in 2022 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, trade and notes receivables were $16.8 billion prior to allowances of $99 million. In 2022, 2021 and, 2020, our provision for bad debts was $29 million, $4 million, and $91 million, respectively. At March&#160;31, 2022 and 2021, the allowance as a percentage of trade and notes receivables was 0.6% and 1.2%, respectively. An increase or decrease of a hypothetical 0.1% in the 2022 allowance as a percentage of trade and notes receivables would result in an increase or decrease in the provision for bad debts of approximately $17 million. The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios. Additional information concerning our allowances for credit losses may be found in Schedule II included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inventories consist of merchandise held for resale. We report inventories at the lower of cost or net realizable value, except for inventories determined using the LIFO method which are valued at the lower of LIFO cost or market. LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors relating to the purchase or distribution of inventory are considered product discounts and are accounted for as a reduction in the cost of inventory and are recognized when the inventory is sold. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether an inventory valuation allowance is required, we consider various factors including estimated quantities of slow-moving inventory by reviewing on-hand quantities, outstanding purchase obligations and forecasted sales. Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products or the loss of one or more significant customers are factors that could affect the value of our inventories. We write down inventories which are considered excess and obsolete as a result of these reviews. These factors could make our estimates of inventory valuation differ from actual results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and 2021, total inventories, net were $18.7 billion and $19.2 billion, respectively, in our Consolidated Balance Sheets. The LIFO method was used to value approximately 63% and 58% of our inventories at March 31, 2022 and 2021, respectively. If we had used the moving average method of inventory valuation, inventories would have been approximately $383&#160;million and $406&#160;million higher than the amounts reported at March 31, 2022 and 2021, respectively. These amounts are equivalent to our LIFO reserves. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. We recognized LIFO credits of $23 million, $38 million, and $252 million in 2022, 2021 and, 2020, respectively, in our Consolidated Statements of Operations. The lower LIFO credits in 2022 compared to 2021 are primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, our LIFO inventory is valued at the lower of LIFO or market.&#160;As of March&#160;31, 2022 and 2021, inventories at LIFO did not exceed market. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that we obtain control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life. Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information regarding our acquisitions. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Long-Lived Assets:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of acquiring businesses, we have $9.5 billion of goodwill at March 31, 2022 and 2021, and $2.1 billion and $2.9&#160;billion of intangible assets, net at March 31, 2022 and 2021, respectively. We perform an impairment test on goodwill balances annually in the third quarter and more frequently if indicators for potential impairment exist. Indicators that are considered include significant declines in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends, or a significant decline in the Company&#8217;s stock price and/or market capitalization for a sustained period of time. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or a component, one level below our operating segments, for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and an impairment charge is recorded equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach. Under the market approach, we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, we use a discounted cash flow model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. In addition, we compare the aggregate of the reporting units&#8217; fair values to our market capitalization as further corroboration of the reasonableness of our concluded fair values.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of fair value result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions at a point in time. Judgments made in determining an estimate of fair value may materially impact our results of operations.&#160;The valuations are based on information available as of the impairment testing date and are based on expectations and assumptions that have been deemed reasonable by management. Any material changes in key assumptions, including failure to meet business plans, negative changes in government reimbursement rates, deterioration in the U.S. and global financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances may decrease the projected cash flows or increase the discount rates and could potentially result in an impairment charge. Under the market approach, significant estimates and assumptions also include the selection of appropriate guideline companies and the determination of appropriate valuation multiples to apply to the reporting unit. Under the income approach, significant estimates and assumptions also include the determination of discount rates.&#160;The discount rates represent the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing, which are weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital structure. Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units&#8217; future cash flow projections. An increase in the unsystematic risk premium increases the discount rate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for 2022, 2021, and 2020 did not indicate any impairment of goodwill. The segment change in the second quarter of 2021 prompted changes in multiple reporting units across the Company and as a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. We recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. At March 31, 2022 and 2021, the balance of goodwill in the International segment primarily relates to our McKesson Canada reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our McKesson Canada reporting unit in our International segment exceeded the carrying value of the reporting unit by 22% in 2022. The goodwill balance of this reporting unit was $1.5 billion at March 31, 2022, or approximately 16% of the consolidated goodwill balance. Generally, a decline in estimated future cash flows in excess of approximately 22% for McKesson Canada or an increase in the discount rate in excess of approximately 2% could result in an indication of goodwill impairment for this reporting unit in future reporting periods under the income approach. Other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods. Refer to Financial Note 11, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the consolidated financial statements included in this Annual Report for additional information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, all of our intangible and other long-lived assets are amortized or depreciated based on the pattern of their economic consumption or a straight-line&#160;basis over their estimated useful lives, ranging from one to 24 years.&#160;We review intangible and other long-lived assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.&#160;Determination of recoverability of intangible and other long-lived assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition.&#160;Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.&#160;Assumptions and estimates about future values and remaining useful lives of our purchased intangible assets are complex and subjective.&#160;They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing consideration of all the factors described previously could result in further impairment charges in the future, which could adversely affect our net income. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for additional information on our long-lived asset impairments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets classified as held for sale are measured at the lower of carrying amount or fair value less costs to sell, and are not depreciated or amortized. Fair value is determined based on the total consideration expected to be received by the Company. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Equity Method Investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We evaluate our investments for other-than-temporary impairments when circumstances indicate those assets may be impaired. When the decline in value is deemed to be other than temporary, an impairment is recognized to the extent that the fair value is less than the carrying value of the investment. We consider various factors in determining whether a loss in value of an investment is other than temporary including: the length of time and the extent to which the fair value has been below cost, the financial condition of the investees, and our intent and ability to retain the investment for a period of time sufficient to allow for recovery of value. Management makes certain judgments and estimates in its assessment including but not limited to: identifying if circumstances indicate a decline in value is other than temporary, expectations about the business operations of investees, as well as industry, financial, and market factors. Any significant changes in assumptions or judgments in assessing impairments could result in an impairment charge.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax expense and deferred tax assets and liabilities reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax provision and in evaluating income tax uncertainties, including those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, and may differ from the actual amounts of tax benefit recognized. We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating our ability to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income. In estimating future taxable income, we develop assumptions including the amount of future federal, state, and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Should tax laws change, our tax expense and cash flows could be materially impacted. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the calculation of our tax liabilities includes estimates for uncertainties in the application of complex new tax regulations across multiple global jurisdictions where we conduct our operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which, additional taxes and related interest will be due. If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result. If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, including claims with customers and vendors, pending and potential legal actions for damages, investigations relating to laws and regulations and other matters arising out of the normal conduct of our business. When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict, and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided. Legal fees are recognized as incurred when the legal services are provided.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the potential loss or range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. In conjunction with the preparation of the consolidated financial statements included in this Annual Report, we considered matters related to ongoing controlled substances claims to which we are a party. On February 25, 2022, the Company and two other U.S. pharmaceutical distribution companies (collectively, &#8220;Distributors&#8221;) determined that there is sufficient state and subdivision participation to proceed with an agreement to settle a substantial majority of opioid-related lawsuits filed against the Distributors by U.S. states, territories, and local governmental entities. Based on our estimated liability under the Settlement and to governmental entities not expected to participate in the settlement, we recorded a charge of $8.1 billion for the year ended March 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in our Consolidated Statement of Operations included in this Annual Report. In connection with the Settlement and other opioid-related settlement accruals, we recorded additional charges of $274 million during the year ended March 31, 2022 within &#8220;Claims and litigation charges, net,&#8221; in our Consolidated Statement of Operations. Because of the many uncertainties associated with the remaining opioid-related litigation matters, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. While we are not able to predict the outcome or reasonably estimate a range of possible losses in these matters, an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, financial position, cash flows, or liquidity. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report for additional information. </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_70"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility. At March 31, 2022, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash classified within Assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,461)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,834)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying consolidated financial statements included in this Annual Report for further information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided from operating activities was $4.4 billion and $4.5 billion for the years ended March 31, 2022 and 2021, respectively. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. Operating activities for the year ended March 31, 2022 were affected by net income adjusted for non-cash items, including the losses on our European businesses held for sale and our classifications of receivables, drafts and accounts payables, and inventories as held for sale. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for further information. Excluding the aforementioned classifications, operating activities for the year ended March 31, 2022 were affected by increases in inventory of $1.2 billion and drafts and accounts payable of $2.8 billion due to timing of purchases, and an increase in receivables of $1.8 billion resulting from timing of collections and higher revenues. Operating activities for the year ended March 31, 2021 were affected by net income adjusted for non-cash items, including the pre-tax $8.1 billion (after-tax $6.8 billion) non-cash charge related to our estimated liability for opioid-related claims, an increase in inventory of $2.3 billion and an increase in drafts and accounts payable of $1.3 billion driven by higher inventory stock levels to meet increased volume demand as part of our inventory management, as well as a decrease in receivables of $1.1 billion driven by timing, higher sales recognized at the end of March 2020, and higher collections in our fourth quarter of 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-cash items within operating activities for the year ended March 31, 2022 includes an adjustment to net income of $191 million related to loss on debt extinguishment, non-cash inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment, and stock-based compensation of $161 million. Other non-cash items for the year ended March 31, 2021 primarily includes stock-based compensation of $151 million and fair value remeasurement charges of $58 million related to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $89 million and $415 million for the years ended March 31, 2022 and 2021, respectively. Investing activities for the year ended March 31, 2022 include $388 million and $147 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in capital expenditures for property, plant, and equipment and capitalized software, respectively. Investing activities for the year ended March 31, 2022 also includes net cash proceeds of $578 million from sales of businesses and investments, primarily driven by our European divestiture activities described above including the disposal of our Austria business, and the sale of certain of our equity investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities for the year ended March 31, 2021 include $451 million and $190 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in capital expenditures for property, plant, and equipment and capitalized software, respectively. Investing activities for the year ended March 31, 2021 also includes net cash proceeds of $400 million from sales of businesses and investments, including $286 million in exchange for the contribution of our German pharmaceutical wholesale business to a joint venture with WBA.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $6.3&#160;billion and $1.7&#160;billion for the years ended March 31, 2022 and 2021, respectively. Financing activities for the year ended March 31, 2022 include cash receipts of $11.2 billion and payments of $11.2 billion for short-term borrowings of commercial paper. Financing activities for the year ended March 31, 2022 include a cash tender offer of $1.1&#160;billion to redeem certain notes with a principal amount of $922 million and the redemption of our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709 million) prior to the maturity date of August 17, 2021 using cash on hand. This resulted in total repayments of long-term debt during the year ended March 31, 2022 of $1.8&#160;billion, including $184 million of cash paid for premiums and transaction fees. This was partially offset by the issuance of long-term debt in August 2021 from a public offering of 1.30% notes due August 15, 2026 for proceeds received of $498 million, which was utilized for general corporate purposes. Financing activities for the year ended March 31, 2022 also include $3.5&#160;billion of cash paid for share repurchases and $277 million of cash paid for dividends. Additionally, financing activities for the year ended March 31, 2022 include payments of $1.0&#160;billion to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. Cash used for other financing activities for the year ended March 31, 2022 includes payments to noncontrolling interests, and funds temporarily held on behalf of unaffiliated medical practice groups.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities for the year ended March 31, 2021 include cash receipts of $6.3 billion and payments of $6.3 billion from short-term borrowings of commercial paper, along with the issuance of the 2025 Notes in a principal amount of $500&#160;million, the retirement of our $700&#160;million total principal amount of notes due on November 30, 2020 at a fixed interest rate of 3.65% upon maturity, and the redemption of our 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. The notes were redeemed using cash on hand and proceeds from the 2025 Notes. Financing activities for the year ended March 31, 2021 also include $742 million of cash paid for stock repurchases and $276 million of dividends paid. Cash used for other financing activities generally includes payments to noncontrolling interests and activity from our finance leases. Other financing activities for the year ended March 31, 2021 also include restricted cash net inflow related to funds temporarily held on behalf of unaffiliated medical practice groups.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions. During the last two years, our share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the share repurchase activity over the last two years is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_6597069768797"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days sales outstanding for: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Based on year-end balances and sales or cost of sales for the last 90 days of the year.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as the sum of short-term borrowings, current portion of long-term debt, and long-term debt divided by the sum of short-term borrowings, current portion of long-term debt, long-term debt, and McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of&#160;March 31, 2022 and 2021&#160;included approximately $1.5 billion and&#160;$2.3 billion&#160;of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other accrued liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital decreased at March 31, 2022 compared to the prior year primarily due to a decrease in cash and cash equivalents and receivables, as well as an increase in other accrued liabilities and an increase in our current portion of debt, partially offset by a decrease in drafts and accounts payable, and an increase in net current assets held for sale related to our E.U. disposal group and U.K. disposal group. Consolidated working capital improved at March 31, 2021 compared to the prior year primarily due to an increase in cash and cash equivalents and inventory, partially offset by an increase in drafts and accounts payable and a decrease in receivables.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the year ended March 31, 2022 primarily due to an increase in McKesson stockholders&#8217; deficit driven by share repurchases, partially offset by net income for the year to date period. Our debt to capital ratio was also impacted by a decrease in total debt from the completion of a cash tender offer to redeem certain notes with a principal amount of $922 million and the redemption of our &#8364;600 million Euro-denominated notes both in July 2021, partially offset by the issuance of notes with a principal amount of $500 million in August 2021. Our debt to capital ratio increased for 2021 primarily due to a decrease in stockholders&#8217; equity driven by net loss for the year and share repurchases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, we raised our quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. Dividends were $1.83 per share in 2022 and $1.67 per share in 2021. We anticipate that we will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors. In 2022 and 2021, we paid total cash dividends of $277 million and $276 million, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our redeemable noncontrolling interests primarily related to our consolidated subsidiary, McKesson Europe. At March 31, 2021, the carrying value was $1.3 billion and we owned approximately 78% of McKesson Europe&#8217;s outstanding common shares. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). During 2022 and 2021, we paid $1.0 billion and $49 million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders, which reduced the balance of our redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, valued at $287 million, were transferred from redeemable noncontrolling interests to noncontrolling interests. At March 31, 2022, we owned approximately 95% of McKesson Europe&#8217;s outstanding common shares. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period in &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six months&#8217; advance notice. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our noncontrolling interest in McKesson Europe will be included in the sale of our E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying consolidated financial statements included in this Annual Report. Refer to Financial Note 8, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying consolidated financial statements included in this Annual Report for additional information regarding redeemable noncontrolling interests.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Cash Requirements: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table and information below presents our significant financial obligations and commitments as of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 1 to 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 3 to 5</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">On balance sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Off balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,814&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents maturities of the Company&#8217;s long-term obligations, including an immaterial amount of finance lease obligations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents undiscounted minimum operating lease obligations under non-cancelable operating leases having an initial remaining term over one year and is not adjusted for imputed interest. Refer to Financial Note 10, &#8220;Leases&#8221; to the consolidated financial statements included in this Annual Report for more information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes our estimated benefit payments for the unfunded benefit plans and minimum funding requirements for the pension plans. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents interest that will become due on our fixed rate long-term debt obligations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily relates to the expected purchase of goods and services, including inventory and capital commitments, from vendors in the normal course of business. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes agreements under which we have guaranteed the repurchase of our customers&#8217; inventory and our customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material cash requirements table above excludes the following obligations:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company accrued $8.3 billion related to the settlement of opioid-related litigation claims with governmental entities, as described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report. The majority of this amount relates to a global settlement payable in annual installments for up to 18 years pursuant to the schedule set forth in the agreement. We expect to pay $1.0 billion prior to March 31, 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the liability recorded for uncertain tax positions, excluding associated interest and penalties, was approximately $1.0 billion. The ultimate amount and timing of any related future cash settlements cannot be predicted with reasonable certainty.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our banks and insurance companies have issued $214 million of standby letters of credit and surety bonds at March 31, 2022. These were issued on our behalf and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and our workers&#8217; compensation and automotive liability programs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_46">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (Concluded)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements, including any future payments that may be made related to our total estimated litigation liability of $8.3 billion as of March 31, 2022 for opioid-related claims, are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, are open and accessible to us should we decide to access those markets. Detailed information regarding our debt and financing activities is included in Financial Note 12, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_73"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELATED PARTY BALANCES AND TRANSACTIONS </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our related party balances and transactions is included in Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 20, &#8220;Related Party Balances and Transactions,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_76"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted, as well as those that have been recently issued but not yet adopted by us, are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_79"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balances earn interest at variable rates. At March 31, 2022 and 2021, we had $3.5 billion and $6.3 billion, respectively, in cash and cash equivalents. The effect of a hypothetical 50 basis points increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings, would not have resulted in a material impact to earnings in 2022 or 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange rate risk: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollar. Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars. We are also exposed to foreign currency exchange rate risk related to our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. The forward contracts and cross-currency swaps are intended to reduce the income statement effects from fluctuations in foreign currency exchange rates and have been designated as cash flow hedges. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022 and 2021, the effect of a hypothetical adverse 10% change in the underlying foreign currency exchange rates would have impacted the fair value of our foreign exchange contracts by approximately $122 million and $267 million, respectively. However, our risk management programs are designed such that the potential loss in value of these risk management portfolios described above would be largely offset by changes in the value of the underlying exposure. Refer to Financial Note 15, &#8220;Hedging Activities,&#8221; for more information on our foreign currency forward contracts and cross-currency swaps.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our intention to exit our businesses in Europe. During 2022, we entered into an agreement to sell certain of our businesses in the European Union which is anticipated to close within the second half of fiscal year 2023. We also completed the sale of our Austrian business during 2022 and, on April 6, 2022, we completed the sale of our retail and distribution businesses in the United Kingdom. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the consolidated financial statements included in this Annual Report for more information on these divestitures. Subsequent to the completion of these divestitures, our foreign currency exchange rate risk will be primarily limited to the Canadian dollar.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The selected hypothetical change in interest rates and foreign currency exchange rates does not reflect what could be considered the best or worst case scenarios.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_82"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Supplementary Data.</span></div><div style="margin-bottom:12pt;padding-left:27pt;padding-right:27pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_85">Management's Annual Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_85">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_88">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_88">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">Consolidated Statements of Operations for the years ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">, and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">Consolidated Statements of Comprehensive Income (Loss) for the years ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">Consolidated Balance Sheets as of March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">Consolidated Statements of Stockholders&#8217; Equity</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100"> (Deficit)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100"> for the years ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">, and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">Consolidated Statements of Cash Flows for the years ended March 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">, and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_106">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_106">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_109">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_109">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_115">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_115">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_115"> - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_115">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_118">Note 3 - Restructuring, Impairment, and Related Charges, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_118">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_121">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_121">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_121"> - Business Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_121">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_124">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_124">5</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_124"> - Share-Based Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_124">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_127">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_127">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_127"> - Other Income, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_127">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_130">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_130">7</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_130"> - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_130">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_133">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_133">8</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_133"> - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_133">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_136">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_136">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_136"> - Earnings</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_136"> (Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_136"> per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_136">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_139">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_139">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_139"> - Leases</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_139">101</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_142">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_142">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_142"> - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_142">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_145">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_145">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_145"> - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_145">107</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_148">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_148">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_148"> - Variable Interest Entities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_148">109</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_151">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_151">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_151"> - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_151">109</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_154">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_154">5</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_154"> - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_154">116</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_157">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_157">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_157"> - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_157">119</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_160">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_160">7</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_160"> - Financial Guarantees and Warranties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_160">121</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_163">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_163">8</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_163"> - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_163">122</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_166">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_166">19</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_166"> - Stockholders' Equit</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_166">y </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_166">(Deficit)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_166">129</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_169">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_169">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_169"> - Related Party Balances and Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_169">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_172">Note 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_172">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_172"> - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_172">132</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_85"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management of McKesson Corporation is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the framework and criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deloitte &amp; Touche LLP, an independent registered public accounting firm, audited the financial statements included in this Annual Report on Form 10-K and has also audited the effectiveness of the Company&#8217;s internal control over financial reporting as of March 31, 2022. This audit report appears on the following page of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;9, 2022 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Brian S. Tyler</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_88"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of McKesson Corporation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of McKesson Corporation and subsidiaries (the &#8220;Company&#8221;) as of March 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity, and cash flows, for each of the three years in the period ended March 31, 2022, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the &#8220;financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of March 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2022, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our responsibility is to express an opinion on these financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Liabilities - Opioid Claims brought by United States (U.S.) Governmental Entities - Refer to Note 1 and Note 18 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances, including opioids. The Company is named as a defendant along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, hospitals, tribal nations, health and welfare funds, third-party payors and individuals. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, the Company and two other United States pharmaceutical distribution companies (collectively, "Distributors") determined that there is sufficient State and subdivision participation to proceed with an agreement ("Settlement") to settle a substantial majority of opioid-related lawsuits filed against the Distributors by U.S. states, territories and local governmental entities (collectively, "Settling Governmental Entities"). The Settlement became effective on April 2, 2022. If all conditions to the Settlement are satisfied, the Distributors would pay the Settling Governmental Entities up to approximately $19.5 billion over 18 years, with up to approximately $7.4 billion to be paid by the Company for its 38.1% portion. Although the Settlement terminated the substantial majority of opioid-related suits pending against the Company, a small number of subdivisions in participating states have opted not to participate in the Settlement, and those suits remain pending. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its estimate for the ultimate loss. The Company reviews all loss contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. The Company also performs an assessment of loss contingencies where a loss is reasonably possible. If it is reasonably possible that a loss may have been incurred and the effect on the financial statements could be material, the Company discloses the nature of the loss contingency and an estimate of the possible loss or range of loss or a statement that such an estimate cannot be made within the notes to the financial statements. For the year ended March 31, 2022, management believes that a loss from opioid claims is both probable and reasonably estimable, and accordingly, an $8.3 billion liability has been recorded by management, inclusive of claims brought by U.S. governmental entities, which represents the Company&#8217;s best estimate of future loss related to opioid litigation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the liabilities associated with opioid claims brought by both Settling Governmental Entities, as well as U.S. governmental entities who are not party to the Settlement, collectively &#8220;Governmental Entities,&#8221; as a critical audit matter because of the significant judgment in auditing management&#8217;s accounting for these matters. Such judgment led to an increased extent of effort, including the need to involve specialists. Specifically, auditing management&#8217;s assessment of the magnitude of the liability and the determination of whether there is a reasonably estimable range of loss in excess of the amount accrued, is subjective and requires significant judgment given the size and complexity of opioid claims brought by Governmental Entities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to liabilities arising from opioid claims brought by Governmental Entities included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to liabilities arising from opioid claims brought by Governmental Entities, and approval of the accounting treatment and related disclosures. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We inquired of the Company&#8217;s internal and external legal counsel, as well as executives and other members of management, to understand the basis for the Company&#8217;s conclusion that a loss related to opioid claims brought by Governmental Entities is probable and reasonably estimable, and that it is not possible to estimate a range of loss in excess of the amount accrued as of March 31, 2022. In addition, we inspected responses to inquiry letters sent to both internal and external legal counsel as it relates to the terms of settlements with Governmental Entities. We also made inquiries of legal counsel regarding the status of discussions and legal proceedings with Governmental Entities who are not currently party to the Settlement. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s analysis of liabilities arising from opioid claims brought by Governmental Entities, including the methodology used by management to determine the probability of such loss and conclusion that it is not possible to estimate a range of loss in excess of the amount accrued as of March 31, 2022. We also evaluated the methodology used by management to estimate the most likely loss to be incurred by the Company as a result of these specific opioid claims. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined Board of Directors meeting minutes, including relevant sub-committee meeting minutes, held inquiries with a director serving on the sub-committee, and compared to internal and external counsel&#8217;s written responses to our inquiry letters. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our specialists in accounting for loss contingencies, we evaluated the facts, evidence and the Company&#8217;s related accounting treatment for liabilities arising from opioid claims brought by Governmental Entities.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated any events subsequent to March 31, 2022 that might impact management&#8217;s accounting treatment.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We obtained written representations from executives and internal counsel of the Company.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined the terms related to settlements with Governmental Entities.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the adequacy of the Company&#8217;s related disclosures for consistency with our testing.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain Tax Position - Opioid Claims brought by Governmental Entities - Refer to Note 1 and Note 7 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded charges and related tax benefit for opioid-related claims, inclusive of those brought by Governmental Entities. In order to account for the uncertainty associated with the ultimate realization of the tax benefit related to opioid claims, the Company recorded an uncertain tax position reserve. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The net amount recognized by management is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized. The Company uses significant judgment in evaluating the technical tax merits of income tax benefits that qualify for recognition, including the determination of the amount that is more likely than not of being realized for U.S. federal and state income tax purposes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the Company&#8217;s uncertain tax position related to liabilities arising from opioid claims brought by Governmental Entities as a critical audit matter because of the challenges in auditing management&#8217;s estimate of the amount of income tax benefit that qualifies for recognition. Specifically, there is significant judgment associated with the assessment of the technical tax merits of such a settlement, including the related interpretation of applicable, newly-enacted tax laws and regulations. Auditing the uncertain tax position related to liabilities arising from opioid claims brought by Governmental Entities required a high degree of auditor judgment and an increased extent of effort, including the need to involve our tax specialists.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Company's uncertain tax position associated with liabilities arising from opioid claims brought by Governmental Entities included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to the Company&#8217;s assessment of the technical merits of its tax position, including the Company&#8217;s assessment as to the amount of benefit that is more likely than not to be realized upon settlement with a taxing authority that has full knowledge of all relevant information. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our tax specialists, we evaluated the facts, evidence and the Company&#8217;s related income tax analysis for liabilities arising from opioid claims brought by Governmental Entities, including assumptions used by management to measure the related recognized and unrecognized tax benefits.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We inquired of the Company&#8217;s internal and external legal counsel to understand the basis for the Company&#8217;s conclusion that a portion of the liabilities arising from opioid claims brought by Governmental Entities would be deductible based on the settlement terms, and expected documentation to be received from Governmental Entities regarding how settlement funds are used. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We held inquiries with the Company&#8217;s internal and external income tax specialists related to the uncertain tax position for liabilities arising from opioid claims brought by Governmental Entities.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We compared management's income tax assessment of this matter to the Company&#8217;s treatment of other recorded opioid charges to evaluate the consistency of the Company&#8217;s judgments related to the uncertain tax position.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated any events subsequent to March 31, 2022 that might impact management&#8217;s accounting treatment.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We obtained written representations from executives and internal counsel of the Company.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined terms related to settlements of opioid claims brought by Governmental Entities.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the Company&#8217;s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to the opioid litigation with Governmental Entities.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill - Refer to Note 1 and Note 11 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s evaluation of goodwill for impairment involves comparing the carrying amount of each reporting unit to its fair value on the first day of the third fiscal quarter or whenever the Company believes a potential indicator of impairment requiring a more frequent assessment has occurred. The Company uses a combination of the income and market approaches to estimate reporting unit fair value. Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose equity securities are actively traded in public markets. Under the income approach, the Company uses a discounted cash flow (&#8220;DCF&#8221;) model where cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate discount rate that is commensurate with the risk inherent within the reporting unit. The rate used to discount to present value includes an unsystematic risk premium, which is intended to address uncertainty related to the reporting unit&#8217;s future cash flow projections. The goodwill balance was $9.5 billion as of March 31, 2022, of which $1.5 billion was allocated to the McKesson Canada reporting unit. The fair value of all reporting units exceeded their respective carrying amounts as of the measurement date and, therefore, no impairment was recognized.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium. In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by potential additional risk of changes in the Canadian business and regulatory environments. Auditing management&#8217;s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Company&#8217;s selection of a discount rate, including determination of the unsystematic risk premium, for the McKesson Canada reporting unit, included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to management&#8217;s goodwill impairment evaluation, including those related to the selection of a discount rate and determination of an unsystematic risk premium.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s ability to accurately forecast operating results for the McKesson Canada reporting unit by comparing actual results to management&#8217;s historical forecasts, in order to consider the reasonableness and adequacy of management&#8217;s selected unsystematic risk premium.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actual results of historical strategic plans</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Internal communications to management and the Board of Directors</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation, and comparing to the discount rate selected by management.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV84OC9mcmFnOjczNTUwNWI5YzhjMDQxZGNhNDhhZDAyYjRjZTM4MTQ0L3RhYmxlOjU1YjkwMzY2ZGFhODQ0ODBiNDhiZWFiOWQ1MDRlY2JjL3RhYmxlcmFuZ2U6NTViOTAzNjZkYWE4NDQ4MGI0OGJlYWI5ZDUwNGVjYmNfMS0wLTEtMS0xMTQwMDUvdGV4dHJlZ2lvbjo3NTYxMGQwZWQzMjY0NGFjODBkNDYxZDM4NTNmNzJmZl8xMDk5NTExNjI3ODI3_12e990ed-5ce9-4b2a-8762-20631b9798c9">Deloitte &amp; Touche LLP</ix:nonNumeric></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV84OC9mcmFnOjczNTUwNWI5YzhjMDQxZGNhNDhhZDAyYjRjZTM4MTQ0L3RhYmxlOjU1YjkwMzY2ZGFhODQ0ODBiNDhiZWFiOWQ1MDRlY2JjL3RhYmxlcmFuZ2U6NTViOTAzNjZkYWE4NDQ4MGI0OGJlYWI5ZDUwNGVjYmNfMi0wLTEtMS0xMTYxOTAvdGV4dHJlZ2lvbjo1MzhkYTc4ZGJhMTk0ZTJlOWZiNjlmNDg5MTY1NDg2Yl8xMDk5NTExNjI3ODA2_d2060ae4-df76-4cbc-9699-a3836612f22d">Dallas, Texas</ix:nonNumeric></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1968.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMi0xLTEtMS02NzUxMg_b9a941c8-8b60-4f6d-ba3a-fe5e6c68f590">263,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMi0zLTEtMS02NzUxMg_d0ee2eb6-4648-4b00-871d-039387870058">238,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMi01LTEtMS02NzUxMg_c7663d06-67f1-4146-bd13-5a149918cd25">231,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMy0xLTEtMS02NzUxMg_2d9fa583-4277-4818-8f2f-92fb6c88b56f">250,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMy0zLTEtMS02NzUxMg_d1d1fe69-702d-4971-8feb-f2ff661ebee3">226,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMy01LTEtMS02NzUxMg_057d9904-510d-4ffe-89fc-3245cee81bb9">219,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNC0xLTEtMS02NzUxMg_6952c2ea-a31e-48cf-9945-06f1a5fc01b7">13,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNC0zLTEtMS02NzUxMg_ef380361-1664-4920-924d-7929ca5e608a">12,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNC01LTEtMS02NzUxMg_4362c69a-bea0-493b-b0fe-06c1b7152c51">12,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNi0xLTEtMS02NzUxMg_daf41ea2-2acf-4bdc-9117-440e99491d4f">10,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNi0zLTEtMS02NzUxMg_327005c0-866e-401c-9231-b7981668553c">8,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNi01LTEtMS02NzUxMg_751a2e86-c9f5-474d-ad0c-bfcbd2fc5190">9,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNy0xLTEtMS02NzUxMg_1ffd150f-1192-41eb-8e61-dad7ef120460">274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNy0zLTEtMS02NzUxMg_2ab43854-e62c-4c27-919f-3fe8c66881bd">7,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNy01LTEtMS02NzUxMg_dadc9af0-d9f4-4ce1-9765-509a934f675b">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOC0xLTEtMS02NzUxMg_c90d2450-487e-427a-8792-a82e63c1879f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOC0zLTEtMS02NzUxMg_287afff0-8f4e-4031-88e6-10f2a38d46f5">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOC01LTEtMS02NzUxMg_a1880056-17aa-4974-b151-4223f55f925e">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOS0xLTEtMS02NzUxMg_a059a6cb-81cd-4d03-850e-8ed14ff972ec">281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOS0zLTEtMS02NzUxMg_7c8ac650-d29e-4c2a-a597-6067153e71fa">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOS01LTEtMS02NzUxMg_7bc20250-d9d7-48de-aa33-6f5591411930">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTItMS0xLTEtNjc1MTI_1691d8a9-1fb1-47a2-adce-3afd3a93938e">11,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTItMy0xLTEtNjc1MTI_22498174-5d45-46f5-8ca3-4cbf376f5fc1">17,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTItNS0xLTEtNjc1MTI_f6e0d7ee-7204-4abc-8d76-59a7848d66ed">9,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTMtMS0xLTEtNjc1MTI_d3aa54e6-3633-4db9-97a5-e219a29085ed">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTMtMy0xLTEtNjc1MTI_2623e02d-4096-4218-8e94-e96116e1b3fe">5,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTMtNS0xLTEtNjc1MTI_d5c7ba30-faef-4435-ad89-621999a51004">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTQtMS0xLTEtNjc1MTI_c9e0f51b-52e9-4d0a-a670-2b46707044f9">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTQtMy0xLTEtNjc1MTI_d5200a52-43e9-420b-981c-032a52dc6a95">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTQtNS0xLTEtNjc1MTI_ba049949-f7fe-4bef-bfa9-07e9e6b0c2bd">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTUtMS0xLTEtNjc1MTI_6383b927-5085-46f9-a0ec-bec0ae65b02f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTUtMy0xLTEtNjc1MTI_319e1d4a-bf3e-4027-b5cd-bdde6b234654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTUtNS0xLTEtNjc1MTI_d1e52688-b106-477b-9bcb-1392c1c925e7">1,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTYtMS0xLTEtNjc1MTI_eca20904-4fe8-4216-8216-84a3254501df">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTYtMy0xLTEtNjc1MTI_a6baa461-d835-4db6-9d43-3d82f90d7429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTYtNS0xLTEtNjc1MTI_b6a60aba-1cdd-456d-ab1e-c85e7f11812f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTctMS0xLTEtNjc1MTI_b3b169e5-e9da-40ae-93a0-f4b225b6aa28">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTctMy0xLTEtNjc1MTI_81e93428-57a5-4e0c-838e-2c3a7550adab">217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTctNS0xLTEtNjc1MTI_0206cf1e-3ade-45e1-9c40-7f30c0ff34c4">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTgtMS0xLTEtNjc1MTI_cf053e6d-c510-48a0-84e0-d08b05b53dec">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTgtMy0xLTEtNjc1MTI_b389c6f5-ab97-454b-991b-073160dd741d">5,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTgtNS0xLTEtNjc1MTI_08584e98-2f41-4442-9662-0b085980533f">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTktMS0xLTEtNjc1MTI_f7b5bb0f-c729-4634-966b-04fd5173a812">636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTktMy0xLTEtNjc1MTI_3bce8f66-c8f2-4413-b7c4-48fbc783caf3">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTktNS0xLTEtNjc1MTI_1209dd7f-852e-4ef3-b160-6ffcb58becc5">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjAtMS0xLTEtNjc1MTI_d5df88bb-5001-4174-bbf3-1139c33053ab">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjAtMy0xLTEtNjc1MTI_e1035e63-9691-490f-84b4-1a541ad2d55d">4,339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjAtNS0xLTEtNjc1MTI_98615732-93e4-4c1b-aad4-9c213b8bda52">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjEtMS0xLTEtNjc1MTI_5908d99c-5ad3-4472-9eae-8c84d175df59">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjEtMy0xLTEtNjc1MTI_7b2542d6-30a0-4dba-afed-059a26b3e6d1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjEtNS0xLTEtNjc1MTI_6fcabd47-1cf4-4a5f-aeb3-148d571e8b22">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjItMS0xLTEtNjc1MTI_23cc31a9-0f5a-45da-b562-4e523dd76b97">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjItMy0xLTEtNjc1MTI_03afa165-f0fd-4044-a28f-2180c98c9514">4,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjItNS0xLTEtNjc1MTI_fe4edbd7-46c6-4ad7-be64-d1b4923ed58f">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjMtMS0xLTEtNjc1MTI_3b0479bf-2592-4706-b0ff-5ca57b0e70ba">173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjMtMy0xLTEtNjc1MTI_8cb72bde-a3b9-4f01-85aa-f0a2b247410d">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjMtNS0xLTEtNjc1MTI_670286f2-5a49-4eea-b466-d7882a3a78e4">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjQtMS0xLTEtNjc1MTI_ae5b2455-5694-4f7f-b16f-54cd14798a22">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjQtMy0xLTEtNjc1MTI_8655abfc-f229-4127-a7f7-d3a4f2b90b78">4,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjQtNS0xLTEtNjc1MTI_d8fc8e96-6d4b-4d2e-b6da-6fb42c7f9140">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjgtMS0xLTEtNjc1MTI_1bbb08f1-8e03-4947-b42e-c0364bcc8137">7.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjgtMy0xLTEtNjc1MTI_1c31b788-4b28-47a7-91fc-92d05d1a51bb">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjgtNS0xLTEtNjc1MTI_204ce099-ee6b-4861-9f39-b3e3357442eb">4.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjktMS0xLTEtNjc1MTI_cc41b691-0122-4e36-b51a-020a3e1f4a4e">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjktMy0xLTEtNjc1MTI_67ab49ae-42f3-441c-8bd3-8997bcbf30a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjktNS0xLTEtNjc1MTI_2d3f6a7f-da1c-4d28-b592-cb5068bd4662">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzAtMS0xLTEtNjc1MTI_dd2cffc7-9e09-4a83-adc1-2581dd99bf68">7.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzAtMy0xLTEtNjc1MTI_c6c9f7b3-1fb8-472a-917d-4298fd0c05d5">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzAtNS0xLTEtNjc1MTI_e2a07f9a-72f9-4d15-ab56-4c59def88d0f">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzItMS0xLTEtNjc1MTI_575b8eee-6745-45e8-bcee-0b789a41f80b">7.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzItMy0xLTEtNjc1MTI_b82602df-a582-42fd-b94f-1f3c2861fb27">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzItNS0xLTEtNjc1MTI_a0106c85-c03d-4555-85f5-b791fbddb0b5">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzMtMS0xLTEtNjc1MTI_50597ce1-79dd-4bc1-9805-c37b8aca8635">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzMtMy0xLTEtNjc1MTI_15c115ae-8c1a-4a5a-99b0-6303f42213a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzMtNS0xLTEtNjc1MTI_1f63acd6-b370-4ad3-84c6-9140fe1252f1">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzQtMS0xLTEtNjc1MTI_ebfc9553-eb37-4e07-aaa5-d85c16314436">7.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzQtMy0xLTEtNjc1MTI_e1f3468b-244f-42b4-9528-e642efaffa8f">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzQtNS0xLTEtNjc1MTI_81c1f699-0deb-4376-97ae-c9bc94b56e74">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzctMS0xLTEtNjc1MTI_5adb72aa-ada8-4d73-a7aa-22d1ab11d7dd">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzctMy0xLTEtNjc1MTI_9dcbc3e3-2210-470f-8cab-38bef81a40cc">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzctNS0xLTEtNjc1MTI_658d8a87-ecdd-4c1c-82b2-99796e343097">181.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzgtMS0xLTEtNjc1MTI_ea20c6dd-3eed-4a48-abc5-7bbfbd68741f">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzgtMy0xLTEtNjc1MTI_5aaa2018-e06a-446c-a288-18b84ee40d5c">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzgtNS0xLTEtNjc1MTI_a549191c-1310-4fcb-9066-43ac3bf3c071">180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMi0xLTEtMS02NzUxMg_a76d9fdd-f276-47f8-968b-9e1f7fa9639f">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMi0zLTEtMS02NzUxMg_5934a6e2-eb06-4cc0-917f-9caaf546530f">4,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMi01LTEtMS02NzUxMg_c6cf5c3e-f049-46c1-923f-3b591aacbf86">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNS0xLTEtMS02NzUxMg_b1c2079f-2401-433c-ac37-d80f203ed8b2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNS0zLTEtMS02NzUxMg_4daca2f1-8e0a-42bc-852d-c481bd7504bd">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNS01LTEtMS02NzUxMg_b8f7f940-a544-442c-aadd-c7666290c0c6">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNi0xLTEtMS02NzUxMg_8af5c32f-b782-4395-ab2d-36318e3e2922">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNi0zLTEtMS02NzUxMg_cb04d009-9741-4b33-b6ec-278e680c21a6">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNi01LTEtMS02NzUxMg_142f8690-4b76-42d0-8e88-4380ce9852c8">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNy0xLTEtMS02NzUxMg_fce84eaa-4116-4520-b193-d9fcd78bbef7">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNy0zLTEtMS02NzUxMg_110ddb2b-cb94-42fb-8808-9ffb93276877">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNy01LTEtMS02NzUxMg_ed5842f3-6d85-45b3-9343-e31daa7da945">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfOC0xLTEtMS02NzUxMg_50afb0c7-3535-4410-ab90-7f7b17893add">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfOC0zLTEtMS02NzUxMg_31a76a0e-ff85-48d7-9695-1730cae51925">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfOC01LTEtMS02NzUxMg_32996de9-4c48-4232-84f3-775da102bdbe">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTAtMS0xLTEtNjc1MTI_c69baffa-79cb-462a-b440-5e3d34a55e43">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTAtMy0xLTEtNjc1MTI_ae97db77-4a16-4dd8-8139-b97897dfc6d9">4,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTAtNS0xLTEtNjc1MTI_c0014569-b6dc-4dcf-85b5-611d0893cca7">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTEtMS0xLTEtNjc1MTI_173d1629-fac5-4ae4-a148-79fdee327295">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTEtMy0xLTEtNjc1MTI_6d1dad82-2a01-4b30-8a95-b7b8ba07e7d6">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTEtNS0xLTEtNjc1MTI_36e2f512-9b8c-412d-a14e-5c7bbef85c05">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTItMS0xLTEtNjc1MTI_f1d5f1ec-fb41-4a0b-ba42-986929f067b3">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTItMy0xLTEtNjc1MTI_6306e91f-9995-4041-b07f-219a93ee18ca">4,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTItNS0xLTEtNjc1MTI_cfc38f1f-3e72-4234-86cd-51bf2eea6060">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNC0xLTEtMS02NzUxMg_ed0b658d-813a-4101-bea5-ed17d5219c4f">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNC0zLTEtMS02NzUxMg_bd716556-4b7f-4a27-84bb-5e687504f5d9">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNS0xLTEtMS02NzUxMg_5b599570-dc36-4536-9afe-844c562d5d71">18,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNS0zLTEtMS02NzUxMg_96a3cf94-6abf-4d18-ab60-6d6dcd97cd6a">19,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNi0xLTEtMS02NzUxMg_d1f40b1d-3986-4c41-bd52-8775d6df7c0a">18,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNi0zLTEtMS02NzUxMg_3fa014fb-0ba9-4a4b-83e2-ed44e4298901">19,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNy0xLTEtMS02NzUxMg_70b640ff-6f61-42e6-b412-b0223eb11c23">4,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNy0zLTEtMS02NzUxMg_5d9fe5f9-3894-4ba2-8e4a-71a3a2a9db95">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOC0xLTEtMS02NzUxMg_3e1344b3-13ea-452c-a3c5-981c59c73a55">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOC0zLTEtMS02NzUxMg_8685530c-99ae-4378-b510-9f3160e6a606">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOS0xLTEtMS02NzUxMg_44fb5b14-5034-4573-a166-78a2ea7641a0">46,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOS0zLTEtMS02NzUxMg_ceef8209-d5d7-48f9-b524-4e8020dfe037">45,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTAtMS0xLTEtNjc1MTI_c86b5852-7a69-44ad-8823-005379ab57d8">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTAtMy0xLTEtNjc1MTI_2877babc-e259-462e-add3-8c2e658090f9">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTEtMS0xLTEtNjc1MTI_73651e29-7625-438f-a437-8952dd1a9315">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTEtMy0xLTEtNjc1MTI_39807d14-7c0e-4127-9f35-57d98915a52c">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTItMS0xLTEtNjc1MTI_200bd1cb-dfe0-416c-b48a-a3c9443772de">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTItMy0xLTEtNjc1MTI_c0d5fbfa-2dcb-4906-9c76-feff2db0bf65">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTMtMS0xLTEtNjc1MTI_5e4d3156-33d9-44c9-b7a7-aee34a4464c2">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTMtMy0xLTEtNjc1MTI_96103e37-1146-417b-9e28-54132ca0ecbe">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTQtMS0xLTEtNjc1MTI_73f1d133-9dd8-4ee6-ae89-75a03e435d8d">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTQtMy0xLTEtNjc1MTI_680e7760-198e-433c-b7e0-12b768716f5d">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTUtMS0xLTEtNjc1MTI_080a1441-88af-40dc-b5bc-e5c246531b97">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTUtMy0xLTEtNjc1MTI_62966732-7c72-4d02-a54d-f5833c2463d0">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTgtMS0xLTEtNjc1MTI_133855b9-679a-410a-9738-314e34bc6cad">38,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTgtMy0xLTEtNjc1MTI_8a61a7e6-5012-4642-bf2d-a747abd10ef6">38,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjAtMS0xLTEtNjc1MTI_4dc80089-6229-4130-b92a-def1f22e6c13">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjAtMy0xLTEtNjc1MTI_101c24e8-d85d-42fe-95b7-ca64d2fcd947">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjEtMS0xLTEtNjc1MTI_4500944e-bdca-4b0e-9ddd-e729d61389ae">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjEtMy0xLTEtNjc1MTI_58841d51-561e-4c4c-9b3b-32178265ca5a">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjItMS0xLTEtNjc1MTI_5e9e5f03-8dd3-4377-9f97-2a45ae86e940">4,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjItMy0xLTEtNjc1MTI_838b91f4-b97f-4840-8762-97ca80008102">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjMtMS0xLTEtNjc1MTI_4bd59242-b25c-42ff-998a-6e0866982f03">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjMtMy0xLTEtNjc1MTI_137e8d83-2151-4643-a2de-cc8a6e34cb12">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjQtMS0xLTEtNjc1MTI_b2ed77a6-f619-4769-9796-ee3885231af5">48,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjQtMy0xLTEtNjc1MTI_abb46c8c-f264-4a51-abb6-5a8fe31047a3">44,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjUtMS0xLTEtNjc1MTI_840ede8c-3467-42ea-95c7-2c4d575a323b">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjUtMy0xLTEtNjc1MTI_5ed8d448-3538-4444-b5d9-8557b2168bce">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjYtMS0xLTEtNjc1MTI_9f55ec29-f869-467f-ad6c-1b0ddea11319">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjYtMy0xLTEtNjc1MTI_77b4a07b-5756-47c1-b069-17538bfb9bb4">1,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjctMS0xLTEtNjc1MTI_0de36982-2980-4b69-a719-100eb1eb7f41">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjctMy0xLTEtNjc1MTI_1608ce41-114d-4f4c-90f3-6165c0704d46">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjgtMS0xLTEtNjc1MTI_63eb9cf1-8a8c-4220-a56f-71b17d5e7576">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjgtMy0xLTEtNjc1MTI_91ecc849-8812-427d-b987-c1bfe41e5e83">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjktMS0xLTEtNjc1MTI_8a2d9e4b-7a3a-4275-b60d-2261c5eeba6a">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjktMy0xLTEtNjc1MTI_0949b4b6-e61d-4053-921f-5e911bd5a93b">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingent liabilities (Note 18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzAtMS0xLTEtNjc1MTI_47dedd25-6c9f-4bb9-b5e1-79a7015efd7f"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzAtMy0xLTEtNjc1MTI_2253b61b-ee2f-41c2-9083-df591f245c91"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzEtMS0xLTEtNjc1MTI_5de8bcb7-7684-4437-acb7-5be341e17167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzEtMy0xLTEtNjc1MTI_2279f291-f689-4fb3-8254-7b3c28ac74d3">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xNjQ5MjY3NDQxOTUz_bcb77b12-454d-4b0b-91e4-bc493c2d00ac"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xNjQ5MjY3NDQxOTUz_c158adf6-371b-4be6-a536-9a1743ce3e35">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDY5_5beca637-50f1-4873-98f3-afa097a32a95"><ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDY5_9b34445b-470e-4fae-8f5e-69ded610e7df">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_4809aa35-c82b-40c1-8f3e-61485d8129d1"><ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_4a4697bd-ed89-465c-ada3-1481e781aaab"><ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_7fbc3cd0-272e-4e6e-8aab-81496ce46432"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_d984dfb3-18c2-490a-9555-1ff4fe492c78">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMS0xLTEtNjc1MTI_064aaed8-9891-490b-830f-86cfb1208e4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMy0xLTEtNjc1MTI_dd66dc00-d4ca-4907-8570-47a05cbccd71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM0_4d288398-a850-43c8-9c90-54c34579b38f"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM0_e69c4519-ec5d-41c9-90a9-97a8898d4f4f">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM4_b19150b6-20f1-4be3-aeb2-15412a78dcd6"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM4_c9690412-469d-49a4-9042-6cbb4cd26dec">800</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTQy_62747050-1c11-483f-ad82-a209698132fe">275</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTQ3_2d6b3e8f-b81e-47a3-b7fd-03172a79ca30">273</ix:nonFraction> shares issued at March 31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMS0xLTEtNjc1MTI_6b494375-c5ff-4f10-a158-da36ef1d27c0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMy0xLTEtNjc1MTI_5a21ecd9-422b-4890-befd-3a956552337b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzUtMS0xLTEtNjc1MTI_c7340324-004d-436a-af2b-e7d5974d04a8">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzUtMy0xLTEtNjc1MTI_fcafe27e-ce1a-40b9-bd3f-3025251be720">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzYtMS0xLTEtNjc1MTI_84375a10-cfcc-482e-bb15-eff6301c4056">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzYtMy0xLTEtNjc1MTI_b9bef5cf-fafe-4096-abdd-6d456da5bc32">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzctMS0xLTEtNjc1MTI_2234b6dd-c246-480d-af80-a6f3ac5491e0">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzctMy0xLTEtNjc1MTI_998fe985-2351-4311-aeb2-680e76f98d78">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjo2YzYxZDM2ZDg5ZmM0MDg1YWU0ZjExNWJkNWJlN2Y0NF8xNjQ5MjY3NDQxNzUx_b22fa869-2db3-43f0-8e44-ec3399e33abc">130</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-3" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjo2YzYxZDM2ZDg5ZmM0MDg1YWU0ZjExNWJkNWJlN2Y0NF8xNjQ5MjY3NDQxNzU0_dc04dcbb-ee8d-498f-ac8f-297db2f82d87">115</ix:nonFraction> shares at March 31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMS0xLTEtNjc1MTI_b64bb2ed-54da-4a68-9cd2-21d50dc64262">17,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMy0xLTEtNjc1MTI_92caff02-31e0-445b-b11e-e569040e5399">13,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDAtMS0xLTEtNjc1MTI_7de748c1-02a6-48a8-b76d-4450a7ae5d6d">2,272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDAtMy0xLTEtNjc1MTI_4d49fd7a-738a-4451-a99e-535d497a5f5e">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDEtMS0xLTEtNjc1MTI_3b95527e-6ca4-42c4-a16f-6699f949e1f8">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDEtMy0xLTEtNjc1MTI_16b7141c-040e-4ebe-880b-d3fc708b57cd">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDItMS0xLTEtNjc1MTI_90742e1f-a0e4-4074-80ba-0cb973262b7d">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDItMy0xLTEtNjc1MTI_44a111ff-aa8a-42c2-9c01-234b894e0ffc">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDMtMS0xLTEtNjc1MTI_5893485f-a78e-40ef-b5c7-5270b7922924">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDMtMy0xLTEtNjc1MTI_aafe17cf-878e-419a-870d-b13166f0e955">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.435%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">McKesson Corporation Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common <br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3deea6c14b24c35a88fb4f3b5239602_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMS0xLTEtNjc1MTI_132455ed-7057-44b3-95e1-b4655bc392d1">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3deea6c14b24c35a88fb4f3b5239602_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMy0xLTEtNjc1MTI_45256cdb-ff0e-4be4-92f4-91ac4a03d4bc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b21cbe51124474092ab038b1d408bb7_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtNS0xLTEtNjc1MTI_86b6e55f-7d3a-4d09-ba6a-b69f6f7b605a">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785292e3540b46a8b3ab968c6707dd77_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtNy0xLTEtNjc1MTI_d144a81f-81d7-442d-a37f-1c9830f5b80e">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6c8a7f661b462f9ac6296df77d8e06_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtOS0xLTEtNjc1MTI_f27f9480-3265-40ae-9fb0-a59bca9f104d">12,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cd9f0cb497242a6826289cfb5fdad80_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTEtMS0xLTY3NTEy_d0d71d6f-9e63-42ea-b25d-35b9b3944795">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ide9952cef22a4bc8b524552d5f4a71b9_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTMtMS0xLTY3NTEy_3a4f7f81-46c6-4993-86c5-8e4accba1936">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide9952cef22a4bc8b524552d5f4a71b9_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTUtMS0xLTY3NTEy_36eef719-68e5-4e82-bc94-500695b464aa">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4592918a3c14823acad8256f0ddfbde_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTctMS0xLTY3NTEy_e95f5efd-6406-48e2-949f-714b72ca4926">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTktMS0xLTY3NTEy_73152a15-8a0b-49d1-a6e8-1c010f57feb9">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8428ec3a9cbb437d8aa822268f3ae46f_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQtOS0xLTEtNjc1MTI_b28da03b-cd35-4d6e-88e7-984061dc0fc8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia689b4eec1084768aaebdb4bc5f99af7_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQtMTktMS0xLTY3NTEy_d9ab0caa-e98c-4f62-b68b-836f9ab9d90e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balances, April 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7820f8179cd488caae5ec4d8b342012_I20190331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMS0xLTEtNjc1MTI_af6c78b7-6869-424d-b1b2-2808ee67a6a9">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7820f8179cd488caae5ec4d8b342012_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMy0xLTEtNjc1MTI_5e25619b-eb40-4a95-bb40-bc959128bca9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa23c711f267453f9563f59bc7ef048a_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtNS0xLTEtNjc1MTI_11d4a320-f0a2-41ac-88a3-5e037493bf6d">6,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b01dc80a44246cd9ff31ee62f1cf4f5_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtNy0xLTEtNjc1MTI_ea5a8d45-deec-4d63-a0cf-33bad08debfc">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f39b2ee8ba4ad9b6df061b0133c8c6_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtOS0xLTEtNjc1MTI_3779b532-85b4-4ca5-ae0b-3b9c156a8465">12,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i180ef1abd93241dd9b099926ef64a73e_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTEtMS0xLTY3NTEy_9e14cb05-8034-4e05-8568-8fa8ada623b2">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7a7555c1d0ba47188d1bf7a199033063_I20190331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTMtMS0xLTY3NTEy_b3adfed1-7c06-4dad-92c8-263bc1ec3955">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a7555c1d0ba47188d1bf7a199033063_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTUtMS0xLTY3NTEy_f6f5830b-9fd8-443e-aa35-08d015a6d736">8,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95e07416b7c42009dca3b45fcac417f_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTctMS0xLTY3NTEy_8070b090-ff7c-4128-83e7-3e383b0b8a11">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aec4e5c4fc44a31a9df1e4f8d8962c9_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTktMS0xLTY3NTEy_b146e536-7590-4773-86c7-a7d0e5a0efa8">8,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b5103e93a3d4aa2b15d717f1d91a04d_D20190401-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtMS0xLTEtNjc1MTI_7dd72e61-18fa-4f06-b95e-b2784f1e1a79">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e972d123eb647c8a45d52545e29ad97_D20190401-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtNS0xLTEtNjc1MTI_4e935116-26f7-44d2-a142-a6f597d5c761">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtMTUtMS0xLTY3NTEy_7c42ce61-eb17-429c-85c0-bdeba5c7d274">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtMTktMS0xLTY3NTEy_b31afb7f-7d09-44af-b54b-813c617de31e">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e972d123eb647c8a45d52545e29ad97_D20190401-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzctNS0xLTEtNjc1MTI_e8c44c3a-6d00-47a3-b390-e01a9ab51b52">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzctMTktMS0xLTY3NTEy_7d1f719b-845c-4f6f-bc90-b1e6a8a226ff">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzgtMTctMS0xLTY3NTEy_687dfdfc-e37f-4da9-b0eb-eda2332de61f">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzgtMTktMS0xLTY3NTEy_a2379b0d-c0ac-40de-85e5-075917412557">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzktMTEtMS0xLTY3NTEy_6c89237e-4272-4f16-9a98-660c088dcb41">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzktMTktMS0xLTY3NTEy_50adff35-9693-4ae7-88df-f1c4030e34d3">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEwLTktMS0xLTY3NTEy_64a7e752-7e06-4b61-8751-1a1e8a9d2c23">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEwLTE3LTEtMS02NzUxMg_3838f2ca-8e5b-4547-8a93-e85a6a93b6e3">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEwLTE5LTEtMS02NzUxMg_05af9eba-3a40-4757-83d0-5172826066fe">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzExLTEzLTEtMS02NzUxMg_1ffb486c-ed14-4cb6-afde-8df17fa6b6bc">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzExLTE1LTEtMS02NzUxMg_b508e533-4cf3-48ca-85e3-845f927fbb6c">1,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzExLTE5LTEtMS02NzUxMg_d4d862d2-c57e-4984-a203-c41c58015eab">1,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Change Healthcare share exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331" decimals="-6" name="mck:StockExchangedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEyLTEzLTEtMS02NzUxMg_0a265ad9-b410-4983-a860-4d336e216bfc">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331" decimals="-6" name="mck:StockExchangedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEyLTE1LTEtMS02NzUxMg_7d29e1f8-b441-4b7a-a015-75074922d664">2,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:StockExchangedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEyLTE5LTEtMS02NzUxMg_fa4b304d-564f-48d9-a151-0e52baa1c032">2,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEzLTAtMS0xLTY3NTEyL3RleHRyZWdpb246OWM4ZDM0YWU0NjUwNGU1MDlkODczYWZmOWY0YTY2MWVfMTA5OTUxMTYyNzgzMg_b48af161-9737-4cb4-aeab-cfcf666f9fa5">1.62</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEzLTktMS0xLTY3NTEy_d5930515-bd1f-43f7-b2c8-fe5d8e0a935b">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEzLTE5LTEtMS02NzUxMg_a6b709d5-44aa-468f-b701-1c7e10c728ca">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b5103e93a3d4aa2b15d717f1d91a04d_D20190401-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTMtMS0xLTY3NTEy_8a055e03-7509-461a-a9a1-96dd4112ac7e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3440078a7adb46d7b5f9accf550ba77b_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTctMS0xLTY3NTEy_0c852d3e-7793-4633-adc3-efac1dc6d4ac">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTktMS0xLTY3NTEy_c0402a1f-284a-45d3-a1a3-55d24dc06336">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTE5LTEtMS02NzUxMg_ab66e482-cb65-4455-aa04-99f3ef648510">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b02a4b752d74cfd80393765ca780d97_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTEtMS0xLTY3NTEy_ba4a6865-5928-4dc5-9022-3d4facb5b3f0">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b02a4b752d74cfd80393765ca780d97_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTMtMS0xLTY3NTEy_cc7da674-65ad-4723-8782-e15813cc3fae">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f88e128a22f4b15be314f3dd2e0d53d_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTUtMS0xLTY3NTEy_cff3a5e6-a17e-4760-8d0d-dbaeb0112b36">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883cca538ace48298886a121db79175e_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTctMS0xLTY3NTEy_aadc5afe-c655-4160-96aa-fa2000ce1e44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic641abc11fc64b27871a5f1b878bbdb6_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTktMS0xLTY3NTEy_2dc8c2ba-5ad6-4852-b21a-7eb2855c8845">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83f0aa9722f4476ca58477e03a36b9f4_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTExLTEtMS02NzUxMg_1735259c-ed8f-486b-b6e3-a5653504aab5">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idb569322fd7143f1924eb4050fec05d0_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTEzLTEtMS02NzUxMg_b8e81b85-170e-45c0-b30c-58bd7c0ba2d3">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb569322fd7143f1924eb4050fec05d0_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTE1LTEtMS02NzUxMg_e8610aee-f493-4407-9f86-788b77fc473d">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2cdad70673142c9a93a6bbb19838852_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTE3LTEtMS02NzUxMg_541f63e7-34e8-41aa-a0ae-bfadb6928768">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTE5LTEtMS02NzUxMg_b0c25c08-7537-4c36-b915-ee3e999e2df7">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8791362274e94d518929bbd7ee69eced_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE2LTktMS0xLTY3NTEy_0bd46fd2-7bb8-4e22-a63f-b403c5e32e9c">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf764aa2c30f43d08cdd30a5094d5c77_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE2LTE5LTEtMS02NzUxMg_8c1b9747-aa14-4f4a-aef9-3712ae439f50">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balances, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic31e30cd614c468c88d7a33e3c01b62c_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTEtMS0xLTY3NTEy_8b069515-c6ec-4d2a-94db-748ed58e12f2">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31e30cd614c468c88d7a33e3c01b62c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTMtMS0xLTY3NTEy_1f12c2d5-26d5-4f25-9c3d-13f491164b53">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d61cae07b149f28ab844297d0650dd_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTUtMS0xLTY3NTEy_e42f8b64-1112-43e5-b41d-0629ed000fc7">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305e3fcf99604bad83df1de067162bda_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTctMS0xLTY3NTEy_5e036253-06cf-4436-92ff-472c760a5025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1eb7d3437fe498bba552eae2bce578c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTktMS0xLTY3NTEy_fcd0963e-f985-44c6-aaa2-b461f754dfa3">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9378e02396964f6fa338e061f8c72449_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTExLTEtMS02NzUxMg_2f5f77d2-eafa-484b-8f6a-a16f3d348879">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib551700663cc480187b2925365dc76f3_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTEzLTEtMS02NzUxMg_09643ac4-0227-4610-8f6f-727282cc063d">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib551700663cc480187b2925365dc76f3_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTE1LTEtMS02NzUxMg_3a72c44b-634c-48f1-b24e-30558610c2af">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210241066bf44247a7e0bfd8995df0e5_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTE3LTEtMS02NzUxMg_3052a94d-1463-40d6-87f3-391bc9340bc0">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc9248dc9c64dae83ba79637793aab6_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTE5LTEtMS02NzUxMg_5ad56cb7-63e3-4f35-800b-17906a98af9f">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57057534f4b548078330647f41d65cd9_D20200401-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTEtMS0xLTY3NTEy_77d9525a-23ea-4843-a417-77e0612f89f9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTUtMS0xLTY3NTEy_ad27764f-38c9-41cc-a7d8-3a45cd5bb04b">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTE1LTEtMS02NzUxMg_0a115c7f-9c14-4691-9be4-e1f078fdd9ce">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTE5LTEtMS02NzUxMg_4ce8391e-4324-4a7e-9457-9eaa4737b6db">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE5LTUtMS0xLTY3NTEy_5123ea37-0ade-4216-a19e-02ae9f06de3b">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE5LTE5LTEtMS02NzUxMg_89b1abf8-15b5-44db-bada-193cbc6b292f">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIwLTE3LTEtMS02NzUxMg_c851454a-fdce-456f-80f7-f255583c2bff">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIwLTE5LTEtMS02NzUxMg_56164596-4b8a-4735-ac4c-3a710e4b38de">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIxLTExLTEtMS02NzUxMg_5dc19850-d4c5-4505-95cc-c94f9ee48a85">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIxLTE5LTEtMS02NzUxMg_112bad83-2e8e-4676-ba05-31c9acfc4d13">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i461023189d294286a463ef01b45de63d_D20200401-20210331" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIyLTktMS0xLTY3NTEy_eece9971-851f-4d68-8980-798ad56fd2f8">4,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIyLTE3LTEtMS02NzUxMg_b5ca3513-9e96-4a05-ba6d-368f80d2f529">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIyLTE5LTEtMS02NzUxMg_8add23b2-8a8f-48a5-8774-478de42ad575">4,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIzLTUtMS0xLTY3NTEy_7a5dea17-c5ae-421f-a37b-18d548c9dfe5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIzLTE5LTEtMS02NzUxMg_37552b11-c15e-4019-9e51-33f46f128442">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI0LTEzLTEtMS02NzUxMg_f5c56633-e55a-4795-9f0d-0c6607a769f9">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI0LTE1LTEtMS02NzUxMg_5d717116-66c5-402b-b5d2-44c1d75da0dc">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI0LTE5LTEtMS02NzUxMg_59e6411d-e994-4aa1-8b9e-cd3d258566dc">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI1LTAtMS0xLTY3NTEyL3RleHRyZWdpb246NDFhYmIxZmE5MWExNGUxMmE4YzNhM2ZiZDkxYmExZTdfMTA5OTUxMTYyNzgzMg_eab194eb-b4b5-46c2-b5b7-cb2398e8645e">1.67</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i461023189d294286a463ef01b45de63d_D20200401-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI1LTktMS0xLTY3NTEy_f86c7ea9-bf44-44ce-858e-086871d0c1d2">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI1LTE5LTEtMS02NzUxMg_fff46ad4-f0cd-4ae6-92b4-2e91846c1b26">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI2LTUtMS0xLTY3NTEy_6a58aeb1-b917-4f1a-bfa7-d39411397991">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i461023189d294286a463ef01b45de63d_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI2LTktMS0xLTY3NTEy_f14822c3-f7d6-4a1f-8121-f91f86a31e65">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI2LTE5LTEtMS02NzUxMg_ed0c0c07-73ca-4dda-92fd-1bdee9dae04f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5b27e96a471495799b6dd0a225ad062_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTEtMS0xLTY3NTEy_cfeeca01-0f5a-4550-adb8-7a578b57ffe0">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b27e96a471495799b6dd0a225ad062_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTMtMS0xLTY3NTEy_4d347c32-7b8e-45fd-a77c-38f5406d3f1f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic951943367684ce392dcd7a2919ab132_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTUtMS0xLTY3NTEy_230ce64e-6868-4975-8364-40cb2351085c">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b967dacd7747f1897007bd0e7d2096_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTctMS0xLTY3NTEy_fffa1e8e-f69e-4204-b724-60ae6142330c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c4849bc12314eb6878d6ecc627ba11c_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTktMS0xLTY3NTEy_469f7049-2702-46de-a42a-4e6851170374">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0f038c81a5a4b8198d4c97be9e3cfa7_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTExLTEtMS02NzUxMg_8392c053-d4cf-435c-a2bb-fe928df0f3e7">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3764f741fee2439f932384b08f26eaf2_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTEzLTEtMS02NzUxMg_02b22330-53d4-4a99-a62e-5c9d28f66577">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3764f741fee2439f932384b08f26eaf2_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTE1LTEtMS02NzUxMg_5ac9ac03-0a8b-4298-aebc-78206cd1c3da">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dec5df30de44f7a83e4f2ce0278a9d7_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTE3LTEtMS02NzUxMg_a915c0d4-2914-4c6a-b6d7-4e5f88b82d61">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTE5LTEtMS02NzUxMg_7e503143-eca8-443d-b6bb-7eb44a65f1b6">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idcca99ee396c495597323a1f0cfd1b93_D20210401-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTEtMS0xLTY3NTEy_d98fef76-905e-4660-947a-c2799ca689c5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTUtMS0xLTY3NTEy_93ebb527-fc2a-4c4b-b936-26c80bd2a1bb">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i199433cd82524872a587c50f96b8c524_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTE1LTEtMS02NzUxMg_3fe18618-5688-4b06-a935-c31fd46a14e0">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTE5LTEtMS02NzUxMg_25e442ad-bca8-414e-a642-69d912f81d1b">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMwLTUtMS0xLTY3NTEy_7af0173b-6e94-46b2-8eb2-798c6d3a3c02">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMwLTE5LTEtMS02NzUxMg_aa96da3e-f680-4900-beb6-f06993dad103">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMxLTE3LTEtMS02NzUxMg_11343526-5525-4d45-a193-5d2c2b82c1ef">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMxLTE5LTEtMS02NzUxMg_f5af0ebc-f009-4061-a593-e56f1a2e66cd">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMyLTExLTEtMS02NzUxMg_5301b4a2-835f-42f4-bc5f-c80c779f05de">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMyLTE3LTEtMS02NzUxMg_6cf96821-9a00-40f0-b08c-e248b2863c89">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMyLTE5LTEtMS02NzUxMg_d4e0bfae-b9d3-426b-b576-3ea631e3c765">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie685032700114a648030b37f3029390e_D20210401-20220331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMzLTktMS0xLTY3NTEy_11d98782-38a7-41cf-b720-b67c4281cc20">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMzLTE3LTEtMS02NzUxMg_7b90889d-2d2e-444a-a6a6-f8a35baa54b9">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMzLTE5LTEtMS02NzUxMg_4a83e498-f097-4d19-8319-006c4f0ad7b2">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM0LTUtMS0xLTY3NTEy_4b937850-4aa1-4bab-bfc4-b3e4bcbf74d8">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM0LTExLTEtMS02NzUxMg_61960a21-2e6e-4ea1-9c47-d6cb84a2233b">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM0LTE5LTEtMS02NzUxMg_0fa754fc-8513-42d4-b1a6-660f54a09395">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTUtMS0xLTY3NTEy_6d986788-f86b-4deb-b604-c790fc640881">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i199433cd82524872a587c50f96b8c524_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTEzLTEtMS02NzUxMg_a7112d5e-9953-49f6-ba64-d151f14304aa">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i199433cd82524872a587c50f96b8c524_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTE1LTEtMS02NzUxMg_4240a356-3d55-4b18-99ac-5550bcf0b521">3,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTE5LTEtMS02NzUxMg_a594b4c6-d97f-4f41-b2bb-731afaa8b3bb">3,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe AG redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM2LTE3LTEtMS02NzUxMg_d40ad4a4-76d8-41cd-a116-a9eb0ae5c5b9">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM2LTE5LTEtMS02NzUxMg_9c05b3f1-08a6-43da-a9d1-fa3155faa6da">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM3LTE3LTEtMS02NzUxMg_5deccff0-c152-4750-9d74-a89e6bc7fad4">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM3LTE5LTEtMS02NzUxMg_4c36260b-a780-41b9-81ca-5de29d6a1aec">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM4LTAtMS0xLTY3NTEyL3RleHRyZWdpb246NTkzMWYwNTI1OWU4NDRlZWIxZTZhNTVmZWVkZjY3ZjlfMTA5OTUxMTYyNzgzMg_bac10196-3b8a-406a-81b2-eedcf389ec2e">1.83</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie685032700114a648030b37f3029390e_D20210401-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM4LTktMS0xLTY3NTEy_069af784-bcca-4685-80cf-d8d15d0d76a8">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM4LTE5LTEtMS02NzUxMg_bf3a9f8d-a9d4-4f88-b6ee-2a8fed0f102d">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTUtMS0xLTY3NTEy_a900fef3-5d27-4f2a-8b11-9452614e16af">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie685032700114a648030b37f3029390e_D20210401-20220331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTktMS0xLTY3NTEy_d30ba1a4-cf25-4ad3-8451-3ef2ee85862a">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTE3LTEtMS02NzUxMg_b29dc390-2471-41af-b944-cb1c272a340a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTE5LTEtMS02NzUxMg_c9210be7-4785-4502-ad5e-ed9f188fced5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balances, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84a83e66e4b34cfcbbd7fafb3e2d383e_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTEtMS0xLTY3NTEy_a17f1726-425a-4988-b7a4-f1180b384f18">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a83e66e4b34cfcbbd7fafb3e2d383e_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTMtMS0xLTY3NTEy_975679b5-f199-4a8f-b13d-71a762830fdf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8062dd2444549b5b588b1c34805e71c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTUtMS0xLTY3NTEy_ce575b59-6a76-43ff-a064-257bc2bacca0">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1996a48e50224bb9a7a3ef02f89a15be_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTctMS0xLTY3NTEy_ea54706e-966d-4315-97d9-dffb28f10278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2b963f2005d473788cd329e855eb9f8_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTktMS0xLTY3NTEy_043fc0c2-c008-40b5-97fc-857bdf794656">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3e04acff1af415fb304c565efd6376b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTExLTEtMS02NzUxMg_faa3c96e-71a6-412d-884f-8e70d0e575cf">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3c565412e4c44e6090973b99e12490b9_I20220331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTEzLTEtMS02NzUxMg_4941d5d0-0500-4a6d-a9bb-fd905f0ad82e">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c565412e4c44e6090973b99e12490b9_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTE1LTEtMS02NzUxMg_163d4dc9-4a11-4fc7-a934-75cb742ee491">17,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cdcc95103d4a2b933719ac01f8cec5_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTE3LTEtMS02NzUxMg_e46198c6-b7d5-462f-a281-3d92eca7b8e7">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTE5LTEtMS02NzUxMg_57bd93a3-d0c9-46b4-8976-eb04cf4f4b35">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMtMS0xLTEtNjc1MTI_6669df60-7881-4355-a936-fe9011976aa0">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMtMy0xLTEtNjc1MTI_61bd9024-00d3-4f65-b206-3844285457c7">4,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMtNS0xLTEtNjc1MTI_76e7d7dd-8a1d-4c92-b4c6-024612958722">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUtMS0xLTEtNjc1MTI_5d02de5d-f619-4d2a-b5c8-00ff1fbfd792">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUtMy0xLTEtNjc1MTI_ec006aaf-4725-4c7b-8a72-5cae038bb1b2">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUtNS0xLTEtNjc1MTI_0af5765d-c856-4fc4-b835-41405499665e">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzYtMS0xLTEtNjc1MTI_5adfb454-dd08-42c7-871d-08556ccef563">481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzYtMy0xLTEtNjc1MTI_73ee59bf-68fe-4b71-8b83-1146e65bd2e9">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzYtNS0xLTEtNjc1MTI_da834903-d8ad-454e-bef6-46523111ebde">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and long-lived asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzctMS0xLTEtNjc1MTI_7aca680a-555a-4407-8bac-37f067d52e78">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzctMy0xLTEtNjc1MTI_7db1f3d1-e3d0-473f-9bb9-c2eb044a431d">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzctNS0xLTEtNjc1MTI_a83569fc-40fb-4141-9062-eb0341201c77">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity earnings and charges from investment in Change Healthcare Joint Venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzgtMS0xLTEtNjc1MTI_908c33b9-06e4-4774-9e5f-fa39bd6e7be0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzgtMy0xLTEtNjc1MTI_2b352301-c608-4325-986e-34c58d57a71a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzgtNS0xLTEtNjc1MTI_8de3dccd-0e25-4981-b236-63ea4c892aef">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzktMS0xLTEtNjc1MTI_910e1b14-9fd6-4dcd-9b11-7b938e64e6c2">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzktMy0xLTEtNjc1MTI_d2d39237-b0f6-43ed-88ad-c435c1009342">908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzktNS0xLTEtNjc1MTI_5ffbff0b-eae8-42fb-a434-132e073ff5e9">342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEwLTEtMS0xLTY3NTEy_f8c86746-c538-4883-bce1-cfc4f1ed1239">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEwLTMtMS0xLTY3NTEy_1c184d9c-a5f6-4183-849d-64599fd96b84">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEwLTUtMS0xLTY3NTEy_c2b2e549-ec6c-46c1-a2ea-0daf211d47eb">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzExLTEtMS0xLTY3NTEy_6cbb65d6-19c7-48b6-aab6-93ad384a8cf5">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzExLTMtMS0xLTY3NTEy_3cdebb92-4f36-4597-81f9-5201ec599fef">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzExLTUtMS0xLTY3NTEy_6311be0e-74a3-40f5-b531-5d25fb44a67b">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) from sales of businesses and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEyLTEtMS0xLTY3NTEy_225b2393-1936-4e89-b30b-bf1cb54d87ee">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEyLTMtMS0xLTY3NTEy_06d1916c-1bfd-4cac-ba4f-1e215f4ae0e6">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEyLTUtMS0xLTY3NTEy_a1331c7c-7961-4614-97cd-587af99f8a3b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European businesses held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTEtMS0xLTg4MTQ1_6bda0ce9-be96-4897-9052-5492034fcc3e">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTMtMS0xLTg4MDY4_ca767774-edb2-4dd3-a315-ed5be29715e0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTUtMS0xLTg3OTMy_c7546795-1b0f-4fcf-87de-82c677f9b990">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTEtMS0xLTY3NTEy_4b292ea6-d829-4ec2-8571-60702149b3c1">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTMtMS0xLTY3NTEy_7dd462ee-c995-4391-b88e-f60f49d03289">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTUtMS0xLTY3NTEy_8e44c9f5-2cc6-4f07-8f8c-734e0ce86dfa">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE1LTEtMS0xLTY3NTEy_f13657aa-bd0b-4816-b0ff-b415afef0499">1,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE1LTMtMS0xLTY3NTEy_2aa3103c-2d90-49e4-83e2-7c4bb81a7544">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE1LTUtMS0xLTY3NTEy_c02f5856-1a59-4de1-8abb-9a4b92e76a9f">2,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE2LTEtMS0xLTY3NTEy_c2c48e22-d94c-4fae-9a8c-578f7a8280aa">1,169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE2LTMtMS0xLTY3NTEy_5b2b160e-64e9-498d-a6e0-a716aa33ccd9">2,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE2LTUtMS0xLTY3NTEy_07cc4895-5787-4253-86e7-3fb9a4a175b2">376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE3LTEtMS0xLTY3NTEy_b47ad9dd-f299-48ad-af9b-8e285bf8141f">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE3LTMtMS0xLTY3NTEy_adfb7259-4ad5-4b50-ac14-28988a85d5ab">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE3LTUtMS0xLTY3NTEy_2069a4d5-8304-4e06-b272-41bc4a364787">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE4LTEtMS0xLTY3NTEy_ef947a54-4ad0-4187-8ee0-818623d5a0a5">356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE4LTMtMS0xLTY3NTEy_8f881d07-366c-4ba0-895b-f8194ba87a81">362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE4LTUtMS0xLTY3NTEy_90d27d23-fb57-45af-877f-ebc4943211f2">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE5LTEtMS0xLTY3NTEy_62d3f875-8712-4826-bef8-7bd249f2c860">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE5LTMtMS0xLTY3NTEy_63727063-ca5f-41ac-8118-2299a6e897c7">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE5LTUtMS0xLTY3NTEy_42567768-954f-4ff5-b017-2bc413746736">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIwLTEtMS0xLTY3NTEy_f193a556-7074-4034-87ca-adbb53dca5af">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIwLTMtMS0xLTY3NTEy_a70fa4b3-f2f6-48f6-9a0d-32626448663c">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIwLTUtMS0xLTY3NTEy_514524c2-6e3f-4248-8fbc-565b882c2bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIxLTEtMS0xLTY3NTEy_a8b2decb-f55d-40fc-899c-997a5f921b3b">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIxLTMtMS0xLTY3NTEy_74811b0c-fca8-4416-bc0d-0a820ecae045">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIxLTUtMS0xLTY3NTEy_ab6ba977-065a-413a-ac7e-f3fe588f934a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIyLTEtMS0xLTY3NTEy_ce4bfb78-e75c-450a-82dc-b401d86d9aeb">4,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIyLTMtMS0xLTY3NTEy_ff725cd4-e736-425e-b1da-0ebdbf925ad6">4,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIyLTUtMS0xLTY3NTEy_4ca7e6b2-7e0c-4e0d-96b6-a29335d2bb39">4,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI1LTEtMS0xLTY3NTEy_e0a4e9ec-cf11-4045-b4d3-599cad742ba6">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI1LTMtMS0xLTY3NTEy_4114eb4a-93d1-4677-a908-ebb50323b032">451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI1LTUtMS0xLTY3NTEy_2fb0a3b7-3da7-454b-96cd-da8c75c952c1">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI2LTEtMS0xLTY3NTEy_ccb013ff-e950-4f90-86c4-9f0c49aae018">147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI2LTMtMS0xLTY3NTEy_8fd6691a-35f1-458f-b12d-77dc613b4860">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI2LTUtMS0xLTY3NTEy_224bafc6-24e6-471b-a2af-646861f9aea8">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI3LTEtMS0xLTY3NTEy_d3a4834b-0854-488c-96be-bdbcfd01f439">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI3LTMtMS0xLTY3NTEy_3a9d94f7-3fca-44b8-aaa9-96d7df2e5c2a">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI3LTUtMS0xLTY3NTEy_6c0eeab6-8aaa-40b0-8e17-335cccb12dc3">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI4LTEtMS0xLTY3NTEy_6ccd631c-7691-48cb-accf-eb945c1a787b">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI4LTMtMS0xLTY3NTEy_628174b9-c561-423b-9513-018efa759b9d">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI4LTUtMS0xLTY3NTEy_c316b256-6406-4382-8bd4-99bfe39e6d61">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI5LTEtMS0xLTY3NTEy_7e092b23-d017-4b80-8276-061182fe42b4">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI5LTMtMS0xLTY3NTEy_c59161c5-f85c-44f2-b841-8ced78da3fd9">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI5LTUtMS0xLTY3NTEy_61a1be77-e385-4400-ae97-ad550fe1838b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMwLTEtMS0xLTY3NTEy_43ace26d-f73d-4729-af64-2046ded20477">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMwLTMtMS0xLTY3NTEy_14acff6c-94f5-406b-bc28-3dfa3a344a9c">415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMwLTUtMS0xLTY3NTEy_17111a74-c3e4-4557-882c-da9817eee220">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMzLTEtMS0xLTY3NTEy_cd27fd38-b3b4-40fd-a633-4caf988c8851">11,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMzLTMtMS0xLTY3NTEy_3dc416e8-b5fe-4a6e-abaf-1f628290f9d5">6,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMzLTUtMS0xLTY3NTEy_c5caf778-b915-4123-91b1-daf0ad5069f2">21,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM0LTEtMS0xLTY3NTEy_269576db-0a1b-4ae5-9b4e-b5c14697b01b">11,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM0LTMtMS0xLTY3NTEy_be8552d1-c5df-4793-8636-43475530a7e0">6,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM0LTUtMS0xLTY3NTEy_9aba2062-3fa4-49cc-bd58-6dfe9b386dbc">21,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuances of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM1LTEtMS0xLTY3NTEy_d4493807-78a9-4793-bab7-e6a230086bbd">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM1LTMtMS0xLTY3NTEy_d37a387e-a4fc-4db9-a928-4d6d17d0cfc3">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM1LTUtMS0xLTY3NTEy_c93b102a-560d-4778-bddf-462cc1419855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM2LTEtMS0xLTY3NTEy_de864e43-3b5f-4a40-b65f-4bed475cf202">1,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM2LTMtMS0xLTY3NTEy_6fd1be30-e56a-4ee7-98d8-5db27a4c85f7">1,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM2LTUtMS0xLTY3NTEy_f10f3655-bc36-40d2-8512-9e1f9fd9df00">298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for debt extinguishments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM3LTEtMS0xLTY3NTEy_99a2b102-682c-49eb-b351-adc4ad5a63a9">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM3LTMtMS0xLTY3NTEy_ad555a76-792d-4962-8b1c-b3833bc83869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM3LTUtMS0xLTY3NTEy_1d10f10f-9f34-4e6a-869a-3f976ceb28ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM5LTEtMS0xLTY3NTEy_41a90294-50fe-412f-ba1e-0512c5e07bb5">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM5LTMtMS0xLTY3NTEy_e37af7a1-e674-4c43-8ef8-6c320a9b500b">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM5LTUtMS0xLTY3NTEy_0aa0f004-0614-4c39-a4cd-87e591b3fe9e">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQwLTEtMS0xLTY3NTEy_2593ad95-509a-4e8a-941b-f43c8e32f6bd">3,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQwLTMtMS0xLTY3NTEy_57bccb55-6434-4ad8-add4-d9832838658a">742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQwLTUtMS0xLTY3NTEy_00a8f384-b80f-4746-b08c-10490acca55b">1,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQxLTEtMS0xLTY3NTEy_60a67f47-5bd7-47ae-9b26-ff6e05f00578">277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQxLTMtMS0xLTY3NTEy_ea95d828-0035-46d4-a8a2-bd07947c6c5b">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQxLTUtMS0xLTY3NTEy_4c52aac7-7f93-4c87-8916-ea8d9d07cb07">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTEtMS0xLTg4MTY2_283f824c-e977-4a72-af14-26b359ed91dd">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTMtMS0xLTg4MDkx_6193b750-4d91-48b7-9dd3-96bfebcabbe9">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTUtMS0xLTg3OTg3_62902676-ba9d-43cf-bcab-7273b34c0c81">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQyLTEtMS0xLTY3NTEy_7232fa69-61aa-49e3-8165-acd9b458fdde">383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQyLTMtMS0xLTY3NTEy_a7c0cd6f-74c2-46c3-9211-b436a2ee8d45">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQyLTUtMS0xLTY3NTEy_cdf88f7f-e7a8-4d94-aea4-3eef5f77985b">318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTEtMS0xLTY3NTEy_7a94f029-6ad9-482f-b6e2-ce388f9b2590">6,321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTMtMS0xLTY3NTEy_a77f2469-9336-42ad-837c-80f3c1c9aeeb">1,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTUtMS0xLTY3NTEy_8b292181-a195-44dd-b93d-87a3a2203d1d">2,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ0LTEtMS0xLTY3NTEy_1b828a30-4cbd-4740-b302-79768f618598">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ0LTMtMS0xLTY3NTEy_3502f9cb-fd9e-4cbd-97b5-c7f8b26250d6">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ0LTUtMS0xLTY3NTEy_b98f9494-753e-47d3-b41f-3536dc936c03">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash classified within Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTEtMS0xLTg4MTc0_acd46828-f557-4ea2-a84e-5b9d9d423d8f">540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTMtMS0xLTg4MDk4_a100de4e-6b50-4172-8635-50667dc07342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTUtMS0xLTg4MDEy_92a55ff8-cf3a-4db9-802a-4dd823f205e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ1LTEtMS0xLTY3NTEy_cc14611d-7423-437d-9a45-0e165c96af98">2,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ1LTMtMS0xLTY3NTEy_ae23be55-a69f-4c1d-8177-ee0a3edcbb39">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ1LTUtMS0xLTY3NTEy_af476c00-f0a0-4994-a32c-7047946bbe5a">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ2LTEtMS0xLTY3NTEy_31a2b0a4-6264-4bdf-8dc6-5276f44ed70b">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ2LTMtMS0xLTY3NTEy_da531134-62c9-4cb0-b30f-10c45393c08d">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ2LTUtMS0xLTY3NTEy_fc3d18f8-d025-4d0d-abd9-8d6ca4721b83">2,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTEtMS0xLTY3NTEy_1756dfeb-1921-4283-b1f1-8282e3a60293">3,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTMtMS0xLTY3NTEy_0bbbf67e-4b07-4738-82e6-86dd55418891">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTUtMS0xLTY3NTEy_7f46f067-9b71-4e18-9073-37b44606dceb">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Restricted cash at end of year included in Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ4LTEtMS0xLTY3NTEy_b3ec5d1e-7eeb-4404-a97f-7c7059665220">403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ4LTMtMS0xLTY3NTEy_4befa896-1328-4a39-8c0f-40b5350d1572">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ4LTUtMS0xLTY3NTEy_7a792aa3-7532-4012-93d0-89ad254fb28d">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUwLTEtMS0xLTY3NTEy_b645853c-822a-41ac-b4ab-fb87ec85d8e4">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUwLTMtMS0xLTY3NTEy_1a200670-4241-4e56-bf8e-d3f084a261d9">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUwLTUtMS0xLTY3NTEy_b99ff91b-8d14-43b6-8a5a-db0ac6c5343d">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU0LTEtMS0xLTY3NTEy_e1c15cc4-7954-4afb-81ae-c59d73588633">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU0LTMtMS0xLTY3NTEy_af7d9e52-d72c-4811-af31-4fb011610869">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU0LTUtMS0xLTY3NTEy_9188d823-1fbf-4c29-a871-111c9d5bf432">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU1LTEtMS0xLTY3NTEy_28b47498-ac1a-47d6-acfd-c29d635cbf71">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU1LTMtMS0xLTY3NTEy_7b61d44a-3434-4b79-b70e-dc0ed842453a">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU1LTUtMS0xLTY3NTEy_a22da047-1c87-4418-b625-3bebaecd8fb3">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_106"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_109"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTk_ed3f812d-9936-4833-b9d6-f839d21e715b" continuedAt="i262a371a254e42fe9598645110d73195" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="i262a371a254e42fe9598645110d73195" continuedAt="ide1c49b543194aa589dc336ba6fff1d7"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson&#8217;s teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTE3ODI_54caed58-2936-4c71-a131-ccc626ee2166">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. Refer to Financial Note 21, &#8220;Segments of Business,&#8221; for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzY1_42a46749-371b-43b5-af9f-fcc33f77898f" continuedAt="i6c116a83a24f4978985379c6c067480c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6c116a83a24f4978985379c6c067480c">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjY3_a031ef21-2603-4f4a-ab52-3e04a2f8ffc0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjM1_6cc8d31e-4397-4779-9a5b-e59c2cb5c542" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior period amounts have been reclassified to conform to the current year presentation.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzIy_4bd0572b-0681-4cc4-b9d6-7bf7fb48a074" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). As COVID-19 further evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzc4_e456feda-e319-4ca7-abdc-3e3fa83fc3a1" continuedAt="ic000235d6fe745cda65b39d756da3961" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic000235d6fe745cda65b39d756da3961">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ide1c49b543194aa589dc336ba6fff1d7" continuedAt="i5cb869bd6b6c47c7a860d6c4768afd2d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjU2_4c26b6f3-53d1-4541-a3f9-aaf8d808fc3f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Restricted cash at March 31, 2022 primarily consists of $<ix:nonFraction unitRef="usd" contextRef="ia875aad6cce743958618a33cce559dc9_I20220331" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTM1MTU_108e53bf-b0c2-490b-97ea-d09658a1b1fc">395</ix:nonFraction>&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash at March 31, 2022 and 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets at March 31, 2022 and 2021.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjg1_cda5bd8c-9ac7-42de-a46d-a0df1609caac" continuedAt="i964c8168587f42e192589e1d0789e403" escape="true">Equity Method Investments:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i964c8168587f42e192589e1d0789e403"> Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjc5_a04a26a3-e877-44ad-9d7e-3fbc8bb91eca" continuedAt="ie863ce7b41fc420db3e68c3d8d12dc76" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Net and Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, legal disputes, or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie863ce7b41fc420db3e68c3d8d12dc76">Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1MjQx_d8dc935b-180e-4c5c-a33e-5ad0d071d677">89</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1MjQ3_715d1387-1bdf-410d-9b62-e07121ad67eb">198</ix:nonFraction> million were included in &#8220;Receivables, net&#8221; on the Consolidated Balance Sheets as of March 31, 2022 and 2021, respectively. Changes in the allowance for the year ended March 31, 2022, were primarily within the U.S Pharmaceutical and International segments.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzYx_db8fdc87-1308-4311-b1e6-104ac8a10ae5" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:AccountsReceivableCustomerAccountsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzItMS0xLTEtNjc1MTI_c6b9dc18-c391-4a1d-8505-1275a1fa36a6">16,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="mck:AccountsReceivableCustomerAccountsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzItMy0xLTEtNjc1MTI_771a8e86-79c7-41e5-be16-1806b95a181f">17,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzMtMS0xLTEtNjc1MTI_263d8480-e963-46d5-9d08-fa650918ccbb">2,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzMtMy0xLTEtNjc1MTI_8c527206-55f9-4b4b-96de-809da76ec58e">2,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzQtMS0xLTEtNjc1MTI_4f79ced7-dfc7-437e-883f-ee64bbdf9876">18,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzQtMy0xLTEtNjc1MTI_ccf3f168-229c-4cbd-8b0d-7b5a6eea1864">19,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzUtMS0xLTEtNjc1MTI_2f046981-5a55-44a0-8924-a8a0b471b9c9">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzUtMy0xLTEtNjc1MTI_0c3f7504-6977-4732-9035-aeee9143c5d4">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzYtMS0xLTEtNjc1MTI_ff7e86de-2646-4ef9-9995-fab7eba8be7c">18,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzYtMy0xLTEtNjc1MTI_2ae208bb-b974-4fe6-97a3-213faa221560">19,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i5cb869bd6b6c47c7a860d6c4768afd2d" continuedAt="ie8813fe8513845a3bd00f7835f299898"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzEz_dcccf0b7-13ca-43cf-b7ed-083a280d5507" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2022, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately <ix:nonFraction unitRef="number" contextRef="ibef844e82df1453ebb9d87c78078c9bb_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0NjY_40bd8ace-d77b-4ea5-9789-932c938e92d5">52</ix:nonFraction>% of its total consolidated revenues and approximately <ix:nonFraction unitRef="number" contextRef="i0ca5a3c42a474837ad3c8ddb0bd7ed5d_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0NzE_4407fd29-8415-4f0a-8d80-a540d83543c8">43</ix:nonFraction>% of total trade accounts receivable at March 31, 2022. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately <ix:nonFraction unitRef="number" contextRef="i497343cb5b494f24aff9bdc1fea240b3_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0NzY_7739bfdc-3eb8-4704-bde2-e5b06230249f">21</ix:nonFraction>% of its total consolidated revenues in 2022 and comprised approximately <ix:nonFraction unitRef="number" contextRef="i1927407de0374cf69e8f7b4d87b815fc_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0ODI_4d760f92-437a-49c6-b6d5-90f9144c642a">28</ix:nonFraction>% of total trade accounts receivable at March 31, 2022. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzYw_7b42e3bb-4c59-46a5-9c7b-b5138ae4d882" continuedAt="i031a9505ee424699a727664c626e6a88" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and 2021, total inventories, net were $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1ODE2MzI_8329b5a9-f19c-415f-b589-7f1f41471c7c">18.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-8" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1ODE2NDA_9e7f790c-32b5-4b16-a9b5-c904a5b3f011">19.2</ix:nonFraction> billion, respectively, in the Company&#8217;s Consolidated Balance Sheets. The LIFO method was used to value approximately <ix:nonFraction unitRef="number" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDA2_475aa01d-dc30-462a-87cb-72459a13fefb">63</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDA5_1e3eb74d-6213-49a5-9bb1-3901d7fb5a3e">58</ix:nonFraction>% of the Company&#8217;s inventories at March 31, 2022 and 2021, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:InventoryLIFOReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDE0_ea42975b-e7ae-441a-a8fb-2f0fffb97673">383</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:InventoryLIFOReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDE3_1f9ac2bc-4af1-40e7-a692-1d99e3559035">406</ix:nonFraction>&#160;million higher than the amounts reported at March 31, 2022 and 2021, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDMz_e894b381-7af0-4c25-bb40-d1d77e42fb5e">23</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDQw_3e56f971-c355-4734-ae56-1ce1edd5e1f6">38</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDQ3_bd368ee4-2a99-4c0f-bd17-44ca7c2cd944">252</ix:nonFraction> million in 2022, 2021, and 2020, respectively, in &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The lower LIFO credits in 2022 compared to 2021 and 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i031a9505ee424699a727664c626e6a88">The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2022 and 2021, inventories at LIFO did not exceed market.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzg2_922a2cec-8a38-4f96-8488-795b1b7df6d4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes costs to pack and deliver inventory to its customers in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statements of Operations. Shipping and handling costs of $<ix:nonFraction unitRef="usd" contextRef="i6c4813acb64c45d2b97a2771fc585000_D20210401-20220331" decimals="-8" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg4MDI_e3d7878d-8b24-436f-b1fa-1dc10864fd22">1.1</ix:nonFraction> billion was recognized in 2022, and $<ix:nonFraction unitRef="usd" contextRef="ica1b10d592e944029941c3362d1e7d7f_D20190401-20200331" decimals="-8" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg4MTA_6f217d57-ee4f-4ba9-a7a3-5a446f4eb669"><ix:nonFraction unitRef="usd" contextRef="idd2a1aaa4aa14613b98b19f05c608e54_D20200401-20210331" decimals="-8" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg4MTA_fe0a320f-e7b9-4115-af22-ae618d95c9e6">1.0</ix:nonFraction></ix:nonFraction> billion was recognized in each of 2021 and 2020.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:HeldforSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzg4_cc2b4a9d-77c4-435d-881b-9b8a24678acb" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for additional information.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie8813fe8513845a3bd00f7835f299898" continuedAt="i67e2ce2dfc8c44a8834d8634f3e92e15"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjM3_d33b498a-027f-4acd-8b85-50be1d1116a2" continuedAt="ia49b68e74f4e4a07a16df8cb57dad86e" escape="true">Property, Plant, and Equipment, Net: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia49b68e74f4e4a07a16df8cb57dad86e">Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from <ix:nonNumeric contextRef="i3520428561d84269863983bba1a927e7_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1Mzky_4ac02b34-d82d-40a7-8b9b-0e697d973ba1">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i4995096937474d1bafc21c7eb57b994e_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1Mzk4_db01e855-9e2b-4573-9a64-7b971f4b58e5">30</ix:nonNumeric> years for building and improvements and <ix:nonNumeric contextRef="id81d0417806f4bd2852861c9771dece6_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1NDM1_39f546f4-4c43-4476-ab26-96bce8a9bd45">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i2bbfc4c323144cdbacc148f6e3af2eae_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1NDQx_d78936d3-7028-4846-a430-ee0f92aa67fa">15</ix:nonNumeric> years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#8220;ROU&#8221;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDEx_ae6c0b14-d3ab-44e1-96dc-eec0fe925c6f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March 31, 2022 and 2021:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzItMS0xLTEtNjc1MTI_a8c5bb49-c1d1-43af-8c2c-477b0ce8ab05">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzItMy0xLTEtNjc1MTI_17d8e465-5d0b-48a1-964b-22e661772708">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzMtMS0xLTEtNjc1MTI_be8af5bb-dbe9-4666-9ec7-7ae869565a5f">1,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzMtMy0xLTEtNjc1MTI_d3101db0-f7d9-4f86-9b2f-e1a753604797">1,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzQtMS0xLTEtNjc1MTI_ee49f54a-bf49-4d28-88f7-2607908dfdb4">2,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzQtMy0xLTEtNjc1MTI_28cdf77d-dcb9-4a01-bd72-7b3b33901168">2,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzUtMS0xLTEtNjc1MTI_fb44949c-326e-492f-ad0d-2c4315a4d4a9">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzUtMy0xLTEtNjc1MTI_0d2e07bf-3bad-43db-b18d-e357c76bbed8">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzYtMS0xLTEtNjc1MTI_44f8e608-f55e-4aa4-a013-ac67a3dd146b">4,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzYtMy0xLTEtNjc1MTI_5f6586fa-3b2f-4a66-bbc2-3668df9a92c8">4,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzctMS0xLTEtNjc1MTI_d00c49f0-235d-4220-819a-83ac4fa76ebb">1,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzctMy0xLTEtNjc1MTI_3c8a3d02-75f4-43c0-8850-b5fae1dd612f">2,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzgtMS0xLTEtNjc1MTI_a6d4bd87-e4bb-4c81-989a-6b7eb1c6d28c">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzgtMy0xLTEtNjc1MTI_d5eafb04-f35f-4c01-a336-e69c4ef7ee96">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense for property, plant, and equipment, net and amortization of the ROU assets of finance leases was $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NTcw_64c96d36-797b-4459-98d5-c692e082c8d5">312</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NTc1_86731f0a-7148-476d-8b7b-2dc22e712a6c">344</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NTgw_2a44f456-0b6e-41d1-bff9-93a2536759d6">335</ix:nonFraction>&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTI_5f8b595f-d457-4689-82c2-d91afbb0ce00" continuedAt="i4ec4b0fe7f7a40df8e77227520fd9cc3" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd">one</span>&#160;to <ix:nonNumeric contextRef="i7f482d9a485949708d2fb871130187fd_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MTQ_2e1df4bc-1eba-4408-8c7b-2f224a5993fc">15</ix:nonNumeric> years, while remaining terms for equipment leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd">one</span>&#160;to <ix:nonNumeric contextRef="i07fbf9f75177477d9f3069a6a3ca5aa5_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MzA_09e840ee-5a36-48c9-8609-03090a4c85f4">five years</ix:nonNumeric>. Most real property leases contain renewal options (typically for <ix:nonNumeric contextRef="i6f3d97d7bd9041e6a3021f9f3286582a_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDc0NjI_786f4297-9f4a-4802-8a2d-4cad4c09f492">five-year</ix:nonNumeric> increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i67e2ce2dfc8c44a8834d8634f3e92e15" continuedAt="i21c6ebdc4a394d318ff237808917c86e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ec4b0fe7f7a40df8e77227520fd9cc3">Refer to Financial Note 10, &#8220;Leases,&#8221; for additional information on the Company&#8217;s leases.</ix:continuation></span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjQ1_e732d387-8caa-405c-a38c-59ba7bd9c6fe" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzMw_6d72597a-dee2-46f6-820c-407b26feb71a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61">one</span> to <ix:nonNumeric contextRef="i866185886e394d17bb4c613ad5943f58_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMzODU_5f2713cf-ea19-42fb-a459-68bb364cd620">24</ix:nonNumeric> years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzE2_2ac1b128-79d7-4b01-8f84-723a0296e6f1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed <ix:nonNumeric contextRef="i866185886e394d17bb4c613ad5943f58_D20210401-20220331" name="mck:CapitalizedSoftwareHeldforInternalUseUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NzM4NDg_c3fe35fe-ebee-4f6e-a518-d96cf5c9c316">10</ix:nonNumeric> years. As of March 31, 2022 and 2021, capitalized software held for internal use was $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjM5_caed40bb-d817-4a78-93d2-50ad4ae48523">320</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjU4_15c128c0-92ff-4ffc-ae09-fa19bcc80819">513</ix:nonFraction> million, respectively, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjY1_c11f8e5b-f07b-424b-8ec2-81b5527fd1f5"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjY1_fed4486b-bcbc-419f-8244-af8a7f1494af">1.4</ix:nonFraction></ix:nonFraction> billion, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. The decrease in capitalized software held for internal use is primarily due to the planned exit of the Company&#8217;s European businesses which resulted in an impairment of certain internal-use software that will not be utilized in the future and classification of certain software as held for sale, as discussed in Note 2, &#8220;Held for Sale.&#8221; Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1Njg2_36a04277-d720-417c-829c-0929fd25c8ad">116</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1Njky_fe7fb357-19e6-4c24-9a2a-b33b85994c48">117</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1Njk1_3ffaa6e4-506a-4ffa-9dfd-8b564de4b226">129</ix:nonFraction>&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:InsuranceProgramsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDI1_2c288cde-b577-4d81-bc69-0ff6c7def1ae" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTM_a14037ec-eaf4-4378-8d38-66818adc2894" continuedAt="i40dc10baf64d4aa5ab5b86733b5e7073" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i21c6ebdc4a394d318ff237808917c86e" continuedAt="i9468f1b11c9a48abb0a7107bef9ec969"><ix:continuation id="i40dc10baf64d4aa5ab5b86733b5e7073" continuedAt="ie06b83cf9f1e445d9d54b0aee8443ca6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately <ix:nonFraction unitRef="number" contextRef="i96172b3b6b994d48bf70c6de9f508828_D20190401-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MTI_124d594b-52fd-46b1-b4dc-bb313c176014"><ix:nonFraction unitRef="number" contextRef="i6056d0a51a7f4646bfa84408265c81c0_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MTI_705d4487-d1d9-4619-a762-94277a57e4bb"><ix:nonFraction unitRef="number" contextRef="i1e41ae776e234aad99573060abfa3d60_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MTI_a5c385ee-ce1a-4ac4-988b-a34ec26f8b69">98</ix:nonFraction></ix:nonFraction></ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0e210e8bb0d04564b3c8c5efbc105415_D20190401-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MjA_1de803e2-4106-45b4-9218-599518e64cc2"><ix:nonFraction unitRef="number" contextRef="ic483b5ea8e204c8a81418d102f77e31e_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MjA_be4836ab-c71f-4ad1-bce1-fc7d7a07fe93"><ix:nonFraction unitRef="number" contextRef="i24fc415a058448cabaac1543f414ee42_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MjA_c08b977d-c5a6-477d-8d15-3ab13e1b339c">2</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of total revenues for each of the years ended March 31, 2022, 2021, and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-8" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTkwNzE_16195623-ec7d-4629-bb6a-095cf2b4afbb">3.2</ix:nonFraction> billion in 2022 and $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-8" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTkwODY_263b0b0a-96a9-4ebe-a77f-8003917407cf"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-8" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTkwODY_ab365f51-48dc-436f-855d-4a9513a73baf">3.1</ix:nonFraction></ix:nonFraction> billion in each of 2021 and 2020. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2022 and 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie06b83cf9f1e445d9d54b0aee8443ca6">The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2022 and 2021. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:SupplierIncentivesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDAz_dbbbb738-1330-4ffc-a045-eb9d875c99f0" continuedAt="i0053375e06b34fa491f63c8ef1892087" escape="true">Supplier Incentives:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0053375e06b34fa491f63c8ef1892087"> Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:SupplierReservesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDM2_da933989-9a67-4a17-b4a7-5eae327e911a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDE0_bb88b692-26ed-4d21-9d6c-ee78a82d10c2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:InterestExpensePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzEw_a1915bb2-c282-4b3b-82a4-04c48f7f493a" continuedAt="i188bb7386bc742a3afa787325a261c3a" escape="true">Interest Expense</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i188bb7386bc742a3afa787325a261c3a">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9468f1b11c9a48abb0a7107bef9ec969" continuedAt="i23edfa266e0842399051c9af14f88c73"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDA4_e0d76dc0-4c86-41fa-a037-ebbb52469f2b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; equity (deficit) accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity (deficit) section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material in 2022, 2021, or 2020. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjcw_2ab29cff-1ff6-4575-a7e5-8663b4fd6e7c" continuedAt="i2e93bc83d53240f996494318ea7c9876" escape="true">Derivative Financial Instruments:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2e93bc83d53240f996494318ea7c9876"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity (deficit) section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 15, &#8220;Hedging Activities,&#8221; for additional information.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzk4_f8302665-9246-4154-bc70-c01f3c891384" continuedAt="ia6597c9027c7425c8ee15570adfb9d71" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#8217; equity (deficit) but are excluded from earnings. The Company&#8217;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia6597c9027c7425c8ee15570adfb9d71">unrealized gains and losses on retirement-related benefit plans.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDQ1_e50a2dad-2a71-4146-9c7d-37f5734ae68a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#8217;s consolidated entities including Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;) and ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; equity (deficit) in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 8, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for additional information.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzUy_49d516ad-25c2-49ca-b1b2-9c664cb29650" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees. Refer to Financial Note 5, &#8220;Share-Based Compensation,&#8221; for additional information.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i23edfa266e0842399051c9af14f88c73"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDAy_85e06398-47ae-4a42-98ea-418c52b04300" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to ongoing controlled substances claims to which the Company is a party.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjgy_46a53e20-e55d-4713-9ebb-872a3d4a275d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for additional information.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzcw_ba5c2176-7e53-4aaf-bceb-8eaf3f1035c5" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:TreasuryStockPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTQ_b2e4a9d5-2d90-4bb7-a70f-2d6baf419270" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDMy_a28e810a-4fcd-4ff7-bd09-620bc7e724c9" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no recently issued accounting standards that could have a material impact to the Company&#8217;s financial position, results of operations, cash flows, or notes to the financial statements upon their adoption.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_115"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzI3NDg3NzkxMTU2MzQ_a39ccaa4-08e9-47c9-8cdd-1160a188420b" continuedAt="iae8bc895598b43efa71ffa495c286efa" escape="true">Held for Sale </ix:nonNumeric></span></div><ix:continuation id="iae8bc895598b43efa71ffa495c286efa" continuedAt="ie0ba36c1cccb4beaa0a3289bab0719f8"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe (&#8220;European Divestiture Activities&#8221;). These activities, further described below, constitute the majority of the assets and liabilities classified as held for sale as of March 31, 2022. Total assets and liabilities that have met the classification as held for sale were $<ix:nonFraction unitRef="usd" contextRef="if5fc2a45b1fb4a57a52e375ee61e2e18_I20220331" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NTY_a699fe8f-f414-4c64-9dcf-ce10fc5e12cc">4.5</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="if5fc2a45b1fb4a57a52e375ee61e2e18_I20220331" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NTk_8a20f0f0-d905-4eb9-881a-7bb40a20c042">4.7</ix:nonFraction>&#160;billion, respectively, as of March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="iaf194e10ae1d4f91ab6ebadc346e333c_I20210331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NjI_5f0ba9b8-918d-438c-85da-790bf9b37b52">12</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf194e10ae1d4f91ab6ebadc346e333c_I20210331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NjU_872f06f4-b003-484f-beb5-0a51c41e7813">9</ix:nonFraction>&#160;million, respectively, as of March 31, 2021, primarily included within the Company&#8217;s International segment. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations. During the year ended March 31, 2022, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="ib36ffbe522794177a4a329b2f1eb434e_D20210401-20220331" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NzUwMDc_789c1dba-dee2-4dd9-9309-0b3861feba42">1.6</ix:nonFraction>&#160;billion, primarily to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell. These charges were largely driven by declines in the British pound sterling and the Euro. During the years ended March 31, 2021 and 2020, the Company recorded losses of $<ix:nonFraction unitRef="usd" contextRef="i8727a45639054efb97996743cbbaa5c5_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NDI1NzU_29165993-6c8f-411f-800f-98986efda516">58</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iafca086d825c49179df146b9365fef4a_D20190401-20200331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NDI1OTI_2ef572d5-934a-4b99-9c83-b181609dcd8e">275</ix:nonFraction>&#160;million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to a joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;) which was completed on November 1, 2020. These charges in each year were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i9cb26398b07540459c29d095fcbe163a_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NTk5NjI_076e2f4e-0c9a-4b20-884b-0dadcc4cce74">1.2</ix:nonFraction>&#160;billion (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i9cb26398b07540459c29d095fcbe163a_I20210705" decimals="-8" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NTk5ODc_acc6f070-63b7-4cfb-a964-cf1c97ae7a8b">1.4</ix:nonFraction>&#160;billion) adjusted for certain items, including cash, net debt, and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction is anticipated to close within the second half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwMDc_9ed44f13-c97b-4ef7-a080-15d7173a7ec1">438</ix:nonFraction>&#160;million to remeasure the E.U. disposal group to fair value less costs to sell. These charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment includes net losses of $<ix:nonFraction unitRef="usd" contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwMjQ_5f71dff4-6984-46dd-895e-eb4f643df27c">151</ix:nonFraction>&#160;million related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie0ba36c1cccb4beaa0a3289bab0719f8" continuedAt="i57a7faaedc3148daa3ef3dc2d10d0aa4"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzI3NDg3NzkxMTU2MzU_3f7ebaa0-63c6-44d6-9b3b-64355e0ee205" continuedAt="i41360b9a1c684a42af95b73bb7c7ede9" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzMtMS0xLTEtOTE2OTc_7347befd-1f6d-407f-84fe-32a0ae7c1d9e">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzQtMS0xLTEtOTE2OTc_57f47390-b151-4918-8e16-68d067bda89b">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzUtMS0xLTEtOTE2OTc_0d7fef96-b433-465a-b25c-9077310bd6d8">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzYtMS0xLTEtOTE2OTc_e80726d0-8af5-4843-a344-5988e3007b2f">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzctMS0xLTEtOTE2OTc_2d49284f-4552-40b3-ad87-fa80ffe3cd11">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzgtMS0xLTEtOTE2OTc_b4d9d7e3-9ba9-44f8-bacc-019385bc370e">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzktMS0xLTEtOTE2OTc_d82190fb-786e-4aca-9342-4caa976f5f2f">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzEwLTEtMS0xLTkxNjk3_f852c961-94c0-473e-821f-594b9b62aa85">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzExLTEtMS0xLTkxNjk3_cd05549d-727f-4d67-b78e-1568191e8cea">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE1LTEtMS0xLTkxNjk3_0a67f619-2642-476b-b90e-985b13261754">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE2LTEtMS0xLTkxNjk3_20515da0-c6ba-4228-b184-ade8c51ba35e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE3LTEtMS0xLTkxNjk3_78399296-4a4e-444e-88c0-d1e4b3b10288">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE4LTEtMS0xLTkxNjk3_ec0c7992-0dab-4446-a224-c07ae256b931">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE5LTEtMS0xLTkxNjk3_7659596c-55b4-46d4-bb61-d2948592f858">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIwLTEtMS0xLTkxNjk3_04a70c14-2bbb-4457-afd9-bd9c0b864210">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIxLTEtMS0xLTkxNjk3_2ee7dd40-8274-4ffa-8e5e-1602b0ded36a">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIyLTEtMS0xLTkxNjk3_8ae1027b-1e33-4c32-b503-5ea4911a78cb">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIzLTEtMS0xLTkxNjk3_65a1f05c-1438-4760-bd84-5959fa4733e6">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges related to the impairment of individual assets, which are primarily comprised of a $<ix:nonFraction unitRef="usd" contextRef="i29e231614cf344e4b636aecd2998ddde_D20210401-20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NDgwMjk_5c500669-672c-44d2-8637-f4b9536896fc">113</ix:nonFraction> million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2021, the Company announced an agreement to sell its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited. In April 2022, the Company entered into an amendment to the agreement for a purchase price of &#163;<ix:nonFraction unitRef="gbp" contextRef="ifd0254ffce6f4249b8b5901d3add0491_I20220430" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwNDU_90248c0e-adc8-46ed-ab7b-28a250086249">110</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="ifd0254ffce6f4249b8b5901d3add0491_I20220430" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwNjc_d5ee33fe-6540-400b-86cd-838452f01eb6">144</ix:nonFraction> million), including certain adjustments. During the year ended March 31, 2022, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i03a43c3fab9f446eb0a8de876cfc5913_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwODQ_9538f335-3ec1-4388-8554-6fa1b1776033">1.2</ix:nonFraction> billion, primarily consisting of adjustments to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustments include a $<ix:nonFraction unitRef="usd" contextRef="i03a43c3fab9f446eb0a8de876cfc5913_D20210401-20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxMDE_4b1eae39-edf5-42f7-8fdf-74fb62cb0da5">734</ix:nonFraction> million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy. The transaction closed on April 6, 2022 and, at closing the buyer assumed and repaid a note payable to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="i78ccaa920a9a4c73a30399adf8117855_D20220401-20220430" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NzM0Njk_9e47f877-c04a-4693-9cb7-b61bbaa161ac">118</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i57a7faaedc3148daa3ef3dc2d10d0aa4" continuedAt="i5a7406d33081404c9a32221a4e12ff8d"><ix:continuation id="i41360b9a1c684a42af95b73bb7c7ede9"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzMtMS0xLTEtMTEzMDIz_1dca8f26-a4fd-49ad-9291-71262ab3b04f">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzQtMS0xLTEtMTEzMDIz_7c6e45d7-c152-4d9b-bb2a-058fa095edaf">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzUtMS0xLTEtMTEzMDIz_53465a1c-f5d7-4541-a229-551741f364a5">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzYtMS0xLTEtMTEzMDIz_74bf789a-025f-4993-9fe2-b8a684d2eb4c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzctMS0xLTEtMTEzMDIz_ac199287-665b-479c-8e12-e154ce385e64">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzgtMS0xLTEtMTEzMDIz_193199ba-4b53-449d-a333-0c4f1cd9b469">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzktMS0xLTEtMTEzMDIz_43b8899f-7f1b-4d67-bfe3-d3cb94ee8f6d">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzEwLTEtMS0xLTExMzAyMw_96401214-9a24-42ab-b1d5-3d0fc7d6f134">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzExLTEtMS0xLTExMzAyMw_83558e36-2921-451e-81d1-28af6727a4ba">1,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzEyLTEtMS0xLTExMzAyMw_24ac0259-5de5-4194-8315-73d8218fda72">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzE2LTEtMS0xLTExMzAyMw_428d4a46-ac11-448e-b24a-f6fc077fc867">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzE4LTEtMS0xLTExMzAyMw_8710840e-4931-4d3e-94f2-b099d4fe8e7f">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzE5LTEtMS0xLTExMzAyMw_453a9a6f-c32c-4471-9b06-05eb396d7078">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzIxLTEtMS0xLTExMzAyMw_64226c94-4c98-4f6c-80cc-795c5eaa553d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzIyLTEtMS0xLTExMzAyMw_aee21b0b-beae-4635-9817-3fa6d2c00633">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzIzLTEtMS0xLTExMzAyMw_cee97a51-3f1b-4b37-9e52-31a8e35cca67">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzI0LTEtMS0xLTExMzAyMw_f444991f-a15d-46ca-9cf7-1287bdc6f8ba">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, the Company completed the sale of its Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i0adedf0f78e24ba5b61ec3c4ef5b7cbf_I20220131" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxMTk_d172f735-461b-43bb-8cf7-a06c9e67a84d">244</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i0adedf0f78e24ba5b61ec3c4ef5b7cbf_I20220131" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxNDE_bbd66635-f8e3-461a-b0d2-720b4a81cf88">276</ix:nonFraction> million), including certain adjustments. The Company divested net assets of the Austrian business of $<ix:nonFraction unitRef="usd" contextRef="ia2d3e091542c4331aa802c94a7053cc5_I20220331" decimals="-6" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NzMyMjk_a8eee715-28c7-43d3-bea9-a4faa586d47a">272</ix:nonFraction> million, primarily within the International segment, and the buyer assumed a note payable to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="i805540d4c73c4b6387871c54c384fbbf_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxNjc_94939154-b1c5-4dd7-9148-cd0a29957a87">63</ix:nonFraction> million which was paid to McKesson in the fourth quarter of 2022. During the year ended March 31, 2022, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="i6fd8b5bc85ab463b9b570056218ced7a_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxOTg_fe37f50d-c567-44cf-9340-1cbebffdfa93">32</ix:nonFraction> million which was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed a transaction with WBA whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson had a <ix:nonFraction unitRef="number" contextRef="ie3680721de0643ebb55f9f02576ae3ff_I20201101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMDc_bef0d14f-63da-4928-a3dd-1a7dc43fa06f">30</ix:nonFraction>% noncontrolling interest.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction consideration for the contribution included a receivable amount of $<ix:nonFraction unitRef="usd" contextRef="i9f12825bbb7d4be19f89e6a7c0f56679_I20201101" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMjI_1875de95-9507-4bd7-8f26-0d4c9651bfe9">41</ix:nonFraction> million, primarily related to working capital and net debt adjustments from WBA, which was received in the first quarter of 2022, and the <ix:nonFraction unitRef="number" contextRef="ie3680721de0643ebb55f9f02576ae3ff_I20201101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMzE_bef0d14f-63da-4928-a3dd-1a7dc43fa06f">30</ix:nonFraction>% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was <ix:nonFraction unitRef="usd" contextRef="i5bb3e221693840dbb9ad1863bc6749ce_I20210331" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMzg_97f1d884-6045-4599-8b7d-437d28e95299">nil</ix:nonFraction> as of March 31, 2021. The Company accounted for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i9ee10d37e08c43bb976ba37d004b5745_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyNTY_3b4be6be-309d-4cec-8ee7-99836c6367ab">291</ix:nonFraction> million as of the transaction date, which was paid to the Company in 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5a7406d33081404c9a32221a4e12ff8d">In conjunction with the contribution, the Company recorded losses of $<ix:nonFraction unitRef="usd" contextRef="i8727a45639054efb97996743cbbaa5c5_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyNzM_29165993-6c8f-411f-800f-98986efda516">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iafca086d825c49179df146b9365fef4a_D20190401-20200331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyOTE_2ef572d5-934a-4b99-9c83-b181609dcd8e">275</ix:nonFraction> million, respectively, in the years ended March 31, 2021 and 2020, which included adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the German pharmaceutical wholesale business disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA.</ix:continuation></span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_118"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwMzA3_2e10c7b3-f239-4bd2-b308-5f50d9dfba21" continuedAt="i7163abbd8f0e492c8b00cabb5098f6c3" escape="true">Restructuring, Impairment, and Related Charges, Net </ix:nonNumeric></span></div><ix:continuation id="i7163abbd8f0e492c8b00cabb5098f6c3" continuedAt="i92df983beebb4ca99cf16f75a2c9b5d3"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges, net, of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg4MDgz_a059a6cb-81cd-4d03-850e-8ed14ff972ec">281</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg4MDg4_7c8ac650-d29e-4c2a-a597-6067153e71fa">334</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg4MDk3_7bc20250-d9d7-48de-aa33-6f5591411930">268</ix:nonFraction> million in 2022, 2021, and 2020, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Consolidated Statements of Operations. In addition, for the years ended March 31, 2021 and 2020, certain charges related to restructuring initiatives were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations and were not material.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="ia00ccbaf67b84520a82cd5bc577ccbf8_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg5MDQ4_a2b0c4c6-cafa-4729-9917-a6f46339cebe">124</ix:nonFraction> million for the year ended March 31, 2022, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the year ended March 31, 2022 and were $<ix:nonFraction unitRef="usd" contextRef="i33304856ba67431dbe134e6a3ab5f8b0_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMxNzM_c29ebc95-1824-4d35-8500-bebd3db3108e">57</ix:nonFraction> million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in 2022 and remaining costs the Company expects to record under this initiative are not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i1a27f3b5cf9d4d86a3c7d1030055337c_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMxODQ_3b824654-307e-445a-b318-ddf9afb5aaf4">62</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i86e51851e38343d889528a7d74ce170b_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMxOTM_bd7c1069-cf23-44e5-9459-775c97c842bd">72</ix:nonFraction> million in 2021 and 2020, respectively, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in 2021 and remaining costs the Company recorded under this initiative were not material. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="id91a5fa4a09149dda8dc0d199e094ffe_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMyMzI_97b50f30-2dc2-4afb-b225-cd1fbcc89218">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i41c0c862a7ce4612a21718defa31e238_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMyNDE_263e7bdf-1f2b-42ca-8b6f-a9236038b971">44</ix:nonFraction> million in 2021 and 2020, respectively, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021 and remaining costs the Company recorded under this initiative, primarily relating to lease costs, were not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2018, the Company announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize the Company&#8217;s operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, the Company committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i69ad3377d9084d09824adc34ca4401cc_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjM4MDk_3f7d7bc4-2909-472c-ad37-7d79fdb7d72c">15</ix:nonFraction> million in 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i92df983beebb4ca99cf16f75a2c9b5d3" continuedAt="i9567a2e703a348a3982b5d910f271b65"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022 </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwMzA0_9a6eac23-602b-4283-a0b3-105a0e8a4a5c" continuedAt="i289f32072771496d8d762b4bdba1688d" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMS0xLTEtNjc1MTI_ba875c85-7c5c-4d06-93ef-369b5f79be08">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMy0xLTEtODkyNTg_3635f4d1-e58c-4bc6-95ab-77668df9aa33">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItNS0xLTEtODkyNzI_3a7220f7-e41f-43e9-8eea-9c54f678b839">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMy0xLTEtNjc1MTI_aa6dccdb-35a1-49fa-99c1-faf1798d8fb9">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItOS0xLTEtNjc1MTI_075a9ff1-44c7-47e5-b0ac-08ffe90c102e">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMTEtMS0xLTY3NTEy_427dcca4-f0da-4fee-bd15-df2083b09c5f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMS0xLTEtNjc1MTI_6ad34e3a-229a-4047-bce9-c027316bf0e2">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMy0xLTEtODkyNTg_248b535f-c0ac-4d58-8e09-dd75d3d62943">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtNS0xLTEtODkyNzI_9474909c-0912-4b06-af2c-6c003b902466">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMy0xLTEtNjc1MTI_8b6414bd-b634-4b43-af56-9b5e5e4f6641">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtOS0xLTEtNjc1MTI_86f4e020-e7d8-4a3a-8b5c-61b214f41c5d">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMTEtMS0xLTY3NTEy_f796f961-bd6e-462f-8796-9949a8d2d8ed">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMS0xLTEtNjc1MTI_32746993-53c8-47eb-8947-c8eb5408f5c1">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMy0xLTEtODkyNTg_076111c7-5115-47ed-9188-5d0a97f13f43">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtNS0xLTEtODkyNzI_fc93669e-0c46-408c-b368-5d636d9eac57">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMy0xLTEtNjc1MTI_6fa77c33-e309-4550-9fde-0eb079dff0f7">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtOS0xLTEtNjc1MTI_b7c7c1b9-d270-49fa-8ec3-16d589c5f1de">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMTEtMS0xLTY3NTEy_2e0f3fc4-3bbe-47ee-88c8-aa1719600bb5">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMS0xLTEtNjc1MTI_ba99c46a-d0cb-442f-bc12-bb371da12e19">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMy0xLTEtODkyNTg_70f9d2d0-907f-475e-9f23-1ca263d9104a">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtNS0xLTEtODkyNzI_64d8a675-1243-4b59-96cf-8dd3601f780b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMy0xLTEtNjc1MTI_be30ec6f-08b6-4238-83a8-02d415383d9a">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtOS0xLTEtNjc1MTI_b53f6c31-b647-466b-b3b4-85252afb9adb">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMTEtMS0xLTY3NTEy_3065443e-6e0f-48b0-a7f4-31ab4e427582">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#8217;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#8217;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMS0xLTEtNjc1MTI_715fec57-39dd-4d0e-a62d-6eb820838d6b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMy0xLTEtODkzODk_2dfbd662-1a38-4d0f-a496-f80b81a49ac5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItNS0xLTEtODk0MDA_e61dec03-91b8-4cf1-ae4c-485a83f24068">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMy0xLTEtNjc1MTI_e04bb60b-83e5-4896-baa8-25e2263128d0">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItOS0xLTEtNjc1MTI_e0986f02-303d-43b1-8c0b-ec47edc67e87">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMTEtMS0xLTY3NTEy_68023934-9c5c-4044-b70d-09b8c81eb5ae">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMS0xLTEtNjc1MTI_d3146e1e-2349-4cb8-8582-16aaeb1e6a00">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMy0xLTEtODkzODk_2f32768b-2b6c-4e7e-9484-f75989a7a32b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtNS0xLTEtODk0MDA_f22e8fea-2040-4e73-956b-28a6f71ca781">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMy0xLTEtNjc1MTI_e329ccc0-847b-4052-a600-8331e31006bc">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtOS0xLTEtNjc1MTI_f2bd56cf-12b7-4d71-85f0-55322302c4ff">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMTEtMS0xLTY3NTEy_5e32da84-e21c-40ea-bfed-cf34d935b43b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMS0xLTEtNjc1MTI_e380d561-fcd8-4eaa-bd60-0680ee85b057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMy0xLTEtODkzODk_f81f0a77-c1b0-4ada-b75d-97f347aeddc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtNS0xLTEtODk0MDA_a7d7cafa-a397-43f8-8fd9-19fcb2ea2ca8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMy0xLTEtNjc1MTI_4588dd1d-f7e9-4bf0-9f4f-e076cb59c9ff">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtOS0xLTEtNjc1MTI_f6493c98-0d00-462c-a1c2-0bd95af86f55">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMTEtMS0xLTY3NTEy_5fa62dd0-a19e-4842-a676-1ec89408c06f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMS0xLTEtNjc1MTI_1edd5ed9-aea0-4fdb-bf0d-f54e3da618db">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMy0xLTEtODkzODk_d3e5079b-3e93-4134-81c1-1b2dd1b2c2bc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtNS0xLTEtODk0MDA_babbeff3-df4f-4bbb-a90a-5346a1e0289e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMy0xLTEtNjc1MTI_35c16db7-4503-4d81-872c-a040249c567d">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtOS0xLTEtNjc1MTI_bba2fad3-ce51-4e93-aeb3-539f8cf0858f">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMTEtMS0xLTY3NTEy_4b1bdc7a-aa7f-4b8b-9f8c-42275f323604">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9567a2e703a348a3982b5d910f271b65" continuedAt="i70721b23ddd546db94b43f82e7f1eda4"><ix:continuation id="i289f32072771496d8d762b4bdba1688d"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMS0xLTEtNjc1MTI_36c87022-de18-4a14-913c-37131810bf77">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMy0xLTEtODk1MDI_2f5fde80-3813-4820-af8c-0efeaef8dd51">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItNS0xLTEtODk1MTM_0b6d0ca5-7535-4ab6-bfea-186201f5f2ea">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMy0xLTEtNjc1MTI_53b54b0a-acc4-4943-a62a-e2e5d79843c5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItOS0xLTEtNjc1MTI_b96385c7-5255-4931-bba7-7a40437044d3">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMTEtMS0xLTY3NTEy_e2dd10ec-657d-4fb4-a48e-751bf1e593a4">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMS0xLTEtNjc1MTI_784b76b0-a5ac-42d3-b517-7e1dd338f088">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMy0xLTEtODk1MDI_6aaf3343-929f-4a6e-9a31-57f2d583ae81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtNS0xLTEtODk1MTM_e47df77f-e10b-4af4-a821-260845f63df8">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMy0xLTEtNjc1MTI_422b71a8-c6d7-4545-b179-33d7577dfc16">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtOS0xLTEtNjc1MTI_28ec0485-4088-4e82-923c-2e4353f40f11">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMTEtMS0xLTY3NTEy_1b904168-e186-417e-a1df-69c035b2b4eb">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMS0xLTEtNjc1MTI_bfdccb9e-0779-4733-b532-82af5ba26511">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMy0xLTEtODk1MDI_e32deeb3-d1dd-4389-87c4-abcc0392022d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtNS0xLTEtODk1MTM_d71b0c80-e54d-4c69-b606-944a49019ddd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMy0xLTEtNjc1MTI_d03f10e3-e2a5-4102-84cf-763551c197f7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtOS0xLTEtNjc1MTI_f418440f-5599-4175-ab51-e4de7c9ec5dc">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMTEtMS0xLTY3NTEy_a45cffaa-2c9f-4c4d-8612-6033856f7659">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMS0xLTEtNjc1MTI_bc9158ce-ca0a-4843-98ab-90b076a0b87d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMy0xLTEtODk1MDI_0a012d4c-47b3-4f6a-a5c2-f4c2eb8fb039">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtNS0xLTEtODk1MTM_7fd4308c-9a7f-4029-ac75-baa7bbe7b969">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMy0xLTEtNjc1MTI_4d36e263-1b7f-44d4-a751-62af838d6776">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtOS0xLTEtNjc1MTI_a7b4a3e9-d554-48d0-aebd-b2853a609b4f">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMTEtMS0xLTY3NTEy_c2459a79-0636-4617-a53c-d2d86c4c61f8">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with dispositions and costs related to the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:continuation><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzI3NDg3NzkwOTAxNDE_df534eae-c104-40ce-bbad-8453a0aa0288" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March 31, 2022 and 2021: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1238be9949344a4ca03b1fd2035c6266_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMS0xLTEtNjc1MTI_12c87e4b-d879-41a3-9831-6b7b62e9a020">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735f207277504040936a46b7a21dbc2a_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMy0xLTEtODk2MzQ_136c3581-2eb9-4513-b249-3ff7a6803cad">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ae2fd5d4d84827a40c6ccf806b3215_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtNS0xLTEtODk2NDU_9aff3c87-8eda-4dfd-96be-8993e91eea5d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7657b4a360fd42b382531c0ba2049a37_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMy0xLTEtNjc1MTI_f594510e-78ad-444e-a1f1-fef62a611d6d">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819b3e5a18554614be6da3dc30c8c20e_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtOS0xLTEtNjc1MTI_f89b0903-3ce2-42cb-a15d-b7b943158e3b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMTEtMS0xLTY3NTEy_42d8a47d-6726-4460-a8b1-d44378d23881">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMS0xLTEtNjc1MTI_03101977-1375-4f1d-8f66-3bdfbc22ec9b">21</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMy0xLTEtODk2MzQ_36968e54-b40e-4323-a5dd-036932ad9432">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItNS0xLTEtODk2NDU_10e984f5-58ac-433f-96f8-7539232be1fd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMy0xLTEtNjc1MTI_23447db6-4abc-4dc3-8745-d55093903aaf">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItOS0xLTEtNjc1MTI_72c75051-e3fb-4cc0-b512-0d160beefc61">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMTEtMS0xLTY3NTEy_5026e923-2d8d-4f69-b151-d6d149aced5d">219</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMS0xLTEtNjc1MTI_9263b6a9-6393-4a01-84f3-bf4da7dfe621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMy0xLTEtODk2MzQ_662bd86b-78b7-4eda-9e97-f7a3a66a099c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtNS0xLTEtODk2NDU_5bc54514-48ba-44ad-9331-b70d26845981">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMy0xLTEtNjc1MTI_860f2f62-7df0-48df-b9f9-6dbe014fcadc">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtOS0xLTEtNjc1MTI_1478827f-d735-42ce-b169-b53cb930a7ba">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMTEtMS0xLTY3NTEy_a53cb152-8ff0-438a-b01b-42a84b6ffc77">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMS0xLTEtNjc1MTI_56de145c-c5d2-4181-8ab7-4fdd95e6297c">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMy0xLTEtODk2MzQ_12a2b584-bd4d-43e3-9e34-21d87340b0f4">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtNS0xLTEtODk2NDU_9033baad-d4e5-471b-a0c4-ece65ea3a23b">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMy0xLTEtNjc1MTI_416fca8c-6a98-426d-87d1-4737b95cc5d6">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtOS0xLTEtNjc1MTI_3f29e8cf-d305-45c9-8afd-aca2df802828">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMTEtMS0xLTY3NTEy_ef70b894-3e15-4af1-a74f-94e852168fd5">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMS0xLTEtNjc1MTI_b09f880e-478a-44cb-83d0-0f0c92c64652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMy0xLTEtODk2MzQ_1f6bf9f7-8056-48bc-9aa9-1a71d435f304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtNS0xLTEtODk2NDU_1de6a342-3115-4111-bc59-b03fad12e9ff">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMy0xLTEtNjc1MTI_8c40d220-f16c-4bfe-b7d6-f41664ce7aaa">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtOS0xLTEtNjc1MTI_145a7b16-142a-4951-a18b-6dbd5dff00f1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMTEtMS0xLTY3NTEy_e0aafa20-8a19-4e4d-9a0d-9d86acd5eb54">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf37a2aea301469bbf8c95c1cb87dea0_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMS0xLTEtNjc1MTI_a3517c01-a6b3-48e5-a85e-fd6ed5a4f782">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e69dbb765c4cbba679db0d75d4e24d_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMy0xLTEtODk2MzQ_b79517b1-d226-443d-b8a6-543c694408a1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3836c14e169d426385529b1516d34376_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtNS0xLTEtODk2NDU_3407e375-ad49-4a41-8b8a-8f9f05069004">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbae9d0f6df24779a201d5522b29b806_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMy0xLTEtNjc1MTI_8c1e15f0-0b58-4837-92b4-6955e272ee20">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5920306c6c74407aa3c61813edac174_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtOS0xLTEtNjc1MTI_6defcc45-e208-4e12-8f54-8d41ec71454b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMTEtMS0xLTY3NTEy_72e62a69-8878-4049-bdb4-d2b849e4a39d">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMS0xLTEtNjc1MTI_22dbb456-3b88-45a0-b49e-45d388ab81dc">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMy0xLTEtODk2MzQ_64364409-2a94-43e8-9d67-e842579bdb0a">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctNS0xLTEtODk2NDU_0a0d35c0-0221-4201-a83a-7340c5b0f8b1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMy0xLTEtNjc1MTI_703a9962-9a8c-4389-afa4-9f0920feef83">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctOS0xLTEtNjc1MTI_257904b8-d2a7-4f8f-9a6c-0d60e98cd787">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMTEtMS0xLTY3NTEy_a4b1e687-e1a7-42c8-b5c1-45d35b878474">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMS0xLTEtNjc1MTI_8e18ff6a-7fa3-49f7-a477-019bc68f4c9e">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMy0xLTEtODk2MzQ_f2271681-1f1a-4504-8683-c46330c7d9f9">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtNS0xLTEtODk2NDU_c1a37185-5f57-4f06-a938-d4f0fec175e3">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMy0xLTEtNjc1MTI_bb60439c-acc2-44a5-be86-b1c656b17fa3">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtOS0xLTEtNjc1MTI_785c66c1-41a9-49e6-8446-1f73fee4eef2">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMTEtMS0xLTY3NTEy_a3d4ea5e-bcac-4164-b126-5f0f77577edf">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMS0xLTEtNjc1MTI_aa1fa0c0-4fad-41c7-b238-ba2a37b200c0">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMy0xLTEtODk2MzQ_144e4cc9-244c-4462-86ec-70b4b4c00277">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktNS0xLTEtODk2NDU_95f79243-d915-43e2-a3ee-76c2a6769825">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMy0xLTEtNjc1MTI_d75ba52d-8d80-4e6a-87fb-4b4ccb4663bf">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktOS0xLTEtNjc1MTI_87155cd9-ea1e-45db-80df-7574619b88fa">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMTEtMS0xLTY3NTEy_05fdc863-2a5a-435c-92d8-902046da1a30">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTEtMS0xLTY3NTEy_13f64748-3525-46bd-8bf8-4f50c8e5e147">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTMtMS0xLTg5NjM0_b122b820-ba0e-43bb-8a80-12d902f52d04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTUtMS0xLTg5NjQ1_5ccaf6a6-ae0e-41ca-91c1-a0888c82e567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTMtMS0xLTY3NTEy_d99ed61b-3ed0-41af-ab9d-65c32946a612">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTktMS0xLTY3NTEy_3bd87fc9-34a3-4738-b518-0937699a41d6">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTExLTEtMS02NzUxMg_eb097718-c40b-4b68-b62f-35b38a0fad02">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75859372620f4bba9fcc690a92937930_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTEtMS0xLTY3NTEy_baa5f3ed-94e9-47b6-85d2-ebcb03cd9fbd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe8302f1495433a8b56aac54216c93a_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTMtMS0xLTg5NjM0_06772916-6bbc-4364-a48d-7a9fed31e858">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fde2da64904433badd4e9125f5242e_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTUtMS0xLTg5NjQ1_672c6899-52aa-40fa-84d6-a530aac3a6a7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i085f9b77e2ff45639871e3f6c4e87e81_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTMtMS0xLTY3NTEy_d28a53d7-35a5-4a00-8f70-26bf8fdd2534">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136fbfde3b204ba88d3ef047c523f6d0_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTktMS0xLTY3NTEy_089947c5-7efe-463e-9468-f773920caf15">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTExLTEtMS02NzUxMg_2943a746-6252-4a1d-8f80-44950e6546f8">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;As of March 31, 2021, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzNDc_ecf08dc5-9762-4213-a712-f875ce5b80af">151</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i94e33cbb297240f8b26bda1df5bbbe78_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzNTE_11a48b0b-199c-4325-829a-648d53cfa214">99</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities&#8221; and $<ix:nonFraction unitRef="usd" contextRef="ifa3be7b53b364d71925dd6edb5685f60_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzMzE_962c15bb-e66b-45d7-8723-5225ac9ddc58">52</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MzI0MjM_186473a5-f38f-44f4-8c1b-465dd7dc6006">130</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i1c6852c1f9a6482689173337df8e42e1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIyOTQ_28e06e2c-1cb4-40b2-9de5-0e36e07ea128">58</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="i70f13591242b45b99e2c1c5db5996175_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzMDQ_aa8ff937-0063-42a4-88d7-c81a4e9bda64">36</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="iea0833513a6441c390d86adb1976e862_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzMTM_45079042-67b9-463d-8735-139694344ba0">36</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i70721b23ddd546db94b43f82e7f1eda4" continuedAt="id1906b13faf248a688f575f53a812059"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company recognized charges totaling $<ix:nonFraction unitRef="usd" contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MzI5MTA_d636ff38-9d3a-4c80-847b-675e1cd10910">36</ix:nonFraction> million to impair certain long-lived assets within the International segment related to the Company&#8217;s operations in Denmark and its retail pharmacy businesses in Canada. The Company used an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived assets. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTM5NzQ_feb0bc90-7789-4240-a54a-46ba9df5960f">115</ix:nonFraction> million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="ie75d55168ab54f22bd06fbcb372e660d_D20190401-20200331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTM5ODM_6a133127-d136-4d91-b038-a2377c190e9e">82</ix:nonFraction> million to impair certain long-lived and intangible assets for its retail pharmacy business in Europe within the Company&#8217;s International segment. These charges related primarily to intangible assets associated with pharmacy licenses within the U.K. retail business due to a decline in estimated future cash flows driven by additional U.K. government reimbursement reductions communicated in the third quarter of 2020. The Company used a combination of an income approach and a market approach to estimate the fair value of the long-lived and intangible assets. </span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id1906b13faf248a688f575f53a812059">In 2020, the Company performed an interim impairment test of long-lived and intangible assets for its Rexall Health retail business, within the Company's International segment, due to the decline in the estimated future cash flows primarily driven by lower than expected growth in both prescription volume and sales of non-prescription goods. As a result, the Company recognized a charge of $<ix:nonFraction unitRef="usd" contextRef="i014202a1f605442dbab72a51287eee8c_D20190401-20200331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTM5OTM_575e6eca-5ed1-4ef9-8ef9-c6d38629b154">30</ix:nonFraction> million to impair certain long-lived and intangible assets, primarily customer relationships. The Company used an income approach for estimating the fair value of the long-lived and intangible assets.</ix:continuation> </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_121"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3ODM_d9197a57-dab1-4707-95b8-5462bd614b34" continuedAt="i0cd43f064d2d40ca87e30379b816bc75" escape="true">Business Acquisitions and Divestitures </ix:nonNumeric></span></div><ix:continuation id="i0cd43f064d2d40ca87e30379b816bc75" continuedAt="i9d8b88e2a2b54eea85bd8c3e565fa7fc"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021, and 2020, the Company did not complete any material acquisitions. For the three years presented, the Company completed several de minimis acquisitions within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates. Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes. However, if the assets of another company are acquired, the goodwill may be deductible for tax purposes. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe. In 2022, the Company entered into agreements to sell the E.U. disposal group and U.K. disposal group and completed the previously announced sale of its Austrian business, as described in Financial Note 2, &#8220;Held for Sale.&#8221; In 2021, the Company contributed the majority of its German pharmaceutical wholesale business to a newly formed joint venture with WBA as discussed in Financial Note 2, &#8220;Held for Sale,&#8221; and, in 2022, sold its interest in the joint venture to WBA, as described in Financial Note 6, &#8220;Other Income, Net.&#8221; In 2020, the Company completed the separation of the Change Healthcare JV, as described below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in the Change Healthcare Joint Venture </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2017, the Company contributed the majority of its McKesson Technology Solutions businesses to form a joint venture, the Change Healthcare JV, under a contribution agreement between McKesson and Change Healthcare Inc. (&#8220;Change&#8221;) and others, including shareholders of Change. In exchange for the contribution, the Company initially owned approximately <ix:nonFraction unitRef="number" contextRef="i850442d9feb244c1b8d54049ca967bf7_I20170331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwMzA_d29ff2ba-4935-4c7d-9e2f-db18e54ce945">70</ix:nonFraction>% of the joint venture, with the remaining equity ownership of approximately <ix:nonFraction unitRef="number" contextRef="i5602bb7b6c1f4462ad47f96096815f13_I20170331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwMzc_82faaade-ef6e-445b-84fa-365f6e16d4f5">30</ix:nonFraction>% held by Change. The Change Healthcare JV was jointly governed by McKesson and shareholders of Change.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9d8b88e2a2b54eea85bd8c3e565fa7fc" continuedAt="iff12e91a49ee4e019449907cd08f385b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change contributed net cash proceeds it received from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;). As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately <ix:nonFraction unitRef="number" contextRef="i850442d9feb244c1b8d54049ca967bf7_I20170331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwNzY_d29ff2ba-4935-4c7d-9e2f-db18e54ce945">70</ix:nonFraction>% to approximately <ix:nonFraction unitRef="number" contextRef="ia25cf3b3c2cb43a3a841dfd73d6b05a3_I20190701" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwODA_b89ea706-09a6-45cb-9cf0-547a0b28b4f2">58.5</ix:nonFraction>%. Accordingly, in the second quarter of 2020, the Company recognized a dilution loss of $<ix:nonFraction unitRef="usd" contextRef="i957db9ee8dda4a86a6807315859b7837_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwOTI_59773187-8833-44da-b2fe-010491a1ff58">246</ix:nonFraction> million, primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. This amount was included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded an other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $<ix:nonFraction unitRef="usd" contextRef="i9dea9ba882cb4ed59e73b4c472a99efc_D20190701-20190930" decimals="-8" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxMDQ_47f743ae-0813-49e5-bf69-059a54c573a3">1.2</ix:nonFraction> billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation of the Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the separation of its interest in the Change Healthcare JV. The separation was affected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly-owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (&#8220;Split-off&#8221;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#8220;Merger&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Split-off, on March 9, 2020, the Company distributed all <ix:nonFraction unitRef="shares" contextRef="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309" decimals="-5" name="mck:ExchangeOfferSharesDistributed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxMzQ_42a2fc7f-b303-440a-8ef0-f048dd19dea2">176.0</ix:nonFraction> million outstanding shares of common stock of SpinCo to participating holders of the Company&#8217;s common stock in exchange for <ix:nonFraction unitRef="shares" contextRef="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309" decimals="-5" name="mck:ExchangeOfferSharesExchanged" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3NDg3NzkwOTIxMzI_d4f22bb8-afa3-4967-9516-344deef521a8">15.4</ix:nonFraction>&#160;million shares of McKesson common stock which now are held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 19, &#8220;Stockholders' Equity (Deficit),&#8221; for more information. Following consummation of the exchange offer, on March 10, 2020, SpinCo was merged with and into Change Healthcare, and each share of SpinCo common stock converted into <ix:nonFraction unitRef="shares" contextRef="i4acf39f6c45042d9825177088805f18a_I20200310" decimals="INF" name="mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNDc_5b505a3d-42b4-4cd4-b5e0-bdbd77fd93df">one</ix:nonFraction> share of Change common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i4acf39f6c45042d9825177088805f18a_I20200310" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNTI_5af28c7d-cd37-4301-9e9c-ac7992792b94">0.001</ix:nonFraction> per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and the Merger are intended to be generally tax-free transactions for U.S. federal income tax purposes. Following the Split-off, the Company does not beneficially own any of Change&#8217;s outstanding securities. In the fourth quarter of 2020, the Company recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="i1946db5930c242abbc59691266086fb6_D20200101-20200331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3NDg3NzkwOTE3MTk_7bd1f739-e76e-4f9c-a6de-b67cc93f754a">414</ix:nonFraction>&#160;million related to the transaction which is included under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020. <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3NDg3NzkwOTE3MDA_16695bc9-ad93-4b51-9f6f-20966f4d3666" continuedAt="i5dccbb3e5ad64e1fa6d4270d88a7a77c" escape="true">The net gain was calculated as follows:</ix:nonNumeric></span></div><ix:continuation id="i5dccbb3e5ad64e1fa6d4270d88a7a77c"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of McKesson common stock accepted (<ix:nonFraction unitRef="shares" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-5" name="mck:EquityMethodInvestmentStockAccepted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzEtMC0xLTEtNzcyNjgvdGV4dHJlZ2lvbjo5NTE1M2VmYTJkOTU0NDZhODVjZjA5ZmQyZDY3N2M5Ml80Mzk4MDQ2NTExMTk5_eb64e49b-471f-4849-ab68-ab18cf273c01">15.4</ix:nonFraction> million shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="i5dd842111f74444da1462dfb1b854980_D20210101-20210331" decimals="2" name="mck:EquityMethodInvestmentStockAcceptedAverageCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzEtMC0xLTEtNzcyNjgvdGV4dHJlZ2lvbjo5NTE1M2VmYTJkOTU0NDZhODVjZjA5ZmQyZDY3N2M5Ml80Mzk4MDQ2NTExMjA1_144fcda0-9a45-42e5-ad3a-f56b9b5cab21">131.97</ix:nonFraction> per share on March 9, 2020)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-6" name="mck:EquityMethodInvestmentFairValueofStockAccepted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzEtMS0xLTEtNzcyNjg_4c273ca6-3cc6-4edf-a49d-6b8c7ea4d30e">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the Change Healthcare JV at exchange date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-6" name="mck:EquityMethodInvestmentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzItMS0xLTEtNzcyNjg_072471f4-12f0-4b6c-8c38-9bb014035d89">2,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of deferred tax liability </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-6" name="mck:EquityMethodInvestmentsReversalOfDeferredTaxLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzMtMS0xLTEtNzcyNjg_315e0115-4a83-481f-9cad-d83263256594">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of accumulated other comprehensive loss attributable to the joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-6" sign="-" name="mck:EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzQtMS0xLTEtNzcyNjg_1932739b-f300-4ef7-aa18-847f2af4f3e4">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-6" name="mck:EquityMethodInvestmentTransactionCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzUtMS0xLTEtNzcyNjg_1ee4db81-d1e5-4573-a74d-9d0df1921df2">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on split-off of the Change Healthcare JV</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzYtMS0xLTEtNzcyNjg_222db3e8-522e-49fe-9bf9-f8872054398f">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investment in the Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of the Company&#8217;s interest in the Change Healthcare JV, this investment was accounted for using the equity method of accounting. Effective April&#160;1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance and, in the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $<ix:nonFraction unitRef="usd" contextRef="i3109ad9f81eb416ab0a243bace22e406_I20190401" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNjc_15807797-52ec-4717-8094-432fcea8c1fb">80</ix:nonFraction> million, net of tax, in the Company&#8217;s opening retained earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iff12e91a49ee4e019449907cd08f385b"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the OTTI and transaction-related items described above, the Company recorded its proportionate share of loss from its investment in the Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNzQ_14b6f95c-577d-49a5-b4ee-852ac6c89857">119</ix:nonFraction> million in 2020, which includes transaction and integration expenses incurred by the Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible amortization and removal of profit associated with the recognition of deferred revenue. This amount was recorded under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of the Change Healthcare JV, McKesson, the Change Healthcare JV, and certain shareholders of Change entered into various ancillary agreements, including a transition services agreement (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;) and certain other agreements. The Advisory Agreement was terminated in 2020 and fees incurred or earned from the agreement were not material for 2020. Fees incurred or earned from the TSA were not material in 2022 nor 2021 and were $<ix:nonFraction unitRef="usd" contextRef="iefb5b025ddcb4d33a1880e89a1d2abc9_D20190401-20200331" decimals="-6" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMyNTQ_cfb3694e-3ed3-4347-9d20-e957e5f7f3de">22</ix:nonFraction> million in 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the TRA, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax year ended March 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare&#160;JV, the aforementioned TRA agreement requires the Change Healthcare&#160;JV to pay McKesson <ix:nonFraction unitRef="number" contextRef="i372b78f92945468a8ee64d9a3cfcac2a_I20210331" decimals="INF" name="mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMzMTE_6ee09f1e-8b72-42b4-983c-069f08ed5b42">85</ix:nonFraction>% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare&#160;JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with <ix:nonFraction unitRef="usd" contextRef="i713d743d96654a20823b67a74fa07746_I20210331" decimals="INF" name="us-gaap:LiabilitiesNoncurrent" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQ5NDc4MDIzNDY0ODI_00145108-d1e6-4b36-8312-19d912abe7c1"><ix:nonFraction unitRef="usd" contextRef="i396a3d47aa6b4128922f47705dca2702_I20220331" decimals="INF" name="us-gaap:LiabilitiesNoncurrent" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQ5NDc4MDIzNDY0ODI_11f0ac2b-6239-4171-ae4f-3ce15327a9ce">no</ix:nonFraction></ix:nonFraction> receivable recognized as of March 31, 2022 or 2021.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_124"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwNzk3NDU_c847fed6-c66e-49b9-a174-565f8a329960" continuedAt="iee64c24f13114c32930713237d072c5e" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="iee64c24f13114c32930713237d072c5e" continuedAt="i5df1daf5ffc24b3cb8a521130ac91ed6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#8220;RSUs&#8221;), performance-based stock units (&#8220;PSUs&#8221;), stock options, and an employee stock purchase plan (&#8220;ESPP&#8221;) (collectively, &#8220;share-based awards&#8221;). Most of the share-based awards are granted in the first quarter of each fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i5df1daf5ffc24b3cb8a521130ac91ed6" continuedAt="i513ab6f6771e4a7b8d8956b8cc0e647a"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on Net Income</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxOTE_733346df-b626-4fad-89c3-16c8396fed10" continuedAt="i05829da936d44ad0ac0a1da0974dcc33" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70f4f23e9a04a66a4f3946139215e69_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzItMS0xLTEtNjc1MTI_a0873293-d4f3-4e45-a876-c02aa0932ff4">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83619a483e764d0bbec67a9c3cdbc05f_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzItMy0xLTEtNjc1MTI_8834c6cd-13e6-464b-8be0-d3bc0ab509b7">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70fb53d969384de7892c6e9555726ec2_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzItNS0xLTEtNjc1MTI_482b95ba-2884-4eec-b566-80129f3b6157">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad2eb9cc2d54973b510383cde197e58_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzMtMS0xLTEtNjc1MTI_6c3bedc7-0723-40ee-89e7-aca2f061427c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf75a56d89594901b67572ed9c73d754_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzMtMy0xLTEtNjc1MTI_0bcacad9-6193-46b5-bc8e-bc1cb5f65940">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155ee628098a42bdba6bed51090a2fd6_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzMtNS0xLTEtNjc1MTI_3c818eb3-a8f7-49b4-8f30-30c9adfad67b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzQtMS0xLTEtNjc1MTI_f5b7f9f6-52fd-4e37-8f35-a680562334bf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6991844f2274f7e8df965bf0500c897_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzQtMy0xLTEtNjc1MTI_37de3f65-341e-40d5-b5f0-a5c9cdb0685f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12086cb093c648ecb1b3b14a73e46526_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzQtNS0xLTEtNjc1MTI_00e55d61-be58-43ee-a9c0-34f18317effc">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzUtMS0xLTEtNjc1MTI_5a5e34b6-3258-4d57-ac0c-fcfe6c75736d">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzUtMy0xLTEtNjc1MTI_d19f8a88-25f0-4752-ac51-feebb7e089c3">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzUtNS0xLTEtNjc1MTI_7ab5463c-2701-403c-8ef5-cf985066bcfc">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzYtMS0xLTEtNjc1MTI_00180007-14bc-4449-937d-6ce1e301f4c6">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzYtMy0xLTEtNjc1MTI_83960876-745b-4674-8550-9b6fa901c355">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzYtNS0xLTEtNjc1MTI_f4b58840-c5b6-4e34-99b7-2405769afa2b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzctMS0xLTEtNjc1MTI_f8a99424-d4d2-435b-a4ab-f7eb8c2031bb">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzctMy0xLTEtNjc1MTI_1fda60c5-e3ae-49e1-b2ca-bef83fa46e19">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzctNS0xLTEtNjc1MTI_0b0c3b73-68c6-43dc-8e05-bd52cf2f8ba5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs and PSUs.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i05829da936d44ad0ac0a1da0974dcc33" continuedAt="i2ab93ac948b0431080e3d22114bd6f4a">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i2ab93ac948b0431080e3d22114bd6f4a">Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2022, 2021, and 2020 included discrete income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwNTE_31579c6a-326a-43b8-bd4d-77dbfab0a1b6">10</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwNjE_c5e35a36-77d9-4321-9790-c7561935415c">2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwNjU_be0c5993-7d15-4a30-877a-abe4558e67d3">2</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company&#8217;s stockholders approved the 2013 Stock Plan to replace the 2005 Stock Plan. Under these stock plans, the Company may issue restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserves <ix:nonFraction unitRef="shares" contextRef="i7a23fb1c43dd4a25ae7f616ad567c312_I20130731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwOTM_0434e921-613b-4af6-a422-0188557b6c2c">30</ix:nonFraction> million shares plus unused reserved shares under the 2005 Stock Plan. As of March 31, 2022, <ix:nonFraction unitRef="shares" contextRef="i4cbf7bb534a14e729833a52263987ab2_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYxMDQ_24699217-bb1f-4ba4-ba5f-58a0c414c69d">19</ix:nonFraction> million shares remain available for future grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs entitle the holder to receive a specified number of shares of the Company&#8217;s common stock which vest over a period of generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODE_2c540d8b-dc0c-4d2c-842e-9bfd3840f523">three</span> to <ix:nonNumeric contextRef="id7175fa977964dc5b6050bcf39c64b38_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODc_095f6d0d-3e66-4e7f-9e7d-f490d69b0799">four years</ix:nonNumeric> as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the price of the Company&#8217;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March 31, 2022, approximately <ix:nonFraction unitRef="shares" contextRef="i9985842113274b9bb12a6616b9b70bf2_I20220331" decimals="-3" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYxMTQ_f2e8d12a-7fec-44b4-9433-e579bfad885b">57,000</ix:nonFraction> RSUs for the Company&#8217;s directors are vested.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a <ix:nonNumeric contextRef="ica790b51350c436380a7c20f7ab4a955_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwODI3Mjc_f566337a-b10a-4cfd-a46b-8efe579f0c71">three-year</ix:nonNumeric> performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally <ix:nonNumeric contextRef="ica790b51350c436380a7c20f7ab4a955_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYxMjc_99f40468-14d8-4a17-b225-89a10724ae94">three years</ix:nonNumeric>. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i513ab6f6771e4a7b8d8956b8cc0e647a" continuedAt="i21006dd519d24959b37a1005358d4b4d"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxODA_ab41f599-7b2c-4a05-8e46-7915fc433b31" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations are as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzItMS0xLTEtNjc1MTI_9066d65b-46e8-4a62-a80d-9e67ea125f4a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzItMy0xLTEtNjc1MTI_ca33b869-5fc0-4cdc-b7b0-2d3567d77223">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzItNS0xLTEtNjc1MTI_39f8f7f6-0fc7-4ceb-b0ac-406c93d48b16">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzMtMS0xLTEtNjc1MTI_94e3a514-4ded-4256-9b2b-a2b0e5ccade6">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzMtMy0xLTEtNjc1MTI_b2d7bdcd-173e-478e-bad7-38b2a8db4f43">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzMtNS0xLTEtNjc1MTI_e3f71b7d-065b-4384-9013-51979fdd459d">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzQtMS0xLTEtNjc1MTI_71acb93c-f367-4b81-99c2-b12c1232d30c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzQtMy0xLTEtNjc1MTI_c8ccccb2-7c1f-4077-8f46-a156a44452b1">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzQtNS0xLTEtNjc1MTI_605dddf3-f019-47d5-bdcd-18c22ee65e4a">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzUtMS0xLTEtNjc1MTI_6bff5682-3ec7-434f-9a9b-4c5c52f66a5d">3</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzUtMy0xLTEtNjc1MTI_1d4942fc-09e6-4504-8ee1-93417109ee57">3</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzUtNS0xLTEtNjc1MTI_8cd956f0-448b-4fb0-9c97-1c48a4213a05">3</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxOTM_06c324eb-0f13-4f5b-b80b-251439e6cf55" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during 2022:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzEtMS0xLTEtNjc1MTI_80d03171-54bb-4119-9bb3-718e1ef26b88">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzEtMy0xLTEtNjc1MTI_25331c6a-f003-413c-ae2e-e3fff6b73bd6">142.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzItMS0xLTEtNjc1MTI_19e7bc7a-aadd-43b3-8853-b43efcf1ffad">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzItMy0xLTEtNjc1MTI_993976fa-e726-432a-b5aa-29f24c7e0c75">200.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="-6" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzMtMS0xLTEtNjc1MTI_33929ba5-aa6d-4de8-9473-54303a652b07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="2" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzMtMy0xLTEtNjc1MTI_f88a9f55-d46e-461e-b3c3-76510ccec9e8">142.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzQtMS0xLTEtNjc1MTI_0fe0652b-bad5-4c34-8655-0e463c010adb">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzQtMy0xLTEtNjc1MTI_3c8b0a5f-6442-4306-9d11-91a0a3c1f0f7">141.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzUtMS0xLTEtNjc1MTI_4079e083-2ac9-4709-91b2-917967370cba">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzUtMy0xLTEtNjc1MTI_baeda943-da22-4e1f-a58a-2e43a8d1ef64">160.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:DataRelatedtoRSUActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgyNDY_5ab8a208-b2c1-4c0b-a8d1-2449a8cb44ac" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzItMS0xLTEtNjc1MTI_f4cdc3d2-c9c2-4ac4-a2f1-81cfbfae3c49">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzItMy0xLTEtNjc1MTI_6d59ad4f-c20c-49fa-89cb-7ac2b7d46a39">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzItNS0xLTEtNjc1MTI_fcb1732d-03e2-4593-9d7e-aaeced9223b4">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzMtMS0xLTEtNjc1MTI_e6490c7d-16c9-4c22-8e12-7c20b20ddd13">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzMtMy0xLTEtNjc1MTI_ef076395-5893-449c-9288-ddca3145a246">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iada693d5d07f484eb5f7830f874b2439_I20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzMtNS0xLTEtNjc1MTI_5a825014-0e28-4e7f-8095-6d2a872d6f00">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzQtMS0xLTEtNjc1MTI_98f6003d-66d6-4930-957a-9d88b256d585">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzQtMy0xLTEtNjc1MTI_486f40bc-7c00-43a8-878d-bf9630fe6fa0">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzQtNS0xLTEtNjc1MTI_2a151e7e-c2d5-4972-9424-675d5eb35081">3</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of <ix:nonNumeric contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYyNTg_9b783488-08cb-4f1b-a103-3324f6238340">seven years</ix:nonNumeric> and follow a <ix:nonNumeric contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwODI3Mjg_2ef7cd79-d4e7-40a3-87fe-dee0ebc3c968">four-year</ix:nonNumeric> vesting schedule. The Company did <ix:nonFraction unitRef="shares" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5NDI_033ce413-5c7d-4498-983f-a9b79ac01637"><ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5NDI_8a4db5b7-a13f-4642-883c-42e22f2c3e85"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5NDI_965f25de-86d2-4082-9fe0-1db144674b07">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t grant any stock options during the years ended March 31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxNzQ_2254b525-4b12-4872-b018-33a66cc31bf0" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March 31, 2022:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMC0xLTEtNjc1MTI_4c24fbab-6ea2-4638-9c51-2cc8aa9bf98a">123.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMi0xLTEtNjc1MTI_5417f041-d8e6-4fad-b00f-af0318d10b42">159.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItNC0xLTEtNjc1MTI_25525b54-6203-4a35-8e50-7fab4e6affcb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItNi0xLTEtNjc1MTI_ef32d191-3f42-42b0-a323-99fec2e4fa44">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItOC0xLTEtNjc1MTI_17595c41-d93e-45ec-9dab-58a41eaacc90">150.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMTAtMS0xLTY3NTEy_5c94ca68-8d48-49f6-9895-9fb77077e645">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMTItMS0xLTY3NTEy_0159dc03-4c85-4927-a9ae-13f7c5fe8ad3">152.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f34988e21e446d58a56961047fed59c_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMC0xLTEtNjc1MTI_f6ad3029-6050-48a2-82e8-770eae6d4e61">159.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f34988e21e446d58a56961047fed59c_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMi0xLTEtNjc1MTI_8088c7ae-577f-408e-81b8-a8b0af5ad7b8">237.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtNC0xLTEtNjc1MTI_235a7644-567b-4b9f-8369-bcdce009fa33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f34988e21e446d58a56961047fed59c_D20210401-20220331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtNi0xLTEtNjc1MTI_14dbfc69-f11e-4ad2-a907-6b8058bfa694">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtOC0xLTEtNjc1MTI_6d8e67ec-74cd-4287-98ae-c4b4ceaa85e6">201.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMTAtMS0xLTY3NTEy_153a5999-3b9e-4725-98d9-635868f03462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMTItMS0xLTY3NTEy_34a6e6e5-9c0f-4f62-925c-d5c609be83c9">201.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzQtNC0xLTEtNjc1MTI_7cae91a0-6fd9-4861-be4f-bb0bb0bfe784">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzQtMTAtMS0xLTY3NTEy_d1ced1fe-4539-48bc-ac45-592215c637aa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i21006dd519d24959b37a1005358d4b4d"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgyMTc_234902ca-9832-4c4b-bb29-4880fc17ddb8" continuedAt="i95516baa024c4796ae20e203fcdaecbe" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtMS0xLTEtNjc1MTI_39ad8012-cf1d-4fcd-92ba-f724fcafcb00">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtMy0xLTEtNjc1MTI_f15146a3-d052-42d6-a746-59b20c52c549">183.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtNS0xLTEtNjc1MTI_9cbf8d69-4c14-4fd7-96ce-fc3d793f4569">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtNy0xLTEtNjc1MTI_3d6e9de8-f0ac-4d77-9013-0799467b5105">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzItMS0xLTEtNjc1MTI_4c2c232f-92e7-43ef-854a-6647a95d0b7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzItMy0xLTEtNjc1MTI_e7a02bd1-8f1b-4567-abe9-550c9ec485b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzMtMS0xLTEtNjc1MTI_454ef5bb-d8a4-464a-af70-e27c4bd762af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzMtMy0xLTEtNjc1MTI_6117c1df-d5a1-4da1-897c-e8ab5580d37e">207.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzQtMS0xLTEtNjc1MTI_8bde10c5-fe3d-4645-a30e-57f455912aa0">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzQtMy0xLTEtNjc1MTI_5306a9c1-2a48-4c56-8f67-232f592324cc">190.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtMS0xLTEtNjc1MTI_07b48d4b-2bc8-4ee4-b1bd-970dd96ca6cf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtMy0xLTEtNjc1MTI_b13c4c0b-96b9-410e-9dc6-e0939aba3cbb">175.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtNS0xLTEtNjc1MTI_91532615-5db8-4299-a8f0-6142d2cb8fe0">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtNy0xLTEtNjc1MTI_c252a8f7-dbb6-46b2-bc77-ca96efd3bf0d">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtMS0xLTEtNjc1MTI_f5a46b35-ca33-45c5-819a-7b8e6be314d4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtMy0xLTEtNjc1MTI_26cb9941-ece3-4550-a738-4da3428e287f">175.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtNS0xLTEtNjc1MTI_0b8b9d0d-3b10-40a0-b3b7-083f8df2bb7d">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtNy0xLTEtNjc1MTI_d4f095c0-0f85-4d07-86f2-3afce85fc305">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctMS0xLTEtNjc1MTI_081ac11e-f272-4a20-a9aa-32cd2af8f370">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctMy0xLTEtNjc1MTI_82fdca5b-75e3-49cd-8526-1d4d26187135">178.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctNS0xLTEtNjc1MTI_31daa9b1-17e2-47b7-a3b0-9b665c311098">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctNy0xLTEtNjc1MTI_f0e21eda-eb9d-44f6-b9b8-e93c928c8838">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i95516baa024c4796ae20e203fcdaecbe" continuedAt="i2d620d455c7d4eff8b41ec0c55adc864">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i2d620d455c7d4eff8b41ec0c55adc864">The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxODk_385dcbae-cbad-4bc0-95ff-6ae4070deb38" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzItMS0xLTEtNjc1MTI_228bd35e-48b9-4ffa-9272-52741cf764f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzItMy0xLTEtNjc1MTI_d68745fa-fee0-409c-840f-cef884dcbda3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzItNS0xLTEtNjc1MTI_e9e6f037-1a81-4866-8ade-ce58aad10171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzMtMS0xLTEtNjc1MTI_464e32d8-26db-40d0-96ec-40fca43f353d">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzMtMy0xLTEtNjc1MTI_ddda1194-f6fa-4297-88c9-0b98bec3a920">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzMtNS0xLTEtNjc1MTI_a3250fc5-158c-4a4a-bc67-bd0d0fdfb9a5">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzQtMS0xLTEtNjc1MTI_aaf6040c-c7fa-4ef3-b96d-21e555fbe216">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzQtMy0xLTEtNjc1MTI_742ddedb-8eae-41c0-a5b6-dea95b12a574">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzQtNS0xLTEtNjc1MTI_a27e2907-1530-4883-b301-0a8c1cca5026">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzUtMS0xLTEtNjc1MTI_160e093e-ab7a-4b03-baa1-902cb5a1b216">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzUtMy0xLTEtNjc1MTI_0d4adc0d-9e21-432d-9b31-17f7f7148ebd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzUtNS0xLTEtNjc1MTI_b4b437c2-a408-4819-8a62-d384ea34ed4f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzYtMS0xLTEtNjc1MTI_d71cace1-824b-4822-8321-c8be728b99fb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzYtMy0xLTEtNjc1MTI_03ff2591-f486-4ff2-8676-bef3e92ea125">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzYtNS0xLTEtNjc1MTI_cf62608a-d3b3-47e3-8f36-e5a14d5eccc7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd23280ebc846d8b2d4860031a724c2_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzctMS0xLTEtNjc1MTI_be7688be-420c-4ab0-acf1-f26aac12aa5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57920885a3494e0ca6394523c80f50e3_I20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzctMy0xLTEtNjc1MTI_42258261-6e67-4f46-8bbb-7f8fa0e72875">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18638b28013f47cc83d0371a8132d139_I20200331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzctNS0xLTEtNjc1MTI_98eb75fa-dd88-4830-9ff5-20d9881d243f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzgtMS0xLTEtNjc1MTI_5ab5bfc7-56ab-4192-9977-c3fbf81b5020">0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzgtMy0xLTEtNjc1MTI_77e134dd-d173-43b5-b959-a2a4c5c3ca70">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzgtNS0xLTEtNjc1MTI_96f2e135-6ed5-4c67-84b0-d5d2c89d4688">2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ESPP under which <ix:nonFraction unitRef="shares" contextRef="ice1ca3402501452f8282a882c66a1a41_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc4Nzk_7e3dc58d-e76d-4ec5-a63d-b505b267489b">21</ix:nonFraction> million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock through payroll deductions. The deductions occur over <ix:nonNumeric contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331" name="mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwODI3Mjk_5148d25f-d95d-4b17-b4c4-941838445aa3">three-month</ix:nonNumeric> purchase periods and the shares are then purchased at <ix:nonFraction unitRef="number" contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5MDQ_f8e3c3c8-4e72-401a-b4ba-0faa1d705659">85</ix:nonFraction>% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The <ix:nonFraction unitRef="number" contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5MDg_9e6f660d-93d1-4e0a-8d80-1478de9bf91d">15</ix:nonFraction>% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in 2022, 2021, and 2020. At March 31, 2022, <ix:nonFraction unitRef="shares" contextRef="ice1ca3402501452f8282a882c66a1a41_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5Mjk_d0a8e9e5-7a42-45b0-82d1-73ba0efe3d8d">2</ix:nonFraction> million shares remain available for issuance.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_127"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzkzNw_af0e5675-c57a-4def-a7f1-9b80dc501165" continuedAt="i6c4899c4731244d7a98b28d1b578c0c5" escape="true">Other Income, Net</ix:nonNumeric></span></div><ix:continuation id="i6c4899c4731244d7a98b28d1b578c0c5" continuedAt="ieb0145dcd6204c07ae5a4cb9051ee8f5"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3Xzk0Ng_5f01ba22-96a6-4125-9eca-3fe6c4a3b741" continuedAt="i7395406b25b44c619660acbf2ece2913" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzItMS0xLTEtNjc1MTI_cdd1e6a3-a5a0-4d2b-8a17-39deceb17439">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzItMy0xLTEtNjc1MTI_5593cb5a-7b14-478e-88da-d40a2ef2440b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzItNS0xLTEtNjc1MTI_b104f28d-9040-450e-b1cb-b45ecbbe1a63">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzMtMS0xLTEtNjc1MTI_0adcee81-f400-4d77-98c0-380cbbbade48">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzMtMy0xLTEtNjc1MTI_84b6b118-8849-4490-aaea-ebc21d67c5d1">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzMtNS0xLTEtNjc1MTI_15d1972a-f547-4268-8e99-fcd1d4d4edef">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzQtMS0xLTEtNjc1MTI_ca6a4e4f-4471-4e5e-8c3f-96ae4208d79d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzQtMy0xLTEtNjc1MTI_497d31c7-1146-4328-b2c5-5cde8c93f257">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzQtNS0xLTEtNjc1MTI_5fdf10c0-788d-4b1b-8960-bdb66518c467">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses) from pension plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzUtMS0xLTEtNjc1MTI_3ff1663e-b9e7-4321-a892-7ad51f94b8ae">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzUtMy0xLTEtNjc1MTI_ab859518-2053-4751-8c55-7e85957a09a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzUtNS0xLTEtNjc1MTI_cea5843c-83f7-428d-88c2-51f779b8ec35">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzctMS0xLTEtNjc1MTI_e6781a2d-0ab0-4d6b-b5e7-1cad530c1f1f">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzctMy0xLTEtNjc1MTI_498cae4d-7fca-4e9c-aa17-d5ebe1c15984">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzctNS0xLTEtNjc1MTI_11911b91-2a2a-4906-a0a0-eb5497280dba">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzgtMS0xLTEtNjc1MTI_ea3f8486-4e7a-4bb5-9627-e550778fdd79">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzgtMy0xLTEtNjc1MTI_dd48b4bb-cbd0-4ecb-957e-b53e1b500b1c">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzgtNS0xLTEtNjc1MTI_fc4a6bc3-ba07-4b33-812a-cf49aef8c5ed">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments. Refer to Financial Note 16, &#8220;Fair Value Measurements&#8221; and Financial Note 21, &#8220;Segments of Business&#8221; for more information.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The year ended March 31, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="i66b903eb87c2421eb495ac4394329d5d_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzQzOTgwNDY1MTIyMTY_2a5ef8dd-2de8-4e81-96ff-614831eda0fb">116</ix:nonFraction> million from the termination of the U.S. defined benefit pension plan and $<ix:nonFraction unitRef="usd" contextRef="i167f7828260e4a198813c305f400a996_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzI3NDg3NzkwNzE4MjY_fba49367-09e6-4627-b7a2-f4fe2de22df0">11</ix:nonFraction>&#160;million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 14, &#8220;Pension Benefits&#8221; for more information.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="ieb0145dcd6204c07ae5a4cb9051ee8f5" continuedAt="i48f1bd3129f1478ea69c83ac778d4ea4"><ix:continuation id="i7395406b25b44c619660acbf2ece2913" continuedAt="i3f97435fadd24a449fa9d58e1a87a421"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes a gain of $<ix:nonFraction unitRef="usd" contextRef="i01e8b5cec568422ebcfc63feb76be4b7_D20210401-20220331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzEwOTk1MTE2MzAyOTE_6255a82d-653d-481d-9ccc-bbdf48a3880e">42</ix:nonFraction>&#160;million for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i48f1bd3129f1478ea69c83ac778d4ea4"><ix:continuation id="i3f97435fadd24a449fa9d58e1a87a421"> as part of the completed sale of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i63827a6bb93940659eeb1ad9423601f5_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzI3NDg3NzkwNzE4NDI_42b7f911-ce1c-4438-9950-7792f89a3d8d">30</ix:nonFraction>% interest in its German pharmaceutical wholesale joint venture to WBA. Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.</ix:continuation></ix:continuation> </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_130"></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczNTE_53b5b379-e77b-44c4-9de1-4f1e46ab7d10" continuedAt="i41fbb7debfdd41cea57a292560bf6590" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="i41fbb7debfdd41cea57a292560bf6590" continuedAt="i0340d3092a004c5884bea58ca86fc836"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczODk_a6385873-4c1f-4e59-9b00-eac70ea395c4" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzMtMS0xLTEtNjc1MTI_45c12591-859b-421a-9865-91aa95d343d7">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzMtMy0xLTEtNjc1MTI_9f1b6686-cbdb-4c02-8739-dcf7cfef17d4">6,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzMtNS0xLTEtNjc1MTI_e3929b19-9c2a-4daf-9728-79ba6eaccc8e">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzQtMS0xLTEtNjc1MTI_f9d1ba0d-a391-4ec0-ac54-b31ba2122db4">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzQtMy0xLTEtNjc1MTI_040a4f97-a5f0-4030-9078-2e2cf0580799">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzQtNS0xLTEtNjc1MTI_55022527-29fb-44f0-9cb6-63eb24add7d8">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzUtMS0xLTEtNjc1MTI_1a232f4d-1b22-4b12-836c-ce26fd377d91">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzUtMy0xLTEtNjc1MTI_1ae65bb1-b545-4826-a5ad-3a6f814aef1e">5,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzUtNS0xLTEtNjc1MTI_6d8ac826-bebd-486f-b7ea-98a253ce8d92">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0340d3092a004c5884bea58ca86fc836" continuedAt="id40fa40adb274f47baca30371a719a95"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczODI_969c86e5-86cc-46e9-95ad-1ff14dcd52d3" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzMtMS0xLTEtNjc1MTI_73fa911f-cf4b-40d1-b029-26c72d0d2b5b">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzMtMy0xLTEtNjc1MTI_66656780-e994-4f39-a385-61a1009fc0b6">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzMtNS0xLTEtNjc1MTI_cf38e8bc-87ab-4740-a4f5-036193b5a40e">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzQtMS0xLTEtNjc1MTI_e749a0cb-bdd5-416b-a06e-77bac09335c4">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzQtMy0xLTEtNjc1MTI_f59c3144-34d9-4627-b311-2cfe2647a55c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzQtNS0xLTEtNjc1MTI_209e080c-b986-4511-bd44-1ff40c7fd29c">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzUtMS0xLTEtNjc1MTI_a20ec3e2-95b7-44dd-ab0f-a0b839de08ed">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzUtMy0xLTEtNjc1MTI_7141806c-2dfb-4325-b7f1-93b8e2aa24d0">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzUtNS0xLTEtNjc1MTI_7c992b2a-6e2d-4f4d-b13b-dbb21862cd16">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzYtMS0xLTEtNjc1MTI_5259fa62-c8d8-4b05-9d03-16d2d3dca94c">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzYtMy0xLTEtNjc1MTI_d830fc6f-d79a-4d5a-a252-e17b56bc6404">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzYtNS0xLTEtNjc1MTI_d2d253c7-71cb-4bb5-a461-e9b5769b39c6">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzktMS0xLTEtNjc1MTI_25d82258-7741-40e8-85a4-a8e2d9f10511">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzktMy0xLTEtNjc1MTI_8c3b3a4c-f9b5-4c46-8b79-41f8e206f2cb">562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzktNS0xLTEtNjc1MTI_38ad3af1-0031-4ca0-a0dc-095e1ea27030">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEwLTEtMS0xLTY3NTEy_a3675195-7af4-4504-a253-32ba7724700d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEwLTMtMS0xLTY3NTEy_214bfcbc-1e68-478d-afb2-d8960595cb95">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEwLTUtMS0xLTY3NTEy_df24596a-fe83-49ac-85cf-c691f4fa8e0c">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzExLTEtMS0xLTY3NTEy_903d9cdd-5fbb-40da-98ec-7d7cfcb02f04">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzExLTMtMS0xLTY3NTEy_2add9f08-9a68-4405-ad8a-f1dd167cbf77">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzExLTUtMS0xLTY3NTEy_9043b410-63fc-45ed-8ab2-b5299e124870">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEyLTEtMS0xLTY3NTEy_16aa0578-8d46-41f2-8f88-147f16242f89">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEyLTMtMS0xLTY3NTEy_a8676bbd-d315-4be3-a240-ca10bb2acda2">908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEyLTUtMS0xLTY3NTEy_6b818c3b-dd13-4462-9830-2e1ed8ec668e">342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEzLTEtMS0xLTY3NTEy_e524ee58-e67a-411e-b3f1-50ee0b709ac8">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEzLTMtMS0xLTY3NTEy_e7ba830d-121a-4792-85de-4abb09d0290e">695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEzLTUtMS0xLTY3NTEy_79314bde-82be-459a-83da-2b219bc51717">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported an income tax expense (benefit) rate of <ix:nonFraction unitRef="number" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzUyMjY_3d909125-ab6c-4527-b5ac-c6c94cef5f96">33.0</ix:nonFraction>%, (<ix:nonFraction unitRef="number" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzUyODc_241c1ffe-6bd1-4501-8117-d3f63e9a624a">13.8</ix:nonFraction>)%, and <ix:nonFraction unitRef="number" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzUzMTU_5f5759c3-1169-423c-a0de-2b015f3b2e0e">1.6</ix:nonFraction>% in 2022, 2021, and 2020. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of certain of its European businesses to fair value less costs to sell in 2022, the impact of opioid-related claims, including charges of $<ix:nonFraction unitRef="usd" contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1Mjc_e74dbd8a-e9ce-4dd4-910c-9d9902172a22">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331" decimals="-8" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1MzM_0d6462b7-df1f-4996-8ad7-20427cdfc550">6.8</ix:nonFraction> billion after-tax) in 2021, the impact of the Change Healthcare joint venture divestiture in 2020, and changes in the mix of earnings between various taxing jurisdictions.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzc0MDE_18372d0b-2956-4db3-a2f4-164fa7614d3b" continuedAt="iad83cc9d61ae4245b354e5450ac545ad" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of <ix:nonFraction unitRef="number" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMTk_6d054350-94e8-43c6-8404-f70f7a0e733e"><ix:nonFraction unitRef="number" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMTk_71a3ce60-4ac3-403c-b130-3cdf954291b4"><ix:nonFraction unitRef="number" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMTk_7678737e-8562-4fd0-927c-e25ee3ca683f">21.0</ix:nonFraction></ix:nonFraction></ix:nonFraction>% to income before income taxes is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzItMS0xLTEtNjc1MTI_1677f435-393c-4cb7-8f50-f94964cf1c62">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzItMy0xLTEtNjc1MTI_5488f22e-7f0c-4ddd-840a-9c17529f73ec">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzItNS0xLTEtNjc1MTI_fd2fe02b-7fa1-49b3-a246-136b4f5146dd">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzMtMS0xLTEtNjc1MTI_1d135522-a97d-4954-a13c-26eb39e8f525">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzMtMy0xLTEtNjc1MTI_0366c4d5-cd37-43b1-980e-8c4011854021">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzMtNS0xLTEtNjc1MTI_3e641748-b164-4b82-9d52-a83a3408cda0">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzQtMS0xLTEtNjc1MTI_9aa0acad-c593-4d88-b31a-f5371b7be47f">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzQtMy0xLTEtNjc1MTI_8078c234-4971-4f96-8b6c-4cec7c671f8b">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzQtNS0xLTEtNjc1MTI_971e901b-e032-4b89-a569-bc01fb1735b0">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzUtMS0xLTEtNjc1MTI_fabf7b92-bf1e-40bd-af03-07c2d92a485d">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzUtMy0xLTEtNjc1MTI_f231d0e5-e8d9-4d53-ad33-e1d6280997f5">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzUtNS0xLTEtNjc1MTI_71d25501-6110-407d-bcec-c91768ac17bd">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzctMS0xLTEtNjc1MTI_67393094-3aa4-46c6-95ca-836643f13f22">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzctMy0xLTEtNjc1MTI_613bdd5e-1013-4e37-b752-b57394b380a2">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzctNS0xLTEtNjc1MTI_fd0826bd-81b9-43ea-a16a-2494346cf350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzgtMS0xLTEtNjc1MTI_4b438d2c-1fcf-4cfe-ba1f-d5f5b3f60f4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzgtMy0xLTEtNjc1MTI_0309b536-1d40-4366-9f6a-aeff25a8e24d">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzgtNS0xLTEtNjc1MTI_85f8a119-69d6-458b-849b-1f8ea59d679e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-free gain on investment exit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzktMS0xLTEtNjc1MTI_71abcce1-872f-46a2-9dd5-b82885a4aca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzktMy0xLTEtNjc1MTI_d9ebc28d-36c8-4e66-87e7-d6020f570367">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzktNS0xLTEtNjc1MTI_0ad8813f-e15d-4dc1-a708-819747d0e89c">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.U. disposal transaction loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEwLTEtMS0xLTY3NTEy_ad31e23e-615a-4126-9087-b8cf53b300b2">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEwLTMtMS0xLTY3NTEy_524d3722-099d-48b7-be1c-d6d91fc26f67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEwLTUtMS0xLTY3NTEy_80f228c5-e481-477f-ba61-bb6b4c71c410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEyLTEtMS0xLTY3NTEy_9c17a491-360d-43e3-b215-0a2af5ccf05b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEyLTMtMS0xLTY3NTEy_c7ab453e-78df-4c2f-80ab-75f57c9de18b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEyLTUtMS0xLTY3NTEy_f6d753ac-4905-4923-a7fe-3b0436a3fc53">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEzLTEtMS0xLTY3NTEy_4b37c69c-9c66-4070-962d-15c0dbe59407">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEzLTMtMS0xLTY3NTEy_3cef75a2-1b49-4245-b0cb-c36fa0ca1723">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEzLTUtMS0xLTY3NTEy_1243c55d-7c9d-45a5-99e9-26f5bd91a77d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzE0LTEtMS0xLTY3NTEy_4255a73f-2639-4d0a-9615-d8daaae39606">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzE0LTMtMS0xLTY3NTEy_3f8c9ddb-ef9f-406c-8e1c-a2a9570e2472">695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzE0LTUtMS0xLTY3NTEy_1103dc7d-a7f4-49c1-95f1-ae25ef3fd453">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information regarding the separation of the Change Healthcare JV.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iad83cc9d61ae4245b354e5450ac545ad" continuedAt="ifbfb33e24bd64331b8f1fe08aa0536b8">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="ifbfb33e24bd64331b8f1fe08aa0536b8">The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMjM_c2c73cd6-fe0e-44f7-9e5e-3ff4c08d5320">4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwNzQ_a352a80f-c976-4b95-9be8-2ba14a9d4c7c">5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwNzg_05207d37-7ca1-495f-b8fe-1fff3decf418">7</ix:nonFraction> million in 2022, 2021, and 2020.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, the Company recorded non-deductible, non-cash pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzgzMzk_9ed44f13-c97b-4ef7-a080-15d7173a7ec1">438</ix:nonFraction> million primarily to remeasure the E.U. disposal group to fair value less costs to sell, and $<ix:nonFraction unitRef="usd" contextRef="i0e32a1fbc82b4b00bc1a50e31b77e798_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg0Nzc_0acd2bf5-b3ff-4de7-bef3-def00267b9b3">1.2</ix:nonFraction> billion to remeasure the U.K. disposal group, as described in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="id40fa40adb274f47baca30371a719a95" continuedAt="ib1ca141818154cd7a621ef9cbf4dd5d7"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rates for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were unfavorably impacted by non-deductible, non-cash charges of $<ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzk5Mzk_ecbf2134-756f-4602-ab84-db7a7eb196fe">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzkxOTQ_a28b9017-2631-4dfe-8247-585559b5906c">275</ix:nonFraction> million, respectively, primarily to remeasure the carrying value of assets and liabilities held for sale related to the formation of a new German pharmaceutical wholesale joint venture within the Company&#8217;s International segment. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rates for 2022 and 2021 were impacted by the charge for pending and future opioid-related claims of $<ix:nonFraction unitRef="usd" contextRef="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg2NTE_cb0cf0d0-d6d2-4c5a-9517-b03b2f22a6d2">274</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331" decimals="-6" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2NDIyNzk_0f217d32-d83d-45b9-9734-2cf2a392b805">237</ix:nonFraction> million after-tax) and $<ix:nonFraction unitRef="usd" contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1NzU_e74dbd8a-e9ce-4dd4-910c-9d9902172a22">8.1</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331" decimals="-8" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1Nzk_0d6462b7-df1f-4996-8ad7-20427cdfc550">6.8</ix:nonFraction>&#160;billion after-tax), respectively, as described further in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="mck:IncomeTaxExpenseBenefitDiscreteItems" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg3Mzk_cd7ce62f-1c5f-41cc-891a-3ef683d29133">105</ix:nonFraction> million was recognized for 2021, with a corresponding increase to a deferred tax assets for the temporary difference arising from the buyer&#8217;s excess tax basis.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV as described in Financial Note 4, &#8220;Business Acquisitions and Divestitures.&#8221; The Company&#8217;s reported income tax expense rate for 2020 was favorably impacted by this transaction given that it was intended to generally be a tax-free split-off for U.S. federal income tax purposes. In the fourth quarter of 2020, the Company recognized a net gain for financial reporting purposes of $<ix:nonFraction unitRef="usd" contextRef="i0fec03c76dc94380a58e045d8dc7b5dc_D20200101-20200331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg3ODk_a9813a52-5b11-4290-98b0-742dfcb54d3b">414</ix:nonFraction> million related to the separation transaction.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczNjk_96bbf535-8bbd-4aa6-baa8-bad5d07881a5" continuedAt="i9f21073991004bf28868a28b55a2cd5f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzMtMS0xLTEtNjc1MTI_12d2604f-99b9-4e73-8fce-bf73e93cac30">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzMtMy0xLTEtNjc1MTI_4f094da3-60b3-4340-95ba-41e6c42797c4">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:DeferredTaxAssetLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzQtMS0xLTEtNjc1MTI_de771aed-cb95-46c8-8aa5-a3af5b353164">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="mck:DeferredTaxAssetLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzQtMy0xLTEtNjc1MTI_24400890-5ede-42e5-97f1-33693418fc22">724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzUtMS0xLTEtNjc1MTI_ff8d94f8-24a5-48db-9431-19ed067c6adb">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzUtMy0xLTEtNjc1MTI_d545e22f-0918-4f26-8bd5-be55fcb94efd">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzYtMS0xLTEtNjc1MTI_3eef2bf3-3d22-4664-9c96-de1d88cdcc63">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzYtMy0xLTEtNjc1MTI_3e52c085-9e56-4e23-bb4b-d338c6d98989">974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:DeferredTaxAssetLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzctMS0xLTEtNjc1MTI_4358a134-3a8a-4cea-95d5-b514eb3efa7d">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="mck:DeferredTaxAssetLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzctMy0xLTEtNjc1MTI_f61b432e-be7b-4f01-b87c-ccc6c0d1b6ae">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzgtMS0xLTEtNjc1MTI_8af39ce9-80de-4443-934e-e15bce5a4ae7">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzgtMy0xLTEtNjc1MTI_b8b766b2-6f47-4775-9061-4915a116faa1">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzktMS0xLTEtNjc1MTI_43f85932-31ce-474b-a460-77730bcbc17d">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzktMy0xLTEtNjc1MTI_424043da-f9a8-4b72-8aa0-d86e024a13a4">2,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEwLTEtMS0xLTY3NTEy_1543905b-838b-4329-a8eb-9193ad34df2a">726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEwLTMtMS0xLTY3NTEy_5b86cd44-62fe-45c9-9e91-f0be4cb44f07">864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzExLTEtMS0xLTY3NTEy_2e11b8a9-f0f1-44d9-a14d-9be88db24b5b">1,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzExLTMtMS0xLTY3NTEy_8dcf095c-9f55-4391-9707-1df17474239a">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEzLTEtMS0xLTY3NTEy_39bf06c4-f4e1-49bb-ad03-eea3688cb0c5">1,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEzLTMtMS0xLTY3NTEy_23fbb6ab-8c8e-45d7-9da3-d4d2e07362d4">1,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE0LTEtMS0xLTY3NTEy_f6b76819-2306-4d39-9fbd-ed612f6ed82f">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE0LTMtMS0xLTY3NTEy_caa1d199-52ee-4039-b751-48349dbb5f80">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE1LTEtMS0xLTY3NTEy_b591c571-c780-42f0-a43a-7207ef082884">233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE1LTMtMS0xLTY3NTEy_07add45c-46c8-41b1-9cf2-9d00eb79ec1c">411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:DeferredTaxLiabilitiesLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE3LTEtMS0xLTY3NTEy_ce95d15a-2dd5-4169-b25a-a0e539b0d430">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="mck:DeferredTaxLiabilitiesLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE3LTMtMS0xLTY3NTEy_a01e12ff-60c7-4068-99ad-792ce1acd644">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE4LTEtMS0xLTY3NTEy_04af241b-5c02-4aa2-8041-638e483a3393">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE4LTMtMS0xLTY3NTEy_98b9b085-7bd9-4e80-9cbe-f88b3d421ad9">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE5LTEtMS0xLTY3NTEy_84073495-7e31-4caf-94b9-4b01a996f101">2,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE5LTMtMS0xLTY3NTEy_f0134d27-729f-453f-8bf8-7ae19f07e051">3,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIwLTEtMS0xLTY3NTEy_ba30df8a-8dc1-46c8-914f-bfdac0d619d7">1,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIwLTMtMS0xLTY3NTEy_4cde8fa0-646f-4ed5-8258-cef5bf5aca9d">1,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIyLTEtMS0xLTY3NTEy_be2d3c57-fc67-49a1-8bf2-3c59bfc2740e">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIyLTMtMS0xLTY3NTEy_dc88496a-b5df-421b-a5c6-cf6818994d42">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIzLTEtMS0xLTY3NTEy_1f7428a7-1d59-4b3e-bd51-cecb8db0d5aa">1,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIzLTMtMS0xLTY3NTEy_9f3cfa9a-9d26-4521-aa84-b4932fbd4caa">1,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzI0LTEtMS0xLTY3NTEy_ef5ad7e9-1761-4d79-9fc5-dde41051dc51">1,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzI0LTMtMS0xLTY3NTEy_7fb59f02-a262-42b0-8b8f-e77c712c1044">1,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ib1ca141818154cd7a621ef9cbf4dd5d7" continuedAt="i469672d84b9645c9a6b56dfbf538063e"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9f21073991004bf28868a28b55a2cd5f">Excluded from the amounts above were $<ix:nonFraction unitRef="usd" contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzE2NDkyNjc0NTY4MzY_c9931ef4-9e22-4775-94e2-40cb2695868f">48</ix:nonFraction> million of net deferred tax liabilities which were classified as held for sale for European divestitures at March 31, 2022, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221;</ix:continuation></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NDQ_1543905b-838b-4329-a8eb-9193ad34df2a">726</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NTM_5b86cd44-62fe-45c9-9e91-f0be4cb44f07">864</ix:nonFraction> million in 2022 and 2021, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The decrease in the valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NTk_cfc83193-33e3-48c9-9db8-a0c868d6dd6b">138</ix:nonFraction> million in the current year relates primarily to classification of deferred tax balances as held for sale for European divestitures, as discussed in Financial Note 2, &#8220;Held for Sale,&#8221; partially offset by the net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has federal, state, and foreign net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ic0ac656b00974ec2a54cd2ed0080a826_I20220331" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4Njk_98f1fd65-8e84-44ec-ad59-ecda86a56600">303</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id468ab83e79c4da3bdeb27a9b9e7e51f_I20220331" decimals="-8" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NzI_9215dadc-c574-4ef1-abf6-7f5fd9da504a">3.9</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="if89d7ba5882b4f0fa002ab7806455632_I20220331" decimals="-8" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NzU_b59b6514-7255-4ad1-be79-a719a528b224">1.5</ix:nonFraction> billion at March 31, 2022, respectively. Federal and state net operating losses will expire at various dates from 2023 through 2042. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i0fb72716661344f2b3ed64c31036af17_I20220331" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc5MjU_18de6a7d-dd54-41db-8774-69f559bcbe83">785</ix:nonFraction> million with indefinite lives. </span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczNTQ_6d5ef2e0-4443-4079-ba55-2745336ec7fe" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzItMS0xLTEtNjc1MTI_dad0d42c-f269-4dd1-9d20-58d224ea5e8f">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzItMy0xLTEtNjc1MTI_1095d7cb-2d86-479d-b7d7-ad47c254cb79">958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzItNS0xLTEtNjc1MTI_197e3aba-e412-4736-927d-b13c7485d7a4">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzMtMS0xLTEtNjc1MTI_634256d6-acf2-4016-89cd-c3db33d18642">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzMtMy0xLTEtNjc1MTI_8c2342c8-b479-4266-beaa-8a98a5d4f00f">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzMtNS0xLTEtNjc1MTI_699b65c9-d539-4d29-8c94-d1740a594001">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzQtMS0xLTEtNjc1MTI_f4c8c674-b1e7-4ec2-92c4-a89500b3a063">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzQtMy0xLTEtNjc1MTI_3e91dfc4-22b3-45a0-8ced-d6c9d80fd550">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzQtNS0xLTEtNjc1MTI_8e37c49c-8805-42c5-b062-01f13b4cd712">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzUtMS0xLTEtNjc1MTI_48054abf-eca4-4423-8b4b-cabcd74a7c7c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzUtMy0xLTEtNjc1MTI_3b72675e-3a99-44ba-bfd9-b0556369031e">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzUtNS0xLTEtNjc1MTI_14357f36-16ad-4d4f-a8aa-074fabe1dc88">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzYtMS0xLTEtNjc1MTI_ec286f97-ddd0-45bf-8ee4-ff5b8cb7c097">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzYtMy0xLTEtNjc1MTI_ec813ad8-24ed-4607-9492-7c3419ccc4c8">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzYtNS0xLTEtNjc1MTI_15799a10-e3ad-4433-a399-67e512e9cfa0">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzctMS0xLTEtNjc1MTI_d7de3aba-9b43-411d-a265-66a71dfcd7e2">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzctMy0xLTEtNjc1MTI_42a44083-932b-47ba-84cd-3ae4be2f6add">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzctNS0xLTEtNjc1MTI_beae0932-6db2-47b5-86e9-bb66fb61e358">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzgtMS0xLTEtNjc1MTI_f36af381-fe94-4218-94cc-1f84792caccf">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzgtMy0xLTEtNjc1MTI_c8b809ca-721c-4448-b0f6-82ee0471f1f0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzgtNS0xLTEtNjc1MTI_14d30294-3acb-4478-8c15-8d1ffd479988">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzktMS0xLTEtNjc1MTI_a5839caf-17d3-4f73-ab2a-24e8b3108003">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzktMy0xLTEtNjc1MTI_aa709cfe-73f2-4d0f-9624-00cdc172e461">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzktNS0xLTEtNjc1MTI_dfffed23-479f-4f70-8c28-62093d1a22cf">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc5NDg_8e832ea4-8bdd-408d-8df2-49102f81facb">1.5</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc5NTc_59183970-7861-4a67-922b-51bc6d642a87">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate, if recognized. The decrease in unrecognized tax benefits in 2022 compared to 2021 is primarily attributable to statute of limitation expirations in various taxing jurisdictions and the reclassification of $<ix:nonFraction unitRef="usd" contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzE2NDkyNjc0NTY5NDc_6e5d109c-4284-46d4-aa7a-295288d8686a">23</ix:nonFraction>&#160;million of unrecognized tax benefits as held for sale for European divestitures, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; The increase in unrecognized tax benefits in 2021 compared to 2020 is primarily attributable to uncertainty in connection with the deductibility of opioid-related litigation and claims. Because many uncertainties associated with any potential settlement arrangements or other resolutions of opioid claims including provisions related to deductibility have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefit may decrease by as much as $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0MzQ_8452b9a0-b40c-4ad9-89b6-c03d79fcb286">170</ix:nonFraction> million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0NDE_75bee3b9-1d0a-4f82-ab2d-d93962800523">8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0NDQ_952bce60-084f-4a72-9fac-6403bc6a2f1b">9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0NDc_2518497f-82ea-45df-ab8c-c32c7fb03131">23</ix:nonFraction> million in 2022, 2021, and 2020, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March 31, 2022 and 2021, it accrued $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0ODY_5190cac7-da72-465e-98f8-4f1ba8b588bb">108</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0ODk_5b117cd2-c719-4270-8de9-b1f141814726">101</ix:nonFraction>&#160;million, cumulatively, in interest and penalties on unrecognized tax benefits.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i469672d84b9645c9a6b56dfbf538063e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign operations of approximately $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1MDc_3b40bec3-2c93-4a32-ba25-a15f9ec063bd">5.0</ix:nonFraction> billion were considered indefinitely reinvested at March 31, 2022. Following enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_133"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0MDY_a0402446-ae21-44a3-8f43-7db4775e495a" continuedAt="ide0f3b17acb34d1bb1f756e228f72147" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ide0f3b17acb34d1bb1f756e228f72147" continuedAt="id2937b3ca8a444f39f0890eb31918b56"> </ix:continuation></span></div><ix:continuation id="id2937b3ca8a444f39f0890eb31918b56" continuedAt="i07a80ac39d04487c89fadf4d72b7f62e"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ifb22ce88060842ff860b7a4f6f4d8c8d_I20141231" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQ5NDc4MDIzMjkxNjM_01cb603a-9cfb-4a7f-b398-63b479303867">0.83</ix:nonFraction> per share. As a result, during 2022, 2021, and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMDI_6d849914-0708-4550-a42e-8babd5f92e4c">8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMTM_6f3efc7d-ad6e-4b3e-a25a-718ffc3f1964">43</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="id49f95b8b84d4733a35b6f6d7352eb6b_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMjI_9fd10a77-025e-4996-a0fd-060728d02ee3">42</ix:nonFraction> million, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i90fb979952704eaeb0354680a480489e_I20141231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMzA_2ca509df-226b-4613-84c7-4574dd349854">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="icdac5b94f2184c3a99658bd787744bdf_I20141231" decimals="INF" name="mck:PutRightValueInterestRateSpread" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMzY_c2fedf6e-9a99-4411-a3ab-63d17cf219ca">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, that court ruled that the Put Amount shall be increased by &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i74517685e93241df8e4050dd6818b8c2_D20180919-20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePriceIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzMxMDg_e76c437a-58ec-44ef-a144-2318298ab95c">0.51</ix:nonFraction> resulting in an adjusted Put Amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="id55a461c58734092bdfe4dbc17c833c2_I20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzMxNTA_1e73cc4f-363e-430e-9493-45ea41e6da2e">23.50</ix:nonFraction>. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount remained at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i314553b738ee43fc96f6e068ba26aa3c_I20210412" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0Mjk_d4db759b-efd7-440c-904f-bcd0654a00bb">22.99</ix:nonFraction>, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="icbf87d883a1e46a99b0a0ea932dfd523_I20210412" decimals="2" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0MTU_96fa69ba-0901-4db4-8d92-adb98c2f762e">0.83</ix:nonFraction> per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises of the Put Right reduced the balance of redeemable noncontrolling interests. The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income or loss, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331" decimals="-8" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjEwMDE_f10473cf-2d74-45b1-a21f-61246bf911cb">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTg0MzI_09d130d1-22ab-433a-ae63-c67a2dc099bf">49</ix:nonFraction> million, respectively, to purchase <ix:nonFraction unitRef="shares" contextRef="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjEwMjU_1b05e278-3ffc-4c4e-a591-ddc2ad394ba9">34.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTg0NDg_91afdb61-ef4a-47a4-adf2-103c002a97c1">1.8</ix:nonFraction>&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjEwNzk_5ff8f1df-24d8-4201-b56f-c6dc5a2f8e75">983</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0NDk_1c8a42d4-1a75-45d5-abd4-ad45a94fa0bc">49</ix:nonFraction>&#160;million, respectively, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $<ix:nonFraction unitRef="usd" contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjExOTI_0e916439-468c-4d40-b884-7c5fb3a5b828">178</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTg3MTg_9196b9c4-0ac0-4917-9fdf-fee57f0ba38d">3</ix:nonFraction> million, respectively, as an increase to McKesson stockholders&#8217; additional paid-in capital. During 2020, there were no material exercises of the Put Right. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjE3OTI_1affcfe5-ffea-4ad3-b44f-f4b5186db8c4">287</ix:nonFraction> million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to the expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported at the greater of its carrying value or its maximum redemption value at each reporting date.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, the carrying value of redeemable noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-8" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTk0NDQ_9511c7cf-172b-4566-b669-134f3c7e0e0c">1.3</ix:nonFraction> billion exceeded the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="i369ed3d532394663ba99e0e952d94674_I20210331" decimals="INF" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTk0ODk_7b73179d-7e43-40a7-a9a7-6fdc6cd9c35f">1.2</ix:nonFraction> billion and the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i369ed3d532394663ba99e0e952d94674_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTk1NTA_f4bff249-442b-45c8-807e-c9887e66be13">78</ix:nonFraction>% of McKesson Europe&#8217;s outstanding common shares.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i07a80ac39d04487c89fadf4d72b7f62e"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also include minority shareholder equity interests in McKesson Europe. Noncontrolling interests in the Company&#8217;s Consolidated Balance Sheets were $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjUyOTY_3b95527e-6ca4-42c4-a16f-6699f949e1f8">480</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjUzMDU_16b7141c-040e-4ebe-880b-d3fc708b57cd">196</ix:nonFraction> million at March 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i2a2d296e2c5c427f97b8588765fa3178_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjQ4MDM_2d9ff9ad-aeba-46ac-a5d1-211476e184a4">95</ix:nonFraction>% of McKesson Europe&#8217;s outstanding common shares. The Company&#8217;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; During 2022, 2021, and 2020, the Company allocated a total of $<ix:nonFraction unitRef="usd" contextRef="i6dc4df20c07240af91fdfc7690f7f39a_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTU2MTM_8563e843-5e80-429d-8059-125ec940294f">165</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5a5f885d18c04e07bd8c41ef8f1ce99b_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTU2MjA_abd534c7-0a27-4c15-946a-fb6eb9ef1a9f">156</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4ac41f1025f14743bb7d39f341e23ed7_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTU2Mjk_02dfa911-fac8-46bf-9d7c-b0a83308f6ea">178</ix:nonFraction> million of net income to noncontrolling interests, respectively.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQxNDY_236318a3-3627-4912-b4ba-d30a7a22e82c" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2022, 2021, and 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4592918a3c14823acad8256f0ddfbde_I20190331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEtMi0xLTEtNjc1MTI_31d4cd92-5f28-4e45-afe8-2b1d8b09cc4a">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb2e420d55e43d0aa913ab1b22cbcaa_I20190331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEtNC0xLTEtNjc1MTI_8ad96e2e-d82c-4085-8cf7-23a51780e85c">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzItMi0xLTEtNjc1MTI_6d534acc-86a2-4493-a505-9b5df6755e38">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzItNC0xLTEtNjc1MTI_c704ffcf-1c31-4b6b-9df2-bd405c570ac6">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzMtMi0xLTEtNjc1MTI_f8e0ebf5-2eae-4d6f-8cb3-89820c8abf24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzMtNC0xLTEtNjc1MTI_c9e788a0-f9a8-4780-be89-f52a356461c7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzQtMi0xLTEtNjc1MTI_2b2395a6-8a4d-4646-a417-1d8df0a42e90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzQtNC0xLTEtNjc1MTI_2a071657-54f8-4a6d-943f-74756d418c5a">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzUtMi0xLTEtNjc1MTI_8e0a4a69-848c-444b-af87-25f2a38fa001">154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzUtNC0xLTEtNjc1MTI_4acc80ac-fd4c-4899-966a-b6811a52e73e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzYtMi0xLTEtNjc1MTI_c6bc751d-793e-490d-8685-3f21292685f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzYtNC0xLTEtNjc1MTI_e12f83f7-41ab-450c-a0a6-a01d67a28e58">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2cdad70673142c9a93a6bbb19838852_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzctMi0xLTEtNjc1MTI_718b1fc5-e8bb-46f4-92ad-8f4b72c10226">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfcdc1a443e549bdae94a956c44c8a5e_I20200331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzctNC0xLTEtNjc1MTI_0175a52e-a020-4935-bdf2-15dff39c76be">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzgtMi0xLTEtNjc1MTI_a09abeb9-2e5a-49cf-afed-f8a94686cd3e">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzgtNC0xLTEtNjc1MTI_06c82f2e-206d-4bee-b45a-dfd7212b3119">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzktMi0xLTEtNjc1MTI_ea17945f-d608-4d70-9d9d-9bd6a7e7b624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzktNC0xLTEtNjc1MTI_5804f0ef-8c64-4e9e-9de2-ff51dbc8834c">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEwLTItMS0xLTY3NTEy_88eff6c4-64e4-4a67-854f-84cb15bdfb04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEwLTQtMS0xLTY3NTEy_20218862-e48b-4229-a59c-f096a0acea38">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzExLTItMS0xLTY3NTEy_b9c6f0bc-9b31-4d58-a8a3-538fcba71de9">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzExLTQtMS0xLTY3NTEy_442db9b5-88d5-4915-ab44-e9c556a3445c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTItMS0xLTkyNjg2_856e19ed-864c-4694-aa73-15719c151e96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTQtMS0xLTkyNjg5_00f6df96-579c-4f03-8ef3-c0e3094337a7">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTItMS0xLTY3NTEy_defd5dd1-2a9e-47e5-9d30-a6974e7a98e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTQtMS0xLTY3NTEy_0a850a47-6fdf-4110-ab58-a7707d21a881">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dec5df30de44f7a83e4f2ce0278a9d7_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEzLTItMS0xLTY3NTEy_0194fc0b-cf30-40de-ba1b-98063518c591">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae40923a8c44fae93e93658b71a6fbe_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEzLTQtMS0xLTY3NTEy_9e1df93e-865f-436f-b029-99795e1193c7">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE0LTItMS0xLTY3NTEy_9252a48a-723f-4957-ba70-d1697ce98fff">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE0LTQtMS0xLTY3NTEy_4d731904-a670-4e2d-b1d4-386f3c2ada3a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE1LTItMS0xLTY3NTEy_97b77afa-a95a-454a-92ae-2f4ef3265424">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE1LTQtMS0xLTY3NTEy_a3885e52-bb68-43f4-9980-0aa7763ad845">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE2LTItMS0xLTY3NTEy_7751cab5-68dc-4cdc-91ab-dea5d71e1613">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE2LTQtMS0xLTY3NTEy_3f221e79-b91b-4497-a290-697834e59126">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE3LTItMS0xLTY3NTEy_bf568aa9-bfad-459d-8de5-d9dc0860bf08">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE3LTQtMS0xLTY3NTEy_efde1c6d-5cbf-4ffb-b924-b0ed100dd192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE4LTItMS0xLTY3NTEy_f7ad27df-d349-47f2-afd1-44f62bfe4d3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE4LTQtMS0xLTY3NTEy_5ff8f1df-24d8-4201-b56f-c6dc5a2f8e75">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTItMS0xLTkyNjk0_06f73503-bae1-4ff7-8357-c6f057914dda">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTQtMS0xLTkyNjk4_1affcfe5-ffea-4ad3-b44f-f4b5186db8c4">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE5LTItMS0xLTY3NTEy_ba42d95d-b12e-478c-86b1-8d579f3848f8">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE5LTQtMS0xLTY3NTEy_5e226e89-61ec-4e94-a6f4-f05772041a92">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cdcc95103d4a2b933719ac01f8cec5_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTItMS0xLTY3NTEy_ab016572-9b7c-4b3f-97ca-64f0d6851901">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2605ebb23764962bfd89d4578016d5b_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTQtMS0xLTY3NTEy_3647994b-e3ad-475f-8bd8-25b5388eeaea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_136"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzExODQ_82866d27-12a6-46b7-9788-7435b9eb182f" continuedAt="i68bed7cd553a47df8baacf470260ac9a" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i68bed7cd553a47df8baacf470260ac9a" continuedAt="i25c750a0716f4cfe91dc0e2a4e06142f">Basic earnings (loss) per common share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i25c750a0716f4cfe91dc0e2a4e06142f" continuedAt="ie923bd6213fc4b428749347537560ad2"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted loss per common share for the year ended March 31, 2021 was calculated by excluding all dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Approximately <ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzE2NDkyNjc0NDM4NjQ_24c63384-5193-4390-850c-5bee24d2f0d8">nil</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzQzOTgwNDY1MTIzNDE_bba40ea9-f745-45b6-8b0a-eccb4e2b7697">2</ix:nonFraction> million of potentially dilutive securities for 2022 and 2020, respectively, were excluded from the computation of diluted net earnings per common share, as they were anti-dilutive.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzExODg_b0e6934c-893d-476f-8b9d-b83fb50ec949" continuedAt="i053d27394a7246e6b0e91bcc81ad0d38" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzItMS0xLTEtNjc1MTI_fabe798e-3e5d-43bd-8a07-36b654ea5bbb">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzItMy0xLTEtNjc1MTI_c0371f74-e47a-4cb1-a0fc-b2ab4f70d6be">4,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzItNS0xLTEtNjc1MTI_4f41114c-e494-46ef-bdb9-8f70f969c41c">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzMtMS0xLTEtNjc1MTI_89315c1a-151f-4bf6-8ba2-136f0cd9c64f">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzMtMy0xLTEtNjc1MTI_7f98df02-3f31-413a-86ec-56126153c806">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzMtNS0xLTEtNjc1MTI_027623b7-eece-4a25-8866-f0e14d5b63f3">220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzQtMS0xLTEtNjc1MTI_4f67a574-9e1c-4396-ac86-ef035e7a312a">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzQtMy0xLTEtNjc1MTI_e426bcce-507e-408b-a506-7a29ef571ca9">4,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzQtNS0xLTEtNjc1MTI_fc35ac2a-c025-446e-9674-2524a2974f70">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzUtMS0xLTEtNjc1MTI_b17347a6-7aa3-47cc-a24d-8568c0493004">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzUtMy0xLTEtNjc1MTI_84b258d8-0324-4f26-bfc6-6bf365bda89a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzUtNS0xLTEtNjc1MTI_2af3e54d-2829-43f4-92ee-ec3c6fd1ecdf">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzYtMS0xLTEtNjc1MTI_5fd1d26d-ef39-4210-b79e-af6adc2ab233">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzYtMy0xLTEtNjc1MTI_c4321dd8-da0b-4386-a430-a918610fa715">4,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzYtNS0xLTEtNjc1MTI_49edc76f-fa02-4355-8d9d-d8027b1945ab">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzktMS0xLTEtNjc1MTI_2c2ab63c-5ada-4f02-add0-332983edc54e">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzktMy0xLTEtNjc1MTI_11aadce4-422b-4694-8e30-7ce8172b52e3">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzktNS0xLTEtNjc1MTI_fa2e32c4-243d-44ab-bb34-d7b6c5ca1392">180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzExLTEtMS0xLTY3NTEy_37cfe301-1617-4e73-8e92-b65a51b7f6e6">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzExLTMtMS0xLTY3NTEy_863f45d5-3054-4d5e-b7bb-647321850dfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzExLTUtMS0xLTY3NTEy_84f3bfe9-3fc9-4423-8a78-b9ee4611d625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEyLTEtMS0xLTY3NTEy_6f0d7de2-7f46-4ed1-8b1a-a3a717c189c9">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEyLTMtMS0xLTY3NTEy_5fbb02b1-469d-4f34-aeb9-2a8ff023f50a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEyLTUtMS0xLTY3NTEy_59d2a70e-5659-49c2-b897-9d089cf970c9">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEzLTEtMS0xLTY3NTEy_fef9557b-6b38-467b-aa43-1cee4b5d8241">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEzLTMtMS0xLTY3NTEy_be98289a-5d03-4d8f-9cf7-f5153580c51d">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEzLTUtMS0xLTY3NTEy_54d2564d-9b26-4f9e-89b2-407b5656ed67">181.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE3LTEtMS0xLTY3NTEy_8f950712-64f3-41af-9ea1-daeb70290081">7.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE3LTMtMS0xLTY3NTEy_077276bf-fc6d-4221-ac5c-6a0f29daec4f">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE3LTUtMS0xLTY3NTEy_8096325c-df6f-4cd6-b6f3-0678aa46ecf4">4.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE4LTEtMS0xLTY3NTEy_32959134-b75a-4a8d-bbb5-20f2b17a4afc">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE4LTMtMS0xLTY3NTEy_7ba0e5fb-a7e3-49d6-94fa-2449762676b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE4LTUtMS0xLTY3NTEy_8fa0dd01-1d01-48ad-92b2-6193f8c07226">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE5LTEtMS0xLTY3NTEy_8fcf357a-6723-4a97-b957-b29e37fe7a2a">7.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE5LTMtMS0xLTY3NTEy_84bf32fe-1a27-4106-adcc-3f82f06ab039">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE5LTUtMS0xLTY3NTEy_4ad3923f-6db1-4c14-b1c6-7e383e1ccd33">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIxLTEtMS0xLTY3NTEy_a67825b8-6083-45ec-8a82-90dd78e45abc">7.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIxLTMtMS0xLTY3NTEy_bc18856e-b648-440e-b2ae-99227c0c3bc8">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIxLTUtMS0xLTY3NTEy_71f633fb-adfa-4dd7-8269-b57b72fb391c">5.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIyLTEtMS0xLTY3NTEy_8b772437-40a1-49ee-9b68-198e4c94018b">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIyLTMtMS0xLTY3NTEy_e87e0358-0c3b-48e2-8b1a-3dfb18b95ded">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIyLTUtMS0xLTY3NTEy_084181be-8ec3-467f-8242-1d2cb1d6d6ff">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIzLTEtMS0xLTY3NTEy_1e270e59-b731-4d34-91c2-85c7bcdd19e6">7.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIzLTMtMS0xLTY3NTEy_1adedc77-2082-4f4e-8102-148cc4982d1b">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIzLTUtMS0xLTY3NTEy_55a6c9a7-55e6-45f5-b460-e6c7dd0eeccb">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie923bd6213fc4b428749347537560ad2" continuedAt="i08a89f3d095f453b8113c7c81f25d260"><ix:continuation id="i053d27394a7246e6b0e91bcc81ad0d38" continuedAt="i29baf2bfbc3443fc8996153b2b44fc76">(2)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i08a89f3d095f453b8113c7c81f25d260"><ix:continuation id="i29baf2bfbc3443fc8996153b2b44fc76">Certain computations may reflect rounding adjustments.</ix:continuation></ix:continuation> </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_139"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:LessorDirectFinancingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNjk_cfe789f8-9479-45b5-83af-2434a4b7742a" continuedAt="id696c8ca2e4e47789f5c389c1b1b0811" escape="true"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzY_eedb9401-624c-4e67-8297-eeee1b4697e4" continuedAt="ie680138bfa404a9997d78eaca405709e" escape="true"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzc_e5ba8d3a-a04e-4f00-ae6a-e1172bde7e63" continuedAt="iea4ec33f88774953aadba664d3980710" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id696c8ca2e4e47789f5c389c1b1b0811" continuedAt="i9dc3fddb44fa4e1386d863f2229c337b"><ix:continuation id="ie680138bfa404a9997d78eaca405709e" continuedAt="i3682dc27dd034621b479b197ae8ba752"><ix:continuation id="iea4ec33f88774953aadba664d3980710" continuedAt="i014cc2a7221b44298539cc9596d67aa9">In the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401" decimals="-8" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzE5Mg_18d34613-b3c0-4508-bd31-3330f84c846f">2.2</ix:nonFraction>&#160;billion of operating lease liabilities, $<ix:nonFraction unitRef="usd" contextRef="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401" decimals="-8" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzIyNw_54d54b60-cf2f-4f48-a2e7-a7a7a4c1f57e">2.1</ix:nonFraction>&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="if31e8179749841c8870313f7d3ba430c_I20190401" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzI5OQ_1a38a20a-b1c7-46f5-a073-4d57f712381d">69</ix:nonFraction>&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $<ix:nonFraction unitRef="usd" contextRef="icc5e78fe538f4bacbd70c847c9f29b70_D20190401-20190401" decimals="-6" name="mck:OperatingLeaseImpairmentLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzQyNw_93b179be-0686-42bb-a099-fceee726c8f6">89</ix:nonFraction>&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.</ix:continuation></ix:continuation></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9dc3fddb44fa4e1386d863f2229c337b" continuedAt="i94f0d4ce290d4c36a61ee0c0c5775b54"><ix:continuation id="i3682dc27dd034621b479b197ae8ba752" continuedAt="if483bf89a6d7440281e5eb01c4f820b2"><ix:continuation id="i014cc2a7221b44298539cc9596d67aa9" continuedAt="i57085865068642aeaa36cf1f049492e4"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyODA_5b8e3646-be70-48ad-87ab-8c6331c0b3a0" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzQtMS0xLTEtNjc1MTI_0dd3477f-4ef9-4905-ab2f-e123b839ab6e">1,548</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzQtMy0xLTEtNjc1MTI_61bdea18-2847-423f-8be8-7795a88a2585">2,100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzYtMS0xLTEtNjc1MTI_7e0c80af-09e3-4b63-b64a-ecc970e7d57f">297</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzYtMy0xLTEtNjc1MTI_641aa5ea-48e9-44a5-826f-4f6208115a7f">390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzctMS0xLTEtNjc1MTI_d68297b0-301e-4813-9f82-c6e80358e26f">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzctMy0xLTEtNjc1MTI_61126235-7b12-4769-a6e2-9fd5a3a2652b">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzgtMS0xLTEtNjc1MTI_3596d6bd-8067-4f90-b542-ce6126cce9a2">1,663</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzgtMy0xLTEtNjc1MTI_6966a1f2-4e8e-4d29-aef1-1810b1f7072a">2,257</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">Property, plant and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTEtMS0xLTY3NTEy_8b55ee4d-8887-4888-81fb-74d25aba8658">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTMtMS0xLTY3NTEy_8389def5-286c-4641-99b2-79c2eed1eca6">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTEtMS0xLTY3NTEy_2d66495e-fee4-4483-8add-608db6bcdab1">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTMtMS0xLTY3NTEy_2202b5b0-40ad-4eb4-878e-ed4d22af7250">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTEtMS0xLTY3NTEy_5e5cff59-1dab-4e17-9a2a-e4c492a80a43">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTMtMS0xLTY3NTEy_a4242e99-cba3-467a-984c-bb97ed60b682">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE1LTEtMS0xLTY3NTEy_0cacf8b5-0cf5-4d45-9210-73a5473cf4f2">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE1LTMtMS0xLTY3NTEy_5ba4c3fe-16e4-46f6-a08d-c7b84a026bc7">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE4LTEtMS0xLTY3NTEy_6788766f-2837-47b8-bf57-4f50d73c0a3d">6.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE4LTMtMS0xLTY3NTEy_97375838-525e-404d-8075-43b3132dd252">7.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE5LTEtMS0xLTY3NTEy_b1fa1318-a9bd-46b6-9e85-fc7856ffc79b">8.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE5LTMtMS0xLTY3NTEy_730eb53f-81e5-4b7f-9eb9-63a07e5b7730">10.1</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIyLTEtMS0xLTY3NTEy_97d0be29-6576-4a6e-8e5b-1307142832f9">2.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIyLTMtMS0xLTY3NTEy_c58cdd6a-830d-4668-b579-c219b2bafd14">2.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIzLTEtMS0xLTY3NTEy_e949f0f1-fde9-4a7c-b7ed-72188c337214">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIzLTMtMS0xLTY3NTEy_5885d32e-b168-4080-a1cd-4cc4fd5b6179">2.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $<ix:nonFraction unitRef="usd" contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzY5MTM_f18eb608-f21e-4d8f-90a8-384db0ed09ee">494</ix:nonFraction> million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term operating lease liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2Mzc4MDg_fc3793c5-8501-4626-be3f-5291061badfb">83</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2Mzc4MjY_7d4afe8c-a908-4490-ac55-c0c52f166576">442</ix:nonFraction> million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div></ix:nonNumeric></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i94f0d4ce290d4c36a61ee0c0c5775b54" continuedAt="i9f8f4320bf4b4119a389fe8fda510fa2"><ix:continuation id="if483bf89a6d7440281e5eb01c4f820b2" continuedAt="i4c5e4aed3e524bc9a9c26e4f0e0d93b7"><ix:continuation id="i57085865068642aeaa36cf1f049492e4" continuedAt="i95df5c15364348e09d20098153aea668"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNjY_85834e19-419c-4a30-b3ee-7729b8e78f98" continuedAt="i6c715794e477485e8fdd1701e1ca86f1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzItMS0xLTEtNjc1MTI_27bdd7b2-c30e-4269-a10c-c016905d78a4">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzItMy0xLTEtOTQyMjE_b1226398-4b7c-416a-94b8-fb34253aee36">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzItMy0xLTEtNjc1MTI_a05d46db-4f37-46c1-818a-c4f56a5c9fa3">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzMtMS0xLTEtNjc1MTI_6fe0a8e9-312c-49d5-af82-b6c887010826">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzMtMy0xLTEtOTQyMjE_4bc3e738-89ca-4c81-a83e-b41d9892b939">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzMtMy0xLTEtNjc1MTI_874d7cd4-1800-46a0-8cb5-0d74d0282069">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzYtMS0xLTEtNjc1MTI_271e45cf-e95c-4593-ba4e-4ed5102ff9cd">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzYtMy0xLTEtOTQyMjE_83425941-d37b-4cb5-a4a4-e66d2f99d28a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzYtMy0xLTEtNjc1MTI_36b2b56c-22fa-483b-9475-f34e54ae69ec">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzctMS0xLTEtNjc1MTI_e1005656-a4fc-4d33-9728-fb59dfb26fdf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzctMy0xLTEtOTQyMjE_b8197efe-886d-4cd2-bd95-be50c65063a9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzctMy0xLTEtNjc1MTI_569430c0-22e9-413d-8653-022d70cab1c0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzgtMS0xLTEtNjc1MTI_6f60181b-fd8a-45d5-a084-ca01c0e5fe37">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzgtMy0xLTEtOTQyMjE_9880641c-ae6d-43f3-9e5c-ffffcc2b8723">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzgtMy0xLTEtNjc1MTI_cbb4e7d1-c9d6-4871-874a-a47182c6b6db">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEwLTEtMS0xLTY3NTEy_867e35ae-1cfa-4028-ae48-19ab2375698f">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEwLTMtMS0xLTk0MjIx_b54ee9d2-6fe4-48c3-8e1c-05b5d09edf29">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEwLTMtMS0xLTY3NTEy_d60f7717-fdd1-4acf-abaa-c41b1903b58d">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzExLTEtMS0xLTY3NTEy_c0faf805-8508-4b59-a43d-39a7b7ebd61c">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzExLTMtMS0xLTk0MjIx_d34e7a18-dbf3-43d1-a4d0-0f0f62781e3c">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzExLTMtMS0xLTY3NTEy_69856261-de38-457f-a634-dfade1ccba8a">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEyLTEtMS0xLTY3NTEy_f59c2c6d-601a-4254-9b6d-6d68cafb6059">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEyLTMtMS0xLTk0MjIx_46b1464d-48dc-48e9-84ab-dece4567897c">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEyLTMtMS0xLTY3NTEy_ed168df5-4d39-4a79-9e6d-780535492ab3">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzMtMS0xLTEtNjc1MTI_a77cde24-6e2f-4823-befd-fd78415acc3f">356</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzMtMy0xLTEtOTQyOTE_164d1c20-862b-4d4f-bb5e-99472092e905">362</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzMtMy0xLTEtNjc1MTI_239c6b07-4768-4d8c-ae18-38990d446605">377</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzQtMS0xLTEtNjc1MTI_dca09908-6ef6-415c-ad51-3a59ea213b6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzQtMy0xLTEtOTQyOTE_9f8d9bb1-fd03-4f2e-9dbf-e0a78a3fb2e9">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzQtMy0xLTEtNjc1MTI_bb32296d-f19e-499e-a021-76b7f81deea4">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzUtMS0xLTEtNjc1MTI_8223cbf6-96f8-4d1c-bd6e-0f74c7ee26f4">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzUtMy0xLTEtOTQyOTE_f25337db-b476-4b3a-8b42-1e5f263aba73">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzUtMy0xLTEtNjc1MTI_09262fa2-a724-4926-9906-8efae8860602">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzctMS0xLTEtNjc1MTI_814ac54d-4f11-48a8-ba93-818eee6e4c61">286</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzctMy0xLTEtOTQyOTE_f8b237b4-16b3-48bb-a1fc-0e1554bc60f6">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzctMy0xLTEtNjc1MTI_461f53df-1655-4ce2-a18a-5b8277fa732c">2,378</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzgtMS0xLTEtNjc1MTI_82aded29-9494-4928-ab65-08227168021b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzgtMy0xLTEtOTQyOTE_fab5cc3b-a36d-40ce-91e6-bb6c2cf17bae">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzgtMy0xLTEtNjc1MTI_913df242-5019-42d1-9b7c-7f51336008b7">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i6c715794e477485e8fdd1701e1ca86f1">(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $<ix:nonFraction unitRef="usd" contextRef="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401" decimals="-8" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzQyNjk_4e3488be-e9bb-484c-8c87-c55beb564c27">2.1</ix:nonFraction>&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases.</ix:continuation> </span></div></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9f8f4320bf4b4119a389fe8fda510fa2"><ix:continuation id="i4c5e4aed3e524bc9a9c26e4f0e0d93b7"><ix:continuation id="i95df5c15364348e09d20098153aea668"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzE_01824885-acce-46ff-9f45-c2c8182b326b" escape="true"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzI_83468ead-3640-48e2-a1b4-ef4d05205f72" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzItMS0xLTEtNjc1MTI_5b9ce6b7-d202-4d0f-be8c-e251289604a0">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzItMy0xLTEtNjc1MTI_7a132751-ff80-4f1b-a60d-c4e886ec0cf5">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzItNS0xLTEtNjc1MTI_e012bca8-47bd-4f22-a7b7-e7b66596998a">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzMtMS0xLTEtNjc1MTI_85006bdb-6aec-4ebc-a539-b0637ad03aad">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzMtMy0xLTEtNjc1MTI_a826d5ae-6675-4dc0-a6da-1607f89a49a0">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzMtNS0xLTEtNjc1MTI_08bbdafd-f729-466f-aa97-7049539bbc64">339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzQtMS0xLTEtNjc1MTI_ed2109e2-3ba6-4561-8c9f-2aa3aa1c09c6">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzQtMy0xLTEtNjc1MTI_a58c0450-6605-45f4-8374-d850aabc9f7e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzQtNS0xLTEtNjc1MTI_e33b8c21-188c-443d-b32b-ebff733b3835">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzUtMS0xLTEtNjc1MTI_e6e861cf-1654-4997-ab33-9a11b7d0e0e0">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzUtMy0xLTEtNjc1MTI_af9034e1-2465-4dc8-aadc-6a9c75665ea6">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzUtNS0xLTEtNjc1MTI_170d7ded-85dc-4281-8241-2d82b740a77f">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzYtMS0xLTEtNjc1MTI_308fc1d4-9578-4bcc-9338-04c2eadf433c">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzYtMy0xLTEtNjc1MTI_99f358b6-5323-4324-9c31-628e110fdedb">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzYtNS0xLTEtNjc1MTI_6b2d7061-2810-4491-a731-7b2020c22711">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzctMS0xLTEtNjc1MTI_fc657851-6c6d-4953-a198-b1083168f0de">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzctMy0xLTEtNjc1MTI_18b8b218-23f8-46d3-86f2-bbc888de3b12">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzctNS0xLTEtNjc1MTI_6724948b-bd96-4a71-a3a5-78c09d56356d">609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzgtMS0xLTEtNjc1MTI_196cba8b-be86-4c9f-a761-f29bb7bf39b6">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzgtMy0xLTEtNjc1MTI_af495207-9a56-44c0-bf60-f2c816aaa051">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzgtNS0xLTEtNjc1MTI_35fa7ffc-0837-4ea2-82be-41fedd0b17bf">2,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzktMS0xLTEtNjc1MTI_4cb51096-34f6-4c8e-bbee-144a2bce1221">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzktMy0xLTEtNjc1MTI_85e96e59-f544-4062-99ba-cd5c711ab92b">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzktNS0xLTEtNjc1MTI_68012ef7-f7a8-4068-9164-3f1a94b7a524">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzEwLTEtMS0xLTY3NTEy_16b1ecb8-3ae8-4898-a791-845c5f898f4c">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzEwLTMtMS0xLTY3NTEy_7be1cc23-a71a-489d-8fd6-e0c5a5d052a0">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzEwLTUtMS0xLTY3NTEy_1f3855de-ffd1-48bb-bf0e-3a451b31a327">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LessorLeasePaymentstobeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU2NDE_3cec9d34-43b4-4ab6-8920-e04aa7d2786e">201</ix:nonFraction> million which are due under future noncancellable subleases.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU2ODY_b355e5c6-3ac3-4c50-aa22-41c06ff1441c">285</ix:nonFraction> million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529">five</span> to <ix:nonNumeric contextRef="ia6fbd33f726e47aba5491ae5385fa919_I20220331" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MzA_6b3d9865-d301-4fe6-8f13-71846660bc3c">15</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3NzA_89a40ea4-0d9e-45c2-8ba2-d5817e1fdaac"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3NzA_f85db839-aa6b-4b6c-af71-80b29f51d806">298</ix:nonFraction></ix:nonFraction> million, respectively, with a weighted-average remaining lease term of approximately <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3OTk_136d3561-590a-4f2d-a162-23b6349a56ef"><ix:nonNumeric contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" name="mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3OTk_be22b36d-88ea-4694-80fe-d9474a6eca10">seven years</ix:nonNumeric></ix:nonNumeric>. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.</span></div></ix:continuation></ix:continuation></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_142"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4Xzc1MzQ_66fbd84b-5f0d-4d24-921a-456753505486" continuedAt="i532f1a453bd54f5eb50ffd805d17b5e1" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><ix:continuation id="i532f1a453bd54f5eb50ffd805d17b5e1" continuedAt="i526283e21af44945a04a70981e5a3c09"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4Xzc1MzU_1518b047-15df-4fbe-882a-fa190024b585" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082e438b9e624b688d526df079a96fae_I20200331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtMS0xLTEtNjc1MTI_411b351a-63d0-4ef1-96e0-0162b2244c52">3,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc65fc10a6f46eb873730b43c245ffd_I20200331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtMy0xLTEtNjc1MTI_b1661aec-f67b-4cf3-8f21-3b65a76892d2">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6ade13b6047f2bc574352c680315a_I20200331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtNS0xLTEtNjc1MTI_058845b2-3699-41cb-8d6c-53a0edc52809">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee45133724c4e4d9e9cc8e6880430af_I20200331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtNy0xLTEtNjc1MTI_04f7fcd1-16f0-44ae-94ae-76c7683da7c7">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtOS0xLTEtNjc1MTI_7336de15-1a7e-441b-8b4e-4331097217f4">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItMS0xLTEtNjc1MTI_af9569cc-7339-47a5-9342-47a5840e35d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItMy0xLTEtNjc1MTI_159f431e-9a47-4c3e-8656-a9e52915ed1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItNS0xLTEtNjc1MTI_9efceea3-ae6e-4110-b598-a393bda58f2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItNy0xLTEtNjc1MTI_ab9c3ac7-fbbb-463a-aca2-3ef17214d05b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItOS0xLTEtNjc1MTI_098cefcd-8061-48f1-8299-79fb82b9b61d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers, and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtMS0xLTEtNjc1MTI_b8afce2d-fda5-4967-8f29-cb1c32bc84b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtMy0xLTEtNjc1MTI_66483adc-b887-4153-9223-e24a86327551">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtNS0xLTEtNjc1MTI_f37420dd-fcfe-4052-ab93-03d4de132ef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtNy0xLTEtNjc1MTI_cab86986-27f8-432d-ba44-43f5a4ad2068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtOS0xLTEtNjc1MTI_2b4ebf61-035a-4871-8199-5cf57d11b1b8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtMS0xLTEtNjc1MTI_836ed7a2-bf37-4447-8e3f-944cb705c744">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtMy0xLTEtNjc1MTI_40d39960-f0b4-4e5c-ac84-101401f1e485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtNS0xLTEtNjc1MTI_59f1f2cf-669c-4ac8-a828-199796bfbecc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtNy0xLTEtNjc1MTI_3bcb4a35-1e99-4be8-895f-216c1aeb7566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtOS0xLTEtNjc1MTI_99f88466-f98f-44f0-a74b-c9178d8c2839">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtMS0xLTEtNjc1MTI_b93bcfdf-79e2-4eed-8705-391ddaeda43d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtMy0xLTEtNjc1MTI_07a7e60d-2d92-48cd-ab8e-bfac155fda8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtNS0xLTEtNjc1MTI_e688d6da-de1a-487e-82d9-adb2f801afff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtNy0xLTEtNjc1MTI_6b493689-8e3b-440f-b92d-1fac474a1a73">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtOS0xLTEtNjc1MTI_17ac37f6-e5e8-42c9-92dd-1cc35276765f">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtMS0xLTEtNjc1MTI_2c715944-435a-4e85-9ea0-9ed56cc2b844">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtMy0xLTEtNjc1MTI_2f1f0dbf-f447-4260-9c2a-c3f2dd677113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtNS0xLTEtNjc1MTI_aa93a1dd-5957-49e6-b55b-018d027d4410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtNy0xLTEtNjc1MTI_3c53c0f3-9184-4142-8028-1beb54bb30cb">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtOS0xLTEtNjc1MTI_a763437f-9d0a-4433-9658-f2bb9f4827f2">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i558a4f91a45148328e79fe9c105520e7_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctMS0xLTEtNjc1MTI_c0472dee-ae2e-4a0f-acbe-d4fd4ff79db6">3,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3167c8a2454bfc8d55421585d3d985_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctMy0xLTEtNjc1MTI_9bf80463-482f-440f-ab30-a697207021dd">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15b55a2e948f4b24a3b527c5ac723106_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctNS0xLTEtNjc1MTI_6d9d171f-6883-40dc-9568-d5f7a3bbc40d">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2898617ea052451ab1b166e16ad0bff1_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctNy0xLTEtNjc1MTI_12f72ffe-7629-453a-a935-73ac9083eb42">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctOS0xLTEtNjc1MTI_dd664305-4183-470b-88c1-10374323270a">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtMS0xLTEtNjc1MTI_dc2a286a-98aa-4dd0-9306-9364ed3775de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1778f09368dd4bde9d01e3bceccc0de4_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtMy0xLTEtNjc1MTI_39efbb8b-6841-4d62-a0f9-f332348c42dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtNS0xLTEtNjc1MTI_28440358-265f-48e5-9c38-ba03c3e983ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtNy0xLTEtNjc1MTI_47ad0b50-cde3-4139-95ca-d40a3be4b2fb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtOS0xLTEtNjc1MTI_63ea6121-457f-4760-90ca-77d8ec9b636b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTEtMS0xLTY3NTEy_de3ce522-af14-473b-b31d-6c4a1865d564">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1778f09368dd4bde9d01e3bceccc0de4_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTMtMS0xLTY3NTEy_54e51538-78f3-403b-8134-e9a767684c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTUtMS0xLTY3NTEy_a2679499-80a6-46a5-a99a-85b3c19b6b09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTctMS0xLTY3NTEy_763e7397-f66e-4003-9ffa-bc856ad15d21">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTktMS0xLTY3NTEy_55443f1f-0425-4386-9702-33f2d7cbca3a">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8bec42efc82456886f328dfaa5e4c78_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTEtMS0xLTY3NTEy_c23a7e24-12cd-4fb2-bda7-608a180c7df4">3,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57b1f3f32ffc4e6ca7fc465f2efcfa9c_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTMtMS0xLTY3NTEy_bf2fbf08-e80a-43c4-ad78-73da5f786310">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89602a22aafc4c248462dc75c787e1db_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTUtMS0xLTY3NTEy_40f532da-4cf8-456d-9689-e6e19cc9cc5b">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c2a80c51924ffea392e70a7d81af35_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTctMS0xLTY3NTEy_cd0110c9-5cac-451d-8343-e0ab17af3461">1,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTktMS0xLTY3NTEy_d69c66f1-6815-44a3-837a-3ed7d8de3935">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i526283e21af44945a04a70981e5a3c09" continuedAt="i80bd02c611d84934a4c4472672e7b212"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Charges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment as of October 1 on an annual basis each year and at an interim date if indicators of potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units was determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#8217;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#8217;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for 2022, 2021, and 2020 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="segment" contextRef="if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzE3NTkyMTg2MDU5NjAz_77f4e669-4d82-4074-b0ab-f90ebe68a364">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ic17f9f344cd2424186b1efb969df180c_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzEwOTk1MTE2MzgxNzg_e61df601-2c1e-4127-9dc0-b83e9a2d1266">69</ix:nonFraction> million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This charge was recorded in &#8220;Goodwill impairment charges&#8221; in the Consolidated Statements of Operations. At March 31, 2021, the balance of goodwill for the reporting units in Europe was approximately <ix:nonFraction unitRef="usd" contextRef="i480ab7e945d745479b45988a832ff1ef_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzM5Mjc_fd9e38c2-89fc-4ed1-be92-fce889468a4f">nil</ix:nonFraction> and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 16, &#8220;Fair Value Measurements,&#8221; for more information on these nonrecurring fair value measurements. As of March 31, 2022 and 2021, accumulated goodwill impairment losses in the Company&#8217;s International segment were $<ix:nonFraction unitRef="usd" contextRef="i65c2a80c51924ffea392e70a7d81af35_I20220331" decimals="-8" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzEwOTk1MTE2MzgxODc_ab61e9ac-42b8-4024-b8b6-2753f98bf1cb">0.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i2898617ea052451ab1b166e16ad0bff1_I20210331" decimals="-8" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzcxNDY4MjU1OTA4Mzc_9283855f-550b-4bd0-95ff-9bc12a0df9d0">3.6</ix:nonFraction> billion, respectively. Most of the goodwill impairment for these reporting units was generally not deductible for income tax purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i80bd02c611d84934a4c4472672e7b212"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4Xzc1MzM_de699a9a-5dfe-4476-b758-0aa267eaac77" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d68a928d7824033ace17d52e23a8dca_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMS0xLTEtNjc1MTI_a0eca3f7-60e1-4684-928d-020837f8ee51">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c222358c854868933a4aec3f197b82_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMy0xLTEtNjc1MTI_1bc64c09-dc51-4bbd-a918-1a7293279dc6">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40c222358c854868933a4aec3f197b82_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItNS0xLTEtNjc1MTI_cff9a9f0-7cad-44a1-8efd-3074cc3534e4">1,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c222358c854868933a4aec3f197b82_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItNy0xLTEtNjc1MTI_7df2339b-f5ae-487c-acc0-b047be25e2d6">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if320149638f44877bc4627df44ee32f0_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItOS0xLTEtNjc1MTI_a9368096-bbb5-4a52-8639-5a2cd05aa16b">3,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if320149638f44877bc4627df44ee32f0_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMTEtMS0xLTY3NTEy_045baa8f-5079-441e-981a-34a6a532f26f">2,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if320149638f44877bc4627df44ee32f0_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMTMtMS0xLTY3NTEy_387aafb3-1c16-4bc1-b7f8-de86f44f8222">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i68562b53b58b4e4eb84618514db2cb80_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMS0xLTEtNjc1MTI_3230aabf-d6ee-47a8-b8ca-1fdd031f429f">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf05e148e384ae29d92e24fc00c4fef_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMy0xLTEtNjc1MTI_42db5374-67cc-4430-a65c-9c65d76501ed">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bf05e148e384ae29d92e24fc00c4fef_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtNS0xLTEtNjc1MTI_76c217b8-544c-4e24-9391-fece602c033c">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf05e148e384ae29d92e24fc00c4fef_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtNy0xLTEtNjc1MTI_0d919e2a-17c5-4f9e-83ce-d6e24e65c8e4">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtOS0xLTEtNjc1MTI_84f45d7e-9a73-4bdb-8734-29a380cd059f">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMTEtMS0xLTY3NTEy_bd45eb5c-7d35-4bb7-a112-0628b930d60a">513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMTMtMS0xLTY3NTEy_33eda84f-2f7a-4507-bb81-28a4662b53c5">568</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtMy0xLTEtNjc1MTI_8b412cbe-ef97-44d6-9164-b8e17b8810ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtNS0xLTEtNjc1MTI_66b709a2-4acc-4ff7-bd3c-949f3bc21661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtNy0xLTEtNjc1MTI_30e79767-2511-4fec-b8da-9f2f8dc79806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1d9b80a624667a047ec06a972915f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtOS0xLTEtNjc1MTI_897ba3f6-4b6b-4acf-9ad1-d5486ff96bdf">497</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61b1d9b80a624667a047ec06a972915f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtMTEtMS0xLTY3NTEy_22081ab6-4354-4e29-87a0-70e6b818480e">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b1d9b80a624667a047ec06a972915f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtMTMtMS0xLTY3NTEy_bc49c157-bc95-462b-aa57-7e0b171207a7">253</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i987e27c5d1bf40c783eef89efb6f9d6e_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMS0xLTEtNjc1MTI_ce7551a9-db99-47a0-9b21-39aa64bd858e">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97df16e5800541ca9604a3cf83a192c2_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMy0xLTEtNjc1MTI_7683aaa4-14dd-4bd9-b29f-d1f81b992f5e">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97df16e5800541ca9604a3cf83a192c2_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtNS0xLTEtNjc1MTI_f6df5b1f-abc4-4c9d-b306-71b57f7defcf">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97df16e5800541ca9604a3cf83a192c2_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtNy0xLTEtNjc1MTI_d1a5064b-bae5-4b3e-a2f6-f630e2bc48aa">433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b657fb07354a6c983690d6eee84e3a_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtOS0xLTEtNjc1MTI_1782e258-ac89-4068-8662-e184c9ca727b">925</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b657fb07354a6c983690d6eee84e3a_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMTEtMS0xLTY3NTEy_af2fff3d-4287-45ee-879f-9bc610552f9d">394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b657fb07354a6c983690d6eee84e3a_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMTMtMS0xLTY3NTEy_73274164-fdb8-4756-b6ee-864bdbf7b415">531</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if68227cf6cac4d3d86ed24a1337b11f2_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMS0xLTEtNjc1MTI_c03656ad-fd83-43ca-a614-a5e7d38c140a">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i260b94765bd84eba92c24f9d3b5ece7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMy0xLTEtNjc1MTI_d9945e48-88ef-4314-b2b3-340bf326fb11">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i260b94765bd84eba92c24f9d3b5ece7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtNS0xLTEtNjc1MTI_3a6caea6-cd08-4fac-bf28-261ae9034b21">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i260b94765bd84eba92c24f9d3b5ece7a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtNy0xLTEtNjc1MTI_9cf158a0-e132-43ab-a6ee-0201df426faf">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtOS0xLTEtNjc1MTI_41324b3c-fbac-4f9f-a263-288becc61cec">150</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMTEtMS0xLTY3NTEy_b8e66f18-6550-45e0-96f8-121011cbfb23">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMTMtMS0xLTY3NTEy_cfa301eb-86c7-4b23-8a24-77ba33b80a4d">28</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63b800d5a4ed46c98d60b8f90472d8b0_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMS0xLTEtNjc1MTI_a0a1a548-1e11-4f7d-bff1-a2a89b90921c">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMy0xLTEtNjc1MTI_eee7e8e6-be4c-4873-b9a4-082d2407f7b9">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctNS0xLTEtNjc1MTI_0b5e785f-a43d-4427-809d-2b702f90bdbc">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctNy0xLTEtNjc1MTI_609cb094-beb0-49e6-b7a8-269dbfb93769">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8bd56dac64452db5d3474b91e08366_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctOS0xLTEtNjc1MTI_56836f7d-c6b7-4841-b481-b15e8ba66deb">254</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8bd56dac64452db5d3474b91e08366_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMTEtMS0xLTY3NTEy_435c4baf-8bcc-4fe7-a38b-c67ea51a303f">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8bd56dac64452db5d3474b91e08366_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMTMtMS0xLTY3NTEy_57f0c9e9-fba3-4288-8c43-2c4c3e07c19e">28</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtMy0xLTEtNjc1MTI_eea7e8d6-c6c1-4725-9478-b3c2f8e51a0e">4,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtNS0xLTEtNjc1MTI_a6d84183-9a9a-4f61-95b0-49515db692fa">2,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtNy0xLTEtNjc1MTI_a78994ef-f598-49bc-9869-a2dff4942c8e">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtOS0xLTEtNjc1MTI_53e885e1-743f-4402-a027-60cd2bad5a30">6,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtMTEtMS0xLTY3NTEy_551a3ed5-1bcc-4a35-8241-e4414c435ee6">3,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtMTMtMS0xLTY3NTEy_3ded7d02-1c82-4506-9836-6d9a1dc3168a">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $<ix:nonFraction unitRef="usd" contextRef="ie64c7a9ecd8140eab1897947f3348779_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMzNjQ_3f2289b3-a59b-4315-a2ff-1b8c4f34cacf">384</ix:nonFraction> million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of 2022.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intangible assets were subject to amortization as of March 31, 2022 and 2021. Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMzMDc_b7263f11-f0f4-4f48-bea5-626b69e11560">332</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzcxNDY4MjU1OTA4ODk_ede654d7-99a6-4fdc-8d3a-3e7c1244a770">422</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzcxNDY4MjU1OTA4ODQ_ca1a407b-3416-44a0-b62b-80b138a8a1e8">462</ix:nonFraction> million for 2022, 2021, and 2020, respectively. Estimated annual amortization expense of intangible assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNDQ_a0660864-97da-49e5-aa9c-4f8fe2df7ce4">225</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNDc_5bc397f1-a2e8-499f-8a64-2899a119638b">214</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTA_9b2b5665-786f-4c6d-90b7-5bec0d3bfba0">208</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTM_976b9a38-8d12-4b38-be53-501c207fb09e">177</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTY_43d04fc5-4338-4747-bcc1-5d40f64a1dd5">171</ix:nonFraction> million for 2023 through 2027, and $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTk_ddd02602-7fe0-4d38-9b54-73910e4ceaa8">1.1</ix:nonFraction> billion thereafter. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for more information on intangible asset impairment charges recorded in 2022, 2021, and 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_145"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEyNjA_6dbab69d-b101-48ab-aa01-beb78120b8c4" continuedAt="i6b69cfbb958040a095a46dceb02bb1a1" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i6b69cfbb958040a095a46dceb02bb1a1" continuedAt="i8c77d5c3474348f796f360726ae62f3d"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzU1NTk_f5f8a3ed-a388-4055-bd7b-004560012dcb" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f5e289f8bb94f8ba82cd55b25264f93_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzUtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozOGZhY2Q3ZjE4ZWE0YTZiOTU4NGZkY2NhZWFlOTIyNV83MTQ2ODI1NTgwNTc5_e3de43e4-6d7e-4714-97ab-3de2dfdae145">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5e289f8bb94f8ba82cd55b25264f93_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzUtMS0xLTEtNjc1MTI_e5af0583-71a0-4b07-8a61-3838eaccc483">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38191160842b4d688580a4d3c249f8c9_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzUtMy0xLTEtNjc1MTI_48c4d7cf-568f-4bef-9429-b51cadf58c0b">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75f9b3f6ce4a48629e8939f2036c9a7e_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzYtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjoyODI3NjM5M2UwZmM0OTVkOWNiYjE5MTJhZGM4OTIzZV83MTQ2ODI1NTgwNTc2_0c225fe3-89a6-4ac6-bc89-181e934a7b77">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f9b3f6ce4a48629e8939f2036c9a7e_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzYtMS0xLTEtNjc1MTI_aeddece7-a461-4d12-8d06-f5c5734d134b">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebf771578eb4688a13cafab7d91e267_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzYtMy0xLTEtNjc1MTI_6c83c217-4c51-49f7-bc09-7303607bac6f">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id41b46d826cf480a9d07b02c6f0fa4b9_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjoxZDljNjMxZmExNmQ0N2Q0YTRiYTM5M2Q0MDIxOGI0N183MTQ2ODI1NTgwNTc2_9887bd4c-e9f5-4395-8ce1-a73889840753">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id41b46d826cf480a9d07b02c6f0fa4b9_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMS0xLTEtNjc1MTI_d03c372f-f6e6-4ecb-b8eb-439a0cb01278">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b257ef2e3f049e28d8f48078592b92a_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMy0xLTEtNjc1MTI_5e2a94fb-3978-447e-890a-1ecdaea8f714">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff19ad24fcaa4efe8adbe9568e74156a_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzgtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjo3YzRlZTc2ODkxNTk0NmI5YTg3NGIyOTQyY2E3YzUzYV83MTQ2ODI1NTgwNTc4_7ca435b7-47b3-4560-92fd-128640b5a62d">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff19ad24fcaa4efe8adbe9568e74156a_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzgtMS0xLTEtNjc1MTI_7175a66f-3aaf-4276-8dac-2bb690b052d2">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5269554a47894df4b123574f180fa7bf_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzgtMy0xLTEtNjc1MTI_02c7ccbf-568a-47a5-b819-07532b1f0eac">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4492282a1a93402a8f44df990dd74728_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMC0xLTEtNzUxNDAvdGV4dHJlZ2lvbjoxOWI2ZThiYjRjMTE0MGIxYWZiNGE3NTIwZjhiMTY5ZF83MTQ2ODI1NTgwNTcz_46595e56-72ed-45ec-8fad-3a3d16f94d3d">1.30</ix:nonFraction>% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4492282a1a93402a8f44df990dd74728_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMS0xLTEtNzUyNTQ_fccc71c4-efc8-4be8-822d-6e181f1c5465">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdebf42f817b45e8837663f7bac80ed5_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMy0xLTEtNzUyMjU_799b2877-44f6-422c-a296-e274a723a1a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02dc743ac553435dba404f92c86d8691_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjowZTc3M2E5ZDBjYzY0YTY2OTQ0N2FlNDU3NzM1Y2E4Ml83MTQ2ODI1NTgwNTc5_e0c75408-4a7b-4d9d-bbf6-3c0c5b0e4b65">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02dc743ac553435dba404f92c86d8691_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMS0xLTEtNjc1MTI_6e566920-dec8-4e02-a676-351d4e1f13bb">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70b14d9641344a939e986c99e6567d70_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMy0xLTEtNjc1MTI_2210cd4e-010c-4b42-9c49-06499982731d">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6b3ed5f2ea54176814a8708c6499848_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEwLTAtMS0xLTY3NTEyL3RleHRyZWdpb246ZTcxYzE2NzU0MDE5NDkyOWIwODdiZTY0YWVjNTJmMTZfNzE0NjgyNTU4MDU3OQ_3e3f3de7-d042-42ba-845d-658eb5d23352">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6b3ed5f2ea54176814a8708c6499848_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEwLTEtMS0xLTY3NTEy_91fd8f97-8d77-40ab-bb8a-e6d873ad9bfb">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd84b2361824bb0bc00064d18891fb0_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEwLTMtMS0xLTY3NTEy_c977d5cb-b9a9-4841-9c31-5a0e4ea9f644">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91a13fda196843f6b109d769cfe0751d_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzExLTAtMS0xLTY3NTEyL3RleHRyZWdpb246MzhkZTAxNDk2MDMxNDkzZjgyOTRkZTI4ZDY0MTExMWJfNzE0NjgyNTU4MDU3NA_104c5d19-ac34-4ab1-bde2-d82d06086990">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a13fda196843f6b109d769cfe0751d_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzExLTEtMS0xLTY3NTEy_20266b29-638b-4117-b40a-4bf027d0067f">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18046743a1974c45821697aea7b0f77f_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzExLTMtMS0xLTY3NTEy_22afae8a-f661-4fae-9511-00fcde504de8">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i776610a612354ff280ad9f037198c296_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEyLTAtMS0xLTY3NTEyL3RleHRyZWdpb246YzdlNjYyODY4NzAyNDk2ZTk1YWE2NTNkY2FlMjU5ZTFfNzE0NjgyNTU4MDU3NQ_548ba801-5a70-44aa-948b-ea94d670ff73">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i776610a612354ff280ad9f037198c296_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEyLTEtMS0xLTY3NTEy_b20dab55-04da-4330-b528-2b4f28e97fda">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8410975cba024c78bef5a76f712f7294_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEyLTMtMS0xLTY3NTEy_d2a02b96-2068-4503-a26c-399eb9bb7f0c">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9099b942bd1b45f78fdeefc39837a3ce_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEzLTAtMS0xLTY3NTEyL3RleHRyZWdpb246OTgyMDkwZGRkNGJkNGExYThiNjc0YzFjMjNlN2ZhY2NfNzE0NjgyNTU4MDU3Ng_4d456e43-f5e7-41b0-b9a1-4a963aacc1ba">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9099b942bd1b45f78fdeefc39837a3ce_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEzLTEtMS0xLTY3NTEy_3ce9d193-663a-4d13-9815-96d37af9964f">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied357647ec7743bea35135bd6969080e_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEzLTMtMS0xLTY3NTEy_101900e9-0d18-42b7-ae2b-f3eac2f09b81">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74426e55813a40cc92bc89945e9dd130_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE1LTAtMS0xLTY3NTEyL3RleHRyZWdpb246ZjQ0ZDA1OWUzMTNiNDhhMDhhNTUxYWE1ZmY2NTQxOTJfNzE0NjgyNTU4MDU4Mg_6598f2d3-fa84-497a-89f7-926e9aefcd85">0.63</ix:nonFraction>% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74426e55813a40cc92bc89945e9dd130_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE1LTEtMS0xLTY3NTEy_caf06871-56e6-48e6-883b-d97f38deabaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29908212c93c4b2cba4a35c49394c7b5_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE1LTMtMS0xLTY3NTEy_196658b9-96b2-44e0-abf5-5c7519d59c67">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a43cf31de784042b8d27a08355df15f_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE2LTAtMS0xLTY3NTEyL3RleHRyZWdpb246MDUyM2NlZTM2NDQxNDA1ZWJkYWJjZjFmMzlmZTc4NmRfNzE0NjgyNTU4MDU4NA_81bd738c-f68a-472b-b532-1fc9f700379b">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a43cf31de784042b8d27a08355df15f_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE2LTEtMS0xLTY3NTEy_4dc62a04-feb0-462b-9a7e-92db1f37d6c5">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie471ed607d464069b849582cde89f693_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE2LTMtMS0xLTY3NTEy_5fcd23e7-1ea4-43f6-be8b-6fbf89b59d83">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03e6233f5e8548d5a04aac3f11cb0d2f_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE3LTAtMS0xLTY3NTEyL3RleHRyZWdpb246MzFlNTMyMzQyMzQwNGFiY2FiYzA2YjYwNWVmYmRiMmVfNzE0NjgyNTU4MDU4Mw_e3850ab4-17b2-4cfe-b161-26406f4bb60f">1.63</ix:nonFraction>% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e6233f5e8548d5a04aac3f11cb0d2f_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE3LTEtMS0xLTY3NTEy_aed12fbc-c79f-43f2-ae88-358d1a20fa5b">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3995850cc8f4cf0bfa3483d28ead8fa_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE3LTMtMS0xLTY3NTEy_4078dc9f-2b26-453b-87b3-9a3823c7cacd">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8b875fcead64ab181ee711d77c92192_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE4LTAtMS0xLTY3NTEyL3RleHRyZWdpb246ZWQ4Zjc4MmI3OGY5NDY4OTk2ZDE3NDM3NGI3NjdkZDVfNzE0NjgyNTU4MDU4OA_6b491cc0-8e82-40a7-a47d-c7d94e9455ba">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8b875fcead64ab181ee711d77c92192_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE4LTEtMS0xLTY3NTEy_e50c46ae-727d-4489-a26a-98c838246529">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd452d00a734f2699190045314018e3_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE4LTMtMS0xLTY3NTEy_1e511b52-2e0d-4383-8391-0ed12a6c2343">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a54c5deff6741e68bb12b5a3eadc2e3_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIwLTEtMS0xLTY3NTEy_a7d54881-feca-40af-b7b4-fe7bdf369de5">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3dbeaa252741fa82864c3f88132372_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIwLTMtMS0xLTY3NTEy_d3912520-0941-4489-b128-72c64944b41d">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIxLTEtMS0xLTY3NTEy_8e93ad74-3a2d-4528-9c62-5720e73abdb1">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIxLTMtMS0xLTY3NTEy_fb4d1a39-2572-4203-8442-c3d7df3a3609">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIyLTEtMS0xLTY3NTEy_f276cc2a-8ba7-4f49-98bc-79a53db9787c">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIyLTMtMS0xLTY3NTEy_ba7ffdd4-39ac-4660-aef5-0ac1567c6632">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIzLTEtMS0xLTY3NTEy_b1ca80df-8417-4d17-beb6-d250ad634d7b">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIzLTMtMS0xLTY3NTEy_89259014-9a8b-48f8-91cc-93d36c7494ae">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these U.S. dollar notes is payable semi-annually.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $<ix:nonFraction unitRef="usd" contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU2Mjk_5db7d611-5718-4a54-8f0d-a5dcfef9ed1b">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU2NTE_f2ee798a-01a1-4aa5-942f-e874d7401b3c">11</ix:nonFraction> million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March 31, 2022 and 2021, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxMjY_34901bfa-b720-45e8-a10a-25f80e946a4c">5.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxMzA_1c100d17-9c7a-4750-bc75-402cc63f0ca4">7.1</ix:nonFraction> billion, respectively, of total debt was outstanding, of which $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxMzc_e8695406-c590-4bbf-bca6-21f52b6d98af">799</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxNDE_ecc3ef77-7a0f-4d0b-b240-8babd869062c">742</ix:nonFraction> million, respectively, was included in &#8220;Current portion of long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i47b2810c0aee413597e8c1646426d086_I20210812" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU4NjM_3bbda959-772b-4b63-a123-26bd9eefb735">1.30</ix:nonFraction>% Notes due August 15, 2026 (the &#8220;2026 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i47b2810c0aee413597e8c1646426d086_I20210812" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU5Mzc_0a273cd2-d347-49d0-96f7-3d138b6458b3">500</ix:nonFraction>&#160;million. Interest on the 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="idc6d4f12944242709bef7d5e0584395f_D20210812-20210812" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTYxNjI_f3657ea6-9f76-4e73-a9af-a529bea95a9f">495</ix:nonFraction>&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i2b3cf2b7fbad458882870ec7a0921f35_I20201203" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDEwNjA_10aeb8f1-5865-411e-ad96-874b90bdd7bb">0.90</ix:nonFraction>% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i2b3cf2b7fbad458882870ec7a0921f35_I20201203" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDEwNjQ_c05ae016-1b66-4771-b16c-c6fec2d9f927">500</ix:nonFraction>&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="if7c1af6fdd3b44f1934218a6f196c0a9_D20201203-20201203" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDEwNzg_4e897896-fc39-4083-82c2-fb3bf8630328">496</ix:nonFraction>&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i8c77d5c3474348f796f360726ae62f3d" continuedAt="i147f225f78fb46468f49f862f8530b88"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each note, which constitutes a &#8220;Series,&#8221; is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed&#160;by materially similar indentures and officers&#8217; certificates. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc., and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase that Series from the holders at a price equal to <ix:nonFraction unitRef="number" contextRef="i06f2539eb1dc470b917574e5cba645f8_D20210401-20220331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDI3NzE_9f3729f9-3de3-43c1-becb-ccf0a4db5d9d">101</ix:nonFraction>% of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2021, the Company redeemed its <ix:nonFraction unitRef="number" contextRef="if911145c95344b73b7494ae283e29168_I20210717" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTcyNzQ_fcef996a-0026-4260-af82-072118f2f34e">0.63</ix:nonFraction>% &#8364;<ix:nonFraction unitRef="eur" contextRef="if911145c95344b73b7494ae283e29168_I20210717" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTcyNzg_73ae7149-4590-436b-84dd-0975830e379c">600</ix:nonFraction> million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="if911145c95344b73b7494ae283e29168_I20210717" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTczMDE_d65c8581-8165-4897-a2c5-0641d8ffa5b1">709</ix:nonFraction> million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand. On December 1, 2020, the Company redeemed its <ix:nonFraction unitRef="number" contextRef="ic6b43789844d4108be63a4a1dd1280fe_I20201201" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTY5NjI_6c230746-3cc9-4fd3-822e-fb6174f5dcb6">4.75</ix:nonFraction>% $<ix:nonFraction unitRef="usd" contextRef="ic6b43789844d4108be63a4a1dd1280fe_I20201201" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTY5NjY_76ad569a-2c43-43bb-8613-3e597921cada">323</ix:nonFraction>&#160;million total principal of notes due on March 1, 2021 prior to maturity. On November 30, 2020, the Company retired its <ix:nonFraction unitRef="number" contextRef="i97437c473f7b4c27959c7f3f98f911fe_I20201130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTkzMzQ_9323ef7b-bbae-4653-b2dc-3682e23217d4">3.65</ix:nonFraction>% $<ix:nonFraction unitRef="usd" contextRef="i97437c473f7b4c27959c7f3f98f911fe_I20201130" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTkzMzg_0b7c9217-cda2-419d-8bb3-5e6167afd3b1">700</ix:nonFraction>&#160;million total principal of notes upon maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above. In 2020, the Company repaid at maturity its &#8364;<ix:nonFraction unitRef="eur" contextRef="i8ae64a0ee64e4ca28a9e634159013ab3_D20190401-20200331" decimals="INF" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTcxODA_869b4d59-6e9a-443e-a363-633782850967">250</ix:nonFraction> million Floating Rate Euro Notes due February 12, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) <ix:nonFraction unitRef="number" contextRef="i5bb94ab329074f2382e57702aeb12464_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1Njg_82194e6e-f4e2-41d9-ab11-589e7fefaffb">2.85</ix:nonFraction>% Notes due 2023, (ii) <ix:nonFraction unitRef="number" contextRef="i7c2711a4ba7d4daeb3142e521b8d969d_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1NzU_15afb7ad-2436-4ba5-9bee-9f39b3dd7669">3.80</ix:nonFraction>% Notes due 2024, (iii) <ix:nonFraction unitRef="number" contextRef="i404ec63c736d4d128bee727971bdc191_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1ODI_a3151fb3-1555-46d3-8a3b-540a8e1fd53f">7.65</ix:nonFraction>% Debentures due 2027, (iv) <ix:nonFraction unitRef="number" contextRef="i7fa0c457401141829a63813967411389_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1ODk_1beda553-c1cc-4c46-8eb8-10eae120a5a3">3.95</ix:nonFraction>% Notes due 2028, (v) <ix:nonFraction unitRef="number" contextRef="i7700fd1bf3b64d08ab4b2725bcf11c2f_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1OTY_47716d4a-8765-41b8-a704-0cc8b9223093">4.75</ix:nonFraction>% Notes due 2029, (vi) <ix:nonFraction unitRef="number" contextRef="ib46cc219b945454c99153f6a6c005bc1_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2MDM_05d6f8f5-9425-4ce8-a2ba-08d6fef7bfd7">6.00</ix:nonFraction>% Notes due 2041, and (vii) <ix:nonFraction unitRef="number" contextRef="if28ea4a9885e4a2aaccecc13941b21fc_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2MTA_b87084e4-f174-4cc4-85ac-3c467ae85ee7">4.88</ix:nonFraction>% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i40b1e6ac876c4f44be5287989b81b43c_I20210723" decimals="-8" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2Mjk_7ec4b693-12bf-4e4a-a660-eee5f7b63c81">1.1</ix:nonFraction> billion to redeem $<ix:nonFraction unitRef="usd" contextRef="i40b1e6ac876c4f44be5287989b81b43c_I20210723" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2NDY_6b4fd596-e108-4950-a484-074d6af19b68">922</ix:nonFraction> million principal amount of the notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2NTE_8aa16147-96ee-4638-91ff-be427230d430">100</ix:nonFraction>% of the principal amount and premiums of $<ix:nonFraction unitRef="usd" contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2Njk_c549c45d-e712-4c0a-abdd-7ad3a2fb1dbb">182</ix:nonFraction> million, plus accrued and unpaid interest of $<ix:nonFraction unitRef="usd" contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723" decimals="-6" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2ODY_6d7d37c0-3cbb-4eff-99c8-239617899f78">14</ix:nonFraction> million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg3MDQ_212c69a2-55f1-4a40-911b-4e26a8d6fafd">191</ix:nonFraction> million in the year ended March 31, 2022, which included premiums of $<ix:nonFraction unitRef="usd" contextRef="i40b1e6ac876c4f44be5287989b81b43c_I20210723" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEyMzI_ad018219-f382-4543-9921-50484f7785a5">182</ix:nonFraction>&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $<ix:nonFraction unitRef="usd" contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723" decimals="-6" name="mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg3ODI_b531577b-5813-4ad3-b16a-f1a1f9780120">9</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments of long-term debt are $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQyMDI_175edb9f-f7ce-4db5-bd9f-a178877f99c2">799</ix:nonFraction>&#160;million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNTM_b221971e-208e-4892-bf7f-917f6680439c">966</ix:nonFraction>&#160;million in 2024, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU3NTY_97968b72-7798-4a0f-a11e-a639bffa688e">35</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNjE_30512e99-5dab-4f77-9af1-3eca8bd3b5d6">1.2</ix:nonFraction>&#160;billion in 2026, $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU3ODQ_d647d532-d230-4d76-b1ca-2e8fb45f3fc3">1.2</ix:nonFraction>&#160;billion in 2027, and $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNjk_c76f4657-798a-4d4f-b6a9-d0f9c7277aac">1.7</ix:nonFraction>&#160;billion thereafter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company entered into a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="ib2f0e560d0dd48aaa9c9a66d529db5b7_I20190930" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNzQ_520cfe65-462a-47dd-b72e-735474842774">4.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i815ce043efb54a79a003ee84bccbc673_D20190701-20190930" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEzMTY_2459dae6-db14-45a7-a9f4-c904455522c5">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i04e0a17bd91147bba817806801ea38d9_I20190930" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzODA_acef4d16-356b-46c0-9f9d-f64434191e95">3.6</ix:nonFraction>&#160;billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="i9d7edea6bbe944938cf631118e7e0c24_D20200401-20210331" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2NDM_405a35a3-2102-4554-99f6-c47fef7a27e0"><ix:nonFraction unitRef="usd" contextRef="i786695c3c8824251b74d57413f2ab330_D20210401-20220331" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2NDM_5d403c85-b4a2-424e-8dd6-fa1473b546c7">no</ix:nonFraction></ix:nonFraction>&#160;borrowings during 2022 and 2021 and <ix:nonFraction unitRef="usd" contextRef="i96bdc5d0996443d4bc99773608909bc1_I20210331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg4MTU_5b8d4fe5-806c-4e48-b232-bf64688cf327"><ix:nonFraction unitRef="usd" contextRef="i7c239f7cb9ba4f119b5f6aac4be47c6f_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg4MTU_a7da01b0-ade7-452d-8de3-aad7c2140f93">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of March 31, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At March 31, 2022, the Company was in compliance with all covenants. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the $<ix:nonFraction unitRef="usd" contextRef="i9f981237ad304136b3c2ae388a494f17_I20190930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDU3OTY_f91abdf7-c641-410d-9243-b532a02413b0">3.5</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i1ae704fbe3b04d318f47ec250c37e298_D20190901-20190930" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEzMTU_314ab5c1-790b-4ab1-ad7f-43f054c9ce9b">five-year</ix:nonNumeric> senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019 and had <ix:nonFraction unitRef="usd" contextRef="ic2d8d6b46e9d4decbb6a76ffd434ad18_D20190401-20190930" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2Mjk_c881703d-cbc1-4b9b-b2a3-90403b1d8628">no</ix:nonFraction> borrowings during the six months ended September 30, 2019.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i147f225f78fb46468f49f862f8530b88"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="i1c59a4ea805b47c08a95056ceb9c564e_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDYzMDU_4b341ad4-f158-4f22-934f-6fde58e125ec">7</ix:nonFraction>&#160;million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="i1c59a4ea805b47c08a95056ceb9c564e_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDYzMDk_7da6e677-ab4d-4a9d-87dc-cdcedc23c728">111</ix:nonFraction>&#160;million as of March 31, 2022. Borrowings and repayments were not material in 2022 and 2021 and amounts outstanding under these credit lines were not material as of March 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="iad7a2e6922f64cf3808e830fd554c3ff_I20220331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2Njk_78704e6f-b2ee-420c-85f1-93575d7ba74b">4.0</ix:nonFraction>&#160;billion in outstanding commercial paper notes. During 2022, 2021, and 2020, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2ODc_1e9a1a73-3798-405c-b44b-954b2097cdaa">11.2</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2NzU_c678607e-d2b6-4c51-9c4f-17ec9bfe0f2b">6.3</ix:nonFraction>&#160;billion, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTk1MjI_723d466b-ad9d-480a-a642-509a74e59c8f">21.4</ix:nonFraction>&#160;billion, respectively, and repaid $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2OTM_523ef753-f8b3-4a88-8a93-7b6bdfdb391a">11.2</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2Nzg_4b8df9e3-f17b-430f-9331-b45a20adf4de">6.3</ix:nonFraction>&#160;billion, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTk1Mzk_3a068ded-87e9-43fd-9948-cf8b3d18cab9">21.4</ix:nonFraction>&#160;billion, respectively, under the program. At March 31, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="i2cb808ca7946448095716d3e591aec2f_I20210331" decimals="INF" name="us-gaap:LongTermDebt" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzkzNDU4NDg4NjcyNTU_3b1dfe55-8450-44a3-8b4e-d492d1b31324"><ix:nonFraction unitRef="usd" contextRef="iad7a2e6922f64cf3808e830fd554c3ff_I20220331" decimals="INF" name="us-gaap:LongTermDebt" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzkzNDU4NDg4NjcyNTU_e37f159f-b256-4ee8-868c-adad886d545a">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_148"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzI5NzQ_00f9fd69-f2a4-47e7-8c14-df0f9b8ce3b7" continuedAt="i7014ff21dc214681830960b5d1ff43c9" escape="true">Variable Interest Entities </ix:nonNumeric></span></div><ix:continuation id="i7014ff21dc214681830960b5d1ff43c9"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#8217;s Consolidated Statements of Operations and Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $<ix:nonFraction unitRef="usd" contextRef="id447a2bd767645c7a12007233124425f_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1NTI_bf9b6679-a841-4e45-9857-63ab45f7a9e8">660</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id447a2bd767645c7a12007233124425f_I20220331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1NTY_d2cad88f-dc91-412e-8a0b-c6b83bdcb413">65</ix:nonFraction> million, respectively, at March 31, 2022, and $<ix:nonFraction unitRef="usd" contextRef="i0d2b3d87c4114cc6b082a6eb3df4484b_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1Mjk_22ceb2e8-b17b-431b-a726-55c0cd0d08c2">662</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0d2b3d87c4114cc6b082a6eb3df4484b_I20210331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1NDM_3c2ae250-8110-4070-a6cf-a32d88910bc5">74</ix:nonFraction>&#160;million, respectively, at March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual, or other relationships with the VIEs. The Company&#8217;s most significant VIE relationships are with oncology and other specialty practices. Under these practice arrangements, the Company generally owns or leases all of the real estate and equipment used by the practices and manages the practices&#8217; administrative functions. Prior to the divestment of the Austrian businesses in 2022, the Company had relationships with certain pharmacies in Europe with whom it provided financing, had equity ownership, and/or had a supply agreement whereby it supplied the vast majority of the pharmacies&#8217; purchases. The Company&#8217;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-8" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1ODU_fa000ca4-3f8a-4bf8-9191-634e1f4e6e20">1.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-8" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1ODA_a2548725-364b-42f4-9336-4bab05f6f4da">1.5</ix:nonFraction> billion at March 31, 2022 and 2021, respectively, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 17, &#8220;Financial Guarantees and Warranties.&#8221; The Company believes there is no material loss exposure on these assets or from these relationships.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_151"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2Mjk5_8ea98bff-1353-447a-bed4-88d0fd7fe31f" continuedAt="ia8fcf5829d81491ba04397640c716acf" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="ia8fcf5829d81491ba04397640c716acf" continuedAt="i90b8f11360cd4c288b4ca0597f265139"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Pension Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an unfunded nonqualified supplemental defined benefit plan for certain U.S. executives, as well as benefit pension plans for eligible employees outside the U.S. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i90b8f11360cd4c288b4ca0597f265139" continuedAt="i938f5b992aeb4b639095856cd73a1779"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately <ix:nonFraction unitRef="participant" contextRef="if8a6c7fc82394698afcdf83d11179f9a_D20190601-20190630" decimals="-2" name="mck:DefinedBenefitPlanSettlementPlanParticipants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzcxNw_ed4d574f-6b17-448a-8f22-a46111fc84f1">1,300</ix:nonFraction> participants elected to receive the settlement, and lump sum payments of approximately $<ix:nonFraction unitRef="usd" contextRef="if8a6c7fc82394698afcdf83d11179f9a_D20190601-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzgwNw_6f703f1f-cad9-4d21-92a1-588f3c27c2bc">49</ix:nonFraction> million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a settlement charge of $<ix:nonFraction unitRef="usd" contextRef="ib56e9807d14242ab8a66d9df9e68b070_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4Xzk3NA_95ffb966-5c79-42d3-9597-143bef89d912">17</ix:nonFraction> million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $<ix:nonFraction unitRef="usd" contextRef="i2f41e21247ae4a519309d2ad4bff9441_D20190701-20190930" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEyMTY_7db7025c-3f73-40a1-aeba-e7cc0833993c">280</ix:nonFraction> million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future pension benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i2f41e21247ae4a519309d2ad4bff9441_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE0NDc_54a5a5f8-1f50-48e3-b2b2-ce783dfad9df">105</ix:nonFraction> million was recorded during the second quarter of 2020. Settlement charges were included within &#8220;Other income, net,&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2020. As of March 31, 2020, this defined benefit pension plan had an accumulated comprehensive loss of approximately <ix:nonFraction unitRef="usd" contextRef="if83736112ca9462697b6ec54e87de910_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE3MzU_a7007b17-e8e2-4a8d-a373-bd7f8cf745a2">nil</ix:nonFraction>.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway, the United Kingdom, Germany, and Canada. Benefits for these plans are based primarily on each employee&#8217;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#8220;SPK&#8221;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law. In the U.K., the Company has subsidiaries that participate in a joint pension plan. The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe&#8217;s Management Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="i8b2f3b3bb37649189b90084615b5a308_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDQ5NjM_c4f3e523-62b0-4540-ac45-2b6f1fd909ea">43</ix:nonFraction>&#160;million of pension liabilities included in liabilities held for sale and $<ix:nonFraction unitRef="usd" contextRef="i805540d4c73c4b6387871c54c384fbbf_D20220101-20220331" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDUwMDM_bf38f472-919a-4a2f-8c2c-a260effe61d4">11</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to the sale of its Austrian business. During the third quarter of 2021, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="i2faa1d1ed13a446eb975b380912a3068_I20211231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzMxOTU_137dee3d-c454-4353-ab5d-ee5c0a15ce6d">187</ix:nonFraction>&#160;million of pension liabilities included in liabilities held for sale and $<ix:nonFraction unitRef="usd" contextRef="i2ec0851116374d82b9e49426d73763b6_D20211001-20211231" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzMyNjM_5d794a39-a7e6-4ecd-8d9b-e7fa430dd8e8">33</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit plan assets and obligations are measured as of the Company&#8217;s fiscal year-end. <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzQ5_4c89ae0d-d51b-4362-9a92-c4a09f11f71b" continuedAt="i3e7e24e2b1924c68929e7e43ba63f276" escape="true">The net periodic expense for the Company&#8217;s pension plans is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="i3e7e24e2b1924c68929e7e43ba63f276"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtMS0xLTEtNjc1MTI_914d48fe-a69a-4f8c-9ddf-a8323f2a33ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtMy0xLTEtNjc1MTI_a947ba40-9a81-4a17-a8a8-629b3bbd4748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtNS0xLTEtNjc1MTI_6f12098c-f09f-4fde-9dfa-da5e24820113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtNy0xLTEtNjc1MTI_565fcad3-c929-45fb-807f-c71e92f7588a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtOS0xLTEtNjc1MTI_e795407d-dc69-4c49-8324-f014a5fc72bf">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtMTEtMS0xLTY3NTEy_b1b2369b-d560-44b1-a89b-d67b321ebbcc">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtMS0xLTEtNjc1MTI_6dc8a3de-4e01-49ca-b6bf-1a2fea85bde7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtMy0xLTEtNjc1MTI_62c74fd3-2957-412d-ae1f-79ac7c4ad374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtNS0xLTEtNjc1MTI_e3d585d4-6dc6-40a4-9fee-b6af74d2dbb9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtNy0xLTEtNjc1MTI_00e91666-e77d-4af6-8d0a-80252675cb1b">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtOS0xLTEtNjc1MTI_a47a3a97-cce9-4b0a-afb9-70f880f3d7ae">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtMTEtMS0xLTY3NTEy_16a671cd-1bd8-4589-acbb-1ab8dca03d30">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtMS0xLTEtNjc1MTI_d5d76674-f88c-4f0f-86fb-c5552370a147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtMy0xLTEtNjc1MTI_a335140d-b05b-4a7b-b65d-4195813148b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtNS0xLTEtNjc1MTI_48282dda-2e00-4aa3-a314-3142fcfba4d8">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtNy0xLTEtNjc1MTI_7a8fb60a-a7b7-4d96-b30d-50cd5bfb427b">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtOS0xLTEtNjc1MTI_ef59bb5e-8319-45db-aa56-a08ca5016961">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtMTEtMS0xLTY3NTEy_cebfde9b-61e2-4d21-8c90-907c9d52d787">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtMS0xLTEtNjc1MTI_2da5e9e6-c5bd-4ccc-ae1e-2dcb55b81fd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtMy0xLTEtNjc1MTI_f654781f-7604-4275-bb62-c0557d84793e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtNS0xLTEtNjc1MTI_d3594a82-9ca3-4d55-b533-8154fb18a5d9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtNy0xLTEtNjc1MTI_00e1820e-f5fa-4fbe-bfdf-ff31252e1e62">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtOS0xLTEtNjc1MTI_62b0343f-bac5-425d-96ff-ee26360958cd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtMTEtMS0xLTY3NTEy_71dd9472-2658-414f-83ae-0c83c1b60152">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctMS0xLTEtNjc1MTI_313a9dac-4290-4eda-a88a-a4081271571e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctMy0xLTEtNjc1MTI_f66a06fa-b5f2-4082-912f-3006f0b48354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctNS0xLTEtNjc1MTI_99f60e03-35e3-4555-a06d-68d4a5a853f8">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctNy0xLTEtNjc1MTI_0368ff7d-5021-420b-9759-9099e3cb8d8b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctOS0xLTEtNjc1MTI_5be80ea4-c5fb-4b91-b927-d37c91ffb9fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctMTEtMS0xLTY3NTEy_f3eb3e53-8570-4740-b7e4-02a0674cfa6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktMS0xLTEtNjc1MTI_c4288f12-c62a-48d1-8232-3bed6da34f45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktMy0xLTEtNjc1MTI_e2cb1a97-e493-47f1-a267-2654ef84775a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktNS0xLTEtNjc1MTI_d0b9f784-cec8-4065-bf7b-294da38c0577">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktNy0xLTEtNjc1MTI_d21bdfc6-bd01-4cbe-a270-75f609b2d7ea">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktOS0xLTEtNjc1MTI_6cfc67f3-a48b-4bac-a2a9-bf70b7ecafbb">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktMTEtMS0xLTY3NTEy_fb70e83c-8e7b-484b-91a5-22daf70f8f27">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="INF" name="mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDUwMTY_1e0847a6-8891-44d8-99ea-2e1279ab2af8">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i938f5b992aeb4b639095856cd73a1779" continuedAt="i3f98867f438d4d5695c28df2deabc884"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzI3NDg3NzkwODk5NTY_3875725c-1abe-442f-9e5d-f982ffb75417" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans is as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtMS0xLTEtNjc1MTI_0138ffb0-5f94-445c-9ff8-38bb46956c41">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83736112ca9462697b6ec54e87de910_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtMy0xLTEtNjc1MTI_ecf00d6e-4a37-4088-9a91-79106b1be522">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtNS0xLTEtNjc1MTI_affe23ba-dd3c-4210-af9c-4da4438b6281">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtNy0xLTEtNjc1MTI_585d6972-c917-47d4-951d-1fecbff726e2">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtMS0xLTEtNjc1MTI_3d5fe84f-3750-4ffc-8506-0914d265b108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtMy0xLTEtNjc1MTI_661d05af-317a-421a-b34d-ae1e100f72cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtNS0xLTEtNjc1MTI_d85e488a-4488-429f-8c97-b2978963076a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtNy0xLTEtNjc1MTI_325fcce4-bcb6-4ad2-b19f-5c7fd04a8ecc">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtMS0xLTEtNjc1MTI_5e6ca065-b19a-4d53-8771-21e476707ea8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtMy0xLTEtNjc1MTI_6df4cde9-cbc9-4cf5-b01f-5cf355386e69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtNS0xLTEtNjc1MTI_e7ba1c8c-9547-4e4c-811c-62a8df605386">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtNy0xLTEtNjc1MTI_b6f0b3d6-4717-417f-b091-511883c1a4ea">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctMS0xLTEtNjc1MTI_5f9666a3-16d0-4889-bb0a-e47e14db32b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctMy0xLTEtNjc1MTI_ed20fb2d-f9e4-43fd-b699-109da22adb1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctNS0xLTEtNjc1MTI_8998e208-6347-4c1c-a4ee-77948af307dc">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctNy0xLTEtNjc1MTI_445aa117-dad3-4a14-8b89-2f549c87dcdf">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtMS0xLTEtNjc1MTI_5515ce47-0bab-41d6-9e86-d6b4a8a351a6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtMy0xLTEtNjc1MTI_0421690f-37c2-47bf-be2d-6be792cf9bfd">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtNS0xLTEtNjc1MTI_dcfd032e-580b-48f6-b791-f5baed50329e">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtNy0xLTEtNjc1MTI_8f7b2ff5-43e5-4bc5-b715-cf6fefd5fd71">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktMS0xLTEtNjc1MTI_ece11021-018d-490a-a655-d949abcdbdfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktMy0xLTEtNjc1MTI_173d166d-6b89-4e7a-910d-82451ac82fb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktNS0xLTEtNjc1MTI_40d9ecf3-7ff2-4bac-b728-d284b56ba3ec">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktNy0xLTEtNjc1MTI_f17ef201-51af-4446-a0b0-3d84d09a4d21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationsExpensesPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTEtMS0xLTY3NTEy_5aad982c-fbb0-4fce-92ea-bbae0d7a6aee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationsExpensesPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTMtMS0xLTY3NTEy_e0195a97-def4-4694-b832-d40d035743e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationsExpensesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTUtMS0xLTY3NTEy_2dfcc9ad-0e9d-489a-a51f-8fe9896fea85">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationsExpensesPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTctMS0xLTY3NTEy_2a6f550e-29fc-4202-a8cc-6fc513cbbfa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTEtMS0xLTY3NTEy_0a30afb8-a012-4f72-af53-f7435e6d7a5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTMtMS0xLTY3NTEy_98f092c5-7fb9-4558-81bb-4719730f7441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTUtMS0xLTY3NTEy_8c66cdfe-dfc6-43e2-8b3f-bca1150e7583">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTctMS0xLTY3NTEy_514b1195-10fa-4097-90df-42b737068783">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTEtMS0xLTY3NTEy_f617605d-11f2-4436-b550-287d370fdb5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTMtMS0xLTY3NTEy_6e090b52-85bb-48da-9e65-02499312344a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTUtMS0xLTY3NTEy_d9338795-dd8e-4c73-a121-330a35d392bf">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTctMS0xLTY3NTEy_f815f7af-f069-4808-a7ad-0661ffc2254f">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTEtMS0xLTY3NTEy_662faa4e-b5e3-452d-91e0-3cc63311e648">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTMtMS0xLTY3NTEy_e8b82bd8-fc15-480f-b4c4-6a9218767923">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTUtMS0xLTY3NTEy_3fc67614-5379-46d0-b530-3164b31107e2">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTctMS0xLTY3NTEy_4070d558-330d-4e77-b569-71fdf9063f2d">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTEtMS0xLTY3NTEy_b12b28f6-5af8-4e4c-8e9d-14ff235c518c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83736112ca9462697b6ec54e87de910_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTMtMS0xLTY3NTEy_d01297a9-81ca-412b-9379-8bdd27d6bd32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTUtMS0xLTY3NTEy_9dd52c1a-5693-4361-bb02-d9493c26738b">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTctMS0xLTY3NTEy_9de4c176-980b-402a-bc0a-03f3b943cf69">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTEtMS0xLTY3NTEy_3d7e0ed5-b6d1-458c-9428-384ef1636421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTMtMS0xLTY3NTEy_0bb0e898-f837-4acc-9d3d-1c3b3c63c56e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTUtMS0xLTY3NTEy_000d0971-d207-487b-93a6-5a351920d2c2">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTctMS0xLTY3NTEy_2acafc8f-7c2c-4a25-b263-20c407f6edcc">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTEtMS0xLTY3NTEy_87a2b23c-5c95-43e6-b6f9-73936b744155">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTMtMS0xLTY3NTEy_a612e148-ad5c-48dc-97d8-984a770feed0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTUtMS0xLTY3NTEy_5923d990-8b49-4a02-a121-ea1f70446017">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTctMS0xLTY3NTEy_790e278c-2085-4f6e-b1cc-5f8d75ed6854">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTEtMS0xLTY3NTEy_9cd9dae2-162f-459b-b310-7961d620d687">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTMtMS0xLTY3NTEy_a239f715-4f99-4bdb-9026-bd4ff0e2848c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTUtMS0xLTY3NTEy_4f63dfb5-c707-4f53-9a3c-0507c7466022">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTctMS0xLTY3NTEy_523a299f-6157-44d8-b86e-c533e9bd2e19">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsExpensesPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTEtMS0xLTY3NTEy_83a45d78-8ceb-42ff-a101-01b538e2ba66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsExpensesPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTMtMS0xLTY3NTEy_82bb3033-431e-4951-95a8-0ccb62037d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsExpensesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTUtMS0xLTY3NTEy_8bde14eb-22b4-482a-9852-556c4cee26d4">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsExpensesPaid" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTctMS0xLTY3NTEy_c40af244-aa13-406f-a979-25e40f732af3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTEtMS0xLTY3NTEy_c5ae3b45-591e-4690-866c-a44b96368b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTMtMS0xLTY3NTEy_e9be1e32-4bd7-441d-b560-b899aa4d7c21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTUtMS0xLTY3NTEy_c5162d66-c7ab-48e9-ab6e-1260920e8b9d">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTctMS0xLTY3NTEy_e2561cef-8825-4264-a97d-66ae5ee00ce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTEtMS0xLTY3NTEy_a3650ac4-8780-4d64-9496-c6cda25794bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTMtMS0xLTY3NTEy_ef38cc19-0687-4ab8-9cb2-21b0d64fc2af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTUtMS0xLTY3NTEy_b8dc0543-3d44-4eeb-8db1-6faec389677b">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTctMS0xLTY3NTEy_50ee7329-b46e-4eda-86d2-3b98f3dd8f87">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTEtMS0xLTY3NTEy_c0cf04ed-9f15-41de-aa4c-c9eddd12556d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTMtMS0xLTY3NTEy_8f46cfb8-c452-400b-a86f-5b48b5e5209e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTUtMS0xLTY3NTEy_461ede86-4f90-4a1b-aeca-d137ed2f345c">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTctMS0xLTY3NTEy_972e0891-2a91-4502-843b-f78b5b266ed8">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTEtMS0xLTY3NTEy_09aaf51f-3a52-4d25-81b4-fb7bce5da12e">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTMtMS0xLTY3NTEy_faba8fdb-3034-49ba-8a6d-7f1bb8edf282">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTUtMS0xLTY3NTEy_473274c2-7634-4674-a85e-0908d6eb6760">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTctMS0xLTY3NTEy_4dab2d6b-0236-4741-81bb-006a32780873">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTEtMS0xLTEyOTE1Ng_4df3a680-141d-4e7e-9dc1-dbae2f4ed864">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTMtMS0xLTEyOTE2NQ_cf76ef8a-ca1f-4c7a-b690-081b3a0c57c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTUtMS0xLTEyOTE3Mg_13ee5d13-5686-4c06-837f-48031856550f">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTctMS0xLTEyOTE3OQ_7f1715f3-e82b-483b-a0ee-5bceda491bc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTEtMS0xLTY3NTEy_91b9ff7c-10f3-4179-abd0-470ab329880e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTMtMS0xLTY3NTEy_9d4c4dc0-a491-422d-b8e2-dd109537a24c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTUtMS0xLTY3NTEy_a57f8130-13ac-4602-a9cf-7c0bf1984d4c">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTctMS0xLTY3NTEy_9bc4b6c5-705f-4505-ad43-add6d6e6ccae">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTEtMS0xLTY3NTEy_17829693-7b17-4802-8076-9d1a7e75a2a2">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTMtMS0xLTY3NTEy_eac7c4c8-0db2-4656-8e3f-7312ba5e1814">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTUtMS0xLTY3NTEy_34cb4cc3-3ecd-43e1-90d0-df477b54d182">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTctMS0xLTY3NTEy_9c98a27c-81fb-4478-85a2-1a03ffc91c82">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTEtMS0xLTY3NTEy_305cac57-260f-4d41-9e39-dd7c247ab8ba">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTMtMS0xLTY3NTEy_79e05a3a-f03e-4c53-8d49-7d1026b265e5">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTUtMS0xLTY3NTEy_fca20eff-46fa-4da1-be56-b9478cb59654">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTctMS0xLTY3NTEy_eef8b266-e421-4b13-9714-efe194582669">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTEtMS0xLTY3NTEy_3222b7c2-95a1-4e0b-a079-56ac410fa94d">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTMtMS0xLTY3NTEy_6af285db-c2ca-4643-a25e-7e3b6ec06bc7">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTUtMS0xLTY3NTEy_ae97add9-7bb1-4a7d-bd32-5b250ddc46e3">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTctMS0xLTY3NTEy_9a1b1f46-d8e8-4d8f-92b8-063715e210d5">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The divestiture relates to the sale of the Company&#8217;s Austrian business in 2022 and to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current assets at March 31, 2022 include $<ix:nonFraction unitRef="usd" contextRef="i90ce3eddb5fc4a9387c2b4a7e93476dd_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU3NzE_6d0cf4ad-3436-41e5-9cc0-44dbd653f8df">49</ix:nonFraction>&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#8217;s U.K. disposal group. Current liabilities at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022 include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i90ce3eddb5fc4a9387c2b4a7e93476dd_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2NDkyNjc0NjMzNTU_fc2d2a5d-e303-4307-9b1d-b33488208c8e">85</ix:nonFraction>&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#8217;s E.U. disposal group. Refer to Financial Note 2, &#8220;Held for Sale&#8221; for additional information.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU4MjI_8998e208-6347-4c1c-a4ee-77948af307dc">55</ix:nonFraction> million in 2022 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzQ1MDI_568be122-ae2d-4364-91cd-f5315d142eaf">69</ix:nonFraction>&#160;million gain): The weighted average discount rate for Non-U.S. plans increased to <ix:nonFraction unitRef="number" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU4NjQ_efba8e28-ca2b-4779-a611-dd1770689cb6">2.67</ix:nonFraction>% as of March 31, 2022 from <ix:nonFraction unitRef="number" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU4OTg_e16c92f0-592f-4f5b-aa34-a59ae2b42727">1.89</ix:nonFraction>% as of March 31, 2021. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i3f98867f438d4d5695c28df2deabc884" continuedAt="ida053b678c5b492aadbe375444efed08"><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzQ2NDY_eea32224-4757-4e1f-8a5e-9508cb8a41c7">14</ix:nonFraction>&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestitures in 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial loss of $<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU5MTg_445aa117-dad3-4a14-8b89-2f549c87dcdf">89</ix:nonFraction> million in 2021 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzQ5ODg_8fc2b3c1-4f09-4da2-ac72-614749b0d64a">32</ix:nonFraction>&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased to <ix:nonFraction unitRef="number" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU5NzM_6a37630b-e762-4180-9997-28c23c5d5692">1.89</ix:nonFraction>% as of March 31, 2021 from <ix:nonFraction unitRef="number" contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzUwNjc_f2c88a78-9e53-452d-a1f8-92fb5e0f67eb">2.03</ix:nonFraction>% as of March 31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzUxMzE_f76338ce-db16-4560-9249-6a111bfd5751">57</ix:nonFraction>&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestiture in 2021.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzA4_b0f902dd-74c2-411d-ad65-123da7aea70a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtMS0xLTEtNjc1MTI_295863a1-3f22-4e58-8382-1aa146513554">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtMy0xLTEtNjc1MTI_7f84b499-6f4d-41e1-b907-fa25ea6d352d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtNS0xLTEtNjc1MTI_c16ae916-9a65-4fc7-aee5-6bf48920b1bc">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtNy0xLTEtNjc1MTI_4192d8ca-a112-4824-bcbd-3eea3d1efafa">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtMS0xLTEtNjc1MTI_69f66631-8010-420e-a13f-60ffae407a4e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtMy0xLTEtNjc1MTI_02dc3050-2720-405b-a600-b1249497276c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtNS0xLTEtNjc1MTI_023e59a1-5f20-4f9f-92ca-200a928146f8">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtNy0xLTEtNjc1MTI_c5a28ce1-d80d-49dd-b4fa-af597e26a64b">847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtMS0xLTEtNjc1MTI_cb18da91-de44-4f77-8072-2712b5d1a688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtMy0xLTEtNjc1MTI_e42f839f-1bd1-4825-850f-0ed5291684bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtNS0xLTEtNjc1MTI_53b5ca90-edd3-4c98-9759-e5e7b1b64edb">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtNy0xLTEtNjc1MTI_92a401c7-e1f4-4f27-809f-f5d4a3d69539">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzAz_20306b15-1435-48ca-a80f-2e0376898bd6" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive loss consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtMS0xLTEtNjc1MTI_268f61e2-6335-4a36-a6e5-0850b0bec5ec">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtMy0xLTEtNjc1MTI_854e1399-4313-4e03-b714-6ba415cc4c48">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtNS0xLTEtNjc1MTI_ca8825d9-c94c-462b-8631-2f844362c891">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtNy0xLTEtNjc1MTI_951a88a1-bf32-420e-bee4-544023fa1b64">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtMS0xLTEtNjc1MTI_ce79b73f-6270-4f92-948d-b65ce05562fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtMy0xLTEtNjc1MTI_53fabd2f-b45d-4c5d-9bf4-5858d83b8d68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtNS0xLTEtNjc1MTI_d9c82875-ec26-48db-aab3-752a6969f4ae">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtNy0xLTEtNjc1MTI_a1d664e0-f714-4917-a4e5-cac1d5ba2e5c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtMS0xLTEtNjc1MTI_fbb7050a-80c8-4b11-9fbc-8cc1793dfbdc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtMy0xLTEtNjc1MTI_dde9f333-5b05-4e06-b06d-9acb5ae67500">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtNS0xLTEtNjc1MTI_bd495301-6553-49e5-b9fd-f0cf8158db39">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtNy0xLTEtNjc1MTI_6b81174c-c9c3-4605-94d1-f8ba3744a12d">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzQ4_64b002e1-a522-48b4-8664-2be3db05ddd1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive income were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtMS0xLTEtNjc1MTI_150ac36f-787b-4825-b707-b83f49fae500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtMy0xLTEtNjc1MTI_33101460-ab27-4f41-a11e-ed61fafd3589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtNS0xLTEtNjc1MTI_aa8f1e6c-6dd2-440a-a0c8-a08c92ea7757">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtNy0xLTEtNjc1MTI_0a1333b6-9b10-4b98-aebe-e43521f4275e">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtOS0xLTEtNjc1MTI_4183b7b7-5992-45aa-80dc-27228fe326b7">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtMTEtMS0xLTY3NTEy_834bc38d-ca66-425c-8fbb-8f566bee516b">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtMS0xLTEtNjc1MTI_141396e4-a34e-4b00-8f86-458fd3467e76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtMy0xLTEtNjc1MTI_0d4e2514-a5f8-4f85-a91c-dd4019201392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtNS0xLTEtNjc1MTI_e5b2839b-f862-4112-b42f-9ac119d7a339">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtNy0xLTEtNjc1MTI_4636f873-322d-4ac5-809e-31edcfcd21dd">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtOS0xLTEtNjc1MTI_8bed4ca8-082c-48e9-a4f8-591eda96f4c0">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtMTEtMS0xLTY3NTEy_39940504-274e-4fd2-b97c-15fcdef0f68d">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit (cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctMS0xLTEtNjc1MTI_8642a37f-e4e7-4cdd-9c58-2acfa1b732e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctMy0xLTEtNjc1MTI_4cdc8585-acd2-496b-a48d-0355e11f4c3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctNS0xLTEtNjc1MTI_7ad5ec0b-ba38-4d16-9863-6b20ea20bc33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctNy0xLTEtNjc1MTI_217a32b9-e0c8-4b96-8dc7-3c59ddfb904a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctOS0xLTEtNjc1MTI_722b36ce-79fe-4116-bd26-3fc9fc3bc62f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctMTEtMS0xLTY3NTEy_90e18a5c-6a42-4493-9013-a4d863bc8b4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtMS0xLTEtNjc1MTI_ad789f88-ecbb-4b14-9482-696e12199626">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtMy0xLTEtNjc1MTI_f5037d95-9868-4504-bb9d-3bda1966e06c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtNS0xLTEtNjc1MTI_934d3891-0877-4f70-9c9d-fd7258decd49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtNy0xLTEtNjc1MTI_0faada61-f59a-4594-80d2-436e5d0b5e4a">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtOS0xLTEtNjc1MTI_74ed0a66-4447-47f8-9ab0-d4437dc58651">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtMTEtMS0xLTY3NTEy_4ed1c4dc-4174-46ba-8643-68166cc4f0ba">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss (income) </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktMS0xLTEtNjc1MTI_5c954c56-6c37-422b-9098-16eb60af47b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktMy0xLTEtNjc1MTI_1db432e1-cfab-4e7e-81ea-102780fa1144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktNS0xLTEtNjc1MTI_df24d707-0001-4360-bb4d-69d8a5434287">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktNy0xLTEtNjc1MTI_178229c2-41dc-4d44-a071-6c75cf8c0c5e">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktOS0xLTEtNjc1MTI_1855c86a-52cc-4a82-beb6-95fa9726ea18">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktMTEtMS0xLTY3NTEy_aad3a9ca-c1bd-4237-bae9-7b6062bc2b34">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ida053b678c5b492aadbe375444efed08" continuedAt="i51b6a2b5bbf64a73b49ef8c6efb1af16"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i6fd8b5bc85ab463b9b570056218ced7a_D20210401-20220331" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4MTU_a74eed66-8d07-4c10-acc1-70da38ab472d">11</ix:nonFraction>&#160;million in actuarial losses for pension plans to stockholders&#8217; equity as a result of the sale of its Austrian business. In 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i226a25479b7c46bf9d8ddd2a5bfcf119_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzU4NjA_335c4af6-2a53-45b0-82d1-2cfa1bfe0e30">33</ix:nonFraction>&#160;million in actuarial losses for pension plans to stockholders&#8217; equity as a result of the contribution of its German pharmaceutical wholesale business to a joint venture. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i1718647e98904b358ee1e9de9b292eb9_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4NDM_8f11759a-c6e2-40dd-8438-1dcdeeb656dd">127</ix:nonFraction> million in actuarial losses for the pension plans to stockholders&#8217; equity in 2020 as a result of the termination of the U.S. defined benefit pension plan and the settlement from the executive benefit retirement plan for a retired executive. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected benefit obligations related to the Company&#8217;s unfunded U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="i7d0132582b984b76ae285cf19ed5c7f6_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4Nzc_04b45c34-c3e8-4bc5-98e0-2ecf3eb7bc98">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2728f1fd9955493099bbd68893348eff_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4ODM_040fe3f6-ba1e-4ddb-aff3-c36a2d2845d1">9</ix:nonFraction> million at March 31, 2022 and 2021, respectively. Pension obligations for its unfunded plans are based on the recommendations of independent actuaries. Projected benefit obligations relating to the Company&#8217;s unfunded non-U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="ic24a302cc95448b6895bf70aef816116_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5MTE_092b96b5-1649-4e0f-9ddb-fcf501e0194a">101</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ief082c01cc5e412cb6ff4de8ad61ca8d_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5MTQ_047411a7-d8fb-4865-9e7f-64cdb8c46445">162</ix:nonFraction> million at March 31, 2022 and 2021, respectively. Funding obligations for its non-U.S. plans vary based on the laws of each non-U.S. jurisdiction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for the Company&#8217;s pension plans are as follows: $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NDM_6ee83515-ceae-4bdb-bddf-e60a4cde0a35">34</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NDY_7838bf90-fe53-41d6-bb20-1e70393335f5">33</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NDk_742fb5aa-12cd-4824-9074-d8fc02d73d0c">33</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NTI_a743b0a4-403b-4970-a7c1-f1cec532038a">34</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NTU_86c5ba9e-e77e-457c-9cc7-35c16dccd613">35</ix:nonFraction> million for 2023 to 2027, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NTg_6e764a91-28a8-4a7b-9954-2669dc8cb2dd">186</ix:nonFraction> million for 2028 through 2032. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#8217;s pension plans are $<ix:nonFraction unitRef="usd" contextRef="i4c424200871342f38c9f8485d07949ef_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwMTM_48379c3f-a236-40c8-bb9d-25d3cef274da">13</ix:nonFraction> million for 2023.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzE3_7a8ba124-453f-45e8-a825-81a4ff44026a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtMS0xLTEtNjc1MTI_27b11cac-5488-4f40-97e0-30f9a934656f">2.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtMy0xLTEtNjc1MTI_3bed6b36-5a86-4052-a0fc-ea114a1f5b91">3.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtNS0xLTEtNjc1MTI_f5847f32-5b51-48cf-9e3e-57fa8ffc9a92">3.66</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtNy0xLTEtNjc1MTI_03aeee68-f8e3-4ee9-b9c1-2b417d7744f6">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtOS0xLTEtNjc1MTI_79c367b3-f7ae-4d43-9f12-fa07998b4b86">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtMTEtMS0xLTY3NTEy_b77ba591-ffc6-447d-843e-997b629a1ffe">2.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzUtNy0xLTEtNjc1MTI_5422284b-43ad-4fb9-8c59-34a0a35d8fe5">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzUtOS0xLTEtNjc1MTI_16213010-d183-42fe-9923-db4ff5379851">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzUtMTEtMS0xLTY3NTEy_1e46fa11-e982-465b-93b5-ef77e75bc4b1">2.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtNS0xLTEtNjc1MTI_306772ce-fa9c-4956-ad3e-ef08dbd8bf65">4.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtNy0xLTEtNjc1MTI_72ac787e-98ad-42c2-88af-3896ce1fb5fc">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtOS0xLTEtNjc1MTI_c1947a1d-0c50-42a1-bf24-5fc462b8cfbe">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtMTEtMS0xLTY3NTEy_4c71b755-68ee-4b03-90cc-7096b0547bc3">3.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtMS0xLTEtNjc1MTI_dbfc3e4f-8bf0-41cd-9348-07e6c05b0bbb">3.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtMy0xLTEtNjc1MTI_86a4bd1d-d55f-4657-b7ba-ff9a732a9328">2.35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if83736112ca9462697b6ec54e87de910_I20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtNS0xLTEtNjc1MTI_209e614a-eb27-44fe-bfa5-3849d082cd71">3.08</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtNy0xLTEtNjc1MTI_55500827-6e2e-4d1c-bb33-ec6d62efa4a8">2.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtOS0xLTEtNjc1MTI_81cb8c17-8628-4f00-a175-3deb72134769">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtMTEtMS0xLTY3NTEy_56f91b25-0ef1-4f99-a3e3-2dd9694da0d0">2.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzktNy0xLTEtNjc1MTI_414dd1a6-04f8-4192-8dfd-a706f935fd37">3.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzktOS0xLTEtNjc1MTI_bd8ef04f-54f9-4f6d-ba90-142a772189b9">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331" decimals="INF" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzktMTEtMS0xLTY3NTEy_a60bfc3f-3db5-44b3-bb95-904ec8e20e08">2.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. For March 31, 2022, the Company&#8217;s U.S. defined benefit liabilities are valued using a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwNTg_9a1770f8-a138-467f-81ef-dbaaf57e30a9">3.35</ix:nonFraction>%, which represents an increase of <ix:nonFraction unitRef="number" contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331" decimals="4" sign="-" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwNzk_55af0708-9969-4092-9c6b-b49783a730d8">100</ix:nonFraction> basis points from its 2021 weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwOTI_4454d8c0-5ef4-40da-8f18-161aed8507bf">2.35</ix:nonFraction>%. The Company&#8217;s non-U.S. defined benefit pension plan liabilities are valued using a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwOTc_e8ee4ef5-d5d3-4efc-a52f-e1559e7f4413">2.67</ix:nonFraction>%, which represents an increase of <ix:nonFraction unitRef="number" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="4" sign="-" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMDM_8d8b9808-f497-4c3b-be9f-85b45b30d3fe">78</ix:nonFraction> basis points from its 2021 weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMTQ_054be3a7-9188-4e2a-bbdf-04d908d6b543">1.89</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For non-U.S. plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i51b6a2b5bbf64a73b49ef8c6efb1af16" continuedAt="id13e2402ea824b99b901cd2aef134ee5"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzU3_4dd9f21a-e04d-44e4-b5a2-724dfc8a32f7" continuedAt="i742154e57e6d478db2881b93862d590c" escape="true">The following tables represent the Company&#8217;s pension plan assets as of March&#160;31, 2022 and 2021, using the fair value hierarchy by asset class:</ix:nonNumeric></span></div><ix:continuation id="i742154e57e6d478db2881b93862d590c"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f84586bbdc64b9db37cbe7a0a6e91a2_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMS0xLTEtNjc1MTI_32b0b49f-8b8a-4405-968a-db748a3b80f7">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24a81b323f944750ad86fa66047de210_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMy0xLTEtNjc1MTI_8c744a79-5109-4add-bb0c-7ec8950d6437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c57f6243c3043139895c497e5082a6c_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtNS0xLTEtNjc1MTI_72b6fc05-f3ce-497f-85f9-b4d19e044291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1feb4c8ee03c4ea8b76a8dec194384a8_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtNy0xLTEtNjc1MTI_4c2fc799-6273-4cff-8d35-57a6d7723520">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice1db9b721a84b9a962dd773d56f5625_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtOS0xLTEtNjc1MTI_41e84c17-71c5-414d-9907-3cb6ec09a854">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42493a65e37c41cd84bfc0a43dfbfcfd_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMTEtMS0xLTY3NTEy_7e87aa5a-aa9f-45dc-8652-bd177dad2954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67a195a2dbc24ab0b3916b6c936b0a81_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMTMtMS0xLTY3NTEy_c4b95af8-d204-4b71-bba0-f9891ac22d59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i802adc56f209414fa2679958ea52481f_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMTUtMS0xLTY3NTEy_59dcc209-df40-4cca-8060-ee20d7aaa0a9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2fc5f76445f4ccb949607a1612c1efb_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMS0xLTEtNjc1MTI_3e34d0bc-bf95-4704-b3ae-f217ccfa44bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie231571b70294eae9fa4e83ed3eeca65_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMy0xLTEtNjc1MTI_7347cd70-edc1-4afd-bef0-d2f231afbc41">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a4ddf8d6704a26b6c3d695218fd03f_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtNS0xLTEtNjc1MTI_8443fe54-402c-40fd-a71d-b0fb1bcca4e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief335562064c476d87395446c7085794_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtNy0xLTEtNjc1MTI_af4dcb47-0831-4227-8f5e-a53f7c7c29c9">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic376ec9b950641b1af873ef2748b3c7c_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtOS0xLTEtNjc1MTI_9aa13d43-0b47-41a7-80cb-f3034949abfb">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b45db4fc0e645fb81133a5906dbd495_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMTEtMS0xLTY3NTEy_73e2787e-90cd-45a9-bebf-b6a5793c6191">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f160bc0e164814a7383b997da65a5c_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMTMtMS0xLTY3NTEy_c59f6b69-4e6e-4018-a65d-fd2f616b57bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecd0a0364703401aba0fda8a20e2d103_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMTUtMS0xLTY3NTEy_fb23b5f5-5797-4ca4-a03a-aba010b00a67">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd6515ad0894db092afa7fcc8fbef3c_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMS0xLTEtNjc1MTI_37582fa6-f72f-4536-ba4f-5ba65b497ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1498edc5a78e460cb75dd394ce55f4bc_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMy0xLTEtNjc1MTI_9e950d3f-e362-4247-b498-13244e35209b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a450f02f814c13ad2c3e1a67df52db_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtNS0xLTEtNjc1MTI_9370cca7-8704-41ad-9fff-3391856b9c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf3513bbbfa54d83b35c2db60004594d_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtNy0xLTEtNjc1MTI_c9de1272-aca6-4e10-bf4b-ada31eda8dd6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98369f24f8ab4c2eb5f3e9a7ec1b1865_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtOS0xLTEtNjc1MTI_ffd0e2eb-a15d-493a-8af2-beadd079312d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d18f2d389c34f889fe5b27bea6dedca_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMTEtMS0xLTY3NTEy_50c3b882-79d3-4f2d-9a2f-2245ede7bb59">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e2be2f8d0b46c798249db103676c1e_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMTMtMS0xLTY3NTEy_11abe291-8be2-45ab-8ae1-d9f87107d04c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06830bb28fe54b568fbb0beb096d29c6_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMTUtMS0xLTY3NTEy_02afce76-5006-4ea2-afaa-559ae696c1f9">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e437bd0e8ac42d1922f9d4c9b56a9e9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMS0xLTEtNjc1MTI_befe44ca-cbb6-4cba-8f35-5ab123d3fc68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb6959cf5a342729ed17f01d0dd71ad_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMy0xLTEtNjc1MTI_a4156062-45c2-4ff0-83fe-12fd8a702d9b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25303d6a03249938b42bc7d3c1357bc_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktNS0xLTEtNjc1MTI_7920932e-23e0-4346-aacb-e1f249559abb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82602c6601f4f45a4a7369ec1b8bf35_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktNy0xLTEtNjc1MTI_90b98cf8-6fed-4741-b018-467919790a2f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ea8b4f7ef14653a641e807f4cd138a_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktOS0xLTEtNjc1MTI_93d08d1d-ec8c-4396-95f7-1434644caab6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cf84e558644557a7de95ff69e39200_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMTEtMS0xLTY3NTEy_9c9c7b9e-8f4c-4cfc-9b57-eab2b965cd85">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549bcf1376444c1c96c41b62e0f53c13_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMTMtMS0xLTY3NTEy_569a4144-974c-43bf-a735-5c1cc1deffb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7992105cb65e4456891d27cc92f31f82_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMTUtMS0xLTY3NTEy_4222ac3e-7c9d-44e7-a22a-0fd844af3446">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6750d94d7246455fa05c465a0a2ce518_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTEtMS0xLTY3NTEy_828c49bc-2e65-4329-9af1-8ecf6a155f9c">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4cdf5216e54e7d8f62bf705dc2eb7b_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTMtMS0xLTY3NTEy_99e273ff-2a50-423b-8b0b-93fc6a1da4a3">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e73ea452a64d409c6a0144d7c8f775_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTUtMS0xLTY3NTEy_af95998a-7875-4129-81d5-6034a3c5f945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789450adbe47425287cf59d8f464ddd4_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTctMS0xLTY3NTEy_ec02fbf6-f5ec-4350-a468-2e12c55262da">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64b7c133d6d4fe4aacc658b24720e06_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTktMS0xLTY3NTEy_95e5f246-6caa-4766-b03d-cb9468aed2d8">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7cc563acc44759bce119f8ce36a604_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTExLTEtMS02NzUxMg_6ae96d4c-b5ab-4777-9660-cd41f25bb6c7">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ebb6ae9dcdc495b9cc3c87d23f6cbec_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTEzLTEtMS02NzUxMg_3444a6a1-6f95-41ae-b980-bf0037e7ca8e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c239fdb13f450da87c6daa53922d8d_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTE1LTEtMS02NzUxMg_91f0987b-f549-4c2b-898c-42bd79853eeb">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c306b0e9f2f4c79a4da4e3080b6d89e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEtMS0xLTEyOTc4Mw_3306757a-81c0-4f2e-a31f-1561d879d54e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21c7e2a081d5465796f47bd8606c00e9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTMtMS0xLTEyOTc5MA_5616fdbc-1eb1-444d-a34a-c8b1d1565a99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5164fe963e2645c899da80d46fd4ae97_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTUtMS0xLTEyOTc5Nw_e41bf428-483c-4a51-b71a-c10e73c76cf7">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7649f7142e4c4b9a4814ec21eff4cd_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTctMS0xLTEyOTgwNA_ca66ef39-7289-4475-980e-3c59269a579a">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5572d95dce3c4525ac5872c923be80d8_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTktMS0xLTEyOTgxOQ_a2ec75f8-8f16-4879-8fbd-7feed3d0d9e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0b53acf3404eb896235616da3a2829_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTExLTEtMS0xMjk4MjY_be9e9c79-0455-425a-81ef-334b4d6ee6f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7038af880144a7ea84a73759de44134_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEzLTEtMS0xMjk4MzM_27778b76-27fc-4aae-afc5-5a56411e627b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9233f3fb62d4e2288e4195f2496e9d8_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTE1LTEtMS0xMjk4NDA_dbd29337-cf71-40b2-ad46-8fdf88b80a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198ca18f282b482093bc4dbc11845c9f_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEtMS0xLTY3NTEy_13e7b3a5-54dd-4eab-9765-1a0c543f8f76">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53073f5452fd4d48a40ef1c67e4481ab_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTMtMS0xLTY3NTEy_0ffdb329-b7f7-4dd2-91ad-63973b40ed98">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7d7e52a71c45f191cff470e5e58900_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTUtMS0xLTY3NTEy_380d6be2-de37-429b-9a92-57b5054d1390">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3049d1d278b041b182572ae407160d16_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTctMS0xLTY3NTEy_e3ca4aed-8c12-4b38-93dc-c6a4de80a116">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd607e6a67e34b6a80181cb19f672808_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTktMS0xLTY3NTEy_3f04c5d7-f73a-4c65-a6be-77ece71ece44">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35d3c0a9434f43f4a185b11c84d8c084_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTExLTEtMS02NzUxMg_a9b59932-a5d4-4a75-b19e-17a3b60527aa">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2db81a22674f35a3dca780612fa224_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEzLTEtMS02NzUxMg_6707ad03-e859-4cbe-aefa-7dcf24708034">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a29ea5f47374404ba20c59dc7af27a8_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTE1LTEtMS02NzUxMg_42bd87cd-f64c-4008-b259-8d78f4ac2093">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088530175de844cdb1ff52c1bae2e520_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTEtMS0xLTY3NTEy_1237b753-e965-4ca3-aa27-25bdb9e3bbd5">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec69e1f822ee4fbca88f48124ec26c7c_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTMtMS0xLTY3NTEy_95134eb5-e4a8-420d-83f5-afff981d6943">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i780bb7e3c18c4e2da57a59b5e8a82b8d_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTUtMS0xLTY3NTEy_3f5edd8b-e898-46e6-8dd7-aa42e17b0a58">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a603bd1125146b48426fed799546156_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTctMS0xLTY3NTEy_7e2bddfb-871e-498d-831b-ad8643fe5d4a">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7187fc49e8d94a85b667b111d6e5dc69_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTktMS0xLTY3NTEy_701a991a-a51a-4fa7-b62b-bcabde6028a6">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04278e26dd54ce48826dbc56cb31d0c_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTExLTEtMS02NzUxMg_c8e42e63-8dd3-4527-8f11-37c6a720d79a">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icee7ff1a301f4f4badf6de78d85f9ee7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTEzLTEtMS02NzUxMg_07b3bcd8-ad9d-4954-a34c-60b5faaee1fe">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65b4babfea54b92be6fb935a4313666_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTE1LTEtMS02NzUxMg_04b3f5bb-105e-4b30-b1ee-662f770bb07c">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a44775f82674797bf85d3b9a8a5ab4f_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIxLTctMS0xLTY3NTEy_867911e3-2a1f-469d-be67-fa7493cef966">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib359c5a79d704e0ebf9e432707a3b141_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIxLTE1LTEtMS02NzUxMg_5b0f7fc5-74df-4923-9ed7-e4bf833e0363">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIyLTctMS0xLTY3NTEy_779f4907-8e0b-4f7d-83e2-e741e9dae675">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIyLTE1LTEtMS02NzUxMg_8f0d00cc-3ba9-4093-8c39-66ea4b280627">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7bc4364d89ca4d929d7940909184939c_D20210401-20220331" decimals="2" name="mck:UnitValueOfCashAndCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMjA_1795ed44-d21f-4132-829f-334c9719bce9">1.00</ix:nonFraction>. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="id13e2402ea824b99b901cd2aef134ee5" continuedAt="ibda54c8ee2c742f0af6374db88d68032"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annuity contracts - The value of the annuity contracts is reported by the Trustee and is based on a valuation of the remaining contracted cash flow of the contract. Inputs in the valuation include discounted future cash flows; these are classified as Level 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other - At March 31, 2022 and 2021, this includes $<ix:nonFraction unitRef="usd" contextRef="i294bbf493f9b404bbff0579c52891b4a_I20220331" decimals="-6" name="mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMzI_faa8d192-e67c-4702-9d6c-2b6d297a14b9">35</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04db204508bd48ea9785a68185baa374_I20210331" decimals="-6" name="mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMzU_ecb71ad2-2590-4dc4-b7be-51d56e5ff68c">36</ix:nonFraction> million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzI3NDg3NzkwOTI1NDE_a2f6595f-ab2c-4d3c-9249-d5d9c3d6ed83" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the year ended March 31, 2022: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2c94dcf99244b7b82fca2d408a16a4_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzEtMS0xLTEtMTMwNjQ0_b724bc46-ec52-4397-b7c5-bc0adb706887">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzItMS0xLTEtMTMwNjQ0_ba7f0f4f-5a90-4714-8db2-58036751fedc">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzMtMS0xLTEtMTMwNjQ0_58b97dcf-7661-4198-84ce-4a89b66281c2">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad63af957fc64549aee083f9cdee9453_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzUtMS0xLTEtMTMwNjQ0_4b3f84b2-997f-4e62-989b-3befbbd9f22a">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity attributable to Level 3 plan assets was not material for the year ended March 31, 2021.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#8220;POA&#8221;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#8217;s withdrawal liability and contributions may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributions and amounts accrued for U.S. plans were not material for the years ended March 31, 2022, 2021, and 2020. Contributions to the POA for non-U.S. plans exceeding <ix:nonFraction unitRef="number" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="INF" name="mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxNjk_5c20263b-c35e-4897-8c90-e2ff991e707a">5</ix:nonFraction>% of total plan contributions were&#160;$<ix:nonFraction unitRef="usd" contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxNzY_19c881fa-3ba0-49cd-956e-dc907108d274">20</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxNzk_200c4242-0cbe-4fa8-9413-d958699e725d">22</ix:nonFraction> million, and&#160;$<ix:nonFraction unitRef="usd" contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxODI_d9fc95d3-a2e3-4220-9a89-b52c152a90e5">17</ix:nonFraction> million in 2022, 2021, and 2020, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately <ix:nonFraction unitRef="number" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="2" name="mck:MultiemployerPlanFundedStatusPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMTc_52c0e885-819a-4b07-8b5b-3af9b26bae53">88</ix:nonFraction>% as of March 31, 2022. <ix:nonFraction unitRef="usd" contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331" decimals="INF" name="us-gaap:MultiemployerPlansWithdrawalObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMjM_7477926b-2664-4150-bb9d-cc40d3fda873">No</ix:nonFraction> amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ibda54c8ee2c742f0af6374db88d68032"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contributory retirement savings plan (&#8220;RSP&#8221;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to <ix:nonFraction unitRef="number" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMzI_43596392-dcfe-4301-87c9-5b0da28a2c8d">75</ix:nonFraction>% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to <ix:nonFraction unitRef="number" contextRef="i8ac275e02b8b48a39ec49c6224a2a136_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMzY_c8c7785f-6c20-413a-aa12-ec8ca29ac51a">100</ix:nonFraction>% of the employee&#8217;s first <ix:nonFraction unitRef="number" contextRef="i8ac275e02b8b48a39ec49c6224a2a136_D20210401-20220331" decimals="INF" name="mck:EmployeeContributions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNDA_3dc6170e-5565-4c82-800f-71a44f84660c">3</ix:nonFraction>% of pay contributed and <ix:nonFraction unitRef="number" contextRef="i195f1f7208864f679b4d15f3687a5587_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNDQ_6541e791-4c96-48f6-8155-ba3f4a1fa3fe">50</ix:nonFraction>% for the next <ix:nonFraction unitRef="number" contextRef="i195f1f7208864f679b4d15f3687a5587_D20210401-20220331" decimals="INF" name="mck:EmployeeContributions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNDk_2c08f35f-7572-44b2-a5a2-5db8e6934775">2</ix:nonFraction>% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNTQ_16f1e6e2-7d0d-494e-844f-d4c435a7ffa9">116</ix:nonFraction> million for the year ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNzY_01bd58e9-fafe-4be1-a762-4a972987e65f"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNzY_192c6b18-09d2-405a-8f7e-c83ba5f4c2f3">102</ix:nonFraction></ix:nonFraction> million for each of the years ended March 31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postretirement Benefits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of postretirement benefit plans, primarily consisting of healthcare and life insurance (&#8220;welfare&#8221;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic (credit) expense for the Company&#8217;s postretirement welfare benefits was <ix:nonFraction unitRef="usd" contextRef="i81e084748f994c2b9dee394b47094c3f_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0OTI_74c7ada5-f057-4709-872c-75f8df95fbc5"><ix:nonFraction unitRef="usd" contextRef="ie8cbf8941d6b49f7a3fd6216544852e1_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0OTI_7cb75c2c-9753-4323-8ad8-f5240f97dffc"><ix:nonFraction unitRef="usd" contextRef="i57a78699f72e4caaa49cdae2c1264ff9_D20190401-20200331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0OTI_94ffd245-480d-45bb-b6ca-f6dd3358e5f5">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t material for the years ended March 31, 2022, 2021, and 2020. The benefit obligation at March 31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="ia5c091f35bda4066898f44d7a15e739b_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0NzU_80c2aa14-b7f4-48fb-a8f0-c2fbff49fc72">56</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib3a2bce002414557a29e4f5c83a868f2_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0Nzg_210d0df6-1359-4313-8c5a-cea2819b2e25">64</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_154"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzI3NDg3NzkwOTQ2MTg_4ee42d6a-5411-4f72-84f8-49d256d0a0c7" continuedAt="i5966012b686f42af987597fc6eb3bca6" escape="true">Hedging Activities </ix:nonNumeric></span></div><ix:continuation id="i5966012b686f42af987597fc6eb3bca6" continuedAt="ie9cbb08882214ed38c70babe6bc1caa8"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022 and 2021, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i2a394ed33cbc477aace60da23a0ce725_I20220331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTIyNjc_a4ef6a5a-fec4-4d81-b333-66060d716a76">1.1</ix:nonFraction> billion and &#8364;<ix:nonFraction unitRef="eur" contextRef="i3a9c80472fe146588b6eac8a58404290_I20210331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTIyOTY_1ef79413-b69d-4c20-866f-5df059ed6971">1.7</ix:nonFraction> billion, respectively, of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company de-designated its &#163;<ix:nonFraction unitRef="gbp" contextRef="i24fdde78e96442cbafbef0fa22f902e4_I20190930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTI0NDg_e36bd460-7400-4ef6-91c8-47243c193963">450</ix:nonFraction> million British pound sterling-denominated notes prospectively from net investment hedges as the hedging relationship ceased to be effective.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains or losses from net investment hedges recorded within Other comprehensive income were gains of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDEyNTY_09e3863a-3583-4f72-bc69-de93cbe51018">73</ix:nonFraction> million in 2022, losses of $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDEyNjM_c69d4e04-ece3-4a7d-a446-3af3b5167891">118</ix:nonFraction> million in 2021, and gains of $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2MzkzMzc_c2243396-520a-4fd9-9be4-5b4eceb5ff98">39</ix:nonFraction> million in 2020. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during 2020 resulted in gains of $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzI3NDg3NzkwOTQ2MDY_8d69cd95-b9f8-4607-b037-a1ea3da02e83">34</ix:nonFraction>&#160;million which were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statement of Operations. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March 31, 2022 and 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie9cbb08882214ed38c70babe6bc1caa8" continuedAt="icdbc510064724469a21af59c055fc903"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022 and 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="icf83c6faa1c2418c96f6ef2cef6c1bcb_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTI4ODI_2bfcca46-aa96-4f7e-8875-5a98d47013ae"><ix:nonFraction unitRef="cad" contextRef="i808f703176d2404abd9b7793bf0a6599_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTI4ODI_7c0d6d52-9873-4eb0-9297-f89887f96a99">500</ix:nonFraction></ix:nonFraction> million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March 31, 2022, 2021, and 2020. The cross-currency swaps will mature in November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company terminated its cross-currency swaps designated as net investment hedges with a total gross notional amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="i07635e9764bd408087acfd4f78ea3577_I20200331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDE4Nzc_35526598-6660-4df9-bed5-57dcade82e22">932</ix:nonFraction> million British pound sterling swaps. The termination was due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $<ix:nonFraction unitRef="usd" contextRef="i5c98cdf793bc4ce48f4a0004d0a47ebc_D20190401-20200331" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMwNzA_8a604e48-4608-4c99-a981-a11aea75af5b">84</ix:nonFraction> million and resulted in a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="i5c98cdf793bc4ce48f4a0004d0a47ebc_D20190401-20200331" decimals="-6" name="us-gaap:GainLossOnSaleOfDerivatives" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMwNzU_603f247b-2e24-4245-8f41-02b7dac3650b">34</ix:nonFraction> million in 2020. This gain was recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="i22b34b6e8ced4d97b4d47ddb2965e898_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMxODA_5c96dcca-9948-4de7-b712-24aacb72d0fb">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifaa55b6bf9f44cd1a8a25b42288d0593_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMxNjU_a42faae8-e6c5-4da1-97e8-69bf617b1118">119</ix:nonFraction> million in 2022 and 2021, respectively, and gains of $<ix:nonFraction unitRef="usd" contextRef="i1f9cac9e86284785ab4d70600ae33ad6_D20190401-20200331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM3NDg_19caeddb-7c35-4561-99d7-d36f5f822b6b">76</ix:nonFraction> million in 2020. There was no ineffectiveness in the Company&#8217;s hedges for the years ended March 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;<ix:nonFraction unitRef="gbp" contextRef="i24fdde78e96442cbafbef0fa22f902e4_I20190930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyMzg_f3ea2101-380b-428d-9ef1-8de3321e2497">450</ix:nonFraction>&#160;million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;<ix:nonFraction unitRef="gbp" contextRef="i24fdde78e96442cbafbef0fa22f902e4_I20190930" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNDc_f3ea2101-380b-428d-9ef1-8de3321e2497">450</ix:nonFraction> million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At March 31, 2022 and 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="i1fb5afe9d8f741d98516f86630f9a369_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNjI_26f81287-53d4-4a4d-a220-80cde403538c">1.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i4ca4b4a7511f40e5a9d3ef22dada90c7_I20210331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNTQ_0907911c-fa1e-428f-ad71-70b6a7e4e547">2.6</ix:nonFraction> billion, respectively, which are designated as cash flow hedges. These swaps will mature between July 2022 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="icdbc510064724469a21af59c055fc903" continuedAt="i7303fd8164c147dcb7c6936fd291f21a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $<ix:nonFraction unitRef="usd" contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNzc_dbb07a20-cea7-48be-bb4e-420d5e7636ea">500</ix:nonFraction> million and &#8364;<ix:nonFraction unitRef="eur" contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyODU_fe3cf442-48c5-47b9-a903-63d739a16092">600</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyOTA_dbb07a20-cea7-48be-bb4e-420d5e7636ea">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;<ix:nonFraction unitRef="eur" contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyOTk_fe3cf442-48c5-47b9-a903-63d739a16092">600</ix:nonFraction> million swaps. The $<ix:nonFraction unitRef="usd" contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyOTU_dbb07a20-cea7-48be-bb4e-420d5e7636ea">500</ix:nonFraction> million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:AmortizationOfLossOnDerivativeTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzI3NDg3NzkwOTQ5OTg_f4a0d856-e200-4358-8097-36236f51bc63">five-year</ix:nonNumeric> life of the 2025 Notes. The &#8364;<ix:nonFraction unitRef="eur" contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDIwMTg_fe3cf442-48c5-47b9-a903-63d739a16092">600</ix:nonFraction> million swaps were terminated in the second quarter of 2022 and the loss on termination of the swaps recorded in interest expense was not material for the year ended March 31, 2022. Refer to Financial Note 12, &#8220;Debt and Financing Activities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with a combined notional amount of $<ix:nonFraction unitRef="usd" contextRef="i0d147eb37a56481b848433e3e940585d_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDMwODc_fa60176e-3069-4a1d-b789-d05b3d734f99">500</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on a planned bond issuance. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i0d147eb37a56481b848433e3e940585d_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDMxMDU_fa60176e-3069-4a1d-b789-d05b3d734f99">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were gains of $<ix:nonFraction unitRef="usd" contextRef="ie2c39129d8ab4c4b9955fcd9310ac053_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMzMjU_aafa59e2-52e9-4546-8dec-ed11203207d2">21</ix:nonFraction> million in 2022, losses of $<ix:nonFraction unitRef="usd" contextRef="i9e32714cfa934a93b4e7c425d1d050de_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMzNDA_860da69e-7e2a-4b31-b4b9-6974662c81cd">42</ix:nonFraction>&#160;million in 2021, and gains of $<ix:nonFraction unitRef="usd" contextRef="i137f365a182943e796f2e1d55d814426_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1Xzc2OTY1ODE0MDc3MDc_3d516694-e5d9-4861-9117-8655c323b561">98</ix:nonFraction>&#160;million in 2020. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations were not material in 2022, 2021, and 2020. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the years ended March 31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At March 31, 2022 and 2021, the total gross notional amounts of these contracts were <ix:nonFraction unitRef="usd" contextRef="i6fb91758a04f4bacb9905307ab195623_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM0NjE_fa769685-05df-46a4-9a29-93342769ad15">nil</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4542a21b25d543c4acc0fa4436d289e7_I20210331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM0NTc_600a7723-89f8-401b-ab8f-894c7ebbbfca">39</ix:nonFraction> million, respectively. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in the fair values were not material in 2022, 2021, and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the non-derivative net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="i012c7ab6d6f04da38da0d95109115f5c_I20191231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM0OTM_702b3755-ecfb-4582-9599-72e3ad465de2">250</ix:nonFraction> million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they are offsetting matured in February 2020 and were not designated for hedge accounting. Changes in the fair value for contracts not designated as hedges are recorded directly in earnings. In 2020, losses of $<ix:nonFraction unitRef="usd" contextRef="i024aefa502ee40d6b34f7f8368e3b55c_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1Xzc2OTY1ODE0MDc3NzE_db4adfa8-c089-4eab-93f5-6a5cf7ab358d">44</ix:nonFraction> million were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations, which offset the ineffectiveness on the Company&#8217;s non-derivative net investment hedges noted above.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i7303fd8164c147dcb7c6936fd291f21a"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzExNTA0_4de03387-9d1e-428e-aa80-81dee09fec47" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff333b050afd48d9b90c24d10c24348a_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtMi0xLTEtNjc1MTI_263c5e53-8062-486a-8e67-11e36e3ecb0a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c57740209a940fa8dafc8433670f167_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtMy0xLTEtNjc1MTI_70d0c2c3-baea-4daf-b0d0-777156eab0fa">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309ac7f13b444d0db3954863ad6e761c_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtNC0xLTEtNjc1MTI_87108835-2b2c-4b73-a8d2-31a57091e357">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i719adfe70a964eb882c96f1004d74bf8_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtNi0xLTEtNjc1MTI_d19d3806-3cc6-4b94-af03-037e61de6f12">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c355ddfeccf45afb84fc6d09c4cd44e_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtNy0xLTEtNjc1MTI_c109c270-3336-4db8-a7f4-cbaea2369882">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e46135b9e374ad194e91da1167d2848_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtOC0xLTEtNjc1MTI_302404a7-0c4b-4f0f-8942-58093a3dabf2">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa2453674034bfe8272f5598f29c014_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtMi0xLTEtNjc1MTI_2e2ae4d4-6a5d-44fb-8f77-504c619ce933">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f221a3ec78445e79e65fa93472e8585_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtMy0xLTEtNjc1MTI_197002dd-fd7d-4705-a482-33cca774cdd8">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5e26180f2064b60a601613f3b0d3643_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtNC0xLTEtNjc1MTI_2f0f05ce-2143-4863-92c3-971f22373bda">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af94175dd994714a8a7faae0f0e5212_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtNi0xLTEtNjc1MTI_1393d38f-b3d0-4b8a-82bf-732321b52e40">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebb892ad00ab49ed8566342454fa928c_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtNy0xLTEtNjc1MTI_b1246fa5-63a0-44c4-9c2a-ddee65879ed5">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4989346074144770b6adc1234e579021_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtOC0xLTEtNjc1MTI_2eb5bc9a-5679-4549-afcc-05bf0af1499a">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70cd65a985648138af1f3c043a64290_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctMi0xLTEtNjc1MTI_12dc3d94-b3af-4f54-a164-3200ea1c2d1a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70cd65a985648138af1f3c043a64290_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctMy0xLTEtNjc1MTI_8a99b0ef-fc89-41a2-9151-4776ecec9a0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70cd65a985648138af1f3c043a64290_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctNC0xLTEtNjc1MTI_5a2f9ce9-2080-4be6-bf27-c8adfccc2f5e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if507dc7fc59b47fea1f9ddc4fc902174_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctNi0xLTEtNjc1MTI_89dba83b-7b4e-4b74-b8d0-a4cc2d9ca5db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if507dc7fc59b47fea1f9ddc4fc902174_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctNy0xLTEtNjc1MTI_6f664402-4ed1-483a-a026-998ceafb6d1f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if507dc7fc59b47fea1f9ddc4fc902174_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctOC0xLTEtNjc1MTI_7cb3a4bf-9605-41e4-a34d-e377d07b4553">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe2788b715640b4b52cee7ba7637f83_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtMi0xLTEtNjc1MTI_6e9117a3-a0fb-4619-9672-3f9e50bbb788">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe2788b715640b4b52cee7ba7637f83_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtMy0xLTEtNjc1MTI_c9eece65-5352-4fca-821d-8c0784984d63">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3508fc7db8ac40f1a7ea81409ab7678f_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtNi0xLTEtNjc1MTI_1e657728-d572-430e-80a3-f3ef61824d2f">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3508fc7db8ac40f1a7ea81409ab7678f_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtNy0xLTEtNjc1MTI_64c23ae6-b3fe-43e9-8d52-9712c00017f0">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTItMS0xLTY3NTEy_90f1358d-252e-4fea-9628-d3afe58a25c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTMtMS0xLTY3NTEy_4c4cdbb0-9b07-469d-b63c-e15946cff764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTQtMS0xLTY3NTEy_0aa1a86e-7c2b-45fa-8311-b62a3255b906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTYtMS0xLTY3NTEy_f1e921e4-851f-4501-bc64-ac98efb946b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTctMS0xLTY3NTEy_aeee1ebd-7e11-4111-8806-f744ce2c05a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTgtMS0xLTY3NTEy_b27dfef2-17a6-45cd-859d-c729beacb44b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8840acf2e77d44af9a2a8cb81017cda9_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTItMS0xLTY3NTEy_f94697a9-fd65-4640-942a-883fdecf1beb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8840acf2e77d44af9a2a8cb81017cda9_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTMtMS0xLTY3NTEy_4d1061c0-a8e3-4d9a-9dfc-24e459c0c8a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8840acf2e77d44af9a2a8cb81017cda9_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTQtMS0xLTY3NTEy_1938e7f0-64f1-42e7-a4b4-eb4e7168abdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTYtMS0xLTY3NTEy_08d93ef7-bd8e-4f41-8792-1646e5fee102">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTctMS0xLTY3NTEy_4bfd46fe-df82-40a0-b38b-6c360e7d4a51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTgtMS0xLTY3NTEy_e240ec16-fffc-47a7-9c67-eee2a2c87c6d">10</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374b081d61104014bfe452acfb9cbcf4_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTItMS0xLTY3NTEy_3108f2ae-17dc-4827-82b0-00c67fcf6d43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374b081d61104014bfe452acfb9cbcf4_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTMtMS0xLTY3NTEy_ec5a3350-ec37-445a-92a7-dccc1f40aeaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3cb819d9d034281bc184dd6e2359115_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTYtMS0xLTY3NTEy_daca0999-9ce9-4eff-b7fb-86c0b4819818">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3cb819d9d034281bc184dd6e2359115_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTctMS0xLTY3NTEy_aa4af045-abed-4d94-88db-09b22c7db1e6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 16, &#8220;Fair Value Measurements,&#8221; for more information on these recurring fair value measurements.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_157"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzcyMTA_5b10c059-4a16-4126-aa73-7ef4e2bdbaee" continuedAt="i691ad8a633324602ac75a6dec4753076" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i691ad8a633324602ac75a6dec4753076" continuedAt="i5eb4db2182b447fea6dad1041157ef20"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March 31, 2022 and 2021 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-5" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg4OTI_069b3c97-8719-4f09-a96c-9956f79d7352">981</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-8" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg4OTY_412fc5b3-9968-4197-ab60-7fb689986bcd">1.6</ix:nonFraction> billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at March 31, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 15, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i5eb4db2182b447fea6dad1041157ef20" continuedAt="i789b11370f8946778a12a54dff007d29"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg5NzQ_b05abe84-2374-42b0-901c-8674c1bf1646">346</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg5Nzc_5f30f5d9-7ce2-47de-bf00-606736504a05">269</ix:nonFraction>&#160;million at March 31, 2022 and 2021, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. During 2022 and 2021, certain of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. Additionally, in 2021, certain of the Company&#8217;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of 2021. Net gains related to the Company&#8217;s investments in these equity securities were approximately $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDk3MDA_2e3fb952-776b-460a-837f-0e3f957d559a">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDk3MDg_8269916c-960a-4aec-8344-ddae0a23393e">133</ix:nonFraction> million, respectively, for the years ended March 31, 2022 and 2021. These net gains were recorded in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges, including long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the assets and liabilities associated with the E.U. disposal group and U.K. disposal group classified as held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale." Additionally, at March 31, 2022, assets measured at fair value on a nonrecurring basis included certain long-lived assets within the International segment related to the Company&#8217;s operations in Denmark and its retail pharmacy businesses in Canada, as discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and its Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; and Financial Note 11, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i3fe727da0df047e9a85ea9962c4b400d_I20220331" decimals="INF" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NTEzNTE_768ead4e-ea99-484a-b909-0731d31cdd98"><ix:nonFraction unitRef="usd" contextRef="ie9ec224cf4764392959e53320ef9a081_I20210331" decimals="INF" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NTEzNTE_face4478-d2b5-4748-91c5-fd6686c8645d">no</ix:nonFraction></ix:nonFraction> other liabilities measured at fair value on a nonrecurring basis at March 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022 and 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzcyMTQ_d90ae671-7e7e-4208-9d8a-d7ce0528262f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is also recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407dcd9fcbb146db960f9ded6cee8015_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItMS0xLTEtNjc1MTI_88ab1b29-45ea-463d-a51e-0580d1c347b5">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407dcd9fcbb146db960f9ded6cee8015_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItMy0xLTEtNjc1MTI_c4d9b6d7-e913-4ba2-8d52-981095c95ca3">5,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d3f99f4a8e4b5aba1d005bdf779310_I20210331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItNS0xLTEtNjc1MTI_aa8b079d-bc03-4457-ae4f-507eb50c08a1">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d3f99f4a8e4b5aba1d005bdf779310_I20210331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItNy0xLTEtNjc1MTI_d8b8c47e-1c0a-48ca-a352-c241d8b695f4">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i789b11370f8946778a12a54dff007d29"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 11, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information regarding goodwill impairment charges recorded for certain reporting units during 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_160"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="mck:FinancialGuaranteesAndWarrantiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzM0MDM_c8a988b5-d711-4b44-8431-bbcdb68f9eab" continuedAt="if4b6a2e3719a45b0983edb77a5435858" escape="true">Financial Guarantees and Warranties</ix:nonNumeric></span></div><ix:continuation id="if4b6a2e3719a45b0983edb77a5435858" continuedAt="i269285a1b0aa4b60bda6bfcf11c069e6"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Guarantees</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain of its customers&#8217; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#8217; inventory or its customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#8217;s inventory repurchase agreements, among other requirements, inventories must be in a resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDA_c483e2c9-dff3-4b92-bc09-7d0567550317">one</span> to <ix:nonNumeric contextRef="i98c151bfae0f42a4b2ce4521c05e9acf_D20210401-20220331" name="mck:GuarantorObligationsPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDQ_d070a0ed-a14a-4b94-a047-2f0faa135eb3">two years</ix:nonNumeric>. Customers&#8217; debt guarantees generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTI_c01062b2-22fa-48c8-ab15-ad2d5e0ffc41">one</span> to <ix:nonNumeric contextRef="ibfe76b97b0b24598b07f33f5ca016907_D20210401-20220331" name="mck:GuarantorObligationsPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTU_4b45b509-e259-4840-91df-8bfa7b3b822e">10</ix:nonNumeric> years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#8217;s customers&#8217; debt guarantees are secured by certain assets of the customer. At March 31, 2022, the maximum amounts of inventory repurchase guarantees and customers&#8217; debt guarantees were $<ix:nonFraction unitRef="usd" contextRef="i77cf6c86ae8c46a682b412b3e0abac24_I20220331" decimals="INF" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyNzY_93972f97-1b55-4eb3-bbf1-ab0fe4b8bff6">367</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2934427a7be2467d8b52f822c45c8593_I20220331" decimals="INF" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyODA_3150a0fd-48b7-491d-b920-ec696f1dfe35">84</ix:nonFraction> million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees are as follows: $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyOTc_2f199ef3-db55-433f-8093-09205480bcdb">309</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMDA_a4a3b42c-d095-46b4-97e4-d1488e15e5c3">45</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMDQ_e2d6176c-9e6e-479e-9310-7eb7ed6966aa">6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMDg_a149db6b-b491-4f21-b746-479b3fa4ffc5">15</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMTM_e5bc738c-9947-4e26-9218-105962241188">12</ix:nonFraction> million&#160;from 2023 through 2027, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMTY_899734ba-7af5-4764-a592-31a080978242">64</ix:nonFraction> million thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company&#8217;s banks and insurance companies have issued $<ix:nonFraction unitRef="usd" contextRef="i60f79f2c96f24d718707c887c792a696_I20220331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyNTI_fa338a1d-07eb-4a56-a5cb-2d95678eb3dd">214</ix:nonFraction> million of standby letters of credit and surety bonds, which were issued on the Company&#8217;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and its workers&#8217; compensation and automotive liability programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#8217;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i269285a1b0aa4b60bda6bfcf11c069e6"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug, and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_163"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI3NDg3NzkxMzkzNTg_e921a1d4-9f70-4515-9566-90fb5dede146" continuedAt="ie1e9509a9994465bb71787d56142e393" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><ix:continuation id="ie1e9509a9994465bb71787d56142e393" continuedAt="i3565f6010b85413fbd03a1e67253b4f3"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, the Company and the <ix:nonFraction unitRef="product" contextRef="i4f60f777e8754ae3b0d798ac833ac49f_I20220225" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjY2MDA_b22c81cd-d17d-4135-bccc-9ed03565939c">two</ix:nonFraction> other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions were satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. On February 25, 2022, the Distributors determined that there was sufficient State and subdivision participation to proceed with an agreement ("Settlement") to settle a substantial majority of opioids-related lawsuits filed against the Distributors by U.S. states, territories, and local governmental entities. As previously disclosed, <ix:nonFraction unitRef="product" contextRef="ia875aad6cce743958618a33cce559dc9_I20220331" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTgxOTA_22794b24-7b1d-49cc-8b5c-83b85721e663">46</ix:nonFraction> of <ix:nonFraction unitRef="product" contextRef="ia875aad6cce743958618a33cce559dc9_I20220331" decimals="INF" name="mck:LossContingencyNumberOfEligibleStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTgxOTQ_6ad86dd7-78fd-44f2-a049-0819ff60895e">49</ix:nonFraction> eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;), have agreed to join the Settlement. To date, over <ix:nonFraction unitRef="number" contextRef="ia875aad6cce743958618a33cce559dc9_I20220331" decimals="2" name="mck:LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTgxOTk_8a9d57eb-870f-4dd5-833a-9d0ec8099c24">98</ix:nonFraction>% of eligible political subdivisions that have brought opioid-related suits against the Company, as calculated by population under the agreement, have agreed to participate in the settlement or have had their claims addressed by state legislation.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i3565f6010b85413fbd03a1e67253b4f3" continuedAt="i4e4775b81013494080d8a8b957b04d86"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement became effective on April 2, 2022. If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $<ix:nonFraction unitRef="usd" contextRef="i8ee8208665914ed2bf9222d6977c182f_D20220402-20220402" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2MzE_2f576fa4-c441-4b6a-a29b-f563d469bad0">19.5</ix:nonFraction>&#160;billion over <ix:nonNumeric contextRef="i8ee8208665914ed2bf9222d6977c182f_D20220402-20220402" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2NDU_c3ea55dd-4cd7-4756-bf6b-57708f158c4d">18</ix:nonNumeric> years, with up to approximately $<ix:nonFraction unitRef="usd" contextRef="i4f7c4180c7d349cdad921bd625aef19c_D20220402-20220402" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2NDc_db07743b-9f40-4b6e-96ab-2af3b68fd566">7.4</ix:nonFraction>&#160;billion to be paid by the Company for its <ix:nonFraction unitRef="number" contextRef="if5f3b6a5a5224458ab102b9be37642c2_I20220402" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2NjE_2b80c17e-c318-4759-816f-ea2c4b05b22e">38.1</ix:nonFraction>% portion. Under the Settlement, a minimum of <ix:nonFraction unitRef="number" contextRef="i1ef52d9fd4b04fa4ade734933f7afdc0_I20220402" decimals="2" name="mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2Njg_9204b25c-3bc5-4770-a157-936f008b26ea">85</ix:nonFraction>% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before the effective date of the Settlement, the Company entered into separate settlement agreements with the states of New York, Ohio, Rhode Island, Texas, and Florida. These states intended to participate in the Settlement when it was finalized, and these agreements provided that each state and its participating subdivisions would receive a settlement consistent with their allocation under the comprehensive Settlement framework, as well as, in some cases, certain attorneys&#8217; fees and costs. Now that the Settlement has become effective, these separate settlement agreements have become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three eligible states, Alabama, Oklahoma, and Washington, did not join the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement in principle under which the Company will pay $<ix:nonFraction unitRef="usd" contextRef="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjQ0MjY_8ea80b21-aab7-4bb0-b5cf-a68933768d38">141</ix:nonFraction>&#160;million in <ix:nonFraction unitRef="installment" contextRef="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402" decimals="INF" name="mck:LossContingencySettlementNumberOfInstallmentPayments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI5MTM3MDU4MjYzMjky_89ea3aaa-89a0-41f4-ab84-11c53871c02a">ten</ix:nonFraction> equal annual installments and an additional approximately $<ix:nonFraction unitRef="usd" contextRef="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjQ0NjY_47f6f6a4-a430-40c7-8473-95615190ff5c">33</ix:nonFraction>&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $<ix:nonFraction unitRef="usd" contextRef="i83583bb4d9614c5fa83041c913ae479e_D20220503-20220503" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjAxMzk_a2aaf6ca-9614-4a34-a0d2-f9fc20a3c3fc">518</ix:nonFraction>&#160;million, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="ie97b0337408f4e61a2e9c5103e016421_I20220503" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjAyNzY_9a9d18d6-9808-41b2-8591-f6515e304b29">38.1</ix:nonFraction>% (or approximately $<ix:nonFraction unitRef="usd" contextRef="i4e30da8843dc43c9ad33ff55a33b1d77_D20220503-20220503" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjAyODM_2e2ea090-e44f-4873-9a7f-411c1138acc3">197</ix:nonFraction>&#160;million), consistent with Washington&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. The claims of the Oklahoma attorney general are pending in the District Court of Bryan County, Oklahoma (Case No. CJ-2020-84, 85, and 86), and trial is scheduled to begin in January 2023. The Company&#8217;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements in principle or, where there is no agreement in principle, amounts equivalent to what that state and its subdivisions would have been allocated under the framework of the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Claims of various West Virginia subdivisions remain pending in both state and federal courts. Trial in the case of Cabell County and City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. The outcome of that trial is pending. The claims of certain other West Virginia subdivisions are pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Distributors for July 5, 2022. The Company&#8217;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $<ix:nonFraction unitRef="usd" contextRef="i4662a32533444a67872a829f9f186342_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkwMjI_70f707aa-de4e-43d1-baad-c25410306f86">75</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="ibb1ba0d32bc5422d928acee1595764cd_D20210928-20210928" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkwMzE_cc475d8b-2225-439a-a1b5-a2c26b696167">6.5</ix:nonNumeric> years to resolve opioid-related claims, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i3baef44f3b9f46039f19cbc1c9ac553f_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkxMDk_2fd8c4dd-e1d5-4905-bac2-d84446aac0e4">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="ibb1ba0d32bc5422d928acee1595764cd_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkxMzI_1e6752bf-c1dd-404d-a61c-0f2fe5327e73">29</ix:nonFraction>&#160;million). The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Distributors would pay the Native American tribes other than the Cherokee Nation approximately $<ix:nonFraction unitRef="usd" contextRef="i0753823b559c4b249d5e8a0ea960fe6e_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1MDE_bf7cc75e-edeb-4049-a77f-dfe9d80e7293">440</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="i9b2d108c832a4b15b42ef645fcac9c15_D20210928-20210928" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1MTA_3dbecd7b-e20f-468e-96d3-8e24fac2c347">6</ix:nonNumeric> years, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="ic52a333760c648e4b96056ff25230e21_I20210928" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1NTU_45c64dac-47a8-42e7-9af8-4887549cd67d">38.1</ix:nonFraction>% (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i9b2d108c832a4b15b42ef645fcac9c15_D20210928-20210928" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1Nzg_5b71723c-567d-4e17-b4a3-ccf54e9a10e2">167</ix:nonFraction>&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Distributors. Under these agreements, a minimum of <ix:nonFraction unitRef="number" contextRef="ic52a333760c648e4b96056ff25230e21_I20210928" decimals="2" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjI3MjY_dfb48b0e-51bd-4c2e-8253-e860534a04db">85</ix:nonFraction>% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#8217;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of March 31, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i4e4775b81013494080d8a8b957b04d86" continuedAt="ie7ebe5e07a694bd5b2a6fe72457835fa"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Settlement terminated the substantial majority of opioid-related suits pending against the Company, a small number of subdivisions in participating states have opted not to participate in the comprehensive settlement, and other suits brought by subdivisions in non-participating states remain pending. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has paid $<ix:nonFraction unitRef="usd" contextRef="i04c16ab737af40eb8c59705ef1b73c45_D20210401-20220331" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTg0Nzk_c6112a2e-08c4-4ff7-bf2a-823ed306cc09">157</ix:nonFraction>&#160;million in payments to date associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes.</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI3NDg3NzkxODcxNzE_25a94260-54cb-4f7e-9bed-d40d3d0edd49" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272671062b484a64b905316d40d3ac81_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzEtMS0xLTEtMTE5NjU0_a833f0fb-ac9d-48c5-b069-102ec35f5a0b">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeabc6ce6174d6d914bf4b541540d89_I20210331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzEtMy0xLTEtMTM0Nzk5_23fd4af0-9e24-47cc-8105-d1e55c7fb622">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272671062b484a64b905316d40d3ac81_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzItMS0xLTEtMTIxMDQx_09884f76-03d9-4b64-a4ac-a3e4bf146494">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeabc6ce6174d6d914bf4b541540d89_I20210331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzItMy0xLTEtMTM0Nzk5_80432de7-87ba-44b8-ab37-f4b3600b2c8f">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272671062b484a64b905316d40d3ac81_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzQtMS0xLTEtMTE5NjQx_19a696af-0f8a-4849-88f1-94beb7d2fabb">8,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeabc6ce6174d6d914bf4b541540d89_I20210331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzQtMy0xLTEtMTM0Nzk5_927e7a4f-ac05-451e-a71d-98079a695200">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet, is the amount estimated to be paid prior to March 31, 2023.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#8220;Long-term litigation liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2021.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the Settlement, the Company placed approximately $<ix:nonFraction unitRef="usd" contextRef="i71cd8720173a496486279e0544a6abce_I20210930" decimals="-6" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjYyOTk_fbb6c6d3-7f90-4e99-ad0f-96de752b291c">354</ix:nonFraction>&#160;million into escrow on September 30, 2021. During the second half of 2022, the Company placed an additional net $<ix:nonFraction unitRef="usd" contextRef="ic7cf3ce788524e9fb74bf1ade9cde623_I20220331" decimals="-6" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjYzMTM_28649783-f437-4006-acee-1b4890ddaf19">41</ix:nonFraction>&#160;million into escrow to reflect the participation of additional states, and as part of a separate agreement in principle with the Alabama attorney general. Those escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Consolidated Balance Sheet as of March 31, 2022. These amounts excluded the proportionate allocation under the Settlement for each non-participating state. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as <ix:nonFraction unitRef="case" contextRef="i12913f42c838424a97ff6d451699968c_I20220331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MzUzNDY_db48fe30-2cc1-45cb-a78c-54e78d35f556">four</ix:nonFraction> cases brought in Canada (<ix:nonFraction unitRef="case" contextRef="i4f2b5de2b7964c299fe4538bbce99201_I20220331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MzUzNzc_8ffeb0bf-9f0d-4b66-99fa-6c9075d4606f">three</ix:nonFraction> by governmental or tribal entities and <ix:nonFraction unitRef="case" contextRef="i6f1569fe7f254494bbcf927a0376e97c_I20220331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MzU0MjI_f3578540-3268-4320-b68a-2910db673673">one</ix:nonFraction> by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. Trial is scheduled for July 18, 2022 in one such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CE19-00472. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2018, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Manchester v. Purdue Pharma, L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within&#160;<ix:nonNumeric contextRef="i2743565c13d0440d9c782b3823bb2dbc_D20190225-20190225" name="mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzExMTUy_a4354753-3177-470c-81d2-05d990286701">90</ix:nonNumeric> days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie7ebe5e07a694bd5b2a6fe72457835fa" continuedAt="ib3cd341731b24cc3a9beb9e020fd8864"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with <ix:nonFraction unitRef="complaint" contextRef="i987dad20a95b4cbdb8b7627a6eaa19cd_I20191231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzExNDc3_156e4b12-c567-4bda-b3b9-f8ed978ca5c4">two</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by the same <ix:nonFraction unitRef="relator" contextRef="i9fa583f3ec4d43c39a9e06debe72ee55_D20191201-20191231" decimals="INF" name="mck:LossContingencyNumberofRelators" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzExNTE3_b97190c6-ffc6-477d-b972-fc23ee233169">two</ix:nonFraction> relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit, which affirmed the dismissal on March 10, 2022. On June 28, 2021, the court in the state action dismissed the complaint with prejudice, and the relators appealed the dismissal to the Superior Court of California, County of San Francisco.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Coverage Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i66664fd861c54faf85787d6861f4bd01_I20201023" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEyMjIx_cf6c9dd2-7d02-44bf-bd7f-73e0ff2fd950">Two</ix:nonFraction> cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AIU Insurance Company et al. v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ace Property and Casualty Insurance Company v. McKesson Corporation et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. On April 5, 2022, the court issued an order granting partial summary judgment to the insurers that the Company&#8217;s defense costs in certain opioid-related litigation were not covered by two of the insurance policies.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$<ix:nonFraction unitRef="usd" contextRef="if6a7e381cd664bfead2365a491df4db8_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEzOTA2_d0edfe81-c345-468a-a20e-0284155d831d">500</ix:nonFraction>&#160;to&#160;$<ix:nonFraction unitRef="usd" contextRef="i349cf2789de1486e908e9763803d4227_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEzOTEy_be5d33ed-a95a-43e3-ad62-7b979bd680fe">1,500</ix:nonFraction>&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, <ix:nonFraction unitRef="faxnumber" contextRef="i14a8cc9bca31458291c36a5f215ed0bb_I20190813" decimals="INF" name="mck:LossContingencyClassActionNumberofFaxesRemainingintheClass" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE0Nzgw_a0a6602c-a994-4a8d-95b4-66102350b7c6">9,490</ix:nonFraction> fax numbers remain in the class, representing <ix:nonFraction unitRef="fax" contextRef="i14a8cc9bca31458291c36a5f215ed0bb_I20190813" decimals="INF" name="mck:LossContingencyClassActionNumberofFaxesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE0ODI5_4cf8772c-2d26-4610-a6e9-71664fe3f849">48,769</ix:nonFraction> faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $<ix:nonFraction unitRef="usd" contextRef="ia7b18f283c214a63941ca5f3aa2f1ba3_D20220427-20220427" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3Njc4NTg_713a45eb-a9d0-41ed-9cf7-74012af415c8">6,500</ix:nonFraction>.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by <ix:nonFraction unitRef="relator" contextRef="i1141187871d64de6b18824ede60c2f14_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfRelators" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjE4Mzc_a7f542d3-b0a6-42b6-986f-a8c16516d692">two</ix:nonFraction> relators, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="i1141187871d64de6b18824ede60c2f14_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjE4Mzk_23a0df1c-b279-49b5-8ba7-6f4a73f7ac31">21</ix:nonFraction> states and the District of Columbia, against USON and <ix:nonFraction unitRef="defendant" contextRef="i1141187871d64de6b18824ede60c2f14_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfAdditionalDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjE4NDI_48984dd2-3843-4cb5-8e6b-ea3283a54018">five</ix:nonFraction> other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al., CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#8217; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#8217;s motion to dismiss the claims pled against it, with leave to amend. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021. Plaintiffs filed a notice of appeal with the Court of Appeals for the Second Circuit on January 4, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ib3cd341731b24cc3a9beb9e020fd8864" continuedAt="i40dcd5823a0b4a8db69e521ea8226a05"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;) was served with a fifth amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hanks v. Amgen, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV-08-03096 (SJ). Previously, the U.S. declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#8217;s motion to dismiss. Following the relator&#8217;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#8217;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2018, a second amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint was filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="i14ac6ad34bca4c4691038eca05b20788_D20180403-20180403" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIyNjUw_77be683c-6115-4262-8568-15a8aaa642a9">30</ix:nonFraction> states, the District of Columbia, and <ix:nonFraction unitRef="city" contextRef="i272a1d83ed104933bc5777159d6a279b_I20180403" decimals="INF" name="mck:LossContingencyNumberofCitiesFiledOnBehalfOf" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIyNjkx_252aa551-1e7a-43e7-9e33-28ebc6425f14">two</ix:nonFraction> cities against McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc. and US Oncology Specialty, L.P., alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG). The United States and the named states have declined to intervene in the case. On October 15, 2018, the Company filed a motion to dismiss the complaint as to all named defendants. On February&#160;4, 2019, the court granted the motion to dismiss in part and denied it in part, leaving the Company and Oncology Therapeutics Network Corporation as the only remaining defendants in the case. On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of another complaint filed by the same relator, alleging the same misconduct and seeking the same relief with respect to US Oncology, Inc., purportedly on behalf of the same government entities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#8217;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic Center, LLC v. Becton, Dickinson, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#8217;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. Defendants filed a motion to dismiss the amended complaint, which the district court granted on March 15, 2021. Plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit, which affirmed the district court&#8217;s dismissal on March 18, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and <ix:nonFraction unitRef="officer" contextRef="i3ca99d687e7a44bf9addf006fbd8fc6c_I20181212" decimals="INF" name="mck:LossContingencyNumberofFormerOfficers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI2Mzgy_0cdc71b6-d8dc-4b00-80bb-e0950c97fbef">two</ix:nonFraction>&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#8217;s motion for class certification.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i40dcd5823a0b4a8db69e521ea8226a05" continuedAt="i0ebff6e7caa8498a861beac0f8843353"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, The Great Atlantic &amp; Pacific Tea Company (&#8220;A&amp;P&#8221;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re The Great Atlantic &amp; Pacific Tea Company, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Adv. Proc. No. 17-08264.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company&#8217;s subsidiary NDCHealth Corporation dba RelayHealth (&#8220;RelayHealth&#8221;) was served with <ix:nonFraction unitRef="complaint" contextRef="i7c871b75f43643cab2812bfd524754ec_I20191031" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NzY_4ee2b8b4-680c-4c9d-996f-888bc4b053b8">three</ix:nonFraction> purported class action complaints filed in the United States District Court for the Northern District of Illinois. The complaints allege that RelayHealth violated the Sherman Act by entering into an agreement with co-defendant Surescripts, LLC not to compete in the electronic prescription routing market, and by conspiring with Surescripts, LLC to monopolize that market, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Powell Prescription Center, et al. v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-06627; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-06778; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Falconer Pharmacy, Inc. v. Surescripts LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-07035. In November 2019, <ix:nonFraction unitRef="complaint" contextRef="i3ad0b32109f349168507a51c296e9f4a_I20191130" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0ODM_a0a959b5-bf48-455e-94c7-a57cc44d067e">three</ix:nonFraction> similar complaints were filed in the United States District Court for the Northern District of Illinois. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7445; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Whitman v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-7448; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BBK Global Corp. v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7640. In December 2019, the <ix:nonFraction unitRef="complaint" contextRef="i7e8e9b14a1e24dbd9dd4da9e2e12f251_I20191231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0ODg_56617245-5f3c-4590-a93f-fcd46af41929">six</ix:nonFraction> actions were consolidated in the Northern District of Illinois. The complaints seek relief including treble damages, attorney fees, and costs. Plaintiffs and RelayHealth reached an agreement in June 2020 to resolve the class action lawsuits and RelayHealth paid into escrow an amount not material in the context of the Company&#8217;s overall financial results. The settlement does not include any admission of liability, and RelayHealth expressly denies wrongdoing. The Court granted Plaintiffs&#8217; motion for final approval of the settlement on February 24, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., <ix:nonFraction unitRef="state" contextRef="id85d07627aee4db8896b725c019fcc18_D20200701-20200731" decimals="INF" name="mck:LossContingencyNumberofStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI5NTY5_b51d2954-bf71-4a9c-b006-9fd29dc4a153">27</ix:nonFraction> states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#8217;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough, and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017 and August 2018, respectively, the Company was served with&#160;<ix:nonFraction unitRef="case" contextRef="i72b34df8ae41427db43c35ab86ae900b_I20180831" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzMxMTA0_ac4e14d6-82ee-4af7-8b14-0db0b87f2b1d">two</ix:nonFraction>&#160;separate Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York relating to the certification the Company obtained for <ix:nonFraction unitRef="softwareproduct" contextRef="i72b34df8ae41427db43c35ab86ae900b_I20180831" decimals="INF" name="mck:NumberofSoftwareProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzMxMjY2_7112ecd2-215e-4044-bac4-e86a5a6439d4">two</ix:nonFraction> software products under the U.S. Department of Health and Human Services&#8217; Electronic Health Record Incentive Program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April and June 2019, the United States Attorney&#8217;s Office for the Eastern District of New York served grand jury subpoenas seeking documents related to the Company&#8217;s anti-diversion policies and procedures and its distribution of Schedule II controlled substances. The Company believes the subpoenas are part of a broader investigation by that office into pharmaceutical manufacturers&#8217; and distributors&#8217; compliance with the Controlled Substances Act and related statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the United States Attorney&#8217;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0ebff6e7caa8498a861beac0f8843353" continuedAt="i48d5e75d9f35485d8c206d7ccbdf54a8"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV was also part of the investigation. The Company resolved this matter in April 2022 by paying fines not material in the context of the Company&#8217;s overall financial results that had been fully reserved for in the third quarter of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding its and its competitors alleged sharing of competitively sensitive information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="INF" name="mck:OpioidStewardshipActNewYorkAnnualSurcharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjI4MDc_9e23a976-7a00-406a-8e12-fca4ff382ed4">100</ix:nonFraction>&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $<ix:nonFraction unitRef="usd" contextRef="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjI4MzM_68774fd6-e170-4a86-ba46-5e00db6071dd">50</ix:nonFraction>&#160;million pre-tax charge ($<ix:nonFraction unitRef="usd" contextRef="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331" decimals="-6" name="mck:LossContingencyAccrualProvisionAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzM0MDE4_def971fb-d1ee-4295-9d29-7e74479915cb">37</ix:nonFraction> million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. That petition was denied on October 4, 2021. In December 2021, McKesson paid $<ix:nonFraction unitRef="usd" contextRef="if0191e84fbf046f1bf6fa863cb4e56bf_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzQzOTgwNDY2Mzc0MTg_09c20829-396d-4d01-9f59-0667f57cea9e">26</ix:nonFraction>&#160;million for the assessment for calendar year 2017 while reserving all rights to challenge the constitutionality of the assessment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V.&#160;Environmental Matters</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily as a result of the operation of the Company&#8217;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at <ix:nonFraction unitRef="site" contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331" decimals="INF" name="mck:SiteContingencyNumberofSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MTQ_435dbaa3-0156-46ae-b59f-dd639174881c">five</ix:nonFraction> sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a determination by the Company&#8217;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#8217;s probable loss associated with the remediation costs for these <ix:nonFraction unitRef="site" contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331" decimals="INF" name="mck:SiteContingencyNumberofSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MjE_435dbaa3-0156-46ae-b59f-dd639174881c">five</ix:nonFraction> sites is $<ix:nonFraction unitRef="usd" contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingenciesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MzA_6f100f95-e8b0-4e49-b9ff-a37417ab8250">15</ix:nonFraction> million, net of amounts anticipated from third parties. The $<ix:nonFraction unitRef="usd" contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingenciesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0Mzg_6f100f95-e8b0-4e49-b9ff-a37417ab8250">15</ix:nonFraction> million is expected to be paid out between April 2022 and March 2052. The Company has accrued for the estimated probable loss for these environmental matters.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i48d5e75d9f35485d8c206d7ccbdf54a8"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been designated as a Potentially Responsible Party (&#8220;PRP&#8221;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at <ix:nonFraction unitRef="site" contextRef="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331" decimals="INF" name="mck:HazardousSubstanceSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NTE_5d19720c-dbe8-43b6-9f8c-ee026cf26714">14</ix:nonFraction> sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. At <ix:nonFraction unitRef="site" contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331" decimals="INF" name="mck:NumberofSitesSelectedforPreferredRemedy" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzM2NjI3_d55feaa4-1d25-4c8c-80ec-cf92368cc54f">one</ix:nonFraction> of these sites, the United States Environmental Protection Agency has selected a preferred remedy with an estimated cost of approximately $<ix:nonFraction unitRef="usd" contextRef="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331" decimals="-8" name="mck:EstimatedEnvironmentalAssessmentAndCleanupCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NTU_68f6d85e-bd2e-4dfb-898f-e06fab27b6e8">1.4</ix:nonFraction> billion. It is not certain at this point in time what proportion of this estimated liability will be borne by the Company. Accordingly, the Company&#8217;s estimated probable loss at those <ix:nonFraction unitRef="site" contextRef="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331" decimals="INF" name="mck:HazardousSubstanceSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NjE_5d19720c-dbe8-43b6-9f8c-ee026cf26714">14</ix:nonFraction> sites is approximately $<ix:nonFraction unitRef="usd" contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NjU_ddb1fbd3-b9c4-4b0d-9dfe-5d8b26bc3d56">29</ix:nonFraction> million, which has been accrued for in the Consolidated Balance Sheets. However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VI. Value Added Tax Assessments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various countries outside the U.S. which&#160;collect value added taxes (&#8220;VAT&#8221;).&#160;The determination of the manner in which a VAT applies to the Company&#8217;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received&#160;assessments for VAT&#160;which are in&#160;various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions.&#160;Certain&#160;VAT assessments relate to years covered by an indemnification agreement.&#160;Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.&#160;However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or&#160;results of operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VII. Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $<ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjMzOTA_ed3dc338-ef1e-410d-981d-309452441a1c">46</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjMzOTc_158cf316-b262-48e4-bd22-42a1adf9743c">181</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MDg_41a9cac9-702e-48c9-955c-c65c44d7174d">22</ix:nonFraction>&#160;million in 2022, 2021, and 2020, respectively, which were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VIII. Other Matters </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings, or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings, and claims will not have a material impact on the Company&#8217;s financial position or results of operations.</span></div></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_166"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzU2MzM_09ef7483-4393-478e-8704-c07c6f253833" continuedAt="ife4d3214bca94e68b8c2d88b0d6c83af" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="ife4d3214bca94e68b8c2d88b0d6c83af" continuedAt="i86d6b12bc1744b4db8482797195fa42a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="INF" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzI3NDg3NzkwOTE4MDE_d32daaf5-2749-49b6-93fa-937c0f85926e">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Board. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the quarterly dividend was raised from $<ix:nonFraction unitRef="usdPerShare" contextRef="ic33eab4418d04068bfb2c3d091c51f4a_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzcxNDY4MjU1ODYyMjI_f04ca35c-b7c0-4b51-99ca-4cb87d71b88e">0.42</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="icb6786f86e4c4e6d8af02b607fd8f48b_D20210701-20210731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzcxNDY4MjU1ODYyMjY_a6e20b39-4d08-4b5a-a2b3-657dcb5a1345">0.47</ix:nonFraction> per common share for dividends declared on or after such date by the Board. Dividends were $<ix:nonFraction unitRef="usdPerShare" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0Xzc2OTY1ODE0MDAyMzM_bac10196-3b8a-406a-81b2-eedcf389ec2e">1.83</ix:nonFraction> per share in 2022, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0Xzc2OTY1ODE0MDAyMjY_eab194eb-b4b5-46c2-b5b7-cb2398e8645e">1.67</ix:nonFraction> per share in 2021, and $<ix:nonFraction unitRef="usdPerShare" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0Xzc2OTY1ODE0MDAyMjE_b48af161-9737-4cb4-aeab-cfcf666f9fa5">1.62</ix:nonFraction> in 2020. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#8217;s future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. During the last three years, the Company&#8217;s share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i86d6b12bc1744b4db8482797195fa42a" continuedAt="i3da72979a7404554b980ecbb85513fc7"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:AcceleratedShareRepurchasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzU2Mjk_fbcd36a6-d914-4af1-94a9-9893ed7e9cd0" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding share repurchase activity over the last three years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzItNi0xLTEtNjc1MTI_4c143fba-6a17-4028-b87b-e76d74f0e195">3,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzMtMi0xLTEtNzI2NzM_89004116-60ce-41d8-9d0e-e38141c5a423">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzMtNC0xLTEtNzI2ODY_2a24d986-8e6e-409f-bac6-d0a2c6094164">144.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzMtNi0xLTEtNjc1MTI_a58b7c55-a5d9-4d37-bca7-8800878605d0">1,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2019 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzQtMi0xLTEtNjc1MTI_00bbe8fa-cae3-4efe-86df-c5afbeb6874d">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzQtNC0xLTEtNjc1MTI_6b4d8525-df9d-47ba-b4ce-7f304161f5fd">127.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzQtNi0xLTEtNjc1MTI_6cd2a59f-e33e-4c34-8c6b-dbaf2ff2bdfd">600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzUtNi0xLTEtNjc1MTI_d48a8715-491b-4b33-a29a-76f37ee792d9">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzYtNi0xLTEtNjc1MTI_cc24037d-d178-4fb5-9ab4-0ccbba3b1651">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzctMi0xLTEtNjc1MTI_25d0e6f8-6996-42be-9538-51e58da73d59">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzctNC0xLTEtNjc1MTI_c3c39a67-e425-4ddd-a763-08e762b41a29">160.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzctNi0xLTEtNjc1MTI_ccc4af40-7355-455f-a43d-891e6da1067f">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzgtNi0xLTEtNjc1MTI_5204034b-a421-41a3-a751-fde04cf86b9a">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASR</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzktMi0xLTEtNzI2NzM_31860f35-40a1-46ec-9002-215da7d48b0a">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzktNC0xLTEtNzI2ODY_e67c1c34-fd01-42ce-a7bf-afd396f28afd">193.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzktNi0xLTEtNjc1MTI_2901afb6-55e7-4e04-befc-b217f564027d">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEwLTItMS0xLTcyNjcz_a471fd14-d44c-446d-bca9-a92c6ac6828d">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEwLTQtMS0xLTcyNjg2_f83d7a63-30b2-4371-9794-70a76e1d10e1">217.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEwLTYtMS0xLTY3NTEy_11bf155d-05d5-4745-a96e-ece9a2889d14">1,007</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzExLTYtMS0xLTY3NTEy_f7b08633-6a22-4024-8e0b-89914e189071">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTItMS0xLTEwMzI0OA_2aa4c1c0-617f-48f6-bf77-ba6900258715">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTQtMS0xLTEwMzI0MA_c8dbaeec-c635-4ebd-83f6-1de74be47f48">265.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTYtMS0xLTEwMzIyOQ_1f86e6e3-0044-42a5-8fab-bb1c3e8a923f">1,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTYtMS0xLTY3NTEy_e2330004-35f3-49c5-b9ba-30e8edc53bb7">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to the Company&#8217;s Split-off of the Change Healthcare JV as described below.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $<ix:nonFraction unitRef="usd" contextRef="i4c08dc9e360548f496960579d4795f54_I20210331" decimals="-6" name="mck:AccruedShareRepurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzEwOTk1MTE2MzM2MzM_39d045b7-f921-4c2c-8185-9671640ca0d4">8</ix:nonFraction>&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="i28c6e70168da414cb0ac4e9c64318d06_I20220228" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzI3NDg3NzkwOTE3ODI_dde3d93a-6767-42ae-8c4a-932b649c334b">1.5</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2020, the Company completed the Split-off of its interest in the Change Healthcare JV. In connection with the Split-off, the Company distributed all <ix:nonFraction unitRef="shares" contextRef="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309" decimals="-5" name="mck:ExchangeOfferSharesDistributed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMjU_42a2fc7f-b303-440a-8ef0-f048dd19dea2">176.0</ix:nonFraction> million outstanding shares of SpinCo common stock, which held all of the Company&#8217;s interests in the Change Healthcare JV, to participating holders of the Company&#8217;s common stock in exchange for <ix:nonFraction unitRef="shares" contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309" decimals="-5" name="mck:EquityMethodInvestmentStockAccepted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMjk_eb64e49b-471f-4849-ab68-ab18cf273c01">15.4</ix:nonFraction> million shares of McKesson stock, which are now held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change with each share of SpinCo common stock converted into <ix:nonFraction unitRef="shares" contextRef="i4acf39f6c45042d9825177088805f18a_I20200310" decimals="INF" name="mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMzM_5b505a3d-42b4-4cd4-b5e0-bdbd77fd93df">one</ix:nonFraction> share of Change common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i4acf39f6c45042d9825177088805f18a_I20200310" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMzc_5af28c7d-cd37-4301-9e9c-ac7992792b94">0.001</ix:nonFraction> per share, with cash being paid in lieu of fractional shares of Change common stock. See Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for more information. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i3da72979a7404554b980ecbb85513fc7" continuedAt="ib215aaebea264c6f9ac25b346b104abd"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzI3NDg3NzkwOTE4MDk_421e193f-7e1a-4ba2-aa44-10255eca0a77" continuedAt="i795464add3824ab9b50cd70e5b0333f2" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive income (loss) by component are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f5d39fcc93f468db79dbc8f03cfc331_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMS0xLTEtMTAzMzQz_bc26c026-d95b-4853-bce0-4d55f453cd4c">1,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b7452f966eb4322aa52d896f745263f_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMy0xLTEtMTAzMzQz_4d41bb73-266c-4fad-959e-65e869b79846">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38e0059bd2b14949ab11b259c08962df_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNS0xLTEtMTAzMzQz_918a8914-125e-4444-955c-64d78968efdc">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8ce6232f2024c3c85f71080415b78ce_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNy0xLTEtMTAzMzQz_a129ddec-d536-4a88-8d30-f38ecf3c2128">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cd9f0cb497242a6826289cfb5fdad80_I20190331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItOS0xLTEtMTAzMzQz_2ba40a10-bb8d-4ab5-93a6-c156bd88595d">1,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMS0xLTEtMTAzMzQz_180de59b-d090-4852-a4cd-63e04d1503d7">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMy0xLTEtMTAzMzQz_1813a0cf-db9c-41f2-a252-5f8253cfca72">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNS0xLTEtMTAzMzQz_9cc0de86-9f26-4406-9afe-d7acf35c4de4">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNy0xLTEtMTAzMzQz_25d44a08-6f0d-4269-bde6-b8b666aae1af">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtOS0xLTEtMTAzMzQz_d2a4a71e-7ced-495e-9797-65fc2a482523">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMS0xLTEtMTAzMzQz_8916139c-e39a-46e7-afeb-012e95d6af28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMy0xLTEtMTAzMzQz_a332b863-66ad-42c4-b046-2f1e98669e2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNS0xLTEtMTAzMzQz_a23370d9-7e8c-4e76-8283-396eabf0cc5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNy0xLTEtMTAzMzQz_0f0baa68-91cf-4eea-a0dc-535562d571fe">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtOS0xLTEtMTAzMzQz_8be42fce-a300-453f-a352-c1b1770b0cad">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMS0xLTEtMTAzMzQz_16229095-f42d-4daf-827f-bbe01b2402fa">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMy0xLTEtMTAzMzQz_13b283cb-014d-4e70-a6b2-1e4d5ee60fae">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNS0xLTEtMTAzMzQz_e13c6f8a-19ea-4bd6-9dc1-0ad0332e997c">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNy0xLTEtMTAzMzQz_3d7aae21-5775-4975-b933-b8a3a5fd8e1e">129</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtOS0xLTEtMTAzMzQz_fd127516-af97-4b1a-b670-cede717d6554">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMS0xLTEtMTAzMzQz_85583a6d-104c-4437-bafa-4aabcf9da403">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMy0xLTEtMTAzMzQz_0c625d73-da0b-4e9d-b39e-aefad7b65316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNS0xLTEtMTAzMzQz_61e66b8a-4d10-4651-a720-af2ec23c7d25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNy0xLTEtMTAzMzQz_2eb38289-740c-4f38-a0db-a3b5f7670560">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtOS0xLTEtMTAzMzQz_3e5cd21a-5b90-48c5-a79d-1e72d3942ffe">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMS0xLTEtMTAzMzQz_002e31d7-3825-4767-8a85-4d21ca984539">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMy0xLTEtMTAzMzQz_962d9c1f-3893-473a-8486-ae43521aff73">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNS0xLTEtMTAzMzQz_f2964bea-59ef-422a-b301-d169743884ae">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNy0xLTEtMTAzMzQz_90b90ea5-8bce-4c23-a88c-72b3d304beb3">127</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctOS0xLTEtMTAzMzQz_31f217f0-1ead-4279-bb23-cb37ec93f952">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1af057e14a6c4a569ffbf7f13a871e72_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMS0xLTEtNjc1MTI_c5bdff42-8733-418c-98b3-a0c406affb37">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c6f6a5ff29462b9d28c777bd2bd274_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMy0xLTEtNjc1MTI_caff038e-1a6f-429e-ad3c-52e1fd513c0a">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad4ab28ad0e4703b8f21cbc668994aa_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNS0xLTEtNjc1MTI_94c86e64-026d-4866-9c8c-671012536a68">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa805c2e2cb74e2fb138905ae2d6aeb5_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNy0xLTEtNjc1MTI_0c8c602d-c5ca-4443-9fa7-70a1d7c0ecd7">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83f0aa9722f4476ca58477e03a36b9f4_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItOS0xLTEtNjc1MTI_be3550a3-c6fe-412d-a061-c53ec43a0df0">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMS0xLTEtNjc1MTI_865ebf36-5bc4-42d2-9a1f-9829a86a08fe">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMy0xLTEtNjc1MTI_58c614f7-be69-4363-95df-37513c75b05c">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNS0xLTEtNjc1MTI_084be150-ef27-4c79-a4e2-1a7bf157fca3">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNy0xLTEtNjc1MTI_4bd91282-0aee-4d71-87fb-6bcc36481221">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtOS0xLTEtNjc1MTI_00eb6432-6b9a-48dd-b27d-cf43615e45d5">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMS0xLTEtNjc1MTI_906be0de-aae1-4bc5-b900-b5c8ab021162">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMy0xLTEtNjc1MTI_9f6e58d3-bc14-4d76-8fe4-3ca51c375c28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNS0xLTEtNjc1MTI_ece76d8a-31e7-473b-8fb9-99601cd532b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNy0xLTEtNjc1MTI_385e2b40-23e6-4818-9350-907bc531dc76">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtOS0xLTEtNjc1MTI_59410b40-b9c3-4664-84bc-274a52812960">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMS0xLTEtNjc1MTI_28311fbe-519e-42cd-80e7-4a5f7cfa8076">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMy0xLTEtNjc1MTI_7e9c3fd3-ca4b-4708-9e9e-c2d6311d6e4a">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNS0xLTEtNjc1MTI_a1053b29-c47c-48ba-8cbe-ef118bc51310">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNy0xLTEtNjc1MTI_29894133-b550-4ef9-8e21-8aa2949d1957">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtOS0xLTEtNjc1MTI_0e3bef2d-89c9-4d67-95db-f77eb6a66171">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMS0xLTEtNjc1MTI_13f2e690-ff9b-4454-b89b-2c2e75d10fbd">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMy0xLTEtNjc1MTI_ddb8535a-a677-4ff3-9315-172bfb8747cd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNS0xLTEtNjc1MTI_c426e90c-5011-46c6-9849-497143d5ee78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNy0xLTEtNjc1MTI_729ea06f-a84b-4354-9b80-db996be4898d">8</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtOS0xLTEtNjc1MTI_84a7e2af-238c-4d52-a45a-5fdcebbd1438">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMS0xLTEtNjc1MTI_bc0b69e1-327f-438c-b67a-ddb6ece25108">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMy0xLTEtNjc1MTI_b093ba60-1fd8-440a-8b08-9fe3f43e5475">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNS0xLTEtNjc1MTI_6f4639a9-dc5c-471c-bebe-58c29953cfca">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNy0xLTEtNjc1MTI_259d72cd-8c4e-4a62-beb4-000b4306c074">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctOS0xLTEtNjc1MTI_e881604e-e487-48f6-95bf-526a29e6d1d1">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85cd2ff97d53454f89e0a9769c6b9cdc_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtMS0xLTEtNjc1MTI_ec6e2128-f5c9-4ec4-bede-e64c5cfed96f">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a18c76ff5b34fad9b94fc6bc03eeab7_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtMy0xLTEtNjc1MTI_46771e7d-83c8-4406-bd2b-06132fe533a1">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec5e0ac198fc4744ac896c1d7596fdf5_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtNS0xLTEtNjc1MTI_40278a76-7bdc-47bd-ad35-179f20a70753">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icda474b56c3e4aa1a24ed971c975e0f8_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtNy0xLTEtNjc1MTI_42ff4538-5e0a-4c4d-9ddf-024d85cabfc8">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0f038c81a5a4b8198d4c97be9e3cfa7_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtOS0xLTEtNjc1MTI_e95f629e-7207-4389-8130-0991708acbbe">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktMS0xLTEtNjc1MTI_fcb704bf-bab8-4937-8ea6-86a632325d73">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktMy0xLTEtNjc1MTI_72d3cb3c-8dcb-46f4-b1a8-a46f8eb01d01">41</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktNS0xLTEtNjc1MTI_b0b34ce4-28a9-442d-8367-309344480cbb">18</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktNy0xLTEtNjc1MTI_ee2cf3d2-922f-4bf4-8d48-84949cc196df">31</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktOS0xLTEtNjc1MTI_f88375c3-1f77-4687-971a-e97ec00d51a3">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTEtMS0xLTY3NTEy_d22f0b2f-5ca5-4779-a928-3f948411c9e8">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTMtMS0xLTY3NTEy_8fc67e53-c57d-4ce2-a51c-063a1b09faa1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTUtMS0xLTY3NTEy_396197d6-1af1-4e51-a147-921fec86df5b">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTctMS0xLTY3NTEy_47cfc860-d414-45ec-bea2-1fd68d481e99">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTktMS0xLTY3NTEy_39dc881d-c17d-4364-afd1-d068cf8849b6">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTEtMS0xLTY3NTEy_a99199a6-54e5-4435-b45d-f869afd7415d">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTMtMS0xLTY3NTEy_a4e715f0-be31-47f4-9751-a0a7441d76fb">40</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTUtMS0xLTY3NTEy_b534068e-a34b-436f-a87a-cf8e22b4f53a">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTctMS0xLTY3NTEy_7f1b68be-2eee-45df-8262-d7cb74b60fa1">41</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTktMS0xLTY3NTEy_48c00fa2-0adc-4e6a-9204-3636f7db2606">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTEtMS0xLTY3NTEy_66ed6a8f-4b8a-4d3e-b1b5-806e713b128d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTMtMS0xLTY3NTEy_3e064b9f-3448-4e5d-aa69-889738b18e01">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTUtMS0xLTY3NTEy_bf75e8ff-ebd2-4666-98a1-eb147c2623f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTctMS0xLTY3NTEy_d262177c-4695-43f4-944d-07c5ce5a8f4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTktMS0xLTY3NTEy_cbdd281f-2017-41b0-bc63-ced056ee51f0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTEtMS0xLTY3NTEy_cd23e352-8bc9-4cad-9d58-fd9861f50e85">15</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTMtMS0xLTY3NTEy_76eb8f47-259a-4966-ba21-cfe7d0cc2598">46</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTUtMS0xLTY3NTEy_216dab95-7fb0-45d9-8c21-0740b631e80b">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTctMS0xLTY3NTEy_0b74963f-9be3-49f7-bcd3-3e672407e0f1">41</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTktMS0xLTY3NTEy_79b18c6e-abec-4385-9101-49949d256cf9">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTEtMS0xLTgzODY0_8b8842f4-acc2-4a07-905c-8a3e41ca05fc">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTMtMS0xLTgzODc1_32cdb6bb-39ba-436d-8189-866045f8ae6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTUtMS0xLTgzOTEx_a795ece0-2b99-4e1a-9830-3f68b11a6471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTctMS0xLTgzOTE0_ba510e58-3da2-4009-8b68-f56fd2aebfdc">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTktMS0xLTgzOTE4_e9a54ece-ec96-4dbb-8e13-d8d246f245b2">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5deabb24d12941e896a4e688121d8f30_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTEtMS0xLTY3NTEy_e0d02add-edc7-43de-bf4e-da30cb70b3de">1,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9922f80e4f24738b404cca8c87f73bd_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTMtMS0xLTY3NTEy_7888bd53-2ac4-4189-8edd-d439ff8ba49e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fff78ca4ca84ca68f9917ec5e4784fe_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTUtMS0xLTY3NTEy_4cf85ad9-7fe4-4f98-bfbc-86f1561477d0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie93e1536edc94513a25b75692a412434_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTctMS0xLTY3NTEy_4a426fc5-cc88-4667-bd91-a5acc5a0bbf4">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3e04acff1af415fb304c565efd6376b_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTktMS0xLTY3NTEy_5b57b03f-66a2-423a-927f-c820fe93b387">1,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts before reclassifications recorded in 2022, 2021, and 2020 include gains (losses) of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU5MTM_09e3863a-3583-4f72-bc69-de93cbe51018">73</ix:nonFraction>&#160;million, $(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU4NzQ_c69d4e04-ece3-4a7d-a446-3af3b5167891">118</ix:nonFraction>)&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU4OTU_c2243396-520a-4fd9-9be4-5b4eceb5ff98">39</ix:nonFraction>&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $(<ix:nonFraction unitRef="usd" contextRef="i22b34b6e8ced4d97b4d47ddb2965e898_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzYxMzc_5c96dcca-9948-4de7-b712-24aacb72d0fb">4</ix:nonFraction>)&#160;million, $(<ix:nonFraction unitRef="usd" contextRef="ifaa55b6bf9f44cd1a8a25b42288d0593_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzYxMDk_a42faae8-e6c5-4da1-97e8-69bf617b1118">119</ix:nonFraction>)&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i1f9cac9e86284785ab4d70600ae33ad6_D20190401-20200331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzYxMjM_19caeddb-7c35-4561-99d7-d36f5f822b6b">76</ix:nonFraction>&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(<ix:nonFraction unitRef="usd" contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzY0Mzg_ad53dfe0-6a85-4d73-b031-87e0c965817d">23</ix:nonFraction>)&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzY0NTA_7dcccba0-0f06-4693-a251-68fa50dca514">62</ix:nonFraction>&#160;million, and $(<ix:nonFraction unitRef="usd" contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzY0NjM_3f7dee84-580b-4462-9848-a9b0ad356374">30</ix:nonFraction>)&#160;million in 2022, 2021, and 2020, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ib215aaebea264c6f9ac25b346b104abd"><ix:continuation id="i795464add3824ab9b50cd70e5b0333f2"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily reflects a reclassification of losses of $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzUzNzQ_0ad13d4f-6a7c-487e-b567-857f5ccdfcb3">127</ix:nonFraction> million, net of $<ix:nonFraction unitRef="usd" contextRef="i073988a4a0ef43228b2f01d389f330b2_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU3NTk_b4b02431-722c-4a95-881d-da04ebcbb081">33</ix:nonFraction>&#160;million of income tax benefit, predominantly on the termination of the Company&#8217;s U.S. defined benefit pension plan from &#8220;Accumulated other comprehensive loss&#8221; to &#8220;Other income, net&#8221; in the Company&#8217;s Consolidated Statement of Operations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Held for Sale&#8221; and Financial Note 6, &#8220;Other Income, Net.&#8221; These amounts were included in the 2021 and 2020 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the Company&#8217;s Austrian business, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included in the 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statement of Operations.</span></div></ix:continuation></ix:continuation><div id="i4b4e3b23ed904498bf3396ff0593cb05_169"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzI3NDg3NzkwNzUwODY_63c28276-25ec-41cc-b535-46babfdede75" continuedAt="i0f2ea7fcebcf491896b91f85fbc43ea1" escape="true">Related Party Balances and Transactions</ix:nonNumeric></span></div><ix:continuation id="i0f2ea7fcebcf491896b91f85fbc43ea1" continuedAt="if119041cb25d488aaf3e5cb657d9fb05"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $<ix:nonFraction unitRef="usd" contextRef="icbf8232e206747f2be913302ec5dbaaf_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0NTk_6ea42a4f-fd53-410b-91d1-f42a18f69dd9">137</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia70ab04be4fc4669bf6269d283c9c79e_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0MzE_5474e5e0-a6a9-4acd-85a1-1c0f06f08033"><ix:nonFraction unitRef="usd" contextRef="ia70ab04be4fc4669bf6269d283c9c79e_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0MzE_e130dbb8-0f18-449a-915b-753b70bb61d1">178</ix:nonFraction></ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i91df3cbe60584b50a204d33eeeed8980_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0Mjc_1e88484f-b882-4070-ace3-f2da83de8b7a">141</ix:nonFraction> million are included in the Consolidated Statements of Operations for the years ended March 31, 2022, 2021, and 2020, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March 31, 2022 and 2021. Predominately all of these pharmacies were divested from the Company in the fourth quarter of 2022 as part of the completed sale of the Company&#8217;s Austrian business, while certain other remaining pharmacies are included in the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, 2021, and 2020, the Company&#8217;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $<ix:nonFraction unitRef="usd" contextRef="iaf9c8554b2fb4c5fbdc95411f1908eac_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0Njg_ca3e9ddb-c21f-4284-bdf7-2ba3dd54ec31">100</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6b2b0cbe0ef24d20b15b7f972083020e_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0NjU_06a7b4f6-e552-47df-b389-e47a23f52f93">111</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i887ec05b39874d2c8d43dc5b0c6812aa_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0NjI_deb8f263-7154-4c05-8db3-8e75437ff9d5">60</ix:nonFraction> million, respectively. Trade receivables related to these transactions from this investee were not material as of March 31, 2022 and 2021. During 2022, the Company&#8217;s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if119041cb25d488aaf3e5cb657d9fb05">Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for information regarding related party balances and transactions with Change and the Change Healthcare JV.</ix:continuation> </span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_172"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3Xzg2MDU_f1db7832-04d0-4ba1-beb5-ac2fac2d306d" continuedAt="i91527727edc248fc8e6b97c92f37aea1" escape="true">Segments of Business </ix:nonNumeric></span></div><ix:continuation id="i91527727edc248fc8e6b97c92f37aea1" continuedAt="ic0330fdddd594d4ab5f87f006ea7a19f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company began reporting under <ix:nonFraction unitRef="segment" contextRef="i8df6b8d2453344e9a3d64c0a536c0e26_D20200701-20210331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MDU4NTE_d3638d6e-ede0-4e16-a536-bca7e912e3c8">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. Other, for retrospective periods presented, consists of the Company&#8217;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment serves McKesson&#8217;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic0330fdddd594d4ab5f87f006ea7a19f" continuedAt="ic30404d4d66e45e79293bf35317cc8b5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="product" contextRef="i89602a22aafc4c248462dc75c787e1db_I20220331" decimals="-3" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MDU4NjE_8b09d5c4-0870-4279-865c-a6ec723305be">285,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="i0992fb1791f946ecaadfede91d31d6cf_I20220331" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzE0ODQzNDA2OTg1Njgz_44a74e12-096e-465b-9571-adc5fdfb8cda">11</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In 2022, the Company entered into agreements to sell the E.U. disposal group and U.K. disposal group, and completed the sale of its Austrian business. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s previous investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic30404d4d66e45e79293bf35317cc8b5" continuedAt="i4e71abdab44447fbb6a83278f8f09f42"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3Xzg1NzU_9aaef035-6614-4bd4-9812-04fd44128e19" continuedAt="iac2703971ad04e978ac92013c088caf6" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMtMS0xLTEtNjc1MTI_55f704dc-4e4a-42eb-8b2d-c404d526a846">212,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMtMy0xLTEtNjc1MTI_2ea81aad-4428-46e6-86f2-0288a7de3d81">189,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf29ddb5c8f42deb929d1d83dbc572f_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMtNS0xLTEtNjc1MTI_3c72bdcc-22dc-4abc-9b32-021026ac5aae">181,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e9915b20bd46ef92252fc1f54b6842_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzQtMS0xLTEtNzcwMDM_2902a25b-5516-4c21-b20f-a7fc47120493">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4014e9c3176b42c78989359017baa154_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzQtMy0xLTEtNzcwMDM_9c630bf3-2834-42d2-b8f0-f16b96642548">2,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7babc476db874b4b8550fefdfe333525_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzQtNS0xLTEtNzcwMDM_6acddf2e-7f08-47c2-b695-2f8d89a42c65">2,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzUtMS0xLTEtNjc1MTI_d96dd305-ce6c-4d6c-9817-1bc01fda6918">11,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzUtMy0xLTEtNjc1MTI_d76f528f-c692-4967-8560-37f5fb7a7726">10,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1bc5bf2b154cf2933d838b8ed000b3_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzUtNS0xLTEtNjc1MTI_ea877eb8-8882-4b52-afe2-bc2ad4d45215">8,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzYtMS0xLTEtNjc1MTI_ede5d4c4-0ae1-403b-b635-be439d599edd">36,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzYtMy0xLTEtNjc1MTI_7280ff11-a9ac-4d62-9360-5484ba35ccc1">35,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzYtNS0xLTEtNjc1MTI_2fca35e5-7319-4ee3-9811-d852ed9d2653">38,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzctMS0xLTEtNjc1MTI_a8548943-cb51-4e7c-b5e3-9e760bde460d">263,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzctMy0xLTEtNjc1MTI_b02a3cf3-a7d0-4b60-990f-dd62545c45bf">238,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzctNS0xLTEtNjc1MTI_ec4a5ef7-3ef1-46fc-9570-931526c520a9">231,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEwLTEtMS0xLTY3NTEy_b0dc7bce-8b1d-4db8-af88-7b3110ea09f9">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEwLTMtMS0xLTY3NTEy_232122b0-101a-4e33-8f00-26d47e4ced81">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEwLTUtMS0xLTY3NTEy_d32248a3-6352-4ce8-8fdc-2b9f99b7648b">2,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzExLTEtMS0xLTY3NTEy_794e16cb-6e4e-4193-901c-79dcc76e922c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzExLTMtMS0xLTY3NTEy_7e081f06-f8fc-4830-a32c-eff5b155fed0">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzExLTUtMS0xLTY3NTEy_302e075f-4894-4a01-9a6f-71edcd20ce8b">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEyLTEtMS0xLTY3NTEy_c4cc2e6d-d0ec-4df1-bbb7-0ef97e4fcf2f">959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEyLTMtMS0xLTY3NTEy_f8b8c215-7428-44a5-bc98-54256cda8dd5">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEyLTUtMS0xLTY3NTEy_5ee82a26-1bf8-4e8e-9eaf-72b545e43307">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTEtMS0xLTc3MTE0_ca03b671-94fe-410c-99d4-bd69cf59fc49">968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTMtMS0xLTc3MTE0_2d2bdd19-fa18-4bb6-97ec-24dee4a6fffd">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTUtMS0xLTc3MTE0_1a06aec2-c892-40b4-b92a-8ae7724c48f1">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTEtMS0xLTY3NTEy_4a7fcf3a-07d2-4f4a-9290-ce6fb2263cc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTMtMS0xLTY3NTEy_93fd2e17-425a-4df4-a4fa-19ce1ad9acea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTUtMS0xLTY3NTEy_3064874b-11ac-4203-83e4-baa54ee981e7">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE1LTEtMS0xLTY3NTEy_45544d98-aa54-4af1-8901-a5a899af5f3b">3,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE1LTMtMS0xLTY3NTEy_b207ba13-72e7-4f99-98b1-3da4b88cd302">3,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE1LTUtMS0xLTY3NTEy_81578f4b-e249-44b4-8dcb-740767c964bf">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE2LTEtMS0xLTY3NTEy_587703a1-472a-470c-b2dd-c9237cbed4dc">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE2LTMtMS0xLTY3NTEy_2a2e20e8-16d5-45c0-afeb-29c79f548e12">8,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE2LTUtMS0xLTY3NTEy_6856eec7-b37a-40cc-9d74-ac158fe6fdff">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTEtMS0xLTc3NjAx_f207f8ae-1181-4b92-bff9-a9202db70a42">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTMtMS0xLTc3NjAx_c3c3143f-8ac8-468e-bb91-0cd485186941">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTUtMS0xLTc3NjUz_c5408173-db1d-40c8-834d-74df568b807d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTEtMS0xLTY3NTEy_fa170296-8eea-4ea7-acc4-58d58272c01c">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTMtMS0xLTY3NTEy_64f93251-35b8-4a6a-aa1c-e3b9ada7f75c">217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTUtMS0xLTY3NTEy_d7831379-9a8d-4045-b724-f183af59e550">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE4LTEtMS0xLTY3NTEy_5e2c1985-bf9d-4081-b770-aa056795e9a3">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE4LTMtMS0xLTY3NTEy_098d6c73-2b0a-4bc7-9bcd-f43bf66eb0b0">5,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE4LTUtMS0xLTY3NTEy_1e401de7-81a5-4635-96ab-43aa599abd85">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIxLTEtMS0xLTY3NTEy_c4ae9182-492a-4634-b3dd-2e041ca71479">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIxLTMtMS0xLTY3NTEy_2fbfd6eb-4f50-4321-9a17-989ea284fdea">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIxLTUtMS0xLTY3NTEy_b43a0b92-dea5-444c-ae07-83dc65a66c9b">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIyLTEtMS0xLTY3NTEy_82a8927e-73cc-47c7-b81f-6e544af6a882">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIyLTMtMS0xLTY3NTEy_8e2b9dfc-0d8a-4f7d-8593-4d55cf8bb397">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIyLTUtMS0xLTY3NTEy_32e1308f-11e0-4a35-ba31-0aaf404ef319">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIzLTEtMS0xLTY3NTEy_ce0abdd7-572a-400d-a541-3d86f73dedcd">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIzLTMtMS0xLTY3NTEy_e19b7313-552b-4ac3-8354-a00df1b9d9a0">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIzLTUtMS0xLTY3NTEy_6a5e033e-909e-48be-86b4-60d9e7938199">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI1LTEtMS0xLTc3MTI2_312f81d7-e6b4-4a15-a961-13b5dbdbf1c1">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI1LTMtMS0xLTc3MTI2_7e6efcc5-0569-4ca9-8661-67cbdf226f10">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI1LTUtMS0xLTc3MTI2_4de36356-1e1a-443a-ba1b-ae3e815b2afd">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI2LTEtMS0xLTY3NTEy_e6c5a151-8dc7-41b4-bb00-90080ee15d35">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI2LTMtMS0xLTY3NTEy_8f998551-8a02-4742-8259-22a128303f28">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI2LTUtMS0xLTY3NTEy_aa143d6d-4cc8-4bf0-acd9-dcaf1b926200">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI3LTEtMS0xLTY3NTEy_fb4d1c02-2d1a-45e1-a338-637fe9bd742b">760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI3LTMtMS0xLTY3NTEy_05889926-06e9-41bb-bfd0-874a5dc2b891">887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI3LTUtMS0xLTY3NTEy_878416aa-9560-46f2-a175-271b43121651">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMwLTEtMS0xLTY3NTEy_8eb24bec-c228-42e0-8b3c-1b875a57d0e6">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMwLTMtMS0xLTY3NTEy_c4e3cea3-11a3-4b33-8614-ff4f50af9996">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMwLTUtMS0xLTY3NTEy_4fd8de60-10cc-4c7e-b67a-6efc8a5c57ee">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMxLTEtMS0xLTY3NTEy_f83d0972-944d-4f70-b9f6-a241367eace5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMxLTMtMS0xLTY3NTEy_f8d89b78-0e70-4427-8921-e34fb6197800">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMxLTUtMS0xLTY3NTEy_6d5549cf-1bbb-414c-980b-61f7a58bd1cc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMyLTEtMS0xLTY3NTEy_2152e567-0c05-4e7b-b8c3-eedc93fffaaa">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMyLTMtMS0xLTY3NTEy_e722e038-c92a-410a-ad6d-0e55d820fa0c">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMyLTUtMS0xLTY3NTEy_713d121c-9ef8-42fe-b614-9b517d720104">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM0LTEtMS0xLTc3MTM4_4e0791f0-8ab5-4585-950d-1553cb249408">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM0LTMtMS0xLTc3MTM4_b5500578-f4f3-4e5e-b83e-bd4f72901c5a">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM0LTUtMS0xLTc3MTM4_44bba497-551b-4d06-b019-f37738ced83d">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM1LTEtMS0xLTY3NTEy_2167299a-b686-463e-94a9-33dbd32a82ad">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM1LTMtMS0xLTY3NTEy_31b4c8ef-eec2-4f60-a044-b8856038ea56">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM1LTUtMS0xLTY3NTEy_2f8ba046-f7ad-41e3-a8e3-abd5788dd077">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM2LTEtMS0xLTY3NTEy_a1d5e92a-556f-4283-b58d-f75a4d7a3539">535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM2LTMtMS0xLTY3NTEy_88b9f849-a7df-47a3-b166-fa6298c99e8a">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM2LTUtMS0xLTY3NTEy_137ed72e-7109-4ab7-b35d-98acc45eedce">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjcz_008e060d-cc49-473a-9d78-9492e94993d9"><ix:nonFraction unitRef="number" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjcz_5c6aa76d-901d-4bab-a3d1-3e8b71899c8f"><ix:nonFraction unitRef="number" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjcz_a2363fac-3688-4035-a812-ca7813a72a92">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg5MzE_3e7e1e74-02e2-4921-9ddf-eba1dd574f11"><ix:nonFraction unitRef="number" contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg5MzE_b2ee6956-b12d-4956-965e-ad5ac06d6e08"><ix:nonFraction unitRef="number" contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331" decimals="INF" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg5MzE_fbb63a76-49de-4386-9955-0bc5c0f99cf0">40</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the RxTS segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjc5_8bde6192-de99-41d3-ab05-db3c46acb4bb"><ix:nonFraction unitRef="number" contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjc5_ecf77e11-9b9b-451b-9b0a-9a893dc8b231"><ix:nonFraction unitRef="number" contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjc5_efc22f4b-2cb4-4f7e-89e2-380b78c126df">3</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than <ix:nonFraction unitRef="number" contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg4MTQ_23025151-f3a2-4f48-a150-1dc12cbebe7e"><ix:nonFraction unitRef="number" contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg4MTQ_8fbf24df-08b0-48c0-be7e-3a089d026ab5"><ix:nonFraction unitRef="number" contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg4MTQ_ae9195d9-f33b-4c7e-b169-72844f79bf61">8</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from the Company&#8217;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i4e71abdab44447fbb6a83278f8f09f42" continuedAt="ieeddec6a92c74773b039447fdcae7574"><ix:continuation id="iac2703971ad04e978ac92013c088caf6"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for 2022, 2021, and 2020 includes credits of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNzM0_ace2a6ea-d9e3-4178-8655-0ebb6879a0b6">23</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNzM3_7eae2c9c-fd13-451c-8328-e0e1249f8883">38</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNzQy_82d5aa80-8cf4-4310-812b-53f3837897c9">252</ix:nonFraction> million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2022, 2021, and 2020 also includes $<ix:nonFraction unitRef="usd" contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODU1_ed3dc338-ef1e-410d-981d-309452441a1c">46</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODU5_158cf316-b262-48e4-bd22-42a1adf9743c">181</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODYy_a2e6672b-892a-498a-90ff-6b746c82b487">22</ix:nonFraction> million, respectively, of cash receipts for the Company&#8217;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $<ix:nonFraction unitRef="usd" contextRef="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODg0_c3edffc0-6f4a-4ab7-ad19-fcb0e9d852fc">50</ix:nonFraction> million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for 2022 and 2021 includes inventory charges of $<ix:nonFraction unitRef="usd" contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYyMjE4_fdf772d5-1447-497b-8ec6-9185a43aa4c9">164</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYxOTUw_61445b5d-0417-43ae-ab0b-53fbcce9020d">136</ix:nonFraction> million, respectively, on certain PPE and other related products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for 2022, 2021, and 2020 reflects the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i7c2308bff3d84467bbd32719c1b729f3_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTkzNTk_fdb99bde-46ea-4124-b476-590c9252143a">1.1</ix:nonFraction> billion to remeasure assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i4306427a0c8f4e4f9a6abfe8b834d477_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTk0NTg_77528d7a-5b92-4d89-9263-af646bfb56c7">383</ix:nonFraction> million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes a gain of $<ix:nonFraction unitRef="usd" contextRef="iecf1fc43ee8743cc841ae8e190b19f5e_D20210401-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTk2MTI_e09f610f-b42d-4f7c-bd41-eb4beacd4604">59</ix:nonFraction> million related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes a gain of $<ix:nonFraction unitRef="usd" contextRef="i1d32ea0d7121424d8050da60bae6313b_D20210401-20220331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzE2OTg_8678cf79-4853-4afb-b816-80eadd97b25c">42</ix:nonFraction> million related to the sale of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i02266411b5ae476685c7f46474a2bc26_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzI3NDg3NzkxMTIwOTM_d22e982c-793e-4b27-9952-d797305b02af">30</ix:nonFraction>% interest in its German pharmaceutical wholesale joint venture to WBA. 2021 and 2020 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i0a61358af12d408d98a32edf22828df2_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzE5MjU_4879623f-46f9-4853-be6e-fd54000738b3">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i57862e2d41134adab208bb4e37e2f526_D20190401-20200331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzE5MzM_1d67dd58-cbd6-452a-83e3-f20065465454">275</ix:nonFraction> million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to the joint venture with WBA completed on November 1, 2020. See Financial Note 2, &#8220;Held for Sale,&#8221; and Financial Note 6, &#8220;Other Income, Net,&#8221; for further details;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 includes a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzA0OTY_dd1eb6c5-0e83-44f2-a0cb-fa942dc9ac2b">69</ix:nonFraction> million related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 11, &#8220;Goodwill and Intangible Assets, Net;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 and 2020 includes long-lived asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTY2MTA_80f6b648-7c79-4414-9ec9-ba519f805bbe">115</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTY2MjA_3ba510f9-8320-4e0c-886a-0d067117a813">112</ix:nonFraction> million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for 2020 includes an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331" decimals="-8" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzY0NzE1_aecf1aa8-18e3-4fd5-a557-e8022544ddc4">1.2</ix:nonFraction> billion and a dilution loss of $<ix:nonFraction unitRef="usd" contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzY0NzE4_daa24bc4-2dc0-44f8-9367-1eb6306c1c7a">246</ix:nonFraction> million associated with the Company&#8217;s previous investment in the Change Healthcare JV, partially offset by a net gain of $<ix:nonFraction unitRef="usd" contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzY0NzIx_cd2b1708-6cf6-4e54-a23a-c9bae18c0661">414</ix:nonFraction> million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2020 also includes the Company&#8217;s proportionate share of loss from the Change Healthcare JV of $<ix:nonFraction unitRef="usd" contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTQ3Njc_1111c7a1-7550-4c13-bd62-d5002d6cce46">119</ix:nonFraction> million.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, for 2022, 2021, and 2020 reflects the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i421693f2ac6f4634892f8037573c7473_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjE4MTY_c53a6b51-75b4-47c8-a4ff-59efa2fb3d77">55</ix:nonFraction> million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i98dde87c16b848c5b435a117b3bcaa0b_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzkyNTE_5c038f8c-061b-45cc-b0a9-8aebdd4c030f">42</ix:nonFraction> million primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 and 2021 includes charges of $<ix:nonFraction unitRef="usd" contextRef="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjI1MjA_8d5619c5-95e2-44af-b955-09ad8dd9b171">274</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA2NjI_1ec87fd0-9c46-4466-9482-6ed23f888795">8.1</ix:nonFraction> billion, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities;" </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 and 2021 includes net gains of $<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjMwMjk_9df5db6e-cbc3-48bf-816a-ebb12e7f48b2">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjI3MDQ_6fa5129c-73bd-455b-8b57-bdc27a693428">133</ix:nonFraction> million, respectively, associated with certain of the Company&#8217;s equity investments, as discussed in more detail in Financial Note 16, &#8220;Fair Value Measurements;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 includes a net gain of $<ix:nonFraction unitRef="usd" contextRef="ia363f8f9a4de48ca805cfea21f6c1846_D20200401-20210331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA2OTI_d8407286-abf8-4f32-a5f1-cf0501ecb1ac">131</ix:nonFraction> million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2020 includes settlement charges of $<ix:nonFraction unitRef="usd" contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA3MDU_d1878cb1-4d4e-460a-ad40-fea23998d826">122</ix:nonFraction> million for the termination of the Company&#8217;s defined benefit pension plan; and </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2020 includes a settlement charge of $<ix:nonFraction unitRef="usd" contextRef="i38c0b8cc6cdd4e5a87c08c8347fa83db_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA3MTU_87491a5e-b6c1-4e88-8916-96115b1fa895">82</ix:nonFraction> million related to opioid claims.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for 2022 consists of a charge of $<ix:nonFraction unitRef="usd" contextRef="ibb4a025d54cc4e119f9bdcce62a65384_D20210401-20220331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTU1OTA_7d4548d7-46a9-43e2-853f-7c91f8322a8a">191</ix:nonFraction> million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 12, &#8220;Debt and Financing Activities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_82">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Concluded)</span></div></div><ix:continuation id="ieeddec6a92c74773b039447fdcae7574"><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3Xzg2MTI_1f38c724-963a-4de0-bccf-0e6ef7a3c726" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75859372620f4bba9fcc690a92937930_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzMtMS0xLTEtNjc1MTI_6faf67f1-0b6f-4610-b259-d0758506958a">38,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf37a2aea301469bbf8c95c1cb87dea0_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzMtMy0xLTEtNjc1MTI_f608d480-8655-4ac9-8c6d-6c5c8cf9fd57">35,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe8302f1495433a8b56aac54216c93a_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzQtMS0xLTEtNjc1MTI_75bfbc24-2bdd-4738-89c7-aeca28b592e1">3,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e69dbb765c4cbba679db0d75d4e24d_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzQtMy0xLTEtNjc1MTI_e1552d8e-2753-41e9-a7b3-628dfbc8e3c7">3,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fde2da64904433badd4e9125f5242e_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzUtMS0xLTEtNjc1MTI_71c4ec97-5006-45da-942d-4eaf6e906ce6">5,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3836c14e169d426385529b1516d34376_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzUtMy0xLTEtNjc1MTI_f652f491-358f-4825-a004-8b424ff8dd3f">5,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i085f9b77e2ff45639871e3f6c4e87e81_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzctMS0xLTEtNzczODk_77af9bf0-9a12-431d-8aaa-450c0763bf45">13,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbae9d0f6df24779a201d5522b29b806_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzctMy0xLTEtNzczODk_a6a9bc71-797e-4587-890d-62626ee22a48">14,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i136fbfde3b204ba88d3ef047c523f6d0_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzgtMS0xLTEtNjc1MTI_a511b0dc-1f58-4d2d-806d-973d781cfb56">1,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5920306c6c74407aa3c61813edac174_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzgtMy0xLTEtNjc1MTI_8d0c2e00-7491-4be6-a6a3-5074cc3f300f">5,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzktMS0xLTEtNjc1MTI_1d3a880f-07c8-4ac8-a579-77203d2b3a80">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzktMy0xLTEtNjc1MTI_beede57f-0d20-460c-909a-ae3780e0e728">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f92dd395054c9e87369fe7c7e30c52_I20220331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEyLTEtMS0xLTY3NTEy_8de8533e-3611-4319-934f-51c28c19a596">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3667722556cc48a986ac133abdb684ef_I20210331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEyLTMtMS0xLTY3NTEy_19ef4068-0be1-4817-894e-55c34a322a2b">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ded543679294c96804c2f7f25ea7ef1_I20220331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEzLTEtMS0xLTY3NTEy_f73dadbe-5f54-4a63-ba40-f114cbfd4bd6">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40175ec1fccc491fb2cbcd0cf1e19dc5_I20210331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEzLTMtMS0xLTY3NTEy_d278e17c-87a6-4695-92f6-886e1950c823">984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzE0LTEtMS0xLTY3NTEy_2531be3e-8478-45aa-a1cd-2e59afa2c859">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzE0LTMtMS0xLTY3NTEy_0d6e5393-2217-446d-882b-2c6721073c14">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software and excludes amounts classified as assets held for sale.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_178"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_181"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this report and have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Control over Financial Reporting</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s report on the Company&#8217;s internal control over financial reporting (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and the related report of our independent registered public accounting firm are included in this Annual Report, under the headings, &#8220;Management&#8217;s Annual Report on Internal Control Over Financial Reporting&#8221; and &#8220;Report of Independent Registered Public Accounting Firm&#8221; and are incorporated herein by reference.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during our fourth quarter of 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_184"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_1968"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_187"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_190"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors, Executive Officers, and Corporate Governance.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our Directors is incorporated by reference from the discussion under Item 1 of our Proxy Statement for the 2022 Annual Meeting of Shareholders (the &#8220;Proxy Statement&#8221;) under the heading &#8220;Election of Directors.&#8221; Information about our Executive Officers is incorporated by reference from the discussion in Part I of this report under the heading &#8220;Information about our Executive Officers.&#8221; Information about our Audit Committee, including the members of the committee and our Audit Committee Financial Experts, is incorporated by reference from the discussion in Item 1 of our Proxy Statement under the heading &#8220;The Board, Committees and Meetings,&#8221; and in Item 2 of our Proxy Statement under the heading &#8220;Audit Committee Report.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the Code of Conduct applicable to all employees, officers, and directors can be found on our website, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.mckesson.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under the caption &#8220;Investors - Governance.&#8221; The Company&#8217;s Corporate Governance Guidelines and Charters for the Audit, Compensation, and Governance Committees can also be found on our website under the same caption.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to post on its website required information regarding any amendment to, or waiver from, the Code of Conduct that applies to our Chief Executive Officer, Chief Financial Officer, Controller, and persons performing similar functions within four business days after any such amendment or waiver. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_193"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this item is incorporated by reference from the discussion under the heading &#8220;Executive Compensation&#8221; in our Proxy Statement.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_196"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about security ownership of certain beneficial owners and management is incorporated by reference from the discussion under the heading &#8220;Principal Shareholders&#8221; in our Proxy Statement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information as of March 31, 2022 with respect to the plans under which the Company&#8217;s common stock is authorized for issuance:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plan Category<br/>(In millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities<br/>to be issued upon<br/>exercise of<br/>outstanding options,<br/>warrants and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">exercise price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">outstanding options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">warrants and rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">security holders</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">security holders</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The weighted-average exercise price set forth in this column is calculated excluding outstanding restricted stock unit (&#8220;RSU&#8221;) awards, since recipients are not required to pay an exercise price to receive the shares subject to these awards.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents option and RSU awards outstanding under the following plans: (i) 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan; (ii) the 2005 Stock Plan; and (iii) the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents 1.9&#160;million shares available for purchase under the 2000 Employee Stock Purchase Plan and 18.5&#160;million shares available for grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of equity plans that have been approved by the Company&#8217;s stockholders. The plans are administered by the Compensation Committee of the Board of Directors, except for the portion of the 2013 Stock Plan and 2005 Stock Plan related to non-employee directors, which is administered by the Board of Directors or its Governance Committee.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Stock Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2013 Stock Plan was adopted by the Board of Directors on May 22, 2013 and approved by the Company&#8217;s stockholders on July 31, 2013. The 2013 Stock Plan permits the grant of awards in the form of stock options, stock appreciation rights, restricted stock (&#8220;RS&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance-based restricted stock units (&#8220;PeRSUs&#8221;), performance shares, and other share-based awards. The number of shares reserved for issuance under the 2013 Stock Plan equals the sum of (i) 30.0 million shares, (ii) the number of shares reserved but unissued under the 2005 Stock Plan as of the effective date of the 2013 Stock Plan, and (iii) the number of shares that become available for reuse under the 2005 Stock Plan following the effective date of the 2013 Stock Plan. For any one share of common stock issued in connection with an RS, RSU, performance share, or other full-share award, three and one-half shares shall be deducted from the shares available for future grants. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, including in respect of the payment of applicable taxes, or shares repurchased on the open market with proceeds from the exercise of options shall not be returned to the reserve of shares available for issuance under the 2013 Stock Plan. Shares withheld to satisfy tax obligations relating to the vesting of a full-share award shall be returned to the reserve of shares available for issuance under the 2013 Stock Plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted at no less than fair market value and those options granted under the 2013 Stock Plan generally have a contractual term of seven years. Options generally become exercisable in four equal annual installments beginning one year after the grant date. The vesting of RS or RSUs is determined by the Compensation Committee at the time of grant. Beginning with awards granted in fiscal year 2021, RS and RSUs generally vest over three years. RSUs granted under the PeRSU program vest three years following the end of the performance period. The Company&#8217;s executive officers and other members of senior management are annually granted performance awards called performance stock units (&#8220;PSUs&#8221;), which have a three-year performance period and are payable in shares without an additional vesting period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors may be granted an award on the date of each annual meeting of the stockholders for up to 5,000 RSUs, as determined by the Board of Directors. Such non-employee director award is fully vested on the date of the grant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2005 Stock Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2005 Stock Plan was adopted by the Board of Directors on May 25, 2005 and approved by the Company&#8217;s stockholders on July 27, 2005. The 2005 Stock Plan permits the granting of up to 42.5 million shares in the form of stock options, RS, RSUs, PeRSUs, performance shares, and other share-based awards. For any one share of common stock issued in connection with an RS, RSU, performance share, or other full-share award, two shares shall be deducted from the shares available for future grants. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, shares withheld to satisfy tax obligations relating to the vesting of a full-share award or shares repurchased on the open market with proceeds from the exercise of options shall not be returned to the reserve of shares available for issuance under the 2005 Stock Plan. Stock options were granted at no less than fair market value and options granted under the 2005 Stock Plan generally have a contractual term of seven years.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the effectiveness of the 2013 Stock Plan, no further shares were made subject to award under the 2005 Stock Plan. Shares reserved but unissued under the 2005 Stock Plan as of the effective date of the 2013 Stock Plan, and shares that become available for reuse under the 2005 Stock Plan following the effectiveness of the 2013 Stock Plan, will be available for awards under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan was approved by the Company&#8217;s stockholders on July 30, 1997; however, stockholder approval of the 2005 Stock Plan on July 27, 2005 had the effect of terminating the 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan such that no new awards would be granted under the 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2000 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 of the Internal Revenue Code. In March 2002, the Board amended the ESPP to allow for participation in the plan by employees of certain of the Company&#8217;s international and other subsidiaries. Currently, 21.1&#160;million shares have been approved by stockholders for issuance under the ESPP.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is implemented through a continuous series of three-month purchase periods (&#8220;Purchase Periods&#8221;) during which contributions can be made toward the purchase of common stock under the plan. Each eligible employee may elect to authorize regular payroll deductions during the next succeeding Purchase Period, the amount of which may not exceed 15% of a participant&#8217;s compensation. At the end of each Purchase Period, the funds withheld by each participant will be used to purchase shares of the Company&#8217;s common stock. The purchase price of each share of the Company&#8217;s common stock is 85% of the fair market value of each share on the last day of the applicable Purchase Period. In general, the maximum number of shares of common stock that may be purchased by a participant for each calendar year is determined by dividing $25,000 by the fair market value of one share of common stock on the offering date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There currently are no equity awards outstanding that were granted under equity plans that were not submitted for approval by the Company&#8217;s stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_199"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Relationships and Related Transactions and Director Independence.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to certain transactions with directors and management is incorporated by reference from the Proxy Statement under the heading &#8220;Related Party Transactions Policy and Transactions with Related Persons.&#8221; Information regarding Director independence is incorporated by reference from the Proxy Statement under the heading &#8220;Director Independence.&#8221; Additional information regarding certain related party balances and transactions is included in the Financial Review section of this Annual Report and Financial Note 20, &#8220;Related Party Balances and Transactions&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_202"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Accounting Fees and Services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding principal accountant fees and services is set forth under the heading &#8220;Ratification of Appointment of Deloitte &amp; Touche LLP as the Company&#8217;s Independent Registered Public Accounting Firm for Fiscal Year 2023&#8221; in our Proxy Statement and all such information is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_205"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_208"></div><div style="-sec-extract:summary;margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits and Financial Statement Schedule.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1)   Consolidated Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_88">Report of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Fir</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_88">m</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMDgvZnJhZzplYjRjODE2NDM2M2E0YWViYjIwMzk5YjQ0ODU5YzNmOC90YWJsZTozZjA1OGFlMmU1NGM0N2VlYmEwYTNiYTg2MGM3NTliMS90YWJsZXJhbmdlOjNmMDU4YWUyZTU0YzQ3ZWViYTBhM2JhODYwYzc1OWIxXzMtMC0xLTEtNzc3MDMvdGV4dHJlZ2lvbjozMzc1YTZjM2U0NmM0YzQ4YWM4YjhiNjBmNTc4NzZmZl80Mzk4MDQ2NTExMjQ5_2b05b3dd-8681-498b-b987-13a086c637eb">34</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_88">65</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">Consolidated Statements of Operations for the years ended March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_91">70</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">Consolidated Statements of Comprehensive Income (Loss) for the years ended March 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_94">71</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">Consolidated Balance Sheets as of March&#160;31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97"> and 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_97">72</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">Consolidated Statements of Stockholders&#8217; Equity</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100"> (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">D</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">ficit)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100"> for the years ended March&#160;31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_100">73</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">Consolidated Statements of Cash Flows for the years ended March&#160;31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">, and 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_103">74</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_106">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_106">75</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(2)   Financial Statement Schedule</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_211">Schedule II-Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_211">142</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other schedules not included have been omitted because of the absence of conditions under which they are required or because the required information, where material, is shown in the financial statements, financial notes, or supplementary financial information.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_214">(a)(3)   Exhibits submitted with this Annual Report on Form 10-K as filed with the SEC and those incorporated by reference to other filings are listed on the Exhibit Index</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_214">143</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_211"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><ix:nonNumeric contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90ZXh0cmVnaW9uOjk1Y2NlNWRjMmFhZTQ3ZjZhZjljN2ZlYTFiM2QyOWQ4XzEyNQ_6f3f5f6d-99c6-409b-87cb-c48826487ccb" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions From Allowance Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at End of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41829b0d50c84e67810fffe88435a9df_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtMS0xLTEtNjc1MTI_3e499164-46f7-4830-a655-f2f90c31467b">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtMy0xLTEtNjc1MTI_e22fa54f-c63a-47d0-92ba-d6d617d2c7a5">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtNS0xLTEtNjc1MTI_d03b715d-1219-4f6e-bd4a-62f031a5564b">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtNy0xLTEtNjc1MTI_bdd4b8d7-d776-4daf-b6a9-1b2dd5157c52">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0016a42d06144f0083c43e8c3861007f_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtOS0xLTEtNjc1MTI_0a4beadf-6a63-4532-885a-d9ecc48b81cb">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief597acca9b943b499ca2cd3b523d72a_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtMS0xLTEtNjc1MTI_f42fad9a-ac82-4a63-a02d-c67a202cd72e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtMy0xLTEtNjc1MTI_5bddf70c-9f35-46e7-9f7b-5fbb777d4f23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtNS0xLTEtNjc1MTI_f8d607f3-b382-4c12-b25a-41e17d1bc623">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtNy0xLTEtNjc1MTI_2f014b91-8988-4a5f-8a97-a72a1243d3f8">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i985cb718c86e4ef0866b20d0c5f9ba59_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtOS0xLTEtNjc1MTI_289764f7-31a0-4f27-af4a-3ce5de25149b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtMS0xLTEtNjc1MTI_a3ef97ad-5128-4764-b8fd-f1e7787e057b">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtMy0xLTEtNjc1MTI_4783f717-8660-41a2-989a-e105e2c48895">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtNS0xLTEtNjc1MTI_7afef175-d188-4e98-9a60-f7b785f316a1">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtNy0xLTEtNjc1MTI_de3af397-dabf-4d3b-8b5c-93d8e4de5d5b">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtOS0xLTEtNjc1MTI_fd2cf002-99c4-40c8-8704-c028b71797bd">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f4961dbfe344bc8e2f41bae9d5131f_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtMS0xLTEtNjc1MTI_a6cc8fa7-ed1e-44a8-b0e8-4f386394e94b">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtMy0xLTEtNjc1MTI_226e366d-3ab7-4df5-b15c-a3c5f956a77e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtNS0xLTEtNjc1MTI_80c2c8ef-fe31-46f6-9d21-61e1f7e34454">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtNy0xLTEtNjc1MTI_23017ec3-a163-407c-925d-35ff8d4aeb66">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41829b0d50c84e67810fffe88435a9df_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtOS0xLTEtNjc1MTI_9bd0b8d4-6f50-40d0-93f6-d77dccca867f">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedade147b8b646c8b00bbb5188244496_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktMS0xLTEtNjc1MTI_f90acfb6-0977-483f-9aa2-eddd7d0d33e6">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktMy0xLTEtNjc1MTI_64abbdc6-3c57-4acf-b4fa-02898ed2726d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktNS0xLTEtNjc1MTI_e7525962-a89d-48da-b33b-1b45bb417cfc">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktNy0xLTEtNjc1MTI_efcd961a-e166-46a1-a2a6-289bdfa2bb14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief597acca9b943b499ca2cd3b523d72a_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktOS0xLTEtNjc1MTI_06f4eeca-a7a8-436b-98a6-1e22310db2fa">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTEtMS0xLTY3NTEy_05a01ed1-472c-4ed1-bd70-6ba11df9d913">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTMtMS0xLTY3NTEy_3c949359-bb3f-4aeb-adb7-8ee8c9d251ea">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTUtMS0xLTY3NTEy_81cf8883-410a-4cad-9c93-40245f8852fe">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTctMS0xLTY3NTEy_0946f946-a40a-4f58-a458-fefb5f32d48f">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTktMS0xLTY3NTEy_a532a203-6bf0-4938-95b7-95d7f5c9ed0f">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c1bd212c45448698e1854f6e5f1080_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTEtMS0xLTY3NTEy_cacd3f94-5d7d-4822-a53a-6c5ab3992617">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTMtMS0xLTY3NTEy_a771e7cd-b289-467e-bb2f-d90f0a723246">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTUtMS0xLTY3NTEy_ec9b9069-6b73-459e-b091-236e599b5550">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTctMS0xLTY3NTEy_aa97d290-da35-46a4-bd79-b0fbeaaec4a5">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f4961dbfe344bc8e2f41bae9d5131f_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTktMS0xLTY3NTEy_59c26897-b87b-4cb5-9479-fc87e45bc217">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48eb2bbbe76d4424947b05d6ff6b3111_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTEtMS0xLTY3NTEy_8f576990-a3c0-4f5d-9d08-59a83ecc4c10">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTMtMS0xLTY3NTEy_a216dd29-8644-4de6-b8c9-874a18c17826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTUtMS0xLTY3NTEy_36b972eb-7e70-492f-8854-4cde01929da3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTctMS0xLTY3NTEy_ceba1da2-f7e2-4003-8b68-b93ae0a229dd">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedade147b8b646c8b00bbb5188244496_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTktMS0xLTY3NTEy_fa736562-8f28-45e4-89e1-c0b6dddf11a5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTEtMS0xLTY3NTEy_7cdf0124-2729-4f0d-8db5-e01c6735d9c2">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTMtMS0xLTY3NTEy_d6026841-5686-401b-8572-2a03264d9542">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTUtMS0xLTY3NTEy_a6738bea-9d90-4071-a400-29db1ecf6e97">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTctMS0xLTY3NTEy_8979d8c1-4cd7-40a7-aba8-8566bf998c36">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTktMS0xLTY3NTEy_2339a8cd-3182-4edc-ac8c-d078c3ee842b">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99beb6352cf47479de57c9883cab9b5_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzItMy0xLTEtNjc1MTI_7557efa5-cc57-4c64-a45c-309bdf1e2289">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73f4dc77fae347c3949ca450f0bd6c27_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzItNS0xLTEtNjc1MTI_0c1c081f-b657-4cb9-9a6a-28c2d1f479ed">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib560e861e6d44cc1bc5d64c84ed65be5_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzItNy0xLTEtNjc1MTI_f0b9566f-64b0-4764-8809-5414a417aee3">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credited to other accounts and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14b84c6208fd487782c55ab942c054c2_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzMtMy0xLTEtNjc1MTI_487b8dad-3732-45fc-82a8-008462b292d6">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13224b1cb34e43ea9f7419286f4e4d8a_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzMtNS0xLTEtNjc1MTI_47d9be82-29e2-4089-9293-e73f4d2fc181">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32eb06e34414e3699858d846e951a74_D20190401-20200331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzMtNy0xLTEtNjc1MTI_932c126d-d7a3-4dc1-9779-1bb9cedafde1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzQtMy0xLTEtNjc1MTI_cef0f73f-5682-4298-85cd-28465676894f">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzQtNS0xLTEtNjc1MTI_1751cbed-4e67-4660-9ffd-4ae941852294">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzQtNy0xLTEtNjc1MTI_c7cf9c82-cd2e-4658-9fcb-e4837a3ea844">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown as deductions from current and non-current receivables (current allowances were $<ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMS0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozZjM2YjZiMmFlOTI0NjZlYjFmOWVmOTBiOTMxZWRkOF82NTk3MDY5NzY2ODM4_69d5c84c-ac29-4849-92a2-f82881b6704b">144</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMS0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozZjM2YjZiMmFlOTI0NjZlYjFmOWVmOTBiOTMxZWRkOF82NTk3MDY5NzY2ODE4_0a13f7e9-6968-434d-8865-34486149d40d">250</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMS0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozZjM2YjZiMmFlOTI0NjZlYjFmOWVmOTBiOTMxZWRkOF82NTk3MDY5NzY2ODI0_6d59b824-5d58-460b-bd08-86fa98f2508a">265</ix:nonFraction> million at March 31, 2022, 2021, and 2020, respectively)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMy0xLTEtNjc1MTI_e139b154-4001-4a37-a982-f6c41aaddece">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtNS0xLTEtNjc1MTI_ce0027d3-0f99-4108-bfef-85d30f85d609">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201940e73632457882da553cf6462766_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtNy0xLTEtNjc1MTI_1ec0c7cf-332f-4a6f-99fc-38f2b3973ca2">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primarily represents reclassifications to other balance sheet accounts.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements included as exhibits to this report are included to provide information regarding their terms and not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements may contain representations and warranties by each of the parties to the applicable agreement that were made solely for the benefit of the other parties to the applicable agreement. Those representations and warranties:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified under &#8220;Incorporated by Reference&#8221; in the table below are on file with the Commission and are incorporated by reference as exhibits hereto.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312516641582/d221363dex21.htm">Agreement of Contribution and Sale, dated as of June 28, 2016, by and among McKesson Corporation, PF2 NewCo LLC, PF2 NewCo Intermediate Holdings, LLC, PF2 NewCo Holdings, LLC, HCIT Holdings, Inc., Change Healthcare, Inc., Change Aggregator L.P. and H&amp;F Echo Holdings, L.P.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 5, 2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517073411/d354020dex21.htm">Amendment No.&#160;1 to Agreement Contribution and Sale, dated as of March&#160;1, 2017, by and among by and among Change Healthcare LLC, Change Healthcare Intermediate Holdings, LLC, Change Healthcare Holdings, LLC, HCIT Holdings, Inc., Change Healthcare, Inc., a Delaware corporation, for itself and in its capacity as Echo Representative, certain affiliates of The Blackstone Group, L.P., certain affiliates of Hellman&#160;&amp; Friedman LLC, and McKesson Corporation, a Delaware corporation.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520029095/d881002dex21.htm">Separation and Distribution Agreement by and between McKesson Corporation, PF2 SpinCo, Inc., Change Healthcare Inc., Change Healthcare LLC, Change Healthcare Intermediate Holdings, LLC and Change Healthcare Holdings, LLC (including form of Tax Matters Agreement)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 10, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012311071695/f59658exv3w1.htm">Amended and Restated Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on July 27, 2011.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765320000021/amendedandrestatedby-l.htm">Amended and Restated By-Laws of the Company, as amended March 11, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/0000929624-97-000781.txt">Indenture, dated as of March 11, 1997, by and between the Company, as issuer, and The First National Bank of Chicago, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 19, 1997</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/0000929624-97-000853.txt">Officers&#8217; Certificate, dated as of March 11, 1997, and related Form of 2027 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-30899</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 8, 1997</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095013407004753/f27940exv4w1.htm">Indenture, dated as of March 5, 2007, by and between the Company, as issuer, and The Bank of New York Trust Company, N.A., as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 5, 2007</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012311019414/f58489exv4w2.htm">First Supplemental Indenture, dated as of February&#160;28, 2011, to the Indenture, dated as of March 5, 2007, among the Company, as issuer, the Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), and Wells Fargo Bank, National Association, as trustee, and related Form of 2021 Note and Form of 2041 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512490067/d447856dex41.htm">Indenture, dated as of December 4, 2012, by and between the Company, as issuer, and Wells Fargo Bank, National Association, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 4, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512490067/d447856dex42.htm">Officers&#8217; Certificate, dated as of December 4, 2012, and related Form of 2022 Note.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 4, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312513097422/d498651dex42.htm">Officers&#8217; Certificate, dated as of March 8, 2013, and related Form of 2023 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 8, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312514090428/d690531dex42.htm">Officers&#8217; Certificate, dated as of March 10, 2014, and related Form of 2024 Note, and Form of 2044 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2014</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517047290/d347385dex41.htm">Officer&#8217;s Certificate, dated as of February 17, 2017, and related Form of 2021 Euro Note, Form of 2025 Euro Note, and Form of 2029 Sterling Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 17, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518040775/d730912dex41.htm">Officer&#8217;s Certificate, dated as of February 12, 2018, and related Form of 2026 Euro Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518051049/d507348dex41.htm">Officer&#8217;s Certificate, dated as of February 16, 2018, and related Form of 2028 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518339803/d634589dex41.htm">Officer&#8217;s Certificate, dated as of November&#160;30, 2018, and Form of 2029 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312520309508/d17547dex41.htm">Officer&#8217;s Certificate, dated as of December&#160;3, 2020, and related Form of 2025 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000119312521244658/d142323dex41.htm">Officer&#8217;s Certificate, dated as of August 12, 2021, and related Form of 2026 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit415x3312022.htm">Description of the Company&#8217;s Securities.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014903001297/f90251exv10w6.txt">McKesson Corporation Supplemental Profit Sharing Investment Plan, as amended and restated on January 29, 2003.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 6, 2003</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765319000021/mckexhibit10209302019.htm">McKesson Corporation Supplemental Retirement Savings Plan, as amended and restated effective July 30, 2019.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014908000067/f39986exv10w7.htm">McKesson Corporation Deferred Compensation Administration Plan II, as amended and restated as of October 28, 2004, and Amendment No. 1 thereto effective July 25, 2007.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 7, 2008</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765319000021/mckexhibit10109302019.htm">McKesson Corporation Deferred Compensation Administration Plan III, as amended and restated effective July 30, 2019.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310004952/f54717exv10w1.htm">McKesson Corporation Executive Survivor Benefits Plan, as amended and restated as of January 20, 2010. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_ex106xseverancepolicyf.htm">McKesson Corporation Severance Policy for Executive Employees, as amended and restated April 26, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mckexhibit1083312020.htm">McKesson Corporation Change in Control Policy for Selected Executive Employees, as amended and restated effective January 28, 2020.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exx108xmanagementincen.htm">McKesson Corporation Management Incentive Plan, as amended and restated April 26, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_ex109xmanagementincent.htm">Form of Statement of Terms and Conditions Applicable to Awards Pursuant to the McKesson Corporation Management Incentive Plan, effective April 26, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310070537/f56102exv10w4.htm">McKesson Corporation 2005 Stock Plan, as amended and restated on July 28, 2010.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 30, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512316890/d371102dex102.htm">Forms of (i) Statement of Terms and Conditions, (ii) Stock Option Grant Notice and (iii), Restricted Stock Unit Agreement, each as applicable to Awards under the McKesson Corporation 2005 Stock Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000015/mck_8kxannualxmeetingxex10-1.htm">McKesson Corporation 2013 Stock Plan, effective July 31, 2013.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_ex1013x3312022xstockpl.htm">Forms of Statement of Terms and Conditions and Grant Notices Applicable to Awards Pursuant to the McKesson Corporation 2013 Stock Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517073411/d354020dex101.htm">Third Amended and Restated Limited Liability Company Agreement of Change Healthcare LLC, dated as of March&#160;1, 2017.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 7, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000092765316000020/mck_exhibit1019x3312016.htm">Form of Commercial Paper Dealer Agreement between McKesson Corporation, as Issuer, and the Dealer.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 5, 2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312515351348/d68211dex101.htm">Credit Agreement, dated as of October 22, 2015, among the Company and Certain Subsidiaries, as Borrowers, Bank of America, N.A. as Administrative Agent, Bank of America, N.A. (acting through its Canada Branch), Citibank, N.A. and Barclays Bank PLC, as Swing Line Lenders, Wells Fargo Bank, National Association as L/C Issuer, Barclays Bank PLC, Citibank N.A., Wells Fargo Bank, National Association as Co-Syndication Agents, Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., The Bank of Tokyo-Mitsubishi UFJ, Ltd. as Co-Documentation Agents, and The Other Lenders Party Thereto, and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Barclays Bank PLC, Citigroup Global Markets Inc., Goldman Sachs Bank USA, J.P. Morgan Securities, LLC, The Bank of Tokyo-Mitsubishi UFJ, Ltd. and Wells Fargo Securities, LLC as Joint Lead Arrangers and Joint Book Runners.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 23, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312514035645/d668841dex101.htm">Amendment No. 2, dated January 30, 2014, and Amendment No. 1, dated November 15, 2013, to the Credit Agreement and the Credit Agreement  dated as of September 23, 2011, among the Company and McKesson Canada Corporation, collectively, the Borrowers, Bank of America, N.A. as Administrative Agent, Bank of America, N.A. (acting through its Canada branch), as Canadian Administrative Agent, JPMorgan Chase Bank, N.A. and Wells Fargo Bank, National Association, as Co-Syndication Agents, Wells Fargo Bank, National Association as L/C Issuer, The Bank of Tokyo-Mitsubishi UFJ, LTD., The Bank of Nova Scotia and U.S. Bank National Association as Co-Documentation Agents, and The Other Lenders Party Thereto, and Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Sole Lead Arranger and Sole Book Manager.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-3252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2014</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">Credit Agreement dated as of September 25, 2019, among the Company and certain subsidiaries, as borrowers, Bank of America, N.A., as administrative agent, Barclays Bank PLC, Citibank, N.A., Wells Fargo Bank, National Association, Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., and HSBC Securities (USA) Inc., as co-syndication agents, the lenders party thereto, the letter of credit issuers party thereto ("2020 Credit Facility").</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 27, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex101-creditagreementamend.htm">Amendment No. 1, dated February 1, 2021, to the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">2020 Credit Facility</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex101-creditagreementamend.htm">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2, 2021</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex102-creditagreementamend.htm">Amendment No. 2, dated March 31, 2021, to the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312519257628/d812550dex101.htm">2020 Credit Facility</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765321000019/ex102-creditagreementamend.htm">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310043581/f54765exv10w27.htm">Form of Director and Officer Indemnification Agreement.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">Tax Matters Agreement, by and between McKesson Corporation, PF2 SpinCo, Inc., Change Healthcare Inc., Change Healthcare LLC and Change Healthcare Holdings, LLC dated as of March 9, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">Distributor Settlement Agreement</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm"> r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">elated to opioids claims</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">entered into on February</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm"> 25, 2022, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">among the Settling States</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">, the Settling </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">Distributors, and the Part</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">icipating S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">ubdivisio</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">s (as defined therein).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-6671</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit21x3312022.htm">List of Significant Subsidiaries of the Registrant.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit23x3312022.htm">Consent of Independent Registered Public Accounting Firm, Deloitte &amp; Touche LLP.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x3312022.htm">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x3312022.htm">Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934 as amended, and adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x3312022.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Annual Report on Form 10-K for the fiscal year ended March 31, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Stockholders' Equity (Deficit), (v) Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant agrees to furnish to the Commission upon request a copy of each instrument defining the rights of security holders with respect to issues of long-term debt of the registrant, the authorized principal amount of which does not exceed 10% of the total assets of the registrant.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_217"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;Form 10-K Summary.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="i4b4e3b23ed904498bf3396ff0593cb05_220"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4b4e3b23ed904498bf3396ff0593cb05_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCKESSON CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian S. Tyler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald R. Knauss</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Donald R. Knauss, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Britt J. Vitalone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bradley E. Lerman</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bradley E. Lerman, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Napoleon B. Rutledge Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Linda P. Mantia</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Napoleon B. Rutledge Jr.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Linda P. Mantia, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Richard H. Carmona</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Maria Martinez</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard H. Carmona, M.D., Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maria Martinez, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dominic J. Caruso</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Edward A. Mueller</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dominic J. Caruso, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Edward A. Mueller, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ W. Roy Dunbar</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Susan R. Salka</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">W. Roy Dunbar, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Susan R. Salka, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James H. Hinton</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kathleen Wilson-Thompson</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">James H. Hinton, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kathleen Wilson-Thompson, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.15
<SEQUENCE>2
<FILENAME>mck_exhibit415x3312022.htm
<DESCRIPTION>EX-4.15
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia9a9e6abcac54e2ebce7df279f863e45_1"></div><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">DESCRIPTION OF THE COMPANY&#8217;S SECURITIES REGISTERED    <br>PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following are brief descriptions of (a) the common stock, $0.01 par value per share (the &#8220;Common Stock&#8221;), (b) the 1.500% Notes due 2025 (the &#8220;2025 Notes&#8221;), (c) the 1.625% Notes due 2026 (the &#8220;2026 Notes&#8221;), and (d) the 3.125% Notes due 2029 (the &#8220;2029 Notes&#8221; and, collectively with the 2025 Notes and the 2026 Notes, the &#8220;Notes&#8221;), of McKesson Corporation (the &#8220;Company&#8221; or &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;), which are the only securities of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;).   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Common Stock</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following descriptions of the Common Stock and of certain provisions of Delaware law do not purport to be complete and are subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated&#160;by-laws,&#160;and the Delaware General Corporation Law (&#8220;DGCL&#8221;). Copies of our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;have been filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and are incorporated by reference herein. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the date hereof, our authorized capital stock consists of 900,000,000 shares, of which 800,000,000 shares are Common Stock and 100,000,000 shares are preferred stock, par value $0.01 per share. We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and&#47;or preferred stock. Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.  All of our outstanding shares of Common Stock are fully paid and&#160;non-assessable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dividend Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Subject to the dividend rights of the holders of any outstanding preferred stock, the holders of shares of Common Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Rights Upon Liquidation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities, and any liquidation preferences of outstanding preferred stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Conversion, Redemption and Preemptive Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Holders of our Common Stock have no conversion, redemption, preemptive, or similar rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders. Our amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated&#160;By-Laws</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;contain certain provisions that may be deemed to have an anti-takeover effect and may delay, deter, or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation also provides that any action required or permitted to be taken by the holders of Common Stock may be effected only at an annual or special meeting of such holders, and that stockholders may act in lieu of such meetings only by unanimous written consent. Our amended and restated&#160;by-laws&#160;provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer, or a majority of our board of directors for any purpose at any time. Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated&#160;by-laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated&#160;by-laws&#160;establish an advance notice procedure for the nomination, other than by or at the direction of our board of directors, of candidates for election as directors, as well as for other stockholder proposals to be considered at annual meetings of stockholders. In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the annual meeting and must contain certain specified information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to our amended and restated certificate of incorporation and the DGCL, our amended and restated certificate of incorporation may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon. Our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;provide that our amended and restated&#160;by-laws&#160;may be amended by a vote of a majority of our board of directors. In addition, our amended and restated&#160;by-laws&#160;provide that our amended and restated&#160;by-laws&#160;may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exclusive Forum Provision of our Amended and Restated By-Laws</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated by-laws provide that, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Court of Chancery of the State of Delaware or the United States District Court for the District of Delaware if the Court of Chancery does not have or declines to accept jurisdiction (collectively, &#8220;Delaware Courts&#8221;). Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;203 of Delaware General Corporation Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are subject to the &#8220;business combination&#8221; statute of the DGCL. In general, such statute prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an &#8220;interested stockholder,&#8221; unless&#58;&#160;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;such transaction is approved by our board of directors prior to the date the interested stockholder obtains such status,</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;upon consummation of such transaction, the &#8220;interested stockholder&#8221; beneficially owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by (a)&#160;persons who are directors and also officers and (b)&#160;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer, or</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the &#8220;business combination&#8221; is approved by our board of directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least&#160;66-2&#47;3%&#160;of the outstanding voting stock which is not owned by the &#8220;interested stockholder.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A &#8220;business combination&#8221; includes mergers, asset sales, and other transactions resulting in financial benefit to the &#8220;interested stockholder.&#8221; An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns (or within three years, did own) beneficially 15% or more of a corporation&#8217;s voting stock. The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Effects of Authorized but Unissued Stock</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our authorized but unissued shares of Common Stock and preferred stock may be issued without additional stockholder approval and may be utilized for a variety of corporate purposes, including future offerings to raise additional capital or to facilitate corporate acquisitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The issuance of preferred stock could have the effect of delaying or preventing a change in control of us. The issuance of preferred stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders. In certain circumstances, such issuance could have the effect of decreasing the market price of our Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One of the effects of the existence of unissued and unreserved Common Stock or preferred stock may be to enable our board of directors to issue shares to persons friendly to current management, which could render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of management. Such additional shares also could be used to dilute the stock ownership of persons seeking to obtain control of us.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Limitation of Liability of Directors</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation contains a provision that limits the liability of our directors for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by the Delaware General Corporation Law. Such limitation does not, however, affect the liability of a director (1)&#160;for any breach of the director&#8217;s duty of loyalty to us or our stockholders, (2)&#160;for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3)&#160;in respect of certain unlawful dividend payments or stock redemptions or purchases, and (4)&#160;for any transaction from which the director derives an improper personal benefit. The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders&#8217; derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1)&#160;through (4) above. This provision does not limit or eliminate our rights or the rights of our stockholders to seek&#160;non-monetary&#160;relief such as an injunction or rescission in the event of a breach of a director&#8217;s duty of care. In addition, our directors and officers have indemnification protection.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our Common Stock is listed on the New York Stock Exchange under the symbol &#8220;MCK&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">Description of Notes</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">General</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 17, 2017, we issued &#163;450,000,000 aggregate principal amount of 3.125% Notes due 2029 and &#8364;600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued &#8364;500,000,000 aggregate principal amount of 1.625% Notes due 2026.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">   </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each series of the Notes was issued pursuant to the Indenture, dated as of December&#160;4, 2012 (the &#8220;Indenture&#8221;) between the Company and Wells Fargo Bank, National Association, as trustee (the &#8220;Trustee&#8221;), in each case, as supplemented by an Officer&#8217;s Certificate setting forth certain terms of the applicable series of the Notes (the &#8220;Officer&#8217;s Certificates&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each series of the Notes is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and future unsecured and unsubordinated indebtedness from time to time outstanding. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following descriptions of the Indenture, the Officer&#8217;s Certificates and the Notes do not purport to be complete and are subject to and qualified in their entirety by reference to the Indenture, the Officer&#8217;s Certificates and the Notes, which have been filed with the SEC and are incorporated by reference herein. Unless otherwise specified, all capitalized and undefined terms in this &#8220;Description of Notes&#8221; have the meanings specified in the Indenture.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General Terms of the Indenture</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may issue, from time to time, debt securities, in one or more series, that will consist of either our senior debt (&#8220;Senior Debt Securities&#8221;), our senior subordinated debt (&#8220;Senior Subordinated Debt Securities&#8221;), our subordinated debt (&#8220;Subordinated Debt Securities&#8221;) or our junior subordinated debt (&#8220;Junior Subordinated Debt Securities&#8221; and, together with the Senior Subordinated Debt Securities and the Subordinated Debt Securities, the &#8220;Subordinated Securities&#8221;). The Indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated by us. Except for the limitations on consolidation, merger and sale of all or substantially all of our assets contained in the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Consolidation, Merger or Sale. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to, any person unless (a)&#160;we will be the continuing corporation or (b)&#160;the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a&#160;co-obligor&#160;of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such&#160;co-obligor,&#160;if any, expressly assumes our obligations on the debt securities and under the Indenture. In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing. Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This covenant would not apply to any recapitalization transaction, a change of control of the Company or a highly leveraged transaction, unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Events of Default. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise indicated, the term &#8220;Event of Default,&#8221; when used in the Indenture with respect to the debt securities of any series, means any of the following&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to pay interest for 30 days after the date payment on any debt security of such series is due and payable&#59; provided that an extension of an interest payment period by the Company in accordance with the terms of the debt securities shall not constitute a failure to pay interest&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to pay principal or premium, if any, on any debt security of such series when due, either at maturity, upon any redemption, by declaration or otherwise&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to perform any other covenant in the Indenture or the debt securities of such series (&#8220;other covenants&#8221;) for 90 days after notice that performance was required&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">events in bankruptcy, insolvency or reorganization of the Company&#59; or</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any other Event of Default provided in the applicable resolution of our board of directors or the officers&#8217; certificate or supplemental Indenture under which we issue such series of debt securities.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">An Event of Default for a particular series of debt securities does not necessarily constitute an Event of Default for any other series of debt securities issued under the Indenture. If an Event of Default relating to the payment of interest, principal or any sinking fund installment involving any series of debt securities has occurred and is continuing, the Trustee or the holders of not less than 25% in aggregate principal amount of the debt securities of each affected series may declare the entire principal of all the debt securities of that series to be due and payable immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Event of Default relating to the performance of other covenants occurs and is continuing for a period of 90 days after notice of such, or if any other Event of Default occurs and is continuing involving all of the series of Senior Debt Securities, then the Trustee or the holders of not less than 25% in aggregate principal amount of all of the series of Senior Debt Securities may declare the entire principal amount of all of the series of Senior Debt Securities due and payable immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Similarly, if an Event of Default relating to the performance of other covenants occurs and is continuing for a period of 90 days after notice of such, or if any other Event of Default occurs and is continuing involving all of the series of Subordinated Securities, then the Trustee or the holders of not less than 25% in aggregate principal amount of all of the series of Subordinated Securities may declare the entire principal amount of all of the series of Subordinated Securities due and payable immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, however, the Event of Default relating to the performance of other covenants or any other Event of Default that has occurred and is continuing is for less than all of the series of Senior Debt Securities or Subordinated Securities, as the case may be, then the Trustee or the holders of not less than 25% in aggregate principal amount of each affected series of the Senior Debt Securities or the Subordinated Securities, as the case may be, may declare the entire principal amount of all debt securities of such affected series due and payable immediately. The holders of not less than a majority in aggregate principal amount of the debt securities of a series may, after satisfying conditions, rescind and annul any of the above-described declarations and consequences involving the series.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Event of Default relating to events in bankruptcy, insolvency or reorganization of the Company occurs and is continuing, then the principal amount of all of the debt securities outstanding, and any accrued interest, will automatically become due and payable immediately, without any declaration or other act by the Trustee or any holder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture imposes limitations on suits brought by holders of debt securities against us. Except as provided below, no holder of debt securities of any series may institute any action against us under the Indenture unless&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the holder has previously given to the Trustee written notice of default and continuance of that default&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the holders of at least 25% in principal amount of the outstanding debt securities of the affected series have requested that the Trustee institute the action&#59;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the requesting holders have offered the Trustee security or indemnity reasonably satisfactory to it for expenses and liabilities that may be incurred by bringing the action&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Trustee has not instituted the action within 60 days of the request&#59; and</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Trustee has not received inconsistent direction by the holders of a majority in principal amount of the outstanding debt securities of the affected series.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, each holder of debt securities of any series has the right, which is absolute and unconditional, to receive payment of the principal of, and premium and interest, if any, on, such debt securities when due and to institute suit for the enforcement of any such payment, and such rights may not be impaired without the consent of that holder of debt securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We will be required to file annually with the Trustee a certificate, signed by an officer of the Company, stating whether or not the officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Modification of the Indenture.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture provides that we and the Trustee may enter into supplemental indentures without the consent of the holders of debt securities to&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">secure any debt securities&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence the assumption by a successor corporation of our obligations&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">add covenants for the protection of the holders of debt securities&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cure any ambiguity or correct any inconsistency in the Indenture&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">establish the forms or terms of debt securities of any series&#59; and</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence and provide for the acceptance of appointment by a successor Trustee.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture also provides that we and the Trustee may, with the consent of the holders of not less than a majority in aggregate principal amount of debt securities of all series of Senior Debt Securities or Subordinated Securities, as the case may be, then outstanding and affected thereby (voting as one class), add any provisions to, or change in any manner, eliminate or modify in any way the provisions of, the Indenture or modify in any manner the rights of the holders of the debt securities. We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">extend the final maturity of any debt security&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the principal amount or premium, if any&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the rate or extend the time of payment of interest&#59;</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce any amount payable on redemption&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">change the currency in which the principal (other than as may be provided otherwise with respect to a series), premium, if any, or interest is payable&#59;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the amount of the principal of any debt security issued with an original issue discount that is payable upon acceleration or provable in bankruptcy&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">modify any of the subordination provisions or the definition of senior indebtedness applicable to any Subordinated Securities in a manner adverse to the holders of those securities&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">alter provisions of the Indenture relating to the debt securities not denominated in U.S. dollars&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">impair the right to institute suit for the enforcement of any payment on any debt security when due&#59; or</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the percentage of holders of debt securities of any series whose consent is required for any modification of the Indenture.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Officer&#8217;s Certificate contains the following covenants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Definitions. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Attributable Debt&#8221; shall mean in connection with a sale and lease-back transaction the lesser of (a)&#160;the fair value of the assets subject to such transaction, as determined by our Board of Directors, or (b)&#160;the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Consolidated Subsidiary&#8221; shall mean any Subsidiary (as defined in the Indenture), substantially all the property of which is located, and substantially all the operations of which are conducted, in the United States of America whose financial statements are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Exempted Debt&#8221; shall mean the sum of the following as of the date of determination&#58; (1)&#160;Indebtedness of ours and our Consolidated Subsidiaries incurred after the date of issuance of the notes and secured by liens not permitted by the limitation on liens provisions, and (2)&#160;Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Indebtedness&#8221; shall mean all items classified as indebtedness on our most recently available consolidated balance sheet, in accordance with accounting principles generally accepted in the United States of America.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Qualified Receivables Transaction&#8221; shall mean any transaction or series of transactions entered into by us or any of our Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1)&#160;a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2)&#160;any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other obligations in respect of such accounts receivable or inventory, proceeds of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Receivables Subsidiary&#8221; shall mean a Subsidiary of ours which engages in no activities other than in connection with the financing of accounts receivable or inventory (a)&#160;no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)&#160;is guaranteed by us or any Subsidiary of ours (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction), (2) is recourse or obligates us or any Subsidiary of ours in any way other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction or (3)&#160;subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of &#8220;Qualified Receivables Transaction&#8221;), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b)&#160;with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c)&#160;with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary&#8217;s financial condition or cause such Subsidiary to achieve certain levels of operating results.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Liens</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. We covenant that, so long as any of the Notes remain outstanding, we will not, and will not permit any Consolidated Subsidiary, to create or assume any Indebtedness for money borrowed which is secured by a mortgage, pledge, security interest or lien (&#8220;liens&#8221;) of or upon any assets, whether now owned or hereafter acquired, of ours or any such Consolidated Subsidiary without equally and ratably securing the notes by a lien ranking equally to and ratably with (or, at our option, senior to) such secured Indebtedness, except that the foregoing restriction shall not apply to&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on assets of any corporation existing at the time such corporation becomes a Consolidated Subsidiary&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on assets existing at the time of acquisition thereof, or to secure the payment of the purchase price of such assets, or to secure indebtedness incurred or guaranteed by us or a Consolidated Subsidiary for the purpose of financing the purchase price of such assets or improvements or construction thereon, which indebtedness is incurred or guaranteed prior to, at the time of or within 360 days after such acquisition, or in the case of real property, completion of such improvement or construction or commencement of full operation of such property, whichever is later&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens securing indebtedness owed by any Consolidated Subsidiary to us or another wholly owned Subsidiary&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of a corporation existing at the time such corporation is merged into or consolidated with us or a Subsidiary or at the time of a purchase, lease or other acquisition of the assets of the corporation or firm as an entirety or substantially as an entirety by us or a Subsidiary&#59;</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of ours or a Consolidated Subsidiary in favor of the United States of America or any state thereof, or in favor of any other country, or political subdivision thereof, to secure certain payments pursuant to any contract or statute or to secure any indebtedness incurred or guaranteed for the purpose of financing all or any part of the purchase price, or, in the case of real property, the cost of construction, of the assets subject to such liens, including, but not limited to, liens incurred in connection with pollution control, industrial revenue or similar financing&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any extension, renewal or replacement, or successive extensions, renewals or replacements, in whole or in part, of any lien referred to in the foregoing&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain statutory liens or other similar liens arising in the ordinary course of our or a Consolidated Subsidiary&#8217;s business, or certain liens arising out of government contracts&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain pledges, deposits or liens made or arising under the worker&#8217;s compensation or similar legislation or in certain other circumstances&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain liens in connection with legal proceedings, including certain liens arising out of judgments or awards&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens for certain taxes or assessments, landlord&#8217;s liens and liens and charges incidental to the conduct of the business or the ownership of our assets or those of a Consolidated Subsidiary, which were not incurred in connection with the borrowing of money and which do not, in our opinion, materially impair the use of such assets in the operation of our business or that of such Consolidated Subsidiary or the value of such assets for the purposes thereof&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens relating to accounts receivable of ours or any of our Subsidiaries which have been sold, assigned or otherwise transferred to another Person in a transaction classified as a sale of accounts receivable in accordance with accounting principles generally accepted in the United States of America, to the extent the sale by us or the applicable Subsidiary is deemed to give rise to a lien in favor of the purchaser thereof in such accounts receivable or the proceeds thereof&#59; or</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of ours or any of our Subsidiaries (including Receivables Subsidiaries) incurred in connection with a Qualified Receivables Transaction.</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the above, we or any of our Consolidated Subsidiaries may, without securing the notes, create or assume any Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions&#59; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Sale and Lease-Back Transactions.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sale and lease-back transactions, except such transactions involving leases for less than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a)&#160;we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b)&#160;the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness. The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2025 Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2025 Notes bear interest at the rate of 1.500%&#160;per year.  Interest on the 2025 Notes is payable on November&#160;17 of each year.   The 2025 Notes will mature on November&#160;17, 2025.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2025 Notes prior to&#160;August&#160;17, 2025, the date that is three months before their maturity date, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;August&#160;17, 2025, we may redeem the 2025 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2025 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2025 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2025 Notes in whole, the Company will be required to offer to repurchase the 2025 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2025 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2026 Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2026 Notes bear interest at the rate of 1.625%&#160;per year. Interest on the 2026 Notes is payable on October&#160;30 of each year.  The 2025 Notes will mature on October 30, 2026.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2026 Notes for cash in whole, at any time, or in part, from time to time, prior to maturity, at a redemption price that includes accrued and unpaid interest and a make-whole premium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2026 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of the 2026 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2026 Notes in whole, the Company will be required to offer to repurchase the 2026 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2026 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2029 Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2029 Notes bear interest at the rate of 3.125%&#160;per year.  Interest on the 2029 Notes is payable on February&#160;17 of each year.  The 2029 Notes will mature on February&#160;17, 2029.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2029 Notes prior to&#160;November&#160;17, 2028, the date that is three months before their maturity date in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;November&#160;17, 2028, we may redeem the 2029 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2029 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2029 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2029 Notes in whole, the Company will be required to offer to repurchase the 2029 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2029 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concerning the Trustee</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Wells Fargo Bank, National Association is the Trustee under the Indenture with respect to the Notes. We may maintain deposit accounts or conduct other banking transactions with the Trustee in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Governing Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture and Notes are governed by, and construed in accordance with, the laws of the State of New York, including, without limitation, Sections&#160;5-1401&#160;and&#160;5-1402&#160;of the New York General Obligations Law and New York Civil Practice Law and Rules 327(b).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our 2025 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK25.&#8221;  Our 2026 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK26.&#8221;  Our 2029 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK29.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">13</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>3
<FILENAME>mck_ex106xseverancepolicyf.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3a4d20a8ecba4dbe98ba058698786fe2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.6</font></div></div><div style="margin-top:100pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDED AND RESTATED </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SEVERANCE POLICY FOR EXECUTIVE EMPLOYEES</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><div id="i3a4d20a8ecba4dbe98ba058698786fe2_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDED AND RESTATED SEVERANCE POLICY FOR EXECUTIVE EMPLOYEES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Dated as of April 26, 2022)</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">ADOPTION AND PURPOSE OF POLICY.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Amended and Restated McKesson Corporation Severance Policy for Executive Employees (the &#8220;Policy&#8221;) is intended to provide a program of severance payments to certain employees of McKesson and its designated subsidiaries. The Policy is an employee welfare benefit plan within the meaning of Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;) and Section 2510.3-1 of the regulations issued thereunder. This document constitutes both the plan document and the summary plan description of the Policy.  The plan administrator of the Policy for purposes of ERISA is McKesson. This Policy is hereby amended and restated effective April 26, 2022.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">SEVERANCE BENEFITS.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Severance Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event that the Company terminates the employment of a Participant without Cause (and other than due to the Participant&#8217;s death or Long-term Disability) under circumstances that (i) constitute or are reasonably expected to result in a Separation from Service and (ii) do not make the Participant eligible for benefits under the McKesson&#8217;s Change in Control Policy for Selected Executive Employees (together, a &#8220;Qualifying Termination&#8221;), the Participant shall be entitled to a severance benefit equal to the lesser of (A) 12 months&#8217; Base Salary plus one additional month for each Year of Service or (B) 24 months&#8217; Base Salary (as applicable, the &#8220;Severance Benefit&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Effect on Other Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as provided in Sections 2(c) and 2(d), nothing in the Policy shall alter or impair any rights a Participant may have upon Separation from Service under any other plan or program of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Other Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Severance Benefit shall be reduced on a dollar-for-dollar basis by the benefit received by the Participant under the Company&#8217;s short-term disability plan.  Moreover, the Severance Benefit may be considered to be &#8220;other income&#8221; that reduces benefits payable under other Company-sponsored welfare plans (e.g., the Company&#8217;s long-term disability plan). </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">No Duplication of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">In no event shall a Participant be entitled to any benefits under the Policy if his or her employment with the Company terminates under circumstances that entitle the Participant to receive severance benefits following a change of control of the Company pursuant to McKesson&#8217;s Change in Control Policy for Executive Employees (or a successor plan) or the terms of any individual written employment or severance agreement&#59; provided, however, to the extent that the benefits provided in the Policy are greater than the benefits provided in such written employment agreement, the benefits shall be paid under the Policy in lieu of the benefits provided in the individual written employment or severance agreement.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">If a Participant receives severance benefits under the Policy, any predecessor plan or any other McKesson-sponsored severance agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or arrangement and if the Participant subsequently provides service to McKesson as an Employee, then any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">new</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> benefits under the Policy after the date of recommencement of service shall be based solely on (x)&#160;the Participant&#8217;s Period of Service after the date of recommencement&#59; and (y)&#160;the Period of Service, if any, attributable to the benefit that was not paid under the Policy.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Release Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision in the Policy, no payments will be made to a Participant under the Policy until the Participant provides to the Company a signed release of claims, in the form that the Company provides to the Participant (the &#8220;Release&#8221;), and does not revoke such Release during the applicable statutory period provided to revoke a release, if any (the &#8220;revocation period&#8221;).  If the Participant does not revoke his or her signed Release by the end of the revocation period, then the Participant shall have an &#8220;Effective Release&#8221; on file with the Company.  No payments will be made to a Participant under the Policy unless the Company has received an Effective Release from that Participant no later than sixty (60) days after the Participant&#8217;s Separation from Service.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">FORM OF BENEFIT.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless otherwise determined by the Administrator, the Severance Benefit shall be paid in installments over the number of months calculated in accordance with Section 2(a) on regular paydays for wages paid to similarly situated active employees of the Company.  Subject to the special rules described in Section 3(b), such payments shall commence no later than 60 calendar days after the later of (x) the date on which the Company has an Effective Release from the Participant, and (y) the effective date of the Participant&#8217;s Qualifying Termination. Notwithstanding the foregoing, if (i) the Participant violates any of the Participant&#8217;s continuing restrictive covenant obligations under any agreement, plan or policy with or of the Company, including any non-disclosure, non-competition, non-solicitation or non-disparagement covenants or the Participant does not comply with the Participant&#8217;s obligations under the Release, (ii) after the Participant&#8217;s termination of employment with the Company, the Company determines that the Participant engaged in an act or omission that, if discovered during the Participant&#8217;s employment, would have entitled the Company to terminate the Participant&#8217;s employment for Cause, or (iii) if the Administrator determines, in its sole discretion, that the Participant has engaged in any other conduct that is not in good faith, which disrupts, damages, impairs or interferes with the business, reputation or employees of the Company, the Administrator may require the Participant to forfeit the Participant&#8217;s entitlement to the Severance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Benefit to the extent not yet paid and require the Participant to repay to the Company any Severance Benefit previously paid to the Participant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Special Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Special Rule for Participants Engaged as Non-Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If a Participant experiences a Qualifying Termination, but commences service to the Company as a non-Employee for a &#8220;transition&#8221; or &#8220;consulting&#8221; period prior to the date of his or her Separation from Service, and to the extent that the Participant&#8217;s severance benefit hereunder is not exempt from Section 409A of the Code under Section 9(g), then such non-exempt payments shall commence on fixed date 60 calendar days following the date of the Participant&#8217;s actual Separation from Service.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Special Rule for Non-409A Exempt Severance Benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Participant&#8217;s Severance Benefit is not exempt from Section 409A of the Code pursuant to Section 9(g), then notwithstanding the general rule for commencement of benefits under Section 3(a), payment of the Severance Benefit shall commence&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">On a fixed date 60 calendar days following the date of the Participant&#8217;s Qualifying Termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">During a specified period no longer than 60 days following the date of the Participant&#8217;s Qualifying Termination, with payments commencing in the later taxable year if such specified period could span two taxable years, provided that in the event of such a delay in the commencement of payments, the first installment paid in the later taxable year shall include any installments that would have been paid in the prior taxable year absent this Section 3(b)(ii)b.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Special Rule for Specified Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Participant is a Specified Employee on the date of his or her Separation from Service, any payment or portion of the payment that is scheduled to be made in the six-month period following the Participant&#8217;s Separation from Service, when considered together with any other severance payments or separation benefits which may be considered deferred compensation under Section 409A of the Code, would result in the imposition of additional tax under Section 409A of the Code if paid to the Participant on or within the six (6) month period following his or her Separation from Service shall be made in the seventh month following the month in which the Participant&#8217;s Separation from Service occurs.  Any payment that is subject to the delay shall include an additional amount representing interest credited at the rate being credited to accounts under McKesson&#8217;s Deferred Compensation Administration Plan III during the relevant period of delay and such interest shall be paid in a lump sum at the same time that the delayed payments are made.  All subsequent payments or benefits will be payable in accordance with the payment schedule applicable to each such payment or benefits.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Re-employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Payments hereunder shall stop and no further payments shall be made to a Participant if during the benefit payment period calculated under Section 2(a) the Participant resumes service as an Employee of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">EFFECT OF DEATH OF EMPLOYEE.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Should a Participant die after Separation from Service and become eligible to receive the Severance Benefit, but prior to the payment of the entire benefit due hereunder, the balance of the Severance Benefit shall be paid in a lump sum to the Participant&#8217;s surviving spouse, or, if none, to his or her surviving children or, if none, to his or her estate, as soon as reasonably practicable, but no later than 90 days, after the date of Participant&#8217;s death.  If a Participant dies prior to Separation from Service, no benefits will be paid under the Policy.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">STOCKHOLDER APPROVAL.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">McKesson shall seek approval or ratification of its stockholders at McKesson&#8217;s next annual or special meeting of stockholders for any arrangement whereby the present value of any Severance Payments for any Participant exceeds 2.99 times such Participant&#8217;s Earnings. This provision will apply to any arrangement or agreement with a Participant entered into after July 30, 2003, including extensions, renewals or modifications (other than modifications based upon subsequent changes in tax law or other legal requirements) after such date of arrangements or agreements entered into prior to such date that increase the Severance Payments (other than increases due to an increase in the components of Earnings) payable to a Participant under such arrangement or agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">AMENDMENT AND TERMINATION.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">McKesson reserves the right to amend the Policy by action of the Compensation Committee of the Board.  The Board in its discretion may at any time terminate the Policy in accordance with Treasury Regulation &#167;1.409A-3(j)(4)(ix).  Notwithstanding the foregoing, no action shall have the effect of decreasing the benefit of a Participant whose Separation from Service occurred prior to the date of the Board&#8217;s or Compensation Committee&#8217;s action. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">ADMINISTRATION AND FIDUCIARIES.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Plan Sponsor and Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. McKesson is the &#8220;plan sponsor&#8221; and the &#8220;Administrator&#8221; of the Policy, within the meaning of ERISA.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Administrative Responsibilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. McKesson shall be the named fiduciary within the meaning of ERISA, with the power and sole discretion to determine who is eligible for benefits under the Policy, to determine the value of benefits paid in any form other than cash or the present value of any cash or other benefits paid over time, to interpret the Policy and to prescribe such forms, make such rules, regulations and computations and prescribe such guidelines as it may determine are necessary or appropriate for the operation and administration of the Policy and to change the terms of or rescind such rules, regulations or guidelines. Such determinations of eligibility, rules, regulations, interpretations, computations and guidelines shall be conclusive and binding upon all persons. In administering the Policy, McKesson shall at all times discharge its duties with respect to the Policy in accordance with the standards set forth in section 404(a)(1) of ERISA.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Allocation and Delegation of Responsibilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Compensation Committee may allocate any of McKesson&#8217;s responsibilities for the operation and administration of the Policy among McKesson&#8217;s officers, employees and agents. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">It may also delegate any of McKesson&#8217;s responsibilities under the Policy by designating, in writing, another person to carry out such responsibilities.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">No Individual Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. It is declared to be the express purpose and intent of McKesson that no individual liability shall attach to or be incurred by any member of the Board of McKesson, or by any officer, employee representative or agent of the Company, under, or by reason of the operation of, the Policy.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Employer Identification Number and Policy Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The employer identification number (EIN) assigned to McKesson by the Internal Revenue Service is 94-3207296.  The plan number (PIN) assigned to the Policy by McKesson is 552.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Policy Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All records with respect to the Policy are kept on a calendar year basis.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Legal Actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No lawsuit can be brought to recover a benefit under the Policy until an individual or his or her representative has done all of the following&#58;  (i)&#160;filed a written claim as required by the Policy, (ii) received a written denial of the claim (or the claim is deemed denied as described below), (iii) filed a written request for a review of the denied claim with the Administrator, and (iv) received written notification that the denial of the claim has been affirmed (or the denial is deemed to be affirmed as described below).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Agent for Service of Legal Process</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If an individual wishes to take legal action after exhausting the Policy&#8217;s claims and appeal procedures, legal process should be served on&#58; Executive Vice President and Chief Human Resources Officer, McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039.  The individual may also serve process with respect to the Policy by serving the Administrator at the address shown above.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">ERISA Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Participants are entitled to certain rights and protections under Title I of ERISA.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Participants may examine without charge all official Policy documents during business hours in the McKesson Human Resources Department.  These documents include the legal texts of the plans, Policy descriptions and annual reports that McKesson files with the U.S. Department of Labor. </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Participants may also obtain a copy of any of these documents by writing to the Administrator, and may be charged a reasonable fee for copies.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">Participants have the right to receive a summary of the Policy&#8217;s annual financial report.  The Administrator is required by law to furnish each Participant with a copy of this summary annual report.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Questions about the Policy should be directed to the Administrator.  A Participant who has any questions about this statement or about his or her rights under ERISA, or who needs assistance in obtaining documents from the Administrator, should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">telephone directory, or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210.  Participants may also obtain certain publications about their rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">No right to a benefit under the Policy shall depend (or shall be deemed to depend) upon whether a Participant retires or elects to receive retirement benefits under the terms of any employee pension benefit plan.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">The Policy shall contain no terms or provisions except those set forth herein, or as hereafter amended in accordance with the provisions of Section 6.  If any description made in any other document is deemed to be in conflict with any provision of the Policy, the provisions of the Policy shall control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">CLAIMS AND APPEAL PROCEDURES</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Informal Resolution of Questions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Participant who has questions or concerns about his or her benefits under the Policy is encouraged to communicate with the Human Resources Department of McKesson. If this discussion does not give the Participant satisfactory results, a formal claim for benefits may be made in accordance with the procedures of this Section 8.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Formal Benefits Claim&#8212;Review by Executive Vice President, Human Resources</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. A Participant may make a written request for review of any matter concerning his or her benefits under the Policy. The claim must be addressed to the Executive Vice President and Chief Human Resources Officer, McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039. The Executive Vice President, Chief Human Resources Officer, or his or her delegate (&#8220;Executive Vice President&#8221;) shall decide the action to be taken with respect to any such request and may require additional information if necessary to process the request. The Executive Vice President shall review the request and shall issue his or her decision, in writing, no later than 90 days after the date the request is received, unless the circumstances require an extension of time. If such an extension is required, written notice of the extension shall be furnished to the person making the request within the initial 90-day period, and the notice shall state the circumstances requiring the extension and the date by which the Executive Vice President expects to reach a decision on the request. In no event shall the extension exceed a period of 90 days from the end of the initial period.  Any claim under the Policy must be brought within two years of the date the events giving rise to the claim first occurred.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notice of Denied Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Executive Vice President denies a request in whole or in part, he or she shall provide the person making the request with written notice of the denial within the period specified in Section 8(b). The notice shall set forth the specific reason for the denial, reference to the specific Policy provisions upon which the denial is based, a description of any additional material or information necessary to perfect the request, an explanation of why such information is required, and an explanation of the Policy&#8217;s appeal procedures and the time limits applicable to such procedures, including a statement of the claimant&#8217;s right to bring a civil action under Section 502(a) of ERISA following an adverse benefit determination on review.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Appeal to Executive Vice President</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A person whose request has been denied in whole or in part (or such person&#8217;s authorized representative) may file an appeal of the decision in writing with the Executive Vice President within 60 days of receipt of the notification of denial. The appeal must be addressed to&#58; Executive Vice President and Chief Human Resources Officer, McKesson Corporation, 6555 North State Highway 161, Irving, Texas 75039. The Executive Vice President, for good cause shown, may extend the period during which the appeal may be filed for another 60 days. The appellant and&#47;or his or her authorized representative shall be permitted to submit written comments, documents, records and other information relating to the claim for benefits. Upon request and free of charge, the applicant should be provided reasonable access to and copies of, all documents, records or other information relevant to the appellant&#8217;s claim.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Executive Vice President&#8217;s review shall take into account all comments, documents, records and other information submitted by the appellant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. The Executive Vice President shall not be restricted in his or her review to those provisions of the Policy cited in the original denial of the claim.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Executive Vice President shall issue a written decision within a reasonable period of time but not later than 60 days after receipt of the appeal, unless special circumstances require an extension of time for processing, in which case the written decision shall be issued as soon as possible, but not later than 120 days after receipt of an appeal. If such an extension is required, written notice shall be furnished to the appellant within the initial 60-day period. This notice shall state the circumstances requiring the extension and the date by which the Executive Vice President expects to reach a decision on the appeal.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the decision on the appeal denies the claim in whole or in part written notice shall be furnished to the appellant. Such notice shall state the reason(s) for the denial, including references to specific Policy provisions upon which the denial was based. The notice shall state that the appellant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the claim for benefits. The notice shall describe any voluntary appeal procedures offered by the Policy and the appellant&#8217;s right to obtain the information about such procedures. The notice shall also include a statement of the appellant&#8217;s right to bring an action under Section 502(a) of ERISA.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The decision of the Executive Vice President on the appeal shall be final, conclusive and binding upon all persons and shall be given the maximum possible deference allowed by law.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Exhaustion of Remedies. No legal or equitable action for benefits under the Policy shall be brought unless and until the claimant has submitted a written claim for benefits in accordance with Section 8(b), has been notified that the claim is denied in accordance with Section 8(c), has filed a written request for a review of the claim in accordance with Section 8(d), and has been notified in writing that the Executive Vice President has affirmed the denial of the claim in accordance with Section 8(d).  A legal or equitable action for benefits must be brought no later </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">than the date that is 90 days after the date on which the claimant was notified in writing that the denial was affirmed on appeal.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">GENERAL PROVISIONS.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Basis of Payments to and from Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All benefits under the Policy shall be paid by McKesson. The Policy shall be unfunded and benefits hereunder shall be paid only from the general assets of McKesson. Nothing contained in the Policy shall be deemed to create a trust of any kind for the benefit of any employee, or create any fiduciary relationship between the Company and any employee with respect to any assets of the Company. McKesson is under no obligation to fund the benefits provided herein prior to payment, although it may do so if it chooses. Any assets which McKesson chooses to use for advance funding shall not cause the Policy to be a funded plan within the meaning of ERISA.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">No Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in the Policy shall be deemed to give any individual the right to remain in the employ of the Company or a subsidiary or to limit in any way the right of the Company or a subsidiary to discharge, demote, reclassify, transfer, relocate an individual or terminate an individual&#8217;s employment at any time and for any reason, which right is hereby reserved.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Non-alienation of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No benefit payable under the Policy shall be subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance or charge, and any attempt to do shall be void.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Legal Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Policy shall be governed and interpreted in accordance with ERISA.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Policy shall be construed and enforced according to federal law except where not preempted by the laws of the State of Delaware, other than its laws respecting choice of law.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  McKesson does not guarantee or warrant the tax consequences of any payment of benefit under the Policy, and a Participant shall, in all cases, be liable for any taxes due as a result of the Policy.  Policy benefits are subject to applicable federal, state and local withholding taxes, as well as other authorized payroll deductions.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of the Policy, McKesson shall administer and construe the Policy in accordance with Section 409A of the Code, the regulations promulgated thereunder, and any other published interpretive authority, as issued or amended from time to time.  </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">The Policy shall be administered and interpreted to maximize exemptions from Section 409A of the Code and to comply with Section 409A of the Code to the extent benefits are subject thereto.  Payments under Section 2(a) paid on or before the last day of the Short-Term Deferral Period shall constitute a &#8220;short-term deferral&#8221; within the meaning of Treasury Regulations &#167;&#160;1.409A-1(b)(9).  Payments under Section 2(a) that are not short-term deferrals shall be administered to satisfy the exception for involuntary separation pay under Treasury Regulations &#167;&#160;1.409A-1(b)(9)(iii) to the extent such payments do not exceed the amount set forth in Treasury Regulations &#167;&#160;1.409A-1(b)(9)(iii)(A).  To the extent a payment under Section 2(a) is not exempt from Section 409A of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Code, each payment shall be construed to the extent permissible as being made in accordance with specified times or a fixed schedule as provided in Treasury Regulations &#167;&#160;1.409A-3(i)(1).</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Each installment payment provided for in the Policy is a separate &#8220;payment&#8221; within the meaning of Treasury Regulation &#167;&#160;1.409A-2(b)(2)(i).</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Notwithstanding any other provision of the Policy, no payment under the Policy shall be made later than the last day of the second calendar year following the year in which the Separation from Service occurs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">DEFINITIONS.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Whenever used and capitalized in the text of the Policy, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Administrator&#8221; means the person specified in Section 7.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Base Salary&#8221; means a Participant&#8217;s monthly base salary as in effect immediately prior to the date of such Participant&#8217;s Separation from Service.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Board&#8221; means the Board of Directors of McKesson.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Cause,&#8221; as determined by the Compensation Committee in good faith, means any of the following&#58; (i) a Participant&#8217;s refusal or failure to perform, or negligence in the performance of, the Participant&#8217;s duties and responsibilities or refusal or failure to carry out the reasonable lawful written direction of the Board, in each case in a manner that causes harm to McKesson or any of its subsidiaries&#59; (ii) a Participant&#8217;s engagement in conduct that involves a breach of fiduciary obligation to McKesson or any of its subsidiaries in a manner that causes harm to McKesson or any of its subsidiaries&#59; (iii) a Participant&#8217;s engagement in conduct that otherwise could reasonably be expected to have an adverse effect upon the business, interests or reputation of McKesson or any of its subsidiaries&#59; (iv) a Participant&#8217;s non-compliance with McKesson policies or procedures, including, without limitation, the McKesson Code of Conduct&#59; (v) a Participant&#8217;s violation of any legal or contractual obligation to McKesson, including without limitation the terms of the Participant&#8217;s Business Asset Protection Agreement with McKesson&#59; (vi) a Participant&#8217;s commission of fraud, embezzlement, theft, or other dishonesty with respect to McKesson or any of its subsidiaries or affiliates&#59; or (vii) a Participant&#8217;s conviction of or plea of nolo contendere to, any felony or any other crime involving dishonesty or moral turpitude.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;Company&#8221; means McKesson and any affiliate that would be considered a service recipient for purposes of Treasury Regulation &#167;&#160;1.409A-1(g).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Earnings&#8221; means a Participant&#8217;s (i) annualized Base Salary plus (ii) target bonus for the fiscal year in which such Participant&#8217;s Separation from Service occurs, in each case inclusive of any amounts deferred by the Participant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Employee&#8221; means an individual who is an employee under the common-law standard as determined by McKesson in its sole discretion based on the Internal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Revenue Service&#8217;s right-to-control and 20-factor test and other applicable guidance.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;Employer&#8221; means McKesson and any other affiliate that would be considered a service recipient or employer for purposes of Treasury Regulation &#167;1.409A-1(h)(3). </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;Long-Term Disability&#8221; means a physical or mental condition in respect of which the administrator of McKesson&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in McKesson&#8217;s long-term disability plan, a physical or mental condition that the administrator of McKesson&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;McKesson&#8221; means McKesson Corporation, a Delaware corporation.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;Participant&#8221; means (i) an executive officer of McKesson or (ii) any other employee of the Company designated as a Participant by the Compensation Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">&#8220;Period of Service&#8221; means the period of time starting on the date that a Participant first performs an hour of service for the Company and ending on the date of his or her termination of employment for any reason.  Breaks in service (e.g., the period of time from termination of employment to the date of rehire by the Company) are not included in a Participant&#8217;s Period of Service.  Non-consecutive Periods of Service shall be aggregated.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Qualifying Termination&#8221; is defined in Section 2(a).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Severance Payments&#8221; means (i) lump-sum cash payments (including payments in lieu of medical and other benefits), (ii) the estimated present value of periodic cash payments under previously established bonus, retirement, deferred compensation, or other Company benefit plans, (iii) fringe benefits other than those provided under Company programs or arrangements applicable to one or more groups of employees in addition to Participants, and (iv) consulting fees (including reimbursable expenses) other than reasonable fees and expenses for bona fide services provided to the Company after termination, paid or payable by the Company to a Participant pursuant to the Policy or otherwise upon a termination by the Company of employment of such Participant at any time other than within two years following a Change in Control, excluding Vested, Accrued or Appropriate Benefits.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Separate from Service&#8221; or &#8220;Separation from Service&#8221; means termination of employment or other services (whether as an Employee or, if applicable a non-Employee) with the Employer, except in the event of death.  A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Employer is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Employer (or if providing service to the Employer less than three years, such lesser period).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;Specified Employee&#8221; means a Participant who is determined by the Administrator to be a &#8220;specified employee&#8221; under Treasury Regulations &#167;&#160;1.409A-1.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;Vested, Accrued or Appropriate Benefits&#8221; means any benefits paid or payable by the Company to a Participant upon a termination by the Company of such Participant&#8217;s employment at any time other than within two years following a Change in Control that are (i) earned, accrued, deferred or otherwise received for employment services rendered through the date of Separation from Service pursuant to bonus, retirement, deferred compensation, or other Company benefit plans, (ii) approved under the terms of bonus, retirement, deferred compensation, or other Company benefit plans existing at the time of such termination at the reasonable discretion of the Compensation Committee taking into consideration the age, length of service and other circumstances of such termination, (iii)&#160;payments or benefits required to be provided by law, and (iv) benefits and perquisites provided by the Company under plans, programs or arrangements of the Company applicable to one or more groups of employees in addition to Participants.  For the avoidance of doubt, Vested, Accrued or Appropriate Benefits shall not include benefits payable pursuant to the Policy.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.36pt">&#8220;Year of Service&#8221; means the number of calendar days in a Participant&#8217;s Period of Service divided by 365.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">EFFECTIVE DATE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Amended and Restated Severance Policy for Executive Employees was adopted on April 26, 2022.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>4
<FILENAME>mck_exx108xmanagementincen.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i612c37e727c14aad9e60677288b4604f_38"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.8</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MANAGEMENT INCENTIVE PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amended and Restated, Effective April 26, 2022</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i612c37e727c14aad9e60677288b4604f_41"></div><hr style="page-break-after:always"><div style="min-height:90.72pt;width:100%"><div style="margin-top:6pt;padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Table of Contents</font></div><div style="padding-left:5.75pt;padding-right:5.75pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Page</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">A.&#160;&#160;&#160;&#160;NAME&#59; EFFECTIVE TIME.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">B.&#160;&#160;&#160;&#160;PURPOSE.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">C.&#160;&#160;&#160;&#160;ADMINISTRATION.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">D.&#160;&#160;&#160;&#160;PARTICIPATION.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">E.&#160;&#160;&#160;&#160;INDIVIDUAL TARGET AWARDS FOR PARTICIPANTS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">2</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">F.&#160;&#160;&#160;&#160;BASIS OF AWARDS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">G.&#160;&#160;&#160;&#160;AWARD DETERMINATION.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">H.&#160;&#160;&#160;&#160;PAYMENT OF AWARDS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">I.&#160;&#160;&#160;&#160;EMPLOYMENT ON PAYMENT DATE.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">J.&#160;&#160;&#160;&#160;CHANGE IN CONTROL.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">K.&#160;&#160;&#160;&#160;FORFEITURE.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">L.&#160;&#160;&#160;&#160;RECOUPMENT.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">M.&#160;&#160;&#160;&#160;WITHHOLDING TAXES.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">N.&#160;&#160;&#160;&#160;EMPLOYMENT RIGHTS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">O.&#160;&#160;&#160;&#160;NONASSIGNMENT&#59; PARTICIPANTS ARE GENERAL CREDITORS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">P.&#160;&#160;&#160;&#160;AMENDMENT OR TERMINATION.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Q.&#160;&#160;&#160;&#160;SUCCESSORS AND ASSIGNS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">R.&#160;&#160;&#160;&#160;GOVERNING LAW.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">S.&#160;&#160;&#160;&#160;INTERPRETATION AND SEVERABILITY.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">T.&#160;&#160;&#160;&#160;DEFINITIONS.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><a href="#i612c37e727c14aad9e60677288b4604f_44" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:none">7</a></font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i</font></div></div></div><div id="i612c37e727c14aad9e60677288b4604f_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDED AND RESTATED MANAGEMENT INCENTIVE PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amended and Restated on April 26,2022</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:24.34pt">NAME&#59; EFFECTIVE TIME.  </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The name of this plan is the Amended and Restated McKesson Corporation Management Incentive Plan (the &#8220;Plan&#8221;).  This Plan has been amended and restated as of April 26, 2022 and became effective as of such date.  </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:25pt">PURPOSE.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The purpose of the Plan is to advance and promote the interests of the Company and its shareholders by providing performance-based incentives to certain employees and to motivate those employees to set and achieve above average financial and non financial objectives.  </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:24.34pt">ADMINISTRATION.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Committee shall have full power and authority, subject to the provisions of the Plan, (i) to designate employees as Participants for any Performance Period, (ii) to add and delete employees, subject to the eligibility requirement set forth in paragraph D.1 below, from the list of designated Participants, (iii) to establish Individual Target Awards for Participants, (iv) to establish performance goals upon achievement of which the Individual Target Awards will be based, and (v) to take all action in connection with the foregoing or in relation to the Plan as it deems necessary or advisable.  Decisions and selections of the Committee shall be made by a majority of its members and, if made pursuant to the provisions of the Plan, shall be final.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Committee may delegate to the Chief Executive Officer (the &#8220;CEO&#8221;) the power and authority, subject to the provisions of the Plan, (i)&#160;to designate employees who are not members of the Officer Group as Participants, (ii)&#160;to recommend members of the Officer Group to the Committee for designation as Participants&#59; provided that the Committee shall review and approve members of the Officer Group as Participants recommended by the CEO, (iii)&#160;to add and delete employees who are not members of the Officer Group, subject to the eligibility requirement set forth in paragraph D.1 below, from the list of designated Participants, (iv)&#160;to establish Individual Target Awards for Participants who are not members of the Officer Group, (v)&#160;to establish performance goals upon achievement of which such Individual Target Awards will be based, and (vi)&#160;to review and approve, modify or disapprove, or otherwise adjust or determine the amount, if any, to be paid to Participants who are not members of the Officer Group for the applicable Performance Period based on such Participants&#8217; performance goals and individual performance.  In addition to the forgoing, the CEO may further delegate his authority to other executive officers of the Company, except that the CEO may not delegate his authority to recommend members of the Officer Group to the Committee for designation as Participants.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">References to the Committee herein shall include references to the CEO and his designees to the extent that the Committee has delegated power and authority under the Plan to the CEO and to the extent that the CEO has further delegated power and authority under the Plan to other executive officers of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Committee may promulgate such rules and regulations as it deems necessary for the proper administration of the Plan and the CEO (but not his designees) may promulgate rules and regulations as he deems necessary for the proper administration of the Plan with respect to Participants who are not members of the Officer Group.  The Committee may interpret the provisions and supervise the administration of the Plan, and take all action in connection therewith or in relation to the Plan as it deems necessary or advisable.  The interpretation and construction by the Committee of any provision of the Plan or of any award shall be final.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:24.34pt">PARTICIPATION.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">1.&#160;&#160;&#160;&#160;Eligibility&#8212;Executives, Managers and Professionals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Only an active employee of the Company who is employed in an executive, managerial or professional capacity may be designated as a Participant under the Plan&#59; provided, however, that designation as a Participant is contingent upon the execution and delivery to the Company of an agreement, within a period following presentment and in a form that is satisfactory to the Company, regarding confidentiality, intellectual property and&#47;or other restrictive covenants, as well as compliance with such agreement&#59; and provided, further, that the Committee shall determine in its sole discretion whether the Participant has complied with such agreement, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">2.&#160;&#160;&#160;&#160;Designation of Participants</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">No person shall be entitled to any award under the Plan for any Performance Period unless he or she is so designated as a Participant for that Performance Period.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:25pt">INDIVIDUAL TARGET AWARDS FOR PARTICIPANTS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">At the beginning of each Performance Period, the Committee shall establish an Individual Target Award for each Participant.  An Individual Target Award shall only be a target and the amount of the target may or may not be paid to the Participant.  Establishment of an Individual Target Award for an employee for any Performance Period shall not imply or require that an Individual Target Award or an Individual Target Award at any specified level will be set for any subsequent year.  The amount of any actual award paid to any Participant may be greater or less than this target.  As set forth in paragraph G.4 below, the actual award may be as much as three times target or as low as zero for any Performance Period.  The Individual Target Award may be established for a Participant by name, job level, position or any other similar identifier.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:25.67pt">BASIS OF AWARDS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">1.&#160;&#160;&#160;&#160;Performance Goals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Committee shall establish measures, which may include financial and non-financial objectives (&#8220;Performance Goals&#8221;) in advance of each Performance Period or within 90 days after the commencement of the Performance Period to which the Performance Goals relate. Performance Goals may be expressed with respect to the Company or one or more operating units or groups, as the Committee may determine. The Committee may determine Performance Goals on an absolute basis or relative to internal goals or relative to levels attained in prior years or related to other companies or indices or as ratios expressing relationships between two or more Performance Goals. In addition, Performance Goals may be based upon the attainment of specified levels of Company performance criteria relative to the performance of other corporations or a designated comparison group.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">2.&#160;&#160;&#160;&#160;Adjustment Of Performance Goals</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Committee may adjust, and&#47;or may provide in any Performance Goal for the adjustment of, any Performance Goal to the extent necessary to prevent dilution or enlargement of any award as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non recurring items&#59; changes in applicable laws, regulations, or accounting principles&#59; currency fluctuations&#59; discontinued operations&#59; non-cash items, such as amortization, depreciation, or reserves&#59; asset impairment&#59; any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin off, split up, combination, liquidation, dissolution, sale of assets, or other similar corporate transaction&#59; or any other occurrences or circumstances as the Committee may deem appropriate.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">3.&#160;&#160;&#160;&#160;Performance Goals Related To More Than One Segment Of The Company</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Awards may be based on performance against objectives for more than one segment of the Company.  For example, awards for corporate management may be based on overall corporate performance against objectives, but awards for a unit&#8217;s management may be based on a combination of corporate, unit and sub-unit performance against objectives.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">4.&#160;&#160;&#160;&#160;Performance Period&#59; Individual Performance</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Committee shall specify the Performance Period over which period Performance Goals will be measured and determined.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Individual performance of each Participant may be measured and used in determining awards under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:23.67pt">AWARD DETERMINATION.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">1.&#160;&#160;&#160;&#160;Award Determined By Committee</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">After any Performance Period for which an Individual Target Award is established for a Participant under the Plan, the Committee shall review and approve, modify or disapprove the amount, if any, to be paid to the Participant for the Performance Period.  The amount paid shall be the Individual Target Award adjusted to reflect both the results against the Participant&#8217;s Performance Goals and the Participant&#8217;s individual performance.  All awards are subject to adjustment at the sole discretion of the Committee.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">2.&#160;&#160;&#160;&#160;Financial And Non-Financial Performance</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Individual Target Award amounts will be modified based on the achievement of financial and non financial objectives by the Company and relevant units and&#47;or sub-units.  Performance results against objectives shall be reviewed and approved by the Committee in accordance with paragraph F.2 above, as applicable.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">3.&#160;&#160;&#160;&#160;Individual Performance</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Any Individual Target Award, adjusted to reflect financial performance, may be further adjusted with the review and approval of the Committee to give full weight to the Participant&#8217;s individual performance during the Performance Period.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">4.&#160;&#160;&#160;&#160;Overall Effect</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The combination of any financial performance adjustment and individual performance adjustment may increase the amount paid under the Plan to a Participant for any Performance Period to as much as three times the Individual Target Award, and may reduce any amount payable to zero.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:23.67pt">PAYMENT OF AWARDS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">An award under the Plan shall be paid in a single sum to the Participant as soon as reasonably practicable after Payment Date, unless the Participant elects to defer his or her award pursuant to the terms and conditions of the Company&#8217;s Deferred Compensation Administration Plan III (&#8220;DCAP III&#8221;) and in compliance with Section 409A of the Code.  To the extent that an award or a portion thereof is not deferred under DCAP III, such award or portion thereof shall be paid no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Section 409A of the Code.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:28.34pt">EMPLOYMENT ON PAYMENT DATE.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">No award shall be made to any Participant who is not an active employee of the Company on the Payment Date&#59; provided, however, that the Committee, in its sole and absolute discretion, may make full or prorated awards to Participants in circumstances that the Committee </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">deems appropriate in its discretion, including, but not limited to, a Participant&#8217;s death, disability, retirement or other termination of employment prior to the Payment Date.  Any such awards shall be determined by the Committee in accordance with Article G above after taking into account the portion of the Performance Period completed.  </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:27pt">CHANGE IN CONTROL.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">In the event of a Change in Control, the Company or any successor or surviving corporation shall pay to each Participant an award for the Performance Period in which the Change in Control occurs and for any previous Performance Period for which awards have been earned but not yet paid.  Subject to the employment requirements of Article I, each such award shall be equal to the greatest of the following&#58; (i)&#160;the Participant&#8217;s Individual Target Award for the applicable Performance Period&#59; (ii)&#160;the Participant&#8217;s Individual Target Award for the applicable Performance Period adjusted based on the actual performance outcome for that Performance Period, provided, that the Committee may not invoke its discretionary authority to reduce the amount of such an award&#59; or (iii)&#160;the average of awards earned and paid to (or deferred by) the Participant in the three (or such fewer number of years that the Participant has been eligible for such an award) completed Performance Periods immediately preceding the applicable Performance Period.  Such awards shall be paid by the Company or any successor or surviving corporation at such time as the awards otherwise would be payable under the Plan&#59; provided, however, that if a Participant is terminated without Cause or terminates for Good Reason within twelve months after a Change in Control, then such Participant shall be paid his or her awards determined under this Article J, within thirty days of such termination.  Notwithstanding the foregoing, any award determined pursuant to this Article J shall be reduced by any corresponding award payable under a Participant&#8217;s individual written employment agreement, if any.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">K.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:23.67pt">FORFEITURE.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Any other provision of the Plan to the contrary notwithstanding, if the Committee determines that a Participant has engaged in criminal activity, fraud, misconduct, embezzlement or any other improper act involving moral turpitude, then upon written notice from the Company to the Participant (i)&#160;the Participant shall not be eligible for any award for the year in which such notice is given or for the preceding year, if such award has not been paid as of the date of the notice, (ii)&#160;any payment of an award received by the Participant within twelve months prior to the date that the Company discovered that the Participant engaged in any action described below shall immediately be repaid to the Company by the Participant in cash (including amounts withheld pursuant to Article L) and (iii)&#160;any award deferred pursuant to Article H within twelve months prior to the date that the Company discovered that the Participant engaged in any action described below shall be forfeited immediately and shall not be distributed to the Participant under any circumstances.  The Committee shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth above, and its determination shall be conclusive and binding on all interested persons.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Any provision of this Article K which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Article K.  The remedy described in this Article K is in addition to and not in lieu of remedies available in law and in equity.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:25pt">RECOUPMENT. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Individual Target Awards, and payments made under such awards, are subject to the Corporation&#8217;s Compensation Recoupment Policy, which was first adopted by the Corporation on January 20, 2010, as amended from time to time, and which is hereby incorporated by reference into this Plan.  </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">M.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:21.68pt">WITHHOLDING TAXES.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Whenever the payment of an award is made, such payment shall be net of an amount sufficient to satisfy federal, state and local income and employment tax withholding requirements and authorized deductions.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">N.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:24.34pt">EMPLOYMENT RIGHTS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Neither the Plan nor designation as a Plan Participant shall be deemed to give any individual a right to remain employed by the Company.  The Company reserves the right to terminate the employment of any employee at any time, with or without cause or for no cause, subject only to the requirements of a written employment contract (if any).</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">O.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:23.67pt">NONASSIGNMENT&#59; PARTICIPANTS ARE GENERAL CREDITORS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The interest of any Participant under the Plan shall not be assignable either by voluntary or involuntary assignment or by operation of law (except by designation of a beneficiary or beneficiaries to the extent allowed under DCAP III or a successor plan with respect to amounts deferred under Article H) and any attempted assignment shall be null, void and of no effect.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">Amounts paid under the Plan shall be paid from the general funds of the Company, and each Participant shall be no more than an unsecured general creditor of the Company with no special or prior right to any assets of the Company for payment of any obligations hereunder.  Nothing contained in the Plan shall be deemed to create a trust of any kind for the benefit of any Participant, or create any fiduciary relationship between the Company and any Participant with respect to any assets of the Company.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:25.67pt">AMENDMENT OR TERMINATION.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The Board of Directors may terminate or suspend the Plan at any time.  The Committee may amend the Plan at any time&#59; provided that no amendment shall retroactively and adversely </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">affect the payment of any award previously made.  Notwithstanding the foregoing, no amendment adopted following the occurrence of a Change in Control shall be effective if it (a)&#160;would reduce a Participant&#8217;s Individual Target Award for the Performance Period in which the Change in Control occurs, (b)&#160;would reduce an award payable to a Participant based on the achievement of Performance Goals in the Performance Period before the Performance Period in which the Change in Control occurs, or (c)&#160;modify the provisions of this Article P.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">Q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:23.67pt">SUCCESSORS AND ASSIGNS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">This Plan shall be binding on the Company and its successors or assigns.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">R.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:24.34pt">GOVERNING LAW.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">The law of the State of Delaware shall govern all question concerning the construction, validity and interpretation of the Plan, without regard to the state&#8217;s conflict of laws rules.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:26.33pt">INTERPRETATION AND SEVERABILITY.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">In case any one or more of the provisions contained in the Plan shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision of the Plan, but the Plan shall be construed as if such invalid, illegal or unenforceable provisions had never been contained herein.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">T.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%;padding-left:25pt">DEFINITIONS.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">1.&#160;&#160;&#160;&#160;&#8220;Cause&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Cause&#8221; shall mean termination of the Participant&#8217;s employment upon the Participant&#8217;s willful engagement in misconduct which is demonstrably and materially injurious to the Company.  No act, or failure to act, on the part of the Participant shall be considered &#8220;willful&#8221; unless done, or omitted to be done, by the Participant not in good faith and without reasonable belief that the Participant&#8217;s action or omission was in the best interest of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">2.&#160;&#160;&#160;&#160;&#8220;Change in Control&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">A &#8220;Change in Control&#8221; shall mean the occurrence of any change in ownership of the Company, change in effective control of the Company, or change in the ownership of a substantial portion of the assets of the Company, as defined in Section 409A(a)(2)(A)(v) of the Code, regulations promulgated thereunder, and any other published interpretive authority, as issued or amended from time to time.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">3.&#160;&#160;&#160;&#160;&#8220;Code&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">4.&#160;&#160;&#160;&#160;&#8220;Committee&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Committee&#8221; shall mean the Compensation Committee of the Board of Directors of McKesson Corporation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">5.&#160;&#160;&#160;&#160;&#8220;Company&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Company&#8221; shall mean McKesson Corporation, a Delaware corporation, including its subsidiaries and affiliates.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">6.&#160;&#160;&#160;&#160;&#8220;Good Reason&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Good Reason&#8221; shall mean any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">a.&#160;&#160;&#160;&#160;any material change by the Company in the functions, duties, or responsibilities of the Participant, which change would cause such Participant&#8217;s position with the Company to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">b.&#160;&#160;&#160;&#160;any reduction in the Participant&#8217;s base salary&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">c.&#160;&#160;&#160;&#160;any material failure by the Company to comply with any of the provisions of any employment agreement between the Company and the Participant&#59;</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">d.&#160;&#160;&#160;&#160;the requirement by the Company that the Participant be based at any office or location more than 25 miles from the office at which the Participant is based on the date immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities and commensurate with the amount of travel required of the Participant prior to the Change in Control&#59; or</font></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">e.&#160;&#160;&#160;&#160;any failure by the Company to obtain the express assumption of this Plan by any successor or assign of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">7.&#160;&#160;&#160;&#160;&#8220;Individual Target Award&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Individual Target Award&#8221; shall mean the target award established for each Participant under Article E, which shall be a percentage of the Participant&#8217;s base salary or a fixed dollar amount, as determined by the Committee.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">8.&#160;&#160;&#160;&#160;&#8220;Officer Group&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Officer Group&#8221; shall mean any officer of the Company designated as part of the Officer Group by the Committee.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">9.&#160;&#160;&#160;&#160;&#8220;Participants&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Participants&#8221; shall mean those employees specifically designated as Participants for a Performance Period under Article D.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">10.&#160;&#160;&#160;&#160;&#8220;Payment Date&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Payment Date&#8221; shall mean the date following the conclusion of a Performance Period on which the Committee certifies that applicable Performance Goals have been satisfied and authorizes payment of corresponding awards.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">11.&#160;&#160;&#160;&#160;&#8220;Performance Goals&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Performance Goals&#8221; shall have the meaning set forth in Article F hereof. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">12.&#160;&#160;&#160;&#160;&#8220;Performance Period&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Performance Period&#8221; shall mean the time period over which Performance Goals of the Company are measured, as the Committee determines in its discretion&#59; provided that if the Committee does not designate a time period, then the Performance Period shall mean the fiscal year of the Company.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">13.&#160;&#160;&#160;&#160;&#8220;Plan&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:130%">&#8220;Plan&#8221; shall mean the McKesson Corporation Management Incentive Plan, as amended from time to time. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>5
<FILENAME>mck_ex109xmanagementincent.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i09e494a6c4284b0aa910fcc2dc1fa4bf_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.9</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STATEMENT OF TERMS AND CONDITIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APPLICABLE TO AWARDS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE MANAGEMENT INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Effective April 26, 2022</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following terms and conditions shall apply to awards made under the McKesson Corporation Management Incentive Plan (the &#8220;Plan&#8221;) to an executive, managerial or professional employee of the Company who is specifically designated as a participant in the Plan.  Capitalized terms used herein are defined in the Plan or in Section&#160;10.  In the event these terms and conditions conflict with the terms of the Plan document, the Plan document shall control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Only an active employee of the Company who is employed in an executive, managerial or professional capacity may be designated as a Participant under the Plan&#59; provided, however, that designation as a Participant is contingent upon the execution and delivery to the Company of an agreement, within a period following presentment and in a form that is satisfactory to the Company, regarding confidentiality, intellectual property and&#47;or other restrictive covenants, as well as compliance with such agreement&#59; and provided, further, that the Committee shall determine in its sole discretion whether the Participant has complied with the provisions of any such agreement, which determination shall be conclusive and binding on all interested persons.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee shall review those employees who are eligible to participate in the Plan and recommended by management and determine which of those employees will become Plan Participants.  The Committee may add to or delete individuals from the list of designated Participants at any time and from time to time, at its sole discretion.  The Committee has delegated the authority to approve Plan Participants to the Chief Executive Officer of the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participation in the Plan during the Performance Period does not guarantee payment of an Actual Award under the Plan for the Performance Period.  Participation in the Plan during one Performance Period does not guarantee participation during a subsequent Performance Period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Individual Target Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Individual Target Award is the percentage of base annual salary specified at the beginning of the Performance Period (or beginning of participation, if later) for a Participant.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt;text-decoration:underline">Newly Eligible Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A newly hired employee, or an employee who is promoted into or transferred from an ineligible position to an eligible position during a Performance Period, may be designated a Participant with an Individual Target Award for that Performance Period.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:25pt;text-decoration:underline">Transfers, Promotions and Demotions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Participant who moves during the Performance Period from one eligible position to a new eligible position with a higher Individual Target Award will, in general, have the determination of his or her Actual Award prorated between the two Individual Target Awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Participant who during the Performance Period is demoted to or transferred to a new eligible position with a lower Individual Target Award will have the determination of his or her Actual Award prorated in management&#8217;s discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Participant who during the Performance Period is demoted from or transferred from an eligible position to an ineligible position will have the determination of his or her Actual Award prorated in management&#8217;s discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, any proration must be based on the achievement of Performance Goals for the Performance Period.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Performance Measures and Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Participant shall have one or more Individual Performance Measures.  Individual Performance Measures may be quantitative, qualitative or both.  The Performance Goals (defined in Article&#160;F of the Plan)&#160;established for each segment of the Company are referred to as the Business Scorecard.  A Participant&#8217;s Individual Performance Measures and the Performance Goals, taken as a whole, will determine the amount of the Participant&#8217;s Actual Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Participant who changes jobs and &#47; or organizations during the Performance Period may have different Business Scorecards applicable to each job &#47; organization.  The Participant may, in management&#8217;s discretion, have the determination of his or her Actual Award prorated between the two Business Scorecards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Individual Performance Modifier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Actual Awards will be adjusted, in management&#8217;s discretion, to reflect the Participant&#8217;s individual contribution to Business Scorecard results and the Participant&#8217;s Individual Performance Measures.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Other Individual Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provision of the Plan to the contrary, no amount shall be payable with respect to the Performance Period unless the Committee certifies that it is satisfied that the requirements (performance or otherwise) associated with such payment have been fully met.  Such requirements may include, but are not limited to&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.8pt">Completion of the Company&#8217;s Legal and Regulatory Compliance and Ethics Training Program.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Award Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any payment to a Participant shall be based on Business Scorecard results during the Performance Period as modified by the Participant&#8217;s Individual Performance Modifier.  The Actual Award is determined by&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.8pt">Taking the Covered Compensation received during the Performance Period&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.8pt">Multiplying by the Individual Target Award&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.8pt">Multiplying that result by the Business Scorecard results (actual&#160;vs. target)&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:31.8pt">Adjusting the result determined above, up or down, by the Individual Performance Modifier.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Management and the Committee shall review and approve, modify or disapprove the Actual Award, if any, to be paid to a Participant for the Performance Period.  Management and the Committee reserve the right to reduce or increase or eliminate the individual payments determined according to the above method.  No Personal Modifier shall exceed 150%.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Effect of a Termination of Employment, Prior to the End of the Performance Period, on Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt;text-decoration:underline">Termination of Employment for Other Than Death, Retirement, Severance or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant ceases to be a bona fide employee of the Company prior to the payment of the Actual Award, for any reason other than death, Retirement, Severance or Long-Term Disability, the Participant&#8217;s interest in the Awards shall be forfeited and no amount shall be payable to the Participant with respect to service during the Performance Period.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:25pt;text-decoration:underline">Termination of Employment by Reason of Death or Long-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant ceases to be a bona fide employee of the Company due to death or Long-Term Disability during the Performance Period, the Participant (or the Participant&#8217;s Beneficiary, if payment is made on account of the death of the Participant)&#160;shall be entitled to receive an Actual Award as calculated under Paragraph&#160;6 above.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt;text-decoration:underline">Termination of Employment by Reason of Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant ceases to be a bona fide employee of the Company due to Retirement prior to January 1 of the Performance Period, the Participant&#8217;s interest in the Awards shall be forfeited and no amount shall be payable to the Participant with respect to service during the Performance Period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant ceases to be a bona fide employee of the Company due to Retirement on or after January 1 of the Performance Period, the Participant shall be entitled to receive an Actual Award as calculated under Paragraph&#160;6 above.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:24.34pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant ceases to be a bona fide employee of the Company due to Severance prior to January 1 of the Performance Period, the Participant&#8217;s interest in the Awards shall be forfeited and no amount shall be payable to the Participant with respect to service during the Performance Period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant ceases to be a bona fide employee of the Company due to Severance on or after January 1 of the Performance Period, the Participant shall be entitled to receive an Actual Award as calculated under Paragraph&#160;6 above.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Data Privacy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting the Award, the Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his or her personal data as described in this document by and among, as applicable, the Participant&#8217;s employer (the &#8220;Employer&#8221;) and the Company for the exclusive purpose of implementing, administering and managing participation in the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Participant understands that the Company and the Employer hold certain personal information about the Participant, including but not limited to his or her name, home address and telephone number, date of birth, social insurance or other identification number, salary, nationality, job title, any shares of Company stock or directorships held in the Company, details of all compensation or any other entitlement to Company-sponsored benefits for the purpose of implementing, administering and managing the Plan (&#8220;Data&#8221;).  The Participant understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Participant&#8217;s country or elsewhere, such as in the United States of America, and that the recipient&#8217;s country may have different data privacy laws and protections than the Participant&#8217;s country.  The Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting the local human resources representative.  The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing participation in the Plan.  The Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan.  The Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing the local human resources representative.  The Participant understands, however, that refusing or withdrawing consent may affect his or her ability to participate in the Plan.  For more information on the consequences of refusal to consent or withdrawal of consent, the Participant understands that he or she may contact the local human resources representative.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">GOVERNING LAW.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The law of the State of Delaware shall govern all question concerning the construction, validity and interpretation of the Plan and any Awards, without regard to the state&#8217;s conflict of laws rules.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms shall have the same meaning as provided in the Plan.  Additional capitalized text that is not included in the Plan, but is used in this Statement of Terms and Conditions, shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#8220;Actual Award&#8221; means the finally determined amount payable under the Plan for a Performance Period.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#8220;Awards&#8221; means, collectively, Individual Target Awards and Actual Awards.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;Covered Compensation&#8221; means regular wages earned by and paid to the Participant during the Performance Period, including any Paid Time Off (PTO)&#160;pay.  Covered Compensation does not include any other compensation received during the Performance Period, including, but not limited to, earnings received during a paid leave, overtime or commission pay.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;&#8220;Long-Term Disability&#8221; means (i)&#160;a physical or mental condition which, in the judgment of the Committee based on competent medical evidence satisfactory to the Committee, including, if required by the Committee, medical evidence obtained by an examination conducted by a physician selected by the Committee, renders an individual unable to engage in any substantial gainful activity for the and which impairment is likely to result in death or to be of long, continued and indefinite duration, or (ii)&#160;a judicial declaration of incompetence.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#8220;Retirement&#8221; means termination from the Company with age plus years of service equal to at least 65.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;&#8220;Severance&#8221; means termination of employment with the Company and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the Amended and Restated McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards as terminated by reason of Severance to the extent his or her employment with the Company is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Company in the United States who qualify for participation in that plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>6
<FILENAME>mck_ex1013x3312022xstockpl.htm
<DESCRIPTION>EX-10.13
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0e578ed7722a4dcca746f73c603c1ab8_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.13</font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTOR</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Div Equiv Units</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNITS GRANTED TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For Grants Beginning July 22, 2021</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Outside Director's country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards.  With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders.  An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Number of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Restricted Stock Units (&#34;Units&#34;) granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $180,000 (with any fractional Unit rounded up to the nearest whole Unit).  In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $120,000 (with any fractional Unit rounded up to the nearest whole Unit).  Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000.  A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2013 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Unit Award. The number of such additional Restricted Stock Units shall be calculated by dividing the aggregate amount or value of the dividends paid with respect to that number of Shares equal to the number of Restricted Stock Units credited as of the record date for such dividend by the Fair Market Value per Share on the payment date for such dividend. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Automatic Deferral Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). &#8220;Separation of service&#8221; shall have the meaning provided under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP&#160;III&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award. Any fractional Shares resulting from the accumulation of dividend equivalents shall be paid in cash. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If an Outside Director is not a United States citizen or resident, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein.  Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt">Data Privacy Information and Consent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis.  If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">3</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction.  Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">4</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i0e578ed7722a4dcca746f73c603c1ab8_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTOR</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Div Equiv Cash</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNITS GRANTED TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUTSIDE DIRECTORS PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For Grants Beginning July 22, 2021</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to Restricted Stock Unit Awards granted under the Plan and are subject to the terms and conditions of the Plan. This Statement of Terms and Conditions is intended to meet the requirements of Code Section 409A and any regulations and rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Unit Award granted to an Outside Director under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Outside Director and the Corporation setting forth the terms and conditions of the Restricted Stock Unit Award. Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Outside Director's country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator administering the Plan has authority to determine the Outside Directors to whom, and the time or times at which, grants of Restricted Stock Units will be made, the number of Units to be awarded, and all other terms and conditions of such awards.  With respect to annual Restricted Stock Unit Awards granted to Outside Directors under the Plan, such awards shall be subject to the following terms, conditions and restrictions. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Outside Director may be granted a Restricted Stock Unit Award on the date of each annual meeting of stockholders.  An Outside Director that is elected to the Board between annual meetings of stockholders may also be granted a Restricted Stock Unit Award on the date that the Board determines in its sole discretion.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Number of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Board or the Governance Committee of the Board (the &#8220;Governance Committee&#8221;), the number of Restricted Stock Units (&#34;Units&#34;) granted for the annual meeting grant will be determined by dividing the Fair Market Value of a Share on the date of grant into $180,000 (with any fractional Unit rounded up to the nearest whole Unit).  In addition to such grant, unless otherwise determined by the Board or the Governance Committee, the Independent Chair shall be granted an annual meeting grant determined by dividing the Fair Market Value of a Share on the date of grant into $120,000 (with any fractional Unit rounded up to the nearest whole Unit).  Notwithstanding the foregoing, in no event shall the aggregate number of Units granted to any Outside Director pursuant to such annual meeting grant or grants exceed 5,000.  A newly elected Outside Director may receive a prorated annual meeting grant effective upon the date of the Outside Director&#8217;s election to the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">No Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Unit Award granted to an Outside Director will be fully vested on the date of grant.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2013 Stock Plan STC (Outside Director)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents in respect of Restricted Stock Units, if granted in tandem with such Units, will be credited on behalf of an Outside Director to a deferred cash account until such time as the underlying Shares are issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Outside Director shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither an Outside Director nor any person entitled to exercise an Outside Director&#8217;s rights in the event of the Outside Director&#8217;s death shall have any of the rights of a stockholder with respect to a Restricted Stock Unit Award except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the underlying Shares paid upon the settlement of any Restricted Stock Unit Award as described in Section II.6 below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as noted in Section II.7 below, Restricted Stock Units granted to Outside Directors shall not be paid until after the Outside Director&#8217;s separation of service with the Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Automatic Deferral Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). &#8220;Separation of service&#8221; shall have the meaning provided under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> the McKesson Corporation Deferred Compensation Administration Plan III (&#8220;DCAP&#160;III&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Payment shall be made in Shares in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Outside Director&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Satisfaction of Director Stock Ownership Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For those Outside Directors who have met the Director Stock Ownership Guidelines in effect at the time, Restricted Stock Unit grants shall not be subject to the Automatic Deferral Requirement and such grants will be immediately converted into Shares and distributed to the Outside Director&#59; provided, however, that the Outside Director may elect to defer receipt of the Shares underlying the Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Deferrals of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Deferrals of Restricted Stock Units, whether elective or pursuant to the Automatic Deferral Requirement, shall be subject to the terms and conditions of DCAP III.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Service with the Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing contained in this Statement of Terms and Conditions, the Plan or a Restricted Stock Unit Agreement shall affect the Corporation&#8217;s right to terminate the service of any Outside Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Outside Directors in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If an Outside Director is not a United States citizen or resident, the Board has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust a Restricted Stock Unit Award to prevailing local conditions, including custom and legal and tax requirements. Furthermore, the Corporation reserves the right to impose other requirements on the Outside Director&#8217;s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Outside Director to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of a Restricted Stock Unit Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 State Highway 161, Irving, Texas 75039, and any notice to be given to an Outside Director shall be addressed to the Outside Director at the address indicated beneath the Outside Director&#8217;s name on the Restricted Stock Unit Agreement or such other address as either party may designate in writing to the other. Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered, or certified and deposited (postage or registration or certification fee prepaid) in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein.  Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All decisions of the Administrator administering the Plan upon any questions arising under the Plan, under this Statement of Terms and Conditions, or under a Restricted Stock Unit Agreement, shall be conclusive and binding on all persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing herein contained shall affect an Outside Director&#8217;s right, if any, to participate in and receive benefits from and in accordance with the then current provisions of any benefit plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Outside Director shall agree to make appropriate arrangements with the Corporation for satisfaction of any applicable federal, state, or local income tax withholding requirements or payroll tax requirements, if any is required.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt">Data Privacy Information and Consent.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Outside Director, including, but not limited to, the Outside Director&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares held in the Corporation, details of all Restricted Stock Units or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Outside Director&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration, and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Outside Director may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Outside Director&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Outside Director&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Outside Director&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Outside Director understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Outside Director&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Outside Director&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Outside Director&#8217;s Data for any of the above purposes, the Outside Director understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Outside Director is providing the consents herein on a purely voluntary basis.  If the Outside Director does not consent, or if the Outside Director later seeks to revoke the Outside Director&#8217;s consent, the Outside Director&#8217;s retainer and fees from or services with the Corporation will not be affected&#59; the only consequence of refusing or withdrawing the Outside Director&#8217;s consent is that the Corporation would not be able to grant Awards to the Outside Director or administer or maintain such Awards.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Outside Director may have a number of rights under data privacy laws in the Outside Director&#8217;s jurisdiction.  Depending on where the Outside Director is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Outside Director and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Outside Director that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Outside Director&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Outside Director feels its processing is inappropriate, (v) request portability of the Outside Director&#8217;s Data that the Outside Director has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Outside Director&#8217;s service on the Board and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Outside Director&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Outside Director can contact the Corporate Secretary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Outside Director is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Statement of Terms and Conditions and the Restricted Stock Unit Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Outside Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as used herein shall include the Outside Director&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The interpretation, performance, and enforcement of this Statement of Terms and Conditions and all Restricted Stock Unit Agreements shall be governed by the laws of the State of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i0e578ed7722a4dcca746f73c603c1ab8_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EXECUTIVE OFFICERS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective for Grants Beginning May 24, 2022</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2013 Stock Plan STC (EO)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;unless otherwise determined by the Administrator in its sole discretion, a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short&#8209;Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Participant who is a U.S. taxpayer validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section&#160;V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice, or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.61pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered, or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance contributions, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting, settlement or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable&#59; or (4) any other method of withholding determined by the Corporation and to the extent required by applicable law or the Plan, approved by the Compensation Committee. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant&#8217;s jurisdictions(s).  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund. In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended, or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language, or has consulted with an advisor who is sufficiently proficient in the English language, and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards, and subject to the provisions of Section VIII.9 of this Statement of Terms and Conditions, as terminated by reason of Severance to the extent his or her employment with the Corporation or an affiliate is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Corporation or an affiliate in the United States who qualify for participation in that plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet.  A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="i0e578ed7722a4dcca746f73c603c1ab8_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES SUBJECT TO STOCK OWNERSHIP POLICY PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective for Grants Beginning May 24, 2022</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2013 Stock Plan STC (Emp Subj to SOP)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;unless otherwise determined by the Administrator in its sole discretion, a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short&#8209;Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the vesting and settlement of a Restricted Stock Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Participant who is a U.S. taxpayer validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of Restricted Stock Units, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">PERFORMANCE STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved, and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.&#160;14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restriction on Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator reserves the right to impose a restriction on the sale of Shares that the Participant receives with respect to the settlement of a Performance Stock Unit Award, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in the Stock Ownership Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.61pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance contributions, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting, settlement or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable&#59; or (4) any other method of withholding determined by the Corporation and to the extent required by applicable law or the Plan, approved by the Compensation Committee. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant's jurisdiction. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund. In the event of under-withholding, the Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language, or has consulted with an advisor who is sufficiently proficient in the English language, and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate, and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards, and subject to the provisions of Section VIII.9 of this Statement of Terms and Conditions, as terminated by reason of Severance to the extent his or her employment with an affiliate is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Corporation or an affiliate in the United States who qualify for participation in that plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet.  A Participant or a Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="i0e578ed7722a4dcca746f73c603c1ab8_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATEMENT OF TERMS AND CONDITIONS APPLICABLE TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTIONS, RESTRICTED STOCK, RESTRICTED STOCK UNITS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AND PERFORMANCE STOCK UNITS GRANTED TO EMPLOYEES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective for Grants Beginning May 24, 2022</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">INTRODUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms and conditions shall apply to an Award granted under the Plan and are subject to the terms and conditions of the Plan.  This Statement of Terms and Conditions is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Statement of Terms and Conditions and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Statement of Terms and Conditions shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option granted under the Plan shall be evidenced by an Option Agreement setting forth the terms and conditions of the Option, including whether the Option is an Incentive Stock Option or a Nonstatutory Stock Option and the number of Shares subject to the Option.  Each Option Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Option Agreement.  The Option is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Exercise Price of an Option, as specified in the Option Agreement, shall be equal to or greater than the Fair Market Value of the Shares underlying the Option on the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall be exercisable only during the applicable Option Period, and during such Option Period the exercisability of the Option shall be subject to the vesting provisions of Section&#160;II.4 as modified by the rules set forth in Sections&#160;II.5 and VI.  The Option Period shall be not more than seven years from the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Right to Exercise Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Subject to Sections&#160;II.5 and VI, an Option shall be exercisable during the Option Period in accordance with the vesting terms and conditions established on the Grant Date and specified in the Option Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Any vested portion of an Option not exercised hereunder shall accumulate and be exercisable at any time on or before the Expiration Date, subject to the rules set forth in Sections&#160;II.5 and VI.  No Option may be exercised for less than 5% of the total number of Shares then available for exercise under such Option.  In no event shall the Corporation be required to issue fractional Shares.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2013 Stock Plan STC (Employee)</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limits on Option Period and Acceleration of Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option Period may end before the Expiration Date, and in certain circumstances the vesting schedule of an Option may be accelerated (subject to the provisions of Section&#160;VI), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period for reasons other than for Cause, Long-Term Disability, Normal Retirement, Early Retirement, Severance under the circumstances provided in Section II.5(F)(ii), or death, the Option Period shall end on the earlier of (i)&#160;90 days after the date of the Participant&#8217;s termination of employment and (ii)&#160;the Expiration Date, and in all cases the Option shall be exercisable only to the extent that it was exercisable at the time of such termination of employment.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Notwithstanding any other provision in this Section II.5, if a Participant&#8217;s employment is terminated for Cause during the Option Period, the Option Period shall end on the date of such termination of employment and the Option shall thereupon not be exercisable to any extent whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Long-Term Disability, the vesting schedule of the Participant&#8217;s Option shall be accelerated, the Option shall become fully exercisable and the Option Period shall end on the earlier of (i) three years after the date of the Participant&#8217;s termination of employment and (ii) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Early Retirement, (i)&#160;the Option shall be exercisable only to the extent that it was exercisable at the time of such retirement and (ii)&#160;the Option Period for that portion of the Option designated as a Nonstatutory Stock Option shall end on the earlier of (a) three years after the date of such retirement and (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Normal Retirement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If such Normal Retirement occurs prior to the first anniversary of the Grant Date of the Option, such Option shall be subject to the provisions of Section II.5(D) as though the Participant were eligible for Early Retirement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If such Normal Retirement occurs on or after the first anniversary of the Grant Date of an Option, (a)&#160;that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (b)&#160;the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant ceases to be a bona fide employee of the Corporation or of its Affiliates during the Option Period by reason of Severance, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, then such Option shall be subject to the Normal Retirement provisions of Section II.5(E)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.41pt">The first anniversary of the Grant Date of the applicable Award has not occurred on or prior to the termination date, then such Option shall be subject to the Early Retirement provision in Section II.5(D)&#59; or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:121.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The first anniversary of the Grant Date of the applicable Award has occurred on or prior to the termination date, then (x) that portion of the Option designated as a Nonstatutory Stock Option shall continue to vest as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such vesting period, and (y) the Option Period for such portion of the Option designated as a Nonstatutory Stock Option shall end on the Expiration Date&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then (a) the vesting schedule of the Participant&#8217;s Option shall be accelerated as to the portion of the Option that would have vested in accordance with the original vesting schedule as though the Participant had continued to be employed by the Corporation or one of its Affiliates six months after the termination date, and (b) the expiration of the Option Period provided in Section II.5(A) shall apply&#59; provided that if the Participant is also eligible for Early Retirement at the time of the termination of employment, then the expiration of the Option Period provided in Section II.5(D) shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant should die (i) while in the employ of the Corporation or an Affiliate and (ii) during the Option Period, the vesting schedule of the Participant&#8217;s Option shall be accelerated and the Option shall become fully exercisable, the Option Period shall end on the earlier of (a) three years after the date of death and (b) the Expiration Date, and the Participant&#8217;s Beneficiary may exercise the entire unexercised portion of the then exercisable Shares covered by such Option (or any lesser amount)&#160;remaining on the date of death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">If a Participant who ceases to be a bona fide employee of the Corporation or an Affiliate is subsequently rehired prior to the expiration of the Participant's Option, then the Option shall continue to remain outstanding until the earlier of (i) such time as the Participant subsequently terminates employment and (ii) the Expiration Date.  Upon the Participant&#8217;s subsequent termination of employment, the post-termination exercise period calculated pursuant to the terms and conditions of this Section II.5 shall be reduced by the number of days between the date of the Participant&#8217;s initial termination of employment and the Participant's re-hire date&#59; provided, however, that if the rehired Participant continues to be employed by the Corporation or an Affiliate for at least one year from the Participant's rehire date, then the post termination exercise period for the Option shall be determined in accordance with Sections II.5(A) through (G) and shall not be adjusted as described in this Section II.5(H).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may exercise an Option with respect to all or any part of the exercisable Shares as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">By giving the Corporation, or its authorized representative designated for this purpose, written notice of such exercise specifying the number of Shares as to which the Option is so exercised.  Such notice shall be accompanied by an amount equal to the Exercise Price multiplied by the number of Shares exercised, in the form of any one or combination of the following&#58;&#160;&#160;cash or a certified check, bank draft, postal or express money order payable to the order of the Corporation in lawful money of the United States.  Unless otherwise determined by the Administrator in its sole discretion, the Participant may pay the Exercise Price, in whole or in part, by tendering to the Corporation or its authorized representative Shares, which have been owned by the Participant for at least six months prior to said tender, and having a fair market value, as determined by the Corporation, equal to the Exercise Price, or in lieu of the delivery of actual Shares in such tender, the Corporation may accept an attestation by the Participant, in a form prescribed by the Corporation or its authorized representative, that the Participant owns sufficient Shares of record or in an account in street name to satisfy the Exercise Price, and such attestation will be deemed a tender of Shares for purposes of this method of exercise.  The Corporation or its authorized representative may accept payment of the amount due upon the exercise of the Option in the form of a Participant&#8217;s personal check.  Payment may also be made by delivery (including by FAX transmission)&#160;to the Corporation or its authorized representative of an executed irrevocable Option exercise form together with irrevocable instructions to an approved registered investment broker to sell Shares in an amount sufficient to pay the Exercise Price plus any applicable Tax-Related Items (as defined in Section VIII.6) and to transfer the proceeds of such sale to the Corporation.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">If required by the Corporation, by giving satisfactory assurance in writing, signed by the Participant, the Participant shall give the Participant's assurance that the Shares subject to the Option are being purchased for investment and not with a view to the distribution thereof&#59; provided that such assurance shall be deemed inapplicable to (i)&#160;any sale of the Shares by such Participant made in accordance with the terms of a registration statement covering such sale, which has heretofore been (or may hereafter be)&#160;filed and become effective under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)&#160;and with respect to which no stop order suspending the effectiveness thereof has been issued, and (ii)&#160;any other sale of the Shares with respect to which, in the opinion of counsel for the Corporation, such assurance is not required to be given in order to comply with the provisions of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">As soon as practicable after receipt of the notice and the assurance described in Sections&#160;II.6(A)&#160;and (B), the Corporation shall, without transfer or issue tax (except for withholding tax arrangements contemplated in Section&#160;VIII.6)&#160;and without other incidental expense to the Participant, credit the purchased Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the purchased Shares&#59; provided, however, that the time of such delivery may be postponed by the Corporation for such period as may be required for it with reasonable diligence to comply with applicable registration requirements under the Securities Act, the Exchange Act, any applicable listing requirements of any national securities exchange and requirements under any other law or regulation applicable to the issuance or transfer of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Limitations on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An Option shall, during a Participant&#8217;s lifetime, be exercisable only by the Participant.  No Option or any right granted thereunder shall be transferable by the Participant by operation of law or otherwise, other than by will or the laws of descent and distribution.  Notwithstanding the foregoing&#58; (A)&#160;unless otherwise determined by the Administrator in its sole discretion, a Participant may designate a beneficiary to succeed, after the Participant&#8217;s death, to all of the Participant&#8217;s Options outstanding on the date of death&#59; (B)&#160;a Nonstatutory Stock Option may be transferable pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act&#59; and (C)&#160;any Participant, who is a senior executive officer recommended by the Chief Executive Officer of the Corporation and approved by the Administrator may voluntarily transfer any Nonstatutory Stock Option to a Family Member as a gift or through a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant)&#160;in exchange for an interest in that entity.  In the event of any attempt by a Participant to alienate, assign, pledge, hypothecate, or otherwise dispose of an Option or of any right thereunder, except as provided herein, or in the event of the levy of any attachment, execution, or similar process upon the rights or interest hereby conferred, the Corporation at its election may terminate the affected Option by notice to the Participant and the Option shall thereupon become null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Shares subject to an Option except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to such Shares upon the exercise of an Option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">RESTRICTED STOCK</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Restricted Stock Award granted under the Plan shall be evidenced by a Restricted Stock Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Award.  Each Restricted Stock Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Agreement.  The Restricted Stock Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Rights with Respect to Shares of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon written acceptance of a Restricted Stock Award by a Participant, including the restrictions and other terms and conditions described in the Plan and the Restricted Stock Agreement, the Corporation shall cause an appropriate book entry to be entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s interest in the Restricted Stock.  From and after the Grant Date, the Participant shall have the rights of Common Stock ownership, including the right to vote and to receive dividends on Shares of Restricted Stock, subject to the terms, conditions and restrictions described in the Plan and the Restricted Stock Agreement.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Restricted Stock Award made under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator&#59; provided, however, that no Restricted Stock grant shall be subject to additional terms, conditions and restrictions which are more favorable to a Participant than the terms, conditions and restrictions set forth elsewhere in the Plan or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Until the restrictions imposed on any Restricted Stock grant shall lapse (the &#8220;Restriction Period&#8221;), Shares of Restricted Stock granted to a Participant&#160;(i)&#160;shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act and (ii)&#160;shall, if the Participant&#8217;s continuous employment with the Corporation or any of its Affiliates shall terminate for any reason (except as otherwise provided in the Plan, or in Section&#160;III.3(B) or Section III.3(C))&#160;be returned to the Corporation forthwith, and all the rights of the Participant to such Shares shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short&#8209;Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Restricted Stock Award shall lapse as to all Shares granted to such Participant pursuant to such Restricted Stock Award on the date of such termination&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Award, the restrictions applicable to such Restricted Stock Award shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period&#59; provided, that notwithstanding any other provision of the Plan or this Statement of Terms and Conditions, this Section III.3(B)(ii) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Award shall be subject to the Normal Retirement provisions of Section&#160;III.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Award shall lapse upon the Participant&#8217;s termination date, as to such Shares of Restricted Stock that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the Participant&#8217;s termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, this Section III.3(C) shall not apply to any Restricted Stock Award the vesting of which is based, in whole or in part, on attainment of performance objectives. The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Award due to a Participant&#8217;s Normal Retirement eligibility.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Cash dividends paid with respect to Restricted Stock during the Restriction Period shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Restricted Stock Award.  Stock dividends paid with respect to Restricted Stock during the Restriction Period shall be treated as Restricted Stock which shall be subject to the same restrictions as the original award for the duration of the Restriction Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Election to Recognize Gross Income in the Year of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any Participant who is a U.S. taxpayer validly elects within 30 days of the Grant Date, to include in gross income for federal income tax purposes an amount equal to the fair market value of the Shares of Restricted Stock granted on the Grant Date, such Participant shall (at the same time or prior to the date that the Participant files the Participant's election with the Internal Revenue Service) (A) pay to the Corporation, or make arrangements satisfactory to the Administrator to pay to the Corporation in the year of such grant, any federal, state or local taxes required to be withheld with respect to such Shares in accordance with Section&#160;VIII.6, and (B) provide the Administrator with a copy of the election filed with the Internal Revenue Service.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restrictive Legend</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each book entry in the records of the Corporation&#8217;s transfer agent evidencing Shares granted pursuant to a Restricted Stock grant may bear an appropriate legend referring to the terms, conditions and restrictions described in the Plan and&#47;or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Expiration of Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If and when the Restriction Period applicable to the Restricted Stock expires without a prior forfeiture, Shares shall be credited to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then an appropriate book entry recording the Participant&#8217;s interest in the unrestricted Shares shall be entered on the records of the Corporation&#8217;s transfer agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be evidenced by a Restricted Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Restricted Stock Units.  Each Restricted Stock Unit Grant Notice shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Restricted Stock Unit Agreement.  The Restricted Stock Units are also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units granted under the Plan shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Administrator, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section IV.2(B) or Section IV.2(C)) prior to the lapse of the restrictions imposed on the Award, the unvested Restricted Stock Units shall be canceled, and all the rights of the Participant to such Awards shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of any time-vesting Restricted Stock Units, the restrictions applicable to such Restricted Stock Units shall continue to lapse at such time(s) as are set forth in the applicable Grant Notice, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary contained in the Restricted Stock Unit Grant Notice, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of a Restricted Stock Unit Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any time-vesting Restricted Stock Unit Award shall be subject to the Normal Retirement provisions of Section IV.2(B)(ii)&#59; or&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then the restrictions applicable to any time-vesting Restricted Stock Unit Award shall lapse upon the termination date, as to such Restricted Stock Units that would have vested at such time(s) as are set forth in the applicable Grant Notice as if the Participant had continued to be employed by the Corporation or one of its Affiliates during the six-month period after the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the discretion of the Compensation Committee, dividend equivalents shall be credited in respect of Restricted Stock Units.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the associated Award of Restricted Stock Units, and cash dividends shall be paid in a lump sum at the same time that the Shares underlying the Restricted Stock Unit Award, and to which the cash dividends relate, are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the underlying Restricted Stock Units, including the same vesting restrictions as the underlying Award. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber Restricted Stock Units, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to an Award of Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on Restricted Stock Units, all Restricted Stock Units that were not forfeited pursuant to Section&#160;IV.2(A), Section IV.2(B)(i), Section IV.2(C)(i),&#160;or Section VI shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant becomes eligible for Normal Retirement, or is eligible for additional vesting under Section IV.2(C)(ii), prior to the date of the lapse of restrictions imposed on Restricted Stock Units and the vesting provisions of Section IV.2(B)(ii) or Section IV.2(C)(ii) apply, then such Restricted Stock Units shall be paid to the Participant&#8217;s brokerage account of record as soon as reasonably practicable after the earlier of the Participant&#8217;s Separation from Service or the originally scheduled vesting date (in any event before the end of the calendar year in which such date occurs), subject to the delay of payment (if applicable) provided in Section VIII.14.  The procedures set forth in Section VIII.6 will be applied for any taxes due upon the lapse of restrictions imposed on a Restricted Stock Unit Award due to a Participant&#8217;s Normal Retirement eligibility or additional vesting as provided in Section IV.2(C)(ii).</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be evidenced by a Performance Stock Unit Agreement to be executed by the Participant and the Corporation setting forth the terms and conditions of the Performance Stock Unit Award.  Performance Stock Unit Awards are &#8220;Other Share-Based Awards&#8221; as provided under Section 11 of the Plan.  Each Performance Stock Unit Agreement shall incorporate by reference and be subject to this Statement of Terms and Conditions, including the special terms and conditions in the Appendix for the Participant&#8217;s country (if any) which forms part of this Statement of Terms and Conditions, and together both documents shall constitute the Performance Stock Unit Agreement.  Performance Stock Unit Awards are also subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Number of Shares Granted Based on Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance period of a Performance Stock Unit Award shall be greater than one year, and performance shall be based on such criteria as the Compensation Committee shall determine in its discretion at the beginning of the performance period.  Following the end of the performance period, the Compensation Committee shall determine the extent to which the criteria have been achieved and shall authorize the grant and issuance of Shares in respect of the Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Special Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Performance Stock Unit Awards shall be subject to the following terms, conditions and restrictions and such additional terms, conditions and restrictions as may be determined by the Compensation Committee, consistent with the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan or in Section V.3(B) or Section V.3(C)) prior to the end of the performance period, any then-outstanding Performance Stock Units shall be canceled, and all the rights of the Participant to such Award shall immediately terminate.  If a Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Compensation Committee may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan or the Award Agreement to the contrary, if a Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of such Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the applicable performance period, a prorated portion of each such Performance Stock Unit Award, equal to (1)&#160;the target number of Performance Stock Units subject to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance criteria determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period applicable to such Award, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on the applicable Grant Date&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in the Performance Stock Unit Grant Notice&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through the date on which the Compensation Committee determines performance against the applicable performance goals.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(B) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant either (a) has attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date or (b)&#160;would have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then any Performance Stock Unit Award shall be subject to the Normal Retirement provisions of Section V.3(B)(ii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the Participant&#8217;s termination date, then if such Participant&#8217;s termination date is no greater than six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, such Participant shall be eligible to vest in such Performance Stock Unit Award following completion of the applicable performance period, as though the Participant had continued to be employed by the Corporation or one of its Affiliates through such performance determination date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts, if any, to be paid under this Section V.3(C) shall be paid in accordance with Section&#160;V.7 and, if applicable, Section&#160;VIII.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise determined by the Compensation Committee in its sole discretion, Dividend Equivalents shall not be accrued with respect to Performance Stock Unit Awards during the performance period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to sell, transfer, pledge, assign or encumber all or any portion of a Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither a Participant nor any person entitled to exercise a Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to a Performance Stock Unit Award, except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any Performance Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Performance Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Compensation Committee shall determine the extent to which Shares are payable pursuant to a Performance Stock Unit Award as soon as practicable following the end of the performance period, and such Shares shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  Payment shall be made in the form of Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares earned pursuant to the Performance Stock Unit Award.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Statement of Terms and Conditions to the contrary notwithstanding, if the Administrator determines that a Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any outstanding Option shall immediately and automatically terminate, be forfeited and shall cease to be exercisable, without limitation.  In addition, any Award of Restricted Stock or Restricted Stock Units as to which the restrictions have not lapsed shall immediately and automatically be forfeited, Performance Stock Unit Awards shall immediately and automatically be forfeited and any such Shares of Restricted Stock shall be returned to the Corporation and all of the rights of the Participant to such Awards and the underlying Shares shall immediately terminate.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the Participant exercised an Option within 12 months prior to the date upon which the Corporation discovered that the Participant engaged in any actions described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained by the exercise of such Option measured at the date of exercise.  In addition, if the restrictions imposed on any Award of Restricted Stock or Restricted Stock Units (including any unpaid dividends or Dividend Equivalents) lapsed, or any Performance Stock Unit Award was settled, within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to such Award, measured at the date such Award vested. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;VI which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;VI.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be, (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;) which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i) in the case of an Option, shall consist of an option with the number of underlying shares and exercise price determined in a manner consistent with Code Section 424(a) with vesting and any other terms continuing in the same manner as the replaced Option&#59; (ii) in the case of a Performance Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Performance Stock Unit Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such Replacement Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; and (iii) in the case of a Restricted Stock Award or Restricted Stock Unit Award, shall consist of restricted stock or restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the Restricted Stock Award or Restricted Stock Unit Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock or restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14), based on the fair market value of the underlying shares on the vesting date, or in the case of options, based on the excess of the fair market value of the underlying shares over the option exercise price on the vesting date. If any Option, Restricted Stock Award, Restricted Stock Unit Award or Performance Stock Unit Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of a Performance Stock Unit Award, shall vest based upon deemed attainment of target performance or actual performance achieved, if greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, any unvested Option, Restricted Stock Award, or Restricted Stock Unit Award shall continue to vest according to the terms and conditions of such Award and any Performance Stock Unit Award shall be replaced with a Restricted Stock Unit Award where the number of shares subject to such Restricted Stock Unit Award shall be equal to the number of Shares assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control with any restrictions on such Restricted Stock Unit Award lapsing at the end of the measuring period over which performance for the replaced Performance Stock Unit Award was to be measured prior to the granting of the Replacement Award&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of an Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VIII.14).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.61pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of a Participant at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants to Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In making grants to Participants in foreign countries, the Administrator has the full discretion to deviate from this Statement of Terms and Conditions in order to adjust grants under the Plan to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan on the Award and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of an Award shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, 6555 North Highway 161, Irving, Texas 75039, and any notice to be given to a Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered, or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.  The parties may use email delivery, so long as the message is clearly marked, sent to the email address(es) set forth herein, and a delivery receipt and a read receipt are made part of the message.&#160; Email delivery will be deemed to occur when the sender receives confirmation that such message has been received and read by the recipient.  Emails to the Corporation shall be delivered to CorpSecretary&#64;McKesson.com.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under an Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect a Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance contributions, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant, vesting, settlement or exercise of the Award, as applicable, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (2) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (1) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (2)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; (3) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable&#59; or (4) any other method of withholding determined by the Corporation and to the extent required by applicable law or the Plan, approved by the Compensation Committee. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  With respect to an Award other than an Option, if adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (3) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporation or the Employer may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates in the Participant's jurisdiction.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan. In the event any excess amounts are withheld to satisfy the obligation for Tax-Related Items, the Participant may be entitled to receive a refund of any over-withheld amount (with no entitlement to the Share equivalent), or if not refunded by the Corporation or the Employer, the Participant must seek a refund from the local tax authorities to the extent the Participant wishes to recover the over-withheld amount in the form of a refund. In the event of under-withholding, the Participant may be </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award and the Shares subject to the Award, and the income from and value of same, are not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Award will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Award will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if the underlying Shares do not increase in value, the Options will have no value&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">in consideration of the grant of the Award, no claim or entitlement to compensation or damages shall arise from forfeiture of the Award which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever, and whether or not such forfeiture is later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; provided that, notwithstanding the foregoing, in the event any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Award, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">for purposes of an Award, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law (for example, the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; similarly, any right to exercise Options under the Plan after termination of employment will be measured as of the date the Participant is no longer a bona fide employee of the Corporation, the Employer or one of the Corporation&#8217;s other Affiliates and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee for purposes of an Award (including whether the Participant may still be considered to be providing services while on a leave of absence)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Fidelity Stock Plan Services LLC and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.  In the latter case, the Participant understands and acknowledges that the Corporation&#8217;s legal basis for the processing of the Participant&#8217;s Data would be compliance with the relevant laws or regulations or the pursuit by the Corporation of respective legitimate interests not outweighed by the Participant&#8217;s interests, rights or freedoms.  When the Corporation no longer needs the Participant&#8217;s Data for any of the above purposes, the Participant understands the Corporation will remove it from its systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) inquire whether and what kind of Data the Corporation holds about the Participant and how it is processed, and to request access or copies of Data the Corporation processes, (ii) request the correction or supplementation of Data about the Participant that is inaccurate, incomplete or out-of-date in light of the purposes underlying the processing, (iii) obtain the erasure of Data no longer necessary for the purposes underlying the processing, processed based on withdrawn consent, processed for legitimate interests that, in the context of the Participant&#8217;s objection, do not prove to be compelling, or processed in non-compliance with applicable legal requirements, (iv) request restrictions on processing of Data in certain situations where the Participant feels its processing is inappropriate, (v) request portability of the Participant&#8217;s Data that the Participant has actively or passively provided to the Corporation (which does not include data derived or inferred from the collected data), where the processing of such Data is based on consent or the Participant&#8217;s employment and is carried out by automated means, (vi) object, in certain circumstances, to the processing of Data for legitimate interests, (vii) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (viii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Statement of Terms and Conditions are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant acknowledges that the Participant is proficient in the English language, or has consulted with an advisor who is sufficiently proficient in the English language, and, accordingly, understands the provisions of the Plan and this Statement of Terms and Conditions.  If the Participant has received this Statement of Terms and Conditions or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (A) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (B) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Statement of Terms and Conditions, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement between the Participant and the Corporation evidencing the grant of an Option, Restricted Stock Award, Restricted Stock Award, Performance Shares or Other Share-Based Award, as applicable.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Early Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment (other than due to death, Long-Term Disability or for Cause) which occurs prior to Normal Retirement but on or after the date on which the Participant&#8217;s age (expressed in terms of years and completed months) plus service with the Corporation or an Affiliate equals 65. For purposes of determining eligibility for Early Retirement, the term &#8220;service&#8221; shall include years and completed whole months of service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59; provided, however, that, any such change attributable to the Corporation&#8217;s no longer being a company with publicly traded common stock shall not constitute Good Reason&#59; and provided, further, that a reduction in the Participant&#8217;s functions, duties or responsibilities solely by virtue of the Corporation being acquired and made part of a larger entity (for example, if following a Change in Control the Participant retains the Participant&#8217;s position, or has a comparable position, with respect to a division or subsidiary of the acquirer that contains the Corporation&#8217;s business) shall not constitute Good Reason&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date that an Option expires as set forth in the Option Grant Notice as the &#8220;Expiration Date.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the notice of an Award granted to the Participant, which sets forth certain terms of such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment (other than due to death, Long-Term Disability or for Cause) at or after age 60 (57, in the case of a participant in the McKesson Corporation 1984 Executive Benefit Retirement Plan) with at least 10 years of service with the Corporation or an Affiliate. For purposes of determining eligibility for Normal Retirement, &#8220;service&#8221; shall mean completed whole years of service (12 consecutive months).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing on the Grant Date of an Option and, except at otherwise provided in Section&#160;II.5, ending on the Expiration Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an affiliate (or, if providing service to the Corporation or an affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an affiliate and qualified for participation in and entitlement to benefits under the McKesson Corporation Severance Pay Plan or the McKesson Corporation Severance Policy for Executive Employees, as applicable, in accordance with the terms and conditions of such plans. A Participant outside the United States who is not qualified for participation in and entitlement to the benefits under such plans will nonetheless be treated for the limited purposes of his or her Awards, and subject to the provisions of Section VIII.9 of this Statement of Terms and Conditions, as terminated by reason of Severance to the extent his or her employment with the Corporation or an affiliate is terminated and he or she would satisfy the conditions for termination for reason of Severance but for the fact that such plan is only applicable to employees of the Corporation or an affiliate in the United States who qualify for participation in that plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><div id="i0e578ed7722a4dcca746f73c603c1ab8_16"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM OF AWARD AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">McKESSON CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SPECIAL INCENTIVE AWARD</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNITS AND RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GRANTED PURSUANT TO THE 2013 STOCK PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">GRANT OF AWARD</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Participant is hereby granted an Award of Performance Stock Units (&#8220;PSUs&#8221;) and Restricted Stock Units (&#8220;RSUs&#8221;), the terms and conditions of which are set forth herein.  The Grant Date is &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;,&#160;2018.  This Award Agreement is intended to meet the requirements of Code Section&#160;409A and any rules promulgated thereunder.  In the event of any inconsistency between this Award Agreement and the Plan, the Plan shall govern.  Capitalized terms not otherwise defined in this Award Agreement shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.72pt">PERFORMANCE STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Participant is hereby granted a target Award of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Performance Stock Units (the &#8220;PSU Award&#8221;), subject to the terms and conditions set forth herein.  The PSU Award is an &#8220;Other Share-Based Award&#8221; as provided under Section 11 of the Plan.  The PSU Award is also subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Lapse of Performance Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The performance goals applicable to the PSU Award are attached as Exhibit A to this Award Agreement.  The vesting and payment of the PSU Award is also subject to Section II.3, Section II.4 and Section&#160;IV.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Payment of Earned PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As soon as practicable following the end of the performance period, Compensation Committee shall determine the extent to which the performance goals have been achieved, and shall determine the number of PSUs that have been earned.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fifty percent (50%) of the Shares underlying earned PSUs shall be paid as soon as practicable thereafter and in any event no later than the end of the period under which payment would be deemed to be a &#8220;short-term deferral&#8221; as defined in the regulations under Code Section 409A.  The remaining fifty percent (50%) of such earned PSUs shall be subject to one additional year of vesting service and shall be evidenced by the issuance of a One-Year RSU Award on the terms and conditions set forth in Section II.4.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Termination of Service Prior to Determination of Performance Against Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section II.3(B) or Section II.3(C)) prior to the lapse of the performance restrictions imposed on the PSU Award, this PSU Award shall be canceled, and all the rights of the Participant to the PSU Award shall immediately terminate.  If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:94%">2013 Stock Plan 2018 Special Incentive</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained herein or in the Plan, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the PSU Award ceases to be a bona fide employee of the Corporation or an Affiliate prior to completion of the performance period as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, the Participant shall be eligible to receive, following completion of the performance period, an amount in cash equal to the value of a prorated portion of the PSU Award, equal to (1)&#160;the target number of PSUs subject to the PSU Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2)&#160;the performance results determined by the Compensation Committee to apply to such Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (3)&#160;a fraction, the numerator of which is the number of whole calendar months, rounded down to the nearest whole month, during which the Participant provided Service to the Corporation or an Affiliate during the performance period, and the denominator of which is the number of calendar months in such performance period&#59; provided, that for purposes of this clause&#160;(3), &#8220;whole calendar months&#8221; shall be calculated commencing on April 1, 2018&#59; provided, however, that in no event shall such amount exceed any applicable cap or limitation set forth in Exhibit A&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date, the Participant shall be eligible to receive, following completion of the performance period, an amount in cash equal to the value of the earned PSUs, paid in installments at the same times as actively employed holders of PSU Awards and calculated as though the Participant had continued to be employed by the Corporation or one of its Affiliates during the entire performance period and additional one-year vesting period applicable to the One-Year RSU Award as set forth in Section&#160;II.4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which the Compensation Committee determines performance against the applicable performance goals, and&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, and would not have attained the requirements for Normal Retirement within six months after the termination date, then the Participant shall be eligible to receive an amount in cash equal to one-half (1&#47;2) of the value of the earned PSUs, paid at the same time as actively employed holders of PSU Awards are paid the first installment of Shares, and calculated as though the Participant had continued to be employed by the Corporation or one of its Affiliates during the entire performance period&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Participant has not attained the requirements for Normal Retirement on or prior to the Participant&#8217;s termination date, but would have attained the requirements for Normal Retirement within six months after the termination date, such Participant shall be eligible for the Normal Retirement benefit set forth in Section&#160;II.3(B)(ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grant of One-Year RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Once the Compensation Committee has determined the number of PSUs that have been earned pursuant to the PSU Award, if any, an award of Restricted Stock Units with respect to one-half (50%) of such earned PSUs (the &#8220;One-Year RSU Award&#8221;) will be granted to the Participant on the terms and conditions set forth below and subject to the terms and conditions of the Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">The restrictions applicable to the One-Year RSU Award shall lapse with respect to 100% of the underlying Shares on the first anniversary of the Grant Date with respect to such One-Year RSU Award, subject to Section II.4(C) and Section IV.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents shall be credited in respect of the One-Year RSU Award.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on the One-Year RSU Award, and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying the One-Year RSU Award are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the One-Year RSU Award.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section II.4(C)(ii) or Section II.4(C)(iii)) prior to the lapse of the restrictions imposed on the One-Year RSU Award, any unvested Restricted Stock Units subject to the One-Year RSU Award shall be canceled, and all the rights of the Participant to the One-Year RSU Award shall immediately terminate.  If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary herein, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the One-Year RSU Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Death or Long-Term Disability, then the restrictions imposed on the One-Year RSU Award shall lapse on the date of such termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Normal Retirement, the One-Year RSU Award shall not be cancelled and will vest and be paid on the first anniversary of such Grant Date, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the applicable Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which such RSU Award is scheduled to vest and be paid, the restrictions applicable to such RSU Award shall lapse upon the termination date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:33pt;text-decoration:underline">Payment of Performance Stock Units and Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided with respect to the payment of earned PSUs in cash following certain terminations of employment under Section&#160;II.3, payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Performance Stock Units or Restricted Stock Units, as applicable.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.83pt">THREE-YEAR RESTRICTED STOCK UNITS </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant is hereby granted an Award of &#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93; Restricted Stock Units (the &#8220;RSU Award&#8221;), subject to the terms and conditions set forth herein.  The RSU Award also subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The restrictions applicable to the RSU Award shall lapse with respect to 100% of the underlying Shares on the third anniversary of the Grant Date, subject to Sections III.4 and IV.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Dividend equivalents shall be credited in respect of the RSU Award granted under this Section III.  Cash dividends shall be credited on behalf of the Participant to a deferred cash account (in a manner designed to comply with Code Section 409A) and the restrictions on such cash dividends shall lapse at the same time that the restrictions lapse on such RSU Award, and cash dividends, along with accrued interest (if any) on such cash dividends, shall be paid in a lump sum at the same time that the Shares underlying such RSU Award are distributed.  Stock dividends shall be converted into additional Restricted Stock Units, which will be subject to all of the terms and conditions of the applicable RSU Award, including the same vesting restrictions as the RSU Award.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant ceases to be a bona fide employee of the Corporation or any Affiliate (except as otherwise provided in the Plan, or in Section III.4(B) or Section III.4(C)) prior to the lapse of the restrictions imposed on the Award, any unvested Restricted Stock Units subject to the RSU Award shall be canceled, and all the rights of the Participant to such portion of the RSU Award shall immediately terminate.  If the Participant is absent from work with the Corporation or an Affiliate because of the Participant's Short-Term Disability or because the Participant is on an approved leave of absence, the Participant shall not be deemed during the period of any such absence, by virtue of such absence alone, to have terminated employment with the Corporation or an Affiliate except as the Administrator may otherwise expressly determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Death, Long-Term Disability or Normal Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any provision contained to the contrary herein, if the Participant who has been in the continuous employment of the Corporation or any of its Affiliates since the Grant Date of the RSU Award ceases to be a bona fide employee of the Corporation or an Affiliate as a result of </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Death or Long-Term Disability, then the restrictions imposed on any Award of Restricted Stock Units shall lapse on the date of such termination&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Normal Retirement on or after the first anniversary of the Grant Date of the RSU Award, such award shall not be cancelled and will vest and be paid on the third anniversary of such Grant Date, as though the Participant had continued to be employed by the Corporation or one of its Affiliates during such restricted period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Termination of Employment by Reason of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary, if the Participant has been in the continuous employment of the Corporation or any of its Affiliates since the applicable Grant Date and ceases to be a bona fide employee of the Corporation or an Affiliate as a result of Severance, and the Participant&#8217;s termination date is within six months prior to the date on which such RSU Award is scheduled to vest and be paid, the restrictions applicable to such RSU Award shall lapse upon the termination date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Time of Payment of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon the lapse of the restriction imposed on the Restricted Stock Units, such units that were not otherwise forfeited pursuant to the terms of the Plan and this Award Agreement shall be paid to the Participant as soon as reasonably practicable after the restrictions lapse.  Payment shall be made in Shares to the Participant&#8217;s brokerage account of record.  If the Participant does not have a brokerage account of record, then in the form of an appropriate book entry entered in the records of the Corporation&#8217;s transfer agent recording the Participant&#8217;s unrestricted interest in the number of Shares subject to the Restricted Stock Units.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">SPECIAL FORFEITURE AND REPAYMENT RULES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other provision of this Award Agreement to the contrary notwithstanding, if the Administrator determines that the Participant has engaged in any of the actions described in 3 below, the consequences set forth in 1 and 2 below shall result&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Performance Stock Units and Restricted Stock Units, to the extent the restrictions have not lapsed, shall immediately and automatically be forfeited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">If the restrictions imposed on an RSU Award (including any unpaid Dividend Equivalents) lapsed within 12 months prior to the date the Corporation discovered that the Participant engaged in any action described in 3 below, the Participant, upon written notice from the Corporation, shall immediately pay to the Corporation the economic value realized or obtained with respect to the PSU Award and any RSU Award, measured at the date on which Shares (or cash, if applicable) was paid in respect of the PSU Award or on which such RSU Award vested. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The consequences described in 1 and 2 above shall apply if the Participant, either before or after termination of employment with the Corporation or its Affiliates&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Discloses to others, or takes or uses for the Participant&#8217;s own purpose or the purpose of others, any trade secrets, confidential information, knowledge, data or know&#8209;how or any other proprietary information or intellectual property belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment, whether or not they are the Participant&#8217;s work product.  Examples of such confidential information or trade secrets include, without limitation, customer lists, supplier lists, pricing and cost data, computer programs, delivery routes, advertising plans, wage and salary data, financial information, research and development plans, processes, equipment, product information and all other types and categories of information as to which the Participant knows or has reason to know that the Corporation or its Affiliates intends or expects secrecy to be maintained&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to promptly return all documents and other tangible items belonging to the Corporation or its Affiliates in the Participant&#8217;s possession or control, including all complete or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about such documents or information contained therein, upon termination of employment, whether pursuant to retirement or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Fails to provide the Corporation with at least 30&#160;days&#8217; written notice prior to directly or indirectly engaging in, becoming employed by, or rendering services, advice or assistance to any business in competition with the Corporation or its Affiliates.  As used herein, &#8220;business in competition&#8221; means any person, organization or enterprise which is engaged in or is about to become engaged in any line of business engaged in by the Corporation or its Affiliates at the time of the termination of the Participant&#8217;s employment with the Corporation or its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to inform any new employer, before accepting employment, of the terms of this paragraph and of the Participant&#8217;s continuing obligation to maintain the confidentiality of the trade secrets and other confidential information belonging to the Corporation or its Affiliates and obtained by the Participant during the term of the Participant&#8217;s employment with the Corporation or any of its Affiliates&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Induces or attempts to induce, directly or indirectly, any of the customers of the Corporation or its Affiliates, employees, representatives or consultants to terminate, discontinue or cease working with or for the Corporation or its Affiliates, or to breach any contract with the Corporation or any of its Affiliates, in order to work with or for, or enter into a contract with, the Participant or any third party&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Engages in conduct which is not in good faith and which disrupts, damages, impairs or interferes with the business, reputation or employees of the Corporation or its Affiliates&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Fails to meet the Participant&#8217;s continuing obligations with respect to non-disclosure, non-competition and&#47;or non-solicitation under the Participant&#8217;s agreement with the Corporation or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall determine in its sole discretion whether the Participant has engaged in any of the acts set forth in (A) through (G) above, and its determination shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of this Section&#160;IV which is determined by a court of competent jurisdiction to be invalid or unenforceable should be construed or limited in a manner that is valid and enforceable and that comes closest to the business objectives intended by such invalid or unenforceable provision, without invalidating or rendering unenforceable the remaining provisions of this Section&#160;IV.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">CHANGE IN CONTROL  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock ceases to be listed for trading on a national securities exchange (an &#8220;Exchange&#8221;), any portion of the PSU Award or an RSU Award granted hereby (for purposes of this Section V, &#8220;RSU Award&#8221; shall include time-vesting RSU awards granted under Section III or Section IV) that is unvested on the effective date of the Change in Control shall continue to vest according to the terms and conditions of such Award, provided that such Award is replaced with an award for voting securities of the resulting corporation or the acquiring corporation, as the case may be (including without limitation, the voting securities of any corporation which as a result of the Change in Control owns the Corporation or all or substantially all of the Corporation&#8217;s assets either directly or through one or more subsidiaries) (the &#8220;Surviving Company&#8221;), which are traded on an Exchange (a &#8220;Replacement Award&#8221;), which Replacement Award, (i)&#160;in the case of the PSU Award, shall consist of restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the PSU Award (determined using the Corporation&#8217;s stock price and assuming attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control), with any restrictions on such restricted stock units lapsing at the end of the PSU Award&#8217;s performance period, with continued vesting after the Change in Control based only on continued service to the Corporation or an Affiliate, as though a time-based vesting award&#59; and (ii) in the case of an RSU Award, shall consist of restricted stock units with a value (determined using the Surviving Company&#8217;s stock price as of the effective date of the Change in Control) equal to the value of the RSU Award (determined using the Corporation&#8217;s stock price as of the effective date of the Change in Control), with any restrictions on such restricted stock units lapsing at the same time and manner as the replaced Award&#59; provided, however, that in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of any Replacement Award, the Replacement Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VI.17), based on the fair market value of the underlying shares on the vesting date. If any portion of the PSU Award or an RSU Award that is unvested at the effective time of the Change in Control is not replaced with a Replacement Award, such Award shall immediately vest and, in the case of the PSU Award, such Award shall vest based upon deemed attainment of target performance or actual performance achieved, if greater, if such Change in Control occurs during the performance period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If as a result of a Change in Control, the Common Stock continues to be listed for trading on an Exchange, (i)&#160;any unvested portion of the PSU Award shall continue to vest with respect to that number of Shares that reflects the deemed attainment of target performance or actual performance achieved, if greater, as of the effective date of the Change in Control, such vesting occurring at such time or times as (x)&#160;performance would have been measured and (y)&#160;the related RSU Award would have vested absent such Change in Control, and (ii)&#160;any unvested portion of an RSU Award shall continue to vest according to the terms and conditions of such Award and&#59; provided however, that, in the event of the Participant&#8217;s involuntary Separation from Service by the Corporation without Cause or Separation from Service by the Participant for Good Reason during the vesting period of this PSU Award or an RSU Award, such Award shall immediately vest and be paid as soon as practicable following such Separation from Service (subject to Section VI.17), based on the fair market value of the underlying Shares on the vesting date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.39pt">PARTICIPANT RIGHTS&#59; MISCELLANEOUS  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restriction on Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant is covered by the Stock Ownership Policy at the time of settlement of an Award granted hereunder, the Compensation Committee reserves the right to impose a restriction on the sale of Shares that the Participant receives upon the settlement of the Performance Stock Units and Restricted Stock Units granted hereunder, unless the Participant has satisfied the ownership targets applicable to the Participant as provided in such policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Participant shall not be permitted to sell, transfer, pledge, assign or encumber the Performance Stock Units or Restricted Stock Units granted hereby, other than pursuant to a qualified domestic relations order as defined in the Code or Title I of the U.S. Employee Retirement Income Security Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Participant nor any person entitled to exercise the Participant&#8217;s rights in the event of the Participant&#8217;s death shall have any of the rights of a stockholder with respect to the Performance Stock Units or Restricted Stock Units except to the extent that a book entry has been entered in the records of the Corporation&#8217;s transfer agent with respect to the Shares paid upon the settlement of any such Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan shall not create a right to further employment with the Participant&#8217;s employer (the &#8220;Employer&#8221;) and shall not interfere with the ability of the Employer to terminate, with or without cause, or change the terms of employment of the Participant at any time.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Participants in Foreign Countries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Administrator has the full discretion to deviate from this Award Agreement in order to adjust the Awards granted hereby to prevailing local conditions, including custom and legal and tax requirements.  Furthermore, the Corporation reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Awards granted hereby and on any Shares acquired under the Plan, to the extent the Corporation determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertaking that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Information Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any information required to be given under the terms of the Awards granted hereby shall be addressed to the Corporation in care of its Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, California 94104, and any notice to be given to the Participant shall be addressed to such Participant at the address indicated beneath the Participant's name on the Award Agreement or such other address as either party may designate in writing to the other.  Any such notice shall be deemed to have been duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, registered or certified and deposited (postage or registration or certification fee prepaid)&#160;in a post office or branch post office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Administrator Decisions Conclusive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All decisions of the Administrator administering the Plan upon any questions arising under the Plan or under this Award Agreement, shall be conclusive and binding on all interested persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Effect on Other Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing herein contained shall affect the Participant&#8217;s right to participate in and receive benefits from and in accordance with the then current provisions of any pensions, insurance or other employment welfare plan or program offered by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Corporation or the Employer takes with respect to any federal, state or local income tax, social insurance, payroll tax, payment on account or other tax-related items related to the Participant&#8217;s participation in the Plan and legally applicable to the Participant (&#8220;Tax-Related Items&#8221;), the Participant acknowledges that the ultimate liability for all Tax-Related Items is and remains the Participant's responsibility and may exceed the amount actually withheld by the Corporation or the Employer.  The Participant further acknowledges that the Corporation and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including the grant or vesting of the Award, the subsequent sale of Shares acquired pursuant to the Plan and the receipt of any dividends and&#47;or dividend equivalents&#59; and (ii) do not commit and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Participant acknowledges that the Corporation and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Corporation and&#47;or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following&#58; (i) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Corporation and&#47;or the Employer&#59; (ii)&#160;withholding from proceeds of the sale of Shares acquired under the Plan either through a voluntary sale or through a mandatory sale arranged by the Corporation (on the Participant&#8217;s behalf pursuant to this authorization and any other authorization the Corporation and&#47;or the broker designated by the Corporation may require the Participant to sign in connection with the sale of Shares)&#59; or (iii) withholding Shares to be issued upon grant, vesting&#47;settlement or exercise, as applicable. Calculation of the number of Shares to be withheld shall be made based on the closing price of the Common Stock on the New York Stock Exchange on the date that the amount of tax to be withheld is determined.  In no event, however, shall the Corporation be required to issue fractional Shares.  If adequate arrangements to satisfy the obligations with regard to all Tax-Related Items are not made by the Participant with the Corporation and&#47;or the Employer prior to the relevant taxable event, the Corporation will satisfy such obligations as provided above in clause (iii) of this paragraph.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To avoid negative accounting treatment, the Corporation may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant will be deemed to have been issued the full number of Shares subject to the Award, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Participant&#8217;s participation in the Plan.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the Participant shall pay to the Corporation or the Employer any amount of Tax-Related Items that the Corporation or the Employer may be required to withhold or account for as a result of the Participant&#8217;s participation in the Plan that cannot be satisfied by the means previously described.  The Corporation may refuse to issue or deliver the Shares or the proceeds of the sale of Shares if the Participant fails to comply with the Participant's obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator shall be authorized to establish such rules, forms and procedures as it deems necessary to implement the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Award Agreements shall be binding upon and inure to the benefit of any successor or successors of the Corporation.  &#8220;Participant&#8221; as used herein shall include the Participant&#8217;s Beneficiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Delaware Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The interpretation, performance, and enforcement of all Award Agreements shall be governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In accepting the grant, the Participant acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Plan is established voluntarily by the Corporation, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Corporation at any time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the grant of the Awards is voluntary and occasional and does not create any contractual or other right to receive future Award grants, or benefits in lieu of Awards, even if Awards have been granted repeatedly in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">all decisions with respect to future Awards, if any, will be at the sole discretion of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">the Award is not part of normal or expected compensation for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Awards will not be interpreted to form an employment contract or relationship with the Corporation&#59; and furthermore, the Awards will not be interpreted to form an employment contract with any subsidiary or Affiliate of the Corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">in consideration of the grant of the Awards, no claim or entitlement to compensation or damages shall arise from forfeiture of the Awards which results from termination of the Participant&#8217;s employment with the Employer or the Corporation or one of its Affiliates (for any reason whatsoever) and the Participant irrevocably releases the Corporation or its Affiliates from any such claim that may arise&#59; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by accepting the Awards, the Participant shall be deemed irrevocably to have waived the Participant's entitlement to pursue such claim&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">for purposes of the Awards, the Participant&#8217;s employment relationship will be considered terminated as of the date the Participant is no longer a bona fide employee of the Corporation or one of its Affiliates (regardless of the reason for such termination and whether or not later found to be invalid or in breach of the employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any), and unless otherwise expressly provided in this Award Agreement or determined by the Corporation in its sole discretion, the Participant&#8217;s right to receive Awards and vest in Awards under the Plan, if any, will terminate effective as of such date and will not be extended by any notice period mandated under local law&#59; the Administrator shall have the sole discretion to determine when the Participant is no longer a bona fide employee&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">the Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding participation in the Plan or the Participant&#8217;s acquisition or sale of Shares&#59; and</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Participant is hereby advised to consult with the Participant's own personal tax, legal and financial advisors regarding Participant&#8217;s participation in the Plan before taking any action related to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Data Privacy Information and Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Collection and Usage.  The Corporation and the Employer may collect, process and use certain personal information about the Participant, including, but not limited to, the Participant&#8217;s name, home address and telephone number, email address, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Corporation, details of all Options, Restricted Stock, Restricted Stock Units, Performance Shares, Other Share-Based Awards, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Employee&#8217;s favor (&#8220;Data&#8221;), for the purposes of implementing, administering and managing the Plan. The legal basis, where required, for the processing of Data is the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Stock Plan Administration Service Providers.  The Corporation transfers Data to Merrill Lynch and its affiliated companies, an independent service provider based in the United States, which is assisting the Corporation with the implementation, administration and management of the Plan. The Corporation may select a different service provider or additional service providers and share Data with such other provider serving in a similar manner. The Participant may be asked to agree on separate terms and data processing practices with the service provider, with such agreement being a condition to the ability to participate in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">International Data Transfers.  The Corporation and its service providers are based in the United States.  The Participant&#8217;s country or jurisdiction may have different data privacy laws and protections than the United States. For example, the European Commission has issued a limited adequacy finding with respect to the United States that applies only to the extent companies register for the EU-U.S. Privacy Shield program. The Corporation&#8217;s legal basis, where required, for the transfer of Data is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Participant&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.12pt">Data Retention.  The Corporation will hold and use the Data only as long as is necessary to implement, administer and manage the Participant&#8217;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under tax and security laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Voluntariness and Consequences of Consent Denial or Withdrawal.  Participation in the Plan is voluntary and the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant&#8217;s consent, the Participant&#8217;s salary from or employment with the Employer will not be affected&#59; the only consequence of refusing or withdrawing the Participant&#8217;s consent is that the Corporation would not be able to grant Awards to the Participant or administer or maintain such Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.68pt">Data Subject Rights.  The Participant may have a number of rights under data privacy laws in the Participant&#8217;s jurisdiction.  Depending on where the Participant is based, such rights may include the right to (i) request access or copies of Data the Corporation processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing of Data, (v) portability of Data, (vi) lodge complaints with competent authorities in the Participant&#8217;s jurisdiction, and&#47;or (vii) receive a list with the names and addresses of any potential recipients of Data.  To receive clarification regarding these rights or to exercise these rights, the Participant can contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">By accepting the Award and indicating consent via the Corporation&#8217;s acceptance procedure, the Participant is declaring that he or she agrees with the data processing practices described herein and consents to the collection, processing and use of Data by the Corporation and the transfer of Data to the recipients mentioned above, including recipients located in countries which do not adduce an adequate level of protection from a European (or other non-U.S.) data protection law perspective, for the purposes described above.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finally, the Participant understands that the Corporation may rely on a different legal basis for the processing or transfer of Data in the future and&#47;or request that the Participant provide another data privacy consent form.  If applicable and upon request of the Corporation, the Participant agrees to provide an executed acknowledgement or data privacy consent form to the Employer or the Corporation (or any other acknowledgements, agreements or consents that may be required by the Employer or the Corporation) that the Corporation and&#47;or the Employer may deem necessary to obtain under the data privacy laws in the Participant&#8217;s country, either now or in the future.  The Participant understands that the Participant will not be able to participate in the Plan if the Participant fails to execute any such acknowledgement, agreement or consent requested by the Corporation and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The provisions in this Award Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the Participant has received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If (i) the Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service, and (ii) some or any portion of the amounts payable to the Participant, if any, when considered together with any other payments or benefits which may be considered deferred compensation under section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Section 409A&#8221;) and subject to the plan aggregation rules under Treasury Regulation section 1.409A-1(c)(3)(viii) (together, the &#8220;Deferred Compensation Benefits&#8221;) would result in the imposition of additional tax under Section 409A if paid to the Participant on or within the six month period following the Separation from Service, then to the extent such portion of the Deferred Compensation Benefits resulting in the imposition of additional tax would otherwise have been payable on or within the first six months following the Separation from Service, it will instead become payable on the first payroll date that occurs in the seventh month following the Separation from Service (or such longer period as is required to avoid the imposition of additional tax under Section 409A). All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.5pt">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When capitalized in this Award Agreement, the following terms shall have the meaning set forth below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this agreement between the Participant and the Corporation evidencing the grant of the PSU Award and the RSU Award, the terms of which are set forth herein and in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s employment with the Corporation or an Affiliate upon the Participant&#8217;s negligent or willful engagement in misconduct which, in the sole determination of the Chief Executive Officer of the Corporation (or the Chief Executive Officer&#8217;s designee), is injurious to the Corporation, its employees, or its customers.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person identified as an &#8220;immediate family&#8221; member in Rule 16(a)&#8209;1(e) of the Exchange Act, as such Rule may be amended from time to time.  Notwithstanding the foregoing, the Administrator may designate any other person(s)&#160;or entity(ies) as a &#8220;family member.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following actions, if taken without the express written consent of the Participant&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;Any material change by the Corporation in the Participant&#8217;s functions, duties, or responsibilities, which change would cause the Participant&#8217;s position with the Corporation to become of less dignity, responsibility, importance, or scope from the position and attributes that applied to the Participant immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;Any significant reduction in the Participant&#8217;s aggregate base annual salary and target incentive opportunity, as in effect immediately prior to the Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Any material failure by the Corporation to comply with any of the provisions of an Award subsequent to a Change in Control&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;The Corporation&#8217;s requiring the Participant to be based at any location which would increase the Participant&#8217;s regular one-way commute by more than 25 miles from that in effect immediately preceding the Change in Control, except for travel reasonably required in the performance of the Participant&#8217;s responsibilities&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;Any change in the person to whom the Participant reports, as this relationship existed immediately prior to a Change in Control&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided that the Participant gives notice to the Corporation of the existence of the Good Reason condition within 30 days of the initial existence of the Good Reason condition and the Corporation is provided 30 days after receipt of the Participant&#8217;s notice to remedy the Good Reason condition&#59; provided further that the Participant&#8217;s Separation from Service must occur within six months from the initial existence of the Good Reason condition if the Corporation does not remedy such condition for such separation to be considered to be for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Administrator grants the Award</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long&#8209;Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a physical or mental condition in respect of which the administrator of the Corporation&#8217;s long-term disability plan has determined that the Participant is eligible to receive income replacement benefits&#59; or, if the Participant is not then a participant in the Corporation&#8217;s long-term disability plan, a physical or mental condition that the administrator of the Corporation&#8217;s long-term disability plan determines would have rendered the Participant eligible to receive income replacement benefits, had the Participant been enrolled in such plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of employment with the Corporation or an Affiliate. A Participant shall be deemed to have had a Separation from Service if the Participant&#8217;s service with the Corporation or an Affiliate is reduced to an annual rate that is equal to or less than 20% of the services rendered, on average, during the immediately preceding three years of service with the Corporation or an Affiliate (or, if providing service to the Corporation or an Affiliate for less than three years, such lesser period).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Short-Term Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means short-term disability as defined in the Corporation&#8217;s short-term disability plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means those employees identified by the Corporation as &#34;Specified Employees&#34; for purposes of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Corporation&#8217;s Stock Ownership Policy, as amended from time to time, which can be found on McKNet.  A Participant or the Participant&#8217;s beneficiary may also request a copy of the Stock Ownership Policy by writing to the Corporate Secretary at McKesson Corporation, One Post Street, San Francisco, CA 94104.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Participant has executed this Award Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;NAME OF EXECUTIVE&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;TITLE&#93;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><div id="i0e578ed7722a4dcca746f73c603c1ab8_19"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUTSIDE DIRECTOR</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MCKESSON CORPORATION 2013 STOCK PLAN </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.374%"><tr><td style="width:1.0%"></td><td style="width:54.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100% vested on grant date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2013 Stock Plan, as may be amended from time to time (the &#8220;Plan&#8221;) to receive shares of common stock of the Company (&#8220;Shares&#8221;).  This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement, which along with the Plan set forth the terms of your grant.   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I agree to receive copies of the stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and </font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;I have access to the Company&#8217;s web site&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The Plan and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs&#59; and</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;I accept ALL the terms and conditions as set forth in the Plan and the ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:256.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* 2013 Stock Plan Prospectus for Non-Employee Directors</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* ST&#38;Cs </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country specific) </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 2021</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.356%"><tr><td style="width:1.0%"></td><td style="width:44.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Please see Appendix</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2013 Stock Plan (the &#8220;Plan&#8221;) which represent the contingent right to receive shares of common stock of the Company (&#8220;Shares&#8221;).  This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided as an attachment to this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Restricted Stock Unit Agreement. Your Restricted Stock Unit Agreement and your RSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;) and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time).</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF RSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company recommends that the Grantee consult with a tax advisor prior to accepting or vesting of this grant of RSUs&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of RSUs.</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:256.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ATTACHMENTS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* 2013 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* ST&#38;Cs Applicable to _________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country-specific)</font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May 2019</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MCKESSON CORPORATION 2013 STOCK PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNIT GRANT NOTICE</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"></td><td style="width:44.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grantee Name&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target PSUs Granted&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Period&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FY&#160;20__ - FY&#160;20__</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (the &#8220;Company&#8221;) is pleased to grant you target performance stock units (&#8220;PSUs&#8221;) under the Company&#8217;s 2013 Stock Plan (the &#8220;Plan&#8221;).  This Grant Notice (&#8220;Notice&#8221;), together with the Statement of Terms and Conditions, as provided with this Notice (the &#8220;ST&#38;Cs&#8221;), constitute your Performance Stock Unit Agreement.  Your Performance Stock Unit Agreement and your PSUs are subject to the terms of the Plan, which incorporates by reference the Company&#8217;s Compensation Recoupment Policy (the &#8220;Recoupment Policy&#8221;), and the Company&#8217;s Stock Ownership Policy (the &#8220;Stock Ownership Policy&#8221;), as both are amended from time to time.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your PSUs will be earned subject to the Company&#8217;s attainment of performance goals that have been pre-established by the Compensation Committee (the &#8220;Committee&#8221;) of the Company&#8217;s Board of Directors.  You may receive 0% - 200% of the target number of PSUs set forth above.  PSUs, if earned, will be paid in the form of shares of the Company&#8217;s Common Stock (&#8220;Shares&#8221;) that are not subject to any further vesting restrictions.  The Committee has the sole discretion to determine the Company&#8217;s performance against the pre-established goals after completion of the performance period, and to authorize the grant of Shares.  </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of documents that are made available to you in connection with this Notice.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE BE SURE TO READ THESE DOCUMENTS BECAUSE THEY CONTAIN IMPORTANT INFORMATION SPECIFIC TO THIS GRANT OF PSUs.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This grant, along with any other outstanding awards under the Plan, can be viewed on the Fidelity web site at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.Netbenefits.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">By signing below, I acknowledge that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I agree to receive copies of the Plan, the Plan prospectus and other Plan information, including information prepared to comply with the laws outside the United States, from the Company&#8217;s website and stockholder information, including copies of any annual report, proxy and Form 10-K, from the Investor Resources section of the McKesson website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.mckesson.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I also acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are available upon written or telephonic request to the Corporate Secretary (1-800-826-9360)&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have access to the Company&#8217;s web site&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I consent to receiving electronically a copy of the documents set forth above and attachments to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Plan (including the Recoupment Policy and Stock Ownership Policy) and ST&#38;Cs are incorporated by reference to this Notice&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I should consult with a tax advisor prior to accepting this grant of PSUs or taking any other action with respect to this grant of PSUs&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I accept ALL the terms and conditions as set forth in the Plan and ST&#38;Cs applicable to this grant of PSUs.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Grantee has executed this Agreement, and the Company has caused these presents to be executed in its name and on its behalf, all as of the Grant Date.</font></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:256.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grantee Signature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan Documents and Related Policies</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* 2013 Stock Plan</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* 2013 Stock Plan Prospectus</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* ST&#38;Cs Applicable to </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Compensation Recoupment Policy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Hedging and Pledging Policy (Section 16 only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Stock Ownership Policy (EOT only)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Appendix (Outside U.S. - country specific)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">May 2019</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>7
<FILENAME>mck_exhibit21x3312022.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i60a6088c888b4462b74ee089c729b35f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 21</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">SUBSIDIARIES OF THE REGISTRANT</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:19pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">There is no parent of the Company. The following is a listing of the significant subsidiaries of the Company.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JURISDICTION</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OF</font></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORGANIZATION</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Europe AG</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Europe Holdings GmbH &#38; Co. KGaA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Global Procurement &#38; Sourcing Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Bermuda IP2A Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Bermuda IP3A Limited</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Ireland Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Holdings Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Supply Chain Services LLP</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Top Holdings Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Plasma and Biologics LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Specialty Care Distribution LLC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson UK Finance I Limited</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson UK Finance II Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson US Finance Corporation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Drug Distributors Ireland Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Drug (Wholesale) Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Oncology Holdings, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Oncology, Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>8
<FILENAME>mck_exhibit23x3312022.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iffd0b694b5584dc8a5337261c9297f72_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 23</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-249817, 333-163642, 333-190847, 333-190848, and 333-213488 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our report dated May&#160;9, 2022, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation&#8217;s internal control over financial reporting appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2022.</font></div><div style="margin-bottom:19pt;text-align:justify"><font><br></font></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.233%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Deloitte &#38; Touche LLP</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas, Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>mck_exhibit311x3312022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibc75c65e85494ecd960829b1b99d1152_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May&#160;9, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>mck_exhibit312x3312022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i48604b30fdda40d0ba5a273fa6fe03be_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May&#160;9, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>11
<FILENAME>mck_exhibit32x3312022.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2580cfb4f2f349d5affc177e01545352_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-K for the year ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><font><br></font></div><div style="margin-top:29pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>mck-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eedc7054-d2b4-49fb-b502-fc8a725b4aca,g:dd1fa40e-8b61-4831-9194-c55f1729d4f8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://mckesson123.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://mckesson123.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>100010003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>100020004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100030005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100040006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>100050007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals">
        <link:definition>100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100070009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>240044001 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesNetDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails">
        <link:definition>240054002 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails">
        <link:definition>240064003 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>210071002 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleTables" roleURI="http://mckesson123.com/role/HeldforSaleTables">
        <link:definition>230083002 - Disclosure - Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>240094004 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails">
        <link:definition>240104005 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (E.U. Disposal Group) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails">
        <link:definition>240114006 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (U.K. Disposal Group) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>210121003 - Disclosure - Restructuring, Impairment, and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>230133003 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>240144007 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails">
        <link:definition>240154008 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails">
        <link:definition>240164009 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestitures" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures">
        <link:definition>210171004 - Disclosure - Business Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresTables" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables">
        <link:definition>230183004 - Disclosure - Business Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails">
        <link:definition>240194010 - Disclosure - Business Acquisitions and Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails">
        <link:definition>240204011 - Disclosure - Business Acquisitions and Divestitures - Net Gain on Split-off of Change Healthcare JV (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://mckesson123.com/role/ShareBasedCompensation">
        <link:definition>210211005 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://mckesson123.com/role/ShareBasedCompensationTables">
        <link:definition>230223005 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240234012 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails">
        <link:definition>240244013 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails">
        <link:definition>240254014 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails">
        <link:definition>240264015 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails">
        <link:definition>240274016 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails">
        <link:definition>240284017 - Disclosure - Share-Based Compensation - Schedule of Assumptions for Stock Options Fair Values (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofOptionsOutstandingDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails">
        <link:definition>240294018 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofStockOptionActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails">
        <link:definition>240304019 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails">
        <link:definition>240314020 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNet" roleURI="http://mckesson123.com/role/OtherIncomeNet">
        <link:definition>210321006 - Disclosure - Other Income, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetTables" roleURI="http://mckesson123.com/role/OtherIncomeNetTables">
        <link:definition>230333006 - Disclosure - Other Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetScheduleofOtherIncomeNetDetails" roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails">
        <link:definition>240344021 - Disclosure - Other Income, Net - Schedule of Other Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetNarrativeDetails" roleURI="http://mckesson123.com/role/OtherIncomeNetNarrativeDetails">
        <link:definition>240354022 - Disclosure - Other Income, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>210361007 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://mckesson123.com/role/IncomeTaxesTables">
        <link:definition>230373007 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
        <link:definition>240384023 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails">
        <link:definition>240394024 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails">
        <link:definition>240404025 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfDeferredTaxBalancesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails">
        <link:definition>240414026 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails">
        <link:definition>240424027 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240434028 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>210441008 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>230453008 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>240464029 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails">
        <link:definition>240474030 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShare" roleURI="http://mckesson123.com/role/EarningsperCommonShare">
        <link:definition>210481009 - Disclosure - Earnings per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShareTables" roleURI="http://mckesson123.com/role/EarningsperCommonShareTables">
        <link:definition>230493009 - Disclosure - Earnings per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails">
        <link:definition>240504031 - Disclosure - Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperCommonShareNarrativeDetails" roleURI="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails">
        <link:definition>240514032 - Disclosure - Earnings per Common Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://mckesson123.com/role/Leases">
        <link:definition>210521010 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://mckesson123.com/role/LeasesTables">
        <link:definition>230533010 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://mckesson123.com/role/LeasesNarrativeDetails">
        <link:definition>240544033 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalbalancesheetinformationDetails" roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails">
        <link:definition>240554034 - Disclosure - Leases - Supplemental balance sheet information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofleasecostsDetails" roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails">
        <link:definition>240564035 - Disclosure - Leases - Components of lease costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalcashflowinformationDetails" roleURI="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails">
        <link:definition>240574036 - Disclosure - Leases - Supplemental cash flow information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofleaseliabilitiesDetails" roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails">
        <link:definition>240584037 - Disclosure - Leases - Maturities of lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofleaseliabilitiesDetails_1" roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1">
        <link:definition>240584037 - Disclosure - Leases - Maturities of lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofleaseliabilitiesDetails_2" roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2">
        <link:definition>240584037 - Disclosure - Leases - Maturities of lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>210591011 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>230603011 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>240614038 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails">
        <link:definition>240624039 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>240634040 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails">
        <link:definition>240644041 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>210651012 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>230663012 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>240674042 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails">
        <link:definition>240684043 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>240694044 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails">
        <link:definition>240704045 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://mckesson123.com/role/VariableInterestEntities">
        <link:definition>210711013 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesDetails" roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails">
        <link:definition>240724046 - Disclosure - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>210731014 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsTables" roleURI="http://mckesson123.com/role/PensionBenefitsTables">
        <link:definition>230743013 - Disclosure - Pension Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>240754047 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails">
        <link:definition>240764048 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails">
        <link:definition>240774049 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails">
        <link:definition>240784050 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails">
        <link:definition>240794051 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>240804052 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails">
        <link:definition>240814053 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails">
        <link:definition>240824054 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails">
        <link:definition>240834055 - Disclosure - Pension Benefits - Schedule of Investments Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>210841015 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>230853014 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>240864056 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails">
        <link:definition>240874057 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>210881016 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>230893015 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>240904058 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
        <link:definition>240914059 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialGuaranteesandWarranties" roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties">
        <link:definition>210921017 - Disclosure - Financial Guarantees and Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialGuaranteesandWarrantiesDetails" roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails">
        <link:definition>240934060 - Disclosure - Financial Guarantees and Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>210941018 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://mckesson123.com/role/CommitmentandContingenciesTables">
        <link:definition>230953016 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails">
        <link:definition>240964061 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
        <link:definition>240974062 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://mckesson123.com/role/StockholdersEquity">
        <link:definition>210981019 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://mckesson123.com/role/StockholdersEquityTables">
        <link:definition>230993017 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>241004063 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofShareRepurchasesDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails">
        <link:definition>241014064 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
        <link:definition>241024065 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyBalancesandTransactions" roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions">
        <link:definition>211031020 - Disclosure - Related Party Balances and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyBalancesandTransactionsDetails" roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails">
        <link:definition>241044066 - Disclosure - Related Party Balances and Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>211051021 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>231063018 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessNarrativeDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails">
        <link:definition>241074067 - Disclosure - Segments of Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessScheduleofSegmentInformationDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails">
        <link:definition>241084068 - Disclosure - Segments of Business - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails">
        <link:definition>241094069 - Disclosure - Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>211101022 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>241114070 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" abstract="true" name="AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FirstPartOfPayContributionMember" abstract="false" name="FirstPartOfPayContributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MachineryEquipmentAndOtherMember" abstract="true" name="MachineryEquipmentAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfOtherDefendants" abstract="false" name="LossContingencyNumberOfOtherDefendants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="LeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TaxReceivableAgreementTRAMember" abstract="true" name="TaxReceivableAgreementTRAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_NumberofSoftwareProducts" abstract="false" name="NumberofSoftwareProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMay2021Member" abstract="true" name="AcceleratedShareRepurchaseMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeNationalPharmaceuticalDistributorsMember" abstract="true" name="ThreeNationalPharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" abstract="false" name="DeferredTaxLiabilitiesLeaseRightofuseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DeferredTaxAssetLeaseObligations" abstract="false" name="DeferredTaxAssetLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyDamagesSoughtPerViolationValue" abstract="false" name="LossContingencyDamagesSoughtPerViolationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" abstract="false" name="LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" abstract="false" name="ReclassificationOfTemporaryEquityToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GermanWholesaleBusinessMember" abstract="true" name="GermanWholesaleBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" abstract="true" name="RestrictedStockUnitsandPerformancebasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A475NotesDueMarch12021Member" abstract="true" name="A475NotesDueMarch12021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="LeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFiveThereafter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" abstract="false" name="DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearThree" abstract="false" name="GuaranteeObligationsExposureExpiringinYearThree" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AustrianBusinessOperationsMember" abstract="true" name="AustrianBusinessOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" abstract="false" name="CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" abstract="false" name="EstimatedEnvironmentalAssessmentAndCleanupCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" abstract="false" name="EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TransitionServicesAgreementsTSAMember" abstract="true" name="TransitionServicesAgreementsTSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ChangeHealthcareInc.Member" abstract="true" name="ChangeHealthcareInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementNumberOfInstallmentPayments" abstract="false" name="LossContingencySettlementNumberOfInstallmentPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LargestCustomerMember" abstract="true" name="LargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_OperatingLeaseImpairmentLossNetOfTax" abstract="false" name="OperatingLeaseImpairmentLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" abstract="true" name="StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" abstract="false" name="LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_PharmacyLicensesMember" abstract="true" name="PharmacyLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" abstract="false" name="NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FinancialGuaranteesAndWarrantiesAbstract" abstract="true" name="FinancialGuaranteesAndWarrantiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" abstract="true" name="UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAnnuityContractsMember" abstract="true" name="DefinedBenefitPlanAnnuityContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupMember" abstract="true" name="UKBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A1.500NotesDue2025Member" abstract="true" name="A1.500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GlobalFacilityMember" abstract="true" name="GlobalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleJointVentureMember" abstract="true" name="GermanPharmaceuticalWholesaleJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" abstract="true" name="CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" abstract="true" name="PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" abstract="false" name="EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TreasuryStockPolicyTextBlock" abstract="false" name="TreasuryStockPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_HazardousSubstanceSites" abstract="false" name="HazardousSubstanceSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:positiveIntegerItemType"/>
  <xs:element id="mck_LossContingencyNumberofRelators" abstract="false" name="LossContingencyNumberofRelators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearThree" abstract="false" name="LeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFour" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFour" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EvanstonPolicePensionFundv.McKessonCorporationMember" abstract="true" name="EvanstonPolicePensionFundv.McKessonCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" abstract="false" name="SECSchedule1209ValuationAllowancesandReservesCurrentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseandOtherObligationsMember" abstract="true" name="LeaseandOtherObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ChangeHealthcareLLCChangeHealthcareMember" abstract="true" name="ChangeHealthcareLLCChangeHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EmployeeContributions" abstract="false" name="EmployeeContributions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" abstract="false" name="DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" abstract="false" name="WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfAdditionalDefendants" abstract="false" name="LossContingencyNumberOfAdditionalDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" abstract="true" name="TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" abstract="false" name="EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_CherokeeNationMember" abstract="true" name="CherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ExchangeOfferSharesExchanged" abstract="false" name="ExchangeOfferSharesExchanged" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_A1.625NotesDue2026Member" abstract="true" name="A1.625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A063EuroNotesDueAugust172021Member" abstract="true" name="A063EuroNotesDueAugust172021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseFebruary2022Member" abstract="true" name="AcceleratedShareRepurchaseFebruary2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IndividualClaimantMember" abstract="true" name="IndividualClaimantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" abstract="true" name="PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitDiscreteItems" abstract="false" name="IncomeTaxExpenseBenefitDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" abstract="true" name="KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" abstract="false" name="RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SecondPartOfPayContributionMember" abstract="false" name="SecondPartOfPayContributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" abstract="false" name="EffectiveIncomeTaxRateReconciliationLitigationAndClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuarantorObligationsPeriod" abstract="false" name="GuarantorObligationsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_LossContingencyNumberofStatesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberofStatesFiledOnBehalfOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InsuranceCoverageLitigationMember" abstract="true" name="InsuranceCoverageLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" abstract="true" name="UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" abstract="true" name="FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SupplierIncentivesPolicyPolicyTextBlock" abstract="false" name="SupplierIncentivesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_RetailPharmacyReportingUnitMember" abstract="true" name="RetailPharmacyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" abstract="false" name="PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" abstract="false" name="CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_DistributorsMember" abstract="true" name="DistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" abstract="true" name="UKBusinessesDisposalGroupAndAustrianBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NorwegianPublicServicePensionFundSPKMember" abstract="true" name="NorwegianPublicServicePensionFundSPKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentCarryingAmount" abstract="false" name="EquityMethodInvestmentCarryingAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedContributionPlanMatchingAxis" abstract="true" name="DefinedContributionPlanMatchingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mck_DefinedContributionPlanMatchingDomain" abstract="true" name="DefinedContributionPlanMatchingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SettlingGovernmentalEntitiesMember" abstract="true" name="SettlingGovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitValueOfCashAndCashEquivalents" abstract="false" name="UnitValueOfCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_RestructuringPlanRemoteWorkTransitioningMember" abstract="true" name="RestructuringPlanRemoteWorkTransitioningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentTransactionCostsIncurred" abstract="false" name="EquityMethodInvestmentTransactionCostsIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" abstract="true" name="UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesReceived" abstract="false" name="LossContingencyClassActionNumberofFaxesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OpenMarketTransactionsMember" abstract="true" name="OpenMarketTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" abstract="false" name="LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_AmortizationOfLossOnDerivativeTerm" abstract="false" name="AmortizationOfLossOnDerivativeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_A3.125NotesDue2029Member" abstract="true" name="A3.125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" abstract="false" name="NoncontrollingInterestDecreaseFromReclassificationToLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_U.S.PharmaceuticalandSpecialtySolutionsMember" abstract="true" name="U.S.PharmaceuticalandSpecialtySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InternallyDevelopedSoftwareMember" abstract="true" name="InternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TenderOfferNotesMember" abstract="true" name="TenderOfferNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StockExchangedDuringPeriodShares" abstract="false" name="StockExchangedDuringPeriodShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" abstract="false" name="PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StateOfWashingtonAndSubdivisionsMember" abstract="true" name="StateOfWashingtonAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" abstract="false" name="LossContingencyClassActionNumberofFaxesRemainingintheClass" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" abstract="false" name="AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RestructuringImpairmentandOtherRelatedCharges" abstract="false" name="RestructuringImpairmentandOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearTwo" abstract="false" name="GuaranteeObligationsExposureExpiringinYearTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RealPropertyMember" abstract="true" name="RealPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" abstract="false" name="IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A130NotesDueAugust152026Member" abstract="true" name="A130NotesDueAugust152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ExchangeOfferSharesDistributed" abstract="false" name="ExchangeOfferSharesDistributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" abstract="true" name="ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" abstract="true" name="StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" abstract="false" name="LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_NewYorkOpioidTaxSurchargeMember" abstract="true" name="NewYorkOpioidTaxSurchargeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DataRelatedtoRSUActivityTableTextBlock" abstract="false" name="DataRelatedtoRSUActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NativeAmericanTribesOtherThanCherokeeNationMember" abstract="true" name="NativeAmericanTribesOtherThanCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MultiemployerPlanFundedStatusPercentage" abstract="false" name="MultiemployerPlanFundedStatusPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_November2018CrossCurrencySwapsMember" abstract="true" name="November2018CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AccruedShareRepurchases" abstract="false" name="AccruedShareRepurchases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" abstract="true" name="ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsMember" abstract="true" name="PrescriptionTechnologySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EnvironmentalLitigationMember" abstract="true" name="EnvironmentalLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" abstract="false" name="DefinedBenefitPlanBenefitObligationsExpensesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" abstract="false" name="TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_GrossProfitNetofExpensesIncludingOtherIncome" abstract="false" name="GrossProfitNetofExpensesIncludingOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" abstract="false" name="DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" abstract="false" name="IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FinancialGuaranteesAndWarrantiesTextBlock" abstract="false" name="FinancialGuaranteesAndWarrantiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" abstract="true" name="ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementInstallmentPaymentsTerm" abstract="false" name="LossContingencySettlementInstallmentPaymentsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_DefinedBenefitPlanPlanAssetsExpensesPaid" abstract="false" name="DefinedBenefitPlanPlanAssetsExpensesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeparationofChangeHealthcareJVMember" abstract="true" name="SeparationofChangeHealthcareJVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearFive" abstract="false" name="LeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" abstract="true" name="UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" abstract="false" name="LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" abstract="false" name="AssetsForPlanBenefitsDefinedBenefitPlanCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="LeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NumberofSitesSelectedforPreferredRemedy" abstract="false" name="NumberofSitesSelectedforPreferredRemedy" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" abstract="false" name="ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TenLargestCustomersMember" abstract="true" name="TenLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" abstract="false" name="DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NotesDueNovember302020Member" abstract="true" name="NotesDueNovember302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" abstract="false" name="EquityMethodInvestmentsReversalOfDeferredTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EuropeanAssetsHeldForSaleMember" abstract="true" name="EuropeanAssetsHeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" abstract="true" name="CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestsMaximumRedemptionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DeferredTaxAssetLitigationAndClaims" abstract="false" name="DeferredTaxAssetLitigationAndClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TerminationofU.SDefinedBenefitPensionPlanMember" abstract="true" name="TerminationofU.SDefinedBenefitPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualProvisionAfterTax" abstract="false" name="LossContingencyAccrualProvisionAfterTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanSettlementPlanParticipants" abstract="false" name="DefinedBenefitPlanSettlementPlanParticipants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" abstract="true" name="GuaranteeObligationsInventoryRepurchaseGuaranteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" abstract="false" name="LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SettlementofExecutiveRetirementBenefitsMember" abstract="true" name="SettlementofExecutiveRetirementBenefitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_PerformancebasedStockUnitsMember" abstract="true" name="PerformancebasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_WalgreensBootsAllianceJointVentureMember" abstract="true" name="WalgreensBootsAllianceJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StockExchangedDuringPeriodValue" abstract="false" name="StockExchangedDuringPeriodValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfRelators" abstract="false" name="LossContingencyNumberOfRelators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMay2019Member" abstract="true" name="AcceleratedShareRepurchaseMay2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ServicesBusinessMember" abstract="true" name="ServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePriceIncrease" abstract="false" name="NoncontrollingInterestsPutRightExercisePriceIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" abstract="false" name="CapitalizedSoftwareHeldforInternalUseUsefulLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_ConsolidatedActionsvSureScriptsLLCMember" abstract="true" name="ConsolidatedActionsvSureScriptsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsCustomersDebtMember" abstract="true" name="GuaranteeObligationsCustomersDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" abstract="false" name="DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFive" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" abstract="true" name="EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" abstract="true" name="UnitedStatesExRelPiacentileVAmgenIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentFairValueofStockAccepted" abstract="false" name="EquityMethodInvestmentFairValueofStockAccepted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" abstract="false" name="ValuationAllowancesAndReservesDeductionsWrittenOffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" abstract="true" name="ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SiteContingencyNumberofSites" abstract="false" name="SiteContingencyNumberofSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EquityMethodInvestmentStockAccepted" abstract="false" name="EquityMethodInvestmentStockAccepted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" abstract="false" name="DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearOne" abstract="false" name="GuaranteeObligationsExposureExpiringinYearOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofCitiesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberofCitiesFiledOnBehalfOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" abstract="true" name="EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DistributionandRetailBusinessMember" abstract="true" name="DistributionandRetailBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EUBusinessesDisposalGroupMember" abstract="true" name="EUBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_RangeOneMember" abstract="false" name="RangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GovernmentalEntitiesMember" abstract="true" name="GovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_LossContingencyNumberofFormerOfficers" abstract="false" name="LossContingencyNumberofFormerOfficers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_OtherNoncurrentAssetsLiabilitiesMember" abstract="true" name="OtherNoncurrentAssetsLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfEligibleStates" abstract="false" name="LossContingencyNumberOfEligibleStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_OtherAllowancesMember" abstract="false" name="OtherAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfAlabamaMember" abstract="true" name="StateOfAlabamaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RexallHealthMember" abstract="true" name="RexallHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" abstract="true" name="TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EquityMethodInvestmentStockAcceptedAverageCost" abstract="false" name="EquityMethodInvestmentStockAcceptedAverageCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_OpioidStewardshipActNewYorkAnnualSurcharge" abstract="false" name="OpioidStewardshipActNewYorkAnnualSurcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EuropeanBusinessesDisposalGroupMember" abstract="true" name="EuropeanBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RangeTwoMember" abstract="false" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsSegmentMember" abstract="true" name="PrescriptionTechnologySolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_HeldforSalePolicyTextBlock" abstract="false" name="HeldforSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_DefinedBenefitPlanOtherFundsMember" abstract="true" name="DefinedBenefitPlanOtherFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A2013StockPlanMember" abstract="true" name="A2013StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ShareholderDerivativeActionMember" abstract="true" name="ShareholderDerivativeActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AccountsReceivableCustomerAccountsGross" abstract="false" name="AccountsReceivableCustomerAccountsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" abstract="true" name="EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" abstract="false" name="OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_LessorLeasePaymentstobeReceived" abstract="false" name="LessorLeasePaymentstobeReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InsuranceProgramsPolicyTextBlock" abstract="false" name="InsuranceProgramsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearFour" abstract="false" name="LeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" abstract="false" name="DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SupplierReservesPolicyTextBlock" abstract="false" name="SupplierReservesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDue" abstract="false" name="LeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>mck-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eedc7054-d2b4-49fb-b502-fc8a725b4aca,g:dd1fa40e-8b61-4831-9194-c55f1729d4f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f2bc608c-6b6e-4dc4-b369-b464f108b9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cbf5bf28-4e6e-4f27-8762-38c4fb0a0673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f2bc608c-6b6e-4dc4-b369-b464f108b9d2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cbf5bf28-4e6e-4f27-8762-38c4fb0a0673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23c2f740-3964-4055-9fae-fca215e02bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f2bc608c-6b6e-4dc4-b369-b464f108b9d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23c2f740-3964-4055-9fae-fca215e02bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650eafe0-d21e-4782-8434-dbfc8ef9c29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2125f3a6-d53a-417c-b9e4-39b6ea42a713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650eafe0-d21e-4782-8434-dbfc8ef9c29d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2125f3a6-d53a-417c-b9e4-39b6ea42a713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_87a6d473-7d6c-451a-8498-a311c3074d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650eafe0-d21e-4782-8434-dbfc8ef9c29d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_87a6d473-7d6c-451a-8498-a311c3074d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6272d5b9-36de-4742-9719-05fb1710c767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650eafe0-d21e-4782-8434-dbfc8ef9c29d" xlink:to="loc_us-gaap_OperatingIncomeLoss_6272d5b9-36de-4742-9719-05fb1710c767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_571ab4ce-7f35-43e2-aeae-397ef7597598" xlink:href="mck-20220331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650eafe0-d21e-4782-8434-dbfc8ef9c29d" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_571ab4ce-7f35-43e2-aeae-397ef7597598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_367e17ee-1292-4d3e-a64c-c8980b01841d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650eafe0-d21e-4782-8434-dbfc8ef9c29d" xlink:to="loc_us-gaap_InterestExpense_367e17ee-1292-4d3e-a64c-c8980b01841d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_330e210a-edc1-426c-a8ec-be678facce22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_2025e0e5-f4ec-4020-9012-fbf2ca983fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_330e210a-edc1-426c-a8ec-be678facce22" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_2025e0e5-f4ec-4020-9012-fbf2ca983fb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_5494c9aa-dfd7-4c31-bd59-b6778aa9bfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_330e210a-edc1-426c-a8ec-be678facce22" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_5494c9aa-dfd7-4c31-bd59-b6778aa9bfd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9384b32b-5995-4acc-9b64-c9c0c9ead77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_84968c3a-f56a-4c19-8d99-b77c6f278114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9384b32b-5995-4acc-9b64-c9c0c9ead77f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_84968c3a-f56a-4c19-8d99-b77c6f278114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_a565b294-96e3-471e-b3e5-7096ec14cd76" xlink:href="mck-20220331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9384b32b-5995-4acc-9b64-c9c0c9ead77f" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_a565b294-96e3-471e-b3e5-7096ec14cd76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bd006270-3788-41d7-8c4f-badc52aaa97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9384b32b-5995-4acc-9b64-c9c0c9ead77f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_bd006270-3788-41d7-8c4f-badc52aaa97f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d3a99690-8e1b-44ab-a4e3-522d2b03e97a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9384b32b-5995-4acc-9b64-c9c0c9ead77f" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d3a99690-8e1b-44ab-a4e3-522d2b03e97a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_63c2e6d8-c467-4c4f-84d2-70c7be65e911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a68789fa-cd82-4ca8-b550-3342ab99ecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_63c2e6d8-c467-4c4f-84d2-70c7be65e911" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a68789fa-cd82-4ca8-b550-3342ab99ecb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_41b59dce-9cd0-44d4-9485-c06fe90dc54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_63c2e6d8-c467-4c4f-84d2-70c7be65e911" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_41b59dce-9cd0-44d4-9485-c06fe90dc54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_56711d1e-21b2-4972-a13f-a406b400b27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_588305cf-b9b8-4fa6-84e1-7347dd325d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_56711d1e-21b2-4972-a13f-a406b400b27f" xlink:to="loc_us-gaap_ProfitLoss_588305cf-b9b8-4fa6-84e1-7347dd325d98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4ddaa0a3-128d-41aa-9559-ab190ebc7e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_56711d1e-21b2-4972-a13f-a406b400b27f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4ddaa0a3-128d-41aa-9559-ab190ebc7e9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e20cc583-2b1a-4819-8263-aa276f0e0e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f33c8e57-b027-4b13-a3b1-dbfee54cff23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e20cc583-2b1a-4819-8263-aa276f0e0e01" xlink:to="loc_us-gaap_GrossProfit_f33c8e57-b027-4b13-a3b1-dbfee54cff23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_bea777ba-93bf-47e3-9973-8447ea18feda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e20cc583-2b1a-4819-8263-aa276f0e0e01" xlink:to="loc_us-gaap_OperatingExpenses_bea777ba-93bf-47e3-9973-8447ea18feda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1c30f577-f3a4-4999-be89-df3989f7120e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c9c35716-bf81-4662-9ec8-34a3f3a975a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1c30f577-f3a4-4999-be89-df3989f7120e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c9c35716-bf81-4662-9ec8-34a3f3a975a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac0865b5-d546-47a5-83df-bc4cf802d6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1c30f577-f3a4-4999-be89-df3989f7120e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ac0865b5-d546-47a5-83df-bc4cf802d6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_13a80e47-0d58-4dd8-9813-e97855099eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_af9f944d-30de-409d-901a-77acbf179e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_13a80e47-0d58-4dd8-9813-e97855099eaa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_af9f944d-30de-409d-901a-77acbf179e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_d2b11255-9804-4264-bbcb-e4ca59556a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_13a80e47-0d58-4dd8-9813-e97855099eaa" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_d2b11255-9804-4264-bbcb-e4ca59556a69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ba80b238-9f77-464d-bafd-18f3d44c0b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_432e6758-49e2-45db-b75b-12e9b3e82222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ba80b238-9f77-464d-bafd-18f3d44c0b0f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_432e6758-49e2-45db-b75b-12e9b3e82222" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ccc4c52-0f95-4bf3-a785-538e96bc72e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ba80b238-9f77-464d-bafd-18f3d44c0b0f" xlink:to="loc_us-gaap_ProfitLoss_6ccc4c52-0f95-4bf3-a785-538e96bc72e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_08a7078f-3787-4152-a78a-8fdfaea2ef2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8b07c5d9-c793-4479-bef8-0c55a454c1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_08a7078f-3787-4152-a78a-8fdfaea2ef2d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8b07c5d9-c793-4479-bef8-0c55a454c1c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_53f4265f-aaeb-4bc8-9d5f-59b171fbeeee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_08a7078f-3787-4152-a78a-8fdfaea2ef2d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_53f4265f-aaeb-4bc8-9d5f-59b171fbeeee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_774c495b-c5c7-4d04-a6bd-ad6fc98a1312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_872573c5-973e-4632-992d-46dabded1549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_774c495b-c5c7-4d04-a6bd-ad6fc98a1312" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_872573c5-973e-4632-992d-46dabded1549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4eeca618-f2ad-4414-ac93-44eb7d236a50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_774c495b-c5c7-4d04-a6bd-ad6fc98a1312" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4eeca618-f2ad-4414-ac93-44eb7d236a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c80333b6-0751-49f8-b521-f19f1fa94987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_774c495b-c5c7-4d04-a6bd-ad6fc98a1312" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c80333b6-0751-49f8-b521-f19f1fa94987" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_436d97d1-2516-42ae-89aa-aa753076d07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_436d97d1-2516-42ae-89aa-aa753076d07a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c88c3a7f-10de-483c-b506-5d595e4126ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_LiabilitiesCurrent_c88c3a7f-10de-483c-b506-5d595e4126ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2a6cbc83-145a-44d7-9826-1564c7d48110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2a6cbc83-145a-44d7-9826-1564c7d48110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4fb6f1f0-7c1b-4612-aad2-02b310263352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4fb6f1f0-7c1b-4612-aad2-02b310263352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_3d8e2d23-781f-4a61-b017-94ad628e7c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_3d8e2d23-781f-4a61-b017-94ad628e7c18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bc9c6a03-09a8-42c7-aebe-3d94a7c8f01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bc9c6a03-09a8-42c7-aebe-3d94a7c8f01d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e9929ce7-edf2-468e-b3a4-d153d118909e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e9929ce7-edf2-468e-b3a4-d153d118909e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_a0fe996c-2fd2-49ae-944f-bbd24367406a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_a0fe996c-2fd2-49ae-944f-bbd24367406a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_685632ce-e372-4a74-adb1-e8c134069a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c0c205e-f703-4787-ae91-b993c5a00983" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_685632ce-e372-4a74-adb1-e8c134069a66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d19b1e16-1d81-4403-b27e-de790e386643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0c4006fa-528c-4fcd-b475-5ece1ba25c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d19b1e16-1d81-4403-b27e-de790e386643" xlink:to="loc_us-gaap_AccountsPayableCurrent_0c4006fa-528c-4fcd-b475-5ece1ba25c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c6121443-3ffd-4d09-9805-07b43cc6561e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d19b1e16-1d81-4403-b27e-de790e386643" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c6121443-3ffd-4d09-9805-07b43cc6561e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6780d420-b00b-467a-b8ea-a1bb2c3f82e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d19b1e16-1d81-4403-b27e-de790e386643" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6780d420-b00b-467a-b8ea-a1bb2c3f82e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8da65da8-d030-4da8-877b-d7bfdd6c7624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d19b1e16-1d81-4403-b27e-de790e386643" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_8da65da8-d030-4da8-877b-d7bfdd6c7624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c72d74ab-3885-42b1-96b5-480a485c66d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d19b1e16-1d81-4403-b27e-de790e386643" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c72d74ab-3885-42b1-96b5-480a485c66d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c3929b00-81fb-47a7-95e0-9e9689e2e914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7cece09f-f5fe-4de2-8099-18de8f7a3924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3929b00-81fb-47a7-95e0-9e9689e2e914" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7cece09f-f5fe-4de2-8099-18de8f7a3924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7129a94b-2e36-41e2-9df3-3c34ec2f38f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3929b00-81fb-47a7-95e0-9e9689e2e914" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7129a94b-2e36-41e2-9df3-3c34ec2f38f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5400e0ac-9cf5-49c1-a4d1-59e8adc04c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3929b00-81fb-47a7-95e0-9e9689e2e914" xlink:to="loc_us-gaap_InventoryNet_5400e0ac-9cf5-49c1-a4d1-59e8adc04c79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ee67c51a-7866-4f03-8d4d-dbc2ebb3db41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3929b00-81fb-47a7-95e0-9e9689e2e914" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ee67c51a-7866-4f03-8d4d-dbc2ebb3db41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_cc43ab62-381d-4434-bd40-bad3b17bd332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3929b00-81fb-47a7-95e0-9e9689e2e914" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_cc43ab62-381d-4434-bd40-bad3b17bd332" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b965835e-b26d-47ca-84c5-b00fbeb1f7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8e021fc0-dd0a-4581-83b7-b8ee29840a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b965835e-b26d-47ca-84c5-b00fbeb1f7c0" xlink:to="loc_us-gaap_StockholdersEquity_8e021fc0-dd0a-4581-83b7-b8ee29840a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5c111835-490f-4cf4-a650-3342a6add061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b965835e-b26d-47ca-84c5-b00fbeb1f7c0" xlink:to="loc_us-gaap_MinorityInterest_5c111835-490f-4cf4-a650-3342a6add061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_6d132f4b-506b-4efe-b864-0df38e02e25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:to="loc_us-gaap_TreasuryStockValue_6d132f4b-506b-4efe-b864-0df38e02e25f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_61327b46-eaab-489e-b49f-b993601a90ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:to="loc_us-gaap_PreferredStockValue_61327b46-eaab-489e-b49f-b993601a90ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3c5d2dce-556f-4704-8143-bc232170fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3c5d2dce-556f-4704-8143-bc232170fca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1599ac8-1a7d-4568-a92a-a69b1a6e2752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1599ac8-1a7d-4568-a92a-a69b1a6e2752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7d9578b0-45dc-4981-8554-ce175c45bc78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7d9578b0-45dc-4981-8554-ce175c45bc78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019670be-1a66-4d97-a02e-364ba0721ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c7ff0403-677c-4434-aec0-041b35bdfaa8" xlink:to="loc_us-gaap_CommonStockValue_019670be-1a66-4d97-a02e-364ba0721ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a18b129c-9461-46de-84c1-7f83e6dafcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:to="loc_us-gaap_AssetsCurrent_a18b129c-9461-46de-84c1-7f83e6dafcaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_af29c060-a8cd-4dee-b59e-6f2e1e791744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_af29c060-a8cd-4dee-b59e-6f2e1e791744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0177bc71-74c3-48db-92dd-aa10f6500a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:to="loc_us-gaap_Goodwill_0177bc71-74c3-48db-92dd-aa10f6500a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_45c44421-d9bb-48ec-8382-c7c55510a9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_45c44421-d9bb-48ec-8382-c7c55510a9ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d2a3e67e-ad8d-472e-976e-68661d095942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d2a3e67e-ad8d-472e-976e-68661d095942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_59f3fe98-b37b-4976-9bea-a8a276ef97f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8411419-93aa-45cf-b87f-e2fa3a3d3654" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_59f3fe98-b37b-4976-9bea-a8a276ef97f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d4a0d54-c91f-4558-bc9f-68646b088703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99957c5e-6aab-48d3-a7be-cb046c22e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d4a0d54-c91f-4558-bc9f-68646b088703" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99957c5e-6aab-48d3-a7be-cb046c22e5f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e46d4793-a699-4e4f-ac9b-a7242ced68c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d4a0d54-c91f-4558-bc9f-68646b088703" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e46d4793-a699-4e4f-ac9b-a7242ced68c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_84ea473f-6cc2-48ee-abdf-5b4f8694982d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d4a0d54-c91f-4558-bc9f-68646b088703" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_84ea473f-6cc2-48ee-abdf-5b4f8694982d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c511505b-4478-44f0-9d40-284d7fb45206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d4a0d54-c91f-4558-bc9f-68646b088703" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c511505b-4478-44f0-9d40-284d7fb45206" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_6407a70b-214f-4a8e-bb23-229fcb53543f" xlink:href="mck-20220331.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d4a0d54-c91f-4558-bc9f-68646b088703" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_6407a70b-214f-4a8e-bb23-229fcb53543f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_ef29adbc-1083-4f15-be9c-b5aef79e0fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_ef29adbc-1083-4f15-be9c-b5aef79e0fcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d3427a0f-7e76-44a5-a27f-880e7cafa6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d3427a0f-7e76-44a5-a27f-880e7cafa6fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e0aba752-83df-40f7-9d5b-98b281a88a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e0aba752-83df-40f7-9d5b-98b281a88a64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_d84ee0cf-787b-4bb1-b84a-941e6594b00a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_d84ee0cf-787b-4bb1-b84a-941e6594b00a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0ff42dc9-ffed-499a-887e-900425db1391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0ff42dc9-ffed-499a-887e-900425db1391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_5295e961-2a30-4fe1-ac9f-e80c8b9868de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_5295e961-2a30-4fe1-ac9f-e80c8b9868de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1a6c16f2-d6ed-4e6a-9c39-704474c0089f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1a6c16f2-d6ed-4e6a-9c39-704474c0089f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_50b1ee0a-4b46-40be-9d33-4df4f5f727de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_50b1ee0a-4b46-40be-9d33-4df4f5f727de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6c243892-4028-48b1-8ade-6f326774b5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6c243892-4028-48b1-8ade-6f326774b5eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_5a7b6d6e-d82d-4ab5-b2f2-29dcdceace2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5d8d173-ce5f-44fc-a531-870f68720cba" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_5a7b6d6e-d82d-4ab5-b2f2-29dcdceace2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_56c9e303-f5a3-43af-b387-5212df331d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_42703d45-75b7-4bcf-8757-035f3b8c8df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_56c9e303-f5a3-43af-b387-5212df331d92" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_42703d45-75b7-4bcf-8757-035f3b8c8df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_bb50c220-fc52-47a3-b800-a2773bd846c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_56c9e303-f5a3-43af-b387-5212df331d92" xlink:to="loc_us-gaap_RestrictedCashCurrent_bb50c220-fc52-47a3-b800-a2773bd846c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3289e33d-776d-4b07-a2db-ddd7e03de390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_90d2f461-2dd4-4881-9938-6a5c428863b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3289e33d-776d-4b07-a2db-ddd7e03de390" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_90d2f461-2dd4-4881-9938-6a5c428863b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_b4ce2450-4fbb-48a6-bda2-bbe4e15929c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3289e33d-776d-4b07-a2db-ddd7e03de390" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_b4ce2450-4fbb-48a6-bda2-bbe4e15929c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e58e5f1a-08e1-4931-8b80-bd566963019b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3289e33d-776d-4b07-a2db-ddd7e03de390" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e58e5f1a-08e1-4931-8b80-bd566963019b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129153f7-1d86-4b29-bab8-d3b2b7e44bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3289e33d-776d-4b07-a2db-ddd7e03de390" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_129153f7-1d86-4b29-bab8-d3b2b7e44bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fbdc56cf-676c-425e-8701-95be41f00a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3289e33d-776d-4b07-a2db-ddd7e03de390" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fbdc56cf-676c-425e-8701-95be41f00a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_3ba4460a-0357-4625-b153-84bcf067329f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_3ba4460a-0357-4625-b153-84bcf067329f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_340d43d6-ba15-4625-babc-ff3198d050a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_340d43d6-ba15-4625-babc-ff3198d050a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3ec13919-66af-4131-a309-3f9ea76b4013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_3ec13919-66af-4131-a309-3f9ea76b4013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_6eb4efd4-6ca3-4290-8997-4ca405125ccf" xlink:href="mck-20220331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_6eb4efd4-6ca3-4290-8997-4ca405125ccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_f5217d79-35bf-4f8c-a385-354899f43592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_f5217d79-35bf-4f8c-a385-354899f43592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_8da2bda8-779f-406d-bbba-9e993fac2579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_8da2bda8-779f-406d-bbba-9e993fac2579" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3036f1ef-3db7-4e50-a4e2-5e6b74f4b65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3036f1ef-3db7-4e50-a4e2-5e6b74f4b65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3d183f5a-b014-4a50-b17f-24c574c73d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3d183f5a-b014-4a50-b17f-24c574c73d75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_da39522a-5e7a-4dc1-b251-6655a63559f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_da39522a-5e7a-4dc1-b251-6655a63559f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ab355ec8-340a-4899-9b1e-87235815501a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_Depreciation_ab355ec8-340a-4899-9b1e-87235815501a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e8efdb5d-e104-4ccf-89f0-de0d4fef91db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e8efdb5d-e104-4ccf-89f0-de0d4fef91db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_3bba86cf-07da-419e-ab4b-c6c07377f7d0" xlink:href="mck-20220331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_3bba86cf-07da-419e-ab4b-c6c07377f7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_ac7f0500-45b4-42fb-93c4-edf8eeef6111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_ac7f0500-45b4-42fb-93c4-edf8eeef6111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_c6142ab4-5d61-4d64-b5fa-df31a04514e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_AdjustmentForAmortization_c6142ab4-5d61-4d64-b5fa-df31a04514e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9f6efd34-8d43-43c0-9a39-7b0a62c42117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_ProfitLoss_9f6efd34-8d43-43c0-9a39-7b0a62c42117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_dbfe3fb7-5d20-4a51-863a-48271f68a2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_OperatingLeaseExpense_dbfe3fb7-5d20-4a51-863a-48271f68a2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1515774c-245b-4bc0-b0f6-8c16c0403b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1515774c-245b-4bc0-b0f6-8c16c0403b78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9a1470db-5684-44ad-b5f0-300e38aa9e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_77be16c8-2645-4b7a-83cd-805c506629de" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9a1470db-5684-44ad-b5f0-300e38aa9e21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_e07ea166-b881-4ee4-8987-ed333b9f3be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_fdb38236-a9da-4744-86e7-331b2be88595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_e07ea166-b881-4ee4-8987-ed333b9f3be4" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_fdb38236-a9da-4744-86e7-331b2be88595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1e80f09c-488d-42b7-b469-414cd1f031d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_e07ea166-b881-4ee4-8987-ed333b9f3be4" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1e80f09c-488d-42b7-b469-414cd1f031d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_e77abb3b-7b66-4715-b048-10c72dffa716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross_c94e7620-60f3-485a-a23b-84e357573a5d" xlink:href="mck-20220331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_e77abb3b-7b66-4715-b048-10c72dffa716" xlink:to="loc_mck_AccountsReceivableCustomerAccountsGross_c94e7620-60f3-485a-a23b-84e357573a5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_6ad208be-13e9-478c-a450-38dc8395063a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_e77abb3b-7b66-4715-b048-10c72dffa716" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_6ad208be-13e9-478c-a450-38dc8395063a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_890b44aa-4fa6-4226-8fd9-c6b451a62006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_c16ebe06-0da4-4229-aa89-8ddb44f8205a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_890b44aa-4fa6-4226-8fd9-c6b451a62006" xlink:to="loc_us-gaap_ConstructionInProgressGross_c16ebe06-0da4-4229-aa89-8ddb44f8205a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_7623501c-6684-4933-8c40-ad3fc91c542c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_890b44aa-4fa6-4226-8fd9-c6b451a62006" xlink:to="loc_us-gaap_Land_7623501c-6684-4933-8c40-ad3fc91c542c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther_e6c05043-9b60-4893-aa28-5c2aebdb2b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_890b44aa-4fa6-4226-8fd9-c6b451a62006" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOther_e6c05043-9b60-4893-aa28-5c2aebdb2b08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_5386a895-8d4c-48e9-bec1-324a3a8afa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_890b44aa-4fa6-4226-8fd9-c6b451a62006" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_5386a895-8d4c-48e9-bec1-324a3a8afa3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5e33cdb5-b1ce-4138-b9ac-fa995ab48200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_368692a1-762b-49fc-987a-b6215245c24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5e33cdb5-b1ce-4138-b9ac-fa995ab48200" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_368692a1-762b-49fc-987a-b6215245c24b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f4358b04-7cf1-4adb-a947-83321146c41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5e33cdb5-b1ce-4138-b9ac-fa995ab48200" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f4358b04-7cf1-4adb-a947-83321146c41d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_a2ddad59-ec3d-49d6-9555-a5f314bc3d1c" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_a2ddad59-ec3d-49d6-9555-a5f314bc3d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_28bcee9e-a1e1-4197-99e2-671ed95a3e19" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_28bcee9e-a1e1-4197-99e2-671ed95a3e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_5354980b-dc67-4468-a5e1-edfdb6835d0b" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_5354980b-dc67-4468-a5e1-edfdb6835d0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_1b9b62cb-ba09-4c93-bf46-e3c2fe5d1fe5" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_1b9b62cb-ba09-4c93-bf46-e3c2fe5d1fe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_f0225c5a-a43c-483b-b092-a6464f767f2a" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_f0225c5a-a43c-483b-b092-a6464f767f2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_b22e5f9a-7629-4eac-a600-0a5f233dcd2d" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_b22e5f9a-7629-4eac-a600-0a5f233dcd2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_235eeb87-1fd3-4a64-988e-46a818e41be9" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_235eeb87-1fd3-4a64-988e-46a818e41be9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_4fb1eeb5-0109-477a-9b2f-e6c4ee1dcaa0" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ba9955c-fc50-4a5f-81f2-85dd7c5a7c11" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_4fb1eeb5-0109-477a-9b2f-e6c4ee1dcaa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_b0d3affc-1b2e-4710-bfd6-0e457ed3abe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_b0d3affc-1b2e-4710-bfd6-0e457ed3abe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_5e2e4bc3-e0bd-4d1d-8d5a-4918f1f2e235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_5e2e4bc3-e0bd-4d1d-8d5a-4918f1f2e235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_8c8b23fd-117d-4a8c-b976-ec3d26e7997b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_8c8b23fd-117d-4a8c-b976-ec3d26e7997b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_14b84dd3-c390-4d25-a358-3f5a5f2be3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_14b84dd3-c390-4d25-a358-3f5a5f2be3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_a81c0e7f-7448-4d02-9fda-e1f12ba08211" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_a81c0e7f-7448-4d02-9fda-e1f12ba08211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_04e0c77e-af78-41d6-b5b7-1576386334a8" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_04e0c77e-af78-41d6-b5b7-1576386334a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_5ecb7ed0-1343-4521-b8ec-c9b1a3eff36a" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_5ecb7ed0-1343-4521-b8ec-c9b1a3eff36a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_0845b6c2-09d0-4d7a-adc8-986e2f72ca36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_0845b6c2-09d0-4d7a-adc8-986e2f72ca36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a7bfb45f-956d-4d6f-87e6-010647c66224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_be8f144e-2d7b-4ea5-a5d4-4e25863982ac" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a7bfb45f-956d-4d6f-87e6-010647c66224" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2b38d6f3-7980-4384-8975-f815c5ad27d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_a42cb246-1c22-4ae6-8618-ebdc3c032ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_2b38d6f3-7980-4384-8975-f815c5ad27d5" xlink:to="loc_us-gaap_SeveranceCosts1_a42cb246-1c22-4ae6-8618-ebdc3c032ef3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_f00e6568-8486-493a-8ae7-9195acf7e3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_2b38d6f3-7980-4384-8975-f815c5ad27d5" xlink:to="loc_us-gaap_BusinessExitCosts1_f00e6568-8486-493a-8ae7-9195acf7e3a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_8f7f3b16-2778-456d-9afa-511b8e5d80d7" xlink:href="mck-20220331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_2b38d6f3-7980-4384-8975-f815c5ad27d5" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_8f7f3b16-2778-456d-9afa-511b8e5d80d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0f812566-0825-4ef9-9a4d-d3249b14642b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_c03c060f-0c03-421b-915c-9175b7456a2a" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0f812566-0825-4ef9-9a4d-d3249b14642b" xlink:to="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_c03c060f-0c03-421b-915c-9175b7456a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_d0dc5aff-60a3-4f9e-8d23-45eaad7b150f" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0f812566-0825-4ef9-9a4d-d3249b14642b" xlink:to="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_d0dc5aff-60a3-4f9e-8d23-45eaad7b150f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount_3f543855-0cc2-4480-9bd9-21b0fb8bbeda" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0f812566-0825-4ef9-9a4d-d3249b14642b" xlink:to="loc_mck_EquityMethodInvestmentCarryingAmount_3f543855-0cc2-4480-9bd9-21b0fb8bbeda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_34857462-f08e-469e-9834-a05caefd4e3c" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0f812566-0825-4ef9-9a4d-d3249b14642b" xlink:to="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_34857462-f08e-469e-9834-a05caefd4e3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_eb875623-755c-4163-a14f-fe57e132b659" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0f812566-0825-4ef9-9a4d-d3249b14642b" xlink:to="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_eb875623-755c-4163-a14f-fe57e132b659" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_b2bfb38f-4ba5-47f3-9c5d-7073fe5d0d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ea26981d-6c4e-42d6-a259-f43ecf2cd191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_b2bfb38f-4ba5-47f3-9c5d-7073fe5d0d1e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ea26981d-6c4e-42d6-a259-f43ecf2cd191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4651c417-5c17-46e1-b8d7-355922cf4164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_b2bfb38f-4ba5-47f3-9c5d-7073fe5d0d1e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4651c417-5c17-46e1-b8d7-355922cf4164" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNetScheduleofOtherIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_402ce4b1-fd32-4552-a275-41d553685205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a3e59aa4-dbaa-4494-b7f6-57fb1a2c3791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_402ce4b1-fd32-4552-a275-41d553685205" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a3e59aa4-dbaa-4494-b7f6-57fb1a2c3791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_809f35e8-621f-43d0-ac6c-61e0941e284f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_402ce4b1-fd32-4552-a275-41d553685205" xlink:to="loc_us-gaap_InvestmentIncomeInterest_809f35e8-621f-43d0-ac6c-61e0941e284f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4bcf541c-bb81-4f58-a761-95b777c88de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_402ce4b1-fd32-4552-a275-41d553685205" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_4bcf541c-bb81-4f58-a761-95b777c88de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_cb5d2ddc-e2d2-4735-b737-e8ed791526af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_402ce4b1-fd32-4552-a275-41d553685205" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_cb5d2ddc-e2d2-4735-b737-e8ed791526af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ec12a2a0-1bf8-4e4a-91dc-579f4f928a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_402ce4b1-fd32-4552-a275-41d553685205" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ec12a2a0-1bf8-4e4a-91dc-579f4f928a63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_02059e7c-835b-472a-8bf1-4bbcdd226132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_38db1685-b338-4ad4-9121-eaa69bc18012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_02059e7c-835b-472a-8bf1-4bbcdd226132" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_38db1685-b338-4ad4-9121-eaa69bc18012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b7d3eb61-e808-4ac8-810e-ebd9650d7da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_02059e7c-835b-472a-8bf1-4bbcdd226132" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b7d3eb61-e808-4ac8-810e-ebd9650d7da7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_870deeb0-bc67-43fc-a7ec-030912dbeab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_efb88097-b8c7-4d8a-b3b8-5f54d973392b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_870deeb0-bc67-43fc-a7ec-030912dbeab7" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_efb88097-b8c7-4d8a-b3b8-5f54d973392b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_712df777-e5ba-485c-ae55-0c24490d79ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_870deeb0-bc67-43fc-a7ec-030912dbeab7" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_712df777-e5ba-485c-ae55-0c24490d79ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2d2f8b9f-e715-4be2-bf5e-b63db0559d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_870deeb0-bc67-43fc-a7ec-030912dbeab7" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2d2f8b9f-e715-4be2-bf5e-b63db0559d80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_743d782d-c176-493d-805f-300839c26328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_81d5249b-2dab-4ece-afd0-002e7c41ad14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_743d782d-c176-493d-805f-300839c26328" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_81d5249b-2dab-4ece-afd0-002e7c41ad14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2de3b8ab-abce-4b69-99b0-d006e045947e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_743d782d-c176-493d-805f-300839c26328" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2de3b8ab-abce-4b69-99b0-d006e045947e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_6b20ba2a-7c4b-400a-9e44-bc0ae552f697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_743d782d-c176-493d-805f-300839c26328" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_6b20ba2a-7c4b-400a-9e44-bc0ae552f697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0867ace5-df7e-4863-b682-10c92694e1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_359d70b2-1c18-40c7-b467-b3e3179294d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0867ace5-df7e-4863-b682-10c92694e1e0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_359d70b2-1c18-40c7-b467-b3e3179294d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1f810a9-acc2-4ef6-b739-c19c15e60521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0867ace5-df7e-4863-b682-10c92694e1e0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1f810a9-acc2-4ef6-b739-c19c15e60521" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_a639ce6e-661f-4a7d-81cf-8a9f0289f597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_a639ce6e-661f-4a7d-81cf-8a9f0289f597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_8285a1b2-3d57-48a9-8aab-0f53ad3b89c6" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_8285a1b2-3d57-48a9-8aab-0f53ad3b89c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7d96f53a-3d95-43d3-aa8b-877e77cb9580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7d96f53a-3d95-43d3-aa8b-877e77cb9580" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_56f89eed-73b5-429a-8b09-1c3d9afc0fec" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_56f89eed-73b5-429a-8b09-1c3d9afc0fec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_b34617d9-d0c0-49a1-8d9b-67de9933c52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_b34617d9-d0c0-49a1-8d9b-67de9933c52b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_44c7fd49-3e78-4804-87e4-f73375894822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_44c7fd49-3e78-4804-87e4-f73375894822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_45808fc8-396f-465a-8791-6b151e04a076" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_45808fc8-396f-465a-8791-6b151e04a076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a932e69e-bed1-4dee-b347-e617a6c8d382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a932e69e-bed1-4dee-b347-e617a6c8d382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_1bf91fb1-2c67-412a-b909-9f35083365b5" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_1bf91fb1-2c67-412a-b909-9f35083365b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_40b1517f-e57f-4d0e-b376-2e8ad754a61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1e9b8585-3fea-40d3-8b26-8eee76520a11" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_40b1517f-e57f-4d0e-b376-2e8ad754a61d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_e7cebf35-2a05-449b-b36f-672846fb3939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_e7cebf35-2a05-449b-b36f-672846fb3939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_0f6217fe-1833-4542-84ac-7174862556fa" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_0f6217fe-1833-4542-84ac-7174862556fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_5c2421b9-8368-4200-bc3b-fd5383b33ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_5c2421b9-8368-4200-bc3b-fd5383b33ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a85e0023-d26f-41e7-ab8d-daa2a7518941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a85e0023-d26f-41e7-ab8d-daa2a7518941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_bbacb789-b867-4078-a587-79e50383dca5" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_bbacb789-b867-4078-a587-79e50383dca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_45616d32-3f8b-4708-ad35-3b97e5e8b462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f130213c-c4f0-4978-94a6-09a4284bb98d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_45616d32-3f8b-4708-ad35-3b97e5e8b462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4a192146-097a-4141-8696-ef683e4bb2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6c2b7541-f236-492a-90cd-a2811bcfc09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4a192146-097a-4141-8696-ef683e4bb2c9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6c2b7541-f236-492a-90cd-a2811bcfc09f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5daa4ec2-cdf9-4b08-94af-f736acba27b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4a192146-097a-4141-8696-ef683e4bb2c9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5daa4ec2-cdf9-4b08-94af-f736acba27b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f8865a4f-2f90-4c52-afc9-d947d1b71a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_409eb1e5-a613-42a2-92be-3ad30fa9e2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f8865a4f-2f90-4c52-afc9-d947d1b71a6b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_409eb1e5-a613-42a2-92be-3ad30fa9e2e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a9a657c8-2415-48a8-a2a4-fc885e8fabc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f8865a4f-2f90-4c52-afc9-d947d1b71a6b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a9a657c8-2415-48a8-a2a4-fc885e8fabc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_814bafae-51c1-4545-98c3-5aab95aa0fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f8865a4f-2f90-4c52-afc9-d947d1b71a6b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_814bafae-51c1-4545-98c3-5aab95aa0fe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_cef5b4e0-c5aa-4034-8f32-30c39e425f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f8865a4f-2f90-4c52-afc9-d947d1b71a6b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_cef5b4e0-c5aa-4034-8f32-30c39e425f6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_6d7552f3-549f-4fdb-ade7-905071efc46a" xlink:href="mck-20220331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f8865a4f-2f90-4c52-afc9-d947d1b71a6b" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_6d7552f3-549f-4fdb-ade7-905071efc46a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_babbdada-2084-4323-a400-e093df6e43e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_42828fc9-1c2c-4577-b726-5ebec3a8214f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_babbdada-2084-4323-a400-e093df6e43e7" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_42828fc9-1c2c-4577-b726-5ebec3a8214f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_63e8b546-860e-4847-b028-7e860cdd0de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_babbdada-2084-4323-a400-e093df6e43e7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_63e8b546-860e-4847-b028-7e860cdd0de3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b154c43a-9919-4e73-ad01-ef56e38d02d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_3002677a-cd6b-484d-ae93-060ff1c2d767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b154c43a-9919-4e73-ad01-ef56e38d02d5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_3002677a-cd6b-484d-ae93-060ff1c2d767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e4ec5540-5cb6-4180-9390-9853f5d91b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b154c43a-9919-4e73-ad01-ef56e38d02d5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e4ec5540-5cb6-4180-9390-9853f5d91b6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_7b3f8bad-75d1-4c26-ada5-349088588c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_acf6c474-b887-467e-a124-81f11489b2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_7b3f8bad-75d1-4c26-ada5-349088588c2c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_acf6c474-b887-467e-a124-81f11489b2c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7d5c8761-4b49-475e-9898-a634ca51abd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_7b3f8bad-75d1-4c26-ada5-349088588c2c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7d5c8761-4b49-475e-9898-a634ca51abd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e3c8cde2-9ded-4ebe-b637-f57b51aa7cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fa19446c-8ddf-4e7d-889c-480fe6cfc1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e3c8cde2-9ded-4ebe-b637-f57b51aa7cfc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fa19446c-8ddf-4e7d-889c-480fe6cfc1a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_80ca0164-a7e4-46d1-9977-498391977041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e3c8cde2-9ded-4ebe-b637-f57b51aa7cfc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_80ca0164-a7e4-46d1-9977-498391977041" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesSupplementalbalancesheetinformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0c12881c-9333-432a-87a7-2057525d126a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_07b6fce2-f60a-4260-b517-8caab22c581b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_0c12881c-9333-432a-87a7-2057525d126a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_07b6fce2-f60a-4260-b517-8caab22c581b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7f4bf055-99db-4ebc-9dad-40c3752217d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_0c12881c-9333-432a-87a7-2057525d126a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7f4bf055-99db-4ebc-9dad-40c3752217d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8bbd5b30-7792-46c5-a6e9-a825b0d89cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_97f23b4c-2ea5-4c50-99a9-05085380037a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8bbd5b30-7792-46c5-a6e9-a825b0d89cee" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_97f23b4c-2ea5-4c50-99a9-05085380037a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_09bcacff-7a39-4492-b8d4-bf3315bee678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8bbd5b30-7792-46c5-a6e9-a825b0d89cee" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_09bcacff-7a39-4492-b8d4-bf3315bee678" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_65763e45-f9b1-453d-80f4-2ffe843e1644" xlink:href="mck-20220331.xsd#mck_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e5bd2c49-890e-4fb4-9ff7-4918f5182ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_FinanceLeaseCost_65763e45-f9b1-453d-80f4-2ffe843e1644" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e5bd2c49-890e-4fb4-9ff7-4918f5182ffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3fd1bcbd-cd59-42ab-a89b-9e711ecfb3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_FinanceLeaseCost_65763e45-f9b1-453d-80f4-2ffe843e1644" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3fd1bcbd-cd59-42ab-a89b-9e711ecfb3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_78f18565-59ef-49fc-980c-0d2bae9d2f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_ccf92323-0cc6-452f-92a8-30eb8792c7db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_78f18565-59ef-49fc-980c-0d2bae9d2f4b" xlink:to="loc_us-gaap_ShortTermLeaseCost_ccf92323-0cc6-452f-92a8-30eb8792c7db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e47f3b6e-b5db-4cac-b686-51b7e2960997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_78f18565-59ef-49fc-980c-0d2bae9d2f4b" xlink:to="loc_us-gaap_OperatingLeaseCost_e47f3b6e-b5db-4cac-b686-51b7e2960997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_5727db0a-bed6-4ca5-b255-ff9fbe15ed00" xlink:href="mck-20220331.xsd#mck_FinanceLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_78f18565-59ef-49fc-980c-0d2bae9d2f4b" xlink:to="loc_mck_FinanceLeaseCost_5727db0a-bed6-4ca5-b255-ff9fbe15ed00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a7131786-f226-4ac2-a438-423c9a145beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_78f18565-59ef-49fc-980c-0d2bae9d2f4b" xlink:to="loc_us-gaap_VariableLeaseCost_a7131786-f226-4ac2-a438-423c9a145beb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_09543104-7f21-41e0-b87e-2b13e9156392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_78f18565-59ef-49fc-980c-0d2bae9d2f4b" xlink:to="loc_us-gaap_SubleaseIncome_09543104-7f21-41e0-b87e-2b13e9156392" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesMaturitiesofleaseliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_4e79f80a-9fe5-44f7-a33b-58f7e6047eb6" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_337e3de7-7490-4152-8197-3605973b9cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour_4e79f80a-9fe5-44f7-a33b-58f7e6047eb6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_337e3de7-7490-4152-8197-3605973b9cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4fb610cd-5879-437c-ae12-404cd7937235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour_4e79f80a-9fe5-44f7-a33b-58f7e6047eb6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4fb610cd-5879-437c-ae12-404cd7937235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_a356afa6-6f1e-4d4e-934d-fa1bea43cbf7" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3c649b65-49f5-4c72-bb50-23074def39c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_a356afa6-6f1e-4d4e-934d-fa1bea43cbf7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3c649b65-49f5-4c72-bb50-23074def39c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c23d440f-e7d7-4377-8035-d5391a4328a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_a356afa6-6f1e-4d4e-934d-fa1bea43cbf7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c23d440f-e7d7-4377-8035-d5391a4328a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_590089ae-da21-4163-b505-1099a4236799" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:to="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_590089ae-da21-4163-b505-1099a4236799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_583bd3c5-36ac-4d91-be34-7747c97aefb5" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearTwo_583bd3c5-36ac-4d91-be34-7747c97aefb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_2a93dc57-b8d3-435c-8996-54d0793d1203" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearThree_2a93dc57-b8d3-435c-8996-54d0793d1203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_630617dd-9217-410a-9a47-b86840b4e108" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFour_630617dd-9217-410a-9a47-b86840b4e108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_7e70d4c0-cc6b-406e-81df-37ee8be78247" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFive_7e70d4c0-cc6b-406e-81df-37ee8be78247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_61572865-f016-4f34-bcfc-54481056dff1" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9ba4417e-7002-49f6-a32a-e18baad03822" xlink:to="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_61572865-f016-4f34-bcfc-54481056dff1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d2865249-fa05-472e-8c62-13f4db4d97c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9426127e-39a1-4e7a-88a8-9536bfeffbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d2865249-fa05-472e-8c62-13f4db4d97c3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9426127e-39a1-4e7a-88a8-9536bfeffbaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8a730d4a-0ce9-4a57-8274-9c222ce1908b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d2865249-fa05-472e-8c62-13f4db4d97c3" xlink:to="loc_us-gaap_OperatingLeaseLiability_8a730d4a-0ce9-4a57-8274-9c222ce1908b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_cc0cc113-6ff4-4220-bed7-fc73b81c443f" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5b1620ce-a4b4-4f0f-9258-9c07b313de9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo_cc0cc113-6ff4-4220-bed7-fc73b81c443f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5b1620ce-a4b4-4f0f-9258-9c07b313de9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_867edb71-9948-4c56-9caf-d2ba5be91e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo_cc0cc113-6ff4-4220-bed7-fc73b81c443f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_867edb71-9948-4c56-9caf-d2ba5be91e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_f5a898fb-dac6-4e29-82cc-c4901b04b0eb" xlink:href="mck-20220331.xsd#mck_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8f043b00-8210-46c4-993c-0988bca6b764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiability_f5a898fb-dac6-4e29-82cc-c4901b04b0eb" xlink:to="loc_us-gaap_OperatingLeaseLiability_8f043b00-8210-46c4-993c-0988bca6b764" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3fb8c9ff-00a6-48a7-b6fa-48c8d4d0c72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiability_f5a898fb-dac6-4e29-82cc-c4901b04b0eb" xlink:to="loc_us-gaap_FinanceLeaseLiability_3fb8c9ff-00a6-48a7-b6fa-48c8d4d0c72a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_1633c153-53da-4205-a236-3925d3888201" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e10b5c8d-7810-4af5-a56a-133d0a686bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive_1633c153-53da-4205-a236-3925d3888201" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e10b5c8d-7810-4af5-a56a-133d0a686bd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ab382c3a-76f9-4738-b442-b39dc7df4ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive_1633c153-53da-4205-a236-3925d3888201" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ab382c3a-76f9-4738-b442-b39dc7df4ed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_05f924c8-b6bb-4844-bb37-ce84d45f0fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_08cfd9ca-47e6-4a13-9051-906f513c26e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_05f924c8-b6bb-4844-bb37-ce84d45f0fd5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_08cfd9ca-47e6-4a13-9051-906f513c26e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2131b941-4650-411e-973c-b499a4c47aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_05f924c8-b6bb-4844-bb37-ce84d45f0fd5" xlink:to="loc_us-gaap_FinanceLeaseLiability_2131b941-4650-411e-973c-b499a4c47aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_204d99e9-4948-42d0-885e-a739f3399d61" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_557d7c60-0f51-4d21-9d3e-50495e0e1820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount_204d99e9-4948-42d0-885e-a739f3399d61" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_557d7c60-0f51-4d21-9d3e-50495e0e1820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_989aac7a-4bef-4e82-9573-c2daddfaff86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount_204d99e9-4948-42d0-885e-a739f3399d61" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_989aac7a-4bef-4e82-9573-c2daddfaff86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_7ea1661a-5310-41ad-b4fa-12af0f280c33" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e8d9020b-7bd3-4be1-b93b-70ae5587a6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree_7ea1661a-5310-41ad-b4fa-12af0f280c33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e8d9020b-7bd3-4be1-b93b-70ae5587a6aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c89c20fd-90d7-4666-b954-f7906e29aa78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree_7ea1661a-5310-41ad-b4fa-12af0f280c33" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c89c20fd-90d7-4666-b954-f7906e29aa78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_835900d3-337c-4ce0-988c-abb978e3e179" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f161b3c7-61da-4b72-8fbd-a22face8e5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_835900d3-337c-4ce0-988c-abb978e3e179" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f161b3c7-61da-4b72-8fbd-a22face8e5cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2aca13c2-3bec-4639-bbed-a1be0bced64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_835900d3-337c-4ce0-988c-abb978e3e179" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2aca13c2-3bec-4639-bbed-a1be0bced64f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_08064db0-3313-41c6-9489-c89bfd9e4994" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_c978108f-98a7-4e8b-8647-913d01ae4439" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_08064db0-3313-41c6-9489-c89bfd9e4994" xlink:to="loc_mck_LeaseLiabilityUndiscountedExcessAmount_c978108f-98a7-4e8b-8647-913d01ae4439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_3d3533a6-a7e6-4453-8fd5-cc5be267b09a" xlink:href="mck-20220331.xsd#mck_LeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_08064db0-3313-41c6-9489-c89bfd9e4994" xlink:to="loc_mck_LeaseLiability_3d3533a6-a7e6-4453-8fd5-cc5be267b09a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cf8a5832-d48e-4079-949d-9f4d17e2404b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cf8a5832-d48e-4079-949d-9f4d17e2404b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_107e89fa-ec88-4411-b9bb-834d4fae74ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_107e89fa-ec88-4411-b9bb-834d4fae74ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2b18ad5c-6325-4d13-aaee-af4aa8b11e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2b18ad5c-6325-4d13-aaee-af4aa8b11e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4ca4785c-6160-49d1-b2b5-133f0677e02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4ca4785c-6160-49d1-b2b5-133f0677e02c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_59d7d7fe-9951-4c67-ab22-730b53c2f3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_59d7d7fe-9951-4c67-ab22-730b53c2f3d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b0a7838b-45dd-4f6d-a98c-3a7b3aa55f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c66e9498-9820-46a5-9cd6-61f036c55953" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b0a7838b-45dd-4f6d-a98c-3a7b3aa55f31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_90ce15d3-4f00-4289-b049-d8ccf3eb45bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_90ce15d3-4f00-4289-b049-d8ccf3eb45bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7a8e6abf-6929-4479-8dc9-5060e6a2f510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7a8e6abf-6929-4479-8dc9-5060e6a2f510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8a778e7d-baab-4e89-b5c5-6e31cf8b7c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8a778e7d-baab-4e89-b5c5-6e31cf8b7c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e21226aa-3172-49ee-9a74-c77eb55b2946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e21226aa-3172-49ee-9a74-c77eb55b2946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d7546ead-b4cd-4bc7-9a58-9c06754b5c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d7546ead-b4cd-4bc7-9a58-9c06754b5c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ed6ee9f7-9d3c-45a3-b581-6d7b35015faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8f4c010e-a9f1-4ba6-93ac-333668eb7315" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ed6ee9f7-9d3c-45a3-b581-6d7b35015faa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_2"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_2d4d9911-7ff3-4458-a374-3dfe9fdf21f7" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d0b0a00-b3c6-4169-8876-444190cba75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_2d4d9911-7ff3-4458-a374-3dfe9fdf21f7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d0b0a00-b3c6-4169-8876-444190cba75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a3e61e67-a54a-4611-9e3f-eabcdafea6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_2d4d9911-7ff3-4458-a374-3dfe9fdf21f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a3e61e67-a54a-4611-9e3f-eabcdafea6b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bdc7563f-f0bf-4bf6-b9af-2c0d971d61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4587a0a0-882f-4dac-a0ed-9f7f203887d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bdc7563f-f0bf-4bf6-b9af-2c0d971d61d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4587a0a0-882f-4dac-a0ed-9f7f203887d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f8ab8453-5812-400f-afcc-76e095e8f113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bdc7563f-f0bf-4bf6-b9af-2c0d971d61d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f8ab8453-5812-400f-afcc-76e095e8f113" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_102bf059-d565-4d9b-8a99-7cb47f577fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_ca1ef7f0-b7df-4c8c-9fac-fe2ed9fb3cd7" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_102bf059-d565-4d9b-8a99-7cb47f577fdf" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_ca1ef7f0-b7df-4c8c-9fac-fe2ed9fb3cd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ce565af1-71c5-4f77-90f7-9a935b04bb23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_102bf059-d565-4d9b-8a99-7cb47f577fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ce565af1-71c5-4f77-90f7-9a935b04bb23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c46623d0-07e2-4781-ba8a-5320d4d57836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_102bf059-d565-4d9b-8a99-7cb47f577fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c46623d0-07e2-4781-ba8a-5320d4d57836" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_20d2843f-84a1-41e2-babb-3ba3320d455a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_102bf059-d565-4d9b-8a99-7cb47f577fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_20d2843f-84a1-41e2-babb-3ba3320d455a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7bd43d75-6c73-47cb-89c4-711c72ed5d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_102bf059-d565-4d9b-8a99-7cb47f577fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7bd43d75-6c73-47cb-89c4-711c72ed5d01" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3335b340-2e7b-431b-a159-bf80b7c2d09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_fdee2b51-1390-44cc-b05f-b55048d38e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3335b340-2e7b-431b-a159-bf80b7c2d09c" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_fdee2b51-1390-44cc-b05f-b55048d38e1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9c3ed4df-fe1e-47e9-b3e8-493b4e03c4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3335b340-2e7b-431b-a159-bf80b7c2d09c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9c3ed4df-fe1e-47e9-b3e8-493b4e03c4ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_0855f9b8-664a-419d-b7aa-ceb42c0bf5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_115bf20f-f04c-4909-9c05-ff388f43005e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_0855f9b8-664a-419d-b7aa-ceb42c0bf5b7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_115bf20f-f04c-4909-9c05-ff388f43005e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_a9649af4-cf97-4d4b-846b-98acbbe66820" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_0855f9b8-664a-419d-b7aa-ceb42c0bf5b7" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_a9649af4-cf97-4d4b-846b-98acbbe66820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c83b7053-3db3-424d-b84c-cfe4ef56c663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_0855f9b8-664a-419d-b7aa-ceb42c0bf5b7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c83b7053-3db3-424d-b84c-cfe4ef56c663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_2d74b1dc-5ad3-4e2b-a663-5914f140a397" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_0855f9b8-664a-419d-b7aa-ceb42c0bf5b7" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_2d74b1dc-5ad3-4e2b-a663-5914f140a397" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_2c59457b-7841-457d-b963-90c018ee21bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_b2940321-6654-48bd-ab25-5c1242b23e98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_2c59457b-7841-457d-b963-90c018ee21bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_b2940321-6654-48bd-ab25-5c1242b23e98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_2d3443d1-81d2-48fd-811d-98d4da6312c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_2c59457b-7841-457d-b963-90c018ee21bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_2d3443d1-81d2-48fd-811d-98d4da6312c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6b66b1b4-7a69-4d63-9b44-7c00d485b970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_0d5550a5-4dc6-4c38-b845-1b97fd7b429c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6b66b1b4-7a69-4d63-9b44-7c00d485b970" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_0d5550a5-4dc6-4c38-b845-1b97fd7b429c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_881e8b42-fc61-40fa-8e3c-4b73631cb4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6b66b1b4-7a69-4d63-9b44-7c00d485b970" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_881e8b42-fc61-40fa-8e3c-4b73631cb4a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_090756f5-6a38-4a8d-851d-8674c574af45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6b66b1b4-7a69-4d63-9b44-7c00d485b970" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_090756f5-6a38-4a8d-851d-8674c574af45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_99fabee0-677d-4d80-8ce9-d3400a58cb7f" xlink:href="mck-20220331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6b66b1b4-7a69-4d63-9b44-7c00d485b970" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_99fabee0-677d-4d80-8ce9-d3400a58cb7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_61fe9b9c-f5f0-46ff-bff3-c1357163cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ebf919-a37b-4328-88c6-62e8eac63d69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_61fe9b9c-f5f0-46ff-bff3-c1357163cec5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_30ebf919-a37b-4328-88c6-62e8eac63d69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b6a7e5ef-d6ea-4e6b-b61b-2a4495b2bc37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_61fe9b9c-f5f0-46ff-bff3-c1357163cec5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_b6a7e5ef-d6ea-4e6b-b61b-2a4495b2bc37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25e1119e-85c9-45f0-acaf-5f854f21e5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b0c1f001-697f-4a50-908a-60ee3723afd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25e1119e-85c9-45f0-acaf-5f854f21e5be" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b0c1f001-697f-4a50-908a-60ee3723afd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c13234d6-ccbe-44a0-9772-b5913b212c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25e1119e-85c9-45f0-acaf-5f854f21e5be" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c13234d6-ccbe-44a0-9772-b5913b212c6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d999eaad-6d5a-46be-8547-308ab9f1b0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_63214e05-bafb-43bf-9a2d-55ea413ac761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d999eaad-6d5a-46be-8547-308ab9f1b0cd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_63214e05-bafb-43bf-9a2d-55ea413ac761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ad6f5d65-d5fc-48f7-8d03-b5596eaac1c1" xlink:href="mck-20220331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d999eaad-6d5a-46be-8547-308ab9f1b0cd" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_ad6f5d65-d5fc-48f7-8d03-b5596eaac1c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_ea323571-5773-4fd9-993a-ca7fbbe25d07" xlink:href="mck-20220331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d999eaad-6d5a-46be-8547-308ab9f1b0cd" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_ea323571-5773-4fd9-993a-ca7fbbe25d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_494d5301-26ba-4967-9f9f-b772205be93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d999eaad-6d5a-46be-8547-308ab9f1b0cd" xlink:to="loc_us-gaap_InterestExpense_494d5301-26ba-4967-9f9f-b772205be93f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>mck-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eedc7054-d2b4-49fb-b502-fc8a725b4aca,g:dd1fa40e-8b61-4831-9194-c55f1729d4f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20220331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended" id="i9396eaec8d9f4e9e830a15fccd502df0_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7b9dfed2-10ca-41a5-9f61-f547c8cd04c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentType_7b9dfed2-10ca-41a5-9f61-f547c8cd04c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_7e17676b-5561-4a58-abb1-38fdfb105650" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentAnnualReport_7e17676b-5561-4a58-abb1-38fdfb105650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c7b42792-95b9-4769-b854-2a1dd99f77f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentPeriodEndDate_c7b42792-95b9-4769-b854-2a1dd99f77f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bf2a1136-ef1d-4f93-82bb-cbbf91c2fa60" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_CurrentFiscalYearEndDate_bf2a1136-ef1d-4f93-82bb-cbbf91c2fa60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_21a8ea52-e1b7-4048-9aea-8965348323d3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentTransitionReport_21a8ea52-e1b7-4048-9aea-8965348323d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9fba9582-7cf5-4196-a5c5-74b9aa975275" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityFileNumber_9fba9582-7cf5-4196-a5c5-74b9aa975275" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5d4f1a31-9858-4a50-b30a-f3b12e0702d5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityRegistrantName_5d4f1a31-9858-4a50-b30a-f3b12e0702d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9616d02d-d64f-4e68-aaf7-280bc26c4623" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9616d02d-d64f-4e68-aaf7-280bc26c4623" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_842a06a2-7916-4139-b245-02c0ee439575" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityTaxIdentificationNumber_842a06a2-7916-4139-b245-02c0ee439575" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8b0347f7-e7f1-487f-9a06-7a0db609df0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressAddressLine1_8b0347f7-e7f1-487f-9a06-7a0db609df0b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_58cabda0-ad0b-4327-a82f-56fb05a9722c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressCityOrTown_58cabda0-ad0b-4327-a82f-56fb05a9722c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8dabdd88-d3f6-43b7-a341-32ac6b961978" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressStateOrProvince_8dabdd88-d3f6-43b7-a341-32ac6b961978" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6a78a934-d689-4827-a303-c34edd87f869" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressPostalZipCode_6a78a934-d689-4827-a303-c34edd87f869" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9134af9a-55e8-4050-a670-49430425cbf4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_CityAreaCode_9134af9a-55e8-4050-a670-49430425cbf4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4378a402-5c88-4fe4-bb94-f860ffc0f228" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_LocalPhoneNumber_4378a402-5c88-4fe4-bb94-f860ffc0f228" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4a7962ef-7d72-41e1-b7d0-7cb3ae41c13d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_Security12bTitle_4a7962ef-7d72-41e1-b7d0-7cb3ae41c13d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_24b80812-b4f9-45ba-9756-3d69540f2985" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_TradingSymbol_24b80812-b4f9-45ba-9756-3d69540f2985" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_945d8ef9-6c23-4b3d-9777-d38accfb1e9b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_SecurityExchangeName_945d8ef9-6c23-4b3d-9777-d38accfb1e9b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_786f7f5d-8ab7-4bf1-b8bd-d5a5e50be033" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_786f7f5d-8ab7-4bf1-b8bd-d5a5e50be033" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_8172440a-db50-4433-9f49-79380e110415" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityVoluntaryFilers_8172440a-db50-4433-9f49-79380e110415" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_fe44182b-0290-4dab-94e1-3d8738ae5b19" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityCurrentReportingStatus_fe44182b-0290-4dab-94e1-3d8738ae5b19" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d3217490-0abc-430c-a86a-c5f76e892a7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityInteractiveDataCurrent_d3217490-0abc-430c-a86a-c5f76e892a7a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_87c5d13f-fa57-423a-92a0-0dab609ef23a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityFilerCategory_87c5d13f-fa57-423a-92a0-0dab609ef23a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_dfd02216-d8ef-415f-acc6-2f338e028b7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntitySmallBusiness_dfd02216-d8ef-415f-acc6-2f338e028b7d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e8d9b0ef-777e-4944-9542-f72a63ef1c81" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityEmergingGrowthCompany_e8d9b0ef-777e-4944-9542-f72a63ef1c81" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0a3e0ec1-691f-4ebe-bc22-3525738d3734" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0a3e0ec1-691f-4ebe-bc22-3525738d3734" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1facff9b-8246-4ab0-8cda-59e6c4484c8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityShellCompany_1facff9b-8246-4ab0-8cda-59e6c4484c8a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_edda859f-97cf-40ee-b729-ed88da66491b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityPublicFloat_edda859f-97cf-40ee-b729-ed88da66491b" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_671c6954-58dc-4fcf-9040-bcfdc6fc0f8c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_671c6954-58dc-4fcf-9040-bcfdc6fc0f8c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d7141ee5-340a-4202-bddd-8957c94a40ea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d7141ee5-340a-4202-bddd-8957c94a40ea" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_638207b3-c7e7-46c6-b0b1-19411cc65e0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityCentralIndexKey_638207b3-c7e7-46c6-b0b1-19411cc65e0c" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_62e71b90-95b3-4cfb-81c7-eb27ea17fd59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_62e71b90-95b3-4cfb-81c7-eb27ea17fd59" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7a71f51d-3f62-43b5-8517-5d4d58f9d121" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentFiscalYearFocus_7a71f51d-3f62-43b5-8517-5d4d58f9d121" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5493d434-5032-476c-9321-f4224eae8206" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_AmendmentFlag_5493d434-5032-476c-9321-f4224eae8206" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:to="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_28cae897-c8dd-4b36-baae-8cadd5729fcf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:to="loc_us-gaap_ClassOfStockDomain_28cae897-c8dd-4b36-baae-8cadd5729fcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:to="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9ce58314-859a-4bfb-b620-8b98c7a06d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_us-gaap_CommonStockMember_9ce58314-859a-4bfb-b620-8b98c7a06d83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member_1cc4c374-a519-410a-b48e-20005a112033" xlink:href="mck-20220331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_mck_A1.500NotesDue2025Member_1cc4c374-a519-410a-b48e-20005a112033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member_a530d056-5d8e-4d62-8f76-5604044105ba" xlink:href="mck-20220331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_mck_A1.625NotesDue2026Member_a530d056-5d8e-4d62-8f76-5604044105ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member_1d6985d7-16b9-4ade-9610-e0025dcfea86" xlink:href="mck-20220331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_mck_A3.125NotesDue2029Member_1d6985d7-16b9-4ade-9610-e0025dcfea86" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="id06ac742a72f48039c632bd20f289707_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2470c3b0-0326-4134-8ccb-4397513447de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2470c3b0-0326-4134-8ccb-4397513447de" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_dd88d9a3-e23f-4173-b09f-4d60c987edbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_SharesOutstanding_dd88d9a3-e23f-4173-b09f-4d60c987edbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_66adf3b0-bcc2-40c5-bc4e-274794fc20a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_66adf3b0-bcc2-40c5-bc4e-274794fc20a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c7a51176-3dff-4fed-bd7d-346fbb59cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_TreasuryStockShares_c7a51176-3dff-4fed-bd7d-346fbb59cf1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_99f856ee-cccb-416e-ae03-24d3014b9212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_99f856ee-cccb-416e-ae03-24d3014b9212" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_e68dbdcb-8603-46df-9755-c8bbc5fc3b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_e68dbdcb-8603-46df-9755-c8bbc5fc3b63" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2accadc7-5fe5-4439-b69f-9c15dc1590b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2accadc7-5fe5-4439-b69f-9c15dc1590b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d9dfbbf1-3137-40a4-b18e-033e72bec940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d9dfbbf1-3137-40a4-b18e-033e72bec940" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a18d7498-98d0-4d4b-8791-00b172f4d5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a18d7498-98d0-4d4b-8791-00b172f4d5fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_51703cbb-bb4f-4eab-b0f2-9490668adbca" xlink:href="mck-20220331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_51703cbb-bb4f-4eab-b0f2-9490668adbca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_82be9d52-d9be-4cc8-82b7-be51513c1d58" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_82be9d52-d9be-4cc8-82b7-be51513c1d58" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_f163b421-3003-4fd4-b8cb-44127efdb887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_f163b421-3003-4fd4-b8cb-44127efdb887" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_28c67474-3fbb-43d4-addb-34dccce0944d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_28c67474-3fbb-43d4-addb-34dccce0944d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_16a24156-3a8f-4106-a7ba-9fc140c598a5" xlink:href="mck-20220331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_16a24156-3a8f-4106-a7ba-9fc140c598a5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_55850ac1-0195-4f88-a544-21f4d9c1917e" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_55850ac1-0195-4f88-a544-21f4d9c1917e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodShares_faef4843-8417-4c21-888e-bb14d2a36dcf" xlink:href="mck-20220331.xsd#mck_StockExchangedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_StockExchangedDuringPeriodShares_faef4843-8417-4c21-888e-bb14d2a36dcf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodValue_e0085257-0f27-459a-a38e-c99394c2465c" xlink:href="mck-20220331.xsd#mck_StockExchangedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_StockExchangedDuringPeriodValue_e0085257-0f27-459a-a38e-c99394c2465c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_b1e0001c-0a6a-49d1-ab9f-2374fd7f543b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_DividendsCommonStockCash_b1e0001c-0a6a-49d1-ab9f-2374fd7f543b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_ec9c97ac-8550-489a-9c5f-3e526594cfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockholdersEquityOther_ec9c97ac-8550-489a-9c5f-3e526594cfb8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_305a29e9-5f5c-4177-bb33-eec40e66fe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_942034a1-2b8a-4346-96b1-59c53ba4c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1e2652c0-d85a-444d-9bad-8f81f40925a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2470c3b0-0326-4134-8ccb-4397513447de" xlink:to="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c998f80b-5522-4f5c-85e9-9727bdceb08b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c998f80b-5522-4f5c-85e9-9727bdceb08b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b84e54a8-7025-4603-98c7-cf245d12f852" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b84e54a8-7025-4603-98c7-cf245d12f852" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_556eea86-e57d-4e9f-b179-60a77376bb95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_556eea86-e57d-4e9f-b179-60a77376bb95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_75fd46d5-389d-45ba-b7ab-b49f76a65b13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:to="loc_us-gaap_EquityComponentDomain_75fd46d5-389d-45ba-b7ab-b49f76a65b13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:to="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e4f5b531-00ee-4a55-a20d-32696c7419a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_CommonStockMember_e4f5b531-00ee-4a55-a20d-32696c7419a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_20bc299a-be92-4bc0-817a-482a1406feb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_20bc299a-be92-4bc0-817a-482a1406feb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_ed93938a-1d01-4f48-9237-dd2caccee129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_ed93938a-1d01-4f48-9237-dd2caccee129" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ca30c023-689b-4898-b912-66f63e371413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_RetainedEarningsMember_ca30c023-689b-4898-b912-66f63e371413" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dae86af6-0153-406f-a98a-ba0d0a0aa520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dae86af6-0153-406f-a98a-ba0d0a0aa520" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_637cab7c-1dfb-48ce-8182-ca63b395480e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_TreasuryStockMember_637cab7c-1dfb-48ce-8182-ca63b395480e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f5a6d836-653b-4b55-bef4-34907f57b1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f5a6d836-653b-4b55-bef4-34907f57b1c2" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended" id="i147b9a812ac24a35907e6740e90b2458_SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_75cfcc0c-328b-444e-9fad-09d7c4c51fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_NumberOfReportableSegments_75cfcc0c-328b-444e-9fad-09d7c4c51fa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_700053d5-6bff-4872-8c07-d3e892af3af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_RestrictedCash_700053d5-6bff-4872-8c07-d3e892af3af4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e75c9077-6bb8-433e-9881-cdaeb7d24bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e75c9077-6bb8-433e-9881-cdaeb7d24bdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_78f6aa88-4e7f-4abf-8acd-aac548b847d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_78f6aa88-4e7f-4abf-8acd-aac548b847d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d94a76bb-6610-4aa4-ad16-bc9ada6b85fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryNet_d94a76bb-6610-4aa4-ad16-bc9ada6b85fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_21105e23-e56d-4a63-976d-54469642ec25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryWriteDown_21105e23-e56d-4a63-976d-54469642ec25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_bd399987-a6a8-4ba3-a7c5-3389d721847d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_bd399987-a6a8-4ba3-a7c5-3389d721847d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_0970f83b-6136-4ff5-8b41-8de58cec1cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryLIFOReserve_0970f83b-6136-4ff5-8b41-8de58cec1cba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_ec3f5951-20fb-4f7b-94d5-f982f7fe4b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_ec3f5951-20fb-4f7b-94d5-f982f7fe4b88" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1588e914-6ba3-479c-ae95-9d726615dabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1588e914-6ba3-479c-ae95-9d726615dabe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a41bd0cd-7ee3-4983-9839-3bd4f6896ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a41bd0cd-7ee3-4983-9839-3bd4f6896ff8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_be09af36-0c9e-4961-9d1c-9b534c948933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_be09af36-0c9e-4961-9d1c-9b534c948933" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d0d2f4e2-26d2-4416-9450-01d190f9e340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d0d2f4e2-26d2-4416-9450-01d190f9e340" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_00c271bc-b204-468c-9529-246a759d060a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_00c271bc-b204-468c-9529-246a759d060a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_365c632c-f0d7-4901-a2e6-15c1712f24cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_365c632c-f0d7-4901-a2e6-15c1712f24cf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_6951532a-6c22-4e7b-82d9-6c3d06118feb" xlink:href="mck-20220331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_6951532a-6c22-4e7b-82d9-6c3d06118feb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_3cb7d2ba-0f10-44ca-bc44-6b2cb8e062eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_3cb7d2ba-0f10-44ca-bc44-6b2cb8e062eb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_ddc7090b-a6d7-43f4-91ba-1e72bb74e979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_ddc7090b-a6d7-43f4-91ba-1e72bb74e979" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_dad4cb77-b7fb-4168-afcf-a5eb9d2580f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_dad4cb77-b7fb-4168-afcf-a5eb9d2580f9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_85d06f7d-be21-4567-974d-b4bd646fa3f8" xlink:href="mck-20220331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_85d06f7d-be21-4567-974d-b4bd646fa3f8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d8b10061-65f9-4a93-9d37-ad94df2a72e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d8b10061-65f9-4a93-9d37-ad94df2a72e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_624fac15-134e-4791-83cd-505d9c512658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_624fac15-134e-4791-83cd-505d9c512658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_38b38224-88a9-49a8-9b1c-38e0d8353f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_38b38224-88a9-49a8-9b1c-38e0d8353f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_227ea533-f60c-4f42-9e4a-f344dba8af7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_227ea533-f60c-4f42-9e4a-f344dba8af7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_79ff89a4-15ac-4089-9cb8-676a168424d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:to="loc_us-gaap_SalesRevenueNetMember_79ff89a4-15ac-4089-9cb8-676a168424d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_d9bc5367-9152-4229-9f92-23ced7b71a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:to="loc_us-gaap_AccountsReceivableMember_d9bc5367-9152-4229-9f92-23ced7b71a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fbdc0697-598d-4055-9787-2a069d13c0f9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:to="loc_srt_NameOfMajorCustomerDomain_fbdc0697-598d-4055-9787-2a069d13c0f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:to="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember_f76e37de-e14c-49ff-b332-6e390e84ec0b" xlink:href="mck-20220331.xsd#mck_LargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:to="loc_mck_LargestCustomerMember_f76e37de-e14c-49ff-b332-6e390e84ec0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenLargestCustomersMember_aba02eb3-ca2d-49e9-82bb-469b877976ea" xlink:href="mck-20220331.xsd#mck_TenLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:to="loc_mck_TenLargestCustomersMember_aba02eb3-ca2d-49e9-82bb-469b877976ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_710ceb9c-c408-407a-97f1-6ab089e95a3e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:to="loc_srt_ProductsAndServicesDomain_710ceb9c-c408-407a-97f1-6ab089e95a3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:to="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_537d99ee-dd04-4a35-b584-1b2c51299b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:to="loc_us-gaap_ShippingAndHandlingMember_537d99ee-dd04-4a35-b584-1b2c51299b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember_88ee46c9-bd26-4f0c-b5b0-b11347679028" xlink:href="mck-20220331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:to="loc_mck_DistributionandRetailBusinessMember_88ee46c9-bd26-4f0c-b5b0-b11347679028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember_6e887181-2aa1-475c-9886-5af36f41360e" xlink:href="mck-20220331.xsd#mck_ServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:to="loc_mck_ServicesBusinessMember_6e887181-2aa1-475c-9886-5af36f41360e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d28b40db-b194-4ef9-ac8a-07cea9f1a071_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:to="loc_srt_RangeMember_d28b40db-b194-4ef9-ac8a-07cea9f1a071_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:to="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3f314ae3-34f5-49cc-8f24-2826cd65fc4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:to="loc_srt_MinimumMember_3f314ae3-34f5-49cc-8f24-2826cd65fc4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9d837dfb-9f4f-40c3-9b4d-a9acd2900e1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:to="loc_srt_MaximumMember_9d837dfb-9f4f-40c3-9b4d-a9acd2900e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:to="loc_us-gaap_SegmentDomain_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5c45aba-3a1a-4acb-b2ab-1ccfe08f973d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:to="loc_us-gaap_SegmentDomain_d5c45aba-3a1a-4acb-b2ab-1ccfe08f973d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_b1eef424-169e-4064-9b9a-4cf237d5b683" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d5c45aba-3a1a-4acb-b2ab-1ccfe08f973d" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_b1eef424-169e-4064-9b9a-4cf237d5b683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd7f5b42-5831-4f6d-9703-25e39d2d2880_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd7f5b42-5831-4f6d-9703-25e39d2d2880_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_80a638b9-8a56-4b51-8684-dc954c20f5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_80a638b9-8a56-4b51-8684-dc954c20f5f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember_a8ef1f04-eb99-4ba5-a435-907766a420c2" xlink:href="mck-20220331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_mck_MachineryEquipmentAndOtherMember_a8ef1f04-eb99-4ba5-a435-907766a420c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_2bc7f34a-8302-4b66-857a-531a28069ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_us-gaap_BuildingMember_2bc7f34a-8302-4b66-857a-531a28069ec2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_42b318fd-b5ee-4ccf-839f-825a2b0ef6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_us-gaap_EquipmentMember_42b318fd-b5ee-4ccf-839f-825a2b0ef6fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember_18fbd44c-500e-4f7b-a3f8-a90d8ee21894" xlink:href="mck-20220331.xsd#mck_RealPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_mck_RealPropertyMember_18fbd44c-500e-4f7b-a3f8-a90d8ee21894" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_39326400-3fb0-4b78-aa8f-219d2d6d94ec_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:to="loc_srt_LitigationCaseTypeDomain_39326400-3fb0-4b78-aa8f-219d2d6d94ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ad5d9a38-136a-4767-8b80-fe3e76e23e96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:to="loc_srt_LitigationCaseTypeDomain_ad5d9a38-136a-4767-8b80-fe3e76e23e96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_fd43cd7a-52c2-4ba3-9302-1e20a43184a4" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ad5d9a38-136a-4767-8b80-fe3e76e23e96" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_fd43cd7a-52c2-4ba3-9302-1e20a43184a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="id4abca6968a14e209c9a44a17b28f900_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_1f27f2a2-4b06-4814-b06f-824fcd6b73ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_1f27f2a2-4b06-4814-b06f-824fcd6b73ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_08682df6-3dfb-42af-9920-53d5bdb25ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_08682df6-3dfb-42af-9920-53d5bdb25ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_47070e20-ee6b-4b00-8920-40155e196c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_47070e20-ee6b-4b00-8920-40155e196c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_e8af2612-a0cc-4326-89fc-ff3f6a311776" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_e8af2612-a0cc-4326-89fc-ff3f6a311776" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_4cf4a129-fe50-45c5-b666-e8952f36bcd9" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_4cf4a129-fe50-45c5-b666-e8952f36bcd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_2532a577-ce78-4012-b6f7-bb2e06823e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_2532a577-ce78-4012-b6f7-bb2e06823e7c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_da98f1f2-eacd-4f0e-8d1e-6fa56fc20dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_da98f1f2-eacd-4f0e-8d1e-6fa56fc20dec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4cdf9f1e-88c7-4b4a-83dd-3dc93668f1f1" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4cdf9f1e-88c7-4b4a-83dd-3dc93668f1f1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_962bab4a-4c7c-4cb9-845a-cacfe8718971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_AssetsNet_962bab4a-4c7c-4cb9-845a-cacfe8718971" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8577ac8b-6b1f-4d18-84c5-51c97054e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8577ac8b-6b1f-4d18-84c5-51c97054e1de" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7806957e-235a-4d56-98ec-57c24d7b4cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_EquityMethodInvestments_7806957e-235a-4d56-98ec-57c24d7b4cdc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08806a56-381d-40a4-b793-c40e2366a70e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08806a56-381d-40a4-b793-c40e2366a70e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_34f3613e-aa7a-4ccd-aa81-a1a574157422" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_GermanWholesaleBusinessMember_34f3613e-aa7a-4ccd-aa81-a1a574157422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_3b9080a3-25f7-420a-a372-957bd4291195" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_3b9080a3-25f7-420a-a372-957bd4291195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_01995e6b-f6e8-4280-8be5-4ed64cc904a0" xlink:href="mck-20220331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_AustrianBusinessOperationsMember_01995e6b-f6e8-4280-8be5-4ed64cc904a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33dfce78-fd09-47ea-bb94-08e55073d3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33dfce78-fd09-47ea-bb94-08e55073d3cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_814516a8-b756-4865-8ef7-385305e3e9f1" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_814516a8-b756-4865-8ef7-385305e3e9f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_de0bf917-2af0-439a-b398-182bc3fb9941" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_de0bf917-2af0-439a-b398-182bc3fb9941" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07e45acb-5515-4385-9753-1a469a827645_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:to="loc_us-gaap_SegmentDomain_07e45acb-5515-4385-9753-1a469a827645_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:to="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_47c06e6c-db48-44d5-a0f8-df29bb30b1cf" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_47c06e6c-db48-44d5-a0f8-df29bb30b1cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_ff09ad15-503e-4460-824b-ce6ce264e9ae" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:to="loc_mck_InternationalSegmentMember_ff09ad15-503e-4460-824b-ce6ce264e9ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6c83e6f2-9aed-492f-a65f-4daa5a0f18dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6c83e6f2-9aed-492f-a65f-4daa5a0f18dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_541a3ac4-5067-443e-8547-1e39cdc44a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6c83e6f2-9aed-492f-a65f-4daa5a0f18dc" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_541a3ac4-5067-443e-8547-1e39cdc44a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_246b5e4c-a539-4990-8acd-f352bb5b413a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:to="loc_srt_OwnershipDomain_246b5e4c-a539-4990-8acd-f352bb5b413a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5c63821d-3eae-4879-a7fe-a4a65fb578b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:to="loc_srt_OwnershipDomain_5c63821d-3eae-4879-a7fe-a4a65fb578b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_93453b63-f418-4a6c-8c3f-3697dbd569ca" xlink:href="mck-20220331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_5c63821d-3eae-4879-a7fe-a4a65fb578b5" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_93453b63-f418-4a6c-8c3f-3697dbd569ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_991fd860-3f99-4aa1-bd5e-e7d67ad985d8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_991fd860-3f99-4aa1-bd5e-e7d67ad985d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8cbc6134-89d9-40e2-abd4-849ded9a319a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8cbc6134-89d9-40e2-abd4-849ded9a319a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_33b50aa3-0b1a-454d-9c94-631da771ed36" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8cbc6134-89d9-40e2-abd4-849ded9a319a" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_33b50aa3-0b1a-454d-9c94-631da771ed36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6552bed3-618d-44f0-a5fa-d12118359265_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6552bed3-618d-44f0-a5fa-d12118359265_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c993d100-5489-4559-b624-c1012d861b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c993d100-5489-4559-b624-c1012d861b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e6e6a3e-699d-4562-a110-bc57c3b9290e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c993d100-5489-4559-b624-c1012d861b06" xlink:to="loc_us-gaap_SubsequentEventMember_4e6e6a3e-699d-4562-a110-bc57c3b9290e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_254da8df-e564-46c6-a96f-35bea44b5dee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:to="loc_srt_ConsolidationItemsDomain_254da8df-e564-46c6-a96f-35bea44b5dee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2005956f-2c56-42ed-9351-e032f7d6cbfc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:to="loc_srt_ConsolidationItemsDomain_2005956f-2c56-42ed-9351-e032f7d6cbfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_07e56682-e6a8-41ff-b2af-4b73f4d5d20e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2005956f-2c56-42ed-9351-e032f7d6cbfc" xlink:to="loc_us-gaap_OperatingSegmentsMember_07e56682-e6a8-41ff-b2af-4b73f4d5d20e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails" xlink:type="extended" id="i03166efa7cb7475fbcb36a0762393ea8_HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d700ec81-e81c-4625-b53d-560705c06bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d700ec81-e81c-4625-b53d-560705c06bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_5db034ab-ed23-44bd-8700-ec51e35bb791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_5db034ab-ed23-44bd-8700-ec51e35bb791" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e05d5cf7-4f25-4035-9ed3-9e3b61cb0e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e05d5cf7-4f25-4035-9ed3-9e3b61cb0e9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_bd59522d-ea41-4049-8b80-b1ec5764d230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_bd59522d-ea41-4049-8b80-b1ec5764d230" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_cd58e446-ed19-4681-a49e-801d50bb7989" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_cd58e446-ed19-4681-a49e-801d50bb7989" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ec08d8c2-0f77-4618-a9a4-a47dd8215f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ec08d8c2-0f77-4618-a9a4-a47dd8215f71" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_cef81fff-4043-43e3-b769-3e6101d080bd" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_cef81fff-4043-43e3-b769-3e6101d080bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_7e65855e-acfc-4166-a7ea-6ba08214bb40" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_7e65855e-acfc-4166-a7ea-6ba08214bb40" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_340eae42-27ca-4ea3-b96f-267ac6a58a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_340eae42-27ca-4ea3-b96f-267ac6a58a30" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_9656cf31-0010-4382-a273-2e61c921b1b4" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_9656cf31-0010-4382-a273-2e61c921b1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_59c71bca-8155-40b7-8bab-54e5336bdbb8" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_59c71bca-8155-40b7-8bab-54e5336bdbb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cb111a60-77d6-44a1-accb-2fca8a32868d" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cb111a60-77d6-44a1-accb-2fca8a32868d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_aaee230d-78f2-4092-995c-1c0186862bee" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_aaee230d-78f2-4092-995c-1c0186862bee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_751ba868-8cea-42b9-aaec-b3e7c9083162" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_751ba868-8cea-42b9-aaec-b3e7c9083162" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1bac4777-c23f-44fe-99df-5f496cf63232" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1bac4777-c23f-44fe-99df-5f496cf63232" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_ec9bea69-6391-4608-905e-1594a40baba0" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_ec9bea69-6391-4608-905e-1594a40baba0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_6d03eb34-cc83-4b14-8560-3c7c828b6560" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_6d03eb34-cc83-4b14-8560-3c7c828b6560" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_db890a79-2076-4b95-aec6-7c16c4242a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_db890a79-2076-4b95-aec6-7c16c4242a8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_bcde2897-5e94-46e2-aeaf-d66eaeb04a01" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_bcde2897-5e94-46e2-aeaf-d66eaeb04a01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_28cfe519-442c-4301-a0d9-f0a12efa83af" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_28cfe519-442c-4301-a0d9-f0a12efa83af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_23713249-eb4b-44bf-877e-29818713e644" xlink:href="mck-20220331.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_23713249-eb4b-44bf-877e-29818713e644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c4f48b3-bb4a-4802-bc11-e55647282b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c4f48b3-bb4a-4802-bc11-e55647282b28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_92e19bc6-4fbe-4df5-ba3e-a48431d0c923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3c4f48b3-bb4a-4802-bc11-e55647282b28" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_92e19bc6-4fbe-4df5-ba3e-a48431d0c923" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" xlink:type="extended" id="i7f202fa6cd424035a38812dae9b3f4bd_HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_33870225-63e3-4313-9be0-ccefe48ff3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_33870225-63e3-4313-9be0-ccefe48ff3e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_577b6f0b-8992-4f1a-be7d-45e5410ed12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_577b6f0b-8992-4f1a-be7d-45e5410ed12f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ad5989b1-c250-4781-a2fb-9b9aa383eff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ad5989b1-c250-4781-a2fb-9b9aa383eff6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3cb092b3-d45f-4d43-97a5-b80e06e69634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3cb092b3-d45f-4d43-97a5-b80e06e69634" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_b613dc9b-ecea-4394-bcfc-05264b6f1440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_b613dc9b-ecea-4394-bcfc-05264b6f1440" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_5bec4576-796b-456c-9b0a-a9c7f2705cc6" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_5bec4576-796b-456c-9b0a-a9c7f2705cc6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ac341741-8b2d-4788-819a-5b6a1bf37843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ac341741-8b2d-4788-819a-5b6a1bf37843" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_6edf17b8-c6eb-4d37-8eda-e5c6d904aa4c" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_6edf17b8-c6eb-4d37-8eda-e5c6d904aa4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_8e8a7e49-af3d-4cbc-a325-a4086f8a6896" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_8e8a7e49-af3d-4cbc-a325-a4086f8a6896" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_3554b69f-283f-4137-99d5-3a6df33c012b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_3554b69f-283f-4137-99d5-3a6df33c012b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_c7d41a06-bb3c-4d22-83c0-fc37b6009dec" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_c7d41a06-bb3c-4d22-83c0-fc37b6009dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_2ff15577-5164-4359-b1ea-a8165492213b" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_2ff15577-5164-4359-b1ea-a8165492213b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_4765b82a-169d-4543-8c29-4e84905c753c" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_4765b82a-169d-4543-8c29-4e84905c753c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_d77b4dd5-c22f-4d09-9431-affd51998f41" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_d77b4dd5-c22f-4d09-9431-affd51998f41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_663f6e9f-d215-4725-8678-e3c6f97f6228" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_663f6e9f-d215-4725-8678-e3c6f97f6228" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_08a402d1-8fb7-4e1d-8326-36d32617e6c4" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_08a402d1-8fb7-4e1d-8326-36d32617e6c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c7b8ac39-2365-404a-839d-2a66253e7dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c7b8ac39-2365-404a-839d-2a66253e7dce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_714fb505-d2ba-49f4-93c1-7c6a32f17fbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_714fb505-d2ba-49f4-93c1-7c6a32f17fbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c8fa36b-5b8b-4051-84d4-6f962ee85b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c8fa36b-5b8b-4051-84d4-6f962ee85b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_b42e55a4-f77c-4153-b2b2-48bd9f1e86e9" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c8fa36b-5b8b-4051-84d4-6f962ee85b34" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_b42e55a4-f77c-4153-b2b2-48bd9f1e86e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4791fdac-e455-44ba-9640-5ee343957808_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4791fdac-e455-44ba-9640-5ee343957808_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_198487db-854a-48d7-bff4-a6d85bd100b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_198487db-854a-48d7-bff4-a6d85bd100b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7de60584-b80d-42d3-9d59-629a606628ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_198487db-854a-48d7-bff4-a6d85bd100b3" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7de60584-b80d-42d3-9d59-629a606628ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="ia001ac0ceca4418eb87c6db41a114981_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e3ae85d9-f8f7-4c5d-8843-f5a1844f1f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:to="loc_us-gaap_RestructuringCharges_e3ae85d9-f8f7-4c5d-8843-f5a1844f1f2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_fe5c5a5c-7340-4c94-91fb-4138383f42f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:to="loc_us-gaap_AssetImpairmentCharges_fe5c5a5c-7340-4c94-91fb-4138383f42f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_92e94549-352a-4f25-9151-daad2f5bc431_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:to="loc_srt_RangeMember_92e94549-352a-4f25-9151-daad2f5bc431_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:to="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1b441f5b-ddd9-49aa-b083-c884ded016d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:to="loc_srt_MinimumMember_1b441f5b-ddd9-49aa-b083-c884ded016d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ff8c4f82-7bde-4d73-8537-22f0dd4aebb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:to="loc_srt_MaximumMember_ff8c4f82-7bde-4d73-8537-22f0dd4aebb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_d29d06b9-bcb6-4e27-a00c-399be0c146d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:to="loc_us-gaap_RestructuringPlanDomain_d29d06b9-bcb6-4e27-a00c-399be0c146d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:to="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a616ee03-cfb7-4bb5-a286-942d4f0d4831" xlink:href="mck-20220331.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a616ee03-cfb7-4bb5-a286-942d4f0d4831" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_1d29bc69-1111-4457-94c8-b6cd404aaf19" xlink:href="mck-20220331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:to="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_1d29bc69-1111-4457-94c8-b6cd404aaf19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_c8fee056-0ceb-4fda-8cec-dfb8561267d9" xlink:href="mck-20220331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_c8fee056-0ceb-4fda-8cec-dfb8561267d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9aafc3f1-8a5f-4e0c-997a-aac068f3630e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:to="loc_srt_SegmentGeographicalDomain_9aafc3f1-8a5f-4e0c-997a-aac068f3630e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b95f6ea8-fafc-42d0-94c4-1041f69b4799" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:to="loc_srt_SegmentGeographicalDomain_b95f6ea8-fafc-42d0-94c4-1041f69b4799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_16f75e15-b515-4bb1-a34e-d785471b3565" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b95f6ea8-fafc-42d0-94c4-1041f69b4799" xlink:to="loc_country_GB_16f75e15-b515-4bb1-a34e-d785471b3565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:to="loc_us-gaap_SegmentDomain_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f301e0e-94a3-4df4-be6e-ba1dd225e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:to="loc_us-gaap_SegmentDomain_7f301e0e-94a3-4df4-be6e-ba1dd225e2d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a525808f-f176-41d6-b264-fa26066e4ee4" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f301e0e-94a3-4df4-be6e-ba1dd225e2d8" xlink:to="loc_mck_InternationalSegmentMember_a525808f-f176-41d6-b264-fa26066e4ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_1084e714-0683-440b-a4b4-42ac6e3a5b7b" xlink:href="mck-20220331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_1084e714-0683-440b-a4b4-42ac6e3a5b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_32104a32-6c9f-4a20-a37d-964d180216f1" xlink:href="mck-20220331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:to="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_32104a32-6c9f-4a20-a37d-964d180216f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_37e2f321-2f85-4cba-bc64-457ff95e1c7d" xlink:href="mck-20220331.xsd#mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:to="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_37e2f321-2f85-4cba-bc64-457ff95e1c7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_06d198d9-9b11-48d3-bfce-eb2d6b41e658_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:to="loc_us-gaap_ReportingUnitDomain_06d198d9-9b11-48d3-bfce-eb2d6b41e658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:to="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_485679c0-a3fc-4473-a4e1-1daa9354003a" xlink:href="mck-20220331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_485679c0-a3fc-4473-a4e1-1daa9354003a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_06d6a8d9-fb7e-4bac-a6b7-49f15076d321" xlink:href="mck-20220331.xsd#mck_RexallHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:to="loc_mck_RexallHealthMember_06d6a8d9-fb7e-4bac-a6b7-49f15076d321" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="extended" id="i04f2e03e1f024276af3bf3b44e94a165_RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_58d75cf5-0713-4247-8ffc-19925aacaa18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_SeveranceCosts1_58d75cf5-0713-4247-8ffc-19925aacaa18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_af2f14ce-8a70-47aa-a13c-5aeff63675a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_BusinessExitCosts1_af2f14ce-8a70-47aa-a13c-5aeff63675a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_c7cb1652-b63c-420d-ac7c-1989bfe21f19" xlink:href="mck-20220331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_c7cb1652-b63c-420d-ac7c-1989bfe21f19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6b1dde14-f438-45ac-bc0a-a63e88c47a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_RestructuringCharges_6b1dde14-f438-45ac-bc0a-a63e88c47a51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:to="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_106b3c08-e5a6-457c-8091-63ff18077bae_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:to="loc_srt_ConsolidationItemsDomain_106b3c08-e5a6-457c-8091-63ff18077bae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:to="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_72c1b2c0-b193-489c-b8c4-602bd620b472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:to="loc_us-gaap_OperatingSegmentsMember_72c1b2c0-b193-489c-b8c4-602bd620b472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ed5edacc-2778-4c9e-8e44-7fc14a0c2313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ed5edacc-2778-4c9e-8e44-7fc14a0c2313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:to="loc_us-gaap_SegmentDomain_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:to="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_98cb1806-bd9f-422f-a239-b097ddabee8f" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_USPharmaceuticalSegmentMember_98cb1806-bd9f-422f-a239-b097ddabee8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_b9bb4fef-30b1-4dee-b808-75ed32781ab7" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_b9bb4fef-30b1-4dee-b808-75ed32781ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_477e19e2-9664-4e9b-87bf-5569324bbfbd" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_477e19e2-9664-4e9b-87bf-5569324bbfbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e204fd37-4430-4549-a986-ae99ad10d60c" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_InternationalSegmentMember_e204fd37-4430-4549-a986-ae99ad10d60c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended" id="i5f5526d9778747aea3fd8e0918a55555_RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8dfee8af-111f-46df-83b8-209805f8050f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8dfee8af-111f-46df-83b8-209805f8050f" xlink:to="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b99f13b1-1e1e-4e6e-a1bb-f977aaa5fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserve_b99f13b1-1e1e-4e6e-a1bb-f977aaa5fe8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_81a8f017-60b2-4295-ab15-72737a1b9b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringCharges_81a8f017-60b2-4295-ab15-72737a1b9b17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9e28b1b0-5dd2-4e7f-9529-35b723918ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9e28b1b0-5dd2-4e7f-9529-35b723918ed2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_1756bb30-eeab-4980-ba47-f7bcef7eecdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_PaymentsForRestructuring_1756bb30-eeab-4980-ba47-f7bcef7eecdc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_80cc7120-059a-4202-bfbe-8b99faaa85f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_80cc7120-059a-4202-bfbe-8b99faaa85f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_312e5b2b-8627-4e8d-b7d0-0919caf63760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8dfee8af-111f-46df-83b8-209805f8050f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_91f18054-31ab-42da-98e4-cd49592f2a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_91f18054-31ab-42da-98e4-cd49592f2a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_be405055-eb64-43fd-b534-d3acd9865b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_be405055-eb64-43fd-b534-d3acd9865b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_a9228606-8272-48ba-be1b-074a7eab6214" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_a9228606-8272-48ba-be1b-074a7eab6214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d7aff948-0b56-4d8a-a292-3bfaa0100344_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:to="loc_srt_ConsolidationItemsDomain_d7aff948-0b56-4d8a-a292-3bfaa0100344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:to="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fa09b4ac-9693-4661-b0c0-d61513b6b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:to="loc_us-gaap_OperatingSegmentsMember_fa09b4ac-9693-4661-b0c0-d61513b6b07d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4dc47f07-3d5e-4dce-a2de-1f9d99e01a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4dc47f07-3d5e-4dce-a2de-1f9d99e01a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1e6d850-013f-42f8-8316-422610016db2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:to="loc_us-gaap_SegmentDomain_e1e6d850-013f-42f8-8316-422610016db2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:to="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_40c7878d-793b-4550-b4c6-bed10c643b81" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_USPharmaceuticalSegmentMember_40c7878d-793b-4550-b4c6-bed10c643b81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_671c517a-7fb4-4dd6-826f-7e7e7d217d77" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_671c517a-7fb4-4dd6-826f-7e7e7d217d77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_4f4b0861-6125-41d6-8954-eb2bf7653c16" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_4f4b0861-6125-41d6-8954-eb2bf7653c16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_14914f30-56b3-4a69-a889-80a8109f5085" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_InternationalSegmentMember_14914f30-56b3-4a69-a889-80a8109f5085" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestituresDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails" xlink:type="extended" id="if2a18fe7e6404a8aae5e5e69cfac864f_BusinessAcquisitionsandDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cf254842-49b4-483e-8a2d-48b3e27428cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cf254842-49b4-483e-8a2d-48b3e27428cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a06f8ebd-70a3-4b1a-8a4b-c3d8ddf52b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a06f8ebd-70a3-4b1a-8a4b-c3d8ddf52b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_1684d87b-79dc-4b6f-8f08-9317914df303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_1684d87b-79dc-4b6f-8f08-9317914df303" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_194f54d4-0732-4cbf-9d59-9c2818282c95" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_ExchangeOfferSharesDistributed_194f54d4-0732-4cbf-9d59-9c2818282c95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_99c5d58c-4598-4ffc-b350-fc1ed37abc4b" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_ExchangeOfferSharesExchanged_99c5d58c-4598-4ffc-b350-fc1ed37abc4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_bea36605-0997-402d-8d75-656440afcf1c" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_bea36605-0997-402d-8d75-656440afcf1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_7209f5e6-d6dd-4006-aa5d-df5cd88ceb50" xlink:href="mck-20220331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_7209f5e6-d6dd-4006-aa5d-df5cd88ceb50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1b35b725-0fc5-4850-bb40-822f56757379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1b35b725-0fc5-4850-bb40-822f56757379" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_4a5c0397-9ef0-45da-88af-5e81fba7a09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_4a5c0397-9ef0-45da-88af-5e81fba7a09c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70a7b8f-e041-43af-8dd9-8e0cf50590d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70a7b8f-e041-43af-8dd9-8e0cf50590d2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3cf5a69e-d593-42c9-b3b3-cf37e925cb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3cf5a69e-d593-42c9-b3b3-cf37e925cb9d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e0340535-4698-4bda-807b-6d2590043990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e0340535-4698-4bda-807b-6d2590043990" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_656bdfde-5fb6-4ba8-85b9-cd633d36325c" xlink:href="mck-20220331.xsd#mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_656bdfde-5fb6-4ba8-85b9-cd633d36325c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_36aedd53-c5e2-421c-85a3-c0289f3b0a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_36aedd53-c5e2-421c-85a3-c0289f3b0a6f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_27b73926-7b26-4712-a63f-5e61d461abe1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:to="loc_us-gaap_RelatedPartyDomain_27b73926-7b26-4712-a63f-5e61d461abe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ad6016bb-c166-4956-8312-05ee1db24b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:to="loc_us-gaap_RelatedPartyDomain_ad6016bb-c166-4956-8312-05ee1db24b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_69183529-59ca-4439-9574-86102b378272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ad6016bb-c166-4956-8312-05ee1db24b63" xlink:to="loc_us-gaap_CorporateJointVentureMember_69183529-59ca-4439-9574-86102b378272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_da737d28-bef5-4622-befb-2e28538e2844_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:to="loc_dei_EntityDomain_da737d28-bef5-4622-befb-2e28538e2844_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_32517167-c9d9-44c7-9ad1-5d735c8aba8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:to="loc_dei_EntityDomain_32517167-c9d9-44c7-9ad1-5d735c8aba8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_39a0da0f-bdf4-48ba-8e00-8c1eeba119f1" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_32517167-c9d9-44c7-9ad1-5d735c8aba8a" xlink:to="loc_mck_ChangeHealthcareInc.Member_39a0da0f-bdf4-48ba-8e00-8c1eeba119f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bb59846c-0fa5-4c09-8de4-14dc56a6434d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bb59846c-0fa5-4c09-8de4-14dc56a6434d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bf2b072e-66f4-423b-a6ef-43a1ce47ca13" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bf2b072e-66f4-423b-a6ef-43a1ce47ca13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_dc9dc317-e7db-47dc-a9ef-e745c99276c1" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bf2b072e-66f4-423b-a6ef-43a1ce47ca13" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_dc9dc317-e7db-47dc-a9ef-e745c99276c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1a15ebd1-b5fd-4f48-a353-47ff9b573f08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1a15ebd1-b5fd-4f48-a353-47ff9b573f08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_c504efad-ef4f-4725-9d2d-0b001490bee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_c504efad-ef4f-4725-9d2d-0b001490bee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_104d3483-746e-4d84-9258-21117dfd1fce" xlink:href="mck-20220331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_c504efad-ef4f-4725-9d2d-0b001490bee0" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_104d3483-746e-4d84-9258-21117dfd1fce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ebaaeb10-760f-4a5a-80f7-cbbec64ec923_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ebaaeb10-760f-4a5a-80f7-cbbec64ec923_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9815a133-0b85-424b-bb48-4c5f1046c073" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9815a133-0b85-424b-bb48-4c5f1046c073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7ddb3561-6768-413e-8af6-74a81fa2400e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9815a133-0b85-424b-bb48-4c5f1046c073" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7ddb3561-6768-413e-8af6-74a81fa2400e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_b6ff74e2-172d-420a-97f8-ee02bd16b14d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:to="loc_us-gaap_TypeOfAdoptionMember_b6ff74e2-172d-420a-97f8-ee02bd16b14d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_46026753-8e66-4310-87c4-c13719c8f5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:to="loc_us-gaap_TypeOfAdoptionMember_46026753-8e66-4310-87c4-c13719c8f5b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_ea768cb1-cb10-4fe6-a51c-aa11ae52c677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_46026753-8e66-4310-87c4-c13719c8f5b2" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_ea768cb1-cb10-4fe6-a51c-aa11ae52c677" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:to="loc_us-gaap_EquityComponentDomain_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ca9dc91-4834-4ef7-a499-a28e0520d0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:to="loc_us-gaap_EquityComponentDomain_3ca9dc91-4834-4ef7-a499-a28e0520d0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_491a01ad-c992-42b5-aff0-11b94b6c6ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3ca9dc91-4834-4ef7-a499-a28e0520d0f8" xlink:to="loc_us-gaap_RetainedEarningsMember_491a01ad-c992-42b5-aff0-11b94b6c6ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember_30b0afd2-03db-4770-9ec8-08c144664bb8" xlink:href="mck-20220331.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:to="loc_mck_TransitionServicesAgreementsTSAMember_30b0afd2-03db-4770-9ec8-08c144664bb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_2d754e4e-f855-46d6-9cb2-af3612bc2f7c" xlink:href="mck-20220331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_2d754e4e-f855-46d6-9cb2-af3612bc2f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6a01a468-847d-42ed-825a-b003f1b28a47" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6a01a468-847d-42ed-825a-b003f1b28a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_5724a6dc-51a7-4c79-bee2-dda4f5b86b7a" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6a01a468-847d-42ed-825a-b003f1b28a47" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_5724a6dc-51a7-4c79-bee2-dda4f5b86b7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e1835613-9d16-444f-ac96-368ecd16b540_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:to="loc_us-gaap_SegmentDomain_e1835613-9d16-444f-ac96-368ecd16b540_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc40199f-6e21-4f99-973b-b5d73c97f938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:to="loc_us-gaap_SegmentDomain_cc40199f-6e21-4f99-973b-b5d73c97f938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_74ea7f43-1272-4227-96f6-4384d304ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cc40199f-6e21-4f99-973b-b5d73c97f938" xlink:to="loc_us-gaap_AllOtherSegmentsMember_74ea7f43-1272-4227-96f6-4384d304ba04" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="extended" id="i59d70bc3b3134cbfb090ad3db6732604_BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_5f1a6ec0-42b2-46b7-a143-775ed1acec2c" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_5f1a6ec0-42b2-46b7-a143-775ed1acec2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount_b380aaa1-628d-4b46-94ea-0d57d8cc1195" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentCarryingAmount_b380aaa1-628d-4b46-94ea-0d57d8cc1195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_66233df9-0bc7-4027-bf7d-ee36f33bc9f0" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_66233df9-0bc7-4027-bf7d-ee36f33bc9f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_f1dc2c4c-661b-4d2e-bd59-a91a5dec94a7" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_f1dc2c4c-661b-4d2e-bd59-a91a5dec94a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_4d4c04a8-b21d-405a-8804-01578910671a" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_4d4c04a8-b21d-405a-8804-01578910671a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6c7ddfb8-cf3a-4dac-a2b9-b5f2ccb3e87a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6c7ddfb8-cf3a-4dac-a2b9-b5f2ccb3e87a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_6b561019-3eab-444b-966f-cf734717f681" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_6b561019-3eab-444b-966f-cf734717f681" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_748b945f-bb38-47c1-8364-f6a6b04f4939" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAcceptedAverageCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_748b945f-bb38-47c1-8364-f6a6b04f4939" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fed34ac2-e439-426a-b60a-748a9bfd981b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fed34ac2-e439-426a-b60a-748a9bfd981b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9d2a08eb-9e72-4caa-a8e8-bd59a43ad2ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9d2a08eb-9e72-4caa-a8e8-bd59a43ad2ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_1a1e7340-f06c-45ed-bf21-d6283041e175" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9d2a08eb-9e72-4caa-a8e8-bd59a43ad2ec" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_1a1e7340-f06c-45ed-bf21-d6283041e175" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:to="loc_us-gaap_RelatedPartyDomain_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6b8175b5-f835-4f4e-8618-e7414c7ab332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:to="loc_us-gaap_RelatedPartyDomain_6b8175b5-f835-4f4e-8618-e7414c7ab332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_b01f7721-6e0e-4a7c-97b1-69b99f9a5deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_6b8175b5-f835-4f4e-8618-e7414c7ab332" xlink:to="loc_us-gaap_CorporateJointVentureMember_b01f7721-6e0e-4a7c-97b1-69b99f9a5deb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="i87f00df980f44c199e97bf2bf85e44d4_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_fff41f20-afbb-4335-8130-9f0a9cbd609d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_fff41f20-afbb-4335-8130-9f0a9cbd609d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1f375a79-a089-4165-9b8c-26f1df5fd570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1f375a79-a089-4165-9b8c-26f1df5fd570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3796ed85-8fe5-444b-b929-894886e8092b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3796ed85-8fe5-444b-b929-894886e8092b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ba0d01-134b-4053-84f7-31577f672c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ba0d01-134b-4053-84f7-31577f672c2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_e8f48e06-1fea-49d1-8e18-f05fb06b3afd" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_e8f48e06-1fea-49d1-8e18-f05fb06b3afd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_62968d26-7322-4bd2-8119-3b6a94a72b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_62968d26-7322-4bd2-8119-3b6a94a72b60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32b741ba-2bfc-44cc-9087-76ceb7b83867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32b741ba-2bfc-44cc-9087-76ceb7b83867" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_27e2e04e-107b-4de4-87af-4424add1ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_27e2e04e-107b-4de4-87af-4424add1ce66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_387408b5-3ffe-4402-83e9-a40473f83325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_387408b5-3ffe-4402-83e9-a40473f83325" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_cd0ac438-41b5-4607-9360-8d95e891015d" xlink:href="mck-20220331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_cd0ac438-41b5-4607-9360-8d95e891015d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8152db4c-56f2-4f8d-8fa8-2963c940ef76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8152db4c-56f2-4f8d-8fa8-2963c940ef76" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_c8498a3e-4de3-4c3f-958a-1814727905a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_c8498a3e-4de3-4c3f-958a-1814727905a5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:to="loc_us-gaap_PlanNameDomain_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ab2d3cb8-a2e2-46fe-a176-b862a698cb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:to="loc_us-gaap_PlanNameDomain_ab2d3cb8-a2e2-46fe-a176-b862a698cb26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember_5edf87c7-b609-4670-a210-b045510f7408" xlink:href="mck-20220331.xsd#mck_A2013StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ab2d3cb8-a2e2-46fe-a176-b862a698cb26" xlink:to="loc_mck_A2013StockPlanMember_5edf87c7-b609-4670-a210-b045510f7408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4aac6f9-50b8-436e-9c94-dafbbc5a451e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4aac6f9-50b8-436e-9c94-dafbbc5a451e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9946d6ba-7f06-4407-96c3-640a7e9d73db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9946d6ba-7f06-4407-96c3-640a7e9d73db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember_b4b548b6-a10c-444d-8b17-0099ba6afb62" xlink:href="mck-20220331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_mck_PerformancebasedStockUnitsMember_b4b548b6-a10c-444d-8b17-0099ba6afb62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4f97c219-640b-4575-ae66-90adf0f95b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4f97c219-640b-4575-ae66-90adf0f95b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_56c78247-f256-46f6-9b32-674f19f0e234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_us-gaap_EmployeeStockMember_56c78247-f256-46f6-9b32-674f19f0e234" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2319d29-ccf8-492d-907f-ad7144a5e821_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:to="loc_srt_RangeMember_e2319d29-ccf8-492d-907f-ad7144a5e821_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:to="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_592a5287-0ef9-49b9-8140-f13e33734d7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:to="loc_srt_MinimumMember_592a5287-0ef9-49b9-8140-f13e33734d7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4de09b01-4042-408e-86e9-d10466d4f301" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:to="loc_srt_MaximumMember_4de09b01-4042-408e-86e9-d10466d4f301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_920dfeea-3a49-45a0-9376-b0a5808ddaee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_920dfeea-3a49-45a0-9376-b0a5808ddaee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b675e63-2cfa-40a1-99cd-f475f9683cfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b675e63-2cfa-40a1-99cd-f475f9683cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_4b0d3c9f-37f1-4dba-a642-e0074bb50b25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b675e63-2cfa-40a1-99cd-f475f9683cfe" xlink:to="loc_srt_DirectorMember_4b0d3c9f-37f1-4dba-a642-e0074bb50b25" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended" id="i7d92e892a87c40a2bc10299584a1ae0e_ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_66911ff8-0f39-4c5c-8979-cc08d5b9d04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_66911ff8-0f39-4c5c-8979-cc08d5b9d04c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_bfb3635e-e6bf-41ab-be86-a6ae91f70cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_bfb3635e-e6bf-41ab-be86-a6ae91f70cb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_9cfd574d-19f7-47de-b732-ffea6fb4ed1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_9cfd574d-19f7-47de-b732-ffea6fb4ed1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:to="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_89c531be-4209-4aef-8b49-a2c44de66e60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_89c531be-4209-4aef-8b49-a2c44de66e60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_dff5e538-13a3-44f8-844e-a837625cbaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_dff5e538-13a3-44f8-844e-a837625cbaf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_316bf5fe-9131-45ab-9e39-3ff262d052f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:to="loc_us-gaap_StockOptionMember_316bf5fe-9131-45ab-9e39-3ff262d052f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_19e8ee8c-2726-4be6-b58e-11a93dba462f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:to="loc_us-gaap_EmployeeStockMember_19e8ee8c-2726-4be6-b58e-11a93dba462f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended" id="i4d10d77e9eab40cd8f2e646ce40ed47e_ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4b252cde-7451-4d59-a2b4-0a72e61e8661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4b252cde-7451-4d59-a2b4-0a72e61e8661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_847f59fd-c575-4bb0-be37-591fee3675fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_847f59fd-c575-4bb0-be37-591fee3675fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6224913e-979d-4d3c-8e37-d3e2b7f4e0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6224913e-979d-4d3c-8e37-d3e2b7f4e0bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b703273a-10af-4da6-9ddb-782289551163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b703273a-10af-4da6-9ddb-782289551163" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:to="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3809d7b-d08e-4d00-8234-5b91db7b8f1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3809d7b-d08e-4d00-8234-5b91db7b8f1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_885f1afc-5d3c-4a00-b874-ed539b4950ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_885f1afc-5d3c-4a00-b874-ed539b4950ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_1629b035-f498-4e1b-825d-989e64bf5f4b" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_885f1afc-5d3c-4a00-b874-ed539b4950ec" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_1629b035-f498-4e1b-825d-989e64bf5f4b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended" id="i6657c4bbf86d4097a74e84ef864a3b4e_ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295f96c-93b3-4b88-bf65-dd6537f6a59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295f96c-93b3-4b88-bf65-dd6537f6a59c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3b29e54a-d566-4cbb-b442-c247d3263ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3b29e54a-d566-4cbb-b442-c247d3263ff6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_5cf8f4b8-f90b-43bf-802c-62ea652dad81" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_5cf8f4b8-f90b-43bf-802c-62ea652dad81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c677c35b-0385-4527-b2ab-adf12a92adfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c677c35b-0385-4527-b2ab-adf12a92adfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3a428c55-e649-4286-90b8-9385e3a643e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1e688e9a-3f26-4ddc-b84f-263b1182a309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1e688e9a-3f26-4ddc-b84f-263b1182a309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e252020-45c4-43d6-bf66-bf8c0df2be3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e252020-45c4-43d6-bf66-bf8c0df2be3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_446fce5b-7ff3-48a7-8984-b7391694670c" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_446fce5b-7ff3-48a7-8984-b7391694670c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bfcaf8c7-6088-4fdb-a9f9-b3687c20bf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bfcaf8c7-6088-4fdb-a9f9-b3687c20bf08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d90cb223-1cb2-49bc-a56d-f82b85e7dad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:to="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09b472b3-ca3a-4454-b1ad-9d7229632250_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09b472b3-ca3a-4454-b1ad-9d7229632250_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc5f9c87-3356-4615-8a28-af6acc50a19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc5f9c87-3356-4615-8a28-af6acc50a19d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_14e28b6a-8e6b-4ddb-a63e-2515ba4c80be" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc5f9c87-3356-4615-8a28-af6acc50a19d" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_14e28b6a-8e6b-4ddb-a63e-2515ba4c80be" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended" id="i7aa21cda0bdf413baf742587dc070378_ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5a17b263-0955-46f9-8026-70dd01ce4663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5a17b263-0955-46f9-8026-70dd01ce4663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d19a983b-02fd-4fb9-a4ce-c4238e47051f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d19a983b-02fd-4fb9-a4ce-c4238e47051f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_efa93eb8-493f-45cd-84db-323922f604a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_efa93eb8-493f-45cd-84db-323922f604a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:to="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d475d8-f806-4cb6-a003-7aaf7da19c0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06d475d8-f806-4cb6-a003-7aaf7da19c0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_411d92d5-8910-4fc4-8e41-05a4ebd3d564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_411d92d5-8910-4fc4-8e41-05a4ebd3d564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9903521b-d247-4fec-8736-0f909efbe594" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_411d92d5-8910-4fc4-8e41-05a4ebd3d564" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9903521b-d247-4fec-8736-0f909efbe594" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="extended" id="i11562f6600db4eceaa47f580d100fdf9_ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_51591c05-d79c-43fb-89b8-a2ca28c9502f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_51591c05-d79c-43fb-89b8-a2ca28c9502f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_abbbce1a-71f6-45f8-bdd0-392ac47ecf89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_abbbce1a-71f6-45f8-bdd0-392ac47ecf89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f46cb91f-9540-4360-ad60-203bb9747cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f46cb91f-9540-4360-ad60-203bb9747cc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d4f7149b-b306-480a-b872-267e42643a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d4f7149b-b306-480a-b872-267e42643a60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:to="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_540a2086-d746-4f49-9c88-74fd97003455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_540a2086-d746-4f49-9c88-74fd97003455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e95950b2-6c2a-4052-85bb-0e9490c885bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_540a2086-d746-4f49-9c88-74fd97003455" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e95950b2-6c2a-4052-85bb-0e9490c885bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationSummaryofOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="extended" id="iac856851376b4c8ea52c8c970738a5a8_ShareBasedCompensationSummaryofOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_46e8e4ce-cd96-4c11-849c-159fdbee2ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_46e8e4ce-cd96-4c11-849c-159fdbee2ce5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_63c14f50-bad2-4269-b127-282fa05f53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_63c14f50-bad2-4269-b127-282fa05f53ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_edb883ee-a64a-4a4b-8cb5-86fb7b4aeb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_edb883ee-a64a-4a4b-8cb5-86fb7b4aeb2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_be11e6cf-712c-43fd-91e7-391efbb15a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_be11e6cf-712c-43fd-91e7-391efbb15a9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_e4bcf881-cd83-4f04-b8ca-894f1c5c6223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_e4bcf881-cd83-4f04-b8ca-894f1c5c6223" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d4eaced9-46c3-4d7e-9cfa-fdc3bdbf072c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d4eaced9-46c3-4d7e-9cfa-fdc3bdbf072c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a599f808-d2f4-48a1-913f-e1f2502ecc90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a599f808-d2f4-48a1-913f-e1f2502ecc90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca878f68-6c45-4219-81e2-4f8132e28c03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_ca878f68-6c45-4219-81e2-4f8132e28c03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeOneMember_06c468e9-609b-4b2e-a3b2-437df1992bec" xlink:href="mck-20220331.xsd#mck_RangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:to="loc_mck_RangeOneMember_06c468e9-609b-4b2e-a3b2-437df1992bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeTwoMember_686b4962-733e-46e4-a587-41a0594c43a0" xlink:href="mck-20220331.xsd#mck_RangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:to="loc_mck_RangeTwoMember_686b4962-733e-46e4-a587-41a0594c43a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended" id="icb216ef133be48938863ada74f80d428_ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9e145c18-b3ab-4206-8c30-dec180fce766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9e145c18-b3ab-4206-8c30-dec180fce766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_45fe8470-7113-4ad3-953e-f6e0b9e0f3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_45fe8470-7113-4ad3-953e-f6e0b9e0f3c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_158fd540-1a76-43cf-a684-6dbed0364784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_158fd540-1a76-43cf-a684-6dbed0364784" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d030d1b8-e5bc-4ecb-99ca-8706b19f0c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d030d1b8-e5bc-4ecb-99ca-8706b19f0c51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6423d237-21d3-4714-a77a-fd1b020eaffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6423d237-21d3-4714-a77a-fd1b020eaffb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2d2d2f9e-33e1-42f7-b81d-f06c615cb62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2d2d2f9e-33e1-42f7-b81d-f06c615cb62c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_04e470b7-68db-4837-b89c-c24a2286838c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_04e470b7-68db-4837-b89c-c24a2286838c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:to="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fdc4fafe-9e45-47bb-9280-0186d4e837fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fdc4fafe-9e45-47bb-9280-0186d4e837fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23d645bf-9692-455e-9e86-113cc0a7ad56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23d645bf-9692-455e-9e86-113cc0a7ad56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a49d634d-8b06-4628-a917-fea197cf324e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23d645bf-9692-455e-9e86-113cc0a7ad56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a49d634d-8b06-4628-a917-fea197cf324e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNetScheduleofOtherIncomeNetDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="extended" id="i244b9e417e454a7b94945eb3eb79a72e_OtherIncomeNetScheduleofOtherIncomeNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e5e44d4e-6c3e-42d4-b6f3-42a3cc7bed9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e5e44d4e-6c3e-42d4-b6f3-42a3cc7bed9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9c8da58d-2989-4e7b-9261-eaaed4bac7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9c8da58d-2989-4e7b-9261-eaaed4bac7c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_d6ea82d7-c2a1-411e-87b4-4b802feddeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_d6ea82d7-c2a1-411e-87b4-4b802feddeb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_7ed2bd4c-a6d3-455b-b03e-abf5fe09ce2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_7ed2bd4c-a6d3-455b-b03e-abf5fe09ce2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_221d3fda-1680-41a3-8496-42bf4f965928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_221d3fda-1680-41a3-8496-42bf4f965928" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0429d882-eb19-49d1-9a1a-86ba8072a3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0429d882-eb19-49d1-9a1a-86ba8072a3aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0ce04b17-b21d-46cf-b216-e0069e17c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0ce04b17-b21d-46cf-b216-e0069e17c5c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:to="loc_us-gaap_RelatedPartyDomain_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e6e11687-da31-41d5-847f-67728c700c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:to="loc_us-gaap_RelatedPartyDomain_e6e11687-da31-41d5-847f-67728c700c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_4e239ec6-fb96-4b18-a706-de1816ed98be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_e6e11687-da31-41d5-847f-67728c700c64" xlink:to="loc_srt_ExecutiveOfficerMember_4e239ec6-fb96-4b18-a706-de1816ed98be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_a2b8b214-1ab9-4664-a1fa-8ed92c06112e" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_a2b8b214-1ab9-4664-a1fa-8ed92c06112e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_c5a9052e-3063-47a3-a76f-7ed10e960b4b" xlink:href="mck-20220331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_c5a9052e-3063-47a3-a76f-7ed10e960b4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_817bef10-1bb7-43c4-a104-62e100ec1a72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_817bef10-1bb7-43c4-a104-62e100ec1a72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1537ff86-5193-4f5f-b54c-1f3fec101bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1537ff86-5193-4f5f-b54c-1f3fec101bd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_33cc2def-71ba-42b1-ad09-1b845d3d0b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1537ff86-5193-4f5f-b54c-1f3fec101bd5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_33cc2def-71ba-42b1-ad09-1b845d3d0b63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_761be32e-3226-4622-9fca-944a6e345576_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_761be32e-3226-4622-9fca-944a6e345576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3ab3242c-5cd4-4e51-aec8-809ce395e14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3ab3242c-5cd4-4e51-aec8-809ce395e14d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_93c0d05b-869d-40ca-9669-c19ddd383b79" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3ab3242c-5cd4-4e51-aec8-809ce395e14d" xlink:to="loc_mck_GermanWholesaleBusinessMember_93c0d05b-869d-40ca-9669-c19ddd383b79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f6af134f-bf6a-4292-b535-a017db1cb393_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f6af134f-bf6a-4292-b535-a017db1cb393_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c8db11f8-0367-4a17-824a-c023e16dae22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c8db11f8-0367-4a17-824a-c023e16dae22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_95086ff5-10e4-46e8-8d3b-7f166bf1d805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c8db11f8-0367-4a17-824a-c023e16dae22" xlink:to="loc_us-gaap_DomesticPlanMember_95086ff5-10e4-46e8-8d3b-7f166bf1d805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d12a417f-d6d1-4577-b5f1-1ee0d23bc21a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_95086ff5-10e4-46e8-8d3b-7f166bf1d805" xlink:to="loc_country_US_d12a417f-d6d1-4577-b5f1-1ee0d23bc21a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/OtherIncomeNetNarrativeDetails" xlink:type="extended" id="i356fc783dd784bb5aa9c468e00d21bad_OtherIncomeNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_15ba2abb-13ca-416c-bd55-20d5e77d1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_15ba2abb-13ca-416c-bd55-20d5e77d1dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0a3a525e-1ebd-49a1-9ebb-cd09554316a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0a3a525e-1ebd-49a1-9ebb-cd09554316a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_418c42d0-6aab-42f1-8f7c-c9c3a3feac89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_418c42d0-6aab-42f1-8f7c-c9c3a3feac89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_972e3c71-42cb-4eb1-a014-46d274364e66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_972e3c71-42cb-4eb1-a014-46d274364e66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_1e74083d-d502-4eec-9504-0f9037ba37eb" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_1e74083d-d502-4eec-9504-0f9037ba37eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_319b8c8f-44cf-41d0-8fbc-3dccccd95474" xlink:href="mck-20220331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_319b8c8f-44cf-41d0-8fbc-3dccccd95474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9bad9a8f-14f5-48b6-b8b0-b93709a93a72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9bad9a8f-14f5-48b6-b8b0-b93709a93a72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4acdcc5f-40c8-46b0-ae4a-c6fa93b99ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4acdcc5f-40c8-46b0-ae4a-c6fa93b99ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_4c815763-08c1-472d-a584-89a04edf6ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4acdcc5f-40c8-46b0-ae4a-c6fa93b99ac7" xlink:to="loc_us-gaap_DomesticPlanMember_4c815763-08c1-472d-a584-89a04edf6ec8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7cb82994-143a-4f9e-8405-5af1f364ca20" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_4c815763-08c1-472d-a584-89a04edf6ec8" xlink:to="loc_country_US_7cb82994-143a-4f9e-8405-5af1f364ca20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_06f833fc-a673-4713-9b8d-d6e535cb262e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_06f833fc-a673-4713-9b8d-d6e535cb262e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_72d5cb5a-71ca-4e08-941e-5a2de0275ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_72d5cb5a-71ca-4e08-941e-5a2de0275ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8fb553df-94f0-4ef4-b998-6681fd21cf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_72d5cb5a-71ca-4e08-941e-5a2de0275ed4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8fb553df-94f0-4ef4-b998-6681fd21cf6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1fe39f26-65ae-43f7-aaa4-fec812c455b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:to="loc_us-gaap_RelatedPartyDomain_1fe39f26-65ae-43f7-aaa4-fec812c455b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_50e91ba5-264d-453b-8f85-eeafaa52397c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:to="loc_us-gaap_RelatedPartyDomain_50e91ba5-264d-453b-8f85-eeafaa52397c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_f7239267-6ced-4bfd-bedc-73d244967dff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_50e91ba5-264d-453b-8f85-eeafaa52397c" xlink:to="loc_srt_ExecutiveOfficerMember_f7239267-6ced-4bfd-bedc-73d244967dff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e7f7089-e048-464b-b865-4e8884e907e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3e7f7089-e048-464b-b865-4e8884e907e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ced7b0b-3af5-4ee2-bfb6-38f886cac4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ced7b0b-3af5-4ee2-bfb6-38f886cac4e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_9755168c-b8b9-4ef3-8cf8-ab2c624ae9f7" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ced7b0b-3af5-4ee2-bfb6-38f886cac4e9" xlink:to="loc_mck_GermanWholesaleBusinessMember_9755168c-b8b9-4ef3-8cf8-ab2c624ae9f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_487957fd-1e41-453e-a207-01593c4a888e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:to="loc_srt_OwnershipDomain_487957fd-1e41-453e-a207-01593c4a888e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2670ca6d-e591-4bac-91f9-6a8b0bb94c8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:to="loc_srt_OwnershipDomain_2670ca6d-e591-4bac-91f9-6a8b0bb94c8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_26cd8225-b794-4d50-97ea-67c2d67bef5e" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_2670ca6d-e591-4bac-91f9-6a8b0bb94c8d" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_26cd8225-b794-4d50-97ea-67c2d67bef5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended" id="i183a51749ffa4b81915bb7941f6913ee_IncomeTaxesComponentsOfDeferredTaxBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f4355d20-47ca-4f04-a1c4-65893478163e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f4355d20-47ca-4f04-a1c4-65893478163e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_7b5b7ff5-76f1-475a-8b95-70de67edb80a" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_7b5b7ff5-76f1-475a-8b95-70de67edb80a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_d29c7f12-3f31-4f5d-8d96-3fd4ef5e2fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_d29c7f12-3f31-4f5d-8d96-3fd4ef5e2fe6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_27511d4e-8677-471f-8fdc-1328b78bfa6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_27511d4e-8677-471f-8fdc-1328b78bfa6e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_4f2f6bc7-798d-4a6a-a417-3d1cd33a6c06" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_4f2f6bc7-798d-4a6a-a417-3d1cd33a6c06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_26900cce-5b99-4376-ba14-f251574d5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_26900cce-5b99-4376-ba14-f251574d5e2a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_23062d0c-d998-48f0-a2f5-759176a8f535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_23062d0c-d998-48f0-a2f5-759176a8f535" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_222ae965-d11a-445f-8fcb-d2f765c54975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_222ae965-d11a-445f-8fcb-d2f765c54975" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_76d7daab-c5eb-4eae-bbfa-b428eddefd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_76d7daab-c5eb-4eae-bbfa-b428eddefd77" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_f7d3d5c4-d8c2-4bc9-b763-e1876dc8f248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_f7d3d5c4-d8c2-4bc9-b763-e1876dc8f248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6b42616b-e17e-4a46-9b56-fea61a360970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6b42616b-e17e-4a46-9b56-fea61a360970" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2a2601ee-b1c9-4168-ba75-f4e3226c5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2a2601ee-b1c9-4168-ba75-f4e3226c5ec6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_b6f3e188-848a-4053-bda4-6e4e9be3a853" xlink:href="mck-20220331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_b6f3e188-848a-4053-bda4-6e4e9be3a853" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_928b8ecd-34d5-48b3-89d3-93819cbcac54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_928b8ecd-34d5-48b3-89d3-93819cbcac54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_eac9856d-bbf4-4e9b-be27-fe8f4a41f56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_eac9856d-bbf4-4e9b-be27-fe8f4a41f56b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_9de49c07-7294-42fa-8b61-36f1a50f5ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_DeferredTaxLiabilities_9de49c07-7294-42fa-8b61-36f1a50f5ccc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_852d77ca-054c-4885-98a1-85cddae963f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_852d77ca-054c-4885-98a1-85cddae963f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c7e1538-836d-4b9c-accd-6f77bb35a285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c7e1538-836d-4b9c-accd-6f77bb35a285" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fda24bb9-7542-4f5f-bce7-70ffd67496b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fda24bb9-7542-4f5f-bce7-70ffd67496b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f5fab197-47d3-4b80-ad2f-55d93b1cfc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f5fab197-47d3-4b80-ad2f-55d93b1cfc8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_02170bde-2db2-4876-88f4-2ab061e798bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f5fab197-47d3-4b80-ad2f-55d93b1cfc8f" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_02170bde-2db2-4876-88f4-2ab061e798bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d5f54f5-f641-437a-8521-62ddc42c8793_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d5f54f5-f641-437a-8521-62ddc42c8793_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_61d4bc6b-e352-4b9e-abd0-eec87b082c14" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_61d4bc6b-e352-4b9e-abd0-eec87b082c14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_f54e8056-7edb-4740-8e83-8c438f748935" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_f54e8056-7edb-4740-8e83-8c438f748935" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="iabab35c254ca43d18de7d8ae4ee45364_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a0759a4a-0376-4baf-b022-2c2844095ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a0759a4a-0376-4baf-b022-2c2844095ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_0a9831ab-dfca-4694-bf81-c5831a6a450b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_0a9831ab-dfca-4694-bf81-c5831a6a450b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_456e84e8-a895-4556-ac0a-588814607b29" xlink:href="mck-20220331.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_456e84e8-a895-4556-ac0a-588814607b29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_322bef9c-91ba-4ff4-b754-3ca9d7800a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_322bef9c-91ba-4ff4-b754-3ca9d7800a6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_52ce3b07-bddf-4f4f-8d18-592e4067f780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_52ce3b07-bddf-4f4f-8d18-592e4067f780" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_76c2c730-2eec-4df0-b930-4feda5f4ab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_76c2c730-2eec-4df0-b930-4feda5f4ab7a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_e2f4aae0-8a50-4827-8b9e-cbcc5c157c11" xlink:href="mck-20220331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_e2f4aae0-8a50-4827-8b9e-cbcc5c157c11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_39306056-86e5-41ce-b3b7-12b0fa5c2028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_39306056-86e5-41ce-b3b7-12b0fa5c2028" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bafad565-d990-4e0a-8066-d507373ed04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bafad565-d990-4e0a-8066-d507373ed04c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_dc4fd177-a195-4c8e-8e84-ebae67d3b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_dc4fd177-a195-4c8e-8e84-ebae67d3b957" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ad89a89a-82b1-4ded-9fc4-33c196b1aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ad89a89a-82b1-4ded-9fc4-33c196b1aec6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a5b413ee-e503-4c1b-bbf0-ed26e6c5b456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a5b413ee-e503-4c1b-bbf0-ed26e6c5b456" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eba4c736-4576-4015-9e8a-8ac384a1278d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eba4c736-4576-4015-9e8a-8ac384a1278d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3a566323-1734-4188-ab45-e042652e6908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3a566323-1734-4188-ab45-e042652e6908" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_12e9f60b-f51a-4f2a-8122-a721545b1212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_12e9f60b-f51a-4f2a-8122-a721545b1212" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_28512066-0443-40b6-8192-e3fb8231d7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_28512066-0443-40b6-8192-e3fb8231d7e1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a0af67d1-7223-4d0f-81b9-5dc09976770d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a0af67d1-7223-4d0f-81b9-5dc09976770d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_57527706-525e-4600-9d25-f150adf5cbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_57527706-525e-4600-9d25-f150adf5cbb9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_c0ed8b63-c289-4823-9958-692731620f48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_c0ed8b63-c289-4823-9958-692731620f48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9a33c999-e726-4884-9397-d879ae88afe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9a33c999-e726-4884-9397-d879ae88afe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_53cb7ac2-bbd2-494e-a0c0-ee1a4d11addd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9a33c999-e726-4884-9397-d879ae88afe4" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_53cb7ac2-bbd2-494e-a0c0-ee1a4d11addd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_480facbd-715a-4f81-a694-8f915e50bf2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_480facbd-715a-4f81-a694-8f915e50bf2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_96d1a8d9-8f42-4b25-a909-175183296cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_96d1a8d9-8f42-4b25-a909-175183296cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_e0d03177-eccb-4263-925f-4a5014ccef06" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_96d1a8d9-8f42-4b25-a909-175183296cea" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_e0d03177-eccb-4263-925f-4a5014ccef06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_037836de-9762-43a8-ad96-4f4ca349589e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:to="loc_us-gaap_SegmentDomain_037836de-9762-43a8-ad96-4f4ca349589e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_192305e4-cab5-47ff-917a-631c4de4ad71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:to="loc_us-gaap_SegmentDomain_192305e4-cab5-47ff-917a-631c4de4ad71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_799f7f6e-8437-4380-91af-a87a58f0ea9e" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_192305e4-cab5-47ff-917a-631c4de4ad71" xlink:to="loc_mck_InternationalSegmentMember_799f7f6e-8437-4380-91af-a87a58f0ea9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b4971b4c-79f7-4c90-b646-4827d803d7b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b4971b4c-79f7-4c90-b646-4827d803d7b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1e1af05f-ae28-457d-85c2-1710ed93ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:to="loc_us-gaap_DomesticCountryMember_1e1af05f-ae28-457d-85c2-1710ed93ea90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_eb09823b-89bc-4ed7-abb9-fa0f544b772b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_eb09823b-89bc-4ed7-abb9-fa0f544b772b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_23fefd11-9688-420b-95a8-f2fe2e078e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:to="loc_us-gaap_ForeignCountryMember_23fefd11-9688-420b-95a8-f2fe2e078e6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ed0b6ea6-e755-4523-bb05-fc5ec36af535_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ed0b6ea6-e755-4523-bb05-fc5ec36af535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ca242776-53ea-40b2-9c30-783879ed9d67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ca242776-53ea-40b2-9c30-783879ed9d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6321f8d5-37a6-4155-9511-ae6bdfe40a85" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ca242776-53ea-40b2-9c30-783879ed9d67" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6321f8d5-37a6-4155-9511-ae6bdfe40a85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b0cb4f35-7475-440a-8126-513766643701_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:to="loc_us-gaap_RelatedPartyDomain_b0cb4f35-7475-440a-8126-513766643701_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fcd14f15-c394-49cd-b869-117add480add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:to="loc_us-gaap_RelatedPartyDomain_fcd14f15-c394-49cd-b869-117add480add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_d246a680-026c-42c2-a06e-6cbb721df2be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fcd14f15-c394-49cd-b869-117add480add" xlink:to="loc_us-gaap_CorporateJointVentureMember_d246a680-026c-42c2-a06e-6cbb721df2be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6ff1e426-758a-40e7-a96b-6ac49fe9e17d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6ff1e426-758a-40e7-a96b-6ac49fe9e17d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4b20c241-f5a5-461f-a649-08f220114dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4b20c241-f5a5-461f-a649-08f220114dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b6365c6d-350a-42c5-b1a6-4941e0b2c3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4b20c241-f5a5-461f-a649-08f220114dbf" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b6365c6d-350a-42c5-b1a6-4941e0b2c3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79057296-06b4-4aad-bbe8-5e98cf0139cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_79057296-06b4-4aad-bbe8-5e98cf0139cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_8d84d480-f115-44f8-a11b-8767fcb3cafd" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_8d84d480-f115-44f8-a11b-8767fcb3cafd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_7f24f8df-17f1-4e9e-bb2c-078f2b7a7695" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:to="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_7f24f8df-17f1-4e9e-bb2c-078f2b7a7695" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="ifdaf93f1534949398e2e0b77004449b0_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_d6db88db-834a-428c-b79f-4c400e0bd80a" xlink:href="mck-20220331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_d6db88db-834a-428c-b79f-4c400e0bd80a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_684826d9-24b4-418e-81e0-834577c80532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_684826d9-24b4-418e-81e0-834577c80532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_475d04b1-a9da-4873-80b3-05cd4c724795" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_475d04b1-a9da-4873-80b3-05cd4c724795" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_e35aca81-ba7b-4a74-aa1f-3117bb62ace0" xlink:href="mck-20220331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_PutRightValueInterestRateSpread_e35aca81-ba7b-4a74-aa1f-3117bb62ace0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_aeb8dc2b-628c-46d4-950a-35a44a7095ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_aeb8dc2b-628c-46d4-950a-35a44a7095ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bbb42b5b-7f68-4136-bc60-7437f335eb9f" xlink:href="mck-20220331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bbb42b5b-7f68-4136-bc60-7437f335eb9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_7a19f300-db91-4939-a73e-35a02994f306" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_7a19f300-db91-4939-a73e-35a02994f306" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_f417318d-983f-4aa9-ba8c-7a78ba45644c" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_f417318d-983f-4aa9-ba8c-7a78ba45644c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_304cdcc5-c529-4492-a524-0fd73c564324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_304cdcc5-c529-4492-a524-0fd73c564324" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_c68d4480-6af1-4d04-839b-5ac099dab411" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_c68d4480-6af1-4d04-839b-5ac099dab411" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8734b571-104b-4f73-a9af-acdec11487a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8734b571-104b-4f73-a9af-acdec11487a6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fb621fdb-b359-40b0-baf9-648a517adc1a" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fb621fdb-b359-40b0-baf9-648a517adc1a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f59b088b-16e7-46d5-9600-fce68aec3219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_MinorityInterest_f59b088b-16e7-46d5-9600-fce68aec3219" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_774a52f8-99c7-4817-bb44-3e82918f377f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_774a52f8-99c7-4817-bb44-3e82918f377f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d8166d56-8ad3-4915-88d8-c496498c7bd0_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:to="loc_dei_EntityDomain_d8166d56-8ad3-4915-88d8-c496498c7bd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_de737061-11a6-4c8e-839b-33237ca962c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:to="loc_dei_EntityDomain_de737061-11a6-4c8e-839b-33237ca962c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_db233137-c21f-422a-94ee-111fd23b95ad" xlink:href="mck-20220331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_de737061-11a6-4c8e-839b-33237ca962c7" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_db233137-c21f-422a-94ee-111fd23b95ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_eab5b9ba-6ebe-4167-a62e-a411530ed12e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:to="loc_srt_OwnershipDomain_eab5b9ba-6ebe-4167-a62e-a411530ed12e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:to="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_cee1d1cb-a1d7-4612-a1ef-c1f0be85918b" xlink:href="mck-20220331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_cee1d1cb-a1d7-4612-a1ef-c1f0be85918b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_191ba972-c564-4bdb-92ac-45f85450764e" xlink:href="mck-20220331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_191ba972-c564-4bdb-92ac-45f85450764e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:to="loc_us-gaap_EquityComponentDomain_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:to="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_00c1d891-e15f-4d96-8f11-bc78111797b2" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_00c1d891-e15f-4d96-8f11-bc78111797b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fa6554b4-1dfc-4ce4-bb9f-5982a883e392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fa6554b4-1dfc-4ce4-bb9f-5982a883e392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_385c360b-7e2a-4c71-bef0-3ec5d07cf1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_385c360b-7e2a-4c71-bef0-3ec5d07cf1cb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended" id="i4f395eafac31426f966d4b992c358a14_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_70eec511-6487-49c6-9fca-3f921c60cd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_70eec511-6487-49c6-9fca-3f921c60cd6d" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3f04f2b6-fdc1-4f0f-b37f-17ef525287c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_MinorityInterest_3f04f2b6-fdc1-4f0f-b37f-17ef525287c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_e95f09a7-f671-4078-9cec-cfe64d8ad00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_e95f09a7-f671-4078-9cec-cfe64d8ad00e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff2e545e-4fbe-4613-aefc-8b7ce572165f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff2e545e-4fbe-4613-aefc-8b7ce572165f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_62e19540-631e-4b99-97ab-18915ed69e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_62e19540-631e-4b99-97ab-18915ed69e85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_15e9cdbe-7fd3-4b21-af7a-c786599cf727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_15e9cdbe-7fd3-4b21-af7a-c786599cf727" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_853006a1-8199-4c89-bdfc-74ad69c9305c" xlink:href="mck-20220331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_853006a1-8199-4c89-bdfc-74ad69c9305c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d0bf9864-3c84-42c5-b106-5ab8743b8924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d0bf9864-3c84-42c5-b106-5ab8743b8924" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_44fc73bc-adea-41d6-8f62-a75d3d788ef2" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_44fc73bc-adea-41d6-8f62-a75d3d788ef2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_d7c1083b-d468-4c8a-8d3d-ea1c93363e49" xlink:href="mck-20220331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_d7c1083b-d468-4c8a-8d3d-ea1c93363e49" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e83de48a-2bcb-4274-9d8d-a335fd4060ea" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e83de48a-2bcb-4274-9d8d-a335fd4060ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b3d6c656-693b-4ff3-8052-65833616c585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0f0499e6-c65f-4373-9108-719b2a2c7cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_70eec511-6487-49c6-9fca-3f921c60cd6d" xlink:to="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5e744308-54a4-4a19-a140-edb2973f99fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:to="loc_us-gaap_EquityComponentDomain_5e744308-54a4-4a19-a140-edb2973f99fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:to="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_93b01913-670a-43d1-8254-05537d202561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:to="loc_us-gaap_NoncontrollingInterestMember_93b01913-670a-43d1-8254-05537d202561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_297bebe2-3ec4-4af0-8ed8-fb2686a79054" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_297bebe2-3ec4-4af0-8ed8-fb2686a79054" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended" id="ic2c0a7229a6347f1bb7b448f222cf8a2_EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4725a638-83db-4094-a331-c6c43f483503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4725a638-83db-4094-a331-c6c43f483503" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff836cd0-09a9-436c-8a79-1a35e84be837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff836cd0-09a9-436c-8a79-1a35e84be837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c977e997-3a21-4221-8da2-0dedb86a5e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c977e997-3a21-4221-8da2-0dedb86a5e99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3dfdf19a-97cf-40f0-89a9-c69bfa11a791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3dfdf19a-97cf-40f0-89a9-c69bfa11a791" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6357a08f-3c1f-4ef0-8d0c-e1c338a2e7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_NetIncomeLoss_6357a08f-3c1f-4ef0-8d0c-e1c338a2e7b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_55d52a63-96be-4914-a705-43798771810b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_55d52a63-96be-4914-a705-43798771810b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9b36406-9681-41dc-a7ac-1d3d49f7e07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_55d52a63-96be-4914-a705-43798771810b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9b36406-9681-41dc-a7ac-1d3d49f7e07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_533d03a1-8401-4211-bcca-6c3547a4f049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_533d03a1-8401-4211-bcca-6c3547a4f049" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b35530c-04f9-47ed-abd3-46bb5a70be3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b35530c-04f9-47ed-abd3-46bb5a70be3e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d9a13a44-48e6-403d-9d7e-a581fca2e270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d9a13a44-48e6-403d-9d7e-a581fca2e270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_815affa0-657f-4921-861a-640a1cbce227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_815affa0-657f-4921-861a-640a1cbce227" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b313342-cc01-421c-9d5c-c43f2e54fca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b313342-cc01-421c-9d5c-c43f2e54fca0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_73388fe7-c6aa-4504-8610-5c6d2f06c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_73388fe7-c6aa-4504-8610-5c6d2f06c85a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_31ad4a66-593f-4ef7-bd70-fca93c9762ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_31ad4a66-593f-4ef7-bd70-fca93c9762ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_79254246-6719-4cb1-8237-60827ca659b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:to="loc_us-gaap_EarningsPerShareBasic_79254246-6719-4cb1-8237-60827ca659b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:to="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f003719-382c-4fec-b317-38d3d74e2aa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f003719-382c-4fec-b317-38d3d74e2aa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e2775ff-f949-4728-a973-99e28ac5ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e2775ff-f949-4728-a973-99e28ac5ed36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3715f4d2-f1af-40af-b768-ac87e02e4dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e2775ff-f949-4728-a973-99e28ac5ed36" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3715f4d2-f1af-40af-b768-ac87e02e4dd6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i8cb8a055204f45d2bab6b8fe42c38871_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a57daa26-ec9c-482a-9ee2-af05bc6936d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_OperatingLeaseLiability_a57daa26-ec9c-482a-9ee2-af05bc6936d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5a8ad77d-2858-4f77-9a4f-6227e2ce5e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5a8ad77d-2858-4f77-9a4f-6227e2ce5e40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e5c1efe6-d7f2-4e3f-8074-fcad73a4645f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e5c1efe6-d7f2-4e3f-8074-fcad73a4645f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseImpairmentLossNetOfTax_77f405bd-2b81-43ae-aabb-0e1abc458314" xlink:href="mck-20220331.xsd#mck_OperatingLeaseImpairmentLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_mck_OperatingLeaseImpairmentLossNetOfTax_77f405bd-2b81-43ae-aabb-0e1abc458314" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6b86cf34-15df-4e2b-9946-86b748023d61" xlink:href="mck-20220331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6b86cf34-15df-4e2b-9946-86b748023d61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_96f0467d-e62e-4e37-aedf-2d4cc075590c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_96f0467d-e62e-4e37-aedf-2d4cc075590c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_496ea35f-6a98-40f0-b11b-629baa6874d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_496ea35f-6a98-40f0-b11b-629baa6874d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_b41e940a-d92c-4cd1-bf6e-dff97faad247" xlink:href="mck-20220331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_b41e940a-d92c-4cd1-bf6e-dff97faad247" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2970e45a-74d2-434b-aa72-4b42001257fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:to="loc_us-gaap_EquityComponentDomain_2970e45a-74d2-434b-aa72-4b42001257fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_acdbcae8-e1fb-470c-9226-593b8a8b63cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:to="loc_us-gaap_EquityComponentDomain_acdbcae8-e1fb-470c-9226-593b8a8b63cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f70b9537-9651-4951-8993-fc01e379f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_acdbcae8-e1fb-470c-9226-593b8a8b63cb" xlink:to="loc_us-gaap_RetainedEarningsMember_f70b9537-9651-4951-8993-fc01e379f9a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36dcb616-1c74-4bae-bcd7-d719af0ee608_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:to="loc_srt_RangeMember_36dcb616-1c74-4bae-bcd7-d719af0ee608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:to="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_afbdee87-846b-44b9-9bb0-ee5f9a0b2afa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:to="loc_srt_MinimumMember_afbdee87-846b-44b9-9bb0-ee5f9a0b2afa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73635aa7-637a-47a8-b622-083d2a46d2f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:to="loc_srt_MaximumMember_73635aa7-637a-47a8-b622-083d2a46d2f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a98a1f77-87fc-403a-b659-bba03601c269_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a98a1f77-87fc-403a-b659-bba03601c269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17e70520-20ee-4d82-845a-50fd1bbe7275" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17e70520-20ee-4d82-845a-50fd1bbe7275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4808d6c3-ef35-4291-a1b5-db3bef828cf9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17e70520-20ee-4d82-845a-50fd1bbe7275" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4808d6c3-ef35-4291-a1b5-db3bef828cf9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesSupplementalbalancesheetinformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="extended" id="i04286acf017c4ee283c24f92483c8939_LeasesSupplementalbalancesheetinformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_70d70d52-a65d-4243-aa05-896a32335178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_70d70d52-a65d-4243-aa05-896a32335178" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9d1e5962-30dc-434b-9c12-b40556bab27c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9d1e5962-30dc-434b-9c12-b40556bab27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_40acfecd-d0c2-4917-8403-4b4a8a637869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_40acfecd-d0c2-4917-8403-4b4a8a637869" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_372a3b8f-be5c-4a8b-babe-9ef4c23be673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseLiability_372a3b8f-be5c-4a8b-babe-9ef4c23be673" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_298de2c7-40ab-43d4-a700-0ad79b996157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_298de2c7-40ab-43d4-a700-0ad79b996157" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_11ed2bfa-50b1-4cfc-8ae1-9ee094a0fb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_11ed2bfa-50b1-4cfc-8ae1-9ee094a0fb37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_34e12b8a-de7b-4672-b319-3bdf21b673fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_34e12b8a-de7b-4672-b319-3bdf21b673fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_2ea9b296-9fc3-4a0f-9e36-dbced9780a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_2ea9b296-9fc3-4a0f-9e36-dbced9780a0f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d68a6e07-77b4-4868-831a-b4e3a8d7538f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d68a6e07-77b4-4868-831a-b4e3a8d7538f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eec07607-0228-47c0-a039-3331975853f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eec07607-0228-47c0-a039-3331975853f3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7911cf02-3f7f-429b-b6c3-61f575296292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiability_7911cf02-3f7f-429b-b6c3-61f575296292" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4e0aad62-2042-40ba-8a46-c47fc57cca04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4e0aad62-2042-40ba-8a46-c47fc57cca04" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_87805c1d-e14b-4612-adab-8f839ca93b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_87805c1d-e14b-4612-adab-8f839ca93b75" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cb8c0c22-e209-4144-8003-7c10d4601463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cb8c0c22-e209-4144-8003-7c10d4601463" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_31b0f7b4-6aaf-4410-a69a-27f80240a53a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_31b0f7b4-6aaf-4410-a69a-27f80240a53a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_ea6bef04-cf97-400f-b6cb-9cdc4ae3a09a" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_ea6bef04-cf97-400f-b6cb-9cdc4ae3a09a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_2a5a8805-67ee-4d3c-a273-980feb37fd02" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_2a5a8805-67ee-4d3c-a273-980feb37fd02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0ce42a9f-0908-475d-9592-4c0ed882d4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0ce42a9f-0908-475d-9592-4c0ed882d4e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2421560d-616e-4251-abc8-73c367cc60c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0ce42a9f-0908-475d-9592-4c0ed882d4e6" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2421560d-616e-4251-abc8-73c367cc60c5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="i4d3e1a816c7047f5bb7c6f20d9897ecd_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_653f8946-af1a-44d9-8639-785e057f4b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_653f8946-af1a-44d9-8639-785e057f4b23" xlink:to="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e33570fa-6110-4430-8fef-a6ba12df2845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_Goodwill_e33570fa-6110-4430-8fef-a6ba12df2845" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b3f629da-8438-44fe-8198-f67bfc2c54db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b3f629da-8438-44fe-8198-f67bfc2c54db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_db5e7e44-3252-4810-985c-8cfa8c43cc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_db5e7e44-3252-4810-985c-8cfa8c43cc7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_c66ed8e7-ce3d-466b-a55e-2d441cb163b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_c66ed8e7-ce3d-466b-a55e-2d441cb163b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c5628077-75c5-429a-b6df-5151d5a0cde6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c5628077-75c5-429a-b6df-5151d5a0cde6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6add13e-3256-4ca0-bb30-a0670c060438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6add13e-3256-4ca0-bb30-a0670c060438" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1463c048-db09-47cd-83c3-3605d0332c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_653f8946-af1a-44d9-8639-785e057f4b23" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f952ea30-ed13-4d08-9fee-9ea732957fd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:to="loc_us-gaap_SegmentDomain_f952ea30-ed13-4d08-9fee-9ea732957fd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:to="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_2cba7698-11c3-423a-8ae8-876c72923ec9" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_USPharmaceuticalSegmentMember_2cba7698-11c3-423a-8ae8-876c72923ec9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_447d85b9-5848-4bc8-85ad-645748d4477c" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_447d85b9-5848-4bc8-85ad-645748d4477c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_ce90f557-68e8-4af7-973c-a67a07deec4f" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_ce90f557-68e8-4af7-973c-a67a07deec4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_1fbf21f3-e94b-40d4-b9df-bc2c2ce3503b" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_InternationalSegmentMember_1fbf21f3-e94b-40d4-b9df-bc2c2ce3503b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended" id="iabc94df48adf46fa8251edfd4ef8142c_GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_8af0d26e-1bed-46ef-a171-7b110008faa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_NumberOfReportableSegments_8af0d26e-1bed-46ef-a171-7b110008faa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_14d93e4a-c8df-4943-a421-9011ef8ef89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_14d93e4a-c8df-4943-a421-9011ef8ef89a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d2542a38-eee5-4740-a1de-6f42768fc755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_Goodwill_d2542a38-eee5-4740-a1de-6f42768fc755" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_530c1f7f-ed1b-4989-ad83-4f1329b309f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_530c1f7f-ed1b-4989-ad83-4f1329b309f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_5030b714-4a6e-45cb-a482-5f2ea5511eea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:to="loc_us-gaap_ReportingUnitDomain_5030b714-4a6e-45cb-a482-5f2ea5511eea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_410e70a5-d044-43a7-9a48-e85b9f9b24a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:to="loc_us-gaap_ReportingUnitDomain_410e70a5-d044-43a7-9a48-e85b9f9b24a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_6f9f7a81-965d-4768-a2e6-683a9bde41b5" xlink:href="mck-20220331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_410e70a5-d044-43a7-9a48-e85b9f9b24a5" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_6f9f7a81-965d-4768-a2e6-683a9bde41b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b971f767-f423-43c1-a095-69842f16cb97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:to="loc_us-gaap_SegmentDomain_b971f767-f423-43c1-a095-69842f16cb97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3a842c5-23b7-4cb9-bbdb-3176cb634e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:to="loc_us-gaap_SegmentDomain_d3a842c5-23b7-4cb9-bbdb-3176cb634e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a6c14671-0301-49b3-8373-81a2d9883a1f" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3a842c5-23b7-4cb9-bbdb-3176cb634e71" xlink:to="loc_mck_InternationalSegmentMember_a6c14671-0301-49b3-8373-81a2d9883a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_16864827-1c99-49bc-b007-00e278049fe5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:to="loc_srt_SegmentGeographicalDomain_16864827-1c99-49bc-b007-00e278049fe5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a11e85e-cd8c-4185-a5db-7e53f1984995" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:to="loc_srt_SegmentGeographicalDomain_3a11e85e-cd8c-4185-a5db-7e53f1984995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_9cd7b535-9365-4559-adfd-d92283fae062" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3a11e85e-cd8c-4185-a5db-7e53f1984995" xlink:to="loc_srt_EuropeMember_9cd7b535-9365-4559-adfd-d92283fae062" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="i2899b498f2f246bbb419562f2abe9150_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_27ae7f76-b50e-4213-b698-fca1698d326b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_27ae7f76-b50e-4213-b698-fca1698d326b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0b36fb05-80f9-4adc-ad96-15cbd0059cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0b36fb05-80f9-4adc-ad96-15cbd0059cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fc336b7a-ba98-4ec4-a9e2-78dcd9f2a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fc336b7a-ba98-4ec4-a9e2-78dcd9f2a89e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0b434a2-7457-4779-ab18-27714ebe8a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0b434a2-7457-4779-ab18-27714ebe8a88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_52911a1a-6549-43de-81df-e2b79ed17a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_52911a1a-6549-43de-81df-e2b79ed17a19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83004d64-17b7-477f-83ae-1e8bd22f4566_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83004d64-17b7-477f-83ae-1e8bd22f4566_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_64991e43-9646-47d1-972c-51b187a05830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_CustomerRelationshipsMember_64991e43-9646-47d1-972c-51b187a05830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_ebabcd08-f976-4ae9-b5b7-14bdce883af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_ServiceAgreementsMember_ebabcd08-f976-4ae9-b5b7-14bdce883af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_2d29d891-7823-4e8b-993f-63138647ed0f" xlink:href="mck-20220331.xsd#mck_PharmacyLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_mck_PharmacyLicensesMember_2d29d891-7823-4e8b-993f-63138647ed0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d1ceebf7-e53f-4709-a4ff-20ea2d2cfed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d1ceebf7-e53f-4709-a4ff-20ea2d2cfed8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dee595f5-75ac-42fd-aef0-cb45b78ee9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dee595f5-75ac-42fd-aef0-cb45b78ee9e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_1adf0f19-b496-45cb-ba70-09333a62d295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_1adf0f19-b496-45cb-ba70-09333a62d295" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_37c03848-1be1-48b3-8275-23e82260bb50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_37c03848-1be1-48b3-8275-23e82260bb50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b2cb0b6d-4662-4e9e-bdb0-72d34c97e02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b2cb0b6d-4662-4e9e-bdb0-72d34c97e02a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8563bb24-0776-4fd3-b3ce-167261abe21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b2cb0b6d-4662-4e9e-bdb0-72d34c97e02a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8563bb24-0776-4fd3-b3ce-167261abe21d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_567f1784-3017-432f-99ec-01ac1c49c389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_567f1784-3017-432f-99ec-01ac1c49c389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember_743bf973-f074-4d38-851a-6767c5410eb2" xlink:href="mck-20220331.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_567f1784-3017-432f-99ec-01ac1c49c389" xlink:to="loc_mck_EuropeanAssetsHeldForSaleMember_743bf973-f074-4d38-851a-6767c5410eb2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="ic8ec0b9f03ca43408257def00b5a4bbc_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8ef0ea7f-59d7-4ec8-beb3-b2dcfb6f74d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_LongTermDebt_8ef0ea7f-59d7-4ec8-beb3-b2dcfb6f74d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fd9a2db5-a04b-489c-b18a-6c7c3ca460ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fd9a2db5-a04b-489c-b18a-6c7c3ca460ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c122949e-f9c5-4de2-8ab4-edc7bd4b7885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c122949e-f9c5-4de2-8ab4-edc7bd4b7885" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_659b3eeb-be91-419a-bd4a-89c037e3ab50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_659b3eeb-be91-419a-bd4a-89c037e3ab50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_e25f6a9f-0a32-4cdd-9a52-b490e036679b" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_e25f6a9f-0a32-4cdd-9a52-b490e036679b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_89ee4485-adfd-4ec6-98f6-00e45c9ce9da" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_89ee4485-adfd-4ec6-98f6-00e45c9ce9da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a350551-e834-4d63-90f0-c38eb646483b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a350551-e834-4d63-90f0-c38eb646483b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c53a4343-5c9a-490f-9303-4eda07c53231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:to="loc_us-gaap_LoansPayableMember_c53a4343-5c9a-490f-9303-4eda07c53231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember_aa488042-ee69-4375-aa9e-2efe399c11fb" xlink:href="mck-20220331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:to="loc_mck_LeaseandOtherObligationsMember_aa488042-ee69-4375-aa9e-2efe399c11fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dadb580f-3c74-478e-981e-369e6b88e778_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dadb580f-3c74-478e-981e-369e6b88e778_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_564d1066-f6f5-47d4-8bf3-65ddecc400e6" xlink:href="mck-20220331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A270NotesDueDecember152022Member_564d1066-f6f5-47d4-8bf3-65ddecc400e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_6d001646-90b9-44e3-b295-48243c1eb4d7" xlink:href="mck-20220331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A285NotesDueMarch152023Member_6d001646-90b9-44e3-b295-48243c1eb4d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_c1bd7d7b-fe70-4a0c-af80-90577ad1b890" xlink:href="mck-20220331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A380NotesDueMarch152024Member_c1bd7d7b-fe70-4a0c-af80-90577ad1b890" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_b9159d24-6262-457b-822b-6b74e2cc2eb9" xlink:href="mck-20220331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A090NotesDueDecember32025Member_b9159d24-6262-457b-822b-6b74e2cc2eb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_113c7471-0f87-44ad-a681-a8a320015bac" xlink:href="mck-20220331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A130NotesDueAugust152026Member_113c7471-0f87-44ad-a681-a8a320015bac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_9e743af1-fbb1-4aa7-b133-934d4b5147d5" xlink:href="mck-20220331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_9e743af1-fbb1-4aa7-b133-934d4b5147d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_071c7f04-6e0a-4653-8cae-b09bedf5a9c6" xlink:href="mck-20220331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A395NotesDueFebruary162028Member_071c7f04-6e0a-4653-8cae-b09bedf5a9c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_79f2e666-5216-4c4f-8e45-102877d1145d" xlink:href="mck-20220331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A475NotesDueMay302029Member_79f2e666-5216-4c4f-8e45-102877d1145d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_e2b8fe67-dc3f-4451-9ad3-b3b4aca1943a" xlink:href="mck-20220331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A600NotesDueMarch12041Member_e2b8fe67-dc3f-4451-9ad3-b3b4aca1943a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_9b841603-41cd-4046-8ab5-3a9777e65699" xlink:href="mck-20220331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A488NotesDueMarch152044Member_9b841603-41cd-4046-8ab5-3a9777e65699" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_8526f745-d947-4f6b-a198-20d28af6b429" xlink:href="mck-20220331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_8526f745-d947-4f6b-a198-20d28af6b429" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_a4fcda4c-ce4f-4b17-94a7-771feb25f81d" xlink:href="mck-20220331.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_a4fcda4c-ce4f-4b17-94a7-771feb25f81d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_d606c9c4-7659-4721-9472-03a3732e4d5d" xlink:href="mck-20220331.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_d606c9c4-7659-4721-9472-03a3732e4d5d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_00b082f8-c70f-41e9-a174-bc940b88b925" xlink:href="mck-20220331.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_00b082f8-c70f-41e9-a174-bc940b88b925" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0994349e-e091-4a6f-aa58-b9310bbb75e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0994349e-e091-4a6f-aa58-b9310bbb75e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0f938af1-825d-45cb-9b9a-343c1e359d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0994349e-e091-4a6f-aa58-b9310bbb75e6" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0f938af1-825d-45cb-9b9a-343c1e359d42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_730544d2-d7d1-4f82-b65c-8408ef2a4cc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_730544d2-d7d1-4f82-b65c-8408ef2a4cc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2b6b713-71e9-4095-869b-47330ae68256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2b6b713-71e9-4095-869b-47330ae68256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_b40bc446-a94c-4402-a711-4a008753bf3c" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2b6b713-71e9-4095-869b-47330ae68256" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_b40bc446-a94c-4402-a711-4a008753bf3c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended" id="i6200fc4d58c64b9cbef9db58a0b40664_DebtandFinancingActivitiesLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1cefa8d-e4b7-4330-9171-4e599397225f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1cefa8d-e4b7-4330-9171-4e599397225f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6fe42964-5097-4244-9422-08422784e172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6fe42964-5097-4244-9422-08422784e172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_76172368-6dcc-404b-a73e-16ddbd7ac809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_76172368-6dcc-404b-a73e-16ddbd7ac809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_af582cb9-99ce-49cd-9007-a70b16de34ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_af582cb9-99ce-49cd-9007-a70b16de34ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2f559506-539d-4a3a-bb83-70e10b5721e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2f559506-539d-4a3a-bb83-70e10b5721e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2eed347c-6049-4ff6-97c4-9ca838342d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2eed347c-6049-4ff6-97c4-9ca838342d62" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_e9f7e684-232f-4ea2-974a-1e9b723860db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_e9f7e684-232f-4ea2-974a-1e9b723860db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_c7616686-17a0-4fd9-a494-61e79a3daf68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_c7616686-17a0-4fd9-a494-61e79a3daf68" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_fa3ea0a6-835f-40b6-8440-1eb9dc3579c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_InterestPaid_fa3ea0a6-835f-40b6-8440-1eb9dc3579c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8ce38ad9-d9ee-44ce-a15b-e4c5db2d857d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8ce38ad9-d9ee-44ce-a15b-e4c5db2d857d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_76ca42cd-2390-455f-8799-fab0d357d427" xlink:href="mck-20220331.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_76ca42cd-2390-455f-8799-fab0d357d427" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_14418c7c-9e05-4e93-aeff-7e18a48dac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_14418c7c-9e05-4e93-aeff-7e18a48dac3e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5fd425b3-6e50-46e7-abc5-4c574465567b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5fd425b3-6e50-46e7-abc5-4c574465567b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b6d5e0be-1d1a-4b7a-a307-dcf8ce87eee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b6d5e0be-1d1a-4b7a-a307-dcf8ce87eee9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_805f62f0-0ada-41bf-9f24-e2dae62bdc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_805f62f0-0ada-41bf-9f24-e2dae62bdc24" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_843d67ba-1c7c-4d11-9fc9-fbd501495a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_843d67ba-1c7c-4d11-9fc9-fbd501495a1b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_08663850-2628-46cc-a33b-b3e05f7edac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_08663850-2628-46cc-a33b-b3e05f7edac9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b671737b-4c09-449f-a01c-4bba1cea4a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b671737b-4c09-449f-a01c-4bba1cea4a2e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_1539543e-0c15-46ed-87e3-c5369ea91972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_1539543e-0c15-46ed-87e3-c5369ea91972" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fa77f234-941f-4d4c-8179-16dde6126e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fa77f234-941f-4d4c-8179-16dde6126e4f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6caba771-fc97-4c81-8858-08b55049c0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebt_6caba771-fc97-4c81-8858-08b55049c0ac" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_d0470a4d-29bb-4c9c-a61c-6574a399b891" xlink:href="mck-20220331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A090NotesDueDecember32025Member_d0470a4d-29bb-4c9c-a61c-6574a399b891" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_e92ab2b0-2f43-41e9-94c1-a3f3d533dbf4" xlink:href="mck-20220331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A130NotesDueAugust152026Member_e92ab2b0-2f43-41e9-94c1-a3f3d533dbf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_56266d63-55e9-44d9-a0bc-4977c3619aa1" xlink:href="mck-20220331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A475NotesDueMarch12021Member_56266d63-55e9-44d9-a0bc-4977c3619aa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_c670d885-b168-47ca-a6db-037be9d76ac7" xlink:href="mck-20220331.xsd#mck_NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_NotesDueNovember302020Member_c670d885-b168-47ca-a6db-037be9d76ac7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_4c79e471-9725-4b40-91b7-ca26d76ad2e6" xlink:href="mck-20220331.xsd#mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_4c79e471-9725-4b40-91b7-ca26d76ad2e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_ef73e888-829d-4d12-bd43-04f9d7f8f38a" xlink:href="mck-20220331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A285NotesDueMarch152023Member_ef73e888-829d-4d12-bd43-04f9d7f8f38a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_2fd04a50-b480-44be-b24b-1878f189e73c" xlink:href="mck-20220331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A380NotesDueMarch152024Member_2fd04a50-b480-44be-b24b-1878f189e73c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_ae03cd06-694a-45cf-82c2-ae7b292825ae" xlink:href="mck-20220331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_ae03cd06-694a-45cf-82c2-ae7b292825ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_8f612324-efa0-4a84-a4e3-5db28d1ed34f" xlink:href="mck-20220331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A395NotesDueFebruary162028Member_8f612324-efa0-4a84-a4e3-5db28d1ed34f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_c4b7617e-ee37-45ef-be79-101d12603f11" xlink:href="mck-20220331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A475NotesDueMay302029Member_c4b7617e-ee37-45ef-be79-101d12603f11" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_a9b8ffd0-f8b0-4110-b868-ad8d398433b7" xlink:href="mck-20220331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A600NotesDueMarch12041Member_a9b8ffd0-f8b0-4110-b868-ad8d398433b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_55c91330-9075-4406-a2fb-854d0b5868b6" xlink:href="mck-20220331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A488NotesDueMarch152044Member_55c91330-9075-4406-a2fb-854d0b5868b6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_61911ac7-f780-402c-abe8-57b7238081e3" xlink:href="mck-20220331.xsd#mck_TenderOfferNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_TenderOfferNotesMember_61911ac7-f780-402c-abe8-57b7238081e3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_e9a0cb1d-860d-444c-9539-ce9cd699f51f" xlink:href="mck-20220331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_e9a0cb1d-860d-444c-9539-ce9cd699f51f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d462a345-d446-4c40-be50-a0b1a5b469ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d462a345-d446-4c40-be50-a0b1a5b469ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_34a3318c-62ba-4118-803e-b04200a92049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_34a3318c-62ba-4118-803e-b04200a92049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_0cbc4e64-39af-4670-ba3b-7f5096e7f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:to="loc_us-gaap_LoansPayableMember_0cbc4e64-39af-4670-ba3b-7f5096e7f13e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="iaa457facdaa949cc8fa557dbd7dcf07d_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61d36ae2-988e-4e5f-ba04-232621e27598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61d36ae2-988e-4e5f-ba04-232621e27598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bd29acbd-83ac-4d57-b899-29542a2efbd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_DebtInstrumentTerm_bd29acbd-83ac-4d57-b899-29542a2efbd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_9d7ea8ed-4dc1-40de-9333-936c0793c1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_9d7ea8ed-4dc1-40de-9333-936c0793c1ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ed856f3d-20f7-4738-87a0-8dfe0d6a3811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCredit_ed856f3d-20f7-4738-87a0-8dfe0d6a3811" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_abefaa1b-7471-4a76-8bda-8ece572b2e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_abefaa1b-7471-4a76-8bda-8ece572b2e90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_4a73212c-f856-41be-8843-f2a104461e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_4a73212c-f856-41be-8843-f2a104461e8b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e45a41cb-3f9b-4eae-9163-016bfa4a2298_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e45a41cb-3f9b-4eae-9163-016bfa4a2298_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_af39d260-327f-47b4-a522-9345f71dd547" xlink:href="mck-20220331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_af39d260-327f-47b4-a522-9345f71dd547" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_332dd664-2a2b-4ccb-aa43-22138c6c9a6c" xlink:href="mck-20220331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_332dd664-2a2b-4ccb-aa43-22138c6c9a6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f4e33fa5-27bf-4390-a74e-235146d0f0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f4e33fa5-27bf-4390-a74e-235146d0f0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_832dd27a-9062-4b5b-82af-5ecc7c32c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f4e33fa5-27bf-4390-a74e-235146d0f0ca" xlink:to="loc_us-gaap_UnsecuredDebtMember_832dd27a-9062-4b5b-82af-5ecc7c32c4ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_56772990-aad4-4e30-ada0-45b2815a6893_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:to="loc_us-gaap_CreditFacilityDomain_56772990-aad4-4e30-ada0-45b2815a6893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:to="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_cdc17ff5-0688-48c3-9e4c-81e34be9735b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_cdc17ff5-0688-48c3-9e4c-81e34be9735b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GlobalFacilityMember_cc9e39c9-535a-44d6-b2e3-fe8dc8cb72ed" xlink:href="mck-20220331.xsd#mck_GlobalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:to="loc_mck_GlobalFacilityMember_cc9e39c9-535a-44d6-b2e3-fe8dc8cb72ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e7216e2a-4678-44b7-ad3f-744c653d0cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:to="loc_us-gaap_LineOfCreditMember_e7216e2a-4678-44b7-ad3f-744c653d0cb1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended" id="ia8116a4a75924a46be0edde855c1a702_DebtandFinancingActivitiesCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34788f67-0dc6-4355-b10b-9831d57625f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34788f67-0dc6-4355-b10b-9831d57625f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f39716a1-1db9-4522-a2c8-cc3977d5e088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f39716a1-1db9-4522-a2c8-cc3977d5e088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_8fc2e008-e661-4528-8b13-ac6775e1f9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_8fc2e008-e661-4528-8b13-ac6775e1f9b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f54e5010-294b-4076-8039-0a737a63d80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_LongTermDebt_f54e5010-294b-4076-8039-0a737a63d80e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:to="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cb43b755-f590-4d61-8859-290b4fcc2230_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:to="loc_us-gaap_CreditFacilityDomain_cb43b755-f590-4d61-8859-290b4fcc2230_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_67a10f23-9e05-4efb-9949-9c266d110815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:to="loc_us-gaap_CreditFacilityDomain_67a10f23-9e05-4efb-9949-9c266d110815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_2b1d5747-45b9-4b0c-a474-6ba319c792b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_67a10f23-9e05-4efb-9949-9c266d110815" xlink:to="loc_us-gaap_CommercialPaperMember_2b1d5747-45b9-4b0c-a474-6ba319c792b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#VariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended" id="i91539d1f1c7740628b192e4a70b785c8_VariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_780f43ab-af00-44ca-be0f-472aabad3ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_Assets_780f43ab-af00-44ca-be0f-472aabad3ebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b119a02e-f621-4fc8-ad97-76b1a4897f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_Liabilities_b119a02e-f621-4fc8-ad97-76b1a4897f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_621b8213-4190-4370-aabb-d167b9dbbb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_621b8213-4190-4370-aabb-d167b9dbbb8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ec5e36bd-dfed-4247-9ba9-5ad96ca06fd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ec5e36bd-dfed-4247-9ba9-5ad96ca06fd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_659deaeb-778c-41f4-bed7-bce2c1af74a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ec5e36bd-dfed-4247-9ba9-5ad96ca06fd6" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_659deaeb-778c-41f4-bed7-bce2c1af74a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="ic6ddb1d77cd348e985e7bb4db6c982f6_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_05670785-acb8-413f-a08d-d603fb13dfc0" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_05670785-acb8-413f-a08d-d603fb13dfc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_121928c2-6650-4d54-b388-77c333d6d7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_121928c2-6650-4d54-b388-77c333d6d7e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_be1649a7-7a2c-439d-91cc-f920faf439ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_be1649a7-7a2c-439d-91cc-f920faf439ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_ea5ec0fe-b017-40a4-a4bf-bd58c75da091" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_ea5ec0fe-b017-40a4-a4bf-bd58c75da091" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_85727fde-2eb5-4867-b756-746e57d07cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_85727fde-2eb5-4867-b756-746e57d07cf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_495cf91a-6eeb-453d-bc90-608f7c79f89d" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_495cf91a-6eeb-453d-bc90-608f7c79f89d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_52200974-64cf-4a22-85f2-7775b0887e50" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_52200974-64cf-4a22-85f2-7775b0887e50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_45345556-020c-4a23-9d41-18eb14eda3d7" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_45345556-020c-4a23-9d41-18eb14eda3d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_ee4a04f6-2a88-4b93-aa1a-b5ce84a15002" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_ee4a04f6-2a88-4b93-aa1a-b5ce84a15002" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_76aac451-4424-406f-b87a-5abc0f67a3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_76aac451-4424-406f-b87a-5abc0f67a3d9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b2950245-aa4e-47da-9bd5-21f717e56a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b2950245-aa4e-47da-9bd5-21f717e56a4d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_e3b0c7e6-0784-4efc-8afb-4c05de8e9dfe" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_e3b0c7e6-0784-4efc-8afb-4c05de8e9dfe" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f20f2d1d-496c-4828-8abd-121cd52d0cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f20f2d1d-496c-4828-8abd-121cd52d0cda" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_ae43debb-c38d-49f1-9aee-d4a9b84bd624" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_ae43debb-c38d-49f1-9aee-d4a9b84bd624" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e11c11dc-9eae-4dc3-a8a7-3016e5157a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e11c11dc-9eae-4dc3-a8a7-3016e5157a6e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1fbdb592-2760-4c5a-b687-9ea063fc314f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1fbdb592-2760-4c5a-b687-9ea063fc314f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ae833b4d-9e57-423b-adbe-6dd9ec4db95d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ae833b4d-9e57-423b-adbe-6dd9ec4db95d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5b6b1588-e8c5-4b7b-91ca-815c7d755ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5b6b1588-e8c5-4b7b-91ca-815c7d755ac8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_715454f2-f1e4-49e7-8b05-06a793a54a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_715454f2-f1e4-49e7-8b05-06a793a54a27" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f3227cf0-e106-4f8d-93ce-e5d04fedcad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f3227cf0-e106-4f8d-93ce-e5d04fedcad6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_70aaf225-0f8b-4aa0-a4cd-0301dcf4bb84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_70aaf225-0f8b-4aa0-a4cd-0301dcf4bb84" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fbec5b03-88bd-409a-8078-c8dd2f51578a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fbec5b03-88bd-409a-8078-c8dd2f51578a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_1d2c260a-40e5-430d-8f77-91c647ef96d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_1d2c260a-40e5-430d-8f77-91c647ef96d5" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d5ee3af1-c039-441a-b8b5-b159088c5260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_7778cadd-00b5-461f-adfa-7aca3af9c0c6" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_7778cadd-00b5-461f-adfa-7aca3af9c0c6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents_2f13e4ea-7a47-45b9-9711-51f3fdb9c06b" xlink:href="mck-20220331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_UnitValueOfCashAndCashEquivalents_2f13e4ea-7a47-45b9-9711-51f3fdb9c06b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_3cc050d7-7664-4253-8a03-e459ebc68363" xlink:href="mck-20220331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_3cc050d7-7664-4253-8a03-e459ebc68363" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e0d1e156-3d6f-4d7f-8d09-c6c1a734a2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e0d1e156-3d6f-4d7f-8d09-c6c1a734a2d7" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_aeafcb50-c697-4451-9d67-77a9ac8efd5b" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_aeafcb50-c697-4451-9d67-77a9ac8efd5b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage_f0152ae2-06ae-41c8-b7a1-64e4fdbfb1f0" xlink:href="mck-20220331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_MultiemployerPlanFundedStatusPercentage_f0152ae2-06ae-41c8-b7a1-64e4fdbfb1f0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_aab04b8b-9675-4796-a74e-3d4d3b57ec17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_aab04b8b-9675-4796-a74e-3d4d3b57ec17" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_0af027cd-217a-4ab8-a65e-51e0fccac926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_0af027cd-217a-4ab8-a65e-51e0fccac926" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5b39fd01-d35b-476e-a8c8-f3b7d43af6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5b39fd01-d35b-476e-a8c8-f3b7d43af6c0" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions_97d5c768-300c-4e3f-8221-16784ad5be7c" xlink:href="mck-20220331.xsd#mck_EmployeeContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_EmployeeContributions_97d5c768-300c-4e3f-8221-16784ad5be7c" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_561bea19-b289-41d7-a639-a4398a48f1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_561bea19-b289-41d7-a639-a4398a48f1de" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40ebc172-c22f-4f81-9786-64f6a9dfb49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40ebc172-c22f-4f81-9786-64f6a9dfb49c" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_0e416699-8a53-4ac2-b706-3fa36888cf67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_0e416699-8a53-4ac2-b706-3fa36888cf67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_0eea5471-b010-4cfa-9711-e732b1a921c2" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_0e416699-8a53-4ac2-b706-3fa36888cf67" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_0eea5471-b010-4cfa-9711-e732b1a921c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_1de46161-3f25-4c7f-b812-6ac0f8078a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:to="loc_us-gaap_DomesticPlanMember_1de46161-3f25-4c7f-b812-6ac0f8078a0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1bc3e059-0d17-488e-9881-a53890b32b82" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_1de46161-3f25-4c7f-b812-6ac0f8078a0d" xlink:to="loc_country_US_1bc3e059-0d17-488e-9881-a53890b32b82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4fc207e3-d708-4670-8b46-f8a6036af7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:to="loc_us-gaap_ForeignPlanMember_4fc207e3-d708-4670-8b46-f8a6036af7e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b499aeb1-0804-464a-a05c-b268a1805f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b499aeb1-0804-464a-a05c-b268a1805f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_772e3459-b81e-4cc2-aa02-5a7bdbcf52e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_772e3459-b81e-4cc2-aa02-5a7bdbcf52e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_6dfd777c-f52b-44a3-beb3-086ada6a285c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_6dfd777c-f52b-44a3-beb3-086ada6a285c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_f1351f2d-aa4a-4943-985a-78581722c6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_f1351f2d-aa4a-4943-985a-78581722c6a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_20e629e5-d446-463d-a8a6-f1e49e8fb08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_f1351f2d-aa4a-4943-985a-78581722c6a4" xlink:to="loc_us-gaap_UnfundedPlanMember_20e629e5-d446-463d-a8a6-f1e49e8fb08e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7c072712-d496-44e4-9060-1133d239ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7c072712-d496-44e4-9060-1133d239ed7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c8ecba4d-d23e-4632-9afd-75be7dd04111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7c072712-d496-44e4-9060-1133d239ed7b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c8ecba4d-d23e-4632-9afd-75be7dd04111" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_2c3d0ea4-ebae-41c2-a1d7-083c61999c85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:to="loc_us-gaap_RetirementPlanNameDomain_2c3d0ea4-ebae-41c2-a1d7-083c61999c85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3b7bf8bd-991a-4dae-b07b-480c3dd9fd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3b7bf8bd-991a-4dae-b07b-480c3dd9fd38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember_bdb48497-2672-409e-ae0d-f54583236eef" xlink:href="mck-20220331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3b7bf8bd-991a-4dae-b07b-480c3dd9fd38" xlink:to="loc_mck_NorwegianPublicServicePensionFundSPKMember_bdb48497-2672-409e-ae0d-f54583236eef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_d0f221f2-7b50-45f7-9a3c-5514f8756424_default" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_d0f221f2-7b50-45f7-9a3c-5514f8756424_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember_3f7ade6a-07c7-49ee-bb59-81569feaf388" xlink:href="mck-20220331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:to="loc_mck_FirstPartOfPayContributionMember_3f7ade6a-07c7-49ee-bb59-81569feaf388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember_20dbb90a-7329-4ab8-8137-bb3071f5cd43" xlink:href="mck-20220331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:to="loc_mck_SecondPartOfPayContributionMember_20dbb90a-7329-4ab8-8137-bb3071f5cd43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5dfb143f-3172-4e18-91fd-0ad8e802ad2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5dfb143f-3172-4e18-91fd-0ad8e802ad2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_c64a7d51-7350-45f9-b8e0-9b6ae98a6d5e" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:to="loc_mck_GermanWholesaleBusinessMember_c64a7d51-7350-45f9-b8e0-9b6ae98a6d5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_ab94d9fb-f8fb-42d7-9f8f-5d43ae79f598" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_ab94d9fb-f8fb-42d7-9f8f-5d43ae79f598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_7cef6bd4-46f7-4193-b9d6-37813030bcc0" xlink:href="mck-20220331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:to="loc_mck_AustrianBusinessOperationsMember_7cef6bd4-46f7-4193-b9d6-37813030bcc0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended" id="i2c54c3e96dfc43c1b64b9ef2991e442c_PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_64af2242-956f-44ed-802d-68bfa893c3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_64af2242-956f-44ed-802d-68bfa893c3e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f79124b6-7397-4762-8e51-01b4461801c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f79124b6-7397-4762-8e51-01b4461801c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1e256d6e-12e2-4f7c-8e5c-75010ce6f23c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1e256d6e-12e2-4f7c-8e5c-75010ce6f23c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_2006d40e-89a5-45ab-b1e5-e623aca30f7a" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_2006d40e-89a5-45ab-b1e5-e623aca30f7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_6de1bcf5-c480-4cb9-a027-1d1e258ff264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_6de1bcf5-c480-4cb9-a027-1d1e258ff264" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c0491b2f-50e9-4e87-9463-47409ecaeaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c0491b2f-50e9-4e87-9463-47409ecaeaa1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_dc947f83-5837-44dd-9fce-2acc3a1807cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_dc947f83-5837-44dd-9fce-2acc3a1807cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_13b6047f-356e-4049-b8f9-f21919e9a7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_13b6047f-356e-4049-b8f9-f21919e9a7e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9a488ea5-5726-48c6-bbf8-1f0ff198a65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_13b6047f-356e-4049-b8f9-f21919e9a7e2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9a488ea5-5726-48c6-bbf8-1f0ff198a65a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_785b6dcd-b543-4003-bf0b-925de92ebeb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_785b6dcd-b543-4003-bf0b-925de92ebeb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d7b9af9d-2dfb-40d0-8e8d-2ef3fa3e5c77" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:to="loc_country_US_d7b9af9d-2dfb-40d0-8e8d-2ef3fa3e5c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_f15329f6-0be8-4ceb-9cd1-4420dce0d910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:to="loc_us-gaap_ForeignPlanMember_f15329f6-0be8-4ceb-9cd1-4420dce0d910" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="iec82b3cda5b44bfd95307651a1de09cd_PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_de23429d-529b-43e7-bec4-db1082d06512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_de23429d-529b-43e7-bec4-db1082d06512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_4108213a-9fa4-4a42-b57e-0807fb99b499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_4108213a-9fa4-4a42-b57e-0807fb99b499" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_5a7c94bb-73f2-4d69-8756-c379d0b0c51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_5a7c94bb-73f2-4d69-8756-c379d0b0c51c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7b9f3741-c3ad-4ab1-b5d7-a1f46db9051c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7b9f3741-c3ad-4ab1-b5d7-a1f46db9051c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_14d8f43d-1e1d-4b3c-9c3c-29098ba71fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_14d8f43d-1e1d-4b3c-9c3c-29098ba71fba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_8924b5dd-ad1e-4f16-a9b1-12e4c9d6e413" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_8924b5dd-ad1e-4f16-a9b1-12e4c9d6e413" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_42549632-832c-4062-86a9-6a46532d26f3" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationsExpensesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_42549632-832c-4062-86a9-6a46532d26f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_4a498f4e-1596-4075-aa7e-ab3dff7fcc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_4a498f4e-1596-4075-aa7e-ab3dff7fcc5c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_30e53197-2c8b-4b30-a22f-fd7ff6ee5a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_30e53197-2c8b-4b30-a22f-fd7ff6ee5a4d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_03855e34-4381-4731-8a19-221649ce6f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c300c2c6-3c92-45de-9418-2d16a3b66d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c300c2c6-3c92-45de-9418-2d16a3b66d32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_48973879-1e18-4920-acbf-bb1d4eb2739a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_48973879-1e18-4920-acbf-bb1d4eb2739a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_3806a476-dbbb-4b89-a69d-a3a1a05a0b67" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_3806a476-dbbb-4b89-a69d-a3a1a05a0b67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3da5c99a-a776-483f-9c91-0dd35b24f401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3da5c99a-a776-483f-9c91-0dd35b24f401" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_a3564afd-eabb-4cae-a839-e6a587b6def2" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanPlanAssetsExpensesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_a3564afd-eabb-4cae-a839-e6a587b6def2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4606950c-22c5-4445-a0fb-1fa250baa405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4606950c-22c5-4445-a0fb-1fa250baa405" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_71bb0440-47a4-4e18-8162-42c44d6e4399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_71bb0440-47a4-4e18-8162-42c44d6e4399" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4633436c-25d0-4a06-ba0d-7a8aaebda8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_0b6e5523-38fa-4508-bc32-692036d92cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_0b6e5523-38fa-4508-bc32-692036d92cee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_214184a3-b68f-4234-b6d1-cbb65a2f9a08" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_214184a3-b68f-4234-b6d1-cbb65a2f9a08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_2379f36c-fee2-4637-84d5-496b19d7d6b1" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_2379f36c-fee2-4637-84d5-496b19d7d6b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_987c53ef-e2eb-426e-aa38-fadd90613a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_987c53ef-e2eb-426e-aa38-fadd90613a10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_8d88be2b-56ac-41c9-8d3e-0fa1835c5519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_8d88be2b-56ac-41c9-8d3e-0fa1835c5519" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_e849ea28-7936-4f76-8446-84f9c62b0dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_e849ea28-7936-4f76-8446-84f9c62b0dfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_94de99d6-ebcd-4cca-94b1-2c9e54fa6165_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_94de99d6-ebcd-4cca-94b1-2c9e54fa6165_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_61847a86-fa71-4343-aa92-e64c3b1afd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_61847a86-fa71-4343-aa92-e64c3b1afd03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d40d04fe-8cc0-4e9e-be00-8c18ddf872a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_61847a86-fa71-4343-aa92-e64c3b1afd03" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d40d04fe-8cc0-4e9e-be00-8c18ddf872a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e538950f-924a-4845-8f2d-53899bc6a39c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e538950f-924a-4845-8f2d-53899bc6a39c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_48ecfe6d-6acc-414c-a36e-7d78861e1ef4" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:to="loc_mck_GermanWholesaleBusinessMember_48ecfe6d-6acc-414c-a36e-7d78861e1ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_2047d874-a578-414d-b8b3-f25e5e46d411" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_2047d874-a578-414d-b8b3-f25e5e46d411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_d4c0b9e1-43d2-460a-bf7e-64d8b7483499" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_d4c0b9e1-43d2-460a-bf7e-64d8b7483499" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c41f1f99-3ec7-4449-989f-f77191adb41e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c41f1f99-3ec7-4449-989f-f77191adb41e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1f41e5e2-abcb-47ff-b3ec-a78062b2d1cc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:to="loc_country_US_1f41e5e2-abcb-47ff-b3ec-a78062b2d1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_78f27527-d447-49f5-b0f0-5589b41c897a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:to="loc_us-gaap_ForeignPlanMember_78f27527-d447-49f5-b0f0-5589b41c897a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended" id="i935e0af4cc464d73b5e55aa22355ba6c_PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5f344c57-96cd-4d04-9f34-d76e2c18c178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5f344c57-96cd-4d04-9f34-d76e2c18c178" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1bd565f5-1209-41c3-9533-6292711a1efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1bd565f5-1209-41c3-9533-6292711a1efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3097008a-3e7d-4c32-8374-8569304928c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3097008a-3e7d-4c32-8374-8569304928c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e25ad84a-a19d-44dd-97ad-7e4f51da6b83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e25ad84a-a19d-44dd-97ad-7e4f51da6b83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_030c1dc4-2e13-45fc-92c2-a49217a75efa" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:to="loc_country_US_030c1dc4-2e13-45fc-92c2-a49217a75efa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_16045988-0352-4728-afc1-4d41eb294167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:to="loc_us-gaap_ForeignPlanMember_16045988-0352-4728-afc1-4d41eb294167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_43059691-85c3-4704-9106-b09b313815e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_43059691-85c3-4704-9106-b09b313815e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b0a3b6c8-71c5-4085-b49a-8b66b936227e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_43059691-85c3-4704-9106-b09b313815e0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b0a3b6c8-71c5-4085-b49a-8b66b936227e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i2eba80d5956d48928141dce908ec4fbc_PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_8b09f8d8-80af-44dd-815e-56a040e2ed24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_8b09f8d8-80af-44dd-815e-56a040e2ed24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_dd89ec6f-4b36-4b70-930b-a3a57e599dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_dd89ec6f-4b36-4b70-930b-a3a57e599dd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_4dbbd5e9-6a3b-4302-b66e-6f0addcf283f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_4dbbd5e9-6a3b-4302-b66e-6f0addcf283f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_333faa59-fa81-4634-9b96-b59f7e3da852_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_333faa59-fa81-4634-9b96-b59f7e3da852_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5fa4a3d1-01a7-4cc0-8ec4-640f55755585" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:to="loc_country_US_5fa4a3d1-01a7-4cc0-8ec4-640f55755585" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1210511a-3aa8-423f-85a3-bafed4199126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:to="loc_us-gaap_ForeignPlanMember_1210511a-3aa8-423f-85a3-bafed4199126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8ba786b4-443d-4bab-a598-55aa2802eead_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8ba786b4-443d-4bab-a598-55aa2802eead_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f1890293-4789-44b3-b213-68e37e784aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f1890293-4789-44b3-b213-68e37e784aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b2061945-6291-4fdb-82d9-e9b14b0c4dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f1890293-4789-44b3-b213-68e37e784aaf" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b2061945-6291-4fdb-82d9-e9b14b0c4dfd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="iecd17ccac2464624af4f0fc3ff8f17fa_PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_f412f8cd-0b00-4077-ba02-d978600d8ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_f412f8cd-0b00-4077-ba02-d978600d8ed1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a2b7b414-2731-4c37-bc35-c913f78a5f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a2b7b414-2731-4c37-bc35-c913f78a5f82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_c873cf46-752c-4397-b3bd-7569dbcb2cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_c873cf46-752c-4397-b3bd-7569dbcb2cd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_1d9d5367-7e80-4377-9d1e-d73dd4df4e2d" xlink:href="mck-20220331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_1d9d5367-7e80-4377-9d1e-d73dd4df4e2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b1962c4f-2d5a-4204-9cdc-f1dff70f49a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b1962c4f-2d5a-4204-9cdc-f1dff70f49a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e4b166ea-298a-4451-8509-99cf859ee6da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e4b166ea-298a-4451-8509-99cf859ee6da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cb0e5ef0-f371-4ef8-a173-3ae37db021cf" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:to="loc_country_US_cb0e5ef0-f371-4ef8-a173-3ae37db021cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_6fe207e7-559f-4533-ab1b-722e5b794a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:to="loc_us-gaap_ForeignPlanMember_6fe207e7-559f-4533-ab1b-722e5b794a81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d4cd61fb-7d57-41d6-91a0-923926f42493_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d4cd61fb-7d57-41d6-91a0-923926f42493_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_55a552bf-2855-4017-9cd8-a63a6bdcaf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_55a552bf-2855-4017-9cd8-a63a6bdcaf9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d5a3445b-4f29-4daf-9334-3d01d269896c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_55a552bf-2855-4017-9cd8-a63a6bdcaf9f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d5a3445b-4f29-4daf-9334-3d01d269896c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended" id="ie5c1e2556e524cbea14b21b7fc10721e_PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6181a654-94e4-4298-b6dc-e4c3c0b5ea51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6181a654-94e4-4298-b6dc-e4c3c0b5ea51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d21c21cf-adbe-4f5c-9f44-54a77719d3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d21c21cf-adbe-4f5c-9f44-54a77719d3ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_27b0ce5c-ead3-4501-82de-69e4a523bc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_27b0ce5c-ead3-4501-82de-69e4a523bc2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d9f7cda0-498a-4bd7-9000-6c824c18c767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d9f7cda0-498a-4bd7-9000-6c824c18c767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_e34edaa8-f385-44d9-85a0-752f72b0bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_e34edaa8-f385-44d9-85a0-752f72b0bf11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_353f72ff-cd4d-414d-acc6-fbe5d410791b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_353f72ff-cd4d-414d-acc6-fbe5d410791b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e51083a9-168d-42c6-b7ef-45b05f68f7f3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:to="loc_country_US_e51083a9-168d-42c6-b7ef-45b05f68f7f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8a3f92ad-3b51-4d09-bb20-46aee98a10a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:to="loc_us-gaap_ForeignPlanMember_8a3f92ad-3b51-4d09-bb20-46aee98a10a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c930a32b-87b9-403f-86ae-25bb05d6b37b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c930a32b-87b9-403f-86ae-25bb05d6b37b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e7fa61c5-c29c-49d9-8a58-b0b18bc44e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e7fa61c5-c29c-49d9-8a58-b0b18bc44e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_abf6e6f1-8a03-4822-8112-06ac0453efda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e7fa61c5-c29c-49d9-8a58-b0b18bc44e71" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_abf6e6f1-8a03-4822-8112-06ac0453efda" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended" id="i00e0ca441cb2468c84ee666b92ebd1fa_PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e4932f55-117a-4471-8a45-7ada52b9f434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_aa260407-e8cf-430a-a2bc-1bcdbb41028f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e4932f55-117a-4471-8a45-7ada52b9f434" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_aa260407-e8cf-430a-a2bc-1bcdbb41028f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e4932f55-117a-4471-8a45-7ada52b9f434" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3baa2c99-385c-436f-9099-8c85f8705a9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3baa2c99-385c-436f-9099-8c85f8705a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b2d87a09-a993-42e7-b89e-a50fad0d4f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b2d87a09-a993-42e7-b89e-a50fad0d4f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d470f639-bb39-45e5-92f5-280e6a21caf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b2d87a09-a993-42e7-b89e-a50fad0d4f2c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d470f639-bb39-45e5-92f5-280e6a21caf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6fb84efc-eb22-4855-8767-e6fdd41854a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6fb84efc-eb22-4855-8767-e6fdd41854a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1539532a-3aac-4ea5-87b7-add9946479cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1539532a-3aac-4ea5-87b7-add9946479cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_ec95e7f2-7ea7-430c-b91c-77480431d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_1539532a-3aac-4ea5-87b7-add9946479cd" xlink:to="loc_us-gaap_ForeignPlanMember_ec95e7f2-7ea7-430c-b91c-77480431d8b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_95c960ea-e81c-4a24-81c2-18d048e3334f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_95c960ea-e81c-4a24-81c2-18d048e3334f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_d0ebb2ed-c1d4-4e64-9f6d-109b7d91d56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_d0ebb2ed-c1d4-4e64-9f6d-109b7d91d56f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_495ee043-d7e2-4480-a805-07a3f4b5505b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_MutualFundMember_495ee043-d7e2-4480-a805-07a3f4b5505b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_6dfba806-4492-4c97-8add-8f1cb50a259f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_6dfba806-4492-4c97-8add-8f1cb50a259f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_036a8c16-5e62-4c2f-9718-27a27cd485f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_036a8c16-5e62-4c2f-9718-27a27cd485f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_082e96f0-c487-43a9-91a0-12fa5aaff3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_FixedIncomeFundsMember_082e96f0-c487-43a9-91a0-12fa5aaff3d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAnnuityContractsMember_e9bb68e5-3e4c-4dcd-84d5-2a98d8a79f5d" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAnnuityContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_mck_DefinedBenefitPlanAnnuityContractsMember_e9bb68e5-3e4c-4dcd-84d5-2a98d8a79f5d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember_ddf95c9c-18dc-44b1-88eb-5eb965043092" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_mck_DefinedBenefitPlanOtherFundsMember_ddf95c9c-18dc-44b1-88eb-5eb965043092" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7dfc12c0-f1a4-485f-aebe-33a3f99251e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7dfc12c0-f1a4-485f-aebe-33a3f99251e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_99e5b117-ec6a-4f8c-a10b-e1832d024d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_99e5b117-ec6a-4f8c-a10b-e1832d024d17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_69dcacd9-2ccf-491a-a334-4ea8e813639c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_69dcacd9-2ccf-491a-a334-4ea8e813639c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b4d892a2-220c-4052-9c58-9ce7f7c6ee0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b4d892a2-220c-4052-9c58-9ce7f7c6ee0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e28e4d83-756e-4b88-b048-170284ec0637_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_e28e4d83-756e-4b88-b048-170284ec0637_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5ed02279-e80b-4f53-8c2f-714c30104061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5ed02279-e80b-4f53-8c2f-714c30104061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_a0b46756-1944-4e90-bea7-96a47356299b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_a0b46756-1944-4e90-bea7-96a47356299b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67c6d499-f5b2-4f71-9acd-e93a024fc4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67c6d499-f5b2-4f71-9acd-e93a024fc4d5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="extended" id="i15defe833bbc4f4c9877798456dee06c_PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e553f0b9-a283-4abf-9c38-589152f910d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e553f0b9-a283-4abf-9c38-589152f910d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_127a83c3-13ad-43b9-b3a9-8a73fab6bcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_127a83c3-13ad-43b9-b3a9-8a73fab6bcb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d928deb4-9c13-4060-bdb2-bb1b1f8989b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d928deb4-9c13-4060-bdb2-bb1b1f8989b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cb36e51-a7f9-418b-bc7b-4dbf08c1459f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a2ad5b04-9842-4289-b7f8-daee8b8b48c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a2ad5b04-9842-4289-b7f8-daee8b8b48c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1697b9d-f152-4557-b027-66c2f4f5c8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1697b9d-f152-4557-b027-66c2f4f5c8a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_15cb29bf-5f5d-45df-8b56-6f2751edca71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1697b9d-f152-4557-b027-66c2f4f5c8a3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_15cb29bf-5f5d-45df-8b56-6f2751edca71" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="iee8991e75c634fb9b8415f27480685de_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_38700dbb-88eb-4146-9e25-1b6beef629b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_LongTermDebt_38700dbb-88eb-4146-9e25-1b6beef629b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_f64e73c6-a0c0-4594-aaf6-9c211819f1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_f64e73c6-a0c0-4594-aaf6-9c211819f1e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_47fc6d7d-3966-42fc-99fc-75597db837f1" xlink:href="mck-20220331.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_47fc6d7d-3966-42fc-99fc-75597db837f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9188eb6f-0b35-4528-8724-ab9377d4928f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9188eb6f-0b35-4528-8724-ab9377d4928f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_2d0bba6e-9465-45d8-8c1d-c6a9b8a3e5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_2d0bba6e-9465-45d8-8c1d-c6a9b8a3e5c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_380e3679-c287-470f-bdcc-636d930553cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_380e3679-c287-470f-bdcc-636d930553cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_19b3ccd2-493f-4c8c-a630-42d022df2191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_19b3ccd2-493f-4c8c-a630-42d022df2191" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_64c72990-af35-4618-88d2-f9d4fbc6581a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_64c72990-af35-4618-88d2-f9d4fbc6581a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AmortizationOfLossOnDerivativeTerm_2b6860cd-0826-4ba9-815b-7824d0eb42fb" xlink:href="mck-20220331.xsd#mck_AmortizationOfLossOnDerivativeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_mck_AmortizationOfLossOnDerivativeTerm_2b6860cd-0826-4ba9-815b-7824d0eb42fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f0347780-a056-41c7-8584-ebb1890ebd1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f0347780-a056-41c7-8584-ebb1890ebd1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_1a636705-72ff-4f4e-8c92-be761f2b7099" xlink:href="mck-20220331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:to="loc_mck_EuroDenominatedNotesMember_1a636705-72ff-4f4e-8c92-be761f2b7099" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_f2eecc47-65b2-4dde-adca-5f946bc10b83" xlink:href="mck-20220331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_f2eecc47-65b2-4dde-adca-5f946bc10b83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c6f2d5c1-af59-4f73-83b4-71b70fa07102_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c6f2d5c1-af59-4f73-83b4-71b70fa07102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a126975b-255c-49c3-9a6d-6ef6a81fa659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a126975b-255c-49c3-9a6d-6ef6a81fa659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5db636c9-9be2-4b99-ad18-acb1d6102385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a126975b-255c-49c3-9a6d-6ef6a81fa659" xlink:to="loc_us-gaap_LoansPayableMember_5db636c9-9be2-4b99-ad18-acb1d6102385" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d8d36708-3cd4-4549-b7c2-56b6892823db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d8d36708-3cd4-4549-b7c2-56b6892823db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3379d0d6-c41f-4e96-8b57-8f4d1da57899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3379d0d6-c41f-4e96-8b57-8f4d1da57899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_889d1e49-522d-4c40-a127-ad19b10d4f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:to="loc_us-gaap_CashFlowHedgingMember_889d1e49-522d-4c40-a127-ad19b10d4f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_81c49e9b-fee8-4b6a-892e-769e475f4384_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_81c49e9b-fee8-4b6a-892e-769e475f4384_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_bd3770ec-5590-49c6-a451-d4e4572d07ae" xlink:href="mck-20220331.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_bd3770ec-5590-49c6-a451-d4e4572d07ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2d898070-41ef-4469-87ac-21186d8471b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_us-gaap_CurrencySwapMember_2d898070-41ef-4469-87ac-21186d8471b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_94e37717-3e06-45a2-8e34-3f6e854eb768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_us-gaap_ForeignExchangeContractMember_94e37717-3e06-45a2-8e34-3f6e854eb768" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_f4c68dc4-b0c5-4aef-9ead-5fd045aa685f" xlink:href="mck-20220331.xsd#mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_f4c68dc4-b0c5-4aef-9ead-5fd045aa685f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e24da8a5-8557-4944-83c2-92493b5dd2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_us-gaap_InterestRateSwapMember_e24da8a5-8557-4944-83c2-92493b5dd2bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_aa74efff-37d4-47d7-b49e-1e657bbe43ab" xlink:href="mck-20220331.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_aa74efff-37d4-47d7-b49e-1e657bbe43ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_994356bc-c2a8-4532-b33b-07670637608a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:to="loc_us-gaap_HedgingDesignationDomain_994356bc-c2a8-4532-b33b-07670637608a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:to="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fafce9a5-c037-4620-9740-dfb7c8ccc9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fafce9a5-c037-4620-9740-dfb7c8ccc9e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_49f8ad48-96dc-4ad2-8a66-f03f06b26b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:to="loc_us-gaap_NondesignatedMember_49f8ad48-96dc-4ad2-8a66-f03f06b26b57" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended" id="i5566c33dffe0487ebc83531e9052be38_HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_65e8fac5-39c0-4a82-83fe-26e10d01d01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_65e8fac5-39c0-4a82-83fe-26e10d01d01c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a7b4d921-10cb-418c-a043-08e0e6c0e2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a7b4d921-10cb-418c-a043-08e0e6c0e2a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d43bd172-9728-46d7-b24e-f355e1453d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d43bd172-9728-46d7-b24e-f355e1453d44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_cf056d91-4cc5-4e91-b470-4872bc840f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_cf056d91-4cc5-4e91-b470-4872bc840f10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d3c28e9-0f69-4d2b-b324-a948c038febd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d3c28e9-0f69-4d2b-b324-a948c038febd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:to="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a844e60-6e0d-4586-a1a3-800aef698ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a844e60-6e0d-4586-a1a3-800aef698ae2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0863456f-dfa3-418c-99d4-7215a36bc80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:to="loc_us-gaap_NondesignatedMember_0863456f-dfa3-418c-99d4-7215a36bc80d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_36548675-4ba7-46dd-ab88-29915354eb01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_36548675-4ba7-46dd-ab88-29915354eb01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_34d964fd-fc35-4eda-ad7b-7dcd39666cb3" xlink:href="mck-20220331.xsd#mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_34d964fd-fc35-4eda-ad7b-7dcd39666cb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_bdcf02ad-3ab8-4226-ac94-313860028b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_bdcf02ad-3ab8-4226-ac94-313860028b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_61b53333-ee73-4e4c-a7b1-3879a0c5d603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_61b53333-ee73-4e4c-a7b1-3879a0c5d603" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d53532c7-1c0f-499a-87ca-cc19ee77a8f6" xlink:href="mck-20220331.xsd#mck_OtherNoncurrentAssetsLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d53532c7-1c0f-499a-87ca-cc19ee77a8f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d6f47996-17fa-4e66-94d1-94a33ce367bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d6f47996-17fa-4e66-94d1-94a33ce367bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_ec8da696-f82b-4356-85d3-8176f8eb9c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_ec8da696-f82b-4356-85d3-8176f8eb9c2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a78cf74c-ef34-4c48-8946-6e25cab9a3af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a78cf74c-ef34-4c48-8946-6e25cab9a3af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b050c304-a4bd-47b9-8d7a-d45155d30811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:to="loc_us-gaap_CurrencySwapMember_b050c304-a4bd-47b9-8d7a-d45155d30811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cf743033-7f1b-4f3a-b8d2-c0472a3cdcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:to="loc_us-gaap_InterestRateSwapMember_cf743033-7f1b-4f3a-b8d2-c0472a3cdcb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_eb363de3-de5b-4b0c-a852-ca0c26251cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:to="loc_us-gaap_ForeignExchangeContractMember_eb363de3-de5b-4b0c-a852-ca0c26251cd9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i3574de9c289b433ca4beb0967769e682_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_670bbe60-d6d3-4d4c-a92c-86a40b6d88ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_670bbe60-d6d3-4d4c-a92c-86a40b6d88ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6e094f04-e49b-44a5-b7d3-76e24a277f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6e094f04-e49b-44a5-b7d3-76e24a277f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_49860e58-4f0c-45b6-959e-70bb8815eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_49860e58-4f0c-45b6-959e-70bb8815eca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_3e0435b7-b4eb-49d6-bff1-1c6049ec645b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_3e0435b7-b4eb-49d6-bff1-1c6049ec645b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_505a8b28-475c-4b3e-ba62-b25dfdb9a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_DebtInstrumentFairValue_505a8b28-475c-4b3e-ba62-b25dfdb9a46a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff571b50-8f5e-43e5-962e-ca935db5abe3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff571b50-8f5e-43e5-962e-ca935db5abe3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fcafa1e9-9afe-409a-aea4-d46807833787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fcafa1e9-9afe-409a-aea4-d46807833787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32d7413e-0102-4672-9b0c-8588bccf1515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fcafa1e9-9afe-409a-aea4-d46807833787" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32d7413e-0102-4672-9b0c-8588bccf1515" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended" id="ibf700a7eaed6437cb05385ff4421695d_FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a98274d9-b9a8-4c88-a95d-88e0a668941c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a98274d9-b9a8-4c88-a95d-88e0a668941c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_64450484-247e-4b03-ae58-6b10afee5d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:to="loc_us-gaap_LongTermDebt_64450484-247e-4b03-ae58-6b10afee5d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20586a75-35b6-43ac-a1bd-79a50b463aa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20586a75-35b6-43ac-a1bd-79a50b463aa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0a9335-102a-4895-a074-a3b0b8f03330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0a9335-102a-4895-a074-a3b0b8f03330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cfdc8d8a-c8fb-4351-bf11-d800aff44c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0a9335-102a-4895-a074-a3b0b8f03330" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cfdc8d8a-c8fb-4351-bf11-d800aff44c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e6473bdd-48ac-48cb-aaf7-af5e49e13546_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e6473bdd-48ac-48cb-aaf7-af5e49e13546_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_49a202de-e727-4c25-9a21-bdf7bce56d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_49a202de-e727-4c25-9a21-bdf7bce56d61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a272b840-0204-4a31-8ffe-236ce64b56f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_49a202de-e727-4c25-9a21-bdf7bce56d61" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a272b840-0204-4a31-8ffe-236ce64b56f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended" id="iace74ef676bb4be0afb16fdc69de9b79_FinancialGuaranteesandWarrantiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod_ca98ffb8-95cd-4d11-9f59-4cb0f5f116f7" xlink:href="mck-20220331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuarantorObligationsPeriod_ca98ffb8-95cd-4d11-9f59-4cb0f5f116f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_adc27e41-a99b-4a32-adcb-139a6eae94cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_adc27e41-a99b-4a32-adcb-139a6eae94cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_c9e015d5-94ba-49c6-8872-6deee9ce9347" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_c9e015d5-94ba-49c6-8872-6deee9ce9347" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_96a363dc-a0f5-4342-99e2-f937c0cc390f" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_96a363dc-a0f5-4342-99e2-f937c0cc390f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_5452231b-d166-4211-878f-2d2b46f247a2" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_5452231b-d166-4211-878f-2d2b46f247a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8430bae0-3814-4d12-a449-1a9882be3423" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8430bae0-3814-4d12-a449-1a9882be3423" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_0c8caab0-6c99-43bc-9f3a-c0246e6b2867" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_0c8caab0-6c99-43bc-9f3a-c0246e6b2867" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_40bfc568-037d-42f6-9dd5-764bf63721a0" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_40bfc568-037d-42f6-9dd5-764bf63721a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_17003407-fb3c-4493-9ffd-39e8fe4ff86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_17003407-fb3c-4493-9ffd-39e8fe4ff86b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:to="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1245ca90-453c-47df-b7f6-b764c64680a2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:to="loc_srt_RangeMember_1245ca90-453c-47df-b7f6-b764c64680a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:to="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_09401bd1-d0d6-4813-9529-172d54122a92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:to="loc_srt_MinimumMember_09401bd1-d0d6-4813-9529-172d54122a92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6d95f1d9-707d-413f-9c50-9e09a9e5ad15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:to="loc_srt_MaximumMember_6d95f1d9-707d-413f-9c50-9e09a9e5ad15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_0086f442-e74c-4552-bdf1-8ab2bb437061" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:to="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_0086f442-e74c-4552-bdf1-8ab2bb437061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember_bffd29e8-91e2-4fdc-a869-0b80044aab75" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:to="loc_mck_GuaranteeObligationsCustomersDebtMember_bffd29e8-91e2-4fdc-a869-0b80044aab75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_a267220f-e76c-47b3-a359-1f8db43ff0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_a267220f-e76c-47b3-a359-1f8db43ff0b9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended" id="i3e5a33c043874352a491a1b257534b7e_CommitmentsandContingentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_2be085c7-7425-469a-8e39-0eed71282c70" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_2be085c7-7425-469a-8e39-0eed71282c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_48827024-3bfd-49b2-b5f7-ce3335e03d55" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofStates_48827024-3bfd-49b2-b5f7-ce3335e03d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_14937612-9849-41c2-8845-d388e551d46f" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_14937612-9849-41c2-8845-d388e551d46f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_71814c78-9db7-4c19-9d9a-b06147fd9a62" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_71814c78-9db7-4c19-9d9a-b06147fd9a62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_99e87a10-f1dc-4ee9-804c-a7a0eebaaf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_99e87a10-f1dc-4ee9-804c-a7a0eebaaf0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_27b5bf8c-5311-47d2-8fdd-6839a456a381" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_27b5bf8c-5311-47d2-8fdd-6839a456a381" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_d9165967-f3c5-45b2-980f-44f0726b09b3" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_d9165967-f3c5-45b2-980f-44f0726b09b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_60143b23-8630-4680-9671-6f57d2e31b0a" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_60143b23-8630-4680-9671-6f57d2e31b0a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_17c88e96-6597-4b9a-bdbf-6b3e777cead3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LitigationSettlementExpense_17c88e96-6597-4b9a-bdbf-6b3e777cead3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_e80e21a3-e447-471c-b285-6657ba5ac899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_e80e21a3-e447-471c-b285-6657ba5ac899" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_ababe4fa-4006-403d-915d-dde73909eb8c" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_ababe4fa-4006-403d-915d-dde73909eb8c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_bbaa8c49-88d1-4bd3-b01d-6e574132538f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_bbaa8c49-88d1-4bd3-b01d-6e574132538f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_be59a75e-6a52-4991-9494-30e8f04b12dc" xlink:href="mck-20220331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_be59a75e-6a52-4991-9494-30e8f04b12dc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators_a4e8d619-4164-487a-b9e9-c5eb97b575f7" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofRelators_a4e8d619-4164-487a-b9e9-c5eb97b575f7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_4b39019c-a691-4adf-8fb2-c389f0da8d57" xlink:href="mck-20220331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_4b39019c-a691-4adf-8fb2-c389f0da8d57" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_106673a1-fad9-4658-aaa2-2beeb928cf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_106673a1-fad9-4658-aaa2-2beeb928cf8c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_c250ef4d-12a2-4ced-a31f-83dc8e90a24d" xlink:href="mck-20220331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_c250ef4d-12a2-4ced-a31f-83dc8e90a24d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_2b89947b-d4ca-4cbf-ab12-992785ed80a7" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofCitiesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_2b89947b-d4ca-4cbf-ab12-992785ed80a7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers_4605688c-7316-47cc-bdf9-b84f20ff61e0" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofFormerOfficers_4605688c-7316-47cc-bdf9-b84f20ff61e0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_22168238-a78a-4f4d-9eec-35f5960b96e4" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_22168238-a78a-4f4d-9eec-35f5960b96e4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b2b12c5f-a647-48f9-92e6-7b2c247b7db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b2b12c5f-a647-48f9-92e6-7b2c247b7db1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b5725f69-8a32-4e37-ae66-8c4430e0c56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b5725f69-8a32-4e37-ae66-8c4430e0c56f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2bb380fc-11b4-4ba9-8359-0b0f9084d761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2bb380fc-11b4-4ba9-8359-0b0f9084d761" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators_e2ce2f50-940a-448d-b3bc-be319f7b99ad" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfRelators_e2ce2f50-940a-448d-b3bc-be319f7b99ad" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants_0c1f1b8d-0d9c-477a-9662-0a108e30d45f" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfAdditionalDefendants_0c1f1b8d-0d9c-477a-9662-0a108e30d45f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_9d395a25-b677-480d-af2a-217a350e40d3" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_9d395a25-b677-480d-af2a-217a350e40d3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts_1ea5dc45-d207-49eb-b0cf-7e5c759fba49" xlink:href="mck-20220331.xsd#mck_NumberofSoftwareProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_NumberofSoftwareProducts_1ea5dc45-d207-49eb-b0cf-7e5c759fba49" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_2bd4a349-6993-4bd2-b944-ce0592f031bd" xlink:href="mck-20220331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_2bd4a349-6993-4bd2-b944-ce0592f031bd" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_42dd6179-7291-4549-80a9-ba6fba467aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_42dd6179-7291-4549-80a9-ba6fba467aa2" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax_2ed95674-ac13-4ba9-aba0-7599b5d41b58" xlink:href="mck-20220331.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyAccrualProvisionAfterTax_2ed95674-ac13-4ba9-aba0-7599b5d41b58" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_66683cc3-8e18-4d4d-af65-84f44cb94e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_66683cc3-8e18-4d4d-af65-84f44cb94e55" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SiteContingencyNumberofSites_4469e3ce-5cf1-4c07-b5be-460b26977fd5" xlink:href="mck-20220331.xsd#mck_SiteContingencyNumberofSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_SiteContingencyNumberofSites_4469e3ce-5cf1-4c07-b5be-460b26977fd5" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_edb3469e-5e20-478e-b2f0-3cb7dc320ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_edb3469e-5e20-478e-b2f0-3cb7dc320ddc" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites_1cbf1868-c243-4ca3-8f57-790ba74fa9cf" xlink:href="mck-20220331.xsd#mck_HazardousSubstanceSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_HazardousSubstanceSites_1cbf1868-c243-4ca3-8f57-790ba74fa9cf" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSitesSelectedforPreferredRemedy_4d339928-152d-4a3c-ae92-9852ccda26ca" xlink:href="mck-20220331.xsd#mck_NumberofSitesSelectedforPreferredRemedy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_NumberofSitesSelectedforPreferredRemedy_4d339928-152d-4a3c-ae92-9852ccda26ca" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_1689611e-651c-4e2f-97af-18b877f10226" xlink:href="mck-20220331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_1689611e-651c-4e2f-97af-18b877f10226" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_656ad91c-b11f-4bd4-a00c-62c5f3659005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_656ad91c-b11f-4bd4-a00c-62c5f3659005" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_02bfd16c-90d6-40d6-ada9-5e0abdb7a03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_02bfd16c-90d6-40d6-ada9-5e0abdb7a03e" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_38ebe919-8afe-4be5-a947-e2bfba206524" xlink:href="mck-20220331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_38ebe919-8afe-4be5-a947-e2bfba206524" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_183c675b-52c6-4106-b1e6-b375482b4405" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_183c675b-52c6-4106-b1e6-b375482b4405" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_0c9eed43-1889-46be-801e-8dd0f6e74cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_EscrowDeposit_0c9eed43-1889-46be-801e-8dd0f6e74cff" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3c72d123-6a1b-4e2a-b92e-960f2183382b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:to="loc_srt_LitigationCaseTypeDomain_3c72d123-6a1b-4e2a-b92e-960f2183382b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:to="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_34222add-52dd-4906-980e-a2529e5cde31" xlink:href="mck-20220331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_34222add-52dd-4906-980e-a2529e5cde31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_182f32cf-c6bc-46e6-8b2d-bfda6041488e" xlink:href="mck-20220331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_182f32cf-c6bc-46e6-8b2d-bfda6041488e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember_60ee108f-eea0-4ac2-861b-c7c76e644fab" xlink:href="mck-20220331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_InsuranceCoverageLitigationMember_60ee108f-eea0-4ac2-861b-c7c76e644fab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_d008c0de-6980-497d-8f49-19653596ad60" xlink:href="mck-20220331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_d008c0de-6980-497d-8f49-19653596ad60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_48d3ab63-e35a-4acc-8ce8-0ad8f4799f8a" xlink:href="mck-20220331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_48d3ab63-e35a-4acc-8ce8-0ad8f4799f8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_e08eace1-b7d8-47fc-b4b9-80b0bac93958" xlink:href="mck-20220331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_e08eace1-b7d8-47fc-b4b9-80b0bac93958" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_19247f8b-ab9b-481f-b93f-d74299ab8a7f" xlink:href="mck-20220331.xsd#mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_19247f8b-ab9b-481f-b93f-d74299ab8a7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_2ef171eb-a1fe-4580-b53c-6d21a313a807" xlink:href="mck-20220331.xsd#mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_2ef171eb-a1fe-4580-b53c-6d21a313a807" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_65152a03-a572-41c8-92e8-0092284d9f97" xlink:href="mck-20220331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_65152a03-a572-41c8-92e8-0092284d9f97" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_b7ca7512-67bc-4cf6-8bd0-3e358961cf79" xlink:href="mck-20220331.xsd#mck_ConsolidatedActionsvSureScriptsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_b7ca7512-67bc-4cf6-8bd0-3e358961cf79" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_f4c38f26-2a17-43d8-a3a1-1de36911fc07" xlink:href="mck-20220331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_f4c38f26-2a17-43d8-a3a1-1de36911fc07" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_81679b2b-2041-4eb6-ba98-4ca09a7f98af" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_81679b2b-2041-4eb6-ba98-4ca09a7f98af" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_132c6e60-980d-4d2c-9322-58fd75ff07f7" xlink:href="mck-20220331.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_132c6e60-980d-4d2c-9322-58fd75ff07f7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9cd8aaed-278d-4c39-9b22-5c9243e74d47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:to="loc_us-gaap_LitigationStatusDomain_9cd8aaed-278d-4c39-9b22-5c9243e74d47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:to="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_9b05395e-895c-4f2c-adf5-ffa0f92407ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:to="loc_us-gaap_PendingLitigationMember_9b05395e-895c-4f2c-adf5-ffa0f92407ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_f9b84def-100a-42e2-be26-d17093d1281c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:to="loc_us-gaap_SettledLitigationMember_f9b84def-100a-42e2-be26-d17093d1281c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_561079c1-1121-44b1-a16e-ecbe10766f1d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:to="loc_srt_SegmentGeographicalDomain_561079c1-1121-44b1-a16e-ecbe10766f1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2fd0bf17-6677-442b-bb95-ae37e1400357" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:to="loc_srt_SegmentGeographicalDomain_2fd0bf17-6677-442b-bb95-ae37e1400357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_af9bd17c-44ef-4942-a681-b7266dc2121a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2fd0bf17-6677-442b-bb95-ae37e1400357" xlink:to="loc_country_CA_af9bd17c-44ef-4942-a681-b7266dc2121a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_58a028fa-f966-4bce-b7a7-37bc26771f18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:to="loc_us-gaap_LossContingencyNatureDomain_58a028fa-f966-4bce-b7a7-37bc26771f18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:to="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_d2e39edf-2ee2-41e9-bbfb-e4b029c65680" xlink:href="mck-20220331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_d2e39edf-2ee2-41e9-bbfb-e4b029c65680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember_73ed6a9f-85ee-4592-818c-668c0628851c" xlink:href="mck-20220331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:to="loc_mck_EnvironmentalLitigationMember_73ed6a9f-85ee-4592-818c-668c0628851c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_c211ef92-4c4c-4cd0-b223-d6e87c351894" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_c211ef92-4c4c-4cd0-b223-d6e87c351894" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_48c5954c-d519-46f9-a3dd-b04fae6e5e89_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:to="loc_dei_EntityDomain_48c5954c-d519-46f9-a3dd-b04fae6e5e89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:to="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_caa2db6c-979d-48cd-af74-8ac8d50aee01" xlink:href="mck-20220331.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_caa2db6c-979d-48cd-af74-8ac8d50aee01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember_adcbf3e2-b164-4046-9374-878d0bfc2464" xlink:href="mck-20220331.xsd#mck_DistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:to="loc_mck_DistributorsMember_adcbf3e2-b164-4046-9374-878d0bfc2464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2ee07a6c-1160-4917-8809-e170093a8a4b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:to="loc_srt_RangeMember_2ee07a6c-1160-4917-8809-e170093a8a4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:to="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_daf4f96a-0490-4abf-80ba-eb0dad0d72cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:to="loc_srt_MinimumMember_daf4f96a-0490-4abf-80ba-eb0dad0d72cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c31d4e22-9b34-4d4a-8e35-9b2defad76a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:to="loc_srt_MaximumMember_c31d4e22-9b34-4d4a-8e35-9b2defad76a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e62c2844-9120-4db0-be23-523987622d66_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e62c2844-9120-4db0-be23-523987622d66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_fd7a7e26-33db-4eef-be1f-c3aefe10535b" xlink:href="mck-20220331.xsd#mck_CherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_CherokeeNationMember_fd7a7e26-33db-4eef-be1f-c3aefe10535b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b42fa756-73aa-47f1-8b73-8434076e0b34" xlink:href="mck-20220331.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b42fa756-73aa-47f1-8b73-8434076e0b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_eccbb972-498f-4785-8952-83be9a3ec301" xlink:href="mck-20220331.xsd#mck_GovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_GovernmentalEntitiesMember_eccbb972-498f-4785-8952-83be9a3ec301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_0a5ea00d-f118-4f16-9e8d-a4c96717e055" xlink:href="mck-20220331.xsd#mck_IndividualClaimantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_IndividualClaimantMember_0a5ea00d-f118-4f16-9e8d-a4c96717e055" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember_001b0f11-d255-4e6f-8392-175c0ce33440" xlink:href="mck-20220331.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_SettlingGovernmentalEntitiesMember_001b0f11-d255-4e6f-8392-175c0ce33440" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember_151639a1-b2b8-455b-9bc8-06c94e95f211" xlink:href="mck-20220331.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_StateOfWashingtonAndSubdivisionsMember_151639a1-b2b8-455b-9bc8-06c94e95f211" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaMember_6eccbc77-4f2c-4d4b-824a-eb60bcf8eca7" xlink:href="mck-20220331.xsd#mck_StateOfAlabamaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_StateOfAlabamaMember_6eccbc77-4f2c-4d4b-824a-eb60bcf8eca7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2228b00-04a0-4f05-8486-ef8d2e18a855_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:to="loc_us-gaap_SegmentDomain_a2228b00-04a0-4f05-8486-ef8d2e18a855_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ca5a5e6-bded-49dd-88c7-1345bd6c9a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:to="loc_us-gaap_SegmentDomain_7ca5a5e6-bded-49dd-88c7-1345bd6c9a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_f58871e1-fbd9-427e-943f-a8a77841fc8c" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7ca5a5e6-bded-49dd-88c7-1345bd6c9a66" xlink:to="loc_mck_USPharmaceuticalSegmentMember_f58871e1-fbd9-427e-943f-a8a77841fc8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:to="loc_srt_ConsolidationItemsDomain_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ce08da4c-91c9-4bef-b798-76d5e12e9e59" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:to="loc_srt_ConsolidationItemsDomain_ce08da4c-91c9-4bef-b798-76d5e12e9e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1e4e2b56-3dd1-4d32-a8f1-62a4c57b280a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ce08da4c-91c9-4bef-b798-76d5e12e9e59" xlink:to="loc_us-gaap_OperatingSegmentsMember_1e4e2b56-3dd1-4d32-a8f1-62a4c57b280a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2795c60c-eaf5-4a2e-8812-b87512d3faa6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2795c60c-eaf5-4a2e-8812-b87512d3faa6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b1f8a8de-c391-4434-8796-309cb0282319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b1f8a8de-c391-4434-8796-309cb0282319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_292eaee4-3219-412b-b773-b065283bee63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b1f8a8de-c391-4434-8796-309cb0282319" xlink:to="loc_us-gaap_SubsequentEventMember_292eaee4-3219-412b-b773-b065283bee63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended" id="i0d3d208b519d4d03a6684431b3805567_CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_3103132d-3ff3-497d-ab5e-ff30c9223f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_3103132d-3ff3-497d-ab5e-ff30c9223f3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_cf4bb52a-7743-42da-acef-0f7aa54ae407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_cf4bb52a-7743-42da-acef-0f7aa54ae407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b7dc3057-50f1-407e-ab56-34ba88e687ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b7dc3057-50f1-407e-ab56-34ba88e687ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d6ed6683-3fcc-47af-8c8e-2533804ea325_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d6ed6683-3fcc-47af-8c8e-2533804ea325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_01a251e8-6fca-4787-83d1-61947472f9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:to="loc_us-gaap_LossContingencyNatureDomain_01a251e8-6fca-4787-83d1-61947472f9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_389d8f00-9389-434c-a93c-51c280a8848a" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_01a251e8-6fca-4787-83d1-61947472f9a8" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_389d8f00-9389-434c-a93c-51c280a8848a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i843447776030456abc2427808553e75e_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_73265fee-e4a6-43bf-9257-6aca57a381f6" xlink:href="mck-20220331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_73265fee-e4a6-43bf-9257-6aca57a381f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_72e913b5-ce82-4100-b667-bb3f8243832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_72e913b5-ce82-4100-b667-bb3f8243832a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_bee1d535-e964-4187-abb4-346fc8387dc4" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_ExchangeOfferSharesDistributed_bee1d535-e964-4187-abb4-346fc8387dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_fe96985a-4c4b-4d0a-80dd-f6e176c77ba3" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_fe96985a-4c4b-4d0a-80dd-f6e176c77ba3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_c57538a5-20f1-4b59-b490-1a3a05a70e4f" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_ExchangeOfferSharesExchanged_c57538a5-20f1-4b59-b490-1a3a05a70e4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_3e9cca32-c4f7-4198-81ab-37ab659d0d50" xlink:href="mck-20220331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_3e9cca32-c4f7-4198-81ab-37ab659d0d50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ad05a38a-8de9-40fb-a5ad-9bc215e0048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ad05a38a-8de9-40fb-a5ad-9bc215e0048a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_9d8c520f-a2e8-4390-8899-3459b00925ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_9d8c520f-a2e8-4390-8899-3459b00925ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_02a9fd4d-68f4-4029-b2eb-b740f4ff8c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_02a9fd4d-68f4-4029-b2eb-b740f4ff8c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_b02376ce-e0ae-4857-bd97-921782a11c87" xlink:href="mck-20220331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_02a9fd4d-68f4-4029-b2eb-b740f4ff8c26" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_b02376ce-e0ae-4857-bd97-921782a11c87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:to="loc_us-gaap_HedgingRelationshipDomain_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1d512d35-d65f-4150-8aed-38cd434e5145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1d512d35-d65f-4150-8aed-38cd434e5145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_637c6b9d-e600-4a89-8339-3676a927b0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1d512d35-d65f-4150-8aed-38cd434e5145" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_637c6b9d-e600-4a89-8339-3676a927b0a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0b2170c8-fdf8-40a6-87b6-4815c1502830_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:to="loc_us-gaap_EquityComponentDomain_0b2170c8-fdf8-40a6-87b6-4815c1502830_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:to="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b9257175-bc6f-4581-b134-73ba9cf51609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b9257175-bc6f-4581-b134-73ba9cf51609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f74cc65-1fd1-40ce-a600-1bb14f3f4108" xlink:href="mck-20220331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f74cc65-1fd1-40ce-a600-1bb14f3f4108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5fabeb2a-6cba-4d75-bac3-191908bda44a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5fabeb2a-6cba-4d75-bac3-191908bda44a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b7fdfae-68a6-4a87-8fec-1552c5e20924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b7fdfae-68a6-4a87-8fec-1552c5e20924" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b306d1ef-0f18-46c3-9fd0-62aef6193d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b7fdfae-68a6-4a87-8fec-1552c5e20924" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b306d1ef-0f18-46c3-9fd0-62aef6193d9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7973007d-d6fa-4faa-9c43-ca630bee93b7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7973007d-d6fa-4faa-9c43-ca630bee93b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9ead3e14-325d-489a-a62c-d614e5b5b33a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9ead3e14-325d-489a-a62c-d614e5b5b33a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6dad2432-7110-4dc9-b02e-7930a7455c9b" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9ead3e14-325d-489a-a62c-d614e5b5b33a" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6dad2432-7110-4dc9-b02e-7930a7455c9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityScheduleofShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="extended" id="ieb90a2ed262b4191ab4bcf45251b7ff0_StockholdersEquityScheduleofShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_40930f9e-c588-494a-9f32-9033e43c9b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_40930f9e-c588-494a-9f32-9033e43c9b82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a7876e1a-738a-4b0c-aef2-45bed76e8c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a7876e1a-738a-4b0c-aef2-45bed76e8c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e5d9f340-baa4-4243-b52c-1be45b49b70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e5d9f340-baa4-4243-b52c-1be45b49b70c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:href="mck-20220331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_186ad381-b829-4024-a79a-3f7a2a58086e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_186ad381-b829-4024-a79a-3f7a2a58086e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b415f3ec-c124-4f16-b9be-c14634612bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b415f3ec-c124-4f16-b9be-c14634612bfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3f0fc4eb-f347-4d29-a888-88b5fbad6a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases_c0c9b282-2206-4b7e-9d31-3599598c8849" xlink:href="mck-20220331.xsd#mck_AccruedShareRepurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_mck_AccruedShareRepurchases_c0c9b282-2206-4b7e-9d31-3599598c8849" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7cdf2124-065f-47d3-82a1-b8542ee8b97a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7cdf2124-065f-47d3-82a1-b8542ee8b97a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember_24e0d2ec-be88-4714-9a7d-942b9c670ca1" xlink:href="mck-20220331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_OpenMarketTransactionsMember_24e0d2ec-be88-4714-9a7d-942b9c670ca1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2019Member_30d720d3-362e-414e-864e-b808ea8fc807" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseMay2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2019Member_30d720d3-362e-414e-864e-b808ea8fc807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2021Member_1c7e72bc-5701-49c3-9b14-d0ddcd08e9d2" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2021Member_1c7e72bc-5701-49c3-9b14-d0ddcd08e9d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_25c66f12-93a5-481e-869a-b06ef715e572" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseFebruary2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_25c66f12-93a5-481e-869a-b06ef715e572" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_10867eb4-9565-4d5b-b47a-d42537c75de3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_10867eb4-9565-4d5b-b47a-d42537c75de3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_12cb634f-f35a-4b2a-8a27-e0e5949c707d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_12cb634f-f35a-4b2a-8a27-e0e5949c707d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e905c3fb-e739-40c6-9fcd-0a58dd0c0998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_12cb634f-f35a-4b2a-8a27-e0e5949c707d" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e905c3fb-e739-40c6-9fcd-0a58dd0c0998" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended" id="if16aa225a02442daa5c7122d524100a9_StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21cd566e-30d4-480f-95bd-06fc7f67672b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21cd566e-30d4-480f-95bd-06fc7f67672b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1ffd01ed-f877-46dc-aee2-5e147b2c184a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1ffd01ed-f877-46dc-aee2-5e147b2c184a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_68ccaa92-ff55-4b2b-982b-5988fe4278db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_68ccaa92-ff55-4b2b-982b-5988fe4278db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_324e39ee-d2ec-4c6e-b324-d832038ac232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_324e39ee-d2ec-4c6e-b324-d832038ac232" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_44f86800-31f4-40c1-b6b0-9dc0eaaf9951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_44f86800-31f4-40c1-b6b0-9dc0eaaf9951" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5206d7cb-c095-4ec3-841c-42837133667b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5206d7cb-c095-4ec3-841c-42837133667b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_53b8c099-8b89-42cf-ad03-69ce27aa0a1e" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_53b8c099-8b89-42cf-ad03-69ce27aa0a1e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7307d44f-af17-4b68-a52d-d8ead14b7335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_4d07a4db-77e8-4d5c-a9fd-e4a4d455f378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_4d07a4db-77e8-4d5c-a9fd-e4a4d455f378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c51ffd08-e848-42b3-b3a8-b2226e19be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c51ffd08-e848-42b3-b3a8-b2226e19be46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_119127b9-3477-4b78-8cf0-3c9e4f9deef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_119127b9-3477-4b78-8cf0-3c9e4f9deef5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_945e9532-a50b-4fce-9f35-0a4956736dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_945e9532-a50b-4fce-9f35-0a4956736dd3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_535d217d-35b2-43d6-8f1c-b6f40bb058f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:to="loc_us-gaap_EquityComponentDomain_535d217d-35b2-43d6-8f1c-b6f40bb058f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:to="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9317bceb-b475-4f24-9793-bdea909992c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9317bceb-b475-4f24-9793-bdea909992c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_c8802b80-971c-4976-b89c-ad66af319540" xlink:href="mck-20220331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_c8802b80-971c-4976-b89c-ad66af319540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ce187bb0-f503-4d28-a882-286a690f5e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ce187bb0-f503-4d28-a882-286a690f5e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_382adc54-8b9a-46d9-9777-7f13fa6661b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_382adc54-8b9a-46d9-9777-7f13fa6661b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01eb8535-12b0-4b59-8068-e416cae87f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01eb8535-12b0-4b59-8068-e416cae87f1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c0447dcb-4acf-494f-969b-11854c3027fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c0447dcb-4acf-494f-969b-11854c3027fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6784a56b-ae98-4aab-a0b0-bb9c656cc464_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6784a56b-ae98-4aab-a0b0-bb9c656cc464_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_899fb684-e5ba-4a8e-9c7f-2909f8ea286e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:to="loc_us-gaap_HedgingRelationshipDomain_899fb684-e5ba-4a8e-9c7f-2909f8ea286e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7604bfa2-1df9-4b50-8e2b-ff6561ce2f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_899fb684-e5ba-4a8e-9c7f-2909f8ea286e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7604bfa2-1df9-4b50-8e2b-ff6561ce2f2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b47e70ab-d173-461f-9617-806b26fe844c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:to="loc_us-gaap_HedgingDesignationDomain_b47e70ab-d173-461f-9617-806b26fe844c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d0d7f5e-b326-4483-b090-6cb6a87e1970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d0d7f5e-b326-4483-b090-6cb6a87e1970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aac8c143-c0fc-4043-9fcf-e1eb514eb9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d0d7f5e-b326-4483-b090-6cb6a87e1970" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aac8c143-c0fc-4043-9fcf-e1eb514eb9ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended" id="i0529c6873bc04daeb4f2519043956eae_RelatedPartyBalancesandTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d2c8fa28-c79a-4925-a5df-dfde1ec8d915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_a5fe731d-8725-48fb-9121-b8308489b28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2c8fa28-c79a-4925-a5df-dfde1ec8d915" xlink:to="loc_us-gaap_RevenueFromRelatedParties_a5fe731d-8725-48fb-9121-b8308489b28c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2c8fa28-c79a-4925-a5df-dfde1ec8d915" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cd4b2791-37fd-49cd-a520-fb10775f6946_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:to="loc_us-gaap_RelatedPartyDomain_cd4b2791-37fd-49cd-a520-fb10775f6946_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4fbc0e56-febb-4bd6-8f9a-27c17a1eded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:to="loc_us-gaap_RelatedPartyDomain_4fbc0e56-febb-4bd6-8f9a-27c17a1eded0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_9c02feae-a660-4724-86c0-3f24757fe6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4fbc0e56-febb-4bd6-8f9a-27c17a1eded0" xlink:to="loc_us-gaap_InvesteeMember_9c02feae-a660-4724-86c0-3f24757fe6c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bf69587-6934-4676-8b20-6055ee4e3e2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:to="loc_us-gaap_SegmentDomain_8bf69587-6934-4676-8b20-6055ee4e3e2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:to="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_c8990b9f-5efc-405c-ac21-7620b6358189" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:to="loc_mck_InternationalSegmentMember_c8990b9f-5efc-405c-ac21-7620b6358189" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_36e6bec8-9e5f-4921-97be-8fb5ae4c4fd2" xlink:href="mck-20220331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:to="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_36e6bec8-9e5f-4921-97be-8fb5ae4c4fd2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended" id="ice6bdd3c02b742839325ed0216801e6d_SegmentsofBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_091bbc91-3322-4070-b78c-1c81d34f04d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_NumberOfReportableSegments_091bbc91-3322-4070-b78c-1c81d34f04d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_cb224988-dd7e-48d9-b23d-b1c6c7c9fc8f" xlink:href="mck-20220331.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_cb224988-dd7e-48d9-b23d-b1c6c7c9fc8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_61b321e8-764a-4579-bf62-26c5876c2227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_61b321e8-764a-4579-bf62-26c5876c2227" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_78f4383d-fac0-4bc4-b987-dd798b3b2733" xlink:href="mck-20220331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_78f4383d-fac0-4bc4-b987-dd798b3b2733" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_283430ae-4d84-4be2-bc12-6de7937aab4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_283430ae-4d84-4be2-bc12-6de7937aab4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_a48476b4-8be1-4418-8c29-fee9f8c19468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_a48476b4-8be1-4418-8c29-fee9f8c19468" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_2de1824f-bded-4632-98f0-120d8b2ea079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_2de1824f-bded-4632-98f0-120d8b2ea079" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_eed621cc-9488-4476-be91-4e034ae2706f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_InventoryWriteDown_eed621cc-9488-4476-be91-4e034ae2706f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_c7fd9d80-7b47-4627-a70b-c2253d93faa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_c7fd9d80-7b47-4627-a70b-c2253d93faa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_c0b334e3-5d73-4254-88a7-49b038c2c728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_c0b334e3-5d73-4254-88a7-49b038c2c728" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_65941608-dc01-4f57-abc2-046ceb6bd0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_65941608-dc01-4f57-abc2-046ceb6bd0a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c03c17a0-c18c-4ad5-b7d6-908189362e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c03c17a0-c18c-4ad5-b7d6-908189362e86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_57c9b142-d31e-4370-90f0-c6542990f762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_57c9b142-d31e-4370-90f0-c6542990f762" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_295e07f3-2f47-408e-aaa2-fb7fef419417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_295e07f3-2f47-408e-aaa2-fb7fef419417" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4904f62a-26cb-4b3d-91d7-8e9fb513133d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_AssetImpairmentCharges_4904f62a-26cb-4b3d-91d7-8e9fb513133d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_f98ef213-4812-4f74-bf20-72b9d231adb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_f98ef213-4812-4f74-bf20-72b9d231adb5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b7c07e55-aa51-4255-b293-e9caa12f0c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b7c07e55-aa51-4255-b293-e9caa12f0c1f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationAdditionalInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2df9f437-e29a-4b2d-8ffa-1a74cd73ec2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2df9f437-e29a-4b2d-8ffa-1a74cd73ec2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_7f358ef7-b942-4025-9365-e2e0663c4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_7f358ef7-b942-4025-9365-e2e0663c4fca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_587616bb-e36a-4658-8e1d-401d302ca4da" xlink:href="mck-20220331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_587616bb-e36a-4658-8e1d-401d302ca4da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3762f933-1b2d-4728-965a-c7afcdc92f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3762f933-1b2d-4728-965a-c7afcdc92f71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_db25db56-5503-4d87-9428-858d4b4748a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_db25db56-5503-4d87-9428-858d4b4748a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_519b01de-116a-44d8-98b2-7bdf273c8dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_519b01de-116a-44d8-98b2-7bdf273c8dc9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c2854f8-4fec-4471-a95f-fa312a2b58ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:to="loc_us-gaap_SegmentDomain_2c2854f8-4fec-4471-a95f-fa312a2b58ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:to="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4d20e24a-fd5b-4f9f-9fa6-505978a542fc" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_InternationalSegmentMember_4d20e24a-fd5b-4f9f-9fa6-505978a542fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_abac0d9b-b767-4c9c-986f-21db62c8bf13" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_USPharmaceuticalSegmentMember_abac0d9b-b767-4c9c-986f-21db62c8bf13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_15c87fbc-a382-49f6-923e-0d3c6ed19cec" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_15c87fbc-a382-49f6-923e-0d3c6ed19cec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_591b7550-306e-4ff4-840b-8dd2b8944f6f" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_591b7550-306e-4ff4-840b-8dd2b8944f6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_724b8de5-0793-47aa-9786-4fdd7f83e5dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:to="loc_us-gaap_RelatedPartyDomain_724b8de5-0793-47aa-9786-4fdd7f83e5dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_54de1b51-e3bb-4b50-b487-71ffd061a18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:to="loc_us-gaap_RelatedPartyDomain_54de1b51-e3bb-4b50-b487-71ffd061a18e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_dc9cd851-ea81-4866-893b-5d534ae42f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_54de1b51-e3bb-4b50-b487-71ffd061a18e" xlink:to="loc_us-gaap_CorporateJointVentureMember_dc9cd851-ea81-4866-893b-5d534ae42f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2b76b12b-b742-44ee-b8bb-de2d2c1a374b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2b76b12b-b742-44ee-b8bb-de2d2c1a374b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_341f61d7-53cc-4c47-9337-cb96f7763ef3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_341f61d7-53cc-4c47-9337-cb96f7763ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7e5ac359-e2ce-4b08-8a79-1bd2a005520a" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_341f61d7-53cc-4c47-9337-cb96f7763ef3" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7e5ac359-e2ce-4b08-8a79-1bd2a005520a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fce674ac-74b1-4b6d-bb9b-8560609110ff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:to="loc_srt_SegmentGeographicalDomain_fce674ac-74b1-4b6d-bb9b-8560609110ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_495d345e-e35a-448e-94c5-f561c90e39a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:to="loc_srt_SegmentGeographicalDomain_495d345e-e35a-448e-94c5-f561c90e39a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_1d78fe75-6335-435a-89c7-459309f54cdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_495d345e-e35a-448e-94c5-f561c90e39a0" xlink:to="loc_srt_EuropeMember_1d78fe75-6335-435a-89c7-459309f54cdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1274be3c-a5b2-4cbe-926d-a3082b6aa67b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1274be3c-a5b2-4cbe-926d-a3082b6aa67b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6efee282-01f6-45ed-826b-5c81a3448fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6efee282-01f6-45ed-826b-5c81a3448fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_94379467-996a-4f8f-9974-1094fb85c338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6efee282-01f6-45ed-826b-5c81a3448fff" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_94379467-996a-4f8f-9974-1094fb85c338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9290dfc6-360b-492b-8b5d-6deca00938bf_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:to="loc_srt_LitigationCaseTypeDomain_9290dfc6-360b-492b-8b5d-6deca00938bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:to="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_e6ecce0a-6bf7-495d-a766-6166ea1fb2d1" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_e6ecce0a-6bf7-495d-a766-6166ea1fb2d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_05d1faa4-c6bb-4682-b45c-896bf70fec66" xlink:href="mck-20220331.xsd#mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:to="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_05d1faa4-c6bb-4682-b45c-896bf70fec66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_4cf20bd4-e89c-453c-a06c-03d254c4cc47" xlink:href="mck-20220331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:to="loc_mck_ShareholderDerivativeActionMember_4cf20bd4-e89c-453c-a06c-03d254c4cc47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_de67c1c1-9fbc-48de-b53c-c3856bacb3d9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:to="loc_srt_ConsolidationItemsDomain_de67c1c1-9fbc-48de-b53c-c3856bacb3d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:to="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d963f1c5-3f62-45ed-beb9-114c112a3e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:to="loc_us-gaap_OperatingSegmentsMember_d963f1c5-3f62-45ed-beb9-114c112a3e4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ff4b6ea8-0887-4f88-a63c-0940ffb3c3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ff4b6ea8-0887-4f88-a63c-0940ffb3c3ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3df3950b-f662-4cba-82c7-d34e8c264fcd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3df3950b-f662-4cba-82c7-d34e8c264fcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f90c426c-3bcd-4823-a319-856d9fe4abb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f90c426c-3bcd-4823-a319-856d9fe4abb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b8f20ece-d234-4b3c-98bd-5298b5f36209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b8f20ece-d234-4b3c-98bd-5298b5f36209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f12c29bf-f855-49e5-a719-ef17e10374f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f12c29bf-f855-49e5-a719-ef17e10374f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_68c2faf7-9aef-4f73-a587-038cfa6c6ef8" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_GermanWholesaleBusinessMember_68c2faf7-9aef-4f73-a587-038cfa6c6ef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_2d279859-b89e-4a23-b422-be849b227c88" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_2d279859-b89e-4a23-b422-be849b227c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_fe67dd91-c948-4b72-beda-c56fb173d028" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_fe67dd91-c948-4b72-beda-c56fb173d028" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_6486bb6e-9eb2-4bce-af33-e51f0234be36" xlink:href="mck-20220331.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_6486bb6e-9eb2-4bce-af33-e51f0234be36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e6de9ec7-fef8-49d0-b253-708a5c7bc09b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e6de9ec7-fef8-49d0-b253-708a5c7bc09b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a7c2faea-cf72-467e-9943-daa33c99331e" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a7c2faea-cf72-467e-9943-daa33c99331e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_680e5c0a-f29a-46ea-b587-e3c0779ceae7" xlink:href="mck-20220331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_680e5c0a-f29a-46ea-b587-e3c0779ceae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d4aba813-d578-4a87-9664-6cc3b47fc491_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:to="loc_srt_OwnershipDomain_d4aba813-d578-4a87-9664-6cc3b47fc491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:to="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_59727569-e9f6-4643-8bd4-a1ae4eed8bc2" xlink:href="mck-20220331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_59727569-e9f6-4643-8bd4-a1ae4eed8bc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_095da0f2-5ac6-4984-8a30-7c4f26b472cd" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:to="loc_mck_GermanWholesaleBusinessMember_095da0f2-5ac6-4984-8a30-7c4f26b472cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_df869215-056d-4528-a952-78fed8fca1a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_df869215-056d-4528-a952-78fed8fca1a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a37e583-38a4-4595-afa9-11e88692e536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a37e583-38a4-4595-afa9-11e88692e536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_55ce5978-e313-4c2a-baee-6e2eafce72d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a37e583-38a4-4595-afa9-11e88692e536" xlink:to="loc_us-gaap_DomesticPlanMember_55ce5978-e313-4c2a-baee-6e2eafce72d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_92e2b228-f944-4e6f-9836-a230bdf60427" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_55ce5978-e313-4c2a-baee-6e2eafce72d8" xlink:to="loc_country_US_92e2b228-f944-4e6f-9836-a230bdf60427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_589de704-8be9-4d89-b932-ddbb76d2893e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_589de704-8be9-4d89-b932-ddbb76d2893e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e978d013-d635-430d-a991-a81e685b0794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e978d013-d635-430d-a991-a81e685b0794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_70e464e7-4fb8-4b15-a72a-5beda7cad35e" xlink:href="mck-20220331.xsd#mck_TenderOfferNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e978d013-d635-430d-a991-a81e685b0794" xlink:to="loc_mck_TenderOfferNotesMember_70e464e7-4fb8-4b15-a72a-5beda7cad35e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_789c3b0d-dbfa-4c76-8321-1bc41fb52e73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_789c3b0d-dbfa-4c76-8321-1bc41fb52e73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d439dc64-65fd-4807-a9ce-b15e751307db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d439dc64-65fd-4807-a9ce-b15e751307db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_cf87f023-a0a9-4d34-83e4-bb6ac67c56ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d439dc64-65fd-4807-a9ce-b15e751307db" xlink:to="loc_us-gaap_LoansPayableMember_cf87f023-a0a9-4d34-83e4-bb6ac67c56ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended" id="ic82cdaf849d64b1493f08e78f1272e14_SegmentsofBusinessScheduleofSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f47bf3e1-9aa6-49af-b0ce-3ebacfb02fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_RevenuesAbstract_f47bf3e1-9aa6-49af-b0ce-3ebacfb02fc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_69359a2e-0473-4071-b1ab-c985448d46c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_f47bf3e1-9aa6-49af-b0ce-3ebacfb02fc6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_69359a2e-0473-4071-b1ab-c985448d46c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_689d9e51-e6c1-4e5a-96bc-b677ff926764" xlink:href="mck-20220331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_689d9e51-e6c1-4e5a-96bc-b677ff926764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_a58c84ca-a316-4444-aeb1-880d499b5a0d" xlink:href="mck-20220331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_a58c84ca-a316-4444-aeb1-880d499b5a0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a2a72f6-95ab-4993-9035-674f0d35da72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a2a72f6-95ab-4993-9035-674f0d35da72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3d766b4d-f11c-44aa-9b42-0a5c4940c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_us-gaap_InterestExpense_3d766b4d-f11c-44aa-9b42-0a5c4940c22c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dfb1276b-d63c-4a3b-9c34-41b23409b60f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dfb1276b-d63c-4a3b-9c34-41b23409b60f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_c7c2805a-4909-40c6-86fb-952349427e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_c7c2805a-4909-40c6-86fb-952349427e4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e4cc888e-8857-4862-b7e8-9fa0aed13bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_c7c2805a-4909-40c6-86fb-952349427e4b" xlink:to="loc_us-gaap_DepreciationAndAmortization_e4cc888e-8857-4862-b7e8-9fa0aed13bdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4b315e11-914b-4361-bca9-40f10da626a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4b315e11-914b-4361-bca9-40f10da626a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_cff97e43-88ed-4af2-848c-b8746c2c8fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4b315e11-914b-4361-bca9-40f10da626a3" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_cff97e43-88ed-4af2-848c-b8746c2c8fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:to="loc_us-gaap_SegmentDomain_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:to="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_aa22b5b9-0999-4d68-a10d-d3495b71d7dd" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_USPharmaceuticalSegmentMember_aa22b5b9-0999-4d68-a10d-d3495b71d7dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a64bfb5b-b5b2-4a13-9cd1-a656d3c73e92" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a64bfb5b-b5b2-4a13-9cd1-a656d3c73e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_6fddede7-f61f-4dc8-9537-74d155b8e710" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_6fddede7-f61f-4dc8-9537-74d155b8e710" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_97fbb584-8986-4821-9c17-4fc775b49e49" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_InternationalSegmentMember_97fbb584-8986-4821-9c17-4fc775b49e49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:to="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_83a1f462-16d1-4b6c-be0a-5b70c7b072ba_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:to="loc_srt_ConsolidationItemsDomain_83a1f462-16d1-4b6c-be0a-5b70c7b072ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:to="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_05610532-5996-4c6c-9017-4876ac78f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:to="loc_us-gaap_OperatingSegmentsMember_05610532-5996-4c6c-9017-4876ac78f22f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_12eac254-8c8c-4fe9-9f9b-d48be3761762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_12eac254-8c8c-4fe9-9f9b-d48be3761762" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="extended" id="i5795f96c754e4d5092ea593c286e5508_SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_69e9fb52-a4c7-4cbc-844e-f365829a7f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:to="loc_us-gaap_AssetsAbstract_69e9fb52-a4c7-4cbc-844e-f365829a7f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0369fa34-1a0f-4dbe-a305-c6ee1eb50973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_69e9fb52-a4c7-4cbc-844e-f365829a7f07" xlink:to="loc_us-gaap_Assets_0369fa34-1a0f-4dbe-a305-c6ee1eb50973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6cbff80-a46d-4528-afb4-f2ddc14b2e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6cbff80-a46d-4528-afb4-f2ddc14b2e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_7f2c05fa-b560-49bf-ab4f-b7c3b84bf60d" xlink:href="mck-20220331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6cbff80-a46d-4528-afb4-f2ddc14b2e74" xlink:to="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_7f2c05fa-b560-49bf-ab4f-b7c3b84bf60d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d4c60323-1740-4b60-a504-c83fcdceb19c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:to="loc_srt_ConsolidationItemsDomain_d4c60323-1740-4b60-a504-c83fcdceb19c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:to="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7bac66f5-ccb3-494b-ba6f-2c1a129b26d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:to="loc_us-gaap_OperatingSegmentsMember_7bac66f5-ccb3-494b-ba6f-2c1a129b26d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e4112728-d0c9-426d-922c-22a0e09e0f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e4112728-d0c9-426d-922c-22a0e09e0f46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a11cf7d1-67e2-49d7-8342-44912fe9a1b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:to="loc_us-gaap_SegmentDomain_a11cf7d1-67e2-49d7-8342-44912fe9a1b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:to="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_0fccf0e6-c1ee-4422-a776-e76795987186" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_USPharmaceuticalSegmentMember_0fccf0e6-c1ee-4422-a776-e76795987186" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4ee5c8a1-3477-4fea-8ad3-76af3f59cae2" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_InternationalSegmentMember_4ee5c8a1-3477-4fea-8ad3-76af3f59cae2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e801139e-3fa1-4b15-a172-b9c481519f72" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e801139e-3fa1-4b15-a172-b9c481519f72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a7a34779-d8ae-4993-b450-baa4a9a43e2e" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a7a34779-d8ae-4993-b450-baa4a9a43e2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_088fa41e-22dc-42d8-aa28-963ecb54facc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:to="loc_srt_SegmentGeographicalDomain_088fa41e-22dc-42d8-aa28-963ecb54facc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:to="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ddc1f694-3a21-49fa-824d-42ec3f35a34d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:to="loc_country_US_ddc1f694-3a21-49fa-824d-42ec3f35a34d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_05f6d90c-a1da-4f40-9bc0-b90e6f21e696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:to="loc_us-gaap_NonUsMember_05f6d90c-a1da-4f40-9bc0-b90e6f21e696" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="i91f8c410467640a5af7173e64baacdbf_SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b9bad1ac-1d27-4104-93e2-2b73755d88bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b9bad1ac-1d27-4104-93e2-2b73755d88bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e50a3b3a-ef78-4748-9454-8c99aa27f795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e50a3b3a-ef78-4748-9454-8c99aa27f795" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7a365c6a-765f-4cca-b18c-286faefec0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7a365c6a-765f-4cca-b18c-286faefec0ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_bb38a66b-94d8-4a94-8035-56b650f2d046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_bb38a66b-94d8-4a94-8035-56b650f2d046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_cf2ac23e-5378-4091-80f9-621ae8bf66a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_98d72b44-1ef3-46a2-8218-f7318847f200" xlink:href="mck-20220331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:to="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_98d72b44-1ef3-46a2-8218-f7318847f200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_d94d7edd-b6c9-4f94-b418-584d6c10a775_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_d94d7edd-b6c9-4f94-b418-584d6c10a775_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_4fe3cd1a-7094-481f-b963-e7cb95a061bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_4fe3cd1a-7094-481f-b963-e7cb95a061bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember_f2efa1cc-9465-40bc-9a6c-59df452fbf8c" xlink:href="mck-20220331.xsd#mck_OtherAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_mck_OtherAllowancesMember_f2efa1cc-9465-40bc-9a6c-59df452fbf8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_7cc156dd-f873-4fcf-b98f-4258915af06c" xlink:href="mck-20220331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_7cc156dd-f873-4fcf-b98f-4258915af06c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_96f7390a-828b-4068-ad07-f08d16c83aeb" xlink:href="mck-20220331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_96f7390a-828b-4068-ad07-f08d16c83aeb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>mck-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eedc7054-d2b4-49fb-b502-fc8a725b4aca,g:dd1fa40e-8b61-4831-9194-c55f1729d4f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_bfd51d22-7427-486a-89de-da8f9b9513e0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_c6cb9a4a-250a-491c-815a-9531fa732178_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_0fc8029e-9793-4330-800a-6c380bdfd9cd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_3568f2ad-1e20-48f9-8903-38b53e7e9431_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_b8708bd4-e987-46b1-b679-fa5b8b13ed57_terseLabel_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK)</link:label>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_label_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK) [Member]</link:label>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_documentation_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember" xlink:href="mck-20220331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NorwegianPublicServicePensionFundSPKMember" xlink:to="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e0a1717a-6b9e-4fde-b2c3-e2c011313648_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0dde24c7-0443-47b5-ad8f-597a3e53abce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TreasuryStockPolicyTextBlock_74163328-8ee3-446f-bab1-cbda3083c7cb_terseLabel_en-US" xlink:label="lab_mck_TreasuryStockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_mck_TreasuryStockPolicyTextBlock_label_en-US" xlink:label="lab_mck_TreasuryStockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Policy Text Block]</link:label>
    <link:label id="lab_mck_TreasuryStockPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_TreasuryStockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TreasuryStockPolicyTextBlock" xlink:href="mck-20220331.xsd#mck_TreasuryStockPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TreasuryStockPolicyTextBlock" xlink:to="lab_mck_TreasuryStockPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_1339b883-4b6a-4026-bc8c-c794d6e05aae_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_8273d528-9007-4887-b7f4-ebb8ae2db2dd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_649f12ee-7ff2-4d87-97ba-3550dd784d43_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_0b6b3479-7402-4aae-8d8f-6c6733cc2175_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, period increase (decrease), net of tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:href="mck-20220331.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:to="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_44395b48-a0ea-47d6-a271-954f92559f2c_terseLabel_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_label_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_documentation_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:href="mck-20220331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:to="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_146781ed-daef-4dd0-87e5-59bb79019eae_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_34881105-8d82-4f25-8b1a-6060ab211c9a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_341428d1-f8fe-4e38-a9c3-a22f43fe785e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities of growth stage companies</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_5f1172b0-f84d-4a21-8a48-d3d560033187_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ba0c5c6c-acca-4af7-b205-3d1e5c108239_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_996a6c90-1787-4368-9429-23ef46230e53_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (Years) - Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5c4e52a9-df5e-40d2-b212-5f928d3ce37c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_a83c40c6-9ded-4d6a-a45b-b0fbbe6f6466_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_06723d8c-ee87-42f4-b414-fe7503aafe1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities (3)</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_b00e9d42-65ba-4828-b6f8-bb5272bd6993_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from termination of swaps</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2044d2ba-e852-4085-b8d6-5171e7f6f7c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_31a0e0af-16e7-476e-9f04-d0ea7fde7d9f_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_8fbc8f45-4b5d-4285-bf6e-c7e9ec5612bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7c2811dd-e13a-4350-91b0-9bbd090e250e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfd000ef-5c31-4310-ba99-12787ab5d2af_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0f72e727-ac13-4e2e-a634-1933f753faac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_60421d81-d1f9-4ee5-ba36-25ec041370e8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_3db72aa2-7181-4944-a59e-7bb2399a0655_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b3f3432d-027a-4135-b338-3edebb9d5e4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value on exercise</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_0ae757c5-f6b6-40e5-9e26-d1d96efda08c_terseLabel_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status (as a percent)</link:label>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_label_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Funded Status, Percentage</link:label>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_documentation_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Funded Status, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage" xlink:href="mck-20220331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MultiemployerPlanFundedStatusPercentage" xlink:to="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_6e28274e-9c11-4ca2-90c2-1ac593296f81_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition accounting, transfers, and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvesteeMember_fb199a3f-80e6-4e0b-a9ba-a6967ff1b5ad_terseLabel_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee</link:label>
    <link:label id="lab_us-gaap_InvesteeMember_label_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvesteeMember" xlink:to="lab_us-gaap_InvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_ff39e213-6ed1-4e98-b015-7f773b9379b4_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expenses Paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expenses Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanPlanAssetsExpensesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:to="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_bb9b7c2e-6311-46ce-8099-13ab75572749_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European businesses held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_0e9a0f75-23b1-4752-90dc-459923000bde_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for remeasurement to fair value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_e445d734-0468-4921-885b-21c0dcb32ccb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices lower limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_69903bf5-94f6-45b6-8b28-8bb0d4d7d5c9_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc.</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_label_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareInc.Member_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareInc.Member" xlink:to="lab_mck_ChangeHealthcareInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f2288a94-f544-4a08-9b1c-d42630916606_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_38fc950c-97d1-42d9-963f-49ca06c43d66_terseLabel_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</link:label>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_label_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</link:label>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_documentation_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:href="mck-20220331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:to="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_1ce711fd-95d5-44c9-83f5-fc4e87116899_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_7c7234c7-4b19-4b31-94cb-538c084fd169_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_edfce1f7-69c5-4e3b-b484-5e8b6d41ea9e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_7bb8969d-7fb5-4716-9521-35000ffa5f82_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_b59794f8-3142-4cb4-968a-427cf14bdc3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a40e55d0-50ab-449a-b264-8e04b15a4d36_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_75efb2a4-a1ea-47a0-b20c-ac5044e75ab6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7be48dad-e4c3-4253-8f1a-b00ec42ea059_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_17f7e477-6c63-4472-bd63-5334b989cef8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c47ad301-6cb5-41e3-8e2f-e23e286d081a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cdaa9d5f-f0fa-40cd-a2f7-1bddbaa8e179_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate - Operating leases (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1dea3f37-ce90-4c68-a30a-0ae9fd257c1a_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities excluded from diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_95cafe6d-9d19-4162-b1cd-ab357446c9d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_985e76ed-2f29-4691-aa51-d6b65983aa45_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_7d6f0091-3ed5-466b-99b7-d5849275a1de_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_22cf8358-cc28-4d3c-8e2b-1b01aa336cf2_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related litigation and claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_70ae7b7a-9013-407a-8981-d3f90e19b301_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_d6a2b15f-7b09-4de2-9374-f3c5d60b1327_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20220331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7889a6ea-a931-4c7d-b726-03ef42e5bc14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1cfcf8ff-4c51-48ae-a929-47d241772d10_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_63b3a9a7-116e-4447-a8ab-559135d1e655_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_094150f4-142b-4c5e-a9ba-30577aa29e9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_86adf661-cdd0-428c-a876-324994494186_terseLabel_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit value of cash and cash equivalents (in dollars per share)</link:label>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_label_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit Value Of Cash And Cash Equivalents</link:label>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_documentation_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit value of cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents" xlink:href="mck-20220331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitValueOfCashAndCashEquivalents" xlink:to="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_81a5cf46-a0d2-41e9-80b9-99c77972e1b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ExchangeOfferSharesExchanged_0a736720-db6b-450f-b0c3-5f825b1d8049_terseLabel_en-US" xlink:label="lab_mck_ExchangeOfferSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock exchanged (in shares)</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesExchanged_label_en-US" xlink:label="lab_mck_ExchangeOfferSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Exchanged</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesExchanged_documentation_en-US" xlink:label="lab_mck_ExchangeOfferSharesExchanged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Exchanged</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ExchangeOfferSharesExchanged" xlink:to="lab_mck_ExchangeOfferSharesExchanged" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_debd1a11-af57-4e95-b95f-44d4f4b85968_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of decrease in unrecognized tax benefits that is reasonably possible in the next twelve months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_342fe923-1495-490f-a811-2824be8ac7e6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_9df85e0f-f866-481e-80ff-6062f508ed0b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_61353468-ac35-48f4-be1b-03be12b0aa13_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2025</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Three</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_471a41bf-b6a9-4d75-add0-823ddc23a027_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_782fded6-9e65-4a26-bf6b-33c6a44b7fc9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_ec91663a-07cc-47aa-ba9f-46543384b139_terseLabel_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which payroll is deducted to purchase shares</link:label>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_label_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Period To Purchase Shares Through Payroll Deductions</link:label>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_documentation_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share based compensation period to purchase shares through payroll deductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:href="mck-20220331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:to="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_672cdd52-5d99-4cfe-80b8-8c1c0498c9fa_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, statutory damages</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_891e096e-a62e-4788-b5ca-555e3c49a24e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_99debd2e-132c-409c-ada4-77643852c66c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_06b06bc4-4dd6-4d7d-990f-f6093c0eb2ec_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_c43f55b1-c462-4302-9a09-71624360ef25_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_label_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:href="mck-20220331.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:to="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_66a6e6fe-4468-47c1-b83a-05e57847583c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_27f6054b-cf76-4391-91ee-1e5d1789bc53_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, including current maturities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_c04b1885-5e0f-4eb4-b1fd-fbb9b7570ad0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_7fbec731-9d15-4db1-ae7e-09898007d22a_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20220331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_3849ada7-d16e-4e11-bb5e-8007c87fd6a7_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding common shares</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_66fd33be-b84a-4d7b-ae64-9e1d25effcc9_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of shares repurchased over last three years</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_295e0e0b-56d2-4a8a-a061-879541964dbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfundedPlanMember_d1971933-7893-47ff-9a9a-5c6971ff4c2f_terseLabel_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded plan</link:label>
    <link:label id="lab_us-gaap_UnfundedPlanMember_label_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Unfunded Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfundedPlanMember" xlink:to="lab_us-gaap_UnfundedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_b4fc61c9-79fe-40ac-ad40-ac3868882d9b_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_487ba2d9-1501-4fb2-a027-5205385f8545_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss in charge for remeasurement to fair value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_fd34b3cc-b02c-4bb5-8c6a-ad3ea8657765_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_e5f82849-6af1-4c61-b9d2-0f9c4e807f5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation and other assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cccac616-e043-4922-80a2-b38cab784d52_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_665fc6a2-e074-4784-9b61-a138bd842585_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingLeaseImpairmentLossNetOfTax_e2d5d445-a720-447c-9846-0d177adc67c7_terseLabel_en-US" xlink:label="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_mck_OperatingLeaseImpairmentLossNetOfTax_label_en-US" xlink:label="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss, Net of Tax</link:label>
    <link:label id="lab_mck_OperatingLeaseImpairmentLossNetOfTax_documentation_en-US" xlink:label="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:href="mck-20220331.xsd#mck_OperatingLeaseImpairmentLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:to="lab_mck_OperatingLeaseImpairmentLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_74741054-4cf1-4dfe-8485-c648aa433ae7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_acb9acd6-eefc-4674-872c-6b89bd3bd41b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_4d379b45-4713-4ee7-bbd0-3b9699804b05_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_7102b01e-c808-481b-b282-154b50d7340c_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate funds and Other</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Funds [Member]</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanOtherFundsMember" xlink:to="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_0c925aef-1d41-4020-82bb-c59333c2a1e0_terseLabel_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:to="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_112faef3-8813-45ed-8fbf-8f3138e2757e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3cafcafe-2549-4b5c-a322-7dd38dfc9a5e_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_e593b945-f8db-443a-b049-b019594e0d7f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_259933eb-ba0c-4c51-88f6-8df5b6d07fa7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e192f487-55a5-4a4f-8430-7784cdcbba92_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bd46180f-d4c6-43a7-a3ea-47ee66945dd4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d41294c1-74f3-4030-826d-ff486a26c149_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_2abab3c7-66f4-4762-becd-41d434d3b751_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_6e653d7c-69ca-434d-889a-936d5af22027_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_6ade3618-68ad-405e-993f-2429f65b1183_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_06404913-329f-4349-88ca-de3ba994b398_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_21bc3e79-c8f4-4094-9b54-7befe4dd1a58_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_590ce9d5-f19e-4af3-aec9-ba17db1c038f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1419a79f-7c1a-40c1-b1bb-2ae58b9b7f60_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ab32bfa6-9cf1-4b5f-9eb0-9bd34f8b9d3a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustments: adoption of new accounting standards</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_b67ff3f0-e0dd-4719-8cde-e785201e0ad7_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_2bae31a8-95fc-4a59-9667-c27cd4c97390_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_7ea5d6b3-47e8-42d2-ad1c-2df306eccceb_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_20363d4e-4893-4904-897e-25287b0d7d3c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative asset, gross fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_f2f5693e-f405-4f90-9a81-6f4dfe1422ad_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss), demographic and assumption changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_07e2d588-a313-4c19-bb59-cf726376c5df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets and systems development costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_0cf543b3-8fd9-466d-84a3-8620b202df22_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_d0b7e341-daf1-44eb-8bfe-f3461d529250_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_a5288f50-abca-4ef6-9331-f6394b3af38b_terseLabel_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_label_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:label id="lab_mck_ChangeHealthcareLLCChangeHealthcareMember_documentation_en-US" xlink:label="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare, LLC (&#8220;Change Healthcare&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:to="lab_mck_ChangeHealthcareLLCChangeHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HazardousSubstanceSites_7baa7b95-f2bd-408d-ba96-57377cb240a4_terseLabel_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites, number</link:label>
    <link:label id="lab_mck_HazardousSubstanceSites_label_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites</link:label>
    <link:label id="lab_mck_HazardousSubstanceSites_documentation_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites that hazardous substances were allegedly disposed at.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites" xlink:href="mck-20220331.xsd#mck_HazardousSubstanceSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HazardousSubstanceSites" xlink:to="lab_mck_HazardousSubstanceSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_62c2c705-6637-4d20-a638-9099c296197f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_767e45cc-01bb-4807-8b19-c4ee652de902_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_38209ef8-fe2b-4ae0-8a50-eed596c68ec9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fbe8c33c-89d0-42c0-95e7-24b7e2c87409_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_20baf1e8-ced1-40f5-a059-b5d30cc277d3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_b3f5bcff-017b-4538-ab5a-c180f88bcf26_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of stock options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_05420fb1-d95e-41b9-be76-eca20a39ef62_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_9c06831d-9b68-4d45-8f11-9d984b2740b5_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income commingled funds</link:label>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeFundsMember" xlink:to="lab_us-gaap_FixedIncomeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_67e00328-aa54-4e88-9ff1-69254fe95d50_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_7a8123ba-6be8-4355-89df-d4d3219bb542_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_c70d0307-b0c9-4528-86cb-4d75ec4db21f_terseLabel_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due August 15, 2026</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_label_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026 [Member]</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_documentation_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member" xlink:href="mck-20220331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A130NotesDueAugust152026Member" xlink:to="lab_mck_A130NotesDueAugust152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_63d67c87-c357-4456-81d6-57b6362766d1_terseLabel_en-US" xlink:label="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</link:label>
    <link:label id="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_label_en-US" xlink:label="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized</link:label>
    <link:label id="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_documentation_en-US" xlink:label="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:href="mck-20220331.xsd#mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:to="lab_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_a3c34304-cd68-4fbb-aed6-fed69c54feb9_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility)</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20220331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ba7080d2-c8e7-4df8-9659-8c088c6772b6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_e02cbee9-9b1e-4ed9-b208-e0e5e807853a_negatedLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net discrete tax benefit</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:href="mck-20220331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:to="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_56e5bae2-81ac-40ec-820c-5a3eafd8c9b7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_acbdcd57-3dbd-4fd6-8bcc-7c07af413b3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_92187486-4600-4e94-9d28-39326a52b2f2_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_318b937c-a494-4964-9232-fd2238b008dc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_673d7e0a-aca9-4550-8297-9e93ade40a47_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_5ac610b7-8ddf-4a9a-a397-a9d849f7aa72_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_dc533abf-e108-4564-ba46-4b14e0fecc77_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ab36bbeb-0dbf-4520-b6b5-1030a9bf8c6c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EnvironmentalLitigationMember_62b87273-abac-42d3-b67a-ad420d8e9d9d_terseLabel_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation</link:label>
    <link:label id="lab_mck_EnvironmentalLitigationMember_label_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation [Member]</link:label>
    <link:label id="lab_mck_EnvironmentalLitigationMember_documentation_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember" xlink:href="mck-20220331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EnvironmentalLitigationMember" xlink:to="lab_mck_EnvironmentalLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_d907ceef-7113-4305-b5c2-444ef0609bd2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0d001b23-605e-47ae-adb0-60c8f71b58c3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8002e468-96c8-45f4-90fc-936d7efc8845_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_1ae6c764-2305-4b9b-8c44-7bd4b360dd40_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_a286e499-17dd-44d7-93e0-660818903f74_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_7529f161-d8cd-4cb2-bb6a-d957150542cd_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges</link:label>
    <link:label id="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_label_en-US" xlink:label="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:href="mck-20220331.xsd#mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:to="lab_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_a42a6ddc-df2e-4451-adba-49d66b82cd1d_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement, payment terms</link:label>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_label_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Number of Installment Payments</link:label>
    <link:label id="lab_mck_LossContingencySettlementNumberOfInstallmentPayments_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Number of Installment Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:to="lab_mck_LossContingencySettlementNumberOfInstallmentPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_90be55eb-a093-4f75-94cb-87737e15e32d_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit) related to adoption of amended accounting guidance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_a0df6675-bf39-4d10-81f3-571e86d75b0e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_4182589b-898e-49b6-8b58-b558294f0977_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_90b7d402-f99d-484a-ab17-dfdb7caae3f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in benefit obligations and plan assets for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_7c7ac1a5-8661-4a27-84c8-30e6760a79fd_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_43a9fd10-1400-4a5a-9569-18674ccc7f63_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would Impact income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_49adc282-ce0f-4b2e-879d-d572b0cccf4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_46669fde-e555-44e9-bc9f-ab7a1da71ac9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_24b7225d-f821-431c-9f94-c63aed23fb65_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_02895d02-b56b-4ca8-b2f0-fa440a6b8714_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_1a34c006-9acd-426b-ba15-cf8b602b93bb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains on investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cc301eb2-3c77-480b-a1ee-0b96edb19ff1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_8a7585dc-e003-4888-bef2-9b8362de8bfc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt, thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_abf5aba6-d011-4280-a528-7216bf375e5e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpensePolicyTextBlock_4e23624c-35ba-4f14-914b-568e51056e18_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpensePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpensePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpensePolicyTextBlock" xlink:to="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_48713ef8-f2e0-46e7-ad3b-34975ace65d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_d677c700-2738-47e2-85db-9809bdea8d5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax pension settlement charges</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_0439777d-a4b6-4971-ae60-129b9f1f42a5_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax pension settlement charges</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_2c0a8971-bff7-4747-956b-2f6be2d5f11e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment assets and long-lived assets by net by geographic areas</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_02313c4b-befc-45f9-be03-037b36de2da7_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_93651d1c-a683-41f2-990d-0a19240cfe71_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_60ae2c28-d6a2-4017-92a7-fa480aaec264_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_b0e3d436-0d13-4eb0-af19-f9ae0482d01f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_ba5ddbbe-ab0b-4550-ab16-c61509b0eadd_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ddcfa385-0343-4944-ba6a-442e8c7cda47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1593bf10-2dfb-4dfb-8a23-f76984dacff5_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_40a1c733-ce26-43b8-941e-82a7b6a4b6a4_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8aab6d88-a3b5-4a5b-bdb1-365feb5d14f6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_a9ea1e13-0a6a-441a-ba7d-070e0a1b40ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_2305b28b-3a63-4fcb-8a13-da8b6034b776_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_76ffd856-8741-48af-8de9-a74455001812_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenderOfferNotesMember_b6ee39b8-c88a-4ff4-9a54-47be339ae1f6_terseLabel_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_label_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes [Member]</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_documentation_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember" xlink:href="mck-20220331.xsd#mck_TenderOfferNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenderOfferNotesMember" xlink:to="lab_mck_TenderOfferNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_18c125e3-21c7-488f-8050-60a7fa9708eb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_a8f8a30b-a2bc-4cb1-a944-cdf59c81a5f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_2d4b1db7-ae5d-4813-a1db-58677f33da67_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_871e2a57-c7bc-453a-9600-2b2d035a9529_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_4f1c664e-1b6b-4177-980b-6ba76ba7d1c2_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20220331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_6ddad278-0805-4191-a3d2-afb4f1af6ea4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_804cae58-1bde-4982-ad44-09d91e9adead_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K.</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0daa326a-408c-4c2b-a213-92771028a178_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7c31aab0-a7a2-432b-8935-f8302de53fce_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_3de28f73-c90e-4689-a63e-b4a648f94d51_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_2967843f-cec6-4056-b895-d3b7c2f51922_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_acb8a225-0452-4cb2-9791-180c6433d620_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_afe63d41-fea8-418d-9eed-f2263187ab2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_b853de4f-c7c3-4821-a3f1-8be7b079b6d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_5d6f9ba9-08c7-4312-b4bd-3d6126e7d25b_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt</link:label>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_label_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt [Member]</link:label>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsCustomersDebtMember" xlink:to="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_a8821c38-136d-477a-8d60-76ea351505fb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_92a1969a-0b6a-499e-b7e3-a164e00c0a1e_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_b441c259-5880-43f0-bbb1-932103dc7ffe_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum redemption value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:to="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_adaf8844-3943-46d4-9ce1-858d1b332373_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_548e5b32-c6b0-413a-b3fc-602e18e02fd4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_24843cea-6628-42ff-8350-f7c2534922c2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_cd00fca6-7d10-4f63-8aee-4c39d9bdf32c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b9d61415-6941-4bac-a98f-4d9b88fb1328_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_62f9da1c-e2bc-422b-874e-46f828cec61b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_158b3a33-67e5-4f56-ba7c-b5cf02ed6142_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_607e40a0-da33-4ef4-a675-4c31e80fb684_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_f477f978-679b-4151-9621-0846f439ed05_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f7050003-a59b-47ad-a788-3aad65d388fe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized, 275 and 273 shares issued at March 31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ec6dd51f-0228-4f56-b38f-12469d8aa99a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate - Finance leases (percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentStockAccepted_c2349eff-d13c-4a5b-88b8-3bac95ab60a2_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAccepted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAccepted_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAccepted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAccepted_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAccepted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentStockAccepted" xlink:to="lab_mck_EquityMethodInvestmentStockAccepted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_6c4a1c5c-572b-4b01-8b5a-2d7dd159bfe8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dd1ccf6e-f45d-4728-a981-93dcfb2db907_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f2f1c674-fd3a-43ce-b509-8238c1e5f305_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which stock option compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_21a83c9e-4df9-4bc8-9af3-1a78d259a38d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9dcef1ee-e175-4a8b-a234-a369348dd8fd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_97510e30-f6da-4914-8bc1-63101a3a7315_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_9c8634fe-c24c-46ae-8ade-8e48c096fb5e_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_f224d35c-9490-4363-9e51-d777a0ce7f07_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_58daaa47-5a44-4fc7-ab3f-ca076c7ab025_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding fair value of derivatives on a gross basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2c5e5dfa-e23e-4248-81e4-cecd1dbb9f87_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_613a74ae-5e8f-4ad1-89ce-d9c9556ae1d6_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_0f5d500e-72d4-41f1-a450-22ca833a5ce0_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_5c34b735-0878-4f46-b695-82c29baafe91_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_15f528e8-d4a8-4aad-ab15-41e36936bea6_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2c981aca-83c4-42bd-8d12-5628ef0b194b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_d975489d-3807-4d5b-8de9-c8754292dc9f_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_7d1d403d-6f8e-4ec0-8b71-a3fd36ed8b51_terseLabel_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange rate fluctuations</link:label>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_label_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</link:label>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:href="mck-20220331.xsd#mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:to="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_60004e87-3a2f-40f0-ad12-8e23a252a483_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_f37a745e-7f02-4b30-9705-3357bfc02e6d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_72e72ac8-2b7b-4743-b07c-12e2b55e7d72_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_3259420b-5819-4c97-a69f-96bea0c44c2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment/settlement loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_94e42be2-5571-4ac9-879e-dfad69ee947c_terseLabel_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Reserves</link:label>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_label_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Reserves [Policy Text Block]</link:label>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierReservesPolicyTextBlock" xlink:href="mck-20220331.xsd#mck_SupplierReservesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SupplierReservesPolicyTextBlock" xlink:to="lab_mck_SupplierReservesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_a46fc714-fdb7-4f59-92a8-1dd09fea41c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_42ef810c-f27f-46d6-baf1-68449cd1d654_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_26f18912-2bc3-47dd-b842-0f5da495b3d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_167e928c-d44e-415a-b891-1c94cfc30845_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_a2e3f400-e349-46d8-80bc-0f13efb8487c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_90dd41c9-4b30-4bc2-a31b-ab9a608ccf38_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenditures for long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ab882c3b-29e0-42c4-9b7e-d73354bb949f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on net investment hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a50d7d93-d301-400e-a42b-bb98a5e2d430_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_f6151e95-e753-4303-98f8-2895bfe215e7_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_823a2fe5-6429-41b2-9efb-4452b6005d1a_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_141abe8b-79a2-4302-82ee-739aecf413b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_544d081d-7bc8-4690-8e4c-865c8221c74d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_7bed33a2-b5eb-4815-b0e3-55114eda07f5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_6b129f10-7ad4-4f8a-bf84-8e854874706d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_55337e63-50f3-428a-9f45-5813e09affec_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3eb92607-bb6c-434d-a50c-b484c64973ef_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_127f6a49-56ad-4c0c-ac71-e0c986d429f4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea440266-93b1-4643-b87f-895276fc5e3f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_64f74e1c-2b1a-449c-b134-877a6fc904c1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_fd67fa2e-b987-4f4c-bf3c-dd0e34121637_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_0d248761-d22f-4256-93d6-6d86deac88af_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_317c842c-c1ff-4055-b67d-c56740e00cfb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_522871f2-d1bd-413f-9673-c1f378d00fec_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement gain recorded in earnings</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfDerivatives_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfDerivatives" xlink:to="lab_us-gaap_GainLossOnSaleOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_42709f53-8f53-464e-b4b6-7630a5a6b8f5_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5f618dbd-5849-418f-bfb6-eb8ab24d0a0c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (Years) - Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_b88f00a4-8e79-432d-aab2-bc6266aa225c_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abd05a0f-2eb0-4165-92c3-f4e555ccf09e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_20b4d6f2-bfe4-4cd7-852b-b68f67653db9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_c814fdc4-272c-4106-9a69-1fb5a2b7e809_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RexallHealthMember_8b213579-270b-4f44-b2fb-b72f54c91f97_terseLabel_en-US" xlink:label="lab_mck_RexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rexall Health</link:label>
    <link:label id="lab_mck_RexallHealthMember_label_en-US" xlink:label="lab_mck_RexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rexall Health [Member]</link:label>
    <link:label id="lab_mck_RexallHealthMember_documentation_en-US" xlink:label="lab_mck_RexallHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rexall Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember" xlink:href="mck-20220331.xsd#mck_RexallHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RexallHealthMember" xlink:to="lab_mck_RexallHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e961bf81-b36d-4685-8c3c-b4416e267a8e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_ed9a7a76-13c8-43fd-b940-263a5ae46a47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d3e40f21-746c-41f5-8e24-105eeacb2765_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2028 through 2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_01656097-db75-4349-814b-7f88aed55879_terseLabel_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_label_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Stock Units [Member]</link:label>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_documentation_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember" xlink:href="mck-20220331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PerformancebasedStockUnitsMember" xlink:to="lab_mck_PerformancebasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_ed32222c-6661-4543-a4a9-93d17aba642a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_0f13eb81-47ba-4e84-9a03-0ae4f5a3d461_terseLabel_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution</link:label>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_label_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution [Member]</link:label>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_documentation_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember" xlink:href="mck-20220331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SecondPartOfPayContributionMember" xlink:to="lab_mck_SecondPartOfPayContributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_ceab74d9-bf68-4fb1-8c25-03d302525168_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_55f932d9-1e82-4907-a7dd-57608abed805_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount borrowed under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockExchangedDuringPeriodShares_95cc0948-1730-49fe-81f9-925f1687b2b7_negatedLabel_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare share exchange (in shares)</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodShares_label_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Shares</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodShares_documentation_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodShares" xlink:href="mck-20220331.xsd#mck_StockExchangedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockExchangedDuringPeriodShares" xlink:to="lab_mck_StockExchangedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_e691f350-7838-44e5-9cfe-d6165789de82_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3afff41c-4cf3-4d73-bf8a-e43d578d9b6f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a7ec2be5-ede4-4dcf-810b-a3629b14ef4c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_25eafd8e-f393-4284-b301-10ac28cb8d7a_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20220331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4f1ccec4-4582-4e50-8858-23bc1de3b472_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41906922-e648-4653-a44a-06da4e9d926d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_7fe5e401-4d3c-40cd-bb95-5a356478bd9b_terseLabel_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_label_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action [Member]</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_documentation_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember" xlink:href="mck-20220331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareholderDerivativeActionMember" xlink:to="lab_mck_ShareholderDerivativeActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_3b68a5d2-db4a-45de-951b-fb9e5a182b73_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_d9710d38-7abb-4599-8117-7ed25bfc5a1d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RangeTwoMember_126a6b23-ae73-44ab-af38-f192b4e936d5_terseLabel_en-US" xlink:label="lab_mck_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two</link:label>
    <link:label id="lab_mck_RangeTwoMember_label_en-US" xlink:label="lab_mck_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:label id="lab_mck_RangeTwoMember_documentation_en-US" xlink:label="lab_mck_RangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeTwoMember" xlink:href="mck-20220331.xsd#mck_RangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RangeTwoMember" xlink:to="lab_mck_RangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_775b50fb-c870-4302-bf29-fcc725963ccf_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total plan contribution - exceeding (percent)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:to="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_372047ed-ca24-4d77-9b1e-c5bf49612bb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:to="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_40a76930-359e-492b-b4de-9a57edbab663_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_a60c331b-3358-41c2-8b96-585e70c140e8_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1.625NotesDue2026Member_30ddd9b4-7e2f-41de-9c3f-32f9b220666f_terseLabel_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes due 2026</link:label>
    <link:label id="lab_mck_A1.625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1.625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member" xlink:href="mck-20220331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1.625NotesDue2026Member" xlink:to="lab_mck_A1.625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_75bd22df-54c8-49ea-bf90-ca5465dd1daa_terseLabel_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations</link:label>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_label_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations [Member]</link:label>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_documentation_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember" xlink:href="mck-20220331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AustrianBusinessOperationsMember" xlink:to="lab_mck_AustrianBusinessOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d9484bb-ea94-4ab9-b524-6e335ab3a2ed_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_eeda67cc-4056-465b-ac94-5978ab1dfdac_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ab0e7c1b-2995-41e2-bbb0-b0f577d83edd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_bc67e7a9-2c6e-4cf5-91b3-3c7763cce4fc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_54c37b89-701e-45e1-8ff5-ed03a927899d_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_c780ab82-cb1f-47b8-b9e7-f7c4663c8469_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of former officers</link:label>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_label_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Officers</link:label>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofFormerOfficers" xlink:to="lab_mck_LossContingencyNumberofFormerOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6247b67c-7211-4c46-ad97-9ad20ab81424_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_22c398d6-13e1-4cec-90d1-b539a17231b2_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3f06f483-c647-421a-8bf5-1462bfbf1dbd_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_935e3172-fc16-4380-ab27-c2b19a1548c1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_5dd24421-a04a-412a-abe8-f15c7f38bec5_terseLabel_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information</link:label>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="mck-20220331.xsd#mck_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_0ed8dc2f-0bd0-48ca-b408-9f7442d7c3b3_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2023</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year One</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a7e5ce09-cbf1-4c1f-9035-debfba0f97b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_fb664bf3-d349-473a-bf7d-5cb74327e3fb_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:href="mck-20220331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:to="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_8c8f32ad-fee4-4a2d-a441-b4087958a82b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_20b50a5b-6ccc-4b52-bf48-c007ca166226_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_964c4471-a9f5-4c3a-903e-ac3e67f77d0e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Receivables</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_214a1671-d6da-45db-92fd-231027e659e4_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7bf50254-8126-4b60-a80e-e86dc501cf51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_cce29e55-8a28-48f2-9913-399560d66b41_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cb540b68-8582-44c5-97c4-3b133e60b519_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_26c8d4fb-4493-4c8e-8012-c596ce4cb9f2_terseLabel_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assumptions used to estimate fair value of PSUs</link:label>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:href="mck-20220331.xsd#mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_32bbe209-89af-49d4-a1f6-195ad45e84f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_8f700eb4-e687-43bd-8ab5-9276fc9ca5fb_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_7ae1d138-4d4f-49c5-ad8c-52270e63507d_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses, net [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Additional Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationAdditionalInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a247e035-f56b-45e2-b49c-6aaca19fee84_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c3f6304-23f8-4fa0-b0bf-f29a0f9736d7_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_6cffe743-f178-4148-a857-51cc307dbf0a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_390a0bfc-1416-454e-a86f-e4f4acccc3a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit for share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e7e3a1a-748f-484a-9409-ff97cd684d88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_db7269d3-ea8d-4f4c-9b8d-4c4343965853_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_adb4ba18-fb10-41f1-8475-c658282f0e23_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right (in euro per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_f06624a2-4a1a-4839-8a42-af2cdd81fcea_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_a9ebe70e-30e3-49e5-9854-65d6dc5d3fff_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0bf3bb5d-21c6-44e5-a9d7-ba83a29b9b57_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_353211ff-ac52-442f-8579-f48e24a4613d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_b29efd02-8af8-4634-b1dd-aa0152ae6d56_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_0731ee90-d323-443a-a125-ce3064b8fe85_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Other Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_b39bf082-b3ea-49ab-ab2e-39068b8fe852_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_fc34bd7f-f7d6-432f-8f4a-d80c75b20ca4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_a634d389-a392-4638-a892-612c3cce0ec6_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1b66d6ea-52a2-4c62-acf0-65ec0f663115_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_d67d1538-9b16-4ff1-8c0c-2835977b30c1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_9e57e921-b0d0-4b4b-8137-5f9df2000bca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_44b4b2a8-aa53-41e3-a454-ab0d185062ca_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e0735e37-a4dc-4730-8e66-deb26d2d066c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of investment in joint venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4d36ce94-ab09-4803-b3e3-c938a8d7f1d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_b0ef79b7-1f69-43e5-a9b2-27e0105b8440_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a00e5379-7549-4f09-8b1e-08d435ba42b7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_5bb92a1b-55ba-4ae8-994c-dc2b3ad970ba_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c29d61c0-a7e9-4fe2-804c-2f049205fba5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1e2228b5-fd2f-49ac-b742-c7fe123bdb80_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_81c8ff78-c2dc-495c-9cab-b1dca3666cca_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:href="mck-20220331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_17756f28-77a7-4503-95af-90ccee477d01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions From Allowance Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0a7b26ae-ab1c-4385-941c-302c8cac0540_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_dbb7b35e-217f-4314-8b68-90e34ddcf71b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_35005822-b4f0-4770-8bed-33be0ae05a6d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_88567841-2945-4734-a6a8-55a0b813741b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c37a637d-49fe-4861-b7fb-76ae4c9dc99b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_56ffc5c7-30fd-4235-9be9-577967cddadc_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_25abbc31-7711-44aa-a33b-9877bb06c91a_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_a6b8340a-a791-4db8-8267-ab42be88c5c3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes/disposals</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f78de06a-f001-443d-8625-5b12d4e143ab_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_6e96d9e8-b24f-4fea-907b-dca389bdc140_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_bd2b7101-93ef-4310-b081-d476f5d898e9_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_943ae6ed-dee1-4a50-9b69-0e64f26c34e7_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931</link:label>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_label_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:href="mck-20220331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:to="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0bdf24b2-b540-44a2-a4bb-df90f7d3f7f9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_577177e3-423b-4db8-93dd-db50bf933488_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_43e8c4cb-891e-447d-8dc8-614458a2b889_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_3cd8c787-22eb-4d86-b314-7271c27a06e9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_b725d9a0-fb50-4173-912f-a8188ee0bcad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of options outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64a025c1-6001-4883-8a90-b311fd182f69_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_fe2b59f6-4ce1-4785-bd82-8fd7832d99a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_c929be23-0ba9-4155-aa14-e7cbdd67915e_terseLabel_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_label_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture [Member]</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_documentation_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:href="mck-20220331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:to="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_6d30eb4f-d1aa-4a88-b17d-6875f0491552_terseLabel_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_label_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_documentation_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:href="mck-20220331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:to="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_e5f1f717-a06f-4722-ad0d-10858831eac3_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20220331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_bade2bff-cf60-4628-9812-5c1e4390569e_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_088aa558-7fcb-4d65-b891-946e1336ce77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_c0f7ff16-4b57-4580-8fc3-cee0d88bee2b_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax dilution loss</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1267b2a4-2d1c-413b-8fee-92fbea4f5132_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_09d407c6-1bd5-41a8-a95a-ce30d380588b_terseLabel_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives</link:label>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:href="mck-20220331.xsd#mck_SupplierIncentivesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:to="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_7b729499-a226-4da7-9069-c0f80b09ae3d_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_73439a0e-b814-4c57-80cc-73590b072f85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_26c533d6-cef4-497f-bb01-9024d1d3e6b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_7ff3cdee-67f6-4853-9677-2dd910d521a4_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_b2ae1fb6-c5d1-4316-a4d8-5fbf36c48e5e_terseLabel_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related litigation and claims</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_label_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Litigation and Claims</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_documentation_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Litigation and Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxAssetLitigationAndClaims" xlink:to="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_685c0194-a6cd-4933-b8a9-88b71720c46c_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross purchase price</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_bc9439e2-25bd-4239-9c2e-87e0aa60e45b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_af0c2b39-7641-4121-9993-45876c3a856e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_7f3babf8-d3d3-4ac1-970c-f2967aac41cf_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:to="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfAlabamaMember_537dae91-d9a2-49a1-a417-bce93b3eda37_terseLabel_en-US" xlink:label="lab_mck_StateOfAlabamaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alabama</link:label>
    <link:label id="lab_mck_StateOfAlabamaMember_label_en-US" xlink:label="lab_mck_StateOfAlabamaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama [Member]</link:label>
    <link:label id="lab_mck_StateOfAlabamaMember_documentation_en-US" xlink:label="lab_mck_StateOfAlabamaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaMember" xlink:href="mck-20220331.xsd#mck_StateOfAlabamaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfAlabamaMember" xlink:to="lab_mck_StateOfAlabamaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_b4a12617-c73a-4e7e-bc65-a8c33d65767e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e5bb4f8f-744c-40a9-b331-459fb899f577_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per stock option (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_69c87701-40f0-42fe-999b-1b6939ef69cc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_e994d50e-ead2-4e96-a38e-2f86e0e2efe6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f2cdaf22-a44a-414f-acba-9472eaf20ba3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_5386e2b4-55db-407a-9de6-ea54f7c984a8_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:href="mck-20220331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c41332bb-dcb5-4ecd-b4ff-1288136d49a9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_c8988cb0-92be-449b-89e3-396b277039bc_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_169eba97-9c14-4f63-8543-642eb98038ac_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts accrued for liability</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Withdrawal Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:to="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_3d108cc0-1924-4783-a4a1-0e5a9349550a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_98531616-4048-44cf-a7bc-795d065bcae5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_11c07392-c4bf-4136-9d03-0ddeb9b706df_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_2fa06cb1-f8ff-4e4e-a63a-7ea84e6c82b4_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_9356b766-f9af-45f7-bdf9-0ad7d2d48804_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_08310d27-1a0b-47ee-bd0b-36f75af9e4d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other income, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GovernmentalEntitiesMember_71df85be-ef8d-4f1f-933a-6ec613b0fa45_terseLabel_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember" xlink:href="mck-20220331.xsd#mck_GovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GovernmentalEntitiesMember" xlink:to="lab_mck_GovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_ee0d557e-771d-48d6-be5a-20b326b4c1f3_terseLabel_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum sublease income</link:label>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_label_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Payments to be Received</link:label>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_documentation_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived" xlink:href="mck-20220331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LessorLeasePaymentstobeReceived" xlink:to="lab_mck_LessorLeasePaymentstobeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_5b3c47ff-da37-49bf-abcc-875881eb7884_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_672f9e4e-8e72-46a3-a7bb-07080182fd2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of pension plan assets using fair value hierarchy by asset class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_83270759-df39-4051-a18e-670bc56b4742_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of share-based compensation expense and related tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_4354bd25-d724-49a1-891d-bb1a3ae08617_terseLabel_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions</link:label>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_label_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_documentation_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:href="mck-20220331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:to="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_056d1a93-0b80-4366-a02c-1d9f0990968b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_16e9e660-593f-48dc-91ce-6d2a4ea7137a_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_3f8f9ab7-7a3b-487e-87e0-93fbf435c8b5_terseLabel_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations</link:label>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_label_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations [Member]</link:label>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_documentation_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember" xlink:href="mck-20220331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseandOtherObligationsMember" xlink:to="lab_mck_LeaseandOtherObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6e9d5e7f-bfca-44af-9930-82b1add850a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_3b6aeac8-2610-45c5-b617-caff19ed61f4_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of businesses held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_dd78bd69-8cdf-473c-8d3e-bcc894ec0891_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fd58159-d194-4693-bd6f-d80b20133e5d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f8c3a855-ef67-4871-9e42-49655ed6c89c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_4d3357c9-dc35-4cc5-b310-3a940b069afc_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_906455e5-420a-464f-8a87-b2d7429070c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_2d699c53-7230-48a2-8d26-f9ac770d0866_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_9b4bfea8-ef3c-4536-82bd-f3c3dcf529c6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_d14ce3c9-db35-455f-915c-4d5d75eab8e7_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f3483946-9960-4023-adff-5a16a29e20f9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2ecda9dc-bc8b-4d0f-8ec0-1ac888c9f318_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and benefit related accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_e2e7e047-501c-40ae-b54c-26c6308bd3e3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_62d9af76-2d13-4647-9d69-713c031ff2af_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20220331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_985d141b-f4a3-4800-8b3c-0cb1dd31f0ac_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_87640cac-17ce-4241-9a7b-6454c9fe1533_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1b2c4fcc-708d-44ca-afa8-c77be050f2bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b198a2b4-06c3-487e-ad86-a1a677651590_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_a32ec37d-cd98-43ea-ad08-8f3e73cac0ae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_ecaf1e33-4ad3-4c2f-8ee6-2b5fe7fa7f81_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20220331.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cf66f474-0d55-4664-87ef-eed6e16039ec_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_05695dff-d71d-4fcc-832c-d8ddeda4a3bd_terseLabel_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_label_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance-based Stock Units [Member]</link:label>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_documentation_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance-based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:to="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_61a122ec-b460-4a15-a2ba-1ab2d8f31d83_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_7e01ad4e-5557-4276-afdb-2112b08d5717_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_a6896969-d4d7-4ab2-8a85-3e1182775196_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_09ea8e8a-5476-4919-b80c-02114d4890bd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_ee19e87c-1cf8-49f5-a54a-0f0c1100f901_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable, weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_a923cf03-72db-4b5a-96ce-edbdef960eb4_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f720e77c-89ab-44c5-8c62-2df2da031aa4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_95fb82e8-da62-43c2-8133-6b1c973c47de_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20220331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_b85d199a-c692-4747-994d-343d4d722d11_verboseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested RSUs (in shares)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_5188061f-3297-4f81-92de-98ac63ca5d7e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_19eb5cc1-e93a-4ff2-94e1-ac3b6fdbe393_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_45188d49-d217-491f-8210-274bc99202e6_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_ab7d478a-e73d-4075-8d05-77cc34bea37b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal option increments for leases (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d383315c-e5b8-49d8-9024-438dbc1c3dfe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_80def048-cbfc-419d-881f-146099367ca8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e9084b6d-6529-44c0-9efd-6035ac144845_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_4dd361fa-83d4-4154-ba06-f6f0a32ba34c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, accrual, current</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_23b555f5-0fc6-43f0-9f98-80a9183cb1ef_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b928f84c-41d7-447e-aa87-42eeb165d68e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DistributorsMember_33182c73-ed73-4292-b506-27601ac08d77_terseLabel_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:label id="lab_mck_DistributorsMember_label_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors [Member]</link:label>
    <link:label id="lab_mck_DistributorsMember_documentation_en-US" xlink:label="lab_mck_DistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember" xlink:href="mck-20220331.xsd#mck_DistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DistributorsMember" xlink:to="lab_mck_DistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_dcfa3bdd-376b-415d-bd88-11a42c83cea4_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_eece86f2-0bbd-41bd-87ba-ac93e511f032_terseLabel_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought per violation</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_label_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_documentation_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:href="mck-20220331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:to="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_8b3c8d10-72c8-442f-8615-6a6d9b65ca2a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_58f288e2-d56a-4b32-b1dd-61145307532c_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_9c2a5d29-a2c0-4e00-b971-9fc495ec914e_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_f580d4bd-8c1c-443d-9984-e96d2282b439_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_32e9644b-cff2-4eaa-9ef9-264d1239f49e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Data by Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_0342475c-d0bb-404e-ac81-3e276641b4fb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_04fffe08-b63d-4399-9fe9-11654607c6eb_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20220331.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_d4a2b353-e08f-4cf7-b046-305f9f5ee23c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of lease costs and supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_f3952d4b-513e-40b5-a8f5-ddbe7a2dce98_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d5e15abe-dc6a-4097-a462-6a91370478a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9a2eb85e-8ecd-43db-941f-94f585f9e39a_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_cb56d022-73f2-42c6-848f-93e7945a8a9c_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_06525c2d-bab1-454b-862d-5e8d4b1c1513_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_5e024142-2e60-4df8-858f-b812d7639473_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment/settlement</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_053579af-c572-4379-b6ae-08865e3dfd28_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0daac7b0-4e7f-4044-96e0-cd2ad0309030_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_d233f1ab-8fa5-49e6-b10e-a6f7c04cda75_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit (cost)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_723b73d6-1ed1-4c43-a8c4-3669152e8cb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_9558baf7-77c8-4cfd-bd23-bd44761eca31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 130 and 115 shares at March 31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_01b42b31-3e45-4877-b266-a866127fe118_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_91a6adb6-be31-4e24-b5bc-34943ae36ac8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketTransactionsMember_fa973455-30a6-49da-ac5f-d14c38b6127b_terseLabel_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions</link:label>
    <link:label id="lab_mck_OpenMarketTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember" xlink:href="mck-20220331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketTransactionsMember" xlink:to="lab_mck_OpenMarketTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_3f48989d-4280-4c82-9eb5-025b2d08c7ef_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5d0ca32b-0c18-4745-86ed-5d851bae3d63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_af51a7fd-f668-4288-ae7c-22f3fb5babd8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_df06335c-c5da-4391-85e4-02aa6d0d2c8b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_2af41c92-35be-4782-9800-8c84e1c4ca74_terseLabel_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation</link:label>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_label_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation [Member]</link:label>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_documentation_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember" xlink:href="mck-20220331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InsuranceCoverageLitigationMember" xlink:to="lab_mck_InsuranceCoverageLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_c37accd7-b00f-44dd-a84d-aaa0e4dbaf30_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss resulting from discount rate changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_6e4ed814-72ad-4ba1-9a0e-d80fda8e94fc_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plan participants elected to receive settlement payments</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanSettlementPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Settlement, Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanSettlementPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOther_a5b1dca1-dc91-405e-bfbb-4834538d9dba_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment, and other</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOther_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOther" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_18afad76-6ce8-418e-8f36-d297844bfd11_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_8b2a69b1-b248-487e-9646-9472b50bfeea_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_634b6c35-f49a-45a5-af7b-d7d629dbc22b_terseLabel_en-US" xlink:label="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:href="mck-20220331.xsd#mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:to="lab_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_087167e6-0d1a-462b-9678-52c4a07a067e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_0762f659-630a-49c2-ad82-e54418c46244_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_516dd6cb-e23f-472f-9aad-ed341224c225_terseLabel_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_label_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_documentation_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanWholesaleBusinessMember" xlink:to="lab_mck_GermanWholesaleBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_38013df7-21f7-470b-891e-cfe412392bff_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_7545d432-edd8-4325-a70d-8cab2923bea2_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_fca10c2b-5920-42d6-9610-a3a9827ce18b_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20220331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_c83e840a-90e7-443e-a355-835589029967_terseLabel_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares distributed in split-off (in shares)</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_a8c356f9-9d32-4ca1-94c8-26183dbc18f8_verboseLabel_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares distributed to stockholders (in shares)</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_label_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Distributed</link:label>
    <link:label id="lab_mck_ExchangeOfferSharesDistributed_documentation_en-US" xlink:label="lab_mck_ExchangeOfferSharesDistributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Offer, Shares Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ExchangeOfferSharesDistributed" xlink:to="lab_mck_ExchangeOfferSharesDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7ed8b765-6897-43af-bf17-5ce96c73b8fb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_12246ee0-ba82-420a-89bf-43224a24019f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_bead05d8-1aba-4f55-9d40-4629e828e8a4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_46bf7259-ab12-46a1-80c9-a47c9938a518_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_61fbd8d4-9d98-411b-be62-e8ed5a807192_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_aadd6281-45c4-44f1-843c-af531e7b904e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_9744e274-2db6-4f52-bc9b-787cb00881de_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross_81013649-7b97-406b-8e33-b1264bc949ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remediation costs</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingenciesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_b869d9bc-1b75-4d98-a635-c8b03067d430_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_433c73f1-dea8-4611-b80d-eb3e1963f332_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_c4dea155-faf2-422b-aaaa-a003f54591be_terseLabel_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:href="mck-20220331.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_ba6be070-78df-47d7-b751-068d5196bc21_terseLabel_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business</link:label>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_label_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business [Member]</link:label>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_documentation_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember" xlink:href="mck-20220331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DistributionandRetailBusinessMember" xlink:to="lab_mck_DistributionandRetailBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_93b26a4f-cd9a-4c0f-813c-193b80c51dd3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_81fc6db4-6d34-4b65-8781-27f2400d8507_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_0dc2cd2f-3bca-41bc-ad28-098195d2eb15_terseLabel_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment, and other</link:label>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_label_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, Equipment, and Other [Member]</link:label>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_documentation_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, Equipment, and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember" xlink:href="mck-20220331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MachineryEquipmentAndOtherMember" xlink:to="lab_mck_MachineryEquipmentAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_ee1c4927-139a-4b0a-a686-6a20dc6ce4fc_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c0f9c551-3556-4029-9382-b5a53b441f4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_12a085bc-a1cf-4272-b4af-74738e88576c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0e3e4f3e-eb5c-4e1d-b24a-37eff2ebdd86_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_6427a51b-343e-48d1-a601-e0b6ff5daf48_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e7d042ff-54b2-41b0-8a0a-084db78333b6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_6d2207d0-eff2-44c2-be02-5faa07d9eb09_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8eafa8d9-7b25-4cb8-96de-6984f184ad98_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8272c049-ba96-4111-af23-5527625ad4cf_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_48d48da0-4a90-40e6-8e33-d728bef0343f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_16593c5e-3f64-4a08-9a78-da7b63a2b92f_terseLabel_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_label_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_documentation_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:href="mck-20220331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:to="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_7688a997-9110-4ca3-90b2-13d276ee7284_negatedTerseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofRelators_d7d4d97c-f615-4295-be93-6fa8203a76f0_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of relators alleging violations</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelators_label_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelators_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofRelators" xlink:to="lab_mck_LossContingencyNumberofRelators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_f9062cdb-2fc3-4a3d-83ce-599c10311d0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_64377af9-3687-4f3e-b6b7-773b584635c5_terseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_5c0cefc4-1188-4434-ba8b-ede32ed879cf_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_be72f457-1946-421b-afa5-c8ea37be87e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c10b35f3-2b1f-4b68-89ef-70979bd1ee4d_verboseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_03bfce16-0cab-4d2f-8691-30506daa8277_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_3baa1c9a-817a-4540-8bdc-27f8493a4094_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2026</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Four</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_efaca81b-c4cb-411a-925c-3c97d0964fae_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_160b67e5-391c-4c5f-a517-aae5f04ffa4a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_438e78d0-6880-4ed0-8eed-49d2f91fa6a5_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_368dfd9d-2f02-4ddf-8bcb-d02e60a13997_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_6e1d2bee-fafe-45fd-8919-8c7fadfe7227_terseLabel_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember" xlink:href="mck-20220331.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_November2018CrossCurrencySwapsMember" xlink:to="lab_mck_November2018CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ba43cf46-b955-47e0-9288-d277c263d19e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4e685824-a583-4e51-9c8c-9c488934cbcb_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_e2dc50a5-0276-49bc-84aa-68fd13324dc2_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_label_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:href="mck-20220331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:to="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_e03df983-08b2-4975-95e0-78d29ba4fc8a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_5a49e2f7-5a11-4bb8-b725-cc0125b2c055_negatedTerseLabel_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity earnings and charges from investment in Change Healthcare Joint Venture</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment</link:label>
    <link:label id="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_documentation_en-US" xlink:label="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:href="mck-20220331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:to="lab_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_c4ff3332-5daf-452f-a064-36e58d07f4a4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_3b1b57c0-360a-4083-b8df-c044529604e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6514e0ba-532e-4d15-9de5-abfc0056cbc0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8afb0322-5b65-457d-a5c4-faf57d1f51f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_5e9d1689-291b-4128-a81c-ff0e196e9255_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes remaining in class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:href="mck-20220331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9a738171-8eb7-418c-9bb2-ae48cd431aba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_1a34111b-e501-4003-bf72-f4adbbd0ecb0_terseLabel_en-US" xlink:label="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640</link:label>
    <link:label id="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_label_en-US" xlink:label="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]</link:label>
    <link:label id="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_documentation_en-US" xlink:label="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:href="mck-20220331.xsd#mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:to="lab_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_0f2186d3-ed99-4f00-a897-79d0014d72f8_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost_196512d6-6391-4061-87f7-23a8aac4f97e_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of shares repurchased (in usd per share)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted, Average Cost</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Stock Accepted, Average Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAcceptedAverageCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:to="lab_mck_EquityMethodInvestmentStockAcceptedAverageCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_0552e213-308d-4a99-be8e-056abd344d25_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bc5214b7-5343-4bbd-ab77-eac291c1e0de_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8fbc0e50-5ac0-4f40-998e-19bbdac5acca_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a08ded25-1caf-4c5e-be07-dfdc4bebf5a2_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_26540a4c-00ac-4ee1-8ccf-4dc7972560fb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_405e566b-ef52-4ac7-9854-408aae898b29_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_aba065b9-bfd6-48a7-8a34-d0e3a721d570_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_32052191-8642-42c7-800b-4c3d8f2b18fe_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_37eabd91-26c8-40a9-a51e-092f7ae21312_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_b568e12b-c306-4ac4-a53c-5047d1a3fc53_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_e817dd70-ad57-4769-ab97-2bfe83536758_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_1c2b43c7-974f-4329-b009-b22ef6b2eaef_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Plans</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_8cef8660-8689-4115-855e-fe81b134d6ab_terseLabel_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales returns from customers</link:label>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_label_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</link:label>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_documentation_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:href="mck-20220331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:to="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_a2b8f60d-aa56-44f0-b75f-dcab94b73f41_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_c251ed6a-3718-4f57-9cee-b356552f20c1_terseLabel_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer accounts</link:label>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_label_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Customer Accounts, Gross</link:label>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_documentation_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Customer Accounts, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross" xlink:href="mck-20220331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccountsReceivableCustomerAccountsGross" xlink:to="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_770ceb93-288f-47f4-80b6-30dbd917802f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_35eeada3-ecf1-432f-9c2a-f29c886ab48f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_c545429e-5514-47ba-b5bc-d7c192322889_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5e9d620b-fa35-4701-b0a5-fdbaa09510ca_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_2352a4d3-346d-42ea-8a7a-0d1e5abd0a43_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c1472655-8664-41ba-b115-903bb640560a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f2b05644-a2f5-4466-b3ce-0f65814ee98d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeparationofChangeHealthcareJVMember_f4de2ead-6cd6-457f-a9ce-fba862ca536a_terseLabel_en-US" xlink:label="lab_mck_SeparationofChangeHealthcareJVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation of Change Healthcare JV</link:label>
    <link:label id="lab_mck_SeparationofChangeHealthcareJVMember_label_en-US" xlink:label="lab_mck_SeparationofChangeHealthcareJVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation of Change Healthcare JV [Member]</link:label>
    <link:label id="lab_mck_SeparationofChangeHealthcareJVMember_documentation_en-US" xlink:label="lab_mck_SeparationofChangeHealthcareJVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation of Change Healthcare JV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember" xlink:href="mck-20220331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeparationofChangeHealthcareJVMember" xlink:to="lab_mck_SeparationofChangeHealthcareJVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_2c725b7c-22ed-4fb8-b577-83649b737c63_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9ebfde06-9de2-4c06-aec3-4e6ee8652841_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_696c76ae-1248-45ba-a543-2f308b9ed5cb_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9bc68158-e0dd-43d4-b2b0-ca1636c80500_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_fffa0c77-6a16-4f5a-829a-d8a16e00224a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_9aec365d-de39-4d64-afb5-f8e7ad2c3d91_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collection of notes receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_33e402c1-0ba1-4a62-8a3f-a0eff56f655a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_564c7264-779c-4a05-a861-6e295426dca5_terseLabel_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_label_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge [Member]</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_documentation_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:href="mck-20220331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:to="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_ee7015e5-de4a-485f-92c0-644496ee2ab6_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentFairValueofStockAccepted_052cd1e3-862d-457e-b366-245a14f01c4e_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentFairValueofStockAccepted_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Fair Value of Stock Accepted</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentFairValueofStockAccepted_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Fair Value of Stock Accepted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:to="lab_mck_EquityMethodInvestmentFairValueofStockAccepted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d4561d85-a7b4-4f8e-9576-73287169bed0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_0ca29734-cfd0-4dc6-9503-fe3c1208c926_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a164c3d2-600f-4584-b317-e8567b42f66f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_f033a416-f527-41d7-80ad-2202550e8dbb_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:href="mck-20220331.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:to="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_17962434-3386-4626-8014-a6c9ae03dbcf_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_45163970-cdb5-45da-b393-612e6f825645_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net periodic expense for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_43311e05-a8e7-4b1b-b338-17af55b90c64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_a6b44332-0736-45ce-9bfa-7b943150854a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconsolidated VIE maximum exposure to loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_d6a71d84-fe71-4269-b707-0abbc7157c95_verboseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_2e8491df-b8c4-4156-aac3-29f3eaf6935b_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f5323e66-a87c-450e-85d8-30931b02bb04_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d6dc1af-f3e9-4d0c-bb3e-07776c012f8b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3a601a92-f67e-4ac4-b0e2-99ba63a91207_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_e9057429-6b57-4f4e-93bf-816b054b539b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and unpaid interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_4d2e4794-7f44-43c5-9ca6-aa51b587eb86_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_87505f59-c2d6-41a6-9a46-4d0accdd45b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_90977e94-af13-46fb-83f3-db97519d3ee9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c1003e97-9f19-4042-bb13-1aaad06a811b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of defined benefit plan amounts recognized in other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0faadeb1-0cdd-4d38-bd1a-9064225f7790_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_7f2d9982-377a-4482-a2e4-b4db9cefadc1_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f5c3148b-940d-4f25-bd5d-4c449e5b02d7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberofSitesSelectedforPreferredRemedy_bef525fe-b916-41e2-a8ec-2abb8c234e10_terseLabel_en-US" xlink:label="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites selected for preferred remediation</link:label>
    <link:label id="lab_mck_NumberofSitesSelectedforPreferredRemedy_label_en-US" xlink:label="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Sites Selected for Preferred Remedy</link:label>
    <link:label id="lab_mck_NumberofSitesSelectedforPreferredRemedy_documentation_en-US" xlink:label="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Sites Selected for Preferred Remedy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSitesSelectedforPreferredRemedy" xlink:href="mck-20220331.xsd#mck_NumberofSitesSelectedforPreferredRemedy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberofSitesSelectedforPreferredRemedy" xlink:to="lab_mck_NumberofSitesSelectedforPreferredRemedy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_71c5c71b-2537-4ad2-b803-9b18a4db700b_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3d2f6ec0-ac88-463a-b572-4ff7aa78bfd0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e63ec820-49eb-4e51-8904-7f543d70aa9c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_30be741e-e567-4bf4-81cb-07711669f24b_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cities filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cities Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cities Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofCitiesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberofCitiesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_20f5cbd1-609d-4c5b-85a8-cbc661a2622a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_e0e3503a-f823-48f0-9c10-f2d66a869a64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_587def26-5e95-4b02-9fa5-d15e35a13754_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_cf0a0b03-fb97-4a2e-9947-e64506c24719_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_0a6a2d8f-6ff0-4e31-a9a1-38d4455df7eb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company match employee contributions (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_f5e477da-dc1d-49a0-ac3b-5d7cc9455714_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_2be8fe98-0730-4cab-abca-25e392e4732a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2019Member_05eb2ae6-1c90-487a-9a9d-0f8e5f4c467a_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2019</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2019Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2019 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2019Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2019Member" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseMay2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMay2019Member" xlink:to="lab_mck_AcceleratedShareRepurchaseMay2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_85d1a3d2-652a-4166-8825-475ee687da46_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity commingled funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_36181d43-dfe1-4d31-a401-4c5316324f85_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_877b1f5b-232f-4da7-b937-2ba4f6b49176_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated loss</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4ecc4a55-936a-439a-884b-bc8ec4da7fa3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_26d64b81-9b84-48f3-bcf4-de3441afcbf8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_936c8a81-2d79-4dc3-bde5-e9179093b292_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_93540bfa-127a-4054-8d8b-bca528ea3ee9_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due After Year Five</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fd82e163-5441-4a00-bb2e-11c12fe6abf7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2166d9d5-5c13-4f39-a873-0e3ef3401ce5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_7ed398d1-9afc-4946-8ee6-c5db56343096_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_f1753984-009d-432a-8cdd-266ca5c4368f_terseLabel_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of data related to restricted stock unit award activity</link:label>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_label_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Related to RSU Activity [Table Text Block]</link:label>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_documentation_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Related to RSU Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:href="mck-20220331.xsd#mck_DataRelatedtoRSUActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:to="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b656d217-1ca6-4d7c-9b57-c9a3b587f025_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_268ade2b-e433-4e6d-8d52-8dda12866076_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b4130a68-98da-403a-8c22-7873fbd6d326_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_de7b46a6-09ee-49f9-abf8-1393d37c5597_terseLabel_en-US" xlink:label="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Euro Notes due February 12, 2020</link:label>
    <link:label id="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_label_en-US" xlink:label="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]</link:label>
    <link:label id="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_documentation_en-US" xlink:label="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:href="mck-20220331.xsd#mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:to="lab_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_59fd3b60-4b14-4496-886c-0d4eb208d73f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8bf05cbd-086e-443f-beae-4c372483b8da_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2cab7e76-00cb-41b8-b289-1a1511ea0d9f_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_9b693c11-b405-40e3-9e0e-156243482258_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_329db1f8-5415-42a4-ac8f-a8ae0302647e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_0c353280-1450-4fcf-affe-cbb938344b8e_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_713d15d1-e656-4651-9775-e6252ac1904b_negatedTerseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:href="mck-20220331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_377dabff-a996-4110-a793-e867f1570c56_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from net investment hedges</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_014eff65-20a2-49a9-b898-e4309c304c07_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_0e2172b2-434b-461d-9cc5-1cb40125f474_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_fb0350da-6d1e-4833-9ecd-74e01dd36f11_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20220331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_95bbf9a4-f078-4643-9a8c-613917bc9473_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20220331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_e44af83b-724b-401d-b8e9-a74efef992cf_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_16a47416-dfb0-4db4-bb4e-2fa870cf01c6_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_9f5d9535-bd82-4fe9-9d07-fb38c537f7d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_91905324-e259-47e8-bfd7-b4ec8d73dd2b_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_2f41f004-a035-46be-83ef-51edffadee33_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash proceeds from settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_87ad7e6b-b4fe-496c-acb6-7e33429f693f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_97355d44-bbb5-4c7e-a0b6-d9be4d6c76b9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_bb316da7-df50-4fb6-8558-37d8a16f1239_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase in interest (percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20220331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_8edc7a41-2ed2-4dcc-b3d7-4f766c0fcdc9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_13cafbe9-7c75-4fea-9314-0d8447534c65_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4814d6ba-5ba0-4b95-87d8-866942418be1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Balances and Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_aae4db7d-8037-4d03-92ea-32303787a9b2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_54b4fafb-6584-4813-bf26-e9591b7bc7df_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExecutiveOfficerMember_b5e1f04c-8fad-4b54-8747-bb4ae2f7a48d_terseLabel_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retired executive</link:label>
    <link:label id="lab_srt_ExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember" xlink:to="lab_srt_ExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_b59f7d3a-aef7-4304-964b-e829fceb70ed_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20220331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9b16315d-9f5f-4424-996b-5386f95dca75_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible compensation (up to percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_e5de8aa8-f82e-407e-a7b9-b0adcfd56c5f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, period increase (decrease)</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_2ebb78f6-82a3-4c5a-9290-093ca5dad79f_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right increase (euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price, Increase</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b3d67562-e544-49b7-91c2-5effd609b6a3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6d435e3a-0d71-47bc-bc42-3c4f4376cdff_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_ce7e3878-d8f7-4290-b6d9-b7e07b615264_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of deferred tax liability</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reversal of Deferred Tax Liability</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Reversal of Deferred Tax Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" xlink:to="lab_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a92a6365-13c6-46a1-974b-39561ca0c053_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest, weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_2d3ba729-7401-4fcf-af67-b06a2572e85f_terseLabel_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Programs</link:label>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_label_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Programs [Policy Text Block]</link:label>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceProgramsPolicyTextBlock" xlink:href="mck-20220331.xsd#mck_InsuranceProgramsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InsuranceProgramsPolicyTextBlock" xlink:to="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_253d4d9d-0e62-45b9-91a9-3b55d9c9ebf1_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchase authorization increase in 2021</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_1811badf-b9f4-4b0c-bdd4-733a86e93029_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0b57b78f-1067-42d2-bd95-b5ca99234338_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory federal income tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f65070e6-8b5d-48f7-bd19-9b7b868166c2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_056244dd-0a3a-49bb-91f4-133828279f5a_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b9c154b2-3fbf-4aac-8884-514604ea9ab6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fdd60ac9-a27b-4401-9813-8d604a43fd52_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_d07119d6-2b99-4b4f-a4ed-8f891acabdc9_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net and Allowances for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_616f2d10-9edd-46a4-8bab-7632ae717379_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4a0274b5-4fd3-4f9d-8845-6619a0829fe4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset, transition adjustment</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_cb456974-176d-4ce2-8824-bfd4ba3cf36a_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:href="mck-20220331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:to="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_56361003-bd84-46da-864e-459e8a3c2c68_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_f1d6d011-35f0-45f1-97be-8f8c531a8cf1_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on split-off of the Change Healthcare JV</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_89f48492-8496-4096-9842-8cc5f95fc22c_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of equity method investment (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_cb6a0e24-4f6b-4bb0-ad5d-1a34951d2065_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c6e306ff-7981-47ad-b40f-16e5397e6e79_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_30af0548-9d15-452a-95df-1e94bc29c06b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_22d5dd70-1108-4e51-83d1-2ed28fbeb091_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:to="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0afc51e2-a7a6-4672-83ac-b76de7c35a43_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d88a5631-253b-4191-ac16-336886a58d90_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_777c413e-c17f-46ae-9677-992c4626c90d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration agreed upon for sale of business</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f5ade07c-6be6-4491-a44f-353467440201_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_6be13944-1a03-43c2-a016-303a593d5565_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember" xlink:href="mck-20220331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementTRAMember" xlink:to="lab_mck_TaxReceivableAgreementTRAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_8187bcc7-8737-4984-801e-56fde7cc9439_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_4d007eb9-4644-415b-ab06-83615edf1832_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Inventory Repurchase Guarantees</link:label>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_label_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Inventory Repurchase Guarantees [Member]</link:label>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GuaranteeObligationsInventoryRepurchaseGuaranteesMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:to="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ad70438d-7297-4e3b-be7c-cd38389ca418_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_8a4691e8-4e3c-4c0c-b7ce-377318d2c811_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in basis points</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:to="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ba4708b9-8c35-4872-9c46-6611ec7942e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_333e54ca-98cf-43ab-b880-1bd0f7b0bae8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_3c2d24f6-bb4c-41e5-a4ac-badab18ecf77_terseLabel_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period within which party can be substituted</link:label>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_label_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Party Substitution Period to Prevent Case Dismissal</link:label>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_documentation_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Party Substitution Period to Prevent Case Dismissal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:href="mck-20220331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:to="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df2318c3-1cc6-4a08-bf4d-51d30fbff20a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_971f783e-6236-4e1f-b2de-bd2d29aafaca_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_9657333f-899d-453f-aeaf-1d099c93ea0e_terseLabel_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_label_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_documentation_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis" xlink:to="lab_mck_DefinedContributionPlanMatchingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bd49a1eb-b979-4136-a733-9f28f720f807_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_e51941e1-685d-4937-938a-7d54167c3879_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0d2f19a1-9a08-4a3a-82b8-2c1abe988756_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_1645f67a-7bf6-43c6-a980-c26b8e42de86_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_76d3f879-5481-4d8d-85a1-214a5cb5b68c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_e7bbd1de-94ac-44c1-b974-2bfe9288e9ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_607e8080-2c6b-4995-989b-509f296c2d8d_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_9af765ed-0194-45dc-a6b7-c67409382be1_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_87c7c2f8-4d4c-4845-b582-d5e57a6401f1_terseLabel_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:href="mck-20220331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:to="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_ba8f8b40-8799-4722-a01d-f3bd6598c8b1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement payments</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_9ee98fe7-9b5e-487e-a879-e93f9bada8b8_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20220331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_a47f2689-dc6d-4244-9f9c-aa97fe59f395_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_223fcf9e-f750-4582-b340-0be50df87c00_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_128a5eee-a089-4e21-a827-b75d2572f4f7_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_664c76aa-20c4-4d87-8a54-d481fa474419_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of States Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberofStatesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_70ddb12e-2070-4da7-ba2f-f980cc0e732d_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_6a4dee94-d4f4-43d5-851b-84db0b28d64d_terseLabel_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York</link:label>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_label_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York [Member]</link:label>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_documentation_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:href="mck-20220331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:to="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_2a4f528d-3704-42cb-9c67-4ad1ceeb131e_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AuditorInformationAbstract_label_en-US" xlink:label="lab_mck_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_mck_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_mck_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AuditorInformationAbstract" xlink:href="mck-20220331.xsd#mck_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AuditorInformationAbstract" xlink:to="lab_mck_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_007fe8ce-6777-4b5d-8c52-4a02dd76daac_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax other-than-temporary impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_abefd23b-d245-48ad-abd3-a9e030457008_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4f7979bf-0efc-4e42-9fc3-98272c6a2a06_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_520c53fe-e702-4459-8e6d-fd94315b3ef0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_68953c86-9804-4de1-8a0b-cf84d0568656_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_a497ad3b-e392-410d-91bb-23dd3d12f199_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3c8b06c9-91cd-4e38-a742-a662f44e6037_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d5c97086-232a-40d2-a9b5-33cefaf91437_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_006aced8-8ff0-4519-be19-2b11f85e34c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from contracts not designated as hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_7f1c4733-3b9f-4d41-8ed6-a39f0f4deaf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_fdc3b6c3-0883-4f4b-88d9-b5688e8cf58c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_c3aef68f-2599-4ab0-8f1f-74c80145a8cf_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_532e9963-b491-4303-9b78-ec55b76c6bcf_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_86737ff6-979f-4265-a4af-dc9724107a31_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_4a7412f6-9341-4d55-9034-ae0931e0fccd_netLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_43d304fc-9724-4c88-b5f5-4e6153d025c8_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_3b812fba-957b-41f2-8013-af5648e1a359_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1d68cdd2-349f-4b95-b4c9-fffe82d9a948_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f4b21edb-caf7-444f-9925-c9b51bb3999f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cd06b8bf-5c8e-43e2-97b2-a6c3882acc0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_910f165f-eb38-48ba-af61-916ed1937784_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_457fb3ca-b199-46ec-bf69-7e5204675d2d_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_594706b1-6d91-4a16-8fa7-53b2c75a32f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_e22013cd-2cda-4a0c-b067-3c483f855cb3_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20220331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7b24d44b-7d9e-488a-8ac4-0d936ff03e77_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RangeOneMember_350a7f43-9a9f-4c41-9cea-8ceeffb8ea86_terseLabel_en-US" xlink:label="lab_mck_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One</link:label>
    <link:label id="lab_mck_RangeOneMember_label_en-US" xlink:label="lab_mck_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:label id="lab_mck_RangeOneMember_documentation_en-US" xlink:label="lab_mck_RangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeOneMember" xlink:href="mck-20220331.xsd#mck_RangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RangeOneMember" xlink:to="lab_mck_RangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_07c0d63c-4e1c-409d-a383-cb32d8f9d9cc_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital loss carryback</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Loss Carryback</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Capital Loss Carryback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8d8b1a33-8756-40ae-9d34-340cbc548547_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7fa0919a-4685-4810-974d-0286a00ad5d0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_3cafbc68-f3c2-4399-9dcc-4eb437b1961d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total consolidated revenues (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_79385e9d-b7c9-47c3-a15e-d8f3185ff22f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_dce5de4e-497e-4712-8c8f-c3a3d3b2d986_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1e6746e8-4e3f-4aeb-b81a-4a23fe88d3ff_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_c26e30dc-795a-4444-aa81-8f8ba8f4e9b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax-free gain on investment exit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f57a5a4c-1b00-45fb-8cf6-b46a288adbd4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_10e52cda-e3e0-4610-b719-a1135bd7b54b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a6b9608a-c7bb-48d6-bfef-53a362ea7b25_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_3b2c1cda-fd5b-416d-8568-42aa87fc47e4_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_399a386c-ea93-4bb1-ab1f-51090f1dcc45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_5fb1ccdb-e2d9-4412-b943-7c6ddc6b4c55_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncancelable lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c246ae4d-8d6e-494b-aecd-e04eb3567f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_e5cf2be3-df85-48bc-9d32-5e3e548644e7_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c0268137-d116-4581-89a8-c6be37afa745_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c9455cd6-1fc3-47e4-b299-6d81e77b8856_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_c5e6d07f-bbca-4c2b-afcb-887302e0067d_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_00081eb6-994f-461b-84cb-02042674776f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuarantorObligationsPeriod_00bf9495-e438-4b4c-a3f5-54e61e680b50_terseLabel_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt guarantee period</link:label>
    <link:label id="lab_mck_GuarantorObligationsPeriod_label_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Period</link:label>
    <link:label id="lab_mck_GuarantorObligationsPeriod_documentation_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod" xlink:href="mck-20220331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuarantorObligationsPeriod" xlink:to="lab_mck_GuarantorObligationsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_b26860a4-0c64-4c9d-ae58-5e88485f0e01_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring compensation (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20220331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IndividualClaimantMember_4f865435-2729-45fb-8d29-2cfc65bbe32a_terseLabel_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_label_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant [Member]</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_documentation_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember" xlink:href="mck-20220331.xsd#mck_IndividualClaimantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IndividualClaimantMember" xlink:to="lab_mck_IndividualClaimantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c83eeff1-6707-4630-a1da-11bf072183a7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_476370f5-06c9-450f-bf8c-ad4cf1a9cac4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_926d8c7a-e61f-491a-9bea-7b1794ddf294_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_d7796144-0b7c-4b00-8093-1310da096799_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, award amount to be used by state and local government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_label_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:to="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dada43e5-9225-4965-9716-ba2e236b3d62_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_1a7eafa7-cfc9-4bc9-b59e-a17833c1479c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_db65facc-54c0-4757-a5cd-ab873cb3a1cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_eac3e7eb-1974-4fcd-8436-209d37d7be84_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_82799fda-51de-4cd3-a460-5e78c3f1486f_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_803c3a43-ef83-4333-9351-4ebe57ebd174_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of complaints served</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_aeb880d8-5e1a-4819-ac2a-7653a0a8df18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_c5420ad5-6958-4b6a-860b-4867b1bed0ec_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_371d8cac-df77-4778-90cc-b6605b88d673_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ef4e407a-bbe3-4bf0-a8ba-2e0cecc71342_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, after 2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_0bd259a4-3904-48ea-96e8-c3c5fdc11040_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_7ebbd7eb-e3f3-4630-b43f-6eb785b01c3c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_fe441c78-0fea-4a72-b0eb-6b87a21af20d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_422f0bf8-3ed9-42f7-a3be-0e68bdf372c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7acb12e6-7801-48b4-9e0c-696eda819020_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_58d19520-ccce-46c4-93d6-363d08ebb173_terseLabel_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current allowances</link:label>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_label_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</link:label>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_documentation_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:href="mck-20220331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:to="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_8ebec7ac-d540-46da-a7e3-2f9b09d3bb23_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution expenses</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_23cf22a2-aa0b-45fc-8332-3aa29e4fea02_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fa075f17-c9dc-4acb-9335-1bd65031392e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_dd4e407f-9112-4917-be46-c716e4e7e2a9_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDue" xlink:to="lab_mck_LeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_490a0f30-fdfe-4f32-85ef-65130b5144ed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_acb90515-aec0-48c0-8ee8-7d41418e75a9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_75291803-861b-4eba-b02c-35a19f490247_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5cb6859-a108-4f00-aff4-1fa7319256ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDeposit_e13f04a4-71eb-4acf-80ec-fdc5b874783d_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposit</link:label>
    <link:label id="lab_us-gaap_EscrowDeposit_label_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDeposit" xlink:to="lab_us-gaap_EscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5ea59a67-0348-4d32-a727-2a19912da935_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_ee1f5510-bd43-4d4d-ad85-9a650a0d2382_terseLabel_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_label_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_documentation_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:href="mck-20220331.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:to="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_7f64ad0a-4f4a-42e5-a202-38b5d6ccf674_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_68a9318e-49de-4b7b-81b0-ba39e5a160bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_56e3d6d2-d09c-4767-a563-1f1a36b22867_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be21c88d-f50d-4f93-b0f9-cb47fa03a262_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_afa083bf-c559-470c-8c20-b81221fad3b6_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligations, Expenses Paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligations, Expenses Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationsExpensesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3.125NotesDue2029Member_0e59677f-848c-4b7e-a1d1-dabe2b63a867_terseLabel_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2029</link:label>
    <link:label id="lab_mck_A3.125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3.125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member" xlink:href="mck-20220331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3.125NotesDue2029Member" xlink:to="lab_mck_A3.125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_edaa92f5-65d6-4eac-b4f4-138a0d9fe4c7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_aec663da-1d9e-4cf8-82c4-d0bc8770f407_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and long-lived asset impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_47b94479-f0f1-4922-a4bc-33a10164749e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_74a65f58-c344-4f9f-84ec-b668589ce5b7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) recorded in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_74475a05-d66a-432c-bc30-7f6f4834e257_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ee444294-fb14-4b5b-bb3c-fa1ba62fa802_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentCarryingAmount_5bd56ee9-b1a9-463e-ae30-6703d35767ac_negatedLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in the Change Healthcare JV at exchange date</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentCarryingAmount_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Carrying Amount</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentCarryingAmount_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentCarryingAmount" xlink:to="lab_mck_EquityMethodInvestmentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fd561ac5-12b4-44b3-a999-b6b6a459a85c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_c53e99c9-060d-48ab-8d5d-503b2ced421a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_6bf131f3-3709-4523-bd5c-5153376c821c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8493e548-69c6-4521-b2c0-bf95f96cb42f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_b6affea9-852c-44fc-9c61-fd87f681b875_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_9179bae9-5b56-4ddf-8146-e8cef78bcb15_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_ef1b0676-f696-4f49-94e8-a5b97985e834_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits realized related to exercise</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_7ec1158a-4493-44f0-b2a7-680c3bb55a5f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_33bc0f65-0949-4bed-abfb-396e3e13175c_terseLabel_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_label_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_documentation_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:to="lab_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_c30f5fa7-4416-48aa-bae8-8eeb29937abc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2a78bac0-bb16-4a87-88a1-71484911b04a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_e4f00c13-bc29-423f-b340-90d42f748f14_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Alignment Plan</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_8dcf0ecf-54e7-4aed-9f4d-46c9af6e3beb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_f1b4eca9-77e6-4071-8073-78af6975722a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_aa529f22-5fd0-464d-a5ca-83a160efff76_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_0191f056-36dc-4fba-a058-5d04f483c9b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b7731c71-753d-40ea-b233-ccebff1c02c7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_d11be23d-550c-47d4-8e6d-c1a462304784_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_ed85f568-22fd-4b0a-a054-b51c7e52af44_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price paid per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_8b6577ad-346f-403a-a8cf-b1a2a976e439_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest in Joint Venture (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_223442ff-4662-4835-abfb-93a7ec84aa18_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_2ed0b388-65d4-45ab-a92a-2efd50b3f500_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held at NAV practical expedient</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_13fb8d70-ad59-4114-82c0-a497d4162014_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_4dfc3259-e1b0-4b50-ba32-1bb942aa1a52_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:to="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_d3dbf943-1345-47c5-9ce4-e2dd22f2d4c5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's International Segment Operating Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3364e104-434b-4dfc-b11d-bf73d5629081_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_fe2af5df-10bd-48b1-b803-3dc9263932bf_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_8a4910d4-b8fc-4e94-aa96-ca0b5fe14b7b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_68ba83b0-df18-423c-8c6e-237ccb28a6a3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_8aa4409d-8de4-4f76-b44d-b1137e292488_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_df0215c6-c4b5-4026-a19f-a7ba73f44b73_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3f3f39dd-18b4-4788-b076-2a644c5de254_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_e1c9e462-ce27-447f-bf9e-9ba6122e7157_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20220331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f2822b58-331c-4f47-a736-4d943d3e0ac5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_0072040f-9738-4f25-8c31-e5586d63d794_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value on a nonrecurring basis</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_d9820afa-bebb-4b37-b24b-24021b6a4953_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_298594ae-45f0-4abb-a7c5-9beb87eec137_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and handling costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_7877b3d4-d24b-47e2-bfa6-60916dc2ced9_terseLabel_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;)</link:label>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_label_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TransitionServicesAgreementsTSAMember_documentation_en-US" xlink:label="lab_mck_TransitionServicesAgreementsTSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreements (&#8220;TSA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember" xlink:href="mck-20220331.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TransitionServicesAgreementsTSAMember" xlink:to="lab_mck_TransitionServicesAgreementsTSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_542b522c-7f2f-4d59-9e57-a12a0a2ec55a_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20220331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_9f7628e9-ca0c-4261-a4ec-06e9a9c44bdd_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_57157582-0674-4ff4-b660-c99d9c00d8f8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b79ed8ad-3412-45bf-93e0-178d00eea516_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, accrual, noncurrent</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_49501f36-cc4a-4bbc-a92f-856f65bfe822_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_84ebf6d8-a8d4-4f33-806c-836f76c6ecc3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_c6abd40e-cc37-4af3-9eea-6b4d5d0dabaf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO reserve</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5c05f197-760c-40b4-881e-ba19e39b821b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9bbe99cc-1766-41ba-97f0-fe03157b8689_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_69301863-cb4b-4841-b0ac-a909e2153a2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ec8bc8cf-4cce-4eb3-a755-9bda9e0ed5ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_dc6b006a-e641-4540-9874-8efcd7e56e3f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c0e4a2c3-c0b9-4930-b360-bb4b5ae51ea2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Exercisable at Year End (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_bbc18c10-afea-40b7-9538-67ddb694d2d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of market price deduction for share purchases</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GlobalFacilityMember_149904ec-6b5b-412f-a689-329c0754ca55_terseLabel_en-US" xlink:label="lab_mck_GlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility</link:label>
    <link:label id="lab_mck_GlobalFacilityMember_label_en-US" xlink:label="lab_mck_GlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility [Member]</link:label>
    <link:label id="lab_mck_GlobalFacilityMember_documentation_en-US" xlink:label="lab_mck_GlobalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GlobalFacilityMember" xlink:href="mck-20220331.xsd#mck_GlobalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GlobalFacilityMember" xlink:to="lab_mck_GlobalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_165cf4e0-6a50-438d-9303-e2ff29ce50ef_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_de675868-ecdc-4eda-aea8-eaf22df3cbc8_terseLabel_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_label_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_documentation_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:href="mck-20220331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:to="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0af8a33f-68ce-42f0-8bf6-2e377bcbf86d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_071357c5-58c8-4d3d-b84e-6270fdb6c672_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_ed7c9293-231d-4561-9ed7-03308b0ef6c8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseFebruary2022Member_fd4def89-4c70-4de3-9d46-00f48d23e8cc_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, February 2022</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseFebruary2022Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, February 2022 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseFebruary2022Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, February 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseFebruary2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:to="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAnnuityContractsMember_83268f76-6c05-4079-9672-6b4bacab3976_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity contracts</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAnnuityContractsMember_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Annuity Contracts [Member]</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAnnuityContractsMember_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Annuity Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAnnuityContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:to="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_eb7c52ae-f825-4662-a28f-99220a1438b6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_a93d5d00-73a7-4229-8856-b7b075ddcdcf_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_6259298a-5aee-48d6-a468-8bd2cf16832e_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_74f51f66-a1f6-431a-a4d6-0fdc8a17e244_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_c8b62b6f-713f-4443-a42a-ad625b4ef584_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_f45cd9be-af96-4dac-aead-e61985f83f6a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_bf54bbae-f699-4d03-afb0-d69730e4ddb6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">#REF!</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_50100f9b-ee29-48e5-b646-49eb07e915ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_21ae02cd-96e9-47fc-8dd2-2b528dd9be44_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_1dbac0fe-7ac6-45d8-ac0c-7854c1a3b36f_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unexpected actuarial losses (as a percent) (exceeding)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:to="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4ea4a90a-a3fd-41f3-8557-69e2f539e2cf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_092976b7-e510-4476-896b-a4e0a9498460_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_3a811987-6a69-4bf2-b862-86581466edcb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_0d059440-1dc8-4448-9c7d-7bc99a89e89b_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of eligible political subdivisions, participation percentage (in percent)</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible Subdivisions, Participation Percentage</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible Subdivisions, Participation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" xlink:to="lab_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_e8e00064-4ae5-483b-adae-4f711d697566_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_b353d1d0-d4b5-4ca8-a0cf-843dc5699772_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_9114d012-cdf7-4c58-8f46-145f3dffb90c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_6ffb0abe-2b08-4a60-80d8-0a94e4ac8550_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_cff69bc2-83ea-44fb-903f-8aba7e3a29e0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_b0c8feab-70b1-4aa1-a6cd-4cbec028bb37_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring after 2027</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five Thereafter</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_0bc53cf7-f8ca-4dbc-842e-3dbc7a4b5b1c_terseLabel_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains recorded in earnings for ineffectiveness of Company's non-derivative hedges</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_label_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:label id="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_documentation_en-US" xlink:label="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:href="mck-20220331.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:to="lab_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8fd68097-002b-4bec-856d-deb57b64dbe6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1aceb808-5a9f-4f26-b8f0-966ae6085d3e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_398d28d1-fa00-4bb1-9298-741e5ebc8fcc_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5970fbc5-3816-401b-b3fa-9085976b0e33_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_ccbc8616-2cc7-4785-896d-57ef3a8ddb35_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_3a69a190-e99f-4a4e-b5f8-855520531a61_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_7f663f47-5f62-4e29-8a48-70095680c62d_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2efd1241-2825-4992-9db7-ae3bb5321710_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_02d70fbb-6776-40dd-a9cf-eb0f323bc5aa_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_label_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:href="mck-20220331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:to="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_e166abec-c59a-4c24-b864-4926ab379314_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increase in compensation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LargestCustomerMember_a6b22073-47eb-47de-b344-8817907e4b41_terseLabel_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS</link:label>
    <link:label id="lab_mck_LargestCustomerMember_label_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:label id="lab_mck_LargestCustomerMember_documentation_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember" xlink:href="mck-20220331.xsd#mck_LargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LargestCustomerMember" xlink:to="lab_mck_LargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_5cf8d0e4-2e13-4909-93b5-b8f63fc1468b_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2027</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_5ce9e0e1-cb58-4067-8d0a-401b4e50adbe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_29e3680c-69ad-491c-9e12-34beb843e8fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_9690832e-026d-46e2-9a97-f25175b76913_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_f6f4640f-7ec8-49e9-ac24-053277859622_terseLabel_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities Payments Due [Abstract]</link:label>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities Payments Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:href="mck-20220331.xsd#mck_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_ea3e5990-9ef3-44aa-a5d1-3e3020ea81df_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity contracts purchased</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:to="lab_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_9b36ffce-215f-4cb4-a622-f881df62301c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_dbd352a5-0fb7-4ceb-a163-5ca7dbb28021_verboseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6667bab5-8044-4f07-9ead-cb32b56ce43f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_4fde242d-5433-41f7-afa1-cde72d0adb5a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_acdbc73e-2978-4da3-b958-8cb2a0e54a2b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_953b2443-6d13-48a2-bb6e-5bf3a93a785e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_e9b85904-ea73-4b1a-b67a-4b3985066606_terseLabel_en-US" xlink:label="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Exit-related Costs and Asset Impairment Charges</link:label>
    <link:label id="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_label_en-US" xlink:label="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]</link:label>
    <link:label id="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_documentation_en-US" xlink:label="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:href="mck-20220331.xsd#mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:to="lab_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c6079263-c06c-49a8-a131-46a508a791af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_44a18a5c-59ca-420b-ae53-614f16e5540d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AmortizationOfLossOnDerivativeTerm_eb86cb5b-972f-4550-8594-b3d8c87fcf0a_terseLabel_en-US" xlink:label="lab_mck_AmortizationOfLossOnDerivativeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of loss on derivative, term (in years)</link:label>
    <link:label id="lab_mck_AmortizationOfLossOnDerivativeTerm_label_en-US" xlink:label="lab_mck_AmortizationOfLossOnDerivativeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Loss On Derivative, Term</link:label>
    <link:label id="lab_mck_AmortizationOfLossOnDerivativeTerm_documentation_en-US" xlink:label="lab_mck_AmortizationOfLossOnDerivativeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Loss On Derivative, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AmortizationOfLossOnDerivativeTerm" xlink:href="mck-20220331.xsd#mck_AmortizationOfLossOnDerivativeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AmortizationOfLossOnDerivativeTerm" xlink:to="lab_mck_AmortizationOfLossOnDerivativeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_7ba335f4-905f-48d1-bac5-7e8c66dee926_terseLabel_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future lease payments</link:label>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_label_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</link:label>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_documentation_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:href="mck-20220331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:to="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9cc5126d-aa8d-4314-b5fb-ec4ef45a5c18_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1d1af3ed-304f-4e26-92cd-168f6269dd78_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_56f48f50-81e0-4764-93b6-7cd7bcb629b9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_1ec68119-7d93-4dd2-88ae-00292381b245_terseLabel_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written-off</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_label_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances And Reserves Deductions Written Off [Member]</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_documentation_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, deductions written off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:href="mck-20220331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:to="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7099e05f-37cf-4278-8709-6e93e2d8f56f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_7b9b14be-5208-43a6-8a3f-ed46ddc59274_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_22ad6905-f64c-4e13-90b1-895c5f5f183b_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_daf3f3cd-2e25-45d4-8a65-033773e7baff_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_410b8e57-b869-4750-8675-16bcbd27a714_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_9bdd470a-51e2-4c07-9e6a-1f1d27eda84f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5a943421-5611-43b5-b6f3-f42490ca652f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e9c96bb-3049-4386-8772-b8364427cbc5_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_22219b72-4988-4280-84a8-cf6426fd5603_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_50004eca-e885-4756-afcb-c771463e8940_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_4002892c-b795-42d0-8ffc-8371ce40dfe5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fees charged under the TSA</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a620fdb9-84c5-46a0-8e58-ff756e72d85c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_bdd76fdf-4f3a-40bd-907a-4850cc14ab1b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RealPropertyMember_37523fbc-20c2-4890-8721-47ba92496728_terseLabel_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property</link:label>
    <link:label id="lab_mck_RealPropertyMember_label_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property [Member]</link:label>
    <link:label id="lab_mck_RealPropertyMember_documentation_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember" xlink:href="mck-20220331.xsd#mck_RealPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RealPropertyMember" xlink:to="lab_mck_RealPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_061137e9-6d6a-4a08-b6c4-55e7ab0af4f8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_22721807-4430-4b8f-b6f6-009c07d1974b_terseLabel_en-US" xlink:label="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC</link:label>
    <link:label id="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_label_en-US" xlink:label="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]</link:label>
    <link:label id="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_documentation_en-US" xlink:label="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:href="mck-20220331.xsd#mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:to="lab_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_45f882b6-1645-4cb2-ab56-aed16c61160e_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of eligible states</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfEligibleStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfEligibleStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Eligible States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfEligibleStates" xlink:to="lab_mck_LossContingencyNumberOfEligibleStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_c4ccfc80-2c1d-4a8e-827c-c7b93822b7f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of restricted stock unit award activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_10b7e894-990d-49c0-84c3-b9900bc23693_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment charges, before tax</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_de8483c4-38ea-473e-92e3-74b5077d621e_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfRelators" xlink:to="lab_mck_LossContingencyNumberOfRelators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_ad5e4e96-37da-4e87-bbd8-e7d02b2abfe0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7e325f1a-7b6a-49f3-9ebd-df09817256dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_a05e4fab-3933-4964-b4b6-e13e57adb2f7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_9c6e8150-517e-45ca-8e21-1fc0b3dee282_terseLabel_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_label_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_documentation_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:href="mck-20220331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:to="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_520b65d5-f0c2-4fd3-aeca-3e62413efd70_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_3debd62d-9868-412c-92e1-2db2ff2de961_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_82be45d6-ab01-4dd3-aaef-3431ba050753_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of plan exceeding total plan contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_e504a6a8-c7ca-4f7d-b892-80cb5640c999_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20220331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_088db89e-95d6-4f1d-b2af-739dbced0065_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains associated with equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_91396568-b0a1-48e4-b418-478fd4eca51f_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE consolidated liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_f5abe7b7-b5f2-4f56-85fb-e01da0e926de_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccruedShareRepurchases_c0d71e57-699d-4961-8cc5-81db4ddc59b7_terseLabel_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued shares repurchased</link:label>
    <link:label id="lab_mck_AccruedShareRepurchases_label_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Share Repurchases</link:label>
    <link:label id="lab_mck_AccruedShareRepurchases_documentation_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Share Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases" xlink:href="mck-20220331.xsd#mck_AccruedShareRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccruedShareRepurchases" xlink:to="lab_mck_AccruedShareRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_0916f4d5-6d96-4e93-a628-8768b06f8bd5_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2024</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Two</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_b1245531-a95a-44a5-b000-ced8c14f573f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_bd12be86-20df-4aec-b87d-195772c276a7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0a5f4b9c-362d-4f60-871d-0a9efe0ba354_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_9d34cbc1-3d55-4e39-a4f0-6e288181dd3b_terseLabel_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, useful life</link:label>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_label_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use, Useful Life</link:label>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_documentation_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:href="mck-20220331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:to="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b53bbe74-9071-4da5-8336-4d8aeeca4dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f4c51d56-7233-49b4-b9f1-ca6d360f2488_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_1ae7774f-4f54-4725-a250-5348d89ede85_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_ea20dd28-eeff-464c-988b-39bbdd6bd3b9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, state and foreign net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d61db563-4b36-483a-bc45-d6a6ba659e5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_af7d91fc-df21-4740-8d16-529577e09fc7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6469c08a-f494-4fff-828f-c01afa4042ea_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_42932c70-e2a4-4c83-825d-69aa1cb9c687_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in other comprehensive loss (income)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ConsolidatedActionsvSureScriptsLLCMember_dc5165c7-21f7-4815-a3ca-042f4a60ae82_terseLabel_en-US" xlink:label="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Actions v SureScripts, LLC</link:label>
    <link:label id="lab_mck_ConsolidatedActionsvSureScriptsLLCMember_label_en-US" xlink:label="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Actions v SureScripts, LLC [Member]</link:label>
    <link:label id="lab_mck_ConsolidatedActionsvSureScriptsLLCMember_documentation_en-US" xlink:label="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Actions v SureScripts, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:href="mck-20220331.xsd#mck_ConsolidatedActionsvSureScriptsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:to="lab_mck_ConsolidatedActionsvSureScriptsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_bae7509d-c0ce-4c20-a9f4-6a9a99a1c025_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_732cccf7-0969-44a8-a5e3-e20e582669e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_00f497cb-9e36-4f6b-9400-5d1b04d36a08_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_4cff744b-b293-476d-93ab-b8ebd0ed456c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_6b1fd48d-8343-4302-9d21-35df167490fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_035fe55d-edc0-4e58-acab-57db37d0c303_terseLabel_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfWashingtonAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Washington and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember" xlink:href="mck-20220331.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfWashingtonAndSubdivisionsMember" xlink:to="lab_mck_StateOfWashingtonAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_03693573-8283-4e7c-8310-bf7c277c2ade_terseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release of accumulated other comprehensive loss attributable to the joint venture</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:to="lab_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e42b6034-3190-4a39-bb38-c0b8fd0a38e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_08421130-0fdd-492a-bab9-1bdcf58e5c89_terseLabel_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_label_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_documentation_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:href="mck-20220331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:to="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_5c719783-3861-4d43-af61-a85b81f96726_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchase amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_41de2234-fe5d-4f78-a062-2ade90dc826e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_054976f0-fb6d-45bf-8f63-ac3d3c675f8e_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_9b4371f7-7e9b-4cf1-a52b-7330d36dd04b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_2fd2ea6d-1a9b-44b2-8bf0-9007a175e9f7_terseLabel_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember" xlink:href="mck-20220331.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlingGovernmentalEntitiesMember" xlink:to="lab_mck_SettlingGovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_4dabb037-4f94-44d5-b35f-1b35e47349a9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_92e2f904-a173-46c2-bca2-958300a86d4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_45e1109e-41e6-45dc-820a-b8da97ecf140_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherAllowancesMember_aaa90682-f986-4e12-861c-85373d869e52_terseLabel_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other allowances</link:label>
    <link:label id="lab_mck_OtherAllowancesMember_label_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Allowances [Member]</link:label>
    <link:label id="lab_mck_OtherAllowancesMember_documentation_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember" xlink:href="mck-20220331.xsd#mck_OtherAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherAllowancesMember" xlink:to="lab_mck_OtherAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_67fcbca4-9137-41b8-84dd-59fde65b9463_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_5dda53a7-0ced-4366-a28c-dbd8e53f5bca_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bac5728d-f747-4352-b586-5161c839f502_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4a1d3733-8008-407d-aa01-7688a6e57d95_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_bd66ef43-e3b9-4dd1-a66a-60e82a029ac2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_5cedbadd-9728-450d-88e8-5cee902374ee_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1fd647e0-339a-4f55-8ed4-d6289ae5b2fb_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NotesDueNovember302020Member_1ef21ff1-f49d-4687-8137-422b08f87d68_terseLabel_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020</link:label>
    <link:label id="lab_mck_NotesDueNovember302020Member_label_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020 [Member]</link:label>
    <link:label id="lab_mck_NotesDueNovember302020Member_documentation_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member" xlink:href="mck-20220331.xsd#mck_NotesDueNovember302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NotesDueNovember302020Member" xlink:to="lab_mck_NotesDueNovember302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_055e02d7-221d-4795-a7cf-5acf2bc25681_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_a615ed37-6e1f-4c8c-ad9a-c27d4e52b59a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f8472687-0f58-4d61-a87d-bd957631ec47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlementofExecutiveRetirementBenefitsMember_c37e155f-d0d0-47c5-a2f1-087c42d4e67c_terseLabel_en-US" xlink:label="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Executive Retirement Benefits</link:label>
    <link:label id="lab_mck_SettlementofExecutiveRetirementBenefitsMember_label_en-US" xlink:label="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Executive Retirement Benefits [Member]</link:label>
    <link:label id="lab_mck_SettlementofExecutiveRetirementBenefitsMember_documentation_en-US" xlink:label="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of Executive Retirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:href="mck-20220331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:to="lab_mck_SettlementofExecutiveRetirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_6ce1269d-bc44-4233-8178-8d486b28bf0c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Gain on Split-off of Change Healthcare JV</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_40b5ece9-509f-4714-a6d2-da07b00b19c7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_3af15ce5-e634-4ff5-8870-bd42c2b22749_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember_ec52a9f3-1e3e-4905-abc3-e5bc4be30053_terseLabel_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember_label_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan [Member]</link:label>
    <link:label id="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember_documentation_en-US" xlink:label="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of U.S Defined Benefit Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:to="lab_mck_TerminationofU.SDefinedBenefitPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_93f0b536-9dce-40b4-9646-18cef36b879a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_faec7483-717a-4f3c-895d-be2cea5ab940_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d29dc98e-3347-45ad-9bde-6086c1b1d1c2_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_f26a7221-3b1e-45a9-a1e7-01a1c5392f10_terseLabel_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldforSalePolicyTextBlock" xlink:href="mck-20220331.xsd#mck_HeldforSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldforSalePolicyTextBlock" xlink:to="lab_mck_HeldforSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_78a95830-0b69-4a26-aa99-09d0b69c17d5_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses, net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20220331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_b5164df7-6eac-4334-8aab-1ab8f39a0287_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_8d72d070-e054-4963-9a86-3c815e4e4fd3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_5131ffbd-1b15-4dfb-bfd3-3426aee21ae6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received upon exercise</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_09d9e100-f825-4d2d-8838-c311a144d08f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SiteContingencyNumberofSites_2300e677-7ef7-4812-bd71-921fe32a7ac2_terseLabel_en-US" xlink:label="lab_mck_SiteContingencyNumberofSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_mck_SiteContingencyNumberofSites_label_en-US" xlink:label="lab_mck_SiteContingencyNumberofSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency Number of Sites</link:label>
    <link:label id="lab_mck_SiteContingencyNumberofSites_documentation_en-US" xlink:label="lab_mck_SiteContingencyNumberofSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of sites requiring environmental conditions to be addressed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SiteContingencyNumberofSites" xlink:href="mck-20220331.xsd#mck_SiteContingencyNumberofSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SiteContingencyNumberofSites" xlink:to="lab_mck_SiteContingencyNumberofSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3575bdb7-c86b-412e-9e13-f93c0cc1621d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dc760a8f-e841-49b2-901d-063fe16399d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_36c89b75-c483-4f3b-a2ef-74e0199d16fc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4fa6dae0-859e-4723-a831-58d29fb6ebfc_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_052817bd-e68a-49df-ace3-300e49371344_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c96103c-70ec-4aec-b73d-8b03ab150fc4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8e915202-3690-474e-a2d5-03f0aa00405a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_806415f8-f13d-4e53-ac9d-54beb25e66dc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_6cc01b3a-2e2f-4b61-8363-74a5f8f1c13a_terseLabel_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated environmental assessment and cleanup costs</link:label>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_label_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Environmental Assessment And Cleanup Costs</link:label>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_documentation_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Environmental Assessment And Cleanup Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:href="mck-20220331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:to="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_03358b09-18a7-4d16-8f68-3dac915ec709_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_66db77bc-54c6-4670-8f95-8361c7bfcdd0_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_3e725370-547c-4545-8bef-30f760e53d67_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1.500NotesDue2025Member_3cac38cb-dd16-48c2-81e2-38317f8707c4_terseLabel_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes due 2025</link:label>
    <link:label id="lab_mck_A1.500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1.500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member" xlink:href="mck-20220331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1.500NotesDue2025Member" xlink:to="lab_mck_A1.500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_209f2fa7-3c05-48cf-bf00-7d39ffa95fcf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_df379b33-fe40-4940-9bee-4c34a86019dc_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_4edeb709-1dac-4398-b732-7e3641856ea5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_43b9d9ca-f5c1-49de-bc00-7c95e2d5c5a5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNet_a1f5df73-a0b5-4b72-9258-cee0725775ea_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:label id="lab_us-gaap_AssetsNet_label_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNet" xlink:to="lab_us-gaap_AssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_7a12e824-4178-49a4-9f59-36dcc03e82a0_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CherokeeNationMember_632ef225-441e-470f-a1ee-40a65b9d8a5c_terseLabel_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:label id="lab_mck_CherokeeNationMember_label_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_CherokeeNationMember_documentation_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember" xlink:href="mck-20220331.xsd#mck_CherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CherokeeNationMember" xlink:to="lab_mck_CherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_efc71748-988b-4a0e-9dde-8257114015f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5f16fbaa-3800-4356-9f24-b79982efdd2e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f721f9b8-a099-4d4b-9d59-b59e72a07924_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_ec756520-4978-4cc4-95eb-da7381ed29e7_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2e458c45-891c-49c9-9a02-8c2dc97e2a2e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_3cbf79e2-fc18-4c01-b30c-5c5f7eb9f7b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_22a4d5da-99cd-433b-bff7-b076d0b2cd53_terseLabel_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software [Member]</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember" xlink:href="mck-20220331.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternallyDevelopedSoftwareMember" xlink:to="lab_mck_InternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_49e180dd-bc8d-4255-9341-3fdc0b08f5d2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_266556ba-3d7a-4866-aae7-1c1b89701894_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_85f055f1-dd8b-466e-9917-3cefbe9a126f_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_5aff5168-c8f6-47ef-81f9-8d8f49b16e0a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_9b3ed65a-2599-412d-a77c-5e956dc07660_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_dbb2453f-f7d4-48d9-9488-4f7f4e738431_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c010ceda-56b9-4308-ba60-961e30a9b6bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_50b30077-c99e-469b-a988-a6ec4bf6b859_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:href="mck-20220331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:to="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_e4078c00-c048-4f11-aea8-02932ed69f5f_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20220331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_59c8db5c-9404-4869-b7e5-0c65dff80b95_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical surgical products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20220331.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmacyLicensesMember_46922e4b-1432-45d6-a8bc-a1ca368a5695_terseLabel_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_label_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Licenses [Member]</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_documentation_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember" xlink:href="mck-20220331.xsd#mck_PharmacyLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmacyLicensesMember" xlink:to="lab_mck_PharmacyLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7a1cda0d-8e9e-40b1-92cb-114d07dea088_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_c20b5aba-bc6e-4f97-90ca-28c7b2e13cc4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_96acf994-43e8-40c6-a1f7-8d6d249f65e9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount expected to be paid</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_5de13f9c-0cd7-428f-9a67-1f5e3e27e6a5_terseLabel_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of data related to stock option activity</link:label>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_label_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award Data Related To Stock Option Activity [Table Text Block]</link:label>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_documentation_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:href="mck-20220331.xsd#mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:to="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_fc302722-bfd0-4c40-8435-bd141a95078b_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_99fdd7ee-eef5-48e1-8817-74cc55b0f3a5_terseLabel_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash classified within Assets held for sale</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_label_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:href="mck-20220331.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:to="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_92666f14-4ad8-4a07-9eca-36c6b84c5df8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_2487f5dc-1c4c-4bdc-bc90-54ce65edb85c_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_f5e28c7f-f26f-450e-9fd8-decb97d52dca_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_d3044fac-3f3d-4921-ba52-d12f1d20dcb1_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_50b3d713-d7ed-4ea1-a433-5b63c154232e_terseLabel_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_label_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Obligations</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_documentation_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxAssetLeaseObligations" xlink:to="lab_mck_DeferredTaxAssetLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_1048c392-107f-4b2a-8a7b-b81491ec075c_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a5c7e3ca-f277-404a-a216-f60dd3901c94_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_869ca669-62d0-4d7b-96c3-9738f306da87_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of market price for share purchase</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_519c9e38-f011-4ff7-aaaa-2007ff54fda1_terseLabel_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_label_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning [Member]</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_documentation_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:href="mck-20220331.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:to="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b624cad-901a-4654-97ff-5929fe0b4462_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5758c649-77a0-493c-b4d9-0d978b2a615c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9261e1fa-b23e-480e-82a6-ed2d269bbc5d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_6db6d0ab-2fba-4fc9-aec4-c176d6de63d3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_4adf5677-e247-4c59-b2f7-2f03e523de0c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_c0164df0-12a2-48a6-a53f-590dd76edd73_terseLabel_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EUBusinessesDisposalGroupMember" xlink:to="lab_mck_EUBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_2965aff3-08b4-4bd9-a5fd-934ff0ce655f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_7f2d4a73-142d-4630-bf6d-e4c991d9cf10_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease receivable</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_1ee94c46-afd7-4549-90f5-fddbaa982c10_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_7544aa86-7399-449e-906d-1015e14586f5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_8f8217a7-e9e6-431a-ab1a-75257438d0e6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f53ebd46-9127-4daa-8d58-e547aa8128ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d23a2ccf-9f8f-4acd-966c-7032b12d8310_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_2473d0fa-498a-4def-98c9-8dcd661fed2f_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties on unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d4bffbb4-6c34-4c88-86c0-66e14da5258b_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_750bb48e-e419-479e-8136-734b1c108679_terseLabel_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_label_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Noncurrent</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_documentation_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:to="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_c0ae1ef8-923a-452c-bec2-f87dc113d887_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_47cc2171-29df-4db1-ad71-44b55ec637f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_8dd136c3-fc85-4279-8ed6-0b17cbf32b4c_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, After Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualProvisionAfterTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax" xlink:href="mck-20220331.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualProvisionAfterTax" xlink:to="lab_mck_LossContingencyAccrualProvisionAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8cc0f21a-a029-4a7d-929e-20d4920e8070_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_51a87c1b-7680-4862-9ea8-fe7dc0a7f63e_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE consolidated assets</link:label>
    <link:label id="lab_us-gaap_Assets_6711650c-1832-4e75-acf0-984c675f4630_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_a1e6bcb1-6716-4eab-a7d1-9b77afccdf95_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_7d351e89-5d8b-4803-9fc6-ccdf8277a265_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement charges</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_e5c7356e-211e-46c5-9fc5-9a51b3abc87c_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_f3a0386d-57ef-4758-befd-62b56a87caed_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_9f092122-4253-4f62-a9cd-ae2bed866586_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest, net</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_18e2c080-347c-4f6b-bdd8-ca65e55de33a_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_7cd9b0db-fc62-489f-a4ff-5f198f5cb1c6_terseLabel_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_label_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_documentation_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember" xlink:href="mck-20220331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RetailPharmacyReportingUnitMember" xlink:to="lab_mck_RetailPharmacyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_b9a71736-7dd8-48cb-8252-e4a6729392f9_terseLabel_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credited to other accounts and other</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_label_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances And Reserves Deductions Credited To Other Accounts [Member]</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_documentation_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, deductions credited to other accounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:href="mck-20220331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:to="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_89f3b296-dc7c-457f-ab4c-d905c2a6cf1d_terseLabel_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale</link:label>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_label_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale [Member]</link:label>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_documentation_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember" xlink:href="mck-20220331.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanAssetsHeldForSaleMember" xlink:to="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_819b810c-37ae-4752-b289-a5819970c5d4_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_f9da658e-9194-4d90-b0e5-3c9d4730e7c7_netLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_b24c2a11-03fb-4216-8094-97395ac86623_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems" xlink:to="lab_us-gaap_GuaranteeObligationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_96c128b3-6098-4e4b-8a8d-8d0e7cf23a1b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_bcc9b00c-96a1-4caa-94b5-5f22976359f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c581235d-1864-4738-8c6d-22174dd5030e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_416f365c-e69a-4952-9adf-5ab3533e8224_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_b7bb29ec-7b74-46c3-a92c-ff883460bf71_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20220331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_7b70ad95-7b9d-4872-8f0a-ea3c1f7c576e_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign operations</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_8fe36f69-e858-43d9-9465-2e08fd8cb990_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_675084ca-cde1-45d7-b923-98270b60728f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_c82201d5-45a2-44e0-816b-df391f47d6f2_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_1b7519ff-dbab-4cdd-b618-5b3daf3c7437_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_79335186-8503-4f07-b765-187d1871f4db_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:to="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b4161f2-86f9-401c-bab9-959c01294489_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_56a6dae7-b406-4638-bda7-8d14f3159953_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_737bbd72-0343-43f2-97c8-08b9dd0f3d5e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_8e513d6e-9a7d-4620-bbff-c6ce71676711_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_961bfbe8-b951-4570-aa56-b51882e8cc1e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_cb919d5b-9ea9-42f1-9a1c-83e59e098287_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_066859d2-87a0-4783-bbb4-2559c4c81a7c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_11a668e8-8e60-4af3-90e0-bbbc8ca95f3e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_6ef74227-55f4-4a07-bfd3-e896c28cc6ec_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_670efa85-31ca-4329-98c5-c4ee3513d65f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c1c99311-e11d-44be-9883-a0e1fdbeb719_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_47319f79-c331-4b18-aa9e-5d6420b7daab_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiability_03a783b2-fe6a-4556-a3c2-5b7d9bb8cfbe_totalLabel_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_mck_LeaseLiability_label_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_mck_LeaseLiability_documentation_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability" xlink:href="mck-20220331.xsd#mck_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiability" xlink:to="lab_mck_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_83ae89ec-15f1-4716-be1f-881c98cb854c_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement, installment payments, term (in years)</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_label_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:to="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_15e0e50c-91c5-4764-9727-b9711c472f31_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost - benefits earned during the year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_0f3f6079-784a-4dfe-9137-eb9aa38094b9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_af417ebf-fc0a-4990-b954-9296019f0902_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c5929e17-2a99-4a4c-9313-874dbdc57c86_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_1d43b825-3c50-42bb-a05f-a41b3dff0893_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_c7981260-bbab-4e4b-80f1-913e25974068_terseLabel_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_label_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Net of Expenses, Including Other Income</link:label>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_documentation_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Net of Expenses, Including Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:href="mck-20220331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:to="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_32c95898-f7d1-46ff-a8c3-9ba40ec14385_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gains (losses) from pension plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_a568a240-3373-4388-bff9-5e53f0371394_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial losses from pension plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_896fd891-b7fd-4c81-827f-289fd631d6d1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNoncurrentAssetsLiabilitiesMember_7ee33d70-0a3c-40f5-8937-e382b679f37f_terseLabel_en-US" xlink:label="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets/liabilities</link:label>
    <link:label id="lab_mck_OtherNoncurrentAssetsLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets / Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherNoncurrentAssetsLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets / Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:href="mck-20220331.xsd#mck_OtherNoncurrentAssetsLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:to="lab_mck_OtherNoncurrentAssetsLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_0f440a32-5e8e-4f62-a406-17937c6bb27c_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_cb4ae05c-06e7-43f0-abd4-a4ca4555850a_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) and Austrian Business</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) and Austrian Business [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. and Austrian Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:to="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b9cd46c3-399c-4463-b761-2a5c06c1bc57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_9aa834f3-c9b4-4150-ba43-d3adb754c3dd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ServicesBusinessMember_189d4b64-05d3-4032-8646-e684f178a8e3_terseLabel_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business</link:label>
    <link:label id="lab_mck_ServicesBusinessMember_label_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business [Member]</link:label>
    <link:label id="lab_mck_ServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember" xlink:href="mck-20220331.xsd#mck_ServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ServicesBusinessMember" xlink:to="lab_mck_ServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_839d2c82-9597-4615-9ce6-9de13d817a3d_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_3b03c5a0-389b-4293-b71e-5d98f9f6b1cf_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected payment period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4d3db171-a246-45c8-b71d-49fba7b9c223_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_bf12702f-1b1b-43ad-a1de-19afe25a7f42_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c08b6f50-2067-4dbb-bdd7-7ac2d9403890_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_bf6da505-078a-4650-b8a9-33f32bb798ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_7402c955-7128-4027-8246-bf32a319cb5c_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenLargestCustomersMember_475fbf9d-36a0-4a70-9991-bde781b0e0a4_terseLabel_en-US" xlink:label="lab_mck_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers</link:label>
    <link:label id="lab_mck_TenLargestCustomersMember_label_en-US" xlink:label="lab_mck_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers [Member]</link:label>
    <link:label id="lab_mck_TenLargestCustomersMember_documentation_en-US" xlink:label="lab_mck_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenLargestCustomersMember" xlink:href="mck-20220331.xsd#mck_TenLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenLargestCustomersMember" xlink:to="lab_mck_TenLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_2f1d748f-6893-4cf4-bdf2-c735849cc8a4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_1491cd02-81b8-4d73-864e-569b2886fe59_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28b1dee7-888c-4082-8609-bd19969ce988_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_5f0ccd00-6469-48d0-a1f8-83b72b006ec7_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized actuarial loss and prior service costs</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:to="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d6ee6e57-fbc6-4f0a-bf84-20d5d75fd67d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e79d599c-ccff-410b-a0cb-be9207f7a51d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_dba19875-59df-441c-ac54-8f4fcd3f4aaa_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_label_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member" xlink:href="mck-20220331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMarch12021Member" xlink:to="lab_mck_A475NotesDueMarch12021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_c4e3da24-60b6-4e6b-85c4-062400458011_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_a207f81d-530a-4f0d-97ed-76a9621a2266_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a436707d-395d-4930-a197-84ab49ca7e95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_8b569d65-b24e-4bac-b7d3-9d38132350f0_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupMember" xlink:to="lab_mck_UKBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_5804c2d8-7c49-4067-9159-52204ea627d8_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d5869ae4-dee7-4fc3-b749-c97ddc3c44f0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_2668ec37-1ff3-4939-b7a5-7fc6d7f60ca0_negatedTerseLabel_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right-of-use assets</link:label>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_label_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease Right-of-use Assets</link:label>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_documentation_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:href="mck-20220331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:to="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_08029bbe-7113-4e41-a0bc-6faa8cf7f4eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9a5a2a8e-453c-4aa4-8ce9-b513c00d5432_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense for property, plant, and equipment, and amortization of finance leases</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_ace706ea-56ab-4538-8d5d-ccd4655da4b4_terseLabel_en-US" xlink:label="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Two Counties In re: National Prescription Opiate Litigation</link:label>
    <link:label id="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Two Counties In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Two Counties In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:href="mck-20220331.xsd#mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_cd2668d9-788b-4304-8073-a37d5ec34649_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer and participant contributions</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Contributions by Employer and Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Contributions by Employer and Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_5d03193d-9597-40a8-b34e-7086da6686a3_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:to="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_9f67c63c-00e5-449d-b9f6-5d47c15aa262_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_0bd12127-cedd-4dba-805f-59906e055548_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockExchangedDuringPeriodValue_7efdc0f9-2cba-4a31-a743-3139a04b5969_negatedLabel_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change Healthcare share exchange</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodValue_label_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Value</link:label>
    <link:label id="lab_mck_StockExchangedDuringPeriodValue_documentation_en-US" xlink:label="lab_mck_StockExchangedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Exchanged During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodValue" xlink:href="mck-20220331.xsd#mck_StockExchangedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockExchangedDuringPeriodValue" xlink:to="lab_mck_StockExchangedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9273221d-3773-42dc-be54-e6517e7df731_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0d872452-0e69-4a21-8d77-4af26b500e6c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c41a7199-c770-4c41-be5c-5d22517437a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_1f64545f-b461-41bb-bb04-371b2a94c27c_terseLabel_en-US" xlink:label="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares converted into per share converted (shares)</link:label>
    <link:label id="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_label_en-US" xlink:label="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</link:label>
    <link:label id="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_documentation_en-US" xlink:label="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:href="mck-20220331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:to="lab_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b23986f5-6c02-4822-8008-53f6deba446c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of details for charges recorded</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_51c1ecc8-d65b-4c98-9abf-34527d0f2746_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_10fa3ffd-4fd8-41c7-963c-8dd92e4a0d96_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_ff584f32-1900-47f2-9f22-979e74a31e8e_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation (2)</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20220331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_34e383fe-faf0-429f-a9bf-207dcf5c8c2b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_502a968a-5ab3-45bd-a188-e30c799f3a64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Accrual Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_24a23ffa-7baf-432d-a67f-fbd0b0f14cf7_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derived revenues (percent)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20220331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquityMethodInvestmentTransactionCostsIncurred_dc44fad6-841f-4126-9ba5-47a3d8f9866b_negatedTerseLabel_en-US" xlink:label="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Transaction costs incurred</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentTransactionCostsIncurred_label_en-US" xlink:label="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Transaction Costs Incurred</link:label>
    <link:label id="lab_mck_EquityMethodInvestmentTransactionCostsIncurred_documentation_en-US" xlink:label="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Transaction Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:to="lab_mck_EquityMethodInvestmentTransactionCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_bc247193-17fa-4f65-8fa7-c31b1b619247_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_91a4e141-dafe-4b10-a043-b6c8359b31ad_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cbb51a36-f43e-47e7-989a-89afb054c4df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations Disclosures</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_1707a702-ae7d-483c-8dbf-6bf1ed909a8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_aadd02a1-0d85-447c-92b1-348a1296dc4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices upper limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_84382caa-8e8f-44c8-bf27-2e158edab399_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_62f061fa-774f-4555-b557-3dc2c3a3892e_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_da70d9f6-5710-4f04-aff9-2cfbe0407246_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_25bf6a4e-2a07-4619-b5be-60a2abb77195_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_a77035a8-da95-455f-89fd-7aa53f1e0448_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment expenditures for long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_5be7eb97-8eb9-4b85-8334-7cb80698ec45_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_639ae969-4323-49f2-a451-cf43feca5186_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_c05acec9-7750-4752-a540-5692886e6876_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_dc3623a2-1e09-4e67-a00b-6d70e78d92f8_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO inventory (percentage)</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory" xlink:to="lab_us-gaap_PercentageOfLIFOInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_e8cbb947-9d08-4102-ad02-b43beba23541_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Shares Purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_45d2cea1-652e-48b9-8ca3-1284df58e585_terseLabel_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_label_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Current</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_documentation_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:to="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_7c56391b-8386-4f0d-ab0a-c70466c4265e_terseLabel_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Domain]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_label_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Domain]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_documentation_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Defined Contribution Plan Matching [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain" xlink:to="lab_mck_DefinedContributionPlanMatchingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a580a783-aa2c-480c-87a4-ecfabe58a955_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a0477d77-4869-4de4-9ffb-9397e50fe5a1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_d9bbdf88-b190-4d4e-9200-656fd3a8f702_terseLabel_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of plan asset value</link:label>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_label_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</link:label>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_documentation_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:href="mck-20220331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:to="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_5c37a4ae-53c1-4569-bcf8-1f5526d226c2_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:to="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_b19b736b-1d86-456a-bfb1-e662b8ef13e3_negatedTerseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tax benefit on intellectual property transfer</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_0a797684-f405-4ba4-84da-308016d763b8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_00dd6e7d-d714-46f4-b62f-877e4485411b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_5caaa4dc-8c05-4184-aadc-abb4f98d58a5_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_e6d8789a-93ca-43f0-8432-66f213da7163_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_f1b09fd8-be15-40be-afff-b90b745d4527_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_549b838f-a833-467b-8334-475c02ba5aa0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_994cfcd7-4ade-4369-a3fa-69c14d57aabb_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_fa3f8b0e-06bb-419d-b2aa-1285eb8c6bd2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_416f8f3e-ff32-4611-a9ba-364546a90367_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_c062c4af-348b-474d-9610-d1ac43df5c67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_994cf029-5840-4924-9eb4-001e838ac6fb_negatedTerseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_label_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_documentation_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:href="mck-20220331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:to="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_82dc0c02-c00f-495b-bac8-94fc5ea0ae65_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_3dda7690-d2fd-408b-a1dc-53b208660da4_terseLabel_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_label_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:href="mck-20220331.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:to="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_490155d1-0f40-4091-8720-5daa943fea3c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_b4e0aa2c-c50b-4541-9a52-b6957bebb314_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_774ff006-971f-41ec-ae89-f189f8f568a2_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total settlement to be used to remediate damages (in percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_fd2d3744-26f1-4dd4-ab19-726f273b47d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_24d64e67-a008-4fcf-9b06-c60d1a3c22d6_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_de03d2db-6cfb-4e46-b8bf-127bf57b1a34_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_58da0a59-c650-417b-a25b-75e1fe832aa3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_bb708dfb-ec95-4428-adc8-4c3b3dada2f5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_fa1e1580-b062-487d-a16b-872e564f7858_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_f7b44f76-f1ae-46c3-a484-55e1c4a43648_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest (percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinanceLeaseCost_d3907de7-0568-4943-8c2f-23ca33f291e5_totalLabel_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_mck_FinanceLeaseCost_label_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_mck_FinanceLeaseCost_documentation_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost" xlink:href="mck-20220331.xsd#mck_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinanceLeaseCost" xlink:to="lab_mck_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_33236079-228d-4bbc-84d1-c4085d09bf1f_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_b0aa8fd8-69ae-4d75-811f-ad4f7e493281_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_a5851e30-5b82-48ed-ba0c-202ed0b76fa0_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8d11d30a-61f5-472c-9c9b-7e1a82b08915_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_6b1bd27a-f94e-4617-8d9d-dfe3c3fb32b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of year included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d7a8ebb6-641a-45f9-a870-6f0d07d48e86_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_0abb729f-fa2b-4e3d-af8e-9d9d90f64180_terseLabel_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution</link:label>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_label_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution [Member]</link:label>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_documentation_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember" xlink:href="mck-20220331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FirstPartOfPayContributionMember" xlink:to="lab_mck_FirstPartOfPayContributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b504f8b5-5ce5-48c3-8aaa-9bbdd1a6c043_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1e673527-ad8d-4941-8eec-5e0919c0dcb1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeContributions_26dc0459-6c3d-47e9-9e24-e8a969408546_terseLabel_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions (as a percent)</link:label>
    <link:label id="lab_mck_EmployeeContributions_label_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Contributions</link:label>
    <link:label id="lab_mck_EmployeeContributions_documentation_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions" xlink:href="mck-20220331.xsd#mck_EmployeeContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeContributions" xlink:to="lab_mck_EmployeeContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2013StockPlanMember_8f8fa5f3-fe51-48eb-b572-32e3e9a63efe_terseLabel_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan</link:label>
    <link:label id="lab_mck_A2013StockPlanMember_label_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan [Member]</link:label>
    <link:label id="lab_mck_A2013StockPlanMember_documentation_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember" xlink:href="mck-20220331.xsd#mck_A2013StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2013StockPlanMember" xlink:to="lab_mck_A2013StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_43b31e48-96b3-4266-841c-ff8168cc18de_terseLabel_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Direct Financing Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:to="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2573b0df-4ee1-471c-94b6-d9784325a348_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0957f820-2a0f-470d-9de6-c09e6eddb105_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_bc50f525-984f-492b-a16c-af4ca80cdc65_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_fa84a9ec-5fae-4223-b7ea-9563559cca8f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bcebf5f4-e282-4d5b-a8db-a6b74616e2ec_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_db8e0394-9da7-4ef3-b9ac-68be430a652d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e9aadf30-0a83-4e96-aaaf-976f79c60902_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_49fdcd8f-d091-4f33-a1d9-f13cf2b53b48_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a0482560-01e0-4184-a897-a99ca23c8629_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_cd713d20-4798-411c-9b83-6d841ef04a59_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_80ae2ce4-fb79-4b76-812b-8bca268e6dc4_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f86ae90e-4b6e-4e26-a3ec-8ff33247129b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_4cea7230-7bd6-4958-b91c-6e410909bfb8_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount awarded to other party, percentage of total settlement award</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_17ca7367-e4cf-45e2-8983-2e524454ae7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e2630191-6374-4d34-84ca-84893eb0b77c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0a13b647-8934-441d-be30-e8d38ddcaa68_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_8baac796-f35a-4ce6-87ca-a7e6f66e289a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_62c4655b-617c-4fe1-b32a-b5eff9d49708_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_79ba869c-3d68-4c76-8eee-4a6942141ac7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), before any tax effect, related to accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a8b0da41-899c-45c4-8739-cf99354f62cf_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_f5e92cf2-9bf3-4d36-8868-d6e3cceef523_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_79e21c85-aa8b-4de0-9c67-84091836c6c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on the lapse of the applicable statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_979317d7-323b-4d6f-90d2-3225211ba41f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_dd5b1085-015f-4a73-8e33-b8c69d15ef98_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_c116766b-6483-4bbf-95fe-93cc34eb3235_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20220331.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_93128814-264d-4267-8c0b-cb4f6e1b90b7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_9d822ee4-7d30-45d3-b9e7-4fa5510be842_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:href="mck-20220331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_9e757fe5-677f-4028-a78e-bcc30007717a_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_5d05ad30-d1f7-4a8b-96be-376784696946_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_7a710cd2-22d1-4057-b8c2-9dd70d79abe7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a851a7d8-b1bd-4843-b580-50f41b8ef69b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8b9bbc24-14ee-4045-a595-29ab372737b2_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1caa5254-0263-4121-9c30-9174e73001a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_12d2322a-e18f-49f3-b301-dedf51bb3f40_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:to="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_1d88c54e-9a5a-44ec-9474-ee548615836b_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_472de787-2697-40d6-beca-4ac39a01ca3e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_512c1a98-0e7c-4f68-9d60-409d5e1df16f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_42ddd871-5fe6-454a-bfda-6c4712735488_terseLabel_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_label_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Text Block]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_documentation_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial guarantees And warranties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:href="mck-20220331.xsd#mck_FinancialGuaranteesAndWarrantiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:to="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_16fc159b-d630-4a43-b017-1abaf5833a16_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_16d7353c-9e6c-4409-9620-78fe91a7757b_negatedTotalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_f4e21e1c-0df4-452d-954b-dc5b7b67dfca_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_0380ec4d-9129-47c0-903c-4c32020feff4_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized on the balance sheet</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_7f298300-e1aa-482a-89bb-edf8ff696b33_verboseLabel_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_label_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Including Net Capitalized Software</link:label>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_documentation_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Including Net Capitalized Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:href="mck-20220331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:to="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2021Member_3f4ad752-6fb6-4988-a354-8e55bf20b5c0_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2021</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2021Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2021 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2021Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2021Member" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMay2021Member" xlink:to="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b04a15db-e936-41a5-a83b-9fdc83574af7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34c00d52-aa33-4c7f-ace3-b47f5793e026_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility borrowing capacity (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_50dadc2a-6902-4ace-ad2d-63e562df5ffe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_bce6d443-5545-402f-ab79-7da6d006e656_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_2e627b72-0d37-4c23-bc75-026e82525287_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_902a5d60-35b7-4779-8141-c746fbe6621d_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_15d4c207-5aeb-44e5-82ae-09a6de42704c_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20220331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_f92e2849-ea4c-4772-bf71-46c99c25a401_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_6b9cd9f8-4c18-4955-addf-19689922990a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Capital</link:label>
    <link:label id="lab_us-gaap_OtherAdditionalCapitalMember_label_en-US" xlink:label="lab_us-gaap_OtherAdditionalCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Additional Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAdditionalCapitalMember" xlink:to="lab_us-gaap_OtherAdditionalCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_0e90934d-847b-4d3f-9bf5-c1620c5aeac0_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_0282cad2-7dec-426e-a4dd-462e4d07e98f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_884625ce-42b3-4803-ba22-3ca25e833503_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_d6cdf837-0d94-4336-8cfc-ee528374babe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_84999ea9-f37b-4d30-8b85-6f234b38fbb2_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_8ab5ab86-aba5-4474-a37a-d067ec270aeb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increase in compensation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_e503fc4a-fba0-4dd1-9863-dc01d54671d7_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_cf30d942-5a68-476a-b22f-d035560a3b10_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_7f85d08b-052d-4981-a7ea-6bc6c03ede9b_negatedLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_3d18d506-2de5-428b-a867-ce4da5bdb11d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative liability, gross fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_7513f143-ba81-4fd2-83a2-fe537fb01451_terseLabel_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes due August 17, 2021</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_label_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021 [Member]</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_documentation_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member" xlink:href="mck-20220331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A063EuroNotesDueAugust172021Member" xlink:to="lab_mck_A063EuroNotesDueAugust172021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_ae97dfa3-0243-4615-bfd0-ae4b196153d1_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfAdditionalDefendants" xlink:to="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_b7791e70-c614-4010-a776-e54400e89f51_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_02fbe954-3cf0-49d5-ad8c-a6d73b00fb53_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberofSoftwareProducts_dfa97a2a-03f7-4c98-b93b-858f6b6bb9da_terseLabel_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of software products</link:label>
    <link:label id="lab_mck_NumberofSoftwareProducts_label_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Software Products</link:label>
    <link:label id="lab_mck_NumberofSoftwareProducts_documentation_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Software Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts" xlink:href="mck-20220331.xsd#mck_NumberofSoftwareProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberofSoftwareProducts" xlink:to="lab_mck_NumberofSoftwareProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_e81a35eb-908b-4536-9d45-3a62e38e8592_terseLabel_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_label_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:href="mck-20220331.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:to="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_d89443ae-e732-422b-a428-b0cd1dad2889_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_5fe18724-950e-4b68-827f-66879c31d083_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Outstanding at Year End (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_aff34689-6553-445f-954f-1860e3ed97a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_f503fe0d-f6c7-433d-a09f-a5bb3f59d517_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_8720327d-15ea-4b97-8ecd-96846ac690ba_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_944d9de1-500e-428c-8157-288dcb3444ba_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_70e8dd71-54ae-4c67-9224-d1700ab0a691_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_73fa3778-9fca-43ee-be44-eb3d3a2bfb0d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_4963af70-b8af-4bde-b1de-ff96e37bf75e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_a188b8f2-7cb7-4b2e-b964-f1f6605a7366_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans, Defined Benefit</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_950b435f-70c0-4b06-8880-fca1add10661_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_5b9f5873-d000-478b-a7c3-623fb07eacd2_terseLabel_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation</link:label>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_label_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation [Member]</link:label>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_documentation_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:href="mck-20220331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:to="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_975eeeb3-a1e4-4019-84fd-bf66577e8ea7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_db4be951-3c9d-43b3-a4e7-bc758698f14f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits and settlements</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_0c4b325f-c0b1-466a-afee-005f1b2a9f99_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_0f71b407-aa0c-47b5-b463-b08e7ea5a9a4_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>mck-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eedc7054-d2b4-49fb-b502-fc8a725b4aca,g:dd1fa40e-8b61-4831-9194-c55f1729d4f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_61819344-b5a1-411c-88a3-82c994eff904" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61819344-b5a1-411c-88a3-82c994eff904" xlink:to="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:to="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_28cae897-c8dd-4b36-baae-8cadd5729fcf" xlink:to="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9ce58314-859a-4bfb-b620-8b98c7a06d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_us-gaap_CommonStockMember_9ce58314-859a-4bfb-b620-8b98c7a06d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member_1cc4c374-a519-410a-b48e-20005a112033" xlink:href="mck-20220331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_mck_A1.500NotesDue2025Member_1cc4c374-a519-410a-b48e-20005a112033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member_a530d056-5d8e-4d62-8f76-5604044105ba" xlink:href="mck-20220331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_mck_A1.625NotesDue2026Member_a530d056-5d8e-4d62-8f76-5604044105ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member_1d6985d7-16b9-4ade-9610-e0025dcfea86" xlink:href="mck-20220331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7550bbd7-37e7-44c2-aae2-26ad24f1327f" xlink:to="loc_mck_A3.125NotesDue2029Member_1d6985d7-16b9-4ade-9610-e0025dcfea86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5bc95699-5d25-48a1-86ee-ec4cf5a73e79" xlink:to="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7b9dfed2-10ca-41a5-9f61-f547c8cd04c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentType_7b9dfed2-10ca-41a5-9f61-f547c8cd04c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_7e17676b-5561-4a58-abb1-38fdfb105650" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentAnnualReport_7e17676b-5561-4a58-abb1-38fdfb105650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c7b42792-95b9-4769-b854-2a1dd99f77f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentPeriodEndDate_c7b42792-95b9-4769-b854-2a1dd99f77f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bf2a1136-ef1d-4f93-82bb-cbbf91c2fa60" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_CurrentFiscalYearEndDate_bf2a1136-ef1d-4f93-82bb-cbbf91c2fa60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_21a8ea52-e1b7-4048-9aea-8965348323d3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentTransitionReport_21a8ea52-e1b7-4048-9aea-8965348323d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9fba9582-7cf5-4196-a5c5-74b9aa975275" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityFileNumber_9fba9582-7cf5-4196-a5c5-74b9aa975275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5d4f1a31-9858-4a50-b30a-f3b12e0702d5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityRegistrantName_5d4f1a31-9858-4a50-b30a-f3b12e0702d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9616d02d-d64f-4e68-aaf7-280bc26c4623" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9616d02d-d64f-4e68-aaf7-280bc26c4623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_842a06a2-7916-4139-b245-02c0ee439575" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityTaxIdentificationNumber_842a06a2-7916-4139-b245-02c0ee439575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8b0347f7-e7f1-487f-9a06-7a0db609df0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressAddressLine1_8b0347f7-e7f1-487f-9a06-7a0db609df0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_58cabda0-ad0b-4327-a82f-56fb05a9722c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressCityOrTown_58cabda0-ad0b-4327-a82f-56fb05a9722c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8dabdd88-d3f6-43b7-a341-32ac6b961978" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressStateOrProvince_8dabdd88-d3f6-43b7-a341-32ac6b961978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6a78a934-d689-4827-a303-c34edd87f869" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityAddressPostalZipCode_6a78a934-d689-4827-a303-c34edd87f869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9134af9a-55e8-4050-a670-49430425cbf4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_CityAreaCode_9134af9a-55e8-4050-a670-49430425cbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4378a402-5c88-4fe4-bb94-f860ffc0f228" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_LocalPhoneNumber_4378a402-5c88-4fe4-bb94-f860ffc0f228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4a7962ef-7d72-41e1-b7d0-7cb3ae41c13d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_Security12bTitle_4a7962ef-7d72-41e1-b7d0-7cb3ae41c13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_24b80812-b4f9-45ba-9756-3d69540f2985" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_TradingSymbol_24b80812-b4f9-45ba-9756-3d69540f2985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_945d8ef9-6c23-4b3d-9777-d38accfb1e9b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_SecurityExchangeName_945d8ef9-6c23-4b3d-9777-d38accfb1e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_786f7f5d-8ab7-4bf1-b8bd-d5a5e50be033" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_786f7f5d-8ab7-4bf1-b8bd-d5a5e50be033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_8172440a-db50-4433-9f49-79380e110415" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityVoluntaryFilers_8172440a-db50-4433-9f49-79380e110415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_fe44182b-0290-4dab-94e1-3d8738ae5b19" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityCurrentReportingStatus_fe44182b-0290-4dab-94e1-3d8738ae5b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d3217490-0abc-430c-a86a-c5f76e892a7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityInteractiveDataCurrent_d3217490-0abc-430c-a86a-c5f76e892a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_87c5d13f-fa57-423a-92a0-0dab609ef23a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityFilerCategory_87c5d13f-fa57-423a-92a0-0dab609ef23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_dfd02216-d8ef-415f-acc6-2f338e028b7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntitySmallBusiness_dfd02216-d8ef-415f-acc6-2f338e028b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e8d9b0ef-777e-4944-9542-f72a63ef1c81" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityEmergingGrowthCompany_e8d9b0ef-777e-4944-9542-f72a63ef1c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_0a3e0ec1-691f-4ebe-bc22-3525738d3734" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_IcfrAuditorAttestationFlag_0a3e0ec1-691f-4ebe-bc22-3525738d3734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1facff9b-8246-4ab0-8cda-59e6c4484c8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityShellCompany_1facff9b-8246-4ab0-8cda-59e6c4484c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_edda859f-97cf-40ee-b729-ed88da66491b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityPublicFloat_edda859f-97cf-40ee-b729-ed88da66491b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_671c6954-58dc-4fcf-9040-bcfdc6fc0f8c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_671c6954-58dc-4fcf-9040-bcfdc6fc0f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d7141ee5-340a-4202-bddd-8957c94a40ea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d7141ee5-340a-4202-bddd-8957c94a40ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_638207b3-c7e7-46c6-b0b1-19411cc65e0c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_EntityCentralIndexKey_638207b3-c7e7-46c6-b0b1-19411cc65e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_62e71b90-95b3-4cfb-81c7-eb27ea17fd59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_62e71b90-95b3-4cfb-81c7-eb27ea17fd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7a71f51d-3f62-43b5-8517-5d4d58f9d121" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_DocumentFiscalYearFocus_7a71f51d-3f62-43b5-8517-5d4d58f9d121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5493d434-5032-476c-9321-f4224eae8206" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a3455405-8c7c-4aa5-b8ed-3e1f1fe3d37d" xlink:to="loc_dei_AmendmentFlag_5493d434-5032-476c-9321-f4224eae8206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/AuditInformation" xlink:type="simple" xlink:href="mck-20220331.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_AuditorInformationAbstract_bdc19127-4b2a-493f-9cbf-03324ee969ff" xlink:href="mck-20220331.xsd#mck_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_78caf992-fca9-412f-8ede-6652bcfa6b86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_AuditorInformationAbstract_bdc19127-4b2a-493f-9cbf-03324ee969ff" xlink:to="loc_dei_AuditorFirmId_78caf992-fca9-412f-8ede-6652bcfa6b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_6715f170-cdd5-41d9-8ad1-8aa677b43391" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_AuditorInformationAbstract_bdc19127-4b2a-493f-9cbf-03324ee969ff" xlink:to="loc_dei_AuditorLocation_6715f170-cdd5-41d9-8ad1-8aa677b43391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_13767f7c-6e49-48fc-aa8a-78e4db0a3c59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_AuditorInformationAbstract_bdc19127-4b2a-493f-9cbf-03324ee969ff" xlink:to="loc_dei_AuditorName_13767f7c-6e49-48fc-aa8a-78e4db0a3c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56d40e94-d9c1-4077-bef9-9a5208c4be0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56d40e94-d9c1-4077-bef9-9a5208c4be0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f41e55ea-429b-45b6-a03b-3f52fcf03f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f41e55ea-429b-45b6-a03b-3f52fcf03f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_671e55c1-1afd-43c9-8a80-187eb48e04a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_GrossProfit_671e55c1-1afd-43c9-8a80-187eb48e04a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_afa6d1f6-a059-433b-8c9f-ba38c8cd8b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_afa6d1f6-a059-433b-8c9f-ba38c8cd8b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_ca21c209-e88d-42d9-8d21-b3226aeee0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_ca21c209-e88d-42d9-8d21-b3226aeee0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_cdcd2cde-35c9-401b-806a-eb4e9df39545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_cdcd2cde-35c9-401b-806a-eb4e9df39545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_d67181ae-8748-47e1-ba5c-875c77f733af" xlink:href="mck-20220331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_d67181ae-8748-47e1-ba5c-875c77f733af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a163a947-ee40-4dd8-8f1c-14682b083248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_OperatingExpenses_a163a947-ee40-4dd8-8f1c-14682b083248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3bacc1b8-1b16-4a21-b76a-03285651369f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_OperatingIncomeLoss_3bacc1b8-1b16-4a21-b76a-03285651369f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_06b54818-6ab7-44da-8bac-180f9238e861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_06b54818-6ab7-44da-8bac-180f9238e861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_0ca25c04-6750-4fd9-9cf7-c686a67a9459" xlink:href="mck-20220331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts_0ca25c04-6750-4fd9-9cf7-c686a67a9459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e4d4d4a5-b877-4b8f-be25-c66c2bab7aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e4d4d4a5-b877-4b8f-be25-c66c2bab7aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a802fb33-ea06-42e3-a1e7-22f36546aa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_InterestExpense_a802fb33-ea06-42e3-a1e7-22f36546aa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf848d75-b23f-4d3f-831d-f21cc681b5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf848d75-b23f-4d3f-831d-f21cc681b5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5d910516-9d5c-4494-943b-b5bd228c739b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5d910516-9d5c-4494-943b-b5bd228c739b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d2fb94d2-5c67-4a6c-8558-4ef4c14b30f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d2fb94d2-5c67-4a6c-8558-4ef4c14b30f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2b7c418d-e0b5-489d-a72f-970e0d2557fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2b7c418d-e0b5-489d-a72f-970e0d2557fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8f461b5c-f722-45bd-814b-2d69f4e338c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_ProfitLoss_8f461b5c-f722-45bd-814b-2d69f4e338c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b2d8844-9088-4b47-a85a-eb8d2ea483e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b2d8844-9088-4b47-a85a-eb8d2ea483e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6fbd206c-7c4f-4e5d-afdd-d76c58635029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_NetIncomeLoss_6fbd206c-7c4f-4e5d-afdd-d76c58635029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_86083ae9-2abd-46f6-844b-8f5f4dcb1ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_86083ae9-2abd-46f6-844b-8f5f4dcb1ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_9ea06431-807d-47e1-87a1-21f4fc0dea1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86083ae9-2abd-46f6-844b-8f5f4dcb1ae5" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_9ea06431-807d-47e1-87a1-21f4fc0dea1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3715d7ce-1b7e-41f0-aea2-224317e42af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9ea06431-807d-47e1-87a1-21f4fc0dea1e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3715d7ce-1b7e-41f0-aea2-224317e42af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_17a5d10d-c95e-481e-ab8f-e461ece635e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9ea06431-807d-47e1-87a1-21f4fc0dea1e" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_17a5d10d-c95e-481e-ab8f-e461ece635e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_886ac607-14c5-4212-a709-81aa4dcb0cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_9ea06431-807d-47e1-87a1-21f4fc0dea1e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_886ac607-14c5-4212-a709-81aa4dcb0cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_36bd412b-c57b-4468-ab34-589e19e54c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86083ae9-2abd-46f6-844b-8f5f4dcb1ae5" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_36bd412b-c57b-4468-ab34-589e19e54c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4e3e790f-ddad-4e80-a9a4-33a500264288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_36bd412b-c57b-4468-ab34-589e19e54c55" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4e3e790f-ddad-4e80-a9a4-33a500264288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_c31cfc82-f461-449f-b263-5528001762df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_36bd412b-c57b-4468-ab34-589e19e54c55" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_c31cfc82-f461-449f-b263-5528001762df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d3acb3e4-90e1-4d48-a8a5-306d837b7162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_36bd412b-c57b-4468-ab34-589e19e54c55" xlink:to="loc_us-gaap_EarningsPerShareBasic_d3acb3e4-90e1-4d48-a8a5-306d837b7162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d0904621-223f-4ef1-8b14-135406d99e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cd68194b-e523-481f-90cc-33e89054ecf0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d0904621-223f-4ef1-8b14-135406d99e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fca0adb9-a33d-4d4f-ae87-bace3f0c855b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d0904621-223f-4ef1-8b14-135406d99e2a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fca0adb9-a33d-4d4f-ae87-bace3f0c855b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d41f9282-4e1b-47c3-a867-ef2f4efac0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d0904621-223f-4ef1-8b14-135406d99e2a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d41f9282-4e1b-47c3-a867-ef2f4efac0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5729473-f560-4259-bb01-33d98bf22196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_74c29b35-d8ce-4a9c-89f9-ec91db13e2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5729473-f560-4259-bb01-33d98bf22196" xlink:to="loc_us-gaap_ProfitLoss_74c29b35-d8ce-4a9c-89f9-ec91db13e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fdab265b-6f6d-48bf-832c-89618d70430e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5729473-f560-4259-bb01-33d98bf22196" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fdab265b-6f6d-48bf-832c-89618d70430e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47013109-eff6-434b-8fa4-a946acf70237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fdab265b-6f6d-48bf-832c-89618d70430e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47013109-eff6-434b-8fa4-a946acf70237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fe7e63d8-1855-4807-bd0d-b3988bdf0bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fdab265b-6f6d-48bf-832c-89618d70430e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fe7e63d8-1855-4807-bd0d-b3988bdf0bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e09f13b2-1232-4531-8753-bda40e6c2ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fdab265b-6f6d-48bf-832c-89618d70430e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e09f13b2-1232-4531-8753-bda40e6c2ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_861e1108-2e24-4e4d-83b3-035bfb53a0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fdab265b-6f6d-48bf-832c-89618d70430e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_861e1108-2e24-4e4d-83b3-035bfb53a0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a21b088a-c90d-4d68-a2cf-1f860512febb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5729473-f560-4259-bb01-33d98bf22196" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a21b088a-c90d-4d68-a2cf-1f860512febb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7dc1deba-f770-4965-9fbe-d29d20ce4a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5729473-f560-4259-bb01-33d98bf22196" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7dc1deba-f770-4965-9fbe-d29d20ce4a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0a376e4c-0888-4e11-8707-3be1af980881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5729473-f560-4259-bb01-33d98bf22196" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0a376e4c-0888-4e11-8707-3be1af980881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_93d10b89-5f29-4d8b-8a83-b1f451bf19e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_93d10b89-5f29-4d8b-8a83-b1f451bf19e2" xlink:to="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_df584d2c-3805-4d02-8693-c1a5291b07fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_df584d2c-3805-4d02-8693-c1a5291b07fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_74a5513e-f6b9-4d99-9315-96aea04af7db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:to="loc_us-gaap_ReceivablesNetCurrent_74a5513e-f6b9-4d99-9315-96aea04af7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8415d394-807c-4596-a5bb-d7ee63b22966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:to="loc_us-gaap_InventoryNet_8415d394-807c-4596-a5bb-d7ee63b22966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_aa786de8-5f77-4445-8a63-ece04b961265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_aa786de8-5f77-4445-8a63-ece04b961265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5516b04a-08a1-4c98-9b75-84bfd35462ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5516b04a-08a1-4c98-9b75-84bfd35462ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f464639e-2e5a-4a69-a935-d9067d781d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_39487fdf-5ae3-46bd-aedb-18b291819679" xlink:to="loc_us-gaap_AssetsCurrent_f464639e-2e5a-4a69-a935-d9067d781d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a40fe818-ea3f-4042-a163-9ab5620b09b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a40fe818-ea3f-4042-a163-9ab5620b09b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e402bd7-48d7-495c-bc5d-65f1dfd12ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e402bd7-48d7-495c-bc5d-65f1dfd12ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2ad683ef-2a70-45e4-b321-aadc24ad9a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_Goodwill_2ad683ef-2a70-45e4-b321-aadc24ad9a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a55c966-29db-4384-a51b-4589fd7384e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a55c966-29db-4384-a51b-4589fd7384e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0f3bd61d-95cf-4e55-9887-21623a2199e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0f3bd61d-95cf-4e55-9887-21623a2199e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_12461869-2471-43ed-9269-bcb437c9e885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a4c5fccf-2f77-4223-8bb5-82a252635856" xlink:to="loc_us-gaap_Assets_12461869-2471-43ed-9269-bcb437c9e885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_93d10b89-5f29-4d8b-8a83-b1f451bf19e2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_79988362-e531-41a3-857f-3cad1574003d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:to="loc_us-gaap_AccountsPayableCurrent_79988362-e531-41a3-857f-3cad1574003d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c29927db-e681-4d44-9425-8fcde180be10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c29927db-e681-4d44-9425-8fcde180be10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_474cd701-80ef-4d2b-903e-640fb8155b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_474cd701-80ef-4d2b-903e-640fb8155b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_065a4711-18df-44a0-a4f9-d57e49b90a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_065a4711-18df-44a0-a4f9-d57e49b90a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a6af53d0-b859-45f8-9f66-1d0fdcffe053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a6af53d0-b859-45f8-9f66-1d0fdcffe053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fdca963b-01ab-403a-988e-946ae987fa1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cbaf81fe-d872-4d54-b41f-b654250fe964" xlink:to="loc_us-gaap_LiabilitiesCurrent_fdca963b-01ab-403a-988e-946ae987fa1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_555ca510-6417-4f22-8337-5997d7edaa09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_555ca510-6417-4f22-8337-5997d7edaa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_be67420f-df87-496d-b5bf-9386a9d68061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_be67420f-df87-496d-b5bf-9386a9d68061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c3b5da6b-42f4-4b8b-9e31-eb348f3e212e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c3b5da6b-42f4-4b8b-9e31-eb348f3e212e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_33b6a685-68dc-4e9c-9ea3-f2e47b60d46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_33b6a685-68dc-4e9c-9ea3-f2e47b60d46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_47acee66-52c6-473d-bc8a-260b666c9a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_47acee66-52c6-473d-bc8a-260b666c9a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ccc5d084-9e2c-4721-bce0-bb4b2308cf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ccc5d084-9e2c-4721-bce0-bb4b2308cf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_99dc7216-dec6-45da-8aa0-94997be1dcec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_99dc7216-dec6-45da-8aa0-94997be1dcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6b115071-1d2b-4eb9-81fb-0271caaebf89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_PreferredStockValue_6b115071-1d2b-4eb9-81fb-0271caaebf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9ca87e58-9591-4376-b372-30801ff25f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_CommonStockValue_9ca87e58-9591-4376-b372-30801ff25f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a0cded8f-8990-401c-a032-602072121dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a0cded8f-8990-401c-a032-602072121dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_299dd54d-3c5b-47a1-aea2-d8a923d3fd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_299dd54d-3c5b-47a1-aea2-d8a923d3fd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8c0e5f10-0c55-476e-a580-aaf6b77b191a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8c0e5f10-0c55-476e-a580-aaf6b77b191a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_282cc2d0-d257-4302-90f1-483b2e1671e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_TreasuryStockValue_282cc2d0-d257-4302-90f1-483b2e1671e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b5741e7-d90e-4d6a-a372-2b8855e69366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_StockholdersEquity_8b5741e7-d90e-4d6a-a372-2b8855e69366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f17d7536-7a6a-4c2f-bc5c-c51a65daf4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_MinorityInterest_f17d7536-7a6a-4c2f-bc5c-c51a65daf4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e2fffe8d-5f8c-4c9e-9ef6-62ff4fd53504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_475f2ecc-3b16-4a56-91fc-36d5a20ca7ef" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e2fffe8d-5f8c-4c9e-9ef6-62ff4fd53504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae2156d2-1106-4733-9b5b-c16303b7460e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfb0e8ba-1d88-4094-9235-7a38e573e7a3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae2156d2-1106-4733-9b5b-c16303b7460e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_51dc5858-42ff-46b9-8e57-b7f2c7a02aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_51dc5858-42ff-46b9-8e57-b7f2c7a02aae" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e0768fee-1412-4787-b6e7-5009b0f1eb86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e0768fee-1412-4787-b6e7-5009b0f1eb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2428cacc-bf57-4893-a6c5-7feb0f24fdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2428cacc-bf57-4893-a6c5-7feb0f24fdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3218b50e-7c29-4791-b989-1271c14b0b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3218b50e-7c29-4791-b989-1271c14b0b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6ba68fdc-e0a6-4c0d-a6cc-e4be19adfe94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6ba68fdc-e0a6-4c0d-a6cc-e4be19adfe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_19c2df75-d87d-4e13-8933-6c99108d2278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_19c2df75-d87d-4e13-8933-6c99108d2278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_13e42006-f8f1-48bc-963e-c80f94c2d1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_13e42006-f8f1-48bc-963e-c80f94c2d1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_149ce004-4863-444c-a899-9baf47d48ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_CommonStockSharesIssued_149ce004-4863-444c-a899-9baf47d48ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b9aa87be-1a6a-48f5-8b76-702529af4e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a85a1124-b90d-4c9f-8969-e485e1c9c139" xlink:to="loc_us-gaap_TreasuryStockShares_b9aa87be-1a6a-48f5-8b76-702529af4e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3ad48688-9561-4c92-b23a-957d1985c74c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3ad48688-9561-4c92-b23a-957d1985c74c" xlink:to="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c998f80b-5522-4f5c-85e9-9727bdceb08b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b84e54a8-7025-4603-98c7-cf245d12f852" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b84e54a8-7025-4603-98c7-cf245d12f852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_556eea86-e57d-4e9f-b179-60a77376bb95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e339d93-ddf9-47de-8fda-f93e308fa41d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_556eea86-e57d-4e9f-b179-60a77376bb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75fd46d5-389d-45ba-b7ab-b49f76a65b13" xlink:to="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e4f5b531-00ee-4a55-a20d-32696c7419a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_CommonStockMember_e4f5b531-00ee-4a55-a20d-32696c7419a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_20bc299a-be92-4bc0-817a-482a1406feb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_20bc299a-be92-4bc0-817a-482a1406feb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAdditionalCapitalMember_ed93938a-1d01-4f48-9237-dd2caccee129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAdditionalCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_OtherAdditionalCapitalMember_ed93938a-1d01-4f48-9237-dd2caccee129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ca30c023-689b-4898-b912-66f63e371413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_RetainedEarningsMember_ca30c023-689b-4898-b912-66f63e371413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dae86af6-0153-406f-a98a-ba0d0a0aa520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dae86af6-0153-406f-a98a-ba0d0a0aa520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_637cab7c-1dfb-48ce-8182-ca63b395480e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_TreasuryStockMember_637cab7c-1dfb-48ce-8182-ca63b395480e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f5a6d836-653b-4b55-bef4-34907f57b1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_efc9b1f3-a3af-4c2c-9750-e64ab708ea76" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f5a6d836-653b-4b55-bef4-34907f57b1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2470c3b0-0326-4134-8ccb-4397513447de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cdf03739-119e-4c85-bf10-4d116f6f7c60" xlink:to="loc_us-gaap_StatementLineItems_2470c3b0-0326-4134-8ccb-4397513447de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2470c3b0-0326-4134-8ccb-4397513447de" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_dd88d9a3-e23f-4173-b09f-4d60c987edbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_SharesOutstanding_dd88d9a3-e23f-4173-b09f-4d60c987edbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_66adf3b0-bcc2-40c5-bc4e-274794fc20a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_66adf3b0-bcc2-40c5-bc4e-274794fc20a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c7a51176-3dff-4fed-bd7d-346fbb59cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_TreasuryStockShares_c7a51176-3dff-4fed-bd7d-346fbb59cf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_99f856ee-cccb-416e-ae03-24d3014b9212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_99f856ee-cccb-416e-ae03-24d3014b9212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_e68dbdcb-8603-46df-9755-c8bbc5fc3b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_e68dbdcb-8603-46df-9755-c8bbc5fc3b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2accadc7-5fe5-4439-b69f-9c15dc1590b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2accadc7-5fe5-4439-b69f-9c15dc1590b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d9dfbbf1-3137-40a4-b18e-033e72bec940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d9dfbbf1-3137-40a4-b18e-033e72bec940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a18d7498-98d0-4d4b-8791-00b172f4d5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a18d7498-98d0-4d4b-8791-00b172f4d5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_51703cbb-bb4f-4eab-b0f2-9490668adbca" xlink:href="mck-20220331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_51703cbb-bb4f-4eab-b0f2-9490668adbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_82be9d52-d9be-4cc8-82b7-be51513c1d58" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_82be9d52-d9be-4cc8-82b7-be51513c1d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_f163b421-3003-4fd4-b8cb-44127efdb887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_f163b421-3003-4fd4-b8cb-44127efdb887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_28c67474-3fbb-43d4-addb-34dccce0944d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_28c67474-3fbb-43d4-addb-34dccce0944d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_16a24156-3a8f-4106-a7ba-9fc140c598a5" xlink:href="mck-20220331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_16a24156-3a8f-4106-a7ba-9fc140c598a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_55850ac1-0195-4f88-a544-21f4d9c1917e" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_55850ac1-0195-4f88-a544-21f4d9c1917e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodShares_faef4843-8417-4c21-888e-bb14d2a36dcf" xlink:href="mck-20220331.xsd#mck_StockExchangedDuringPeriodShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_StockExchangedDuringPeriodShares_faef4843-8417-4c21-888e-bb14d2a36dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockExchangedDuringPeriodValue_e0085257-0f27-459a-a38e-c99394c2465c" xlink:href="mck-20220331.xsd#mck_StockExchangedDuringPeriodValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_mck_StockExchangedDuringPeriodValue_e0085257-0f27-459a-a38e-c99394c2465c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_b1e0001c-0a6a-49d1-ab9f-2374fd7f543b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_DividendsCommonStockCash_b1e0001c-0a6a-49d1-ab9f-2374fd7f543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_ec9c97ac-8550-489a-9c5f-3e526594cfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockholdersEquityOther_ec9c97ac-8550-489a-9c5f-3e526594cfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_305a29e9-5f5c-4177-bb33-eec40e66fe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_SharesOutstanding_305a29e9-5f5c-4177-bb33-eec40e66fe0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_942034a1-2b8a-4346-96b1-59c53ba4c2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_942034a1-2b8a-4346-96b1-59c53ba4c2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1e2652c0-d85a-444d-9bad-8f81f40925a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0109ca1b-89b3-4fde-84b9-9e440419ee28" xlink:to="loc_us-gaap_TreasuryStockShares_1e2652c0-d85a-444d-9bad-8f81f40925a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4878e9a5-6cda-4cf4-9cab-6e4df4e24d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_508bf547-3fcd-41fc-bb90-7378852f8c36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4878e9a5-6cda-4cf4-9cab-6e4df4e24d0f" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_508bf547-3fcd-41fc-bb90-7378852f8c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_739d4e14-22b9-4d37-81b6-fb8c30bc9fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_739d4e14-22b9-4d37-81b6-fb8c30bc9fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3ff782d2-104f-4f69-adf0-868756a4e57c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_739d4e14-22b9-4d37-81b6-fb8c30bc9fdd" xlink:to="loc_us-gaap_ProfitLoss_3ff782d2-104f-4f69-adf0-868756a4e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_739d4e14-22b9-4d37-81b6-fb8c30bc9fdd" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a949a988-c0f4-44e5-bc8d-c9e7f166c569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_Depreciation_a949a988-c0f4-44e5-bc8d-c9e7f166c569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5a8afdbc-8e3f-4bd3-a2f5-2c580e0c6a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_AdjustmentForAmortization_5a8afdbc-8e3f-4bd3-a2f5-2c580e0c6a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_a4e0c52e-2fba-4ae8-bf01-abdb952223d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_a4e0c52e-2fba-4ae8-bf01-abdb952223d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_9f9263be-5732-4ed0-b7e5-7e809e636dc3" xlink:href="mck-20220331.xsd#mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment_9f9263be-5732-4ed0-b7e5-7e809e636dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e73576b5-7218-43c5-8dc4-a3228a0a1b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_e73576b5-7218-43c5-8dc4-a3228a0a1b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_9c425ea8-fc35-4992-b1fc-ee7b94ce2c04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_9c425ea8-fc35-4992-b1fc-ee7b94ce2c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_fd58257a-bacd-40f2-9bb3-50d33b12cd11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_OperatingLeaseExpense_fd58257a-bacd-40f2-9bb3-50d33b12cd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_e32a78a6-b7eb-4192-8de4-f516ebd22d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_e32a78a6-b7eb-4192-8de4-f516ebd22d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_a0ec6206-35cb-4a4b-a91d-0e9e0c7c6db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_a0ec6206-35cb-4a4b-a91d-0e9e0c7c6db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_4c1d8a85-7166-421b-9e6d-2fc1c3e34c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_4c1d8a85-7166-421b-9e6d-2fc1c3e34c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_84c8d3a6-3959-411c-92b9-787e4141bcf4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_1b7f873f-0662-4880-9570-6e161a859494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_1b7f873f-0662-4880-9570-6e161a859494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c685dd42-f289-49d9-b315-234dae42bebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c685dd42-f289-49d9-b315-234dae42bebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3a3882f3-8f05-4f1d-b3ab-feab5fb44dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3a3882f3-8f05-4f1d-b3ab-feab5fb44dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_d72ee5d2-1a37-475b-ad45-b4f0f1ada4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_d72ee5d2-1a37-475b-ad45-b4f0f1ada4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_853b205e-9360-4135-ab57-916d3d83bc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_853b205e-9360-4135-ab57-916d3d83bc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_2af0632f-a7a9-460a-98c2-edd9a937fb55" xlink:href="mck-20220331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_2af0632f-a7a9-460a-98c2-edd9a937fb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_22327555-60a0-430a-9a20-57e1acfcbf54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_51950b58-086a-44ef-a6f7-f3577ca260d8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_22327555-60a0-430a-9a20-57e1acfcbf54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_944bf235-3a7b-4582-86f1-de2f4de1af8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_739d4e14-22b9-4d37-81b6-fb8c30bc9fdd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_944bf235-3a7b-4582-86f1-de2f4de1af8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4ace0f2f-9c14-4b54-813c-3685d740fbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4ace0f2f-9c14-4b54-813c-3685d740fbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_1fecae14-6420-4489-9370-2e50cbe1ccbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_1fecae14-6420-4489-9370-2e50cbe1ccbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_524dec1f-7ed9-4cc1-a535-850175672139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_524dec1f-7ed9-4cc1-a535-850175672139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_5484e865-76b9-4d3a-8117-2f8766495867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_5484e865-76b9-4d3a-8117-2f8766495867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2c3668a5-2571-400f-b036-05eab0e4d774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2c3668a5-2571-400f-b036-05eab0e4d774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4fa0f7ea-0aa9-4d8e-8d18-06f29832fad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cf9b514e-2daa-42ee-af9f-d7b58975cb96" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4fa0f7ea-0aa9-4d8e-8d18-06f29832fad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_47eb388f-7361-4409-b62d-913b6b16971d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_47eb388f-7361-4409-b62d-913b6b16971d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_e770e127-c4a4-42a5-92ef-bb2abfc2ef60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_e770e127-c4a4-42a5-92ef-bb2abfc2ef60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8bf80f7c-2427-48a8-9a66-968b10e4cc71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8bf80f7c-2427-48a8-9a66-968b10e4cc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_89999fa2-f783-422e-bb1c-007a9d779709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_89999fa2-f783-422e-bb1c-007a9d779709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_548f2eb6-b5d8-4e09-a8b5-fa264fa43dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_548f2eb6-b5d8-4e09-a8b5-fa264fa43dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_6f8185d3-377d-47e7-80a5-770820f68f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_6f8185d3-377d-47e7-80a5-770820f68f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cb525b51-c852-464e-8652-c89ae1a223b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_6f8185d3-377d-47e7-80a5-770820f68f3f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cb525b51-c852-464e-8652-c89ae1a223b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_186278c1-d058-4e40-a68e-34789c2ea4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_6f8185d3-377d-47e7-80a5-770820f68f3f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_186278c1-d058-4e40-a68e-34789c2ea4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_43c5d204-7f71-4551-b842-6793e6938311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_43c5d204-7f71-4551-b842-6793e6938311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_8d556f45-0cc5-4192-94a4-e00cbf5e98b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_8d556f45-0cc5-4192-94a4-e00cbf5e98b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3538b8c8-79f9-4986-8451-66f9a798b9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3538b8c8-79f9-4986-8451-66f9a798b9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_987a0397-f222-4ad7-8cd4-aa845c81fbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cd2bc1ee-f68f-47c4-8a93-b9218a801cfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_987a0397-f222-4ad7-8cd4-aa845c81fbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14552bb4-ba31-40a6-a47d-9fd9b6a7ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_14552bb4-ba31-40a6-a47d-9fd9b6a7ab66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_7a636e1a-b2ba-4156-821d-43a1665fb637" xlink:href="mck-20220331.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_7a636e1a-b2ba-4156-821d-43a1665fb637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb0a53d2-3dee-420f-b585-95507523b208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb0a53d2-3dee-420f-b585-95507523b208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5fd12f6a-0d10-45a0-a8b8-922776b68c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5fd12f6a-0d10-45a0-a8b8-922776b68c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7d91a3-0785-45a2-b32a-f2e29d44c281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7d91a3-0785-45a2-b32a-f2e29d44c281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_86774b76-ed76-4032-92f6-1c48941ff0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9a6dd5f7-58ec-4cfa-bc9c-fcfc51a9f7f8" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_86774b76-ed76-4032-92f6-1c48941ff0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_f4c7b4e4-6030-400b-bd31-fa7d2a7edd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_86774b76-ed76-4032-92f6-1c48941ff0c7" xlink:to="loc_us-gaap_RestrictedCashCurrent_f4c7b4e4-6030-400b-bd31-fa7d2a7edd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5fd14945-977c-4102-a243-ea554811cb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_86774b76-ed76-4032-92f6-1c48941ff0c7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5fd14945-977c-4102-a243-ea554811cb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_012374ea-1814-4600-9eb8-8061ebabc0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_86774b76-ed76-4032-92f6-1c48941ff0c7" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_012374ea-1814-4600-9eb8-8061ebabc0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fada1969-39a6-48f3-afc7-4822bfcc9b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_012374ea-1814-4600-9eb8-8061ebabc0ff" xlink:to="loc_us-gaap_InterestPaidNet_fada1969-39a6-48f3-afc7-4822bfcc9b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_96410826-dae4-4d17-bd49-5f7552b3e7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_012374ea-1814-4600-9eb8-8061ebabc0ff" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_96410826-dae4-4d17-bd49-5f7552b3e7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9a84c74e-3456-4604-8ebe-869de9284115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f73f18cf-c988-4b96-8e92-7d50f725cdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a84c74e-3456-4604-8ebe-869de9284115" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f73f18cf-c988-4b96-8e92-7d50f725cdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_0e13f92e-b487-4cbf-8e1f-dac958bf6c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_0e13f92e-b487-4cbf-8e1f-dac958bf6c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_92ca67bc-954b-45aa-b81c-3172914bb223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_FiscalPeriod_92ca67bc-954b-45aa-b81c-3172914bb223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_50f0a015-fe5a-422d-9f05-abdb93ede60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_50f0a015-fe5a-422d-9f05-abdb93ede60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_63b89a11-1ef9-4629-ba0d-9b7df66a7d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_UseOfEstimates_63b89a11-1ef9-4629-ba0d-9b7df66a7d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_83d6f68c-eb72-4757-a42b-07c7ae01d09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_83d6f68c-eb72-4757-a42b-07c7ae01d09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_98249cdc-81f8-435f-b644-fa10839a6463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_98249cdc-81f8-435f-b644-fa10839a6463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_fea2a5c4-09cb-46c2-ab71-7b5ceba429c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_fea2a5c4-09cb-46c2-ab71-7b5ceba429c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_44a06fe6-61a1-4f94-ae00-ba83a3705e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_44a06fe6-61a1-4f94-ae00-ba83a3705e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_1b9323cf-7231-4d98-a31d-aa51f1e19099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_1b9323cf-7231-4d98-a31d-aa51f1e19099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_d8c6121e-a78b-4070-9b29-ddeebb936bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_d8c6121e-a78b-4070-9b29-ddeebb936bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_9737a2b1-6160-4252-bdce-068b559b994b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_9737a2b1-6160-4252-bdce-068b559b994b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldforSalePolicyTextBlock_a8922123-19ef-4a5d-b63d-a2d7ec58e8ca" xlink:href="mck-20220331.xsd#mck_HeldforSalePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_mck_HeldforSalePolicyTextBlock_a8922123-19ef-4a5d-b63d-a2d7ec58e8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_383ea728-9fd2-4bd2-a5d5-2d928d6c079c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_383ea728-9fd2-4bd2-a5d5-2d928d6c079c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_369bb513-8101-42fa-8143-4afc409fab0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_369bb513-8101-42fa-8143-4afc409fab0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_a74b300c-b6b6-453d-8cc0-bf7db7fc7464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_a74b300c-b6b6-453d-8cc0-bf7db7fc7464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_c3fa4446-a2f7-4afe-8650-3f90ecdf9fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_c3fa4446-a2f7-4afe-8650-3f90ecdf9fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_fb80ffa0-d3c1-438d-99c6-d52e1cbe5d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_fb80ffa0-d3c1-438d-99c6-d52e1cbe5d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceProgramsPolicyTextBlock_4f2d9eb7-8779-4f2e-b562-397deaeeb17b" xlink:href="mck-20220331.xsd#mck_InsuranceProgramsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_mck_InsuranceProgramsPolicyTextBlock_4f2d9eb7-8779-4f2e-b562-397deaeeb17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4bae2a75-6b1a-44dd-977d-dffb054407ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4bae2a75-6b1a-44dd-977d-dffb054407ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierIncentivesPolicyPolicyTextBlock_09a5f17f-33c1-4a15-92e8-4f1cda510463" xlink:href="mck-20220331.xsd#mck_SupplierIncentivesPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_mck_SupplierIncentivesPolicyPolicyTextBlock_09a5f17f-33c1-4a15-92e8-4f1cda510463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierReservesPolicyTextBlock_1dee78dc-d83f-417c-afd1-52b4e0066ca5" xlink:href="mck-20220331.xsd#mck_SupplierReservesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_mck_SupplierReservesPolicyTextBlock_1dee78dc-d83f-417c-afd1-52b4e0066ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_3725359d-1806-4638-b9af-1de136fa9f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_3725359d-1806-4638-b9af-1de136fa9f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpensePolicyTextBlock_2b80c0db-a8d6-4091-a91e-24c4f9383f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_InterestExpensePolicyTextBlock_2b80c0db-a8d6-4091-a91e-24c4f9383f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e783bb7e-bf17-4ade-95a5-0411c3814667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e783bb7e-bf17-4ade-95a5-0411c3814667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7dc8e9e5-1d44-47d5-a411-45fd284834c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7dc8e9e5-1d44-47d5-a411-45fd284834c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b4934bfc-313c-4e2e-8188-47ece7689088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b4934bfc-313c-4e2e-8188-47ece7689088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_270597e7-57cf-4987-b8a2-4ba82d383d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_270597e7-57cf-4987-b8a2-4ba82d383d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4e56e10a-92b5-481c-ace1-1bf352e381da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4e56e10a-92b5-481c-ace1-1bf352e381da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_eb224f42-29db-4d26-900f-71f15812035d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_eb224f42-29db-4d26-900f-71f15812035d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_ba194d6b-05f6-495c-8ef7-b04a4679332d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_ba194d6b-05f6-495c-8ef7-b04a4679332d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_1a846cc3-687a-4cf5-819e-ea203621ec90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_1a846cc3-687a-4cf5-819e-ea203621ec90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TreasuryStockPolicyTextBlock_2cb918f5-3328-417e-810f-585a3304198e" xlink:href="mck-20220331.xsd#mck_TreasuryStockPolicyTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_mck_TreasuryStockPolicyTextBlock_2cb918f5-3328-417e-810f-585a3304198e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b4004019-3e5f-4b7c-9290-7dba993dc5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2ae64f0e-d5fd-4752-8e9a-cc8a7f73008e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b4004019-3e5f-4b7c-9290-7dba993dc5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4e1a997a-8a6b-4154-a692-bcce3b5f56c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_dca23d04-0278-4a1b-ba5f-0117036c2378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4e1a997a-8a6b-4154-a692-bcce3b5f56c8" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_dca23d04-0278-4a1b-ba5f-0117036c2378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0230ee25-3eb6-420c-8011-1592857b553a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4e1a997a-8a6b-4154-a692-bcce3b5f56c8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0230ee25-3eb6-420c-8011-1592857b553a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_17d09ba7-300b-4543-ac3f-f98c61c88f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_17d09ba7-300b-4543-ac3f-f98c61c88f11" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d8b10061-65f9-4a93-9d37-ad94df2a72e3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_624fac15-134e-4791-83cd-505d9c512658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_624fac15-134e-4791-83cd-505d9c512658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_38b38224-88a9-49a8-9b1c-38e0d8353f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_83f1565e-41d3-4eb1-a159-85a328e2ec0a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_38b38224-88a9-49a8-9b1c-38e0d8353f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_227ea533-f60c-4f42-9e4a-f344dba8af7f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_79ff89a4-15ac-4089-9cb8-676a168424d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:to="loc_us-gaap_SalesRevenueNetMember_79ff89a4-15ac-4089-9cb8-676a168424d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_d9bc5367-9152-4229-9f92-23ced7b71a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b1942eb-4987-4408-b3ae-b1bad42333c9" xlink:to="loc_us-gaap_AccountsReceivableMember_d9bc5367-9152-4229-9f92-23ced7b71a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_fbdc0697-598d-4055-9787-2a069d13c0f9" xlink:to="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember_f76e37de-e14c-49ff-b332-6e390e84ec0b" xlink:href="mck-20220331.xsd#mck_LargestCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:to="loc_mck_LargestCustomerMember_f76e37de-e14c-49ff-b332-6e390e84ec0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenLargestCustomersMember_aba02eb3-ca2d-49e9-82bb-469b877976ea" xlink:href="mck-20220331.xsd#mck_TenLargestCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_af9d00a7-ae7e-4ee6-9be7-619ed9aab387" xlink:to="loc_mck_TenLargestCustomersMember_aba02eb3-ca2d-49e9-82bb-469b877976ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_710ceb9c-c408-407a-97f1-6ab089e95a3e" xlink:to="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_537d99ee-dd04-4a35-b584-1b2c51299b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:to="loc_us-gaap_ShippingAndHandlingMember_537d99ee-dd04-4a35-b584-1b2c51299b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember_88ee46c9-bd26-4f0c-b5b0-b11347679028" xlink:href="mck-20220331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:to="loc_mck_DistributionandRetailBusinessMember_88ee46c9-bd26-4f0c-b5b0-b11347679028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember_6e887181-2aa1-475c-9886-5af36f41360e" xlink:href="mck-20220331.xsd#mck_ServicesBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5077489a-fa6a-4395-8f60-7f8962d3dca0" xlink:to="loc_mck_ServicesBusinessMember_6e887181-2aa1-475c-9886-5af36f41360e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d28b40db-b194-4ef9-ac8a-07cea9f1a071" xlink:to="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3f314ae3-34f5-49cc-8f24-2826cd65fc4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:to="loc_srt_MinimumMember_3f314ae3-34f5-49cc-8f24-2826cd65fc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9d837dfb-9f4f-40c3-9b4d-a9acd2900e1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4a755cbc-b970-4a9d-99ed-bb70181a38df" xlink:to="loc_srt_MaximumMember_9d837dfb-9f4f-40c3-9b4d-a9acd2900e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5c45aba-3a1a-4acb-b2ab-1ccfe08f973d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_884e2e03-a1f3-47a6-80f1-a9962ee3c9dc" xlink:to="loc_us-gaap_SegmentDomain_d5c45aba-3a1a-4acb-b2ab-1ccfe08f973d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_b1eef424-169e-4064-9b9a-4cf237d5b683" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d5c45aba-3a1a-4acb-b2ab-1ccfe08f973d" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_b1eef424-169e-4064-9b9a-4cf237d5b683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd7f5b42-5831-4f6d-9703-25e39d2d2880" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_80a638b9-8a56-4b51-8684-dc954c20f5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_80a638b9-8a56-4b51-8684-dc954c20f5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember_a8ef1f04-eb99-4ba5-a435-907766a420c2" xlink:href="mck-20220331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_mck_MachineryEquipmentAndOtherMember_a8ef1f04-eb99-4ba5-a435-907766a420c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_2bc7f34a-8302-4b66-857a-531a28069ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_us-gaap_BuildingMember_2bc7f34a-8302-4b66-857a-531a28069ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_42b318fd-b5ee-4ccf-839f-825a2b0ef6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_us-gaap_EquipmentMember_42b318fd-b5ee-4ccf-839f-825a2b0ef6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember_18fbd44c-500e-4f7b-a3f8-a90d8ee21894" xlink:href="mck-20220331.xsd#mck_RealPropertyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f2903c4-6ce6-4a0a-89ea-d66140765c8f" xlink:to="loc_mck_RealPropertyMember_18fbd44c-500e-4f7b-a3f8-a90d8ee21894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ad5d9a38-136a-4767-8b80-fe3e76e23e96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_39326400-3fb0-4b78-aa8f-219d2d6d94ec" xlink:to="loc_srt_LitigationCaseTypeDomain_ad5d9a38-136a-4767-8b80-fe3e76e23e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_fd43cd7a-52c2-4ba3-9302-1e20a43184a4" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ad5d9a38-136a-4767-8b80-fe3e76e23e96" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_fd43cd7a-52c2-4ba3-9302-1e20a43184a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c5b116a9-49ec-46eb-a456-eeab99373eb4" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_75cfcc0c-328b-444e-9fad-09d7c4c51fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_NumberOfReportableSegments_75cfcc0c-328b-444e-9fad-09d7c4c51fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_700053d5-6bff-4872-8c07-d3e892af3af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_RestrictedCash_700053d5-6bff-4872-8c07-d3e892af3af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e75c9077-6bb8-433e-9881-cdaeb7d24bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e75c9077-6bb8-433e-9881-cdaeb7d24bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_78f6aa88-4e7f-4abf-8acd-aac548b847d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_78f6aa88-4e7f-4abf-8acd-aac548b847d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d94a76bb-6610-4aa4-ad16-bc9ada6b85fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryNet_d94a76bb-6610-4aa4-ad16-bc9ada6b85fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_21105e23-e56d-4a63-976d-54469642ec25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryWriteDown_21105e23-e56d-4a63-976d-54469642ec25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_bd399987-a6a8-4ba3-a7c5-3389d721847d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_bd399987-a6a8-4ba3-a7c5-3389d721847d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_0970f83b-6136-4ff5-8b41-8de58cec1cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryLIFOReserve_0970f83b-6136-4ff5-8b41-8de58cec1cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_ec3f5951-20fb-4f7b-94d5-f982f7fe4b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_ec3f5951-20fb-4f7b-94d5-f982f7fe4b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1588e914-6ba3-479c-ae95-9d726615dabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1588e914-6ba3-479c-ae95-9d726615dabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a41bd0cd-7ee3-4983-9839-3bd4f6896ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a41bd0cd-7ee3-4983-9839-3bd4f6896ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_be09af36-0c9e-4961-9d1c-9b534c948933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_be09af36-0c9e-4961-9d1c-9b534c948933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d0d2f4e2-26d2-4416-9450-01d190f9e340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d0d2f4e2-26d2-4416-9450-01d190f9e340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_00c271bc-b204-468c-9529-246a759d060a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_00c271bc-b204-468c-9529-246a759d060a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_365c632c-f0d7-4901-a2e6-15c1712f24cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_365c632c-f0d7-4901-a2e6-15c1712f24cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_6951532a-6c22-4e7b-82d9-6c3d06118feb" xlink:href="mck-20220331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_6951532a-6c22-4e7b-82d9-6c3d06118feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_3cb7d2ba-0f10-44ca-bc44-6b2cb8e062eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_3cb7d2ba-0f10-44ca-bc44-6b2cb8e062eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_ddc7090b-a6d7-43f4-91ba-1e72bb74e979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_ddc7090b-a6d7-43f4-91ba-1e72bb74e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_dad4cb77-b7fb-4168-afcf-a5eb9d2580f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_dad4cb77-b7fb-4168-afcf-a5eb9d2580f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_85d06f7d-be21-4567-974d-b4bd646fa3f8" xlink:href="mck-20220331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b502491d-fdb3-469a-a810-6000a056dcfe" xlink:to="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_85d06f7d-be21-4567-974d-b4bd646fa3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract_6e7286cd-0c3a-4c74-987d-ae9eeb3b50e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross_3465103d-d048-4c1f-9f7a-06ab746fe0cc" xlink:href="mck-20220331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_6e7286cd-0c3a-4c74-987d-ae9eeb3b50e2" xlink:to="loc_mck_AccountsReceivableCustomerAccountsGross_3465103d-d048-4c1f-9f7a-06ab746fe0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_fff56bba-f4e7-4b2d-86d6-af48c6680cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_6e7286cd-0c3a-4c74-987d-ae9eeb3b50e2" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_fff56bba-f4e7-4b2d-86d6-af48c6680cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_fb3cc4c7-c77d-4c6a-93ec-8093703c7bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_6e7286cd-0c3a-4c74-987d-ae9eeb3b50e2" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_fb3cc4c7-c77d-4c6a-93ec-8093703c7bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8e2be57d-c4d8-4c02-b2d9-84027d5ae119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_6e7286cd-0c3a-4c74-987d-ae9eeb3b50e2" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8e2be57d-c4d8-4c02-b2d9-84027d5ae119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4725bc56-d02f-479a-bb9c-a42ffba7a3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_6e7286cd-0c3a-4c74-987d-ae9eeb3b50e2" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4725bc56-d02f-479a-bb9c-a42ffba7a3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_d6c8a39e-61cc-4074-b20b-8ca6f6550e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_Land_d6c8a39e-61cc-4074-b20b-8ca6f6550e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_40b4ba80-5920-4bd8-a6c7-9964ae2bc448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_40b4ba80-5920-4bd8-a6c7-9964ae2bc448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther_eff7d13a-a1f1-4739-9a13-0c4dbf0f7fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOther_eff7d13a-a1f1-4739-9a13-0c4dbf0f7fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_49a796e9-fcde-4db7-b466-2caf68d8d520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_ConstructionInProgressGross_49a796e9-fcde-4db7-b466-2caf68d8d520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_99116791-5874-4088-ae9f-85414b5bd600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_99116791-5874-4088-ae9f-85414b5bd600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4cccd888-0019-4c5f-be75-3510a8a6cf65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4cccd888-0019-4c5f-be75-3510a8a6cf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41b6e6d3-7645-498b-af5c-ac04c346e4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_00726818-eda2-461c-9576-de986ab8fdc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_41b6e6d3-7645-498b-af5c-ac04c346e4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0b564592-85e9-443e-83b2-d5069937948f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_753f82bd-2b42-4620-a039-e771e945de0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0b564592-85e9-443e-83b2-d5069937948f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_753f82bd-2b42-4620-a039-e771e945de0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleTables" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a0a41be1-417a-49ab-8845-7abf881b0cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_2b7db392-d22e-4c3e-ab62-4b035acecbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a0a41be1-417a-49ab-8845-7abf881b0cc0" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_2b7db392-d22e-4c3e-ab62-4b035acecbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_84c3d54c-b57c-4957-858d-692f13d09f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_84c3d54c-b57c-4957-858d-692f13d09f7d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_08806a56-381d-40a4-b793-c40e2366a70e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_34f3613e-aa7a-4ccd-aa81-a1a574157422" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_GermanWholesaleBusinessMember_34f3613e-aa7a-4ccd-aa81-a1a574157422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_3b9080a3-25f7-420a-a372-957bd4291195" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_3b9080a3-25f7-420a-a372-957bd4291195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_01995e6b-f6e8-4280-8be5-4ed64cc904a0" xlink:href="mck-20220331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_AustrianBusinessOperationsMember_01995e6b-f6e8-4280-8be5-4ed64cc904a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33dfce78-fd09-47ea-bb94-08e55073d3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33dfce78-fd09-47ea-bb94-08e55073d3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_814516a8-b756-4865-8ef7-385305e3e9f1" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_814516a8-b756-4865-8ef7-385305e3e9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_de0bf917-2af0-439a-b398-182bc3fb9941" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a774ac8c-d10c-4442-90f2-09716060c760" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_de0bf917-2af0-439a-b398-182bc3fb9941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07e45acb-5515-4385-9753-1a469a827645" xlink:to="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_47c06e6c-db48-44d5-a0f8-df29bb30b1cf" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_47c06e6c-db48-44d5-a0f8-df29bb30b1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_ff09ad15-503e-4460-824b-ce6ce264e9ae" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_483bd881-4d62-4f84-a04c-15efaf4a963a" xlink:to="loc_mck_InternationalSegmentMember_ff09ad15-503e-4460-824b-ce6ce264e9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6c83e6f2-9aed-492f-a65f-4daa5a0f18dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cb8d9577-4746-498e-a2de-5e6c3fcc0c3a" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6c83e6f2-9aed-492f-a65f-4daa5a0f18dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_541a3ac4-5067-443e-8547-1e39cdc44a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6c83e6f2-9aed-492f-a65f-4daa5a0f18dc" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_541a3ac4-5067-443e-8547-1e39cdc44a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5c63821d-3eae-4879-a7fe-a4a65fb578b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_246b5e4c-a539-4990-8acd-f352bb5b413a" xlink:to="loc_srt_OwnershipDomain_5c63821d-3eae-4879-a7fe-a4a65fb578b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_93453b63-f418-4a6c-8c3f-3697dbd569ca" xlink:href="mck-20220331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_5c63821d-3eae-4879-a7fe-a4a65fb578b5" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_93453b63-f418-4a6c-8c3f-3697dbd569ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8cbc6134-89d9-40e2-abd4-849ded9a319a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_991fd860-3f99-4aa1-bd5e-e7d67ad985d8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8cbc6134-89d9-40e2-abd4-849ded9a319a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_33b50aa3-0b1a-454d-9c94-631da771ed36" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8cbc6134-89d9-40e2-abd4-849ded9a319a" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_33b50aa3-0b1a-454d-9c94-631da771ed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c993d100-5489-4559-b624-c1012d861b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6552bed3-618d-44f0-a5fa-d12118359265" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c993d100-5489-4559-b624-c1012d861b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e6e6a3e-699d-4562-a110-bc57c3b9290e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c993d100-5489-4559-b624-c1012d861b06" xlink:to="loc_us-gaap_SubsequentEventMember_4e6e6a3e-699d-4562-a110-bc57c3b9290e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2005956f-2c56-42ed-9351-e032f7d6cbfc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_254da8df-e564-46c6-a96f-35bea44b5dee" xlink:to="loc_srt_ConsolidationItemsDomain_2005956f-2c56-42ed-9351-e032f7d6cbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_07e56682-e6a8-41ff-b2af-4b73f4d5d20e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2005956f-2c56-42ed-9351-e032f7d6cbfc" xlink:to="loc_us-gaap_OperatingSegmentsMember_07e56682-e6a8-41ff-b2af-4b73f4d5d20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9fc40b36-d526-458f-a653-6a5b76dd81e3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_1f27f2a2-4b06-4814-b06f-824fcd6b73ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_1f27f2a2-4b06-4814-b06f-824fcd6b73ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_08682df6-3dfb-42af-9920-53d5bdb25ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_08682df6-3dfb-42af-9920-53d5bdb25ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_47070e20-ee6b-4b00-8920-40155e196c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_47070e20-ee6b-4b00-8920-40155e196c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_e8af2612-a0cc-4326-89fc-ff3f6a311776" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_e8af2612-a0cc-4326-89fc-ff3f6a311776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_4cf4a129-fe50-45c5-b666-e8952f36bcd9" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_4cf4a129-fe50-45c5-b666-e8952f36bcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_2532a577-ce78-4012-b6f7-bb2e06823e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_2532a577-ce78-4012-b6f7-bb2e06823e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_da98f1f2-eacd-4f0e-8d1e-6fa56fc20dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_da98f1f2-eacd-4f0e-8d1e-6fa56fc20dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4cdf9f1e-88c7-4b4a-83dd-3dc93668f1f1" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_4cdf9f1e-88c7-4b4a-83dd-3dc93668f1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_962bab4a-4c7c-4cb9-845a-cacfe8718971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_AssetsNet_962bab4a-4c7c-4cb9-845a-cacfe8718971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8577ac8b-6b1f-4d18-84c5-51c97054e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8577ac8b-6b1f-4d18-84c5-51c97054e1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7806957e-235a-4d56-98ec-57c24d7b4cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_534cefa6-4d87-4b77-8fbf-9f7bb8cecdaa" xlink:to="loc_us-gaap_EquityMethodInvestments_7806957e-235a-4d56-98ec-57c24d7b4cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_438d2bfe-54be-471f-bfa8-f75ebd7a8a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_438d2bfe-54be-471f-bfa8-f75ebd7a8a69" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5cdd4a4a-c1c2-4cdf-abc3-b273de9c62c1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_28cfe519-442c-4301-a0d9-f0a12efa83af" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_28cfe519-442c-4301-a0d9-f0a12efa83af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_23713249-eb4b-44bf-877e-29818713e644" xlink:href="mck-20220331.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_521a13d5-91df-43fb-ab7f-05f4542cf19e" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_23713249-eb4b-44bf-877e-29818713e644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c4f48b3-bb4a-4802-bc11-e55647282b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_da02dffb-8aca-43e1-9b83-1f4d3d8f4bf5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c4f48b3-bb4a-4802-bc11-e55647282b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_92e19bc6-4fbe-4df5-ba3e-a48431d0c923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3c4f48b3-bb4a-4802-bc11-e55647282b28" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_92e19bc6-4fbe-4df5-ba3e-a48431d0c923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ae8c2482-acdf-47d8-831e-6cdc806c2d6c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d700ec81-e81c-4625-b53d-560705c06bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_d700ec81-e81c-4625-b53d-560705c06bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_5db034ab-ed23-44bd-8700-ec51e35bb791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_5db034ab-ed23-44bd-8700-ec51e35bb791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e05d5cf7-4f25-4035-9ed3-9e3b61cb0e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_e05d5cf7-4f25-4035-9ed3-9e3b61cb0e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_bd59522d-ea41-4049-8b80-b1ec5764d230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_bd59522d-ea41-4049-8b80-b1ec5764d230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_cd58e446-ed19-4681-a49e-801d50bb7989" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_cd58e446-ed19-4681-a49e-801d50bb7989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ec08d8c2-0f77-4618-a9a4-a47dd8215f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ec08d8c2-0f77-4618-a9a4-a47dd8215f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_cef81fff-4043-43e3-b769-3e6101d080bd" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_cef81fff-4043-43e3-b769-3e6101d080bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_7e65855e-acfc-4166-a7ea-6ba08214bb40" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_7e65855e-acfc-4166-a7ea-6ba08214bb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_340eae42-27ca-4ea3-b96f-267ac6a58a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_24c406aa-7bc4-4059-aae5-a9b9229d2779" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_340eae42-27ca-4ea3-b96f-267ac6a58a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_9656cf31-0010-4382-a273-2e61c921b1b4" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_9656cf31-0010-4382-a273-2e61c921b1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_59c71bca-8155-40b7-8bab-54e5336bdbb8" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_59c71bca-8155-40b7-8bab-54e5336bdbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cb111a60-77d6-44a1-accb-2fca8a32868d" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cb111a60-77d6-44a1-accb-2fca8a32868d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_aaee230d-78f2-4092-995c-1c0186862bee" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_aaee230d-78f2-4092-995c-1c0186862bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_751ba868-8cea-42b9-aaec-b3e7c9083162" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_751ba868-8cea-42b9-aaec-b3e7c9083162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1bac4777-c23f-44fe-99df-5f496cf63232" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_1bac4777-c23f-44fe-99df-5f496cf63232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_ec9bea69-6391-4608-905e-1594a40baba0" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_ec9bea69-6391-4608-905e-1594a40baba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_6d03eb34-cc83-4b14-8560-3c7c828b6560" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_6d03eb34-cc83-4b14-8560-3c7c828b6560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_db890a79-2076-4b95-aec6-7c16c4242a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_1afa654f-cbc1-478e-bf3a-95998c26579e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_db890a79-2076-4b95-aec6-7c16c4242a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_bcde2897-5e94-46e2-aeaf-d66eaeb04a01" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_39170cb3-27ea-4813-861a-c5dec90d005e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_bcde2897-5e94-46e2-aeaf-d66eaeb04a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4a540746-b2fa-4eb0-ad5f-355c3d602e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4a540746-b2fa-4eb0-ad5f-355c3d602e10" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c8fa36b-5b8b-4051-84d4-6f962ee85b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_714fb505-d2ba-49f4-93c1-7c6a32f17fbc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c8fa36b-5b8b-4051-84d4-6f962ee85b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_b42e55a4-f77c-4153-b2b2-48bd9f1e86e9" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c8fa36b-5b8b-4051-84d4-6f962ee85b34" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_b42e55a4-f77c-4153-b2b2-48bd9f1e86e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_198487db-854a-48d7-bff4-a6d85bd100b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4791fdac-e455-44ba-9640-5ee343957808" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_198487db-854a-48d7-bff4-a6d85bd100b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7de60584-b80d-42d3-9d59-629a606628ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_198487db-854a-48d7-bff4-a6d85bd100b3" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7de60584-b80d-42d3-9d59-629a606628ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_09486333-bd35-40d2-b3d3-835a36e2ea8b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_33870225-63e3-4313-9be0-ccefe48ff3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_33870225-63e3-4313-9be0-ccefe48ff3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_577b6f0b-8992-4f1a-be7d-45e5410ed12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_577b6f0b-8992-4f1a-be7d-45e5410ed12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ad5989b1-c250-4781-a2fb-9b9aa383eff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_ad5989b1-c250-4781-a2fb-9b9aa383eff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3cb092b3-d45f-4d43-97a5-b80e06e69634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3cb092b3-d45f-4d43-97a5-b80e06e69634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_b613dc9b-ecea-4394-bcfc-05264b6f1440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_b613dc9b-ecea-4394-bcfc-05264b6f1440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_5bec4576-796b-456c-9b0a-a9c7f2705cc6" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_5bec4576-796b-456c-9b0a-a9c7f2705cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ac341741-8b2d-4788-819a-5b6a1bf37843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ac341741-8b2d-4788-819a-5b6a1bf37843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_6edf17b8-c6eb-4d37-8eda-e5c6d904aa4c" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_6edf17b8-c6eb-4d37-8eda-e5c6d904aa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_8e8a7e49-af3d-4cbc-a325-a4086f8a6896" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_8e8a7e49-af3d-4cbc-a325-a4086f8a6896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_3554b69f-283f-4137-99d5-3a6df33c012b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_bdc652d0-540d-4bc9-9b04-218be1ed98b4" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_3554b69f-283f-4137-99d5-3a6df33c012b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07d7b158-f1e2-40cc-8d69-a6da2b962bdc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_c7d41a06-bb3c-4d22-83c0-fc37b6009dec" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_c7d41a06-bb3c-4d22-83c0-fc37b6009dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_2ff15577-5164-4359-b1ea-a8165492213b" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_2ff15577-5164-4359-b1ea-a8165492213b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_4765b82a-169d-4543-8c29-4e84905c753c" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_4765b82a-169d-4543-8c29-4e84905c753c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_d77b4dd5-c22f-4d09-9431-affd51998f41" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_d77b4dd5-c22f-4d09-9431-affd51998f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_663f6e9f-d215-4725-8678-e3c6f97f6228" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_663f6e9f-d215-4725-8678-e3c6f97f6228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_08a402d1-8fb7-4e1d-8326-36d32617e6c4" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_08a402d1-8fb7-4e1d-8326-36d32617e6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c7b8ac39-2365-404a-839d-2a66253e7dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_dcbb9129-55d9-4b91-8b28-af7140f63e9e" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c7b8ac39-2365-404a-839d-2a66253e7dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ee561367-d84e-4957-89cb-89c2e299cca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_21446010-028b-403a-9ca0-3740b0906042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ee561367-d84e-4957-89cb-89c2e299cca7" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_21446010-028b-403a-9ca0-3740b0906042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_93b705f4-a941-459b-b035-01fc2da52a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ccf55bf8-ef87-46eb-8f5b-81f5596615e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_93b705f4-a941-459b-b035-01fc2da52a42" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ccf55bf8-ef87-46eb-8f5b-81f5596615e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6422bd47-ff9d-458d-88c3-89c353004d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_93b705f4-a941-459b-b035-01fc2da52a42" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6422bd47-ff9d-458d-88c3-89c353004d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b8df2f11-fe74-4f35-b114-bdb5d7711bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b8df2f11-fe74-4f35-b114-bdb5d7711bc7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_92e94549-352a-4f25-9151-daad2f5bc431" xlink:to="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1b441f5b-ddd9-49aa-b083-c884ded016d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:to="loc_srt_MinimumMember_1b441f5b-ddd9-49aa-b083-c884ded016d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ff8c4f82-7bde-4d73-8537-22f0dd4aebb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c35a2eaa-3ca3-445a-b125-d5e88aa1505c" xlink:to="loc_srt_MaximumMember_ff8c4f82-7bde-4d73-8537-22f0dd4aebb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_d29d06b9-bcb6-4e27-a00c-399be0c146d9" xlink:to="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a616ee03-cfb7-4bb5-a286-942d4f0d4831" xlink:href="mck-20220331.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_a616ee03-cfb7-4bb5-a286-942d4f0d4831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_1d29bc69-1111-4457-94c8-b6cd404aaf19" xlink:href="mck-20220331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:to="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_1d29bc69-1111-4457-94c8-b6cd404aaf19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_c8fee056-0ceb-4fda-8cec-dfb8561267d9" xlink:href="mck-20220331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_579c2cc7-910c-48d7-acb4-35a9ed936c71" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_c8fee056-0ceb-4fda-8cec-dfb8561267d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b95f6ea8-fafc-42d0-94c4-1041f69b4799" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9aafc3f1-8a5f-4e0c-997a-aac068f3630e" xlink:to="loc_srt_SegmentGeographicalDomain_b95f6ea8-fafc-42d0-94c4-1041f69b4799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_16f75e15-b515-4bb1-a34e-d785471b3565" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b95f6ea8-fafc-42d0-94c4-1041f69b4799" xlink:to="loc_country_GB_16f75e15-b515-4bb1-a34e-d785471b3565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f301e0e-94a3-4df4-be6e-ba1dd225e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_26c5bb45-f4ef-43a1-b762-c48ab5cbaa50" xlink:to="loc_us-gaap_SegmentDomain_7f301e0e-94a3-4df4-be6e-ba1dd225e2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a525808f-f176-41d6-b264-fa26066e4ee4" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f301e0e-94a3-4df4-be6e-ba1dd225e2d8" xlink:to="loc_mck_InternationalSegmentMember_a525808f-f176-41d6-b264-fa26066e4ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7f0f2ed2-97fe-4616-bc5e-4c15ae8dea8f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_1084e714-0683-440b-a4b4-42ac6e3a5b7b" xlink:href="mck-20220331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_1084e714-0683-440b-a4b4-42ac6e3a5b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_32104a32-6c9f-4a20-a37d-964d180216f1" xlink:href="mck-20220331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:to="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_32104a32-6c9f-4a20-a37d-964d180216f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_37e2f321-2f85-4cba-bc64-457ff95e1c7d" xlink:href="mck-20220331.xsd#mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_16af4ed0-86c9-4650-bbec-4eb8eacc6936" xlink:to="loc_mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember_37e2f321-2f85-4cba-bc64-457ff95e1c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_06d198d9-9b11-48d3-bfce-eb2d6b41e658" xlink:to="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_485679c0-a3fc-4473-a4e1-1daa9354003a" xlink:href="mck-20220331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_485679c0-a3fc-4473-a4e1-1daa9354003a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RexallHealthMember_06d6a8d9-fb7e-4bac-a6b7-49f15076d321" xlink:href="mck-20220331.xsd#mck_RexallHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_1c83a0f3-82b1-409a-b76a-6245a113db76" xlink:to="loc_mck_RexallHealthMember_06d6a8d9-fb7e-4bac-a6b7-49f15076d321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_28bf7601-d3eb-4114-aeb6-a7f965d484e5" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e3ae85d9-f8f7-4c5d-8843-f5a1844f1f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:to="loc_us-gaap_RestructuringCharges_e3ae85d9-f8f7-4c5d-8843-f5a1844f1f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_fe5c5a5c-7340-4c94-91fb-4138383f42f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_35015255-7a6e-43cb-b5a4-954d625cc507" xlink:to="loc_us-gaap_AssetImpairmentCharges_fe5c5a5c-7340-4c94-91fb-4138383f42f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fb11b7db-22be-4e47-886e-577e6b603b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_fb11b7db-22be-4e47-886e-577e6b603b2c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:to="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_106b3c08-e5a6-457c-8091-63ff18077bae" xlink:to="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_72c1b2c0-b193-489c-b8c4-602bd620b472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:to="loc_us-gaap_OperatingSegmentsMember_72c1b2c0-b193-489c-b8c4-602bd620b472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ed5edacc-2778-4c9e-8e44-7fc14a0c2313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7ac435ac-666b-43e2-86ad-c87d3706bed3" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ed5edacc-2778-4c9e-8e44-7fc14a0c2313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb33c3b1-42e4-4e2c-bc07-0e01eccc0d48" xlink:to="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_98cb1806-bd9f-422f-a239-b097ddabee8f" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_USPharmaceuticalSegmentMember_98cb1806-bd9f-422f-a239-b097ddabee8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_b9bb4fef-30b1-4dee-b808-75ed32781ab7" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_b9bb4fef-30b1-4dee-b808-75ed32781ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_477e19e2-9664-4e9b-87bf-5569324bbfbd" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_477e19e2-9664-4e9b-87bf-5569324bbfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e204fd37-4430-4549-a986-ae99ad10d60c" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a2c03ac1-2106-4298-b2d1-7e6cd696f803" xlink:to="loc_mck_InternationalSegmentMember_e204fd37-4430-4549-a986-ae99ad10d60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_58edc13f-eb26-4cdd-ab12-82aa96b68c0a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_58d75cf5-0713-4247-8ffc-19925aacaa18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_SeveranceCosts1_58d75cf5-0713-4247-8ffc-19925aacaa18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_af2f14ce-8a70-47aa-a13c-5aeff63675a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_BusinessExitCosts1_af2f14ce-8a70-47aa-a13c-5aeff63675a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_c7cb1652-b63c-420d-ac7c-1989bfe21f19" xlink:href="mck-20220331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_c7cb1652-b63c-420d-ac7c-1989bfe21f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6b1dde14-f438-45ac-bc0a-a63e88c47a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2f941439-b871-4c5e-8e94-b9d08df0cb89" xlink:to="loc_us-gaap_RestructuringCharges_6b1dde14-f438-45ac-bc0a-a63e88c47a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9f70d12a-81c3-4407-8ef0-008c9883c4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9f70d12a-81c3-4407-8ef0-008c9883c4ef" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_77ce2e5f-47aa-4071-a58c-5e90b9a7fc28" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_91f18054-31ab-42da-98e4-cd49592f2a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_91f18054-31ab-42da-98e4-cd49592f2a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_be405055-eb64-43fd-b534-d3acd9865b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_be405055-eb64-43fd-b534-d3acd9865b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_a9228606-8272-48ba-be1b-074a7eab6214" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_70229a4c-4bb4-495b-8fb8-dd2cc051792b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_a9228606-8272-48ba-be1b-074a7eab6214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d7aff948-0b56-4d8a-a292-3bfaa0100344" xlink:to="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fa09b4ac-9693-4661-b0c0-d61513b6b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:to="loc_us-gaap_OperatingSegmentsMember_fa09b4ac-9693-4661-b0c0-d61513b6b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4dc47f07-3d5e-4dce-a2de-1f9d99e01a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_27e4293c-af9c-4b6b-889d-79518df98b01" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4dc47f07-3d5e-4dce-a2de-1f9d99e01a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1e6d850-013f-42f8-8316-422610016db2" xlink:to="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_40c7878d-793b-4550-b4c6-bed10c643b81" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_USPharmaceuticalSegmentMember_40c7878d-793b-4550-b4c6-bed10c643b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_671c517a-7fb4-4dd6-826f-7e7e7d217d77" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_671c517a-7fb4-4dd6-826f-7e7e7d217d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_4f4b0861-6125-41d6-8954-eb2bf7653c16" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_4f4b0861-6125-41d6-8954-eb2bf7653c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_14914f30-56b3-4a69-a889-80a8109f5085" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0c483a75-c580-49ff-a55f-225d8906fa07" xlink:to="loc_mck_InternationalSegmentMember_14914f30-56b3-4a69-a889-80a8109f5085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8dfee8af-111f-46df-83b8-209805f8050f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7cdbae7c-a2d0-4b88-ae8d-5ce149055f4d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8dfee8af-111f-46df-83b8-209805f8050f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8dfee8af-111f-46df-83b8-209805f8050f" xlink:to="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b99f13b1-1e1e-4e6e-a1bb-f977aaa5fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserve_b99f13b1-1e1e-4e6e-a1bb-f977aaa5fe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_81a8f017-60b2-4295-ab15-72737a1b9b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringCharges_81a8f017-60b2-4295-ab15-72737a1b9b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9e28b1b0-5dd2-4e7f-9529-35b723918ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_9e28b1b0-5dd2-4e7f-9529-35b723918ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_1756bb30-eeab-4980-ba47-f7bcef7eecdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_PaymentsForRestructuring_1756bb30-eeab-4980-ba47-f7bcef7eecdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_80cc7120-059a-4202-bfbe-8b99faaa85f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_80cc7120-059a-4202-bfbe-8b99faaa85f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_312e5b2b-8627-4e8d-b7d0-0919caf63760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2cdd7f0c-465b-43c7-afdb-ca13d52f4bf5" xlink:to="loc_us-gaap_RestructuringReserve_312e5b2b-8627-4e8d-b7d0-0919caf63760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ce99e11d-27fc-4327-8d15-56446aa980c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_5cac089e-d3b9-4f6a-9ccc-02b62ba6b26d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ce99e11d-27fc-4327-8d15-56446aa980c5" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_5cac089e-d3b9-4f6a-9ccc-02b62ba6b26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ef8a1e0b-7920-441f-92c0-86afc9881c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_0a058484-e5a3-4ba2-afd7-e3f660d030e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ef8a1e0b-7920-441f-92c0-86afc9881c55" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_0a058484-e5a3-4ba2-afd7-e3f660d030e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestituresDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cfa36ae8-5518-4f98-b849-034e219d18ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cfa36ae8-5518-4f98-b849-034e219d18ff" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ad6016bb-c166-4956-8312-05ee1db24b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_27b73926-7b26-4712-a63f-5e61d461abe1" xlink:to="loc_us-gaap_RelatedPartyDomain_ad6016bb-c166-4956-8312-05ee1db24b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_69183529-59ca-4439-9574-86102b378272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ad6016bb-c166-4956-8312-05ee1db24b63" xlink:to="loc_us-gaap_CorporateJointVentureMember_69183529-59ca-4439-9574-86102b378272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_32517167-c9d9-44c7-9ad1-5d735c8aba8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_da737d28-bef5-4622-befb-2e28538e2844" xlink:to="loc_dei_EntityDomain_32517167-c9d9-44c7-9ad1-5d735c8aba8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareInc.Member_39a0da0f-bdf4-48ba-8e00-8c1eeba119f1" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_32517167-c9d9-44c7-9ad1-5d735c8aba8a" xlink:to="loc_mck_ChangeHealthcareInc.Member_39a0da0f-bdf4-48ba-8e00-8c1eeba119f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bf2b072e-66f4-423b-a6ef-43a1ce47ca13" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bb59846c-0fa5-4c09-8de4-14dc56a6434d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bf2b072e-66f4-423b-a6ef-43a1ce47ca13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_dc9dc317-e7db-47dc-a9ef-e745c99276c1" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bf2b072e-66f4-423b-a6ef-43a1ce47ca13" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_dc9dc317-e7db-47dc-a9ef-e745c99276c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_c504efad-ef4f-4725-9d2d-0b001490bee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1a15ebd1-b5fd-4f48-a353-47ff9b573f08" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_c504efad-ef4f-4725-9d2d-0b001490bee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_104d3483-746e-4d84-9258-21117dfd1fce" xlink:href="mck-20220331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_c504efad-ef4f-4725-9d2d-0b001490bee0" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_104d3483-746e-4d84-9258-21117dfd1fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9815a133-0b85-424b-bb48-4c5f1046c073" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ebaaeb10-760f-4a5a-80f7-cbbec64ec923" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9815a133-0b85-424b-bb48-4c5f1046c073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7ddb3561-6768-413e-8af6-74a81fa2400e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9815a133-0b85-424b-bb48-4c5f1046c073" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7ddb3561-6768-413e-8af6-74a81fa2400e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_46026753-8e66-4310-87c4-c13719c8f5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b6ff74e2-172d-420a-97f8-ee02bd16b14d" xlink:to="loc_us-gaap_TypeOfAdoptionMember_46026753-8e66-4310-87c4-c13719c8f5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_ea768cb1-cb10-4fe6-a51c-aa11ae52c677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_46026753-8e66-4310-87c4-c13719c8f5b2" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_ea768cb1-cb10-4fe6-a51c-aa11ae52c677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ca9dc91-4834-4ef7-a499-a28e0520d0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c1b2c58-a3cf-4a4f-bbf2-c02abf6b3944" xlink:to="loc_us-gaap_EquityComponentDomain_3ca9dc91-4834-4ef7-a499-a28e0520d0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_491a01ad-c992-42b5-aff0-11b94b6c6ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3ca9dc91-4834-4ef7-a499-a28e0520d0f8" xlink:to="loc_us-gaap_RetainedEarningsMember_491a01ad-c992-42b5-aff0-11b94b6c6ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_0e3ee5aa-e79e-475a-92c9-8077cb1b1bd5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TransitionServicesAgreementsTSAMember_30b0afd2-03db-4770-9ec8-08c144664bb8" xlink:href="mck-20220331.xsd#mck_TransitionServicesAgreementsTSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:to="loc_mck_TransitionServicesAgreementsTSAMember_30b0afd2-03db-4770-9ec8-08c144664bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_2d754e4e-f855-46d6-9cb2-af3612bc2f7c" xlink:href="mck-20220331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d851bb72-b6eb-4528-8f2d-befb13f9bd4f" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_2d754e4e-f855-46d6-9cb2-af3612bc2f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6a01a468-847d-42ed-825a-b003f1b28a47" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e099ea58-7d3d-4bf7-b944-5b1c9b5c7ce8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6a01a468-847d-42ed-825a-b003f1b28a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_5724a6dc-51a7-4c79-bee2-dda4f5b86b7a" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6a01a468-847d-42ed-825a-b003f1b28a47" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_5724a6dc-51a7-4c79-bee2-dda4f5b86b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc40199f-6e21-4f99-973b-b5d73c97f938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e1835613-9d16-444f-ac96-368ecd16b540" xlink:to="loc_us-gaap_SegmentDomain_cc40199f-6e21-4f99-973b-b5d73c97f938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_74ea7f43-1272-4227-96f6-4384d304ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cc40199f-6e21-4f99-973b-b5d73c97f938" xlink:to="loc_us-gaap_AllOtherSegmentsMember_74ea7f43-1272-4227-96f6-4384d304ba04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d89a45f-6bb3-46bd-9932-2285c0060fdc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cf254842-49b4-483e-8a2d-48b3e27428cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cf254842-49b4-483e-8a2d-48b3e27428cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a06f8ebd-70a3-4b1a-8a4b-c3d8ddf52b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_a06f8ebd-70a3-4b1a-8a4b-c3d8ddf52b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_1684d87b-79dc-4b6f-8f08-9317914df303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_1684d87b-79dc-4b6f-8f08-9317914df303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_194f54d4-0732-4cbf-9d59-9c2818282c95" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_ExchangeOfferSharesDistributed_194f54d4-0732-4cbf-9d59-9c2818282c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_99c5d58c-4598-4ffc-b350-fc1ed37abc4b" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_ExchangeOfferSharesExchanged_99c5d58c-4598-4ffc-b350-fc1ed37abc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_bea36605-0997-402d-8d75-656440afcf1c" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_bea36605-0997-402d-8d75-656440afcf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_7209f5e6-d6dd-4006-aa5d-df5cd88ceb50" xlink:href="mck-20220331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_7209f5e6-d6dd-4006-aa5d-df5cd88ceb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1b35b725-0fc5-4850-bb40-822f56757379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1b35b725-0fc5-4850-bb40-822f56757379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_4a5c0397-9ef0-45da-88af-5e81fba7a09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_4a5c0397-9ef0-45da-88af-5e81fba7a09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70a7b8f-e041-43af-8dd9-8e0cf50590d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f70a7b8f-e041-43af-8dd9-8e0cf50590d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3cf5a69e-d593-42c9-b3b3-cf37e925cb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3cf5a69e-d593-42c9-b3b3-cf37e925cb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e0340535-4698-4bda-807b-6d2590043990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e0340535-4698-4bda-807b-6d2590043990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_656bdfde-5fb6-4ba8-85b9-cd633d36325c" xlink:href="mck-20220331.xsd#mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized_656bdfde-5fb6-4ba8-85b9-cd633d36325c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_36aedd53-c5e2-421c-85a3-c0289f3b0a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0fb2553e-fcb8-4b26-a49b-7acd1c3ea5b3" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_36aedd53-c5e2-421c-85a3-c0289f3b0a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c0f20d2f-4db6-4d6b-8255-dd8539805e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c0f20d2f-4db6-4d6b-8255-dd8539805e7f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9d2a08eb-9e72-4caa-a8e8-bd59a43ad2ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fed34ac2-e439-426a-b60a-748a9bfd981b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9d2a08eb-9e72-4caa-a8e8-bd59a43ad2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_1a1e7340-f06c-45ed-bf21-d6283041e175" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9d2a08eb-9e72-4caa-a8e8-bd59a43ad2ec" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_1a1e7340-f06c-45ed-bf21-d6283041e175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6b8175b5-f835-4f4e-8618-e7414c7ab332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4879ec1-ba2d-4d0e-89ba-fe7492fe9bf8" xlink:to="loc_us-gaap_RelatedPartyDomain_6b8175b5-f835-4f4e-8618-e7414c7ab332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_b01f7721-6e0e-4a7c-97b1-69b99f9a5deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_6b8175b5-f835-4f4e-8618-e7414c7ab332" xlink:to="loc_us-gaap_CorporateJointVentureMember_b01f7721-6e0e-4a7c-97b1-69b99f9a5deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb1e591f-cc29-4f3a-abf8-be107a2dc29f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_5f1a6ec0-42b2-46b7-a143-775ed1acec2c" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentFairValueofStockAccepted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentFairValueofStockAccepted_5f1a6ec0-42b2-46b7-a143-775ed1acec2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentCarryingAmount_b380aaa1-628d-4b46-94ea-0d57d8cc1195" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentCarryingAmount_b380aaa1-628d-4b46-94ea-0d57d8cc1195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_66233df9-0bc7-4027-bf7d-ee36f33bc9f0" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability_66233df9-0bc7-4027-bf7d-ee36f33bc9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_f1dc2c4c-661b-4d2e-bd59-a91a5dec94a7" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss_f1dc2c4c-661b-4d2e-bd59-a91a5dec94a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_4d4c04a8-b21d-405a-8804-01578910671a" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentTransactionCostsIncurred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentTransactionCostsIncurred_4d4c04a8-b21d-405a-8804-01578910671a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6c7ddfb8-cf3a-4dac-a2b9-b5f2ccb3e87a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6c7ddfb8-cf3a-4dac-a2b9-b5f2ccb3e87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_6b561019-3eab-444b-966f-cf734717f681" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_6b561019-3eab-444b-966f-cf734717f681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_748b945f-bb38-47c1-8364-f6a6b04f4939" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAcceptedAverageCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6f88e75-0989-4ed6-9874-66a2cdd7f51d" xlink:to="loc_mck_EquityMethodInvestmentStockAcceptedAverageCost_748b945f-bb38-47c1-8364-f6a6b04f4939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae286dcf-8cae-4c4b-8df5-16505468e2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_549060bc-4905-46af-937b-4b5a7b558390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae286dcf-8cae-4c4b-8df5-16505468e2da" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_549060bc-4905-46af-937b-4b5a7b558390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2e890091-5404-4348-9f2a-b798f7841a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_2e890091-5404-4348-9f2a-b798f7841a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_82b25b88-17f3-42b9-b0d3-c061fef4e2c6" xlink:href="mck-20220331.xsd#mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_82b25b88-17f3-42b9-b0d3-c061fef4e2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_caa69c07-04be-42b6-bf11-a4afe0b5c746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_caa69c07-04be-42b6-bf11-a4afe0b5c746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DataRelatedtoRSUActivityTableTextBlock_07516612-8b3b-4062-a4ff-3b0526479354" xlink:href="mck-20220331.xsd#mck_DataRelatedtoRSUActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_mck_DataRelatedtoRSUActivityTableTextBlock_07516612-8b3b-4062-a4ff-3b0526479354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_b619ee0a-0bb6-4304-bcb0-745e8431b711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_b619ee0a-0bb6-4304-bcb0-745e8431b711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f09166c1-d0b1-4ec6-8e8f-97c757872602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f09166c1-d0b1-4ec6-8e8f-97c757872602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_ecf1c39f-f4f9-428d-b23c-f987ea3f35c9" xlink:href="mck-20220331.xsd#mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79fcaed1-c079-4f59-b3f9-905a1f768b09" xlink:to="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_ecf1c39f-f4f9-428d-b23c-f987ea3f35c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_138eaa64-1235-4a38-82f0-4aa0daaecc62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_138eaa64-1235-4a38-82f0-4aa0daaecc62" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ab2d3cb8-a2e2-46fe-a176-b862a698cb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_bfa8f6b1-927b-4c96-9caa-a2cfdb40e4aa" xlink:to="loc_us-gaap_PlanNameDomain_ab2d3cb8-a2e2-46fe-a176-b862a698cb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember_5edf87c7-b609-4670-a210-b045510f7408" xlink:href="mck-20220331.xsd#mck_A2013StockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ab2d3cb8-a2e2-46fe-a176-b862a698cb26" xlink:to="loc_mck_A2013StockPlanMember_5edf87c7-b609-4670-a210-b045510f7408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a4aac6f9-50b8-436e-9c94-dafbbc5a451e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9946d6ba-7f06-4407-96c3-640a7e9d73db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9946d6ba-7f06-4407-96c3-640a7e9d73db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember_b4b548b6-a10c-444d-8b17-0099ba6afb62" xlink:href="mck-20220331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_mck_PerformancebasedStockUnitsMember_b4b548b6-a10c-444d-8b17-0099ba6afb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4f97c219-640b-4575-ae66-90adf0f95b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4f97c219-640b-4575-ae66-90adf0f95b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_56c78247-f256-46f6-9b32-674f19f0e234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8cda280-3976-47cf-adf5-668e8e917294" xlink:to="loc_us-gaap_EmployeeStockMember_56c78247-f256-46f6-9b32-674f19f0e234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e2319d29-ccf8-492d-907f-ad7144a5e821" xlink:to="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_592a5287-0ef9-49b9-8140-f13e33734d7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:to="loc_srt_MinimumMember_592a5287-0ef9-49b9-8140-f13e33734d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4de09b01-4042-408e-86e9-d10466d4f301" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b5265bc-2dcd-4f88-9ecb-de5dc6e790b0" xlink:to="loc_srt_MaximumMember_4de09b01-4042-408e-86e9-d10466d4f301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b675e63-2cfa-40a1-99cd-f475f9683cfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_920dfeea-3a49-45a0-9376-b0a5808ddaee" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b675e63-2cfa-40a1-99cd-f475f9683cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_4b0d3c9f-37f1-4dba-a642-e0074bb50b25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9b675e63-2cfa-40a1-99cd-f475f9683cfe" xlink:to="loc_srt_DirectorMember_4b0d3c9f-37f1-4dba-a642-e0074bb50b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_810ccd36-6637-4608-a70a-6efd9a858a2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_fff41f20-afbb-4335-8130-9f0a9cbd609d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_fff41f20-afbb-4335-8130-9f0a9cbd609d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1f375a79-a089-4165-9b8c-26f1df5fd570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1f375a79-a089-4165-9b8c-26f1df5fd570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3796ed85-8fe5-444b-b929-894886e8092b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3796ed85-8fe5-444b-b929-894886e8092b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ba0d01-134b-4053-84f7-31577f672c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36ba0d01-134b-4053-84f7-31577f672c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_e8f48e06-1fea-49d1-8e18-f05fb06b3afd" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_e8f48e06-1fea-49d1-8e18-f05fb06b3afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_62968d26-7322-4bd2-8119-3b6a94a72b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_62968d26-7322-4bd2-8119-3b6a94a72b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32b741ba-2bfc-44cc-9087-76ceb7b83867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32b741ba-2bfc-44cc-9087-76ceb7b83867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_27e2e04e-107b-4de4-87af-4424add1ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_27e2e04e-107b-4de4-87af-4424add1ce66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_387408b5-3ffe-4402-83e9-a40473f83325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_387408b5-3ffe-4402-83e9-a40473f83325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_cd0ac438-41b5-4607-9360-8d95e891015d" xlink:href="mck-20220331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_cd0ac438-41b5-4607-9360-8d95e891015d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8152db4c-56f2-4f8d-8fa8-2963c940ef76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8152db4c-56f2-4f8d-8fa8-2963c940ef76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_c8498a3e-4de3-4c3f-958a-1814727905a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90618e1c-22f6-4731-9f74-8df71c4e0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_c8498a3e-4de3-4c3f-958a-1814727905a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_43a45f48-cc9c-4d88-8c1b-96b6c5423107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_43a45f48-cc9c-4d88-8c1b-96b6c5423107" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:to="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_89c531be-4209-4aef-8b49-a2c44de66e60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_dff5e538-13a3-44f8-844e-a837625cbaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_dff5e538-13a3-44f8-844e-a837625cbaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_316bf5fe-9131-45ab-9e39-3ff262d052f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:to="loc_us-gaap_StockOptionMember_316bf5fe-9131-45ab-9e39-3ff262d052f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_19e8ee8c-2726-4be6-b58e-11a93dba462f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09292ad0-a207-4b95-a2f5-bf672ceb906d" xlink:to="loc_us-gaap_EmployeeStockMember_19e8ee8c-2726-4be6-b58e-11a93dba462f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ba02cfb-c41a-4394-8a1a-89c350d31cb6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_66911ff8-0f39-4c5c-8979-cc08d5b9d04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_66911ff8-0f39-4c5c-8979-cc08d5b9d04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_bfb3635e-e6bf-41ab-be86-a6ae91f70cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_bfb3635e-e6bf-41ab-be86-a6ae91f70cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_9cfd574d-19f7-47de-b732-ffea6fb4ed1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6ad8c614-a686-42c1-ac8d-36c414c6056b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_9cfd574d-19f7-47de-b732-ffea6fb4ed1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_528d4332-787d-478c-815b-a3671102f32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_528d4332-787d-478c-815b-a3671102f32e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:to="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_885f1afc-5d3c-4a00-b874-ed539b4950ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d3809d7b-d08e-4d00-8234-5b91db7b8f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_885f1afc-5d3c-4a00-b874-ed539b4950ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_1629b035-f498-4e1b-825d-989e64bf5f4b" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_885f1afc-5d3c-4a00-b874-ed539b4950ec" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_1629b035-f498-4e1b-825d-989e64bf5f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d0d90c-40ca-40b6-9152-2b10a8770c76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4b252cde-7451-4d59-a2b4-0a72e61e8661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4b252cde-7451-4d59-a2b4-0a72e61e8661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_847f59fd-c575-4bb0-be37-591fee3675fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_847f59fd-c575-4bb0-be37-591fee3675fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6224913e-979d-4d3c-8e37-d3e2b7f4e0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6224913e-979d-4d3c-8e37-d3e2b7f4e0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b703273a-10af-4da6-9ddb-782289551163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d86885cb-1782-4df2-b4a5-e2e7777b90e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b703273a-10af-4da6-9ddb-782289551163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_769b38a2-7ac3-474b-9026-a2bdad5ab611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_769b38a2-7ac3-474b-9026-a2bdad5ab611" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:to="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc5f9c87-3356-4615-8a28-af6acc50a19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_09b472b3-ca3a-4454-b1ad-9d7229632250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc5f9c87-3356-4615-8a28-af6acc50a19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_14e28b6a-8e6b-4ddb-a63e-2515ba4c80be" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fc5f9c87-3356-4615-8a28-af6acc50a19d" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_14e28b6a-8e6b-4ddb-a63e-2515ba4c80be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_21f809f7-e39b-4f31-8a95-9e965eb71fff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295f96c-93b3-4b88-bf65-dd6537f6a59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295f96c-93b3-4b88-bf65-dd6537f6a59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3b29e54a-d566-4cbb-b442-c247d3263ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3b29e54a-d566-4cbb-b442-c247d3263ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_5cf8f4b8-f90b-43bf-802c-62ea652dad81" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_5cf8f4b8-f90b-43bf-802c-62ea652dad81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c677c35b-0385-4527-b2ab-adf12a92adfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c677c35b-0385-4527-b2ab-adf12a92adfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3a428c55-e649-4286-90b8-9385e3a643e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_869adfc8-97ff-451d-af8e-cab6b056f4ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3a428c55-e649-4286-90b8-9385e3a643e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3bfc5704-e035-4374-bc53-2edbe770875f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1e688e9a-3f26-4ddc-b84f-263b1182a309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1e688e9a-3f26-4ddc-b84f-263b1182a309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e252020-45c4-43d6-bf66-bf8c0df2be3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e252020-45c4-43d6-bf66-bf8c0df2be3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_446fce5b-7ff3-48a7-8984-b7391694670c" xlink:href="mck-20220331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_446fce5b-7ff3-48a7-8984-b7391694670c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bfcaf8c7-6088-4fdb-a9f9-b3687c20bf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bfcaf8c7-6088-4fdb-a9f9-b3687c20bf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d90cb223-1cb2-49bc-a56d-f82b85e7dad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1ae9fd3e-3e33-4a62-bd2a-61be40b68d26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d90cb223-1cb2-49bc-a56d-f82b85e7dad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4f9ee97a-2cb2-404d-a37a-42fa8ceec7db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4f9ee97a-2cb2-404d-a37a-42fa8ceec7db" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:to="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_411d92d5-8910-4fc4-8e41-05a4ebd3d564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_06d475d8-f806-4cb6-a003-7aaf7da19c0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_411d92d5-8910-4fc4-8e41-05a4ebd3d564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9903521b-d247-4fec-8736-0f909efbe594" xlink:href="mck-20220331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_411d92d5-8910-4fc4-8e41-05a4ebd3d564" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_9903521b-d247-4fec-8736-0f909efbe594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8967b3b5-ab59-4bc3-a083-8ffaecb65506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5a17b263-0955-46f9-8026-70dd01ce4663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_5a17b263-0955-46f9-8026-70dd01ce4663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d19a983b-02fd-4fb9-a4ce-c4238e47051f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d19a983b-02fd-4fb9-a4ce-c4238e47051f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_efa93eb8-493f-45cd-84db-323922f604a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6fa373c-9a5a-41c2-97a5-bf4ebea8d1b0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_efa93eb8-493f-45cd-84db-323922f604a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9f2dee0-d52f-4a9b-b94b-3ac52cb767b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9f2dee0-d52f-4a9b-b94b-3ac52cb767b4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:to="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_540a2086-d746-4f49-9c88-74fd97003455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3a4f332a-5c2b-47a5-a12e-134c9e4b2f8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_540a2086-d746-4f49-9c88-74fd97003455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e95950b2-6c2a-4052-85bb-0e9490c885bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_540a2086-d746-4f49-9c88-74fd97003455" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e95950b2-6c2a-4052-85bb-0e9490c885bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72ab4ed3-5fc9-4313-bf7c-1aabe80ee654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_51591c05-d79c-43fb-89b8-a2ca28c9502f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_51591c05-d79c-43fb-89b8-a2ca28c9502f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_abbbce1a-71f6-45f8-bdd0-392ac47ecf89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_abbbce1a-71f6-45f8-bdd0-392ac47ecf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f46cb91f-9540-4360-ad60-203bb9747cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f46cb91f-9540-4360-ad60-203bb9747cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d4f7149b-b306-480a-b872-267e42643a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f10bd5a3-3377-40fa-be46-913e8080ae57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d4f7149b-b306-480a-b872-267e42643a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationSummaryofOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ca5743d-e10c-4ead-a622-1a33f1b37199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ca5743d-e10c-4ead-a622-1a33f1b37199" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ca878f68-6c45-4219-81e2-4f8132e28c03" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeOneMember_06c468e9-609b-4b2e-a3b2-437df1992bec" xlink:href="mck-20220331.xsd#mck_RangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:to="loc_mck_RangeOneMember_06c468e9-609b-4b2e-a3b2-437df1992bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RangeTwoMember_686b4962-733e-46e4-a587-41a0594c43a0" xlink:href="mck-20220331.xsd#mck_RangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_fb803bc5-ac43-44f7-adc2-f3d0e81f57b9" xlink:to="loc_mck_RangeTwoMember_686b4962-733e-46e4-a587-41a0594c43a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_2e4939c8-f85f-4ee6-bbe3-1ec5d7378cd4" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_46e8e4ce-cd96-4c11-849c-159fdbee2ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_46e8e4ce-cd96-4c11-849c-159fdbee2ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_63c14f50-bad2-4269-b127-282fa05f53ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_63c14f50-bad2-4269-b127-282fa05f53ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_edb883ee-a64a-4a4b-8cb5-86fb7b4aeb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_edb883ee-a64a-4a4b-8cb5-86fb7b4aeb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_be11e6cf-712c-43fd-91e7-391efbb15a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_be11e6cf-712c-43fd-91e7-391efbb15a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_e4bcf881-cd83-4f04-b8ca-894f1c5c6223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_e4bcf881-cd83-4f04-b8ca-894f1c5c6223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d4eaced9-46c3-4d7e-9cfa-fdc3bdbf072c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d4eaced9-46c3-4d7e-9cfa-fdc3bdbf072c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a599f808-d2f4-48a1-913f-e1f2502ecc90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_5f4bc464-e0f4-4f45-8e56-38928a1a89c3" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a599f808-d2f4-48a1-913f-e1f2502ecc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1a140aa-702d-4f51-b878-06e36f1e28a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1a140aa-702d-4f51-b878-06e36f1e28a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54e87eef-8677-42df-b4b7-dcfd5b17e327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54e87eef-8677-42df-b4b7-dcfd5b17e327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ece091d0-c0b1-4a99-9c3c-a25de9b5dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ece091d0-c0b1-4a99-9c3c-a25de9b5dcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_22ade0ba-1569-43f2-a191-7a8e59c8ee4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_22ade0ba-1569-43f2-a191-7a8e59c8ee4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_28a662ad-1486-45cf-b889-d3592e2a86c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_28a662ad-1486-45cf-b889-d3592e2a86c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f41cabf-eb89-46a5-9866-907b3468a8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0a785c8f-0eaf-42a1-91c1-23d422a8781c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f41cabf-eb89-46a5-9866-907b3468a8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1a140aa-702d-4f51-b878-06e36f1e28a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d6c16fa8-0d2d-42ad-a442-b6d4d93ac74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d6c16fa8-0d2d-42ad-a442-b6d4d93ac74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dedd0fa2-32a5-49a2-95b7-5c26429bf7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dedd0fa2-32a5-49a2-95b7-5c26429bf7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1daeacfe-8026-4a07-9a4b-726761ce5092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1daeacfe-8026-4a07-9a4b-726761ce5092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_da71b99c-5938-43ce-b704-c757418f5b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_da71b99c-5938-43ce-b704-c757418f5b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_953d10e2-80be-4f1c-a1c9-d266c30936ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_07dae31e-6800-405d-ba79-d96d639594d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_953d10e2-80be-4f1c-a1c9-d266c30936ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b196c666-df56-4458-8a37-26fdc6383143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1a140aa-702d-4f51-b878-06e36f1e28a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b196c666-df56-4458-8a37-26fdc6383143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5f25a142-55f4-4bf3-977e-08739e3e0e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b196c666-df56-4458-8a37-26fdc6383143" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5f25a142-55f4-4bf3-977e-08739e3e0e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f8b1327c-7cdb-45c8-8e12-0109c47410fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_b196c666-df56-4458-8a37-26fdc6383143" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f8b1327c-7cdb-45c8-8e12-0109c47410fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c1a140aa-702d-4f51-b878-06e36f1e28a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_89a9458b-ae36-4bea-9f24-0a06bfbf7e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_89a9458b-ae36-4bea-9f24-0a06bfbf7e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_72f3b20a-cba6-4b30-8ca4-e23278674ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_72f3b20a-cba6-4b30-8ca4-e23278674ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_08ef781a-9f85-4516-b6a4-3ab6edb983f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_08ef781a-9f85-4516-b6a4-3ab6edb983f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_760124fd-a1db-4449-ae55-a59d54ebf4be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_760124fd-a1db-4449-ae55-a59d54ebf4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9dc696aa-ffae-4274-a62a-d03957ffd3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9dc696aa-ffae-4274-a62a-d03957ffd3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b034bb7a-b78f-4e98-9ec3-d4aa9491b05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b034bb7a-b78f-4e98-9ec3-d4aa9491b05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0f8cecf9-4983-4175-a857-e2208fe85b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0f8cecf9-4983-4175-a857-e2208fe85b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_23a2e571-3925-4d77-9246-85005eb35611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_00fca237-e3d3-4bf1-bd4d-3f25b59f7bd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_23a2e571-3925-4d77-9246-85005eb35611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72286699-d5ae-44c6-83d6-2aca28a8bcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72286699-d5ae-44c6-83d6-2aca28a8bcb7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:to="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23d645bf-9692-455e-9e86-113cc0a7ad56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fdc4fafe-9e45-47bb-9280-0186d4e837fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23d645bf-9692-455e-9e86-113cc0a7ad56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a49d634d-8b06-4628-a917-fea197cf324e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23d645bf-9692-455e-9e86-113cc0a7ad56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a49d634d-8b06-4628-a917-fea197cf324e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c5cdd3a-f618-496d-a587-4ca970343701" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9e145c18-b3ab-4206-8c30-dec180fce766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9e145c18-b3ab-4206-8c30-dec180fce766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_45fe8470-7113-4ad3-953e-f6e0b9e0f3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_45fe8470-7113-4ad3-953e-f6e0b9e0f3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_158fd540-1a76-43cf-a684-6dbed0364784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_158fd540-1a76-43cf-a684-6dbed0364784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d030d1b8-e5bc-4ecb-99ca-8706b19f0c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d030d1b8-e5bc-4ecb-99ca-8706b19f0c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6423d237-21d3-4714-a77a-fd1b020eaffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_6423d237-21d3-4714-a77a-fd1b020eaffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2d2d2f9e-33e1-42f7-b81d-f06c615cb62c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2d2d2f9e-33e1-42f7-b81d-f06c615cb62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_04e470b7-68db-4837-b89c-c24a2286838c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8c6d676-45df-4aac-a6c9-f04a734b1ae5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_04e470b7-68db-4837-b89c-c24a2286838c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNet" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0554f6ed-16dd-43cd-a025-df0c52539dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_5db23e19-71ed-4db2-880a-47fb5153b00a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0554f6ed-16dd-43cd-a025-df0c52539dcf" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_5db23e19-71ed-4db2-880a-47fb5153b00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fa7d16e0-5e14-4b2b-8755-ddfbd147e11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_f9f95d39-68ce-47e2-b7ca-51a6baeefa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_fa7d16e0-5e14-4b2b-8755-ddfbd147e11c" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_f9f95d39-68ce-47e2-b7ca-51a6baeefa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNetScheduleofOtherIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0a7008c9-4843-482c-be08-8f222bd8b702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0a7008c9-4843-482c-be08-8f222bd8b702" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e6e11687-da31-41d5-847f-67728c700c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5b1e3a0f-21a2-4d15-9d6f-6ee1134bbecc" xlink:to="loc_us-gaap_RelatedPartyDomain_e6e11687-da31-41d5-847f-67728c700c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_4e239ec6-fb96-4b18-a706-de1816ed98be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e6e11687-da31-41d5-847f-67728c700c64" xlink:to="loc_srt_ExecutiveOfficerMember_4e239ec6-fb96-4b18-a706-de1816ed98be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_f2daa907-3058-4e7f-bb5b-ba1ef5bd1860" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_a2b8b214-1ab9-4664-a1fa-8ed92c06112e" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_a2b8b214-1ab9-4664-a1fa-8ed92c06112e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_c5a9052e-3063-47a3-a76f-7ed10e960b4b" xlink:href="mck-20220331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8a467bb0-029a-4c3f-8064-4e549833976a" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_c5a9052e-3063-47a3-a76f-7ed10e960b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1537ff86-5193-4f5f-b54c-1f3fec101bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_817bef10-1bb7-43c4-a104-62e100ec1a72" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1537ff86-5193-4f5f-b54c-1f3fec101bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_33cc2def-71ba-42b1-ad09-1b845d3d0b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1537ff86-5193-4f5f-b54c-1f3fec101bd5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_33cc2def-71ba-42b1-ad09-1b845d3d0b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3ab3242c-5cd4-4e51-aec8-809ce395e14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_761be32e-3226-4622-9fca-944a6e345576" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3ab3242c-5cd4-4e51-aec8-809ce395e14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_93c0d05b-869d-40ca-9669-c19ddd383b79" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3ab3242c-5cd4-4e51-aec8-809ce395e14d" xlink:to="loc_mck_GermanWholesaleBusinessMember_93c0d05b-869d-40ca-9669-c19ddd383b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c8db11f8-0367-4a17-824a-c023e16dae22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_f6af134f-bf6a-4292-b535-a017db1cb393" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c8db11f8-0367-4a17-824a-c023e16dae22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_95086ff5-10e4-46e8-8d3b-7f166bf1d805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c8db11f8-0367-4a17-824a-c023e16dae22" xlink:to="loc_us-gaap_DomesticPlanMember_95086ff5-10e4-46e8-8d3b-7f166bf1d805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d12a417f-d6d1-4577-b5f1-1ee0d23bc21a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_95086ff5-10e4-46e8-8d3b-7f166bf1d805" xlink:to="loc_country_US_d12a417f-d6d1-4577-b5f1-1ee0d23bc21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6ad61479-5640-4634-ab42-0a9a4b888f6d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e5e44d4e-6c3e-42d4-b6f3-42a3cc7bed9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e5e44d4e-6c3e-42d4-b6f3-42a3cc7bed9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9c8da58d-2989-4e7b-9261-eaaed4bac7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9c8da58d-2989-4e7b-9261-eaaed4bac7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_d6ea82d7-c2a1-411e-87b4-4b802feddeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_d6ea82d7-c2a1-411e-87b4-4b802feddeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_7ed2bd4c-a6d3-455b-b03e-abf5fe09ce2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_7ed2bd4c-a6d3-455b-b03e-abf5fe09ce2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_221d3fda-1680-41a3-8496-42bf4f965928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_221d3fda-1680-41a3-8496-42bf4f965928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0429d882-eb19-49d1-9a1a-86ba8072a3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0429d882-eb19-49d1-9a1a-86ba8072a3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0ce04b17-b21d-46cf-b216-e0069e17c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c23a5c8c-70fe-4da6-8316-f9af845c638d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0ce04b17-b21d-46cf-b216-e0069e17c5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#OtherIncomeNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_27be181c-e875-4bf7-8d08-1c1600777b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_27be181c-e875-4bf7-8d08-1c1600777b45" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_972e3c71-42cb-4eb1-a014-46d274364e66" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_1e74083d-d502-4eec-9504-0f9037ba37eb" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanMember_1e74083d-d502-4eec-9504-0f9037ba37eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlementofExecutiveRetirementBenefitsMember_319b8c8f-44cf-41d0-8fbc-3dccccd95474" xlink:href="mck-20220331.xsd#mck_SettlementofExecutiveRetirementBenefitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_d2b293b5-fc2c-4f90-9d20-4eef5219db98" xlink:to="loc_mck_SettlementofExecutiveRetirementBenefitsMember_319b8c8f-44cf-41d0-8fbc-3dccccd95474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4acdcc5f-40c8-46b0-ae4a-c6fa93b99ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9bad9a8f-14f5-48b6-b8b0-b93709a93a72" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4acdcc5f-40c8-46b0-ae4a-c6fa93b99ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_4c815763-08c1-472d-a584-89a04edf6ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4acdcc5f-40c8-46b0-ae4a-c6fa93b99ac7" xlink:to="loc_us-gaap_DomesticPlanMember_4c815763-08c1-472d-a584-89a04edf6ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7cb82994-143a-4f9e-8405-5af1f364ca20" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_4c815763-08c1-472d-a584-89a04edf6ec8" xlink:to="loc_country_US_7cb82994-143a-4f9e-8405-5af1f364ca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_72d5cb5a-71ca-4e08-941e-5a2de0275ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_06f833fc-a673-4713-9b8d-d6e535cb262e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_72d5cb5a-71ca-4e08-941e-5a2de0275ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8fb553df-94f0-4ef4-b998-6681fd21cf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_72d5cb5a-71ca-4e08-941e-5a2de0275ed4" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8fb553df-94f0-4ef4-b998-6681fd21cf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_50e91ba5-264d-453b-8f85-eeafaa52397c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1fe39f26-65ae-43f7-aaa4-fec812c455b6" xlink:to="loc_us-gaap_RelatedPartyDomain_50e91ba5-264d-453b-8f85-eeafaa52397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_f7239267-6ced-4bfd-bedc-73d244967dff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_50e91ba5-264d-453b-8f85-eeafaa52397c" xlink:to="loc_srt_ExecutiveOfficerMember_f7239267-6ced-4bfd-bedc-73d244967dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ced7b0b-3af5-4ee2-bfb6-38f886cac4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3e7f7089-e048-464b-b865-4e8884e907e0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ced7b0b-3af5-4ee2-bfb6-38f886cac4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_9755168c-b8b9-4ef3-8cf8-ab2c624ae9f7" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7ced7b0b-3af5-4ee2-bfb6-38f886cac4e9" xlink:to="loc_mck_GermanWholesaleBusinessMember_9755168c-b8b9-4ef3-8cf8-ab2c624ae9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2670ca6d-e591-4bac-91f9-6a8b0bb94c8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_487957fd-1e41-453e-a207-01593c4a888e" xlink:to="loc_srt_OwnershipDomain_2670ca6d-e591-4bac-91f9-6a8b0bb94c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_26cd8225-b794-4d50-97ea-67c2d67bef5e" xlink:href="mck-20220331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_2670ca6d-e591-4bac-91f9-6a8b0bb94c8d" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_26cd8225-b794-4d50-97ea-67c2d67bef5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_60d825af-7154-41a8-80a0-591efe22da2b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_15ba2abb-13ca-416c-bd55-20d5e77d1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_15ba2abb-13ca-416c-bd55-20d5e77d1dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0a3a525e-1ebd-49a1-9ebb-cd09554316a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_0a3a525e-1ebd-49a1-9ebb-cd09554316a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_418c42d0-6aab-42f1-8f7c-c9c3a3feac89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a0a2290-38af-4be7-8cc3-dfb6d4c3f56f" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_418c42d0-6aab-42f1-8f7c-c9c3a3feac89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6c966afe-4ef9-460c-bc86-6a03d0b10153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_37b12a1e-8027-4da1-a029-e0c117739e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c966afe-4ef9-460c-bc86-6a03d0b10153" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_37b12a1e-8027-4da1-a029-e0c117739e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_77d9bd3a-5cda-40aa-83b7-6e95c7849683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8ee305ff-2813-43ae-925f-4cfa3c6d80b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77d9bd3a-5cda-40aa-83b7-6e95c7849683" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8ee305ff-2813-43ae-925f-4cfa3c6d80b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c70ab2e2-5619-457c-9b51-05d690fa9c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77d9bd3a-5cda-40aa-83b7-6e95c7849683" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_c70ab2e2-5619-457c-9b51-05d690fa9c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_eb809fba-ffaf-4006-8076-7fea1fbd940e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77d9bd3a-5cda-40aa-83b7-6e95c7849683" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_eb809fba-ffaf-4006-8076-7fea1fbd940e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_fc6e1b15-dd9c-403b-944e-5f0fa97059e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77d9bd3a-5cda-40aa-83b7-6e95c7849683" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_fc6e1b15-dd9c-403b-944e-5f0fa97059e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_ab7faadb-7bb4-456f-ad84-c4d7bdfae514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77d9bd3a-5cda-40aa-83b7-6e95c7849683" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_ab7faadb-7bb4-456f-ad84-c4d7bdfae514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2798bc99-ab2a-4b4d-af6a-123486aabb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_cc4db6c6-a8a8-404a-bcba-01ab8716322f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2798bc99-ab2a-4b4d-af6a-123486aabb6b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_cc4db6c6-a8a8-404a-bcba-01ab8716322f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1c87badd-1641-41dc-840f-2ef1452f4a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_cc4db6c6-a8a8-404a-bcba-01ab8716322f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1c87badd-1641-41dc-840f-2ef1452f4a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_377163e6-1aee-4220-b7b2-1c356cd683ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_cc4db6c6-a8a8-404a-bcba-01ab8716322f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_377163e6-1aee-4220-b7b2-1c356cd683ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e98a3902-c467-4e23-afca-97c324c16ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_cc4db6c6-a8a8-404a-bcba-01ab8716322f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e98a3902-c467-4e23-afca-97c324c16ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c75dd824-a2cb-4093-83eb-70a4c144489b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac7d6016-388a-48af-bf07-e95d10a4e7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c75dd824-a2cb-4093-83eb-70a4c144489b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac7d6016-388a-48af-bf07-e95d10a4e7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_6ed767ea-2231-4b7f-8398-5938f3c6b12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac7d6016-388a-48af-bf07-e95d10a4e7d7" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_6ed767ea-2231-4b7f-8398-5938f3c6b12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7a8d0dca-9faa-4a7c-a216-28a334247897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac7d6016-388a-48af-bf07-e95d10a4e7d7" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7a8d0dca-9faa-4a7c-a216-28a334247897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4f586ed5-b7d5-4087-9402-9f6999b96c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac7d6016-388a-48af-bf07-e95d10a4e7d7" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4f586ed5-b7d5-4087-9402-9f6999b96c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e1b64ac0-e06a-40fa-9ede-bc2146096c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac7d6016-388a-48af-bf07-e95d10a4e7d7" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e1b64ac0-e06a-40fa-9ede-bc2146096c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ca73111e-996a-47ad-b03c-d94474219f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c75dd824-a2cb-4093-83eb-70a4c144489b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ca73111e-996a-47ad-b03c-d94474219f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1c3564eb-785c-41b0-ade6-23fd8f416131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ca73111e-996a-47ad-b03c-d94474219f9d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1c3564eb-785c-41b0-ade6-23fd8f416131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e12ebca7-0003-472e-a453-1cc37c3f03e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ca73111e-996a-47ad-b03c-d94474219f9d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e12ebca7-0003-472e-a453-1cc37c3f03e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b270bf3d-2127-4b40-82f5-e26449e280fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ca73111e-996a-47ad-b03c-d94474219f9d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b270bf3d-2127-4b40-82f5-e26449e280fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1ec8975f-a57c-44fb-a9e5-b83da0c817e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ca73111e-996a-47ad-b03c-d94474219f9d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1ec8975f-a57c-44fb-a9e5-b83da0c817e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c404efa7-966b-4eb0-8721-51e58f5f26ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c75dd824-a2cb-4093-83eb-70a4c144489b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c404efa7-966b-4eb0-8721-51e58f5f26ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3f4f3b1c-0a69-476d-b035-8c808a2a00f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3f4f3b1c-0a69-476d-b035-8c808a2a00f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_83fbe8b1-698c-4b69-8f4b-5bbaee9e16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_83fbe8b1-698c-4b69-8f4b-5bbaee9e16a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3ca1d02e-d93e-40d4-bf50-71d4149ed7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3ca1d02e-d93e-40d4-bf50-71d4149ed7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_459ccb8f-8996-473b-82af-aaf9545424e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_459ccb8f-8996-473b-82af-aaf9545424e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_e8425cf3-a2b0-43c9-9cb0-13d9ede84e6f" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_e8425cf3-a2b0-43c9-9cb0-13d9ede84e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_c91a3afc-7acf-446b-b0e2-e49d2ef63417" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_c91a3afc-7acf-446b-b0e2-e49d2ef63417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_9e696eee-50bf-4848-93bd-dc0f5d446c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_9e696eee-50bf-4848-93bd-dc0f5d446c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_a58987ee-f73f-4632-804c-c6dca540504c" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_a58987ee-f73f-4632-804c-c6dca540504c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_96630ca6-acbd-411c-a177-e684602c52fc" xlink:href="mck-20220331.xsd#mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback_96630ca6-acbd-411c-a177-e684602c52fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_c753aef7-ee0d-4ccf-938d-041d0ac84bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_c753aef7-ee0d-4ccf-938d-041d0ac84bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7ad3734a-01bb-43b3-9ec9-8d8e89558642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7ad3734a-01bb-43b3-9ec9-8d8e89558642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0ac3f719-e9bd-4a9c-ab62-878399b40193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0ac3f719-e9bd-4a9c-ab62-878399b40193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a38a2fb2-6fe4-4d01-8edb-4ac5233159b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af02e55f-eea6-445e-a424-51ce35646247" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a38a2fb2-6fe4-4d01-8edb-4ac5233159b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9becc71c-ae03-4c90-9472-e0575955d47e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9becc71c-ae03-4c90-9472-e0575955d47e" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f5fab197-47d3-4b80-ad2f-55d93b1cfc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fda24bb9-7542-4f5f-bce7-70ffd67496b4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f5fab197-47d3-4b80-ad2f-55d93b1cfc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_02170bde-2db2-4876-88f4-2ab061e798bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f5fab197-47d3-4b80-ad2f-55d93b1cfc8f" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_02170bde-2db2-4876-88f4-2ab061e798bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d5f54f5-f641-437a-8521-62ddc42c8793" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_61d4bc6b-e352-4b9e-abd0-eec87b082c14" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_61d4bc6b-e352-4b9e-abd0-eec87b082c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_f54e8056-7edb-4740-8e83-8c438f748935" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1cea6385-335e-4d21-b6c7-75036e8e6872" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_f54e8056-7edb-4740-8e83-8c438f748935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_52b46d26-b730-445d-9209-72e0f87c4a15" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f4355d20-47ca-4f04-a1c4-65893478163e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f4355d20-47ca-4f04-a1c4-65893478163e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_7b5b7ff5-76f1-475a-8b95-70de67edb80a" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_7b5b7ff5-76f1-475a-8b95-70de67edb80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_d29c7f12-3f31-4f5d-8d96-3fd4ef5e2fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_d29c7f12-3f31-4f5d-8d96-3fd4ef5e2fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_27511d4e-8677-471f-8fdc-1328b78bfa6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_27511d4e-8677-471f-8fdc-1328b78bfa6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_4f2f6bc7-798d-4a6a-a417-3d1cd33a6c06" xlink:href="mck-20220331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_4f2f6bc7-798d-4a6a-a417-3d1cd33a6c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_26900cce-5b99-4376-ba14-f251574d5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_26900cce-5b99-4376-ba14-f251574d5e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_23062d0c-d998-48f0-a2f5-759176a8f535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_23062d0c-d998-48f0-a2f5-759176a8f535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_222ae965-d11a-445f-8fcb-d2f765c54975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_222ae965-d11a-445f-8fcb-d2f765c54975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_76d7daab-c5eb-4eae-bbfa-b428eddefd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_946df948-7d3a-4b15-8aa5-29db888ef613" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_76d7daab-c5eb-4eae-bbfa-b428eddefd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_f7d3d5c4-d8c2-4bc9-b763-e1876dc8f248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_f7d3d5c4-d8c2-4bc9-b763-e1876dc8f248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6b42616b-e17e-4a46-9b56-fea61a360970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6b42616b-e17e-4a46-9b56-fea61a360970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2a2601ee-b1c9-4168-ba75-f4e3226c5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2a2601ee-b1c9-4168-ba75-f4e3226c5ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_b6f3e188-848a-4053-bda4-6e4e9be3a853" xlink:href="mck-20220331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_b6f3e188-848a-4053-bda4-6e4e9be3a853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_928b8ecd-34d5-48b3-89d3-93819cbcac54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_928b8ecd-34d5-48b3-89d3-93819cbcac54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_eac9856d-bbf4-4e9b-be27-fe8f4a41f56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5dc0f0cc-da7e-40a5-bac6-d4617647da5b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_eac9856d-bbf4-4e9b-be27-fe8f4a41f56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_9de49c07-7294-42fa-8b61-36f1a50f5ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_DeferredTaxLiabilities_9de49c07-7294-42fa-8b61-36f1a50f5ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_852d77ca-054c-4885-98a1-85cddae963f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_852d77ca-054c-4885-98a1-85cddae963f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c7e1538-836d-4b9c-accd-6f77bb35a285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_7a49f6f2-73b1-4d69-b611-d9a88d1f48a0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2c7e1538-836d-4b9c-accd-6f77bb35a285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d2770dad-3875-47bb-b926-b003c0de2ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2770dad-3875-47bb-b926-b003c0de2ce8" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_cb737be3-4342-442c-b82a-406ac05267f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_cb737be3-4342-442c-b82a-406ac05267f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_92a0ca2a-f7f9-488f-92bb-a02185310a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_92a0ca2a-f7f9-488f-92bb-a02185310a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_577713c1-3fe5-48e3-8ee0-e4bd57136cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_577713c1-3fe5-48e3-8ee0-e4bd57136cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_49c5160c-dbcf-44b3-9a79-b7baeab2b15f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_49c5160c-dbcf-44b3-9a79-b7baeab2b15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_f0eec638-3969-4a88-90f4-47c0d40ef54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_f0eec638-3969-4a88-90f4-47c0d40ef54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_95f97fd8-9cf9-4b07-9cd9-66ddfb63310f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_95f97fd8-9cf9-4b07-9cd9-66ddfb63310f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_d6dcda50-fed6-4d8b-9d42-12df15bceee7" xlink:href="mck-20220331.xsd#mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_d6dcda50-fed6-4d8b-9d42-12df15bceee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_782559a2-aeff-4b4e-a31c-1912cd320907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cbf7a7c6-bf7d-4994-a17e-1f5e88c18659" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_782559a2-aeff-4b4e-a31c-1912cd320907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_23518ea1-0975-41bc-b008-5165734dce66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23518ea1-0975-41bc-b008-5165734dce66" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_9a33c999-e726-4884-9397-d879ae88afe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_c0ed8b63-c289-4823-9958-692731620f48" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_9a33c999-e726-4884-9397-d879ae88afe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_53cb7ac2-bbd2-494e-a0c0-ee1a4d11addd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_9a33c999-e726-4884-9397-d879ae88afe4" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_53cb7ac2-bbd2-494e-a0c0-ee1a4d11addd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_96d1a8d9-8f42-4b25-a909-175183296cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_480facbd-715a-4f81-a694-8f915e50bf2f" xlink:to="loc_us-gaap_LossContingencyNatureDomain_96d1a8d9-8f42-4b25-a909-175183296cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_e0d03177-eccb-4263-925f-4a5014ccef06" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_96d1a8d9-8f42-4b25-a909-175183296cea" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_e0d03177-eccb-4263-925f-4a5014ccef06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_192305e4-cab5-47ff-917a-631c4de4ad71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_037836de-9762-43a8-ad96-4f4ca349589e" xlink:to="loc_us-gaap_SegmentDomain_192305e4-cab5-47ff-917a-631c4de4ad71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_799f7f6e-8437-4380-91af-a87a58f0ea9e" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_192305e4-cab5-47ff-917a-631c4de4ad71" xlink:to="loc_mck_InternationalSegmentMember_799f7f6e-8437-4380-91af-a87a58f0ea9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b4971b4c-79f7-4c90-b646-4827d803d7b9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1e1af05f-ae28-457d-85c2-1710ed93ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:to="loc_us-gaap_DomesticCountryMember_1e1af05f-ae28-457d-85c2-1710ed93ea90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_eb09823b-89bc-4ed7-abb9-fa0f544b772b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_eb09823b-89bc-4ed7-abb9-fa0f544b772b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_23fefd11-9688-420b-95a8-f2fe2e078e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ff15d777-6fec-4350-8f75-04c16c0c5e78" xlink:to="loc_us-gaap_ForeignCountryMember_23fefd11-9688-420b-95a8-f2fe2e078e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ca242776-53ea-40b2-9c30-783879ed9d67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ed0b6ea6-e755-4523-bb05-fc5ec36af535" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ca242776-53ea-40b2-9c30-783879ed9d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6321f8d5-37a6-4155-9511-ae6bdfe40a85" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ca242776-53ea-40b2-9c30-783879ed9d67" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6321f8d5-37a6-4155-9511-ae6bdfe40a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fcd14f15-c394-49cd-b869-117add480add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b0cb4f35-7475-440a-8126-513766643701" xlink:to="loc_us-gaap_RelatedPartyDomain_fcd14f15-c394-49cd-b869-117add480add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_d246a680-026c-42c2-a06e-6cbb721df2be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fcd14f15-c394-49cd-b869-117add480add" xlink:to="loc_us-gaap_CorporateJointVentureMember_d246a680-026c-42c2-a06e-6cbb721df2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4b20c241-f5a5-461f-a649-08f220114dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_6ff1e426-758a-40e7-a96b-6ac49fe9e17d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4b20c241-f5a5-461f-a649-08f220114dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b6365c6d-350a-42c5-b1a6-4941e0b2c3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_4b20c241-f5a5-461f-a649-08f220114dbf" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b6365c6d-350a-42c5-b1a6-4941e0b2c3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_79057296-06b4-4aad-bbe8-5e98cf0139cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_8d84d480-f115-44f8-a11b-8767fcb3cafd" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_8d84d480-f115-44f8-a11b-8767fcb3cafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_7f24f8df-17f1-4e9e-bb2c-078f2b7a7695" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ca4d9df2-3e45-42f0-9d8c-37eb9fe7b841" xlink:to="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_7f24f8df-17f1-4e9e-bb2c-078f2b7a7695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeeb8789-a9a9-45db-a0f7-d14db93017a7" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a0759a4a-0376-4baf-b022-2c2844095ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a0759a4a-0376-4baf-b022-2c2844095ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_0a9831ab-dfca-4694-bf81-c5831a6a450b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_0a9831ab-dfca-4694-bf81-c5831a6a450b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_456e84e8-a895-4556-ac0a-588814607b29" xlink:href="mck-20220331.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_456e84e8-a895-4556-ac0a-588814607b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_322bef9c-91ba-4ff4-b754-3ca9d7800a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_322bef9c-91ba-4ff4-b754-3ca9d7800a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_52ce3b07-bddf-4f4f-8d18-592e4067f780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_52ce3b07-bddf-4f4f-8d18-592e4067f780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_76c2c730-2eec-4df0-b930-4feda5f4ab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_76c2c730-2eec-4df0-b930-4feda5f4ab7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_e2f4aae0-8a50-4827-8b9e-cbcc5c157c11" xlink:href="mck-20220331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_e2f4aae0-8a50-4827-8b9e-cbcc5c157c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_39306056-86e5-41ce-b3b7-12b0fa5c2028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_39306056-86e5-41ce-b3b7-12b0fa5c2028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bafad565-d990-4e0a-8066-d507373ed04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bafad565-d990-4e0a-8066-d507373ed04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_dc4fd177-a195-4c8e-8e84-ebae67d3b957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_dc4fd177-a195-4c8e-8e84-ebae67d3b957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ad89a89a-82b1-4ded-9fc4-33c196b1aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ad89a89a-82b1-4ded-9fc4-33c196b1aec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a5b413ee-e503-4c1b-bbf0-ed26e6c5b456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a5b413ee-e503-4c1b-bbf0-ed26e6c5b456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eba4c736-4576-4015-9e8a-8ac384a1278d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eba4c736-4576-4015-9e8a-8ac384a1278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3a566323-1734-4188-ab45-e042652e6908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3a566323-1734-4188-ab45-e042652e6908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_12e9f60b-f51a-4f2a-8122-a721545b1212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_12e9f60b-f51a-4f2a-8122-a721545b1212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_28512066-0443-40b6-8192-e3fb8231d7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_28512066-0443-40b6-8192-e3fb8231d7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a0af67d1-7223-4d0f-81b9-5dc09976770d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_a0af67d1-7223-4d0f-81b9-5dc09976770d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_57527706-525e-4600-9d25-f150adf5cbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ac2d7a7a-55e1-4190-9547-6654828bda62" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_57527706-525e-4600-9d25-f150adf5cbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20220331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_316c9192-4788-4108-82a7-a06ebcec06d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_08548eee-032c-4aad-bf22-7391a079dbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_316c9192-4788-4108-82a7-a06ebcec06d6" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_08548eee-032c-4aad-bf22-7391a079dbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20220331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_441b0eec-e8f7-4ba7-bf77-144617294720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_895e51dd-28c3-4f43-8fe6-ebf36381dc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_441b0eec-e8f7-4ba7-bf77-144617294720" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_895e51dd-28c3-4f43-8fe6-ebf36381dc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_05ef6835-e3c2-462c-b779-df8f9cdf6925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_05ef6835-e3c2-462c-b779-df8f9cdf6925" xlink:to="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_de737061-11a6-4c8e-839b-33237ca962c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d8166d56-8ad3-4915-88d8-c496498c7bd0" xlink:to="loc_dei_EntityDomain_de737061-11a6-4c8e-839b-33237ca962c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_db233137-c21f-422a-94ee-111fd23b95ad" xlink:href="mck-20220331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_de737061-11a6-4c8e-839b-33237ca962c7" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_db233137-c21f-422a-94ee-111fd23b95ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_eab5b9ba-6ebe-4167-a62e-a411530ed12e" xlink:to="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_cee1d1cb-a1d7-4612-a1ef-c1f0be85918b" xlink:href="mck-20220331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_cee1d1cb-a1d7-4612-a1ef-c1f0be85918b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_191ba972-c564-4bdb-92ac-45f85450764e" xlink:href="mck-20220331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_91e23779-633a-4ab2-9fad-10a1d67aa865" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_191ba972-c564-4bdb-92ac-45f85450764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7909a4bb-ef4b-4861-9d9a-2c5e4c53e35c" xlink:to="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_00c1d891-e15f-4d96-8f11-bc78111797b2" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_00c1d891-e15f-4d96-8f11-bc78111797b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fa6554b4-1dfc-4ce4-bb9f-5982a883e392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fa6554b4-1dfc-4ce4-bb9f-5982a883e392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_385c360b-7e2a-4c71-bef0-3ec5d07cf1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_31f181ad-e369-4587-ba44-8e1cb3d9255a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_385c360b-7e2a-4c71-bef0-3ec5d07cf1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_cf3ccfa1-3f6c-438c-80a4-e486284618e3" xlink:to="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_d6db88db-834a-428c-b79f-4c400e0bd80a" xlink:href="mck-20220331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_d6db88db-834a-428c-b79f-4c400e0bd80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_684826d9-24b4-418e-81e0-834577c80532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_684826d9-24b4-418e-81e0-834577c80532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_475d04b1-a9da-4873-80b3-05cd4c724795" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_475d04b1-a9da-4873-80b3-05cd4c724795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_e35aca81-ba7b-4a74-aa1f-3117bb62ace0" xlink:href="mck-20220331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_PutRightValueInterestRateSpread_e35aca81-ba7b-4a74-aa1f-3117bb62ace0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_aeb8dc2b-628c-46d4-950a-35a44a7095ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_aeb8dc2b-628c-46d4-950a-35a44a7095ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bbb42b5b-7f68-4136-bc60-7437f335eb9f" xlink:href="mck-20220331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_bbb42b5b-7f68-4136-bc60-7437f335eb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_7a19f300-db91-4939-a73e-35a02994f306" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_7a19f300-db91-4939-a73e-35a02994f306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_f417318d-983f-4aa9-ba8c-7a78ba45644c" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_f417318d-983f-4aa9-ba8c-7a78ba45644c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_304cdcc5-c529-4492-a524-0fd73c564324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_304cdcc5-c529-4492-a524-0fd73c564324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_c68d4480-6af1-4d04-839b-5ac099dab411" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_c68d4480-6af1-4d04-839b-5ac099dab411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8734b571-104b-4f73-a9af-acdec11487a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8734b571-104b-4f73-a9af-acdec11487a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fb621fdb-b359-40b0-baf9-648a517adc1a" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_fb621fdb-b359-40b0-baf9-648a517adc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f59b088b-16e7-46d5-9600-fce68aec3219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_MinorityInterest_f59b088b-16e7-46d5-9600-fce68aec3219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_774a52f8-99c7-4817-bb44-3e82918f377f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3035a071-9c8b-4404-934b-8fd68719f3ce" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_774a52f8-99c7-4817-bb44-3e82918f377f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_76087927-d689-40c0-912b-95e5765b2689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_76087927-d689-40c0-912b-95e5765b2689" xlink:to="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5e744308-54a4-4a19-a140-edb2973f99fc" xlink:to="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_93b01913-670a-43d1-8254-05537d202561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:to="loc_us-gaap_NoncontrollingInterestMember_93b01913-670a-43d1-8254-05537d202561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_297bebe2-3ec4-4af0-8ed8-fb2686a79054" xlink:href="mck-20220331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91fb5907-9044-46df-8cd8-f2cc3a901f34" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_297bebe2-3ec4-4af0-8ed8-fb2686a79054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_70eec511-6487-49c6-9fca-3f921c60cd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_def13150-ca5f-4530-8a8a-f265dac8fe65" xlink:to="loc_us-gaap_MinorityInterestLineItems_70eec511-6487-49c6-9fca-3f921c60cd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_70eec511-6487-49c6-9fca-3f921c60cd6d" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3f04f2b6-fdc1-4f0f-b37f-17ef525287c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_MinorityInterest_3f04f2b6-fdc1-4f0f-b37f-17ef525287c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_e95f09a7-f671-4078-9cec-cfe64d8ad00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_e95f09a7-f671-4078-9cec-cfe64d8ad00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff2e545e-4fbe-4613-aefc-8b7ce572165f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff2e545e-4fbe-4613-aefc-8b7ce572165f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_62e19540-631e-4b99-97ab-18915ed69e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_62e19540-631e-4b99-97ab-18915ed69e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_15e9cdbe-7fd3-4b21-af7a-c786599cf727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_15e9cdbe-7fd3-4b21-af7a-c786599cf727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_853006a1-8199-4c89-bdfc-74ad69c9305c" xlink:href="mck-20220331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_853006a1-8199-4c89-bdfc-74ad69c9305c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d0bf9864-3c84-42c5-b106-5ab8743b8924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d0bf9864-3c84-42c5-b106-5ab8743b8924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_44fc73bc-adea-41d6-8f62-a75d3d788ef2" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_44fc73bc-adea-41d6-8f62-a75d3d788ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_d7c1083b-d468-4c8a-8d3d-ea1c93363e49" xlink:href="mck-20220331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_d7c1083b-d468-4c8a-8d3d-ea1c93363e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e83de48a-2bcb-4274-9d8d-a335fd4060ea" xlink:href="mck-20220331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_e83de48a-2bcb-4274-9d8d-a335fd4060ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b3d6c656-693b-4ff3-8052-65833616c585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_MinorityInterest_b3d6c656-693b-4ff3-8052-65833616c585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0f0499e6-c65f-4373-9108-719b2a2c7cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_821b466b-296f-422f-851d-430066321c2a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0f0499e6-c65f-4373-9108-719b2a2c7cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="simple" xlink:href="mck-20220331.xsd#EarningsperCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5488f318-5888-4af6-ac51-e7ba10560d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_948e3409-6350-4885-91a1-40f796c90286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5488f318-5888-4af6-ac51-e7ba10560d4a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_948e3409-6350-4885-91a1-40f796c90286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="simple" xlink:href="mck-20220331.xsd#EarningsperCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e4310c67-02fd-455a-aebb-5eab4f6df19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2edd2c7b-e707-46ab-85f9-ac0f8952bc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e4310c67-02fd-455a-aebb-5eab4f6df19d" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2edd2c7b-e707-46ab-85f9-ac0f8952bc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5eca7732-7f2f-44a6-8506-3a22ee336c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5eca7732-7f2f-44a6-8506-3a22ee336c54" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:to="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e2775ff-f949-4728-a973-99e28ac5ed36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4f003719-382c-4fec-b317-38d3d74e2aa8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e2775ff-f949-4728-a973-99e28ac5ed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3715f4d2-f1af-40af-b768-ac87e02e4dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e2775ff-f949-4728-a973-99e28ac5ed36" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3715f4d2-f1af-40af-b768-ac87e02e4dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9eb5b983-fdd5-41dc-a53c-f24384bc3258" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4725a638-83db-4094-a331-c6c43f483503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4725a638-83db-4094-a331-c6c43f483503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff836cd0-09a9-436c-8a79-1a35e84be837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff836cd0-09a9-436c-8a79-1a35e84be837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c977e997-3a21-4221-8da2-0dedb86a5e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c977e997-3a21-4221-8da2-0dedb86a5e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3dfdf19a-97cf-40f0-89a9-c69bfa11a791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3dfdf19a-97cf-40f0-89a9-c69bfa11a791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6357a08f-3c1f-4ef0-8d0c-e1c338a2e7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_NetIncomeLoss_6357a08f-3c1f-4ef0-8d0c-e1c338a2e7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_55d52a63-96be-4914-a705-43798771810b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_55d52a63-96be-4914-a705-43798771810b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9b36406-9681-41dc-a7ac-1d3d49f7e07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_55d52a63-96be-4914-a705-43798771810b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9b36406-9681-41dc-a7ac-1d3d49f7e07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_533d03a1-8401-4211-bcca-6c3547a4f049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_533d03a1-8401-4211-bcca-6c3547a4f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b35530c-04f9-47ed-abd3-46bb5a70be3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b35530c-04f9-47ed-abd3-46bb5a70be3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_92b18b5f-7fcd-4549-ba62-9484a7168118" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d9a13a44-48e6-403d-9d7e-a581fca2e270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d9a13a44-48e6-403d-9d7e-a581fca2e270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_815affa0-657f-4921-861a-640a1cbce227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_815affa0-657f-4921-861a-640a1cbce227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b313342-cc01-421c-9d5c-c43f2e54fca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5aff961c-f073-4657-9da1-d547038156e8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b313342-cc01-421c-9d5c-c43f2e54fca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_9871888c-84ef-49dc-ae9b-6ae9ec5e5e0b" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_73388fe7-c6aa-4504-8610-5c6d2f06c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_73388fe7-c6aa-4504-8610-5c6d2f06c85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_31ad4a66-593f-4ef7-bd70-fca93c9762ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_31ad4a66-593f-4ef7-bd70-fca93c9762ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_79254246-6719-4cb1-8237-60827ca659b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2acd5cec-24aa-4d9a-8e2c-99facb2fb512" xlink:to="loc_us-gaap_EarningsPerShareBasic_79254246-6719-4cb1-8237-60827ca659b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#EarningsperCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6cb7e2f7-06a7-45b3-ada8-4540dc6cbbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d6261b69-6998-4b18-aae7-149aef56a671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6cb7e2f7-06a7-45b3-ada8-4540dc6cbbb2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d6261b69-6998-4b18-aae7-149aef56a671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/Leases" xlink:type="simple" xlink:href="mck-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_27d5f40c-640f-4c2b-8873-d45b4097003d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_057db1b4-a213-49b2-8a6a-7510501415da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_27d5f40c-640f-4c2b-8873-d45b4097003d" xlink:to="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_057db1b4-a213-49b2-8a6a-7510501415da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_79d07d23-b446-40af-abe2-4cac87315b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_27d5f40c-640f-4c2b-8873-d45b4097003d" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_79d07d23-b446-40af-abe2-4cac87315b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8eae12a2-58dc-408a-8106-346d868a690c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_27d5f40c-640f-4c2b-8873-d45b4097003d" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8eae12a2-58dc-408a-8106-346d868a690c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_c5e79902-8620-45a6-8630-9b9d8cb12747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock_2954eed9-64cc-4f4d-a25a-c88d220b1532" xlink:href="mck-20220331.xsd#mck_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_c5e79902-8620-45a6-8630-9b9d8cb12747" xlink:to="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock_2954eed9-64cc-4f4d-a25a-c88d220b1532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_40df7277-a6b0-485d-bb77-feb80c9e50ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_c5e79902-8620-45a6-8630-9b9d8cb12747" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_40df7277-a6b0-485d-bb77-feb80c9e50ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f36e205a-87a0-4b61-90fd-3b8d21c9b1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_c5e79902-8620-45a6-8630-9b9d8cb12747" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f36e205a-87a0-4b61-90fd-3b8d21c9b1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_ba5fc28e-6a67-4d2b-b972-5cc42b4b0a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_c5e79902-8620-45a6-8630-9b9d8cb12747" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_ba5fc28e-6a67-4d2b-b972-5cc42b4b0a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_9cbef0a3-d285-4adf-a527-fbec6bc67fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9cbef0a3-d285-4adf-a527-fbec6bc67fef" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_acdbcae8-e1fb-470c-9226-593b8a8b63cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2970e45a-74d2-434b-aa72-4b42001257fc" xlink:to="loc_us-gaap_EquityComponentDomain_acdbcae8-e1fb-470c-9226-593b8a8b63cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f70b9537-9651-4951-8993-fc01e379f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_acdbcae8-e1fb-470c-9226-593b8a8b63cb" xlink:to="loc_us-gaap_RetainedEarningsMember_f70b9537-9651-4951-8993-fc01e379f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_36dcb616-1c74-4bae-bcd7-d719af0ee608" xlink:to="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_afbdee87-846b-44b9-9bb0-ee5f9a0b2afa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:to="loc_srt_MinimumMember_afbdee87-846b-44b9-9bb0-ee5f9a0b2afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73635aa7-637a-47a8-b622-083d2a46d2f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f764ff58-8d2f-48ad-9e6c-c330d7ab40a3" xlink:to="loc_srt_MaximumMember_73635aa7-637a-47a8-b622-083d2a46d2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17e70520-20ee-4d82-845a-50fd1bbe7275" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a98a1f77-87fc-403a-b659-bba03601c269" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17e70520-20ee-4d82-845a-50fd1bbe7275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4808d6c3-ef35-4291-a1b5-db3bef828cf9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_17e70520-20ee-4d82-845a-50fd1bbe7275" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4808d6c3-ef35-4291-a1b5-db3bef828cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_90e7a77a-8404-4858-833b-22002f522cae" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a57daa26-ec9c-482a-9ee2-af05bc6936d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_OperatingLeaseLiability_a57daa26-ec9c-482a-9ee2-af05bc6936d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5a8ad77d-2858-4f77-9a4f-6227e2ce5e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5a8ad77d-2858-4f77-9a4f-6227e2ce5e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e5c1efe6-d7f2-4e3f-8074-fcad73a4645f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e5c1efe6-d7f2-4e3f-8074-fcad73a4645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseImpairmentLossNetOfTax_77f405bd-2b81-43ae-aabb-0e1abc458314" xlink:href="mck-20220331.xsd#mck_OperatingLeaseImpairmentLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_mck_OperatingLeaseImpairmentLossNetOfTax_77f405bd-2b81-43ae-aabb-0e1abc458314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6b86cf34-15df-4e2b-9946-86b748023d61" xlink:href="mck-20220331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_6b86cf34-15df-4e2b-9946-86b748023d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_96f0467d-e62e-4e37-aedf-2d4cc075590c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_96f0467d-e62e-4e37-aedf-2d4cc075590c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_496ea35f-6a98-40f0-b11b-629baa6874d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_496ea35f-6a98-40f0-b11b-629baa6874d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_b41e940a-d92c-4cd1-bf6e-dff97faad247" xlink:href="mck-20220331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_b1804138-35d2-4e73-81a0-fa92d6960d71" xlink:to="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_b41e940a-d92c-4cd1-bf6e-dff97faad247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesSupplementalbalancesheetinformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_485042c7-55e7-45b5-a1a4-0f773c5659f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_485042c7-55e7-45b5-a1a4-0f773c5659f5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_af5a9d90-4fbf-46f6-9b94-a1d45b1bf25d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_ea6bef04-cf97-400f-b6cb-9cdc4ae3a09a" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_ea6bef04-cf97-400f-b6cb-9cdc4ae3a09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_2a5a8805-67ee-4d3c-a273-980feb37fd02" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_56872e0f-dd74-49fc-95d6-ec826391a0e8" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_2a5a8805-67ee-4d3c-a273-980feb37fd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0ce42a9f-0908-475d-9592-4c0ed882d4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_86b983a2-3b23-4d4d-9f1c-4ff690fdccbc" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0ce42a9f-0908-475d-9592-4c0ed882d4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2421560d-616e-4251-abc8-73c367cc60c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0ce42a9f-0908-475d-9592-4c0ed882d4e6" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2421560d-616e-4251-abc8-73c367cc60c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7b64953a-5c05-420e-ab26-b4f544c514bd" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_70d70d52-a65d-4243-aa05-896a32335178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_70d70d52-a65d-4243-aa05-896a32335178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9d1e5962-30dc-434b-9c12-b40556bab27c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9d1e5962-30dc-434b-9c12-b40556bab27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_40acfecd-d0c2-4917-8403-4b4a8a637869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_40acfecd-d0c2-4917-8403-4b4a8a637869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_372a3b8f-be5c-4a8b-babe-9ef4c23be673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseLiability_372a3b8f-be5c-4a8b-babe-9ef4c23be673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_298de2c7-40ab-43d4-a700-0ad79b996157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_298de2c7-40ab-43d4-a700-0ad79b996157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_11ed2bfa-50b1-4cfc-8ae1-9ee094a0fb37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_11ed2bfa-50b1-4cfc-8ae1-9ee094a0fb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_34e12b8a-de7b-4672-b319-3bdf21b673fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_34e12b8a-de7b-4672-b319-3bdf21b673fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_2ea9b296-9fc3-4a0f-9e36-dbced9780a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_2ea9b296-9fc3-4a0f-9e36-dbced9780a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d68a6e07-77b4-4868-831a-b4e3a8d7538f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d68a6e07-77b4-4868-831a-b4e3a8d7538f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eec07607-0228-47c0-a039-3331975853f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eec07607-0228-47c0-a039-3331975853f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7911cf02-3f7f-429b-b6c3-61f575296292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseLiability_7911cf02-3f7f-429b-b6c3-61f575296292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4e0aad62-2042-40ba-8a46-c47fc57cca04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4e0aad62-2042-40ba-8a46-c47fc57cca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_87805c1d-e14b-4612-adab-8f839ca93b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_87805c1d-e14b-4612-adab-8f839ca93b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cb8c0c22-e209-4144-8003-7c10d4601463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cb8c0c22-e209-4144-8003-7c10d4601463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_31b0f7b4-6aaf-4410-a69a-27f80240a53a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75ade301-2081-4e21-9c3a-1c10b734d9a9" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_31b0f7b4-6aaf-4410-a69a-27f80240a53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_8eeca256-adc0-4b76-9fcd-4096e4dbc4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_ShortTermLeaseCost_8eeca256-adc0-4b76-9fcd-4096e4dbc4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3e84fa24-a870-423d-9cb8-a33eb4397d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_OperatingLeaseCost_3e84fa24-a870-423d-9cb8-a33eb4397d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_aacdd4ac-c344-4650-94e5-3ad4aefadf66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_aacdd4ac-c344-4650-94e5-3ad4aefadf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_eb3b48c3-c6a6-4487-9f03-2e28ea084135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_eb3b48c3-c6a6-4487-9f03-2e28ea084135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_6b125fe5-80b4-4f00-8111-0d33a5b9f7b0" xlink:href="mck-20220331.xsd#mck_FinanceLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_mck_FinanceLeaseCost_6b125fe5-80b4-4f00-8111-0d33a5b9f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4c39472e-f65d-4320-bfd7-6e74cce6ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_VariableLeaseCost_4c39472e-f65d-4320-bfd7-6e74cce6ff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_62fe33a3-ad12-4ad1-9693-8625d4de2b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_SubleaseIncome_62fe33a3-ad12-4ad1-9693-8625d4de2b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e92bac1a-ed3b-4ed5-bf19-a4f14ebe3d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe7842e8-02c9-4f98-92b9-af109bc7c42f" xlink:to="loc_us-gaap_LeaseCost_e92bac1a-ed3b-4ed5-bf19-a4f14ebe3d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesSupplementalcashflowinformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7cf037aa-3c98-461d-9ae8-6ac158a95ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:to="loc_us-gaap_OperatingLeasePayments_7cf037aa-3c98-461d-9ae8-6ac158a95ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_5caf6486-6fb0-4826-a9f5-43c4cb96d7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_5caf6486-6fb0-4826-a9f5-43c4cb96d7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_78217c76-a58d-4f39-8310-4f8610b3ec4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_78217c76-a58d-4f39-8310-4f8610b3ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b1e8bb1b-4db3-4893-9c10-2225e66b217d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b1e8bb1b-4db3-4893-9c10-2225e66b217d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d266913c-b76a-4d0f-9f1e-8a3710502c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d266913c-b76a-4d0f-9f1e-8a3710502c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_101d4f60-45e0-427e-8158-ba9c7d31a97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a297e028-31b4-4d0d-9a3a-0496cfd38755" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_101d4f60-45e0-427e-8158-ba9c7d31a97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesMaturitiesofleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cd76b281-f930-4be7-8bfb-11b02622f320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cd76b281-f930-4be7-8bfb-11b02622f320" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b423a410-9e31-4982-9c84-9bb3bdc5af78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b423a410-9e31-4982-9c84-9bb3bdc5af78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ea8d958c-5dc1-4049-9271-0af84bdda6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ea8d958c-5dc1-4049-9271-0af84bdda6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ca03c707-63a0-4fad-be3c-5480a8c9b3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ca03c707-63a0-4fad-be3c-5480a8c9b3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_507990c0-e543-4d6f-b79a-3c87cbc12975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_507990c0-e543-4d6f-b79a-3c87cbc12975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_166d6873-517c-4f39-8cb2-b051267f8281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_166d6873-517c-4f39-8cb2-b051267f8281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ea4c5f15-0c2e-4918-b923-e52a8ba53a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ea4c5f15-0c2e-4918-b923-e52a8ba53a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_245e2427-2f7e-4ae5-9a9d-a6692d837e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_245e2427-2f7e-4ae5-9a9d-a6692d837e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ec0df617-1e0f-4b12-b362-5c333db412e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ec0df617-1e0f-4b12-b362-5c333db412e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_96ea327f-662f-4f15-a8ae-f30cd41a8314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_75dc7906-b489-4f98-aef2-8c35950e520d" xlink:to="loc_us-gaap_OperatingLeaseLiability_96ea327f-662f-4f15-a8ae-f30cd41a8314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cd76b281-f930-4be7-8bfb-11b02622f320" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3108dd04-1552-43b6-8d50-4fbbde05064c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3108dd04-1552-43b6-8d50-4fbbde05064c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_aa776fa8-c67a-4169-b44d-44e69a776feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_aa776fa8-c67a-4169-b44d-44e69a776feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7cee8edc-147d-4165-94c4-eae02b211cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_7cee8edc-147d-4165-94c4-eae02b211cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2efc3c8c-f6af-4f60-9713-e0bc15e3920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2efc3c8c-f6af-4f60-9713-e0bc15e3920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_a0c2f31a-fd86-4c04-9d51-1944616112df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_a0c2f31a-fd86-4c04-9d51-1944616112df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_6be9950f-8eb9-4232-bd0b-dfe4c1d799fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_6be9950f-8eb9-4232-bd0b-dfe4c1d799fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0f04a26d-b06a-46fb-9629-5fdda72c6f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0f04a26d-b06a-46fb-9629-5fdda72c6f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_757187e3-b91a-427c-9943-b2c75168da1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_757187e3-b91a-427c-9943-b2c75168da1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f9dc970a-33eb-4360-8994-e8f081bd1e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_cfe6c53e-9f57-405f-b808-218abd16e3e5" xlink:to="loc_us-gaap_FinanceLeaseLiability_f9dc970a-33eb-4360-8994-e8f081bd1e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:href="mck-20220331.xsd#mck_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cd76b281-f930-4be7-8bfb-11b02622f320" xlink:to="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_baff0471-5c65-489d-b218-ef0213516fd5" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_baff0471-5c65-489d-b218-ef0213516fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_9eee02ea-3fa8-4891-9bed-35c546b244e4" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearTwo_9eee02ea-3fa8-4891-9bed-35c546b244e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_915b1dbf-5ca6-46ea-b9ff-418959fb63c4" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearThree_915b1dbf-5ca6-46ea-b9ff-418959fb63c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_878ab126-d225-4fe1-aee6-8fa14f387d97" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFour_878ab126-d225-4fe1-aee6-8fa14f387d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_4b3a91a5-9641-4984-982d-b178eff6b0b2" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFive_4b3a91a5-9641-4984-982d-b178eff6b0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_d242e32c-dc7c-4ce0-bdaf-18103a059935" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_d242e32c-dc7c-4ce0-bdaf-18103a059935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_911964df-5f9a-42fc-98b7-a1c98f8123aa" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityPaymentsDue_911964df-5f9a-42fc-98b7-a1c98f8123aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_d394bc05-360a-4abe-b157-2f2f27b5931f" xlink:href="mck-20220331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiabilityUndiscountedExcessAmount_d394bc05-360a-4abe-b157-2f2f27b5931f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_88e58ab0-83e4-4dd8-b6eb-dc123e52c750" xlink:href="mck-20220331.xsd#mck_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_bbfa17eb-0617-4a1d-8d04-811a27b264d6" xlink:to="loc_mck_LeaseLiability_88e58ab0-83e4-4dd8-b6eb-dc123e52c750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived_39b8386c-1f71-4599-844c-93274056453b" xlink:href="mck-20220331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cd76b281-f930-4be7-8bfb-11b02622f320" xlink:to="loc_mck_LessorLeasePaymentstobeReceived_39b8386c-1f71-4599-844c-93274056453b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="simple" xlink:href="mck-20220331.xsd#LeasesMaturitiesofleaseliabilitiesDetails_2"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7065df7-31d7-470f-a756-38929bc09134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1fffbdf6-6367-47e2-ad1b-319bd5faf89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7065df7-31d7-470f-a756-38929bc09134" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1fffbdf6-6367-47e2-ad1b-319bd5faf89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_80a3647b-9b76-427c-aadc-682cdbc4f910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8e0ffde7-62ac-405d-9603-9397bf2ac85b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_80a3647b-9b76-427c-aadc-682cdbc4f910" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8e0ffde7-62ac-405d-9603-9397bf2ac85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9b6e026b-98af-4ebf-8c5b-e1a4e80d17dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_80a3647b-9b76-427c-aadc-682cdbc4f910" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9b6e026b-98af-4ebf-8c5b-e1a4e80d17dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6ef799ec-1cf3-48b6-932b-91842a789315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6ef799ec-1cf3-48b6-932b-91842a789315" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f952ea30-ed13-4d08-9fee-9ea732957fd9" xlink:to="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_2cba7698-11c3-423a-8ae8-876c72923ec9" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_USPharmaceuticalSegmentMember_2cba7698-11c3-423a-8ae8-876c72923ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_447d85b9-5848-4bc8-85ad-645748d4477c" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_447d85b9-5848-4bc8-85ad-645748d4477c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_ce90f557-68e8-4af7-973c-a67a07deec4f" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_ce90f557-68e8-4af7-973c-a67a07deec4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_1fbf21f3-e94b-40d4-b9df-bc2c2ce3503b" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_719bd3e7-2e9f-4528-b4e4-05757c939f56" xlink:to="loc_mck_InternationalSegmentMember_1fbf21f3-e94b-40d4-b9df-bc2c2ce3503b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_653f8946-af1a-44d9-8639-785e057f4b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2a43a77a-f981-46bb-942b-16e7a625654e" xlink:to="loc_us-gaap_GoodwillLineItems_653f8946-af1a-44d9-8639-785e057f4b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_653f8946-af1a-44d9-8639-785e057f4b23" xlink:to="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e33570fa-6110-4430-8fef-a6ba12df2845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_Goodwill_e33570fa-6110-4430-8fef-a6ba12df2845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b3f629da-8438-44fe-8198-f67bfc2c54db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b3f629da-8438-44fe-8198-f67bfc2c54db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_db5e7e44-3252-4810-985c-8cfa8c43cc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_db5e7e44-3252-4810-985c-8cfa8c43cc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_c66ed8e7-ce3d-466b-a55e-2d441cb163b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_c66ed8e7-ce3d-466b-a55e-2d441cb163b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c5628077-75c5-429a-b6df-5151d5a0cde6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c5628077-75c5-429a-b6df-5151d5a0cde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6add13e-3256-4ca0-bb30-a0670c060438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d6add13e-3256-4ca0-bb30-a0670c060438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1463c048-db09-47cd-83c3-3605d0332c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dffd431-fc2a-4383-a2ea-7716abff8da0" xlink:to="loc_us-gaap_Goodwill_1463c048-db09-47cd-83c3-3605d0332c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2a8c533-70f9-4319-a014-1867ed6517f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e2a8c533-70f9-4319-a014-1867ed6517f7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_410e70a5-d044-43a7-9a48-e85b9f9b24a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_5030b714-4a6e-45cb-a482-5f2ea5511eea" xlink:to="loc_us-gaap_ReportingUnitDomain_410e70a5-d044-43a7-9a48-e85b9f9b24a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_6f9f7a81-965d-4768-a2e6-683a9bde41b5" xlink:href="mck-20220331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_410e70a5-d044-43a7-9a48-e85b9f9b24a5" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_6f9f7a81-965d-4768-a2e6-683a9bde41b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3a842c5-23b7-4cb9-bbdb-3176cb634e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b971f767-f423-43c1-a095-69842f16cb97" xlink:to="loc_us-gaap_SegmentDomain_d3a842c5-23b7-4cb9-bbdb-3176cb634e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_a6c14671-0301-49b3-8373-81a2d9883a1f" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3a842c5-23b7-4cb9-bbdb-3176cb634e71" xlink:to="loc_mck_InternationalSegmentMember_a6c14671-0301-49b3-8373-81a2d9883a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a11e85e-cd8c-4185-a5db-7e53f1984995" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_16864827-1c99-49bc-b007-00e278049fe5" xlink:to="loc_srt_SegmentGeographicalDomain_3a11e85e-cd8c-4185-a5db-7e53f1984995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_9cd7b535-9365-4559-adfd-d92283fae062" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3a11e85e-cd8c-4185-a5db-7e53f1984995" xlink:to="loc_srt_EuropeMember_9cd7b535-9365-4559-adfd-d92283fae062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ae93cb8e-9159-4e88-a19e-1205b8c2dcc9" xlink:to="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_8af0d26e-1bed-46ef-a171-7b110008faa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_NumberOfReportableSegments_8af0d26e-1bed-46ef-a171-7b110008faa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_14d93e4a-c8df-4943-a421-9011ef8ef89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_14d93e4a-c8df-4943-a421-9011ef8ef89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d2542a38-eee5-4740-a1de-6f42768fc755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_Goodwill_d2542a38-eee5-4740-a1de-6f42768fc755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_530c1f7f-ed1b-4989-ad83-4f1329b309f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_15e780e7-49e0-46a2-9aec-ec3f6cf88d0c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_530c1f7f-ed1b-4989-ad83-4f1329b309f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4a7016be-4068-40a7-8596-599b852c662d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4a7016be-4068-40a7-8596-599b852c662d" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83004d64-17b7-477f-83ae-1e8bd22f4566" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_64991e43-9646-47d1-972c-51b187a05830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_CustomerRelationshipsMember_64991e43-9646-47d1-972c-51b187a05830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_ebabcd08-f976-4ae9-b5b7-14bdce883af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_ServiceAgreementsMember_ebabcd08-f976-4ae9-b5b7-14bdce883af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_2d29d891-7823-4e8b-993f-63138647ed0f" xlink:href="mck-20220331.xsd#mck_PharmacyLicensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_mck_PharmacyLicensesMember_2d29d891-7823-4e8b-993f-63138647ed0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d1ceebf7-e53f-4709-a4ff-20ea2d2cfed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d1ceebf7-e53f-4709-a4ff-20ea2d2cfed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dee595f5-75ac-42fd-aef0-cb45b78ee9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_dee595f5-75ac-42fd-aef0-cb45b78ee9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_1adf0f19-b496-45cb-ba70-09333a62d295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_125cb459-2c63-4593-bf38-b9d7ff969f92" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_1adf0f19-b496-45cb-ba70-09333a62d295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b2cb0b6d-4662-4e9e-bdb0-72d34c97e02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_37c03848-1be1-48b3-8275-23e82260bb50" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b2cb0b6d-4662-4e9e-bdb0-72d34c97e02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8563bb24-0776-4fd3-b3ce-167261abe21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b2cb0b6d-4662-4e9e-bdb0-72d34c97e02a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_8563bb24-0776-4fd3-b3ce-167261abe21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_567f1784-3017-432f-99ec-01ac1c49c389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ac2b9289-8c5a-4e0a-ad26-5ee7da0b1d44" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_567f1784-3017-432f-99ec-01ac1c49c389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember_743bf973-f074-4d38-851a-6767c5410eb2" xlink:href="mck-20220331.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_567f1784-3017-432f-99ec-01ac1c49c389" xlink:to="loc_mck_EuropeanAssetsHeldForSaleMember_743bf973-f074-4d38-851a-6767c5410eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_f5e3b567-399f-4acf-b0ab-efdd035b2010" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_27ae7f76-b50e-4213-b698-fca1698d326b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_27ae7f76-b50e-4213-b698-fca1698d326b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0b36fb05-80f9-4adc-ad96-15cbd0059cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0b36fb05-80f9-4adc-ad96-15cbd0059cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fc336b7a-ba98-4ec4-a9e2-78dcd9f2a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fc336b7a-ba98-4ec4-a9e2-78dcd9f2a89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0b434a2-7457-4779-ab18-27714ebe8a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0b434a2-7457-4779-ab18-27714ebe8a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_52911a1a-6549-43de-81df-e2b79ed17a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9ebdceab-95c2-47ff-a6ac-527eec0a44b5" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_52911a1a-6549-43de-81df-e2b79ed17a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_67e01548-0162-4914-876b-ac5d725cd896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_67e01548-0162-4914-876b-ac5d725cd896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7280e993-c2e3-4fcc-8411-a4d75efb4077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7280e993-c2e3-4fcc-8411-a4d75efb4077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5a319d74-009f-46d0-beab-bab739498d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5a319d74-009f-46d0-beab-bab739498d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_baa25c55-2dd4-4464-9df8-8c30bcea5f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_baa25c55-2dd4-4464-9df8-8c30bcea5f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1ca63879-cabc-4a2d-a686-87ea6a905890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1ca63879-cabc-4a2d-a686-87ea6a905890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_94af9b58-0af2-416a-9b08-c64b20a4f6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_94af9b58-0af2-416a-9b08-c64b20a4f6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_370fee22-50f0-4656-b200-fb6cf4b849d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88e407eb-d44e-45ed-9b83-3f88f65e6b6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_370fee22-50f0-4656-b200-fb6cf4b849d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_39cef8e0-893e-4b09-819a-39aaafbbbebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e4220517-4b06-4938-82fe-c7fc8db67290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_39cef8e0-893e-4b09-819a-39aaafbbbebb" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e4220517-4b06-4938-82fe-c7fc8db67290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_52660f0f-382c-45b7-9171-55e6f5ff8455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_2b600bff-af4d-44e3-9d4e-2dbdd3af4069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_52660f0f-382c-45b7-9171-55e6f5ff8455" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_2b600bff-af4d-44e3-9d4e-2dbdd3af4069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_36f4bfda-5ab4-4966-a30e-31ac8d0ac3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_36f4bfda-5ab4-4966-a30e-31ac8d0ac3ad" xlink:to="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4a350551-e834-4d63-90f0-c38eb646483b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c53a4343-5c9a-490f-9303-4eda07c53231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:to="loc_us-gaap_LoansPayableMember_c53a4343-5c9a-490f-9303-4eda07c53231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember_aa488042-ee69-4375-aa9e-2efe399c11fb" xlink:href="mck-20220331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c99d0988-0ca9-449f-ae26-c58162a14339" xlink:to="loc_mck_LeaseandOtherObligationsMember_aa488042-ee69-4375-aa9e-2efe399c11fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dadb580f-3c74-478e-981e-369e6b88e778" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_564d1066-f6f5-47d4-8bf3-65ddecc400e6" xlink:href="mck-20220331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A270NotesDueDecember152022Member_564d1066-f6f5-47d4-8bf3-65ddecc400e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_6d001646-90b9-44e3-b295-48243c1eb4d7" xlink:href="mck-20220331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A285NotesDueMarch152023Member_6d001646-90b9-44e3-b295-48243c1eb4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_c1bd7d7b-fe70-4a0c-af80-90577ad1b890" xlink:href="mck-20220331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A380NotesDueMarch152024Member_c1bd7d7b-fe70-4a0c-af80-90577ad1b890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_b9159d24-6262-457b-822b-6b74e2cc2eb9" xlink:href="mck-20220331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A090NotesDueDecember32025Member_b9159d24-6262-457b-822b-6b74e2cc2eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_113c7471-0f87-44ad-a681-a8a320015bac" xlink:href="mck-20220331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A130NotesDueAugust152026Member_113c7471-0f87-44ad-a681-a8a320015bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_9e743af1-fbb1-4aa7-b133-934d4b5147d5" xlink:href="mck-20220331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_9e743af1-fbb1-4aa7-b133-934d4b5147d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_071c7f04-6e0a-4653-8cae-b09bedf5a9c6" xlink:href="mck-20220331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A395NotesDueFebruary162028Member_071c7f04-6e0a-4653-8cae-b09bedf5a9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_79f2e666-5216-4c4f-8e45-102877d1145d" xlink:href="mck-20220331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A475NotesDueMay302029Member_79f2e666-5216-4c4f-8e45-102877d1145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_e2b8fe67-dc3f-4451-9ad3-b3b4aca1943a" xlink:href="mck-20220331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A600NotesDueMarch12041Member_e2b8fe67-dc3f-4451-9ad3-b3b4aca1943a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_9b841603-41cd-4046-8ab5-3a9777e65699" xlink:href="mck-20220331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A488NotesDueMarch152044Member_9b841603-41cd-4046-8ab5-3a9777e65699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_8526f745-d947-4f6b-a198-20d28af6b429" xlink:href="mck-20220331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_8526f745-d947-4f6b-a198-20d28af6b429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_a4fcda4c-ce4f-4b17-94a7-771feb25f81d" xlink:href="mck-20220331.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_a4fcda4c-ce4f-4b17-94a7-771feb25f81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_d606c9c4-7659-4721-9472-03a3732e4d5d" xlink:href="mck-20220331.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_d606c9c4-7659-4721-9472-03a3732e4d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_00b082f8-c70f-41e9-a174-bc940b88b925" xlink:href="mck-20220331.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3db18104-38f5-4203-a08d-2a4e1876ee8b" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_00b082f8-c70f-41e9-a174-bc940b88b925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0994349e-e091-4a6f-aa58-b9310bbb75e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e9bc4fe9-bf81-4d9d-9502-5a970a1da6ad" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0994349e-e091-4a6f-aa58-b9310bbb75e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0f938af1-825d-45cb-9b9a-343c1e359d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0994349e-e091-4a6f-aa58-b9310bbb75e6" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0f938af1-825d-45cb-9b9a-343c1e359d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2b6b713-71e9-4095-869b-47330ae68256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_730544d2-d7d1-4f82-b65c-8408ef2a4cc2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2b6b713-71e9-4095-869b-47330ae68256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_b40bc446-a94c-4402-a711-4a008753bf3c" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c2b6b713-71e9-4095-869b-47330ae68256" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_b40bc446-a94c-4402-a711-4a008753bf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e7be5b-09ae-458c-95d2-4b766381185f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8ef0ea7f-59d7-4ec8-beb3-b2dcfb6f74d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_LongTermDebt_8ef0ea7f-59d7-4ec8-beb3-b2dcfb6f74d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fd9a2db5-a04b-489c-b18a-6c7c3ca460ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fd9a2db5-a04b-489c-b18a-6c7c3ca460ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c122949e-f9c5-4de2-8ab4-edc7bd4b7885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c122949e-f9c5-4de2-8ab4-edc7bd4b7885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_659b3eeb-be91-419a-bd4a-89c037e3ab50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_659b3eeb-be91-419a-bd4a-89c037e3ab50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_e25f6a9f-0a32-4cdd-9a52-b490e036679b" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_e25f6a9f-0a32-4cdd-9a52-b490e036679b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_89ee4485-adfd-4ec6-98f6-00e45c9ce9da" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8b6ec452-cb4d-4924-be0a-e662ec1cb199" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_89ee4485-adfd-4ec6-98f6-00e45c9ce9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a6d97ef4-394a-42b4-8def-2743a8ef4e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a6d97ef4-394a-42b4-8def-2743a8ef4e1b" xlink:to="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_09436cbe-ea22-4d30-8a34-1a5d4ad0fe6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_d0470a4d-29bb-4c9c-a61c-6574a399b891" xlink:href="mck-20220331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A090NotesDueDecember32025Member_d0470a4d-29bb-4c9c-a61c-6574a399b891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_e92ab2b0-2f43-41e9-94c1-a3f3d533dbf4" xlink:href="mck-20220331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A130NotesDueAugust152026Member_e92ab2b0-2f43-41e9-94c1-a3f3d533dbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_56266d63-55e9-44d9-a0bc-4977c3619aa1" xlink:href="mck-20220331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A475NotesDueMarch12021Member_56266d63-55e9-44d9-a0bc-4977c3619aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_c670d885-b168-47ca-a6db-037be9d76ac7" xlink:href="mck-20220331.xsd#mck_NotesDueNovember302020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_NotesDueNovember302020Member_c670d885-b168-47ca-a6db-037be9d76ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_4c79e471-9725-4b40-91b7-ca26d76ad2e6" xlink:href="mck-20220331.xsd#mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember_4c79e471-9725-4b40-91b7-ca26d76ad2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_ef73e888-829d-4d12-bd43-04f9d7f8f38a" xlink:href="mck-20220331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A285NotesDueMarch152023Member_ef73e888-829d-4d12-bd43-04f9d7f8f38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_2fd04a50-b480-44be-b24b-1878f189e73c" xlink:href="mck-20220331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A380NotesDueMarch152024Member_2fd04a50-b480-44be-b24b-1878f189e73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_ae03cd06-694a-45cf-82c2-ae7b292825ae" xlink:href="mck-20220331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_ae03cd06-694a-45cf-82c2-ae7b292825ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_8f612324-efa0-4a84-a4e3-5db28d1ed34f" xlink:href="mck-20220331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A395NotesDueFebruary162028Member_8f612324-efa0-4a84-a4e3-5db28d1ed34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_c4b7617e-ee37-45ef-be79-101d12603f11" xlink:href="mck-20220331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A475NotesDueMay302029Member_c4b7617e-ee37-45ef-be79-101d12603f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_a9b8ffd0-f8b0-4110-b868-ad8d398433b7" xlink:href="mck-20220331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A600NotesDueMarch12041Member_a9b8ffd0-f8b0-4110-b868-ad8d398433b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_55c91330-9075-4406-a2fb-854d0b5868b6" xlink:href="mck-20220331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A488NotesDueMarch152044Member_55c91330-9075-4406-a2fb-854d0b5868b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_61911ac7-f780-402c-abe8-57b7238081e3" xlink:href="mck-20220331.xsd#mck_TenderOfferNotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_TenderOfferNotesMember_61911ac7-f780-402c-abe8-57b7238081e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_e9a0cb1d-860d-444c-9539-ce9cd699f51f" xlink:href="mck-20220331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c44b094c-eca1-4bea-9636-316258273b87" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_e9a0cb1d-860d-444c-9539-ce9cd699f51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d462a345-d446-4c40-be50-a0b1a5b469ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_34a3318c-62ba-4118-803e-b04200a92049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_34a3318c-62ba-4118-803e-b04200a92049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_0cbc4e64-39af-4670-ba3b-7f5096e7f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d7e8e74c-471e-4905-8d17-6e5306e3151a" xlink:to="loc_us-gaap_LoansPayableMember_0cbc4e64-39af-4670-ba3b-7f5096e7f13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_011baa47-0deb-46d9-9713-68264ba312f2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1cefa8d-e4b7-4330-9171-4e599397225f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1cefa8d-e4b7-4330-9171-4e599397225f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6fe42964-5097-4244-9422-08422784e172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6fe42964-5097-4244-9422-08422784e172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_76172368-6dcc-404b-a73e-16ddbd7ac809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_76172368-6dcc-404b-a73e-16ddbd7ac809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_af582cb9-99ce-49cd-9007-a70b16de34ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_af582cb9-99ce-49cd-9007-a70b16de34ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2f559506-539d-4a3a-bb83-70e10b5721e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2f559506-539d-4a3a-bb83-70e10b5721e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2eed347c-6049-4ff6-97c4-9ca838342d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_2eed347c-6049-4ff6-97c4-9ca838342d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_e9f7e684-232f-4ea2-974a-1e9b723860db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_e9f7e684-232f-4ea2-974a-1e9b723860db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_c7616686-17a0-4fd9-a494-61e79a3daf68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_c7616686-17a0-4fd9-a494-61e79a3daf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_fa3ea0a6-835f-40b6-8440-1eb9dc3579c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_InterestPaid_fa3ea0a6-835f-40b6-8440-1eb9dc3579c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8ce38ad9-d9ee-44ce-a15b-e4c5db2d857d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8ce38ad9-d9ee-44ce-a15b-e4c5db2d857d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_76ca42cd-2390-455f-8799-fab0d357d427" xlink:href="mck-20220331.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_76ca42cd-2390-455f-8799-fab0d357d427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_14418c7c-9e05-4e93-aeff-7e18a48dac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_14418c7c-9e05-4e93-aeff-7e18a48dac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5fd425b3-6e50-46e7-abc5-4c574465567b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5fd425b3-6e50-46e7-abc5-4c574465567b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b6d5e0be-1d1a-4b7a-a307-dcf8ce87eee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b6d5e0be-1d1a-4b7a-a307-dcf8ce87eee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_805f62f0-0ada-41bf-9f24-e2dae62bdc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_805f62f0-0ada-41bf-9f24-e2dae62bdc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_843d67ba-1c7c-4d11-9fc9-fbd501495a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_843d67ba-1c7c-4d11-9fc9-fbd501495a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_08663850-2628-46cc-a33b-b3e05f7edac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_08663850-2628-46cc-a33b-b3e05f7edac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b671737b-4c09-449f-a01c-4bba1cea4a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_b671737b-4c09-449f-a01c-4bba1cea4a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_1539543e-0c15-46ed-87e3-c5369ea91972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_1539543e-0c15-46ed-87e3-c5369ea91972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fa77f234-941f-4d4c-8179-16dde6126e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fa77f234-941f-4d4c-8179-16dde6126e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6caba771-fc97-4c81-8858-08b55049c0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bacb747-4d75-45c9-8ef1-ce3408531d93" xlink:to="loc_us-gaap_LongTermDebt_6caba771-fc97-4c81-8858-08b55049c0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6fc013a8-d1b4-405a-8834-773435e02872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6fc013a8-d1b4-405a-8834-773435e02872" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e45a41cb-3f9b-4eae-9163-016bfa4a2298" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_af39d260-327f-47b4-a522-9345f71dd547" xlink:href="mck-20220331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_af39d260-327f-47b4-a522-9345f71dd547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_332dd664-2a2b-4ccb-aa43-22138c6c9a6c" xlink:href="mck-20220331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b590b4dc-0022-48bc-9bfa-0b49c7bda549" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_332dd664-2a2b-4ccb-aa43-22138c6c9a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f4e33fa5-27bf-4390-a74e-235146d0f0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2a8bde67-f9a2-4c02-ac04-ee94caa1d1cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f4e33fa5-27bf-4390-a74e-235146d0f0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_832dd27a-9062-4b5b-82af-5ecc7c32c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f4e33fa5-27bf-4390-a74e-235146d0f0ca" xlink:to="loc_us-gaap_UnsecuredDebtMember_832dd27a-9062-4b5b-82af-5ecc7c32c4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_56772990-aad4-4e30-ada0-45b2815a6893" xlink:to="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_cdc17ff5-0688-48c3-9e4c-81e34be9735b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_cdc17ff5-0688-48c3-9e4c-81e34be9735b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GlobalFacilityMember_cc9e39c9-535a-44d6-b2e3-fe8dc8cb72ed" xlink:href="mck-20220331.xsd#mck_GlobalFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:to="loc_mck_GlobalFacilityMember_cc9e39c9-535a-44d6-b2e3-fe8dc8cb72ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e7216e2a-4678-44b7-ad3f-744c653d0cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a8a20ea7-e3a6-4c5b-8817-cdc3f99594b0" xlink:to="loc_us-gaap_LineOfCreditMember_e7216e2a-4678-44b7-ad3f-744c653d0cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c90f8a16-46ed-4046-a68f-12e156f3b7ed" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61d36ae2-988e-4e5f-ba04-232621e27598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61d36ae2-988e-4e5f-ba04-232621e27598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bd29acbd-83ac-4d57-b899-29542a2efbd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_DebtInstrumentTerm_bd29acbd-83ac-4d57-b899-29542a2efbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_9d7ea8ed-4dc1-40de-9333-936c0793c1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_9d7ea8ed-4dc1-40de-9333-936c0793c1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ed856f3d-20f7-4738-87a0-8dfe0d6a3811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCredit_ed856f3d-20f7-4738-87a0-8dfe0d6a3811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_abefaa1b-7471-4a76-8bda-8ece572b2e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_abefaa1b-7471-4a76-8bda-8ece572b2e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_4a73212c-f856-41be-8843-f2a104461e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b36b1735-a790-497b-bc1c-4cd09c95bc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_4a73212c-f856-41be-8843-f2a104461e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e7a36d72-cf7a-49e0-b6ed-70c99483b6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e7a36d72-cf7a-49e0-b6ed-70c99483b6c8" xlink:to="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:to="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_67a10f23-9e05-4efb-9949-9c266d110815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_cb43b755-f590-4d61-8859-290b4fcc2230" xlink:to="loc_us-gaap_CreditFacilityDomain_67a10f23-9e05-4efb-9949-9c266d110815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_2b1d5747-45b9-4b0c-a474-6ba319c792b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_67a10f23-9e05-4efb-9949-9c266d110815" xlink:to="loc_us-gaap_CommercialPaperMember_2b1d5747-45b9-4b0c-a474-6ba319c792b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_378799ce-2ba5-465c-8339-58083430de01" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34788f67-0dc6-4355-b10b-9831d57625f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34788f67-0dc6-4355-b10b-9831d57625f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f39716a1-1db9-4522-a2c8-cc3977d5e088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_f39716a1-1db9-4522-a2c8-cc3977d5e088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_8fc2e008-e661-4528-8b13-ac6775e1f9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_8fc2e008-e661-4528-8b13-ac6775e1f9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f54e5010-294b-4076-8039-0a737a63d80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1027611b-0ff9-489f-b506-7514d609d114" xlink:to="loc_us-gaap_LongTermDebt_f54e5010-294b-4076-8039-0a737a63d80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="mck-20220331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_530ae17d-cabd-4fd3-9528-abe0a9f96dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_bcf67d77-15c4-43e0-aed4-ad21a5bda9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_530ae17d-cabd-4fd3-9528-abe0a9f96dc0" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_bcf67d77-15c4-43e0-aed4-ad21a5bda9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#VariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_c5929139-c6de-4eb8-ad05-48528e252613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_c5929139-c6de-4eb8-ad05-48528e252613" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ec5e36bd-dfed-4247-9ba9-5ad96ca06fd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f479ffb9-6b8a-4582-8f4f-9cbc8c6e42da" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ec5e36bd-dfed-4247-9ba9-5ad96ca06fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_659deaeb-778c-41f4-bed7-bce2c1af74a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ec5e36bd-dfed-4247-9ba9-5ad96ca06fd6" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_659deaeb-778c-41f4-bed7-bce2c1af74a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f3d1aa61-3ee0-4ad0-ad42-c78fb3dad9e5" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_780f43ab-af00-44ca-be0f-472aabad3ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_Assets_780f43ab-af00-44ca-be0f-472aabad3ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b119a02e-f621-4fc8-ad97-76b1a4897f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_Liabilities_b119a02e-f621-4fc8-ad97-76b1a4897f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_621b8213-4190-4370-aabb-d167b9dbbb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_10335141-0efa-419e-922e-44e771a7ad84" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_621b8213-4190-4370-aabb-d167b9dbbb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0044d5eb-234c-4ad0-ac16-792bf7b4c87a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5704a2ac-647e-4cd2-9d43-df8681786f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0044d5eb-234c-4ad0-ac16-792bf7b4c87a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5704a2ac-647e-4cd2-9d43-df8681786f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2dea713b-7581-4867-9962-0e221ef00e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2dea713b-7581-4867-9962-0e221ef00e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_0a08ac88-683b-4b21-9e8a-a466e9d534bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_0a08ac88-683b-4b21-9e8a-a466e9d534bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_19d8eba9-4ba2-4ba9-90cc-128a6d976aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_19d8eba9-4ba2-4ba9-90cc-128a6d976aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_88263c94-416c-4981-9810-f45413f401ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_88263c94-416c-4981-9810-f45413f401ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_55913fb2-fe4e-4002-9c7a-ffd6b7f28200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_55913fb2-fe4e-4002-9c7a-ffd6b7f28200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b6f45bc6-03aa-4658-a8e4-f93f23531d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b6f45bc6-03aa-4658-a8e4-f93f23531d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_1942560e-5749-4ee9-9597-35f8f0eb8e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_1942560e-5749-4ee9-9597-35f8f0eb8e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_e551c44c-7190-43e1-9396-034a5efb38f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f2b8310-0053-44a0-aef5-2be4ba870772" xlink:to="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_e551c44c-7190-43e1-9396-034a5efb38f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7781c5bd-ca17-41e8-8a08-e1f074c3cb71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7781c5bd-ca17-41e8-8a08-e1f074c3cb71" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_0e416699-8a53-4ac2-b706-3fa36888cf67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c5e1cdaf-aeb2-4281-bfa2-0d16f7586a6e" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_0e416699-8a53-4ac2-b706-3fa36888cf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_0eea5471-b010-4cfa-9711-e732b1a921c2" xlink:href="mck-20220331.xsd#mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_0e416699-8a53-4ac2-b706-3fa36888cf67" xlink:to="loc_mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember_0eea5471-b010-4cfa-9711-e732b1a921c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0ae2e5e5-e300-4a1f-8e0a-8a069d6b43a9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_1de46161-3f25-4c7f-b812-6ac0f8078a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:to="loc_us-gaap_DomesticPlanMember_1de46161-3f25-4c7f-b812-6ac0f8078a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1bc3e059-0d17-488e-9881-a53890b32b82" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_1de46161-3f25-4c7f-b812-6ac0f8078a0d" xlink:to="loc_country_US_1bc3e059-0d17-488e-9881-a53890b32b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_4fc207e3-d708-4670-8b46-f8a6036af7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ef832d6c-6ed1-4cdd-a0a0-9b13406e858c" xlink:to="loc_us-gaap_ForeignPlanMember_4fc207e3-d708-4670-8b46-f8a6036af7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_fafb7fa8-b72a-47e3-bfbd-483b6adb2c4c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b499aeb1-0804-464a-a05c-b268a1805f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b499aeb1-0804-464a-a05c-b268a1805f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_772e3459-b81e-4cc2-aa02-5a7bdbcf52e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_63be34c7-2e72-4477-8767-7002abe8f2fc" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_772e3459-b81e-4cc2-aa02-5a7bdbcf52e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_f1351f2d-aa4a-4943-985a-78581722c6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_6dfd777c-f52b-44a3-beb3-086ada6a285c" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_f1351f2d-aa4a-4943-985a-78581722c6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_20e629e5-d446-463d-a8a6-f1e49e8fb08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_f1351f2d-aa4a-4943-985a-78581722c6a4" xlink:to="loc_us-gaap_UnfundedPlanMember_20e629e5-d446-463d-a8a6-f1e49e8fb08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7c072712-d496-44e4-9060-1133d239ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c5ab5a37-72d3-4bd5-ac05-5f3e6019af45" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7c072712-d496-44e4-9060-1133d239ed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c8ecba4d-d23e-4632-9afd-75be7dd04111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7c072712-d496-44e4-9060-1133d239ed7b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c8ecba4d-d23e-4632-9afd-75be7dd04111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3b7bf8bd-991a-4dae-b07b-480c3dd9fd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_2c3d0ea4-ebae-41c2-a1d7-083c61999c85" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3b7bf8bd-991a-4dae-b07b-480c3dd9fd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember_bdb48497-2672-409e-ae0d-f54583236eef" xlink:href="mck-20220331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3b7bf8bd-991a-4dae-b07b-480c3dd9fd38" xlink:to="loc_mck_NorwegianPublicServicePensionFundSPKMember_bdb48497-2672-409e-ae0d-f54583236eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:href="mck-20220331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_d0f221f2-7b50-45f7-9a3c-5514f8756424" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember_3f7ade6a-07c7-49ee-bb59-81569feaf388" xlink:href="mck-20220331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:to="loc_mck_FirstPartOfPayContributionMember_3f7ade6a-07c7-49ee-bb59-81569feaf388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember_20dbb90a-7329-4ab8-8137-bb3071f5cd43" xlink:href="mck-20220331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_ced0cf5f-9853-4b25-8f6a-d2a09cf021be" xlink:to="loc_mck_SecondPartOfPayContributionMember_20dbb90a-7329-4ab8-8137-bb3071f5cd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfb143f-3172-4e18-91fd-0ad8e802ad2a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_c64a7d51-7350-45f9-b8e0-9b6ae98a6d5e" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:to="loc_mck_GermanWholesaleBusinessMember_c64a7d51-7350-45f9-b8e0-9b6ae98a6d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_ab94d9fb-f8fb-42d7-9f8f-5d43ae79f598" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_ab94d9fb-f8fb-42d7-9f8f-5d43ae79f598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_7cef6bd4-46f7-4193-b9d6-37813030bcc0" xlink:href="mck-20220331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27a15d85-c9f8-4615-8c64-cd1392e9840d" xlink:to="loc_mck_AustrianBusinessOperationsMember_7cef6bd4-46f7-4193-b9d6-37813030bcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ac9aa179-c9a8-45ab-bdf2-1e2a9ec4cac8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_05670785-acb8-413f-a08d-d603fb13dfc0" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanSettlementPlanParticipants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanSettlementPlanParticipants_05670785-acb8-413f-a08d-d603fb13dfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_121928c2-6650-4d54-b388-77c333d6d7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_121928c2-6650-4d54-b388-77c333d6d7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_be1649a7-7a2c-439d-91cc-f920faf439ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_be1649a7-7a2c-439d-91cc-f920faf439ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_ea5ec0fe-b017-40a4-a4bf-bd58c75da091" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract_ea5ec0fe-b017-40a4-a4bf-bd58c75da091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_85727fde-2eb5-4867-b756-746e57d07cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_85727fde-2eb5-4867-b756-746e57d07cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_495cf91a-6eeb-453d-bc90-608f7c79f89d" xlink:href="mck-20220331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_495cf91a-6eeb-453d-bc90-608f7c79f89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_52200974-64cf-4a22-85f2-7775b0887e50" xlink:href="mck-20220331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_52200974-64cf-4a22-85f2-7775b0887e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_45345556-020c-4a23-9d41-18eb14eda3d7" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_45345556-020c-4a23-9d41-18eb14eda3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_ee4a04f6-2a88-4b93-aa1a-b5ce84a15002" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_ee4a04f6-2a88-4b93-aa1a-b5ce84a15002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_76aac451-4424-406f-b87a-5abc0f67a3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_76aac451-4424-406f-b87a-5abc0f67a3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b2950245-aa4e-47da-9bd5-21f717e56a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b2950245-aa4e-47da-9bd5-21f717e56a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_e3b0c7e6-0784-4efc-8afb-4c05de8e9dfe" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_e3b0c7e6-0784-4efc-8afb-4c05de8e9dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f20f2d1d-496c-4828-8abd-121cd52d0cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f20f2d1d-496c-4828-8abd-121cd52d0cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_ae43debb-c38d-49f1-9aee-d4a9b84bd624" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_ae43debb-c38d-49f1-9aee-d4a9b84bd624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e11c11dc-9eae-4dc3-a8a7-3016e5157a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e11c11dc-9eae-4dc3-a8a7-3016e5157a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1fbdb592-2760-4c5a-b687-9ea063fc314f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1fbdb592-2760-4c5a-b687-9ea063fc314f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ae833b4d-9e57-423b-adbe-6dd9ec4db95d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ae833b4d-9e57-423b-adbe-6dd9ec4db95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5b6b1588-e8c5-4b7b-91ca-815c7d755ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5b6b1588-e8c5-4b7b-91ca-815c7d755ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_715454f2-f1e4-49e7-8b05-06a793a54a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_715454f2-f1e4-49e7-8b05-06a793a54a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f3227cf0-e106-4f8d-93ce-e5d04fedcad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f3227cf0-e106-4f8d-93ce-e5d04fedcad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_70aaf225-0f8b-4aa0-a4cd-0301dcf4bb84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_70aaf225-0f8b-4aa0-a4cd-0301dcf4bb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fbec5b03-88bd-409a-8078-c8dd2f51578a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fbec5b03-88bd-409a-8078-c8dd2f51578a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_1d2c260a-40e5-430d-8f77-91c647ef96d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_1d2c260a-40e5-430d-8f77-91c647ef96d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d5ee3af1-c039-441a-b8b5-b159088c5260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d5ee3af1-c039-441a-b8b5-b159088c5260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_7778cadd-00b5-461f-adfa-7aca3af9c0c6" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_7778cadd-00b5-461f-adfa-7aca3af9c0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents_2f13e4ea-7a47-45b9-9711-51f3fdb9c06b" xlink:href="mck-20220331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_UnitValueOfCashAndCashEquivalents_2f13e4ea-7a47-45b9-9711-51f3fdb9c06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_3cc050d7-7664-4253-8a03-e459ebc68363" xlink:href="mck-20220331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_3cc050d7-7664-4253-8a03-e459ebc68363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e0d1e156-3d6f-4d7f-8d09-c6c1a734a2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_e0d1e156-3d6f-4d7f-8d09-c6c1a734a2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_aeafcb50-c697-4451-9d67-77a9ac8efd5b" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_aeafcb50-c697-4451-9d67-77a9ac8efd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage_f0152ae2-06ae-41c8-b7a1-64e4fdbfb1f0" xlink:href="mck-20220331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_MultiemployerPlanFundedStatusPercentage_f0152ae2-06ae-41c8-b7a1-64e4fdbfb1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_aab04b8b-9675-4796-a74e-3d4d3b57ec17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_aab04b8b-9675-4796-a74e-3d4d3b57ec17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_0af027cd-217a-4ab8-a65e-51e0fccac926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_0af027cd-217a-4ab8-a65e-51e0fccac926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5b39fd01-d35b-476e-a8c8-f3b7d43af6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5b39fd01-d35b-476e-a8c8-f3b7d43af6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions_97d5c768-300c-4e3f-8221-16784ad5be7c" xlink:href="mck-20220331.xsd#mck_EmployeeContributions"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_mck_EmployeeContributions_97d5c768-300c-4e3f-8221-16784ad5be7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_561bea19-b289-41d7-a639-a4398a48f1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_561bea19-b289-41d7-a639-a4398a48f1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40ebc172-c22f-4f81-9786-64f6a9dfb49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6d133872-06de-4bc2-9eee-c5097246a7d7" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40ebc172-c22f-4f81-9786-64f6a9dfb49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5e885cc6-e95c-4b68-8aad-24c978ba3dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5e885cc6-e95c-4b68-8aad-24c978ba3dd0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_13b6047f-356e-4049-b8f9-f21919e9a7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dc947f83-5837-44dd-9fce-2acc3a1807cb" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_13b6047f-356e-4049-b8f9-f21919e9a7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9a488ea5-5726-48c6-bbf8-1f0ff198a65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_13b6047f-356e-4049-b8f9-f21919e9a7e2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9a488ea5-5726-48c6-bbf8-1f0ff198a65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_785b6dcd-b543-4003-bf0b-925de92ebeb7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d7b9af9d-2dfb-40d0-8e8d-2ef3fa3e5c77" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:to="loc_country_US_d7b9af9d-2dfb-40d0-8e8d-2ef3fa3e5c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_f15329f6-0be8-4ceb-9cd1-4420dce0d910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e633f7ab-8416-4281-86ce-9bd382c25610" xlink:to="loc_us-gaap_ForeignPlanMember_f15329f6-0be8-4ceb-9cd1-4420dce0d910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c51fbf32-06cb-460f-9abe-51b2a64ba141" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_64af2242-956f-44ed-802d-68bfa893c3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_64af2242-956f-44ed-802d-68bfa893c3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f79124b6-7397-4762-8e51-01b4461801c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f79124b6-7397-4762-8e51-01b4461801c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1e256d6e-12e2-4f7c-8e5c-75010ce6f23c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1e256d6e-12e2-4f7c-8e5c-75010ce6f23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_2006d40e-89a5-45ab-b1e5-e623aca30f7a" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_2006d40e-89a5-45ab-b1e5-e623aca30f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_6de1bcf5-c480-4cb9-a027-1d1e258ff264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_6de1bcf5-c480-4cb9-a027-1d1e258ff264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c0491b2f-50e9-4e87-9463-47409ecaeaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51b941dd-7c33-4703-9bf7-ba36e5476d37" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c0491b2f-50e9-4e87-9463-47409ecaeaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_50455c0b-b0b0-467a-ac28-a09cc5238ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_50455c0b-b0b0-467a-ac28-a09cc5238ed8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_61847a86-fa71-4343-aa92-e64c3b1afd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_94de99d6-ebcd-4cca-94b1-2c9e54fa6165" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_61847a86-fa71-4343-aa92-e64c3b1afd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d40d04fe-8cc0-4e9e-be00-8c18ddf872a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_61847a86-fa71-4343-aa92-e64c3b1afd03" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d40d04fe-8cc0-4e9e-be00-8c18ddf872a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e538950f-924a-4845-8f2d-53899bc6a39c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_48ecfe6d-6acc-414c-a36e-7d78861e1ef4" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:to="loc_mck_GermanWholesaleBusinessMember_48ecfe6d-6acc-414c-a36e-7d78861e1ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_2047d874-a578-414d-b8b3-f25e5e46d411" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_2047d874-a578-414d-b8b3-f25e5e46d411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_d4c0b9e1-43d2-460a-bf7e-64d8b7483499" xlink:href="mck-20220331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_08946475-c561-4eb5-9b6b-3ecd783a0082" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_d4c0b9e1-43d2-460a-bf7e-64d8b7483499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c41f1f99-3ec7-4449-989f-f77191adb41e" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1f41e5e2-abcb-47ff-b3ec-a78062b2d1cc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:to="loc_country_US_1f41e5e2-abcb-47ff-b3ec-a78062b2d1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_78f27527-d447-49f5-b0f0-5589b41c897a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_0796afd4-7c7c-4f31-965b-7b04e1d9b779" xlink:to="loc_us-gaap_ForeignPlanMember_78f27527-d447-49f5-b0f0-5589b41c897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_18f0df27-76ac-485e-9fee-5dc0384e2ba8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_de23429d-529b-43e7-bec4-db1082d06512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_de23429d-529b-43e7-bec4-db1082d06512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_4108213a-9fa4-4a42-b57e-0807fb99b499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_4108213a-9fa4-4a42-b57e-0807fb99b499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_5a7c94bb-73f2-4d69-8756-c379d0b0c51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_5a7c94bb-73f2-4d69-8756-c379d0b0c51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7b9f3741-c3ad-4ab1-b5d7-a1f46db9051c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7b9f3741-c3ad-4ab1-b5d7-a1f46db9051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_14d8f43d-1e1d-4b3c-9c3c-29098ba71fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_14d8f43d-1e1d-4b3c-9c3c-29098ba71fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_8924b5dd-ad1e-4f16-a9b1-12e4c9d6e413" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_8924b5dd-ad1e-4f16-a9b1-12e4c9d6e413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_42549632-832c-4062-86a9-6a46532d26f3" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanBenefitObligationsExpensesPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_42549632-832c-4062-86a9-6a46532d26f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_4a498f4e-1596-4075-aa7e-ab3dff7fcc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_4a498f4e-1596-4075-aa7e-ab3dff7fcc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_30e53197-2c8b-4b30-a22f-fd7ff6ee5a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_30e53197-2c8b-4b30-a22f-fd7ff6ee5a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_03855e34-4381-4731-8a19-221649ce6f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f94114cb-cb98-4aa7-bc7f-acdaef037022" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_03855e34-4381-4731-8a19-221649ce6f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c300c2c6-3c92-45de-9418-2d16a3b66d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c300c2c6-3c92-45de-9418-2d16a3b66d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_48973879-1e18-4920-acbf-bb1d4eb2739a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_48973879-1e18-4920-acbf-bb1d4eb2739a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_3806a476-dbbb-4b89-a69d-a3a1a05a0b67" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_3806a476-dbbb-4b89-a69d-a3a1a05a0b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3da5c99a-a776-483f-9c91-0dd35b24f401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3da5c99a-a776-483f-9c91-0dd35b24f401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_a3564afd-eabb-4cae-a839-e6a587b6def2" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanPlanAssetsExpensesPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_a3564afd-eabb-4cae-a839-e6a587b6def2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4606950c-22c5-4445-a0fb-1fa250baa405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_4606950c-22c5-4445-a0fb-1fa250baa405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_71bb0440-47a4-4e18-8162-42c44d6e4399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_71bb0440-47a4-4e18-8162-42c44d6e4399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4633436c-25d0-4a06-ba0d-7a8aaebda8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ec8ac166-6bec-485d-8d30-e6158247f258" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4633436c-25d0-4a06-ba0d-7a8aaebda8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_0b6e5523-38fa-4508-bc32-692036d92cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_0b6e5523-38fa-4508-bc32-692036d92cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_046d69e4-592a-49b7-81a6-70b33aa42e16" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_214184a3-b68f-4234-b6d1-cbb65a2f9a08" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_214184a3-b68f-4234-b6d1-cbb65a2f9a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_2379f36c-fee2-4637-84d5-496b19d7d6b1" xlink:href="mck-20220331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_2379f36c-fee2-4637-84d5-496b19d7d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_987c53ef-e2eb-426e-aa38-fadd90613a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_987c53ef-e2eb-426e-aa38-fadd90613a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_8d88be2b-56ac-41c9-8d3e-0fa1835c5519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_8d88be2b-56ac-41c9-8d3e-0fa1835c5519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_e849ea28-7936-4f76-8446-84f9c62b0dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_f26848ac-abc0-402e-961b-7dae32b31469" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_e849ea28-7936-4f76-8446-84f9c62b0dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8647c37f-7379-431c-854f-c33e308681e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8647c37f-7379-431c-854f-c33e308681e1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_e25ad84a-a19d-44dd-97ad-7e4f51da6b83" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_030c1dc4-2e13-45fc-92c2-a49217a75efa" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:to="loc_country_US_030c1dc4-2e13-45fc-92c2-a49217a75efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_16045988-0352-4728-afc1-4d41eb294167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff3310ef-7c47-4d3a-bc98-c3406871cc97" xlink:to="loc_us-gaap_ForeignPlanMember_16045988-0352-4728-afc1-4d41eb294167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_43059691-85c3-4704-9106-b09b313815e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ed17db58-8f4b-4fd0-ac96-3b9dae9a27f7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_43059691-85c3-4704-9106-b09b313815e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b0a3b6c8-71c5-4085-b49a-8b66b936227e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_43059691-85c3-4704-9106-b09b313815e0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b0a3b6c8-71c5-4085-b49a-8b66b936227e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_35c05102-e618-4a08-813b-937b937fd5df" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5f344c57-96cd-4d04-9f34-d76e2c18c178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5f344c57-96cd-4d04-9f34-d76e2c18c178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1bd565f5-1209-41c3-9533-6292711a1efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1bd565f5-1209-41c3-9533-6292711a1efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3097008a-3e7d-4c32-8374-8569304928c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b5ca5dc7-a44e-469d-85fe-5cb8c1bd5f00" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3097008a-3e7d-4c32-8374-8569304928c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d91148b-1b27-4250-a4bd-4f0758432b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d91148b-1b27-4250-a4bd-4f0758432b06" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_333faa59-fa81-4634-9b96-b59f7e3da852" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5fa4a3d1-01a7-4cc0-8ec4-640f55755585" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:to="loc_country_US_5fa4a3d1-01a7-4cc0-8ec4-640f55755585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1210511a-3aa8-423f-85a3-bafed4199126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3754f13-c3f4-4cfd-bfc9-b3ad81ee5b11" xlink:to="loc_us-gaap_ForeignPlanMember_1210511a-3aa8-423f-85a3-bafed4199126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f1890293-4789-44b3-b213-68e37e784aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8ba786b4-443d-4bab-a598-55aa2802eead" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f1890293-4789-44b3-b213-68e37e784aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b2061945-6291-4fdb-82d9-e9b14b0c4dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f1890293-4789-44b3-b213-68e37e784aaf" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b2061945-6291-4fdb-82d9-e9b14b0c4dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ca60e589-f8a9-44cd-94ac-28766de6720a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_8b09f8d8-80af-44dd-815e-56a040e2ed24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_8b09f8d8-80af-44dd-815e-56a040e2ed24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_dd89ec6f-4b36-4b70-930b-a3a57e599dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_dd89ec6f-4b36-4b70-930b-a3a57e599dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_4dbbd5e9-6a3b-4302-b66e-6f0addcf283f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4fc7c36d-df0a-485a-881c-732258df76a1" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_4dbbd5e9-6a3b-4302-b66e-6f0addcf283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7275f11f-bf9b-44a1-b900-87226b28c49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7275f11f-bf9b-44a1-b900-87226b28c49a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_e4b166ea-298a-4451-8509-99cf859ee6da" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cb0e5ef0-f371-4ef8-a173-3ae37db021cf" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:to="loc_country_US_cb0e5ef0-f371-4ef8-a173-3ae37db021cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_6fe207e7-559f-4533-ab1b-722e5b794a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f7721096-7d25-47cf-9ab0-9cfeba4c5709" xlink:to="loc_us-gaap_ForeignPlanMember_6fe207e7-559f-4533-ab1b-722e5b794a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_55a552bf-2855-4017-9cd8-a63a6bdcaf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d4cd61fb-7d57-41d6-91a0-923926f42493" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_55a552bf-2855-4017-9cd8-a63a6bdcaf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d5a3445b-4f29-4daf-9334-3d01d269896c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_55a552bf-2855-4017-9cd8-a63a6bdcaf9f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d5a3445b-4f29-4daf-9334-3d01d269896c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_869c118d-81fa-4d81-a0f8-ef7e7e3d023f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_f412f8cd-0b00-4077-ba02-d978600d8ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_f412f8cd-0b00-4077-ba02-d978600d8ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a2b7b414-2731-4c37-bc35-c913f78a5f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a2b7b414-2731-4c37-bc35-c913f78a5f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_c873cf46-752c-4397-b3bd-7569dbcb2cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_0600b775-c02e-4487-960f-0f3afdc6acc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_c873cf46-752c-4397-b3bd-7569dbcb2cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_1d9d5367-7e80-4377-9d1e-d73dd4df4e2d" xlink:href="mck-20220331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_1d9d5367-7e80-4377-9d1e-d73dd4df4e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b1962c4f-2d5a-4204-9cdc-f1dff70f49a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c302ac9f-1049-432a-96e1-52ff7ba3515b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b1962c4f-2d5a-4204-9cdc-f1dff70f49a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_38f56643-684c-4bee-aaaf-a11e93986f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_38f56643-684c-4bee-aaaf-a11e93986f9a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_353f72ff-cd4d-414d-acc6-fbe5d410791b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e51083a9-168d-42c6-b7ef-45b05f68f7f3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:to="loc_country_US_e51083a9-168d-42c6-b7ef-45b05f68f7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8a3f92ad-3b51-4d09-bb20-46aee98a10a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c754fe79-1e3e-4096-beb8-86b13967a5b8" xlink:to="loc_us-gaap_ForeignPlanMember_8a3f92ad-3b51-4d09-bb20-46aee98a10a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e7fa61c5-c29c-49d9-8a58-b0b18bc44e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c930a32b-87b9-403f-86ae-25bb05d6b37b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e7fa61c5-c29c-49d9-8a58-b0b18bc44e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_abf6e6f1-8a03-4822-8112-06ac0453efda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e7fa61c5-c29c-49d9-8a58-b0b18bc44e71" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_abf6e6f1-8a03-4822-8112-06ac0453efda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_22c67d85-2bc0-4851-ac1d-a972fe7ec2e3" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6181a654-94e4-4298-b6dc-e4c3c0b5ea51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6181a654-94e4-4298-b6dc-e4c3c0b5ea51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d21c21cf-adbe-4f5c-9f44-54a77719d3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d21c21cf-adbe-4f5c-9f44-54a77719d3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_27b0ce5c-ead3-4501-82de-69e4a523bc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4e984eaf-cec1-4378-82d0-9ab27d9a4160" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_27b0ce5c-ead3-4501-82de-69e4a523bc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e5061066-3f99-4f87-b99a-553c0fe80be6" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d9f7cda0-498a-4bd7-9000-6c824c18c767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_d9f7cda0-498a-4bd7-9000-6c824c18c767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_e34edaa8-f385-44d9-85a0-752f72b0bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_9e309346-0c55-46a5-9e82-d0b4f1599e13" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_e34edaa8-f385-44d9-85a0-752f72b0bf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_681e62e3-99b8-496b-8587-ac24951e896e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_681e62e3-99b8-496b-8587-ac24951e896e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b2d87a09-a993-42e7-b89e-a50fad0d4f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3baa2c99-385c-436f-9099-8c85f8705a9d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b2d87a09-a993-42e7-b89e-a50fad0d4f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d470f639-bb39-45e5-92f5-280e6a21caf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b2d87a09-a993-42e7-b89e-a50fad0d4f2c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d470f639-bb39-45e5-92f5-280e6a21caf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1539532a-3aac-4ea5-87b7-add9946479cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fb84efc-eb22-4855-8767-e6fdd41854a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1539532a-3aac-4ea5-87b7-add9946479cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_ec95e7f2-7ea7-430c-b91c-77480431d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_1539532a-3aac-4ea5-87b7-add9946479cd" xlink:to="loc_us-gaap_ForeignPlanMember_ec95e7f2-7ea7-430c-b91c-77480431d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_95c960ea-e81c-4a24-81c2-18d048e3334f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_d0ebb2ed-c1d4-4e64-9f6d-109b7d91d56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_d0ebb2ed-c1d4-4e64-9f6d-109b7d91d56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_495ee043-d7e2-4480-a805-07a3f4b5505b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_MutualFundMember_495ee043-d7e2-4480-a805-07a3f4b5505b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_6dfba806-4492-4c97-8add-8f1cb50a259f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_6dfba806-4492-4c97-8add-8f1cb50a259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_036a8c16-5e62-4c2f-9718-27a27cd485f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_036a8c16-5e62-4c2f-9718-27a27cd485f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_082e96f0-c487-43a9-91a0-12fa5aaff3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_us-gaap_FixedIncomeFundsMember_082e96f0-c487-43a9-91a0-12fa5aaff3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAnnuityContractsMember_e9bb68e5-3e4c-4dcd-84d5-2a98d8a79f5d" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanAnnuityContractsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_mck_DefinedBenefitPlanAnnuityContractsMember_e9bb68e5-3e4c-4dcd-84d5-2a98d8a79f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember_ddf95c9c-18dc-44b1-88eb-5eb965043092" xlink:href="mck-20220331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e570e25e-d156-45f1-a853-f6796a6dc479" xlink:to="loc_mck_DefinedBenefitPlanOtherFundsMember_ddf95c9c-18dc-44b1-88eb-5eb965043092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7dfc12c0-f1a4-485f-aebe-33a3f99251e1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_99e5b117-ec6a-4f8c-a10b-e1832d024d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_99e5b117-ec6a-4f8c-a10b-e1832d024d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_69dcacd9-2ccf-491a-a334-4ea8e813639c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_69dcacd9-2ccf-491a-a334-4ea8e813639c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b4d892a2-220c-4052-9c58-9ce7f7c6ee0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f150ead-05bf-4efb-9ec6-75506151a0cb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b4d892a2-220c-4052-9c58-9ce7f7c6ee0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_e28e4d83-756e-4b88-b048-170284ec0637" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5ed02279-e80b-4f53-8c2f-714c30104061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5ed02279-e80b-4f53-8c2f-714c30104061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_a0b46756-1944-4e90-bea7-96a47356299b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_a0b46756-1944-4e90-bea7-96a47356299b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67c6d499-f5b2-4f71-9acd-e93a024fc4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_444b4503-faf9-459f-a7ec-b691e44a101f" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_67c6d499-f5b2-4f71-9acd-e93a024fc4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e4932f55-117a-4471-8a45-7ada52b9f434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1b8499f-f90f-41bd-a1e7-4ac3fff8548b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e4932f55-117a-4471-8a45-7ada52b9f434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_aa260407-e8cf-430a-a2bc-1bcdbb41028f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e4932f55-117a-4471-8a45-7ada52b9f434" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_aa260407-e8cf-430a-a2bc-1bcdbb41028f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_9b065669-c08a-41dc-a16d-bd9f5f0aabed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_9b065669-c08a-41dc-a16d-bd9f5f0aabed" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1697b9d-f152-4557-b027-66c2f4f5c8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a2ad5b04-9842-4289-b7f8-daee8b8b48c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1697b9d-f152-4557-b027-66c2f4f5c8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_15cb29bf-5f5d-45df-8b56-6f2751edca71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1697b9d-f152-4557-b027-66c2f4f5c8a3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_15cb29bf-5f5d-45df-8b56-6f2751edca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8ecb2c3b-833f-4e3d-8e6f-a0f9a97df7c9" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e553f0b9-a283-4abf-9c38-589152f910d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e553f0b9-a283-4abf-9c38-589152f910d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_127a83c3-13ad-43b9-b3a9-8a73fab6bcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_127a83c3-13ad-43b9-b3a9-8a73fab6bcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d928deb4-9c13-4060-bdb2-bb1b1f8989b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d928deb4-9c13-4060-bdb2-bb1b1f8989b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cb36e51-a7f9-418b-bc7b-4dbf08c1459f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ac9559fb-90cd-41c3-b51e-d9410e4ca287" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cb36e51-a7f9-418b-bc7b-4dbf08c1459f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20220331.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db3d6896-10b3-4292-b6d7-9a3bbf918af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_a50790c2-1d93-4a39-b8f6-f6c0df7b9a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db3d6896-10b3-4292-b6d7-9a3bbf918af5" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_a50790c2-1d93-4a39-b8f6-f6c0df7b9a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6b43a0bb-b6a1-49ef-ab1f-7283f1732241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c18b995f-eac7-4666-a24d-09edba5e8c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6b43a0bb-b6a1-49ef-ab1f-7283f1732241" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c18b995f-eac7-4666-a24d-09edba5e8c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_03632415-7dbd-4ad9-8b4e-29b9ef6244d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_03632415-7dbd-4ad9-8b4e-29b9ef6244d5" xlink:to="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f0347780-a056-41c7-8584-ebb1890ebd1b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_1a636705-72ff-4f4e-8c92-be761f2b7099" xlink:href="mck-20220331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:to="loc_mck_EuroDenominatedNotesMember_1a636705-72ff-4f4e-8c92-be761f2b7099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_f2eecc47-65b2-4dde-adca-5f946bc10b83" xlink:href="mck-20220331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa32c12c-8692-4154-a05f-f21ba43f83f8" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_f2eecc47-65b2-4dde-adca-5f946bc10b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a126975b-255c-49c3-9a6d-6ef6a81fa659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c6f2d5c1-af59-4f73-83b4-71b70fa07102" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a126975b-255c-49c3-9a6d-6ef6a81fa659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5db636c9-9be2-4b99-ad18-acb1d6102385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a126975b-255c-49c3-9a6d-6ef6a81fa659" xlink:to="loc_us-gaap_LoansPayableMember_5db636c9-9be2-4b99-ad18-acb1d6102385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d8d36708-3cd4-4549-b7c2-56b6892823db" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_3379d0d6-c41f-4e96-8b57-8f4d1da57899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_3379d0d6-c41f-4e96-8b57-8f4d1da57899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_889d1e49-522d-4c40-a127-ad19b10d4f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8cd2fa3b-3a34-4609-8587-6aaface5e12f" xlink:to="loc_us-gaap_CashFlowHedgingMember_889d1e49-522d-4c40-a127-ad19b10d4f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81c49e9b-fee8-4b6a-892e-769e475f4384" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_bd3770ec-5590-49c6-a451-d4e4572d07ae" xlink:href="mck-20220331.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_bd3770ec-5590-49c6-a451-d4e4572d07ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2d898070-41ef-4469-87ac-21186d8471b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_us-gaap_CurrencySwapMember_2d898070-41ef-4469-87ac-21186d8471b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_94e37717-3e06-45a2-8e34-3f6e854eb768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_us-gaap_ForeignExchangeContractMember_94e37717-3e06-45a2-8e34-3f6e854eb768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_f4c68dc4-b0c5-4aef-9ead-5fd045aa685f" xlink:href="mck-20220331.xsd#mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember_f4c68dc4-b0c5-4aef-9ead-5fd045aa685f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e24da8a5-8557-4944-83c2-92493b5dd2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_us-gaap_InterestRateSwapMember_e24da8a5-8557-4944-83c2-92493b5dd2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_aa74efff-37d4-47d7-b49e-1e657bbe43ab" xlink:href="mck-20220331.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee7acb70-93bf-40c1-b9ff-19f2146e7fd8" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_aa74efff-37d4-47d7-b49e-1e657bbe43ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_994356bc-c2a8-4532-b33b-07670637608a" xlink:to="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fafce9a5-c037-4620-9740-dfb7c8ccc9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fafce9a5-c037-4620-9740-dfb7c8ccc9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_49f8ad48-96dc-4ad2-8a66-f03f06b26b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8a98c305-019a-40a4-a708-1c6f0c06e492" xlink:to="loc_us-gaap_NondesignatedMember_49f8ad48-96dc-4ad2-8a66-f03f06b26b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_85f6856b-5640-472e-aeed-946765f087b3" xlink:to="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_38700dbb-88eb-4146-9e25-1b6beef629b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_LongTermDebt_38700dbb-88eb-4146-9e25-1b6beef629b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_f64e73c6-a0c0-4594-aaf6-9c211819f1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_f64e73c6-a0c0-4594-aaf6-9c211819f1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_47fc6d7d-3966-42fc-99fc-75597db837f1" xlink:href="mck-20220331.xsd#mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax_47fc6d7d-3966-42fc-99fc-75597db837f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9188eb6f-0b35-4528-8724-ab9377d4928f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9188eb6f-0b35-4528-8724-ab9377d4928f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_2d0bba6e-9465-45d8-8c1d-c6a9b8a3e5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_2d0bba6e-9465-45d8-8c1d-c6a9b8a3e5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfDerivatives_380e3679-c287-470f-bdcc-636d930553cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_GainLossOnSaleOfDerivatives_380e3679-c287-470f-bdcc-636d930553cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_19b3ccd2-493f-4c8c-a630-42d022df2191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_19b3ccd2-493f-4c8c-a630-42d022df2191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_64c72990-af35-4618-88d2-f9d4fbc6581a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_64c72990-af35-4618-88d2-f9d4fbc6581a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AmortizationOfLossOnDerivativeTerm_2b6860cd-0826-4ba9-815b-7824d0eb42fb" xlink:href="mck-20220331.xsd#mck_AmortizationOfLossOnDerivativeTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3df2e920-d9b2-4cb8-a2fe-a3e27fb186e4" xlink:to="loc_mck_AmortizationOfLossOnDerivativeTerm_2b6860cd-0826-4ba9-815b-7824d0eb42fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8b755e44-3809-45a8-a8c3-3552b9010f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8b755e44-3809-45a8-a8c3-3552b9010f16" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5d3c28e9-0f69-4d2b-b324-a948c038febd" xlink:to="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a844e60-6e0d-4586-a1a3-800aef698ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6a844e60-6e0d-4586-a1a3-800aef698ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_0863456f-dfa3-418c-99d4-7215a36bc80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9bfb90fc-f0de-4938-a292-f179b83b0ac9" xlink:to="loc_us-gaap_NondesignatedMember_0863456f-dfa3-418c-99d4-7215a36bc80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_36548675-4ba7-46dd-ab88-29915354eb01" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_34d964fd-fc35-4eda-ad7b-7dcd39666cb3" xlink:href="mck-20220331.xsd#mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember_34d964fd-fc35-4eda-ad7b-7dcd39666cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_bdcf02ad-3ab8-4226-ac94-313860028b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_bdcf02ad-3ab8-4226-ac94-313860028b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_61b53333-ee73-4e4c-a7b1-3879a0c5d603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_61b53333-ee73-4e4c-a7b1-3879a0c5d603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d53532c7-1c0f-499a-87ca-cc19ee77a8f6" xlink:href="mck-20220331.xsd#mck_OtherNoncurrentAssetsLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_mck_OtherNoncurrentAssetsLiabilitiesMember_d53532c7-1c0f-499a-87ca-cc19ee77a8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d6f47996-17fa-4e66-94d1-94a33ce367bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d6f47996-17fa-4e66-94d1-94a33ce367bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_ec8da696-f82b-4356-85d3-8176f8eb9c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c8c43cf7-9cdd-40c1-81a8-687164c4847e" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_ec8da696-f82b-4356-85d3-8176f8eb9c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a78cf74c-ef34-4c48-8946-6e25cab9a3af" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b050c304-a4bd-47b9-8d7a-d45155d30811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:to="loc_us-gaap_CurrencySwapMember_b050c304-a4bd-47b9-8d7a-d45155d30811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cf743033-7f1b-4f3a-b8d2-c0472a3cdcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:to="loc_us-gaap_InterestRateSwapMember_cf743033-7f1b-4f3a-b8d2-c0472a3cdcb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_eb363de3-de5b-4b0c-a852-ca0c26251cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d729e697-9270-4cd8-ad3e-7b202d438736" xlink:to="loc_us-gaap_ForeignExchangeContractMember_eb363de3-de5b-4b0c-a852-ca0c26251cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_97a9aea4-33a3-432b-9257-5dc8ca06c03a" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_65e8fac5-39c0-4a82-83fe-26e10d01d01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_65e8fac5-39c0-4a82-83fe-26e10d01d01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a7b4d921-10cb-418c-a043-08e0e6c0e2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a7b4d921-10cb-418c-a043-08e0e6c0e2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d43bd172-9728-46d7-b24e-f355e1453d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d43bd172-9728-46d7-b24e-f355e1453d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_cf056d91-4cc5-4e91-b470-4872bc840f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7f34cb0d-c81b-4e37-beb2-f134100a79f3" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_cf056d91-4cc5-4e91-b470-4872bc840f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_25147261-65c0-414b-8fe5-65cc1e9c4206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d09d7066-d955-4fd9-8543-24c213af54c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_25147261-65c0-414b-8fe5-65cc1e9c4206" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d09d7066-d955-4fd9-8543-24c213af54c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c7883299-6d1c-40ab-a98f-7a6b80f1f939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_a6c88bbd-a3d4-44c5-b800-a6d447b0452f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c7883299-6d1c-40ab-a98f-7a6b80f1f939" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_a6c88bbd-a3d4-44c5-b800-a6d447b0452f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c3eea35a-8b97-4cd3-bbff-96afe3641e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c3eea35a-8b97-4cd3-bbff-96afe3641e42" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fcafa1e9-9afe-409a-aea4-d46807833787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ff571b50-8f5e-43e5-962e-ca935db5abe3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fcafa1e9-9afe-409a-aea4-d46807833787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32d7413e-0102-4672-9b0c-8588bccf1515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fcafa1e9-9afe-409a-aea4-d46807833787" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_32d7413e-0102-4672-9b0c-8588bccf1515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_392c5ae3-9ed0-48bc-be78-b71a834c796c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_670bbe60-d6d3-4d4c-a92c-86a40b6d88ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_670bbe60-d6d3-4d4c-a92c-86a40b6d88ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6e094f04-e49b-44a5-b7d3-76e24a277f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6e094f04-e49b-44a5-b7d3-76e24a277f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_49860e58-4f0c-45b6-959e-70bb8815eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_49860e58-4f0c-45b6-959e-70bb8815eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_3e0435b7-b4eb-49d6-bff1-1c6049ec645b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_3e0435b7-b4eb-49d6-bff1-1c6049ec645b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_505a8b28-475c-4b3e-ba62-b25dfdb9a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_67170581-daae-4c44-b307-c9d9eaecfada" xlink:to="loc_us-gaap_DebtInstrumentFairValue_505a8b28-475c-4b3e-ba62-b25dfdb9a46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04ae76fa-6be4-40ee-a6d5-9069aba1bfdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04ae76fa-6be4-40ee-a6d5-9069aba1bfdb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0a9335-102a-4895-a074-a3b0b8f03330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_20586a75-35b6-43ac-a1bd-79a50b463aa3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0a9335-102a-4895-a074-a3b0b8f03330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_cfdc8d8a-c8fb-4351-bf11-d800aff44c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0a9335-102a-4895-a074-a3b0b8f03330" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_cfdc8d8a-c8fb-4351-bf11-d800aff44c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_49a202de-e727-4c25-9a21-bdf7bce56d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e6473bdd-48ac-48cb-aaf7-af5e49e13546" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_49a202de-e727-4c25-9a21-bdf7bce56d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a272b840-0204-4a31-8ffe-236ce64b56f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_49a202de-e727-4c25-9a21-bdf7bce56d61" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a272b840-0204-4a31-8ffe-236ce64b56f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_58fe6a02-bdd8-49ed-b4ea-1a512466dc6c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a98274d9-b9a8-4c88-a95d-88e0a668941c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a98274d9-b9a8-4c88-a95d-88e0a668941c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_64450484-247e-4b03-ae58-6b10afee5d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3a8b793e-a25b-41f3-8bb2-028c3a50bed2" xlink:to="loc_us-gaap_LongTermDebt_64450484-247e-4b03-ae58-6b10afee5d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="simple" xlink:href="mck-20220331.xsd#FinancialGuaranteesandWarranties"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_a222309d-5bfe-4554-8bb8-952d521204a8" xlink:href="mck-20220331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock_77d12670-83f1-4751-917c-ee299d69261b" xlink:href="mck-20220331.xsd#mck_FinancialGuaranteesAndWarrantiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_a222309d-5bfe-4554-8bb8-952d521204a8" xlink:to="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock_77d12670-83f1-4751-917c-ee299d69261b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_88ad6cb3-553b-477d-81f4-b642dde09e9c" xlink:href="mck-20220331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_88ad6cb3-553b-477d-81f4-b642dde09e9c" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:to="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1245ca90-453c-47df-b7f6-b764c64680a2" xlink:to="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_09401bd1-d0d6-4813-9529-172d54122a92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:to="loc_srt_MinimumMember_09401bd1-d0d6-4813-9529-172d54122a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6d95f1d9-707d-413f-9c50-9e09a9e5ad15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10066c52-b496-4d0e-9312-8588b206f28c" xlink:to="loc_srt_MaximumMember_6d95f1d9-707d-413f-9c50-9e09a9e5ad15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_8f738dd6-10d7-47dc-8ef0-7c9d394c7b62" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_0086f442-e74c-4552-bdf1-8ab2bb437061" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:to="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_0086f442-e74c-4552-bdf1-8ab2bb437061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember_bffd29e8-91e2-4fdc-a869-0b80044aab75" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:to="loc_mck_GuaranteeObligationsCustomersDebtMember_bffd29e8-91e2-4fdc-a869-0b80044aab75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_a267220f-e76c-47b3-a359-1f8db43ff0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5cadce25-339e-428c-83c4-7b3efeb2d760" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_a267220f-e76c-47b3-a359-1f8db43ff0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b0b53dac-28df-4def-8fa5-73c00b02171c" xlink:to="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod_ca98ffb8-95cd-4d11-9f59-4cb0f5f116f7" xlink:href="mck-20220331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuarantorObligationsPeriod_ca98ffb8-95cd-4d11-9f59-4cb0f5f116f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_adc27e41-a99b-4a32-adcb-139a6eae94cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_adc27e41-a99b-4a32-adcb-139a6eae94cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_c9e015d5-94ba-49c6-8872-6deee9ce9347" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_c9e015d5-94ba-49c6-8872-6deee9ce9347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_96a363dc-a0f5-4342-99e2-f937c0cc390f" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_96a363dc-a0f5-4342-99e2-f937c0cc390f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_5452231b-d166-4211-878f-2d2b46f247a2" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_5452231b-d166-4211-878f-2d2b46f247a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8430bae0-3814-4d12-a449-1a9882be3423" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_8430bae0-3814-4d12-a449-1a9882be3423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_0c8caab0-6c99-43bc-9f3a-c0246e6b2867" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_0c8caab0-6c99-43bc-9f3a-c0246e6b2867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_40bfc568-037d-42f6-9dd5-764bf63721a0" xlink:href="mck-20220331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_40bfc568-037d-42f6-9dd5-764bf63721a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_17003407-fb3c-4493-9ffd-39e8fe4ff86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_b40e654c-f6c7-4522-a1b5-4e975ff83b83" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_17003407-fb3c-4493-9ffd-39e8fe4ff86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20220331.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d180dae7-5749-43ad-845d-4b9871d7cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5c3d2a74-bcb6-41ec-a953-665626ab0d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d180dae7-5749-43ad-845d-4b9871d7cd97" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5c3d2a74-bcb6-41ec-a953-665626ab0d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="mck-20220331.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ee1c76e9-5238-4570-b12b-cd18edac09b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_f3884c51-1111-40cd-87e1-da310721f127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ee1c76e9-5238-4570-b12b-cd18edac09b0" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_f3884c51-1111-40cd-87e1-da310721f127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25dbd3a3-69a7-44ab-b131-cad68d18ce8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25dbd3a3-69a7-44ab-b131-cad68d18ce8d" xlink:to="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_3c72d123-6a1b-4e2a-b92e-960f2183382b" xlink:to="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_34222add-52dd-4906-980e-a2529e5cde31" xlink:href="mck-20220331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_34222add-52dd-4906-980e-a2529e5cde31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_182f32cf-c6bc-46e6-8b2d-bfda6041488e" xlink:href="mck-20220331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_182f32cf-c6bc-46e6-8b2d-bfda6041488e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember_60ee108f-eea0-4ac2-861b-c7c76e644fab" xlink:href="mck-20220331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_InsuranceCoverageLitigationMember_60ee108f-eea0-4ac2-861b-c7c76e644fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_d008c0de-6980-497d-8f49-19653596ad60" xlink:href="mck-20220331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_d008c0de-6980-497d-8f49-19653596ad60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_48d3ab63-e35a-4acc-8ce8-0ad8f4799f8a" xlink:href="mck-20220331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_48d3ab63-e35a-4acc-8ce8-0ad8f4799f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_e08eace1-b7d8-47fc-b4b9-80b0bac93958" xlink:href="mck-20220331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_e08eace1-b7d8-47fc-b4b9-80b0bac93958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_19247f8b-ab9b-481f-b93f-d74299ab8a7f" xlink:href="mck-20220331.xsd#mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember_19247f8b-ab9b-481f-b93f-d74299ab8a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_2ef171eb-a1fe-4580-b53c-6d21a313a807" xlink:href="mck-20220331.xsd#mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member_2ef171eb-a1fe-4580-b53c-6d21a313a807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_65152a03-a572-41c8-92e8-0092284d9f97" xlink:href="mck-20220331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_65152a03-a572-41c8-92e8-0092284d9f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_b7ca7512-67bc-4cf6-8bd0-3e358961cf79" xlink:href="mck-20220331.xsd#mck_ConsolidatedActionsvSureScriptsLLCMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_ConsolidatedActionsvSureScriptsLLCMember_b7ca7512-67bc-4cf6-8bd0-3e358961cf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_f4c38f26-2a17-43d8-a3a1-1de36911fc07" xlink:href="mck-20220331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_f4c38f26-2a17-43d8-a3a1-1de36911fc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_81679b2b-2041-4eb6-ba98-4ca09a7f98af" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_81679b2b-2041-4eb6-ba98-4ca09a7f98af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_132c6e60-980d-4d2c-9322-58fd75ff07f7" xlink:href="mck-20220331.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_62f0b873-3977-4086-959c-d29b51727d47" xlink:to="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_132c6e60-980d-4d2c-9322-58fd75ff07f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_9cd8aaed-278d-4c39-9b22-5c9243e74d47" xlink:to="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_9b05395e-895c-4f2c-adf5-ffa0f92407ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:to="loc_us-gaap_PendingLitigationMember_9b05395e-895c-4f2c-adf5-ffa0f92407ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_f9b84def-100a-42e2-be26-d17093d1281c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a6325458-8876-47bb-92fc-2856d6a618ce" xlink:to="loc_us-gaap_SettledLitigationMember_f9b84def-100a-42e2-be26-d17093d1281c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2fd0bf17-6677-442b-bb95-ae37e1400357" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_561079c1-1121-44b1-a16e-ecbe10766f1d" xlink:to="loc_srt_SegmentGeographicalDomain_2fd0bf17-6677-442b-bb95-ae37e1400357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_af9bd17c-44ef-4942-a681-b7266dc2121a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2fd0bf17-6677-442b-bb95-ae37e1400357" xlink:to="loc_country_CA_af9bd17c-44ef-4942-a681-b7266dc2121a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_58a028fa-f966-4bce-b7a7-37bc26771f18" xlink:to="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_d2e39edf-2ee2-41e9-bbfb-e4b029c65680" xlink:href="mck-20220331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_d2e39edf-2ee2-41e9-bbfb-e4b029c65680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember_73ed6a9f-85ee-4592-818c-668c0628851c" xlink:href="mck-20220331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:to="loc_mck_EnvironmentalLitigationMember_73ed6a9f-85ee-4592-818c-668c0628851c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_c211ef92-4c4c-4cd0-b223-d6e87c351894" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_89137aa0-7a14-4923-afe3-e24b904bf9f2" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_c211ef92-4c4c-4cd0-b223-d6e87c351894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_48c5954c-d519-46f9-a3dd-b04fae6e5e89" xlink:to="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_caa2db6c-979d-48cd-af74-8ac8d50aee01" xlink:href="mck-20220331.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_caa2db6c-979d-48cd-af74-8ac8d50aee01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributorsMember_adcbf3e2-b164-4046-9374-878d0bfc2464" xlink:href="mck-20220331.xsd#mck_DistributorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_10815d15-7beb-4456-87de-bac70b7114ae" xlink:to="loc_mck_DistributorsMember_adcbf3e2-b164-4046-9374-878d0bfc2464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2ee07a6c-1160-4917-8809-e170093a8a4b" xlink:to="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_daf4f96a-0490-4abf-80ba-eb0dad0d72cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:to="loc_srt_MinimumMember_daf4f96a-0490-4abf-80ba-eb0dad0d72cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c31d4e22-9b34-4d4a-8e35-9b2defad76a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b12e29cf-21b7-43f1-9d23-d6895966093d" xlink:to="loc_srt_MaximumMember_c31d4e22-9b34-4d4a-8e35-9b2defad76a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e62c2844-9120-4db0-be23-523987622d66" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_fd7a7e26-33db-4eef-be1f-c3aefe10535b" xlink:href="mck-20220331.xsd#mck_CherokeeNationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_CherokeeNationMember_fd7a7e26-33db-4eef-be1f-c3aefe10535b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b42fa756-73aa-47f1-8b73-8434076e0b34" xlink:href="mck-20220331.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b42fa756-73aa-47f1-8b73-8434076e0b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_eccbb972-498f-4785-8952-83be9a3ec301" xlink:href="mck-20220331.xsd#mck_GovernmentalEntitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_GovernmentalEntitiesMember_eccbb972-498f-4785-8952-83be9a3ec301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_0a5ea00d-f118-4f16-9e8d-a4c96717e055" xlink:href="mck-20220331.xsd#mck_IndividualClaimantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_IndividualClaimantMember_0a5ea00d-f118-4f16-9e8d-a4c96717e055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesMember_001b0f11-d255-4e6f-8392-175c0ce33440" xlink:href="mck-20220331.xsd#mck_SettlingGovernmentalEntitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_SettlingGovernmentalEntitiesMember_001b0f11-d255-4e6f-8392-175c0ce33440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWashingtonAndSubdivisionsMember_151639a1-b2b8-455b-9bc8-06c94e95f211" xlink:href="mck-20220331.xsd#mck_StateOfWashingtonAndSubdivisionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_StateOfWashingtonAndSubdivisionsMember_151639a1-b2b8-455b-9bc8-06c94e95f211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaMember_6eccbc77-4f2c-4d4b-824a-eb60bcf8eca7" xlink:href="mck-20220331.xsd#mck_StateOfAlabamaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a7572f7e-ddd6-4b97-a98b-084fbb56f0b2" xlink:to="loc_mck_StateOfAlabamaMember_6eccbc77-4f2c-4d4b-824a-eb60bcf8eca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ca5a5e6-bded-49dd-88c7-1345bd6c9a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2228b00-04a0-4f05-8486-ef8d2e18a855" xlink:to="loc_us-gaap_SegmentDomain_7ca5a5e6-bded-49dd-88c7-1345bd6c9a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_f58871e1-fbd9-427e-943f-a8a77841fc8c" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7ca5a5e6-bded-49dd-88c7-1345bd6c9a66" xlink:to="loc_mck_USPharmaceuticalSegmentMember_f58871e1-fbd9-427e-943f-a8a77841fc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ce08da4c-91c9-4bef-b798-76d5e12e9e59" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f6677ee3-a776-4ce9-80a7-7fc6c85a77fd" xlink:to="loc_srt_ConsolidationItemsDomain_ce08da4c-91c9-4bef-b798-76d5e12e9e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1e4e2b56-3dd1-4d32-a8f1-62a4c57b280a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ce08da4c-91c9-4bef-b798-76d5e12e9e59" xlink:to="loc_us-gaap_OperatingSegmentsMember_1e4e2b56-3dd1-4d32-a8f1-62a4c57b280a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b1f8a8de-c391-4434-8796-309cb0282319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2795c60c-eaf5-4a2e-8812-b87512d3faa6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b1f8a8de-c391-4434-8796-309cb0282319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_292eaee4-3219-412b-b773-b065283bee63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b1f8a8de-c391-4434-8796-309cb0282319" xlink:to="loc_us-gaap_SubsequentEventMember_292eaee4-3219-412b-b773-b065283bee63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a3716ac2-3d53-470a-b193-36710a7794e2" xlink:to="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_2be085c7-7425-469a-8e39-0eed71282c70" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_2be085c7-7425-469a-8e39-0eed71282c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_48827024-3bfd-49b2-b5f7-ce3335e03d55" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofStates_48827024-3bfd-49b2-b5f7-ce3335e03d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleStates_14937612-9849-41c2-8845-d388e551d46f" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfEligibleStates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfEligibleStates_14937612-9849-41c2-8845-d388e551d46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_71814c78-9db7-4c19-9d9a-b06147fd9a62" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage_71814c78-9db7-4c19-9d9a-b06147fd9a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_99e87a10-f1dc-4ee9-804c-a7a0eebaaf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_99e87a10-f1dc-4ee9-804c-a7a0eebaaf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_27b5bf8c-5311-47d2-8fdd-6839a456a381" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_27b5bf8c-5311-47d2-8fdd-6839a456a381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_d9165967-f3c5-45b2-980f-44f0726b09b3" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_d9165967-f3c5-45b2-980f-44f0726b09b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_60143b23-8630-4680-9671-6f57d2e31b0a" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_60143b23-8630-4680-9671-6f57d2e31b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_17c88e96-6597-4b9a-bdbf-6b3e777cead3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LitigationSettlementExpense_17c88e96-6597-4b9a-bdbf-6b3e777cead3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_e80e21a3-e447-471c-b285-6657ba5ac899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_e80e21a3-e447-471c-b285-6657ba5ac899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_ababe4fa-4006-403d-915d-dde73909eb8c" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_ababe4fa-4006-403d-915d-dde73909eb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_bbaa8c49-88d1-4bd3-b01d-6e574132538f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_bbaa8c49-88d1-4bd3-b01d-6e574132538f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_be59a75e-6a52-4991-9494-30e8f04b12dc" xlink:href="mck-20220331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_be59a75e-6a52-4991-9494-30e8f04b12dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators_a4e8d619-4164-487a-b9e9-c5eb97b575f7" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofRelators_a4e8d619-4164-487a-b9e9-c5eb97b575f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_4b39019c-a691-4adf-8fb2-c389f0da8d57" xlink:href="mck-20220331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_4b39019c-a691-4adf-8fb2-c389f0da8d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_106673a1-fad9-4658-aaa2-2beeb928cf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_106673a1-fad9-4658-aaa2-2beeb928cf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_c250ef4d-12a2-4ced-a31f-83dc8e90a24d" xlink:href="mck-20220331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_c250ef4d-12a2-4ced-a31f-83dc8e90a24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_2b89947b-d4ca-4cbf-ab12-992785ed80a7" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofCitiesFiledOnBehalfOf"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofCitiesFiledOnBehalfOf_2b89947b-d4ca-4cbf-ab12-992785ed80a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers_4605688c-7316-47cc-bdf9-b84f20ff61e0" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofFormerOfficers_4605688c-7316-47cc-bdf9-b84f20ff61e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_22168238-a78a-4f4d-9eec-35f5960b96e4" xlink:href="mck-20220331.xsd#mck_LossContingencySettlementNumberOfInstallmentPayments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencySettlementNumberOfInstallmentPayments_22168238-a78a-4f4d-9eec-35f5960b96e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b2b12c5f-a647-48f9-92e6-7b2c247b7db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b2b12c5f-a647-48f9-92e6-7b2c247b7db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b5725f69-8a32-4e37-ae66-8c4430e0c56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_b5725f69-8a32-4e37-ae66-8c4430e0c56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2bb380fc-11b4-4ba9-8359-0b0f9084d761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_2bb380fc-11b4-4ba9-8359-0b0f9084d761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators_e2ce2f50-940a-448d-b3bc-be319f7b99ad" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfRelators_e2ce2f50-940a-448d-b3bc-be319f7b99ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants_0c1f1b8d-0d9c-477a-9662-0a108e30d45f" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberOfAdditionalDefendants_0c1f1b8d-0d9c-477a-9662-0a108e30d45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_9d395a25-b677-480d-af2a-217a350e40d3" xlink:href="mck-20220331.xsd#mck_LossContingencyNumberofStatesFiledOnBehalfOf"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyNumberofStatesFiledOnBehalfOf_9d395a25-b677-480d-af2a-217a350e40d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts_1ea5dc45-d207-49eb-b0cf-7e5c759fba49" xlink:href="mck-20220331.xsd#mck_NumberofSoftwareProducts"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_NumberofSoftwareProducts_1ea5dc45-d207-49eb-b0cf-7e5c759fba49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_2bd4a349-6993-4bd2-b944-ce0592f031bd" xlink:href="mck-20220331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_2bd4a349-6993-4bd2-b944-ce0592f031bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_42dd6179-7291-4549-80a9-ba6fba467aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_42dd6179-7291-4549-80a9-ba6fba467aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualProvisionAfterTax_2ed95674-ac13-4ba9-aba0-7599b5d41b58" xlink:href="mck-20220331.xsd#mck_LossContingencyAccrualProvisionAfterTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyAccrualProvisionAfterTax_2ed95674-ac13-4ba9-aba0-7599b5d41b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_66683cc3-8e18-4d4d-af65-84f44cb94e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_66683cc3-8e18-4d4d-af65-84f44cb94e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SiteContingencyNumberofSites_4469e3ce-5cf1-4c07-b5be-460b26977fd5" xlink:href="mck-20220331.xsd#mck_SiteContingencyNumberofSites"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_SiteContingencyNumberofSites_4469e3ce-5cf1-4c07-b5be-460b26977fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_edb3469e-5e20-478e-b2f0-3cb7dc320ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingenciesGross"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingenciesGross_edb3469e-5e20-478e-b2f0-3cb7dc320ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites_1cbf1868-c243-4ca3-8f57-790ba74fa9cf" xlink:href="mck-20220331.xsd#mck_HazardousSubstanceSites"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_HazardousSubstanceSites_1cbf1868-c243-4ca3-8f57-790ba74fa9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSitesSelectedforPreferredRemedy_4d339928-152d-4a3c-ae92-9852ccda26ca" xlink:href="mck-20220331.xsd#mck_NumberofSitesSelectedforPreferredRemedy"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_NumberofSitesSelectedforPreferredRemedy_4d339928-152d-4a3c-ae92-9852ccda26ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_1689611e-651c-4e2f-97af-18b877f10226" xlink:href="mck-20220331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_1689611e-651c-4e2f-97af-18b877f10226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_656ad91c-b11f-4bd4-a00c-62c5f3659005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_656ad91c-b11f-4bd4-a00c-62c5f3659005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_02bfd16c-90d6-40d6-ada9-5e0abdb7a03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_02bfd16c-90d6-40d6-ada9-5e0abdb7a03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_38ebe919-8afe-4be5-a947-e2bfba206524" xlink:href="mck-20220331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_38ebe919-8afe-4be5-a947-e2bfba206524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_183c675b-52c6-4106-b1e6-b375482b4405" xlink:href="mck-20220331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_183c675b-52c6-4106-b1e6-b375482b4405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_0c9eed43-1889-46be-801e-8dd0f6e74cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f3e1ea47-fec4-4755-8ecc-145113f7537b" xlink:to="loc_us-gaap_EscrowDeposit_0c9eed43-1889-46be-801e-8dd0f6e74cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_383fd2c6-d81f-4e48-b561-914743855fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_383fd2c6-d81f-4e48-b561-914743855fc6" xlink:to="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_01a251e8-6fca-4787-83d1-61947472f9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d6ed6683-3fcc-47af-8c8e-2533804ea325" xlink:to="loc_us-gaap_LossContingencyNatureDomain_01a251e8-6fca-4787-83d1-61947472f9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_389d8f00-9389-434c-a93c-51c280a8848a" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_01a251e8-6fca-4787-83d1-61947472f9a8" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_389d8f00-9389-434c-a93c-51c280a8848a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6a15d1fd-11ff-4b5d-9091-ad69dc0d6c53" xlink:to="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_3103132d-3ff3-497d-ab5e-ff30c9223f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_3103132d-3ff3-497d-ab5e-ff30c9223f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_cf4bb52a-7743-42da-acef-0f7aa54ae407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_cf4bb52a-7743-42da-acef-0f7aa54ae407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b7dc3057-50f1-407e-ab56-34ba88e687ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ebd4709a-7cf5-4a5d-adc1-9978b5bf4158" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_b7dc3057-50f1-407e-ab56-34ba88e687ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquity" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_246e7b01-a0d5-45e5-82cf-c99c01f18f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6f513bfd-0776-4f57-b6e3-4956b9c4ebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_246e7b01-a0d5-45e5-82cf-c99c01f18f98" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6f513bfd-0776-4f57-b6e3-4956b9c4ebbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e897e460-7872-40b9-a32e-10a1bfc0a58e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_896c7d51-2a01-4af1-a6aa-9f8460d5be2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e897e460-7872-40b9-a32e-10a1bfc0a58e" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_896c7d51-2a01-4af1-a6aa-9f8460d5be2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b31dd359-5ed0-48d8-90f0-ee351bbf8a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e897e460-7872-40b9-a32e-10a1bfc0a58e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b31dd359-5ed0-48d8-90f0-ee351bbf8a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_8ee37271-014e-44d1-b4a8-9b443442e0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8ee37271-014e-44d1-b4a8-9b443442e0d0" xlink:to="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_02a9fd4d-68f4-4029-b2eb-b740f4ff8c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_9d8c520f-a2e8-4390-8899-3459b00925ea" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_02a9fd4d-68f4-4029-b2eb-b740f4ff8c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeparationofChangeHealthcareJVMember_b02376ce-e0ae-4857-bd97-921782a11c87" xlink:href="mck-20220331.xsd#mck_SeparationofChangeHealthcareJVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_02a9fd4d-68f4-4029-b2eb-b740f4ff8c26" xlink:to="loc_mck_SeparationofChangeHealthcareJVMember_b02376ce-e0ae-4857-bd97-921782a11c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1d512d35-d65f-4150-8aed-38cd434e5145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_63d8c0a6-c9e8-40b2-ac21-b3a518d20c76" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1d512d35-d65f-4150-8aed-38cd434e5145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_637c6b9d-e600-4a89-8339-3676a927b0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1d512d35-d65f-4150-8aed-38cd434e5145" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_637c6b9d-e600-4a89-8339-3676a927b0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0b2170c8-fdf8-40a6-87b6-4815c1502830" xlink:to="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b9257175-bc6f-4581-b134-73ba9cf51609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b9257175-bc6f-4581-b134-73ba9cf51609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f74cc65-1fd1-40ce-a600-1bb14f3f4108" xlink:href="mck-20220331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_785b7b34-8dcc-45f5-b785-e17177e73dd8" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_5f74cc65-1fd1-40ce-a600-1bb14f3f4108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b7fdfae-68a6-4a87-8fec-1552c5e20924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5fabeb2a-6cba-4d75-bac3-191908bda44a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b7fdfae-68a6-4a87-8fec-1552c5e20924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b306d1ef-0f18-46c3-9fd0-62aef6193d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b7fdfae-68a6-4a87-8fec-1552c5e20924" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b306d1ef-0f18-46c3-9fd0-62aef6193d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9ead3e14-325d-489a-a62c-d614e5b5b33a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7973007d-d6fa-4faa-9c43-ca630bee93b7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9ead3e14-325d-489a-a62c-d614e5b5b33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6dad2432-7110-4dc9-b02e-7930a7455c9b" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9ead3e14-325d-489a-a62c-d614e5b5b33a" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_6dad2432-7110-4dc9-b02e-7930a7455c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_3ed00819-f62d-47ef-8d38-0efb3cbea3ab" xlink:to="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_73265fee-e4a6-43bf-9257-6aca57a381f6" xlink:href="mck-20220331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_73265fee-e4a6-43bf-9257-6aca57a381f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_72e913b5-ce82-4100-b667-bb3f8243832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_72e913b5-ce82-4100-b667-bb3f8243832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesDistributed_bee1d535-e964-4187-abb4-346fc8387dc4" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesDistributed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_ExchangeOfferSharesDistributed_bee1d535-e964-4187-abb4-346fc8387dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquityMethodInvestmentStockAccepted_fe96985a-4c4b-4d0a-80dd-f6e176c77ba3" xlink:href="mck-20220331.xsd#mck_EquityMethodInvestmentStockAccepted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_EquityMethodInvestmentStockAccepted_fe96985a-4c4b-4d0a-80dd-f6e176c77ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ExchangeOfferSharesExchanged_c57538a5-20f1-4b59-b490-1a3a05a70e4f" xlink:href="mck-20220331.xsd#mck_ExchangeOfferSharesExchanged"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_ExchangeOfferSharesExchanged_c57538a5-20f1-4b59-b490-1a3a05a70e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_3e9cca32-c4f7-4198-81ab-37ab659d0d50" xlink:href="mck-20220331.xsd#mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted_3e9cca32-c4f7-4198-81ab-37ab659d0d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ad05a38a-8de9-40fb-a5ad-9bc215e0048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_df21c2de-188d-4dda-979b-4574c58c7c12" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ad05a38a-8de9-40fb-a5ad-9bc215e0048a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityScheduleofShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_569c3f99-f682-4e46-be4a-9d023ee5018a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_569c3f99-f682-4e46-be4a-9d023ee5018a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7cdf2124-065f-47d3-82a1-b8542ee8b97a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember_24e0d2ec-be88-4714-9a7d-942b9c670ca1" xlink:href="mck-20220331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_OpenMarketTransactionsMember_24e0d2ec-be88-4714-9a7d-942b9c670ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2019Member_30d720d3-362e-414e-864e-b808ea8fc807" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseMay2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2019Member_30d720d3-362e-414e-864e-b808ea8fc807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2021Member_1c7e72bc-5701-49c3-9b14-d0ddcd08e9d2" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseMay2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2021Member_1c7e72bc-5701-49c3-9b14-d0ddcd08e9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_25c66f12-93a5-481e-869a-b06ef715e572" xlink:href="mck-20220331.xsd#mck_AcceleratedShareRepurchaseFebruary2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_784a56f3-8792-42f4-b9b4-1026479f397f" xlink:to="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_25c66f12-93a5-481e-869a-b06ef715e572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_12cb634f-f35a-4b2a-8a27-e0e5949c707d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_10867eb4-9565-4d5b-b47a-d42537c75de3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_12cb634f-f35a-4b2a-8a27-e0e5949c707d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e905c3fb-e739-40c6-9fcd-0a58dd0c0998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_12cb634f-f35a-4b2a-8a27-e0e5949c707d" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e905c3fb-e739-40c6-9fcd-0a58dd0c0998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_4c33b454-a617-45db-b2c0-839e96f25d27" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_40930f9e-c588-494a-9f32-9033e43c9b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_40930f9e-c588-494a-9f32-9033e43c9b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a7876e1a-738a-4b0c-aef2-45bed76e8c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a7876e1a-738a-4b0c-aef2-45bed76e8c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e5d9f340-baa4-4243-b52c-1be45b49b70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e5d9f340-baa4-4243-b52c-1be45b49b70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:href="mck-20220331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_09e50663-3e2e-430b-aa66-1a179174dc49" xlink:to="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_186ad381-b829-4024-a79a-3f7a2a58086e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_186ad381-b829-4024-a79a-3f7a2a58086e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b415f3ec-c124-4f16-b9be-c14634612bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b415f3ec-c124-4f16-b9be-c14634612bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3f0fc4eb-f347-4d29-a888-88b5fbad6a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3f0fc4eb-f347-4d29-a888-88b5fbad6a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases_c0c9b282-2206-4b7e-9d31-3599598c8849" xlink:href="mck-20220331.xsd#mck_AccruedShareRepurchases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_8584d203-a962-45f3-bc51-0fa6b1d33377" xlink:to="loc_mck_AccruedShareRepurchases_c0c9b282-2206-4b7e-9d31-3599598c8849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0143d410-0e56-4dcb-8a13-aec4ac87b315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0143d410-0e56-4dcb-8a13-aec4ac87b315" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_535d217d-35b2-43d6-8f1c-b6f40bb058f2" xlink:to="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9317bceb-b475-4f24-9793-bdea909992c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9317bceb-b475-4f24-9793-bdea909992c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_c8802b80-971c-4976-b89c-ad66af319540" xlink:href="mck-20220331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_c8802b80-971c-4976-b89c-ad66af319540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ce187bb0-f503-4d28-a882-286a690f5e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_ce187bb0-f503-4d28-a882-286a690f5e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_382adc54-8b9a-46d9-9777-7f13fa6661b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_382adc54-8b9a-46d9-9777-7f13fa6661b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01eb8535-12b0-4b59-8068-e416cae87f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_01eb8535-12b0-4b59-8068-e416cae87f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c0447dcb-4acf-494f-969b-11854c3027fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a253a023-f53c-47ae-951b-5140ae54f18d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c0447dcb-4acf-494f-969b-11854c3027fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_899fb684-e5ba-4a8e-9c7f-2909f8ea286e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6784a56b-ae98-4aab-a0b0-bb9c656cc464" xlink:to="loc_us-gaap_HedgingRelationshipDomain_899fb684-e5ba-4a8e-9c7f-2909f8ea286e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_7604bfa2-1df9-4b50-8e2b-ff6561ce2f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_899fb684-e5ba-4a8e-9c7f-2909f8ea286e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_7604bfa2-1df9-4b50-8e2b-ff6561ce2f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5d0d7f5e-b326-4483-b090-6cb6a87e1970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b47e70ab-d173-461f-9617-806b26fe844c" xlink:to="loc_us-gaap_HedgingDesignationDomain_5d0d7f5e-b326-4483-b090-6cb6a87e1970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aac8c143-c0fc-4043-9fcf-e1eb514eb9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5d0d7f5e-b326-4483-b090-6cb6a87e1970" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aac8c143-c0fc-4043-9fcf-e1eb514eb9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_81c9f259-ced7-4912-8f87-7bdd8727944e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21cd566e-30d4-480f-95bd-06fc7f67672b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_21cd566e-30d4-480f-95bd-06fc7f67672b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1ffd01ed-f877-46dc-aee2-5e147b2c184a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1ffd01ed-f877-46dc-aee2-5e147b2c184a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_68ccaa92-ff55-4b2b-982b-5988fe4278db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_68ccaa92-ff55-4b2b-982b-5988fe4278db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_324e39ee-d2ec-4c6e-b324-d832038ac232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_324e39ee-d2ec-4c6e-b324-d832038ac232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_44f86800-31f4-40c1-b6b0-9dc0eaaf9951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_44f86800-31f4-40c1-b6b0-9dc0eaaf9951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5206d7cb-c095-4ec3-841c-42837133667b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5206d7cb-c095-4ec3-841c-42837133667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_53b8c099-8b89-42cf-ad03-69ce27aa0a1e" xlink:href="mck-20220331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_53b8c099-8b89-42cf-ad03-69ce27aa0a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7307d44f-af17-4b68-a52d-d8ead14b7335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_dc87cfe9-fd90-4d13-b566-ed26370630de" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7307d44f-af17-4b68-a52d-d8ead14b7335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_4d07a4db-77e8-4d5c-a9fd-e4a4d455f378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_4d07a4db-77e8-4d5c-a9fd-e4a4d455f378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c51ffd08-e848-42b3-b3a8-b2226e19be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c51ffd08-e848-42b3-b3a8-b2226e19be46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_119127b9-3477-4b78-8cf0-3c9e4f9deef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_119127b9-3477-4b78-8cf0-3c9e4f9deef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_945e9532-a50b-4fce-9f35-0a4956736dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_081e69b4-a430-4f6e-bab3-a12dc08f28b1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_945e9532-a50b-4fce-9f35-0a4956736dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="simple" xlink:href="mck-20220331.xsd#RelatedPartyBalancesandTransactions"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_9a19a388-05cc-413f-a6b7-66e20ba63516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7eae6322-c0f6-44b0-8972-5468c8289fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_9a19a388-05cc-413f-a6b7-66e20ba63516" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7eae6322-c0f6-44b0-8972-5468c8289fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_5a3bc131-d76a-412a-8690-c68bbc240eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_5a3bc131-d76a-412a-8690-c68bbc240eb0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4fbc0e56-febb-4bd6-8f9a-27c17a1eded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd4b2791-37fd-49cd-a520-fb10775f6946" xlink:to="loc_us-gaap_RelatedPartyDomain_4fbc0e56-febb-4bd6-8f9a-27c17a1eded0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_9c02feae-a660-4724-86c0-3f24757fe6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4fbc0e56-febb-4bd6-8f9a-27c17a1eded0" xlink:to="loc_us-gaap_InvesteeMember_9c02feae-a660-4724-86c0-3f24757fe6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8bf69587-6934-4676-8b20-6055ee4e3e2b" xlink:to="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_c8990b9f-5efc-405c-ac21-7620b6358189" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:to="loc_mck_InternationalSegmentMember_c8990b9f-5efc-405c-ac21-7620b6358189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_36e6bec8-9e5f-4921-97be-8fb5ae4c4fd2" xlink:href="mck-20220331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fec6fd5c-0322-48f6-8b8a-9923f6d2e45f" xlink:to="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_36e6bec8-9e5f-4921-97be-8fb5ae4c4fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d2c8fa28-c79a-4925-a5df-dfde1ec8d915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ee815abe-5b94-4825-9e86-f2d9bba16be1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d2c8fa28-c79a-4925-a5df-dfde1ec8d915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_a5fe731d-8725-48fb-9121-b8308489b28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2c8fa28-c79a-4925-a5df-dfde1ec8d915" xlink:to="loc_us-gaap_RevenueFromRelatedParties_a5fe731d-8725-48fb-9121-b8308489b28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6e5431d5-8342-4ef7-a924-4c6d93d59616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_6b57d5cd-024d-49b8-83dd-68f9d634b79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6e5431d5-8342-4ef7-a924-4c6d93d59616" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_6b57d5cd-024d-49b8-83dd-68f9d634b79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0cb25dc2-888a-4599-9d88-2943223a1b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_381890dd-ac1b-4fe9-905d-164e007bfb47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0cb25dc2-888a-4599-9d88-2943223a1b01" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_381890dd-ac1b-4fe9-905d-164e007bfb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_f9632604-5be7-49a8-8127-1bb1893257b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0cb25dc2-888a-4599-9d88-2943223a1b01" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_f9632604-5be7-49a8-8127-1bb1893257b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fe34a8c4-734b-4f93-8691-476924ddab22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fe34a8c4-734b-4f93-8691-476924ddab22" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2c2854f8-4fec-4471-a95f-fa312a2b58ad" xlink:to="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4d20e24a-fd5b-4f9f-9fa6-505978a542fc" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_InternationalSegmentMember_4d20e24a-fd5b-4f9f-9fa6-505978a542fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_abac0d9b-b767-4c9c-986f-21db62c8bf13" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_USPharmaceuticalSegmentMember_abac0d9b-b767-4c9c-986f-21db62c8bf13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_15c87fbc-a382-49f6-923e-0d3c6ed19cec" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_15c87fbc-a382-49f6-923e-0d3c6ed19cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_591b7550-306e-4ff4-840b-8dd2b8944f6f" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_575f9218-38a0-48ef-a59b-732a5ad22f20" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_591b7550-306e-4ff4-840b-8dd2b8944f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_54de1b51-e3bb-4b50-b487-71ffd061a18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_724b8de5-0793-47aa-9786-4fdd7f83e5dc" xlink:to="loc_us-gaap_RelatedPartyDomain_54de1b51-e3bb-4b50-b487-71ffd061a18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_dc9cd851-ea81-4866-893b-5d534ae42f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_54de1b51-e3bb-4b50-b487-71ffd061a18e" xlink:to="loc_us-gaap_CorporateJointVentureMember_dc9cd851-ea81-4866-893b-5d534ae42f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_341f61d7-53cc-4c47-9337-cb96f7763ef3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2b76b12b-b742-44ee-b8bb-de2d2c1a374b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_341f61d7-53cc-4c47-9337-cb96f7763ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7e5ac359-e2ce-4b08-8a79-1bd2a005520a" xlink:href="mck-20220331.xsd#mck_ChangeHealthcareLLCChangeHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_341f61d7-53cc-4c47-9337-cb96f7763ef3" xlink:to="loc_mck_ChangeHealthcareLLCChangeHealthcareMember_7e5ac359-e2ce-4b08-8a79-1bd2a005520a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_495d345e-e35a-448e-94c5-f561c90e39a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fce674ac-74b1-4b6d-bb9b-8560609110ff" xlink:to="loc_srt_SegmentGeographicalDomain_495d345e-e35a-448e-94c5-f561c90e39a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_1d78fe75-6335-435a-89c7-459309f54cdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_495d345e-e35a-448e-94c5-f561c90e39a0" xlink:to="loc_srt_EuropeMember_1d78fe75-6335-435a-89c7-459309f54cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6efee282-01f6-45ed-826b-5c81a3448fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1274be3c-a5b2-4cbe-926d-a3082b6aa67b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6efee282-01f6-45ed-826b-5c81a3448fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_94379467-996a-4f8f-9974-1094fb85c338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6efee282-01f6-45ed-826b-5c81a3448fff" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_94379467-996a-4f8f-9974-1094fb85c338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9290dfc6-360b-492b-8b5d-6deca00938bf" xlink:to="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_e6ecce0a-6bf7-495d-a766-6166ea1fb2d1" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_e6ecce0a-6bf7-495d-a766-6166ea1fb2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_05d1faa4-c6bb-4682-b45c-896bf70fec66" xlink:href="mck-20220331.xsd#mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:to="loc_mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember_05d1faa4-c6bb-4682-b45c-896bf70fec66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_4cf20bd4-e89c-453c-a06c-03d254c4cc47" xlink:href="mck-20220331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ab675dd0-375a-42d6-a98a-386582336c65" xlink:to="loc_mck_ShareholderDerivativeActionMember_4cf20bd4-e89c-453c-a06c-03d254c4cc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_de67c1c1-9fbc-48de-b53c-c3856bacb3d9" xlink:to="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d963f1c5-3f62-45ed-beb9-114c112a3e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:to="loc_us-gaap_OperatingSegmentsMember_d963f1c5-3f62-45ed-beb9-114c112a3e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ff4b6ea8-0887-4f88-a63c-0940ffb3c3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_32e20cb0-07c6-458d-982b-7b09919e9a1e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ff4b6ea8-0887-4f88-a63c-0940ffb3c3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3df3950b-f662-4cba-82c7-d34e8c264fcd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f90c426c-3bcd-4823-a319-856d9fe4abb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f90c426c-3bcd-4823-a319-856d9fe4abb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b8f20ece-d234-4b3c-98bd-5298b5f36209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9d69825-eb71-4076-8380-86b8d6e0c485" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b8f20ece-d234-4b3c-98bd-5298b5f36209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f12c29bf-f855-49e5-a719-ef17e10374f6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_68c2faf7-9aef-4f73-a587-038cfa6c6ef8" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_GermanWholesaleBusinessMember_68c2faf7-9aef-4f73-a587-038cfa6c6ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_2d279859-b89e-4a23-b422-be849b227c88" xlink:href="mck-20220331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_2d279859-b89e-4a23-b422-be849b227c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_fe67dd91-c948-4b72-beda-c56fb173d028" xlink:href="mck-20220331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_fe67dd91-c948-4b72-beda-c56fb173d028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_6486bb6e-9eb2-4bce-af33-e51f0234be36" xlink:href="mck-20220331.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_64908a69-b498-4efa-a0c2-8b9b78c8a5e9" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_6486bb6e-9eb2-4bce-af33-e51f0234be36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_e6de9ec7-fef8-49d0-b253-708a5c7bc09b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_a7c2faea-cf72-467e-9943-daa33c99331e" xlink:href="mck-20220331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_a7c2faea-cf72-467e-9943-daa33c99331e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_680e5c0a-f29a-46ea-b587-e3c0779ceae7" xlink:href="mck-20220331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_5dee8570-2609-40fb-ba0e-84c34400e0c9" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_680e5c0a-f29a-46ea-b587-e3c0779ceae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_d4aba813-d578-4a87-9664-6cc3b47fc491" xlink:to="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_59727569-e9f6-4643-8bd4-a1ae4eed8bc2" xlink:href="mck-20220331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_59727569-e9f6-4643-8bd4-a1ae4eed8bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_095da0f2-5ac6-4984-8a30-7c4f26b472cd" xlink:href="mck-20220331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ccd1b3d0-754e-4411-9503-e300d8d38470" xlink:to="loc_mck_GermanWholesaleBusinessMember_095da0f2-5ac6-4984-8a30-7c4f26b472cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a37e583-38a4-4595-afa9-11e88692e536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_df869215-056d-4528-a952-78fed8fca1a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a37e583-38a4-4595-afa9-11e88692e536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_55ce5978-e313-4c2a-baee-6e2eafce72d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a37e583-38a4-4595-afa9-11e88692e536" xlink:to="loc_us-gaap_DomesticPlanMember_55ce5978-e313-4c2a-baee-6e2eafce72d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_92e2b228-f944-4e6f-9836-a230bdf60427" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_55ce5978-e313-4c2a-baee-6e2eafce72d8" xlink:to="loc_country_US_92e2b228-f944-4e6f-9836-a230bdf60427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e978d013-d635-430d-a991-a81e685b0794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_589de704-8be9-4d89-b932-ddbb76d2893e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e978d013-d635-430d-a991-a81e685b0794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_70e464e7-4fb8-4b15-a72a-5beda7cad35e" xlink:href="mck-20220331.xsd#mck_TenderOfferNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e978d013-d635-430d-a991-a81e685b0794" xlink:to="loc_mck_TenderOfferNotesMember_70e464e7-4fb8-4b15-a72a-5beda7cad35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d439dc64-65fd-4807-a9ce-b15e751307db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_789c3b0d-dbfa-4c76-8321-1bc41fb52e73" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d439dc64-65fd-4807-a9ce-b15e751307db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_cf87f023-a0a9-4d34-83e4-bb6ac67c56ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d439dc64-65fd-4807-a9ce-b15e751307db" xlink:to="loc_us-gaap_LoansPayableMember_cf87f023-a0a9-4d34-83e4-bb6ac67c56ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e22b5-16aa-497f-b222-7b2bdfc29c9b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_091bbc91-3322-4070-b78c-1c81d34f04d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_NumberOfReportableSegments_091bbc91-3322-4070-b78c-1c81d34f04d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_cb224988-dd7e-48d9-b23d-b1c6c7c9fc8f" xlink:href="mck-20220331.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_cb224988-dd7e-48d9-b23d-b1c6c7c9fc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_61b321e8-764a-4579-bf62-26c5876c2227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_61b321e8-764a-4579-bf62-26c5876c2227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_78f4383d-fac0-4bc4-b987-dd798b3b2733" xlink:href="mck-20220331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_78f4383d-fac0-4bc4-b987-dd798b3b2733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_283430ae-4d84-4be2-bc12-6de7937aab4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_283430ae-4d84-4be2-bc12-6de7937aab4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_a48476b4-8be1-4418-8c29-fee9f8c19468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_a48476b4-8be1-4418-8c29-fee9f8c19468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_2de1824f-bded-4632-98f0-120d8b2ea079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_2de1824f-bded-4632-98f0-120d8b2ea079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_eed621cc-9488-4476-be91-4e034ae2706f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_InventoryWriteDown_eed621cc-9488-4476-be91-4e034ae2706f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_c7fd9d80-7b47-4627-a70b-c2253d93faa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_c7fd9d80-7b47-4627-a70b-c2253d93faa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_c0b334e3-5d73-4254-88a7-49b038c2c728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_c0b334e3-5d73-4254-88a7-49b038c2c728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_65941608-dc01-4f57-abc2-046ceb6bd0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_65941608-dc01-4f57-abc2-046ceb6bd0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c03c17a0-c18c-4ad5-b7d6-908189362e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c03c17a0-c18c-4ad5-b7d6-908189362e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_57c9b142-d31e-4370-90f0-c6542990f762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_57c9b142-d31e-4370-90f0-c6542990f762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_295e07f3-2f47-408e-aaa2-fb7fef419417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_295e07f3-2f47-408e-aaa2-fb7fef419417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4904f62a-26cb-4b3d-91d7-8e9fb513133d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_8904535e-ccc6-4dda-aa51-56d0cef438d9" xlink:to="loc_us-gaap_AssetImpairmentCharges_4904f62a-26cb-4b3d-91d7-8e9fb513133d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_f98ef213-4812-4f74-bf20-72b9d231adb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_f98ef213-4812-4f74-bf20-72b9d231adb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b7c07e55-aa51-4255-b293-e9caa12f0c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b7c07e55-aa51-4255-b293-e9caa12f0c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationAdditionalInformationAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2df9f437-e29a-4b2d-8ffa-1a74cd73ec2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_2df9f437-e29a-4b2d-8ffa-1a74cd73ec2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_7f358ef7-b942-4025-9365-e2e0663c4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment_7f358ef7-b942-4025-9365-e2e0663c4fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_587616bb-e36a-4658-8e1d-401d302ca4da" xlink:href="mck-20220331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_587616bb-e36a-4658-8e1d-401d302ca4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3762f933-1b2d-4728-965a-c7afcdc92f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3762f933-1b2d-4728-965a-c7afcdc92f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_db25db56-5503-4d87-9428-858d4b4748a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_db0a11c4-5982-480d-b65c-6b7b6bc388a6" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_db25db56-5503-4d87-9428-858d4b4748a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_519b01de-116a-44d8-98b2-7bdf273c8dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_3537cb60-5bb0-45d0-8fe1-d096ea83d1be" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_519b01de-116a-44d8-98b2-7bdf273c8dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e0c54928-c375-4488-96e3-52861c02cde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e0c54928-c375-4488-96e3-52861c02cde8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef20cf90-8b5c-4d29-bd07-9e970e2bfc19" xlink:to="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_aa22b5b9-0999-4d68-a10d-d3495b71d7dd" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_USPharmaceuticalSegmentMember_aa22b5b9-0999-4d68-a10d-d3495b71d7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a64bfb5b-b5b2-4a13-9cd1-a656d3c73e92" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a64bfb5b-b5b2-4a13-9cd1-a656d3c73e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_6fddede7-f61f-4dc8-9537-74d155b8e710" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_6fddede7-f61f-4dc8-9537-74d155b8e710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_97fbb584-8986-4821-9c17-4fc775b49e49" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6d8cacac-d5b8-4a26-9cb9-48f3727b736f" xlink:to="loc_mck_InternationalSegmentMember_97fbb584-8986-4821-9c17-4fc775b49e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:to="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_83a1f462-16d1-4b6c-be0a-5b70c7b072ba" xlink:to="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_05610532-5996-4c6c-9017-4876ac78f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:to="loc_us-gaap_OperatingSegmentsMember_05610532-5996-4c6c-9017-4876ac78f22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_12eac254-8c8c-4fe9-9f9b-d48be3761762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_102c0c77-c887-4927-b2ce-c0a00364bd2d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_12eac254-8c8c-4fe9-9f9b-d48be3761762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f18e579c-51bf-4775-a428-6c8f84c33800" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f47bf3e1-9aa6-49af-b0ce-3ebacfb02fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_RevenuesAbstract_f47bf3e1-9aa6-49af-b0ce-3ebacfb02fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_69359a2e-0473-4071-b1ab-c985448d46c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f47bf3e1-9aa6-49af-b0ce-3ebacfb02fc6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_69359a2e-0473-4071-b1ab-c985448d46c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_689d9e51-e6c1-4e5a-96bc-b677ff926764" xlink:href="mck-20220331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_689d9e51-e6c1-4e5a-96bc-b677ff926764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_a58c84ca-a316-4444-aeb1-880d499b5a0d" xlink:href="mck-20220331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_a58c84ca-a316-4444-aeb1-880d499b5a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a2a72f6-95ab-4993-9035-674f0d35da72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8a2a72f6-95ab-4993-9035-674f0d35da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3d766b4d-f11c-44aa-9b42-0a5c4940c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_us-gaap_InterestExpense_3d766b4d-f11c-44aa-9b42-0a5c4940c22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dfb1276b-d63c-4a3b-9c34-41b23409b60f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_42339c2a-b78d-4c4a-aeae-a38e9452d318" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dfb1276b-d63c-4a3b-9c34-41b23409b60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_c7c2805a-4909-40c6-86fb-952349427e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_c7c2805a-4909-40c6-86fb-952349427e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e4cc888e-8857-4862-b7e8-9fa0aed13bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_c7c2805a-4909-40c6-86fb-952349427e4b" xlink:to="loc_us-gaap_DepreciationAndAmortization_e4cc888e-8857-4862-b7e8-9fa0aed13bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4b315e11-914b-4361-bca9-40f10da626a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cebc7009-1ebd-4f9e-8888-e4001134722f" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4b315e11-914b-4361-bca9-40f10da626a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_cff97e43-88ed-4af2-848c-b8746c2c8fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4b315e11-914b-4361-bca9-40f10da626a3" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_cff97e43-88ed-4af2-848c-b8746c2c8fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_34785ce7-1346-4351-acc9-e74eec268bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_34785ce7-1346-4351-acc9-e74eec268bb9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d4c60323-1740-4b60-a504-c83fcdceb19c" xlink:to="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7bac66f5-ccb3-494b-ba6f-2c1a129b26d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:to="loc_us-gaap_OperatingSegmentsMember_7bac66f5-ccb3-494b-ba6f-2c1a129b26d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e4112728-d0c9-426d-922c-22a0e09e0f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b3a7aafc-02ed-4c6f-89c2-8de3ec689e34" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e4112728-d0c9-426d-922c-22a0e09e0f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a11cf7d1-67e2-49d7-8342-44912fe9a1b9" xlink:to="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_0fccf0e6-c1ee-4422-a776-e76795987186" xlink:href="mck-20220331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_USPharmaceuticalSegmentMember_0fccf0e6-c1ee-4422-a776-e76795987186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4ee5c8a1-3477-4fea-8ad3-76af3f59cae2" xlink:href="mck-20220331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_InternationalSegmentMember_4ee5c8a1-3477-4fea-8ad3-76af3f59cae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e801139e-3fa1-4b15-a172-b9c481519f72" xlink:href="mck-20220331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e801139e-3fa1-4b15-a172-b9c481519f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a7a34779-d8ae-4993-b450-baa4a9a43e2e" xlink:href="mck-20220331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c2598b0e-4f11-4f40-84fb-3a6829654885" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_a7a34779-d8ae-4993-b450-baa4a9a43e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_088fa41e-22dc-42d8-aa28-963ecb54facc" xlink:to="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ddc1f694-3a21-49fa-824d-42ec3f35a34d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:to="loc_country_US_ddc1f694-3a21-49fa-824d-42ec3f35a34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_05f6d90c-a1da-4f40-9bc0-b90e6f21e696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_edbac064-eb8d-4939-ae40-e4a6507dca82" xlink:to="loc_us-gaap_NonUsMember_05f6d90c-a1da-4f40-9bc0-b90e6f21e696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be003a7c-7a77-48f0-969b-638bde52cc81" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_69e9fb52-a4c7-4cbc-844e-f365829a7f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:to="loc_us-gaap_AssetsAbstract_69e9fb52-a4c7-4cbc-844e-f365829a7f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0369fa34-1a0f-4dbe-a305-c6ee1eb50973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_69e9fb52-a4c7-4cbc-844e-f365829a7f07" xlink:to="loc_us-gaap_Assets_0369fa34-1a0f-4dbe-a305-c6ee1eb50973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6cbff80-a46d-4528-afb4-f2ddc14b2e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1c083e60-d353-4728-a037-a0a1e7d521b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6cbff80-a46d-4528-afb4-f2ddc14b2e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_7f2c05fa-b560-49bf-ab4f-b7c3b84bf60d" xlink:href="mck-20220331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c6cbff80-a46d-4528-afb4-f2ddc14b2e74" xlink:to="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_7f2c05fa-b560-49bf-ab4f-b7c3b84bf60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="mck-20220331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_3e093937-a25c-4a53-8d29-be63a7e54511" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_41683f6d-8176-4bfc-bee3-472f4a10975d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_3e093937-a25c-4a53-8d29-be63a7e54511" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_41683f6d-8176-4bfc-bee3-472f4a10975d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20220331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_ae3e400c-b375-4c31-a167-8df76377c94c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_ae3e400c-b375-4c31-a167-8df76377c94c" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_d94d7edd-b6c9-4f94-b418-584d6c10a775" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_4fe3cd1a-7094-481f-b963-e7cb95a061bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_4fe3cd1a-7094-481f-b963-e7cb95a061bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember_f2efa1cc-9465-40bc-9a6c-59df452fbf8c" xlink:href="mck-20220331.xsd#mck_OtherAllowancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_mck_OtherAllowancesMember_f2efa1cc-9465-40bc-9a6c-59df452fbf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_7cc156dd-f873-4fcf-b98f-4258915af06c" xlink:href="mck-20220331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_7cc156dd-f873-4fcf-b98f-4258915af06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_96f7390a-828b-4068-ad07-f08d16c83aeb" xlink:href="mck-20220331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_52f978a4-b205-40ff-b139-4fb764acf892" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_96f7390a-828b-4068-ad07-f08d16c83aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_99e5a255-0961-4228-8a41-2905be3d48a4" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b9bad1ac-1d27-4104-93e2-2b73755d88bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b9bad1ac-1d27-4104-93e2-2b73755d88bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e50a3b3a-ef78-4748-9454-8c99aa27f795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e50a3b3a-ef78-4748-9454-8c99aa27f795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7a365c6a-765f-4cca-b18c-286faefec0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_7a365c6a-765f-4cca-b18c-286faefec0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_bb38a66b-94d8-4a94-8035-56b650f2d046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_bb38a66b-94d8-4a94-8035-56b650f2d046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_cf2ac23e-5378-4091-80f9-621ae8bf66a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_184ce8d7-02dc-44ac-ac5a-98614f6e78d0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_cf2ac23e-5378-4091-80f9-621ae8bf66a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_98d72b44-1ef3-46a2-8218-f7318847f200" xlink:href="mck-20220331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_05b0683d-31d9-4045-8c02-31f6a938c995" xlink:to="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_98d72b44-1ef3-46a2-8218-f7318847f200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mck-20220331_g1.jpg
<TEXT>
begin 644 mck-20220331_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
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MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
MM6>%?V?M:TW3=?LM1N9[Z SQM91JP"AMISEASFO,?^'EOPV_Z!&O?]^(_P#X
MNO'?^"GW_)1/"'_8,?\ ]&FOBS'%?3Y?E&&Q.&C5J7NSY#,L\Q>%Q<Z--JR\
MC]E/@/\ M+>$OV@H-4_X1XW-M=:<Z^=9WJA)=C#Y74 G*Y!'7C'N*];Z5^+'
M[/?Q@N_@C\3]+\10,YLPWD7T*DXEMV(##'J,!A[J*_9?0=:L_$>CV>J6$RW-
ME>0K-#*AR&5AD$5X6:9?]2J^[\+/H\FS/^T*7O\ QK<Y[XL?$W3/A#X(OO%&
MKPW$]A9[=Z6JAI#N( P"1ZU\[+_P4N^&_P#T"=>_\!X__BZ[K]NK_DVWQ-]8
M?_1@K\D*]+*<MH8RBYU>C/*SK-L3@:\:='9H_<'X5_$?3OBWX#TOQ7I,4\.G
MZB':*.X4+(-LC(<@$]T/?O17FW[#O_)K_@C_ *Y7'_I5+17S5>"IU906R;/K
ML+4E5H0G+=I&-_P4"_Y-MUG_ *^K;_T8*_*"OU?_ ."@7_)MNL_]?5M_Z,K\
MGVZ5]YP__NK]3\UXF_WQ>A)- ]NP61"C8# ,,'!Z'\J_1_\ X)I_$?\ MSX>
M:WX0N),W&BW(GA4GGR)<GCZ.K?F*^1/CY\/_ .P?!WPP\2PQE;;6]#1)& P/
M.B8@_CM*UL?L-_$3_A7W[0FC+-)Y=CK2-I4^>F7(,9_[^*@^A-=&81CC<%*4
M=U^AR974EE^/@I;/]3[E_;N^(Q\ _ '5((9-E[KDJ:7#CJ X+2'\$5OQ(K\G
MK>&2XF2&)&DD<X55&2?8"OK_ /X*3?$?_A(OB9H_A2WDS:Z':^=*H/'GRX//
M8X14_-J\F_9+^'O_  GGQ0EEEB,EEHNFW.I3'&1E8R$!_P"!LO'IFL,KBL'@
M?;2ZZG1G-26.S#V,.FAXNRE6*L,$'!%?H=_P2[_Y%+QQ_P!?MO\ ^@-7YZW/
M_'U-_P!=&_F:_0K_ ()=_P#(I>./^OVW_P#0&K;.G? M^ACP^K9A%>IYW_P4
MXUJ:X^)WAC2RS>1:Z:TX7MNDD()Q]$'YU\P?"7PC%X^^)_A;P[<,5MM1U"&"
M8@X/EEQO /J5!Q]17UO_ ,%//!L\/B/PEXH2,FVFMY+"63L&5MZ#\0S?E7QK
MX-\477@CQ=HWB"R57N],NX[N-6) 8HX;:2.QQC\359;[V7I4][/[R<U]W,Y.
MKM=?<?N/H^CV6@Z7:Z?I]M'9V=M&(HH(5"JB@8  ':KW:N"^$WQJ\*_&+PW;
M:KX?U.&=Y$#2V;N!/ V.5=,Y!!_"NQU+6+'1K.2[O[V"RMHQEIIY BCZDU^<
M3A.,W&:U/U:E4I2@I0:L7?6OSS_X*A?\C)X(_P"O:X_]"6OT(AF2XA22-UD1
MP&5E.00>A%?GQ_P5"_Y&3P1_UZW'_H2UZV3:8V'S/$S_ %P$FO(^+O#)"^)-
M)8G"B[A))XQ\ZU]6?ML_M6'QY*/ /A6Z_P"*?LP%U"\B;B\E ^X#_P \U(Y]
M3]*^0!U!%#<U^AU<+3K5859J_*?EU'&5*%&=&#^+<N:-H][XAU2UTW3;62]O
M[J18H+>%=S.Q.  *_5G]D?\ 9:LO@/X874-42.\\8WZ W=P!E;=3R(8SZ#N>
MY]L"O&?^";?PZ\%W>EZCXL:ZCU+QE!*T!M9 ,V$1^ZR@]2_/SCTQV.?O"OC<
MZS&4YO#0T2W\S[WA_*X0@L54U;V\@KY!_P""E_\ R1S1_P#L*)_Z"U?7]?('
M_!3#_DCFC_\ 843_ -!:O&RS_?*?J>]G'^XU?0_,ZOU^_8NV?\,R^!L[<_99
M.O\ UWDK\@:U;/Q9KFGVZ6]KK.H6L$?"Q0W4BJO.<  \<D_G7W^9X&6.IQC&
M5K'YCE681RZI*I*/-<_=?]WZK1F/U6OPN/CCQ)_T,&J_^!LO_P 52?\ "<>)
M/^A@U3_P-E_^*KYW_5VI_P _/P/JO]::?_/K\3]U%QV Q[5\'_\ !4R>Y73_
M (<PJ6%HTM\\GIO"P;/QPSU],_LJ7<U]^SOX#GN9I+B>3349Y)6+,QR>23R3
M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
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M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mck-20220331_g2.jpg
<TEXT>
begin 644 mck-20220331_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /(/VD/V\?V5/V3]6T_PW\:OBYIUAK.I7-E'!H%J_VF_2&YNDM8[I[:/,B6
MXD?!E*[?E8#)&*[;X5?'+X,?'/P(GQ1^#'Q7\.^*_#CLZ_VYX?UF&[M59 "Z
M-)$Q563/S*2"O<"OR#_:K^.7Q)_X);?\%'_B7=?MF> =0;X1?'_XY> _%OA+
MXZ6\+SV>BII5[9M+I.H%06B2*"&41*.0$+*K+([1?IGI/[)_[-WQ3^$'Q"TO
MP+K-O>>"?CMXEA\5>(I/#-Y%]CUB*>TTZ"ZCCEA^5[>]@L<3.IW2"[G(8%@P
M *WP<_X*E?\ !.C]H/XP2? 'X)_MH?#SQ-XP621(="TGQ)#)+=M&"76W.=MR
M0 21$7X4GH":[S]HW]JC]G']D+P!_P +2_:=^-7AWP-H!N5MXM2\1:FENL\[
M D11!CNED(#'8@9L*3C )KX%_P""\?[!OP*U_P"#/P0\-_LN_!KPWX1^,H^.
M'AS3/@_J?@W0X-/N[#;*\]T0;=%(M(+6":Y?^"/[.C<$#/WCX[_9/^!WQ5^-
MFG?';XL>!=.\4ZKH6A'3/#%KXAL(KNVT3S)6DN;BUCD4B.><>1')+][9:QJI
M4%PP!9_9Q_:I_9O_ &O? /\ PM#]F+XV>'/'.@K<FWFU'PYJ:7"P3  F*55.
MZ*3!!V.%;# XP0:R_P!H[]N#]C[]D"YTFS_:D_:6\%^ )M>29]&A\5:_#9O>
MK$4$K1B1@6"F1 2.FX5\:_\ !/S]EGPE\(/^"Y_[4OCS]EWPU;>'/A6G@?P]
MI7B[1M$A$&ER^,I0EXX@B0",20VC!Y54#8^H'(!D(KQ?_@H+XX^/7[//[8WQ
M&_:Y_P""C7_!%3P=\>/V?A=VFFZ!XXVZ7XBU+P5X>M%8>>NGW,<OEI+-+<W4
MQQ"/WR))-B",4 ?J[\&?C9\)/VB?AQI_Q?\ @7\1=)\6>%M6\W^S/$&A7BW%
MI=>7*T4GER+E7VR(Z''1E(ZBNHKS[]E+Q-^SKXT_9O\ !?C#]DBPT"U^&NJZ
M!!=^#;;POI<=C8Q64B[T2*WC1%@P20T>U2C!E(!!%>@T %%9/CKQ#JGA3PC?
M^(]$\*W>N7=I 9(-)L643739'R(6XS]?2O(?^&L/C9_T8_X[_P# JV_^*H G
M_8(U34]7^#6JW.K:C/=2+XWUA%DN)F=@HN2 N6)X Z#M7MM?.'_!/'Q3K,OP
M-U*5_!=\C/XTU5V0LN4+3;BI]U)*GW4U[O\ \)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\
M)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J
M_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO
M_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L44D;%
MXU=D*DJ"5/4>U+0 4444 %%%% !1110 4444 %%%% !1110 4444 ? G[8_[
M:W[&/[37PT\3_LL?M ^(_!VG:EX4^/WA_0?'/@'QOJ,$/VS1XO$MGMOS#=;/
M.LIK3;(TH!C4^8N[]V37EO\ P22\?_"#_@FA^S#^TO\ &KQE\3[_ $3]DO0/
MBQ=77P)U#Q%<33"73"@$XTSS,R7-K-=L([8IN\]E=UW&1G;])?BA\%OA7\:;
M'3M.^*?@>QUJ'2=9L]5TY;M#F"[M;B.X@D5E(/RRQHQ7.U@-K!E)!Z@  8 P
M!T% 'Y._"?\ X.#/^".&L>/9?VQOVBOVN[:X\=OI4VG^"?!&G>"M<O#X0TR4
MJ[V<3+9>7+J%RT<1NKA6\O*101N8H?-E^@O^"BW_  6L_9@_8CT_PA\(?B/\
M8M+^'GQ(^(.D0WAA\1:;/J/_  A5E)'NDO;ZWLDE:21#NCAMQQ/,N"Z1+)*G
MW!10!\._\$UO^"FG_!+CXO\ BW2_V*_^">'Q4U;XAZK'9ZAXA\7:Q_PCNHPR
M+N<276KZE=WMO +BXN;R>-6,>YC)/]U$7 ['PU_P62_X)D?'#0_$_@[PI\>-
M/\2:[IM]?:'J7PL?1K@>)-3N8F>&6S@T>>);F[WD%<I&T>&^=E ;'UC52UT#
M0;'5)];LM$M(;VZ %S=Q6RK+,!T#.!EN@ZGM0!\_?\$E/V4/%'[$7_!.[X9_
MLS^-K=;?5]!TV[N=1T]+H3KITM]?W-^UD)02)!;FZ\C>"0WE9'!%?1E%% !1
M110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;_L>]9_\ 2DU[I0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7\Z/\ P_=_X*L?]'3_ /ECZ'_\@U_1=7\B]?HW &!P6-^L_6*4
M9VY+<T4[7Y[VNG:]C\I\3LQS# ?5/JM:5/F]I?EDXWMR6O9J]KNWJ?77_#]W
M_@JQ_P!'3_\ ECZ'_P#(-'_#]W_@JQ_T=/\ ^6/H?_R#7R+17Z-_8>2_] U/
M_P  C_D?E/\ K%Q!_P!!E7_P9/\ S/W1_P"" O[=W[5G[;'_  MG_AISXJ?\
M)-_PC/\ 8/\ 8G_$CL;+[-]H_M'SO^/2"+?N\B+[^[&SC&3G]%Z_(O\ X-7?
M^:[?]RO_ .Y:OUTK\6XMH4,-Q!6IT8J,5RV2227N1>RTW/Z!X(Q.(Q?"^'JU
MYN<GSW<FVW:<EJWKMH%%%%?.'U84444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_\$]_^
M2)ZM_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*37NE !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
MOI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z
M6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'
M_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=
M7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)
M=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0
MO?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"
M]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#
M8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C
M_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL
M?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_
M .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_
M *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[
MZ6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_
M[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:
M-BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A
M)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$
MEU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%
M"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z
M%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
MOI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z
M6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'
M_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=
M7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)
M=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0
MO?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"
M]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#
M8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C
M_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL
M?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_
M .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_
M *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[
MZ6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_
M[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^%OQW_:#LUB\;:EI=Y8^)G2)4%U=V%_<Z>]SM3"CSC:^=A0%_>_* ,"OI6@
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M^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG_7R2V2V2T/1PN%H8/#QHT5:,?ZN^[>[;U;U84445B= 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?_!/?_DB>K?]
MCWK/_I2:]TKPO_@GO_R1/5O^Q[UG_P!*37NE !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_P"">_\
MR1/5O^Q[UG_TI->Z5X7_ ,$]_P#DB>K?]CWK/_I2:]TH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY,3<$=1MW^=]S5!INFZ=HVG6^CZ/80VEI:0)#:VMM$$CAC4!51%4 *H   '
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M[<GA7_@HC^R%X9_:;\/^'9-"OK\W&G^*?#4\WF2:+J]K*T-W:,V!N"R*61B
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M+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V
M**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$
M'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:C_A!](_Y^
M;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GY
MO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "
MVH V**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+
M:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'
M_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:C_A!]
M(_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'T
MC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W
M_P "VH V*P/B=\3_  %\&O VH?$CXF>)K;2-%TN$R7E[=-@ = J@<N[' 5%!
M9B0 "36%\3_$GPC^#7AQ_%7Q(\9OIEH,B+S;UC).P_@C09:1O90?7I7RQJ'[
M*?QP_;L^**?$7XJZOJ'AGX<Z=>-)X2T2^B*W+1=%N3 S,//9?^6LAPFX>6A'
M)\',^(<)@*_U2E%UL0U=4H6<K/9S;:C3C_>FTGLKO0]C 9-B,91^L5)*E13L
MZD]%?M%*[G+^[%-][+4T/ W[;GQC^)?QE3XD6^F:I!HDMC+;^!OA#I5K')J6
MLI)@C4M3D(864?"LBYW!3G!0EY?7=-_9O^)/QSU"'Q9^UUXF2:SCD$MC\/="
MG9-.MB.5-PX.ZY<?7:#G!*G%=O\ #']F?X3?"#26TKP+H\]J9<&[O&N2UQ=-
M_>EDZL<Y..@R< 5T_P#P@^D?\_-[_P"!;5Y\<AQN<R57/)J4=U0A?V2_QMV=
M9_XDJ?:G=7.QYQA<L7)E,7&76K*WM'_@2NJ2_P +<_[]M#0TG2-*T#38-&T/
M3+>RL[:,1V]K:PK''$HZ*JJ %'L*L5C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_
M .!;5]9&,8148JR6R/G)2E*3;=VS8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W
M_P "VJA&Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S
M>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%
MM0!L45C_ /"#Z1_S\WO_ (%M7QW^UE\3/'G[4/QJN/\ @G?^Q=XIO;*]@C5O
MC+\2K>Y9X?">GOD&RA8'#7\PW*%!R@ST(=H>O!X2>,J\J=DM92>T5U;_ $6[
M=DM6<6/QU/ 4>9KFDW:,5O*3V2_5[)7;T1%\<_'OC+_@J+\9M4_8T_9_\276
MF?!KPK>B#XT_$/3)-IUJ92"= L)!PV>D\@R .#\N%G^RO /@'P9\+?!6E_#G
MX>>&[71]#T6RCM-+TRRCV16\*#"JH_F3R3DDDDFN0^!?[*_P=_9Q^%FD_!SX
M2:+<:9H>C6XCMX4N3OE8\O-(PQOD=LLS'J2?I77?\(/I'_/S>_\ @6U:XW%P
MJI4*"M2CLNK?64O-_@M%YX9?@:E&4L1B'S5I[M;)=(1_NK[Y.\GO9;%%8_\
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M^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U
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MY2D^LI-M]SQ\?F.-S*M[3$SYFM%T27:,5912Z))+R"BBBO1.(**** "BBB@
MHHHH **^=/\ @K-\=_BM^S-_P3]\?_&[X(^*O[$\4:)_97]F:G]A@N?)\[5;
M.WD_=W"/&V8I9%^93C=D8(!'XN?\/W?^"K'_ $=/_P"6/H?_ ,@U]-DW"N89
MYA77H2@DI<OO-IW23Z1>FI\CG_&>5\.XR.&Q,)N3BI>ZHM6;:ZR6NCZ']%U%
M?SH_\/W?^"K'_1T__ECZ'_\ (-'_  _=_P""K'_1T_\ Y8^A_P#R#7K?\0\S
MK_GY3^^7_P @>'_Q%+A__GU5_P# 8?\ R9^PW[<7[67Q,G\>V/["/[%DD-Y\
M7_%=IYNJ:RPWVO@;26P)-2NB,@2[6'E1GDEE;!W1I)ZO^R'^R9\,_P!C;X.V
MGPF^'*37,K2M>>(/$%^=U[K>H2<S7EPYR6=ST!)VJ HX%>!_\$+O".C:I^P]
MIO[3FN1R:AX]^*6L:KJ?CGQ1?2&2[U.>'4[NVB#.?NHL<0VQC"@LY &XU]FU
M\YF<U@Y2R^E\,)-2?6<EHW_A6JBNVKU;/K,HA+'QCFE;652*<%TA"2327]YJ
MSF^KT6B04445XQ[P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!X7_P3W_Y(GJW_8]ZS_Z4
MFO=*\+_X)[_\D3U;_L>]9_\ 2DU[I0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  7=_P"44_Q4_P"X'_Z?=/K^=&OV3P\_Y$M3_KX__28'X)XI?\E!2_Z]1_\
M2YA1117WA^;']%W_  0B_P"44_PK_P"XY_Z?=0KZZKY%_P""$7_**?X5_P#<
M<_\ 3[J%?75?SGGG_(ZQ/_7R?_I3/ZKX=_Y)_!_]>J?_ *0@HHHKRSV0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^'O@PB62V8=7OK@ QV4:Y!8OEE!!*;?F'FOG_P#!03_@I'Q:+K'[.7P9NO\
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M.MVVVVV>'F? &39K75:M4J<UK-\R;>K=WS1>NMM+))))*Q_.C_PXB_X*L?\
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M)/&VK21L"?F1Y]ZGZ%6!_&O=_P#A,?#'_0:@_P"^J\6_X)[:;IR_!+5573X
M!XYU@ "(< 7! '3L !^%>Z_V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ
M% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_
M]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__
M #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%
M']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]
M^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,
M/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__
M #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[Z
MJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/
M^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!
MJ#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'
M_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^
MJ/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:
M@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0
M:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ
M_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4
M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
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M![9H_P!7\RQ6N.S"K)?RT^6C'Y.*=7_RJ']LX'#_ .Z8*G'SGS5)?=)^S_\
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M#P?NI-IR?\TK?@NGJ?2EGX'_ &4-=A_M#3_ /@6\C;I/#H=I(#^(0TDGP?\
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M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
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M#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\
M0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\
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MUS6_ _PQ\0P:3XBUJ75M7\"W'Q#UJ;PQ<WDC[WEDT9[LV4V6Y"2Q.B\!5
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M/A[JNGZ/^SU\2/A/.)(9!JT_B:^O;R2WEW (B0Z<'8D@G[V,$#/%>,CX@?\
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MV2?V;/AWL?PO\&]$66/&RYO;;[7*I]0\Y=@?H:]#BBB@B6"")41  B(N H]
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MP%4!5     %?HU_P<$#6/^$3^%[0%_[/&HZK]J SM\[R[7RL^^WSL?C7YE4
M%?1G[$?QAU+X@>//"'['WQW^*6O_ /"J=:\11BX\/VUYLBEN6R(+=Y,;TMGG
M,8>-6"Y;?@,-P^<ZT?!_]K_\);I?_"/;_M_]HP?8?+SN\[S%V8QSG=CI0!_1
M9H.@Z)X6T6T\-^&M(MK#3[&W2"RLK.%8XH(E&%1%4 *H   %6Z** "BBB@ H
MHHH **** "BJFO:]H7A;1KKQ'XGUJTT[3K&!IKV_O[E88;>-1EG=W(5% Y))
M %?(/BG_ (*'?&3]JOQ%>?"7_@EQ\-(?$BV\YMM:^,WBJ&2#PSI#=&^SY&_4
M)E[*@*CY6Q(A)KLPN!Q&,NX*T5O)Z17JWIZ+=]$SAQN8X7 V51WE+X8I7E+T
M2U]7LNK2/H7]I/\ :N^ '[(_@9OB#\?OB/8Z%9L2MC;R,9+J_E'_ "RMX$S)
M,_(X4'&<L0,FOFK^T/\ @H'_ ,%(QMT:/6/V<O@S=?\ +[,JCQIXCMS_ '%Y
M73(V'\7,@X(,B-BO1?V;/^":GPW^%7CI?V@OC]XRU'XN_%N8*TWCKQ@@=;!@
M<A-/M>8K*-23MVY9<D!E!VU]*5U_6,%@-,,O:3_GDM%_AB__ $J7RBF<'U7,
M,SUQ;]G3_P"?<7[S_P <U_Z3#3O*2T/,_P!F/]D#]GK]C_P8?!7P&^'EKI*3
MD/J>IR9FOM3E'66YN'S)*V23@G:NXA0HXKTRBBO,JUJM>HZE23E)[MZMGL4*
M%'#4E2I148K9)62^04445F:A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 >%_P#!/?\ Y(GJW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[U
MG_TI->Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 45%?7UEIEE-J6I7D5O;6\32W%Q/($2)%&69F/"@ $DG@ 5XAXX_X
M*5_L0^ [C[!>?'_2=4NRVV*T\-QRZF\K?W5-JCKGZD"@#W2BOGKPE^WGK'Q.
M\5:9HGPL_8_^*M_IEYJ$,-UXDUG05TVQ@@=P'G5YGS*$4EMH )QCO7:_M0>-
M?B+X?\&P6OP=^+GP^\*ZR=03[??>/9SY,5GL?>8E5US+O\O&[Y=N[OBLJU>C
MAZ;G5DHQ75M)?>S2G2JUI\E.+D^R5V>H45\(>(-?;79_LWQP_P""LWB;4&E.
M!I/PH\.)IQ'^PD]M'*6_WFQ75_L_GX4_!+Q'>^,_@/\ L]?&WQEKNIV/V2Z\
M2>*IIV2YAWJ^WS)Y!&"653GRP1ZX)%?/5.,N%J<W".+A.2^S3?M)?^ T^9_@
M>S#ACB"<5)X:48OK-<B^^?*OQ/;OCA^V[^RY^SEKG_"+?%[XL6NFZL84E328
M;2>YN65\[#Y<$;D;L<$X%?,W[=?[8D?[3/[)_C'X:_!_]G/XI7-GJ%I;RR>+
M=0\+FQTR&.&ZAG+>;*X9LB(KMV@G</6O=3XD_:[\5:Z?%'AO]D[P9X;U%XA$
MNK^*/$$=S.8QG 8VJ"0*,GY<\9-+XA^"?[8GQ6T.Z\-?$KX\>$M)TV_A:*^T
M[0?" O(Y8SU3==G(^O4=:YZ_%%:M1E_9V"KU9V?+>FZ4;VTO[:5)VOO;6VQO
M1R"E2JQ^NXJE3C=7M/G=NMO9*HKVV\]S\H/AG\,[3P7:"^O@LNI2K^\D'(B'
M]Q?ZGO\ 2NLKVW]K3]B?QK^S+=1ZY:7CZUX8N65(=82#8T$I'^KF0$["3G:V
M<-['BO$J_A7C=\42XDKOB!-8F^J>R73EM=<EOAL[?.Y_6W"JR!9'263-.A;2
MV]^O-?7F[WU.4^)/PRL_&UM]LLBD&HQKB.9AA9!_=?'Z'M7W]^QB?CU:_L9>
M$_@5HO[+.F^)M-MK:9YM:\7:I NFW!>]EN49;=U+RJC,N#C@Q@\<5Y#^QK^Q
M?XE_:0UZ/Q+XACFL/!UE<8O;[&U[UEZP0>I[,_10>YP*_2KPWX;T'PAH-IX8
M\,:3!8Z?8P+#:6ELFU(D'0 ?Y)/)K^BO!G+^.<?P_P N*Q4Z."7\*R@ZDN_*
MYPG:GO:R3N_=:1^*>*&,X3PF<WH8>-7%/^)=RY%VNH2C>??I;XE<\4T?X*?M
M=:S9+I^K_&SPMX%T_P#BTKX?^%U8 >@EGPR'W45>MOV$OA)JTZ7WQ6\3^+?'
M-PK;MWB?Q'-)&&_V4B* #V.17M5%?LJX-R*H[XN$L0_^GTYU5_X!-N"^44C\
MP?$^;P5L-)45_P!.HQIO_P "BE)_.3.;\$_!WX4?#=5'@/X<:+I+*,>=8Z;'
M'(?JX&YOQ)KI***^BP^%PV#I*E0@H172*27W+0\2M7KXFHZE:3E)]6VW]["B
MBBMS(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q?\ ;W_90L_VP_V=]1^&,%S#
M;:U:SKJ/AJ]GSLBO8U8*KD<A'1WC)YQOW8)4"OPZ^(OPW\=?"3QE??#[XD^%
M[O1M9TZ4QWEA>Q[70]B.S*1R&4E6!!!(.:_HMKC/C!^SO\#?C]IT>F?&7X6Z
M-XA2%2MO+J%F#- #U$<HQ)'GOM89H _GJK[7_P""1_[!'B_XN_%;2?VC_B)H
M$UGX,\-7BWFE-=1E?[8OHVS$(P?O11N [/\ =)0(,Y?;]^>#O^"9O["?@76$
MUW0OV<-%DN$?<@U2>XOXP?7R[F61/_':]RM[>WL[>.TM($BBB0)%%&H544#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*37NE !1110 4444 %%%%
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
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M-?9Y>JZ>AS'Q/^'?@?Q9I5QJ7BNT^2*T=;AEG$0ECP?E9L?D>HSUKZ=\/?\
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M?G%!_:U5?%A:J^4'_P"DS9]7?\)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5?*/\
MPDO_  6PT;G4O@'^SEK6WDC1_$&J6V[V'GJ<>G/J*/\ A?O_  5QT;C4O^"9
M_@36L=3H_P 7+6V#>X\^,X]>:/[)JOX:M-_]Q(+\V@_MN@OBHU5_W"F__24S
MZN_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^J^4?^&TO^"ANE?\ (U_\$;=:A ^]
M_9'Q:T:__+8BYXQ^H[4?\/'?CII/_(V_\$E_C;"1]_\ L?3K/4/RV2+GH?T]
M:/['QW3E?I4IO\I,/[>RY?%SKUI55^<$?5W_  F/AC_H-0?]]5\\?\%6OVG/
M'/[.W[ WCWXQ_ 3Q[%I'BS1_[+_LG4%LH+DQ>;JMI!+^[N(WC;,4LB_,IQNR
M,$ CF/\ A['X8T_CQ9_P3E_:>T?'WI;OX/%HOP=)SGL.G4BOG7_@K%_P4L_9
M\^/7[ 'C[X.^&OAE\1M!UW6/[*^Q#Q3\/KFPA!BU6SG<-,P*)\D3XR>2 .I%
M=^59+CGFE#VE&\.>-]FK<RO?=6MN>;G/$&6K)\3[*ORS]G/EWB^;E=K7L[WV
MZW/AO_A^[_P58_Z.G_\ +'T/_P"0:/\ A^[_ ,%6/^CI_P#RQ]#_ /D&OD6B
MOVG^P\E_Z!J?_@$?\C^?O]8N(/\ H,J_^#)_YGUU_P /W?\ @JQ_T=/_ .6/
MH?\ \@U^RO\ P2E_:<\<_M$_L#> OC'\>_'L6K^+-8_M3^UM0:R@MC+Y6JW<
M$7[NWC2-<111K\JC.W)R22?YL*_HJ_X(365G+_P2J^%DDMI$S'^W,LT8)/\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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M)3_]'3_^6/KG_P @T?\ #]W_ ()3_P#1T_\ Y8^N?_(-?SHT5[/_ !#S)?\
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MR\I)).,A5+':JCBO4/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H5YE:M5Q%1U*LG*3W;U9Z]"A0PU)4J,5&*V25DOD4_^$Q\,?]!J#_OJC_A,
M?#'_ $&H/^^JN?V=I_\ SXP_]^A1_9VG_P#/C#_WZ%9FI3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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MB>K?]CWK/_I2:]TKPO\ X)[_ /)$]6_['O6?_2DU[I0 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0?6\YH_Q<,IKO3FK_=-0M_X$SZ^HKY!_X2O_ (+6_!W_ )#?PH^#/QCL(O\
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M1/5O^Q[UG_TI->Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ' _%?]E?\ 9H^.J2#XR? +P?XFDD7!
MN=:\.V\\Z^ZRLA=#[J0:\'U7_@BW^QYI>H2ZY\!=8^(?PCU*5M[WWPT\?7ED
M2_8[)6E0#V50*^MJ*[:&98_#1Y:5627:[M]VWX'GXG*<LQ<N:M1C*7>RO\GN
MOO/Y%Z***_I,_DL*_1;_ (($? 7]H#X[?\+8TWX,_M>ZQ\*]-L_[!_X2--!\
M.6MW=:MO_M'R0EQ,=UKY6R;[@._SAG[@K\Z:_73_ (-7?^:[?]RO_P"Y:OG.
M+:T\/P_6J0M=<NZ37QQZ--?AION?5\$8>GBN*,/2G>SY]FXOX)/>+3]==5H]
M#ZX3_@C+^SUXP83_ +27QM^,/Q:=CNF@\=?$>Z:V)]%BMO)V+Z+DX]:]5^%_
M_!.S]A7X->7)\._V3_ UG/#CRKZYT"*[N4QZ3W >3_QZO9Z*_$JN:YE6CRSK
M2MVNTON5E^!_0U')<IP\^>%"/-W:3E][N_Q([6UMK*W2SLK>.&*-0L<42!50
M#H !P!4E%%>>>GL%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5I\(/ ,K?PVND;KG6)4QP1)JMW)"3U/]FJ.V*\)_:[_8+_X*\?LU_&OXE_\
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MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
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M4 %%%% !1110 4444 %%%% 'A?\ P3W_ .2)ZM_V/>L_^E)KW2O"_P#@GO\
M\D3U;_L>]9_]*37NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;_L>]
M9_\ 2DU[I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$]6_['O6?_2DU[I7A?\ P3W_ .2)ZM_V/>L_^E)KW2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[U[U10!X+_PK[_@H?_T<%X$_\)=Z/^%??\%#_P#HX+P)_P"$N]>]44 >"_\
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M/PI^U9^S=96=Y;^-O#4.IZ'8Z[?-;QPRO\LEO<211RE7AD$D;[5;+Q$ X.X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '+?&CXQ^!_@+\.;_P")OQ NYTL;+9'#:V5N9[O4+F1Q'!9VT*_-/<S2
MLD4<2Y9W=5'6OD+2_P!CGXH?#+]@[]JSXT^-=)CB^-G[0/A;Q)X@\166G3"?
M^R9#H\UKI&BQ2IQ-]CMQ%$9!Q),\SK\K*!J_MC_\$]_^"A_[1'[4NF?M!_!+
M_@J7I/PRTCPQ9/#X-\'O\ [/7X]+FEC"7%ZTM[J&V6[<&2,3K%&T<,CQ( ))
MC+W7[%G[(G[;'P7^)6N?$S]M3_@I!??':>YT5--\+Z7#\,['PK8Z+&THEN9&
M@LII%NY9#';A9),-$L;JI(E8  \0_P""(6M>%[#_ (-W?AMK:RQ?V=:?"[7G
MO6XV@QW6H>?GZ.LF?QI?^#6W1?$NB?\ !#_X.Q^)(Y(Q<S:_<Z?%+D%;9]<O
MF0X/0-\SCU#@]Z[.P_X)4_$/X<? SQ]^Q)^SW^TC8>$?@9\0]5U.>70_^$2>
MXUOPQ8:FS/J>F:5>?:E@C@E:28PO+;R/;>?)_K3L*?47@#X/>'_@=\#]%^!G
M[/MAIOAO2_"V@6^D^%K>YL9+JVLH((UCB#QK+$\N%49_>*S')+9)) /B3_@W
M._Y(9^T9_P!GC>//_1EI7V/^UO\ M"^'?V3?V8/'_P"TMXJC66R\#^$[[6#;
M$X-U)#"S16ZXZO+($C4=V<"O&O\ @E]_P3V^*_\ P3R\/_$'PCXP_:0T+Q]I
MWC[XD:OXWG^P_#V;1I[/4=1: S1J[:G=*]NODG:A0/E^7(&#Z+^VM^R]JW[7
M?@7PG\*)/%EOIWAJT^).AZ_XWL+BV:4ZWIFFW0OAIPP0%$MU!:;V.1Y:2+C+
M @ S?^":'[._B+]E[]A[X?\ PL\>NTOBZ32GUKQ[=2+\]QX@U*9]0U.1CU8_
M:[F8 G^%5'&,5[M110 4444 %%%% !1110 4444 %%%% !1110 4444 (S*B
MEW8  9))Z5\E>"/AE9_MR?MV^&/V[=2MP_PZ^#.C:KI'P7G8?\C#JVHA(=3U
MZ/ULU@A2TM6Y$Q:XG3,30/)V'_!2#]DW]IC]L[X+P?!3]GS]L.S^#UG>WF[Q
M;?R?#Q=?FUFT&TK8XDO;=(K=R&$R%9/.0B,[4,BR>2?#/_@G?_P50T_Q]X3D
M^.__  6JE\6?#_0=7M+K6? /AS]GK1_#?]LVUNZR)9&]M+II;> M&BNB##Q[
MXR-K< 'EO_!(C3M0T+_@MC_P49TOQ@K)K%QXI\$W=HLX^=K![+47A*Y_A\J2
M#\"M._8%M]4UG_@Y,_;I\3:(K-HMEX0\"V.IS1_<-\=(M/+![;@L-P/7Y37U
M/\5/V(O$L'[8"?MW?LO_ !!T?PKX]U'P=_PBWC:P\1:#+?Z5XETY)1-:R2QP
M7$$D5W;R A)U9MT3M$RD;&3=_8K_ &*_#?[(>E^,_$-YXLD\5>/?B;XNN/$_
MQ(\9SV"VIU34)0%6.& ._P!FM((PL4$&^0H@.7=F=V /F#Q)_P K3OAW_LQR
M?_U*Y:ZG_@N;X"^ '[3'P?\ A_\ L&_$#P=+K'Q%^,/C7[)\'[FTO3:3^&]2
ML[=[BYU_SU!98K*V\R1XU!:;>L/RB0R)UNK?\$[_ ([ZE_P53L?^"F<?[4?A
M:,6'PR?P#%X'/PNN&#:0VH/?ES>?VP#]J\Q\>8(0FU1^ZSS7??MG?L31_M/>
M+?AE\;_ GQ#'@[XF_!OQ+/K'@'Q//I7V^U47-N;:^L;NU\V)IK6Y@.QPDL4B
ME497&"& /B+_ ()?>,_VA/V'/^"E.J_L ?\ !2?2/^$V^)WQ!\,R2_"']I22
M::>;QGH.F1>8=(E$S-]DDMXUDG>*/:&D\R27S7D2XF_56O!=/_9%\8?$7]J/
MP3^UI^TQXTT'5M:^&6D:K9_#W0_"^ARVEKIL^IQQ0WU[-+//+)<RO!$L,:@1
MI$DDN1(S*Z>]4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7RE_P43\
M&S_MU:<__!-'P1=/_9WB2:PN_C;K]LV!X?\ #23I<&R5QP+_ % PB"*/JD#7
M$[8"1"7Z.^*FC?$7Q%\.-:T'X1^.[#POXFO-.DAT3Q%JF@G5(-.N&&%G:T$\
M'G[>H0R*"0,Y&0?@7X:?\$H_^"Q7P?\ "UWX4^'?_!>ZVL$U'4KC4=3OY/V5
M=#N;R^O9VW2W,\\]\\DTK8"[G+;41$7"HBJ <Y_P5;\+1>%_^"RO_!.*1-.2
MU\):=XC\6:9800Q[;>TNC862V\0 X4G;&$'_ $S..E6_^"Y]OJFL_P#!0G_@
MGCX:\,*S:J_[0DM\JQ??^PVWV&2\/'.T0DENV.M?3/QG_P"";VD_'+]D_P"'
MOP/\;?&O6;GX@?##6-*\3>$OC!=6BS:A%XILG\TZK) S[9(YY6F\VUWA#',T
M:LFU&6WX)_8B\8>+?VM_#_[;7[6_Q&T+Q5XN\"^&KO1/AQHWA?P[-IVE>'EO
M=HO[X+<7-Q+->7"HD6\NB1PCRPC,6E8 \!_X.4O^3)?AU_V<=X*_]+7KZ+_X
M*E_L/P?\%'/V"?B)^QR?%$>B7?BW3(#I&KS1EH[6_M;J&\MFD"\F(S01J^,G
M8S8!.*YC_@JC_P $]_BC_P %'/A;X:^$7A+]HS1/A_IGA_QKI?BAY[WX?RZU
M<7-Y82221(&74K54B+,NX;6;Y#AAGCZ(DA^*-EX \B'4M U+Q2D 'VIK*>QT
M^67=RWE>;/)&H7/R^8Y)'W@#P ?D)_P5O^-'_!1^P_X(U67[$/[2_P"RUX9L
M_B/\1-3\/?#C2=6T;XAQZ@_BW4A=0.+C3[**WWCS4M6:03O"(C(,;\J*_6WX
M!?#>?X-_ KP5\(;K4!=R^%?"6FZ/)=#.)FMK6. OSSR4SSZUY3X$_8576OVE
M;#]LK]J[XA0_$'X@>'K&:Q\ VMKHYL-"\&6\P G;3[-YIG-W, %EO)I7D=5"
MH(4_=U]!T %%%% !1110 4444 %%%% !1110 4444 %%%% !7G?[2_Q\@^ 7
MP_&J:-X;E\1^+=;N/[-\!^#;.4)<:_JSHS16ZD\1Q@*TLTY^2"".65\*AKT2
MOA#XP?\ !-C_ (*D>.?VK?$7[4'PQ_X+%Z/X,?4K5M-\.:"O[-FGZK'X>TGS
M-XM+>6]U)V#2,L;SRJ$-P\<98!8H8XP#R/\ X*1?L0:_^Q]_P;??'3X0:-K*
MZYXVUBSD\8?$KQ%80,BZOK%WK-K?:O<HIY6$1B2- >1#"F[)!)]%_;.UKPO:
M_P#!LMK^J6DL1TR?]E'3TT]AC:1+H]ND&/JSIC\*]X_96_8K^.?@OX;_ ! \
M'?M^?MAW/[16H?$*'^S=2N=1\#VOA[3[?1/L[P_V<FGVDKQ#<9[EI)@0\HD1
M6_U2D^8G_@DGX[\1?LMZ#_P3F^)7[2UOK7[/7A_4+11HP\,21>(]6T2SNDN;
M+0KO41=F'[/&T<43S16Z2RPPI&/+)>1P#T+_ ()DZ[:_!/\ X)#? GQ-\;M?
M@T2T\._ ?P]=:[?ZK-Y:6%O'I4#GS6;[NR/ (/0KBJ_[&/[/OB'Q9^TK\0_^
M"EGQA\*W.C>)/B1I-CX>\">'=2@,=YX>\'V3-);QW*'F.ZO+B22\FA/,(:"$
MX>*3.5_P4"_8)_;*_:Q\8^";C]G3_@H#H_P=\)^")8;ZT\)'X+6OB&.]U.(G
MR+F<W-]'#(D&$:"'R-L4J";+.D1B?^RW^Q-_P42^'_Q[TWXK?MD?\%8;WXQ^
M'=$L+K^R/ ^F_!W3?"EN-0EC\E;NXFLKB1[I4A><+!("@>1) 0T8R > ?\&I
M^GZAH?\ P3O\<>&_$BLNOZ7^T#XIM/$R2C$B7Z?9?,#]]V-F<\T[_@V5M]4N
M?A1^U#XLB5ET+6?VOO%]QH/]R2/9:!I$[%3\JY'>,CM7T7:_L#?%WX&_%SXJ
M_$']B+X[Z!X&TWXTZF-:\7:)XB\&2:JFD^(&B$-QK.F^7>6ZK+/&J-)#.LB-
M-&DF0NZ)_5OV-/V1_A)^PO\ LW>&?V8?@G:72Z'X;MG7[9J,PEN]1NI9&EN+
MRXD &^::9WD8@ 9;"A5"J #U"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ JCXG\3^'/!7AO4/&/C#7K/2])TJREO-3U/4+A88+2WC0O)+([$*B*H+%B0
M  2:O5\K?\%'OV(/VP_VT-0\):=\!/V]M,^$7AOPW?1ZGJ&A7/PA@\2?VWJ,
M4A>"2Y-S?11/!"0CI;M"RB9!*S,R1", 7]D_X':K\8OVO_%W_!43XG^&[G2K
MKQ!X0MO!7PDT/4K9H;O3O"4-P]V]Y<QL T5Q?W3F<1, \-O';HX60RHGSI_P
M;$Z=J&@?!;]I_P ,>+%9/$MA^V+XOCU^.88E$HM].4EL\X+K)^(:O=?V<OV'
M/^"DO@_X]:!\3/VO/^"N]Y\6O"7A\3SQ?#_2_@KIGA:"\O6A>**:XN;.X>2=
M(O,9Q P*&1(WX*#/0S_L)_%#X/?M&?$G]H;]BOXQ^'?!TOQBBM)_'F@>*_!\
MVK62:Q;QM#'K-FL-Y;&.=HFVS0N62=HXWW(P;> ?-?\ P;UV^J7_ ,=OV\O&
MEFK'P]J7[8?B6/2I5_U<D\=Q*T[+VY66W)^HKWOXW?#2Q_X*)_M9> O#JP+<
M?"?]GSQXOBG7M4QF+Q!XTM(Y(;'3K=OXXK!III[EQE/M'D6XR\5PL4T'_!-7
MQK\%/^"?,O[$7["W[4MU\+]<U*YN+CQ!\6=4\+#6M7O[F\=Y=0O0J7-JL5Y/
M(_$X8B%!MC0%8WC\B\(_\$K?^"MGA;P/I/P=L_\ @NJFF>!]/@BL9M"\(_LQ
M:'I$YTY?EDM[>[BNS):.R;@)T_>(QW@D]0#Z5_X*F_\ *,7]HW_L@_B__P!,
MMW6'_P $;?\ E$Y^S?\ ]D4\-_\ INAKO/VR_P!GCQI^TO\ LH>-/V7_ (;_
M !)TKP:OC;PA?^&K[6M4\,RZO]EL;RTDM93%"EY;?O0DF59G901RK55_8*_9
MJ\=_L=_LH>"/V7O&_P 5M*\9+X#\.6>AZ3KFF>%9-(,UI;0K%$987O+H-)M4
M99652>BB@#V*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKSG]K'X9?
M'CXQ_ ?7?AG^S=^T);_"SQ5K%O\ 9K7QU+X4_MF73(FXD>"W-S;J)BN0DC.0
MA.[8Q P >'_M0_#6Q_X*+_M#^#?@%:PK<_"[X.>/+3Q7\3=7 S%JVOV2E].\
M/0GI((Y)%N[P\A!';P<M+((O O'NGZAI_P#P=C>!]6\3!OL>H_LB74/AN1Q\
MAFCU:Z::-3_>"F1B!SAQZUO>"O\ @E-_P5^^'WPVL/@WX*_X+SQ:'X9L;;[,
MMIH/[+6AVUSY+$F4K<F\>19W+.[7!+2F1S(S,Q)/TC^TS^P5I'Q>\5?"?XV?
M"3QL/"7Q,^"-U*W@/Q/J-D^I0SV-Q;?9;W3-0B,T<ES;W$. 6$JRI(J2*V0R
MN ?*7[4UOJFL_P#!TE^S!;>'59CHWP$\2WWB#R_X;&4:C!$7Q_#]H* 9XS7U
M=_P4 \7>-?&OPVO?V,/@#=Q-\2/BKHEUIEO=LF^+POHTP^SWNO70!^5((Y&6
M%#S/<M%$/E\UXV_ []B+7?!'[0_CG]MKXM_$32O$OQB\8^&;?PWINK6GAZ2W
MTGPUHENS2PZ?:VS7+S2(UPQN)W><-,X&T0J H^=/#?\ P2Q_X+!>"_&/BSQ[
MX._X+L:;I^J^--6-_KEZ?V5M'NI6*@K# DESJ,CK;P(2L4.XI&"Q W.[, ?;
MO[.OP&^'G[+OP'\(?LZ?"?3GM?#G@KP]:Z/H\4K!I##!&J!Y& &Z1L%W;'S,
MS'O7SXOPUL?V^/VZ/!?[3EQ"LWPL^ +ZHG@&\QE/%7BJZ06MUJ$6>'LK&%)(
M(I1Q+<S3,IV6Z/)G_$S_ ()[?MS>-_V%HOV5]%_X*AWEEXZUO5KF[^)'QAU#
MX81W-YK\,LC'[);64=_##ID/E"* K$7!CB(787<GE/ /_!-;_@JKINJ>&/#'
MQ/\ ^"V8U;X<Z-?62ZSX#\)_LWZ+X<.IZ7;NA.FQWEI=&6RB>-/*W0@%48@"
M@#[QHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK^='_A^[_P5
M8_Z.G_\ +'T/_P"0:/\ A^[_ ,%6/^CI_P#RQ]#_ /D&OO/^(>9U_P _*?WR
M_P#D#\U_XBEP_P#\^JO_ (##_P"3/Z+J*_G1_P"'[O\ P58_Z.G_ /+'T/\
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M2"5! /HRBJ/AK4-7U70+/4M?T!]*O9X%>ZTV2Y29K9R.8RZ$JQ'3*DCTJ]0
M4444 %%%% !1110 45C_ !"^(7@?X3>!=7^)OQ,\5V&A>'M TZ6_UK6=4N5A
MM[*VB4O)+([<*JJ"2:^>?@__ ,% /BU^T_X3M_C#^R[^Q!XLUWX=:@IET'Q;
MXJ\0V.@2^(;7G;=V%E.S3M!(,&-[H6N]2& VD,0#Z>HKQ+]DS]N'PG^UIXX^
M(WPZTKX3>,O!NM_"_5K+3/%&C>-]/AMKN*ZN;;[0%58998Y(PA4K-'(\<@;<
MC,F&;VV@ HHHH **** "BBB@ HHK/O/%GAJP\46/@J]URVBU?4[.YN]/TYY0
M)KB"W:%9Y$7J51KB ,>QE3U% &A17EUK\:?C=-^V+<_ "?\ 9=U.+X>P^ 5U
MN'XPG7X#:3:H;H0G2!9A?-#B+,WFEL8&-@R&/J- !1110 4444 %%%% !111
M0 4444 %%%?!_P"WC_P61L/@CXNOO@Y^S?H6GZYKNFRM!J_B#4BSV5G,#AH8
MHT93-(IR&8L%5AC#\X /O"BOQ=TW_@LK^WS8ZT-4NOB;I=Y '!.FW/ABS$)&
M>F8XUDQ_P//O7WA_P3Z_X*D>#?VP;S_A67CS1+?PWXZCMVEBM()B;35449=K
M<N=RNHR3$Q8A1N#, VT ^LJ*** "BBB@ HKBOVC/VA/A-^RC\#?$_P"T9\<_
M%":-X3\(:4^H:UJ#QERD:X 5$7EY'<JB(.6=U4<D5\Z_%'_@J#\8_@)\!K_]
MJSXX_P#!-GXH:1\/++17U6XNM+UG2-0UC3+39YB2ZAIL=R'MEVX,GE/.8<YD
M"!7*@'U_16?X2U^/Q7X5TSQ3#;-"FI:?#=)"S9*"2,.%)[XSBOCVU_X+.>!M
M<^&NK?M6>#_V>O$NJ?L_Z#XS/AO5/BY'JMFF]EODL)-2MM.+^?<:?'<R!&FR
MLN$=UA=5S0!]I45'>27$-I+-:6WG2I&QBAWA?,8#A<G@9/&:^*/#'_!8GQ=X
M\_:S^)O[%_PY_P""=7Q2\1^-?A'%:3>-+?2O$GAN*&*&ZB6:VD@>\U* 3^;&
MZLJC##.&"GB@#[;HKP']A'_@I+^S=_P4*TKQ5%\&WU_1O$W@+6FTGQ]X \::
M3]@USPY>!G4174 =U&6BD >-W0F-UW;E8#WNZNK:QMI+V]N(X888R\LLKA51
M0,EB3P !R2: 'T5\)_!__@MQKOQX^.^A?"CX:?\ !*_]J"X\,^)?$$=GHOQ7
MOOAP]IX9N-.DDQ'K'VR5@HLGAQ.K]6C9=JEF"GZ"_:$_;2\-?!SXS^$OV7?
MG@:_\<_%+QM876I:/X/TJ[AMUL]+MB!/J=]<S$+:6JNRQ*V'>65@D<;D.5 /
M:J*\C_97_;!\#?M0W'C'P=:^']0\,^./AOKXT7XA>!M;>)KS1KIHA- ^Z)F2
M:VN(66:"=#MD0]%=71?)-4_X*U^ Y?AYXQ_:5\ ? OQ3XG^"/P^UNZTWQ7\5
M=)N;4Q,+23RK^_L;,OY]]8VCAA-<)M)$,QA2<)D@'UO15#PMXH\.>-_#&G>-
M/!^MVNIZ1J]A#>Z7J5E,)(;NVE0212QNO#(R,K!AP00:^8O^"@?_  5'LO\
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MI:BFP2^= DVW&] V,],BG4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 >7?M1?M<?#3]D?0=*
M\1?$O0/%-_!J]X]M;)X6\.3:C(CJFXEUB!*+CH3U->+?\/I?V4_^B<?%W_PU
M]]_\37UU17=0K9?"FE5I.4NZG;\.5_F>;B:&:3JMT:\8Q[.',_OYU^1\B_\
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MD$1D.D:Q;AO(N"H(+(5>2)P.?+F?:0V".$_9B_;"_P""B/PX\!:9\&_VW_\
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M"_L#4I;@P:EJ&ZX%U;W%G%=.CVT=M(7>"/RS(CLZ '<_\&TWC7Q1X^_X(A_
MC6O%US+-=6VDZMIL$LQ))M;/6K^UME&?X5@AB0>RC'&*\R_X.(?^2W_L&?\
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M#?B;X:LTL-5UZ3Q'I&HVOB54&V.]4V%Y.T<S(!YJNJ+Y@9D.&VK]-4 %%%%
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M6].TL:7XQG9C_P )#%:W\T<)4(PBARSM;QB3#!F!D .X_P""/W[<'Q>_:?\
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MHZ+KEA)9ZE9RD@21.,'!'*L.JL"&5@""" :^8?VE/B%^U;9_M2Z_I'C_ /:
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M02N(R4MX/.6.9E" HXXG]N/X _\ !3'X<?M;?"K_ (*[_L8?L_Z3XJ\;:?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'CWQ^_8F^#_ .T+XQTKQOXG@FL[ZSF4:E)880ZG
M;J.(93U!!P X^8+E?[I7U?1-$T?PUH]MX?\ #^FPV=C9PK#:VMM&$CBC48"J
M!P !5JBO+P>291E^.K8W#4(PJUFG.25G*VU_ZU>KUU/0Q.:YEC,)2PM>K*5.
ME=0BWI&_;^M%HM HHHKU#SPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507431496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,365,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">DOCUMENTS INCORPORATED BY REFERENCEPortions of the registrant&#8217;s Proxy Statement for its 2022 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock, $0.01 par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member', window );">1.500% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member', window );">1.625% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member', window );">3.125% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507432536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Dallas, Texas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509143016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 263,966<span></span>
</td>
<td class="nump">$ 238,228<span></span>
</td>
<td class="nump">$ 231,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(250,836)<span></span>
</td>
<td class="num">(226,080)<span></span>
</td>
<td class="num">(219,028)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">13,130<span></span>
</td>
<td class="nump">12,148<span></span>
</td>
<td class="nump">12,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(10,537)<span></span>
</td>
<td class="num">(8,849)<span></span>
</td>
<td class="num">(9,182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Claims and litigation charges, net</a></td>
<td class="num">(274)<span></span>
</td>
<td class="num">(7,936)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="num">(281)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(11,092)<span></span>
</td>
<td class="num">(17,188)<span></span>
</td>
<td class="num">(9,534)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">2,038<span></span>
</td>
<td class="num">(5,040)<span></span>
</td>
<td class="nump">2,489<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">1,928<span></span>
</td>
<td class="num">(5,034)<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(636)<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="num">(4,339)<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 1,114<span></span>
</td>
<td class="num">$ (4,539)<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">7.23<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">7.35<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">5.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 7.32<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">181.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">152.3<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">180.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509141768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,287<span></span>
</td>
<td class="num">$ (4,340)<span></span>
</td>
<td class="nump">$ 1,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow hedges</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="num">(4,170)<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="num">(223)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 1,230<span></span>
</td>
<td class="num">$ (4,316)<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509211784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,532<span></span>
</td>
<td class="nump">$ 6,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">18,583<span></span>
</td>
<td class="nump">19,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">18,702<span></span>
</td>
<td class="nump">19,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">4,516<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">898<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">46,231<span></span>
</td>
<td class="nump">45,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,451<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">63,298<span></span>
</td>
<td class="nump">65,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">38,086<span></span>
</td>
<td class="nump">38,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">4,741<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,543<span></span>
</td>
<td class="nump">3,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">48,466<span></span>
</td>
<td class="nump">44,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">5,080<span></span>
</td>
<td class="nump">6,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">1,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,366<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,220<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,540<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">#REF!</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized, 275 and 273 shares issued at March 31, 2022 and 2021, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,275<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">9,030<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 130 and 115 shares at March 31, 2022 and 2021, respectively</a></td>
<td class="num">(17,045)<span></span>
</td>
<td class="num">(13,670)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; deficit</a></td>
<td class="num">(2,272)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity (deficit)</a></td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</a></td>
<td class="nump">$ 63,298<span></span>
</td>
<td class="nump">$ 65,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506066520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">275,000,000<span></span>
</td>
<td class="nump">273,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">130,000,000<span></span>
</td>
<td class="nump">115,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276499067384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustments: adoption of new accounting standards</div></th>
<th class="th">
<div>Opening retained earnings adjustments: adoption of new accounting standards </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance</div></th>
<th class="th">
<div>Adjusted balance </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Other Capital</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, common stock (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,409<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 8,298<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,420<span></span>
</td>
<td class="num">$ (1,849)<span></span>
</td>
<td class="num">$ (8,902)<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance, treasury common stock (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockExchangedDuringPeriodShares', window );">Change Healthcare share exchange (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockExchangedDuringPeriodValue', window );">Change Healthcare share exchange</a></td>
<td class="num">(2,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="num">(4,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2021</a></td>
<td class="num">(115,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(3,508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="num">$ (1,792)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 7,275<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,030<span></span>
</td>
<td class="num">$ (1,534)<span></span>
</td>
<td class="num">$ (17,045)<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2022</a></td>
<td class="num">(130,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease from Reclassification to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseFromReclassificationToLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockExchangedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Exchanged During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockExchangedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockExchangedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Exchanged During Period, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockExchangedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276511260536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507772712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,287<span></span>
</td>
<td class="num">$ (4,340)<span></span>
</td>
<td class="nump">$ 1,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Goodwill and long-lived asset impairment charges</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(908)<span></span>
</td>
<td class="num">(342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss (gain) from sales of businesses and investments</a></td>
<td class="num">(132)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,843)<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="num">(2,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,169)<span></span>
</td>
<td class="num">(2,276)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="nump">2,802<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">3,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(356)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="num">(377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="nump">243<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">4,434<span></span>
</td>
<td class="nump">4,542<span></span>
</td>
<td class="nump">4,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(388)<span></span>
</td>
<td class="num">(451)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">578<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(415)<span></span>
</td>
<td class="num">(579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">11,192<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
<td class="nump">21,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(11,192)<span></span>
</td>
<td class="num">(6,323)<span></span>
</td>
<td class="num">(21,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuances of long-term debt</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,648)<span></span>
</td>
<td class="num">(1,040)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="num">(184)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquityAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(3,516)<span></span>
</td>
<td class="num">(742)<span></span>
</td>
<td class="num">(1,934)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(383)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(318)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(6,321)<span></span>
</td>
<td class="num">(1,693)<span></span>
</td>
<td class="num">(2,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">55<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease', window );">Cash, cash equivalents, and restricted cash classified within Assets held for sale</a></td>
<td class="num">(540)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(2,461)<span></span>
</td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of year</a></td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">2,981<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of year</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Less: Restricted cash at end of period included in Other Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of year included in Prepaid expenses and other</a></td>
<td class="num">(403)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">6,278<span></span>
</td>
<td class="nump">4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest, net</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes, net of refunds</a></td>
<td class="nump">$ 359<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506028520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson&#8217;s teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. The Company&#8217;s equity method investment in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. Refer to Financial Note 21, &#8220;Segments of Business,&#8221; for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior period amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). As COVID-19 further evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Restricted cash at March 31, 2022 primarily consists of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash at March 31, 2022 and 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets at March 31, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Net and Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, legal disputes, or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $89 million and $198 million were included in &#8220;Receivables, net&#8221; on the Consolidated Balance Sheets as of March 31, 2022 and 2021, respectively. Changes in the allowance for the year ended March 31, 2022, were primarily within the U.S Pharmaceutical and International segments. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,181&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2022, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 52% of its total consolidated revenues and approximately 43% of total trade accounts receivable at March 31, 2022. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of its total consolidated revenues in 2022 and comprised approximately 28% of total trade accounts receivable at March 31, 2022. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and 2021, total inventories, net were $18.7 billion and $19.2 billion, respectively, in the Company&#8217;s Consolidated Balance Sheets. The LIFO method was used to value approximately 63% and 58% of the Company&#8217;s inventories at March 31, 2022 and 2021, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $383&#160;million and $406&#160;million higher than the amounts reported at March 31, 2022 and 2021, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $23 million, $38 million, and $252 million in 2022, 2021, and 2020, respectively, in &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The lower LIFO credits in 2022 compared to 2021 and 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2022 and 2021, inventories at LIFO did not exceed market. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes costs to pack and deliver inventory to its customers in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statements of Operations. Shipping and handling costs of $1.1 billion was recognized in 2022, and $1.0 billion was recognized in each of 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment, Net: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#8220;ROU&#8221;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March 31, 2022 and 2021:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense for property, plant, and equipment, net and amortization of the ROU assets of finance leases was $312&#160;million, $344&#160;million, and $335&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd">one</span>&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 10, &#8220;Leases,&#8221; for additional information on the Company&#8217;s leases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61">one</span> to 24 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2022 and 2021, capitalized software held for internal use was $320 million and $513 million, respectively, net of accumulated amortization of $1.4 billion, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. The decrease in capitalized software held for internal use is primarily due to the planned exit of the Company&#8217;s European businesses which resulted in an impairment of certain internal-use software that will not be utilized in the future and classification of certain software as held for sale, as discussed in Note 2, &#8220;Held for Sale.&#8221; Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $116&#160;million, $117&#160;million, and $129&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March 31, 2022, 2021, and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.2 billion in 2022 and $3.1 billion in each of 2021 and 2020. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2022 and 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2022 and 2021. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Incentives:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; equity (deficit) accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity (deficit) section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material in 2022, 2021, or 2020. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity (deficit) section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 15, &#8220;Hedging Activities,&#8221; for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#8217; equity (deficit) but are excluded from earnings. The Company&#8217;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrealized gains and losses on retirement-related benefit plans. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#8217;s consolidated entities including Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;) and ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; equity (deficit) in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 8, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees. Refer to Financial Note 5, &#8220;Share-Based Compensation,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to ongoing controlled substances claims to which the Company is a party.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no recently issued accounting standards that could have a material impact to the Company&#8217;s financial position, results of operations, cash flows, or notes to the financial statements upon their adoption.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506347544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text">Held for Sale <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe (&#8220;European Divestiture Activities&#8221;). These activities, further described below, constitute the majority of the assets and liabilities classified as held for sale as of March 31, 2022. Total assets and liabilities that have met the classification as held for sale were $4.5&#160;billion and $4.7&#160;billion, respectively, as of March 31, 2022 and $12&#160;million and $9&#160;million, respectively, as of March 31, 2021, primarily included within the Company&#8217;s International segment. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations. During the year ended March 31, 2022, the Company recorded charges totaling $1.6&#160;billion, primarily to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell. These charges were largely driven by declines in the British pound sterling and the Euro. During the years ended March 31, 2021 and 2020, the Company recorded losses of $58&#160;million and $275&#160;million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to a joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;) which was completed on November 1, 2020. These charges in each year were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2&#160;billion (or, approximately $1.4&#160;billion) adjusted for certain items, including cash, net debt, and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the transaction closing date. The transaction is anticipated to close within the second half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, the Company recorded charges totaling $438&#160;million to remeasure the E.U. disposal group to fair value less costs to sell. These charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment includes net losses of $151&#160;million related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2021, the Company announced an agreement to sell its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited. In April 2022, the Company entered into an amendment to the agreement for a purchase price of &#163;110&#160;million (or, approximately $144 million), including certain adjustments. During the year ended March 31, 2022, the Company recorded charges totaling $1.2 billion, primarily consisting of adjustments to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustments include a $734 million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy. The transaction closed on April 6, 2022 and, at closing the buyer assumed and repaid a note payable to the Company of approximately $118&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, the Company completed the sale of its Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#8364;244&#160;million (or, approximately $276 million), including certain adjustments. The Company divested net assets of the Austrian business of $272 million, primarily within the International segment, and the buyer assumed a note payable to the Company of approximately $63 million which was paid to McKesson in the fourth quarter of 2022. During the year ended March 31, 2022, the Company recognized a loss of $32 million which was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed a transaction with WBA whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson had a 30% noncontrolling interest.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction consideration for the contribution included a receivable amount of $41 million, primarily related to working capital and net debt adjustments from WBA, which was received in the first quarter of 2022, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of March 31, 2021. The Company accounted for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $291 million as of the transaction date, which was paid to the Company in 2021.</span></div>In conjunction with the contribution, the Company recorded losses of $58 million and $275 million, respectively, in the years ended March 31, 2021 and 2020, which included adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the German pharmaceutical wholesale business disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505995112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges, Net <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges, net, of $281 million, $334 million, and $268 million in 2022, 2021, and 2020, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Consolidated Statements of Operations. In addition, for the years ended March 31, 2021 and 2020, certain charges related to restructuring initiatives were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations and were not material.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $124 million for the year ended March 31, 2022, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the year ended March 31, 2022 and were $57 million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in 2022 and remaining costs the Company expects to record under this initiative are not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $62 million and $72 million in 2021 and 2020, respectively, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in 2021 and remaining costs the Company recorded under this initiative were not material. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $28 million and $44 million in 2021 and 2020, respectively, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021 and remaining costs the Company recorded under this initiative, primarily relating to lease costs, were not material.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2018, the Company announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize the Company&#8217;s operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, the Company committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material. The Company recorded charges of $15 million in 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022 </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#8217;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#8217;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with dispositions and costs related to the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March 31, 2022 and 2021: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#8220;Other accrued liabilities&#8221; and $52 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company recognized charges totaling $36 million to impair certain long-lived assets within the International segment related to the Company&#8217;s operations in Denmark and its retail pharmacy businesses in Canada. The Company used an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived assets. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach and a market approach to estimate the fair value of the long-lived assets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company recognized charges of $82 million to impair certain long-lived and intangible assets for its retail pharmacy business in Europe within the Company&#8217;s International segment. These charges related primarily to intangible assets associated with pharmacy licenses within the U.K. retail business due to a decline in estimated future cash flows driven by additional U.K. government reimbursement reductions communicated in the third quarter of 2020. The Company used a combination of an income approach and a market approach to estimate the fair value of the long-lived and intangible assets. </span></div>In 2020, the Company performed an interim impairment test of long-lived and intangible assets for its Rexall Health retail business, within the Company's International segment, due to the decline in the estimated future cash flows primarily driven by lower than expected growth in both prescription volume and sales of non-prescription goods. As a result, the Company recognized a charge of $30 million to impair certain long-lived and intangible assets, primarily customer relationships. The Company used an income approach for estimating the fair value of the long-lived and intangible assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506319608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Acquisitions and Divestitures</a></td>
<td class="text">Business Acquisitions and Divestitures <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021, and 2020, the Company did not complete any material acquisitions. For the three years presented, the Company completed several de minimis acquisitions within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates. Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes. However, if the assets of another company are acquired, the goodwill may be deductible for tax purposes. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe. In 2022, the Company entered into agreements to sell the E.U. disposal group and U.K. disposal group and completed the previously announced sale of its Austrian business, as described in Financial Note 2, &#8220;Held for Sale.&#8221; In 2021, the Company contributed the majority of its German pharmaceutical wholesale business to a newly formed joint venture with WBA as discussed in Financial Note 2, &#8220;Held for Sale,&#8221; and, in 2022, sold its interest in the joint venture to WBA, as described in Financial Note 6, &#8220;Other Income, Net.&#8221; In 2020, the Company completed the separation of the Change Healthcare JV, as described below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in the Change Healthcare Joint Venture </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2017, the Company contributed the majority of its McKesson Technology Solutions businesses to form a joint venture, the Change Healthcare JV, under a contribution agreement between McKesson and Change Healthcare Inc. (&#8220;Change&#8221;) and others, including shareholders of Change. In exchange for the contribution, the Company initially owned approximately 70% of the joint venture, with the remaining equity ownership of approximately 30% held by Change. The Change Healthcare JV was jointly governed by McKesson and shareholders of Change.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#8220;IPO&#8221;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change contributed net cash proceeds it received from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#8220;LLC Units&#8221;). As a result, McKesson&#8217;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5%. Accordingly, in the second quarter of 2020, the Company recognized a dilution loss of $246 million, primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#8217;s carrying value. This amount was included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company recorded an other-than-temporary&#160;impairment (&#8220;OTTI&#8221;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#8217;s investment and the fair value derived from the corresponding closing price of Change&#8217;s common stock at September 30, 2019. This charge was included in &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation of the Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the separation of its interest in the Change Healthcare JV. The separation was affected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly-owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (&#8220;Split-off&#8221;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#8220;Merger&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Split-off, on March 9, 2020, the Company distributed all 176.0 million outstanding shares of common stock of SpinCo to participating holders of the Company&#8217;s common stock in exchange for 15.4&#160;million shares of McKesson common stock which now are held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 19, &#8220;Stockholders' Equity (Deficit),&#8221; for more information. Following consummation of the exchange offer, on March 10, 2020, SpinCo was merged with and into Change Healthcare, and each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and the Merger are intended to be generally tax-free transactions for U.S. federal income tax purposes. Following the Split-off, the Company does not beneficially own any of Change&#8217;s outstanding securities. In the fourth quarter of 2020, the Company recognized a net gain of $414&#160;million related to the transaction which is included under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020. The net gain was calculated as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the Change Healthcare JV at exchange date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of deferred tax liability </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of accumulated other comprehensive loss attributable to the joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on split-off of the Change Healthcare JV</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investment in the Change Healthcare Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the separation of the Company&#8217;s interest in the Change Healthcare JV, this investment was accounted for using the equity method of accounting. Effective April&#160;1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance and, in the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#8217;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, in the Company&#8217;s opening retained earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the OTTI and transaction-related items described above, the Company recorded its proportionate share of loss from its investment in the Change Healthcare JV of $119 million in 2020, which includes transaction and integration expenses incurred by the Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible amortization and removal of profit associated with the recognition of deferred revenue. This amount was recorded under the caption &#8220;Equity earnings and charges from investment in Change Healthcare Joint Venture&#8221; in the Company&#8217;s Consolidated Statement of Operations for the year ended March 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the formation of the Change Healthcare JV, McKesson, the Change Healthcare JV, and certain shareholders of Change entered into various ancillary agreements, including a transition services agreement (&#8220;TSA&#8221;), a transaction and advisory fee agreement (&#8220;Advisory Agreement&#8221;), a tax receivable agreement (&#8220;TRA&#8221;) and certain other agreements. The Advisory Agreement was terminated in 2020 and fees incurred or earned from the agreement were not material for 2020. Fees incurred or earned from the TSA were not material in 2022 nor 2021 and were $22 million in 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the TRA, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax year ended March 31, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After McKesson&#8217;s separation of its interest in the Change Healthcare&#160;JV, the aforementioned TRA agreement requires the Change Healthcare&#160;JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare&#160;JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of March 31, 2022 or 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506347544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#8220;RSUs&#8221;), performance-based stock units (&#8220;PSUs&#8221;), stock options, and an employee stock purchase plan (&#8220;ESPP&#8221;) (collectively, &#8220;share-based awards&#8221;). Most of the share-based awards are granted in the first quarter of each fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on Net Income</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs and PSUs.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2022, 2021, and 2020 included discrete income tax expense of $10 million, $2 million, and $2 million, respectively. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company&#8217;s stockholders approved the 2013 Stock Plan to replace the 2005 Stock Plan. Under these stock plans, the Company may issue restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserves 30 million shares plus unused reserved shares under the 2005 Stock Plan. As of March 31, 2022, 19 million shares remain available for future grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs entitle the holder to receive a specified number of shares of the Company&#8217;s common stock which vest over a period of generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODE_2c540d8b-dc0c-4d2c-842e-9bfd3840f523">three</span> to four years as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the price of the Company&#8217;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March 31, 2022, approximately 57,000 RSUs for the Company&#8217;s directors are vested.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a three-year performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally three years. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations are as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during 2022:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.47&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of seven years and follow a four-year vesting schedule. The Company did not grant any stock options during the years ended March 31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March 31, 2022:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$123.98</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$159.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.48&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ESPP under which 21 million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock through payroll deductions. The deductions occur over three-month purchase periods and the shares are then purchased at 85% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The 15% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in 2022, 2021, and 2020. At March 31, 2022, 2 million shares remain available for issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506176328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income, Net</a></td>
<td class="text">Other Income, Net<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses) from pension plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments. Refer to Financial Note 16, &#8220;Fair Value Measurements&#8221; and Financial Note 21, &#8220;Segments of Business&#8221; for more information.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The year ended March 31, 2020 includes $116 million from the termination of the U.S. defined benefit pension plan and $11&#160;million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 14, &#8220;Pension Benefits&#8221; for more information.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes a gain of $42&#160;million for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022</span> as part of the completed sale of the Company&#8217;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505826536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported an income tax expense (benefit) rate of 33.0%, (13.8)%, and 1.6% in 2022, 2021, and 2020. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of certain of its European businesses to fair value less costs to sell in 2022, the impact of opioid-related claims, including charges of $8.1 billion ($6.8 billion after-tax) in 2021, the impact of the Change Healthcare joint venture divestiture in 2020, and changes in the mix of earnings between various taxing jurisdictions.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-free gain on investment exit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.U. disposal transaction loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information regarding the separation of the Change Healthcare JV.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $4 million, $5 million, and $7 million in 2022, 2021, and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, the Company recorded non-deductible, non-cash pre-tax charges of $438 million primarily to remeasure the E.U. disposal group to fair value less costs to sell, and $1.2 billion to remeasure the U.K. disposal group, as described in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rates for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were unfavorably impacted by non-deductible, non-cash charges of $58 million and $275 million, respectively, primarily to remeasure the carrying value of assets and liabilities held for sale related to the formation of a new German pharmaceutical wholesale joint venture within the Company&#8217;s International segment. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rates for 2022 and 2021 were impacted by the charge for pending and future opioid-related claims of $274 million ($237 million after-tax) and $8.1&#160;billion ($6.8&#160;billion after-tax), respectively, as described further in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; discrete tax benefits of $105 million was recognized for 2021, with a corresponding increase to a deferred tax assets for the temporary difference arising from the buyer&#8217;s excess tax basis.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV as described in Financial Note 4, &#8220;Business Acquisitions and Divestitures.&#8221; The Company&#8217;s reported income tax expense rate for 2020 was favorably impacted by this transaction given that it was intended to generally be a tax-free split-off for U.S. federal income tax purposes. In the fourth quarter of 2020, the Company recognized a net gain for financial reporting purposes of $414 million related to the separation transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,828)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluded from the amounts above were $48 million of net deferred tax liabilities which were classified as held for sale for European divestitures at March 31, 2022, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $726 million and $864 million in 2022 and 2021, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The decrease in the valuation allowance of $138 million in the current year relates primarily to classification of deferred tax balances as held for sale for European divestitures, as discussed in Financial Note 2, &#8220;Held for Sale,&#8221; partially offset by the net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has federal, state, and foreign net operating loss carryforwards of $303 million, $3.9 billion, and $1.5 billion at March 31, 2022, respectively. Federal and state net operating losses will expire at various dates from 2023 through 2042. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $785 million with indefinite lives. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company had $1.5 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate, if recognized. The decrease in unrecognized tax benefits in 2022 compared to 2021 is primarily attributable to statute of limitation expirations in various taxing jurisdictions and the reclassification of $23&#160;million of unrecognized tax benefits as held for sale for European divestitures, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; The increase in unrecognized tax benefits in 2021 compared to 2020 is primarily attributable to uncertainty in connection with the deductibility of opioid-related litigation and claims. Because many uncertainties associated with any potential settlement arrangements or other resolutions of opioid claims including provisions related to deductibility have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next twelve months, it is reasonably possible that the Company&#8217;s unrecognized tax benefit may decrease by as much as $170 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $8 million, $9 million, and $23 million in 2022, 2021, and 2020, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March 31, 2022 and 2021, it accrued $108&#160;million and $101&#160;million, cumulatively, in interest and penalties on unrecognized tax benefits.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign operations of approximately $5.0 billion were considered indefinitely reinvested at March 31, 2022. Following enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507270168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, during 2022, 2021, and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million, $43 million, and $42 million, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, that court ruled that the Put Amount shall be increased by &#8364;0.51 resulting in an adjusted Put Amount of &#8364;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount remained at &#8364;22.99, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;0.83 per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises of the Put Right reduced the balance of redeemable noncontrolling interests. The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income or loss, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, the Company paid $1.0 billion and $49 million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49&#160;million, respectively, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson stockholders&#8217; additional paid-in capital. During 2020, there were no material exercises of the Put Right. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to the expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported at the greater of its carrying value or its maximum redemption value at each reporting date.</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, the carrying value of redeemable noncontrolling interests of $1.3 billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also include minority shareholder equity interests in McKesson Europe. Noncontrolling interests in the Company&#8217;s Consolidated Balance Sheets were $480 million and $196 million at March 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company owned approximately 95% of McKesson Europe&#8217;s outstanding common shares. The Company&#8217;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221; During 2022, 2021, and 2020, the Company allocated a total of $165 million, $156 million, and $178 million of net income to noncontrolling interests, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2022, 2021, and 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505826536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common ShareBasic earnings (loss) per common share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units.<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted loss per common share for the year ended March 31, 2021 was calculated by excluding all dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Approximately nil and 2 million of potentially dilutive securities for 2022 and 2020, respectively, were excluded from the computation of diluted net earnings per common share, as they were anti-dilutive.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div>(2)Certain computations may reflect rounding adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507431128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorDirectFinancingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">Property, plant and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $285 million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529">five</span> to 15 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">Property, plant and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $285 million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529">five</span> to 15 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#8217;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#8217;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated statements of operations and cash flows.<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">Property, plant and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $285 million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529">five</span> to 15 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorDirectFinancingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorDirectFinancingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276512329896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers, and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Charges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment as of October 1 on an annual basis each year and at an interim date if indicators of potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units was determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#8217;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#8217;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for 2022, 2021, and 2020 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This charge was recorded in &#8220;Goodwill impairment charges&#8221; in the Consolidated Statements of Operations. At March 31, 2021, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 16, &#8220;Fair Value Measurements,&#8221; for more information on these nonrecurring fair value measurements. As of March 31, 2022 and 2021, accumulated goodwill impairment losses in the Company&#8217;s International segment were $0.7 billion and $3.6 billion, respectively. Most of the goodwill impairment for these reporting units was generally not deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intangible assets were subject to amortization as of March 31, 2022 and 2021. Amortization expense of intangible assets was $332 million, $422 million, and $462 million for 2022, 2021, and 2020, respectively. Estimated annual amortization expense of intangible assets is as follows: $225 million, $214 million, $208 million, $177 million, and $171 million for 2023 through 2027, and $1.1 billion thereafter. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for more information on intangible asset impairment charges recorded in 2022, 2021, and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505866856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these U.S. dollar notes is payable semi-annually.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $4 million and $11 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March 31, 2022 and 2021, $5.9 billion and $7.1 billion, respectively, of total debt was outstanding, of which $799 million and $742 million, respectively, was included in &#8220;Current portion of long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company completed a public offering of 1.30% Notes due August 15, 2026 (the &#8220;2026 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $495&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each note, which constitutes a &#8220;Series,&#8221; is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed&#160;by materially similar indentures and officers&#8217; certificates. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#8217;s Investors Service, Inc., and Standard &amp; Poor&#8217;s Ratings Services within a specified period, an offer must be made to purchase that Series from the holders at a price equal to 101% of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2021, the Company redeemed its 0.63% &#8364;600 million (or, approximately $709 million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand. On December 1, 2020, the Company redeemed its 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. On November 30, 2020, the Company retired its 3.65% $700&#160;million total principal of notes upon maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above. In 2020, the Company repaid at maturity its &#8364;250 million Floating Rate Euro Notes due February 12, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1 billion to redeem $922 million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182 million, plus accrued and unpaid interest of $14 million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191 million in the year ended March 31, 2022, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments of long-term debt are $799&#160;million in 2023, $966&#160;million in 2024, $35 million in 2025, $1.2&#160;billion in 2026, $1.2&#160;billion in 2027, and $1.7&#160;billion thereafter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, the Company entered into a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $4.0&#160;billion five-year senior unsecured credit facility with a $3.6&#160;billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during 2022 and 2021 and no amounts outstanding as of March 31, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At March 31, 2022, the Company was in compliance with all covenants. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the $3.5&#160;billion five-year senior unsecured revolving credit facility (the &#8220;Global Facility&#8221;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019 and had no borrowings during the six months ended September 30, 2019.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $7&#160;million and an uncommitted amount of $111&#160;million as of March 31, 2022. Borrowings and repayments were not material in 2022 and 2021 and amounts outstanding under these credit lines were not material as of March 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0&#160;billion in outstanding commercial paper notes. During 2022, 2021, and 2020, the Company borrowed $11.2&#160;billion, $6.3&#160;billion, and $21.4&#160;billion, respectively, and repaid $11.2&#160;billion, $6.3&#160;billion, and $21.4&#160;billion, respectively, under the program. At March 31, 2022 and 2021, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505831640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#8217;s Consolidated Statements of Operations and Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $660 million and $65 million, respectively, at March 31, 2022, and $662 million and $74&#160;million, respectively, at March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual, or other relationships with the VIEs. The Company&#8217;s most significant VIE relationships are with oncology and other specialty practices. Under these practice arrangements, the Company generally owns or leases all of the real estate and equipment used by the practices and manages the practices&#8217; administrative functions. Prior to the divestment of the Austrian businesses in 2022, the Company had relationships with certain pharmacies in Europe with whom it provided financing, had equity ownership, and/or had a supply agreement whereby it supplied the vast majority of the pharmacies&#8217; purchases. The Company&#8217;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $1.4 billion and $1.5 billion at March 31, 2022 and 2021, respectively, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 17, &#8220;Financial Guarantees and Warranties.&#8221; The Company believes there is no material loss exposure on these assets or from these relationships.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505963272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Benefit Pension Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an unfunded nonqualified supplemental defined benefit plan for certain U.S. executives, as well as benefit pension plans for eligible employees outside the U.S. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2018, the Company&#8217;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#8220;Plan&#8221;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#8217;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future pension benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $105 million was recorded during the second quarter of 2020. Settlement charges were included within &#8220;Other income, net,&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2020. As of March 31, 2020, this defined benefit pension plan had an accumulated comprehensive loss of approximately nil.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway, the United Kingdom, Germany, and Canada. Benefits for these plans are based primarily on each employee&#8217;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#8220;SPK&#8221;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law. In the U.K., the Company has subsidiaries that participate in a joint pension plan. The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe&#8217;s Management Board.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company derecognized $43&#160;million of pension liabilities included in liabilities held for sale and $11&#160;million of accumulated other comprehensive loss related to the sale of its Austrian business. During the third quarter of 2021, the Company derecognized $187&#160;million of pension liabilities included in liabilities held for sale and $33&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit plan assets and obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic expense for the Company&#8217;s pension plans is as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans is as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The divestiture relates to the sale of the Company&#8217;s Austrian business in 2022 and to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#8217;s U.K. disposal group. Current liabilities at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022 include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#8217;s E.U. disposal group. Refer to Financial Note 2, &#8220;Held for Sale&#8221; for additional information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $55 million in 2022 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($69&#160;million gain): The weighted average discount rate for Non-U.S. plans increased to 2.67% as of March 31, 2022 from 1.89% as of March 31, 2021. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($14&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestitures in 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial loss of $89 million in 2021 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($32&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased to 1.89% as of March 31, 2021 from 2.03% as of March 31, 2020.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> ($57&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestiture in 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive loss consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive income were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit (cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss (income) </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company recognized $11&#160;million in actuarial losses for pension plans to stockholders&#8217; equity as a result of the sale of its Austrian business. In 2021, the Company recognized $33&#160;million in actuarial losses for pension plans to stockholders&#8217; equity as a result of the contribution of its German pharmaceutical wholesale business to a joint venture. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information. The Company recognized $127 million in actuarial losses for the pension plans to stockholders&#8217; equity in 2020 as a result of the termination of the U.S. defined benefit pension plan and the settlement from the executive benefit retirement plan for a retired executive. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected benefit obligations related to the Company&#8217;s unfunded U.S. plans were $8 million and $9 million at March 31, 2022 and 2021, respectively. Pension obligations for its unfunded plans are based on the recommendations of independent actuaries. Projected benefit obligations relating to the Company&#8217;s unfunded non-U.S. plans were $101 million and $162 million at March 31, 2022 and 2021, respectively. Funding obligations for its non-U.S. plans vary based on the laws of each non-U.S. jurisdiction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for the Company&#8217;s pension plans are as follows: $34 million, $33 million, $33 million, $34 million, and $35 million for 2023 to 2027, respectively, and $186 million for 2028 through 2032. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#8217;s pension plans are $13 million for 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. For March 31, 2022, the Company&#8217;s U.S. defined benefit liabilities are valued using a weighted-average discount rate of 3.35%, which represents an increase of 100 basis points from its 2021 weighted-average discount rate of 2.35%. The Company&#8217;s non-U.S. defined benefit pension plan liabilities are valued using a weighted-average discount rate of 2.67%, which represents an increase of 78 basis points from its 2021 weighted-average discount rate of 1.89%.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For non-U.S. plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. The following tables represent the Company&#8217;s pension plan assets as of March&#160;31, 2022 and 2021, using the fair value hierarchy by asset class:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $1.00. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annuity contracts - The value of the annuity contracts is reported by the Trustee and is based on a valuation of the remaining contracted cash flow of the contract. Inputs in the valuation include discounted future cash flows; these are classified as Level 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other - At March 31, 2022 and 2021, this includes $35 million and $36 million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the year ended March 31, 2022: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity attributable to Level 3 plan assets was not material for the year ended March 31, 2021.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#8220;POA&#8221;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#8217;s withdrawal liability and contributions may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributions and amounts accrued for U.S. plans were not material for the years ended March 31, 2022, 2021, and 2020. Contributions to the POA for non-U.S. plans exceeding 5% of total plan contributions were&#160;$20 million, $22 million, and&#160;$17 million in 2022, 2021, and 2020, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately 88% as of March 31, 2022. No amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contributory retirement savings plan (&#8220;RSP&#8221;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to 75% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to 100% of the employee&#8217;s first 3% of pay contributed and 50% for the next 2% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $116 million for the year ended March 31, 2022 and $102 million for each of the years ended March 31, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postretirement Benefits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of postretirement benefit plans, primarily consisting of healthcare and life insurance (&#8220;welfare&#8221;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic (credit) expense for the Company&#8217;s postretirement welfare benefits was not material for the years ended March 31, 2022, 2021, and 2020. The benefit obligation at March 31, 2022 and 2021 was $56 million and $64 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506324296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022 and 2021, the Company had &#8364;1.1 billion and &#8364;1.7 billion, respectively, of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company de-designated its &#163;450 million British pound sterling-denominated notes prospectively from net investment hedges as the hedging relationship ceased to be effective.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains or losses from net investment hedges recorded within Other comprehensive income were gains of $73 million in 2022, losses of $118 million in 2021, and gains of $39 million in 2020. Ineffectiveness on the Company&#8217;s non-derivative net investment hedges during 2020 resulted in gains of $34&#160;million which were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statement of Operations. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022 and 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the years ended March 31, 2022, 2021, and 2020. The cross-currency swaps will mature in November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company terminated its cross-currency swaps designated as net investment hedges with a total gross notional amount of &#163;932 million British pound sterling swaps. The termination was due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million in 2020. This gain was recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $4 million and $119 million in 2022 and 2021, respectively, and gains of $76 million in 2020. There was no ineffectiveness in the Company&#8217;s hedges for the years ended March 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;450&#160;million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At March 31, 2022 and 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $1.3 billion and $2.6 billion, respectively, which are designated as cash flow hedges. These swaps will mature between July 2022 and January 2024. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#8364;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. The &#8364;600 million swaps were terminated in the second quarter of 2022 and the loss on termination of the swaps recorded in interest expense was not material for the year ended March 31, 2022. Refer to Financial Note 12, &#8220;Debt and Financing Activities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with a combined notional amount of $500 million, to hedge the variability of future benchmark interest rates on a planned bond issuance. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were gains of $21 million in 2022, losses of $42&#160;million in 2021, and gains of $98&#160;million in 2020. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations were not material in 2022, 2021, and 2020. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the years ended March 31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At March 31, 2022 and 2021, the total gross notional amounts of these contracts were nil and $39 million, respectively. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in the fair values were not material in 2022, 2021, and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the non-derivative net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#8364;250 million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they are offsetting matured in February 2020 and were not designated for hedge accounting. Changes in the fair value for contracts not designated as hedges are recorded directly in earnings. In 2020, losses of $44 million were recorded in earnings in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations, which offset the ineffectiveness on the Company&#8217;s non-derivative net investment hedges noted above.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 16, &#8220;Fair Value Measurements,&#8221; for more information on these recurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505963272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March 31, 2022 and 2021 included investments in money market funds of $981 million and $1.6 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at March 31, 2022 and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 15, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $346&#160;million and $269&#160;million at March 31, 2022 and 2021, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. During 2022 and 2021, certain of the Company&#8217;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. Additionally, in 2021, certain of the Company&#8217;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of 2021. Net gains related to the Company&#8217;s investments in these equity securities were approximately $98 million and $133 million, respectively, for the years ended March 31, 2022 and 2021. These net gains were recorded in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges, including long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the assets and liabilities associated with the E.U. disposal group and U.K. disposal group classified as held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale." Additionally, at March 31, 2022, assets measured at fair value on a nonrecurring basis included certain long-lived assets within the International segment related to the Company&#8217;s operations in Denmark and its retail pharmacy businesses in Canada, as discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and its Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; and Financial Note 11, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other liabilities measured at fair value on a nonrecurring basis at March 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022 and 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is also recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 11, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information regarding goodwill impairment charges recorded for certain reporting units during 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505810008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Guarantees and Warranties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FinancialGuaranteesAndWarrantiesAbstract', window );"><strong>Financial Guarantees And Warranties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FinancialGuaranteesAndWarrantiesTextBlock', window );">Financial Guarantees And Warranties</a></td>
<td class="text">Financial Guarantees and Warranties<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Guarantees</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain of its customers&#8217; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#8217; inventory or its customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#8217;s inventory repurchase agreements, among other requirements, inventories must be in a resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDA_c483e2c9-dff3-4b92-bc09-7d0567550317">one</span> to two years. Customers&#8217; debt guarantees generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTI_c01062b2-22fa-48c8-ab15-ad2d5e0ffc41">one</span> to 10 years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#8217;s customers&#8217; debt guarantees are secured by certain assets of the customer. At March 31, 2022, the maximum amounts of inventory repurchase guarantees and customers&#8217; debt guarantees were $367 million and $84 million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees are as follows: $309 million, $45 million, $6 million, $15 million, and $12 million&#160;from 2023 through 2027, respectively, and $64 million thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company&#8217;s banks and insurance companies have issued $214 million of standby letters of credit and surety bonds, which were issued on the Company&#8217;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and its workers&#8217; compensation and automotive liability programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#8217;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug, and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinancialGuaranteesAndWarrantiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Guarantees And Warranties [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinancialGuaranteesAndWarrantiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinancialGuaranteesAndWarrantiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial guarantees And warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinancialGuaranteesAndWarrantiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506033624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, the Company and the two other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions were satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. On February 25, 2022, the Distributors determined that there was sufficient State and subdivision participation to proceed with an agreement ("Settlement") to settle a substantial majority of opioids-related lawsuits filed against the Distributors by U.S. states, territories, and local governmental entities. As previously disclosed, 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;), have agreed to join the Settlement. To date, over 98% of eligible political subdivisions that have brought opioid-related suits against the Company, as calculated by population under the agreement, have agreed to participate in the settlement or have had their claims addressed by state legislation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement became effective on April 2, 2022. If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $19.5&#160;billion over 18 years, with up to approximately $7.4&#160;billion to be paid by the Company for its 38.1% portion. Under the Settlement, a minimum of 85% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before the effective date of the Settlement, the Company entered into separate settlement agreements with the states of New York, Ohio, Rhode Island, Texas, and Florida. These states intended to participate in the Settlement when it was finalized, and these agreements provided that each state and its participating subdivisions would receive a settlement consistent with their allocation under the comprehensive Settlement framework, as well as, in some cases, certain attorneys&#8217; fees and costs. Now that the Settlement has become effective, these separate settlement agreements have become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three eligible states, Alabama, Oklahoma, and Washington, did not join the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement in principle under which the Company will pay $141&#160;million in ten equal annual installments and an additional approximately $33&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $518&#160;million, of which the Company&#8217;s portion would be 38.1% (or approximately $197&#160;million), consistent with Washington&#8217;s allocation under the comprehensive framework, as well as certain additional attorneys&#8217; fees and costs. The claims of the Oklahoma attorney general are pending in the District Court of Bryan County, Oklahoma (Case No. CJ-2020-84, 85, and 86), and trial is scheduled to begin in January 2023. The Company&#8217;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements in principle or, where there is no agreement in principle, amounts equivalent to what that state and its subdivisions would have been allocated under the framework of the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Claims of various West Virginia subdivisions remain pending in both state and federal courts. Trial in the case of Cabell County and City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. The outcome of that trial is pending. The claims of certain other West Virginia subdivisions are pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Distributors for July 5, 2022. The Company&#8217;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#8217;s portion would be 38.1% (or, approximately $29&#160;million). The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Distributors would pay the Native American tribes other than the Cherokee Nation approximately $440&#160;million over 6 years, of which the Company&#8217;s portion would be 38.1% (or, approximately $167&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Distributors. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#8217;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of March 31, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Settlement terminated the substantial majority of opioid-related suits pending against the Company, a small number of subdivisions in participating states have opted not to participate in the comprehensive settlement, and other suits brought by subdivisions in non-participating states remain pending. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has paid $157&#160;million in payments to date associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet, is the amount estimated to be paid prior to March 31, 2023.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#8220;Long-term litigation liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the terms of the Settlement, the Company placed approximately $354&#160;million into escrow on September 30, 2021. During the second half of 2022, the Company placed an additional net $41&#160;million into escrow to reflect the participation of additional states, and as part of a separate agreement in principle with the Alabama attorney general. Those escrow amounts were presented as restricted cash within &#8220;Prepaid expenses and other&#8221; in our Consolidated Balance Sheet as of March 31, 2022. These amounts excluded the proportionate allocation under the Settlement for each non-participating state. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. Trial is scheduled for July 18, 2022 in one such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CE19-00472. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2018, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Manchester v. Purdue Pharma, L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within&#160;90 days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with two </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit, which affirmed the dismissal on March 10, 2022. On June 28, 2021, the court in the state action dismissed the complaint with prejudice, and the relators appealed the dismissal to the Superior Court of California, County of San Francisco.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Coverage Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AIU Insurance Company et al. v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ace Property and Casualty Insurance Company v. McKesson Corporation et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. On April 5, 2022, the court issued an order granting partial summary judgment to the insurers that the Company&#8217;s defense costs in certain opioid-related litigation were not covered by two of the insurance policies.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $6,500.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al., CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#8217; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#8217;s motion to dismiss the claims pled against it, with leave to amend. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021. Plaintiffs filed a notice of appeal with the Court of Appeals for the Second Circuit on January 4, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;) was served with a fifth amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hanks v. Amgen, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV-08-03096 (SJ). Previously, the U.S. declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#8217;s motion to dismiss. Following the relator&#8217;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#8217;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2018, a second amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint was filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities against McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc. and US Oncology Specialty, L.P., alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 12-CV-06440 (NG). The United States and the named states have declined to intervene in the case. On October 15, 2018, the Company filed a motion to dismiss the complaint as to all named defendants. On February&#160;4, 2019, the court granted the motion to dismiss in part and denied it in part, leaving the Company and Oncology Therapeutics Network Corporation as the only remaining defendants in the case. On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of another complaint filed by the same relator, alleging the same misconduct and seeking the same relief with respect to US Oncology, Inc., purportedly on behalf of the same government entities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-05125. The United States and the named states declined to intervene in the case. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#8217;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marion Diagnostic Center, LLC v. Becton, Dickinson, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#8217;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. Defendants filed a motion to dismiss the amended complaint, which the district court granted on March 15, 2021. Plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit, which affirmed the district court&#8217;s dismissal on March 18, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#8217;s motion for class certification.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, The Great Atlantic &amp; Pacific Tea Company (&#8220;A&amp;P&#8221;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re The Great Atlantic &amp; Pacific Tea Company, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Adv. Proc. No. 17-08264.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the Company&#8217;s subsidiary NDCHealth Corporation dba RelayHealth (&#8220;RelayHealth&#8221;) was served with three purported class action complaints filed in the United States District Court for the Northern District of Illinois. The complaints allege that RelayHealth violated the Sherman Act by entering into an agreement with co-defendant Surescripts, LLC not to compete in the electronic prescription routing market, and by conspiring with Surescripts, LLC to monopolize that market, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Powell Prescription Center, et al. v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-06627; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-06778; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Falconer Pharmacy, Inc. v. Surescripts LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-07035. In November 2019, three similar complaints were filed in the United States District Court for the Northern District of Illinois. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7445; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Whitman v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 1:19-cv-7448; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BBK Global Corp. v. SureScripts, LLC et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1:19-cv-7640. In December 2019, the six actions were consolidated in the Northern District of Illinois. The complaints seek relief including treble damages, attorney fees, and costs. Plaintiffs and RelayHealth reached an agreement in June 2020 to resolve the class action lawsuits and RelayHealth paid into escrow an amount not material in the context of the Company&#8217;s overall financial results. The settlement does not include any admission of liability, and RelayHealth expressly denies wrongdoing. The Court granted Plaintiffs&#8217; motion for final approval of the settlement on February 24, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#8217;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough, and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017 and August 2018, respectively, the Company was served with&#160;two&#160;separate Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York relating to the certification the Company obtained for two software products under the U.S. Department of Health and Human Services&#8217; Electronic Health Record Incentive Program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April and June 2019, the United States Attorney&#8217;s Office for the Eastern District of New York served grand jury subpoenas seeking documents related to the Company&#8217;s anti-diversion policies and procedures and its distribution of Schedule II controlled substances. The Company believes the subpoenas are part of a broader investigation by that office into pharmaceutical manufacturers&#8217; and distributors&#8217; compliance with the Controlled Substances Act and related statutes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the United States Attorney&#8217;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV was also part of the investigation. The Company resolved this matter in April 2022 by paying fines not material in the context of the Company&#8217;s overall financial results that had been fully reserved for in the third quarter of 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding its and its competitors alleged sharing of competitively sensitive information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37 million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. That petition was denied on October 4, 2021. In December 2021, McKesson paid $26&#160;million for the assessment for calendar year 2017 while reserving all rights to challenge the constitutionality of the assessment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V.&#160;Environmental Matters</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily as a result of the operation of the Company&#8217;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at five sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a determination by the Company&#8217;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#8217;s probable loss associated with the remediation costs for these five sites is $15 million, net of amounts anticipated from third parties. The $15 million is expected to be paid out between April 2022 and March 2052. The Company has accrued for the estimated probable loss for these environmental matters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been designated as a Potentially Responsible Party (&#8220;PRP&#8221;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at 14 sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. At one of these sites, the United States Environmental Protection Agency has selected a preferred remedy with an estimated cost of approximately $1.4 billion. It is not certain at this point in time what proportion of this estimated liability will be borne by the Company. Accordingly, the Company&#8217;s estimated probable loss at those 14 sites is approximately $29 million, which has been accrued for in the Consolidated Balance Sheets. However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VI. Value Added Tax Assessments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various countries outside the U.S. which&#160;collect value added taxes (&#8220;VAT&#8221;).&#160;The determination of the manner in which a VAT applies to the Company&#8217;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received&#160;assessments for VAT&#160;which are in&#160;various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions.&#160;Certain&#160;VAT assessments relate to years covered by an indemnification agreement.&#160;Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.&#160;However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or&#160;results of operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VII. Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $46 million, $181&#160;million, and $22&#160;million in 2022, 2021, and 2020, respectively, which were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VIII. Other Matters </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings, or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings, and claims will not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505838600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Board. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the quarterly dividend was raised from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. Dividends were $1.83 per share in 2022, $1.67 per share in 2021, and $1.62 in 2020. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#8217;s future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. During the last three years, the Company&#8217;s share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding share repurchase activity over the last three years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2019 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASR</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to the Company&#8217;s Split-off of the Change Healthcare JV as described below.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2020, the Company completed the Split-off of its interest in the Change Healthcare JV. In connection with the Split-off, the Company distributed all 176.0 million outstanding shares of SpinCo common stock, which held all of the Company&#8217;s interests in the Change Healthcare JV, to participating holders of the Company&#8217;s common stock in exchange for 15.4 million shares of McKesson stock, which are now held as treasury stock on the Company&#8217;s Consolidated Balance Sheets. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change with each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. See Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive income (loss) by component are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts before reclassifications recorded in 2022, 2021, and 2020 include gains (losses) of $73&#160;million, $(118)&#160;million, and $39&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $(4)&#160;million, $(119)&#160;million, and $76&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(23)&#160;million, $62&#160;million, and $(30)&#160;million in 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily reflects a reclassification of losses of $127 million, net of $33&#160;million of income tax benefit, predominantly on the termination of the Company&#8217;s U.S. defined benefit pension plan from &#8220;Accumulated other comprehensive loss&#8221; to &#8220;Other income, net&#8221; in the Company&#8217;s Consolidated Statement of Operations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Held for Sale&#8221; and Financial Note 6, &#8220;Other Income, Net.&#8221; These amounts were included in the 2021 and 2020 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the Company&#8217;s Austrian business, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included in the 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505967800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Balances and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Balances and Transactions</a></td>
<td class="text">Related Party Balances and Transactions<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $137 million, $178 million, and $141 million are included in the Consolidated Statements of Operations for the years ended March 31, 2022, 2021, and 2020, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March 31, 2022 and 2021. Predominately all of these pharmacies were divested from the Company in the fourth quarter of 2022 as part of the completed sale of the Company&#8217;s Austrian business, while certain other remaining pharmacies are included in the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, 2021, and 2020, the Company&#8217;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $100 million, $111 million, and $60 million, respectively. Trade receivables related to these transactions from this investee were not material as of March 31, 2022 and 2021. During 2022, the Company&#8217;s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.</span></div>Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for information regarding related party balances and transactions with Change and the Change Healthcare JV.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505880248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company began reporting under four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. Other, for retrospective periods presented, consists of the Company&#8217;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment serves McKesson&#8217;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 285,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 11 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In 2022, the Company entered into agreements to sell the E.U. disposal group and U.K. disposal group, and completed the sale of its Austrian business. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, for retrospective periods presented consists of the Company&#8217;s previous investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 40% of the RxTS segment&#8217;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from the Company&#8217;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for 2022, 2021, and 2020 includes credits of $23 million, $38 million, and $252 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2022, 2021, and 2020 also includes $46 million, $181 million, and $22 million, respectively, of cash receipts for the Company&#8217;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for 2022 and 2021 includes inventory charges of $164 million and $136 million, respectively, on certain PPE and other related products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for 2022, 2021, and 2020 reflects the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $1.1 billion to remeasure assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $383 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes a gain of $59 million related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes a gain of $42 million related to the sale of the Company&#8217;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. 2021 and 2020 includes charges of $58 million and $275 million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to the joint venture with WBA completed on November 1, 2020. See Financial Note 2, &#8220;Held for Sale,&#8221; and Financial Note 6, &#8220;Other Income, Net,&#8221; for further details;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 includes a goodwill impairment charge of $69 million related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 11, &#8220;Goodwill and Intangible Assets, Net;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 and 2020 includes long-lived asset impairment charges of $115 million and $112 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#8217;s previous investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2020 also includes the Company&#8217;s proportionate share of loss from the Change Healthcare JV of $119 million.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, for 2022, 2021, and 2020 reflects the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $55 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $42 million primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 and 2021 includes charges of $274 million and $8.1 billion, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities;" </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 and 2021 includes net gains of $98 million and $133 million, respectively, associated with certain of the Company&#8217;s equity investments, as discussed in more detail in Financial Note 16, &#8220;Fair Value Measurements;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2020 includes settlement charges of $122 million for the termination of the Company&#8217;s defined benefit pension plan; and </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2020 includes a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for 2022 consists of a charge of $191 million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 12, &#8220;Debt and Financing Activities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software and excludes amounts classified as assets held for sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507771672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:34.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions From Allowance Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at End of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:55.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credited to other accounts and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown as deductions from current and non-current receivables (current allowances were $144 million, $250 million, and $265 million at March 31, 2022, 2021, and 2020, respectively)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primarily represents reclassifications to other balance sheet accounts.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276504973384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span>The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior period amounts have been reclassified to conform to the current year presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). As COVID-19 further evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash Equivalents: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Restricted cash at March 31, 2022 primarily consists of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash at March 31, 2022 and 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets at March 31, 2022 and 2021.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Equity Method Investments: Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables, Net and Allowances for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Net and Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, legal disputes, or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div>Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $89 million and $198 million were included in &#8220;Receivables, net&#8221; on the Consolidated Balance Sheets as of March 31, 2022 and 2021, respectively. Changes in the allowance for the year ended March 31, 2022, were primarily within the U.S Pharmaceutical and International segments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Receivables</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2022, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 52% of its total consolidated revenues and approximately 43% of total trade accounts receivable at March 31, 2022. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 21% of its total consolidated revenues in 2022 and comprised approximately 28% of total trade accounts receivable at March 31, 2022. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and 2021, total inventories, net were $18.7 billion and $19.2 billion, respectively, in the Company&#8217;s Consolidated Balance Sheets. The LIFO method was used to value approximately 63% and 58% of the Company&#8217;s inventories at March 31, 2022 and 2021, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $383&#160;million and $406&#160;million higher than the amounts reported at March 31, 2022 and 2021, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $23 million, $38 million, and $252 million in 2022, 2021, and 2020, respectively, in &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The lower LIFO credits in 2022 compared to 2021 and 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. </span></div>The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2022 and 2021, inventories at LIFO did not exceed market.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes costs to pack and deliver inventory to its customers in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statements of Operations. Shipping and handling costs of $1.1 billion was recognized in 2022, and $1.0 billion was recognized in each of 2021 and 2020.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HeldforSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant, and Equipment, Net: Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#8220;ROU&#8221;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd">one</span>&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.</span></div>Refer to Financial Note 10, &#8220;Leases,&#8221; for additional information on the Company&#8217;s leases.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61">one</span> to 24 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Capitalized Software Held for Internal Use</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2022 and 2021, capitalized software held for internal use was $320 million and $513 million, respectively, net of accumulated amortization of $1.4 billion, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. The decrease in capitalized software held for internal use is primarily due to the planned exit of the Company&#8217;s European businesses which resulted in an impairment of certain internal-use software that will not be utilized in the future and classification of certain software as held for sale, as discussed in Note 2, &#8220;Held for Sale.&#8221; Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $116&#160;million, $117&#160;million, and $129&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_InsuranceProgramsPolicyTextBlock', window );">Insurance Programs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March 31, 2022, 2021, and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.2 billion in 2022 and $3.1 billion in each of 2021 and 2020. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2022 and 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div>The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2022 and 2021. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SupplierIncentivesPolicyPolicyTextBlock', window );">Supplier Incentives</a></td>
<td class="text">Supplier Incentives: Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SupplierReservesPolicyTextBlock', window );">Supplier Reserves</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpensePolicyTextBlock', window );">Interest Expense</a></td>
<td class="text">Interest Expense: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; equity (deficit) accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity (deficit) section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material in 2022, 2021, or 2020. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments: Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; equity (deficit) section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 15, &#8220;Hedging Activities,&#8221; for additional information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#8217; equity (deficit) but are excluded from earnings. The Company&#8217;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span>unrealized gains and losses on retirement-related benefit plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling Interests and Redeemable Noncontrolling Interests</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#8217;s consolidated entities including Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;) and ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; equity (deficit) in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 8, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees. Refer to Financial Note 5, &#8220;Share-Based Compensation,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 18, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to ongoing controlled substances claims to which the Company is a party.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_TreasuryStockPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no recently issued accounting standards that could have a material impact to the Company&#8217;s financial position, results of operations, cash flows, or notes to the financial statements upon their adoption.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldforSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Held for Sale [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldforSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_InsuranceProgramsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_InsuranceProgramsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SupplierIncentivesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplier Incentives, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SupplierIncentivesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SupplierReservesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SupplierReservesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TreasuryStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TreasuryStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 10<br> -Section 05<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28365394&amp;loc=d3e23770-108382<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276730767208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of receivables</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2022 and 2021:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,181&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment, net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March 31, 2022 and 2021:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505825128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet are as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507347816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of details for charges recorded</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#8217;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#8217;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with dispositions and costs related to the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the growth initiative described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#8217;s corporate headquarters described above.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March 31, 2022 and 2021: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020 </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#8220;Other accrued liabilities&#8221; and $52 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505937064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Net Gain on Split-off of Change Healthcare JV</a></td>
<td class="text">The net gain was calculated as follows:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in the Change Healthcare JV at exchange date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of deferred tax liability </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of accumulated other comprehensive loss attributable to the joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Transaction costs incurred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on split-off of the Change Healthcare JV</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509181704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of components of share-based compensation expense and related tax benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs and PSUs.</span></div>(2)Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2022, 2021, and 2020 included discrete income tax expense of $10 million, $2 million, and $2 million, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to estimate fair value of PSUs</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations are as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of restricted stock unit award activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during 2022:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.47&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DataRelatedtoRSUActivityTableTextBlock', window );">Schedule of data related to restricted stock unit award activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of options outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March 31, 2022:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$123.98</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$159.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.00</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.48&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div>(2)The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock', window );">Summary of data related to stock option activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DataRelatedtoRSUActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Data Related to RSU Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DataRelatedtoRSUActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506040904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock', window );">Schedule of other income, net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses) from pension plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments. Refer to Financial Note 16, &#8220;Fair Value Measurements&#8221; and Financial Note 21, &#8220;Segments of Business&#8221; for more information.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The year ended March 31, 2020 includes $116 million from the termination of the U.S. defined benefit pension plan and $11&#160;million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 14, &#8220;Pension Benefits&#8221; for more information.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes a gain of $42&#160;million for the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022</span> as part of the completed sale of the Company&#8217;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the detailed components of other nonoperating income. May include methodology, assumptions and amounts for: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276511108680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income (loss) from continuing operations before income taxes</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax expense (benefit) related to continuing operations</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-free gain on investment exit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.U. disposal transaction loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital loss carryback</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Refer to Financial Note 4, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information regarding the separation of the Change Healthcare JV.</span></div>(2)The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $4 million, $5 million, and $7 million in 2022, 2021, and 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax balances</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,828)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Excluded from the amounts above were $48 million of net deferred tax liabilities which were classified as held for sale for European divestitures at March 31, 2022, as discussed in Financial Note 2, &#8220;Held for Sale.&#8221;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of gross unrecognized tax benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505863976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Schedule of Changes in Noncontrolling Interest</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2022, 2021, and 2020 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505881976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted earnings per common share</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div>(2)Certain computations may reflect rounding adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506492856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases, Operating [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental balance sheet information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">Property, plant and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (Years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.71&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease costs and supplemental cash flow information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276502086648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting, transfers, and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other changes/disposals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505967800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of long-term debt</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these U.S. dollar notes is payable semi-annually.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $4 million and $11 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505023128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of net periodic expense for pension plans</a></td>
<td class="text">The net periodic expense for the Company&#8217;s pension plans is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of changes in benefit obligations and plan assets for pension plans</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans is as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The divestiture relates to the sale of the Company&#8217;s Austrian business in 2022 and to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#8217;s U.K. disposal group. Current liabilities at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022 include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#8217;s E.U. disposal group. Refer to Financial Note 2, &#8220;Held for Sale&#8221; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of defined benefit plan amounts recognized in other comprehensive loss</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive loss consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive income were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss (gain)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit (cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss (income) </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.66%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Summary of pension plan assets using fair value hierarchy by asset class</a></td>
<td class="text">The following tables represent the Company&#8217;s pension plan assets as of March&#160;31, 2022 and 2021, using the fair value hierarchy by asset class:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock', window );">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the year ended March 31, 2022: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506031032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of information regarding fair value of derivatives on a gross basis</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505971864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is also recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505827096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Estimated Accrual Liability</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet, is the amount estimated to be paid prior to March 31, 2023.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#8220;Long-term litigation liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510754088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of shares repurchased over last three years</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding share repurchase activity over the last three years is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2019 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASR</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchase authorization increase in 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to the Company&#8217;s Split-off of the Change Healthcare JV as described below.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive income (loss) by component are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,628)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts before reclassifications recorded in 2022, 2021, and 2020 include gains (losses) of $73&#160;million, $(118)&#160;million, and $39&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $(4)&#160;million, $(119)&#160;million, and $76&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(23)&#160;million, $62&#160;million, and $(30)&#160;million in 2022, 2021, and 2020, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily reflects a reclassification of losses of $127 million, net of $33&#160;million of income tax benefit, predominantly on the termination of the Company&#8217;s U.S. defined benefit pension plan from &#8220;Accumulated other comprehensive loss&#8221; to &#8220;Other income, net&#8221; in the Company&#8217;s Consolidated Statement of Operations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Held for Sale&#8221; and Financial Note 6, &#8220;Other Income, Net.&#8221; These amounts were included in the 2021 and 2020 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the Company&#8217;s Austrian business, as discussed in more detail in Financial Note 2, &#8220;Held for Sale.&#8221; These amounts were included in the 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510756872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of segment information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 40% of the RxTS segment&#8217;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from the Company&#8217;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for 2022, 2021, and 2020 includes credits of $23 million, $38 million, and $252 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2022, 2021, and 2020 also includes $46 million, $181 million, and $22 million, respectively, of cash receipts for the Company&#8217;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Financial Note 18, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for 2022 and 2021 includes inventory charges of $164 million and $136 million, respectively, on certain PPE and other related products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating loss for 2022, 2021, and 2020 reflects the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $1.1 billion to remeasure assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $383 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes a gain of $59 million related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes a gain of $42 million related to the sale of the Company&#8217;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. 2021 and 2020 includes charges of $58 million and $275 million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to the joint venture with WBA completed on November 1, 2020. See Financial Note 2, &#8220;Held for Sale,&#8221; and Financial Note 6, &#8220;Other Income, Net,&#8221; for further details;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 includes a goodwill impairment charge of $69 million related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 11, &#8220;Goodwill and Intangible Assets, Net;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 and 2020 includes long-lived asset impairment charges of $115 million and $112 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#8217;s previous investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2020 also includes the Company&#8217;s proportionate share of loss from the Change Healthcare JV of $119 million.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, for 2022, 2021, and 2020 reflects the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $55 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 includes charges of $42 million primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Held for Sale;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 and 2021 includes charges of $274 million and $8.1 billion, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 18, &#8220;Commitments and Contingent Liabilities;" </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2022 and 2021 includes net gains of $98 million and $133 million, respectively, associated with certain of the Company&#8217;s equity investments, as discussed in more detail in Financial Note 16, &#8220;Fair Value Measurements;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2021 includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2020 includes settlement charges of $122 million for the termination of the Company&#8217;s defined benefit pension plan; and </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">2020 includes a settlement charge of $82 million related to opioid claims.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for 2022 consists of a charge of $191 million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 12, &#8220;Debt and Financing Activities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Schedule of segment assets and long-lived assets by net by geographic areas</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software and excludes amounts classified as assets held for sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497225016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,246<span></span>
</td>
<td class="nump">$ 18,702<span></span>
</td>
<td class="nump">$ 19,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">LIFO inventory (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,537<span></span>
</td>
<td class="nump">8,849<span></span>
</td>
<td class="nump">9,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense for property, plant, and equipment, and amortization of finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software held for internal use, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Capitalized software held for internal use, accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized software held for internal use, amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns', window );">Sales returns from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember', window );">Real Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal option increments for leases (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery, equipment, and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife', window );">Capitalized software held for internal use, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery, equipment, and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | CVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | Ten Largest Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | CVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Ten Largest Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Sales Revenue, Net | Distribution and Retail Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Sales Revenue, Net | Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capitalized Software Held for Internal Use, Useful Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CapitalizedSoftwareHeldforInternalUseUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_MachineryEquipmentAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_MachineryEquipmentAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mck_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mck_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mck_TenLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mck_TenLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mck_DistributionandRetailBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mck_DistributionandRetailBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mck_ServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mck_ServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507440200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrentAbstract', window );"><strong>Receivables, Net, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AccountsReceivableCustomerAccountsGross', window );">Customer accounts</a></td>
<td class="nump">$ 16,438<span></span>
</td>
<td class="nump">$ 17,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Other</a></td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">2,325<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Total receivables</a></td>
<td class="nump">18,727<span></span>
</td>
<td class="nump">19,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">$ 18,583<span></span>
</td>
<td class="nump">$ 19,181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AccountsReceivableCustomerAccountsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Customer Accounts, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AccountsReceivableCustomerAccountsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276504983608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">1,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Machinery, equipment, and other</a></td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">2,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant, and equipment</a></td>
<td class="nump">4,086<span></span>
</td>
<td class="nump">4,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(1,994)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">$ 2,092<span></span>
</td>
<td class="nump">$ 2,581<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501150008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,516<span></span>
</td>
<td class="nump">$ 4,516<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember', window );">German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of investment in joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | International | Held-for-sale | Walgreens Boots Alliance Joint Venture | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember', window );">Austrian Business Operations | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration agreed upon for sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">&#8364; 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">&#8364; 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | International | Held-for-sale | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group) | Held-for-sale | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group) | International | Held-for-sale | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Expected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501112552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (E.U. Disposal Group) (Details) - Held-for-sale<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="nump">$ 1,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of businesses held for sale to fair value less costs to sell</a></td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">3,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">1,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">2,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware', window );">Impairment charge</a></td>
<td class="nump">$ 113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276504533176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Held for Sale - Assets and Liabilities Held for Sale (U.K. Disposal Group) (Details) - U.K. Businesses (Disposal Group) - Held-for-sale<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of businesses held for sale to fair value less costs to sell</a></td>
<td class="num">(1,159)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">1,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 2,018<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501000392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember', window );">Employee Severance, Exit-related Costs and Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Retail Pharmacy Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Rexall Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">U.K. | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan, Remote Work Transitioning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember', window );">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs | Employee Severance, Accelerated Depreciation and Project Consulting Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Employee Retention Expenses, Asset Impairments and Accelerated Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RexallHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RexallHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501228920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation (2)</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation (2)</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation (2)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation (2)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation (2)</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation (2)</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501651784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(139)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497444008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 10, 2020</div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,309,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,792,000,000)<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="nump">$ 5,309,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,287,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="num">$ (48,000,000)<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized', window );">Percentage of net cash tax savings realized or deemed realized under TRA (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;) | Change Healthcare | Other Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,022,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,030,000,000<span></span>
</td>
<td class="nump">$ 8,202,000,000<span></span>
</td>
<td class="nump">13,022,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,409,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustments: adoption of new accounting standards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustments: adoption of new accounting standards | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember', window );">Separation of Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesDistributed', window );">Shares distributed in split-off (in shares)</a></td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesExchanged', window );">Shares of common stock exchanged (in shares)</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted', window );">Number of shares converted into per share converted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAccepted', window );">Shares repurchased (in shares)</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="nump">414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Transition Services Agreements (&#8220;TSA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Total fees charged under the TSA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Pre-tax other-than-temporary impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(414,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare | Opening retained earnings adjustments: adoption of new accounting standards | ASU 2014-09 | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Distributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Exchanged</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mck_TransitionServicesAgreementsTSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ChangeHealthcareInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509252184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Net Gain on Split-off of Change Healthcare JV (Details) - Change Healthcare - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentFairValueofStockAccepted', window );">Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)</a></td>
<td class="nump">$ 2,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentCarryingAmount', window );">Investment in the Change Healthcare JV at exchange date</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability', window );">Reversal of deferred tax liability</a></td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss', window );">Release of accumulated other comprehensive loss attributable to the joint venture</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentTransactionCostsIncurred', window );">Less: Transaction costs incurred</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain on split-off of the Change Healthcare JV</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAccepted', window );">Shares repurchased (in shares)</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Net gain on split-off of the Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="num">$ (414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAcceptedAverageCost', window );">Cost of shares repurchased (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentFairValueofStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Fair Value of Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentFairValueofStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAcceptedAverageCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted, Average Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAcceptedAverageCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentTransactionCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Transaction Costs Incurred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentTransactionCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Reversal of Deferred Tax Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497188696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax expense (benefit) related to adoption of amended accounting guidance</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested', window );">Vested RSUs (in shares)</a></td>
<td class="nump">57,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock award contractual term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (shares)</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions', window );">Period over which payroll is deducted to purchase shares</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of market price for share purchase</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Percentage of market price deduction for share purchases</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mck_A2013StockPlanMember', window );">2013 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee service share based compensation period to purchase shares through payroll deductions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mck_A2013StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mck_A2013StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507261912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Components of Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit for share-based compensation expense</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense, net of tax</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501566104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details) - RSUs and PSUs<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility (percent)</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (percent)</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510509976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details) - RSUs and PSUs<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod', window );">Cancelled (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted- Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per shares) | $ / shares</a></td>
<td class="nump">$ 142.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">200.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1', window );">Cancelled (in dollars per share) | $ / shares</a></td>
<td class="nump">142.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">141.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per shares) | $ / shares</a></td>
<td class="nump">$ 160.47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510645064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details) - RSUs and PSUs - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501913720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Options Outstanding (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeOneMember', window );">Range One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices lower limit (in dollars per share)</a></td>
<td class="nump">$ 123.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices upper limit (in dollars per share)</a></td>
<td class="nump">$ 159.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 150.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 152.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeTwoMember', window );">Range Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices lower limit (in dollars per share)</a></td>
<td class="nump">159.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices upper limit (in dollars per share)</a></td>
<td class="nump">$ 237.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Life (Years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 201.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 201.56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=mck_RangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276502016232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 183.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">207.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">190.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 175.23<span></span>
</td>
<td class="nump">$ 183.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Stock options outstanding, remaining contractual term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock options outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options vested and expected to vest (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Stock options vested and expected to vest, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 175.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Stock options vested and exercisable, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 178.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Stock options vested and expected to vest, weighted average remaining contractual term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Stock options vested and exercisable, weighted average remaining contractual term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Stock options vested and expected to vest, aggregate intrinsic value</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Stock options vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276502016248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details) - Stock options - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per stock option (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value on exercise</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received upon exercise</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefits realized related to exercise</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of stock options vested</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which stock option compensation cost is expected to be recognized</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501023416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net - Schedule of Other Income, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings, net</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net gains on investments in equity securities</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial gains (losses) from pension plans</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment (in dollars per share)</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember', window );">Termination of U.S Defined Benefit Pension Plan | Pension Plans, Defined Benefit | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial gains (losses) from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember', window );">Retired executive | Settlement of Executive Retirement Benefits | Pension Plans, Defined Benefit | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial gains (losses) from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509262936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember', window );">German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest (percent)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment (in dollars per share)</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember', window );">Termination of U.S Defined Benefit Pension Plan | United States | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember', window );">Settlement of Executive Retirement Benefits | United States | Pension Plans, Defined Benefit | Retired executive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial losses from pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_SettlementofExecutiveRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501910936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) from continuing operations before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="nump">$ 1,944<span></span>
</td>
<td class="num">$ (6,019)<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">985<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">$ 1,928<span></span>
</td>
<td class="num">$ (5,034)<span></span>
</td>
<td class="nump">$ 1,144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501099064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 233<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">88<span></span>
</td>
<td class="num">(562)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(908)<span></span>
</td>
<td class="num">(342)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="num">$ (695)<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276504905640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax expense (benefit) at federal statutory rate</a></td>
<td class="nump">$ 405<span></span>
</td>
<td class="num">$ (1,057)<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">83<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax effect of foreign operations</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Unrecognized tax benefits and settlements</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims', window );">Opioid-related litigation and claims</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit', window );">Net tax benefit on intellectual property transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax-free gain on investment exit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount', window );">Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback', window );">Capital loss carryback</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="num">$ (695)<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate (percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Capital Loss Carryback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Litigation and Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276500973016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components Of Deferred Tax Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Receivable allowances</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DeferredTaxAssetLitigationAndClaims', window );">Opioid-related litigation and claims</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation and benefit related accruals</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Net operating loss and credit carryforwards</a></td>
<td class="nump">739<span></span>
</td>
<td class="nump">974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DeferredTaxAssetLeaseObligations', window );">Lease obligations</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">2,333<span></span>
</td>
<td class="nump">2,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(726)<span></span>
</td>
<td class="num">(864)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total assets</a></td>
<td class="nump">1,607<span></span>
</td>
<td class="nump">1,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory valuation and other assets</a></td>
<td class="num">(1,993)<span></span>
</td>
<td class="num">(1,939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets and systems development costs</a></td>
<td class="num">(184)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(233)<span></span>
</td>
<td class="num">(411)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets', window );">Lease right-of-use assets</a></td>
<td class="num">(401)<span></span>
</td>
<td class="num">(505)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total liabilities</a></td>
<td class="num">(2,828)<span></span>
</td>
<td class="num">(3,088)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Long-term deferred tax asset</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liability</a></td>
<td class="num">(1,418)<span></span>
</td>
<td class="num">$ (1,411)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxAssetLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxAssetLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxAssetLitigationAndClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Litigation and Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxAssetLitigationAndClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxLiabilitiesLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509260408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at beginning of period</a></td>
<td class="nump">$ 1,754<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions based on tax positions related to prior years</a></td>
<td class="num">(131)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to current year</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions based on settlements</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions based on the lapse of the applicable statutes of limitations</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation', window );">Exchange rate fluctuations</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of period</a></td>
<td class="nump">$ 1,523<span></span>
</td>
<td class="nump">$ 1,754<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498577496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax expense (benefit) rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="num">(13.80%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,509<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">908<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Net discrete tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">726<span></span>
</td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">1,523<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">958<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would Impact income tax expense and the effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Amount of decrease in unrecognized tax benefits that is reasonably possible in the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax expense (benefit), before any tax effect, related to accrued interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Accrued interest and penalties on unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember', window );">U.K. Businesses (Disposal Group) and Austrian Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare | Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Loss contingency accrual, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">Loss contingency accrual, period increase (decrease), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember', window );">Capital Loss Carryforward | Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123452999&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498786600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 19, 2018 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right (in euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 23.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Annual increase in interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,031,000,000<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying amount of redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease', window );">Put Right increase (euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000,000<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,000,000<span></span>
</td>
<td class="nump">199,000,000<span></span>
</td>
<td class="nump">220,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983,000,000)<span></span>
</td>
<td class="num">(49,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying amount of redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271,000,000<span></span>
</td>
<td class="nump">1,402,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,393,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000,000<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="nump">217,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="nump">178,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue', window );">Maximum redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of outstanding common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000,000<span></span>
</td>
<td class="nump">$ 156,000,000<span></span>
</td>
<td class="nump">$ 178,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring compensation (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price, Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interests, Maximum Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498719368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Beginning balance</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Beginning balance</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="num">(983)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,271<span></span>
</td>
<td class="nump">$ 1,402<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501196520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="num">$ (4,339)<span></span>
</td>
<td class="nump">$ 1,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to McKesson</a></td>
<td class="nump">1,119<span></span>
</td>
<td class="num">(4,538)<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 1,114<span></span>
</td>
<td class="num">$ (4,539)<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">152.3<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">180.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
<td class="nump">181.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.04)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">7.23<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">7.35<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
<td class="nump">5.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 7.32<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276505948824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Common Share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from diluted earnings per share</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498733336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 1,663<span></span>
</td>
<td class="nump">$ 2,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments', window );">Future lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived', window );">Total lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Opening retained earnings adjustments: adoption of new accounting standards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OperatingLeaseImpairmentLossNetOfTax', window );">Impairment charges</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Noncancelable lease terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Noncancelable lease terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,030<span></span>
</td>
<td class="nump">$ 8,202<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">12,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Opening retained earnings adjustments: adoption of new accounting standards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative effect adjustment</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OperatingLeaseImpairmentLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Impairment Loss, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OperatingLeaseImpairmentLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510540120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental balance sheet information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 1,548<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,366<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 1,663<span></span>
</td>
<td class="nump">$ 2,257<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property, plant, and equipment, net<span></span>
</td>
<td class="text">Property, plant, and equipment, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Less: Current portion<span></span>
</td>
<td class="text">Less: Current portion<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (Years) - Operating leases</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (Years) - Finance leases</a></td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">10 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - Operating leases (percent)</a></td>
<td class="nump">2.47%<span></span>
</td>
<td class="nump">2.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - Finance leases (percent)</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">$ 442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510276936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of lease costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 598<span></span>
</td>
<td class="nump">$ 615<span></span>
</td>
<td class="nump">$ 599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507769944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental cash flow information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="num">$ (356)<span></span>
</td>
<td class="num">$ (362)<span></span>
</td>
<td class="num">$ (377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="nump">2,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use asset, transition adjustment</a></td>
<td class="nump">$ 1,548<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498651656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of lease liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">$ 2,257<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">1,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LessorLeasePaymentstobeReceived', window );">Minimum sublease income</a></td>
<td class="nump">$ 201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities Payments Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LessorLeasePaymentstobeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Lease, Payments to be Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LessorLeasePaymentstobeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507495672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 9,493<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers, and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">9,451<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">3,963<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers, and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(40)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">3,923<span></span>
</td>
<td class="nump">3,963<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers, and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers, and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting, transfers, and other adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other changes/disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 1,533<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="nump">$ 1,443<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497173672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,493<span></span>
</td>
<td class="nump">9,451<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">1,533<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">$ 1,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember', window );">Retail Pharmacy Reporting Unit [Member] | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498774616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 4,996<span></span>
</td>
<td class="nump">$ 6,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,937)<span></span>
</td>
<td class="num">(3,768)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Assets Held for Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">$ 384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,777<span></span>
</td>
<td class="nump">3,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,691)<span></span>
</td>
<td class="num">(2,269)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,086<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,085<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(573)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember', window );">Pharmacy licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 819<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(386)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510274696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">$ 422<span></span>
</td>
<td class="nump">$ 462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization expense, 2027</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated annual amortization expense, after 2028</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498084744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Jul. 17, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 03, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">5,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 2.70% Notes due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 2.85% Notes due March 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 3.80% Notes due March 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 0.90% Notes due December 3, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 1.30% Notes due August 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 7.65% Debentures due March 1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 3.95% Notes due February 16, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 4.75% Notes due May 30, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 6.00% Notes due March 1, 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 4.88% Notes due March 15, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 0.63% Euro Notes due August 17, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 1.50% Euro Notes due November 17, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 1.63% Euro Notes due October 30, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 3.13% Sterling Notes due February 17, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember', window );">Lease and Other Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276499445656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,648,000,000<span></span>
</td>
<td class="nump">$ 1,040,000,000<span></span>
</td>
<td class="nump">$ 298,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Scheduled principal payments of long-term debt in 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Scheduled principal payments of long-term debt in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Scheduled principal payments of long-term debt in 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Scheduled principal payments of long-term debt in 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Scheduled principal payments of long-term debt in 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Scheduled principal payments of long-term debt, thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900,000,000<span></span>
</td>
<td class="nump">7,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799,000,000<span></span>
</td>
<td class="nump">742,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,879,000,000<span></span>
</td>
<td class="nump">7,148,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member', window );">1.30% Notes due August 15, 2026 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance, net</a></td>
<td class="nump">$ 495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member', window );">4.75% Notes Due March 1, 2021 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member', window );">Notes Due November 30, 2020 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember', window );">Floating Rate Euro Notes due February 12, 2020 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 360,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 918,000,000<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">167,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,000,000<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,000,000<span></span>
</td>
<td class="nump">282,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255,000,000<span></span>
</td>
<td class="nump">411,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember', window );">Tender Offer Notes | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 922,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt instrument, repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (191,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts', window );">Write-off of Deferred Debt Issuance Cost and Transaction Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 709,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 704,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of Deferred Debt Issuance Cost and Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510547848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mck_GlobalFacilityMember', window );">Global Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Amount borrowed under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember', window );">Senior Unsecured Credit Facility (the 2020 Credit Facility) | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="nump">4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Amount borrowed under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember', window );">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mck_GlobalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mck_GlobalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276507601912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Commercial paper issuances</a></td>
<td class="nump">$ 11,200,000,000<span></span>
</td>
<td class="nump">$ 6,300,000,000<span></span>
</td>
<td class="nump">$ 21,400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Commercial paper repaid</a></td>
<td class="nump">11,200,000,000<span></span>
</td>
<td class="nump">6,300,000,000<span></span>
</td>
<td class="nump">$ 21,400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">5,879,000,000<span></span>
</td>
<td class="nump">7,148,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity (up to)</a></td>
<td class="nump">4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510554600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">VIE consolidated assets</a></td>
<td class="nump">$ 63,298<span></span>
</td>
<td class="nump">$ 65,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Unconsolidated VIE maximum exposure to loss</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Variable Interest Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">VIE consolidated assets</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">VIE consolidated liabilities</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276500423880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>participant</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Percentage of eligible compensation (up to percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Contribution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,000,000<span></span>
</td>
<td class="nump">$ 102,000,000<span></span>
</td>
<td class="nump">$ 102,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember', window );">First Part Of Pay Contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company match employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EmployeeContributions', window );">Employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember', window );">Second Part Of Pay Contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company match employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EmployeeContributions', window );">Employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized', window );">Pension liabilities derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive loss derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | Austrian Business Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive loss derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets', window );">Unexpected actuarial losses (as a percent) (exceeding)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Expected benefit payments in 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Expected benefit payments in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Expected benefit payments in 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Expected benefit payments in 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Expected benefit payments in 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Expected benefit payments in 2028 through 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contributions in next fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_UnitValueOfCashAndCashEquivalents', window );">Unit value of cash and cash equivalents (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Held-for-sale | Austrian Business Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized', window );">Pension liabilities derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="nump">64,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanSettlementPlanParticipants', window );">Number of plan participants elected to receive settlement payments | participant</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax pension settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract', window );">Annuity contracts purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 129,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints', window );">Increase (decrease) in basis points</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.0100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 131,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plans, Defined Benefit | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans | Pension Plans, Defined Benefit | Unfunded plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="num">(89,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate', window );">Actuarial loss resulting from discount rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="num">$ (32,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges', window );">Actuarial gain (loss), demographic and assumption changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,000,000)<span></span>
</td>
<td class="num">$ (57,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 701,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 701,000,000<span></span>
</td>
<td class="nump">$ 875,000,000<span></span>
</td>
<td class="nump">$ 896,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints', window );">Increase (decrease) in basis points</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.0078)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Amounts of plan exceeding total plan contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="nump">$ 22,000,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset', window );">Percentage of total plan contribution - exceeding (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_MultiemployerPlanFundedStatusPercentage', window );">Funded status (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlansWithdrawalObligation', window );">Amounts accrued for liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit | Norwegian Public Service Pension Fund (SPK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue', window );">Amount of plan asset value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit | Unfunded plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000,000<span></span>
</td>
<td class="nump">$ 162,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember', window );">Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits | U.S. Plans | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets for Plan Benefits, Defined Benefit Plan, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Payment For Annuity Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanSettlementPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Settlement, Plan Participants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanSettlementPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EmployeeContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EmployeeContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_MultiemployerPlanFundedStatusPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Multiemployer Plan, Funded Status, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_MultiemployerPlanFundedStatusPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_UnitValueOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unit value of cash and cash equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_UnitValueOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansWithdrawalObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansWithdrawalObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=mck_NorwegianPublicServicePensionFundSPKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=mck_NorwegianPublicServicePensionFundSPKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510231672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets', window );">Amortization of unrecognized actuarial loss and prior service costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailment/settlement loss (gain)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the year</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets', window );">Amortization of unrecognized actuarial loss and prior service costs</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailment/settlement loss (gain)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497571832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement', window );">Curtailment/settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid', window );">Expenses paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants', window );">Employer and participant contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsExpensesPaid', window );">Expenses paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">$ (49)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities (3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement', window );">Curtailment/settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid', window );">Expenses paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants', window );">Employer and participant contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsExpensesPaid', window );">Expenses paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities (3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | European Businesses (Disposal Group) | Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities (3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets for Plan Benefits, Defined Benefit Plan, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets for Plan Benefits, Defined Benefit Plan, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligations, Expenses Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationsExpensesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Contributions by Employer and Plan Participants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanPlanAssetsExpensesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Expenses Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanPlanAssetsExpensesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498594200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 681<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501096104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service credit</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510035336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details) - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract', window );"><strong>Amortization of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service credit (cost)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax', window );">Foreign exchange impact and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in other comprehensive loss (income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract', window );"><strong>Amortization of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net actuarial loss</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service credit (cost)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax', window );">Foreign exchange impact and other</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in other comprehensive loss (income)</a></td>
<td class="num">$ (50)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510228392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details) - Pension Plans, Defined Benefit<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic pension expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rates</a></td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
<td class="nump">3.66%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">3.08%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic pension expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rates</a></td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of increase in compensation</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.93%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="nump">2.56%<span></span>
</td>
<td class="nump">2.56%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates</a></td>
<td class="nump">2.67%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">2.03%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of increase in compensation</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.93%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276499257400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Assets held at NAV practical expedient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanAnnuityContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanAnnuityContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanOtherFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanOtherFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276502011176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Investments Measured at Fair Value (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase', window );">Purchases</a></td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Return on assets</a></td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">$ 175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase in plan asset of defined benefit plan from purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276499174792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 5,879,000,000<span></span>
</td>
<td class="nump">$ 7,148,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Gains (losses) from net investment hedges</a></td>
<td class="nump">73,000,000<span></span>
</td>
<td class="num">(118,000,000)<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax', window );">Gains recorded in earnings for ineffectiveness of Company's non-derivative hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) recorded in other comprehensive income</a></td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AmortizationOfLossOnDerivativeTerm', window );">Amortization of loss on derivative, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember', window );">Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges | Derivatives Not Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gains (losses) from contracts not designated as hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember', window );">Forward Contracts to Hedge Euro Against British Pound Cash Flows | Derivatives Not Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Gains (losses) from net investment hedges</a></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="num">(119,000,000)<span></span>
</td>
<td class="nump">76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | November 2018 Cross Currency Swaps | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from termination of swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Settlement gain recorded in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) recorded in other comprehensive income</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="num">(42,000,000)<span></span>
</td>
<td class="nump">$ 98,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Currency Swap | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Loans payable | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AmortizationOfLossOnDerivativeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Loss On Derivative, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AmortizationOfLossOnDerivativeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497586392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Prepaid expenses and other/Other accrued liabilities | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Prepaid expenses and other | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Other accrued liabilities | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Other accrued liabilities | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Other non-current assets/liabilities | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Other noncurrent liabilities | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Other noncurrent assets | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Prepaid expenses and other | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Other accrued liabilities | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative asset, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative liability, gross fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNoncurrentAssetsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNoncurrentAssetsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276509097000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Investments in money market funds</a></td>
<td class="nump">$ 981,000,000<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities of growth stage companies</a></td>
<td class="nump">346,000,000<span></span>
</td>
<td class="nump">269,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on securities</a></td>
<td class="nump">98,000,000<span></span>
</td>
<td class="nump">133,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Measurements, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value on a nonrecurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276504946968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="nump">$ 7,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, including current maturities</a></td>
<td class="nump">5,999<span></span>
</td>
<td class="nump">7,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt outstanding</a></td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="nump">$ 7,148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276501617064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Guarantees and Warranties (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearOne', window );">Guarantee obligations, expiring in 2023</a></td>
<td class="nump">$ 309,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearTwo', window );">Guarantee obligations, expiring in 2024</a></td>
<td class="nump">45,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearThree', window );">Guarantee obligations, expiring in 2025</a></td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFour', window );">Guarantee obligations, expiring in 2026</a></td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFive', window );">Guarantee obligations, expiring in 2027</a></td>
<td class="nump">12,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter', window );">Guarantee obligations, expiring after 2027</a></td>
<td class="nump">64,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember', window );">Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">367,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember', window );">Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">84,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">$ 214,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Five Thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuarantorObligationsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuarantorObligationsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276487600760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 02, 2022 </div>
<div>USD ($) </div>
<div>installment</div>
</th>
<th class="th">
<div>Sep. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 25, 2019</div></th>
<th class="th">
<div>Apr. 03, 2018 </div>
<div>city </div>
<div>state</div>
</th>
<th class="th">
<div>May 17, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 16, 2013 </div>
<div>defendant </div>
<div>state </div>
<div>relator</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>complaint </div>
<div>relator</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>case </div>
<div>site </div>
<div>product</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2022 </div>
<div>product</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>case</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>complaint</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>complaint</div>
</th>
<th class="th">
<div>Aug. 13, 2019 </div>
<div>faxNumber </div>
<div>fax</div>
</th>
<th class="th">
<div>Dec. 12, 2018 </div>
<div>officer</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>softwareProduct </div>
<div>case</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge', window );">Annual surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Net cash proceeds from settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (181,000,000)<span></span>
</td>
<td class="num">$ (22,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember', window );">New York Opioid Tax Surcharge | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualProvisionAfterTax', window );">After-tax charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Loss contingency accrual, payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember', window );">Environmental Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SiteContingencyNumberofSites', window );">Number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingenciesGross', window );">Remediation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HazardousSubstanceSites', window );">Hazardous substance sites, number | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberofSitesSelectedforPreferredRemedy', window );">Number of sites selected for preferred remediation | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts', window );">Estimated environmental assessment and cleanup costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Estimated loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Loss contingency, accrual, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,046,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Loss contingency, accrual, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,220,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,067,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,266,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,067,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opiate Litigation | Governmental Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opiate Litigation | Individual Claimant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember', window );">United States ex rel. Manchester v. Purdue Pharma, L.P., et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal', window );">Period within which party can be substituted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member', window );">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofRelators', window );">Number of relators alleging violations | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember', window );">Insurance Coverage Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass', window );">Number of faxes remaining in class | faxNumber</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesReceived', window );">Number of faxes received | fax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss contingency, statutory damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Damages sought per violation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Damages sought per violation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member', window );">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCitiesFiledOnBehalfOf', window );">Number of cities filed on behalf of | city</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember', window );">Evanston Police Pension Fund v. McKesson Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofFormerOfficers', window );">Number of former officers | officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember', window );">Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member', window );">Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember', window );">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ConsolidatedActionsvSureScriptsLLCMember', window );">Consolidated Actions v SureScripts, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember', window );">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberofSoftwareProducts', window );">Number of software products | softwareProduct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfEligibleStates', window );">Number of eligible states | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage', window );">Number of eligible political subdivisions, participation percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Litigation settlement, amount awarded to other party, percentage of total settlement award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Litigation settlement, amount awarded to other party, percentage of total settlement award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages', window );">Percentage of total settlement to be used to remediate damages (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Three National Pharmaceutical Distributors | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Three National Pharmaceutical Distributors | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Pending Litigation | Alabama | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation settlement payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementNumberOfInstallmentPayments', window );">Settlement, payment terms | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Settling Governmental Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 354,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Settling Governmental Entities | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Litigation settlement, amount awarded to other party, percentage of total settlement award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | State of Washington and Subdivisions | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="nump">$ 197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Litigation settlement, amount awarded to other party, percentage of total settlement award</a></td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Distributors | Settling Governmental Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other defendants | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Distributors | Settling Governmental Entities | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Expected payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment', window );">Litigation settlement, award amount to be used by state and local government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Distributors | State of Washington and Subdivisions | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="nump">$ 518,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember', window );">United States ex rel. Piacentile v. Amgen Inc., et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfRelators', window );">Number of relators | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfAdditionalDefendants', window );">Number of additional defendants | defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Environmental Assessment And Cleanup Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EstimatedEnvironmentalAssessmentAndCleanupCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HazardousSubstanceSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of sites that hazardous substances were allegedly disposed at.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HazardousSubstanceSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:positiveIntegerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Award Amount To Be Used by State and Local Government</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualProvisionAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Provision, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualProvisionAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Remaining in the Class</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesRemainingintheClass</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyDamagesSoughtPerViolationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Sought Per Violation, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyDamagesSoughtPerViolationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfAdditionalDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfAdditionalDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfEligibleStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Eligible States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfEligibleStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Eligible Subdivisions, Participation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfOtherDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Other Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfOtherDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfRelators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Relators</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfRelators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCitiesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cities Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCitiesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofFormerOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Former Officers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofFormerOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofRelators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of Relators</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofRelators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStatesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of States Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStatesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Party Substitution Period to Prevent Case Dismissal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementInstallmentPaymentsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Installment Payments, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementInstallmentPaymentsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementNumberOfInstallmentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Number of Installment Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementNumberOfInstallmentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberofSitesSelectedforPreferredRemedy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Sites Selected for Preferred Remedy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberofSitesSelectedforPreferredRemedy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberofSoftwareProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Software Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberofSoftwareProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, New York, Annual Surcharge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActNewYorkAnnualSurcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SiteContingencyNumberofSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of sites requiring environmental conditions to be addressed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SiteContingencyNumberofSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6395460&amp;loc=d3e13647-108346<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingenciesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount of the accrual for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingenciesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_IndividualClaimantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_IndividualClaimantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ConsolidatedActionsvSureScriptsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ConsolidatedActionsvSureScriptsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_CherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_CherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfAlabamaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfAlabamaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_DistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_DistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276511256408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details) - National Prescription Opiate Litigation - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Loss contingency, accrual, current</a></td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Loss contingency, accrual, noncurrent</a></td>
<td class="nump">7,220<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="nump">$ 8,266<span></span>
</td>
<td class="nump">$ 8,067<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497058728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 10, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
<td class="nump">$ 1.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_EquityMethodInvestmentStockAccepted', window );">Shares repurchased (in shares)</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember', window );">Separation of Change Healthcare JV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesDistributed', window );">Shares distributed to stockholders (in shares)</a></td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ExchangeOfferSharesExchanged', window );">Shares of common stock exchanged (in shares)</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted', window );">Number of shares converted into per share converted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquityMethodInvestmentStockAccepted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Stock Accepted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquityMethodInvestmentStockAccepted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Distributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ExchangeOfferSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exchange Offer, Shares Exchanged</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ExchangeOfferSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=mck_SeparationofChangeHealthcareJVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276498658280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Share Repurchases (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Shares repurchase authorization increase in 2021</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Beginning balance</a></td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">$ 3,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Ending balance</a></td>
<td class="nump">$ 3,278<span></span>
</td>
<td class="nump">2,785<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AccruedShareRepurchases', window );">Accrued shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember', window );">Open Market Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share (in dollars per share)</a></td>
<td class="nump">$ 217.73<span></span>
</td>
<td class="nump">$ 160.33<span></span>
</td>
<td class="nump">$ 144.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="num">$ (1,007)<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
<td class="num">$ (1,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2019Member', window );">Accelerated Share Repurchase, May 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2021Member', window );">Accelerated Share Repurchase, May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share (in dollars per share)</a></td>
<td class="nump">$ 193.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseFebruary2022Member', window );">Accelerated Share Repurchase, February 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share (in dollars per share)</a></td>
<td class="nump">$ 265.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Shares repurchase authorization increase in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="num">$ (1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AccruedShareRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Share Repurchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AccruedShareRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseFebruary2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseFebruary2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276497138536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">5,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</a></td>
<td class="nump">73<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Actuarial gains (losses) from pension plans</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,361)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(51)<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">419<span></span>
</td>
<td class="num">(152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">41<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">40<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(174)<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Unrealized gain (loss) on net investment hedges, tax</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">18<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="num">(1,849)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income attributable to McKesson</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (1,534)<span></span>
</td>
<td class="num">$ (1,480)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510888712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Balances and Transactions (Details) - Investee - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">U.S. Pharmaceutical and Specialty Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_U.S.PharmaceuticalandSpecialtySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_U.S.PharmaceuticalandSpecialtySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276486541992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Narrative (Details)<br> product in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>country </div>
<div>product </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
<td class="num">$ (252)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Corporate expenses, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment', window );">Net gains associated with equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="num">(8,645)<span></span>
</td>
<td class="num">(973)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember', window );">Tender Offer Notes | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Corporate expenses, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Corporate expenses, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Loss contingency accrual, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember', window );">For Two Counties In re: National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Corporate expenses, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember', window );">Shareholder Derivative Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Corporate expenses, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(131)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Corporate expenses, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Pre-tax pension settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember', window );">Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture | Change Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(414)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Pre-tax other-than-temporary impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Pre-tax dilution loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity earnings and charges from investment in Change Healthcare Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Canadian Health Benefit Claims Management and Plan Administrative Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | German Wholesale Business | Walgreens Boots Alliance Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity operates | country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | New York Opioid Tax Surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Net cash proceeds from settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (181)<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical surgical products | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Company's International Segment Operating Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Derived revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in earnings from investment in debt and equity securities measured at fair value with change in fair value recognized in net income, and recognized from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity) to investment in debt security measured at fair value with change in fair value recognized in net income (trading). Excludes other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationAdditionalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_ChangeHealthcareLLCChangeHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276487579080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Schedule of Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 263,966<span></span>
</td>
<td class="nump">$ 238,228<span></span>
</td>
<td class="nump">$ 231,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="nump">3,370<span></span>
</td>
<td class="nump">3,828<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate expenses, net</a></td>
<td class="num">(1,073)<span></span>
</td>
<td class="num">(8,645)<span></span>
</td>
<td class="num">(973)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">1,928<span></span>
</td>
<td class="num">(5,034)<span></span>
</td>
<td class="nump">1,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">887<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,113)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">212,149<span></span>
</td>
<td class="nump">189,274<span></span>
</td>
<td class="nump">181,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="nump">2,879<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">2,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">3,864<span></span>
</td>
<td class="nump">2,890<span></span>
</td>
<td class="nump">2,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">11,608<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">8,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="nump">959<span></span>
</td>
<td class="nump">707<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">36,345<span></span>
</td>
<td class="nump">35,965<span></span>
</td>
<td class="nump">38,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Operating income</a></td>
<td class="num">(968)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GrossProfitNetofExpensesIncludingOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Profit, Net of Expenses, Including Other Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GrossProfitNetofExpensesIncludingOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276510291224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 63,298<span></span>
</td>
<td class="nump">$ 65,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">2,412<span></span>
</td>
<td class="nump">3,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">38,346<span></span>
</td>
<td class="nump">35,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,717<span></span>
</td>
<td class="nump">14,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,830<span></span>
</td>
<td class="nump">5,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,528<span></span>
</td>
<td class="nump">3,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,877<span></span>
</td>
<td class="nump">$ 5,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant and Equipment, Including Net Capitalized Software</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140276506592024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 261<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount', window );">Current allowances</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowances for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember', window );">Other allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember', window );">Written-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember', window );">Credited to other accounts and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>mck-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mck-20220331.xsd" xlink:type="simple"/>
    <context id="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3.125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e45aeb91b9541c99e6059f70915b672_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i67fe817fe4174122acfb22089bd77bb2_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6ddb54fd3967467a87bab9dd990e6cad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia3deea6c14b24c35a88fb4f3b5239602_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5b21cbe51124474092ab038b1d408bb7_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i785292e3540b46a8b3ab968c6707dd77_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i6a6c8a7f661b462f9ac6296df77d8e06_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1cd9f0cb497242a6826289cfb5fdad80_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ide9952cef22a4bc8b524552d5f4a71b9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ie4592918a3c14823acad8256f0ddfbde_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3028b894dc5241e6bdae80eea3de8d1f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i8428ec3a9cbb437d8aa822268f3ae46f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia689b4eec1084768aaebdb4bc5f99af7_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ie7820f8179cd488caae5ec4d8b342012_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iaa23c711f267453f9563f59bc7ef048a_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1b01dc80a44246cd9ff31ee62f1cf4f5_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib9f39b2ee8ba4ad9b6df061b0133c8c6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i180ef1abd93241dd9b099926ef64a73e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7a7555c1d0ba47188d1bf7a199033063_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib95e07416b7c42009dca3b45fcac417f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7aec4e5c4fc44a31a9df1e4f8d8962c9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i6b5103e93a3d4aa2b15d717f1d91a04d_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7e972d123eb647c8a45d52545e29ad97_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i64627de0752a4f38a0331018368b8865_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3440078a7adb46d7b5f9accf550ba77b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5b02a4b752d74cfd80393765ca780d97_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6f88e128a22f4b15be314f3dd2e0d53d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i883cca538ace48298886a121db79175e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic641abc11fc64b27871a5f1b878bbdb6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i83f0aa9722f4476ca58477e03a36b9f4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idb569322fd7143f1924eb4050fec05d0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib2cdad70673142c9a93a6bbb19838852_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i201940e73632457882da553cf6462766_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8791362274e94d518929bbd7ee69eced_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibf764aa2c30f43d08cdd30a5094d5c77_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic31e30cd614c468c88d7a33e3c01b62c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia8d61cae07b149f28ab844297d0650dd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i305e3fcf99604bad83df1de067162bda_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia1eb7d3437fe498bba552eae2bce578c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9378e02396964f6fa338e061f8c72449_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib551700663cc480187b2925365dc76f3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i210241066bf44247a7e0bfd8995df0e5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5dc9248dc9c64dae83ba79637793aab6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i57057534f4b548078330647f41d65cd9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i973951133a204d4eb8580125b92aed26_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i461023189d294286a463ef01b45de63d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia5b27e96a471495799b6dd0a225ad062_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic951943367684ce392dcd7a2919ab132_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i36b967dacd7747f1897007bd0e7d2096_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0c4849bc12314eb6878d6ecc627ba11c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib0f038c81a5a4b8198d4c97be9e3cfa7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3764f741fee2439f932384b08f26eaf2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6dec5df30de44f7a83e4f2ce0278a9d7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idcca99ee396c495597323a1f0cfd1b93_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i199433cd82524872a587c50f96b8c524_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie685032700114a648030b37f3029390e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i84a83e66e4b34cfcbbd7fafb3e2d383e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib8062dd2444549b5b588b1c34805e71c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1996a48e50224bb9a7a3ef02f89a15be_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:OtherAdditionalCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2b963f2005d473788cd329e855eb9f8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id3e04acff1af415fb304c565efd6376b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3c565412e4c44e6090973b99e12490b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i52cdcc95103d4a2b933719ac01f8cec5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia875aad6cce743958618a33cce559dc9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibef844e82df1453ebb9d87c78078c9bb_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0ca5a3c42a474837ad3c8ddb0bd7ed5d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i497343cb5b494f24aff9bdc1fea240b3_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1927407de0374cf69e8f7b4d87b815fc_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6c4813acb64c45d2b97a2771fc585000_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica1b10d592e944029941c3362d1e7d7f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idd2a1aaa4aa14613b98b19f05c608e54_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3520428561d84269863983bba1a927e7_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4995096937474d1bafc21c7eb57b994e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id81d0417806f4bd2852861c9771dece6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2bbfc4c323144cdbacc148f6e3af2eae_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i975f1db8bccf423181a945e065415fff_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7f482d9a485949708d2fb871130187fd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92ca8c27ec4649008fa3211cb422f720_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07fbf9f75177477d9f3069a6a3ca5aa5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6f3d97d7bd9041e6a3021f9f3286582a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:RealPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i430c0a72e23b438a8649c6275316dac5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i866185886e394d17bb4c613ad5943f58_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i96172b3b6b994d48bf70c6de9f508828_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6056d0a51a7f4646bfa84408265c81c0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1e41ae776e234aad99573060abfa3d60_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e210e8bb0d04564b3c8c5efbc105415_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic483b5ea8e204c8a81418d102f77e31e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24fc415a058448cabaac1543f414ee42_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if5fc2a45b1fb4a57a52e375ee61e2e18_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf194e10ae1d4f91ab6ebadc346e333c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib36ffbe522794177a4a329b2f1eb434e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8727a45639054efb97996743cbbaa5c5_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iafca086d825c49179df146b9365fef4a_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9cb26398b07540459c29d095fcbe163a_I20210705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-05</instant>
        </period>
    </context>
    <context id="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i148d988b662042b2a7deeb2a40ab602b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i29e231614cf344e4b636aecd2998ddde_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifd0254ffce6f4249b8b5901d3add0491_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i03a43c3fab9f446eb0a8de876cfc5913_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i78ccaa920a9a4c73a30399adf8117855_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i72fd68575bf94328b58c74040ee351f4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0adedf0f78e24ba5b61ec3c4ef5b7cbf_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="ia2d3e091542c4331aa802c94a7053cc5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i805540d4c73c4b6387871c54c384fbbf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6fd8b5bc85ab463b9b570056218ced7a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie3680721de0643ebb55f9f02576ae3ff_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i9f12825bbb7d4be19f89e6a7c0f56679_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i5bb3e221693840dbb9ad1863bc6749ce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9ee10d37e08c43bb976ba37d004b5745_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia00ccbaf67b84520a82cd5bc577ccbf8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i33304856ba67431dbe134e6a3ab5f8b0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1a27f3b5cf9d4d86a3c7d1030055337c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i86e51851e38343d889528a7d74ce170b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id91a5fa4a09149dda8dc0d199e094ffe_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i41c0c862a7ce4612a21718defa31e238_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i69ad3377d9084d09824adc34ca4401cc_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i271b7492525f41e3932ace993871f8cd_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9a42c42c2a65463aa226579177d34729_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if28008f04c494b7db3a30fbf432da178_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1238be9949344a4ca03b1fd2035c6266_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i735f207277504040936a46b7a21dbc2a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i44ae2fd5d4d84827a40c6ccf806b3215_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7657b4a360fd42b382531c0ba2049a37_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i819b3e5a18554614be6da3dc30c8c20e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaf37a2aea301469bbf8c95c1cb87dea0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i38e69dbb765c4cbba679db0d75d4e24d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3836c14e169d426385529b1516d34376_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifbae9d0f6df24779a201d5522b29b806_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie5920306c6c74407aa3c61813edac174_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75859372620f4bba9fcc690a92937930_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3fe8302f1495433a8b56aac54216c93a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i60fde2da64904433badd4e9125f5242e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i085f9b77e2ff45639871e3f6c4e87e81_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i136fbfde3b204ba88d3ef047c523f6d0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94e33cbb297240f8b26bda1df5bbbe78_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifa3be7b53b364d71925dd6edb5685f60_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1c6852c1f9a6482689173337df8e42e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i70f13591242b45b99e2c1c5db5996175_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iea0833513a6441c390d86adb1976e862_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie75d55168ab54f22bd06fbcb372e660d_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i014202a1f605442dbab72a51287eee8c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RexallHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i850442d9feb244c1b8d54049ca967bf7_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i5602bb7b6c1f4462ad47f96096815f13_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ChangeHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="ia25cf3b3c2cb43a3a841dfd73d6b05a3_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i957db9ee8dda4a86a6807315859b7837_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9dea9ba882cb4ed59e73b4c472a99efc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i4acf39f6c45042d9825177088805f18a_I20200310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">mck:SeparationofChangeHealthcareJVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-10</instant>
        </period>
    </context>
    <context id="i1946db5930c242abbc59691266086fb6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i644b2169690443038315b62f32a3e6f6_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i5dd842111f74444da1462dfb1b854980_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3109ad9f81eb416ab0a243bace22e406_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iefb5b025ddcb4d33a1880e89a1d2abc9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TransitionServicesAgreementsTSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i372b78f92945468a8ee64d9a3cfcac2a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i713d743d96654a20823b67a74fa07746_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i396a3d47aa6b4128922f47705dca2702_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia70f4f23e9a04a66a4f3946139215e69_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83619a483e764d0bbec67a9c3cdbc05f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70fb53d969384de7892c6e9555726ec2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icad2eb9cc2d54973b510383cde197e58_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf75a56d89594901b67572ed9c73d754_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i155ee628098a42bdba6bed51090a2fd6_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic6991844f2274f7e8df965bf0500c897_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i12086cb093c648ecb1b3b14a73e46526_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7a23fb1c43dd4a25ae7f616ad567c312_I20130731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-07-31</instant>
        </period>
    </context>
    <context id="i4cbf7bb534a14e729833a52263987ab2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id75ca3120774435ca04f05387924ec80_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id7175fa977964dc5b6050bcf39c64b38_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9985842113274b9bb12a6616b9b70bf2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ica790b51350c436380a7c20f7ab4a955_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iada693d5d07f484eb5f7830f874b2439_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5f34988e21e446d58a56961047fed59c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib5991194f40e4d9fb3ea2ad222435266_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">mck:RangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3dd23280ebc846d8b2d4860031a724c2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i57920885a3494e0ca6394523c80f50e3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i18638b28013f47cc83d0371a8132d139_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ice1ca3402501452f8282a882c66a1a41_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i66b903eb87c2421eb495ac4394329d5d_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i167f7828260e4a198813c305f400a996_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:SettlementofExecutiveRetirementBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i01e8b5cec568422ebcfc63feb76be4b7_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63827a6bb93940659eeb1ad9423601f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e32a1fbc82b4b00bc1a50e31b77e798_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0fec03c76dc94380a58e045d8dc7b5dc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:ChangeHealthcareLLCChangeHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idd7a390cba074697a32fefbb6fab99ca_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic0ac656b00974ec2a54cd2ed0080a826_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id468ab83e79c4da3bdeb27a9b9e7e51f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if89d7ba5882b4f0fa002ab7806455632_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0fb72716661344f2b3ed64c31036af17_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifb22ce88060842ff860b7a4f6f4d8c8d_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id49f95b8b84d4733a35b6f6d7352eb6b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i90fb979952704eaeb0354680a480489e_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="icdac5b94f2184c3a99658bd787744bdf_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i74517685e93241df8e4050dd6818b8c2_D20180919-20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2018-09-19</startDate>
            <endDate>2018-09-19</endDate>
        </period>
    </context>
    <context id="id55a461c58734092bdfe4dbc17c833c2_I20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-09-19</instant>
        </period>
    </context>
    <context id="i314553b738ee43fc96f6e068ba26aa3c_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="icbf87d883a1e46a99b0a0ea932dfd523_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i369ed3d532394663ba99e0e952d94674_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a2d296e2c5c427f97b8588765fa3178_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6dc4df20c07240af91fdfc7690f7f39a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5a5f885d18c04e07bd8c41ef8f1ce99b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4ac41f1025f14743bb7d39f341e23ed7_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8fb2e420d55e43d0aa913ab1b22cbcaa_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idfcdc1a443e549bdae94a956c44c8a5e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6ae40923a8c44fae93e93658b71a6fbe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if2605ebb23764962bfd89d4578016d5b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="if31e8179749841c8870313f7d3ba430c_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="icc5e78fe538f4bacbd70c847c9f29b70_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="i95419da414bb4ab191a0c6bdfc3acda0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia6fbd33f726e47aba5491ae5385fa919_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i082e438b9e624b688d526df079a96fae_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idcc65fc10a6f46eb873730b43c245ffd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifab6ade13b6047f2bc574352c680315a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4ee45133724c4e4d9e9cc8e6880430af_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i558a4f91a45148328e79fe9c105520e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idb3167c8a2454bfc8d55421585d3d985_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i15b55a2e948f4b24a3b527c5ac723106_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2898617ea052451ab1b166e16ad0bff1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1778f09368dd4bde9d01e3bceccc0de4_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8bec42efc82456886f328dfaa5e4c78_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i57b1f3f32ffc4e6ca7fc465f2efcfa9c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i89602a22aafc4c248462dc75c787e1db_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i65c2a80c51924ffea392e70a7d81af35_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic17f9f344cd2424186b1efb969df180c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i480ab7e945d745479b45988a832ff1ef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0d68a928d7824033ace17d52e23a8dca_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i40c222358c854868933a4aec3f197b82_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if320149638f44877bc4627df44ee32f0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i68562b53b58b4e4eb84618514db2cb80_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3bf05e148e384ae29d92e24fc00c4fef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i61b1d9b80a624667a047ec06a972915f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i987e27c5d1bf40c783eef89efb6f9d6e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i97df16e5800541ca9604a3cf83a192c2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i17b657fb07354a6c983690d6eee84e3a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if68227cf6cac4d3d86ed24a1337b11f2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i260b94765bd84eba92c24f9d3b5ece7a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63b800d5a4ed46c98d60b8f90472d8b0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9d8bd56dac64452db5d3474b91e08366_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie64c7a9ecd8140eab1897947f3348779_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanAssetsHeldForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6f5e289f8bb94f8ba82cd55b25264f93_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i38191160842b4d688580a4d3c249f8c9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75f9b3f6ce4a48629e8939f2036c9a7e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaebf771578eb4688a13cafab7d91e267_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id41b46d826cf480a9d07b02c6f0fa4b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9b257ef2e3f049e28d8f48078592b92a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iff19ad24fcaa4efe8adbe9568e74156a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5269554a47894df4b123574f180fa7bf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4492282a1a93402a8f44df990dd74728_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icdebf42f817b45e8837663f7bac80ed5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02dc743ac553435dba404f92c86d8691_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i70b14d9641344a939e986c99e6567d70_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia6b3ed5f2ea54176814a8708c6499848_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5dd84b2361824bb0bc00064d18891fb0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i91a13fda196843f6b109d769cfe0751d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18046743a1974c45821697aea7b0f77f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i776610a612354ff280ad9f037198c296_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8410975cba024c78bef5a76f712f7294_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9099b942bd1b45f78fdeefc39837a3ce_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied357647ec7743bea35135bd6969080e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i74426e55813a40cc92bc89945e9dd130_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i29908212c93c4b2cba4a35c49394c7b5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8a43cf31de784042b8d27a08355df15f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie471ed607d464069b849582cde89f693_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i03e6233f5e8548d5a04aac3f11cb0d2f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3995850cc8f4cf0bfa3483d28ead8fa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8b875fcead64ab181ee711d77c92192_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8fd452d00a734f2699190045314018e3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9a54c5deff6741e68bb12b5a3eadc2e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0a3dbeaa252741fa82864c3f88132372_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i47b2810c0aee413597e8c1646426d086_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="idc6d4f12944242709bef7d5e0584395f_D20210812-20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="i2b3cf2b7fbad458882870ec7a0921f35_I20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-03</instant>
        </period>
    </context>
    <context id="if7c1af6fdd3b44f1934218a6f196c0a9_D20201203-20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-03</startDate>
            <endDate>2020-12-03</endDate>
        </period>
    </context>
    <context id="i06f2539eb1dc470b917574e5cba645f8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if911145c95344b73b7494ae283e29168_I20210717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-17</instant>
        </period>
    </context>
    <context id="ic6b43789844d4108be63a4a1dd1280fe_I20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="i97437c473f7b4c27959c7f3f98f911fe_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i8ae64a0ee64e4ca28a9e634159013ab3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5bb94ab329074f2382e57702aeb12464_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i7c2711a4ba7d4daeb3142e521b8d969d_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i404ec63c736d4d128bee727971bdc191_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i7fa0c457401141829a63813967411389_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i7700fd1bf3b64d08ab4b2725bcf11c2f_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ib46cc219b945454c99153f6a6c005bc1_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="if28ea4a9885e4a2aaccecc13941b21fc_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i40b1e6ac876c4f44be5287989b81b43c_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="ib2f0e560d0dd48aaa9c9a66d529db5b7_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i815ce043efb54a79a003ee84bccbc673_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i04e0a17bd91147bba817806801ea38d9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i9d7edea6bbe944938cf631118e7e0c24_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i786695c3c8824251b74d57413f2ab330_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i96bdc5d0996443d4bc99773608909bc1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7c239f7cb9ba4f119b5f6aac4be47c6f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f981237ad304136b3c2ae388a494f17_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i1ae704fbe3b04d318f47ec250c37e298_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic2d8d6b46e9d4decbb6a76ffd434ad18_D20190401-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mck:GlobalFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1c59a4ea805b47c08a95056ceb9c564e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iad7a2e6922f64cf3808e830fd554c3ff_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2cb808ca7946448095716d3e591aec2f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id447a2bd767645c7a12007233124425f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0d2b3d87c4114cc6b082a6eb3df4484b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8a6c7fc82394698afcdf83d11179f9a_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib56e9807d14242ab8a66d9df9e68b070_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2f41e21247ae4a519309d2ad4bff9441_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if83736112ca9462697b6ec54e87de910_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8b2f3b3bb37649189b90084615b5a308_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2faa1d1ed13a446eb975b380912a3068_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ec0851116374d82b9e49426d73763b6_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4c424200871342f38c9f8485d07949ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9a003a64326a491fb3ed09f382ba84b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8d6f450ac22e49d6bf0df50d025ae906_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i60c1e60e920e4d629a84b4eff86bead7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i493c2820033f44e2891698cc75e5d9f0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i90ce3eddb5fc4a9387c2b4a7e93476dd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i226a25479b7c46bf9d8ddd2a5bfcf119_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1718647e98904b358ee1e9de9b292eb9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mck:TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7d0132582b984b76ae285cf19ed5c7f6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2728f1fd9955493099bbd68893348eff_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic24a302cc95448b6895bf70aef816116_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ief082c01cc5e412cb6ff4de8ad61ca8d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8f84586bbdc64b9db37cbe7a0a6e91a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i24a81b323f944750ad86fa66047de210_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0c57f6243c3043139895c497e5082a6c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1feb4c8ee03c4ea8b76a8dec194384a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ice1db9b721a84b9a962dd773d56f5625_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i42493a65e37c41cd84bfc0a43dfbfcfd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i67a195a2dbc24ab0b3916b6c936b0a81_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i802adc56f209414fa2679958ea52481f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic2fc5f76445f4ccb949607a1612c1efb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie231571b70294eae9fa4e83ed3eeca65_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib7a4ddf8d6704a26b6c3d695218fd03f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ief335562064c476d87395446c7085794_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic376ec9b950641b1af873ef2748b3c7c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9b45db4fc0e645fb81133a5906dbd495_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie9f160bc0e164814a7383b997da65a5c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iecd0a0364703401aba0fda8a20e2d103_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3cd6515ad0894db092afa7fcc8fbef3c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1498edc5a78e460cb75dd394ce55f4bc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i51a450f02f814c13ad2c3e1a67df52db_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idf3513bbbfa54d83b35c2db60004594d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i98369f24f8ab4c2eb5f3e9a7ec1b1865_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3d18f2d389c34f889fe5b27bea6dedca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05e2be2f8d0b46c798249db103676c1e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i06830bb28fe54b568fbb0beb096d29c6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e437bd0e8ac42d1922f9d4c9b56a9e9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibeb6959cf5a342729ed17f01d0dd71ad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if25303d6a03249938b42bc7d3c1357bc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib82602c6601f4f45a4a7369ec1b8bf35_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic7ea8b4f7ef14653a641e807f4cd138a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i69cf84e558644557a7de95ff69e39200_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i549bcf1376444c1c96c41b62e0f53c13_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7992105cb65e4456891d27cc92f31f82_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6750d94d7246455fa05c465a0a2ce518_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icb4cdf5216e54e7d8f62bf705dc2eb7b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia3e73ea452a64d409c6a0144d7c8f775_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i789450adbe47425287cf59d8f464ddd4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib64b7c133d6d4fe4aacc658b24720e06_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8e7cc563acc44759bce119f8ce36a604_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1ebb6ae9dcdc495b9cc3c87d23f6cbec_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if1c239fdb13f450da87c6daa53922d8d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6c306b0e9f2f4c79a4da4e3080b6d89e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i21c7e2a081d5465796f47bd8606c00e9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5164fe963e2645c899da80d46fd4ae97_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e7649f7142e4c4b9a4814ec21eff4cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5572d95dce3c4525ac5872c923be80d8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ife0b53acf3404eb896235616da3a2829_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7038af880144a7ea84a73759de44134_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib9233f3fb62d4e2288e4195f2496e9d8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i198ca18f282b482093bc4dbc11845c9f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i53073f5452fd4d48a40ef1c67e4481ab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f7d7e52a71c45f191cff470e5e58900_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3049d1d278b041b182572ae407160d16_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idd607e6a67e34b6a80181cb19f672808_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i35d3c0a9434f43f4a185b11c84d8c084_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iec2db81a22674f35a3dca780612fa224_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a29ea5f47374404ba20c59dc7af27a8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i088530175de844cdb1ff52c1bae2e520_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iec69e1f822ee4fbca88f48124ec26c7c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i780bb7e3c18c4e2da57a59b5e8a82b8d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a603bd1125146b48426fed799546156_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7187fc49e8d94a85b667b111d6e5dc69_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib04278e26dd54ce48826dbc56cb31d0c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icee7ff1a301f4f4badf6de78d85f9ee7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia65b4babfea54b92be6fb935a4313666_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4a44775f82674797bf85d3b9a8a5ab4f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib359c5a79d704e0ebf9e432707a3b141_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7bc4364d89ca4d929d7940909184939c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i294bbf493f9b404bbff0579c52891b4a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i04db204508bd48ea9785a68185baa374_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibe2c94dcf99244b7b82fca2d408a16a4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iad63af957fc64549aee083f9cdee9453_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8ac275e02b8b48a39ec49c6224a2a136_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:FirstPartOfPayContributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i195f1f7208864f679b4d15f3687a5587_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:SecondPartOfPayContributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i81e084748f994c2b9dee394b47094c3f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8cbf8941d6b49f7a3fd6216544852e1_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i57a78699f72e4caaa49cdae2c1264ff9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia5c091f35bda4066898f44d7a15e739b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib3a2bce002414557a29e4f5c83a868f2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a394ed33cbc477aace60da23a0ce725_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3a9c80472fe146588b6eac8a58404290_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i24fdde78e96442cbafbef0fa22f902e4_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="icf83c6faa1c2418c96f6ef2cef6c1bcb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i808f703176d2404abd9b7793bf0a6599_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07635e9764bd408087acfd4f78ea3577_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5c98cdf793bc4ce48f4a0004d0a47ebc_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i22b34b6e8ced4d97b4d47ddb2965e898_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifaa55b6bf9f44cd1a8a25b42288d0593_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1f9cac9e86284785ab4d70600ae33ad6_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1fb5afe9d8f741d98516f86630f9a369_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4ca4b4a7511f40e5a9d3ef22dada90c7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ida89f12ac9244f9baa939ba550b7cf4c_I20200427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-27</instant>
        </period>
    </context>
    <context id="i0d147eb37a56481b848433e3e940585d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie2c39129d8ab4c4b9955fcd9310ac053_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e32714cfa934a93b4e7c425d1d050de_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i137f365a182943e796f2e1d55d814426_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6fb91758a04f4bacb9905307ab195623_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4542a21b25d543c4acc0fa4436d289e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i012c7ab6d6f04da38da0d95109115f5c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i024aefa502ee40d6b34f7f8368e3b55c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iff333b050afd48d9b90c24d10c24348a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7c57740209a940fa8dafc8433670f167_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i309ac7f13b444d0db3954863ad6e761c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i719adfe70a964eb882c96f1004d74bf8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2c355ddfeccf45afb84fc6d09c4cd44e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0e46135b9e374ad194e91da1167d2848_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9fa2453674034bfe8272f5598f29c014_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f221a3ec78445e79e65fa93472e8585_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia5e26180f2064b60a601613f3b0d3643_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0af94175dd994714a8a7faae0f0e5212_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iebb892ad00ab49ed8566342454fa928c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4989346074144770b6adc1234e579021_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNoncurrentAssetsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia70cd65a985648138af1f3c043a64290_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if507dc7fc59b47fea1f9ddc4fc902174_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibbe2788b715640b4b52cee7ba7637f83_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3508fc7db8ac40f1a7ea81409ab7678f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8840acf2e77d44af9a2a8cb81017cda9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i374b081d61104014bfe452acfb9cbcf4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3cb819d9d034281bc184dd6e2359115_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3fe727da0df047e9a85ea9962c4b400d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie9ec224cf4764392959e53320ef9a081_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i407dcd9fcbb146db960f9ded6cee8015_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i41d3f99f4a8e4b5aba1d005bdf779310_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0352fcb39b434a9cbd835b33a19c1e6d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i98c151bfae0f42a4b2ce4521c05e9acf_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7a8333254bac48c78da787f6e428f9aa_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibfe76b97b0b24598b07f33f5ca016907_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i77cf6c86ae8c46a682b412b3e0abac24_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2934427a7be2467d8b52f822c45c8593_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i60f79f2c96f24d718707c887c792a696_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f60f777e8754ae3b0d798ac833ac49f_I20220225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-25</instant>
        </period>
    </context>
    <context id="i8ee8208665914ed2bf9222d6977c182f_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i4f7c4180c7d349cdad921bd625aef19c_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="if5f3b6a5a5224458ab102b9be37642c2_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i1ef52d9fd4b04fa4ade734933f7afdc0_I20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-02</instant>
        </period>
    </context>
    <context id="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-02</startDate>
            <endDate>2022-04-02</endDate>
        </period>
    </context>
    <context id="i83583bb4d9614c5fa83041c913ae479e_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="ie97b0337408f4e61a2e9c5103e016421_I20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="i4e30da8843dc43c9ad33ff55a33b1d77_D20220503-20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWashingtonAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="i4662a32533444a67872a829f9f186342_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="ibb1ba0d32bc5422d928acee1595764cd_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i3baef44f3b9f46039f19cbc1c9ac553f_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i0753823b559c4b249d5e8a0ea960fe6e_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i9b2d108c832a4b15b42ef645fcac9c15_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="ic52a333760c648e4b96056ff25230e21_I20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="i04c16ab737af40eb8c59705ef1b73c45_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i272671062b484a64b905316d40d3ac81_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0eeabc6ce6174d6d914bf4b541540d89_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i71cd8720173a496486279e0544a6abce_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic7cf3ce788524e9fb74bf1ade9cde623_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i12913f42c838424a97ff6d451699968c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f2b5de2b7964c299fe4538bbce99201_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6f1569fe7f254494bbcf927a0376e97c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2743565c13d0440d9c782b3823bb2dbc_D20190225-20190225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-25</startDate>
            <endDate>2019-02-25</endDate>
        </period>
    </context>
    <context id="i987dad20a95b4cbdb8b7627a6eaa19cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9fa583f3ec4d43c39a9e06debe72ee55_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i66664fd861c54faf85787d6861f4bd01_I20201023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="if6a7e381cd664bfead2365a491df4db8_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i349cf2789de1486e908e9763803d4227_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i14a8cc9bca31458291c36a5f215ed0bb_I20190813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="ia7b18f283c214a63941ca5f3aa2f1ba3_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <context id="i1141187871d64de6b18824ede60c2f14_D20130416-20130416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-16</startDate>
            <endDate>2013-04-16</endDate>
        </period>
    </context>
    <context id="i14ac6ad34bca4c4691038eca05b20788_D20180403-20180403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-03</startDate>
            <endDate>2018-04-03</endDate>
        </period>
    </context>
    <context id="i272a1d83ed104933bc5777159d6a279b_I20180403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-03</instant>
        </period>
    </context>
    <context id="i3ca99d687e7a44bf9addf006fbd8fc6c_I20181212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-12</instant>
        </period>
    </context>
    <context id="i7c871b75f43643cab2812bfd524754ec_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i3ad0b32109f349168507a51c296e9f4a_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i7e8e9b14a1e24dbd9dd4da9e2e12f251_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ConsolidatedActionsvSureScriptsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id85d07627aee4db8896b725c019fcc18_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i72b34df8ae41427db43c35ab86ae900b_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if0191e84fbf046f1bf6fa863cb4e56bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice2a4f3691c84bacb13e16b89ee569b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic33eab4418d04068bfb2c3d091c51f4a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icb6786f86e4c4e6d8af02b607fd8f48b_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4c08dc9e360548f496960579d4795f54_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i28c6e70168da414cb0ac4e9c64318d06_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i1f5d39fcc93f468db79dbc8f03cfc331_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1b7452f966eb4322aa52d896f745263f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i38e0059bd2b14949ab11b259c08962df_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia8ce6232f2024c3c85f71080415b78ce_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2e181f7f03474d17a658711503e83555_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1af057e14a6c4a569ffbf7f13a871e72_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i29c6f6a5ff29462b9d28c777bd2bd274_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7ad4ab28ad0e4703b8f21cbc668994aa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaa805c2e2cb74e2fb138905ae2d6aeb5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i341fc51538c24926bae5c478238735ef_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i85cd2ff97d53454f89e0a9769c6b9cdc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5a18c76ff5b34fad9b94fc6bc03eeab7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iec5e0ac198fc4744ac896c1d7596fdf5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icda474b56c3e4aa1a24ed971c975e0f8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idd07866af62b438392a2793d370d5438_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9064356341ec491b885a59f02c3152b5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5deabb24d12941e896a4e688121d8f30_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9922f80e4f24738b404cca8c87f73bd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7fff78ca4ca84ca68f9917ec5e4784fe_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie93e1536edc94513a25b75692a412434_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i073988a4a0ef43228b2f01d389f330b2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icbf8232e206747f2be913302ec5dbaaf_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia70ab04be4fc4669bf6269d283c9c79e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i91df3cbe60584b50a204d33eeeed8980_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iaf9c8554b2fb4c5fbdc95411f1908eac_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6b2b0cbe0ef24d20b15b7f972083020e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i887ec05b39874d2c8d43dc5b0c6812aa_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8df6b8d2453344e9a3d64c0a536c0e26_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0992fb1791f946ecaadfede91d31d6cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5cf29ddb5c8f42deb929d1d83dbc572f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i75e9915b20bd46ef92252fc1f54b6842_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4014e9c3176b42c78989359017baa154_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7babc476db874b4b8550fefdfe333525_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3b1bc5bf2b154cf2933d838b8ed000b3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7c2308bff3d84467bbd32719c1b729f3_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4306427a0c8f4e4f9a6abfe8b834d477_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iecf1fc43ee8743cc841ae8e190b19f5e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d32ea0d7121424d8050da60bae6313b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i02266411b5ae476685c7f46474a2bc26_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0a61358af12d408d98a32edf22828df2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i57862e2d41134adab208bb4e37e2f526_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i421693f2ac6f4634892f8037573c7473_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i98dde87c16b848c5b435a117b3bcaa0b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia363f8f9a4de48ca805cfea21f6c1846_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i38c0b8cc6cdd4e5a87c08c8347fa83db_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibb4a025d54cc4e119f9bdcce62a65384_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4f92dd395054c9e87369fe7c7e30c52_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3667722556cc48a986ac133abdb684ef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2ded543679294c96804c2f7f25ea7ef1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i40175ec1fccc491fb2cbcd0cf1e19dc5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i41829b0d50c84e67810fffe88435a9df_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0016a42d06144f0083c43e8c3861007f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ief597acca9b943b499ca2cd3b523d72a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i985cb718c86e4ef0866b20d0c5f9ba59_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i25f4961dbfe344bc8e2f41bae9d5131f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iedade147b8b646c8b00bbb5188244496_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i93c1bd212c45448698e1854f6e5f1080_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i48eb2bbbe76d4424947b05d6ff6b3111_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if99beb6352cf47479de57c9883cab9b5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i73f4dc77fae347c3949ca450f0bd6c27_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib560e861e6d44cc1bc5d64c84ed65be5_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i14b84c6208fd487782c55ab942c054c2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i13224b1cb34e43ea9f7419286f4e4d8a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib32eb06e34414e3699858d846e951a74_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="participant">
        <measure>mck:participant</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="product">
        <measure>mck:product</measure>
    </unit>
    <unit id="installment">
        <measure>mck:installment</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="complaint">
        <measure>mck:complaint</measure>
    </unit>
    <unit id="relator">
        <measure>mck:relator</measure>
    </unit>
    <unit id="faxnumber">
        <measure>mck:faxNumber</measure>
    </unit>
    <unit id="fax">
        <measure>mck:fax</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="defendant">
        <measure>mck:defendant</measure>
    </unit>
    <unit id="city">
        <measure>mck:city</measure>
    </unit>
    <unit id="officer">
        <measure>mck:officer</measure>
    </unit>
    <unit id="softwareproduct">
        <measure>mck:softwareProduct</measure>
    </unit>
    <unit id="site">
        <measure>mck:site</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV8zLTItMS0xLTY3NTEy_e444f33a-b7fa-4d95-ab10-1d29f0aff172">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV80LTItMS0xLTY3NTEy_4fb4110c-37e7-4fe0-bae9-dc04cba116ce">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV80LTItMS0xLTY3NTEy_88006d8d-10eb-40d4-8c70-d3c31bf331f1">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV81LTItMS0xLTY3NTEy_ef86f3a6-4c96-4d8f-a152-ad0822c1f61c">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV82LTItMS0xLTY3NTEy_3819a34a-a937-4719-85dd-b6b32421ea54">2022</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV80L2ZyYWc6ZjExMmVlNDM1MjM3NDdlYzhlMDIzZGRhN2Q0MDEzODMvdGFibGU6ODVlYTA2YzgwNWQ5NDExYmEyNjdhZjAwNTQ3ODYwZTEvdGFibGVyYW5nZTo4NWVhMDZjODA1ZDk0MTFiYTI2N2FmMDA1NDc4NjBlMV83LTItMS0xLTY3NTEy_bc83a56b-7ab0-476d-8cd4-e739a9b06553">false</dei:AmendmentFlag>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i975f1db8bccf423181a945e065415fff_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i92ca8c27ec4649008fa3211cb422f720_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i430c0a72e23b438a8649c6275316dac5_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id75ca3120774435ca04f05387924ec80_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODE_2c540d8b-dc0c-4d2c-842e-9bfd3840f523">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i95419da414bb4ab191a0c6bdfc3acda0_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529">P5Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <mck:GuarantorObligationsPeriod
      contextRef="i0352fcb39b434a9cbd835b33a19c1e6d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDA_c483e2c9-dff3-4b92-bc09-7d0567550317">P1Y</mck:GuarantorObligationsPeriod>
    <mck:GuarantorObligationsPeriod
      contextRef="i7a8333254bac48c78da787f6e428f9aa_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTI_c01062b2-22fa-48c8-ab15-ad2d5e0ffc41">P1Y</mck:GuarantorObligationsPeriod>
    <dei:DocumentType
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgw_3452fba0-26e0-4cc7-a442-ff94dfecf3da">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6ZmQyOWVjOTlmMDY1NDRmNGFkOTJjZjYzNWY0MWNkOWQvdGFibGVyYW5nZTpmZDI5ZWM5OWYwNjU0NGY0YWQ5MmNmNjM1ZjQxY2Q5ZF8wLTAtMS0xLTY3NTEy_64e0d364-0ba7-4430-a387-5c2ff97538ab">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6NjNhYTNkZGQ3ZTNiNDllN2EyNjc5ZGEwODAyMTRiZTEvdGFibGVyYW5nZTo2M2FhM2RkZDdlM2I0OWU3YTI2NzlkYTA4MDIxNGJlMV8wLTAtMS0xLTY3NTEy_64f8a5fc-1660-454b-b2dc-bc866543a132">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTkx_781f42d9-6045-422f-82f7-76b6880851f1">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgy_2de66835-c278-4759-b3d7-9d17b2ac4d71">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6NDFlNTllZGFlMmU0NDAxY2I3YTFkOGI5NjgyMjg4NjQvdGFibGVyYW5nZTo0MWU1OWVkYWUyZTQ0MDFjYjdhMWQ4Yjk2ODIyODg2NF8wLTAtMS0xLTY3NTEy_165aac78-846a-41fb-8981-6936348dab1d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6NDFlNTllZGFlMmU0NDAxY2I3YTFkOGI5NjgyMjg4NjQvdGFibGVyYW5nZTo0MWU1OWVkYWUyZTQ0MDFjYjdhMWQ4Yjk2ODIyODg2NF8wLTItMS0xLTY3NTEy_c26217d9-6d7e-4997-abec-6762e2cc8c07">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTky_61c840c2-a142-4b1c-b969-51ffe9e08885">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTkz_166632e9-6960-4be4-b7eb-17ca45b65aeb">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTk0_cefe9836-d3ca-4639-9d01-409581634d2c">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg2_c0dbbdc5-8103-480a-8df2-a34b6fc0d497">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg3_3d3bf180-c289-4186-bfa8-8a18808d7074">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgz_849606aa-b5a0-4b9a-87ba-0308cee47bef">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8xLTAtMS0xLTY3NTEy_65bf1773-e530-443a-8315-06e4259acd3b">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8xLTEtMS0xLTY3NTEy_c0f27736-5048-437b-923d-cf4df0b7833e">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7b96719b3fc240aeb27d26533f63319d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8xLTItMS0xLTY3NTEy_5aaed74e-e153-485f-90c1-d37f85672b93">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8zLTAtMS0xLTY3NTEy_bceaba6c-9529-476d-b106-b456cb129aa1">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8zLTEtMS0xLTY3NTEy_213de9d0-9ebf-4833-be48-19b5020b2465">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id87229675bdd40af8e57f8dec6e19020_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF8zLTItMS0xLTY3NTEy_2a38097e-e7d1-42a1-ba00-aca8137ac02b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF80LTAtMS0xLTY3NTEy_f3b9cd6e-bc86-489b-9c37-4589a12dba52">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF80LTEtMS0xLTY3NTEy_b05c00a6-420c-44d8-9b5d-b282109ab105">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3fff7f1231194d829b259df2f39e40c0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF80LTItMS0xLTY3NTEy_9f08e4e6-5c4f-4ee3-a0f4-4ef9b2e0fe60">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF81LTAtMS0xLTY3NTEy_97b7b546-7457-42b9-a40e-1fc9513dc132">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF81LTEtMS0xLTY3NTEy_75d3421b-b607-49e6-bb29-b84a0a890e4a">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8f6a60fc4cc94eae8478df4fcbfe822b_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6N2E3NTViOWRlNTliNDZhN2FhZGU3Mzg2YjI2MzU5MDAvdGFibGVyYW5nZTo3YTc1NWI5ZGU1OWI0NmE3YWFkZTczODZiMjYzNTkwMF81LTItMS0xLTY3NTEy_60586485-a18a-4e7f-967e-f010cc645c21">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTgx_8ab2d9a7-e963-4476-952a-a6cc94f13a91">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg4_c94fde65-b260-4799-80eb-193375cf429c">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg5_14fe1338-927f-4165-abba-612406e815ae">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg0_cd4b31bd-5105-4ad1-9c38-c2a94260c73a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6OTQzZDNlYTc1NzAwNDI5Yzk5MTZkNmUzNTMwYjQ0N2MvdGFibGVyYW5nZTo5NDNkM2VhNzU3MDA0MjljOTkxNmQ2ZTM1MzBiNDQ3Y18wLTAtMS0xLTY3NTEy_48e02f68-489e-4a1f-b22b-85edf9605e0b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6OTQzZDNlYTc1NzAwNDI5Yzk5MTZkNmUzNTMwYjQ0N2MvdGFibGVyYW5nZTo5NDNkM2VhNzU3MDA0MjljOTkxNmQ2ZTM1MzBiNDQ3Y18xLTYtMS0xLTY3NTEy_9dd0a7d4-ea0a-4159-9dbf-31c193acb4e1">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGFibGU6OTQzZDNlYTc1NzAwNDI5Yzk5MTZkNmUzNTMwYjQ0N2MvdGFibGVyYW5nZTo5NDNkM2VhNzU3MDA0MjljOTkxNmQ2ZTM1MzBiNDQ3Y18yLTYtMS0xLTY3NTEy_50556989-4979-4220-a572-d39f56a0aa47">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTg1_8de452cc-d218-4be1-9030-8798524e1634">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTk1_b8de0133-ec03-42f9-ad11-ccfe68c3d250">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i7e45aeb91b9541c99e6059f70915b672_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8xNjQ5MjY3NDQ1MjE5_adbe7b67-77fc-422a-9d99-9c44848428a4"
      unitRef="usd">30400000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i67fe817fe4174122acfb22089bd77bb2_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8xNjQ5MjY3NDQ1MjI5_d7d62342-a579-4ac4-96cc-2d7cbadb0c30"
      unitRef="shares">145365324</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xL2ZyYWc6YzFmOGY1MDZiZWM1NDliOWI1NjcwYzAwZmZkMWI5Y2QvdGV4dHJlZ2lvbjpjMWY4ZjUwNmJlYzU0OWI5YjU2NzBjMDBmZmQxYjljZF8zMTkw_210faaad-e2ef-4e4f-9b12-6462feac8715">DOCUMENTS INCORPORATED BY REFERENCEPortions of the registrant&#x2019;s Proxy Statement for its 2022 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV84OC9mcmFnOjczNTUwNWI5YzhjMDQxZGNhNDhhZDAyYjRjZTM4MTQ0L3RhYmxlOjU1YjkwMzY2ZGFhODQ0ODBiNDhiZWFiOWQ1MDRlY2JjL3RhYmxlcmFuZ2U6NTViOTAzNjZkYWE4NDQ4MGI0OGJlYWI5ZDUwNGVjYmNfMS0wLTEtMS0xMTQwMDUvdGV4dHJlZ2lvbjo3NTYxMGQwZWQzMjY0NGFjODBkNDYxZDM4NTNmNzJmZl8xMDk5NTExNjI3ODI3_12e990ed-5ce9-4b2a-8762-20631b9798c9">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV84OC9mcmFnOjczNTUwNWI5YzhjMDQxZGNhNDhhZDAyYjRjZTM4MTQ0L3RhYmxlOjU1YjkwMzY2ZGFhODQ0ODBiNDhiZWFiOWQ1MDRlY2JjL3RhYmxlcmFuZ2U6NTViOTAzNjZkYWE4NDQ4MGI0OGJlYWI5ZDUwNGVjYmNfMi0wLTEtMS0xMTYxOTAvdGV4dHJlZ2lvbjo1MzhkYTc4ZGJhMTk0ZTJlOWZiNjlmNDg5MTY1NDg2Yl8xMDk5NTExNjI3ODA2_d2060ae4-df76-4cbc-9699-a3836612f22d">Dallas, Texas</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMi0xLTEtMS02NzUxMg_b9a941c8-8b60-4f6d-ba3a-fe5e6c68f590"
      unitRef="usd">263966000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMi0zLTEtMS02NzUxMg_d0ee2eb6-4648-4b00-871d-039387870058"
      unitRef="usd">238228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMi01LTEtMS02NzUxMg_c7663d06-67f1-4146-bd13-5a149918cd25"
      unitRef="usd">231051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMy0xLTEtMS02NzUxMg_2d9fa583-4277-4818-8f2f-92fb6c88b56f"
      unitRef="usd">250836000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMy0zLTEtMS02NzUxMg_d1d1fe69-702d-4971-8feb-f2ff661ebee3"
      unitRef="usd">226080000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMy01LTEtMS02NzUxMg_057d9904-510d-4ffe-89fc-3245cee81bb9"
      unitRef="usd">219028000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNC0xLTEtMS02NzUxMg_6952c2ea-a31e-48cf-9945-06f1a5fc01b7"
      unitRef="usd">13130000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNC0zLTEtMS02NzUxMg_ef380361-1664-4920-924d-7929ca5e608a"
      unitRef="usd">12148000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNC01LTEtMS02NzUxMg_4362c69a-bea0-493b-b0fe-06c1b7152c51"
      unitRef="usd">12023000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNi0xLTEtMS02NzUxMg_daf41ea2-2acf-4bdc-9117-440e99491d4f"
      unitRef="usd">10537000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNi0zLTEtMS02NzUxMg_327005c0-866e-401c-9231-b7981668553c"
      unitRef="usd">8849000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNi01LTEtMS02NzUxMg_751a2e86-c9f5-474d-ad0c-bfcbd2fc5190"
      unitRef="usd">9182000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNy0xLTEtMS02NzUxMg_1ffd150f-1192-41eb-8e61-dad7ef120460"
      unitRef="usd">-274000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNy0zLTEtMS02NzUxMg_2ab43854-e62c-4c27-919f-3fe8c66881bd"
      unitRef="usd">-7936000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfNy01LTEtMS02NzUxMg_dadc9af0-d9f4-4ce1-9765-509a934f675b"
      unitRef="usd">-82000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOC0xLTEtMS02NzUxMg_c90d2450-487e-427a-8792-a82e63c1879f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOC0zLTEtMS02NzUxMg_287afff0-8f4e-4031-88e6-10f2a38d46f5"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOC01LTEtMS02NzUxMg_a1880056-17aa-4974-b151-4223f55f925e"
      unitRef="usd">2000000</us-gaap:GoodwillImpairmentLoss>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOS0xLTEtMS02NzUxMg_a059a6cb-81cd-4d03-850e-8ed14ff972ec"
      unitRef="usd">281000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOS0zLTEtMS02NzUxMg_7c8ac650-d29e-4c2a-a597-6067153e71fa"
      unitRef="usd">334000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfOS01LTEtMS02NzUxMg_7bc20250-d9d7-48de-aa33-6f5591411930"
      unitRef="usd">268000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:OperatingExpenses
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTItMS0xLTEtNjc1MTI_1691d8a9-1fb1-47a2-adce-3afd3a93938e"
      unitRef="usd">11092000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTItMy0xLTEtNjc1MTI_22498174-5d45-46f5-8ca3-4cbf376f5fc1"
      unitRef="usd">17188000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTItNS0xLTEtNjc1MTI_f6e0d7ee-7204-4abc-8d76-59a7848d66ed"
      unitRef="usd">9534000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTMtMS0xLTEtNjc1MTI_d3aa54e6-3633-4db9-97a5-e219a29085ed"
      unitRef="usd">2038000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTMtMy0xLTEtNjc1MTI_2623e02d-4096-4218-8e94-e96116e1b3fe"
      unitRef="usd">-5040000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTMtNS0xLTEtNjc1MTI_d5c7ba30-faef-4435-ad89-621999a51004"
      unitRef="usd">2489000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTQtMS0xLTEtNjc1MTI_c9e0f51b-52e9-4d0a-a670-2b46707044f9"
      unitRef="usd">259000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTQtMy0xLTEtNjc1MTI_d5200a52-43e9-420b-981c-032a52dc6a95"
      unitRef="usd">223000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTQtNS0xLTEtNjc1MTI_ba049949-f7fe-4bef-bfa9-07e9e6b0c2bd"
      unitRef="usd">12000000</us-gaap:NonoperatingIncomeExpense>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTUtMS0xLTEtNjc1MTI_6383b927-5085-46f9-a0ec-bec0ae65b02f"
      unitRef="usd">0</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTUtMy0xLTEtNjc1MTI_319e1d4a-bf3e-4027-b5cd-bdde6b234654"
      unitRef="usd">0</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTUtNS0xLTEtNjc1MTI_d1e52688-b106-477b-9bcb-1392c1c925e7"
      unitRef="usd">-1108000000</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTYtMS0xLTEtNjc1MTI_eca20904-4fe8-4216-8216-84a3254501df"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTYtMy0xLTEtNjc1MTI_a6baa461-d835-4db6-9d43-3d82f90d7429"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTYtNS0xLTEtNjc1MTI_b6a60aba-1cdd-456d-ab1e-c85e7f11812f"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTctMS0xLTEtNjc1MTI_b3b169e5-e9da-40ae-93a0-f4b225b6aa28"
      unitRef="usd">178000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTctMy0xLTEtNjc1MTI_81e93428-57a5-4e0c-838e-2c3a7550adab"
      unitRef="usd">217000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTctNS0xLTEtNjc1MTI_0206cf1e-3ade-45e1-9c40-7f30c0ff34c4"
      unitRef="usd">249000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTgtMS0xLTEtNjc1MTI_cf053e6d-c510-48a0-84e0-d08b05b53dec"
      unitRef="usd">1928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTgtMy0xLTEtNjc1MTI_b389c6f5-ab97-454b-991b-073160dd741d"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTgtNS0xLTEtNjc1MTI_08584e98-2f41-4442-9662-0b085980533f"
      unitRef="usd">1144000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTktMS0xLTEtNjc1MTI_f7b5bb0f-c729-4634-966b-04fd5173a812"
      unitRef="usd">636000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTktMy0xLTEtNjc1MTI_3bce8f66-c8f2-4413-b7c4-48fbc783caf3"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMTktNS0xLTEtNjc1MTI_1209dd7f-852e-4ef3-b160-6ffcb58becc5"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjAtMS0xLTEtNjc1MTI_d5df88bb-5001-4174-bbf3-1139c33053ab"
      unitRef="usd">1292000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjAtMy0xLTEtNjc1MTI_e1035e63-9691-490f-84b4-1a541ad2d55d"
      unitRef="usd">-4339000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjAtNS0xLTEtNjc1MTI_98615732-93e4-4c1b-aad4-9c213b8bda52"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjEtMS0xLTEtNjc1MTI_5908d99c-5ad3-4472-9eae-8c84d175df59"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjEtMy0xLTEtNjc1MTI_7b2542d6-30a0-4dba-afed-059a26b3e6d1"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjEtNS0xLTEtNjc1MTI_6fcabd47-1cf4-4a5f-aeb3-148d571e8b22"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjItMS0xLTEtNjc1MTI_23cc31a9-0f5a-45da-b562-4e523dd76b97"
      unitRef="usd">1287000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjItMy0xLTEtNjc1MTI_03afa165-f0fd-4044-a28f-2180c98c9514"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjItNS0xLTEtNjc1MTI_fe4edbd7-46c6-4ad7-be64-d1b4923ed58f"
      unitRef="usd">1120000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjMtMS0xLTEtNjc1MTI_3b0479bf-2592-4706-b0ff-5ca57b0e70ba"
      unitRef="usd">173000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjMtMy0xLTEtNjc1MTI_8cb72bde-a3b9-4f01-85aa-f0a2b247410d"
      unitRef="usd">199000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjMtNS0xLTEtNjc1MTI_670286f2-5a49-4eea-b466-d7882a3a78e4"
      unitRef="usd">220000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjQtMS0xLTEtNjc1MTI_ae5b2455-5694-4f7f-b16f-54cd14798a22"
      unitRef="usd">1114000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjQtMy0xLTEtNjc1MTI_8655abfc-f229-4127-a7f7-d3a4f2b90b78"
      unitRef="usd">-4539000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjQtNS0xLTEtNjc1MTI_d8fc8e96-6d4b-4d2e-b6da-6fb42c7f9140"
      unitRef="usd">900000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjgtMS0xLTEtNjc1MTI_1bbb08f1-8e03-4947-b42e-c0364bcc8137"
      unitRef="usdPerShare">7.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjgtMy0xLTEtNjc1MTI_1c31b788-4b28-47a7-91fc-92d05d1a51bb"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjgtNS0xLTEtNjc1MTI_204ce099-ee6b-4861-9f39-b3e3357442eb"
      unitRef="usdPerShare">4.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjktMS0xLTEtNjc1MTI_cc41b691-0122-4e36-b51a-020a3e1f4a4e"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjktMy0xLTEtNjc1MTI_67ab49ae-42f3-441c-8bd3-8997bcbf30a3"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMjktNS0xLTEtNjc1MTI_2d3f6a7f-da1c-4d28-b592-cb5068bd4662"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzAtMS0xLTEtNjc1MTI_dd2cffc7-9e09-4a83-adc1-2581dd99bf68"
      unitRef="usdPerShare">7.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzAtMy0xLTEtNjc1MTI_c6c9f7b3-1fb8-472a-917d-4298fd0c05d5"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzAtNS0xLTEtNjc1MTI_e2a07f9a-72f9-4d15-ab56-4c59def88d0f"
      unitRef="usdPerShare">4.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzItMS0xLTEtNjc1MTI_575b8eee-6745-45e8-bcee-0b789a41f80b"
      unitRef="usdPerShare">7.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzItMy0xLTEtNjc1MTI_b82602df-a582-42fd-b94f-1f3c2861fb27"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzItNS0xLTEtNjc1MTI_a0106c85-c03d-4555-85f5-b791fbddb0b5"
      unitRef="usdPerShare">5.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzMtMS0xLTEtNjc1MTI_50597ce1-79dd-4bc1-9805-c37b8aca8635"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzMtMy0xLTEtNjc1MTI_15c115ae-8c1a-4a5a-99b0-6303f42213a6"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzMtNS0xLTEtNjc1MTI_1f63acd6-b370-4ad3-84c6-9140fe1252f1"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzQtMS0xLTEtNjc1MTI_ebfc9553-eb37-4e07-aaa5-d85c16314436"
      unitRef="usdPerShare">7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzQtMy0xLTEtNjc1MTI_e1f3468b-244f-42b4-9528-e642efaffa8f"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzQtNS0xLTEtNjc1MTI_81c1f699-0deb-4376-97ae-c9bc94b56e74"
      unitRef="usdPerShare">4.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzctMS0xLTEtNjc1MTI_5adb72aa-ada8-4d73-a7aa-22d1ab11d7dd"
      unitRef="shares">154100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzctMy0xLTEtNjc1MTI_9dcbc3e3-2210-470f-8cab-38bef81a40cc"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzctNS0xLTEtNjc1MTI_658d8a87-ecdd-4c1c-82b2-99796e343097"
      unitRef="shares">181600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzgtMS0xLTEtNjc1MTI_ea20c6dd-3eed-4a48-abc5-7bbfbd68741f"
      unitRef="shares">152300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzgtMy0xLTEtNjc1MTI_5aaa2018-e06a-446c-a288-18b84ee40d5c"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85MS9mcmFnOmIyNjMyNGMwNDI2YTRlMGFhNmNhZWRkMWY3M2RlYmQ1L3RhYmxlOjEyNzkxZDIwMzIwOTRlZjRiNTE2NjRlNjU1NDc4N2MxL3RhYmxlcmFuZ2U6MTI3OTFkMjAzMjA5NGVmNGI1MTY2NGU2NTU0Nzg3YzFfMzgtNS0xLTEtNjc1MTI_a549191c-1310-4fcb-9066-43ac3bf3c071"
      unitRef="shares">180600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMi0xLTEtMS02NzUxMg_a76d9fdd-f276-47f8-968b-9e1f7fa9639f"
      unitRef="usd">1287000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMi0zLTEtMS02NzUxMg_5934a6e2-eb06-4cc0-917f-9caaf546530f"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMi01LTEtMS02NzUxMg_c6cf5c3e-f049-46c1-923f-3b591aacbf86"
      unitRef="usd">1120000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNS0xLTEtMS02NzUxMg_b1c2079f-2401-433c-ac37-d80f203ed8b2"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNS0zLTEtMS02NzUxMg_4daca2f1-8e0a-42bc-852d-c481bd7504bd"
      unitRef="usd">184000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNS01LTEtMS02NzUxMg_b8f7f940-a544-442c-aadd-c7666290c0c6"
      unitRef="usd">-66000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNi0xLTEtMS02NzUxMg_8af5c32f-b782-4395-ab2d-36318e3e2922"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNi0zLTEtMS02NzUxMg_cb04d009-9741-4b33-b6ec-278e680c21a6"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNi01LTEtMS02NzUxMg_142f8690-4b76-42d0-8e88-4380ce9852c8"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNy0xLTEtMS02NzUxMg_fce84eaa-4116-4520-b193-d9fcd78bbef7"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNy0zLTEtMS02NzUxMg_110ddb2b-cb94-42fb-8808-9ffb93276877"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfNy01LTEtMS02NzUxMg_ed5842f3-6d85-45b3-9343-e31daa7da945"
      unitRef="usd">-129000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfOC0xLTEtMS02NzUxMg_50afb0c7-3535-4410-ab90-7f7b17893add"
      unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfOC0zLTEtMS02NzUxMg_31a76a0e-ff85-48d7-9695-1730cae51925"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfOC01LTEtMS02NzUxMg_32996de9-4c48-4232-84f3-775da102bdbe"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTAtMS0xLTEtNjc1MTI_c69baffa-79cb-462a-b440-5e3d34a55e43"
      unitRef="usd">1402000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTAtMy0xLTEtNjc1MTI_ae97db77-4a16-4dd8-8139-b97897dfc6d9"
      unitRef="usd">-4170000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTAtNS0xLTEtNjc1MTI_c0014569-b6dc-4dcf-85b5-611d0893cca7"
      unitRef="usd">1269000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTEtMS0xLTEtNjc1MTI_173d1629-fac5-4ae4-a148-79fdee327295"
      unitRef="usd">172000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTEtMy0xLTEtNjc1MTI_6d1dad82-2a01-4b30-8a95-b7b8ba07e7d6"
      unitRef="usd">146000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTEtNS0xLTEtNjc1MTI_36e2f512-9b8c-412d-a14e-5c7bbef85c05"
      unitRef="usd">223000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTItMS0xLTEtNjc1MTI_f1d5f1ec-fb41-4a0b-ba42-986929f067b3"
      unitRef="usd">1230000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTItMy0xLTEtNjc1MTI_6306e91f-9995-4041-b07f-219a93ee18ca"
      unitRef="usd">-4316000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85NC9mcmFnOjNkYmFlZGVhMGZiNDQxY2ZhNjUwYWRjNjJmOTM2NDU3L3RhYmxlOjNiMjBlZjczMjYwYTQzNWM4ZWVjZGI1N2E3NDgzNGQ0L3RhYmxlcmFuZ2U6M2IyMGVmNzMyNjBhNDM1YzhlZWNkYjU3YTc0ODM0ZDRfMTItNS0xLTEtNjc1MTI_cfc38f1f-3e72-4234-86cd-51bf2eea6060"
      unitRef="usd">1046000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNC0xLTEtMS02NzUxMg_ed0b658d-813a-4101-bea5-ed17d5219c4f"
      unitRef="usd">3532000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNC0zLTEtMS02NzUxMg_bd716556-4b7f-4a27-84bb-5e687504f5d9"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNS0xLTEtMS02NzUxMg_5b599570-dc36-4536-9afe-844c562d5d71"
      unitRef="usd">18583000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNS0zLTEtMS02NzUxMg_96a3cf94-6abf-4d18-ab60-6d6dcd97cd6a"
      unitRef="usd">19181000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNi0xLTEtMS02NzUxMg_d1f40b1d-3986-4c41-bd52-8775d6df7c0a"
      unitRef="usd">18702000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNi0zLTEtMS02NzUxMg_3fa014fb-0ba9-4a4b-83e2-ed44e4298901"
      unitRef="usd">19246000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNy0xLTEtMS02NzUxMg_70b640ff-6f61-42e6-b412-b0223eb11c23"
      unitRef="usd">4516000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNy0zLTEtMS02NzUxMg_5d9fe5f9-3894-4ba2-8e4a-71a3a2a9db95"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOC0xLTEtMS02NzUxMg_3e1344b3-13ea-452c-a3c5-981c59c73a55"
      unitRef="usd">898000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOC0zLTEtMS02NzUxMg_8685530c-99ae-4378-b510-9f3160e6a606"
      unitRef="usd">665000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOS0xLTEtMS02NzUxMg_44fb5b14-5034-4573-a166-78a2ea7641a0"
      unitRef="usd">46231000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfOS0zLTEtMS02NzUxMg_ceef8209-d5d7-48f9-b524-4e8020dfe037"
      unitRef="usd">45382000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTAtMS0xLTEtNjc1MTI_c86b5852-7a69-44ad-8823-005379ab57d8"
      unitRef="usd">2092000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTAtMy0xLTEtNjc1MTI_2877babc-e259-462e-add3-8c2e658090f9"
      unitRef="usd">2581000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTEtMS0xLTEtNjc1MTI_73651e29-7625-438f-a437-8952dd1a9315"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTEtMy0xLTEtNjc1MTI_39807d14-7c0e-4127-9f35-57d98915a52c"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTItMS0xLTEtNjc1MTI_200bd1cb-dfe0-416c-b48a-a3c9443772de"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTItMy0xLTEtNjc1MTI_c0d5fbfa-2dcb-4906-9c76-feff2db0bf65"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTMtMS0xLTEtNjc1MTI_5e4d3156-33d9-44c9-b7a7-aee34a4464c2"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTMtMy0xLTEtNjc1MTI_96103e37-1146-417b-9e28-54132ca0ecbe"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTQtMS0xLTEtNjc1MTI_73f1d133-9dd8-4ee6-ae89-75a03e435d8d"
      unitRef="usd">1917000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTQtMy0xLTEtNjc1MTI_680e7760-198e-433c-b7e0-12b768716f5d"
      unitRef="usd">2581000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTUtMS0xLTEtNjc1MTI_080a1441-88af-40dc-b5bc-e5c246531b97"
      unitRef="usd">63298000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTUtMy0xLTEtNjc1MTI_62966732-7c72-4d02-a54d-f5833c2463d0"
      unitRef="usd">65015000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTgtMS0xLTEtNjc1MTI_133855b9-679a-410a-9738-314e34bc6cad"
      unitRef="usd">38086000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMTgtMy0xLTEtNjc1MTI_8a61a7e6-5012-4642-bf2d-a747abd10ef6"
      unitRef="usd">38975000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjAtMS0xLTEtNjc1MTI_4dc80089-6229-4130-b92a-def1f22e6c13"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjAtMy0xLTEtNjc1MTI_101c24e8-d85d-42fe-95b7-ca64d2fcd947"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjEtMS0xLTEtNjc1MTI_4500944e-bdca-4b0e-9ddd-e729d61389ae"
      unitRef="usd">297000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjEtMy0xLTEtNjc1MTI_58841d51-561e-4c4c-9b3b-32178265ca5a"
      unitRef="usd">390000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjItMS0xLTEtNjc1MTI_5e9e5f03-8dd3-4377-9f97-2a45ae86e940"
      unitRef="usd">4741000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjItMy0xLTEtNjc1MTI_838b91f4-b97f-4840-8762-97ca80008102"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjMtMS0xLTEtNjc1MTI_4bd59242-b25c-42ff-998a-6e0866982f03"
      unitRef="usd">4543000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjMtMy0xLTEtNjc1MTI_137e8d83-2151-4643-a2de-cc8a6e34cb12"
      unitRef="usd">3987000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjQtMS0xLTEtNjc1MTI_b2ed77a6-f619-4769-9796-ee3885231af5"
      unitRef="usd">48466000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjQtMy0xLTEtNjc1MTI_abb46c8c-f264-4a51-abb6-5a8fe31047a3"
      unitRef="usd">44103000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjUtMS0xLTEtNjc1MTI_840ede8c-3467-42ea-95c7-2c4d575a323b"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjUtMy0xLTEtNjc1MTI_5ed8d448-3538-4444-b5d9-8557b2168bce"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjYtMS0xLTEtNjc1MTI_9f55ec29-f869-467f-ad6c-1b0ddea11319"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjYtMy0xLTEtNjc1MTI_77b4a07b-5756-47c1-b069-17538bfb9bb4"
      unitRef="usd">1411000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjctMS0xLTEtNjc1MTI_0de36982-2980-4b69-a719-100eb1eb7f41"
      unitRef="usd">1366000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjctMy0xLTEtNjc1MTI_1608ce41-114d-4f4c-90f3-6165c0704d46"
      unitRef="usd">1867000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjgtMS0xLTEtNjc1MTI_63eb9cf1-8a8c-4220-a56f-71b17d5e7576"
      unitRef="usd">7220000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjgtMy0xLTEtNjc1MTI_91ecc849-8812-427d-b987-c1bfe41e5e83"
      unitRef="usd">8067000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjktMS0xLTEtNjc1MTI_8a2d9e4b-7a3a-4275-b60d-2261c5eeba6a"
      unitRef="usd">1540000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMjktMy0xLTEtNjc1MTI_0949b4b6-e61d-4053-921f-5e911bd5a93b"
      unitRef="usd">1715000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzAtMS0xLTEtNjc1MTI_47dedd25-6c9f-4bb9-b5e1-79a7015efd7f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzAtMy0xLTEtNjc1MTI_2253b61b-ee2f-41c2-9083-df591f245c91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzEtMS0xLTEtNjc1MTI_5de8bcb7-7684-4437-acb7-5be341e17167"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzEtMy0xLTEtNjc1MTI_2279f291-f689-4fb3-8254-7b3c28ac74d3"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xNjQ5MjY3NDQxOTUz_bcb77b12-454d-4b0b-91e4-bc493c2d00ac"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xNjQ5MjY3NDQxOTUz_c158adf6-371b-4be6-a536-9a1743ce3e35"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDY5_5beca637-50f1-4873-98f3-afa097a32a95"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDY5_9b34445b-470e-4fae-8f5e-69ded610e7df"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_4809aa35-c82b-40c1-8f3e-61485d8129d1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_4a4697bd-ed89-465c-ada3-1481e781aaab"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_7fbc3cd0-272e-4e6e-8aab-81496ce46432"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjpjNjJjYjQ4MmI5NDc0OTc0ODZhODBlOGE2NzIzNDBkMl8xMDk5NTExNjI4MDgx_d984dfb3-18c2-490a-9555-1ff4fe492c78"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMS0xLTEtNjc1MTI_064aaed8-9891-490b-830f-86cfb1208e4b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzMtMy0xLTEtNjc1MTI_dd66dc00-d4ca-4907-8570-47a05cbccd71"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM0_4d288398-a850-43c8-9c90-54c34579b38f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM0_e69c4519-ec5d-41c9-90a9-97a8898d4f4f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM4_b19150b6-20f1-4be3-aeb2-15412a78dcd6"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTM4_c9690412-469d-49a4-9042-6cbb4cd26dec"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTQy_62747050-1c11-483f-ad82-a209698132fe"
      unitRef="shares">275000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjplOGMzZjY2OGEyN2M0M2U3YjMzNGUzNTExMTliNjc2ZV8xMDk5NTExNjI3OTQ3_2d6b3e8f-b81e-47a3-b7fd-03172a79ca30"
      unitRef="shares">273000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMS0xLTEtNjc1MTI_6b494375-c5ff-4f10-a158-da36ef1d27c0"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzQtMy0xLTEtNjc1MTI_5a21ecd9-422b-4890-befd-3a956552337b"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzUtMS0xLTEtNjc1MTI_c7340324-004d-436a-af2b-e7d5974d04a8"
      unitRef="usd">7275000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzUtMy0xLTEtNjc1MTI_fcafe27e-ce1a-40b9-bd3f-3025251be720"
      unitRef="usd">6925000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzYtMS0xLTEtNjc1MTI_84375a10-cfcc-482e-bb15-eff6301c4056"
      unitRef="usd">9030000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzYtMy0xLTEtNjc1MTI_b9bef5cf-fafe-4096-abdd-6d456da5bc32"
      unitRef="usd">8202000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzctMS0xLTEtNjc1MTI_2234b6dd-c246-480d-af80-a6f3ac5491e0"
      unitRef="usd">-1534000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzctMy0xLTEtNjc1MTI_998fe985-2351-4311-aeb2-680e76f98d78"
      unitRef="usd">-1480000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjo2YzYxZDM2ZDg5ZmM0MDg1YWU0ZjExNWJkNWJlN2Y0NF8xNjQ5MjY3NDQxNzUx_b22fa869-2db3-43f0-8e44-ec3399e33abc"
      unitRef="shares">130000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjo2YzYxZDM2ZDg5ZmM0MDg1YWU0ZjExNWJkNWJlN2Y0NF8xNjQ5MjY3NDQxNzU0_dc04dcbb-ee8d-498f-ac8f-297db2f82d87"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMS0xLTEtNjc1MTI_b64bb2ed-54da-4a68-9cd2-21d50dc64262"
      unitRef="usd">17045000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfMzktMy0xLTEtNjc1MTI_92caff02-31e0-445b-b11e-e569040e5399"
      unitRef="usd">13670000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDAtMS0xLTEtNjc1MTI_7de748c1-02a6-48a8-b76d-4450a7ae5d6d"
      unitRef="usd">-2272000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDAtMy0xLTEtNjc1MTI_4d49fd7a-738a-4451-a99e-535d497a5f5e"
      unitRef="usd">-21000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDEtMS0xLTEtNjc1MTI_3b95527e-6ca4-42c4-a16f-6699f949e1f8"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDEtMy0xLTEtNjc1MTI_16b7141c-040e-4ebe-880b-d3fc708b57cd"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDItMS0xLTEtNjc1MTI_90742e1f-a0e4-4074-80ba-0cb973262b7d"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDItMy0xLTEtNjc1MTI_44a111ff-aa8a-42c2-9c01-234b894e0ffc"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDMtMS0xLTEtNjc1MTI_5893485f-a78e-40ef-b5c7-5270b7922924"
      unitRef="usd">63298000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV85Ny9mcmFnOjZiZTkyYzQ5N2VkNDQ4NTk5OWY2ZTcwYzQ0ZjFlYTA5L3RhYmxlOmM0YTQ2YzA3ZmEzNDQ3OTJhYTQ1YzIwN2NkYjQwYTc5L3RhYmxlcmFuZ2U6YzRhNDZjMDdmYTM0NDc5MmFhNDVjMjA3Y2RiNDBhNzlfNDMtMy0xLTEtNjc1MTI_aafe17cf-878e-419a-870d-b13166f0e955"
      unitRef="usd">65015000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ia3deea6c14b24c35a88fb4f3b5239602_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMS0xLTEtNjc1MTI_132455ed-7057-44b3-95e1-b4655bc392d1"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3deea6c14b24c35a88fb4f3b5239602_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMy0xLTEtNjc1MTI_45256cdb-ff0e-4be4-92f4-91ac4a03d4bc"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b21cbe51124474092ab038b1d408bb7_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtNS0xLTEtNjc1MTI_86b6e55f-7d3a-4d09-ba6a-b69f6f7b605a"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i785292e3540b46a8b3ab968c6707dd77_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtNy0xLTEtNjc1MTI_d144a81f-81d7-442d-a37f-1c9830f5b80e"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a6c8a7f661b462f9ac6296df77d8e06_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtOS0xLTEtNjc1MTI_f27f9480-3265-40ae-9fb0-a59bca9f104d"
      unitRef="usd">12409000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1cd9f0cb497242a6826289cfb5fdad80_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTEtMS0xLTY3NTEy_d0d71d6f-9e63-42ea-b25d-35b9b3944795"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ide9952cef22a4bc8b524552d5f4a71b9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTMtMS0xLTY3NTEy_3a4f7f81-46c6-4993-86c5-8e4accba1936"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide9952cef22a4bc8b524552d5f4a71b9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTUtMS0xLTY3NTEy_36eef719-68e5-4e82-bc94-500695b464aa"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4592918a3c14823acad8256f0ddfbde_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTctMS0xLTY3NTEy_e95f5efd-6406-48e2-949f-714b72ca4926"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMtMTktMS0xLTY3NTEy_73152a15-8a0b-49d1-a6e8-1c010f57feb9"
      unitRef="usd">8287000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8428ec3a9cbb437d8aa822268f3ae46f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQtOS0xLTEtNjc1MTI_b28da03b-cd35-4d6e-88e7-984061dc0fc8"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia689b4eec1084768aaebdb4bc5f99af7_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQtMTktMS0xLTY3NTEy_d9ab0caa-e98c-4f62-b68b-836f9ab9d90e"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ie7820f8179cd488caae5ec4d8b342012_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMS0xLTEtNjc1MTI_af6c78b7-6869-424d-b1b2-2808ee67a6a9"
      unitRef="shares">271000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7820f8179cd488caae5ec4d8b342012_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMy0xLTEtNjc1MTI_5e25619b-eb40-4a95-bb40-bc959128bca9"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa23c711f267453f9563f59bc7ef048a_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtNS0xLTEtNjc1MTI_11d4a320-f0a2-41ac-88a3-5e037493bf6d"
      unitRef="usd">6435000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b01dc80a44246cd9ff31ee62f1cf4f5_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtNy0xLTEtNjc1MTI_ea5a8d45-deec-4d63-a0cf-33bad08debfc"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9f39b2ee8ba4ad9b6df061b0133c8c6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtOS0xLTEtNjc1MTI_3779b532-85b4-4ca5-ae0b-3b9c156a8465"
      unitRef="usd">12420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i180ef1abd93241dd9b099926ef64a73e_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTEtMS0xLTY3NTEy_9e14cb05-8034-4e05-8568-8fa8ada623b2"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i7a7555c1d0ba47188d1bf7a199033063_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTMtMS0xLTY3NTEy_b3adfed1-7c06-4dad-92c8-263bc1ec3955"
      unitRef="shares">81000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a7555c1d0ba47188d1bf7a199033063_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTUtMS0xLTY3NTEy_f6f5830b-9fd8-443e-aa35-08d015a6d736"
      unitRef="usd">-8902000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib95e07416b7c42009dca3b45fcac417f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTctMS0xLTY3NTEy_8070b090-ff7c-4128-83e7-3e383b0b8a11"
      unitRef="usd">193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7aec4e5c4fc44a31a9df1e4f8d8962c9_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzUtMTktMS0xLTY3NTEy_b146e536-7590-4773-86c7-a7d0e5a0efa8"
      unitRef="usd">8298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6b5103e93a3d4aa2b15d717f1d91a04d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtMS0xLTEtNjc1MTI_7dd72e61-18fa-4f06-b95e-b2784f1e1a79"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7e972d123eb647c8a45d52545e29ad97_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtNS0xLTEtNjc1MTI_4e935116-26f7-44d2-a142-a6f597d5c761"
      unitRef="usd">113000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtMTUtMS0xLTY3NTEy_7c42ce61-eb17-429c-85c0-bdeba5c7d274"
      unitRef="usd">-20000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzYtMTktMS0xLTY3NTEy_b31afb7f-7d09-44af-b54b-813c617de31e"
      unitRef="usd">93000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7e972d123eb647c8a45d52545e29ad97_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzctNS0xLTEtNjc1MTI_e8c44c3a-6d00-47a3-b390-e01a9ab51b52"
      unitRef="usd">115000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzctMTktMS0xLTY3NTEy_7d1f719b-845c-4f6f-bc90-b1e6a8a226ff"
      unitRef="usd">115000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzgtMTctMS0xLTY3NTEy_687dfdfc-e37f-4da9-b0eb-eda2332de61f"
      unitRef="usd">154000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzgtMTktMS0xLTY3NTEy_a2379b0d-c0ac-40de-85e5-075917412557"
      unitRef="usd">154000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzktMTEtMS0xLTY3NTEy_6c89237e-4272-4f16-9a98-660c088dcb41"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzktMTktMS0xLTY3NTEy_50adff35-9693-4ae7-88df-f1c4030e34d3"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEwLTktMS0xLTY3NTEy_64a7e752-7e06-4b61-8751-1a1e8a9d2c23"
      unitRef="usd">900000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEwLTE3LTEtMS02NzUxMg_3838f2ca-8e5b-4547-8a93-e85a6a93b6e3"
      unitRef="usd">178000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEwLTE5LTEtMS02NzUxMg_05af9eba-3a40-4757-83d0-5172826066fe"
      unitRef="usd">1078000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzExLTEzLTEtMS02NzUxMg_1ffb486c-ed14-4cb6-afde-8df17fa6b6bc"
      unitRef="shares">14000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzExLTE1LTEtMS02NzUxMg_b508e533-4cf3-48ca-85e3-845f927fbb6c"
      unitRef="usd">1934000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzExLTE5LTEtMS02NzUxMg_d4d862d2-c57e-4984-a203-c41c58015eab"
      unitRef="usd">1934000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:StockExchangedDuringPeriodShares
      contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEyLTEzLTEtMS02NzUxMg_0a265ad9-b410-4983-a860-4d336e216bfc"
      unitRef="shares">15000000</mck:StockExchangedDuringPeriodShares>
    <mck:StockExchangedDuringPeriodValue
      contextRef="i64627de0752a4f38a0331018368b8865_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEyLTE1LTEtMS02NzUxMg_7d29e1f8-b441-4b7a-a015-75074922d664"
      unitRef="usd">2036000000</mck:StockExchangedDuringPeriodValue>
    <mck:StockExchangedDuringPeriodValue
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEyLTE5LTEtMS02NzUxMg_fa4b304d-564f-48d9-a151-0e52baa1c032"
      unitRef="usd">2036000000</mck:StockExchangedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEzLTAtMS0xLTY3NTEyL3RleHRyZWdpb246OWM4ZDM0YWU0NjUwNGU1MDlkODczYWZmOWY0YTY2MWVfMTA5OTUxMTYyNzgzMg_b48af161-9737-4cb4-aeab-cfcf666f9fa5"
      unitRef="usdPerShare">1.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEzLTktMS0xLTY3NTEy_d5930515-bd1f-43f7-b2c8-fe5d8e0a935b"
      unitRef="usd">294000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzEzLTE5LTEtMS02NzUxMg_a6b709d5-44aa-468f-b701-1c7e10c728ca"
      unitRef="usd">294000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i6b5103e93a3d4aa2b15d717f1d91a04d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTMtMS0xLTY3NTEy_8a055e03-7509-461a-a9a1-96dd4112ac7e"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i3440078a7adb46d7b5f9accf550ba77b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTctMS0xLTY3NTEy_0c852d3e-7793-4633-adc3-efac1dc6d4ac"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i1d68277ac31445ae8059b7445b6f1ada_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTktMS0xLTY3NTEy_c0402a1f-284a-45d3-a1a3-55d24dc06336"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE0LTE5LTEtMS02NzUxMg_ab66e482-cb65-4455-aa04-99f3ef648510"
      unitRef="usd">3000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i5b02a4b752d74cfd80393765ca780d97_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTEtMS0xLTY3NTEy_ba4a6865-5928-4dc5-9022-3d4facb5b3f0"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b02a4b752d74cfd80393765ca780d97_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTMtMS0xLTY3NTEy_cc7da674-65ad-4723-8782-e15813cc3fae"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f88e128a22f4b15be314f3dd2e0d53d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTUtMS0xLTY3NTEy_cff3a5e6-a17e-4760-8d0d-dbaeb0112b36"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i883cca538ace48298886a121db79175e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTctMS0xLTY3NTEy_aadc5afe-c655-4160-96aa-fa2000ce1e44"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic641abc11fc64b27871a5f1b878bbdb6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTktMS0xLTY3NTEy_2dc8c2ba-5ad6-4852-b21a-7eb2855c8845"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83f0aa9722f4476ca58477e03a36b9f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTExLTEtMS02NzUxMg_1735259c-ed8f-486b-b6e3-a5653504aab5"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="idb569322fd7143f1924eb4050fec05d0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTEzLTEtMS02NzUxMg_b8e81b85-170e-45c0-b30c-58bd7c0ba2d3"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb569322fd7143f1924eb4050fec05d0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTE1LTEtMS02NzUxMg_e8610aee-f493-4407-9f86-788b77fc473d"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2cdad70673142c9a93a6bbb19838852_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTE3LTEtMS02NzUxMg_541f63e7-34e8-41aa-a0ae-bfadb6928768"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE1LTE5LTEtMS02NzUxMg_b0c25c08-7537-4c36-b915-ee3e999e2df7"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8791362274e94d518929bbd7ee69eced_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE2LTktMS0xLTY3NTEy_0bd46fd2-7bb8-4e22-a63f-b403c5e32e9c"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf764aa2c30f43d08cdd30a5094d5c77_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE2LTE5LTEtMS02NzUxMg_8c1b9747-aa14-4f4a-aef9-3712ae439f50"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ic31e30cd614c468c88d7a33e3c01b62c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTEtMS0xLTY3NTEy_8b069515-c6ec-4d2a-94db-748ed58e12f2"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic31e30cd614c468c88d7a33e3c01b62c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTMtMS0xLTY3NTEy_1f12c2d5-26d5-4f25-9c3d-13f491164b53"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8d61cae07b149f28ab844297d0650dd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTUtMS0xLTY3NTEy_e42f8b64-1112-43e5-b41d-0629ed000fc7"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i305e3fcf99604bad83df1de067162bda_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTctMS0xLTY3NTEy_5e036253-06cf-4436-92ff-472c760a5025"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1eb7d3437fe498bba552eae2bce578c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTktMS0xLTY3NTEy_fcd0963e-f985-44c6-aaa2-b461f754dfa3"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9378e02396964f6fa338e061f8c72449_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTExLTEtMS02NzUxMg_2f5f77d2-eafa-484b-8f6a-a16f3d348879"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ib551700663cc480187b2925365dc76f3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTEzLTEtMS02NzUxMg_09643ac4-0227-4610-8f6f-727282cc063d"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib551700663cc480187b2925365dc76f3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTE1LTEtMS02NzUxMg_3a72c44b-634c-48f1-b24e-30558610c2af"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i210241066bf44247a7e0bfd8995df0e5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTE3LTEtMS02NzUxMg_3052a94d-1463-40d6-87f3-391bc9340bc0"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dc9248dc9c64dae83ba79637793aab6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE3LTE5LTEtMS02NzUxMg_5ad56cb7-63e3-4f35-800b-17906a98af9f"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i57057534f4b548078330647f41d65cd9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTEtMS0xLTY3NTEy_77d9525a-23ea-4843-a417-77e0612f89f9"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTUtMS0xLTY3NTEy_ad27764f-38c9-41cc-a7d8-3a45cd5bb04b"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTE1LTEtMS02NzUxMg_0a115c7f-9c14-4691-9be4-e1f078fdd9ce"
      unitRef="usd">-28000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE4LTE5LTEtMS02NzUxMg_4ce8391e-4324-4a7e-9457-9eaa4737b6db"
      unitRef="usd">64000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE5LTUtMS0xLTY3NTEy_5123ea37-0ade-4216-a19e-02ae9f06de3b"
      unitRef="usd">151000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzE5LTE5LTEtMS02NzUxMg_89b1abf8-15b5-44db-bada-193cbc6b292f"
      unitRef="usd">151000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIwLTE3LTEtMS02NzUxMg_c851454a-fdce-456f-80f7-f255583c2bff"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIwLTE5LTEtMS02NzUxMg_56164596-4b8a-4735-ac4c-3a710e4b38de"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIxLTExLTEtMS02NzUxMg_5dc19850-d4c5-4505-95cc-c94f9ee48a85"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIxLTE5LTEtMS02NzUxMg_112bad83-2e8e-4676-ba05-31c9acfc4d13"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i461023189d294286a463ef01b45de63d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIyLTktMS0xLTY3NTEy_eece9971-851f-4d68-8980-798ad56fd2f8"
      unitRef="usd">-4539000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIyLTE3LTEtMS02NzUxMg_b5ca3513-9e96-4a05-ba6d-368f80d2f529"
      unitRef="usd">156000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIyLTE5LTEtMS02NzUxMg_8add23b2-8a8f-48a5-8774-478de42ad575"
      unitRef="usd">-4383000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIzLTUtMS0xLTY3NTEy_7a5dea17-c5ae-421f-a37b-18d548c9dfe5"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzIzLTE5LTEtMS02NzUxMg_37552b11-c15e-4019-9e51-33f46f128442"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI0LTEzLTEtMS02NzUxMg_f5c56633-e55a-4795-9f0d-0c6607a769f9"
      unitRef="shares">5000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i06fd1889709d4f5bb0849944ee8df615_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI0LTE1LTEtMS02NzUxMg_5d717116-66c5-402b-b5d2-44c1d75da0dc"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI0LTE5LTEtMS02NzUxMg_59e6411d-e994-4aa1-8b9e-cd3d258566dc"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI1LTAtMS0xLTY3NTEyL3RleHRyZWdpb246NDFhYmIxZmE5MWExNGUxMmE4YzNhM2ZiZDkxYmExZTdfMTA5OTUxMTYyNzgzMg_eab194eb-b4b5-46c2-b5b7-cb2398e8645e"
      unitRef="usdPerShare">1.67</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i461023189d294286a463ef01b45de63d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI1LTktMS0xLTY3NTEy_f86c7ea9-bf44-44ce-858e-086871d0c1d2"
      unitRef="usd">270000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI1LTE5LTEtMS02NzUxMg_fff46ad4-f0cd-4ae6-92b4-2e91846c1b26"
      unitRef="usd">270000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI2LTUtMS0xLTY3NTEy_6a58aeb1-b917-4f1a-bfa7-d39411397991"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i461023189d294286a463ef01b45de63d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI2LTktMS0xLTY3NTEy_f14822c3-f7d6-4a1f-8121-f91f86a31e65"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI2LTE5LTEtMS02NzUxMg_ed0c0c07-73ca-4dda-92fd-1bdee9dae04f"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="ia5b27e96a471495799b6dd0a225ad062_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTEtMS0xLTY3NTEy_cfeeca01-0f5a-4550-adb8-7a578b57ffe0"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5b27e96a471495799b6dd0a225ad062_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTMtMS0xLTY3NTEy_4d347c32-7b8e-45fd-a77c-38f5406d3f1f"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic951943367684ce392dcd7a2919ab132_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTUtMS0xLTY3NTEy_230ce64e-6868-4975-8364-40cb2351085c"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36b967dacd7747f1897007bd0e7d2096_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTctMS0xLTY3NTEy_fffa1e8e-f69e-4204-b724-60ae6142330c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c4849bc12314eb6878d6ecc627ba11c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTktMS0xLTY3NTEy_469f7049-2702-46de-a42a-4e6851170374"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0f038c81a5a4b8198d4c97be9e3cfa7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTExLTEtMS02NzUxMg_8392c053-d4cf-435c-a2bb-fe928df0f3e7"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3764f741fee2439f932384b08f26eaf2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTEzLTEtMS02NzUxMg_02b22330-53d4-4a99-a62e-5c9d28f66577"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3764f741fee2439f932384b08f26eaf2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTE1LTEtMS02NzUxMg_5ac9ac03-0a8b-4298-aebc-78206cd1c3da"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6dec5df30de44f7a83e4f2ce0278a9d7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTE3LTEtMS02NzUxMg_a915c0d4-2914-4c6a-b6d7-4e5f88b82d61"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI3LTE5LTEtMS02NzUxMg_7e503143-eca8-443d-b6bb-7eb44a65f1b6"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idcca99ee396c495597323a1f0cfd1b93_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTEtMS0xLTY3NTEy_d98fef76-905e-4660-947a-c2799ca689c5"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTUtMS0xLTY3NTEy_93ebb527-fc2a-4c4b-b936-26c80bd2a1bb"
      unitRef="usd">220000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i199433cd82524872a587c50f96b8c524_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTE1LTEtMS02NzUxMg_3fe18618-5688-4b06-a935-c31fd46a14e0"
      unitRef="usd">-71000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzI5LTE5LTEtMS02NzUxMg_25e442ad-bca8-414e-a642-69d912f81d1b"
      unitRef="usd">149000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMwLTUtMS0xLTY3NTEy_7af0173b-6e94-46b2-8eb2-798c6d3a3c02"
      unitRef="usd">154000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMwLTE5LTEtMS02NzUxMg_aa96da3e-f680-4900-beb6-f06993dad103"
      unitRef="usd">154000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMxLTE3LTEtMS02NzUxMg_11343526-5525-4d45-a193-5d2c2b82c1ef"
      unitRef="usd">155000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMxLTE5LTEtMS02NzUxMg_f5af0ebc-f009-4061-a593-e56f1a2e66cd"
      unitRef="usd">155000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMyLTExLTEtMS02NzUxMg_5301b4a2-835f-42f4-bc5f-c80c779f05de"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMyLTE3LTEtMS02NzUxMg_6cf96821-9a00-40f0-b08c-e248b2863c89"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMyLTE5LTEtMS02NzUxMg_d4e0bfae-b9d3-426b-b576-3ea631e3c765"
      unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie685032700114a648030b37f3029390e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMzLTktMS0xLTY3NTEy_11d98782-38a7-41cf-b720-b67c4281cc20"
      unitRef="usd">1114000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMzLTE3LTEtMS02NzUxMg_7b90889d-2d2e-444a-a6a6-f8a35baa54b9"
      unitRef="usd">165000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzMzLTE5LTEtMS02NzUxMg_4a83e498-f097-4d19-8319-006c4f0ad7b2"
      unitRef="usd">1279000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM0LTUtMS0xLTY3NTEy_4b937850-4aa1-4bab-bfc4-b3e4bcbf74d8"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM0LTExLTEtMS02NzUxMg_61960a21-2e6e-4ea1-9c47-d6cb84a2233b"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM0LTE5LTEtMS02NzUxMg_0fa754fc-8513-42d4-b1a6-660f54a09395"
      unitRef="usd">8000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTUtMS0xLTY3NTEy_6d986788-f86b-4deb-b604-c790fc640881"
      unitRef="usd">204000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i199433cd82524872a587c50f96b8c524_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTEzLTEtMS02NzUxMg_a7112d5e-9953-49f6-ba64-d151f14304aa"
      unitRef="shares">15000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i199433cd82524872a587c50f96b8c524_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTE1LTEtMS02NzUxMg_4240a356-3d55-4b18-99ac-5550bcf0b521"
      unitRef="usd">3304000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM1LTE5LTEtMS02NzUxMg_a594b4c6-d97f-4f41-b2bb-731afaa8b3bb"
      unitRef="usd">3508000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM2LTE3LTEtMS02NzUxMg_d40ad4a4-76d8-41cd-a116-a9eb0ae5c5b9"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM2LTE5LTEtMS02NzUxMg_9c05b3f1-08a6-43da-a9d1-fa3155faa6da"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM3LTE3LTEtMS02NzUxMg_5deccff0-c152-4750-9d74-a89e6bc7fad4"
      unitRef="usd">7000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM3LTE5LTEtMS02NzUxMg_4c36260b-a780-41b9-81ca-5de29d6a1aec"
      unitRef="usd">7000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM4LTAtMS0xLTY3NTEyL3RleHRyZWdpb246NTkzMWYwNTI1OWU4NDRlZWIxZTZhNTVmZWVkZjY3ZjlfMTA5OTUxMTYyNzgzMg_bac10196-3b8a-406a-81b2-eedcf389ec2e"
      unitRef="usdPerShare">1.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie685032700114a648030b37f3029390e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM4LTktMS0xLTY3NTEy_069af784-bcca-4685-80cf-d8d15d0d76a8"
      unitRef="usd">279000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM4LTE5LTEtMS02NzUxMg_bf3a9f8d-a9d4-4f88-b6ee-2a8fed0f102d"
      unitRef="usd">279000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTUtMS0xLTY3NTEy_a900fef3-5d27-4f2a-8b11-9452614e16af"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie685032700114a648030b37f3029390e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTktMS0xLTY3NTEy_d30ba1a4-cf25-4ad3-8451-3ef2ee85862a"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTE3LTEtMS02NzUxMg_b29dc390-2471-41af-b944-cb1c272a340a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzM5LTE5LTEtMS02NzUxMg_c9210be7-4785-4502-ad5e-ed9f188fced5"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i84a83e66e4b34cfcbbd7fafb3e2d383e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTEtMS0xLTY3NTEy_a17f1726-425a-4988-b7a4-f1180b384f18"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84a83e66e4b34cfcbbd7fafb3e2d383e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTMtMS0xLTY3NTEy_975679b5-f199-4a8f-b13d-71a762830fdf"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8062dd2444549b5b588b1c34805e71c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTUtMS0xLTY3NTEy_ce575b59-6a76-43ff-a064-257bc2bacca0"
      unitRef="usd">7275000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1996a48e50224bb9a7a3ef02f89a15be_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTctMS0xLTY3NTEy_ea54706e-966d-4315-97d9-dffb28f10278"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2b963f2005d473788cd329e855eb9f8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTktMS0xLTY3NTEy_043fc0c2-c008-40b5-97fc-857bdf794656"
      unitRef="usd">9030000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3e04acff1af415fb304c565efd6376b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTExLTEtMS02NzUxMg_faa3c96e-71a6-412d-884f-8e70d0e575cf"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3c565412e4c44e6090973b99e12490b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTEzLTEtMS02NzUxMg_4941d5d0-0500-4a6d-a9bb-fd905f0ad82e"
      unitRef="shares">130000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c565412e4c44e6090973b99e12490b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTE1LTEtMS02NzUxMg_163d4dc9-4a11-4fc7-a934-75cb742ee491"
      unitRef="usd">-17045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52cdcc95103d4a2b933719ac01f8cec5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTE3LTEtMS02NzUxMg_e46198c6-b7d5-462f-a281-3d92eca7b8e7"
      unitRef="usd">480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDAvZnJhZzpkNmZhMGJiOWM1N2Y0NjkyYjMzYmM1NmYzMmIzY2I4ZC90YWJsZTpjODg5N2RlMDZhNDk0MzhjYmM3N2YzNGZlZWQzMTk2NC90YWJsZXJhbmdlOmM4ODk3ZGUwNmE0OTQzOGNiYzc3ZjM0ZmVlZDMxOTY0XzQwLTE5LTEtMS02NzUxMg_57bd93a3-d0c9-46b4-8976-eb04cf4f4b35"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMtMS0xLTEtNjc1MTI_6669df60-7881-4355-a936-fe9011976aa0"
      unitRef="usd">1287000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMtMy0xLTEtNjc1MTI_61bd9024-00d3-4f65-b206-3844285457c7"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMtNS0xLTEtNjc1MTI_76e7d7dd-8a1d-4c92-b4c6-024612958722"
      unitRef="usd">1120000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUtMS0xLTEtNjc1MTI_5d02de5d-f619-4d2a-b5c8-00ff1fbfd792"
      unitRef="usd">279000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUtMy0xLTEtNjc1MTI_ec006aaf-4725-4c7b-8a72-5cae038bb1b2"
      unitRef="usd">321000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUtNS0xLTEtNjc1MTI_0af5765d-c856-4fc4-b835-41405499665e"
      unitRef="usd">321000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzYtMS0xLTEtNjc1MTI_5adfb454-dd08-42c7-871d-08556ccef563"
      unitRef="usd">481000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzYtMy0xLTEtNjc1MTI_73ee59bf-68fe-4b71-8b83-1146e65bd2e9"
      unitRef="usd">566000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzYtNS0xLTEtNjc1MTI_da834903-d8ad-454e-bef6-46523111ebde"
      unitRef="usd">601000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzctMS0xLTEtNjc1MTI_7aca680a-555a-4407-8bac-37f067d52e78"
      unitRef="usd">175000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzctMy0xLTEtNjc1MTI_7db1f3d1-e3d0-473f-9bb9-c2eb044a431d"
      unitRef="usd">242000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzctNS0xLTEtNjc1MTI_a83569fc-40fb-4141-9062-eb0341201c77"
      unitRef="usd">139000000</us-gaap:OtherAssetImpairmentCharges>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzgtMS0xLTEtNjc1MTI_908c33b9-06e4-4774-9e5f-fa39bd6e7be0"
      unitRef="usd">0</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzgtMy0xLTEtNjc1MTI_2b352301-c608-4325-986e-34c58d57a71a"
      unitRef="usd">0</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment>
    <mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzgtNS0xLTEtNjc1MTI_8de3dccd-0e25-4981-b236-63ea4c892aef"
      unitRef="usd">-1084000000</mck:IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzktMS0xLTEtNjc1MTI_910e1b14-9fd6-4dcd-9b11-7b938e64e6c2"
      unitRef="usd">-34000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzktMy0xLTEtNjc1MTI_d2d39237-b0f6-43ed-88ad-c435c1009342"
      unitRef="usd">908000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzktNS0xLTEtNjc1MTI_5ffbff0b-eae8-42fb-a434-132e073ff5e9"
      unitRef="usd">342000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEwLTEtMS0xLTY3NTEy_f8c86746-c538-4883-bce1-cfc4f1ed1239"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEwLTMtMS0xLTY3NTEy_1c184d9c-a5f6-4183-849d-64599fd96b84"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEwLTUtMS0xLTY3NTEy_c2b2e549-ec6c-46c1-a2ea-0daf211d47eb"
      unitRef="usd">-252000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzExLTEtMS0xLTY3NTEy_6cbb65d6-19c7-48b6-aab6-93ad384a8cf5"
      unitRef="usd">241000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzExLTMtMS0xLTY3NTEy_3cdebb92-4f36-4597-81f9-5201ec599fef"
      unitRef="usd">334000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzExLTUtMS0xLTY3NTEy_6311be0e-74a3-40f5-b531-5d25fb44a67b"
      unitRef="usd">366000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEyLTEtMS0xLTY3NTEy_225b2393-1936-4e89-b30b-bf1cb54d87ee"
      unitRef="usd">132000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEyLTMtMS0xLTY3NTEy_06d1916c-1bfd-4cac-ba4f-1e215f4ae0e6"
      unitRef="usd">9000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEyLTUtMS0xLTY3NTEy_a1331c7c-7961-4614-97cd-587af99f8a3b"
      unitRef="usd">-33000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTEtMS0xLTg4MTQ1_6bda0ce9-be96-4897-9052-5492034fcc3e"
      unitRef="usd">1509000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTMtMS0xLTg4MDY4_ca767774-edb2-4dd3-a315-ed5be29715e0"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTUtMS0xLTg3OTMy_c7546795-1b0f-4fcf-87de-82c677f9b990"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTEtMS0xLTY3NTEy_4b292ea6-d829-4ec2-8571-60702149b3c1"
      unitRef="usd">-501000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTMtMS0xLTY3NTEy_7dd462ee-c995-4391-b88e-f60f49d03289"
      unitRef="usd">-188000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzEzLTUtMS0xLTY3NTEy_8e44c9f5-2cc6-4f07-8f8c-734e0ce86dfa"
      unitRef="usd">-615000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE1LTEtMS0xLTY3NTEy_f13657aa-bd0b-4816-b0ff-b415afef0499"
      unitRef="usd">1843000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE1LTMtMS0xLTY3NTEy_2aa3103c-2d90-49e4-83e2-7c4bb81a7544"
      unitRef="usd">-1145000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE1LTUtMS0xLTY3NTEy_c02f5856-1a59-4de1-8abb-9a4b92e76a9f"
      unitRef="usd">2494000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE2LTEtMS0xLTY3NTEy_c2c48e22-d94c-4fae-9a8c-578f7a8280aa"
      unitRef="usd">1169000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE2LTMtMS0xLTY3NTEy_5b2b160e-64e9-498d-a6e0-a716aa33ccd9"
      unitRef="usd">2276000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE2LTUtMS0xLTY3NTEy_07cc4895-5787-4253-86e7-3fb9a4a175b2"
      unitRef="usd">376000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE3LTEtMS0xLTY3NTEy_b47ad9dd-f299-48ad-af9b-8e285bf8141f"
      unitRef="usd">2802000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE3LTMtMS0xLTY3NTEy_adfb7259-4ad5-4b50-ac14-28988a85d5ab"
      unitRef="usd">1267000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE3LTUtMS0xLTY3NTEy_2069a4d5-8304-4e06-b272-41bc4a364787"
      unitRef="usd">3952000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE4LTEtMS0xLTY3NTEy_ef947a54-4ad0-4187-8ee0-818623d5a0a5"
      unitRef="usd">-356000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE4LTMtMS0xLTY3NTEy_8f881d07-366c-4ba0-895b-f8194ba87a81"
      unitRef="usd">-362000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE4LTUtMS0xLTY3NTEy_90d27d23-fb57-45af-877f-ebc4943211f2"
      unitRef="usd">-377000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE5LTEtMS0xLTY3NTEy_62d3f875-8712-4826-bef8-7bd249f2c860"
      unitRef="usd">243000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE5LTMtMS0xLTY3NTEy_63727063-ca5f-41ac-8118-2299a6e897c7"
      unitRef="usd">-166000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzE5LTUtMS0xLTY3NTEy_42567768-954f-4ff5-b017-2bc413746736"
      unitRef="usd">-8000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIwLTEtMS0xLTY3NTEy_f193a556-7074-4034-87ca-adbb53dca5af"
      unitRef="usd">199000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIwLTMtMS0xLTY3NTEy_a70fa4b3-f2f6-48f6-9a0d-32626448663c"
      unitRef="usd">8067000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIwLTUtMS0xLTY3NTEy_514524c2-6e3f-4248-8fbc-565b882c2bd2"
      unitRef="usd">0</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIxLTEtMS0xLTY3NTEy_a8b2decb-f55d-40fc-899c-997a5f921b3b"
      unitRef="usd">-206000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIxLTMtMS0xLTY3NTEy_74811b0c-fca8-4416-bc0d-0a820ecae045"
      unitRef="usd">-511000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIxLTUtMS0xLTY3NTEy_ab6ba977-065a-413a-ac7e-f3fe588f934a"
      unitRef="usd">8000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIyLTEtMS0xLTY3NTEy_ce4bfb78-e75c-450a-82dc-b401d86d9aeb"
      unitRef="usd">4434000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIyLTMtMS0xLTY3NTEy_ff725cd4-e736-425e-b1da-0ebdbf925ad6"
      unitRef="usd">4542000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzIyLTUtMS0xLTY3NTEy_4ca7e6b2-7e0c-4e0d-96b6-a29335d2bb39"
      unitRef="usd">4374000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI1LTEtMS0xLTY3NTEy_e0a4e9ec-cf11-4045-b4d3-599cad742ba6"
      unitRef="usd">388000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI1LTMtMS0xLTY3NTEy_4114eb4a-93d1-4677-a908-ebb50323b032"
      unitRef="usd">451000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI1LTUtMS0xLTY3NTEy_2fb0a3b7-3da7-454b-96cd-da8c75c952c1"
      unitRef="usd">362000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI2LTEtMS0xLTY3NTEy_ccb013ff-e950-4f90-86c4-9f0c49aae018"
      unitRef="usd">147000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI2LTMtMS0xLTY3NTEy_8fd6691a-35f1-458f-b12d-77dc613b4860"
      unitRef="usd">190000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI2LTUtMS0xLTY3NTEy_224bafc6-24e6-471b-a2af-646861f9aea8"
      unitRef="usd">144000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI3LTEtMS0xLTY3NTEy_d3a4834b-0854-488c-96be-bdbcfd01f439"
      unitRef="usd">6000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI3LTMtMS0xLTY3NTEy_3a9d94f7-3fca-44b8-aaa9-96d7df2e5c2a"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI3LTUtMS0xLTY3NTEy_6c0eeab6-8aaa-40b0-8e17-335cccb12dc3"
      unitRef="usd">133000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI4LTEtMS0xLTY3NTEy_6ccd631c-7691-48cb-accf-eb945c1a787b"
      unitRef="usd">578000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI4LTMtMS0xLTY3NTEy_628174b9-c561-423b-9513-018efa759b9d"
      unitRef="usd">400000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI4LTUtMS0xLTY3NTEy_c316b256-6406-4382-8bd4-99bfe39e6d61"
      unitRef="usd">37000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI5LTEtMS0xLTY3NTEy_7e092b23-d017-4b80-8276-061182fe42b4"
      unitRef="usd">126000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI5LTMtMS0xLTY3NTEy_c59161c5-f85c-44f2-b841-8ced78da3fd9"
      unitRef="usd">139000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzI5LTUtMS0xLTY3NTEy_61a1be77-e385-4400-ae97-ad550fe1838b"
      unitRef="usd">-23000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMwLTEtMS0xLTY3NTEy_43ace26d-f73d-4729-af64-2046ded20477"
      unitRef="usd">-89000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMwLTMtMS0xLTY3NTEy_14acff6c-94f5-406b-bc28-3dfa3a344a9c"
      unitRef="usd">-415000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMwLTUtMS0xLTY3NTEy_17111a74-c3e4-4557-882c-da9817eee220"
      unitRef="usd">-579000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMzLTEtMS0xLTY3NTEy_cd27fd38-b3b4-40fd-a633-4caf988c8851"
      unitRef="usd">11192000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMzLTMtMS0xLTY3NTEy_3dc416e8-b5fe-4a6e-abaf-1f628290f9d5"
      unitRef="usd">6323000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzMzLTUtMS0xLTY3NTEy_c5caf778-b915-4123-91b1-daf0ad5069f2"
      unitRef="usd">21437000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM0LTEtMS0xLTY3NTEy_269576db-0a1b-4ae5-9b4e-b5c14697b01b"
      unitRef="usd">11192000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM0LTMtMS0xLTY3NTEy_be8552d1-c5df-4793-8636-43475530a7e0"
      unitRef="usd">6323000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM0LTUtMS0xLTY3NTEy_9aba2062-3fa4-49cc-bd58-6dfe9b386dbc"
      unitRef="usd">21437000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM1LTEtMS0xLTY3NTEy_d4493807-78a9-4793-bab7-e6a230086bbd"
      unitRef="usd">498000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM1LTMtMS0xLTY3NTEy_d37a387e-a4fc-4db9-a928-4d6d17d0cfc3"
      unitRef="usd">500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM1LTUtMS0xLTY3NTEy_c93b102a-560d-4778-bddf-462cc1419855"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM2LTEtMS0xLTY3NTEy_de864e43-3b5f-4a40-b65f-4bed475cf202"
      unitRef="usd">1648000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM2LTMtMS0xLTY3NTEy_6fd1be30-e56a-4ee7-98d8-5db27a4c85f7"
      unitRef="usd">1040000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM2LTUtMS0xLTY3NTEy_f10f3655-bc36-40d2-8512-9e1f9fd9df00"
      unitRef="usd">298000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM3LTEtMS0xLTY3NTEy_99a2b102-682c-49eb-b351-adc4ad5a63a9"
      unitRef="usd">184000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM3LTMtMS0xLTY3NTEy_ad555a76-792d-4962-8b1c-b3833bc83869"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM3LTUtMS0xLTY3NTEy_1d10f10f-9f34-4e6a-869a-3f976ceb28ec"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM5LTEtMS0xLTY3NTEy_41a90294-50fe-412f-ba1e-0512c5e07bb5"
      unitRef="usd">220000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM5LTMtMS0xLTY3NTEy_e37af7a1-e674-4c43-8ef8-6c320a9b500b"
      unitRef="usd">92000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzM5LTUtMS0xLTY3NTEy_0aa0f004-0614-4c39-a4cd-87e591b3fe9e"
      unitRef="usd">113000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQwLTEtMS0xLTY3NTEy_2593ad95-509a-4e8a-941b-f43c8e32f6bd"
      unitRef="usd">3516000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQwLTMtMS0xLTY3NTEy_57bccb55-6434-4ad8-add4-d9832838658a"
      unitRef="usd">742000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQwLTUtMS0xLTY3NTEy_00a8f384-b80f-4746-b08c-10490acca55b"
      unitRef="usd">1934000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQxLTEtMS0xLTY3NTEy_60a67f47-5bd7-47ae-9b26-ff6e05f00578"
      unitRef="usd">277000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQxLTMtMS0xLTY3NTEy_ea95d828-0035-46d4-a8a2-bd07947c6c5b"
      unitRef="usd">276000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQxLTUtMS0xLTY3NTEy_4c52aac7-7f93-4c87-8916-ea8d9d07cb07"
      unitRef="usd">294000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTEtMS0xLTg4MTY2_283f824c-e977-4a72-af14-26b359ed91dd"
      unitRef="usd">1031000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTMtMS0xLTg4MDkx_6193b750-4d91-48b7-9dd3-96bfebcabbe9"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTUtMS0xLTg3OTg3_62902676-ba9d-43cf-bcab-7273b34c0c81"
      unitRef="usd">3000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQyLTEtMS0xLTY3NTEy_7232fa69-61aa-49e3-8165-acd9b458fdde"
      unitRef="usd">-383000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQyLTMtMS0xLTY3NTEy_a7c0cd6f-74c2-46c3-9211-b436a2ee8d45"
      unitRef="usd">-178000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQyLTUtMS0xLTY3NTEy_cdf88f7f-e7a8-4d94-aea4-3eef5f77985b"
      unitRef="usd">-318000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTEtMS0xLTY3NTEy_7a94f029-6ad9-482f-b6e2-ce388f9b2590"
      unitRef="usd">-6321000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTMtMS0xLTY3NTEy_a77f2469-9336-42ad-837c-80f3c1c9aeeb"
      unitRef="usd">-1693000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQzLTUtMS0xLTY3NTEy_8b292181-a195-44dd-b93d-87a3a2203d1d"
      unitRef="usd">-2734000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ0LTEtMS0xLTY3NTEy_1b828a30-4cbd-4740-b302-79768f618598"
      unitRef="usd">55000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ0LTMtMS0xLTY3NTEy_3502f9cb-fd9e-4cbd-97b5-c7f8b26250d6"
      unitRef="usd">-61000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ0LTUtMS0xLTY3NTEy_b98f9494-753e-47d3-b41f-3536dc936c03"
      unitRef="usd">-19000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTEtMS0xLTg4MTc0_acd46828-f557-4ea2-a84e-5b9d9d423d8f"
      unitRef="usd">-540000000</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTMtMS0xLTg4MDk4_a100de4e-6b50-4172-8635-50667dc07342"
      unitRef="usd">0</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTUtMS0xLTg4MDEy_92a55ff8-cf3a-4db9-802a-4dd823f205e3"
      unitRef="usd">0</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ1LTEtMS0xLTY3NTEy_cc14611d-7423-437d-9a45-0e165c96af98"
      unitRef="usd">-2461000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ1LTMtMS0xLTY3NTEy_ae23be55-a69f-4c1d-8177-ee0a3edcbb39"
      unitRef="usd">2373000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ1LTUtMS0xLTY3NTEy_af476c00-f0a0-4994-a32c-7047946bbe5a"
      unitRef="usd">1042000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ2LTEtMS0xLTY3NTEy_31a2b0a4-6264-4bdf-8dc6-5276f44ed70b"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ2LTMtMS0xLTY3NTEy_da531134-62c9-4cb0-b30f-10c45393c08d"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ2LTUtMS0xLTY3NTEy_fc3d18f8-d025-4d0d-abd9-8d6ca4721b83"
      unitRef="usd">2981000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTEtMS0xLTY3NTEy_1756dfeb-1921-4283-b1f1-8282e3a60293"
      unitRef="usd">3935000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTMtMS0xLTY3NTEy_0bbbf67e-4b07-4738-82e6-86dd55418891"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ3LTUtMS0xLTY3NTEy_7f46f067-9b71-4e18-9073-37b44606dceb"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ4LTEtMS0xLTY3NTEy_b3ec5d1e-7eeb-4404-a97f-7c7059665220"
      unitRef="usd">403000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ4LTMtMS0xLTY3NTEy_4befa896-1328-4a39-8c0f-40b5350d1572"
      unitRef="usd">118000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzQ4LTUtMS0xLTY3NTEy_7a792aa3-7532-4012-93d0-89ad254fb28d"
      unitRef="usd">8000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUwLTEtMS0xLTY3NTEy_b645853c-822a-41ac-b4ab-fb87ec85d8e4"
      unitRef="usd">3532000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUwLTMtMS0xLTY3NTEy_1a200670-4241-4e56-bf8e-d3f084a261d9"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzUwLTUtMS0xLTY3NTEy_b99ff91b-8d14-43b6-8a5a-db0ac6c5343d"
      unitRef="usd">4015000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU0LTEtMS0xLTY3NTEy_e1c15cc4-7954-4afb-81ae-c59d73588633"
      unitRef="usd">186000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU0LTMtMS0xLTY3NTEy_af7d9e52-d72c-4811-af31-4fb011610869"
      unitRef="usd">220000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU0LTUtMS0xLTY3NTEy_9188d823-1fbf-4c29-a871-111c9d5bf432"
      unitRef="usd">235000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU1LTEtMS0xLTY3NTEy_28b47498-ac1a-47d6-acfd-c29d635cbf71"
      unitRef="usd">359000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU1LTMtMS0xLTY3NTEy_7b61d44a-3434-4b79-b70e-dc0ed842453a"
      unitRef="usd">379000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDMvZnJhZzphZTViYjQ2OGNlMTc0OWI3OTI0NDQ4NDM4M2Y4MTFlYS90YWJsZToxOTk5MGRjZmUyOTI0NjFjOTMwMTE0NWE5OGVlZjVmYy90YWJsZXJhbmdlOjE5OTkwZGNmZTI5MjQ2MWM5MzAxMTQ1YTk4ZWVmNWZjXzU1LTUtMS0xLTY3NTEy_a22da047-1c87-4418-b625-3bebaecd8fb3"
      unitRef="usd">368000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTk_ed3f812d-9936-4833-b9d6-f839d21e715b">Significant Accounting Policies &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson&#x2019;s teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#x201c;RxTS&#x201d;), Medical-Surgical Solutions, and International. The Company&#x2019;s equity method investment in Change Healthcare LLC (&#x201c;Change Healthcare JV&#x201d;), which was split-off from McKesson in the fourth quarter of 2020, has been included in Other for retrospective periods presented. Refer to Financial Note 21, &#x201c;Segments of Business,&#x201d; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;). As COVID-19 further evolves, the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#x2019;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#x201c;Prepaid expenses and other&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Restricted cash at March 31, 2022 primarily consists of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 18, &#x201c;Commitments and Contingent Liabilities.&#x201d; Additionally, restricted cash at March 31, 2022 and 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets at March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables, Net and Allowances for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, legal disputes, or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $89 million and $198 million were included in &#x201c;Receivables, net&#x201d; on the Consolidated Balance Sheets as of March 31, 2022 and 2021, respectively. Changes in the allowance for the year ended March 31, 2022, were primarily within the U.S Pharmaceutical and International segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s receivables as of March 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentrations of Credit Risk and Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2022, sales to the Company&#x2019;s ten largest customers, including group purchasing organizations (&#x201c;GPOs&#x201d;), accounted for approximately 52% of its total consolidated revenues and approximately 43% of total trade accounts receivable at March 31, 2022. Sales to the Company&#x2019;s largest customer, CVS Health Corporation (&#x201c;CVS&#x201d;), accounted for approximately 21% of its total consolidated revenues in 2022 and comprised approximately 28% of total trade accounts receivable at March 31, 2022. As a result, the Company&#x2019;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#x2019;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#x2019;s customer base as well as its geographic dispersion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#x201c;LIFO&#x201d;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#x201c;FIFO&#x201d;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and 2021, total inventories, net were $18.7 billion and $19.2 billion, respectively, in the Company&#x2019;s Consolidated Balance Sheets. The LIFO method was used to value approximately 63% and 58% of the Company&#x2019;s inventories at March 31, 2022 and 2021, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $383&#160;million and $406&#160;million higher than the amounts reported at March 31, 2022 and 2021, respectively. These amounts are equivalent to the Company&#x2019;s LIFO reserves. The Company&#x2019;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $23 million, $38 million, and $252 million in 2022, 2021, and 2020, respectively, in &#x201c;Cost of sales&#x201d; in its Consolidated Statements of Operations. The lower LIFO credits in 2022 compared to 2021 and 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#x201c;market&#x201d;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2022 and 2021, inventories at LIFO did not exceed market. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Costs: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes costs to pack and deliver inventory to its customers in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in its Consolidated Statements of Operations. Shipping and handling costs of $1.1 billion was recognized in 2022, and $1.0 billion was recognized in each of 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Held for Sale: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and Equipment, Net: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#x201c;ROU&#x201d;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s property, plant, and equipment, net as of March 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total depreciation expense for property, plant, and equipment, net and amortization of the ROU assets of finance leases was $312&#160;million, $344&#160;million, and $335&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd"&gt;one&lt;/span&gt;&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 10, &#x201c;Leases,&#x201d; for additional information on the Company&#x2019;s leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#x201c;DCF&#x201d;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#x2019; fair values to the Company&#x2019;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently all of the Company&#x2019;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61"&gt;one&lt;/span&gt; to 24 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Software Held for Internal Use: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2022 and 2021, capitalized software held for internal use was $320 million and $513 million, respectively, net of accumulated amortization of $1.4 billion, and is included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. The decrease in capitalized software held for internal use is primarily due to the planned exit of the Company&#x2019;s European businesses which resulted in an impairment of certain internal-use software that will not be utilized in the future and classification of certain software as held for sale, as discussed in Note 2, &#x201c;Held for Sale.&#x201d; Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $116&#160;million, $117&#160;million, and $129&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Programs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#x201c;Captives&#x201d;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 18, &#x201c;Commitments and Contingent Liabilities,&#x201d; as well as those risks required to be insured by law or contract. It is the Company&#x2019;s policy to retain a significant portion of certain losses, including those related to workers&#x2019; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#x2019;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#x2019;s premium costs within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#x2019;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#x2019; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#x2019;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March 31, 2022, 2021, and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.2 billion in 2022 and $3.1 billion in each of 2021 and 2020. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2022 and 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#x2019;s services arrangements and are recognized as revenues over the periods when services are performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2022 and 2021. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Incentives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Reserves: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#x2019;s estimate. The supplier reserves primarily pertain to the Company&#x2019;s U.S. Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Interest expense primarily includes interest for the Company&#x2019;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#x2019; equity (deficit) accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity (deficit) section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations and were not material in 2022, 2021, or 2020. The Company releases cumulative translation adjustments from stockholders&#x2019; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity (deficit) section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 15, &#x201c;Hedging Activities,&#x201d; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Income (Loss): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#x2019; equity (deficit) but are excluded from earnings. The Company&#x2019;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unrealized gains and losses on retirement-related benefit plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests and Redeemable Noncontrolling Interests: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#x2019;s consolidated entities including Vantage Oncology Holdings, LLC (&#x201c;Vantage&#x201d;) and ClarusONE Sourcing Services LLP (&#x201c;ClarusONE&#x201d;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#x2019;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#x2019; equity (deficit) in the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 8, &#x201c;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees. Refer to Financial Note 5, &#x201c;Share-Based Compensation,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 18, &#x201c;Commitments and Contingent Liabilities,&#x201d; for additional information related to ongoing controlled substances claims to which the Company is a party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#x2019;s expected useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#x2019; equity in the Company&#x2019;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#x2019;s consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no recently issued accounting standards that could have a material impact to the Company&#x2019;s financial position, results of operations, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTE3ODI_54caed58-2936-4c71-a131-ccc626ee2166"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzY1_42a46749-371b-43b5-af9f-fcc33f77898f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.&lt;/span&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjY3_a031ef21-2603-4f4a-ab52-3e04a2f8ffc0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjM1_6cc8d31e-4397-4779-9a5b-e59c2cb5c542">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzIy_4bd0572b-0681-4cc4-b9d6-7bf7fb48a074">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;). As COVID-19 further evolves, the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzc4_e456feda-e319-4ca7-abdc-3e3fa83fc3a1">Cash and Cash Equivalents: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#x2019;s foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Deposits may exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjU2_4c26b6f3-53d1-4541-a3f9-aaf8d808fc3f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#x201c;Prepaid expenses and other&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Restricted cash at March 31, 2022 primarily consists of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities, as discussed in more detail in Financial Note 18, &#x201c;Commitments and Contingent Liabilities.&#x201d; Additionally, restricted cash at March 31, 2022 and 2021 includes funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. These amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets at March 31, 2022 and 2021.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCash
      contextRef="ia875aad6cce743958618a33cce559dc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTM1MTU_108e53bf-b0c2-490b-97ea-d09658a1b1fc"
      unitRef="usd">395000000</us-gaap:RestrictedCash>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjg1_cda5bd8c-9ac7-42de-a46d-a0df1609caac">Equity Method Investments: Investments in business entities in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that may have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjc5_a04a26a3-e877-44ad-9d7e-3fbc8bb91eca">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables, Net and Allowances for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, legal disputes, or bankruptcies, as well as reasonable and supportable forecasts. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. &lt;/span&gt;&lt;/div&gt;Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $89 million and $198 million were included in &#x201c;Receivables, net&#x201d; on the Consolidated Balance Sheets as of March 31, 2022 and 2021, respectively. Changes in the allowance for the year ended March 31, 2022, were primarily within the U.S Pharmaceutical and International segments.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1MjQx_d8dc935b-180e-4c5c-a33e-5ad0d071d677"
      unitRef="usd">89000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1MjQ3_715d1387-1bdf-410d-9b62-e07121ad67eb"
      unitRef="usd">198000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzYx_db8fdc87-1308-4311-b1e6-104ac8a10ae5">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s receivables as of March 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <mck:AccountsReceivableCustomerAccountsGross
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzItMS0xLTEtNjc1MTI_c6b9dc18-c391-4a1d-8505-1275a1fa36a6"
      unitRef="usd">16438000000</mck:AccountsReceivableCustomerAccountsGross>
    <mck:AccountsReceivableCustomerAccountsGross
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzItMy0xLTEtNjc1MTI_771a8e86-79c7-41e5-be16-1806b95a181f"
      unitRef="usd">17106000000</mck:AccountsReceivableCustomerAccountsGross>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzMtMS0xLTEtNjc1MTI_263d8480-e963-46d5-9d08-fa650918ccbb"
      unitRef="usd">2289000000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzMtMy0xLTEtNjc1MTI_8c527206-55f9-4b4b-96de-809da76ec58e"
      unitRef="usd">2325000000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzQtMS0xLTEtNjc1MTI_4f79ced7-dfc7-437e-883f-ee64bbdf9876"
      unitRef="usd">18727000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzQtMy0xLTEtNjc1MTI_ccf3f168-229c-4cbd-8b0d-7b5a6eea1864"
      unitRef="usd">19431000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzUtMS0xLTEtNjc1MTI_2f046981-5a55-44a0-8924-a8a0b471b9c9"
      unitRef="usd">144000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzUtMy0xLTEtNjc1MTI_0c3f7504-6977-4732-9035-aeee9143c5d4"
      unitRef="usd">250000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzYtMS0xLTEtNjc1MTI_ff7e86de-2646-4ef9-9995-fab7eba8be7c"
      unitRef="usd">18583000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZTo4OTQxYzFmYzczMDg0OTdkYTRjZmMyYTU5ODlmZDUwNy90YWJsZXJhbmdlOjg5NDFjMWZjNzMwODQ5N2RhNGNmYzJhNTk4OWZkNTA3XzYtMy0xLTEtNjc1MTI_2ae208bb-b974-4fe6-97a3-213faa221560"
      unitRef="usd">19181000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzEz_dcccf0b7-13ca-43cf-b7ed-083a280d5507">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentrations of Credit Risk and Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During 2022, sales to the Company&#x2019;s ten largest customers, including group purchasing organizations (&#x201c;GPOs&#x201d;), accounted for approximately 52% of its total consolidated revenues and approximately 43% of total trade accounts receivable at March 31, 2022. Sales to the Company&#x2019;s largest customer, CVS Health Corporation (&#x201c;CVS&#x201d;), accounted for approximately 21% of its total consolidated revenues in 2022 and comprised approximately 28% of total trade accounts receivable at March 31, 2022. As a result, the Company&#x2019;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivables balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#x2019;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy and changes in reimbursement policies. This credit risk is mitigated by the size and diversity of the Company&#x2019;s customer base as well as its geographic dispersion.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibef844e82df1453ebb9d87c78078c9bb_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0NjY_40bd8ace-d77b-4ea5-9789-932c938e92d5"
      unitRef="number">0.52</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0ca5a3c42a474837ad3c8ddb0bd7ed5d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0NzE_4407fd29-8415-4f0a-8d80-a540d83543c8"
      unitRef="number">0.43</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i497343cb5b494f24aff9bdc1fea240b3_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0NzY_7739bfdc-3eb8-4704-bde2-e5b06230249f"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1927407de0374cf69e8f7b4d87b815fc_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc0ODI_4d760f92-437a-49c6-b6d5-90f9144c642a"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzYw_7b42e3bb-4c59-46a5-9c7b-b5138ae4d882">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#x201c;LIFO&#x201d;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#x201c;FIFO&#x201d;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and 2021, total inventories, net were $18.7 billion and $19.2 billion, respectively, in the Company&#x2019;s Consolidated Balance Sheets. The LIFO method was used to value approximately 63% and 58% of the Company&#x2019;s inventories at March 31, 2022 and 2021, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $383&#160;million and $406&#160;million higher than the amounts reported at March 31, 2022 and 2021, respectively. These amounts are equivalent to the Company&#x2019;s LIFO reserves. The Company&#x2019;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized LIFO credits of $23 million, $38 million, and $252 million in 2022, 2021, and 2020, respectively, in &#x201c;Cost of sales&#x201d; in its Consolidated Statements of Operations. The lower LIFO credits in 2022 compared to 2021 and 2020 is primarily due to higher brand inflation and delays of branded off-patent to generic drug launches. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. &lt;/span&gt;&lt;/div&gt;The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#x201c;market&#x201d;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2022 and 2021, inventories at LIFO did not exceed market.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1ODE2MzI_8329b5a9-f19c-415f-b589-7f1f41471c7c"
      unitRef="usd">18700000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1ODE2NDA_9e7f790c-32b5-4b16-a9b5-c904a5b3f011"
      unitRef="usd">19200000000</us-gaap:InventoryNet>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDA2_475aa01d-dc30-462a-87cb-72459a13fefb"
      unitRef="number">0.63</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDA5_1e3eb74d-6213-49a5-9bb1-3901d7fb5a3e"
      unitRef="number">0.58</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:InventoryLIFOReserve
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDE0_ea42975b-e7ae-441a-a8fb-2f0fffb97673"
      unitRef="usd">383000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDE3_1f9ac2bc-4af1-40e7-a692-1d99e3559035"
      unitRef="usd">406000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDMz_e894b381-7af0-4c25-bb40-d1d77e42fb5e"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDQw_3e56f971-c355-4734-ae56-1ce1edd5e1f6"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NDQ3_bd368ee4-2a99-4c0f-bd17-44ca7c2cd944"
      unitRef="usd">-252000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzg2_922a2cec-8a38-4f96-8488-795b1b7df6d4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Costs: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes costs to pack and deliver inventory to its customers in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in its Consolidated Statements of Operations. Shipping and handling costs of $1.1 billion was recognized in 2022, and $1.0 billion was recognized in each of 2021 and 2020.&lt;/span&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6c4813acb64c45d2b97a2771fc585000_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg4MDI_e3d7878d-8b24-436f-b1fa-1dc10864fd22"
      unitRef="usd">1100000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ica1b10d592e944029941c3362d1e7d7f_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg4MTA_6f217d57-ee4f-4ba9-a7a3-5a446f4eb669"
      unitRef="usd">1000000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="idd2a1aaa4aa14613b98b19f05c608e54_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg4MTA_fe0a320f-e7b9-4115-af22-ae618d95c9e6"
      unitRef="usd">1000000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <mck:HeldforSalePolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzg4_cc2b4a9d-77c4-435d-881b-9b8a24678acb">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Held for Sale: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for additional information.&lt;/span&gt;</mck:HeldforSalePolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjM3_d33b498a-027f-4acd-8b85-50be1d1116a2">Property, Plant, and Equipment, Net: Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and 3 to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#x201c;ROU&#x201d;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3520428561d84269863983bba1a927e7_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1Mzky_4ac02b34-d82d-40a7-8b9b-0e697d973ba1">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4995096937474d1bafc21c7eb57b994e_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1Mzk4_db01e855-9e2b-4573-9a64-7b971f4b58e5">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id81d0417806f4bd2852861c9771dece6_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1NDM1_39f546f4-4c43-4476-ab26-96bce8a9bd45">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2bbfc4c323144cdbacc148f6e3af2eae_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzE1NDQx_d78936d3-7028-4846-a430-ee0f92aa67fa">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDEx_ae6c0b14-d3ab-44e1-96dc-eec0fe925c6f">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s property, plant, and equipment, net as of March 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzItMS0xLTEtNjc1MTI_a8c5bb49-c1d1-43af-8c2c-477b0ce8ab05"
      unitRef="usd">104000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzItMy0xLTEtNjc1MTI_17d8e465-5d0b-48a1-964b-22e661772708"
      unitRef="usd">156000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzMtMS0xLTEtNjc1MTI_be8af5bb-dbe9-4666-9ec7-7ae869565a5f"
      unitRef="usd">1331000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzMtMy0xLTEtNjc1MTI_d3101db0-f7d9-4f86-9b2f-e1a753604797"
      unitRef="usd">1745000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzQtMS0xLTEtNjc1MTI_ee49f54a-bf49-4d28-88f7-2607908dfdb4"
      unitRef="usd">2338000000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzQtMy0xLTEtNjc1MTI_28cdf77d-dcb9-4a01-bd72-7b3b33901168"
      unitRef="usd">2512000000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:ConstructionInProgressGross
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzUtMS0xLTEtNjc1MTI_fb44949c-326e-492f-ad0d-2c4315a4d4a9"
      unitRef="usd">313000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzUtMy0xLTEtNjc1MTI_0d2e07bf-3bad-43db-b18d-e357c76bbed8"
      unitRef="usd">382000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzYtMS0xLTEtNjc1MTI_44f8e608-f55e-4aa4-a013-ac67a3dd146b"
      unitRef="usd">4086000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzYtMy0xLTEtNjc1MTI_5f6586fa-3b2f-4a66-bbc2-3668df9a92c8"
      unitRef="usd">4795000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzctMS0xLTEtNjc1MTI_d00c49f0-235d-4220-819a-83ac4fa76ebb"
      unitRef="usd">1994000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzctMy0xLTEtNjc1MTI_3c8a3d02-75f4-43c0-8850-b5fae1dd612f"
      unitRef="usd">2214000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzgtMS0xLTEtNjc1MTI_a6d4bd87-e4bb-4c81-989a-6b7eb1c6d28c"
      unitRef="usd">2092000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90YWJsZToxNzIzNjBjYWMwNjg0MzM2ODMxYWE2N2E0ZjMzOGM4My90YWJsZXJhbmdlOjE3MjM2MGNhYzA2ODQzMzY4MzFhYTY3YTRmMzM4YzgzXzgtMy0xLTEtNjc1MTI_d5eafb04-f35f-4c01-a336-e69c4ef7ee96"
      unitRef="usd">2581000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NTcw_64c96d36-797b-4459-98d5-c692e082c8d5"
      unitRef="usd">312000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NTc1_86731f0a-7148-476d-8b7b-2dc22e712a6c"
      unitRef="usd">344000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NTgw_2a44f456-0b6e-41d1-bff9-93a2536759d6"
      unitRef="usd">335000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTI_5f8b595f-d457-4689-82c2-d91afbb0ce00">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MDU_00c1fc73-58a6-4d2d-9162-42beda6b2dcd"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MjA_c84cca03-8b94-4b99-b2fd-bcce231b88bd"&gt;one&lt;/span&gt;&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. For existing leases that commenced prior to the adoption of the amended leasing guidance, the Company determined the discount rate on April&#160;1, 2019 using the full lease term. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.&lt;/span&gt;&lt;/div&gt;Refer to Financial Note 10, &#x201c;Leases,&#x201d; for additional information on the Company&#x2019;s leases.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i7f482d9a485949708d2fb871130187fd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MTQ_2e1df4bc-1eba-4408-8c7b-2f224a5993fc">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i07fbf9f75177477d9f3069a6a3ca5aa5_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1Njg0MzA_09e840ee-5a36-48c9-8609-03090a4c85f4">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6f3d97d7bd9041e6a3021f9f3286582a_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDc0NjI_786f4297-9f4a-4802-8a2d-4cad4c09f492">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjQ1_e732d387-8caa-405c-a38c-59ba7bd9c6fe">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis in the third quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#x201c;DCF&#x201d;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#x2019; fair values to the Company&#x2019;s market capitalization as a further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline companies for comparisons and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzMw_6d72597a-dee2-46f6-820c-407b26feb71a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently all of the Company&#x2019;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTc2OTg_0fd2721e-6dec-4491-8b24-3541af438b61"&gt;one&lt;/span&gt; to 24 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair market value.&lt;/span&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i866185886e394d17bb4c613ad5943f58_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMzODU_5f2713cf-ea19-42fb-a459-68bb364cd620">P24Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzE2_2ac1b128-79d7-4b01-8f84-723a0296e6f1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Software Held for Internal Use: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2022 and 2021, capitalized software held for internal use was $320 million and $513 million, respectively, net of accumulated amortization of $1.4 billion, and is included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. The decrease in capitalized software held for internal use is primarily due to the planned exit of the Company&#x2019;s European businesses which resulted in an impairment of certain internal-use software that will not be utilized in the future and classification of certain software as held for sale, as discussed in Note 2, &#x201c;Held for Sale.&#x201d; Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $116&#160;million, $117&#160;million, and $129&#160;million for the years ended March 31, 2022, 2021, and 2020, respectively.&lt;/span&gt;</us-gaap:InternalUseSoftwarePolicy>
    <mck:CapitalizedSoftwareHeldforInternalUseUsefulLife
      contextRef="i866185886e394d17bb4c613ad5943f58_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NzM4NDg_c3fe35fe-ebee-4f6e-a518-d96cf5c9c316">P10Y</mck:CapitalizedSoftwareHeldforInternalUseUsefulLife>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjM5_caed40bb-d817-4a78-93d2-50ad4ae48523"
      unitRef="usd">320000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjU4_15c128c0-92ff-4ffc-ae09-fa19bcc80819"
      unitRef="usd">513000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjY1_c11f8e5b-f07b-424b-8ec2-81b5527fd1f5"
      unitRef="usd">1400000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1NjY1_fed4486b-bcbc-419f-8244-af8a7f1494af"
      unitRef="usd">1400000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1Njg2_36a04277-d720-417c-829c-0929fd25c8ad"
      unitRef="usd">116000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1Njky_fe7fb357-19e6-4c24-9a2a-b33b85994c48"
      unitRef="usd">117000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzIzMDg5NzQ0MjQ1Njk1_3ffaa6e4-506a-4ffa-9dfd-8b564de4b226"
      unitRef="usd">129000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <mck:InsuranceProgramsPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDI1_2c288cde-b577-4d81-bc69-0ff6c7def1ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Programs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#x201c;Captives&#x201d;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 18, &#x201c;Commitments and Contingent Liabilities,&#x201d; as well as those risks required to be insured by law or contract. It is the Company&#x2019;s policy to retain a significant portion of certain losses, including those related to workers&#x2019; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#x2019;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#x2019;s premium costs within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;</mck:InsuranceProgramsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTM_a14037ec-eaf4-4378-8d38-66818adc2894">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.&lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#x2019;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#x2019; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#x2019;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 98% and 2% of total revenues for each of the years ended March 31, 2022, 2021, and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.2 billion in 2022 and $3.1 billion in each of 2021 and 2020. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2022 and 2021. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#x2019;s services arrangements and are recognized as revenues over the periods when services are performed. &lt;/span&gt;&lt;/div&gt;The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2022 and 2021. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i96172b3b6b994d48bf70c6de9f508828_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MTI_124d594b-52fd-46b1-b4dc-bb313c176014"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6056d0a51a7f4646bfa84408265c81c0_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MTI_705d4487-d1d9-4619-a762-94277a57e4bb"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1e41ae776e234aad99573060abfa3d60_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MTI_a5c385ee-ce1a-4ac4-988b-a34ec26f8b69"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0e210e8bb0d04564b3c8c5efbc105415_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MjA_1de803e2-4106-45b4-9218-599518e64cc2"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic483b5ea8e204c8a81418d102f77e31e_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MjA_be4836ab-c71f-4ad1-bce1-fc7d7a07fe93"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i24fc415a058448cabaac1543f414ee42_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTg5MjA_c08b977d-c5a6-477d-8d15-3ab13e1b339c"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTkwNzE_16195623-ec7d-4629-bb6a-095cf2b4afbb"
      unitRef="usd">3200000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTkwODY_263b0b0a-96a9-4ebe-a77f-8003917407cf"
      unitRef="usd">3100000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQzOTgwNDY1NTkwODY_ab365f51-48dc-436f-855d-4a9513a73baf"
      unitRef="usd">3100000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:SupplierIncentivesPolicyPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDAz_dbbbb738-1330-4ffc-a045-eb9d875c99f0">Supplier Incentives: Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.</mck:SupplierIncentivesPolicyPolicyTextBlock>
    <mck:SupplierReservesPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDM2_da933989-9a67-4a17-b4a7-5eae327e911a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Reserves: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims may be different than the Company&#x2019;s estimate. The supplier reserves primarily pertain to the Company&#x2019;s U.S. Pharmaceutical segment.&lt;/span&gt;</mck:SupplierReservesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDE0_bb88b692-26ed-4d21-9d6c-ee78a82d10c2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon effective settlement.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InterestExpensePolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzEw_a1915bb2-c282-4b3b-82a4-04c48f7f493a">Interest Expense: Interest expense primarily includes interest for the Company&#x2019;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</us-gaap:InterestExpensePolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDA4_e0d76dc0-4c86-41fa-a037-ebbb52469f2b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#x2019; equity (deficit) accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity (deficit) section of the Consolidated Balance Sheets. Realized gains and losses from currency exchange transactions are recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations and were not material in 2022, 2021, or 2020. The Company releases cumulative translation adjustments from stockholders&#x2019; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjcw_2ab29cff-1ff6-4575-a7e5-8663b4fd6e7c">Derivative Financial Instruments: Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company uses foreign currency-denominated notes and cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; equity (deficit) section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 15, &#x201c;Hedging Activities,&#x201d; for additional information.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzk4_f8302665-9246-4154-bc70-c01f3c891384">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Income (Loss): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#x2019; equity (deficit) but are excluded from earnings. The Company&#x2019;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;unrealized gains and losses on retirement-related benefit plans.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDQ1_e50a2dad-2a71-4146-9c7d-37f5734ae68a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests and Redeemable Noncontrolling Interests: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes recurring compensation that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. Net income attributable to noncontrolling interests also includes third-party equity interests in the Company&#x2019;s consolidated entities including Vantage Oncology Holdings, LLC (&#x201c;Vantage&#x201d;) and ClarusONE Sourcing Services LLP (&#x201c;ClarusONE&#x201d;), which was established between McKesson and Walmart, Inc in 2017. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#x2019;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#x2019; equity (deficit) in the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 8, &#x201c;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#x201d; for additional information.&lt;/span&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzUy_49d516ad-25c2-49ca-b1b2-9c664cb29650">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees. Refer to Financial Note 5, &#x201c;Share-Based Compensation,&#x201d; for additional information.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDAy_85e06398-47ae-4a42-98ea-418c52b04300">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 18, &#x201c;Commitments and Contingent Liabilities,&#x201d; for additional information related to ongoing controlled substances claims to which the Company is a party.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMjgy_46a53e20-e55d-4713-9ebb-872a3d4a275d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; for additional information.&lt;/span&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwMzcw_ba5c2176-7e53-4aaf-bceb-8eaf3f1035c5">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a method that is a form or variation of the income approach, whereby a forecast of future cash flows attributable to the asset are discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#x2019;s expected useful life.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <mck:TreasuryStockPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzI3NDg3NzkxNDMxMTQ_b2e4a9d5-2d90-4bb7-a70f-2d6baf419270">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#x2019; equity in the Company&#x2019;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.&lt;/span&gt;</mck:TreasuryStockPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMDkvZnJhZzo3OWIxM2E2Nzk3Mzc0OTk3OTI0NjhjOTRhYjIxNmY4Mi90ZXh0cmVnaW9uOjc5YjEzYTY3OTczNzQ5OTc5MjQ2OGM5NGFiMjE2ZjgyXzQwNDMy_a28e810a-4fcd-4ff7-bd09-620bc7e724c9">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company prospectively adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#x2019;s consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no recently issued accounting standards that could have a material impact to the Company&#x2019;s financial position, results of operations, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzI3NDg3NzkxMTU2MzQ_a39ccaa4-08e9-47c9-8cdd-1160a188420b">Held for Sale &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company announced its intention to exit its businesses in Europe (&#x201c;European Divestiture Activities&#x201d;). These activities, further described below, constitute the majority of the assets and liabilities classified as held for sale as of March 31, 2022. Total assets and liabilities that have met the classification as held for sale were $4.5&#160;billion and $4.7&#160;billion, respectively, as of March 31, 2022 and $12&#160;million and $9&#160;million, respectively, as of March 31, 2021, primarily included within the Company&#x2019;s International segment. The Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations. During the year ended March 31, 2022, the Company recorded charges totaling $1.6&#160;billion, primarily to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell. These charges were largely driven by declines in the British pound sterling and the Euro. During the years ended March 31, 2021 and 2020, the Company recorded losses of $58&#160;million and $275&#160;million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to a joint venture with Walgreens Boots Alliance (&#x201c;WBA&#x201d;) which was completed on November 1, 2020. These charges in each year were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;European Divestiture Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2021, the Company entered into an agreement to sell certain of its businesses in the European Union (&#x201c;E.U.&#x201d;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#x201c;E.U. disposal group&#x201d;) to the PHOENIX Group for a purchase price of &#x20ac;1.2&#160;billion (or, approximately $1.4&#160;billion) adjusted for certain items, including cash, net debt, and working capital adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;) at the transaction closing date. The transaction is anticipated to close within the second half of fiscal year 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2022, the Company recorded charges totaling $438&#160;million to remeasure the E.U. disposal group to fair value less costs to sell. These charges also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole. The remeasurement adjustment includes net losses of $151&#160;million related to the accumulated other comprehensive income balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations. The Company&#x2019;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2021, the Company announced an agreement to sell its retail and distribution businesses in the United Kingdom (&#x201c;U.K. disposal group&#x201d;) to Aurelius Elephant Limited. In April 2022, the Company entered into an amendment to the agreement for a purchase price of &#xa3;110&#160;million (or, approximately $144 million), including certain adjustments. During the year ended March 31, 2022, the Company recorded charges totaling $1.2 billion, primarily consisting of adjustments to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustments include a $734 million loss related to the accumulated other comprehensive income balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations. The Company&#x2019;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy. The transaction closed on April 6, 2022 and, at closing the buyer assumed and repaid a note payable to the Company of approximately $118&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2022, the Company completed the sale of its Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#x20ac;244&#160;million (or, approximately $276 million), including certain adjustments. The Company divested net assets of the Austrian business of $272 million, primarily within the International segment, and the buyer assumed a note payable to the Company of approximately $63 million which was paid to McKesson in the fourth quarter of 2022. During the year ended March 31, 2022, the Company recognized a loss of $32 million which was recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;German Pharmaceutical Wholesale Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2020, the Company completed a transaction with WBA whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson had a 30% noncontrolling interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction consideration for the contribution included a receivable amount of $41 million, primarily related to working capital and net debt adjustments from WBA, which was received in the first quarter of 2022, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of March 31, 2021. The Company accounted for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $291 million as of the transaction date, which was paid to the Company in 2021.&lt;/span&gt;&lt;/div&gt;In conjunction with the contribution, the Company recorded losses of $58 million and $275 million, respectively, in the years ended March 31, 2021 and 2020, which included adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. The Company&#x2019;s measurement of the fair value of the German pharmaceutical wholesale business disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if5fc2a45b1fb4a57a52e375ee61e2e18_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NTY_a699fe8f-f414-4c64-9dcf-ce10fc5e12cc"
      unitRef="usd">4500000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="if5fc2a45b1fb4a57a52e375ee61e2e18_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NTk_8a20f0f0-d905-4eb9-881a-7bb40a20c042"
      unitRef="usd">4700000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iaf194e10ae1d4f91ab6ebadc346e333c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NjI_5f0ba9b8-918d-438c-85da-790bf9b37b52"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iaf194e10ae1d4f91ab6ebadc346e333c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2MzI1NjU_872f06f4-b003-484f-beb5-0a51c41e7813"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ib36ffbe522794177a4a329b2f1eb434e_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NzUwMDc_789c1dba-dee2-4dd9-9309-0b3861feba42"
      unitRef="usd">1600000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i8727a45639054efb97996743cbbaa5c5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NDI1NzU_29165993-6c8f-411f-800f-98986efda516"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="iafca086d825c49179df146b9365fef4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NDI1OTI_2ef572d5-934a-4b99-9c83-b181609dcd8e"
      unitRef="usd">275000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i9cb26398b07540459c29d095fcbe163a_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NTk5NjI_076e2f4e-0c9a-4b20-884b-0dadcc4cce74"
      unitRef="eur">1200000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i9cb26398b07540459c29d095fcbe163a_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NTk5ODc_acc6f070-63b7-4cfb-a964-cf1c97ae7a8b"
      unitRef="usd">1400000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwMDc_9ed44f13-c97b-4ef7-a080-15d7173a7ec1"
      unitRef="usd">438000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwMjQ_5f71dff4-6984-46dd-895e-eb4f643df27c"
      unitRef="usd">151000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzI3NDg3NzkxMTU2MzU_3f7ebaa0-63c6-44d6-9b3b-64355e0ee205">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that have met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges related to the impairment of individual assets, which are primarily comprised of a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the U.K. disposal group that have met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzMtMS0xLTEtOTE2OTc_7347befd-1f6d-407f-84fe-32a0ae7c1d9e"
      unitRef="usd">1322000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzQtMS0xLTEtOTE2OTc_57f47390-b151-4918-8e16-68d067bda89b"
      unitRef="usd">809000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzUtMS0xLTEtOTE2OTc_0d7fef96-b433-465a-b25c-9077310bd6d8"
      unitRef="usd">72000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzYtMS0xLTEtOTE2OTc_e80726d0-8af5-4843-a344-5988e3007b2f"
      unitRef="usd">304000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzctMS0xLTEtOTE2OTc_2d49284f-4552-40b3-ad87-fa80ffe3cd11"
      unitRef="usd">224000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzgtMS0xLTEtOTE2OTc_b4d9d7e3-9ba9-44f8-bacc-019385bc370e"
      unitRef="usd">267000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzktMS0xLTEtOTE2OTc_d82190fb-786e-4aca-9342-4caa976f5f2f"
      unitRef="usd">328000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzEwLTEtMS0xLTkxNjk3_f852c961-94c0-473e-821f-594b9b62aa85"
      unitRef="usd">302000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzExLTEtMS0xLTkxNjk3_cd05549d-727f-4d67-b78e-1568191e8cea"
      unitRef="usd">3024000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE1LTEtMS0xLTkxNjk3_0a67f619-2642-476b-b90e-985b13261754"
      unitRef="usd">1826000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE2LTEtMS0xLTkxNjk3_20515da0-c6ba-4228-b184-ade8c51ba35e"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE3LTEtMS0xLTkxNjk3_78399296-4a4e-444e-88c0-d1e4b3b10288"
      unitRef="usd">33000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE4LTEtMS0xLTkxNjk3_ec0c7992-0dab-4446-a224-c07ae256b931"
      unitRef="usd">473000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzE5LTEtMS0xLTkxNjk3_7659596c-55b4-46d4-bb61-d2948592f858"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIwLTEtMS0xLTkxNjk3_04a70c14-2bbb-4457-afd9-bd9c0b864210"
      unitRef="usd">55000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIxLTEtMS0xLTkxNjk3_2ee7dd40-8274-4ffa-8e5e-1602b0ded36a"
      unitRef="usd">180000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIyLTEtMS0xLTkxNjk3_8ae1027b-1e33-4c32-b503-5ea4911a78cb"
      unitRef="usd">138000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i148d988b662042b2a7deeb2a40ab602b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTo3MGQ3YmJmMmNlNWE0MjZiYWVkODEzMzU2ZThiMzA0NC90YWJsZXJhbmdlOjcwZDdiYmYyY2U1YTQyNmJhZWQ4MTMzNTZlOGIzMDQ0XzIzLTEtMS0xLTkxNjk3_65a1f05c-1438-4760-bd84-5959fa4733e6"
      unitRef="usd">2720000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware
      contextRef="i29e231614cf344e4b636aecd2998ddde_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NDgwMjk_5c500669-672c-44d2-8637-f4b9536896fc"
      unitRef="usd">113000000</mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="ifd0254ffce6f4249b8b5901d3add0491_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwNDU_90248c0e-adc8-46ed-ab7b-28a250086249"
      unitRef="gbp">110000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="ifd0254ffce6f4249b8b5901d3add0491_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwNjc_d5ee33fe-6540-400b-86cd-838452f01eb6"
      unitRef="usd">144000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i03a43c3fab9f446eb0a8de876cfc5913_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAwODQ_9538f335-3ec1-4388-8554-6fa1b1776033"
      unitRef="usd">1200000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i03a43c3fab9f446eb0a8de876cfc5913_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxMDE_4b1eae39-edf5-42f7-8fdf-74fb62cb0da5"
      unitRef="usd">734000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i78ccaa920a9a4c73a30399adf8117855_D20220401-20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NzM0Njk_9e47f877-c04a-4693-9cb7-b61bbaa161ac"
      unitRef="usd">118000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzMtMS0xLTEtMTEzMDIz_1dca8f26-a4fd-49ad-9291-71262ab3b04f"
      unitRef="usd">531000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzQtMS0xLTEtMTEzMDIz_7c6e45d7-c152-4d9b-bb2a-058fa095edaf"
      unitRef="usd">931000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzUtMS0xLTEtMTEzMDIz_53465a1c-f5d7-4541-a229-551741f364a5"
      unitRef="usd">563000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzYtMS0xLTEtMTEzMDIz_74bf789a-025f-4993-9fe2-b8a684d2eb4c"
      unitRef="usd">50000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzctMS0xLTEtMTEzMDIz_ac199287-665b-479c-8e12-e154ce385e64"
      unitRef="usd">91000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzgtMS0xLTEtMTEzMDIz_193199ba-4b53-449d-a333-0c4f1cd9b469"
      unitRef="usd">270000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzktMS0xLTEtMTEzMDIz_43b8899f-7f1b-4d67-bfe3-d3cb94ee8f6d"
      unitRef="usd">117000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzEwLTEtMS0xLTExMzAyMw_96401214-9a24-42ab-b1d5-3d0fc7d6f134"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzExLTEtMS0xLTExMzAyMw_83558e36-2921-451e-81d1-28af6727a4ba"
      unitRef="usd">1159000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzEyLTEtMS0xLTExMzAyMw_24ac0259-5de5-4194-8315-73d8218fda72"
      unitRef="usd">1482000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzE2LTEtMS0xLTExMzAyMw_428d4a46-ac11-448e-b24a-f6fc077fc867"
      unitRef="usd">1593000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzE4LTEtMS0xLTExMzAyMw_8710840e-4931-4d3e-94f2-b099d4fe8e7f"
      unitRef="usd">50000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzE5LTEtMS0xLTExMzAyMw_453a9a6f-c32c-4471-9b06-05eb396d7078"
      unitRef="usd">59000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzIxLTEtMS0xLTExMzAyMw_64226c94-4c98-4f6c-80cc-795c5eaa553d"
      unitRef="usd">16000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzIyLTEtMS0xLTExMzAyMw_aee21b0b-beae-4635-9817-3fa6d2c00633"
      unitRef="usd">262000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzIzLTEtMS0xLTExMzAyMw_cee97a51-3f1b-4b37-9e52-31a8e35cca67"
      unitRef="usd">38000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i72fd68575bf94328b58c74040ee351f4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90YWJsZTpkMTk1OGMzY2MyNWU0MzkxOWZlZTA3NThhMzI1OTZhMC90YWJsZXJhbmdlOmQxOTU4YzNjYzI1ZTQzOTE5ZmVlMDc1OGEzMjU5NmEwXzI0LTEtMS0xLTExMzAyMw_f444991f-a15d-46ca-9cf7-1287bdc6f8ba"
      unitRef="usd">2018000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i0adedf0f78e24ba5b61ec3c4ef5b7cbf_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxMTk_d172f735-461b-43bb-8cf7-a06c9e67a84d"
      unitRef="eur">244000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i0adedf0f78e24ba5b61ec3c4ef5b7cbf_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxNDE_bbd66635-f8e3-461a-b0d2-720b4a81cf88"
      unitRef="usd">276000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:AssetsNet
      contextRef="ia2d3e091542c4331aa802c94a7053cc5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NzMyMjk_a8eee715-28c7-43d3-bea9-a4faa586d47a"
      unitRef="usd">272000000</us-gaap:AssetsNet>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i805540d4c73c4b6387871c54c384fbbf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxNjc_94939154-b1c5-4dd7-9148-cd0a29957a87"
      unitRef="usd">63000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i6fd8b5bc85ab463b9b570056218ced7a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAxOTg_fe37f50d-c567-44cf-9340-1cbebffdfa93"
      unitRef="usd">32000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie3680721de0643ebb55f9f02576ae3ff_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMDc_bef0d14f-63da-4928-a3dd-1a7dc43fa06f"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="i9f12825bbb7d4be19f89e6a7c0f56679_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMjI_1875de95-9507-4bd7-8f26-0d4c9651bfe9"
      unitRef="usd">41000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie3680721de0643ebb55f9f02576ae3ff_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMzE_bef0d14f-63da-4928-a3dd-1a7dc43fa06f"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i5bb3e221693840dbb9ad1863bc6749ce_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyMzg_97f1d884-6045-4599-8b7d-437d28e95299"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i9ee10d37e08c43bb976ba37d004b5745_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyNTY_3b4be6be-309d-4cec-8ee7-99836c6367ab"
      unitRef="usd">291000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i8727a45639054efb97996743cbbaa5c5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyNzM_29165993-6c8f-411f-800f-98986efda516"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="iafca086d825c49179df146b9365fef4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTUvZnJhZzo5ZjhjN2NmNWNlMWQ0NmVlYjE1NGE5OTAyYzk3OWE5Zi90ZXh0cmVnaW9uOjlmOGM3Y2Y1Y2UxZDQ2ZWViMTU0YTk5MDJjOTc5YTlmXzEwOTk1MTE2NjAyOTE_2ef572d5-934a-4b99-9c83-b181609dcd8e"
      unitRef="usd">275000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwMzA3_2e10c7b3-f239-4bd2-b308-5f50d9dfba21">Restructuring, Impairment, and Related Charges, Net &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges, net, of $281 million, $334 million, and $268 million in 2022, 2021, and 2020, respectively. These charges are included in &#x201c;Restructuring, impairment, and related charges, net&#x201d; in the Consolidated Statements of Operations. In addition, for the years ended March 31, 2021 and 2020, certain charges related to restructuring initiatives were included in &#x201c;Cost of sales&#x201d; in the Consolidated Statements of Operations and were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#x2019;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $124 million for the year ended March 31, 2022, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#x201c;U.K.&#x201d;), which is included in the Company&#x2019;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the year ended March 31, 2022 and were $57 million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in 2022 and remaining costs the Company expects to record under this initiative are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company continues to implement centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also include reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $62 million and $72 million in 2021 and 2020, respectively, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in 2021 and remaining costs the Company recorded under this initiative were not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $28 million and $44 million in 2021 and 2020, respectively, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021 and remaining costs the Company recorded under this initiative, primarily relating to lease costs, were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 25, 2018, the Company announced a strategic growth initiative intended to drive long-term incremental profit growth and to increase operational efficiency. The initiative consisted of multiple growth priorities and plans to optimize the Company&#x2019;s operating models and cost structures primarily through centralization, cost management, and outsourcing of certain administrative functions. As part of the growth initiative, the Company committed to implement certain actions including a reduction in workforce, facility consolidation, and store closures. This set of initiatives was substantially complete by the end of 2020 and charges in 2021 were not material. The Company recorded charges of $15 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2022 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#x2019;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#x2019;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#x2019;s headquarters described above in addition to various other initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with dispositions and costs related to the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the years ended March 31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $52 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, the Company recognized charges totaling $36 million to impair certain long-lived assets within the International segment related to the Company&#x2019;s operations in Denmark and its retail pharmacy businesses in Canada. The Company used an income approach (a DCF method) and a market approach to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#x2019;s International segment. These charges primarily related to long-lived assets associated with the Company&#x2019;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach and a market approach to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company recognized charges of $82 million to impair certain long-lived and intangible assets for its retail pharmacy business in Europe within the Company&#x2019;s International segment. These charges related primarily to intangible assets associated with pharmacy licenses within the U.K. retail business due to a decline in estimated future cash flows driven by additional U.K. government reimbursement reductions communicated in the third quarter of 2020. The Company used a combination of an income approach and a market approach to estimate the fair value of the long-lived and intangible assets. &lt;/span&gt;&lt;/div&gt;In 2020, the Company performed an interim impairment test of long-lived and intangible assets for its Rexall Health retail business, within the Company's International segment, due to the decline in the estimated future cash flows primarily driven by lower than expected growth in both prescription volume and sales of non-prescription goods. As a result, the Company recognized a charge of $30 million to impair certain long-lived and intangible assets, primarily customer relationships. The Company used an income approach for estimating the fair value of the long-lived and intangible assets.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg4MDgz_a059a6cb-81cd-4d03-850e-8ed14ff972ec"
      unitRef="usd">281000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg4MDg4_7c8ac650-d29e-4c2a-a597-6067153e71fa"
      unitRef="usd">334000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg4MDk3_7bc20250-d9d7-48de-aa33-6f5591411930"
      unitRef="usd">268000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia00ccbaf67b84520a82cd5bc577ccbf8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwOTk1MTE2Mjg5MDQ4_a2b0c4c6-cafa-4729-9917-a6f46339cebe"
      unitRef="usd">124000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i33304856ba67431dbe134e6a3ab5f8b0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMxNzM_c29ebc95-1824-4d35-8500-bebd3db3108e"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1a27f3b5cf9d4d86a3c7d1030055337c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMxODQ_3b824654-307e-445a-b318-ddf9afb5aaf4"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i86e51851e38343d889528a7d74ce170b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMxOTM_bd7c1069-cf23-44e5-9459-775c97c842bd"
      unitRef="usd">72000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id91a5fa4a09149dda8dc0d199e094ffe_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMyMzI_97b50f30-2dc2-4afb-b225-cd1fbcc89218"
      unitRef="usd">28000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i41c0c862a7ce4612a21718defa31e238_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjMyNDE_263e7bdf-1f2b-42ca-8b6f-a9236038b971"
      unitRef="usd">44000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i69ad3377d9084d09824adc34ca4401cc_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MjM4MDk_3f7d7bc4-2909-472c-ad37-7d79fdb7d72c"
      unitRef="usd">15000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzEwMzA0_9a6eac23-602b-4283-a0b3-105a0e8a4a5c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#x2019;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#x2019;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#x2019;s headquarters described above in addition to various other initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with dispositions and costs related to the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the growth initiative described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the growth initiative, operating model cost optimization efforts, and with the relocation of the Company&#x2019;s corporate headquarters described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMS0xLTEtNjc1MTI_ba875c85-7c5c-4d06-93ef-369b5f79be08"
      unitRef="usd">8000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMy0xLTEtODkyNTg_3635f4d1-e58c-4bc6-95ab-77668df9aa33"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItNS0xLTEtODkyNzI_3a7220f7-e41f-43e9-8eea-9c54f678b839"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMy0xLTEtNjc1MTI_aa6dccdb-35a1-49fa-99c1-faf1798d8fb9"
      unitRef="usd">8000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItOS0xLTEtNjc1MTI_075a9ff1-44c7-47e5-b0ac-08ffe90c102e"
      unitRef="usd">-7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzItMTEtMS0xLTY3NTEy_427dcca4-f0da-4fee-bd15-df2083b09c5f"
      unitRef="usd">9000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMS0xLTEtNjc1MTI_6ad34e3a-229a-4047-bce9-c027316bf0e2"
      unitRef="usd">9000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMy0xLTEtODkyNTg_248b535f-c0ac-4d58-8e09-dd75d3d62943"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtNS0xLTEtODkyNzI_9474909c-0912-4b06-af2c-6c003b902466"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMy0xLTEtNjc1MTI_8b6414bd-b634-4b43-af56-9b5e5e4f6641"
      unitRef="usd">33000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtOS0xLTEtNjc1MTI_86f4e020-e7d8-4a3a-8b5c-61b214f41c5d"
      unitRef="usd">46000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzMtMTEtMS0xLTY3NTEy_f796f961-bd6e-462f-8796-9949a8d2d8ed"
      unitRef="usd">97000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMS0xLTEtNjc1MTI_32746993-53c8-47eb-8947-c8eb5408f5c1"
      unitRef="usd">18000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMy0xLTEtODkyNTg_076111c7-5115-47ed-9188-5d0a97f13f43"
      unitRef="usd">20000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtNS0xLTEtODkyNzI_fc93669e-0c46-408c-b368-5d636d9eac57"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMy0xLTEtNjc1MTI_6fa77c33-e309-4550-9fde-0eb079dff0f7"
      unitRef="usd">35000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtOS0xLTEtNjc1MTI_b7c7c1b9-d270-49fa-8ec3-16d589c5f1de"
      unitRef="usd">61000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzQtMTEtMS0xLTY3NTEy_2e0f3fc4-3bbe-47ee-88c8-aa1719600bb5"
      unitRef="usd">139000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMS0xLTEtNjc1MTI_ba99c46a-d0cb-442f-bc12-bb371da12e19"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMy0xLTEtODkyNTg_70f9d2d0-907f-475e-9f23-1ca263d9104a"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtNS0xLTEtODkyNzI_64d8a675-1243-4b59-96cf-8dd3601f780b"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMy0xLTEtNjc1MTI_be30ec6f-08b6-4238-83a8-02d415383d9a"
      unitRef="usd">76000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtOS0xLTEtNjc1MTI_b53f6c31-b647-466b-b3b4-85252afb9adb"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTpiNDUzYWY3Y2NlYjU0ZDY4YTNiM2JkMmYxOTQ3ZTRiMC90YWJsZXJhbmdlOmI0NTNhZjdjY2ViNTRkNjhhM2IzYmQyZjE5NDdlNGIwXzUtMTEtMS0xLTY3NTEy_3065443e-6e0f-48b0-a7f4-31ab4e427582"
      unitRef="usd">245000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMS0xLTEtNjc1MTI_715fec57-39dd-4d0e-a62d-6eb820838d6b"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMy0xLTEtODkzODk_2dfbd662-1a38-4d0f-a496-f80b81a49ac5"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItNS0xLTEtODk0MDA_e61dec03-91b8-4cf1-ae4c-485a83f24068"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMy0xLTEtNjc1MTI_e04bb60b-83e5-4896-baa8-25e2263128d0"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItOS0xLTEtNjc1MTI_e0986f02-303d-43b1-8c0b-ec47edc67e87"
      unitRef="usd">69000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzItMTEtMS0xLTY3NTEy_68023934-9c5c-4044-b70d-09b8c81eb5ae"
      unitRef="usd">104000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMS0xLTEtNjc1MTI_d3146e1e-2349-4cb8-8582-16aaeb1e6a00"
      unitRef="usd">11000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMy0xLTEtODkzODk_2f32768b-2b6c-4e7e-9484-f75989a7a32b"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtNS0xLTEtODk0MDA_f22e8fea-2040-4e73-956b-28a6f71ca781"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMy0xLTEtNjc1MTI_e329ccc0-847b-4052-a600-8331e31006bc"
      unitRef="usd">17000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtOS0xLTEtNjc1MTI_f2bd56cf-12b7-4d71-85f0-55322302c4ff"
      unitRef="usd">27000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzMtMTEtMS0xLTY3NTEy_5e32da84-e21c-40ea-bfed-cf34d935b43b"
      unitRef="usd">59000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMS0xLTEtNjc1MTI_e380d561-fcd8-4eaa-bd60-0680ee85b057"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMy0xLTEtODkzODk_f81f0a77-c1b0-4ada-b75d-97f347aeddc1"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtNS0xLTEtODk0MDA_a7d7cafa-a397-43f8-8fd9-19fcb2ea2ca8"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMy0xLTEtNjc1MTI_4588dd1d-f7e9-4bf0-9f4f-e076cb59c9ff"
      unitRef="usd">46000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtOS0xLTEtNjc1MTI_f6493c98-0d00-462c-a1c2-0bd95af86f55"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzQtMTEtMS0xLTY3NTEy_5fa62dd0-a19e-4842-a676-1ec89408c06f"
      unitRef="usd">56000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMS0xLTEtNjc1MTI_1edd5ed9-aea0-4fdb-bf0d-f54e3da618db"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMy0xLTEtODkzODk_d3e5079b-3e93-4134-81c1-1b2dd1b2c2bc"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtNS0xLTEtODk0MDA_babbeff3-df4f-4bbb-a90a-5346a1e0289e"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMy0xLTEtNjc1MTI_35c16db7-4503-4d81-872c-a040249c567d"
      unitRef="usd">85000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtOS0xLTEtNjc1MTI_bba2fad3-ce51-4e93-aeb3-539f8cf0858f"
      unitRef="usd">105000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo1YzdkMjllMDAxZjQ0NDMyYWEwYTg2YmFmNWE1OGFlOS90YWJsZXJhbmdlOjVjN2QyOWUwMDFmNDQ0MzJhYTBhODZiYWY1YTU4YWU5XzUtMTEtMS0xLTY3NTEy_4b1bdc7a-aa7f-4b8b-9f8c-42275f323604"
      unitRef="usd">219000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMS0xLTEtNjc1MTI_36c87022-de18-4a14-913c-37131810bf77"
      unitRef="usd">12000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMy0xLTEtODk1MDI_2f5fde80-3813-4820-af8c-0efeaef8dd51"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItNS0xLTEtODk1MTM_0b6d0ca5-7535-4ab6-bfea-186201f5f2ea"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMy0xLTEtNjc1MTI_53b54b0a-acc4-4943-a62a-e2e5d79843c5"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItOS0xLTEtNjc1MTI_b96385c7-5255-4931-bba7-7a40437044d3"
      unitRef="usd">30000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzItMTEtMS0xLTY3NTEy_e2dd10ec-657d-4fb4-a48e-751bf1e593a4"
      unitRef="usd">47000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMS0xLTEtNjc1MTI_784b76b0-a5ac-42d3-b517-7e1dd338f088"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMy0xLTEtODk1MDI_6aaf3343-929f-4a6e-9a31-57f2d583ae81"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtNS0xLTEtODk1MTM_e47df77f-e10b-4af4-a821-260845f63df8"
      unitRef="usd">19000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMy0xLTEtNjc1MTI_422b71a8-c6d7-4545-b179-33d7577dfc16"
      unitRef="usd">13000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtOS0xLTEtNjc1MTI_28ec0485-4088-4e82-923c-2e4353f40f11"
      unitRef="usd">46000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzMtMTEtMS0xLTY3NTEy_1b904168-e186-417e-a1df-69c035b2b4eb"
      unitRef="usd">79000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMS0xLTEtNjc1MTI_bfdccb9e-0779-4733-b532-82af5ba26511"
      unitRef="usd">10000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMy0xLTEtODk1MDI_e32deeb3-d1dd-4389-87c4-abcc0392022d"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtNS0xLTEtODk1MTM_d71b0c80-e54d-4c69-b606-944a49019ddd"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMy0xLTEtNjc1MTI_d03f10e3-e2a5-4102-84cf-763551c197f7"
      unitRef="usd">6000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtOS0xLTEtNjc1MTI_f418440f-5599-4175-ab51-e4de7c9ec5dc"
      unitRef="usd">13000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzQtMTEtMS0xLTY3NTEy_a45cffaa-2c9f-4c4d-8612-6033856f7659"
      unitRef="usd">30000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMS0xLTEtNjc1MTI_bc9158ce-ca0a-4843-98ab-90b076a0b87d"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMy0xLTEtODk1MDI_0a012d4c-47b3-4f6a-a5c2-f4c2eb8fb039"
      unitRef="usd">-1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtNS0xLTEtODk1MTM_7fd4308c-9a7f-4029-ac75-baa7bbe7b969"
      unitRef="usd">24000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMy0xLTEtNjc1MTI_4d36e263-1b7f-44d4-a751-62af838d6776"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtOS0xLTEtNjc1MTI_a7b4a3e9-d554-48d0-aebd-b2853a609b4f"
      unitRef="usd">89000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo3YTEyNzk1YTZiYjg0MTg0YjhlMTVlNjhkNzYyMWI0NC90YWJsZXJhbmdlOjdhMTI3OTVhNmJiODQxODRiOGUxNWU2OGQ3NjIxYjQ0XzUtMTEtMS0xLTY3NTEy_c2459a79-0636-4617-a53c-d2d86c4c61f8"
      unitRef="usd">156000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzI3NDg3NzkwOTAxNDE_df534eae-c104-40ce-bbad-8453a0aa0288">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the years ended March 31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $52 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i1238be9949344a4ca03b1fd2035c6266_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMS0xLTEtNjc1MTI_12c87e4b-d879-41a3-9831-6b7b62e9a020"
      unitRef="usd">29000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i735f207277504040936a46b7a21dbc2a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMy0xLTEtODk2MzQ_136c3581-2eb9-4513-b249-3ff7a6803cad"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i44ae2fd5d4d84827a40c6ccf806b3215_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtNS0xLTEtODk2NDU_9aff3c87-8eda-4dfd-96be-8993e91eea5d"
      unitRef="usd">22000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7657b4a360fd42b382531c0ba2049a37_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMy0xLTEtNjc1MTI_f594510e-78ad-444e-a1f1-fef62a611d6d"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i819b3e5a18554614be6da3dc30c8c20e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtOS0xLTEtNjc1MTI_f89b0903-3ce2-42cb-a15d-b7b943158e3b"
      unitRef="usd">39000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEtMTEtMS0xLTY3NTEy_42d8a47d-6726-4460-a8b1-d44378d23881"
      unitRef="usd">157000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMS0xLTEtNjc1MTI_03101977-1375-4f1d-8f66-3bdfbc22ec9b"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMy0xLTEtODk2MzQ_36968e54-b40e-4323-a5dd-036932ad9432"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItNS0xLTEtODk2NDU_10e984f5-58ac-433f-96f8-7539232be1fd"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMy0xLTEtNjc1MTI_23447db6-4abc-4dc3-8745-d55093903aaf"
      unitRef="usd">85000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItOS0xLTEtNjc1MTI_72c75051-e3fb-4cc0-b512-0d160beefc61"
      unitRef="usd">105000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzItMTEtMS0xLTY3NTEy_5026e923-2d8d-4f69-b151-d6d149aced5d"
      unitRef="usd">219000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMS0xLTEtNjc1MTI_9263b6a9-6393-4a01-84f3-bf4da7dfe621"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMy0xLTEtODk2MzQ_662bd86b-78b7-4eda-9e97-f7a3a66a099c"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtNS0xLTEtODk2NDU_5bc54514-48ba-44ad-9331-b70d26845981"
      unitRef="usd">1000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMy0xLTEtNjc1MTI_860f2f62-7df0-48df-b9f9-6dbe014fcadc"
      unitRef="usd">46000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtOS0xLTEtNjc1MTI_1478827f-d735-42ce-b169-b53cb930a7ba"
      unitRef="usd">9000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzMtMTEtMS0xLTY3NTEy_a53cb152-8ff0-438a-b01b-42a84b6ffc77"
      unitRef="usd">56000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMS0xLTEtNjc1MTI_56de145c-c5d2-4181-8ab7-4fdd95e6297c"
      unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMy0xLTEtODk2MzQ_12a2b584-bd4d-43e3-9e34-21d87340b0f4"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtNS0xLTEtODk2NDU_9033baad-d4e5-471b-a0c4-ece65ea3a23b"
      unitRef="usd">21000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMy0xLTEtNjc1MTI_416fca8c-6a98-426d-87d1-4737b95cc5d6"
      unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtOS0xLTEtNjc1MTI_3f29e8cf-d305-45c9-8afd-aca2df802828"
      unitRef="usd">75000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzQtMTEtMS0xLTY3NTEy_ef70b894-3e15-4af1-a74f-94e852168fd5"
      unitRef="usd">159000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMS0xLTEtNjc1MTI_b09f880e-478a-44cb-83d0-0f0c92c64652"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMy0xLTEtODk2MzQ_1f6bf9f7-8056-48bc-9aa9-1a71d435f304"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtNS0xLTEtODk2NDU_1de6a342-3115-4111-bc59-b03fad12e9ff"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMy0xLTEtNjc1MTI_8c40d220-f16c-4bfe-b7d6-f41664ce7aaa"
      unitRef="usd">-8000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtOS0xLTEtNjc1MTI_145a7b16-142a-4951-a18b-6dbd5dff00f1"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzUtMTEtMS0xLTY3NTEy_e0aafa20-8a19-4e4d-9a0d-9d86acd5eb54"
      unitRef="usd">-10000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="iaf37a2aea301469bbf8c95c1cb87dea0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMS0xLTEtNjc1MTI_a3517c01-a6b3-48e5-a85e-fd6ed5a4f782"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i38e69dbb765c4cbba679db0d75d4e24d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMy0xLTEtODk2MzQ_b79517b1-d226-443d-b8a6-543c694408a1"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3836c14e169d426385529b1516d34376_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtNS0xLTEtODk2NDU_3407e375-ad49-4a41-8b8a-8f9f05069004"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifbae9d0f6df24779a201d5522b29b806_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMy0xLTEtNjc1MTI_8c1e15f0-0b58-4837-92b4-6955e272ee20"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie5920306c6c74407aa3c61813edac174_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtOS0xLTEtNjc1MTI_6defcc45-e208-4e12-8f54-8d41ec71454b"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzYtMTEtMS0xLTY3NTEy_72e62a69-8878-4049-bdb4-d2b849e4a39d"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMS0xLTEtNjc1MTI_22dbb456-3b88-45a0-b49e-45d388ab81dc"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMy0xLTEtODk2MzQ_64364409-2a94-43e8-9d67-e842579bdb0a"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctNS0xLTEtODk2NDU_0a0d35c0-0221-4201-a83a-7340c5b0f8b1"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMy0xLTEtNjc1MTI_703a9962-9a8c-4389-afa4-9f0920feef83"
      unitRef="usd">76000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctOS0xLTEtNjc1MTI_257904b8-d2a7-4f8f-9a6c-0d60e98cd787"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzctMTEtMS0xLTY3NTEy_a4b1e687-e1a7-42c8-b5c1-45d35b878474"
      unitRef="usd">245000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMS0xLTEtNjc1MTI_8e18ff6a-7fa3-49f7-a477-019bc68f4c9e"
      unitRef="usd">18000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMy0xLTEtODk2MzQ_f2271681-1f1a-4504-8683-c46330c7d9f9"
      unitRef="usd">20000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtNS0xLTEtODk2NDU_c1a37185-5f57-4f06-a938-d4f0fec175e3"
      unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMy0xLTEtNjc1MTI_bb60439c-acc2-44a5-be86-b1c656b17fa3"
      unitRef="usd">35000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtOS0xLTEtNjc1MTI_785c66c1-41a9-49e6-8446-1f73fee4eef2"
      unitRef="usd">61000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzgtMTEtMS0xLTY3NTEy_a3d4ea5e-bcac-4164-b126-5f0f77577edf"
      unitRef="usd">139000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMS0xLTEtNjc1MTI_aa1fa0c0-4fad-41c7-b238-ba2a37b200c0"
      unitRef="usd">18000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMy0xLTEtODk2MzQ_144e4cc9-244c-4462-86ec-70b4b4c00277"
      unitRef="usd">6000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktNS0xLTEtODk2NDU_95f79243-d915-43e2-a3ee-76c2a6769825"
      unitRef="usd">6000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMy0xLTEtNjc1MTI_d75ba52d-8d80-4e6a-87fb-4b4ccb4663bf"
      unitRef="usd">28000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktOS0xLTEtNjc1MTI_87155cd9-ea1e-45db-80df-7574619b88fa"
      unitRef="usd">29000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzktMTEtMS0xLTY3NTEy_05fdc863-2a5a-435c-92d8-902046da1a30"
      unitRef="usd">87000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTEtMS0xLTY3NTEy_13f64748-3525-46bd-8bf8-4f50c8e5e147"
      unitRef="usd">-7000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTMtMS0xLTg5NjM0_b122b820-ba0e-43bb-8a80-12d902f52d04"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTUtMS0xLTg5NjQ1_5ccaf6a6-ae0e-41ca-91c1-a0888c82e567"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTMtMS0xLTY3NTEy_d99ed61b-3ed0-41af-ab9d-65c32946a612"
      unitRef="usd">-23000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTktMS0xLTY3NTEy_3bd87fc9-34a3-4738-b518-0937699a41d6"
      unitRef="usd">-10000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzEwLTExLTEtMS02NzUxMg_eb097718-c40b-4b68-b62f-35b38a0fad02"
      unitRef="usd">-40000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i75859372620f4bba9fcc690a92937930_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTEtMS0xLTY3NTEy_baa5f3ed-94e9-47b6-85d2-ebcb03cd9fbd"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3fe8302f1495433a8b56aac54216c93a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTMtMS0xLTg5NjM0_06772916-6bbc-4364-a48d-7a9fed31e858"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i60fde2da64904433badd4e9125f5242e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTUtMS0xLTg5NjQ1_672c6899-52aa-40fa-84d6-a530aac3a6a7"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i085f9b77e2ff45639871e3f6c4e87e81_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTMtMS0xLTY3NTEy_d28a53d7-35a5-4a00-8f70-26bf8fdd2534"
      unitRef="usd">56000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i136fbfde3b204ba88d3ef047c523f6d0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTktMS0xLTY3NTEy_089947c5-7efe-463e-9468-f773920caf15"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90YWJsZTo5OWVhMThjYjQwYzA0MmY3Yjg2Nzg1NTgxNDM4N2ZhMS90YWJsZXJhbmdlOjk5ZWExOGNiNDBjMDQyZjdiODY3ODU1ODE0Mzg3ZmExXzExLTExLTEtMS02NzUxMg_2943a746-6252-4a1d-8f80-44950e6546f8"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzNDc_ecf08dc5-9762-4213-a712-f875ce5b80af"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i94e33cbb297240f8b26bda1df5bbbe78_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzNTE_11a48b0b-199c-4325-829a-648d53cfa214"
      unitRef="usd">99000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifa3be7b53b364d71925dd6edb5685f60_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzMzE_962c15bb-e66b-45d7-8723-5225ac9ddc58"
      unitRef="usd">52000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MzI0MjM_186473a5-f38f-44f4-8c1b-465dd7dc6006"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1c6852c1f9a6482689173337df8e42e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIyOTQ_28e06e2c-1cb4-40b2-9de5-0e36e07ea128"
      unitRef="usd">58000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i70f13591242b45b99e2c1c5db5996175_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzMDQ_aa8ff937-0063-42a4-88d7-c81a4e9bda64"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iea0833513a6441c390d86adb1976e862_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTIzMTM_45079042-67b9-463d-8735-139694344ba0"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:AssetImpairmentCharges
      contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzQzOTgwNDY1MzI5MTA_d636ff38-9d3a-4c80-847b-675e1cd10910"
      unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTM5NzQ_feb0bc90-7789-4240-a54a-46ba9df5960f"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie75d55168ab54f22bd06fbcb372e660d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTM5ODM_6a133127-d136-4d91-b038-a2377c190e9e"
      unitRef="usd">82000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i014202a1f605442dbab72a51287eee8c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMTgvZnJhZzphNzA2Y2E5N2MwNGQ0YjVmOTFkNDAxNzNhM2YwMDA4Yi90ZXh0cmVnaW9uOmE3MDZjYTk3YzA0ZDRiNWY5MWQ0MDE3M2EzZjAwMDhiXzkzNDU4NDg4NTM5OTM_575e6eca-5ed1-4ef9-8ef9-c6d38629b154"
      unitRef="usd">30000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3ODM_d9197a57-dab1-4707-95b8-5462bd614b34">Business Acquisitions and Divestitures &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, 2021, and 2020, the Company did not complete any material acquisitions. For the three years presented, the Company completed several de minimis acquisitions within its operating segments. Financial results for the Company&#x2019;s business acquisitions have been included in the Company&#x2019;s consolidated financial statements since their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates. Goodwill recognized for business acquisitions is generally not expected to be deductible for tax purposes. However, if the assets of another company are acquired, the goodwill may be deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company announced its intention to exit its businesses in Europe. In 2022, the Company entered into agreements to sell the E.U. disposal group and U.K. disposal group and completed the previously announced sale of its Austrian business, as described in Financial Note 2, &#x201c;Held for Sale.&#x201d; In 2021, the Company contributed the majority of its German pharmaceutical wholesale business to a newly formed joint venture with WBA as discussed in Financial Note 2, &#x201c;Held for Sale,&#x201d; and, in 2022, sold its interest in the joint venture to WBA, as described in Financial Note 6, &#x201c;Other Income, Net.&#x201d; In 2020, the Company completed the separation of the Change Healthcare JV, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in the Change Healthcare Joint Venture &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2017, the Company contributed the majority of its McKesson Technology Solutions businesses to form a joint venture, the Change Healthcare JV, under a contribution agreement between McKesson and Change Healthcare Inc. (&#x201c;Change&#x201d;) and others, including shareholders of Change. In exchange for the contribution, the Company initially owned approximately 70% of the joint venture, with the remaining equity ownership of approximately 30% held by Change. The Change Healthcare JV was jointly governed by McKesson and shareholders of Change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2019, common stock and certain other securities of Change began trading on the NASDAQ (&#x201c;IPO&#x201d;). Change was a holding company and did not own any material assets or have any operations other than its interest in the Change Healthcare JV. On July 1, 2019, upon the completion of its IPO, Change contributed net cash proceeds it received from its offering of common stock to the Change Healthcare&#160;JV in exchange for additional membership interests of the Change Healthcare JV (&#x201c;LLC Units&#x201d;). As a result, McKesson&#x2019;s equity interest in the Change Healthcare JV was diluted from approximately 70% to approximately 58.5%. Accordingly, in the second quarter of 2020, the Company recognized a dilution loss of $246 million, primarily representing the difference between its proportionate share of the IPO proceeds and the dilution effect on the investment&#x2019;s carrying value. This amount was included in &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statement of Operations for the year ended March 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company recorded an other-than-temporary&#160;impairment (&#x201c;OTTI&#x201d;) charge of $1.2 billion to its investment in the Change Healthcare JV, representing the difference between the carrying value of the Company&#x2019;s investment and the fair value derived from the corresponding closing price of Change&#x2019;s common stock at September 30, 2019. This charge was included in &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statement of Operations for the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Separation of the Change Healthcare Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2020, the Company completed the separation of its interest in the Change Healthcare JV. The separation was affected through the split-off of PF2 SpinCo, Inc. (&#x201c;SpinCo&#x201d;), a wholly-owned subsidiary of the Company that held all of the Company&#x2019;s interest in the Change Healthcare JV, to certain of the Company&#x2019;s stockholders through an exchange offer (&#x201c;Split-off&#x201d;), followed by the merger of SpinCo with and into Change, with Change surviving the merger (&#x201c;Merger&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Split-off, on March 9, 2020, the Company distributed all 176.0 million outstanding shares of common stock of SpinCo to participating holders of the Company&#x2019;s common stock in exchange for 15.4&#160;million shares of McKesson common stock which now are held as treasury stock on the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 19, &#x201c;Stockholders' Equity (Deficit),&#x201d; for more information. Following consummation of the exchange offer, on March 10, 2020, SpinCo was merged with and into Change Healthcare, and each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. The Split-off and the Merger are intended to be generally tax-free transactions for U.S. federal income tax purposes. Following the Split-off, the Company does not beneficially own any of Change&#x2019;s outstanding securities. In the fourth quarter of 2020, the Company recognized a net gain of $414&#160;million related to the transaction which is included under the caption &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statement of Operations for the year ended March 31, 2020. The net gain was calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in the Change Healthcare JV at exchange date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversal of deferred tax liability &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Release of accumulated other comprehensive loss attributable to the joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Transaction costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain on split-off of the Change Healthcare JV&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investment in the Change Healthcare Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the separation of the Company&#x2019;s interest in the Change Healthcare JV, this investment was accounted for using the equity method of accounting. Effective April&#160;1, 2019, the Change Healthcare JV adopted the amended revenue recognition guidance and, in the first quarter of 2020, the Company recorded its proportionate share of the joint venture&#x2019;s adoption impact of the amended revenue recognition guidance of approximately $80 million, net of tax, in the Company&#x2019;s opening retained earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding the OTTI and transaction-related items described above, the Company recorded its proportionate share of loss from its investment in the Change Healthcare JV of $119 million in 2020, which includes transaction and integration expenses incurred by the Change Healthcare JV and basis differences between the joint venture and McKesson, including amortization of fair value adjustments primarily representing incremental intangible amortization and removal of profit associated with the recognition of deferred revenue. This amount was recorded under the caption &#x201c;Equity earnings and charges from investment in Change Healthcare Joint Venture&#x201d; in the Company&#x2019;s Consolidated Statement of Operations for the year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the formation of the Change Healthcare JV, McKesson, the Change Healthcare JV, and certain shareholders of Change entered into various ancillary agreements, including a transition services agreement (&#x201c;TSA&#x201d;), a transaction and advisory fee agreement (&#x201c;Advisory Agreement&#x201d;), a tax receivable agreement (&#x201c;TRA&#x201d;) and certain other agreements. The Advisory Agreement was terminated in 2020 and fees incurred or earned from the agreement were not material for 2020. Fees incurred or earned from the TSA were not material in 2022 nor 2021 and were $22 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the TRA, McKesson had the ability to adjust the manner in which certain depreciation or amortization deductions are allocated among Change and McKesson. McKesson exercised its right under the agreement and allocated certain depreciation and amortization deductions to Change for the tax year ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After McKesson&#x2019;s separation of its interest in the Change Healthcare&#160;JV, the aforementioned TRA agreement requires the Change Healthcare&#160;JV to pay McKesson 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the depreciation or amortization allocated to Change by McKesson. The receipt of any payments from the Change Healthcare&#160;JV under the TRA is dependent upon Change benefiting from this depreciation or amortization in future tax return filings. This creates uncertainty over the amount, timing, and probability of the gain recognized. As such, the Company accounts for the TRA as a gain contingency, with no receivable recognized as of March 31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i850442d9feb244c1b8d54049ca967bf7_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwMzA_d29ff2ba-4935-4c7d-9e2f-db18e54ce945"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i5602bb7b6c1f4462ad47f96096815f13_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwMzc_82faaade-ef6e-445b-84fa-365f6e16d4f5"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i850442d9feb244c1b8d54049ca967bf7_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwNzY_d29ff2ba-4935-4c7d-9e2f-db18e54ce945"
      unitRef="number">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia25cf3b3c2cb43a3a841dfd73d6b05a3_I20190701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwODA_b89ea706-09a6-45cb-9cf0-547a0b28b4f2"
      unitRef="number">0.585</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i957db9ee8dda4a86a6807315859b7837_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMwOTI_59773187-8833-44da-b2fe-010491a1ff58"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i9dea9ba882cb4ed59e73b4c472a99efc_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxMDQ_47f743ae-0813-49e5-bf69-059a54c573a3"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <mck:ExchangeOfferSharesDistributed
      contextRef="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxMzQ_42a2fc7f-b303-440a-8ef0-f048dd19dea2"
      unitRef="shares">176000000</mck:ExchangeOfferSharesDistributed>
    <mck:ExchangeOfferSharesExchanged
      contextRef="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3NDg3NzkwOTIxMzI_d4f22bb8-afa3-4967-9516-344deef521a8"
      unitRef="shares">15400000</mck:ExchangeOfferSharesExchanged>
    <mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted
      contextRef="i4acf39f6c45042d9825177088805f18a_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNDc_5b505a3d-42b4-4cd4-b5e0-bdbd77fd93df"
      unitRef="shares">1</mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4acf39f6c45042d9825177088805f18a_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNTI_5af28c7d-cd37-4301-9e9c-ac7992792b94"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i1946db5930c242abbc59691266086fb6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3NDg3NzkwOTE3MTk_7bd1f739-e76e-4f9c-a6de-b67cc93f754a"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzI3NDg3NzkwOTE3MDA_16695bc9-ad93-4b51-9f6f-20966f4d3666">The net gain was calculated as follows:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in the Change Healthcare JV at exchange date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversal of deferred tax liability &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Release of accumulated other comprehensive loss attributable to the joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Transaction costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain on split-off of the Change Healthcare JV&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Under the agreement with the Change Healthcare JV, McKesson, Change, and certain subsidiaries of the Change Healthcare JV, there may be changes in future periods to the amount reversed as the relevant periods are audited by tax authorities. Any such change is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <mck:EquityMethodInvestmentStockAccepted
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzEtMC0xLTEtNzcyNjgvdGV4dHJlZ2lvbjo5NTE1M2VmYTJkOTU0NDZhODVjZjA5ZmQyZDY3N2M5Ml80Mzk4MDQ2NTExMTk5_eb64e49b-471f-4849-ab68-ab18cf273c01"
      unitRef="shares">15400000</mck:EquityMethodInvestmentStockAccepted>
    <mck:EquityMethodInvestmentStockAcceptedAverageCost
      contextRef="i5dd842111f74444da1462dfb1b854980_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzEtMC0xLTEtNzcyNjgvdGV4dHJlZ2lvbjo5NTE1M2VmYTJkOTU0NDZhODVjZjA5ZmQyZDY3N2M5Ml80Mzk4MDQ2NTExMjA1_144fcda0-9a45-42e5-ad3a-f56b9b5cab21"
      unitRef="usdPerShare">131.97</mck:EquityMethodInvestmentStockAcceptedAverageCost>
    <mck:EquityMethodInvestmentFairValueofStockAccepted
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzEtMS0xLTEtNzcyNjg_4c273ca6-3cc6-4edf-a49d-6b8c7ea4d30e"
      unitRef="usd">2036000000</mck:EquityMethodInvestmentFairValueofStockAccepted>
    <mck:EquityMethodInvestmentCarryingAmount
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzItMS0xLTEtNzcyNjg_072471f4-12f0-4b6c-8c38-9bb014035d89"
      unitRef="usd">2096000000</mck:EquityMethodInvestmentCarryingAmount>
    <mck:EquityMethodInvestmentsReversalOfDeferredTaxLiability
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzMtMS0xLTEtNzcyNjg_315e0115-4a83-481f-9cad-d83263256594"
      unitRef="usd">521000000</mck:EquityMethodInvestmentsReversalOfDeferredTaxLiability>
    <mck:EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzQtMS0xLTEtNzcyNjg_1932739b-f300-4ef7-aa18-847f2af4f3e4"
      unitRef="usd">-24000000</mck:EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss>
    <mck:EquityMethodInvestmentTransactionCostsIncurred
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzUtMS0xLTEtNzcyNjg_1ee4db81-d1e5-4573-a74d-9d0df1921df2"
      unitRef="usd">23000000</mck:EquityMethodInvestmentTransactionCostsIncurred>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90YWJsZTowYTFhMjNkNDNiNTg0ZjViYWY0ZTkyOTJlNGU3ZTYyYS90YWJsZXJhbmdlOjBhMWEyM2Q0M2I1ODRmNWJhZjRlOTI5MmU0ZTdlNjJhXzYtMS0xLTEtNzcyNjg_222db3e8-522e-49fe-9bf9-f8872054398f"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3109ad9f81eb416ab0a243bace22e406_I20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNjc_15807797-52ec-4717-8094-432fcea8c1fb"
      unitRef="usd">80000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMxNzQ_14b6f95c-577d-49a5-b4ee-852ac6c89857"
      unitRef="usd">-119000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="iefb5b025ddcb4d33a1880e89a1d2abc9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMyNTQ_cfb3694e-3ed3-4347-9d20-e957e5f7f3de"
      unitRef="usd">22000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized
      contextRef="i372b78f92945468a8ee64d9a3cfcac2a_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQzOTgwNDY1MjMzMTE_6ee09f1e-8b72-42b4-983c-069f08ed5b42"
      unitRef="number">0.85</mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i713d743d96654a20823b67a74fa07746_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQ5NDc4MDIzNDY0ODI_00145108-d1e6-4b36-8312-19d912abe7c1"
      unitRef="usd">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i396a3d47aa6b4128922f47705dca2702_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjEvZnJhZzo4MGE5NWE0ZmVlM2E0NWY3OTE1N2Y1ZWEzZThlMjEzOS90ZXh0cmVnaW9uOjgwYTk1YTRmZWUzYTQ1Zjc5MTU3ZjVlYTNlOGUyMTM5XzQ5NDc4MDIzNDY0ODI_11f0ac2b-6239-4171-ae4f-3ce15327a9ce"
      unitRef="usd">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwNzk3NDU_c847fed6-c66e-49b9-a174-565f8a329960">Share-Based Compensation&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#x201c;RSUs&#x201d;), performance-based stock units (&#x201c;PSUs&#x201d;), stock options, and an employee stock purchase plan (&#x201c;ESPP&#x201d;) (collectively, &#x201c;share-based awards&#x201d;). Most of the share-based awards are granted in the first quarter of each fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact on Net Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of share-based compensation expense and related tax benefits are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit for share-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes compensation expense recognized for RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2022, 2021, and 2020 included discrete income tax expense of $10 million, $2 million, and $2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2013, the Company&#x2019;s stockholders approved the 2013 Stock Plan to replace the 2005 Stock Plan. Under these stock plans, the Company may issue restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserves 30 million shares plus unused reserved shares under the 2005 Stock Plan. As of March 31, 2022, 19 million shares remain available for future grant under the 2013 Stock Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Unit Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs entitle the holder to receive a specified number of shares of the Company&#x2019;s common stock which vest over a period of generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODE_2c540d8b-dc0c-4d2c-842e-9bfd3840f523"&gt;three&lt;/span&gt; to four years as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the price of the Company&#x2019;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March 31, 2022, approximately 57,000 RSUs for the Company&#x2019;s directors are vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a three-year performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally three years. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the Monte Carlo valuations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to restricted stock unit award activity: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted stock unit award cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of seven years and follow a four-year vesting schedule. The Company did not grant any stock options during the years ended March 31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock options outstanding at March 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range of Exercise&lt;br/&gt;Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;br/&gt;at Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Exercisable at&lt;br/&gt;Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$123.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$159.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of options expected to vest takes into account an estimate of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The intrinsic value is calculated as the difference between the period-end market price of the Company&#x2019;s common stock and the exercise price of &#x201c;in-the-money&#x201d; options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value on exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received upon exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized related to exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of stock options vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an ESPP under which 21 million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#x2019;s common stock through payroll deductions. The deductions occur over three-month purchase periods and the shares are then purchased at 85% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The 15% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in 2022, 2021, and 2020. At March 31, 2022, 2 million shares remain available for issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxOTE_733346df-b626-4fad-89c3-16c8396fed10">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of share-based compensation expense and related tax benefits are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit for share-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes compensation expense recognized for RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;(2)Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax expense for 2022, 2021, and 2020 included discrete income tax expense of $10 million, $2 million, and $2 million, respectively.</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia70f4f23e9a04a66a4f3946139215e69_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzItMS0xLTEtNjc1MTI_a0873293-d4f3-4e45-a876-c02aa0932ff4"
      unitRef="usd">148000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i83619a483e764d0bbec67a9c3cdbc05f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzItMy0xLTEtNjc1MTI_8834c6cd-13e6-464b-8be0-d3bc0ab509b7"
      unitRef="usd">137000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i70fb53d969384de7892c6e9555726ec2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzItNS0xLTEtNjc1MTI_482b95ba-2884-4eec-b566-80129f3b6157"
      unitRef="usd">104000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icad2eb9cc2d54973b510383cde197e58_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzMtMS0xLTEtNjc1MTI_6c3bedc7-0723-40ee-89e7-aca2f061427c"
      unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf75a56d89594901b67572ed9c73d754_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzMtMy0xLTEtNjc1MTI_0bcacad9-6193-46b5-bc8e-bc1cb5f65940"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i155ee628098a42bdba6bed51090a2fd6_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzMtNS0xLTEtNjc1MTI_3c818eb3-a8f7-49b4-8f30-30c9adfad67b"
      unitRef="usd">7000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzQtMS0xLTEtNjc1MTI_f5b7f9f6-52fd-4e37-8f35-a680562334bf"
      unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic6991844f2274f7e8df965bf0500c897_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzQtMy0xLTEtNjc1MTI_37de3f65-341e-40d5-b5f0-a5c9cdb0685f"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i12086cb093c648ecb1b3b14a73e46526_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzQtNS0xLTEtNjc1MTI_00e55d61-be58-43ee-a9c0-34f18317effc"
      unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzUtMS0xLTEtNjc1MTI_5a5e34b6-3258-4d57-ac0c-fcfe6c75736d"
      unitRef="usd">161000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzUtMy0xLTEtNjc1MTI_d19f8a88-25f0-4752-ac51-feebb7e089c3"
      unitRef="usd">151000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzUtNS0xLTEtNjc1MTI_7ab5463c-2701-403c-8ef5-cf985066bcfc"
      unitRef="usd">119000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzYtMS0xLTEtNjc1MTI_00180007-14bc-4449-937d-6ce1e301f4c6"
      unitRef="usd">35000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzYtMy0xLTEtNjc1MTI_83960876-745b-4674-8550-9b6fa901c355"
      unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzYtNS0xLTEtNjc1MTI_f4b58840-c5b6-4e34-99b7-2405769afa2b"
      unitRef="usd">18000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzctMS0xLTEtNjc1MTI_f8a99424-d4d2-435b-a4ab-f7eb8c2031bb"
      unitRef="usd">126000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzctMy0xLTEtNjc1MTI_1fda60c5-e3ae-49e1-b2ca-bef83fa46e19"
      unitRef="usd">128000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo3YTJkYmNkZDU0MjY0ZjQ4YWExZDkxYzdjZTcwZTVlMC90YWJsZXJhbmdlOjdhMmRiY2RkNTQyNjRmNDhhYTFkOTFjN2NlNzBlNWUwXzctNS0xLTEtNjc1MTI_0b0c3b73-68c6-43dc-8e05-bd52cf2f8ba5"
      unitRef="usd">101000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwNTE_31579c6a-326a-43b8-bd4d-77dbfab0a1b6"
      unitRef="usd">10000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwNjE_c5e35a36-77d9-4321-9790-c7561935415c"
      unitRef="usd">2000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwNjU_be0c5993-7d15-4a30-877a-abe4558e67d3"
      unitRef="usd">2000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7a23fb1c43dd4a25ae7f616ad567c312_I20130731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwOTM_0434e921-613b-4af6-a422-0188557b6c2c"
      unitRef="shares">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4cbf7bb534a14e729833a52263987ab2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYxMDQ_24699217-bb1f-4ba4-ba5f-58a0c414c69d"
      unitRef="shares">19000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id7175fa977964dc5b6050bcf39c64b38_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYwODc_095f6d0d-3e66-4e7f-9e7d-f490d69b0799">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested
      contextRef="i9985842113274b9bb12a6616b9b70bf2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYxMTQ_f2e8d12a-7fec-44b4-9433-e579bfad885b"
      unitRef="shares">57000</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ica790b51350c436380a7c20f7ab4a955_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwODI3Mjc_f566337a-b10a-4cfd-a46b-8efe579f0c71">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ica790b51350c436380a7c20f7ab4a955_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYxMjc_99f40468-14d8-4a17-b225-89a10724ae94">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxODA_ab41f599-7b2c-4a05-8e46-7915fc433b31">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the Monte Carlo valuations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzItMS0xLTEtNjc1MTI_9066d65b-46e8-4a62-a80d-9e67ea125f4a"
      unitRef="number">0.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzItMy0xLTEtNjc1MTI_ca33b869-5fc0-4cdc-b7b0-2d3567d77223"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzItNS0xLTEtNjc1MTI_39f8f7f6-0fc7-4ceb-b0ac-406c93d48b16"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzMtMS0xLTEtNjc1MTI_94e3a514-4ded-4256-9b2b-a2b0e5ccade6"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzMtMy0xLTEtNjc1MTI_b2d7bdcd-173e-478e-bad7-38b2a8db4f43"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzMtNS0xLTEtNjc1MTI_e3f71b7d-065b-4384-9013-51979fdd459d"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzQtMS0xLTEtNjc1MTI_71acb93c-f367-4b81-99c2-b12c1232d30c"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzQtMy0xLTEtNjc1MTI_c8ccccb2-7c1f-4077-8f46-a156a44452b1"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzQtNS0xLTEtNjc1MTI_605dddf3-f019-47d5-bdcd-18c22ee65e4a"
      unitRef="number">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzUtMS0xLTEtNjc1MTI_6bff5682-3ec7-434f-9a9b-4c5c52f66a5d">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzUtMy0xLTEtNjc1MTI_1d4942fc-09e6-4504-8ee1-93417109ee57">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToxMzc5OGUzY2I3ZmM0MTJjYmJhZmYyZDhjYmVjZmI5Yy90YWJsZXJhbmdlOjEzNzk4ZTNjYjdmYzQxMmNiYmFmZjJkOGNiZWNmYjljXzUtNS0xLTEtNjc1MTI_8cd956f0-448b-4fb0-9c97-1c48a4213a05">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxOTM_06c324eb-0f13-4f5b-b80b-251439e6cf55">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzEtMS0xLTEtNjc1MTI_80d03171-54bb-4119-9bb3-718e1ef26b88"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzEtMy0xLTEtNjc1MTI_25331c6a-f003-413c-ae2e-e3fff6b73bd6"
      unitRef="usdPerShare">142.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzItMS0xLTEtNjc1MTI_19e7bc7a-aadd-43b3-8853-b43efcf1ffad"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzItMy0xLTEtNjc1MTI_993976fa-e726-432a-b5aa-29f24c7e0c75"
      unitRef="usdPerShare">200.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzMtMS0xLTEtNjc1MTI_33929ba5-aa6d-4de8-9473-54303a652b07"
      unitRef="shares">0</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzMtMy0xLTEtNjc1MTI_f88a9f55-d46e-461e-b3c3-76510ccec9e8"
      unitRef="usdPerShare">142.40</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzQtMS0xLTEtNjc1MTI_0fe0652b-bad5-4c34-8655-0e463c010adb"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzQtMy0xLTEtNjc1MTI_3c8b0a5f-6442-4306-9d11-91a0a3c1f0f7"
      unitRef="usdPerShare">141.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzUtMS0xLTEtNjc1MTI_4079e083-2ac9-4709-91b2-917967370cba"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZToyNjUwMWUzMjc3MjI0OTM3Yjg3NjUyMjkyOWI1MjQ3ZC90YWJsZXJhbmdlOjI2NTAxZTMyNzcyMjQ5MzdiODc2NTIyOTI5YjUyNDdkXzUtMy0xLTEtNjc1MTI_baeda943-da22-4e1f-a58a-2e43a8d1ef64"
      unitRef="usdPerShare">160.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <mck:DataRelatedtoRSUActivityTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgyNDY_5ab8a208-b2c1-4c0b-a8d1-2449a8cb44ac">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to restricted stock unit award activity: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted stock unit award cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:DataRelatedtoRSUActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzItMS0xLTEtNjc1MTI_f4cdc3d2-c9c2-4ac4-a2f1-81cfbfae3c49"
      unitRef="usd">144000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzItMy0xLTEtNjc1MTI_6d59ad4f-c20c-49fa-89cb-7ac2b7d46a39"
      unitRef="usd">79000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzItNS0xLTEtNjc1MTI_fcb1732d-03e2-4593-9d7e-aaeced9223b4"
      unitRef="usd">67000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i175cc7c6a1594b97be43a0cf3d7ebe9c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzMtMS0xLTEtNjc1MTI_e6490c7d-16c9-4c22-8e12-7c20b20ddd13"
      unitRef="usd">165000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i0de78c2495d84cb2bf86aad5fed6c64a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzMtMy0xLTEtNjc1MTI_ef076395-5893-449c-9288-ddca3145a246"
      unitRef="usd">147000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iada693d5d07f484eb5f7830f874b2439_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzMtNS0xLTEtNjc1MTI_5a825014-0e28-4e7f-8095-6d2a872d6f00"
      unitRef="usd">155000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzQtMS0xLTEtNjc1MTI_98f6003d-66d6-4930-957a-9d88b256d585">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8c7a5fcb9add466083f95a32c386faa0_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzQtMy0xLTEtNjc1MTI_486f40bc-7c00-43a8-878d-bf9630fe6fa0">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i2260515900774fd0bb313d7a2bea0be6_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo4YWZiMjdhOTc4NmU0MjZjODJmMTc2OGNjMjI0MjgwMC90YWJsZXJhbmdlOjhhZmIyN2E5Nzg2ZTQyNmM4MmYxNzY4Y2MyMjQyODAwXzQtNS0xLTEtNjc1MTI_2a151e7e-c2d5-4972-9424-675d5eb35081">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2MzYyNTg_9b783488-08cb-4f1b-a103-3324f6238340">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwODI3Mjg_2ef7cd79-d4e7-40a3-87fe-dee0ebc3c968">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5NDI_033ce413-5c7d-4498-983f-a9b79ac01637"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5NDI_8a4db5b7-a13f-4642-883c-42e22f2c3e85"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5NDI_965f25de-86d2-4082-9fe0-1db144674b07"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxNzQ_2254b525-4b12-4872-b018-33a66cc31bf0">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock options outstanding at March 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range of Exercise&lt;br/&gt;Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;br/&gt;at Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Exercisable at&lt;br/&gt;Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$123.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$159.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMC0xLTEtNjc1MTI_4c24fbab-6ea2-4638-9c51-2cc8aa9bf98a"
      unitRef="usdPerShare">123.98</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMi0xLTEtNjc1MTI_5417f041-d8e6-4fad-b00f-af0318d10b42"
      unitRef="usdPerShare">159.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItNC0xLTEtNjc1MTI_25525b54-6203-4a35-8e50-7fab4e6affcb"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="id14cd5e8ee774ee6812fd9ab85502267_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItNi0xLTEtNjc1MTI_ef32d191-3f42-42b0-a323-99fec2e4fa44">P3Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItOC0xLTEtNjc1MTI_17595c41-d93e-45ec-9dab-58a41eaacc90"
      unitRef="usdPerShare">150.35</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMTAtMS0xLTY3NTEy_5c94ca68-8d48-49f6-9895-9fb77077e645"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i5ba8fd6e1fcd4ccb9b3389951bd71c4f_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzItMTItMS0xLTY3NTEy_0159dc03-4c85-4927-a9ae-13f7c5fe8ad3"
      unitRef="usdPerShare">152.20</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i5f34988e21e446d58a56961047fed59c_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMC0xLTEtNjc1MTI_f6ad3029-6050-48a2-82e8-770eae6d4e61"
      unitRef="usdPerShare">159.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i5f34988e21e446d58a56961047fed59c_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMi0xLTEtNjc1MTI_8088c7ae-577f-408e-81b8-a8b0af5ad7b8"
      unitRef="usdPerShare">237.86</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtNC0xLTEtNjc1MTI_235a7644-567b-4b9f-8369-bcdce009fa33"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i5f34988e21e446d58a56961047fed59c_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtNi0xLTEtNjc1MTI_14dbfc69-f11e-4ad2-a907-6b8058bfa694">P1Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtOC0xLTEtNjc1MTI_6d8e67ec-74cd-4287-98ae-c4b4ceaa85e6"
      unitRef="usdPerShare">201.56</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMTAtMS0xLTY3NTEy_153a5999-3b9e-4725-98d9-635868f03462"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="ib5991194f40e4d9fb3ea2ad222435266_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzMtMTItMS0xLTY3NTEy_34a6e6e5-9c0f-4f62-925c-d5c609be83c9"
      unitRef="usdPerShare">201.56</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzQtNC0xLTEtNjc1MTI_7cae91a0-6fd9-4861-be4f-bb0bb0bfe784"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTowYzNlN2VhZmVjOWE0NTQ4OGI4NmY1ZDFjZDU4MzkwZS90YWJsZXJhbmdlOjBjM2U3ZWFmZWM5YTQ1NDg4Yjg2ZjVkMWNkNTgzOTBlXzQtMTAtMS0xLTY3NTEy_d1ced1fe-4539-48bc-ac45-592215c637aa"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgyMTc_234902ca-9832-4c4b-bb29-4880fc17ddb8">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of options expected to vest takes into account an estimate of expected forfeitures.&lt;/span&gt;&lt;/div&gt;(2)The intrinsic value is calculated as the difference between the period-end market price of the Company&#x2019;s common stock and the exercise price of &#x201c;in-the-money&#x201d; options.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtMS0xLTEtNjc1MTI_39ad8012-cf1d-4fcd-92ba-f724fcafcb00"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtMy0xLTEtNjc1MTI_f15146a3-d052-42d6-a746-59b20c52c549"
      unitRef="usdPerShare">183.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtNS0xLTEtNjc1MTI_9cbf8d69-4c14-4fd7-96ce-fc3d793f4569">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzEtNy0xLTEtNjc1MTI_3d6e9de8-f0ac-4d77-9013-0799467b5105"
      unitRef="usd">36000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzItMS0xLTEtNjc1MTI_4c2c232f-92e7-43ef-854a-6647a95d0b7e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzItMy0xLTEtNjc1MTI_e7a02bd1-8f1b-4567-abe9-550c9ec485b1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzMtMS0xLTEtNjc1MTI_454ef5bb-d8a4-464a-af70-e27c4bd762af"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzMtMy0xLTEtNjc1MTI_6117c1df-d5a1-4da1-897c-e8ab5580d37e"
      unitRef="usdPerShare">207.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzQtMS0xLTEtNjc1MTI_8bde10c5-fe3d-4645-a30e-57f455912aa0"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzQtMy0xLTEtNjc1MTI_5306a9c1-2a48-4c56-8f67-232f592324cc"
      unitRef="usdPerShare">190.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtMS0xLTEtNjc1MTI_07b48d4b-2bc8-4ee4-b1bd-970dd96ca6cf"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtMy0xLTEtNjc1MTI_b13c4c0b-96b9-410e-9dc6-e0939aba3cbb"
      unitRef="usdPerShare">175.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtNS0xLTEtNjc1MTI_91532615-5db8-4299-a8f0-6142d2cb8fe0">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzUtNy0xLTEtNjc1MTI_c252a8f7-dbb6-46b2-bc77-ca96efd3bf0d"
      unitRef="usd">114000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtMS0xLTEtNjc1MTI_f5a46b35-ca33-45c5-819a-7b8e6be314d4"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtMy0xLTEtNjc1MTI_26cb9941-ece3-4550-a738-4da3428e287f"
      unitRef="usdPerShare">175.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtNS0xLTEtNjc1MTI_0b8b9d0d-3b10-40a0-b3b7-083f8df2bb7d">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzYtNy0xLTEtNjc1MTI_d4f095c0-0f85-4d07-86f2-3afce85fc305"
      unitRef="usd">114000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctMS0xLTEtNjc1MTI_081ac11e-f272-4a20-a9aa-32cd2af8f370"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctMy0xLTEtNjc1MTI_82fdca5b-75e3-49cd-8526-1d4d26187135"
      unitRef="usdPerShare">178.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctNS0xLTEtNjc1MTI_31daa9b1-17e2-47b7-a3b0-9b665c311098">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo5NTY2NDdiOTQ3Yzk0NDMwYWM5YTU0NzczNzkxYzkyZS90YWJsZXJhbmdlOjk1NjY0N2I5NDdjOTQ0MzBhYzlhNTQ3NzM3OTFjOTJlXzctNy0xLTEtNjc1MTI_f0e21eda-eb9d-44f6-b9b8-e93c928c8838"
      unitRef="usd">101000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzgxODk_385dcbae-cbad-4bc0-95ff-6ae4070deb38">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value on exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received upon exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized related to exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of stock options vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzItMS0xLTEtNjc1MTI_228bd35e-48b9-4ffa-9272-52741cf764f9"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzItMy0xLTEtNjc1MTI_d68745fa-fee0-409c-840f-cef884dcbda3"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzItNS0xLTEtNjc1MTI_e9e6f037-1a81-4866-8ade-ce58aad10171"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzMtMS0xLTEtNjc1MTI_464e32d8-26db-40d0-96ec-40fca43f353d"
      unitRef="usd">28000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzMtMy0xLTEtNjc1MTI_ddda1194-f6fa-4297-88c9-0b98bec3a920"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzMtNS0xLTEtNjc1MTI_a3250fc5-158c-4a4a-bc67-bd0d0fdfb9a5"
      unitRef="usd">17000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzQtMS0xLTEtNjc1MTI_aaf6040c-c7fa-4ef3-b96d-21e555fbe216"
      unitRef="usd">157000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzQtMy0xLTEtNjc1MTI_742ddedb-8eae-41c0-a5b6-dea95b12a574"
      unitRef="usd">38000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzQtNS0xLTEtNjc1MTI_a27e2907-1530-4883-b301-0a8c1cca5026"
      unitRef="usd">66000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzUtMS0xLTEtNjc1MTI_160e093e-ab7a-4b03-baa1-902cb5a1b216"
      unitRef="usd">5000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzUtMy0xLTEtNjc1MTI_0d4adc0d-9e21-432d-9b31-17f7f7148ebd"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzUtNS0xLTEtNjc1MTI_b4b437c2-a408-4819-8a62-d384ea34ed4f"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzYtMS0xLTEtNjc1MTI_d71cace1-824b-4822-8321-c8be728b99fb"
      unitRef="usd">5000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzYtMy0xLTEtNjc1MTI_03ff2591-f486-4ff2-8676-bef3e92ea125"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzYtNS0xLTEtNjc1MTI_cf62608a-d3b3-47e3-8f36-e5a14d5eccc7"
      unitRef="usd">16000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3dd23280ebc846d8b2d4860031a724c2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzctMS0xLTEtNjc1MTI_be7688be-420c-4ab0-acf1-f26aac12aa5e"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i57920885a3494e0ca6394523c80f50e3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzctMy0xLTEtNjc1MTI_42258261-6e67-4f46-8bbb-7f8fa0e72875"
      unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i18638b28013f47cc83d0371a8132d139_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzctNS0xLTEtNjc1MTI_98eb75fa-dd88-4830-9ff5-20d9881d243f"
      unitRef="usd">6000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzgtMS0xLTEtNjc1MTI_5ab5bfc7-56ab-4192-9977-c3fbf81b5020">P0Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzgtMy0xLTEtNjc1MTI_77e134dd-d173-43b5-b959-a2a4c5c3ca70">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90YWJsZTo2NDBlZGE5NTY2YTg0ZDRmYTIxMjVhNzY0N2ZmNDJlYS90YWJsZXJhbmdlOjY0MGVkYTk1NjZhODRkNGZhMjEyNWE3NjQ3ZmY0MmVhXzgtNS0xLTEtNjc1MTI_96f2e135-6ed5-4c67-84b0-d5d2c89d4688">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ice1ca3402501452f8282a882c66a1a41_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc4Nzk_7e3dc58d-e76d-4ec5-a63d-b505b267489b"
      unitRef="shares">21000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions
      contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzI3NDg3NzkwODI3Mjk_5148d25f-d95d-4b17-b4c4-941838445aa3">P3M</mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5MDQ_f8e3c3c8-4e72-401a-b4ba-0faa1d705659"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="i11cf5e08485b45ceb7b9c6baa8bb091e_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5MDg_9e6f660d-93d1-4e0a-8d80-1478de9bf91d"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ice1ca3402501452f8282a882c66a1a41_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjQvZnJhZzpjMmM0MWQzNzk5YmM0ZDI0OGY0NjM4NzM2YTAwNDhlZi90ZXh0cmVnaW9uOmMyYzQxZDM3OTliYzRkMjQ4ZjQ2Mzg3MzZhMDA0OGVmXzEwOTk1MTE2Mzc5Mjk_d0a8e9e5-7a42-45b0-82d1-73ba0efe3d8d"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzkzNw_af0e5675-c57a-4def-a7f1-9b80dc501165">Other Income, Net&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains on investments in equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses) from pension plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily recorded within the Company&#x2019;s International segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents net realized and unrealized gains on the Company&#x2019;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments. Refer to Financial Note 16, &#x201c;Fair Value Measurements&#x201d; and Financial Note 21, &#x201c;Segments of Business&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The year ended March 31, 2020 includes $116 million from the termination of the U.S. defined benefit pension plan and $11&#160;million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 14, &#x201c;Pension Benefits&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes a gain of $42&#160;million for the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2022&lt;/span&gt; as part of the completed sale of the Company&#x2019;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3Xzk0Ng_5f01ba22-96a6-4125-9eca-3fe6c4a3b741">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains on investments in equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses) from pension plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily recorded within the Company&#x2019;s International segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents net realized and unrealized gains on the Company&#x2019;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on disposal of certain of these investments. Refer to Financial Note 16, &#x201c;Fair Value Measurements&#x201d; and Financial Note 21, &#x201c;Segments of Business&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The year ended March 31, 2020 includes $116 million from the termination of the U.S. defined benefit pension plan and $11&#160;million related to a settlement from the executive benefit retirement plan for a retired executive. Refer to Financial Note 14, &#x201c;Pension Benefits&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes a gain of $42&#160;million for the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2022&lt;/span&gt; as part of the completed sale of the Company&#x2019;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.</us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzItMS0xLTEtNjc1MTI_cdd1e6a3-a5a0-4d2b-8a17-39deceb17439"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzItMy0xLTEtNjc1MTI_5593cb5a-7b14-478e-88da-d40a2ef2440b"
      unitRef="usd">12000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzItNS0xLTEtNjc1MTI_b104f28d-9040-450e-b1cb-b45ecbbe1a63"
      unitRef="usd">49000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzMtMS0xLTEtNjc1MTI_0adcee81-f400-4d77-98c0-380cbbbade48"
      unitRef="usd">43000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzMtMy0xLTEtNjc1MTI_84b6b118-8849-4490-aaea-ebc21d67c5d1"
      unitRef="usd">48000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzMtNS0xLTEtNjc1MTI_15d1972a-f547-4268-8e99-fcd1d4d4edef"
      unitRef="usd">36000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzQtMS0xLTEtNjc1MTI_ca6a4e4f-4471-4e5e-8c3f-96ae4208d79d"
      unitRef="usd">98000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzQtMy0xLTEtNjc1MTI_497d31c7-1146-4328-b2c5-5cde8c93f257"
      unitRef="usd">133000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzQtNS0xLTEtNjc1MTI_5fdf10c0-788d-4b1b-8960-bdb66518c467"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzUtMS0xLTEtNjc1MTI_3ff1663e-b9e7-4321-a892-7ad51f94b8ae"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzUtMy0xLTEtNjc1MTI_ab859518-2053-4751-8c55-7e85957a09a4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzUtNS0xLTEtNjc1MTI_cea5843c-83f7-428d-88c2-51f779b8ec35"
      unitRef="usd">-127000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzctMS0xLTEtNjc1MTI_e6781a2d-0ab0-4d6b-b5e7-1cad530c1f1f"
      unitRef="usd">103000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzctMy0xLTEtNjc1MTI_498cae4d-7fca-4e9c-aa17-d5ebe1c15984"
      unitRef="usd">30000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzctNS0xLTEtNjc1MTI_11911b91-2a2a-4906-a0a0-eb5497280dba"
      unitRef="usd">37000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzgtMS0xLTEtNjc1MTI_ea3f8486-4e7a-4bb5-9627-e550778fdd79"
      unitRef="usd">259000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzgtMy0xLTEtNjc1MTI_dd48b4bb-cbd0-4ecb-957e-b53e1b500b1c"
      unitRef="usd">223000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90YWJsZTplYjhmMjE0NjU1MzY0MjhkYmM1YTk4NzI2YzFlMTZlMy90YWJsZXJhbmdlOmViOGYyMTQ2NTUzNjQyOGRiYzVhOTg3MjZjMWUxNmUzXzgtNS0xLTEtNjc1MTI_fc4a6bc3-ba07-4b33-812a-cf49aef8c5ed"
      unitRef="usd">12000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i66b903eb87c2421eb495ac4394329d5d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzQzOTgwNDY1MTIyMTY_2a5ef8dd-2de8-4e81-96ff-614831eda0fb"
      unitRef="usd">-116000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="i167f7828260e4a198813c305f400a996_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzI3NDg3NzkwNzE4MjY_fba49367-09e6-4627-b7a2-f4fe2de22df0"
      unitRef="usd">-11000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i01e8b5cec568422ebcfc63feb76be4b7_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzEwOTk1MTE2MzAyOTE_6255a82d-653d-481d-9ccc-bbdf48a3880e"
      unitRef="usd">42000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i63827a6bb93940659eeb1ad9423601f5_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMjcvZnJhZzphNTRkMDk5OTVmNTM0YWI3YmMzMWFjMWI5NDA1YTM4Ny90ZXh0cmVnaW9uOmE1NGQwOTk5NWY1MzRhYjdiYzMxYWMxYjk0MDVhMzg3XzI3NDg3NzkwNzE4NDI_42b7f911-ce1c-4438-9950-7792f89a3d8d"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczNTE_53b5b379-e77b-44c4-9de1-4f1e46ab7d10">Income Taxes&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) related to continuing operations consists of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reported an income tax expense (benefit) rate of 33.0%, (13.8)%, and 1.6% in 2022, 2021, and 2020. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of certain of its European businesses to fair value less costs to sell in 2022, the impact of opioid-related claims, including charges of $8.1 billion ($6.8 billion after-tax) in 2021, the impact of the Change Healthcare joint venture divestiture in 2020, and changes in the mix of earnings between various taxing jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net tax benefit on intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-free gain on investment exit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E.U. disposal transaction loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Refer to Financial Note 4, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information regarding the separation of the Change Healthcare JV.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $4 million, $5 million, and $7 million in 2022, 2021, and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2022, the Company recorded non-deductible, non-cash pre-tax charges of $438 million primarily to remeasure the E.U. disposal group to fair value less costs to sell, and $1.2 billion to remeasure the U.K. disposal group, as described in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax rates for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; were unfavorably impacted by non-deductible, non-cash charges of $58 million and $275 million, respectively, primarily to remeasure the carrying value of assets and liabilities held for sale related to the formation of a new German pharmaceutical wholesale joint venture within the Company&#x2019;s International segment. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax rates for 2022 and 2021 were impacted by the charge for pending and future opioid-related claims of $274 million ($237 million after-tax) and $8.1&#160;billion ($6.8&#160;billion after-tax), respectively, as described further in Financial Note 18, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#x201c;Intra-Entity Transfers of Assets Other Than Inventory,&#x201d; discrete tax benefits of $105 million was recognized for 2021, with a corresponding increase to a deferred tax assets for the temporary difference arising from the buyer&#x2019;s excess tax basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2020, the Company completed the previously announced separation of its interest in the Change Healthcare JV as described in Financial Note 4, &#x201c;Business Acquisitions and Divestitures.&#x201d; The Company&#x2019;s reported income tax expense rate for 2020 was favorably impacted by this transaction given that it was intended to generally be a tax-free split-off for U.S. federal income tax purposes. In the fourth quarter of 2020, the Company recognized a net gain for financial reporting purposes of $414 million related to the separation transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax balances consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefit related accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory valuation and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets and systems development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluded from the amounts above were $48 million of net deferred tax liabilities which were classified as held for sale for European divestitures at March 31, 2022, as discussed in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $726 million and $864 million in 2022 and 2021, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The decrease in the valuation allowance of $138 million in the current year relates primarily to classification of deferred tax balances as held for sale for European divestitures, as discussed in Financial Note 2, &#x201c;Held for Sale,&#x201d; partially offset by the net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has federal, state, and foreign net operating loss carryforwards of $303 million, $3.9 billion, and $1.5 billion at March 31, 2022, respectively. Federal and state net operating losses will expire at various dates from 2023 through 2042. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $785 million with indefinite lives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits for the last three years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on the lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2022, the Company had $1.5 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate, if recognized. The decrease in unrecognized tax benefits in 2022 compared to 2021 is primarily attributable to statute of limitation expirations in various taxing jurisdictions and the reclassification of $23&#160;million of unrecognized tax benefits as held for sale for European divestitures, as discussed in Financial Note 2, &#x201c;Held for Sale.&#x201d; The increase in unrecognized tax benefits in 2021 compared to 2020 is primarily attributable to uncertainty in connection with the deductibility of opioid-related litigation and claims. Because many uncertainties associated with any potential settlement arrangements or other resolutions of opioid claims including provisions related to deductibility have not been finalized, the actual amount of the tax benefit related to uncertain tax positions may differ from these estimates. Refer to Financial Note 18, &#x201c;Commitments and Contingent Liabilities,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the next twelve months, it is reasonably possible that the Company&#x2019;s unrecognized tax benefit may decrease by as much as $170 million due to settlements of tax examinations and statute of limitations expirations in the U.S. federal and state jurisdictions and in foreign jurisdictions. However, this amount may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $8 million, $9 million, and $23 million in 2022, 2021, and 2020, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March 31, 2022 and 2021, it accrued $108&#160;million and $101&#160;million, cumulatively, in interest and penalties on unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2014 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign operations of approximately $5.0 billion were considered indefinitely reinvested at March 31, 2022. Following enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczODk_a6385873-4c1f-4e59-9b00-eac70ea395c4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzMtMS0xLTEtNjc1MTI_45c12591-859b-421a-9865-91aa95d343d7"
      unitRef="usd">1944000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzMtMy0xLTEtNjc1MTI_9f1b6686-cbdb-4c02-8739-dcf7cfef17d4"
      unitRef="usd">-6019000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzMtNS0xLTEtNjc1MTI_e3929b19-9c2a-4daf-9728-79ba6eaccc8e"
      unitRef="usd">216000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzQtMS0xLTEtNjc1MTI_f9d1ba0d-a391-4ec0-ac54-b31ba2122db4"
      unitRef="usd">-16000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzQtMy0xLTEtNjc1MTI_040a4f97-a5f0-4030-9078-2e2cf0580799"
      unitRef="usd">985000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzQtNS0xLTEtNjc1MTI_55022527-29fb-44f0-9cb6-63eb24add7d8"
      unitRef="usd">928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzUtMS0xLTEtNjc1MTI_1a232f4d-1b22-4b12-836c-ce26fd377d91"
      unitRef="usd">1928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzUtMy0xLTEtNjc1MTI_1ae65bb1-b545-4826-a5ad-3a6f814aef1e"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZmE1ODg5NGM5N2U0MjlmOWQ1ZGQxYzMxOTVlZjBjYi90YWJsZXJhbmdlOjVmYTU4ODk0Yzk3ZTQyOWY5ZDVkZDFjMzE5NWVmMGNiXzUtNS0xLTEtNjc1MTI_6d8ac826-bebd-486f-b7ea-98a253ce8d92"
      unitRef="usd">1144000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczODI_969c86e5-86cc-46e9-95ad-1ff14dcd52d3">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) related to continuing operations consists of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzMtMS0xLTEtNjc1MTI_73fa911f-cf4b-40d1-b029-26c72d0d2b5b"
      unitRef="usd">233000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzMtMy0xLTEtNjc1MTI_66656780-e994-4f39-a385-61a1009fc0b6"
      unitRef="usd">-15000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzMtNS0xLTEtNjc1MTI_cf38e8bc-87ab-4740-a4f5-036193b5a40e"
      unitRef="usd">170000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzQtMS0xLTEtNjc1MTI_e749a0cb-bdd5-416b-a06e-77bac09335c4"
      unitRef="usd">129000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzQtMy0xLTEtNjc1MTI_f59c3144-34d9-4627-b311-2cfe2647a55c"
      unitRef="usd">47000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzQtNS0xLTEtNjc1MTI_209e080c-b986-4511-bd44-1ff40c7fd29c"
      unitRef="usd">48000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzUtMS0xLTEtNjc1MTI_a20ec3e2-95b7-44dd-ab0f-a0b839de08ed"
      unitRef="usd">240000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzUtMy0xLTEtNjc1MTI_7141806c-2dfb-4325-b7f1-93b8e2aa24d0"
      unitRef="usd">181000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzUtNS0xLTEtNjc1MTI_7c992b2a-6e2d-4f4d-b13b-dbb21862cd16"
      unitRef="usd">142000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzYtMS0xLTEtNjc1MTI_5259fa62-c8d8-4b05-9d03-16d2d3dca94c"
      unitRef="usd">602000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzYtMy0xLTEtNjc1MTI_d830fc6f-d79a-4d5a-a252-e17b56bc6404"
      unitRef="usd">213000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzYtNS0xLTEtNjc1MTI_d2d253c7-71cb-4bb5-a461-e9b5769b39c6"
      unitRef="usd">360000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzktMS0xLTEtNjc1MTI_25d82258-7741-40e8-85a4-a8e2d9f10511"
      unitRef="usd">88000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzktMy0xLTEtNjc1MTI_8c3b3a4c-f9b5-4c46-8b79-41f8e206f2cb"
      unitRef="usd">-562000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzktNS0xLTEtNjc1MTI_38ad3af1-0031-4ca0-a0dc-095e1ea27030"
      unitRef="usd">-204000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEwLTEtMS0xLTY3NTEy_a3675195-7af4-4504-a253-32ba7724700d"
      unitRef="usd">-16000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEwLTMtMS0xLTY3NTEy_214bfcbc-1e68-478d-afb2-d8960595cb95"
      unitRef="usd">-204000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEwLTUtMS0xLTY3NTEy_df24596a-fe83-49ac-85cf-c691f4fa8e0c"
      unitRef="usd">-105000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzExLTEtMS0xLTY3NTEy_903d9cdd-5fbb-40da-98ec-7d7cfcb02f04"
      unitRef="usd">-38000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzExLTMtMS0xLTY3NTEy_2add9f08-9a68-4405-ad8a-f1dd167cbf77"
      unitRef="usd">-142000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzExLTUtMS0xLTY3NTEy_9043b410-63fc-45ed-8ab2-b5299e124870"
      unitRef="usd">-33000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEyLTEtMS0xLTY3NTEy_16aa0578-8d46-41f2-8f88-147f16242f89"
      unitRef="usd">34000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEyLTMtMS0xLTY3NTEy_a8676bbd-d315-4be3-a240-ca10bb2acda2"
      unitRef="usd">-908000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEyLTUtMS0xLTY3NTEy_6b818c3b-dd13-4462-9830-2e1ed8ec668e"
      unitRef="usd">-342000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEzLTEtMS0xLTY3NTEy_e524ee58-e67a-411e-b3f1-50ee0b709ac8"
      unitRef="usd">636000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEzLTMtMS0xLTY3NTEy_e7ba830d-121a-4792-85de-4abb09d0290e"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo1ZDY0MDgwYzc2ZmI0OGNlOTVlZTAwMmI5NjljZTczNS90YWJsZXJhbmdlOjVkNjQwODBjNzZmYjQ4Y2U5NWVlMDAyYjk2OWNlNzM1XzEzLTUtMS0xLTY3NTEy_79314bde-82be-459a-83da-2b219bc51717"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzUyMjY_3d909125-ab6c-4527-b5ac-c6c94cef5f96"
      unitRef="number">0.330</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzUyODc_241c1ffe-6bd1-4501-8117-d3f63e9a624a"
      unitRef="number">-0.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzUzMTU_5f5759c3-1169-423c-a0de-2b015f3b2e0e"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1Mjc_e74dbd8a-e9ce-4dd4-910c-9d9902172a22"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1MzM_0d6462b7-df1f-4996-8ad7-20427cdfc550"
      unitRef="usd">6800000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzc0MDE_18372d0b-2956-4db3-a2f4-164fa7614d3b">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net tax benefit on intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-free gain on investment exit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E.U. disposal transaction loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital loss carryback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Refer to Financial Note 4, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information regarding the separation of the Change Healthcare JV.&lt;/span&gt;&lt;/div&gt;(2)The Company&#x2019;s effective tax rates were impacted by other favorable U.S. federal permanent differences including research and development credits of $4 million, $5 million, and $7 million in 2022, 2021, and 2020.</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMTk_6d054350-94e8-43c6-8404-f70f7a0e733e"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMTk_71a3ce60-4ac3-403c-b130-3cdf954291b4"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMTk_7678737e-8562-4fd0-927c-e25ee3ca683f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzItMS0xLTEtNjc1MTI_1677f435-393c-4cb7-8f50-f94964cf1c62"
      unitRef="usd">405000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzItMy0xLTEtNjc1MTI_5488f22e-7f0c-4ddd-840a-9c17529f73ec"
      unitRef="usd">-1057000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzItNS0xLTEtNjc1MTI_fd2fe02b-7fa1-49b3-a246-136b4f5146dd"
      unitRef="usd">240000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzMtMS0xLTEtNjc1MTI_1d135522-a97d-4954-a13c-26eb39e8f525"
      unitRef="usd">83000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzMtMy0xLTEtNjc1MTI_0366c4d5-cd37-43b1-980e-8c4011854021"
      unitRef="usd">-206000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzMtNS0xLTEtNjc1MTI_3e641748-b164-4b82-9d52-a83a3408cda0"
      unitRef="usd">-41000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzQtMS0xLTEtNjc1MTI_9aa0acad-c593-4d88-b31a-f5371b7be47f"
      unitRef="usd">-186000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzQtMy0xLTEtNjc1MTI_8078c234-4971-4f96-8b6c-4cec7c671f8b"
      unitRef="usd">-77000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzQtNS0xLTEtNjc1MTI_971e901b-e032-4b89-a569-bc01fb1735b0"
      unitRef="usd">-81000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzUtMS0xLTEtNjc1MTI_fabf7b92-bf1e-40bd-af03-07c2d92a485d"
      unitRef="usd">-26000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzUtMy0xLTEtNjc1MTI_f231d0e5-e8d9-4d53-ad33-e1d6280997f5"
      unitRef="usd">41000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzUtNS0xLTEtNjc1MTI_71d25501-6110-407d-bcec-c91768ac17bd"
      unitRef="usd">-7000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzctMS0xLTEtNjc1MTI_67393094-3aa4-46c6-95ca-836643f13f22"
      unitRef="usd">38000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzctMy0xLTEtNjc1MTI_613bdd5e-1013-4e37-b752-b57394b380a2"
      unitRef="usd">715000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzctNS0xLTEtNjc1MTI_fd0826bd-81b9-43ea-a16a-2494346cf350"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzgtMS0xLTEtNjc1MTI_4b438d2c-1fcf-4cfe-ba1f-d5f5b3f60f4f"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzgtMy0xLTEtNjc1MTI_0309b536-1d40-4366-9f6a-aeff25a8e24d"
      unitRef="usd">105000000</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzgtNS0xLTEtNjc1MTI_85f8a119-69d6-458b-849b-1f8ea59d679e"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzktMS0xLTEtNjc1MTI_71abcce1-872f-46a2-9dd5-b82885a4aca5"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzktMy0xLTEtNjc1MTI_d9ebc28d-36c8-4e66-87e7-d6020f570367"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzktNS0xLTEtNjc1MTI_0ad8813f-e15d-4dc1-a708-819747d0e89c"
      unitRef="usd">-87000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEwLTEtMS0xLTY3NTEy_ad31e23e-615a-4126-9087-b8cf53b300b2"
      unitRef="usd">345000000</mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount>
    <mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEwLTMtMS0xLTY3NTEy_524d3722-099d-48b7-be1c-d6d91fc26f67"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount>
    <mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEwLTUtMS0xLTY3NTEy_80f228c5-e481-477f-ba61-bb6b4c71c410"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount>
    <mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEyLTEtMS0xLTY3NTEy_9c17a491-360d-43e3-b215-0a2af5ccf05b"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback>
    <mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEyLTMtMS0xLTY3NTEy_c7ab453e-78df-4c2f-80ab-75f57c9de18b"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback>
    <mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEyLTUtMS0xLTY3NTEy_f6d753ac-4905-4923-a7fe-3b0436a3fc53"
      unitRef="usd">-19000000</mck:EffectiveIncomeTaxRateReconciliationCapitalLossCarryback>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEzLTEtMS0xLTY3NTEy_4b37c69c-9c66-4070-962d-15c0dbe59407"
      unitRef="usd">-23000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEzLTMtMS0xLTY3NTEy_3cef75a2-1b49-4245-b0cb-c36fa0ca1723"
      unitRef="usd">-6000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzEzLTUtMS0xLTY3NTEy_1243c55d-7c9d-45a5-99e9-26f5bd91a77d"
      unitRef="usd">13000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzE0LTEtMS0xLTY3NTEy_4255a73f-2639-4d0a-9615-d8daaae39606"
      unitRef="usd">636000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzE0LTMtMS0xLTY3NTEy_3f8c9ddb-ef9f-406c-8e1c-a2a9570e2472"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTphZGYxYjg1YjUwYzY0YTk2OTMwOTA3ZTJjMGFiYTY2YS90YWJsZXJhbmdlOmFkZjFiODViNTBjNjRhOTY5MzA5MDdlMmMwYWJhNjZhXzE0LTUtMS0xLTY3NTEy_1103dc7d-a7f4-49c1-95f1-ae25ef3fd453"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwMjM_c2c73cd6-fe0e-44f7-9e5e-3ff4c08d5320"
      unitRef="usd">4000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwNzQ_a352a80f-c976-4b95-9be8-2ba14a9d4c7c"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzYwNzg_05207d37-7ca1-495f-b8fe-1fff3decf418"
      unitRef="usd">7000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzgzMzk_9ed44f13-c97b-4ef7-a080-15d7173a7ec1"
      unitRef="usd">438000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i0e32a1fbc82b4b00bc1a50e31b77e798_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg0Nzc_0acd2bf5-b3ff-4de7-bef3-def00267b9b3"
      unitRef="usd">1200000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzk5Mzk_ecbf2134-756f-4602-ab84-db7a7eb196fe"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2MzkxOTQ_a28b9017-2631-4dfe-8247-585559b5906c"
      unitRef="usd">275000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg2NTE_cb0cf0d0-d6d2-4c5a-9517-b03b2f22a6d2"
      unitRef="usd">274000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2NDIyNzk_0f217d32-d83d-45b9-9734-2cf2a392b805"
      unitRef="usd">237000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1NzU_e74dbd8a-e9ce-4dd4-910c-9d9902172a22"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1Nzk_0d6462b7-df1f-4996-8ad7-20427cdfc550"
      unitRef="usd">6800000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg3Mzk_cd7ce62f-1c5f-41cc-891a-3ef683d29133"
      unitRef="usd">-105000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i0fec03c76dc94380a58e045d8dc7b5dc_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzEwOTk1MTE2Mzg3ODk_a9813a52-5b11-4290-98b0-742dfcb54d3b"
      unitRef="usd">414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczNjk_96bbf535-8bbd-4aa6-baa8-bad5d07881a5">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax balances consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefit related accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory valuation and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets and systems development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Excluded from the amounts above were $48 million of net deferred tax liabilities which were classified as held for sale for European divestitures at March 31, 2022, as discussed in Financial Note 2, &#x201c;Held for Sale.&#x201d;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzMtMS0xLTEtNjc1MTI_12d2604f-99b9-4e73-8fce-bf73e93cac30"
      unitRef="usd">49000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzMtMy0xLTEtNjc1MTI_4f094da3-60b3-4340-95ba-41e6c42797c4"
      unitRef="usd">69000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <mck:DeferredTaxAssetLitigationAndClaims
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzQtMS0xLTEtNjc1MTI_de771aed-cb95-46c8-8aa5-a3af5b353164"
      unitRef="usd">755000000</mck:DeferredTaxAssetLitigationAndClaims>
    <mck:DeferredTaxAssetLitigationAndClaims
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzQtMy0xLTEtNjc1MTI_24400890-5ede-42e5-97f1-33693418fc22"
      unitRef="usd">724000000</mck:DeferredTaxAssetLitigationAndClaims>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzUtMS0xLTEtNjc1MTI_ff8d94f8-24a5-48db-9431-19ed067c6adb"
      unitRef="usd">285000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzUtMy0xLTEtNjc1MTI_d545e22f-0918-4f26-8bd5-be55fcb94efd"
      unitRef="usd">305000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzYtMS0xLTEtNjc1MTI_3eef2bf3-3d22-4664-9c96-de1d88cdcc63"
      unitRef="usd">739000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzYtMy0xLTEtNjc1MTI_3e52c085-9e56-4e23-bb4b-d338c6d98989"
      unitRef="usd">974000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <mck:DeferredTaxAssetLeaseObligations
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzctMS0xLTEtNjc1MTI_4358a134-3a8a-4cea-95d5-b514eb3efa7d"
      unitRef="usd">422000000</mck:DeferredTaxAssetLeaseObligations>
    <mck:DeferredTaxAssetLeaseObligations
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzctMy0xLTEtNjc1MTI_f61b432e-be7b-4f01-b87c-ccc6c0d1b6ae"
      unitRef="usd">539000000</mck:DeferredTaxAssetLeaseObligations>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzgtMS0xLTEtNjc1MTI_8af39ce9-80de-4443-934e-e15bce5a4ae7"
      unitRef="usd">83000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzgtMy0xLTEtNjc1MTI_b8b766b2-6f47-4775-9061-4915a116faa1"
      unitRef="usd">115000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzktMS0xLTEtNjc1MTI_43f85932-31ce-474b-a460-77730bcbc17d"
      unitRef="usd">2333000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzktMy0xLTEtNjc1MTI_424043da-f9a8-4b72-8aa0-d86e024a13a4"
      unitRef="usd">2726000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEwLTEtMS0xLTY3NTEy_1543905b-838b-4329-a8eb-9193ad34df2a"
      unitRef="usd">726000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEwLTMtMS0xLTY3NTEy_5b86cd44-62fe-45c9-9e91-f0be4cb44f07"
      unitRef="usd">864000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzExLTEtMS0xLTY3NTEy_2e11b8a9-f0f1-44d9-a14d-9be88db24b5b"
      unitRef="usd">1607000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzExLTMtMS0xLTY3NTEy_8dcf095c-9f55-4391-9707-1df17474239a"
      unitRef="usd">1862000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEzLTEtMS0xLTY3NTEy_39bf06c4-f4e1-49bb-ad03-eea3688cb0c5"
      unitRef="usd">1993000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzEzLTMtMS0xLTY3NTEy_23fbb6ab-8c8e-45d7-9da3-d4d2e07362d4"
      unitRef="usd">1939000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE0LTEtMS0xLTY3NTEy_f6b76819-2306-4d39-9fbd-ed612f6ed82f"
      unitRef="usd">184000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE0LTMtMS0xLTY3NTEy_caa1d199-52ee-4039-b751-48349dbb5f80"
      unitRef="usd">196000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE1LTEtMS0xLTY3NTEy_b591c571-c780-42f0-a43a-7207ef082884"
      unitRef="usd">233000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE1LTMtMS0xLTY3NTEy_07add45c-46c8-41b1-9cf2-9d00eb79ec1c"
      unitRef="usd">411000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <mck:DeferredTaxLiabilitiesLeaseRightofuseAssets
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE3LTEtMS0xLTY3NTEy_ce95d15a-2dd5-4169-b25a-a0e539b0d430"
      unitRef="usd">401000000</mck:DeferredTaxLiabilitiesLeaseRightofuseAssets>
    <mck:DeferredTaxLiabilitiesLeaseRightofuseAssets
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE3LTMtMS0xLTY3NTEy_a01e12ff-60c7-4068-99ad-792ce1acd644"
      unitRef="usd">505000000</mck:DeferredTaxLiabilitiesLeaseRightofuseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE4LTEtMS0xLTY3NTEy_04af241b-5c02-4aa2-8041-638e483a3393"
      unitRef="usd">17000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE4LTMtMS0xLTY3NTEy_98b9b085-7bd9-4e80-9cbe-f88b3d421ad9"
      unitRef="usd">37000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE5LTEtMS0xLTY3NTEy_84073495-7e31-4caf-94b9-4b01a996f101"
      unitRef="usd">2828000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzE5LTMtMS0xLTY3NTEy_f0134d27-729f-453f-8bf8-7ae19f07e051"
      unitRef="usd">3088000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIwLTEtMS0xLTY3NTEy_ba30df8a-8dc1-46c8-914f-bfdac0d619d7"
      unitRef="usd">1221000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIwLTMtMS0xLTY3NTEy_4cde8fa0-646f-4ed5-8258-cef5bf5aca9d"
      unitRef="usd">1226000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIyLTEtMS0xLTY3NTEy_be2d3c57-fc67-49a1-8bf2-3c59bfc2740e"
      unitRef="usd">197000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIyLTMtMS0xLTY3NTEy_dc88496a-b5df-421b-a5c6-cf6818994d42"
      unitRef="usd">185000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIzLTEtMS0xLTY3NTEy_1f7428a7-1d59-4b3e-bd51-cecb8db0d5aa"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzIzLTMtMS0xLTY3NTEy_9f3cfa9a-9d26-4521-aa84-b4932fbd4caa"
      unitRef="usd">1411000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzI0LTEtMS0xLTY3NTEy_ef5ad7e9-1761-4d79-9fc5-dde41051dc51"
      unitRef="usd">1221000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTpkMTAyZTZmNzU3NWY0MjQ2OTUzZjU5MGEyNmZkNjE1NS90YWJsZXJhbmdlOmQxMDJlNmY3NTc1ZjQyNDY5NTNmNTkwYTI2ZmQ2MTU1XzI0LTMtMS0xLTY3NTEy_7fb59f02-a262-42b0-8b8f-e77c712c1044"
      unitRef="usd">1226000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzE2NDkyNjc0NTY4MzY_c9931ef4-9e22-4775-94e2-40cb2695868f"
      unitRef="usd">48000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NDQ_1543905b-838b-4329-a8eb-9193ad34df2a"
      unitRef="usd">726000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NTM_5b86cd44-62fe-45c9-9e91-f0be4cb44f07"
      unitRef="usd">864000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NTk_cfc83193-33e3-48c9-9db8-a0c868d6dd6b"
      unitRef="usd">138000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic0ac656b00974ec2a54cd2ed0080a826_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4Njk_98f1fd65-8e84-44ec-ad59-ecda86a56600"
      unitRef="usd">303000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="id468ab83e79c4da3bdeb27a9b9e7e51f_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NzI_9215dadc-c574-4ef1-abf6-7f5fd9da504a"
      unitRef="usd">3900000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if89d7ba5882b4f0fa002ab7806455632_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc4NzU_b59b6514-7255-4ad1-be79-a719a528b224"
      unitRef="usd">1500000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i0fb72716661344f2b3ed64c31036af17_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc5MjU_18de6a7d-dd54-41db-8774-69f559bcbe83"
      unitRef="usd">785000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzczNTQ_6d5ef2e0-4443-4079-ba55-2745336ec7fe">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits for the last three years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on the lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzItMS0xLTEtNjc1MTI_dad0d42c-f269-4dd1-9d20-58d224ea5e8f"
      unitRef="usd">1754000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzItMy0xLTEtNjc1MTI_1095d7cb-2d86-479d-b7d7-ad47c254cb79"
      unitRef="usd">958000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzItNS0xLTEtNjc1MTI_197e3aba-e412-4736-927d-b13c7485d7a4"
      unitRef="usd">1052000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzMtMS0xLTEtNjc1MTI_634256d6-acf2-4016-89cd-c3db33d18642"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzMtMy0xLTEtNjc1MTI_8c2342c8-b479-4266-beaa-8a98a5d4f00f"
      unitRef="usd">53000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzMtNS0xLTEtNjc1MTI_699b65c9-d539-4d29-8c94-d1740a594001"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzQtMS0xLTEtNjc1MTI_f4c8c674-b1e7-4ec2-92c4-a89500b3a063"
      unitRef="usd">131000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzQtMy0xLTEtNjc1MTI_3e91dfc4-22b3-45a0-8ced-d6c9d80fd550"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzQtNS0xLTEtNjc1MTI_8e37c49c-8805-42c5-b062-01f13b4cd712"
      unitRef="usd">168000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzUtMS0xLTEtNjc1MTI_48054abf-eca4-4423-8b4b-cabcd74a7c7c"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzUtMy0xLTEtNjc1MTI_3b72675e-3a99-44ba-bfd9-b0556369031e"
      unitRef="usd">755000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzUtNS0xLTEtNjc1MTI_14357f36-16ad-4d4f-a8aa-074fabe1dc88"
      unitRef="usd">82000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzYtMS0xLTEtNjc1MTI_ec286f97-ddd0-45bf-8ee4-ff5b8cb7c097"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzYtMy0xLTEtNjc1MTI_ec813ad8-24ed-4607-9492-7c3419ccc4c8"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzYtNS0xLTEtNjc1MTI_15799a10-e3ad-4433-a399-67e512e9cfa0"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzctMS0xLTEtNjc1MTI_d7de3aba-9b43-411d-a265-66a71dfcd7e2"
      unitRef="usd">102000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzctMy0xLTEtNjc1MTI_42a44083-932b-47ba-84cd-3ae4be2f6add"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzctNS0xLTEtNjc1MTI_beae0932-6db2-47b5-86e9-bb66fb61e358"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzgtMS0xLTEtNjc1MTI_f36af381-fe94-4218-94cc-1f84792caccf"
      unitRef="usd">-6000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzgtMy0xLTEtNjc1MTI_c8b809ca-721c-4448-b0f6-82ee0471f1f0"
      unitRef="usd">13000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzgtNS0xLTEtNjc1MTI_14d30294-3acb-4478-8c15-8d1ffd479988"
      unitRef="usd">-7000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzktMS0xLTEtNjc1MTI_a5839caf-17d3-4f73-ab2a-24e8b3108003"
      unitRef="usd">1523000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzktMy0xLTEtNjc1MTI_aa709cfe-73f2-4d0f-9624-00cdc172e461"
      unitRef="usd">1754000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90YWJsZTo4ZGFjYWVhYjZmMTU0OTFhYTIwNDY0MDUyNmU4MWI3Mi90YWJsZXJhbmdlOjhkYWNhZWFiNmYxNTQ5MWFhMjA0NjQwNTI2ZTgxYjcyXzktNS0xLTEtNjc1MTI_dfffed23-479f-4f70-8c28-62093d1a22cf"
      unitRef="usd">958000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc5NDg_8e832ea4-8bdd-408d-8df2-49102f81facb"
      unitRef="usd">1500000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjc5NTc_59183970-7861-4a67-922b-51bc6d642a87"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4bc3fffe20cd4a228f81a4987ca2dd4c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzE2NDkyNjc0NTY5NDc_6e5d109c-4284-46d4-aa7a-295288d8686a"
      unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0MzQ_8452b9a0-b40c-4ad9-89b6-c03d79fcb286"
      unitRef="usd">170000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0NDE_75bee3b9-1d0a-4f82-ab2d-d93962800523"
      unitRef="usd">8000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0NDQ_952bce60-084f-4a72-9fac-6403bc6a2f1b"
      unitRef="usd">9000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0NDc_2518497f-82ea-45df-ab8c-c32c7fb03131"
      unitRef="usd">23000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0ODY_5190cac7-da72-465e-98f8-4f1ba8b588bb"
      unitRef="usd">108000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg0ODk_5b117cd2-c719-4270-8de9-b1f141814726"
      unitRef="usd">101000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzAvZnJhZzpjZmMwYzk0NjU1NDE0YWIwODhmOTRlNzliM2U3NjA4ZS90ZXh0cmVnaW9uOmNmYzBjOTQ2NTU0MTRhYjA4OGY5NGU3OWIzZTc2MDhlXzIxOTkwMjMyNjg1MDc_3b40bec3-2c93-4a32-ba25-a15f9ec063bd"
      unitRef="usd">5000000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0MDY_a0402446-ae21-44a3-8f43-7db4775e495a">Redeemable Noncontrolling Interests and Noncontrolling Interests &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, during 2022, 2021, and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million, $43 million, and $42 million, respectively. All amounts were recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the Domination Agreement&#x2019;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#x201c;Appraisal Proceedings&#x201d;) with the Stuttgart Regional Court to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, that court ruled that the Put Amount shall be increased by &#x20ac;0.51 resulting in an adjusted Put Amount of &#x20ac;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount remained at &#x20ac;22.99, thereby rejecting the lower court&#x2019;s increase, and the recurring compensation remained at &#x20ac;0.83 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercises of the Put Right reduced the balance of redeemable noncontrolling interests. The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income or loss, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022 and 2021, the Company paid $1.0 billion and $49 million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49&#160;million, respectively, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson stockholders&#x2019; additional paid-in capital. During 2020, there were no material exercises of the Put Right. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; in the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Prior to the expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported at the greater of its carrying value or its maximum redemption value at each reporting date.&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2021, the carrying value of redeemable noncontrolling interests of $1.3 billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP, and Vantage Oncology Holdings, LLC. As discussed above, after June 15, 2021, noncontrolling interests also include minority shareholder equity interests in McKesson Europe. Noncontrolling interests in the Company&#x2019;s Consolidated Balance Sheets were $480 million and $196 million at March 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022, the Company owned approximately 95% of McKesson Europe&#x2019;s outstanding common shares. The Company&#x2019;s noncontrolling interest in McKesson Europe will be included in the sale of the E.U. disposal group, as discussed in Financial Note 2, &#x201c;Held for Sale.&#x201d; During 2022, 2021, and 2020, the Company allocated a total of $165 million, $156 million, and $178 million of net income to noncontrolling interests, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2022, 2021, and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="ifb22ce88060842ff860b7a4f6f4d8c8d_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQ5NDc4MDIzMjkxNjM_01cb603a-9cfb-4a7f-b398-63b479303867"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMDI_6d849914-0708-4550-a42e-8babd5f92e4c"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMTM_6f3efc7d-ad6e-4b3e-a25a-718ffc3f1964"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="id49f95b8b84d4733a35b6f6d7352eb6b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMjI_9fd10a77-025e-4996-a0fd-060728d02ee3"
      unitRef="usd">42000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i90fb979952704eaeb0354680a480489e_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMzA_2ca509df-226b-4613-84c7-4574dd349854"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="icdac5b94f2184c3a99658bd787744bdf_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTUzMzY_c2fedf6e-9a99-4411-a3ab-63d17cf219ca"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <mck:NoncontrollingInterestsPutRightExercisePriceIncrease
      contextRef="i74517685e93241df8e4050dd6818b8c2_D20180919-20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzMxMDg_e76c437a-58ec-44ef-a144-2318298ab95c"
      unitRef="eurPerShare">0.51</mck:NoncontrollingInterestsPutRightExercisePriceIncrease>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="id55a461c58734092bdfe4dbc17c833c2_I20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzMxNTA_1e73cc4f-363e-430e-9493-45ea41e6da2e"
      unitRef="eurPerShare">23.50</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i314553b738ee43fc96f6e068ba26aa3c_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0Mjk_d4db759b-efd7-440c-904f-bcd0654a00bb"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="icbf87d883a1e46a99b0a0ea932dfd523_I20210412"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0MTU_96fa69ba-0901-4db4-8d92-adb98c2f762e"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjEwMDE_f10473cf-2d74-45b1-a21f-61246bf911cb"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTg0MzI_09d130d1-22ab-433a-ae63-c67a2dc099bf"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i697acb285ffe4724a5ce79e46dc216cc_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjEwMjU_1b05e278-3ffc-4c4e-a591-ddc2ad394ba9"
      unitRef="shares">34500000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i8ea1fe0fbd714a839b4165ba6b46fb24_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTg0NDg_91afdb61-ef4a-47a4-adf2-103c002a97c1"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjEwNzk_5ff8f1df-24d8-4201-b56f-c6dc5a2f8e75"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzI3NDg3NzkwODQ0NDk_1c8a42d4-1a75-45d5-abd4-ad45a94fa0bc"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i388ef90bc58145ecbf23cf8b5d548393_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjExOTI_0e916439-468c-4d40-b884-7c5fb3a5b828"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i40c2e064b0354809a45b8ab7b5c9539e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTg3MTg_9196b9c4-0ac0-4917-9fdf-fee57f0ba38d"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjE3OTI_1affcfe5-ffea-4ad3-b44f-f4b5186db8c4"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTk0NDQ_9511c7cf-172b-4566-b669-134f3c7e0e0c"
      unitRef="usd">1300000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i369ed3d532394663ba99e0e952d94674_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTk0ODk_7b73179d-7e43-40a7-a9a7-6fdc6cd9c35f"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i369ed3d532394663ba99e0e952d94674_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTk1NTA_f4bff249-442b-45c8-807e-c9887e66be13"
      unitRef="number">0.78</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterest
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjUyOTY_3b95527e-6ca4-42c4-a16f-6699f949e1f8"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjUzMDU_16b7141c-040e-4ebe-880b-d3fc708b57cd"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i2a2d296e2c5c427f97b8588765fa3178_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MjQ4MDM_2d9ff9ad-aeba-46ac-a5d1-211476e184a4"
      unitRef="number">0.95</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6dc4df20c07240af91fdfc7690f7f39a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTU2MTM_8563e843-5e80-429d-8059-125ec940294f"
      unitRef="usd">165000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5a5f885d18c04e07bd8c41ef8f1ce99b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTU2MjA_abd534c7-0a27-4c15-946a-fb6eb9ef1a9f"
      unitRef="usd">156000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4ac41f1025f14743bb7d39f341e23ed7_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQzOTgwNDY1MTU2Mjk_02dfa911-fac8-46bf-9d7c-b0a83308f6ea"
      unitRef="usd">178000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90ZXh0cmVnaW9uOmQzYWFlODkxMzlkOTQ0NjNiNTcyZjc5YTA4ZWE4YTQ5XzQxNDY_236318a3-3627-4912-b4ba-d30a7a22e82c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2022, 2021, and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="ie4592918a3c14823acad8256f0ddfbde_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEtMi0xLTEtNjc1MTI_31d4cd92-5f28-4e45-afe8-2b1d8b09cc4a"
      unitRef="usd">193000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i8fb2e420d55e43d0aa913ab1b22cbcaa_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEtNC0xLTEtNjc1MTI_8ad96e2e-d82c-4085-8cf7-23a51780e85c"
      unitRef="usd">1393000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzItMi0xLTEtNjc1MTI_6d534acc-86a2-4493-a505-9b5df6755e38"
      unitRef="usd">178000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzItNC0xLTEtNjc1MTI_c704ffcf-1c31-4b6b-9df2-bd405c570ac6"
      unitRef="usd">42000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzMtMi0xLTEtNjc1MTI_f8e0ebf5-2eae-4d6f-8cb3-89820c8abf24"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzMtNC0xLTEtNjc1MTI_c9e788a0-f9a8-4780-be89-f52a356461c7"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzQtMi0xLTEtNjc1MTI_2b2395a6-8a4d-4646-a417-1d8df0a42e90"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzQtNC0xLTEtNjc1MTI_2a071657-54f8-4a6d-943f-74756d418c5a"
      unitRef="usd">42000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzUtMi0xLTEtNjc1MTI_8e0a4a69-848c-444b-af87-25f2a38fa001"
      unitRef="usd">154000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzUtNC0xLTEtNjc1MTI_4acc80ac-fd4c-4899-966a-b6811a52e73e"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i7ae06a80e24f43fb8e14e134c626b309_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzYtMi0xLTEtNjc1MTI_c6bc751d-793e-490d-8685-3f21292685f7"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="if46afc85e6c0485194f1d6eb437caa92_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzYtNC0xLTEtNjc1MTI_e12f83f7-41ab-450c-a0a6-a01d67a28e58"
      unitRef="usd">6000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="ib2cdad70673142c9a93a6bbb19838852_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzctMi0xLTEtNjc1MTI_718b1fc5-e8bb-46f4-92ad-8f4b72c10226"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="idfcdc1a443e549bdae94a956c44c8a5e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzctNC0xLTEtNjc1MTI_0175a52e-a020-4935-bdf2-15dff39c76be"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzgtMi0xLTEtNjc1MTI_a09abeb9-2e5a-49cf-afed-f8a94686cd3e"
      unitRef="usd">156000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzgtNC0xLTEtNjc1MTI_06c82f2e-206d-4bee-b45a-dfd7212b3119"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzktMi0xLTEtNjc1MTI_ea17945f-d608-4d70-9d9d-9bd6a7e7b624"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzktNC0xLTEtNjc1MTI_5804f0ef-8c64-4e9e-9de2-ff51dbc8834c"
      unitRef="usd">-79000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEwLTItMS0xLTY3NTEy_88eff6c4-64e4-4a67-854f-84cb15bdfb04"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEwLTQtMS0xLTY3NTEy_20218862-e48b-4229-a59c-f096a0acea38"
      unitRef="usd">43000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzExLTItMS0xLTY3NTEy_b9c6f0bc-9b31-4d58-a8a3-538fcba71de9"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzExLTQtMS0xLTY3NTEy_442db9b5-88d5-4915-ab44-e9c556a3445c"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTItMS0xLTkyNjg2_856e19ed-864c-4694-aa73-15719c151e96"
      unitRef="usd">0</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTQtMS0xLTkyNjg5_00f6df96-579c-4f03-8ef3-c0e3094337a7"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i973951133a204d4eb8580125b92aed26_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTItMS0xLTY3NTEy_defd5dd1-2a9e-47e5-9d30-a6974e7a98e5"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ib770885ebe9e47868872f5f9d7781558_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEyLTQtMS0xLTY3NTEy_0a850a47-6fdf-4110-ab58-a7707d21a881"
      unitRef="usd">-3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i6dec5df30de44f7a83e4f2ce0278a9d7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEzLTItMS0xLTY3NTEy_0194fc0b-cf30-40de-ba1b-98063518c591"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i6ae40923a8c44fae93e93658b71a6fbe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzEzLTQtMS0xLTY3NTEy_9e1df93e-865f-436f-b029-99795e1193c7"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE0LTItMS0xLTY3NTEy_9252a48a-723f-4957-ba70-d1697ce98fff"
      unitRef="usd">165000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE0LTQtMS0xLTY3NTEy_4d731904-a670-4e2d-b1d4-386f3c2ada3a"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE1LTItMS0xLTY3NTEy_97b77afa-a95a-454a-92ae-2f4ef3265424"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE1LTQtMS0xLTY3NTEy_a3885e52-bb68-43f4-9980-0aa7763ad845"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE2LTItMS0xLTY3NTEy_7751cab5-68dc-4cdc-91ab-dea5d71e1613"
      unitRef="usd">7000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE2LTQtMS0xLTY3NTEy_3f221e79-b91b-4497-a290-697834e59126"
      unitRef="usd">8000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE3LTItMS0xLTY3NTEy_bf568aa9-bfad-459d-8de5-d9dc0860bf08"
      unitRef="usd">155000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE3LTQtMS0xLTY3NTEy_efde1c6d-5cbf-4ffb-b924-b0ed100dd192"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE4LTItMS0xLTY3NTEy_f7ad27df-d349-47f2-afd1-44f62bfe4d3f"
      unitRef="usd">0</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE4LTQtMS0xLTY3NTEy_5ff8f1df-24d8-4201-b56f-c6dc5a2f8e75"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTItMS0xLTkyNjk0_06f73503-bae1-4ff7-8357-c6f057914dda"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTQtMS0xLTkyNjk4_1affcfe5-ffea-4ad3-b44f-f4b5186db8c4"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE5LTItMS0xLTY3NTEy_ba42d95d-b12e-478c-86b1-8d579f3848f8"
      unitRef="usd">-2000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i701e1a12fff54760a1b5baf21d7cb6a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzE5LTQtMS0xLTY3NTEy_5e226e89-61ec-4e94-a6f4-f05772041a92"
      unitRef="usd">-4000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i52cdcc95103d4a2b933719ac01f8cec5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTItMS0xLTY3NTEy_ab016572-9b7c-4b3f-97ca-64f0d6851901"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="if2605ebb23764962bfd89d4578016d5b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzMvZnJhZzpkM2FhZTg5MTM5ZDk0NDYzYjU3MmY3OWEwOGVhOGE0OS90YWJsZTpkYjIwODgyMjNlNjE0ZDhmYWJmMDgxODMwNDEwZjBjNS90YWJsZXJhbmdlOmRiMjA4ODIyM2U2MTRkOGZhYmYwODE4MzA0MTBmMGM1XzIwLTQtMS0xLTY3NTEy_3647994b-e3ad-475f-8bd8-25b5388eeaea"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzExODQ_82866d27-12a6-46b7-9788-7435b9eb182f">Earnings (Loss) Per Common ShareBasic earnings (loss) per common share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units.&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted loss per common share for the year ended March 31, 2021 was calculated by excluding all dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Approximately nil and 2 million of potentially dilutive securities for 2022 and 2020, respectively, were excluded from the computation of diluted net earnings per common share, as they were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;(2)Certain computations may reflect rounding adjustments.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzE2NDkyNjc0NDM4NjQ_24c63384-5193-4390-850c-5bee24d2f0d8"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzQzOTgwNDY1MTIzNDE_bba40ea9-f745-45b6-8b0a-eccb4e2b7697"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90ZXh0cmVnaW9uOmM3ZTQ1ZTVlYjZlOTQxYmM4YTg2NjU1NDQ1NDQyMTU0XzExODg_b0e6934c-893d-476f-8b9d-b83fb50ec949">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;(2)Certain computations may reflect rounding adjustments.</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzItMS0xLTEtNjc1MTI_fabe798e-3e5d-43bd-8a07-36b654ea5bbb"
      unitRef="usd">1292000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzItMy0xLTEtNjc1MTI_c0371f74-e47a-4cb1-a0fc-b2ab4f70d6be"
      unitRef="usd">-4339000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzItNS0xLTEtNjc1MTI_4f41114c-e494-46ef-bdb9-8f70f969c41c"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzMtMS0xLTEtNjc1MTI_89315c1a-151f-4bf6-8ba2-136f0cd9c64f"
      unitRef="usd">173000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzMtMy0xLTEtNjc1MTI_7f98df02-3f31-413a-86ec-56126153c806"
      unitRef="usd">199000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzMtNS0xLTEtNjc1MTI_027623b7-eece-4a25-8866-f0e14d5b63f3"
      unitRef="usd">220000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzQtMS0xLTEtNjc1MTI_4f67a574-9e1c-4396-ac86-ef035e7a312a"
      unitRef="usd">1119000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzQtMy0xLTEtNjc1MTI_e426bcce-507e-408b-a506-7a29ef571ca9"
      unitRef="usd">-4538000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzQtNS0xLTEtNjc1MTI_fc35ac2a-c025-446e-9674-2524a2974f70"
      unitRef="usd">906000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzUtMS0xLTEtNjc1MTI_b17347a6-7aa3-47cc-a24d-8568c0493004"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzUtMy0xLTEtNjc1MTI_84b258d8-0324-4f26-bfc6-6bf365bda89a"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzUtNS0xLTEtNjc1MTI_2af3e54d-2829-43f4-92ee-ec3c6fd1ecdf"
      unitRef="usd">-6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzYtMS0xLTEtNjc1MTI_5fd1d26d-ef39-4210-b79e-af6adc2ab233"
      unitRef="usd">1114000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzYtMy0xLTEtNjc1MTI_c4321dd8-da0b-4386-a430-a918610fa715"
      unitRef="usd">-4539000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzYtNS0xLTEtNjc1MTI_49edc76f-fa02-4355-8d9d-d8027b1945ab"
      unitRef="usd">900000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzktMS0xLTEtNjc1MTI_2c2ab63c-5ada-4f02-add0-332983edc54e"
      unitRef="shares">152300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzktMy0xLTEtNjc1MTI_11aadce4-422b-4694-8e30-7ce8172b52e3"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzktNS0xLTEtNjc1MTI_fa2e32c4-243d-44ab-bb34-d7b6c5ca1392"
      unitRef="shares">180600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzExLTEtMS0xLTY3NTEy_37cfe301-1617-4e73-8e92-b65a51b7f6e6"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ieaac7d868dca4d1a8cc10a613cbf5670_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzExLTMtMS0xLTY3NTEy_863f45d5-3054-4d5e-b7bb-647321850dfa"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6665c7b87a924988ab47714e9f8ee1e3_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzExLTUtMS0xLTY3NTEy_84f3bfe9-3fc9-4423-8a78-b9ee4611d625"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEyLTEtMS0xLTY3NTEy_6f0d7de2-7f46-4ed1-8b1a-a3a717c189c9"
      unitRef="shares">1600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEyLTMtMS0xLTY3NTEy_5fbb02b1-469d-4f34-aeb9-2a8ff023f50a"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEyLTUtMS0xLTY3NTEy_59d2a70e-5659-49c2-b897-9d089cf970c9"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEzLTEtMS0xLTY3NTEy_fef9557b-6b38-467b-aa43-1cee4b5d8241"
      unitRef="shares">154100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEzLTMtMS0xLTY3NTEy_be98289a-5d03-4d8f-9cf7-f5153580c51d"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzEzLTUtMS0xLTY3NTEy_54d2564d-9b26-4f9e-89b2-407b5656ed67"
      unitRef="shares">181600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE3LTEtMS0xLTY3NTEy_8f950712-64f3-41af-9ea1-daeb70290081"
      unitRef="usdPerShare">7.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE3LTMtMS0xLTY3NTEy_077276bf-fc6d-4221-ac5c-6a0f29daec4f"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE3LTUtMS0xLTY3NTEy_8096325c-df6f-4cd6-b6f3-0678aa46ecf4"
      unitRef="usdPerShare">4.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE4LTEtMS0xLTY3NTEy_32959134-b75a-4a8d-bbb5-20f2b17a4afc"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE4LTMtMS0xLTY3NTEy_7ba0e5fb-a7e3-49d6-94fa-2449762676b0"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE4LTUtMS0xLTY3NTEy_8fa0dd01-1d01-48ad-92b2-6193f8c07226"
      unitRef="usdPerShare">-0.04</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE5LTEtMS0xLTY3NTEy_8fcf357a-6723-4a97-b957-b29e37fe7a2a"
      unitRef="usdPerShare">7.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE5LTMtMS0xLTY3NTEy_84bf32fe-1a27-4106-adcc-3f82f06ab039"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzE5LTUtMS0xLTY3NTEy_4ad3923f-6db1-4c14-b1c6-7e383e1ccd33"
      unitRef="usdPerShare">4.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIxLTEtMS0xLTY3NTEy_a67825b8-6083-45ec-8a82-90dd78e45abc"
      unitRef="usdPerShare">7.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIxLTMtMS0xLTY3NTEy_bc18856e-b648-440e-b2ae-99227c0c3bc8"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIxLTUtMS0xLTY3NTEy_71f633fb-adfa-4dd7-8269-b57b72fb391c"
      unitRef="usdPerShare">5.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIyLTEtMS0xLTY3NTEy_8b772437-40a1-49ee-9b68-198e4c94018b"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIyLTMtMS0xLTY3NTEy_e87e0358-0c3b-48e2-8b1a-3dfb18b95ded"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIyLTUtMS0xLTY3NTEy_084181be-8ec3-467f-8242-1d2cb1d6d6ff"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIzLTEtMS0xLTY3NTEy_1e270e59-b731-4d34-91c2-85c7bcdd19e6"
      unitRef="usdPerShare">7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIzLTMtMS0xLTY3NTEy_1adedc77-2082-4f4e-8102-148cc4982d1b"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzYvZnJhZzpjN2U0NWU1ZWI2ZTk0MWJjOGE4NjY1NTQ0NTQ0MjE1NC90YWJsZTo0NzQyY2E3YmQ3OGQ0MmNhYWM1ZTk4Y2E0ZGU1ZmQwNS90YWJsZXJhbmdlOjQ3NDJjYTdiZDc4ZDQyY2FhYzVlOThjYTRkZTVmZDA1XzIzLTUtMS0xLTY3NTEy_55a6c9a7-55e6-45f5-b460-e6c7dd0eeccb"
      unitRef="usdPerShare">4.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:LessorDirectFinancingLeasesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNjk_cfe789f8-9479-45b5-83af-2434a4b7742a">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#x2019;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#x2019;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated statements of operations and cash flows.&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $285 million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529"&gt;five&lt;/span&gt; to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorDirectFinancingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzY_eedb9401-624c-4e67-8297-eeee1b4697e4">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#x2019;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#x2019;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated statements of operations and cash flows.&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $285 million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529"&gt;five&lt;/span&gt; to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzc_e5ba8d3a-a04e-4f00-ae6a-e1172bde7e63">LeasesIn the first quarter of 2020, the Company adopted amended guidance for leases using the modified retrospective method. Upon adoption of this amended guidance, the Company recorded $2.2&#160;billion of operating lease liabilities, $2.1&#160;billion of operating lease ROU assets, and a cumulative-effect adjustment of $69&#160;million to opening retained earnings as of April 1, 2019. The adjustment to opening retained earnings included impairment charges of $89&#160;million, net of tax, to the ROU assets primarily related to previously impaired long-lived assets at the retail pharmacies in the Company&#x2019;s U.K. and Canadian businesses, partially offset by the derecognition of an existing deferred gain on the Company&#x2019;s sale-leaseback transaction related to its former corporate headquarters building. The Company also elected to adopt the transition package of practical expedients provided within the amended guidance which eliminated the requirements to reassess lease identification, lease classification, and initial direct costs for leases which commenced before April 1, 2019. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated statements of operations and cash flows.&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2022, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $285 million that are not reflected in the table above. These operating leases will commence between 2023 and 2024 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MjU_5b616173-8fb4-435b-b2ab-454a4cbfb529"&gt;five&lt;/span&gt; to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2022 and 2021, the total lease receivable was $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzE5Mg_18d34613-b3c0-4508-bd31-3330f84c846f"
      unitRef="usd">2200000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzIyNw_54d54b60-cf2f-4f48-a2e7-a7a7a4c1f57e"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if31e8179749841c8870313f7d3ba430c_I20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzI5OQ_1a38a20a-b1c7-46f5-a073-4d57f712381d"
      unitRef="usd">69000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:OperatingLeaseImpairmentLossNetOfTax
      contextRef="icc5e78fe538f4bacbd70c847c9f29b70_D20190401-20190401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzQyNw_93b179be-0686-42bb-a099-fceee726c8f6"
      unitRef="usd">89000000</mck:OperatingLeaseImpairmentLossNetOfTax>
    <mck:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyODA_5b8e3646-be70-48ad-87ab-8c6331c0b3a0">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_9e5d19d5-ee65-4383-9964-207c98d9042f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTAtMS0xLTY3NTEy_c3ce0094-8804-499c-a3f5-49f9b5983640"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_1d84fbce-aea0-428c-8c1a-731ec3c26b15"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTAtMS0xLTY3NTEy_61eb64e4-e354-479e-9ddd-57fd39cc9514"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_8ee3b29c-2e68-43e2-bb20-f1187c33a31a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTAtMS0xLTY3NTEy_9efe9a95-b129-4182-a969-42676c7bdd23"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (Years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; the Company rationalized its office space, including certain property leases, in North America during 2022. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. This initiative did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494 million as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term operating lease liabilities of approximately $83 million and $442 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;</mck:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzQtMS0xLTEtNjc1MTI_0dd3477f-4ef9-4905-ab2f-e123b839ab6e"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzQtMy0xLTEtNjc1MTI_61bdea18-2847-423f-8be8-7795a88a2585"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzYtMS0xLTEtNjc1MTI_7e0c80af-09e3-4b63-b64a-ecc970e7d57f"
      unitRef="usd">297000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzYtMy0xLTEtNjc1MTI_641aa5ea-48e9-44a5-826f-4f6208115a7f"
      unitRef="usd">390000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzctMS0xLTEtNjc1MTI_d68297b0-301e-4813-9f82-c6e80358e26f"
      unitRef="usd">1366000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzctMy0xLTEtNjc1MTI_61126235-7b12-4769-a6e2-9fd5a3a2652b"
      unitRef="usd">1867000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzgtMS0xLTEtNjc1MTI_3596d6bd-8067-4f90-b542-ce6126cce9a2"
      unitRef="usd">1663000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzgtMy0xLTEtNjc1MTI_6966a1f2-4e8e-4d29-aef1-1810b1f7072a"
      unitRef="usd">2257000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTEtMS0xLTY3NTEy_8b55ee4d-8887-4888-81fb-74d25aba8658"
      unitRef="usd">206000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzExLTMtMS0xLTY3NTEy_8389def5-286c-4641-99b2-79c2eed1eca6"
      unitRef="usd">237000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTEtMS0xLTY3NTEy_2d66495e-fee4-4483-8add-608db6bcdab1"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzEzLTMtMS0xLTY3NTEy_2202b5b0-40ad-4eb4-878e-ed4d22af7250"
      unitRef="usd">22000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTEtMS0xLTY3NTEy_5e5cff59-1dab-4e17-9a2a-e4c492a80a43"
      unitRef="usd">185000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE0LTMtMS0xLTY3NTEy_a4242e99-cba3-467a-984c-bb97ed60b682"
      unitRef="usd">206000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE1LTEtMS0xLTY3NTEy_0cacf8b5-0cf5-4d45-9210-73a5473cf4f2"
      unitRef="usd">210000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE1LTMtMS0xLTY3NTEy_5ba4c3fe-16e4-46f6-a08d-c7b84a026bc7"
      unitRef="usd">228000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE4LTEtMS0xLTY3NTEy_6788766f-2837-47b8-bf57-4f50d73c0a3d">P6Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE4LTMtMS0xLTY3NTEy_97375838-525e-404d-8075-43b3132dd252">P7Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE5LTEtMS0xLTY3NTEy_b1fa1318-a9bd-46b6-9e85-fc7856ffc79b">P8Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzE5LTMtMS0xLTY3NTEy_730eb53f-81e5-4b7f-9eb9-63a07e5b7730">P10Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIyLTEtMS0xLTY3NTEy_97d0be29-6576-4a6e-8e5b-1307142832f9"
      unitRef="number">0.0247</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIyLTMtMS0xLTY3NTEy_c58cdd6a-830d-4668-b579-c219b2bafd14"
      unitRef="number">0.0253</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIzLTEtMS0xLTY3NTEy_e949f0f1-fde9-4a7c-b7ed-72188c337214"
      unitRef="number">0.0250</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTplNzIxY2ZiNzI3ZWU0ZGY2YjUzNDNiMzJjZDBhN2ZkMS90YWJsZXJhbmdlOmU3MjFjZmI3MjdlZTRkZjZiNTM0M2IzMmNkMGE3ZmQxXzIzLTMtMS0xLTY3NTEy_5885d32e-b168-4080-a1cd-4cc4fd5b6179"
      unitRef="number">0.0271</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzY5MTM_f18eb608-f21e-4d8f-90a8-384db0ed09ee"
      unitRef="usd">494000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2Mzc4MDg_fc3793c5-8501-4626-be3f-5291061badfb"
      unitRef="usd">83000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2Mzc4MjY_7d4afe8c-a908-4490-ac55-c0c52f166576"
      unitRef="usd">442000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNjY_85834e19-419c-4a30-b3ee-7729b8e78f98">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) &#160;&#160;&#160;&#160;The amount for the year ended March 31, 2020 includes the transition adjustment of $2.1&#160;billion for operating lease right-of-use assets recorded as of April 1, 2019 upon adoption of the amended leasing guidance included in ASU 2016-02, Leases.</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:ShortTermLeaseCost
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzItMS0xLTEtNjc1MTI_27bdd7b2-c30e-4269-a10c-c016905d78a4"
      unitRef="usd">43000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzItMy0xLTEtOTQyMjE_b1226398-4b7c-416a-94b8-fb34253aee36"
      unitRef="usd">32000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzItMy0xLTEtNjc1MTI_a05d46db-4f37-46c1-818a-c4f56a5c9fa3"
      unitRef="usd">29000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzMtMS0xLTEtNjc1MTI_6fe0a8e9-312c-49d5-af82-b6c887010826"
      unitRef="usd">431000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzMtMy0xLTEtOTQyMjE_4bc3e738-89ca-4c81-a83e-b41d9892b939"
      unitRef="usd">465000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzMtMy0xLTEtNjc1MTI_874d7cd4-1800-46a0-8cb5-0d74d0282069"
      unitRef="usd">459000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzYtMS0xLTEtNjc1MTI_271e45cf-e95c-4593-ba4e-4ed5102ff9cd"
      unitRef="usd">33000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzYtMy0xLTEtOTQyMjE_83425941-d37b-4cb5-a4a4-e66d2f99d28a"
      unitRef="usd">23000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzYtMy0xLTEtNjc1MTI_36b2b56c-22fa-483b-9475-f34e54ae69ec"
      unitRef="usd">14000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzctMS0xLTEtNjc1MTI_e1005656-a4fc-4d33-9728-fb59dfb26fdf"
      unitRef="usd">5000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzctMy0xLTEtOTQyMjE_b8197efe-886d-4cd2-bd95-be50c65063a9"
      unitRef="usd">6000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzctMy0xLTEtNjc1MTI_569430c0-22e9-413d-8653-022d70cab1c0"
      unitRef="usd">5000000</us-gaap:FinanceLeaseInterestExpense>
    <mck:FinanceLeaseCost
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzgtMS0xLTEtNjc1MTI_6f60181b-fd8a-45d5-a084-ca01c0e5fe37"
      unitRef="usd">38000000</mck:FinanceLeaseCost>
    <mck:FinanceLeaseCost
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzgtMy0xLTEtOTQyMjE_9880641c-ae6d-43f3-9e5c-ffffcc2b8723"
      unitRef="usd">29000000</mck:FinanceLeaseCost>
    <mck:FinanceLeaseCost
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzgtMy0xLTEtNjc1MTI_cbb4e7d1-c9d6-4871-874a-a47182c6b6db"
      unitRef="usd">19000000</mck:FinanceLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEwLTEtMS0xLTY3NTEy_867e35ae-1cfa-4028-ae48-19ab2375698f"
      unitRef="usd">127000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEwLTMtMS0xLTk0MjIx_b54ee9d2-6fe4-48c3-8e1c-05b5d09edf29"
      unitRef="usd">125000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEwLTMtMS0xLTY3NTEy_d60f7717-fdd1-4acf-abaa-c41b1903b58d"
      unitRef="usd">125000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzExLTEtMS0xLTY3NTEy_c0faf805-8508-4b59-a43d-39a7b7ebd61c"
      unitRef="usd">41000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzExLTMtMS0xLTk0MjIx_d34e7a18-dbf3-43d1-a4d0-0f0f62781e3c"
      unitRef="usd">36000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzExLTMtMS0xLTY3NTEy_69856261-de38-457f-a634-dfade1ccba8a"
      unitRef="usd">33000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEyLTEtMS0xLTY3NTEy_f59c2c6d-601a-4254-9b6d-6d68cafb6059"
      unitRef="usd">598000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEyLTMtMS0xLTk0MjIx_46b1464d-48dc-48e9-84ab-dece4567897c"
      unitRef="usd">615000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTpiM2IzMjk3MzAwZWE0YTdlOTE4NWI5MmMyNTMwM2E3My90YWJsZXJhbmdlOmIzYjMyOTczMDBlYTRhN2U5MTg1YjkyYzI1MzAzYTczXzEyLTMtMS0xLTY3NTEy_ed168df5-4d39-4a79-9e6d-780535492ab3"
      unitRef="usd">599000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzMtMS0xLTEtNjc1MTI_a77cde24-6e2f-4823-befd-fd78415acc3f"
      unitRef="usd">356000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzMtMy0xLTEtOTQyOTE_164d1c20-862b-4d4f-bb5e-99472092e905"
      unitRef="usd">362000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzMtMy0xLTEtNjc1MTI_239c6b07-4768-4d8c-ae18-38990d446605"
      unitRef="usd">377000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzQtMS0xLTEtNjc1MTI_dca09908-6ef6-415c-ad51-3a59ea213b6d"
      unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzQtMy0xLTEtOTQyOTE_9f8d9bb1-fd03-4f2e-9dbf-e0a78a3fb2e9"
      unitRef="usd">4000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzQtMy0xLTEtNjc1MTI_bb32296d-f19e-499e-a021-76b7f81deea4"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzUtMS0xLTEtNjc1MTI_8223cbf6-96f8-4d1c-bd6e-0f74c7ee26f4"
      unitRef="usd">31000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzUtMy0xLTEtOTQyOTE_f25337db-b476-4b3a-8b42-1e5f263aba73"
      unitRef="usd">31000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzUtMy0xLTEtNjc1MTI_09262fa2-a724-4926-9906-8efae8860602"
      unitRef="usd">18000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzctMS0xLTEtNjc1MTI_814ac54d-4f11-48a8-ba93-818eee6e4c61"
      unitRef="usd">286000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzctMy0xLTEtOTQyOTE_f8b237b4-16b3-48bb-a1fc-0e1554bc60f6"
      unitRef="usd">321000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzctMy0xLTEtNjc1MTI_461f53df-1655-4ce2-a18a-5b8277fa732c"
      unitRef="usd">2378000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzgtMS0xLTEtNjc1MTI_82aded29-9494-4928-ab65-08227168021b"
      unitRef="usd">32000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzgtMy0xLTEtOTQyOTE_fab5cc3b-a36d-40ce-91e6-bb6c2cf17bae"
      unitRef="usd">75000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo2MWUxZjBiY2VkZGQ0ZGUzYjllMDI1ZjRkNDU1YWIyOS90YWJsZXJhbmdlOjYxZTFmMGJjZWRkZDRkZTNiOWUwMjVmNGQ0NTVhYjI5XzgtMy0xLTEtNjc1MTI_913df242-5019-42d1-9b7c-7f51336008b7"
      unitRef="usd">166000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i046e3ecb45094e2c874a7c2bf57a0a82_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzQyNjk_4e3488be-e9bb-484c-8c87-c55beb564c27"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzE_01824885-acce-46ff-9f45-c2c8182b326b">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzUyNzI_83468ead-3640-48e2-a1b4-ef4d05205f72">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by minimum sublease income&#160;of $201 million which are due under future noncancellable subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzItMS0xLTEtNjc1MTI_5b9ce6b7-d202-4d0f-be8c-e251289604a0"
      unitRef="usd">328000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzItMy0xLTEtNjc1MTI_7a132751-ff80-4f1b-a60d-c4e886ec0cf5"
      unitRef="usd">29000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <mck:LeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzItNS0xLTEtNjc1MTI_e012bca8-47bd-4f22-a7b7-e7b66596998a"
      unitRef="usd">357000000</mck:LeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzMtMS0xLTEtNjc1MTI_85006bdb-6aec-4ebc-a539-b0637ad03aad"
      unitRef="usd">310000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzMtMy0xLTEtNjc1MTI_a826d5ae-6675-4dc0-a6da-1607f89a49a0"
      unitRef="usd">29000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <mck:LeaseLiabilityPaymentsDueYearTwo
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzMtNS0xLTEtNjc1MTI_08bbdafd-f729-466f-aa97-7049539bbc64"
      unitRef="usd">339000000</mck:LeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzQtMS0xLTEtNjc1MTI_ed2109e2-3ba6-4561-8c9f-2aa3aa1c09c6"
      unitRef="usd">268000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzQtMy0xLTEtNjc1MTI_a58c0450-6605-45f4-8374-d850aabc9f7e"
      unitRef="usd">27000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <mck:LeaseLiabilityPaymentsDueYearThree
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzQtNS0xLTEtNjc1MTI_e33b8c21-188c-443d-b32b-ebff733b3835"
      unitRef="usd">295000000</mck:LeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzUtMS0xLTEtNjc1MTI_e6e861cf-1654-4997-ab33-9a11b7d0e0e0"
      unitRef="usd">223000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzUtMy0xLTEtNjc1MTI_af9034e1-2465-4dc8-aadc-6a9c75665ea6"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <mck:LeaseLiabilityPaymentsDueYearFour
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzUtNS0xLTEtNjc1MTI_170d7ded-85dc-4281-8241-2d82b740a77f"
      unitRef="usd">248000000</mck:LeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzYtMS0xLTEtNjc1MTI_308fc1d4-9578-4bcc-9338-04c2eadf433c"
      unitRef="usd">180000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzYtMy0xLTEtNjc1MTI_99f358b6-5323-4324-9c31-628e110fdedb"
      unitRef="usd">24000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <mck:LeaseLiabilityPaymentsDueYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzYtNS0xLTEtNjc1MTI_6b2d7061-2810-4491-a731-7b2020c22711"
      unitRef="usd">204000000</mck:LeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzctMS0xLTEtNjc1MTI_fc657851-6c6d-4953-a198-b1083168f0de"
      unitRef="usd">506000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzctMy0xLTEtNjc1MTI_18b8b218-23f8-46d3-86f2-bbc888de3b12"
      unitRef="usd">103000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <mck:LeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzctNS0xLTEtNjc1MTI_6724948b-bd96-4a71-a3a5-78c09d56356d"
      unitRef="usd">609000000</mck:LeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzgtMS0xLTEtNjc1MTI_196cba8b-be86-4c9f-a761-f29bb7bf39b6"
      unitRef="usd">1815000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzgtMy0xLTEtNjc1MTI_af495207-9a56-44c0-bf60-f2c816aaa051"
      unitRef="usd">237000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <mck:LeaseLiabilityPaymentsDue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzgtNS0xLTEtNjc1MTI_35fa7ffc-0837-4ea2-82be-41fedd0b17bf"
      unitRef="usd">2052000000</mck:LeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzktMS0xLTEtNjc1MTI_4cb51096-34f6-4c8e-bbee-144a2bce1221"
      unitRef="usd">152000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzktMy0xLTEtNjc1MTI_85e96e59-f544-4062-99ba-cd5c711ab92b"
      unitRef="usd">27000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <mck:LeaseLiabilityUndiscountedExcessAmount
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzktNS0xLTEtNjc1MTI_68012ef7-f7a8-4068-9164-3f1a94b7a524"
      unitRef="usd">179000000</mck:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzEwLTEtMS0xLTY3NTEy_16b1ecb8-3ae8-4898-a791-845c5f898f4c"
      unitRef="usd">1663000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzEwLTMtMS0xLTY3NTEy_7be1cc23-a71a-489d-8fd6-e0c5a5d052a0"
      unitRef="usd">210000000</us-gaap:FinanceLeaseLiability>
    <mck:LeaseLiability
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90YWJsZTo3ZGFhMGVmYzZlNGM0ZWU0YjNjMGNmODM5ZDJkMWMyNy90YWJsZXJhbmdlOjdkYWEwZWZjNmU0YzRlZTRiM2MwY2Y4MzlkMmQxYzI3XzEwLTUtMS0xLTY3NTEy_1f3855de-ffd1-48bb-bf0e-3a451b31a327"
      unitRef="usd">1873000000</mck:LeaseLiability>
    <mck:LessorLeasePaymentstobeReceived
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU2NDE_3cec9d34-43b4-4ab6-8920-e04aa7d2786e"
      unitRef="usd">201000000</mck:LessorLeasePaymentstobeReceived>
    <mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU2ODY_b355e5c6-3ac3-4c50-aa22-41c06ff1441c"
      unitRef="usd">285000000</mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ia6fbd33f726e47aba5491ae5385fa919_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3MzA_6b3d9865-d301-4fe6-8f13-71846660bc3c">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3NzA_89a40ea4-0d9e-45c2-8ba2-d5817e1fdaac"
      unitRef="usd">298000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3NzA_f85db839-aa6b-4b6c-af71-80b29f51d806"
      unitRef="usd">298000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3OTk_136d3561-590a-4f2d-a162-23b6349a56ef">P7Y</mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm>
    <mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xMzkvZnJhZzo5NTg0MzA5Y2VmNDE0MjZjODcyZDQ2ZmQ5YjgwNDYzZS90ZXh0cmVnaW9uOjk1ODQzMDljZWY0MTQyNmM4NzJkNDZmZDliODA0NjNlXzEwOTk1MTE2MzU3OTk_be22b36d-88ea-4694-80fe-d9474a6eca10">P7Y</mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4Xzc1MzQ_66fbd84b-5f0d-4d24-921a-456753505486">Goodwill and Intangible Assets, Net &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers, and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other changes/disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment as of October 1 on an annual basis each year and at an interim date if indicators of potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the reporting units was determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#x2019;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#x2019;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#x2019;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#x2019;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual impairment testing performed for 2022, 2021, and 2020 did not indicate any impairment of goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a goodwill impairment charge of $69 million in 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This charge was recorded in &#x201c;Goodwill impairment charges&#x201d; in the Consolidated Statements of Operations. At March 31, 2021, the balance of goodwill for the reporting units in Europe was approximately nil and the remaining balance of goodwill in the International segment primarily relates to one of its reporting units in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 16, &#x201c;Fair Value Measurements,&#x201d; for more information on these nonrecurring fair value measurements. As of March 31, 2022 and 2021, accumulated goodwill impairment losses in the Company&#x2019;s International segment were $0.7 billion and $3.6 billion, respectively. Most of the goodwill impairment for these reporting units was generally not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; This amount was included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intangible assets were subject to amortization as of March 31, 2022 and 2021. Amortization expense of intangible assets was $332 million, $422 million, and $462 million for 2022, 2021, and 2020, respectively. Estimated annual amortization expense of intangible assets is as follows: $225 million, $214 million, $208 million, $177 million, and $171 million for 2023 through 2027, and $1.1 billion thereafter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; for more information on intangible asset impairment charges recorded in 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4Xzc1MzU_1518b047-15df-4fbe-882a-fa190024b585">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting, transfers, and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other changes/disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i082e438b9e624b688d526df079a96fae_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtMS0xLTEtNjc1MTI_411b351a-63d0-4ef1-96e0-0162b2244c52"
      unitRef="usd">3924000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idcc65fc10a6f46eb873730b43c245ffd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtMy0xLTEtNjc1MTI_b1661aec-f67b-4cf3-8f21-3b65a76892d2"
      unitRef="usd">1540000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifab6ade13b6047f2bc574352c680315a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtNS0xLTEtNjc1MTI_058845b2-3699-41cb-8d6c-53a0edc52809"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4ee45133724c4e4d9e9cc8e6880430af_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtNy0xLTEtNjc1MTI_04f7fcd1-16f0-44ae-94ae-76c7683da7c7"
      unitRef="usd">1443000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEtOS0xLTEtNjc1MTI_7336de15-1a7e-441b-8b4e-4331097217f4"
      unitRef="usd">9360000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItMS0xLTEtNjc1MTI_af9569cc-7339-47a5-9342-47a5840e35d7"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItMy0xLTEtNjc1MTI_159f431e-9a47-4c3e-8656-a9e52915ed1f"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItNS0xLTEtNjc1MTI_9efceea3-ae6e-4110-b598-a393bda58f2f"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItNy0xLTEtNjc1MTI_ab9c3ac7-fbbb-463a-aca2-3ef17214d05b"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzItOS0xLTEtNjc1MTI_098cefcd-8061-48f1-8299-79fb82b9b61d"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtMS0xLTEtNjc1MTI_b8afce2d-fda5-4967-8f29-cb1c32bc84b0"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtMy0xLTEtNjc1MTI_66483adc-b887-4153-9223-e24a86327551"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtNS0xLTEtNjc1MTI_f37420dd-fcfe-4052-ab93-03d4de132ef9"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtNy0xLTEtNjc1MTI_cab86986-27f8-432d-ba44-43f5a4ad2068"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzMtOS0xLTEtNjc1MTI_2b4ebf61-035a-4871-8199-5cf57d11b1b8"
      unitRef="usd">2000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtMS0xLTEtNjc1MTI_836ed7a2-bf37-4447-8e3f-944cb705c744"
      unitRef="usd">-1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtMy0xLTEtNjc1MTI_40d39960-f0b4-4e5c-ac84-101401f1e485"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtNS0xLTEtNjc1MTI_59f1f2cf-669c-4ac8-a828-199796bfbecc"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtNy0xLTEtNjc1MTI_3bcb4a35-1e99-4be8-895f-216c1aeb7566"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzQtOS0xLTEtNjc1MTI_99f88466-f98f-44f0-a74b-c9178d8c2839"
      unitRef="usd">-1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtMS0xLTEtNjc1MTI_b93bcfdf-79e2-4eed-8705-391ddaeda43d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtMy0xLTEtNjc1MTI_07a7e60d-2d92-48cd-ab8e-bfac155fda8e"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtNS0xLTEtNjc1MTI_e688d6da-de1a-487e-82d9-adb2f801afff"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtNy0xLTEtNjc1MTI_6b493689-8e3b-440f-b92d-1fac474a1a73"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzUtOS0xLTEtNjc1MTI_17ac37f6-e5e8-42c9-92dd-1cc35276765f"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtMS0xLTEtNjc1MTI_2c715944-435a-4e85-9ea0-9ed56cc2b844"
      unitRef="usd">40000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i398eb6774e344f8797bab87792c9dd38_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtMy0xLTEtNjc1MTI_2f1f0dbf-f447-4260-9c2a-c3f2dd677113"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtNS0xLTEtNjc1MTI_aa93a1dd-5957-49e6-b55b-018d027d4410"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtNy0xLTEtNjc1MTI_3c53c0f3-9184-4142-8028-1beb54bb30cb"
      unitRef="usd">156000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzYtOS0xLTEtNjc1MTI_a763437f-9d0a-4433-9658-f2bb9f4827f2"
      unitRef="usd">196000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i558a4f91a45148328e79fe9c105520e7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctMS0xLTEtNjc1MTI_c0472dee-ae2e-4a0f-acbe-d4fd4ff79db6"
      unitRef="usd">3963000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idb3167c8a2454bfc8d55421585d3d985_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctMy0xLTEtNjc1MTI_9bf80463-482f-440f-ab30-a697207021dd"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i15b55a2e948f4b24a3b527c5ac723106_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctNS0xLTEtNjc1MTI_6d9d171f-6883-40dc-9568-d5f7a3bbc40d"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2898617ea052451ab1b166e16ad0bff1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctNy0xLTEtNjc1MTI_12f72ffe-7629-453a-a935-73ac9083eb42"
      unitRef="usd">1535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzctOS0xLTEtNjc1MTI_dd664305-4183-470b-88c1-10374323270a"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtMS0xLTEtNjc1MTI_dc2a286a-98aa-4dd0-9306-9364ed3775de"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1778f09368dd4bde9d01e3bceccc0de4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtMy0xLTEtNjc1MTI_39efbb8b-6841-4d62-a0f9-f332348c42dd"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtNS0xLTEtNjc1MTI_28440358-265f-48e5-9c38-ba03c3e983ab"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtNy0xLTEtNjc1MTI_47ad0b50-cde3-4139-95ca-d40a3be4b2fb"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzgtOS0xLTEtNjc1MTI_63ea6121-457f-4760-90ca-77d8ec9b636b"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTEtMS0xLTY3NTEy_de3ce522-af14-473b-b31d-6c4a1865d564"
      unitRef="usd">-40000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1778f09368dd4bde9d01e3bceccc0de4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTMtMS0xLTY3NTEy_54e51538-78f3-403b-8134-e9a767684c62"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTUtMS0xLTY3NTEy_a2679499-80a6-46a5-a99a-85b3c19b6b09"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTctMS0xLTY3NTEy_763e7397-f66e-4003-9ffa-bc856ad15d21"
      unitRef="usd">-7000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEyLTktMS0xLTY3NTEy_55443f1f-0425-4386-9702-33f2d7cbca3a"
      unitRef="usd">-47000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ie8bec42efc82456886f328dfaa5e4c78_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTEtMS0xLTY3NTEy_c23a7e24-12cd-4fb2-bda7-608a180c7df4"
      unitRef="usd">3923000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i57b1f3f32ffc4e6ca7fc465f2efcfa9c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTMtMS0xLTY3NTEy_bf2fbf08-e80a-43c4-ad78-73da5f786310"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i89602a22aafc4c248462dc75c787e1db_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTUtMS0xLTY3NTEy_40f532da-4cf8-456d-9689-e6e19cc9cc5b"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i65c2a80c51924ffea392e70a7d81af35_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTctMS0xLTY3NTEy_cd0110c9-5cac-451d-8343-e0ab17af3461"
      unitRef="usd">1533000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo2ZWVmNjhhNzg2ZWQ0YWM0ODI3NTM4NWViN2I4YTc1NS90YWJsZXJhbmdlOjZlZWY2OGE3ODZlZDRhYzQ4Mjc1Mzg1ZWI3YjhhNzU1XzEzLTktMS0xLTY3NTEy_d69c66f1-6815-44a3-837a-3ed7d8de3935"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:NumberOfReportableSegments
      contextRef="if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzE3NTkyMTg2MDU5NjAz_77f4e669-4d82-4074-b0ab-f90ebe68a364"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic17f9f344cd2424186b1efb969df180c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzEwOTk1MTE2MzgxNzg_e61df601-2c1e-4127-9dc0-b83e9a2d1266"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i480ab7e945d745479b45988a832ff1ef_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzM5Mjc_fd9e38c2-89fc-4ed1-be92-fce889468a4f"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i65c2a80c51924ffea392e70a7d81af35_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzEwOTk1MTE2MzgxODc_ab61e9ac-42b8-4024-b8b6-2753f98bf1cb"
      unitRef="usd">700000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2898617ea052451ab1b166e16ad0bff1_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzcxNDY4MjU1OTA4Mzc_9283855f-550b-4bd0-95ff-9bc12a0df9d0"
      unitRef="usd">3600000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4Xzc1MzM_de699a9a-5dfe-4476-b758-0aa267eaac77">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; This amount was included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i0d68a928d7824033ace17d52e23a8dca_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMS0xLTEtNjc1MTI_a0eca3f7-60e1-4684-928d-020837f8ee51">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i40c222358c854868933a4aec3f197b82_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMy0xLTEtNjc1MTI_1bc64c09-dc51-4bbd-a918-1a7293279dc6"
      unitRef="usd">2777000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i40c222358c854868933a4aec3f197b82_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItNS0xLTEtNjc1MTI_cff9a9f0-7cad-44a1-8efd-3074cc3534e4"
      unitRef="usd">1691000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i40c222358c854868933a4aec3f197b82_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItNy0xLTEtNjc1MTI_7df2339b-f5ae-487c-acc0-b047be25e2d6"
      unitRef="usd">1086000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if320149638f44877bc4627df44ee32f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItOS0xLTEtNjc1MTI_a9368096-bbb5-4a52-8639-5a2cd05aa16b"
      unitRef="usd">3739000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if320149638f44877bc4627df44ee32f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMTEtMS0xLTY3NTEy_045baa8f-5079-441e-981a-34a6a532f26f"
      unitRef="usd">2269000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if320149638f44877bc4627df44ee32f0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzItMTMtMS0xLTY3NTEy_387aafb3-1c16-4bc1-b7f8-de86f44f8222"
      unitRef="usd">1470000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i68562b53b58b4e4eb84618514db2cb80_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMS0xLTEtNjc1MTI_3230aabf-d6ee-47a8-b8ca-1fdd031f429f">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3bf05e148e384ae29d92e24fc00c4fef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMy0xLTEtNjc1MTI_42db5374-67cc-4430-a65c-9c65d76501ed"
      unitRef="usd">1085000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3bf05e148e384ae29d92e24fc00c4fef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtNS0xLTEtNjc1MTI_76c217b8-544c-4e24-9391-fece602c033c"
      unitRef="usd">573000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3bf05e148e384ae29d92e24fc00c4fef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtNy0xLTEtNjc1MTI_0d919e2a-17c5-4f9e-83ce-d6e24e65c8e4"
      unitRef="usd">512000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtOS0xLTEtNjc1MTI_84f45d7e-9a73-4bdb-8734-29a380cd059f"
      unitRef="usd">1081000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMTEtMS0xLTY3NTEy_bd45eb5c-7d35-4bb7-a112-0628b930d60a"
      unitRef="usd">513000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1c674c0fc97d479f9e40a5e4a2d8080f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzMtMTMtMS0xLTY3NTEy_33eda84f-2f7a-4507-bb81-28a4662b53c5"
      unitRef="usd">568000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtMy0xLTEtNjc1MTI_8b412cbe-ef97-44d6-9164-b8e17b8810ec"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtNS0xLTEtNjc1MTI_66b709a2-4acc-4ff7-bd3c-949f3bc21661"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5b8b75d338804848bbfb3bbb3de0de7b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtNy0xLTEtNjc1MTI_30e79767-2511-4fec-b8da-9f2f8dc79806"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i61b1d9b80a624667a047ec06a972915f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtOS0xLTEtNjc1MTI_897ba3f6-4b6b-4acf-9ad1-d5486ff96bdf"
      unitRef="usd">497000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i61b1d9b80a624667a047ec06a972915f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtMTEtMS0xLTY3NTEy_22081ab6-4354-4e29-87a0-70e6b818480e"
      unitRef="usd">244000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i61b1d9b80a624667a047ec06a972915f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzQtMTMtMS0xLTY3NTEy_bc49c157-bc95-462b-aa57-7e0b171207a7"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i987e27c5d1bf40c783eef89efb6f9d6e_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMS0xLTEtNjc1MTI_ce7551a9-db99-47a0-9b21-39aa64bd858e">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i97df16e5800541ca9604a3cf83a192c2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMy0xLTEtNjc1MTI_7683aaa4-14dd-4bd9-b29f-d1f81b992f5e"
      unitRef="usd">819000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i97df16e5800541ca9604a3cf83a192c2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtNS0xLTEtNjc1MTI_f6df5b1f-abc4-4c9d-b306-71b57f7defcf"
      unitRef="usd">386000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i97df16e5800541ca9604a3cf83a192c2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtNy0xLTEtNjc1MTI_d1a5064b-bae5-4b3e-a2f6-f630e2bc48aa"
      unitRef="usd">433000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i17b657fb07354a6c983690d6eee84e3a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtOS0xLTEtNjc1MTI_1782e258-ac89-4068-8662-e184c9ca727b"
      unitRef="usd">925000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i17b657fb07354a6c983690d6eee84e3a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMTEtMS0xLTY3NTEy_af2fff3d-4287-45ee-879f-9bc610552f9d"
      unitRef="usd">394000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i17b657fb07354a6c983690d6eee84e3a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzUtMTMtMS0xLTY3NTEy_73274164-fdb8-4756-b6ee-864bdbf7b415"
      unitRef="usd">531000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="if68227cf6cac4d3d86ed24a1337b11f2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMS0xLTEtNjc1MTI_c03656ad-fd83-43ca-a614-a5e7d38c140a">P1Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i260b94765bd84eba92c24f9d3b5ece7a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMy0xLTEtNjc1MTI_d9945e48-88ef-4314-b2b3-340bf326fb11"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i260b94765bd84eba92c24f9d3b5ece7a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtNS0xLTEtNjc1MTI_3a6caea6-cd08-4fac-bf28-261ae9034b21"
      unitRef="usd">116000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i260b94765bd84eba92c24f9d3b5ece7a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtNy0xLTEtNjc1MTI_9cf158a0-e132-43ab-a6ee-0201df426faf"
      unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtOS0xLTEtNjc1MTI_41324b3c-fbac-4f9f-a263-288becc61cec"
      unitRef="usd">150000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMTEtMS0xLTY3NTEy_b8e66f18-6550-45e0-96f8-121011cbfb23"
      unitRef="usd">122000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i62d22f492e084afb8ae7a2c9cc74dd52_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzYtMTMtMS0xLTY3NTEy_cfa301eb-86c7-4b23-8a24-77ba33b80a4d"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i63b800d5a4ed46c98d60b8f90472d8b0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMS0xLTEtNjc1MTI_a0a1a548-1e11-4f7d-bff1-a2a89b90921c">P9Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMy0xLTEtNjc1MTI_eee7e8e6-be4c-4873-b9a4-082d2407f7b9"
      unitRef="usd">187000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctNS0xLTEtNjc1MTI_0b5e785f-a43d-4427-809d-2b702f90bdbc"
      unitRef="usd">171000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icb7d0643b6f444caa7a10e9b10c6a54b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctNy0xLTEtNjc1MTI_609cb094-beb0-49e6-b7a8-269dbfb93769"
      unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d8bd56dac64452db5d3474b91e08366_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctOS0xLTEtNjc1MTI_56836f7d-c6b7-4841-b481-b15e8ba66deb"
      unitRef="usd">254000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9d8bd56dac64452db5d3474b91e08366_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMTEtMS0xLTY3NTEy_435c4baf-8bcc-4fe7-a38b-c67ea51a303f"
      unitRef="usd">226000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9d8bd56dac64452db5d3474b91e08366_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzctMTMtMS0xLTY3NTEy_57f0c9e9-fba3-4288-8c43-2c4c3e07c19e"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtMy0xLTEtNjc1MTI_eea7e8d6-c6c1-4725-9478-b3c2f8e51a0e"
      unitRef="usd">4996000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtNS0xLTEtNjc1MTI_a6d84183-9a9a-4f61-95b0-49515db692fa"
      unitRef="usd">2937000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtNy0xLTEtNjc1MTI_a78994ef-f598-49bc-9869-a2dff4942c8e"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtOS0xLTEtNjc1MTI_53e885e1-743f-4402-a027-60cd2bad5a30"
      unitRef="usd">6646000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtMTEtMS0xLTY3NTEy_551a3ed5-1bcc-4a35-8241-e4414c435ee6"
      unitRef="usd">3768000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90YWJsZTo1ZTA4NGE3NzA4YjU0YzhkYjA1MTMzYjdiNGQxMzEzZS90YWJsZXJhbmdlOjVlMDg0YTc3MDhiNTRjOGRiMDUxMzNiN2I0ZDEzMTNlXzgtMTMtMS0xLTY3NTEy_3ded7d02-1c82-4506-9836-6d9a1dc3168a"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="ie64c7a9ecd8140eab1897947f3348779_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMzNjQ_3f2289b3-a59b-4315-a2ff-1b8c4f34cacf"
      unitRef="usd">384000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMzMDc_b7263f11-f0f4-4f48-bea5-626b69e11560"
      unitRef="usd">332000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzcxNDY4MjU1OTA4ODk_ede654d7-99a6-4fdc-8d3a-3e7c1244a770"
      unitRef="usd">422000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzcxNDY4MjU1OTA4ODQ_ca1a407b-3416-44a0-b62b-80b138a8a1e8"
      unitRef="usd">462000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNDQ_a0660864-97da-49e5-aa9c-4f8fe2df7ce4"
      unitRef="usd">225000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNDc_5bc397f1-a2e8-499f-8a64-2899a119638b"
      unitRef="usd">214000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTA_9b2b5665-786f-4c6d-90b7-5bec0d3bfba0"
      unitRef="usd">208000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTM_976b9a38-8d12-4b38-be53-501c207fb09e"
      unitRef="usd">177000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTY_43d04fc5-4338-4747-bcc1-5d40f64a1dd5"
      unitRef="usd">171000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDIvZnJhZzozYjhhMGMxNmQ3OGU0NGU0YTMzODYwMzUzOGNkZTIzOC90ZXh0cmVnaW9uOjNiOGEwYzE2ZDc4ZTQ0ZTRhMzM4NjAzNTM4Y2RlMjM4XzYwNDczMTM5NjMyNTk_ddd02602-7fe0-4d38-9b54-73910e4ceaa8"
      unitRef="usd">1100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEyNjA_6dbab69d-b101-48ab-aa01-beb78120b8c4">Debt and Financing Activities&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these U.S. dollar notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term debt of approximately $4 million and $11 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March 31, 2022 and 2021, $5.9 billion and $7.1 billion, respectively, of total debt was outstanding, of which $799 million and $742 million, respectively, was included in &#x201c;Current portion of long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 12, 2021, the Company completed a public offering of 1.30% Notes due August 15, 2026 (the &#x201c;2026 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $495&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#x201c;2025 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million. The Company utilized the net proceeds from this note for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each note, which constitutes a &#x201c;Series,&#x201d; is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#x2019;s existing and, from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed&#160;by materially similar indentures and officers&#x2019; certificates. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of Fitch Inc., Moody&#x2019;s Investors Service, Inc., and Standard &amp;amp; Poor&#x2019;s Ratings Services within a specified period, an offer must be made to purchase that Series from the holders at a price equal to 101% of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#x2019; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#x2019; consent. The indentures also contain customary events of default provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 17, 2021, the Company redeemed its 0.63% &#x20ac;600 million (or, approximately $709 million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand. On December 1, 2020, the Company redeemed its 4.75% $323&#160;million total principal of notes due on March 1, 2021 prior to maturity. On November 30, 2020, the Company retired its 3.65% $700&#160;million total principal of notes upon maturity. These notes were redeemed using cash on hand and the proceeds of the notes offering discussed above. In 2020, the Company repaid at maturity its &#x20ac;250 million Floating Rate Euro Notes due February 12, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tender Offer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#x201c;Tender Offer Notes&#x201d;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1 billion to redeem $922 million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182 million, plus accrued and unpaid interest of $14 million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191 million in the year ended March 31, 2022, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments of long-term debt are $799&#160;million in 2023, $966&#160;million in 2024, $35 million in 2025, $1.2&#160;billion in 2026, $1.2&#160;billion in 2027, and $1.7&#160;billion thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2020, the Company entered into a Credit Agreement, dated as of September 25, 2019 (the &#x201c;2020 Credit Facility&#x201d;), that provides a syndicated $4.0&#160;billion five-year senior unsecured credit facility with a $3.6&#160;billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during 2022 and 2021 and no amounts outstanding as of March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At March 31, 2022, the Company was in compliance with all covenants. The remaining terms and conditions of the 2020 Credit Facility are substantially similar to those previously in place under the $3.5&#160;billion five-year senior unsecured revolving credit facility (the &#x201c;Global Facility&#x201d;), which was scheduled to mature in October 2020. The Global Facility was terminated in connection with the execution of the 2020 Credit Facility in September 2019 and had no borrowings during the six months ended September 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euros with a committed amount of $7&#160;million and an uncommitted amount of $111&#160;million as of March 31, 2022. Borrowings and repayments were not material in 2022 and 2021 and amounts outstanding under these credit lines were not material as of March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0&#160;billion in outstanding commercial paper notes. During 2022, 2021, and 2020, the Company borrowed $11.2&#160;billion, $6.3&#160;billion, and $21.4&#160;billion, respectively, and repaid $11.2&#160;billion, $6.3&#160;billion, and $21.4&#160;billion, respectively, under the program. At March 31, 2022 and 2021, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzU1NTk_f5f8a3ed-a388-4055-bd7b-004560012dcb">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these U.S. dollar notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term debt of approximately $4 million and $11 million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f5e289f8bb94f8ba82cd55b25264f93_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzUtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozOGZhY2Q3ZjE4ZWE0YTZiOTU4NGZkY2NhZWFlOTIyNV83MTQ2ODI1NTgwNTc5_e3de43e4-6d7e-4714-97ab-3de2dfdae145"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6f5e289f8bb94f8ba82cd55b25264f93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzUtMS0xLTEtNjc1MTI_e5af0583-71a0-4b07-8a61-3838eaccc483"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i38191160842b4d688580a4d3c249f8c9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzUtMy0xLTEtNjc1MTI_48c4d7cf-568f-4bef-9429-b51cadf58c0b"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i75f9b3f6ce4a48629e8939f2036c9a7e_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzYtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjoyODI3NjM5M2UwZmM0OTVkOWNiYjE5MTJhZGM4OTIzZV83MTQ2ODI1NTgwNTc2_0c225fe3-89a6-4ac6-bc89-181e934a7b77"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i75f9b3f6ce4a48629e8939f2036c9a7e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzYtMS0xLTEtNjc1MTI_aeddece7-a461-4d12-8d06-f5c5734d134b"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaebf771578eb4688a13cafab7d91e267_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzYtMy0xLTEtNjc1MTI_6c83c217-4c51-49f7-bc09-7303607bac6f"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id41b46d826cf480a9d07b02c6f0fa4b9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjoxZDljNjMxZmExNmQ0N2Q0YTRiYTM5M2Q0MDIxOGI0N183MTQ2ODI1NTgwNTc2_9887bd4c-e9f5-4395-8ce1-a73889840753"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id41b46d826cf480a9d07b02c6f0fa4b9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMS0xLTEtNjc1MTI_d03c372f-f6e6-4ecb-b8eb-439a0cb01278"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9b257ef2e3f049e28d8f48078592b92a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMy0xLTEtNjc1MTI_5e2a94fb-3978-447e-890a-1ecdaea8f714"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iff19ad24fcaa4efe8adbe9568e74156a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzgtMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjo3YzRlZTc2ODkxNTk0NmI5YTg3NGIyOTQyY2E3YzUzYV83MTQ2ODI1NTgwNTc4_7ca435b7-47b3-4560-92fd-128640b5a62d"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iff19ad24fcaa4efe8adbe9568e74156a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzgtMS0xLTEtNjc1MTI_7175a66f-3aaf-4276-8dac-2bb690b052d2"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5269554a47894df4b123574f180fa7bf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzgtMy0xLTEtNjc1MTI_02c7ccbf-568a-47a5-b819-07532b1f0eac"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4492282a1a93402a8f44df990dd74728_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMC0xLTEtNzUxNDAvdGV4dHJlZ2lvbjoxOWI2ZThiYjRjMTE0MGIxYWZiNGE3NTIwZjhiMTY5ZF83MTQ2ODI1NTgwNTcz_46595e56-72ed-45ec-8fad-3a3d16f94d3d"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4492282a1a93402a8f44df990dd74728_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMS0xLTEtNzUyNTQ_fccc71c4-efc8-4be8-822d-6e181f1c5465"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icdebf42f817b45e8837663f7bac80ed5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzctMy0xLTEtNzUyMjU_799b2877-44f6-422c-a296-e274a723a1a4"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i02dc743ac553435dba404f92c86d8691_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMC0xLTEtNjc1MTIvdGV4dHJlZ2lvbjowZTc3M2E5ZDBjYzY0YTY2OTQ0N2FlNDU3NzM1Y2E4Ml83MTQ2ODI1NTgwNTc5_e0c75408-4a7b-4d9d-bbf6-3c0c5b0e4b65"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i02dc743ac553435dba404f92c86d8691_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMS0xLTEtNjc1MTI_6e566920-dec8-4e02-a676-351d4e1f13bb"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i70b14d9641344a939e986c99e6567d70_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzktMy0xLTEtNjc1MTI_2210cd4e-010c-4b42-9c49-06499982731d"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia6b3ed5f2ea54176814a8708c6499848_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEwLTAtMS0xLTY3NTEyL3RleHRyZWdpb246ZTcxYzE2NzU0MDE5NDkyOWIwODdiZTY0YWVjNTJmMTZfNzE0NjgyNTU4MDU3OQ_3e3f3de7-d042-42ba-845d-658eb5d23352"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia6b3ed5f2ea54176814a8708c6499848_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEwLTEtMS0xLTY3NTEy_91fd8f97-8d77-40ab-bb8a-e6d873ad9bfb"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5dd84b2361824bb0bc00064d18891fb0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEwLTMtMS0xLTY3NTEy_c977d5cb-b9a9-4841-9c31-5a0e4ea9f644"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i91a13fda196843f6b109d769cfe0751d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzExLTAtMS0xLTY3NTEyL3RleHRyZWdpb246MzhkZTAxNDk2MDMxNDkzZjgyOTRkZTI4ZDY0MTExMWJfNzE0NjgyNTU4MDU3NA_104c5d19-ac34-4ab1-bde2-d82d06086990"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i91a13fda196843f6b109d769cfe0751d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzExLTEtMS0xLTY3NTEy_20266b29-638b-4117-b40a-4bf027d0067f"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i18046743a1974c45821697aea7b0f77f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzExLTMtMS0xLTY3NTEy_22afae8a-f661-4fae-9511-00fcde504de8"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i776610a612354ff280ad9f037198c296_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEyLTAtMS0xLTY3NTEyL3RleHRyZWdpb246YzdlNjYyODY4NzAyNDk2ZTk1YWE2NTNkY2FlMjU5ZTFfNzE0NjgyNTU4MDU3NQ_548ba801-5a70-44aa-948b-ea94d670ff73"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i776610a612354ff280ad9f037198c296_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEyLTEtMS0xLTY3NTEy_b20dab55-04da-4330-b528-2b4f28e97fda"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8410975cba024c78bef5a76f712f7294_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEyLTMtMS0xLTY3NTEy_d2a02b96-2068-4503-a26c-399eb9bb7f0c"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9099b942bd1b45f78fdeefc39837a3ce_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEzLTAtMS0xLTY3NTEyL3RleHRyZWdpb246OTgyMDkwZGRkNGJkNGExYThiNjc0YzFjMjNlN2ZhY2NfNzE0NjgyNTU4MDU3Ng_4d456e43-f5e7-41b0-b9a1-4a963aacc1ba"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9099b942bd1b45f78fdeefc39837a3ce_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEzLTEtMS0xLTY3NTEy_3ce9d193-663a-4d13-9815-96d37af9964f"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ied357647ec7743bea35135bd6969080e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzEzLTMtMS0xLTY3NTEy_101900e9-0d18-42b7-ae2b-f3eac2f09b81"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i74426e55813a40cc92bc89945e9dd130_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE1LTAtMS0xLTY3NTEyL3RleHRyZWdpb246ZjQ0ZDA1OWUzMTNiNDhhMDhhNTUxYWE1ZmY2NTQxOTJfNzE0NjgyNTU4MDU4Mg_6598f2d3-fa84-497a-89f7-926e9aefcd85"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i74426e55813a40cc92bc89945e9dd130_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE1LTEtMS0xLTY3NTEy_caf06871-56e6-48e6-883b-d97f38deabaa"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i29908212c93c4b2cba4a35c49394c7b5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE1LTMtMS0xLTY3NTEy_196658b9-96b2-44e0-abf5-5c7519d59c67"
      unitRef="usd">704000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8a43cf31de784042b8d27a08355df15f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE2LTAtMS0xLTY3NTEyL3RleHRyZWdpb246MDUyM2NlZTM2NDQxNDA1ZWJkYWJjZjFmMzlmZTc4NmRfNzE0NjgyNTU4MDU4NA_81bd738c-f68a-472b-b532-1fc9f700379b"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8a43cf31de784042b8d27a08355df15f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE2LTEtMS0xLTY3NTEy_4dc62a04-feb0-462b-9a7e-92db1f37d6c5"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie471ed607d464069b849582cde89f693_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE2LTMtMS0xLTY3NTEy_5fcd23e7-1ea4-43f6-be8b-6fbf89b59d83"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i03e6233f5e8548d5a04aac3f11cb0d2f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE3LTAtMS0xLTY3NTEyL3RleHRyZWdpb246MzFlNTMyMzQyMzQwNGFiY2FiYzA2YjYwNWVmYmRiMmVfNzE0NjgyNTU4MDU4Mw_e3850ab4-17b2-4cfe-b161-26406f4bb60f"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i03e6233f5e8548d5a04aac3f11cb0d2f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE3LTEtMS0xLTY3NTEy_aed12fbc-c79f-43f2-ae88-358d1a20fa5b"
      unitRef="usd">554000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie3995850cc8f4cf0bfa3483d28ead8fa_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE3LTMtMS0xLTY3NTEy_4078dc9f-2b26-453b-87b3-9a3823c7cacd"
      unitRef="usd">587000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8b875fcead64ab181ee711d77c92192_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE4LTAtMS0xLTY3NTEyL3RleHRyZWdpb246ZWQ4Zjc4MmI3OGY5NDY4OTk2ZDE3NDM3NGI3NjdkZDVfNzE0NjgyNTU4MDU4OA_6b491cc0-8e82-40a7-a47d-c7d94e9455ba"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if8b875fcead64ab181ee711d77c92192_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE4LTEtMS0xLTY3NTEy_e50c46ae-727d-4489-a26a-98c838246529"
      unitRef="usd">582000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8fd452d00a734f2699190045314018e3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzE4LTMtMS0xLTY3NTEy_1e511b52-2e0d-4383-8391-0ed12a6c2343"
      unitRef="usd">627000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9a54c5deff6741e68bb12b5a3eadc2e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIwLTEtMS0xLTY3NTEy_a7d54881-feca-40af-b7b4-fe7bdf369de5"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0a3dbeaa252741fa82864c3f88132372_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIwLTMtMS0xLTY3NTEy_d3912520-0941-4489-b128-72c64944b41d"
      unitRef="usd">270000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIxLTEtMS0xLTY3NTEy_8e93ad74-3a2d-4528-9c62-5720e73abdb1"
      unitRef="usd">5879000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIxLTMtMS0xLTY3NTEy_fb4d1a39-2572-4203-8442-c3d7df3a3609"
      unitRef="usd">7148000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIyLTEtMS0xLTY3NTEy_f276cc2a-8ba7-4f49-98bc-79a53db9787c"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIyLTMtMS0xLTY3NTEy_ba7ffdd4-39ac-4660-aef5-0ac1567c6632"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIzLTEtMS0xLTY3NTEy_b1ca80df-8417-4d17-beb6-d250ad634d7b"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90YWJsZTplMDRhYTllNGQ3ZWE0MDRkOTJlMzk0YmI3YTA5ZGVlYS90YWJsZXJhbmdlOmUwNGFhOWU0ZDdlYTQwNGQ5MmUzOTRiYjdhMDlkZWVhXzIzLTMtMS0xLTY3NTEy_89259014-9a8b-48f8-91cc-93d36c7494ae"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU2Mjk_5db7d611-5718-4a54-8f0d-a5dcfef9ed1b"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="idd7a390cba074697a32fefbb6fab99ca_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU2NTE_f2ee798a-01a1-4aa5-942f-e874d7401b3c"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxMjY_34901bfa-b720-45e8-a10a-25f80e946a4c"
      unitRef="usd">5900000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxMzA_1c100d17-9c7a-4750-bc75-402cc63f0ca4"
      unitRef="usd">7100000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxMzc_e8695406-c590-4bbf-bca6-21f52b6d98af"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU1ODYxNDE_ecc3ef77-7a0f-4d0b-b240-8babd869062c"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i47b2810c0aee413597e8c1646426d086_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU4NjM_3bbda959-772b-4b63-a123-26bd9eefb735"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i47b2810c0aee413597e8c1646426d086_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU5Mzc_0a273cd2-d347-49d0-96f7-3d138b6458b3"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="idc6d4f12944242709bef7d5e0584395f_D20210812-20210812"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTYxNjI_f3657ea6-9f76-4e73-a9af-a529bea95a9f"
      unitRef="usd">495000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2b3cf2b7fbad458882870ec7a0921f35_I20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDEwNjA_10aeb8f1-5865-411e-ad96-874b90bdd7bb"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2b3cf2b7fbad458882870ec7a0921f35_I20201203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDEwNjQ_c05ae016-1b66-4771-b16c-c6fec2d9f927"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="if7c1af6fdd3b44f1934218a6f196c0a9_D20201203-20201203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDEwNzg_4e897896-fc39-4083-82c2-fb3bf8630328"
      unitRef="usd">496000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i06f2539eb1dc470b917574e5cba645f8_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDI3NzE_9f3729f9-3de3-43c1-becb-ccf0a4db5d9d"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if911145c95344b73b7494ae283e29168_I20210717"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTcyNzQ_fcef996a-0026-4260-af82-072118f2f34e"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="if911145c95344b73b7494ae283e29168_I20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTcyNzg_73ae7149-4590-436b-84dd-0975830e379c"
      unitRef="eur">600000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="if911145c95344b73b7494ae283e29168_I20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTczMDE_d65c8581-8165-4897-a2c5-0641d8ffa5b1"
      unitRef="usd">709000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic6b43789844d4108be63a4a1dd1280fe_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTY5NjI_6c230746-3cc9-4fd3-822e-fb6174f5dcb6"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic6b43789844d4108be63a4a1dd1280fe_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTY5NjY_76ad569a-2c43-43bb-8613-3e597921cada"
      unitRef="usd">323000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i97437c473f7b4c27959c7f3f98f911fe_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTkzMzQ_9323ef7b-bbae-4653-b2dc-3682e23217d4"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i97437c473f7b4c27959c7f3f98f911fe_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTkzMzg_0b7c9217-cda2-419d-8bb3-5e6167afd3b1"
      unitRef="usd">700000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8ae64a0ee64e4ca28a9e634159013ab3_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTcxODA_869b4d59-6e9a-443e-a363-633782850967"
      unitRef="eur">250000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5bb94ab329074f2382e57702aeb12464_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1Njg_82194e6e-f4e2-41d9-ab11-589e7fefaffb"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c2711a4ba7d4daeb3142e521b8d969d_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1NzU_15afb7ad-2436-4ba5-9bee-9f39b3dd7669"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i404ec63c736d4d128bee727971bdc191_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1ODI_a3151fb3-1555-46d3-8a3b-540a8e1fd53f"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7fa0c457401141829a63813967411389_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1ODk_1beda553-c1cc-4c46-8eb8-10eae120a5a3"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7700fd1bf3b64d08ab4b2725bcf11c2f_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg1OTY_47716d4a-8765-41b8-a704-0cc8b9223093"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib46cc219b945454c99153f6a6c005bc1_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2MDM_05d6f8f5-9425-4ce8-a2ba-08d6fef7bfd7"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if28ea4a9885e4a2aaccecc13941b21fc_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2MTA_b87084e4-f174-4cc4-85ac-3c467ae85ee7"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i40b1e6ac876c4f44be5287989b81b43c_I20210723"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2Mjk_7ec4b693-12bf-4e4a-a660-eee5f7b63c81"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i40b1e6ac876c4f44be5287989b81b43c_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2NDY_6b4fd596-e108-4950-a484-074d6af19b68"
      unitRef="usd">922000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2NTE_8aa16147-96ee-4638-91ff-be427230d430"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2Njk_c549c45d-e712-4c0a-abdd-7ad3a2fb1dbb"
      unitRef="usd">182000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:InterestPaid
      contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg2ODY_6d7d37c0-3cbb-4eff-99c8-239617899f78"
      unitRef="usd">14000000</us-gaap:InterestPaid>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg3MDQ_212c69a2-55f1-4a40-911b-4e26a8d6fafd"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i40b1e6ac876c4f44be5287989b81b43c_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEyMzI_ad018219-f382-4543-9921-50484f7785a5"
      unitRef="usd">182000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts
      contextRef="ic0f0b8c0e0dd47a0970c7871a6207428_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg3ODI_b531577b-5813-4ad3-b16a-f1a1f9780120"
      unitRef="usd">9000000</mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQyMDI_175edb9f-f7ce-4db5-bd9f-a178877f99c2"
      unitRef="usd">799000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNTM_b221971e-208e-4892-bf7f-917f6680439c"
      unitRef="usd">966000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU3NTY_97968b72-7798-4a0f-a11e-a639bffa688e"
      unitRef="usd">35000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNjE_30512e99-5dab-4f77-9af1-3eca8bd3b5d6"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTU3ODQ_d647d532-d230-4d76-b1ca-2e8fb45f3fc3"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNjk_c76f4657-798a-4d4f-b6a9-d0f9c7277aac"
      unitRef="usd">1700000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib2f0e560d0dd48aaa9c9a66d529db5b7_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzNzQ_520cfe65-462a-47dd-b72e-735474842774"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i815ce043efb54a79a003ee84bccbc673_D20190701-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEzMTY_2459dae6-db14-45a7-a9f4-c904455522c5">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i04e0a17bd91147bba817806801ea38d9_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDQzODA_acef4d16-356b-46c0-9f9d-f64434191e95"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i9d7edea6bbe944938cf631118e7e0c24_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2NDM_405a35a3-2102-4554-99f6-c47fef7a27e0"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i786695c3c8824251b74d57413f2ab330_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2NDM_5d403c85-b4a2-424e-8dd6-fa1473b546c7"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i96bdc5d0996443d4bc99773608909bc1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg4MTU_5b8d4fe5-806c-4e48-b232-bf64688cf327"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i7c239f7cb9ba4f119b5f6aac4be47c6f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTg4MTU_a7da01b0-ade7-452d-8de3-aad7c2140f93"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9f981237ad304136b3c2ae388a494f17_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDU3OTY_f91abdf7-c641-410d-9243-b532a02413b0"
      unitRef="usd">3500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1ae704fbe3b04d318f47ec250c37e298_D20190901-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzI3NDg3NzkxMDEzMTU_314ab5c1-790b-4ab1-ad7f-43f054c9ce9b">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ic2d8d6b46e9d4decbb6a76ffd434ad18_D20190401-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2Mjk_c881703d-cbc1-4b9b-b2a3-90403b1d8628"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="i1c59a4ea805b47c08a95056ceb9c564e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDYzMDU_4b341ad4-f158-4f22-934f-6fde58e125ec"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i1c59a4ea805b47c08a95056ceb9c564e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDYzMDk_7da6e677-ab4d-4a9d-87dc-cdcedc23c728"
      unitRef="usd">111000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iad7a2e6922f64cf3808e830fd554c3ff_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2Njk_78704e6f-b2ee-420c-85f1-93575d7ba74b"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2ODc_1e9a1a73-3798-405c-b44b-954b2097cdaa"
      unitRef="usd">11200000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2NzU_c678607e-d2b6-4c51-9c4f-17ec9bfe0f2b"
      unitRef="usd">6300000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTk1MjI_723d466b-ad9d-480a-a642-509a74e59c8f"
      unitRef="usd">21400000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2OTM_523ef753-f8b3-4a88-8a93-7b6bdfdb391a"
      unitRef="usd">11200000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzcxNDY4MjU2MDY2Nzg_4b8df9e3-f17b-430f-9331-b45a20adf4de"
      unitRef="usd">6300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzEwOTk1MTE2NTk1Mzk_3a068ded-87e9-43fd-9948-cf8b3d18cab9"
      unitRef="usd">21400000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermDebt
      contextRef="i2cb808ca7946448095716d3e591aec2f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzkzNDU4NDg4NjcyNTU_3b1dfe55-8450-44a3-8b4e-d492d1b31324"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iad7a2e6922f64cf3808e830fd554c3ff_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDUvZnJhZzozMDBjOGJhZmJkMmE0Mjg2YjdkMjg5YmY0YWFhYzkxNy90ZXh0cmVnaW9uOjMwMGM4YmFmYmQyYTQyODZiN2QyODliZjRhYWFjOTE3XzkzNDU4NDg4NjcyNTU_e37f159f-b256-4ee8-868c-adad886d545a"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzI5NzQ_00f9fd69-f2a4-47e7-8c14-df0f9b8ce3b7">Variable Interest Entities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#x2019;s Consolidated Statements of Operations and Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $660 million and $65 million, respectively, at March 31, 2022, and $662 million and $74&#160;million, respectively, at March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Unconsolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual, or other relationships with the VIEs. The Company&#x2019;s most significant VIE relationships are with oncology and other specialty practices. Under these practice arrangements, the Company generally owns or leases all of the real estate and equipment used by the practices and manages the practices&#x2019; administrative functions. Prior to the divestment of the Austrian businesses in 2022, the Company had relationships with certain pharmacies in Europe with whom it provided financing, had equity ownership, and/or had a supply agreement whereby it supplied the vast majority of the pharmacies&#x2019; purchases. The Company&#x2019;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $1.4 billion and $1.5 billion at March 31, 2022 and 2021, respectively, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 17, &#x201c;Financial Guarantees and Warranties.&#x201d; The Company believes there is no material loss exposure on these assets or from these relationships.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="id447a2bd767645c7a12007233124425f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1NTI_bf9b6679-a841-4e45-9857-63ab45f7a9e8"
      unitRef="usd">660000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="id447a2bd767645c7a12007233124425f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1NTY_d2cad88f-dc91-412e-8a0b-c6b83bdcb413"
      unitRef="usd">65000000</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="i0d2b3d87c4114cc6b082a6eb3df4484b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1Mjk_22ceb2e8-b17b-431b-a726-55c0cd0d08c2"
      unitRef="usd">662000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i0d2b3d87c4114cc6b082a6eb3df4484b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1NDM_3c2ae250-8110-4070-a6cf-a32d88910bc5"
      unitRef="usd">74000000</us-gaap:Liabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1ODU_fa000ca4-3f8a-4bf8-9191-634e1f4e6e20"
      unitRef="usd">1400000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNDgvZnJhZzowYjFhNjdjMWZkYWE0OTE5OWFhZDdlMjc0NmZlNjZlYS90ZXh0cmVnaW9uOjBiMWE2N2MxZmRhYTQ5MTk5YWFkN2UyNzQ2ZmU2NmVhXzcxNDY4MjU1ODM1ODA_a2548725-364b-42f4-9336-4bab05f6f4da"
      unitRef="usd">1500000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2Mjk5_8ea98bff-1353-447a-bed4-88d0fd7fe31f">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an unfunded nonqualified supplemental defined benefit plan for certain U.S. executives, as well as benefit pension plans for eligible employees outside the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 23, 2018, the Company&#x2019;s Board of Directors approved the termination of its frozen U.S. defined benefit pension plan (&#x201c;Plan&#x201d;). During the first quarter of 2020, the Company offered the option of receiving a lump sum payment to certain participants with vested qualified Plan benefits in lieu of receiving monthly annuity payments. Approximately 1,300 participants elected to receive the settlement, and lump sum payments of approximately $49 million were made from Plan assets to these participants in June 2019. The benefit obligation settled approximated payments to Plan participants and a settlement charge of $17 million was recorded during the first quarter of 2020. During the second quarter of 2020, the Company transferred the remainder of the Plan&#x2019;s pension obligation to a third-party insurance provider by purchasing annuity contracts for approximately $280 million which was fully funded directly by Plan assets. The third-party insurance provider assumed the obligation to pay future pension benefits and provide administrative services on November 1, 2019 and a pre-tax settlement charge of $105 million was recorded during the second quarter of 2020. Settlement charges were included within &#x201c;Other income, net,&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2020. As of March 31, 2020, this defined benefit pension plan had an accumulated comprehensive loss of approximately nil.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway, the United Kingdom, Germany, and Canada. Benefits for these plans are based primarily on each employee&#x2019;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#x201c;SPK&#x201d;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law. In the U.K., the Company has subsidiaries that participate in a joint pension plan. The pension obligation in Germany is unfunded with the exception of the contractual trust arrangement used to fund pensions of McKesson Europe&#x2019;s Management Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company derecognized $43&#160;million of pension liabilities included in liabilities held for sale and $11&#160;million of accumulated other comprehensive loss related to the sale of its Austrian business. During the third quarter of 2021, the Company derecognized $187&#160;million of pension liabilities included in liabilities held for sale and $33&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit plan assets and obligations are measured as of the Company&#x2019;s fiscal year-end. The net periodic expense for the Company&#x2019;s pension plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost - benefits earned during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized actuarial loss and prior service costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the changes in benefit obligations and plan assets for the Company&#x2019;s pension plans is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer and participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The benefit obligation is the projected benefit obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The divestiture relates to the sale of the Company&#x2019;s Austrian business in 2022 and to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#x2019;s U.K. disposal group. Current liabilities at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2022 include &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#x2019;s E.U. disposal group. Refer to Financial Note 2, &#x201c;Held for Sale&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actuarial gain of $55 million in 2022 was primarily attributable to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Discount rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($69&#160;million gain): The weighted average discount rate for Non-U.S. plans increased to 2.67% as of March 31, 2022 from 1.89% as of March 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Demographic and assumption changes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($14&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestitures in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actuarial loss of $89 million in 2021 was primarily attributable to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Discount rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($32&#160;million loss): The weighted average discount rate for Non-U.S. plans decreased to 1.89% as of March 31, 2021 from 2.03% as of March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Demographic and assumption changes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; ($57&#160;million loss): This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the divestiture in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#x2019;s pension plans, including accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in accumulated other comprehensive loss consist of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other changes in accumulated other comprehensive income were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit (cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive loss (income) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, the Company recognized $11&#160;million in actuarial losses for pension plans to stockholders&#x2019; equity as a result of the sale of its Austrian business. In 2021, the Company recognized $33&#160;million in actuarial losses for pension plans to stockholders&#x2019; equity as a result of the contribution of its German pharmaceutical wholesale business to a joint venture. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for more information. The Company recognized $127 million in actuarial losses for the pension plans to stockholders&#x2019; equity in 2020 as a result of the termination of the U.S. defined benefit pension plan and the settlement from the executive benefit retirement plan for a retired executive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected benefit obligations related to the Company&#x2019;s unfunded U.S. plans were $8 million and $9 million at March 31, 2022 and 2021, respectively. Pension obligations for its unfunded plans are based on the recommendations of independent actuaries. Projected benefit obligations relating to the Company&#x2019;s unfunded non-U.S. plans were $101 million and $162 million at March 31, 2022 and 2021, respectively. Funding obligations for its non-U.S. plans vary based on the laws of each non-U.S. jurisdiction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments for the Company&#x2019;s pension plans are as follows: $34 million, $33 million, $33 million, $34 million, and $35 million for 2023 to 2027, respectively, and $186 million for 2028 through 2032. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#x2019;s pension plans are $13 million for 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. For March 31, 2022, the Company&#x2019;s U.S. defined benefit liabilities are valued using a weighted-average discount rate of 3.35%, which represents an increase of 100 basis points from its 2021 weighted-average discount rate of 2.35%. The Company&#x2019;s non-U.S. defined benefit pension plan liabilities are valued using a weighted-average discount rate of 2.67%, which represents an increase of 78 basis points from its 2021 weighted-average discount rate of 1.89%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment Strategy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For non-U.S. plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets of the non-U.S. plans are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. The following tables represent the Company&#x2019;s pension plan assets as of March&#160;31, 2022 and 2021, using the fair value hierarchy by asset class:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate funds and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held at NAV practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $1.00. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annuity contracts - The value of the annuity contracts is reported by the Trustee and is based on a valuation of the remaining contracted cash flow of the contract. Inputs in the valuation include discounted future cash flows; these are classified as Level 3 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other - At March 31, 2022 and 2021, this includes $35 million and $36 million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the year ended March 31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity attributable to Level 3 plan assets was not material for the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Multiemployer Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#x201c;POA&#x201d;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#x2019;s withdrawal liability and contributions may increase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contributions and amounts accrued for U.S. plans were not material for the years ended March 31, 2022, 2021, and 2020. Contributions to the POA for non-U.S. plans exceeding 5% of total plan contributions were&#160;$20 million, $22 million, and&#160;$17 million in 2022, 2021, and 2020, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately 88% as of March 31, 2022. No amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a contributory retirement savings plan (&#x201c;RSP&#x201d;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to 75% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to 100% of the employee&#x2019;s first 3% of pay contributed and 50% for the next 2% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $116 million for the year ended March 31, 2022 and $102 million for each of the years ended March 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a number of postretirement benefit plans, primarily consisting of healthcare and life insurance (&#x201c;welfare&#x201d;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#x2019;s fiscal year-end. The net periodic (credit) expense for the Company&#x2019;s postretirement welfare benefits was not material for the years ended March 31, 2022, 2021, and 2020. The benefit obligation at March 31, 2022 and 2021 was $56 million and $64 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <mck:DefinedBenefitPlanSettlementPlanParticipants
      contextRef="if8a6c7fc82394698afcdf83d11179f9a_D20190601-20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzcxNw_ed4d574f-6b17-448a-8f22-a46111fc84f1"
      unitRef="participant">1300</mck:DefinedBenefitPlanSettlementPlanParticipants>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="if8a6c7fc82394698afcdf83d11179f9a_D20190601-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzgwNw_6f703f1f-cad9-4d21-92a1-588f3c27c2bc"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ib56e9807d14242ab8a66d9df9e68b070_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4Xzk3NA_95ffb966-5c79-42d3-9597-143bef89d912"
      unitRef="usd">-17000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract
      contextRef="i2f41e21247ae4a519309d2ad4bff9441_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEyMTY_7db7025c-3f73-40a1-aeba-e7cc0833993c"
      unitRef="usd">280000000</mck:DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i2f41e21247ae4a519309d2ad4bff9441_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE0NDc_54a5a5f8-1f50-48e3-b2b2-ce783dfad9df"
      unitRef="usd">-105000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="if83736112ca9462697b6ec54e87de910_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE3MzU_a7007b17-e8e2-4a8d-a373-bd7f8cf745a2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized
      contextRef="i8b2f3b3bb37649189b90084615b5a308_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDQ5NjM_c4f3e523-62b0-4540-ac45-2b6f1fd909ea"
      unitRef="usd">43000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i805540d4c73c4b6387871c54c384fbbf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDUwMDM_bf38f472-919a-4a2f-8c2c-a260effe61d4"
      unitRef="usd">-11000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized
      contextRef="i2faa1d1ed13a446eb975b380912a3068_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzMxOTU_137dee3d-c454-4353-ab5d-ee5c0a15ce6d"
      unitRef="usd">187000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i2ec0851116374d82b9e49426d73763b6_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzMyNjM_5d794a39-a7e6-4ecd-8d9b-e7fa430dd8e8"
      unitRef="usd">-33000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzQ5_4c89ae0d-d51b-4362-9a92-c4a09f11f71b">The net periodic expense for the Company&#x2019;s pension plans is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost - benefits earned during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized actuarial loss and prior service costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtMS0xLTEtNjc1MTI_914d48fe-a69a-4f8c-9ddf-a8323f2a33ea"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtMy0xLTEtNjc1MTI_a947ba40-9a81-4a17-a8a8-629b3bbd4748"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtNS0xLTEtNjc1MTI_6f12098c-f09f-4fde-9dfa-da5e24820113"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtNy0xLTEtNjc1MTI_565fcad3-c929-45fb-807f-c71e92f7588a"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtOS0xLTEtNjc1MTI_e795407d-dc69-4c49-8324-f014a5fc72bf"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzMtMTEtMS0xLTY3NTEy_b1b2369b-d560-44b1-a89b-d67b321ebbcc"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtMS0xLTEtNjc1MTI_6dc8a3de-4e01-49ca-b6bf-1a2fea85bde7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtMy0xLTEtNjc1MTI_62c74fd3-2957-412d-ae1f-79ac7c4ad374"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtNS0xLTEtNjc1MTI_e3d585d4-6dc6-40a4-9fee-b6af74d2dbb9"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtNy0xLTEtNjc1MTI_00e91666-e77d-4af6-8d0a-80252675cb1b"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtOS0xLTEtNjc1MTI_a47a3a97-cce9-4b0a-afb9-70f880f3d7ae"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzQtMTEtMS0xLTY3NTEy_16a671cd-1bd8-4589-acbb-1ab8dca03d30"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtMS0xLTEtNjc1MTI_d5d76674-f88c-4f0f-86fb-c5552370a147"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtMy0xLTEtNjc1MTI_a335140d-b05b-4a7b-b65d-4195813148b0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtNS0xLTEtNjc1MTI_48282dda-2e00-4aa3-a314-3142fcfba4d8"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtNy0xLTEtNjc1MTI_7a8fb60a-a7b7-4d96-b30d-50cd5bfb427b"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtOS0xLTEtNjc1MTI_ef59bb5e-8319-45db-aa56-a08ca5016961"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzUtMTEtMS0xLTY3NTEy_cebfde9b-61e2-4d21-8c90-907c9d52d787"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtMS0xLTEtNjc1MTI_2da5e9e6-c5bd-4ccc-ae1e-2dcb55b81fd4"
      unitRef="usd">0</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtMy0xLTEtNjc1MTI_f654781f-7604-4275-bb62-c0557d84793e"
      unitRef="usd">0</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtNS0xLTEtNjc1MTI_d3594a82-9ca3-4d55-b533-8154fb18a5d9"
      unitRef="usd">2000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtNy0xLTEtNjc1MTI_00e1820e-f5fa-4fbe-bfdf-ff31252e1e62"
      unitRef="usd">3000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtOS0xLTEtNjc1MTI_62b0343f-bac5-425d-96ff-ee26360958cd"
      unitRef="usd">5000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzYtMTEtMS0xLTY3NTEy_71dd9472-2658-414f-83ae-0c83c1b60152"
      unitRef="usd">6000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctMS0xLTEtNjc1MTI_313a9dac-4290-4eda-a88a-a4081271571e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctMy0xLTEtNjc1MTI_f66a06fa-b5f2-4082-912f-3006f0b48354"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctNS0xLTEtNjc1MTI_99f60e03-35e3-4555-a06d-68d4a5a853f8"
      unitRef="usd">-127000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctNy0xLTEtNjc1MTI_0368ff7d-5021-420b-9759-9099e3cb8d8b"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctOS0xLTEtNjc1MTI_5be80ea4-c5fb-4b91-b927-d37c91ffb9fe"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzctMTEtMS0xLTY3NTEy_f3eb3e53-8570-4740-b7e4-02a0674cfa6e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktMS0xLTEtNjc1MTI_c4288f12-c62a-48d1-8232-3bed6da34f45"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktMy0xLTEtNjc1MTI_e2cb1a97-e493-47f1-a267-2654ef84775a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktNS0xLTEtNjc1MTI_d0b9f784-cec8-4065-bf7b-294da38c0577"
      unitRef="usd">131000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktNy0xLTEtNjc1MTI_d21bdfc6-bd01-4cbe-a270-75f609b2d7ea"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktOS0xLTEtNjc1MTI_6cfc67f3-a48b-4bac-a2a9-bf70b7ecafbb"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxYmE5OTkxNmQwNWU0Y2Y4OGNhZDgyNWNlNWI3MDI2OC90YWJsZXJhbmdlOjFiYTk5OTE2ZDA1ZTRjZjg4Y2FkODI1Y2U1YjcwMjY4XzktMTEtMS0xLTY3NTEy_fb70e83c-8e7b-484b-91a5-22daf70f8f27"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDUwMTY_1e0847a6-8891-44d8-99ea-2e1279ab2af8"
      unitRef="number">0.10</mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzI3NDg3NzkwODk5NTY_3875725c-1abe-442f-9e5d-f982ffb75417">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the changes in benefit obligations and plan assets for the Company&#x2019;s pension plans is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer and participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The benefit obligation is the projected benefit obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The divestiture relates to the sale of the Company&#x2019;s Austrian business in 2022 and to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture in 2021 as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#x2019;s U.K. disposal group. Current liabilities at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2022 include &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#x2019;s E.U. disposal group. Refer to Financial Note 2, &#x201c;Held for Sale&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtMS0xLTEtNjc1MTI_0138ffb0-5f94-445c-9ff8-38bb46956c41"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if83736112ca9462697b6ec54e87de910_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtMy0xLTEtNjc1MTI_ecf00d6e-4a37-4088-9a91-79106b1be522"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtNS0xLTEtNjc1MTI_affe23ba-dd3c-4210-af9c-4da4438b6281"
      unitRef="usd">875000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzQtNy0xLTEtNjc1MTI_585d6972-c917-47d4-951d-1fecbff726e2"
      unitRef="usd">896000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtMS0xLTEtNjc1MTI_3d5fe84f-3750-4ffc-8506-0914d265b108"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtMy0xLTEtNjc1MTI_661d05af-317a-421a-b34d-ae1e100f72cf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtNS0xLTEtNjc1MTI_d85e488a-4488-429f-8c97-b2978963076a"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzUtNy0xLTEtNjc1MTI_325fcce4-bcb6-4ad2-b19f-5c7fd04a8ecc"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtMS0xLTEtNjc1MTI_5e6ca065-b19a-4d53-8771-21e476707ea8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtMy0xLTEtNjc1MTI_6df4cde9-cbc9-4cf5-b01f-5cf355386e69"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtNS0xLTEtNjc1MTI_e7ba1c8c-9547-4e4c-811c-62a8df605386"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzYtNy0xLTEtNjc1MTI_b6f0b3d6-4717-417f-b091-511883c1a4ea"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctMS0xLTEtNjc1MTI_5f9666a3-16d0-4889-bb0a-e47e14db32b3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctMy0xLTEtNjc1MTI_ed20fb2d-f9e4-43fd-b699-109da22adb1e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctNS0xLTEtNjc1MTI_8998e208-6347-4c1c-a4ee-77948af307dc"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzctNy0xLTEtNjc1MTI_445aa117-dad3-4a14-8b89-2f549c87dcdf"
      unitRef="usd">-89000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtMS0xLTEtNjc1MTI_5515ce47-0bab-41d6-9e86-d6b4a8a351a6"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtMy0xLTEtNjc1MTI_0421690f-37c2-47bf-be2d-6be792cf9bfd"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtNS0xLTEtNjc1MTI_dcfd032e-580b-48f6-b791-f5baed50329e"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzgtNy0xLTEtNjc1MTI_8f7b2ff5-43e5-4bc5-b715-cf6fefd5fd71"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktMS0xLTEtNjc1MTI_ece11021-018d-490a-a655-d949abcdbdfb"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktMy0xLTEtNjc1MTI_173d166d-6b89-4e7a-910d-82451ac82fb8"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktNS0xLTEtNjc1MTI_40d9ecf3-7ff2-4bac-b728-d284b56ba3ec"
      unitRef="usd">32000000</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzktNy0xLTEtNjc1MTI_f17ef201-51af-4446-a0b0-3d84d09a4d21"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement>
    <mck:DefinedBenefitPlanBenefitObligationsExpensesPaid
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTEtMS0xLTY3NTEy_5aad982c-fbb0-4fce-92ea-bbae0d7a6aee"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationsExpensesPaid>
    <mck:DefinedBenefitPlanBenefitObligationsExpensesPaid
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTMtMS0xLTY3NTEy_e0195a97-def4-4694-b832-d40d035743e8"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationsExpensesPaid>
    <mck:DefinedBenefitPlanBenefitObligationsExpensesPaid
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTUtMS0xLTY3NTEy_2dfcc9ad-0e9d-489a-a51f-8fe9896fea85"
      unitRef="usd">1000000</mck:DefinedBenefitPlanBenefitObligationsExpensesPaid>
    <mck:DefinedBenefitPlanBenefitObligationsExpensesPaid
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEwLTctMS0xLTY3NTEy_2a6f550e-29fc-4202-a8cc-6fc513cbbfa7"
      unitRef="usd">0</mck:DefinedBenefitPlanBenefitObligationsExpensesPaid>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTEtMS0xLTY3NTEy_0a30afb8-a012-4f72-af53-f7435e6d7a5d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTMtMS0xLTY3NTEy_98f092c5-7fb9-4558-81bb-4719730f7441"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTUtMS0xLTY3NTEy_8c66cdfe-dfc6-43e2-8b3f-bca1150e7583"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzExLTctMS0xLTY3NTEy_514b1195-10fa-4097-90df-42b737068783"
      unitRef="usd">187000000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTEtMS0xLTY3NTEy_f617605d-11f2-4436-b550-287d370fdb5a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTMtMS0xLTY3NTEy_6e090b52-85bb-48da-9e65-02499312344a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTUtMS0xLTY3NTEy_d9338795-dd8e-4c73-a121-330a35d392bf"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzEzLTctMS0xLTY3NTEy_f815f7af-f069-4808-a7ad-0661ffc2254f"
      unitRef="usd">77000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTEtMS0xLTY3NTEy_662faa4e-b5e3-452d-91e0-3cc63311e648"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTMtMS0xLTY3NTEy_e8b82bd8-fc15-480f-b4c4-6a9218767923"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTUtMS0xLTY3NTEy_3fc67614-5379-46d0-b530-3164b31107e2"
      unitRef="usd">701000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE0LTctMS0xLTY3NTEy_4070d558-330d-4e77-b569-71fdf9063f2d"
      unitRef="usd">875000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTEtMS0xLTY3NTEy_b12b28f6-5af8-4e4c-8e9d-14ff235c518c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if83736112ca9462697b6ec54e87de910_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTMtMS0xLTY3NTEy_d01297a9-81ca-412b-9379-8bdd27d6bd32"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTUtMS0xLTY3NTEy_9dd52c1a-5693-4361-bb02-d9493c26738b"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE3LTctMS0xLTY3NTEy_9de4c176-980b-402a-bc0a-03f3b943cf69"
      unitRef="usd">594000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTEtMS0xLTY3NTEy_3d7e0ed5-b6d1-458c-9428-384ef1636421"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTMtMS0xLTY3NTEy_0bb0e898-f837-4acc-9d3d-1c3b3c63c56e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTUtMS0xLTY3NTEy_000d0971-d207-487b-93a6-5a351920d2c2"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE4LTctMS0xLTY3NTEy_2acafc8f-7c2c-4a25-b263-20c407f6edcc"
      unitRef="usd">87000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTEtMS0xLTY3NTEy_87a2b23c-5c95-43e6-b6f9-73936b744155"
      unitRef="usd">1000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTMtMS0xLTY3NTEy_a612e148-ad5c-48dc-97d8-984a770feed0"
      unitRef="usd">1000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTUtMS0xLTY3NTEy_5923d990-8b49-4a02-a121-ea1f70446017"
      unitRef="usd">43000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzE5LTctMS0xLTY3NTEy_790e278c-2085-4f6e-b1cc-5f8d75ed6854"
      unitRef="usd">27000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTEtMS0xLTY3NTEy_9cd9dae2-162f-459b-b310-7961d620d687"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTMtMS0xLTY3NTEy_a239f715-4f99-4bdb-9026-bd4ff0e2848c"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTUtMS0xLTY3NTEy_4f63dfb5-c707-4f53-9a3c-0507c7466022"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIwLTctMS0xLTY3NTEy_523a299f-6157-44d8-b86e-c533e9bd2e19"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <mck:DefinedBenefitPlanPlanAssetsExpensesPaid
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTEtMS0xLTY3NTEy_83a45d78-8ceb-42ff-a101-01b538e2ba66"
      unitRef="usd">0</mck:DefinedBenefitPlanPlanAssetsExpensesPaid>
    <mck:DefinedBenefitPlanPlanAssetsExpensesPaid
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTMtMS0xLTY3NTEy_82bb3033-431e-4951-95a8-0ccb62037d6c"
      unitRef="usd">0</mck:DefinedBenefitPlanPlanAssetsExpensesPaid>
    <mck:DefinedBenefitPlanPlanAssetsExpensesPaid
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTUtMS0xLTY3NTEy_8bde14eb-22b4-482a-9852-556c4cee26d4"
      unitRef="usd">1000000</mck:DefinedBenefitPlanPlanAssetsExpensesPaid>
    <mck:DefinedBenefitPlanPlanAssetsExpensesPaid
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIyLTctMS0xLTY3NTEy_c40af244-aa13-406f-a979-25e40f732af3"
      unitRef="usd">0</mck:DefinedBenefitPlanPlanAssetsExpensesPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTEtMS0xLTY3NTEy_c5ae3b45-591e-4690-866c-a44b96368b13"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTMtMS0xLTY3NTEy_e9be1e32-4bd7-441d-b560-b899aa4d7c21"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTUtMS0xLTY3NTEy_c5162d66-c7ab-48e9-ab6e-1260920e8b9d"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzIzLTctMS0xLTY3NTEy_e2561cef-8825-4264-a97d-66ae5ee00ce7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTEtMS0xLTY3NTEy_a3650ac4-8780-4d64-9496-c6cda25794bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTMtMS0xLTY3NTEy_ef38cc19-0687-4ab8-9cb2-21b0d64fc2af"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTUtMS0xLTY3NTEy_b8dc0543-3d44-4eeb-8db1-6faec389677b"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI0LTctMS0xLTY3NTEy_50ee7329-b46e-4eda-86d2-3b98f3dd8f87"
      unitRef="usd">61000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTEtMS0xLTY3NTEy_c0cf04ed-9f15-41de-aa4c-c9eddd12556d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTMtMS0xLTY3NTEy_8f46cfb8-c452-400b-a86f-5b48b5e5209e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTUtMS0xLTY3NTEy_461ede86-4f90-4a1b-aeca-d137ed2f345c"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI1LTctMS0xLTY3NTEy_972e0891-2a91-4502-843b-f78b5b266ed8"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTEtMS0xLTY3NTEy_09aaf51f-3a52-4d25-81b4-fb7bce5da12e"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTMtMS0xLTY3NTEy_faba8fdb-3034-49ba-8a6d-7f1bb8edf282"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTUtMS0xLTY3NTEy_473274c2-7634-4674-a85e-0908d6eb6760"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzI3LTctMS0xLTY3NTEy_4dab2d6b-0236-4741-81bb-006a32780873"
      unitRef="usd">-140000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTEtMS0xLTEyOTE1Ng_4df3a680-141d-4e7e-9dc1-dbae2f4ed864"
      unitRef="usd">0</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTMtMS0xLTEyOTE2NQ_cf76ef8a-ca1f-4c7a-b690-081b3a0c57c3"
      unitRef="usd">0</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTUtMS0xLTEyOTE3Mg_13ee5d13-5686-4c06-837f-48031856550f"
      unitRef="usd">49000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTctMS0xLTEyOTE3OQ_7f1715f3-e82b-483b-a0ee-5bceda491bc7"
      unitRef="usd">0</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTEtMS0xLTY3NTEy_91b9ff7c-10f3-4179-abd0-470ab329880e"
      unitRef="usd">0</mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTMtMS0xLTY3NTEy_9d4c4dc0-a491-422d-b8e2-dd109537a24c"
      unitRef="usd">0</mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTUtMS0xLTY3NTEy_a57f8130-13ac-4602-a9cf-7c0bf1984d4c"
      unitRef="usd">40000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMwLTctMS0xLTY3NTEy_9bc4b6c5-705f-4505-ad43-add6d6e6ccae"
      unitRef="usd">54000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTEtMS0xLTY3NTEy_17829693-7b17-4802-8076-9d1a7e75a2a2"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTMtMS0xLTY3NTEy_eac7c4c8-0db2-4656-8e3f-7312ba5e1814"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTUtMS0xLTY3NTEy_34cb4cc3-3ecd-43e1-90d0-df477b54d182"
      unitRef="usd">90000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMxLTctMS0xLTY3NTEy_9c98a27c-81fb-4478-85a2-1a03ffc91c82"
      unitRef="usd">9000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTEtMS0xLTY3NTEy_305cac57-260f-4d41-9e39-dd7c247ab8ba"
      unitRef="usd">7000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTMtMS0xLTY3NTEy_79e05a3a-f03e-4c53-8d49-7d1026b265e5"
      unitRef="usd">8000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTUtMS0xLTY3NTEy_fca20eff-46fa-4da1-be56-b9478cb59654"
      unitRef="usd">19000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMyLTctMS0xLTY3NTEy_eef8b266-e421-4b13-9714-efe194582669"
      unitRef="usd">185000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTEtMS0xLTY3NTEy_3222b7c2-95a1-4e0b-a079-56ac410fa94d"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTMtMS0xLTY3NTEy_6af285db-c2ca-4643-a25e-7e3b6ec06bc7"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTUtMS0xLTY3NTEy_ae97add9-7bb1-4a7d-bd32-5b250ddc46e3"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo2YjBhYWI5YmExOTQ0Y2NiYmMwYjg5YmQxM2M2MDE1ZS90YWJsZXJhbmdlOjZiMGFhYjliYTE5NDRjY2JiYzBiODliZDEzYzYwMTVlXzMzLTctMS0xLTY3NTEy_9a1b1f46-d8e8-4d8f-92b8-063715e210d5"
      unitRef="usd">-140000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i90ce3eddb5fc4a9387c2b4a7e93476dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU3NzE_6d0cf4ad-3436-41e5-9cc0-44dbd653f8df"
      unitRef="usd">49000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i90ce3eddb5fc4a9387c2b4a7e93476dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2NDkyNjc0NjMzNTU_fc2d2a5d-e303-4307-9b1d-b33488208c8e"
      unitRef="usd">85000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU4MjI_8998e208-6347-4c1c-a4ee-77948af307dc"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzQ1MDI_568be122-ae2d-4364-91cd-f5315d142eaf"
      unitRef="usd">69000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU4NjQ_efba8e28-ca2b-4779-a611-dd1770689cb6"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU4OTg_e16c92f0-592f-4f5b-aa34-a59ae2b42727"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzQ2NDY_eea32224-4757-4e1f-8a5e-9508cb8a41c7"
      unitRef="usd">-14000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU5MTg_445aa117-dad3-4a14-8b89-2f549c87dcdf"
      unitRef="usd">-89000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzQ5ODg_8fc2b3c1-4f09-4da2-ac72-614749b0d64a"
      unitRef="usd">-32000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDU5NzM_6a37630b-e762-4180-9997-28c23c5d5692"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzUwNjc_f2c88a78-9e53-452d-a1f8-92fb5e0f67eb"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzUxMzE_f76338ce-db16-4560-9249-6a111bfd5751"
      unitRef="usd">-57000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzA4_b0f902dd-74c2-411d-ad65-123da7aea70a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#x2019;s pension plans, including accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtMS0xLTEtNjc1MTI_295863a1-3f22-4e58-8382-1aa146513554"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtMy0xLTEtNjc1MTI_7f84b499-6f4d-41e1-b907-fa25ea6d352d"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtNS0xLTEtNjc1MTI_c16ae916-9a65-4fc7-aee5-6bf48920b1bc"
      unitRef="usd">701000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzMtNy0xLTEtNjc1MTI_4192d8ca-a112-4824-bcbd-3eea3d1efafa"
      unitRef="usd">875000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtMS0xLTEtNjc1MTI_69f66631-8010-420e-a13f-60ffae407a4e"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtMy0xLTEtNjc1MTI_02dc3050-2720-405b-a600-b1249497276c"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtNS0xLTEtNjc1MTI_023e59a1-5f20-4f9f-92ca-200a928146f8"
      unitRef="usd">689000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzQtNy0xLTEtNjc1MTI_c5a28ce1-d80d-49dd-b4fa-af597e26a64b"
      unitRef="usd">847000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtMS0xLTEtNjc1MTI_cb18da91-de44-4f77-8072-2712b5d1a688"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtMy0xLTEtNjc1MTI_e42f839f-1bd1-4825-850f-0ed5291684bc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtNS0xLTEtNjc1MTI_53b5ca90-edd3-4c98-9759-e5e7b1b64edb"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZToxMjcwMGMyZWIwZjM0MmFlYTE2NGU4YmRmYzdmOGZlYi90YWJsZXJhbmdlOjEyNzAwYzJlYjBmMzQyYWVhMTY0ZThiZGZjN2Y4ZmViXzUtNy0xLTEtNjc1MTI_92a401c7-e1f4-4f27-809f-f5d4a3d69539"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzAz_20306b15-1435-48ca-a80f-2e0376898bd6">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in accumulated other comprehensive loss consist of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtMS0xLTEtNjc1MTI_268f61e2-6335-4a36-a6e5-0850b0bec5ec"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtMy0xLTEtNjc1MTI_854e1399-4313-4e03-b714-6ba415cc4c48"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtNS0xLTEtNjc1MTI_ca8825d9-c94c-462b-8631-2f844362c891"
      unitRef="usd">-70000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzMtNy0xLTEtNjc1MTI_951a88a1-bf32-420e-bee4-544023fa1b64"
      unitRef="usd">-120000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtMS0xLTEtNjc1MTI_ce79b73f-6270-4f92-948d-b65ce05562fa"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtMy0xLTEtNjc1MTI_53fabd2f-b45d-4c5d-9bf4-5858d83b8d68"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtNS0xLTEtNjc1MTI_d9c82875-ec26-48db-aab3-752a6969f4ae"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzQtNy0xLTEtNjc1MTI_a1d664e0-f714-4917-a4e5-cac1d5ba2e5c"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtMS0xLTEtNjc1MTI_fbb7050a-80c8-4b11-9fbc-8cc1793dfbdc"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtMy0xLTEtNjc1MTI_dde9f333-5b05-4e06-b06d-9acb5ae67500"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtNS0xLTEtNjc1MTI_bd495301-6553-49e5-b9fd-f0cf8158db39"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozZGJkZTNhYmU1YzA0ZWYyYjRmNzEzMjFiMTg1OGUxZi90YWJsZXJhbmdlOjNkYmRlM2FiZTVjMDRlZjJiNGY3MTMyMWIxODU4ZTFmXzUtNy0xLTEtNjc1MTI_6b81174c-c9c3-4605-94d1-f8ba3744a12d"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzQ4_64b002e1-a522-48b4-8664-2be3db05ddd1">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other changes in accumulated other comprehensive income were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit (cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive loss (income) &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtMS0xLTEtNjc1MTI_150ac36f-787b-4825-b707-b83f49fae500"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtMy0xLTEtNjc1MTI_33101460-ab27-4f41-a11e-ed61fafd3589"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtNS0xLTEtNjc1MTI_aa8f1e6c-6dd2-440a-a0c8-a08c92ea7757"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtNy0xLTEtNjc1MTI_0a1333b6-9b10-4b98-aebe-e43521f4275e"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtOS0xLTEtNjc1MTI_4183b7b7-5992-45aa-80dc-27228fe326b7"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzMtMTEtMS0xLTY3NTEy_834bc38d-ca66-425c-8fbb-8f566bee516b"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtMS0xLTEtNjc1MTI_141396e4-a34e-4b00-8f86-458fd3467e76"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtMy0xLTEtNjc1MTI_0d4e2514-a5f8-4f85-a91c-dd4019201392"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtNS0xLTEtNjc1MTI_e5b2839b-f862-4112-b42f-9ac119d7a339"
      unitRef="usd">-129000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtNy0xLTEtNjc1MTI_4636f873-322d-4ac5-809e-31edcfcd21dd"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtOS0xLTEtNjc1MTI_8bed4ca8-082c-48e9-a4f8-591eda96f4c0"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzYtMTEtMS0xLTY3NTEy_39940504-274e-4fd2-b97c-15fcdef0f68d"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctMS0xLTEtNjc1MTI_8642a37f-e4e7-4cdd-9c58-2acfa1b732e6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctMy0xLTEtNjc1MTI_4cdc8585-acd2-496b-a48d-0355e11f4c3c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctNS0xLTEtNjc1MTI_7ad5ec0b-ba38-4d16-9863-6b20ea20bc33"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctNy0xLTEtNjc1MTI_217a32b9-e0c8-4b96-8dc7-3c59ddfb904a"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctOS0xLTEtNjc1MTI_722b36ce-79fe-4116-bd26-3fc9fc3bc62f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzctMTEtMS0xLTY3NTEy_90e18a5c-6a42-4493-9013-a4d863bc8b4c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtMS0xLTEtNjc1MTI_ad789f88-ecbb-4b14-9482-696e12199626"
      unitRef="usd">0</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtMy0xLTEtNjc1MTI_f5037d95-9868-4504-bb9d-3bda1966e06c"
      unitRef="usd">0</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtNS0xLTEtNjc1MTI_934d3891-0877-4f70-9c9d-fd7258decd49"
      unitRef="usd">0</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtNy0xLTEtNjc1MTI_0faada61-f59a-4594-80d2-436e5d0b5e4a"
      unitRef="usd">5000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtOS0xLTEtNjc1MTI_74ed0a66-4447-47f8-9ab0-d4437dc58651"
      unitRef="usd">-15000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzgtMTEtMS0xLTY3NTEy_4ed1c4dc-4174-46ba-8643-68166cc4f0ba"
      unitRef="usd">6000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktMS0xLTEtNjc1MTI_5c954c56-6c37-422b-9098-16eb60af47b9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktMy0xLTEtNjc1MTI_1db432e1-cfab-4e7e-81ea-102780fa1144"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktNS0xLTEtNjc1MTI_df24d707-0001-4360-bb4d-69d8a5434287"
      unitRef="usd">-132000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktNy0xLTEtNjc1MTI_178229c2-41dc-4d44-a071-6c75cf8c0c5e"
      unitRef="usd">-50000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktOS0xLTEtNjc1MTI_1855c86a-52cc-4a82-beb6-95fa9726ea18"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozODY5ZTQ3ODNjZGM0MjVkYThkOTUwYmNlODJlZTczOS90YWJsZXJhbmdlOjM4NjllNDc4M2NkYzQyNWRhOGQ5NTBiY2U4MmVlNzM5XzktMTEtMS0xLTY3NTEy_aad3a9ca-c1bd-4237-bae9-7b6062bc2b34"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i6fd8b5bc85ab463b9b570056218ced7a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4MTU_a74eed66-8d07-4c10-acc1-70da38ab472d"
      unitRef="usd">-11000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i226a25479b7c46bf9d8ddd2a5bfcf119_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzU4NjA_335c4af6-2a53-45b0-82d1-2cfa1bfe0e30"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i1718647e98904b358ee1e9de9b292eb9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4NDM_8f11759a-c6e2-40dd-8438-1dcdeeb656dd"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7d0132582b984b76ae285cf19ed5c7f6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4Nzc_04b45c34-c3e8-4bc5-98e0-2ecf3eb7bc98"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i2728f1fd9955493099bbd68893348eff_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY4ODM_040fe3f6-ba1e-4ddb-aff3-c36a2d2845d1"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic24a302cc95448b6895bf70aef816116_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5MTE_092b96b5-1649-4e0f-9ddb-fcf501e0194a"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ief082c01cc5e412cb6ff4de8ad61ca8d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5MTQ_047411a7-d8fb-4865-9e7f-64cdb8c46445"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NDM_6ee83515-ceae-4bdb-bddf-e60a4cde0a35"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NDY_7838bf90-fe53-41d6-bb20-1e70393335f5"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NDk_742fb5aa-12cd-4824-9074-d8fc02d73d0c"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NTI_a743b0a4-403b-4970-a7c1-f1cec532038a"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NTU_86c5ba9e-e77e-457c-9cc7-35c16dccd613"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDY5NTg_6e764a91-28a8-4a7b-9954-2669dc8cb2dd"
      unitRef="usd">186000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i4c424200871342f38c9f8485d07949ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwMTM_48379c3f-a236-40c8-bb9d-25d3cef274da"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzE3_7a8ba124-453f-45e8-a825-81a4ff44026a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.66%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;This assumption is no longer needed in actuarial valuations as U.S. plans are frozen or have fixed benefits for the remaining active participants.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtMS0xLTEtNjc1MTI_27b11cac-5488-4f40-97e0-30f9a934656f"
      unitRef="number">0.0235</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i8a5f7d20c1ed49b591e9cfb3340fff7d_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtMy0xLTEtNjc1MTI_3bed6b36-5a86-4052-a0fc-ea114a1f5b91"
      unitRef="number">0.0308</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtNS0xLTEtNjc1MTI_f5847f32-5b51-48cf-9e3e-57fa8ffc9a92"
      unitRef="number">0.0366</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtNy0xLTEtNjc1MTI_03aeee68-f8e3-4ee9-b9c1-2b417d7744f6"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtOS0xLTEtNjc1MTI_79c367b3-f7ae-4d43-9f12-fa07998b4b86"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzQtMTEtMS0xLTY3NTEy_b77ba591-ffc6-447d-843e-997b629a1ffe"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzUtNy0xLTEtNjc1MTI_5422284b-43ad-4fb9-8c59-34a0a35d8fe5"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzUtOS0xLTEtNjc1MTI_16213010-d183-42fe-9923-db4ff5379851"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzUtMTEtMS0xLTY3NTEy_1e46fa11-e982-465b-93b5-ef77e75bc4b1"
      unitRef="number">0.0293</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtNS0xLTEtNjc1MTI_306772ce-fa9c-4956-ad3e-ef08dbd8bf65"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtNy0xLTEtNjc1MTI_72ac787e-98ad-42c2-88af-3896ce1fb5fc"
      unitRef="number">0.0256</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtOS0xLTEtNjc1MTI_c1947a1d-0c50-42a1-bf24-5fc462b8cfbe"
      unitRef="number">0.0256</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzYtMTEtMS0xLTY3NTEy_4c71b755-68ee-4b03-90cc-7096b0547bc3"
      unitRef="number">0.0301</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtMS0xLTEtNjc1MTI_dbfc3e4f-8bf0-41cd-9348-07e6c05b0bbb"
      unitRef="number">0.0335</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtMy0xLTEtNjc1MTI_86a4bd1d-d55f-4657-b7ba-ff9a732a9328"
      unitRef="number">0.0235</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="if83736112ca9462697b6ec54e87de910_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtNS0xLTEtNjc1MTI_209e614a-eb27-44fe-bfa5-3849d082cd71"
      unitRef="number">0.0308</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtNy0xLTEtNjc1MTI_55500827-6e2e-4d1c-bb33-ec6d62efa4a8"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtOS0xLTEtNjc1MTI_81cb8c17-8628-4f00-a175-3deb72134769"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzgtMTEtMS0xLTY3NTEy_56f91b25-0ef1-4f99-a3e3-2dd9694da0d0"
      unitRef="number">0.0203</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzktNy0xLTEtNjc1MTI_414dd1a6-04f8-4192-8dfd-a706f935fd37"
      unitRef="number">0.0367</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzktOS0xLTEtNjc1MTI_bd8ef04f-54f9-4f6d-ba90-142a772189b9"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i8d6f450ac22e49d6bf0df50d025ae906_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTo5OWU1YTEyMDMxNzQ0MTkzODAxNTM1NGRmMjJhYmIyNi90YWJsZXJhbmdlOjk5ZTVhMTIwMzE3NDQxOTM4MDE1MzU0ZGYyMmFiYjI2XzktMTEtMS0xLTY3NTEy_a60bfc3f-3db5-44b3-bb95-904ec8e20e08"
      unitRef="number">0.0293</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i60c1e60e920e4d629a84b4eff86bead7_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwNTg_9a1770f8-a138-467f-81ef-dbaaf57e30a9"
      unitRef="number">0.0335</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints
      contextRef="i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwNzk_55af0708-9969-4092-9c6b-b49783a730d8"
      unitRef="number">-0.0100</mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i1620020e026c4ef9a6d1ab37d5a50a39_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwOTI_4454d8c0-5ef4-40da-8f18-161aed8507bf"
      unitRef="number">0.0235</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcwOTc_e8ee4ef5-d5d3-4efc-a52f-e1559e7f4413"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMDM_8d8b9808-f497-4c3b-be9f-85b45b30d3fe"
      unitRef="number">-0.0078</mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMTQ_054be3a7-9188-4e2a-bbdf-04d908d6b543"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzE2MzU3_4dd9f21a-e04d-44e4-b5a2-724dfc8a32f7">The following tables represent the Company&#x2019;s pension plan assets as of March&#160;31, 2022 and 2021, using the fair value hierarchy by asset class:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate funds and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held at NAV practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8f84586bbdc64b9db37cbe7a0a6e91a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMS0xLTEtNjc1MTI_32b0b49f-8b8a-4405-968a-db748a3b80f7"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24a81b323f944750ad86fa66047de210_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMy0xLTEtNjc1MTI_8c744a79-5109-4add-bb0c-7ec8950d6437"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0c57f6243c3043139895c497e5082a6c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtNS0xLTEtNjc1MTI_72b6fc05-f3ce-497f-85f9-b4d19e044291"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1feb4c8ee03c4ea8b76a8dec194384a8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtNy0xLTEtNjc1MTI_4c2fc799-6273-4cff-8d35-57a6d7723520"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ice1db9b721a84b9a962dd773d56f5625_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtOS0xLTEtNjc1MTI_41e84c17-71c5-414d-9907-3cb6ec09a854"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i42493a65e37c41cd84bfc0a43dfbfcfd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMTEtMS0xLTY3NTEy_7e87aa5a-aa9f-45dc-8652-bd177dad2954"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i67a195a2dbc24ab0b3916b6c936b0a81_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMTMtMS0xLTY3NTEy_c4b95af8-d204-4b71-bba0-f9891ac22d59"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i802adc56f209414fa2679958ea52481f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzMtMTUtMS0xLTY3NTEy_59dcc209-df40-4cca-8060-ee20d7aaa0a9"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2fc5f76445f4ccb949607a1612c1efb_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMS0xLTEtNjc1MTI_3e34d0bc-bf95-4704-b3ae-f217ccfa44bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie231571b70294eae9fa4e83ed3eeca65_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMy0xLTEtNjc1MTI_7347cd70-edc1-4afd-bef0-d2f231afbc41"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib7a4ddf8d6704a26b6c3d695218fd03f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtNS0xLTEtNjc1MTI_8443fe54-402c-40fd-a71d-b0fb1bcca4e8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ief335562064c476d87395446c7085794_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtNy0xLTEtNjc1MTI_af4dcb47-0831-4227-8f5e-a53f7c7c29c9"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic376ec9b950641b1af873ef2748b3c7c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtOS0xLTEtNjc1MTI_9aa13d43-0b47-41a7-80cb-f3034949abfb"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b45db4fc0e645fb81133a5906dbd495_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMTEtMS0xLTY3NTEy_73e2787e-90cd-45a9-bebf-b6a5793c6191"
      unitRef="usd">117000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie9f160bc0e164814a7383b997da65a5c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMTMtMS0xLTY3NTEy_c59f6b69-4e6e-4018-a65d-fd2f616b57bd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iecd0a0364703401aba0fda8a20e2d103_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzYtMTUtMS0xLTY3NTEy_fb23b5f5-5797-4ca4-a03a-aba010b00a67"
      unitRef="usd">181000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3cd6515ad0894db092afa7fcc8fbef3c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMS0xLTEtNjc1MTI_37582fa6-f72f-4536-ba4f-5ba65b497ab3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1498edc5a78e460cb75dd394ce55f4bc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMy0xLTEtNjc1MTI_9e950d3f-e362-4247-b498-13244e35209b"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51a450f02f814c13ad2c3e1a67df52db_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtNS0xLTEtNjc1MTI_9370cca7-8704-41ad-9fff-3391856b9c73"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idf3513bbbfa54d83b35c2db60004594d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtNy0xLTEtNjc1MTI_c9de1272-aca6-4e10-bf4b-ada31eda8dd6"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i98369f24f8ab4c2eb5f3e9a7ec1b1865_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtOS0xLTEtNjc1MTI_ffd0e2eb-a15d-493a-8af2-beadd079312d"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3d18f2d389c34f889fe5b27bea6dedca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMTEtMS0xLTY3NTEy_50c3b882-79d3-4f2d-9a2f-2245ede7bb59"
      unitRef="usd">144000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i05e2be2f8d0b46c798249db103676c1e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMTMtMS0xLTY3NTEy_11abe291-8be2-45ab-8ae1-d9f87107d04c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i06830bb28fe54b568fbb0beb096d29c6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzgtMTUtMS0xLTY3NTEy_02afce76-5006-4ea2-afaa-559ae696c1f9"
      unitRef="usd">149000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9e437bd0e8ac42d1922f9d4c9b56a9e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMS0xLTEtNjc1MTI_befe44ca-cbb6-4cba-8f35-5ab123d3fc68"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibeb6959cf5a342729ed17f01d0dd71ad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMy0xLTEtNjc1MTI_a4156062-45c2-4ff0-83fe-12fd8a702d9b"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if25303d6a03249938b42bc7d3c1357bc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktNS0xLTEtNjc1MTI_7920932e-23e0-4346-aacb-e1f249559abb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib82602c6601f4f45a4a7369ec1b8bf35_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktNy0xLTEtNjc1MTI_90b98cf8-6fed-4741-b018-467919790a2f"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic7ea8b4f7ef14653a641e807f4cd138a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktOS0xLTEtNjc1MTI_93d08d1d-ec8c-4396-95f7-1434644caab6"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69cf84e558644557a7de95ff69e39200_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMTEtMS0xLTY3NTEy_9c9c7b9e-8f4c-4cfc-9b57-eab2b965cd85"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i549bcf1376444c1c96c41b62e0f53c13_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMTMtMS0xLTY3NTEy_569a4144-974c-43bf-a735-5c1cc1deffb3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7992105cb65e4456891d27cc92f31f82_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzktMTUtMS0xLTY3NTEy_4222ac3e-7c9d-44e7-a22a-0fd844af3446"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6750d94d7246455fa05c465a0a2ce518_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTEtMS0xLTY3NTEy_828c49bc-2e65-4329-9af1-8ecf6a155f9c"
      unitRef="usd">336000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icb4cdf5216e54e7d8f62bf705dc2eb7b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTMtMS0xLTY3NTEy_99e273ff-2a50-423b-8b0b-93fc6a1da4a3"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia3e73ea452a64d409c6a0144d7c8f775_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTUtMS0xLTY3NTEy_af95998a-7875-4129-81d5-6034a3c5f945"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i789450adbe47425287cf59d8f464ddd4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTctMS0xLTY3NTEy_ec02fbf6-f5ec-4350-a468-2e12c55262da"
      unitRef="usd">361000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib64b7c133d6d4fe4aacc658b24720e06_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTktMS0xLTY3NTEy_95e5f246-6caa-4766-b03d-cb9468aed2d8"
      unitRef="usd">51000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e7cc563acc44759bce119f8ce36a604_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTExLTEtMS02NzUxMg_6ae96d4c-b5ab-4777-9660-cd41f25bb6c7"
      unitRef="usd">222000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1ebb6ae9dcdc495b9cc3c87d23f6cbec_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTEzLTEtMS02NzUxMg_3444a6a1-6f95-41ae-b980-bf0037e7ca8e"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if1c239fdb13f450da87c6daa53922d8d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzEyLTE1LTEtMS02NzUxMg_91f0987b-f549-4c2b-898c-42bd79853eeb"
      unitRef="usd">274000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6c306b0e9f2f4c79a4da4e3080b6d89e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEtMS0xLTEyOTc4Mw_3306757a-81c0-4f2e-a31f-1561d879d54e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i21c7e2a081d5465796f47bd8606c00e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTMtMS0xLTEyOTc5MA_5616fdbc-1eb1-444d-a34a-c8b1d1565a99"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5164fe963e2645c899da80d46fd4ae97_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTUtMS0xLTEyOTc5Nw_e41bf428-483c-4a51-b71a-c10e73c76cf7"
      unitRef="usd">173000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0e7649f7142e4c4b9a4814ec21eff4cd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTctMS0xLTEyOTgwNA_ca66ef39-7289-4475-980e-3c59269a579a"
      unitRef="usd">173000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5572d95dce3c4525ac5872c923be80d8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTktMS0xLTEyOTgxOQ_a2ec75f8-8f16-4879-8fbd-7feed3d0d9e8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife0b53acf3404eb896235616da3a2829_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTExLTEtMS0xMjk4MjY_be9e9c79-0455-425a-81ef-334b4d6ee6f7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if7038af880144a7ea84a73759de44134_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEzLTEtMS0xMjk4MzM_27778b76-27fc-4aae-afc5-5a56411e627b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib9233f3fb62d4e2288e4195f2496e9d8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTE1LTEtMS0xMjk4NDA_dbd29337-cf71-40b2-ad46-8fdf88b80a2f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i198ca18f282b482093bc4dbc11845c9f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEtMS0xLTY3NTEy_13e7b3a5-54dd-4eab-9765-1a0c543f8f76"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i53073f5452fd4d48a40ef1c67e4481ab_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTMtMS0xLTY3NTEy_0ffdb329-b7f7-4dd2-91ad-63973b40ed98"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f7d7e52a71c45f191cff470e5e58900_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTUtMS0xLTY3NTEy_380d6be2-de37-429b-9a92-57b5054d1390"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3049d1d278b041b182572ae407160d16_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTctMS0xLTY3NTEy_e3ca4aed-8c12-4b38-93dc-c6a4de80a116"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idd607e6a67e34b6a80181cb19f672808_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTktMS0xLTY3NTEy_3f04c5d7-f73a-4c65-a6be-77ece71ece44"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i35d3c0a9434f43f4a185b11c84d8c084_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTExLTEtMS02NzUxMg_a9b59932-a5d4-4a75-b19e-17a3b60527aa"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iec2db81a22674f35a3dca780612fa224_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTEzLTEtMS02NzUxMg_6707ad03-e859-4cbe-aefa-7dcf24708034"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2a29ea5f47374404ba20c59dc7af27a8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE0LTE1LTEtMS02NzUxMg_42bd87cd-f64c-4008-b259-8d78f4ac2093"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i088530175de844cdb1ff52c1bae2e520_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTEtMS0xLTY3NTEy_1237b753-e965-4ca3-aa27-25bdb9e3bbd5"
      unitRef="usd">382000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iec69e1f822ee4fbca88f48124ec26c7c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTMtMS0xLTY3NTEy_95134eb5-e4a8-420d-83f5-afff981d6943"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i780bb7e3c18c4e2da57a59b5e8a82b8d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTUtMS0xLTY3NTEy_3f5edd8b-e898-46e6-8dd7-aa42e17b0a58"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a603bd1125146b48426fed799546156_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTctMS0xLTY3NTEy_7e2bddfb-871e-498d-831b-ad8643fe5d4a"
      unitRef="usd">641000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7187fc49e8d94a85b667b111d6e5dc69_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTktMS0xLTY3NTEy_701a991a-a51a-4fa7-b62b-bcabde6028a6"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib04278e26dd54ce48826dbc56cb31d0c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTExLTEtMS02NzUxMg_c8e42e63-8dd3-4527-8f11-37c6a720d79a"
      unitRef="usd">517000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icee7ff1a301f4f4badf6de78d85f9ee7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTEzLTEtMS02NzUxMg_07b3bcd8-ad9d-4954-a34c-60b5faaee1fe"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia65b4babfea54b92be6fb935a4313666_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzE1LTE1LTEtMS02NzUxMg_04b3f5bb-105e-4b30-b1ee-662f770bb07c"
      unitRef="usd">683000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4a44775f82674797bf85d3b9a8a5ab4f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIxLTctMS0xLTY3NTEy_867911e3-2a1f-469d-be67-fa7493cef966"
      unitRef="usd">40000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib359c5a79d704e0ebf9e432707a3b141_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIxLTE1LTEtMS02NzUxMg_5b0f7fc5-74df-4923-9ed7-e4bf833e0363"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIyLTctMS0xLTY3NTEy_779f4907-8e0b-4f7d-83e2-e741e9dae675"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a003a64326a491fb3ed09f382ba84b7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTozYWZkYWNiNzE4NTI0MWY1OWE5NjcyMjM5YjZmZGRlOC90YWJsZXJhbmdlOjNhZmRhY2I3MTg1MjQxZjU5YTk2NzIyMzliNmZkZGU4XzIyLTE1LTEtMS02NzUxMg_8f0d00cc-3ba9-4093-8c39-66ea4b280627"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <mck:UnitValueOfCashAndCashEquivalents
      contextRef="i7bc4364d89ca4d929d7940909184939c_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMjA_1795ed44-d21f-4132-829f-334c9719bce9"
      unitRef="usdPerShare">1.00</mck:UnitValueOfCashAndCashEquivalents>
    <mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue
      contextRef="i294bbf493f9b404bbff0579c52891b4a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMzI_faa8d192-e67c-4702-9d6c-2b6d297a14b9"
      unitRef="usd">35000000</mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue>
    <mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue
      contextRef="i04db204508bd48ea9785a68185baa374_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxMzU_ecb71ad2-2590-4dc4-b7be-51d56e5ff68c"
      unitRef="usd">36000000</mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue>
    <us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzI3NDg3NzkwOTI1NDE_a2f6595f-ab2c-4d3c-9249-d5d9c3d6ed83">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the year ended March 31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibe2c94dcf99244b7b82fca2d408a16a4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzEtMS0xLTEtMTMwNjQ0_b724bc46-ec52-4397-b7c5-bc0adb706887"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzItMS0xLTEtMTMwNjQ0_ba7f0f4f-5a90-4714-8db2-58036751fedc"
      unitRef="usd">196000000</us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzMtMS0xLTEtMTMwNjQ0_58b97dcf-7661-4198-84ce-4a89b66281c2"
      unitRef="usd">-25000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iad63af957fc64549aee083f9cdee9453_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90YWJsZTpkMTk2MDYyMzBmMjg0NTNiOGEwNTY5ZGE5YmEzNTYxYS90YWJsZXJhbmdlOmQxOTYwNjIzMGYyODQ1M2I4YTA1NjlkYTliYTM1NjFhXzUtMS0xLTEtMTMwNjQ0_4b3f84b2-997f-4e62-989b-3befbbd9f22a"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxNjk_5c20263b-c35e-4897-8c90-e2ff991e707a"
      unitRef="number">0.05</mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ibfd7ada242314e7b9d273003a8a382eb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxNzY_19c881fa-3ba0-49cd-956e-dc907108d274"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie34c7793aa314d3e961a59451b80dd41_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxNzk_200c4242-0cbe-4fa8-9413-d958699e725d"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ic1b31cb50d8a4fe8bc08b6d4400b0da5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcxODI_d9fc95d3-a2e3-4220-9a89-b52c152a90e5"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <mck:MultiemployerPlanFundedStatusPercentage
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMTc_52c0e885-819a-4b07-8b5b-3af9b26bae53"
      unitRef="number">0.88</mck:MultiemployerPlanFundedStatusPercentage>
    <us-gaap:MultiemployerPlansWithdrawalObligation
      contextRef="i493c2820033f44e2891698cc75e5d9f0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMjM_7477926b-2664-4150-bb9d-cc40d3fda873"
      unitRef="usd">0</us-gaap:MultiemployerPlansWithdrawalObligation>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMzI_43596392-dcfe-4301-87c9-5b0da28a2c8d"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i8ac275e02b8b48a39ec49c6224a2a136_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyMzY_c8c7785f-6c20-413a-aa12-ec8ca29ac51a"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <mck:EmployeeContributions
      contextRef="i8ac275e02b8b48a39ec49c6224a2a136_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNDA_3dc6170e-5565-4c82-800f-71a44f84660c"
      unitRef="number">0.03</mck:EmployeeContributions>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i195f1f7208864f679b4d15f3687a5587_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNDQ_6541e791-4c96-48f6-8155-ba3f4a1fa3fe"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <mck:EmployeeContributions
      contextRef="i195f1f7208864f679b4d15f3687a5587_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNDk_2c08f35f-7572-44b2-a5a2-5db8e6934775"
      unitRef="number">0.02</mck:EmployeeContributions>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNTQ_16f1e6e2-7d0d-494e-844f-d4c435a7ffa9"
      unitRef="usd">116000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNzY_01bd58e9-fafe-4be1-a762-4a972987e65f"
      unitRef="usd">102000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDcyNzY_192c6b18-09d2-405a-8f7e-c83ba5f4c2f3"
      unitRef="usd">102000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i81e084748f994c2b9dee394b47094c3f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0OTI_74c7ada5-f057-4709-872c-75f8df95fbc5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie8cbf8941d6b49f7a3fd6216544852e1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0OTI_7cb75c2c-9753-4323-8ad8-f5240f97dffc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i57a78699f72e4caaa49cdae2c1264ff9_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0OTI_94ffd245-480d-45bb-b6ca-f6dd3358e5f5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia5c091f35bda4066898f44d7a15e739b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0NzU_80c2aa14-b7f4-48fb-a8f0-c2fbff49fc72"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib3a2bce002414557a29e4f5c83a868f2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTEvZnJhZzpkNGJkODBlNDMxMTY0YzM2ODE0NDNjNjE4ZWU0NDQ3OC90ZXh0cmVnaW9uOmQ0YmQ4MGU0MzExNjRjMzY4MTQ0M2M2MThlZTQ0NDc4XzEwOTk1MTE2NDc0Nzg_210d0df6-1359-4313-8c5a-cea2819b2e25"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzI3NDg3NzkwOTQ2MTg_4ee42d6a-5411-4f72-84f8-49d256d0a0c7">Hedging Activities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency exchange risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022 and 2021, the Company had &#x20ac;1.1 billion and &#x20ac;1.7 billion, respectively, of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company de-designated its &#xa3;450 million British pound sterling-denominated notes prospectively from net investment hedges as the hedging relationship ceased to be effective.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains or losses from net investment hedges recorded within Other comprehensive income were gains of $73 million in 2022, losses of $118 million in 2021, and gains of $39 million in 2020. Ineffectiveness on the Company&#x2019;s non-derivative net investment hedges during 2020 resulted in gains of $34&#160;million which were recorded in earnings in &#x201c;Other income, net&#x201d; in the Consolidated Statement of Operations. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the years ended March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022 and 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#x201c;Accumulated other comprehensive loss&#x201d; in the Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the years ended March 31, 2022, 2021, and 2020. The cross-currency swaps will mature in November 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company terminated its cross-currency swaps designated as net investment hedges with a total gross notional amount of &#xa3;932 million British pound sterling swaps. The termination was due to ineffectiveness in its British pound sterling hedging program that arose due to 2019 impairments of goodwill and certain long-lived assets in the U.K. businesses. Proceeds from the termination of these swaps totaled $84 million and resulted in a settlement gain of $34 million in 2020. This gain was recorded in earnings in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from the Company&#x2019;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $4 million and $119 million in 2022 and 2021, respectively, and gains of $76 million in 2020. There was no ineffectiveness in the Company&#x2019;s hedges for the years ended March 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#xa3;450&#160;million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#xa3;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At March 31, 2022 and 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $1.3 billion and $2.6 billion, respectively, which are designated as cash flow hedges. These swaps will mature between July 2022 and January 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#x20ac;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#x201c;EURIBOR&#x201d;) for the &#x20ac;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. The &#x20ac;600 million swaps were terminated in the second quarter of 2022 and the loss on termination of the swaps recorded in interest expense was not material for the year ended March 31, 2022. Refer to Financial Note 12, &#x201c;Debt and Financing Activities,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with a combined notional amount of $500 million, to hedge the variability of future benchmark interest rates on a planned bond issuance. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from cash flow hedges recorded in Other comprehensive income were gains of $21 million in 2022, losses of $42&#160;million in 2021, and gains of $98&#160;million in 2020. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations were not material in 2022, 2021, and 2020. There was no ineffectiveness in the Company&#x2019;s cash flow hedges for the years ended March 31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in value included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At March 31, 2022 and 2021, the total gross notional amounts of these contracts were nil and $39 million, respectively. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. Changes in the fair values were not material in 2022, 2021, and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the Company also entered into a number of forward contracts and swaps to offset a portion of the earnings impacts from the ineffectiveness of the non-derivative net investment hedges discussed above. These contracts matured through January 2020 and none of these contracts were designated for hedge accounting. In December 2019, the Company entered into a series of forward contracts with a total notional amount of &#x20ac;250 million to offset the earnings impact from its Euro-denominated notes. These contracts and the notes against which they are offsetting matured in February 2020 and were not designated for hedge accounting. Changes in the fair value for contracts not designated as hedges are recorded directly in earnings. In 2020, losses of $44 million were recorded in earnings in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations, which offset the ineffectiveness on the Company&#x2019;s non-derivative net investment hedges noted above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 16, &#x201c;Fair Value Measurements,&#x201d; for more information on these recurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i2a394ed33cbc477aace60da23a0ce725_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTIyNjc_a4ef6a5a-fec4-4d81-b333-66060d716a76"
      unitRef="eur">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3a9c80472fe146588b6eac8a58404290_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTIyOTY_1ef79413-b69d-4c20-866f-5df059ed6971"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i24fdde78e96442cbafbef0fa22f902e4_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTI0NDg_e36bd460-7400-4ef6-91c8-47243c193963"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDEyNTY_09e3863a-3583-4f72-bc69-de93cbe51018"
      unitRef="usd">73000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDEyNjM_c69d4e04-ece3-4a7d-a446-3af3b5167891"
      unitRef="usd">-118000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2MzkzMzc_c2243396-520a-4fd9-9be4-5b4eceb5ff98"
      unitRef="usd">39000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzI3NDg3NzkwOTQ2MDY_8d69cd95-b9f8-4607-b037-a1ea3da02e83"
      unitRef="usd">34000000</mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icf83c6faa1c2418c96f6ef2cef6c1bcb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTI4ODI_2bfcca46-aa96-4f7e-8875-5a98d47013ae"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i808f703176d2404abd9b7793bf0a6599_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTI4ODI_7c0d6d52-9873-4eb0-9297-f89887f96a99"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i07635e9764bd408087acfd4f78ea3577_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDE4Nzc_35526598-6660-4df9-bed5-57dcade82e22"
      unitRef="gbp">932000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i5c98cdf793bc4ce48f4a0004d0a47ebc_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMwNzA_8a604e48-4608-4c99-a981-a11aea75af5b"
      unitRef="usd">84000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="i5c98cdf793bc4ce48f4a0004d0a47ebc_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMwNzU_603f247b-2e24-4245-8f41-02b7dac3650b"
      unitRef="usd">34000000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i22b34b6e8ced4d97b4d47ddb2965e898_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMxODA_5c96dcca-9948-4de7-b712-24aacb72d0fb"
      unitRef="usd">-4000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ifaa55b6bf9f44cd1a8a25b42288d0593_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMxNjU_a42faae8-e6c5-4da1-97e8-69bf617b1118"
      unitRef="usd">-119000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i1f9cac9e86284785ab4d70600ae33ad6_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM3NDg_19caeddb-7c35-4561-99d7-d36f5f822b6b"
      unitRef="usd">76000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:LongTermDebt
      contextRef="i24fdde78e96442cbafbef0fa22f902e4_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyMzg_f3ea2101-380b-428d-9ef1-8de3321e2497"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i24fdde78e96442cbafbef0fa22f902e4_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNDc_f3ea2101-380b-428d-9ef1-8de3321e2497"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1fb5afe9d8f741d98516f86630f9a369_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNjI_26f81287-53d4-4a4d-a220-80cde403538c"
      unitRef="usd">1300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4ca4b4a7511f40e5a9d3ef22dada90c7_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNTQ_0907911c-fa1e-428f-ad71-70b6a7e4e547"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyNzc_dbb07a20-cea7-48be-bb4e-420d5e7636ea"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyODU_fe3cf442-48c5-47b9-a903-63d739a16092"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyOTA_dbb07a20-cea7-48be-bb4e-420d5e7636ea"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyOTk_fe3cf442-48c5-47b9-a903-63d739a16092"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMyOTU_dbb07a20-cea7-48be-bb4e-420d5e7636ea"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <mck:AmortizationOfLossOnDerivativeTerm
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzI3NDg3NzkwOTQ5OTg_f4a0d856-e200-4358-8097-36236f51bc63">P5Y</mck:AmortizationOfLossOnDerivativeTerm>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida89f12ac9244f9baa939ba550b7cf4c_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDIwMTg_fe3cf442-48c5-47b9-a903-63d739a16092"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d147eb37a56481b848433e3e940585d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDMwODc_fa60176e-3069-4a1d-b789-d05b3d734f99"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d147eb37a56481b848433e3e940585d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzEwOTk1MTE2NDMxMDU_fa60176e-3069-4a1d-b789-d05b3d734f99"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ie2c39129d8ab4c4b9955fcd9310ac053_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMzMjU_aafa59e2-52e9-4546-8dec-ed11203207d2"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9e32714cfa934a93b4e7c425d1d050de_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTMzNDA_860da69e-7e2a-4b31-b4b9-6974662c81cd"
      unitRef="usd">-42000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i137f365a182943e796f2e1d55d814426_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1Xzc2OTY1ODE0MDc3MDc_3d516694-e5d9-4861-9117-8655c323b561"
      unitRef="usd">98000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6fb91758a04f4bacb9905307ab195623_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM0NjE_fa769685-05df-46a4-9a29-93342769ad15"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4542a21b25d543c4acc0fa4436d289e7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM0NTc_600a7723-89f8-401b-ab8f-894c7ebbbfca"
      unitRef="usd">39000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i012c7ab6d6f04da38da0d95109115f5c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzcxNDY4MjU1OTM0OTM_702b3755-ecfb-4582-9599-72e3ad465de2"
      unitRef="eur">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i024aefa502ee40d6b34f7f8368e3b55c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1Xzc2OTY1ODE0MDc3NzE_db4adfa8-c089-4eab-93f5-6a5cf7ab358d"
      unitRef="usd">-44000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90ZXh0cmVnaW9uOjFlZDA5YWQ3NzA2ZjQ2OThhMDJhNzc5NzEyYWU1MDU1XzExNTA0_4de03387-9d1e-428e-aa80-81dee09fec47">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iff333b050afd48d9b90c24d10c24348a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtMi0xLTEtNjc1MTI_263c5e53-8062-486a-8e67-11e36e3ecb0a"
      unitRef="usd">30000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7c57740209a940fa8dafc8433670f167_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtMy0xLTEtNjc1MTI_70d0c2c3-baea-4daf-b0d0-777156eab0fa"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i309ac7f13b444d0db3954863ad6e761c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtNC0xLTEtNjc1MTI_87108835-2b2c-4b73-a8d2-31a57091e357"
      unitRef="usd">1537000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i719adfe70a964eb882c96f1004d74bf8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtNi0xLTEtNjc1MTI_d19d3806-3cc6-4b94-af03-037e61de6f12"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2c355ddfeccf45afb84fc6d09c4cd44e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtNy0xLTEtNjc1MTI_c109c270-3336-4db8-a7f4-cbaea2369882"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0e46135b9e374ad194e91da1167d2848_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzUtOC0xLTEtNjc1MTI_302404a7-0c4b-4f0f-8942-58093a3dabf2"
      unitRef="usd">826000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9fa2453674034bfe8272f5598f29c014_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtMi0xLTEtNjc1MTI_2e2ae4d4-6a5d-44fb-8f77-504c619ce933"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3f221a3ec78445e79e65fa93472e8585_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtMy0xLTEtNjc1MTI_197002dd-fd7d-4705-a482-33cca774cdd8"
      unitRef="usd">36000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia5e26180f2064b60a601613f3b0d3643_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtNC0xLTEtNjc1MTI_2f0f05ce-2143-4863-92c3-971f22373bda"
      unitRef="usd">679000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0af94175dd994714a8a7faae0f0e5212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtNi0xLTEtNjc1MTI_1393d38f-b3d0-4b8a-82bf-732321b52e40"
      unitRef="usd">72000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iebb892ad00ab49ed8566342454fa928c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtNy0xLTEtNjc1MTI_b1246fa5-63a0-44c4-9c2a-ddee65879ed5"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i4989346074144770b6adc1234e579021_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzYtOC0xLTEtNjc1MTI_2eb5bc9a-5679-4549-afcc-05bf0af1499a"
      unitRef="usd">2663000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia70cd65a985648138af1f3c043a64290_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctMi0xLTEtNjc1MTI_12dc3d94-b3af-4f54-a164-3200ea1c2d1a"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia70cd65a985648138af1f3c043a64290_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctMy0xLTEtNjc1MTI_8a99b0ef-fc89-41a2-9151-4776ecec9a0d"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ia70cd65a985648138af1f3c043a64290_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctNC0xLTEtNjc1MTI_5a2f9ce9-2080-4be6-bf27-c8adfccc2f5e"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if507dc7fc59b47fea1f9ddc4fc902174_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctNi0xLTEtNjc1MTI_89dba83b-7b4e-4b74-b8d0-a4cc2d9ca5db"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if507dc7fc59b47fea1f9ddc4fc902174_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctNy0xLTEtNjc1MTI_6f664402-4ed1-483a-a026-998ceafb6d1f"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="if507dc7fc59b47fea1f9ddc4fc902174_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzctOC0xLTEtNjc1MTI_7cb3a4bf-9605-41e4-a34d-e377d07b4553"
      unitRef="usd">704000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibbe2788b715640b4b52cee7ba7637f83_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtMi0xLTEtNjc1MTI_6e9117a3-a0fb-4619-9672-3f9e50bbb788"
      unitRef="usd">61000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibbe2788b715640b4b52cee7ba7637f83_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtMy0xLTEtNjc1MTI_c9eece65-5352-4fca-821d-8c0784984d63"
      unitRef="usd">75000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3508fc7db8ac40f1a7ea81409ab7678f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtNi0xLTEtNjc1MTI_1e657728-d572-430e-80a3-f3ef61824d2f"
      unitRef="usd">76000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3508fc7db8ac40f1a7ea81409ab7678f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzgtNy0xLTEtNjc1MTI_64c23ae6-b3fe-43e9-8d52-9712c00017f0"
      unitRef="usd">146000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTItMS0xLTY3NTEy_90f1358d-252e-4fea-9628-d3afe58a25c4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTMtMS0xLTY3NTEy_4c4cdbb0-9b07-469d-b63c-e15946cff764"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i39bb1ecd28cd4f3f84ed1b1a9d008563_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTQtMS0xLTY3NTEy_0aa1a86e-7c2b-45fa-8311-b62a3255b906"
      unitRef="usd">0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTYtMS0xLTY3NTEy_f1e921e4-851f-4501-bc64-ac98efb946b9"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTctMS0xLTY3NTEy_aeee1ebd-7e11-4111-8806-f744ce2c05a5"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iadd4d8e5ee0e4868a0e947e9a8ce0d5c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEwLTgtMS0xLTY3NTEy_b27dfef2-17a6-45cd-859d-c729beacb44b"
      unitRef="usd">29000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8840acf2e77d44af9a2a8cb81017cda9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTItMS0xLTY3NTEy_f94697a9-fd65-4640-942a-883fdecf1beb"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8840acf2e77d44af9a2a8cb81017cda9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTMtMS0xLTY3NTEy_4d1061c0-a8e3-4d9a-9dfc-24e459c0c8a4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i8840acf2e77d44af9a2a8cb81017cda9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTQtMS0xLTY3NTEy_1938e7f0-64f1-42e7-a4b4-eb4e7168abdb"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTYtMS0xLTY3NTEy_08d93ef7-bd8e-4f41-8792-1646e5fee102"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTctMS0xLTY3NTEy_4bfd46fe-df82-40a0-b38b-6c360e7d4a51"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib8d97744ec424e1a8bc3209a6c88bf16_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzExLTgtMS0xLTY3NTEy_e240ec16-fffc-47a7-9c67-eee2a2c87c6d"
      unitRef="usd">10000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i374b081d61104014bfe452acfb9cbcf4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTItMS0xLTY3NTEy_3108f2ae-17dc-4827-82b0-00c67fcf6d43"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i374b081d61104014bfe452acfb9cbcf4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTMtMS0xLTY3NTEy_ec5a3350-ec37-445a-92a7-dccc1f40aeaa"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if3cb819d9d034281bc184dd6e2359115_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTYtMS0xLTY3NTEy_daca0999-9ce9-4eff-b7fb-86c0b4819818"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if3cb819d9d034281bc184dd6e2359115_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTQvZnJhZzoxZWQwOWFkNzcwNmY0Njk4YTAyYTc3OTcxMmFlNTA1NS90YWJsZToyNjAwOGRiMzU4Zjc0YjhjYTMyZWFiYmViYjJhYzcwYy90YWJsZXJhbmdlOjI2MDA4ZGIzNThmNzRiOGNhMzJlYWJiZWJiMmFjNzBjXzEyLTctMS0xLTY3NTEy_aa4af045-abed-4d94-88db-09b22c7db1e6"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzcyMTA_5b10c059-4a16-4126-aa73-7ef4e2bdbaee">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at March 31, 2022 and 2021 included investments in money market funds of $981 million and $1.6 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#x2019;s marketable securities were not material at March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps and foreign currency forward contracts were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 15, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $346&#160;million and $269&#160;million at March 31, 2022 and 2021, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. During 2022 and 2021, certain of the Company&#x2019;s investments in equity securities without readily determinable fair values experienced transactions which resulted in changes in the observable price of those securities. Additionally, in 2021, certain of the Company&#x2019;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of 2021. Net gains related to the Company&#x2019;s investments in these equity securities were approximately $98 million and $133 million, respectively, for the years ended March 31, 2022 and 2021. These net gains were recorded in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges, including long-lived assets associated with the Company&#x2019;s restructuring initiatives as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022, the assets and liabilities associated with the E.U. disposal group and U.K. disposal group classified as held for sale were measured at the lower of carrying value or fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale." Additionally, at March 31, 2022, assets measured at fair value on a nonrecurring basis included certain long-lived assets within the International segment related to the Company&#x2019;s operations in Denmark and its retail pharmacy businesses in Canada, as discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s International segment and its Europe Retail Pharmacy reporting unit within the International segment. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net&#x201d; and Financial Note 11, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other liabilities measured at fair value on a nonrecurring basis at March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022 and 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is also recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 11, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information regarding goodwill impairment charges recorded for certain reporting units during 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net&#x201d; under the heading &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Lived Asset Impairments&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg4OTI_069b3c97-8719-4f09-a96c-9956f79d7352"
      unitRef="usd">981000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg4OTY_412fc5b3-9968-4197-ab60-7fb689986bcd"
      unitRef="usd">1600000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg5NzQ_b05abe84-2374-42b0-901c-8674c1bf1646"
      unitRef="usd">346000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDg5Nzc_5f30f5d9-7ce2-47de-bf00-606736504a05"
      unitRef="usd">269000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDk3MDA_2e3fb952-776b-460a-837f-0e3f957d559a"
      unitRef="usd">98000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NDk3MDg_8269916c-960a-4aec-8344-ddae0a23393e"
      unitRef="usd">133000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3fe727da0df047e9a85ea9962c4b400d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NTEzNTE_768ead4e-ea99-484a-b909-0731d31cdd98"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie9ec224cf4764392959e53320ef9a081_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzE2NDkyNjc0NTEzNTE_face4478-d2b5-4748-91c5-fd6686c8645d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90ZXh0cmVnaW9uOmNmM2IyZTNjZDZiNzQ5MGY4ZTU2ZTExN2FlMjU1Mzg2XzcyMTQ_d90ae671-7e7e-4208-9d8a-d7ce0528262f">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is also recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i407dcd9fcbb146db960f9ded6cee8015_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItMS0xLTEtNjc1MTI_88ab1b29-45ea-463d-a51e-0580d1c347b5"
      unitRef="usd">5879000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i407dcd9fcbb146db960f9ded6cee8015_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItMy0xLTEtNjc1MTI_c4d9b6d7-e913-4ba2-8d52-981095c95ca3"
      unitRef="usd">5999000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i41d3f99f4a8e4b5aba1d005bdf779310_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItNS0xLTEtNjc1MTI_aa8b079d-bc03-4457-ae4f-507eb50c08a1"
      unitRef="usd">7148000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i41d3f99f4a8e4b5aba1d005bdf779310_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNTcvZnJhZzpjZjNiMmUzY2Q2Yjc0OTBmOGU1NmUxMTdhZTI1NTM4Ni90YWJsZToxZWFmNGRlNDMxMDE0M2I0YTQxNTFjZmY0NThmYTM5NC90YWJsZXJhbmdlOjFlYWY0ZGU0MzEwMTQzYjRhNDE1MWNmZjQ1OGZhMzk0XzItNy0xLTEtNjc1MTI_d8b8c47e-1c0a-48ca-a352-c241d8b695f4"
      unitRef="usd">7785000000</us-gaap:DebtInstrumentFairValue>
    <mck:FinancialGuaranteesAndWarrantiesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzM0MDM_c8a988b5-d711-4b44-8431-bbcdb68f9eab">Financial Guarantees and Warranties&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with certain of its customers&#x2019; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#x2019; inventory or its customers&#x2019; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#x2019;s inventory repurchase agreements, among other requirements, inventories must be in a resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDA_c483e2c9-dff3-4b92-bc09-7d0567550317"&gt;one&lt;/span&gt; to two years. Customers&#x2019; debt guarantees generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTI_c01062b2-22fa-48c8-ab15-ad2d5e0ffc41"&gt;one&lt;/span&gt; to 10 years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#x2019;s customers&#x2019; debt guarantees are secured by certain assets of the customer. At March 31, 2022, the maximum amounts of inventory repurchase guarantees and customers&#x2019; debt guarantees were $367 million and $84 million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees are as follows: $309 million, $45 million, $6 million, $15 million, and $12 million&#160;from 2023 through 2027, respectively, and $64 million thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022, the Company&#x2019;s banks and insurance companies have issued $214 million of standby letters of credit and surety bonds, which were issued on the Company&#x2019;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and its workers&#x2019; compensation and automotive liability programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#x2019;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug, and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</mck:FinancialGuaranteesAndWarrantiesTextBlock>
    <mck:GuarantorObligationsPeriod
      contextRef="i98c151bfae0f42a4b2ce4521c05e9acf_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyMDQ_d070a0ed-a14a-4b94-a047-2f0faa135eb3">P2Y</mck:GuarantorObligationsPeriod>
    <mck:GuarantorObligationsPeriod
      contextRef="ibfe76b97b0b24598b07f33f5ca016907_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzExOTU_4b45b509-e259-4840-91df-8bfa7b3b822e">P10Y</mck:GuarantorObligationsPeriod>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i77cf6c86ae8c46a682b412b3e0abac24_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyNzY_93972f97-1b55-4eb3-bbf1-ab0fe4b8bff6"
      unitRef="usd">367000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i2934427a7be2467d8b52f822c45c8593_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyODA_3150a0fd-48b7-491d-b920-ec696f1dfe35"
      unitRef="usd">84000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <mck:GuaranteeObligationsExposureExpiringinYearOne
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyOTc_2f199ef3-db55-433f-8093-09205480bcdb"
      unitRef="usd">309000000</mck:GuaranteeObligationsExposureExpiringinYearOne>
    <mck:GuaranteeObligationsExposureExpiringinYearTwo
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMDA_a4a3b42c-d095-46b4-97e4-d1488e15e5c3"
      unitRef="usd">45000000</mck:GuaranteeObligationsExposureExpiringinYearTwo>
    <mck:GuaranteeObligationsExposureExpiringinYearThree
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMDQ_e2d6176c-9e6e-479e-9310-7eb7ed6966aa"
      unitRef="usd">6000000</mck:GuaranteeObligationsExposureExpiringinYearThree>
    <mck:GuaranteeObligationsExposureExpiringinYearFour
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMDg_a149db6b-b491-4f21-b746-479b3fa4ffc5"
      unitRef="usd">15000000</mck:GuaranteeObligationsExposureExpiringinYearFour>
    <mck:GuaranteeObligationsExposureExpiringinYearFive
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMTM_e5bc738c-9947-4e26-9218-105962241188"
      unitRef="usd">12000000</mck:GuaranteeObligationsExposureExpiringinYearFive>
    <mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEzMTY_899734ba-7af5-4764-a592-31a080978242"
      unitRef="usd">64000000</mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i60f79f2c96f24d718707c887c792a696_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjAvZnJhZzpjMmY5OGMyNzYzYzU0N2VkOTUxODRhMjc3OGQ4ODViOC90ZXh0cmVnaW9uOmMyZjk4YzI3NjNjNTQ3ZWQ5NTE4NGEyNzc4ZDg4NWI4XzEwOTk1MTE2MzEyNTI_fa338a1d-07eb-4a56-a5cb-2d95678eb3dd"
      unitRef="usd">214000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI3NDg3NzkxMzkzNTg_e921a1d4-9f70-4515-9566-90fb5dede146">Commitments and Contingent Liabilities&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Consolidated Statement of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 21, 2021, the Company and the two other national pharmaceutical distributors (collectively &#x201c;Distributors&#x201d;) announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions were satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. On February 25, 2022, the Distributors determined that there was sufficient State and subdivision participation to proceed with an agreement ("Settlement") to settle a substantial majority of opioids-related lawsuits filed against the Distributors by U.S. states, territories, and local governmental entities. As previously disclosed, 46 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#x201c;Settling Governmental Entities&#x201d;), have agreed to join the Settlement. To date, over 98% of eligible political subdivisions that have brought opioid-related suits against the Company, as calculated by population under the agreement, have agreed to participate in the settlement or have had their claims addressed by state legislation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Settlement became effective on April 2, 2022. If all conditions to the Settlement are satisfied, including the receipt of approval by relevant courts of consent decrees to dismiss the lawsuits, the Distributors would pay the Settling Governmental Entities up to approximately $19.5&#160;billion over 18 years, with up to approximately $7.4&#160;billion to be paid by the Company for its 38.1% portion. Under the Settlement, a minimum of 85% of the settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and would be payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Before the effective date of the Settlement, the Company entered into separate settlement agreements with the states of New York, Ohio, Rhode Island, Texas, and Florida. These states intended to participate in the Settlement when it was finalized, and these agreements provided that each state and its participating subdivisions would receive a settlement consistent with their allocation under the comprehensive Settlement framework, as well as, in some cases, certain attorneys&#x2019; fees and costs. Now that the Settlement has become effective, these separate settlement agreements have become part of that broader agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three eligible states, Alabama, Oklahoma, and Washington, did not join the Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the claims of the Alabama attorney general, the Company has negotiated an agreement in principle under which the Company will pay $141&#160;million in ten equal annual installments and an additional approximately $33&#160;million in attorney fees and costs to resolve the opioid-related claims of the state of Alabama and its subdivisions. On May 3, 2022, the Distributors announced an agreement with the attorney general of Washington to settle the claims of the state of Washington and its subdivisions. Under that agreement, Washington and its subdivisions would be paid up to $518&#160;million, of which the Company&#x2019;s portion would be 38.1% (or approximately $197&#160;million), consistent with Washington&#x2019;s allocation under the comprehensive framework, as well as certain additional attorneys&#x2019; fees and costs. The claims of the Oklahoma attorney general are pending in the District Court of Bryan County, Oklahoma (Case No. CJ-2020-84, 85, and 86), and trial is scheduled to begin in January 2023. The Company&#x2019;s loss contingency accruals for these three states and their subdivisions reflect the amounts of these agreements in principle or, where there is no agreement in principle, amounts equivalent to what that state and its subdivisions would have been allocated under the framework of the Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company previously settled with the state of West Virginia, and West Virginia and its subdivisions were not eligible to participate in the comprehensive Settlement. Claims of various West Virginia subdivisions remain pending in both state and federal courts. Trial in the case of Cabell County and City of Huntington occurred in the U.S. District Court for the Southern District of West Virginia and concluded on July 28, 2021. The outcome of that trial is pending. The claims of certain other West Virginia subdivisions are pending in the federal Multi-district Litigation and before the state Mass Litigation Panel. On September 30, 2021, the Mass Litigation Panel issued an order scheduling a liability-only trial on the public nuisance claims of certain political subdivisions against the Distributors for July 5, 2022. The Company&#x2019;s loss contingency accruals for the West Virginia subdivisions are reflected in the estimated liability for the opioid-related claims as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the claims of Native American tribes, on September 28, 2021, the Company announced that the Distributors reached an agreement with the Cherokee Nation to pay approximately $75&#160;million over 6.5 years to resolve opioid-related claims, of which the Company&#x2019;s portion would be 38.1% (or, approximately $29&#160;million). The Company has also negotiated a broad resolution of opioid-related claims brought by Native American tribes. Under the proposed agreement, which has been endorsed by the leadership committee of counsel representing the tribes, the Distributors would pay the Native American tribes other than the Cherokee Nation approximately $440&#160;million over 6 years, of which the Company&#x2019;s portion would be 38.1% (or, approximately $167&#160;million). This broad resolution is contingent on the participation of a substantial majority of the Native American tribes that have brought opioid-related claims against the Distributors. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic. The Company&#x2019;s loss-contingency accruals for the Native American tribes reflect these amounts and are reflected in the estimated liability for the opioid-related claims as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Settlement terminated the substantial majority of opioid-related suits pending against the Company, a small number of subdivisions in participating states have opted not to participate in the comprehensive settlement, and other suits brought by subdivisions in non-participating states remain pending. The Company continues to prepare for trial in these pending matters and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved. The Company&#x2019;s loss contingency accruals for these subdivisions are reflected in the estimated liability for the opioid-related claims consistent with what would be allocated under the framework of the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has paid $157&#160;million in payments to date associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This amount, recorded in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet, is the amount estimated to be paid prior to March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#x201c;Long-term litigation liabilities&#x201d; in our Consolidated Balance Sheet as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the terms of the Settlement, the Company placed approximately $354&#160;million into escrow on September 30, 2021. During the second half of 2022, the Company placed an additional net $41&#160;million into escrow to reflect the participation of additional states, and as part of a separate agreement in principle with the Alabama attorney general. Those escrow amounts were presented as restricted cash within &#x201c;Prepaid expenses and other&#x201d; in our Consolidated Balance Sheet as of March 31, 2022. These amounts excluded the proportionate allocation under the Settlement for each non-participating state. The Settlement created a binding obligation to release the funds from escrow upon entry of consent judgments and establishment of a settlement administrator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. Trial is scheduled for July 18, 2022 in one such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court. These plaintiffs seek to recover for damages allegedly arising from their family members&#x2019; abuse of prescription opioids. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poppell v. Cardinal Health, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CE19-00472. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with the remaining opioid-related litigation matters, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 8, 2018, the Company was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Manchester v. Purdue Pharma, L.P., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within&#160;90 days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company was served with two &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-2233, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State of California ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit, which affirmed the dismissal on March 10, 2022. On June 28, 2021, the court in the state action dismissed the complaint with prejudice, and the relators appealed the dismissal to the Superior Court of California, County of San Francisco.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Two cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AIU Insurance Company et al. v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ace Property and Casualty Insurance Company v. McKesson Corporation et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits pending in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. On April 5, 2022, the court issued an order granting partial summary judgment to the insurers that the Company&#x2019;s defense costs in certain opioid-related litigation were not covered by two of the insurance policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#x201c;TCPA&#x201d;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#x2019; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $6,500.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2013, the Company&#x2019;s subsidiary, U.S. Oncology, Inc. (&#x201c;USON&#x201d;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Piacentile v. Amgen Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et al., CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 30, 2013, the court granted the United States&#x2019; motion to dismiss the claims pled against Amgen. On September 17, 2018, the court granted USON&#x2019;s motion to dismiss the claims pled against it, with leave to amend. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021. Plaintiffs filed a notice of appeal with the Court of Appeals for the Second Circuit on January 4, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 17, 2014, U.S. Oncology Specialty, LP (&#x201c;USOS&#x201d;) was served with a fifth amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hanks v. Amgen, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CV-08-03096 (SJ). Previously, the U.S. declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#x2019;s motion to dismiss. Following the relator&#x2019;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#x2019;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 3, 2018, a second amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint was filed in the United States District Court for the Eastern District of New York by a relator, purportedly on behalf of the United States, 30 states, the District of Columbia, and two cities against McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc. and US Oncology Specialty, L.P., alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 12-CV-06440 (NG). The United States and the named states have declined to intervene in the case. On October 15, 2018, the Company filed a motion to dismiss the complaint as to all named defendants. On February&#160;4, 2019, the court granted the motion to dismiss in part and denied it in part, leaving the Company and Oncology Therapeutics Network Corporation as the only remaining defendants in the case. On December 9, 2019, the United States District Court for the Eastern District of New York ordered the unsealing of another complaint filed by the same relator, alleging the same misconduct and seeking the same relief with respect to US Oncology, Inc., purportedly on behalf of the same government entities, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-05125. The United States and the named states declined to intervene in the case. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a defendant in an amended complaint filed on June 15, 2018 in a case pending in the United States District Court for the Southern District of Illinois alleging that the Company&#x2019;s subsidiary, McKesson Medical-Surgical Inc., among others, violated the Sherman Act by restraining trade in the sale of safety and conventional syringes and safety IV catheters. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marion Diagnostic Center, LLC v. Becton, Dickinson, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 18:1059. The action is filed on behalf of a purported class of purchasers, and seeks treble damages and further relief, all in unspecified amounts. On July 20, 2018, the defendants filed a motion to dismiss. On November 30, 2018, the district court granted the motion to dismiss, and dismissed the complaint with prejudice. On December 27, 2018, plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit. On March 5, 2020, the United States Court of Appeals for the Seventh Circuit vacated the district court&#x2019;s order, and ruled that dismissal was appropriate on alternative grounds. The case was remanded to the district court to allow the plaintiffs an opportunity to amend their complaint. Plaintiffs filed an amended complaint on August 21, 2020. Defendants filed a motion to dismiss the amended complaint, which the district court granted on March 15, 2021. Plaintiffs appealed the order to the United States Court of Appeals for the Seventh Circuit, which affirmed the district court&#x2019;s dismissal on March 18, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reliable Pharmacy, et al. v. Actavis Holdco US, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evanston Police Pension Fund v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On February 8, 2019, the court appointed the Pension Trust Fund for Operating Engineers as the lead plaintiff. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. On April 8, 2021, the court granted plaintiff&#x2019;s motion for class certification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2015, The Great Atlantic &amp;amp; Pacific Tea Company (&#x201c;A&amp;amp;P&#x201d;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re The Great Atlantic &amp;amp; Pacific Tea Company, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp;amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Adv. Proc. No. 17-08264.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the Company&#x2019;s subsidiary NDCHealth Corporation dba RelayHealth (&#x201c;RelayHealth&#x201d;) was served with three purported class action complaints filed in the United States District Court for the Northern District of Illinois. The complaints allege that RelayHealth violated the Sherman Act by entering into an agreement with co-defendant Surescripts, LLC not to compete in the electronic prescription routing market, and by conspiring with Surescripts, LLC to monopolize that market, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Powell Prescription Center, et al. v. Surescripts, LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 1:19-cv-06627; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 1:19-cv-06778; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Falconer Pharmacy, Inc. v. Surescripts LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 1:19-cv-07035. In November 2019, three similar complaints were filed in the United States District Court for the Northern District of Illinois. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 1:19-cv-7445; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Whitman v. SureScripts, LLC et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 1:19-cv-7448; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;BBK Global Corp. v. SureScripts, LLC et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 1:19-cv-7640. In December 2019, the six actions were consolidated in the Northern District of Illinois. The complaints seek relief including treble damages, attorney fees, and costs. Plaintiffs and RelayHealth reached an agreement in June 2020 to resolve the class action lawsuits and RelayHealth paid into escrow an amount not material in the context of the Company&#x2019;s overall financial results. The settlement does not include any admission of liability, and RelayHealth expressly denies wrongdoing. The Court granted Plaintiffs&#x2019; motion for final approval of the settlement on February 24, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company was served with a first amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hart v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#x2019;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough, and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017 and August 2018, respectively, the Company was served with&#160;two&#160;separate Civil Investigative Demands by the U.S. Attorney&#x2019;s Office for the Eastern District of New York relating to the certification the Company obtained for two software products under the U.S. Department of Health and Human Services&#x2019; Electronic Health Record Incentive Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April and June 2019, the United States Attorney&#x2019;s Office for the Eastern District of New York served grand jury subpoenas seeking documents related to the Company&#x2019;s anti-diversion policies and procedures and its distribution of Schedule II controlled substances. The Company believes the subpoenas are part of a broader investigation by that office into pharmaceutical manufacturers&#x2019; and distributors&#x2019; compliance with the Controlled Substances Act and related statutes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the United States Attorney&#x2019;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2016, the Belgian Competition Authority carried out inspections at the premises of several Belgian wholesalers, including Belmedis SA, which was subsequently acquired by the Company. Pharma Belgium NV was also part of the investigation. The Company resolved this matter in April 2022 by paying fines not material in the context of the Company&#x2019;s overall financial results that had been fully reserved for in the third quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding its and its competitors alleged sharing of competitively sensitive information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IV. State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect the Company&#x2019;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#x201c;OSA&#x201d;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#x2019;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37 million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. That petition was denied on October 4, 2021. In December 2021, McKesson paid $26&#160;million for the assessment for calendar year 2017 while reserving all rights to challenge the constitutionality of the assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;V.&#160;Environmental Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Primarily as a result of the operation of the Company&#x2019;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at five sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on a determination by the Company&#x2019;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#x2019;s probable loss associated with the remediation costs for these five sites is $15 million, net of amounts anticipated from third parties. The $15 million is expected to be paid out between April 2022 and March 2052. The Company has accrued for the estimated probable loss for these environmental matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been designated as a Potentially Responsible Party (&#x201c;PRP&#x201d;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at 14 sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. At one of these sites, the United States Environmental Protection Agency has selected a preferred remedy with an estimated cost of approximately $1.4 billion. It is not certain at this point in time what proportion of this estimated liability will be borne by the Company. Accordingly, the Company&#x2019;s estimated probable loss at those 14 sites is approximately $29 million, which has been accrued for in the Consolidated Balance Sheets. However, it is possible that the ultimate costs of these matters may exceed or be less than the reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VI. Value Added Tax Assessments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in various countries outside the U.S. which&#160;collect value added taxes (&#x201c;VAT&#x201d;).&#160;The determination of the manner in which a VAT applies to the Company&#x2019;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received&#160;assessments for VAT&#160;which are in&#160;various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions.&#160;Certain&#160;VAT assessments relate to years covered by an indemnification agreement.&#160;Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters.&#160;However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or&#160;results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VII. Antitrust Settlements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $46 million, $181&#160;million, and $22&#160;million in 2022, 2021, and 2020, respectively, which were included in &#x201c;Cost of sales&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VIII. Other Matters &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings, or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings, and claims will not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i4f60f777e8754ae3b0d798ac833ac49f_I20220225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjY2MDA_b22c81cd-d17d-4135-bccc-9ed03565939c"
      unitRef="product">2</mck:LossContingencyNumberOfOtherDefendants>
    <mck:LossContingencyNumberofStates
      contextRef="ia875aad6cce743958618a33cce559dc9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTgxOTA_22794b24-7b1d-49cc-8b5c-83b85721e663"
      unitRef="product">46</mck:LossContingencyNumberofStates>
    <mck:LossContingencyNumberOfEligibleStates
      contextRef="ia875aad6cce743958618a33cce559dc9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTgxOTQ_6ad86dd7-78fd-44f2-a049-0819ff60895e"
      unitRef="product">49</mck:LossContingencyNumberOfEligibleStates>
    <mck:LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage
      contextRef="ia875aad6cce743958618a33cce559dc9_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTgxOTk_8a9d57eb-870f-4dd5-833a-9d0ec8099c24"
      unitRef="number">0.98</mck:LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i8ee8208665914ed2bf9222d6977c182f_D20220402-20220402"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2MzE_2f576fa4-c441-4b6a-a29b-f563d469bad0"
      unitRef="usd">19500000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="i8ee8208665914ed2bf9222d6977c182f_D20220402-20220402"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2NDU_c3ea55dd-4cd7-4756-bf6b-57708f158c4d">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i4f7c4180c7d349cdad921bd625aef19c_D20220402-20220402"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2NDc_db07743b-9f40-4b6e-96ab-2af3b68fd566"
      unitRef="usd">7400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="if5f3b6a5a5224458ab102b9be37642c2_I20220402"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2NjE_2b80c17e-c318-4759-816f-ea2c4b05b22e"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
      contextRef="i1ef52d9fd4b04fa4ade734933f7afdc0_I20220402"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NDQ2Njg_9204b25c-3bc5-4770-a157-936f008b26ea"
      unitRef="number">0.85</mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjQ0MjY_8ea80b21-aab7-4bb0-b5cf-a68933768d38"
      unitRef="usd">141000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementNumberOfInstallmentPayments
      contextRef="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI5MTM3MDU4MjYzMjky_89ea3aaa-89a0-41f4-ab84-11c53871c02a"
      unitRef="installment">10</mck:LossContingencySettlementNumberOfInstallmentPayments>
    <us-gaap:LitigationSettlementExpense
      contextRef="i2db33a1d8c0f47209ade1022863e8d6e_D20220402-20220402"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjQ0NjY_47f6f6a4-a430-40c7-8473-95615190ff5c"
      unitRef="usd">33000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i83583bb4d9614c5fa83041c913ae479e_D20220503-20220503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjAxMzk_a2aaf6ca-9614-4a34-a0d2-f9fc20a3c3fc"
      unitRef="usd">518000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ie97b0337408f4e61a2e9c5103e016421_I20220503"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjAyNzY_9a9d18d6-9808-41b2-8591-f6515e304b29"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i4e30da8843dc43c9ad33ff55a33b1d77_D20220503-20220503"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjAyODM_2e2ea090-e44f-4873-9a7f-411c1138acc3"
      unitRef="usd">197000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i4662a32533444a67872a829f9f186342_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkwMjI_70f707aa-de4e-43d1-baad-c25410306f86"
      unitRef="usd">75000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="ibb1ba0d32bc5422d928acee1595764cd_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkwMzE_cc475d8b-2225-439a-a1b5-a2c26b696167">P6Y6M</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i3baef44f3b9f46039f19cbc1c9ac553f_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkxMDk_2fd8c4dd-e1d5-4905-bac2-d84446aac0e4"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ibb1ba0d32bc5422d928acee1595764cd_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MjkxMzI_1e6752bf-c1dd-404d-a61c-0f2fe5327e73"
      unitRef="usd">29000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i0753823b559c4b249d5e8a0ea960fe6e_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1MDE_bf7cc75e-edeb-4049-a77f-dfe9d80e7293"
      unitRef="usd">440000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="i9b2d108c832a4b15b42ef645fcac9c15_D20210928-20210928"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1MTA_3dbecd7b-e20f-468e-96d3-8e24fac2c347">P6Y</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="ic52a333760c648e4b96056ff25230e21_I20210928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1NTU_45c64dac-47a8-42e7-9af8-4887549cd67d"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9b2d108c832a4b15b42ef645fcac9c15_D20210928-20210928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1Mjk1Nzg_5b71723c-567d-4e17-b4a3-ccf54e9a10e2"
      unitRef="usd">167000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
      contextRef="ic52a333760c648e4b96056ff25230e21_I20210928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjI3MjY_dfb48b0e-51bd-4c2e-8253-e860534a04db"
      unitRef="number">0.85</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i04c16ab737af40eb8c59705ef1b73c45_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NTg0Nzk_c6112a2e-08c4-4ff7-bf2a-823ed306cc09"
      unitRef="usd">157000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI3NDg3NzkxODcxNzE_25a94260-54cb-4f7e-9bed-d40d3d0edd49">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of governmental entities is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This amount, recorded in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet, is the amount estimated to be paid prior to March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In light of the uncertainty of the timing of amounts that would be paid with respect to the charge, the charge was recorded in &#x201c;Long-term litigation liabilities&#x201d; in our Consolidated Balance Sheet as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i272671062b484a64b905316d40d3ac81_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzEtMS0xLTEtMTE5NjU0_a833f0fb-ac9d-48c5-b069-102ec35f5a0b"
      unitRef="usd">1046000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i0eeabc6ce6174d6d914bf4b541540d89_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzEtMy0xLTEtMTM0Nzk5_23fd4af0-9e24-47cc-8105-d1e55c7fb622"
      unitRef="usd">0</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i272671062b484a64b905316d40d3ac81_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzItMS0xLTEtMTIxMDQx_09884f76-03d9-4b64-a4ac-a3e4bf146494"
      unitRef="usd">7220000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i0eeabc6ce6174d6d914bf4b541540d89_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzItMy0xLTEtMTM0Nzk5_80432de7-87ba-44b8-ab37-f4b3600b2c8f"
      unitRef="usd">8067000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i272671062b484a64b905316d40d3ac81_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzQtMS0xLTEtMTE5NjQx_19a696af-0f8a-4849-88f1-94beb7d2fabb"
      unitRef="usd">8266000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0eeabc6ce6174d6d914bf4b541540d89_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90YWJsZTo1MmQzMmRkNDYxODM0Yzk4YjE5NjBjNGQwNjIzZTkyNS90YWJsZXJhbmdlOjUyZDMyZGQ0NjE4MzRjOThiMTk2MGM0ZDA2MjNlOTI1XzQtMy0xLTEtMTM0Nzk5_927e7a4f-ac05-451e-a71d-98079a695200"
      unitRef="usd">8067000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:EscrowDeposit
      contextRef="i71cd8720173a496486279e0544a6abce_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjYyOTk_fbb6c6d3-7f90-4e99-ad0f-96de752b291c"
      unitRef="usd">354000000</us-gaap:EscrowDeposit>
    <us-gaap:EscrowDeposit
      contextRef="ic7cf3ce788524e9fb74bf1ade9cde623_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3NjYzMTM_28649783-f437-4006-acee-1b4890ddaf19"
      unitRef="usd">41000000</us-gaap:EscrowDeposit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i12913f42c838424a97ff6d451699968c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MzUzNDY_db48fe30-2cc1-45cb-a78c-54e78d35f556"
      unitRef="case">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i4f2b5de2b7964c299fe4538bbce99201_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MzUzNzc_8ffeb0bf-9f0d-4b66-99fa-6c9075d4606f"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i6f1569fe7f254494bbcf927a0376e97c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE2NDkyNjc1MzU0MjI_f3578540-3268-4320-b68a-2910db673673"
      unitRef="case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal
      contextRef="i2743565c13d0440d9c782b3823bb2dbc_D20190225-20190225"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzExMTUy_a4354753-3177-470c-81d2-05d990286701">P90D</mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i987dad20a95b4cbdb8b7627a6eaa19cd_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzExNDc3_156e4b12-c567-4bda-b3b9-f8ed978ca5c4"
      unitRef="complaint">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofRelators
      contextRef="i9fa583f3ec4d43c39a9e06debe72ee55_D20191201-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzExNTE3_b97190c6-ffc6-477d-b972-fc23ee233169"
      unitRef="relator">2</mck:LossContingencyNumberofRelators>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i66664fd861c54faf85787d6861f4bd01_I20201023"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEyMjIx_cf6c9dd2-7d02-44bf-bd7f-73e0ff2fd950"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="if6a7e381cd664bfead2365a491df4db8_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEzOTA2_d0edfe81-c345-468a-a20e-0284155d831d"
      unitRef="usd">500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="i349cf2789de1486e908e9763803d4227_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEzOTEy_be5d33ed-a95a-43e3-ad62-7b979bd680fe"
      unitRef="usd">1500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyClassActionNumberofFaxesRemainingintheClass
      contextRef="i14a8cc9bca31458291c36a5f215ed0bb_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE0Nzgw_a0a6602c-a994-4a8d-95b4-66102350b7c6"
      unitRef="faxnumber">9490</mck:LossContingencyClassActionNumberofFaxesRemainingintheClass>
    <mck:LossContingencyClassActionNumberofFaxesReceived
      contextRef="i14a8cc9bca31458291c36a5f215ed0bb_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzE0ODI5_4cf8772c-2d26-4610-a6e9-71664fe3f849"
      unitRef="fax">48769</mck:LossContingencyClassActionNumberofFaxesReceived>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ia7b18f283c214a63941ca5f3aa2f1ba3_D20220427-20220427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzEwOTk1MTE3Njc4NTg_713a45eb-a9d0-41ed-9cf7-74012af415c8"
      unitRef="usd">6500</us-gaap:LossContingencyDamagesAwardedValue>
    <mck:LossContingencyNumberOfRelators
      contextRef="i1141187871d64de6b18824ede60c2f14_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjE4Mzc_a7f542d3-b0a6-42b6-986f-a8c16516d692"
      unitRef="relator">2</mck:LossContingencyNumberOfRelators>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="i1141187871d64de6b18824ede60c2f14_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjE4Mzk_23a0df1c-b279-49b5-8ba7-6f4a73f7ac31"
      unitRef="state">21</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfAdditionalDefendants
      contextRef="i1141187871d64de6b18824ede60c2f14_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjE4NDI_48984dd2-3843-4cb5-8e6b-ea3283a54018"
      unitRef="defendant">5</mck:LossContingencyNumberOfAdditionalDefendants>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="i14ac6ad34bca4c4691038eca05b20788_D20180403-20180403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIyNjUw_77be683c-6115-4262-8568-15a8aaa642a9"
      unitRef="state">30</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberofCitiesFiledOnBehalfOf
      contextRef="i272a1d83ed104933bc5777159d6a279b_I20180403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIyNjkx_252aa551-1e7a-43e7-9e33-28ebc6425f14"
      unitRef="city">2</mck:LossContingencyNumberofCitiesFiledOnBehalfOf>
    <mck:LossContingencyNumberofFormerOfficers
      contextRef="i3ca99d687e7a44bf9addf006fbd8fc6c_I20181212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI2Mzgy_0cdc71b6-d8dc-4b00-80bb-e0950c97fbef"
      unitRef="officer">2</mck:LossContingencyNumberofFormerOfficers>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7c871b75f43643cab2812bfd524754ec_I20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NzY_4ee2b8b4-680c-4c9d-996f-888bc4b053b8"
      unitRef="complaint">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3ad0b32109f349168507a51c296e9f4a_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0ODM_a0a959b5-bf48-455e-94c7-a57cc44d067e"
      unitRef="complaint">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7e8e9b14a1e24dbd9dd4da9e2e12f251_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0ODg_56617245-5f3c-4590-a93f-fcd46af41929"
      unitRef="complaint">6</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStatesFiledOnBehalfOf
      contextRef="id85d07627aee4db8896b725c019fcc18_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzI5NTY5_b51d2954-bf71-4a9c-b006-9fd29dc4a153"
      unitRef="state">27</mck:LossContingencyNumberofStatesFiledOnBehalfOf>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i72b34df8ae41427db43c35ab86ae900b_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzMxMTA0_ac4e14d6-82ee-4af7-8b14-0db0b87f2b1d"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:NumberofSoftwareProducts
      contextRef="i72b34df8ae41427db43c35ab86ae900b_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzMxMjY2_7112ecd2-215e-4044-bac4-e86a5a6439d4"
      unitRef="softwareproduct">2</mck:NumberofSoftwareProducts>
    <mck:OpioidStewardshipActNewYorkAnnualSurcharge
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjI4MDc_9e23a976-7a00-406a-8e12-fca4ff382ed4"
      unitRef="usd">100000000</mck:OpioidStewardshipActNewYorkAnnualSurcharge>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjI4MzM_68774fd6-e170-4a86-ba46-5e00db6071dd"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <mck:LossContingencyAccrualProvisionAfterTax
      contextRef="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzM0MDE4_def971fb-d1ee-4295-9d29-7e74479915cb"
      unitRef="usd">37000000</mck:LossContingencyAccrualProvisionAfterTax>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="if0191e84fbf046f1bf6fa863cb4e56bf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzQzOTgwNDY2Mzc0MTg_09c20829-396d-4d01-9f59-0667f57cea9e"
      unitRef="usd">26000000</us-gaap:LossContingencyAccrualPayments>
    <mck:SiteContingencyNumberofSites
      contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MTQ_435dbaa3-0156-46ae-b59f-dd639174881c"
      unitRef="site">5</mck:SiteContingencyNumberofSites>
    <mck:SiteContingencyNumberofSites
      contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MjE_435dbaa3-0156-46ae-b59f-dd639174881c"
      unitRef="site">5</mck:SiteContingencyNumberofSites>
    <us-gaap:AccrualForEnvironmentalLossContingenciesGross
      contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MzA_6f100f95-e8b0-4e49-b9ff-a37417ab8250"
      unitRef="usd">15000000</us-gaap:AccrualForEnvironmentalLossContingenciesGross>
    <us-gaap:AccrualForEnvironmentalLossContingenciesGross
      contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0Mzg_6f100f95-e8b0-4e49-b9ff-a37417ab8250"
      unitRef="usd">15000000</us-gaap:AccrualForEnvironmentalLossContingenciesGross>
    <mck:HazardousSubstanceSites
      contextRef="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NTE_5d19720c-dbe8-43b6-9f8c-ee026cf26714"
      unitRef="site">14</mck:HazardousSubstanceSites>
    <mck:NumberofSitesSelectedforPreferredRemedy
      contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzM2NjI3_d55feaa4-1d25-4c8c-80ec-cf92368cc54f"
      unitRef="site">1</mck:NumberofSitesSelectedforPreferredRemedy>
    <mck:EstimatedEnvironmentalAssessmentAndCleanupCosts
      contextRef="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NTU_68f6d85e-bd2e-4dfb-898f-e06fab27b6e8"
      unitRef="usd">1400000000</mck:EstimatedEnvironmentalAssessmentAndCleanupCosts>
    <mck:HazardousSubstanceSites
      contextRef="i2ae80d078ba64f71a5cfdf20e56cce42_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NjE_5d19720c-dbe8-43b6-9f8c-ee026cf26714"
      unitRef="site">14</mck:HazardousSubstanceSites>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="ice2a4f3691c84bacb13e16b89ee569b8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0NjU_ddb1fbd3-b9c4-4b0d-9dfe-5d8b26bc3d56"
      unitRef="usd">29000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjMzOTA_ed3dc338-ef1e-410d-981d-309452441a1c"
      unitRef="usd">-46000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjMzOTc_158cf316-b262-48e4-bd22-42a1adf9743c"
      unitRef="usd">-181000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjMvZnJhZzozMTkwM2E4NDUyOTU0OTc5YmEwODhjYTU1OWY2NWI0MS90ZXh0cmVnaW9uOjMxOTAzYTg0NTI5NTQ5NzliYTA4OGNhNTU5ZjY1YjQxXzIxOTkwMjMzMjM0MDg_41a9cac9-702e-48c9-955c-c65c44d7174d"
      unitRef="usd">-22000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzU2MzM_09ef7483-4393-478e-8704-c07c6f253833">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Board. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the quarterly dividend was raised from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. Dividends were $1.83 per share in 2022, $1.67 per share in 2021, and $1.62 in 2020. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#x2019;s future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions. During the last three years, the Company&#x2019;s share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding share repurchase activity over the last three years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share Repurchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except price per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Price &lt;br/&gt;Paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate &lt;br/&gt;Dollar Value of &lt;br/&gt;Shares that May &lt;br/&gt;Yet Be Purchased &lt;br/&gt;Under the &lt;br/&gt;Programs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2019 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase authorization increase in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2021&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASR&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase authorization increase in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - February 2022 ASR &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to the Company&#x2019;s Split-off of the Change Healthcare JV as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of shares purchased reflects rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Of the total dollar value, $8&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#x2019;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2020, the Company completed the Split-off of its interest in the Change Healthcare JV. In connection with the Split-off, the Company distributed all 176.0 million outstanding shares of SpinCo common stock, which held all of the Company&#x2019;s interests in the Change Healthcare JV, to participating holders of the Company&#x2019;s common stock in exchange for 15.4 million shares of McKesson stock, which are now held as treasury stock on the Company&#x2019;s Consolidated Balance Sheets. Following consummation of the exchange offer, on March 10, 2020, SpinCo merged with and into Change with each share of SpinCo common stock converted into one share of Change common stock, par value $0.001 per share, with cash being paid in lieu of fractional shares of Change common stock. See Financial Note 4, &#x201c;Business Acquisitions and Divestitures,&#x201d; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s accumulated other comprehensive income (loss) by component are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts before reclassifications recorded in 2022, 2021, and 2020 include gains (losses) of $73&#160;million, $(118)&#160;million, and $39&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $(4)&#160;million, $(119)&#160;million, and $76&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(23)&#160;million, $62&#160;million, and $(30)&#160;million in 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily reflects a reclassification of losses of $127 million, net of $33&#160;million of income tax benefit, predominantly on the termination of the Company&#x2019;s U.S. defined benefit pension plan from &#x201c;Accumulated other comprehensive loss&#x201d; to &#x201c;Other income, net&#x201d; in the Company&#x2019;s Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale&#x201d; and Financial Note 6, &#x201c;Other Income, Net.&#x201d; These amounts were included in the 2021 and 2020 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the Company&#x2019;s Austrian business, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included in the 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzI3NDg3NzkwOTE4MDE_d32daaf5-2749-49b6-93fa-937c0f85926e"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic33eab4418d04068bfb2c3d091c51f4a_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzcxNDY4MjU1ODYyMjI_f04ca35c-b7c0-4b51-99ca-4cb87d71b88e"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icb6786f86e4c4e6d8af02b607fd8f48b_D20210701-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzcxNDY4MjU1ODYyMjY_a6e20b39-4d08-4b5a-a2b3-657dcb5a1345"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0Xzc2OTY1ODE0MDAyMzM_bac10196-3b8a-406a-81b2-eedcf389ec2e"
      unitRef="usdPerShare">1.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0Xzc2OTY1ODE0MDAyMjY_eab194eb-b4b5-46c2-b5b7-cb2398e8645e"
      unitRef="usdPerShare">1.67</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0Xzc2OTY1ODE0MDAyMjE_b48af161-9737-4cb4-aeab-cfcf666f9fa5"
      unitRef="usdPerShare">1.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:AcceleratedShareRepurchasesTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzU2Mjk_fbcd36a6-d914-4af1-94a9-9893ed7e9cd0">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding share repurchase activity over the last three years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share Repurchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except price per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Price &lt;br/&gt;Paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate &lt;br/&gt;Dollar Value of &lt;br/&gt;Shares that May &lt;br/&gt;Yet Be Purchased &lt;br/&gt;Under the &lt;br/&gt;Programs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2019 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase authorization increase in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2021&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASR&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchase authorization increase in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - February 2022 ASR &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to the Company&#x2019;s Split-off of the Change Healthcare JV as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of shares purchased reflects rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Of the total dollar value, $8&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#x2019;s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzItNi0xLTEtNjc1MTI_4c143fba-6a17-4028-b87b-e76d74f0e195"
      unitRef="usd">3469000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzMtMi0xLTEtNzI2NzM_89004116-60ce-41d8-9d0e-e38141c5a423"
      unitRef="shares">9200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzMtNC0xLTEtNzI2ODY_2a24d986-8e6e-409f-bac6-d0a2c6094164"
      unitRef="usdPerShare">144.68</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7859e43de68740b39aa32ec326cac02f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzMtNi0xLTEtNjc1MTI_a58b7c55-a5d9-4d37-bca7-8800878605d0"
      unitRef="usd">1334000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzQtMi0xLTEtNjc1MTI_00bbe8fa-cae3-4efe-86df-c5afbeb6874d"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzQtNC0xLTEtNjc1MTI_6b4d8525-df9d-47ba-b4ce-7f304161f5fd"
      unitRef="usdPerShare">127.68</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1e0cfd9a5edb41a8bdf7e0ae8d6363c5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzQtNi0xLTEtNjc1MTI_6cd2a59f-e33e-4c34-8c6b-dbaf2ff2bdfd"
      unitRef="usd">600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzUtNi0xLTEtNjc1MTI_d48a8715-491b-4b33-a29a-76f37ee792d9"
      unitRef="usd">1535000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzYtNi0xLTEtNjc1MTI_cc24037d-d178-4fb5-9ab4-0ccbba3b1651"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzctMi0xLTEtNjc1MTI_25d0e6f8-6996-42be-9538-51e58da73d59"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzctNC0xLTEtNjc1MTI_c3c39a67-e425-4ddd-a763-08e762b41a29"
      unitRef="usdPerShare">160.33</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie32d61a0cd994becabdf3614ceff4fd1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzctNi0xLTEtNjc1MTI_ccc4af40-7355-455f-a43d-891e6da1067f"
      unitRef="usd">750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzgtNi0xLTEtNjc1MTI_5204034b-a421-41a3-a751-fde04cf86b9a"
      unitRef="usd">2785000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzktMi0xLTEtNzI2NzM_31860f35-40a1-46ec-9002-215da7d48b0a"
      unitRef="shares">5200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzktNC0xLTEtNzI2ODY_e67c1c34-fd01-42ce-a7bf-afd396f28afd"
      unitRef="usdPerShare">193.22</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4470c2a8306c4db9ae67fe6e5c193888_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzktNi0xLTEtNjc1MTI_2901afb6-55e7-4e04-befc-b217f564027d"
      unitRef="usd">1000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEwLTItMS0xLTcyNjcz_a471fd14-d44c-446d-bca9-a92c6ac6828d"
      unitRef="shares">4600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEwLTQtMS0xLTcyNjg2_f83d7a63-30b2-4371-9794-70a76e1d10e1"
      unitRef="usdPerShare">217.73</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i99c32ad1b4b246088302ef90e433b984_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEwLTYtMS0xLTY3NTEy_11bf155d-05d5-4745-a96e-ece9a2889d14"
      unitRef="usd">1007000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzExLTYtMS0xLTY3NTEy_f7b08633-6a22-4024-8e0b-89914e189071"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTItMS0xLTEwMzI0OA_2aa4c1c0-617f-48f6-bf77-ba6900258715"
      unitRef="shares">4800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTQtMS0xLTEwMzI0MA_c8dbaeec-c635-4ebd-83f6-1de74be47f48"
      unitRef="usdPerShare">265.56</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i81c35ea4cce04bcd9b84720d6f43d54c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTYtMS0xLTEwMzIyOQ_1f86e6e3-0044-42a5-8fab-bb1c3e8a923f"
      unitRef="usd">1500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZTpmZWNhYzllMmNlZDI0ZDJkYjAwZjA0NTBkZmZiNDQwYy90YWJsZXJhbmdlOmZlY2FjOWUyY2VkMjRkMmRiMDBmMDQ1MGRmZmI0NDBjXzEyLTYtMS0xLTY3NTEy_e2330004-35f3-49c5-b9ba-30e8edc53bb7"
      unitRef="usd">3278000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <mck:AccruedShareRepurchases
      contextRef="i4c08dc9e360548f496960579d4795f54_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzEwOTk1MTE2MzM2MzM_39d045b7-f921-4c2c-8185-9671640ca0d4"
      unitRef="usd">8000000</mck:AccruedShareRepurchases>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i28c6e70168da414cb0ac4e9c64318d06_I20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzI3NDg3NzkwOTE3ODI_dde3d93a-6767-42ae-8c4a-932b649c334b"
      unitRef="usd">1500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <mck:ExchangeOfferSharesDistributed
      contextRef="id4f2e891a1484378a859acc53e8681a0_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMjU_42a2fc7f-b303-440a-8ef0-f048dd19dea2"
      unitRef="shares">176000000</mck:ExchangeOfferSharesDistributed>
    <mck:EquityMethodInvestmentStockAccepted
      contextRef="i644b2169690443038315b62f32a3e6f6_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMjk_eb64e49b-471f-4849-ab68-ab18cf273c01"
      unitRef="shares">15400000</mck:EquityMethodInvestmentStockAccepted>
    <mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted
      contextRef="i4acf39f6c45042d9825177088805f18a_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMzM_5b505a3d-42b4-4cd4-b5e0-bdbd77fd93df"
      unitRef="shares">1</mck:CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4acf39f6c45042d9825177088805f18a_I20200310"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzkzNDU4NDg4NTgwMzc_5af28c7d-cd37-4301-9e9c-ac7992792b94"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzI3NDg3NzkwOTE4MDk_421e193f-7e1a-4ba2-aa44-10255eca0a77">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s accumulated other comprehensive income (loss) by component are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts before reclassifications recorded in 2022, 2021, and 2020 include gains (losses) of $73&#160;million, $(118)&#160;million, and $39&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $(4)&#160;million, $(119)&#160;million, and $76&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(23)&#160;million, $62&#160;million, and $(30)&#160;million in 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily reflects a reclassification of losses of $127 million, net of $33&#160;million of income tax benefit, predominantly on the termination of the Company&#x2019;s U.S. defined benefit pension plan from &#x201c;Accumulated other comprehensive loss&#x201d; to &#x201c;Other income, net&#x201d; in the Company&#x2019;s Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale&#x201d; and Financial Note 6, &#x201c;Other Income, Net.&#x201d; These amounts were included in the 2021 and 2020 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the Company&#x2019;s Austrian business, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale.&#x201d; These amounts were included in the 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within Selling, distribution, general, and administrative expenses in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f5d39fcc93f468db79dbc8f03cfc331_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMS0xLTEtMTAzMzQz_bc26c026-d95b-4853-bce0-4d55f453cd4c"
      unitRef="usd">-1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b7452f966eb4322aa52d896f745263f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMy0xLTEtMTAzMzQz_4d41bb73-266c-4fad-959e-65e869b79846"
      unitRef="usd">53000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38e0059bd2b14949ab11b259c08962df_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNS0xLTEtMTAzMzQz_918a8914-125e-4444-955c-64d78968efdc"
      unitRef="usd">-37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8ce6232f2024c3c85f71080415b78ce_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNy0xLTEtMTAzMzQz_a129ddec-d536-4a88-8d30-f38ecf3c2128"
      unitRef="usd">-237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1cd9f0cb497242a6826289cfb5fdad80_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItOS0xLTEtMTAzMzQz_2ba40a10-bb8d-4ab5-93a6-c156bd88595d"
      unitRef="usd">-1849000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMS0xLTEtMTAzMzQz_180de59b-d090-4852-a4cd-63e04d1503d7"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMy0xLTEtMTAzMzQz_1813a0cf-db9c-41f2-a252-5f8253cfca72"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNS0xLTEtMTAzMzQz_9cc0de86-9f26-4406-9afe-d7acf35c4de4"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNy0xLTEtMTAzMzQz_25d44a08-6f0d-4269-bde6-b8b666aae1af"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtOS0xLTEtMTAzMzQz_d2a4a71e-7ced-495e-9797-65fc2a482523"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMS0xLTEtMTAzMzQz_8916139c-e39a-46e7-afeb-012e95d6af28"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMy0xLTEtMTAzMzQz_a332b863-66ad-42c4-b046-2f1e98669e2c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNS0xLTEtMTAzMzQz_a23370d9-7e8c-4e76-8283-396eabf0cc5c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNy0xLTEtMTAzMzQz_0f0baa68-91cf-4eea-a0dc-535562d571fe"
      unitRef="usd">-96000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtOS0xLTEtMTAzMzQz_8be42fce-a300-453f-a352-c1b1770b0cad"
      unitRef="usd">-96000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMS0xLTEtMTAzMzQz_16229095-f42d-4daf-827f-bbe01b2402fa"
      unitRef="usd">-151000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMy0xLTEtMTAzMzQz_13b283cb-014d-4e70-a6b2-1e4d5ee60fae"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNS0xLTEtMTAzMzQz_e13c6f8a-19ea-4bd6-9dc1-0ad0332e997c"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNy0xLTEtMTAzMzQz_3d7aae21-5775-4975-b933-b8a3a5fd8e1e"
      unitRef="usd">129000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtOS0xLTEtMTAzMzQz_fd127516-af97-4b1a-b670-cede717d6554"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMS0xLTEtMTAzMzQz_85583a6d-104c-4437-bafa-4aabcf9da403"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMy0xLTEtMTAzMzQz_0c625d73-da0b-4e9d-b39e-aefad7b65316"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNS0xLTEtMTAzMzQz_61e66b8a-4d10-4651-a720-af2ec23c7d25"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNy0xLTEtMTAzMzQz_2eb38289-740c-4f38-a0db-a3b5f7670560"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtOS0xLTEtMTAzMzQz_3e5cd21a-5b90-48c5-a79d-1e72d3942ffe"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7bed6e7cc6634f758953554e35addfba_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMS0xLTEtMTAzMzQz_002e31d7-3825-4767-8a85-4d21ca984539"
      unitRef="usd">-152000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMy0xLTEtMTAzMzQz_962d9c1f-3893-473a-8486-ae43521aff73"
      unitRef="usd">85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2e181f7f03474d17a658711503e83555_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNS0xLTEtMTAzMzQz_f2964bea-59ef-422a-b301-d169743884ae"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2896024f8dd24c96b7e1d0a48fa179b2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNy0xLTEtMTAzMzQz_90b90ea5-8bce-4c23-a88c-72b3d304beb3"
      unitRef="usd">127000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8437485c0b5b42e68f93c5f0f2d92053_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctOS0xLTEtMTAzMzQz_31f217f0-1ead-4279-bb23-cb37ec93f952"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1af057e14a6c4a569ffbf7f13a871e72_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMS0xLTEtNjc1MTI_c5bdff42-8733-418c-98b3-a0c406affb37"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29c6f6a5ff29462b9d28c777bd2bd274_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItMy0xLTEtNjc1MTI_caff038e-1a6f-429e-ad3c-52e1fd513c0a"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ad4ab28ad0e4703b8f21cbc668994aa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNS0xLTEtNjc1MTI_94c86e64-026d-4866-9c8c-671012536a68"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa805c2e2cb74e2fb138905ae2d6aeb5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItNy0xLTEtNjc1MTI_0c8c602d-c5ca-4443-9fa7-70a1d7c0ecd7"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83f0aa9722f4476ca58477e03a36b9f4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzItOS0xLTEtNjc1MTI_be3550a3-c6fe-412d-a061-c53ec43a0df0"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMS0xLTEtNjc1MTI_865ebf36-5bc4-42d2-9a1f-9829a86a08fe"
      unitRef="usd">312000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtMy0xLTEtNjc1MTI_58c614f7-be69-4363-95df-37513c75b05c"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNS0xLTEtNjc1MTI_084be150-ef27-4c79-a4e2-1a7bf157fca3"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtNy0xLTEtNjc1MTI_4bd91282-0aee-4d71-87fb-6bcc36481221"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzMtOS0xLTEtNjc1MTI_00eb6432-6b9a-48dd-b27d-cf43615e45d5"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMS0xLTEtNjc1MTI_906be0de-aae1-4bc5-b900-b5c8ab021162"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtMy0xLTEtNjc1MTI_9f6e58d3-bc14-4d76-8fe4-3ca51c375c28"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNS0xLTEtNjc1MTI_ece76d8a-31e7-473b-8fb9-99601cd532b7"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtNy0xLTEtNjc1MTI_385e2b40-23e6-4818-9350-907bc531dc76"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzQtOS0xLTEtNjc1MTI_59410b40-b9c3-4664-84bc-274a52812960"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMS0xLTEtNjc1MTI_28311fbe-519e-42cd-80e7-4a5f7cfa8076"
      unitRef="usd">359000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtMy0xLTEtNjc1MTI_7e9c3fd3-ca4b-4708-9e9e-c2d6311d6e4a"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNS0xLTEtNjc1MTI_a1053b29-c47c-48ba-8cbe-ef118bc51310"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtNy0xLTEtNjc1MTI_29894133-b550-4ef9-8e21-8aa2949d1957"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzUtOS0xLTEtNjc1MTI_0e3bef2d-89c9-4d67-95db-f77eb6a66171"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMS0xLTEtNjc1MTI_13f2e690-ff9b-4454-b89b-2c2e75d10fbd"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtMy0xLTEtNjc1MTI_ddb8535a-a677-4ff3-9315-172bfb8747cd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNS0xLTEtNjc1MTI_c426e90c-5011-46c6-9849-497143d5ee78"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtNy0xLTEtNjc1MTI_729ea06f-a84b-4354-9b80-db996be4898d"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzYtOS0xLTEtNjc1MTI_84a7e2af-238c-4d52-a45a-5fdcebbd1438"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i341fc51538c24926bae5c478238735ef_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMS0xLTEtNjc1MTI_bc0b69e1-327f-438c-b67a-ddb6ece25108"
      unitRef="usd">419000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctMy0xLTEtNjc1MTI_b093ba60-1fd8-440a-8b08-9fe3f43e5475"
      unitRef="usd">-174000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3648819787fd4ec78cd863a3188b4bc5_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNS0xLTEtNjc1MTI_6f4639a9-dc5c-471c-bebe-58c29953cfca"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibc7e915d248447fca898b2a99cdc833f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctNy0xLTEtNjc1MTI_259d72cd-8c4e-4a62-beb4-000b4306c074"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i820bdbc1d84a4b92902db99a6cfc735a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzctOS0xLTEtNjc1MTI_e881604e-e487-48f6-95bf-526a29e6d1d1"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85cd2ff97d53454f89e0a9769c6b9cdc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtMS0xLTEtNjc1MTI_ec6e2128-f5c9-4ec4-bede-e64c5cfed96f"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a18c76ff5b34fad9b94fc6bc03eeab7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtMy0xLTEtNjc1MTI_46771e7d-83c8-4406-bd2b-06132fe533a1"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec5e0ac198fc4744ac896c1d7596fdf5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtNS0xLTEtNjc1MTI_40278a76-7bdc-47bd-ad35-179f20a70753"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icda474b56c3e4aa1a24ed971c975e0f8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtNy0xLTEtNjc1MTI_42ff4538-5e0a-4c4d-9ddf-024d85cabfc8"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0f038c81a5a4b8198d4c97be9e3cfa7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzgtOS0xLTEtNjc1MTI_e95f629e-7207-4389-8130-0991708acbbe"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktMS0xLTEtNjc1MTI_fcb704bf-bab8-4937-8ea6-86a632325d73"
      unitRef="usd">-51000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktMy0xLTEtNjc1MTI_72d3cb3c-8dcb-46f4-b1a8-a46f8eb01d01"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktNS0xLTEtNjc1MTI_b0b34ce4-28a9-442d-8367-309344480cbb"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktNy0xLTEtNjc1MTI_ee2cf3d2-922f-4bf4-8d48-84949cc196df"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzktOS0xLTEtNjc1MTI_f88375c3-1f77-4687-971a-e97ec00d51a3"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTEtMS0xLTY3NTEy_d22f0b2f-5ca5-4779-a928-3f948411c9e8"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTMtMS0xLTY3NTEy_8fc67e53-c57d-4ce2-a51c-063a1b09faa1"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTUtMS0xLTY3NTEy_396197d6-1af1-4e51-a147-921fec86df5b"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTctMS0xLTY3NTEy_47cfc860-d414-45ec-bea2-1fd68d481e99"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEwLTktMS0xLTY3NTEy_39dc881d-c17d-4364-afd1-d068cf8849b6"
      unitRef="usd">-76000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTEtMS0xLTY3NTEy_a99199a6-54e5-4435-b45d-f869afd7415d"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTMtMS0xLTY3NTEy_a4e715f0-be31-47f4-9751-a0a7441d76fb"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTUtMS0xLTY3NTEy_b534068e-a34b-436f-a87a-cf8e22b4f53a"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTctMS0xLTY3NTEy_7f1b68be-2eee-45df-8262-d7cb74b60fa1"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzExLTktMS0xLTY3NTEy_48c00fa2-0adc-4e6a-9204-3636f7db2606"
      unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTEtMS0xLTY3NTEy_66ed6a8f-4b8a-4d3e-b1b5-806e713b128d"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTMtMS0xLTY3NTEy_3e064b9f-3448-4e5d-aa69-889738b18e01"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTUtMS0xLTY3NTEy_bf75e8ff-ebd2-4666-98a1-eb147c2623f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTctMS0xLTY3NTEy_d262177c-4695-43f4-944d-07c5ce5a8f4b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEyLTktMS0xLTY3NTEy_cbdd281f-2017-41b0-bc63-ced056ee51f0"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTEtMS0xLTY3NTEy_cd23e352-8bc9-4cad-9d58-fd9861f50e85"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTMtMS0xLTY3NTEy_76eb8f47-259a-4966-ba21-cfe7d0cc2598"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTUtMS0xLTY3NTEy_216dab95-7fb0-45d9-8c21-0740b631e80b"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTctMS0xLTY3NTEy_0b74963f-9be3-49f7-bcd3-3e672407e0f1"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzEzLTktMS0xLTY3NTEy_79b18c6e-abec-4385-9101-49949d256cf9"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="idd07866af62b438392a2793d370d5438_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTEtMS0xLTgzODY0_8b8842f4-acc2-4a07-905c-8a3e41ca05fc"
      unitRef="usd">-158000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTMtMS0xLTgzODc1_32cdb6bb-39ba-436d-8189-866045f8ae6d"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i9064356341ec491b885a59f02c3152b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTUtMS0xLTgzOTEx_a795ece0-2b99-4e1a-9830-3f68b11a6471"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ie9fca0da92c24e5094bd13365fa8498f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTctMS0xLTgzOTE0_ba510e58-3da2-4009-8b68-f56fd2aebfdc"
      unitRef="usd">-12000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i1bc0743e901649f3bbd9287e5f834b89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTktMS0xLTgzOTE4_e9a54ece-ec96-4dbb-8e13-d8d246f245b2"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5deabb24d12941e896a4e688121d8f30_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTEtMS0xLTY3NTEy_e0d02add-edc7-43de-bf4e-da30cb70b3de"
      unitRef="usd">-1504000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9922f80e4f24738b404cca8c87f73bd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTMtMS0xLTY3NTEy_7888bd53-2ac4-4189-8edd-d439ff8ba49e"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7fff78ca4ca84ca68f9917ec5e4784fe_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTUtMS0xLTY3NTEy_4cf85ad9-7fe4-4f98-bfbc-86f1561477d0"
      unitRef="usd">27000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie93e1536edc94513a25b75692a412434_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTctMS0xLTY3NTEy_4a426fc5-cc88-4667-bd91-a5acc5a0bbf4"
      unitRef="usd">-67000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3e04acff1af415fb304c565efd6376b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90YWJsZToyN2Y1YmU3Mjk0ZWY0YjcxYTQ0ZmZjMmMzMmZjZDk1Ny90YWJsZXJhbmdlOjI3ZjViZTcyOTRlZjRiNzFhNDRmZmMyYzMyZmNkOTU3XzE0LTktMS0xLTY3NTEy_5b57b03f-66a2-423a-927f-c820fe93b387"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU5MTM_09e3863a-3583-4f72-bc69-de93cbe51018"
      unitRef="usd">73000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU4NzQ_c69d4e04-ece3-4a7d-a446-3af3b5167891"
      unitRef="usd">-118000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU4OTU_c2243396-520a-4fd9-9be4-5b4eceb5ff98"
      unitRef="usd">39000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i22b34b6e8ced4d97b4d47ddb2965e898_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzYxMzc_5c96dcca-9948-4de7-b712-24aacb72d0fb"
      unitRef="usd">-4000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ifaa55b6bf9f44cd1a8a25b42288d0593_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzYxMDk_a42faae8-e6c5-4da1-97e8-69bf617b1118"
      unitRef="usd">-119000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i1f9cac9e86284785ab4d70600ae33ad6_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzYxMjM_19caeddb-7c35-4561-99d7-d36f5f822b6b"
      unitRef="usd">76000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i74ab1ed0d9ef43228fd12810c0d7b539_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzY0Mzg_ad53dfe0-6a85-4d73-b031-87e0c965817d"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i96f4f8ca1ae74804ac526c42127c2ea3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzY0NTA_7dcccba0-0f06-4693-a251-68fa50dca514"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9bc121f4bf244d1da7550c1a1d70e281_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzY0NjM_3f7dee84-580b-4462-9848-a9b0ad356374"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzUzNzQ_0ad13d4f-6a7c-487e-b567-857f5ccdfcb3"
      unitRef="usd">-127000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i073988a4a0ef43228b2f01d389f330b2_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjYvZnJhZzo1NzQ3NjEzYjRhM2U0MDJmODljZmQ1MDE1ZGI5ZWJiNC90ZXh0cmVnaW9uOjU3NDc2MTNiNGEzZTQwMmY4OWNmZDUwMTVkYjllYmI0XzIxOTkwMjMyNzU3NTk_b4b02431-722c-4a95-881d-da04ebcbb081"
      unitRef="usd">-33000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzI3NDg3NzkwNzUwODY_63c28276-25ec-41cc-b535-46babfdede75">Related Party Balances and Transactions&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $137 million, $178 million, and $141 million are included in the Consolidated Statements of Operations for the years ended March 31, 2022, 2021, and 2020, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March 31, 2022 and 2021. Predominately all of these pharmacies were divested from the Company in the fourth quarter of 2022 as part of the completed sale of the Company&#x2019;s Austrian business, while certain other remaining pharmacies are included in the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, 2021, and 2020, the Company&#x2019;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $100 million, $111 million, and $60 million, respectively. Trade receivables related to these transactions from this investee were not material as of March 31, 2022 and 2021. During 2022, the Company&#x2019;s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;Refer to Financial Note 4, &#x201c;Business Acquisitions and Divestitures,&#x201d; for information regarding related party balances and transactions with Change and the Change Healthcare JV.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="icbf8232e206747f2be913302ec5dbaaf_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0NTk_6ea42a4f-fd53-410b-91d1-f42a18f69dd9"
      unitRef="usd">137000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia70ab04be4fc4669bf6269d283c9c79e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0MzE_5474e5e0-a6a9-4acd-85a1-1c0f06f08033"
      unitRef="usd">178000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia70ab04be4fc4669bf6269d283c9c79e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0MzE_e130dbb8-0f18-449a-915b-753b70bb61d1"
      unitRef="usd">178000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i91df3cbe60584b50a204d33eeeed8980_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0Mjc_1e88484f-b882-4070-ace3-f2da83de8b7a"
      unitRef="usd">141000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iaf9c8554b2fb4c5fbdc95411f1908eac_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0Njg_ca3e9ddb-c21f-4284-bdf7-2ba3dd54ec31"
      unitRef="usd">100000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i6b2b0cbe0ef24d20b15b7f972083020e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0NjU_06a7b4f6-e552-47df-b389-e47a23f52f93"
      unitRef="usd">111000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i887ec05b39874d2c8d43dc5b0c6812aa_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNjkvZnJhZzplODU2MzNjZmJjZDI0NTc2ODljNDg3MGJlMjYxMGJhNy90ZXh0cmVnaW9uOmU4NTYzM2NmYmNkMjQ1NzY4OWM0ODcwYmUyNjEwYmE3XzcxNDY4MjU1ODI0NjI_deb8f263-7154-4c05-8db3-8e75437ff9d5"
      unitRef="usd">60000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3Xzg2MDU_f1db7832-04d0-4ba1-beb5-ac2fac2d306d">Segments of Business &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing with the second quarter of 2021, the Company began reporting under four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. Other, for retrospective periods presented, consists of the Company&#x2019;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment serves McKesson&#x2019;s biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys. RxTS works across healthcare to connect pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions designed to benefit stakeholders and help people get the medicine they need to live healthier lives. RxTS also offers third-party logistics and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 285,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of high-quality products through a network of distribution centers within the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 11 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. In 2022, the Company entered into agreements to sell the E.U. disposal group and U.K. disposal group, and completed the sale of its Austrian business. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other, for retrospective periods presented consists of the Company&#x2019;s previous investment in the Change Healthcare JV, which was split-off from the Company in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the consolidated totals is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment expenditures for long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 40% of the RxTS segment&#x2019;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from the Company&#x2019;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for 2022, 2021, and 2020 includes credits of $23 million, $38 million, and $252 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2022, 2021, and 2020 also includes $46 million, $181 million, and $22 million, respectively, of cash receipts for the Company&#x2019;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in Financial Note 18, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for 2022 and 2021 includes inventory charges of $164 million and $136 million, respectively, on certain PPE and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for 2022, 2021, and 2020 reflects the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $1.1 billion to remeasure assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $383 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes a gain of $59 million related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes a gain of $42 million related to the sale of the Company&#x2019;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. 2021 and 2020 includes charges of $58 million and $275 million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to the joint venture with WBA completed on November 1, 2020. See Financial Note 2, &#x201c;Held for Sale,&#x201d; and Financial Note 6, &#x201c;Other Income, Net,&#x201d; for further details;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2021 includes a goodwill impairment charge of $69 million related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 11, &#x201c;Goodwill and Intangible Assets, Net;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2021 and 2020 includes long-lived asset impairment charges of $115 million and $112 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#x2019;s previous investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2020 also includes the Company&#x2019;s proportionate share of loss from the Change Healthcare JV of $119 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net, for 2022, 2021, and 2020 reflects the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $55 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $42 million primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 and 2021 includes charges of $274 million and $8.1 billion, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 18, &#x201c;Commitments and Contingent Liabilities;" &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 and 2021 includes net gains of $98 million and $133 million, respectively, associated with certain of the Company&#x2019;s equity investments, as discussed in more detail in Financial Note 16, &#x201c;Fair Value Measurements;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2021 includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2020 includes settlement charges of $122 million for the termination of the Company&#x2019;s defined benefit pension plan; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2020 includes a settlement charge of $82 million related to opioid claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for 2022 consists of a charge of $191 million related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 12, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment assets and long-lived assets by geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software and excludes amounts classified as assets held for sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8df6b8d2453344e9a3d64c0a536c0e26_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MDU4NTE_d3638d6e-ede0-4e16-a536-bca7e912e3c8"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="i89602a22aafc4c248462dc75c787e1db_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MDU4NjE_8b09d5c4-0870-4279-865c-a6ec723305be"
      unitRef="product">285000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="i0992fb1791f946ecaadfede91d31d6cf_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzE0ODQzNDA2OTg1Njgz_44a74e12-096e-465b-9571-adc5fdfb8cda"
      unitRef="country">11</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3Xzg1NzU_9aaef035-6614-4bd4-9812-04fd44128e19">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the consolidated totals is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment expenditures for long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 40% of the RxTS segment&#x2019;s total revenues, less than 3% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments. For retrospective periods presented, operating loss for Other reflects equity earnings and charges from the Company&#x2019;s previous equity method investment in the Change Healthcare JV, which was split-off from McKesson in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for 2022, 2021, and 2020 includes credits of $23 million, $38 million, and $252 million, respectively, related to the LIFO method of accounting for inventories. Operating profit for 2022, 2021, and 2020 also includes $46 million, $181 million, and $22 million, respectively, of cash receipts for the Company&#x2019;s share of antitrust legal settlements. In addition, operating profit for 2021 includes a charge of $50 million recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in Financial Note 18, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for 2022 and 2021 includes inventory charges of $164 million and $136 million, respectively, on certain PPE and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating loss for 2022, 2021, and 2020 reflects the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $1.1 billion to remeasure assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $383 million to remeasure assets and liabilities of the E.U. disposal group to fair value less costs to sell and to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes a gain of $59 million related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes a gain of $42 million related to the sale of the Company&#x2019;s 30% interest in its German pharmaceutical wholesale joint venture to WBA. 2021 and 2020 includes charges of $58 million and $275 million, respectively, related to the contribution of a majority of its German pharmaceutical wholesale business to the joint venture with WBA completed on November 1, 2020. See Financial Note 2, &#x201c;Held for Sale,&#x201d; and Financial Note 6, &#x201c;Other Income, Net,&#x201d; for further details;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2021 includes a goodwill impairment charge of $69 million related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 11, &#x201c;Goodwill and Intangible Assets, Net;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2021 and 2020 includes long-lived asset impairment charges of $115 million and $112 million, respectively, primarily related to retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Operating loss for Other for 2020 includes an impairment charge of $1.2 billion and a dilution loss of $246 million associated with the Company&#x2019;s previous investment in the Change Healthcare JV, partially offset by a net gain of $414 million (pre-tax and after-tax) related to the separation of its interest in the Change Healthcare JV completed during the fourth quarter of 2020. Operating loss for 2020 also includes the Company&#x2019;s proportionate share of loss from the Change Healthcare JV of $119 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net, for 2022, 2021, and 2020 reflects the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $55 million primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 includes charges of $42 million primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Held for Sale;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 and 2021 includes charges of $274 million and $8.1 billion, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 18, &#x201c;Commitments and Contingent Liabilities;" &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2022 and 2021 includes net gains of $98 million and $133 million, respectively, associated with certain of the Company&#x2019;s equity investments, as discussed in more detail in Financial Note 16, &#x201c;Fair Value Measurements;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2021 includes a net gain of $131 million recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2020 includes settlement charges of $122 million for the termination of the Company&#x2019;s defined benefit pension plan; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;2020 includes a settlement charge of $82 million related to opioid claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for 2022 consists of a charge of $191 million related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 12, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i13e5a130e4bd4b46ab18a9ee73038fb9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMtMS0xLTEtNjc1MTI_55f704dc-4e4a-42eb-8b2d-c404d526a846"
      unitRef="usd">212149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b9f31a9035f47a793e52b29f6e3c6b7_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMtMy0xLTEtNjc1MTI_2ea81aad-4428-46e6-86f2-0288a7de3d81"
      unitRef="usd">189274000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cf29ddb5c8f42deb929d1d83dbc572f_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMtNS0xLTEtNjc1MTI_3c72bdcc-22dc-4abc-9b32-021026ac5aae"
      unitRef="usd">181700000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75e9915b20bd46ef92252fc1f54b6842_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzQtMS0xLTEtNzcwMDM_2902a25b-5516-4c21-b20f-a7fc47120493"
      unitRef="usd">3864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4014e9c3176b42c78989359017baa154_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzQtMy0xLTEtNzcwMDM_9c630bf3-2834-42d2-b8f0-f16b96642548"
      unitRef="usd">2890000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7babc476db874b4b8550fefdfe333525_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzQtNS0xLTEtNzcwMDM_6acddf2e-7f08-47c2-b695-2f8d89a42c65"
      unitRef="usd">2705000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzUtMS0xLTEtNjc1MTI_d96dd305-ce6c-4d6c-9817-1bc01fda6918"
      unitRef="usd">11608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzUtMy0xLTEtNjc1MTI_d76f528f-c692-4967-8560-37f5fb7a7726"
      unitRef="usd">10099000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b1bc5bf2b154cf2933d838b8ed000b3_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzUtNS0xLTEtNjc1MTI_ea877eb8-8882-4b52-afe2-bc2ad4d45215"
      unitRef="usd">8305000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i704ec323ae714e6e92464eb8cdff4077_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzYtMS0xLTEtNjc1MTI_ede5d4c4-0ae1-403b-b635-be439d599edd"
      unitRef="usd">36345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzYtMy0xLTEtNjc1MTI_7280ff11-a9ac-4d62-9360-5484ba35ccc1"
      unitRef="usd">35965000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzYtNS0xLTEtNjc1MTI_2fca35e5-7319-4ee3-9811-d852ed9d2653"
      unitRef="usd">38341000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzctMS0xLTEtNjc1MTI_a8548943-cb51-4e7c-b5e3-9e760bde460d"
      unitRef="usd">263966000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzctMy0xLTEtNjc1MTI_b02a3cf3-a7d0-4b60-990f-dd62545c45bf"
      unitRef="usd">238228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzctNS0xLTEtNjc1MTI_ec4a5ef7-3ef1-46fc-9570-931526c520a9"
      unitRef="usd">231051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEwLTEtMS0xLTY3NTEy_b0dc7bce-8b1d-4db8-af88-7b3110ea09f9"
      unitRef="usd">2879000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEwLTMtMS0xLTY3NTEy_232122b0-101a-4e33-8f00-26d47e4ced81"
      unitRef="usd">2763000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEwLTUtMS0xLTY3NTEy_d32248a3-6352-4ce8-8fdc-2b9f99b7648b"
      unitRef="usd">2745000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzExLTEtMS0xLTY3NTEy_794e16cb-6e4e-4193-901c-79dcc76e922c"
      unitRef="usd">500000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzExLTMtMS0xLTY3NTEy_7e081f06-f8fc-4830-a32c-eff5b155fed0"
      unitRef="usd">395000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzExLTUtMS0xLTY3NTEy_302e075f-4894-4a01-9a6f-71edcd20ce8b"
      unitRef="usd">396000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEyLTEtMS0xLTY3NTEy_c4cc2e6d-d0ec-4df1-bbb7-0ef97e4fcf2f"
      unitRef="usd">959000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEyLTMtMS0xLTY3NTEy_f8b8c215-7428-44a5-bc98-54256cda8dd5"
      unitRef="usd">707000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzEyLTUtMS0xLTY3NTEy_5ee82a26-1bf8-4e8e-9eaf-72b545e43307"
      unitRef="usd">499000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTEtMS0xLTc3MTE0_ca03b671-94fe-410c-99d4-bd69cf59fc49"
      unitRef="usd">-968000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTMtMS0xLTc3MTE0_2d2bdd19-fa18-4bb6-97ec-24dee4a6fffd"
      unitRef="usd">-37000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTUtMS0xLTc3MTE0_1a06aec2-c892-40b4-b92a-8ae7724c48f1"
      unitRef="usd">-161000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTEtMS0xLTY3NTEy_4a7fcf3a-07d2-4f4a-9290-ce6fb2263cc6"
      unitRef="usd">0</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTMtMS0xLTY3NTEy_93fd2e17-425a-4df4-a4fa-19ce1ad9acea"
      unitRef="usd">0</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE0LTUtMS0xLTY3NTEy_3064874b-11ac-4203-83e4-baa54ee981e7"
      unitRef="usd">-1113000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE1LTEtMS0xLTY3NTEy_45544d98-aa54-4af1-8901-a5a899af5f3b"
      unitRef="usd">3370000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE1LTMtMS0xLTY3NTEy_b207ba13-72e7-4f99-98b1-3da4b88cd302"
      unitRef="usd">3828000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE1LTUtMS0xLTY3NTEy_81578f4b-e249-44b4-8dcb-740767c964bf"
      unitRef="usd">2366000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE2LTEtMS0xLTY3NTEy_587703a1-472a-470c-b2dd-c9237cbed4dc"
      unitRef="usd">1073000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE2LTMtMS0xLTY3NTEy_2a2e20e8-16d5-45c0-afeb-29c79f548e12"
      unitRef="usd">8645000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE2LTUtMS0xLTY3NTEy_6856eec7-b37a-40cc-9d74-ac158fe6fdff"
      unitRef="usd">973000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTEtMS0xLTc3NjAx_f207f8ae-1181-4b92-bff9-a9202db70a42"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTMtMS0xLTc3NjAx_c3c3143f-8ac8-468e-bb91-0cd485186941"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTUtMS0xLTc3NjUz_c5408173-db1d-40c8-834d-74df568b807d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTEtMS0xLTY3NTEy_fa170296-8eea-4ea7-acc4-58d58272c01c"
      unitRef="usd">178000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTMtMS0xLTY3NTEy_64f93251-35b8-4a6a-aa1c-e3b9ada7f75c"
      unitRef="usd">217000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE3LTUtMS0xLTY3NTEy_d7831379-9a8d-4045-b724-f183af59e550"
      unitRef="usd">249000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE4LTEtMS0xLTY3NTEy_5e2c1985-bf9d-4081-b770-aa056795e9a3"
      unitRef="usd">1928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE4LTMtMS0xLTY3NTEy_098d6c73-2b0a-4bc7-9bcd-f43bf66eb0b0"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzE4LTUtMS0xLTY3NTEy_1e401de7-81a5-4635-96ab-43aa599abd85"
      unitRef="usd">1144000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DepreciationAndAmortization
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIxLTEtMS0xLTY3NTEy_c4ae9182-492a-4634-b3dd-2e041ca71479"
      unitRef="usd">228000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIxLTMtMS0xLTY3NTEy_2fbfd6eb-4f50-4321-9a17-989ea284fdea"
      unitRef="usd">211000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIxLTUtMS0xLTY3NTEy_b43a0b92-dea5-444c-ae07-83dc65a66c9b"
      unitRef="usd">208000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIyLTEtMS0xLTY3NTEy_82a8927e-73cc-47c7-b81f-6e544af6a882"
      unitRef="usd">82000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIyLTMtMS0xLTY3NTEy_8e2b9dfc-0d8a-4f7d-8593-4d55cf8bb397"
      unitRef="usd">87000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIyLTUtMS0xLTY3NTEy_32e1308f-11e0-4a35-ba31-0aaf404ef319"
      unitRef="usd">85000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIzLTEtMS0xLTY3NTEy_ce0abdd7-572a-400d-a541-3d86f73dedcd"
      unitRef="usd">129000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIzLTMtMS0xLTY3NTEy_e19b7313-552b-4ac3-8354-a00df1b9d9a0"
      unitRef="usd">130000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzIzLTUtMS0xLTY3NTEy_6a5e033e-909e-48be-86b4-60d9e7938199"
      unitRef="usd">136000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI1LTEtMS0xLTc3MTI2_312f81d7-e6b4-4a15-a961-13b5dbdbf1c1"
      unitRef="usd">204000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI1LTMtMS0xLTc3MTI2_7e6efcc5-0569-4ca9-8661-67cbdf226f10"
      unitRef="usd">334000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI1LTUtMS0xLTc3MTI2_4de36356-1e1a-443a-ba1b-ae3e815b2afd"
      unitRef="usd">357000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI2LTEtMS0xLTY3NTEy_e6c5a151-8dc7-41b4-bb00-90080ee15d35"
      unitRef="usd">117000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI2LTMtMS0xLTY3NTEy_8f998551-8a02-4742-8259-22a128303f28"
      unitRef="usd">125000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI2LTUtMS0xLTY3NTEy_aa143d6d-4cc8-4bf0-acd9-dcaf1b926200"
      unitRef="usd">136000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI3LTEtMS0xLTY3NTEy_fb4d1c02-2d1a-45e1-a338-637fe9bd742b"
      unitRef="usd">760000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI3LTMtMS0xLTY3NTEy_05889926-06e9-41bb-bfd0-874a5dc2b891"
      unitRef="usd">887000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzI3LTUtMS0xLTY3NTEy_878416aa-9560-46f2-a175-271b43121651"
      unitRef="usd">922000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMwLTEtMS0xLTY3NTEy_8eb24bec-c228-42e0-8b3c-1b875a57d0e6"
      unitRef="usd">137000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMwLTMtMS0xLTY3NTEy_c4e3cea3-11a3-4b33-8614-ff4f50af9996"
      unitRef="usd">246000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMwLTUtMS0xLTY3NTEy_4fd8de60-10cc-4c7e-b67a-6efc8a5c57ee"
      unitRef="usd">109000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMxLTEtMS0xLTY3NTEy_f83d0972-944d-4f70-b9f6-a241367eace5"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMxLTMtMS0xLTY3NTEy_f8d89b78-0e70-4427-8921-e34fb6197800"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMxLTUtMS0xLTY3NTEy_6d5549cf-1bbb-414c-980b-61f7a58bd1cc"
      unitRef="usd">23000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMyLTEtMS0xLTY3NTEy_2152e567-0c05-4e7b-b8c3-eedc93fffaaa"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMyLTMtMS0xLTY3NTEy_e722e038-c92a-410a-ad6d-0e55d820fa0c"
      unitRef="usd">57000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzMyLTUtMS0xLTY3NTEy_713d121c-9ef8-42fe-b614-9b517d720104"
      unitRef="usd">36000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM0LTEtMS0xLTc3MTM4_4e0791f0-8ab5-4585-950d-1553cb249408"
      unitRef="usd">177000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM0LTMtMS0xLTc3MTM4_b5500578-f4f3-4e5e-b83e-bd4f72901c5a"
      unitRef="usd">212000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM0LTUtMS0xLTc3MTM4_44bba497-551b-4d06-b019-f37738ced83d"
      unitRef="usd">218000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4e4b053820b245bf88df9072df1a2e57_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM1LTEtMS0xLTY3NTEy_2167299a-b686-463e-94a9-33dbd32a82ad"
      unitRef="usd">137000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9a42c42c2a65463aa226579177d34729_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM1LTMtMS0xLTY3NTEy_31b4c8ef-eec2-4f60-a044-b8856038ea56"
      unitRef="usd">104000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i1fb9508d1f9b428790964f80ade8968d_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM1LTUtMS0xLTY3NTEy_2f8ba046-f7ad-41e3-a8e3-abd5788dd077"
      unitRef="usd">120000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM2LTEtMS0xLTY3NTEy_a1d5e92a-556f-4283-b58d-f75a4d7a3539"
      unitRef="usd">535000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM2LTMtMS0xLTY3NTEy_88b9f849-a7df-47a3-b166-fa6298c99e8a"
      unitRef="usd">641000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTo2MjI3ZWY5ZTE2Mjg0ZGE0YmUzZDU4NGZiNmVmYTc1MC90YWJsZXJhbmdlOjYyMjdlZjllMTYyODRkYTRiZTNkNTg0ZmI2ZWZhNzUwXzM2LTUtMS0xLTY3NTEy_137ed72e-7109-4ab7-b35d-98acc45eedce"
      unitRef="usd">506000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjcz_008e060d-cc49-473a-9d78-9492e94993d9"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjcz_5c6aa76d-901d-4bab-a3d1-3e8b71899c8f"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjcz_a2363fac-3688-4035-a812-ca7813a72a92"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i271b7492525f41e3932ace993871f8cd_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg5MzE_3e7e1e74-02e2-4921-9ddf-eba1dd574f11"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i4db6528cd08241969dc5cba193ad1860_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg5MzE_b2ee6956-b12d-4956-965e-ad5ac06d6e08"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i94dfc708a2e94c5c83735f97c10c4476_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg5MzE_fbb63a76-49de-4386-9955-0bc5c0f99cf0"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i7e09597e4f554ce69f412a65c08f384c_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjc5_8bde6192-de99-41d3-ab05-db3c46acb4bb"
      unitRef="number">0.03</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i027ff0390e744c24bcdac1db60f408b0_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjc5_ecf77e11-9b9b-451b-9b0a-9a893dc8b231"
      unitRef="number">0.03</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="iceebb1bf4e6247a3a743c89657717634_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNjc5_efc22f4b-2cb4-4f7e-89e2-380b78c126df"
      unitRef="number">0.03</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="if28008f04c494b7db3a30fbf432da178_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg4MTQ_23025151-f3a2-4f48-a150-1dc12cbebe7e"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i8ac39d13c45c4df1acbcb49bcaf431df_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg4MTQ_8fbf24df-08b0-48c0-be7e-3a089d026ab5"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ie55ae020243144e5b558ffcd246d2623_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3Mzg4MTQ_ae9195d9-f33b-4c7e-b169-72844f79bf61"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNzM0_ace2a6ea-d9e3-4178-8655-0ebb6879a0b6"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNzM3_7eae2c9c-fd13-451c-8328-e0e1249f8883"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwNzQy_82d5aa80-8cf4-4310-812b-53f3837897c9"
      unitRef="usd">-252000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i226b90d3700f491cb9e08e85bfda902c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODU1_ed3dc338-ef1e-410d-981d-309452441a1c"
      unitRef="usd">-46000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i5f47a380f97a4c9584ce1feb502d79dd_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODU5_158cf316-b262-48e4-bd22-42a1adf9743c"
      unitRef="usd">-181000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i82990072cf164f71b8ee1aeb62be5dda_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODYy_a2e6672b-892a-498a-90ff-6b746c82b487"
      unitRef="usd">-22000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i00d8536befaa4a43b1db0edc398132f8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYwODg0_c3edffc0-6f4a-4ab7-ad19-fcb0e9d852fc"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:InventoryWriteDown
      contextRef="i88194fa64ed54b2cb4fe8b717846e00f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYyMjE4_fdf772d5-1447-497b-8ec6-9185a43aa4c9"
      unitRef="usd">164000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i4ca5df6f0cd14586a0ef6423d4d3c6a8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzYxOTUw_61445b5d-0417-43ae-ab0b-53fbcce9020d"
      unitRef="usd">136000000</us-gaap:InventoryWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i7c2308bff3d84467bbd32719c1b729f3_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTkzNTk_fdb99bde-46ea-4124-b476-590c9252143a"
      unitRef="usd">1100000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i4306427a0c8f4e4f9a6abfe8b834d477_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTk0NTg_77528d7a-5b92-4d89-9263-af646bfb56c7"
      unitRef="usd">383000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="iecf1fc43ee8743cc841ae8e190b19f5e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTk2MTI_e09f610f-b42d-4f7c-bd41-eb4beacd4604"
      unitRef="usd">59000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i1d32ea0d7121424d8050da60bae6313b_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzE2OTg_8678cf79-4853-4afb-b816-80eadd97b25c"
      unitRef="usd">42000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i02266411b5ae476685c7f46474a2bc26_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzI3NDg3NzkxMTIwOTM_d22e982c-793e-4b27-9952-d797305b02af"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i0a61358af12d408d98a32edf22828df2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzE5MjU_4879623f-46f9-4853-be6e-fd54000738b3"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i57862e2d41134adab208bb4e37e2f526_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzE5MzM_1d67dd58-cbd6-452a-83e3-f20065465454"
      unitRef="usd">275000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzA0OTY_dd1eb6c5-0e83-44f2-a0cb-fa942dc9ac2b"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4ce15140a3744627920ddf20b02d2263_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTY2MTA_80f6b648-7c79-4414-9ec9-ba519f805bbe"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1e994e2cc9744e8091ca5aaef8c7da9b_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTY2MjA_3ba510f9-8320-4e0c-886a-0d067117a813"
      unitRef="usd">112000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzY0NzE1_aecf1aa8-18e3-4fd5-a557-e8022544ddc4"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzY0NzE4_daa24bc4-2dc0-44f8-9367-1eb6306c1c7a"
      unitRef="usd">-246000000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzEzNzQzODk1MzY0NzIx_cd2b1708-6cf6-4e54-a23a-c9bae18c0661"
      unitRef="usd">-414000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie15c7249f2c3477a9b25ff1c01ec56fa_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTQ3Njc_1111c7a1-7550-4c13-bd62-d5002d6cce46"
      unitRef="usd">-119000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i421693f2ac6f4634892f8037573c7473_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjE4MTY_c53a6b51-75b4-47c8-a4ff-59efa2fb3d77"
      unitRef="usd">55000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i98dde87c16b848c5b435a117b3bcaa0b_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MzkyNTE_5c038f8c-061b-45cc-b0a9-8aebdd4c030f"
      unitRef="usd">42000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i5b468eb783fc4fd093126467c4635fce_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjI1MjA_8d5619c5-95e2-44af-b955-09ad8dd9b171"
      unitRef="usd">274000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i0c00b4a3fb9f4828917390d908cb259f_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA2NjI_1ec87fd0-9c46-4466-9482-6ed23f888795"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjMwMjk_9df5db6e-cbc3-48bf-816a-ebb12e7f48b2"
      unitRef="usd">-98000000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjI3MDQ_6fa5129c-73bd-455b-8b57-bdc27a693428"
      unitRef="usd">-133000000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ia363f8f9a4de48ca805cfea21f6c1846_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA2OTI_d8407286-abf8-4f32-a5f1-cf0501ecb1ac"
      unitRef="usd">131000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i3f934bf79b96435d865e92864a81db4a_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA3MDU_d1878cb1-4d4e-460a-ad40-fea23998d826"
      unitRef="usd">-122000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i38c0b8cc6cdd4e5a87c08c8347fa83db_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MjA3MTU_87491a5e-b6c1-4e88-8916-96115b1fa895"
      unitRef="usd">-82000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibb4a025d54cc4e119f9bdcce62a65384_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3XzM4NDgyOTA3MTU1OTA_7d4548d7-46a9-43e2-853f-7c91f8322a8a"
      unitRef="usd">191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90ZXh0cmVnaW9uOmI1ODAyZTUyYjAxNjRmMDdhM2YyZWQwOWU3N2ZhYmY3Xzg2MTI_1f38c724-963a-4de0-bccf-0e6ef7a3c726">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment assets and long-lived assets by geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software and excludes amounts classified as assets held for sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i75859372620f4bba9fcc690a92937930_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzMtMS0xLTEtNjc1MTI_6faf67f1-0b6f-4610-b259-d0758506958a"
      unitRef="usd">38346000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iaf37a2aea301469bbf8c95c1cb87dea0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzMtMy0xLTEtNjc1MTI_f608d480-8655-4ac9-8c6d-6c5c8cf9fd57"
      unitRef="usd">35236000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3fe8302f1495433a8b56aac54216c93a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzQtMS0xLTEtNjc1MTI_75bfbc24-2bdd-4738-89c7-aeca28b592e1"
      unitRef="usd">3528000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i38e69dbb765c4cbba679db0d75d4e24d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzQtMy0xLTEtNjc1MTI_e1552d8e-2753-41e9-a7b3-628dfbc8e3c7"
      unitRef="usd">3446000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i60fde2da64904433badd4e9125f5242e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzUtMS0xLTEtNjc1MTI_71c4ec97-5006-45da-942d-4eaf6e906ce6"
      unitRef="usd">5830000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3836c14e169d426385529b1516d34376_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzUtMy0xLTEtNjc1MTI_f652f491-358f-4825-a004-8b424ff8dd3f"
      unitRef="usd">5986000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i085f9b77e2ff45639871e3f6c4e87e81_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzctMS0xLTEtNzczODk_77af9bf0-9a12-431d-8aaa-450c0763bf45"
      unitRef="usd">13717000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifbae9d0f6df24779a201d5522b29b806_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzctMy0xLTEtNzczODk_a6a9bc71-797e-4587-890d-62626ee22a48"
      unitRef="usd">14987000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i136fbfde3b204ba88d3ef047c523f6d0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzgtMS0xLTEtNjc1MTI_a511b0dc-1f58-4d2d-806d-973d781cfb56"
      unitRef="usd">1877000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie5920306c6c74407aa3c61813edac174_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzgtMy0xLTEtNjc1MTI_8d0c2e00-7491-4be6-a6a3-5074cc3f300f"
      unitRef="usd">5360000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzktMS0xLTEtNjc1MTI_1d3a880f-07c8-4ac8-a579-77203d2b3a80"
      unitRef="usd">63298000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzktMy0xLTEtNjc1MTI_beede57f-0d20-460c-909a-ae3780e0e728"
      unitRef="usd">65015000000</us-gaap:Assets>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="if4f92dd395054c9e87369fe7c7e30c52_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEyLTEtMS0xLTY3NTEy_8de8533e-3611-4319-934f-51c28c19a596"
      unitRef="usd">2060000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i3667722556cc48a986ac133abdb684ef_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEyLTMtMS0xLTY3NTEy_19ef4068-0be1-4817-894e-55c34a322a2b"
      unitRef="usd">2110000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i2ded543679294c96804c2f7f25ea7ef1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEzLTEtMS0xLTY3NTEy_f73dadbe-5f54-4a63-ba40-f114cbfd4bd6"
      unitRef="usd">352000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i40175ec1fccc491fb2cbcd0cf1e19dc5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzEzLTMtMS0xLTY3NTEy_d278e17c-87a6-4695-92f6-886e1950c823"
      unitRef="usd">984000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzE0LTEtMS0xLTY3NTEy_2531be3e-8478-45aa-a1cd-2e59afa2c859"
      unitRef="usd">2412000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8xNzIvZnJhZzpiNTgwMmU1MmIwMTY0ZjA3YTNmMmVkMDllNzdmYWJmNy90YWJsZTozOTAxOGMzOGRhYTU0YWZmYTE5OWE1Y2QyMWNkMDY2ZS90YWJsZXJhbmdlOjM5MDE4YzM4ZGFhNTRhZmZhMTk5YTVjZDIxY2QwNjZlXzE0LTMtMS0xLTY3NTEy_0d6e5393-2217-446d-882b-2c6721073c14"
      unitRef="usd">3094000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <dei:AuditorFirmId
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMDgvZnJhZzplYjRjODE2NDM2M2E0YWViYjIwMzk5YjQ0ODU5YzNmOC90YWJsZTozZjA1OGFlMmU1NGM0N2VlYmEwYTNiYTg2MGM3NTliMS90YWJsZXJhbmdlOjNmMDU4YWUyZTU0YzQ3ZWViYTBhM2JhODYwYzc1OWIxXzMtMC0xLTEtNzc3MDMvdGV4dHJlZ2lvbjozMzc1YTZjM2U0NmM0YzQ4YWM4YjhiNjBmNTc4NzZmZl80Mzk4MDQ2NTExMjQ5_2b05b3dd-8681-498b-b987-13a086c637eb">34</dei:AuditorFirmId>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90ZXh0cmVnaW9uOjk1Y2NlNWRjMmFhZTQ3ZjZhZjljN2ZlYTFiM2QyOWQ4XzEyNQ_6f3f5f6d-99c6-409b-87cb-c48826487ccb">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Charged to Other Accounts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions From Allowance Accounts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at End of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credited to other accounts and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts shown as deductions from current and non-current receivables (current allowances were $144 million, $250 million, and $265 million at March 31, 2022, 2021, and 2020, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Primarily represents reclassifications to other balance sheet accounts.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i41829b0d50c84e67810fffe88435a9df_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtMS0xLTEtNjc1MTI_3e499164-46f7-4830-a655-f2f90c31467b"
      unitRef="usd">211000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtMy0xLTEtNjc1MTI_e22fa54f-c63a-47d0-92ba-d6d617d2c7a5"
      unitRef="usd">29000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtNS0xLTEtNjc1MTI_d03b715d-1219-4f6e-bd4a-62f031a5564b"
      unitRef="usd">-35000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i1cdbccd74e0d4b33afa806a15bba442f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtNy0xLTEtNjc1MTI_bdd4b8d7-d776-4daf-b6a9-1b2dd5157c52"
      unitRef="usd">106000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0016a42d06144f0083c43e8c3861007f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzMtOS0xLTEtNjc1MTI_0a4beadf-6a63-4532-885a-d9ecc48b81cb"
      unitRef="usd">99000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ief597acca9b943b499ca2cd3b523d72a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtMS0xLTEtNjc1MTI_f42fad9a-ac82-4a63-a02d-c67a202cd72e"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtMy0xLTEtNjc1MTI_5bddf70c-9f35-46e7-9f7b-5fbb777d4f23"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtNS0xLTEtNjc1MTI_f8d607f3-b382-4c12-b25a-41e17d1bc623"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i2d4a7bb8bb0542afb4b4719810ef631d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtNy0xLTEtNjc1MTI_2f014b91-8988-4a5f-8a97-a72a1243d3f8"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i985cb718c86e4ef0866b20d0c5f9ba59_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzQtOS0xLTEtNjc1MTI_289764f7-31a0-4f27-af4a-3ce5de25149b"
      unitRef="usd">52000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtMS0xLTEtNjc1MTI_a3ef97ad-5128-4764-b8fd-f1e7787e057b"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtMy0xLTEtNjc1MTI_4783f717-8660-41a2-989a-e105e2c48895"
      unitRef="usd">29000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtNS0xLTEtNjc1MTI_7afef175-d188-4e98-9a60-f7b785f316a1"
      unitRef="usd">-31000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtNy0xLTEtNjc1MTI_de3af397-dabf-4d3b-8b5c-93d8e4de5d5b"
      unitRef="usd">108000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzUtOS0xLTEtNjc1MTI_fd2cf002-99c4-40c8-8704-c028b71797bd"
      unitRef="usd">151000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i25f4961dbfe344bc8e2f41bae9d5131f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtMS0xLTEtNjc1MTI_a6cc8fa7-ed1e-44a8-b0e8-4f386394e94b"
      unitRef="usd">252000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtMy0xLTEtNjc1MTI_226e366d-3ab7-4df5-b15c-a3c5f956a77e"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtNS0xLTEtNjc1MTI_80c2c8ef-fe31-46f6-9d21-61e1f7e34454"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i2ead5bc7a68b45b48c614fd3f8c10faf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtNy0xLTEtNjc1MTI_23017ec3-a163-407c-925d-35ff8d4aeb66"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i41829b0d50c84e67810fffe88435a9df_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzgtOS0xLTEtNjc1MTI_9bd0b8d4-6f50-40d0-93f6-d77dccca867f"
      unitRef="usd">211000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iedade147b8b646c8b00bbb5188244496_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktMS0xLTEtNjc1MTI_f90acfb6-0977-483f-9aa2-eddd7d0d33e6"
      unitRef="usd">30000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktMy0xLTEtNjc1MTI_64abbdc6-3c57-4acf-b4fa-02898ed2726d"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktNS0xLTEtNjc1MTI_e7525962-a89d-48da-b33b-1b45bb417cfc"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id472c2e9cd204c37ace5c63a7c778ed8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktNy0xLTEtNjc1MTI_efcd961a-e166-46a1-a2a6-289bdfa2bb14"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ief597acca9b943b499ca2cd3b523d72a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzktOS0xLTEtNjc1MTI_06f4eeca-a7a8-436b-98a6-1e22310db2fa"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTEtMS0xLTY3NTEy_05a01ed1-472c-4ed1-bd70-6ba11df9d913"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTMtMS0xLTY3NTEy_3c949359-bb3f-4aeb-adb7-8ee8c9d251ea"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTUtMS0xLTY3NTEy_81cf8883-410a-4cad-9c93-40245f8852fe"
      unitRef="usd">10000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTctMS0xLTY3NTEy_0946f946-a40a-4f58-a458-fefb5f32d48f"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEwLTktMS0xLTY3NTEy_a532a203-6bf0-4938-95b7-95d7f5c9ed0f"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i93c1bd212c45448698e1854f6e5f1080_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTEtMS0xLTY3NTEy_cacd3f94-5d7d-4822-a53a-6c5ab3992617"
      unitRef="usd">273000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTMtMS0xLTY3NTEy_a771e7cd-b289-467e-bb2f-d90f0a723246"
      unitRef="usd">91000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTUtMS0xLTY3NTEy_ec9b9069-6b73-459e-b091-236e599b5550"
      unitRef="usd">-19000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i470255b4348841ee951e959a0c5f01fb_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTctMS0xLTY3NTEy_aa97d290-da35-46a4-bd79-b0fbeaaec4a5"
      unitRef="usd">93000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i25f4961dbfe344bc8e2f41bae9d5131f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzEzLTktMS0xLTY3NTEy_59c26897-b87b-4cb5-9479-fc87e45bc217"
      unitRef="usd">252000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i48eb2bbbe76d4424947b05d6ff6b3111_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTEtMS0xLTY3NTEy_8f576990-a3c0-4f5d-9d08-59a83ecc4c10"
      unitRef="usd">24000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTMtMS0xLTY3NTEy_a216dd29-8644-4de6-b8c9-874a18c17826"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTUtMS0xLTY3NTEy_36b972eb-7e70-492f-8854-4cde01929da3"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i45a0818d093b4eeab00a9e2bec0f4f7c_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTctMS0xLTY3NTEy_ceba1da2-f7e2-4003-8b68-b93ae0a229dd"
      unitRef="usd">-6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iedade147b8b646c8b00bbb5188244496_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE0LTktMS0xLTY3NTEy_fa736562-8f28-45e4-89e1-c0b6dddf11a5"
      unitRef="usd">30000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3028b894dc5241e6bdae80eea3de8d1f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTEtMS0xLTY3NTEy_7cdf0124-2729-4f0d-8db5-e01c6735d9c2"
      unitRef="usd">297000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTMtMS0xLTY3NTEy_d6026841-5686-401b-8572-2a03264d9542"
      unitRef="usd">91000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTUtMS0xLTY3NTEy_a6738bea-9d90-4071-a400-29db1ecf6e97"
      unitRef="usd">-19000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTctMS0xLTY3NTEy_8979d8c1-4cd7-40a7-aba8-8566bf998c36"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo5YjFmYjI3ZmUyMDY0MDkwYjk0Nzk3MTk1YjA3MGY3My90YWJsZXJhbmdlOjliMWZiMjdmZTIwNjQwOTBiOTQ3OTcxOTViMDcwZjczXzE1LTktMS0xLTY3NTEy_2339a8cd-3182-4edc-ac8c-d078c3ee842b"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="if99beb6352cf47479de57c9883cab9b5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzItMy0xLTEtNjc1MTI_7557efa5-cc57-4c64-a45c-309bdf1e2289"
      unitRef="usd">106000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i73f4dc77fae347c3949ca450f0bd6c27_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzItNS0xLTEtNjc1MTI_0c1c081f-b657-4cb9-9a6a-28c2d1f479ed"
      unitRef="usd">40000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib560e861e6d44cc1bc5d64c84ed65be5_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzItNy0xLTEtNjc1MTI_f0b9566f-64b0-4764-8809-5414a417aee3"
      unitRef="usd">93000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i14b84c6208fd487782c55ab942c054c2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzMtMy0xLTEtNjc1MTI_487b8dad-3732-45fc-82a8-008462b292d6"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i13224b1cb34e43ea9f7419286f4e4d8a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzMtNS0xLTEtNjc1MTI_47d9be82-29e2-4089-9293-e73f4d2fc181"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib32eb06e34414e3699858d846e951a74_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzMtNy0xLTEtNjc1MTI_932c126d-d7a3-4dc1-9779-1bb9cedafde1"
      unitRef="usd">-6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzQtMy0xLTEtNjc1MTI_cef0f73f-5682-4298-85cd-28465676894f"
      unitRef="usd">108000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i0cf849e6c9764e35b2e9db82b3d61daf_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzQtNS0xLTEtNjc1MTI_1751cbed-4e67-4660-9ffd-4ae941852294"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzQtNy0xLTEtNjc1MTI_c7cf9c82-cd2e-4658-9fcb-e4837a3ea844"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMS0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozZjM2YjZiMmFlOTI0NjZlYjFmOWVmOTBiOTMxZWRkOF82NTk3MDY5NzY2ODM4_69d5c84c-ac29-4849-92a2-f82881b6704b"
      unitRef="usd">144000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMS0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozZjM2YjZiMmFlOTI0NjZlYjFmOWVmOTBiOTMxZWRkOF82NTk3MDY5NzY2ODE4_0a13f7e9-6968-434d-8865-34486149d40d"
      unitRef="usd">250000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMS0xLTEtNjc1MTIvdGV4dHJlZ2lvbjozZjM2YjZiMmFlOTI0NjZlYjFmOWVmOTBiOTMxZWRkOF82NTk3MDY5NzY2ODI0_6d59b824-5d58-460b-bd08-86fa98f2508a"
      unitRef="usd">265000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6ddb54fd3967467a87bab9dd990e6cad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtMy0xLTEtNjc1MTI_e139b154-4001-4a37-a982-f6c41aaddece"
      unitRef="usd">151000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied4fb100eb7e4d488f31db285fa7c8ca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtNS0xLTEtNjc1MTI_ce0027d3-0f99-4108-bfef-85d30f85d609"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i201940e73632457882da553cf6462766_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiNGUzYjIzZWQ5MDQ0OThiZjMzOTZmZjA1OTNjYjA1L3NlYzo0YjRlM2IyM2VkOTA0NDk4YmYzMzk2ZmYwNTkzY2IwNV8yMTEvZnJhZzo5NWNjZTVkYzJhYWU0N2Y2YWY5YzdmZWExYjNkMjlkOC90YWJsZTo2YTUwZDIzODMwYjM0ZWEyOWI2OTFlNDMwMzFjNDA0OS90YWJsZXJhbmdlOjZhNTBkMjM4MzBiMzRlYTI5YjY5MWU0MzAzMWM0MDQ5XzYtNy0xLTEtNjc1MTI_1ec0c7cf-332f-4a6f-99fc-38f2b3973ca2"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>139
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .I!J50'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #J0:E4^\D33.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.NDV$%'7"V@GD)"8!.(6)=X6K6FCQ*C=VY.&K1."!^ 8^\_G
MSY)K[:7N [Z$WF,@B_%F=&T7I?9K=B#R$B#J SH5RY3H4G/7!Z<H/<,>O-)'
MM4>H.+\%AZ2,(@43L/ SD36UT5('5-2',][H&>\_0YMA1@.VZ+"C"*(4P)II
MHC^-;0U7P 0C#"Y^%]#,Q%S]$YL[P,[),=HY-0Q#.2QR+NT@X/WYZ36O6]@N
MDNHTIE_12CIY7+/+Y+?%P^-VPYJ*5U7!5P6_WXI*BJ5<W7U,KC_\KL*N-W9G
M_['Q1;"IX===-%]02P,$%     @ ZD&I5)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #J0:E4(>0\"RD'  #1(0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+5:VW+;-A!];K\"HZ:==B:22)"4[=3VC"S+C2:QK)&<IFZG#S )61R3A J
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MZN(])XJYM5@HOC63W)(KG O-:X*S/@@-P.]KSM7K0CLH_WL8_0]02P,$%
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M%11#,TVA@Q*A#>!\QKG:++2#JB?W_P%02P,$%     @ ZD&I5,.$,+LU"@
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M!;4#D@-P$#L %J-G%9K&:^7#I<NK:L/+K,U*S:%J0W4N'L D1/VREPW=) 2
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M91R"D7YP>UD59W$5OU@L1-944N(E:Q\%*EX+E&U/D'7L_4:)!<X#H.+NHU(
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MC-LWM5PWMVX?9%W+5?-R*;@N$0Q ?[^0LGY[8WY@=]/[_+]02P,$%     @
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M:^EN2>]UKV[*55TNRT5>=]G58M'T=5?6J^Q#4Y6+TMB73SJ:!(\^6>B KV7
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M[E85_?*BXC1[P_*NL0,HD_%8'#$\0T+'X*U=EUO(14("R0(BX&QZ=O:7";\
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M9#XO6?/2YIK/1#XE,75*L,NJ-Y!]O&F-T#;A&X@.DF:KYM2$I:?*.@@N(@"
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M=E #J#_[9Z5T9=&-Y$+/-P!^%0D%<!.MP=-;S8&%*ES"*Y<$3D> ':PO NB
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MF/ ^^VV)OFUZ)$&C4U9:M* Y&N!:,+"V\ JL0%)CXCE/G!N49IE6"_!X"8(
MB@7CF47TH*7D:D3ZJC0KC3,%%VB08L*,F4X"E#N9']")9([BBKXMJ'<A'9:_
M]F<#VADMM<&\>:;G9Z YJ>ET0G/.,DDPL1:"4<U;X*@;BHYA"<#=.BKS)(%T
M;TA^*B#V)=*M$_V8H^_<PFTO^#VW4)A D.<*D0.*)F!^)@H18A'C<T3T_5*"
M93(/M*B\<@_>@$$P7)4$YAFQLS2&UL[H<K$D-\$X2.1.,20B^C.L!]D%_C]
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M.3YRI]#"ET*OZ,0TD*O0.7W$9D<8O %^GVM=A"\X076$_M7_ %!+ P04
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M<V#)X()E-! JI(VZVH2715)S):]NW:@']W>U^+Z!M@'<7>S)NC8-/%4RJ#3
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MP!%B!8M$D*;9G";B0S5 TY*4D/>2^4K*&13MC%#;SP_Q&3B_Y$&)*K\7@+N
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M+IW.Q*_L6C2PZFC[H*2FI(#+69)>\4> DEA9XT'CW\,"FTXNDJNTL5&HL5>
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M3P2ZALA]"7.4]&??%(N/@N!ZM+#1I5.&D=[6"A_UJQ=\H4UPEV6/I]'RH$V
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M#<#OJP+<PW^A#9IWX5_^!U!+ P04    " #J0:E4^>,FJY@)  #I'0  &0
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M/M;<N,D\DB;,C9MQ:$K!OCD%SDXB=WK1-3C I#B/VK.W5?<G9R2=]OSQ:;-
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M%?;MYE6!3O=)PH5!@YPX;#'Y?$X!C^"BJHQ>"^SF'%VKA/26I]A9I6QRL_K
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MEF5%%IR3AERLPL[!F+ZCR2$&TX;P1,UY]8B^PA9'_"*8CAB0(WO1)F-7*,&
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M"U^&^J?]=[7K\#GI,#Q\E$/R;74-UJ@VF(I6.CO#3I8_=(4;;QK^N 12C+;
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M*=.;/B?PM;9A;&R1*?&ORXW-,QC'OY\A/JN(SYCX[,]"\P^0$Q],NCO/59;
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MIU%2)X*9*KEW8:8R<B9(*\O:\QE[9Y-2M3,-!1SP/ZA/RH)5/83JX,IZ(@N
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M-X>5?Q[VL@^_2/\)"8GHXLT)"Z\(9;'-3O"9A!GN,!LEGV."\XB,(SZHO'5
MR>:/)R4_^[.[TOSHQHI0-W(OYS,7T,B7U_'K>/6_S3?>@WC^W0"YWQAPAJ4U
MMI[-+E]-\M%@>$F^D_OORB?@*H\-:= 3"V!][0%@>6$#XP\B-_\#4$L#!!0
M   ( .I!J51IA>?N71H  /Y9   9    >&PO=V]R:W-H965T<R]S:&5E=#(S
M+GAM;.T\:W/;1I)_9<JG7$E5%$6 3SE.JF3'WO5F;:NL)%M75_=A2 S)B4&
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M1 Q'PF_-F:8GKN.8<;YD=\@O5S'W2H6 B8:Z&O%URX@##5LXZ%U8-PQY?*D
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M2_,%7VM5+E?T6.G$2X--#$!"LF+<L$0K8X["TN:6%S#WEDCPP2W7*>PU)^/
M,RAZ<S,T>(C:X4FB=,KS1$!PV54LZ[??/)N,SYX;5JA,)IM!0RH.#J#R;(,2
MDV+8RFN_*#6J$*>W+%7P;*XL;2P>CR- OA1'P$M3B*3,G!?6$[SKUS=HCEU'
M>H7MIJ!]PU"[E741];(40$/ _MGGX=40!,HRKIU[XUX794X0B-[A5D&W 1/@
M/)5R33DW,I5<2S2GS).L),'?EEH-V&L-OF96H*82)C6@9W#,I5/[&Y[#'GE>
MK3MD;V@#!@6ZWYT,NFN6LA4'G7# -9A8@I@\O1'HQ1(VGE@P0J?-%C('H^+S
M8'5 870S;LEL6A1*6Y&V=3)L*!1B@6=&Q0&QP_W))EJ %7W\[*%!<LNDB@W%
M<P->DBL <^XES%5^U&FDIK@KC!"A+=^I5R=GH=52\[57"WKG[D@BBW:%(8GB
MIMAS!!EB*7*A>58%$:A,+18&R 8:M% 6<!@-"-I2:XA9"\(C-C.Q6 B<?*'5
MNDN#N*B".313\TPN'2 ]3*^PF: A+2"R! 05AC,%,PH&A@;%(ISEA'V[=3YD
M_X0U>]+-I3 PG(0#2R*20P  A$*V _BKTAUM#5Z,FZ"ZXBD#SY_.3IZ/AV,V
MEUE&K"://CZK/AY@1!2"&$\&J :QCG%\%.L'-BE08[%,J+ :P5@.=I(Y0)DE
MFZQ(XDIW[AT9N;0RD[\Y\]+'#*./+ (K=X5N<V93&8M"-8XCQI?@[<:YB_,)
MG+(_)U58 ;Z9FXP^PP%;IIOS#!."09'Q^0@D"),!&#*OH@ J+5UU*8?LL48R
M[80%+1)(:_%K">Y$FW5V36J,3+C6&T2*&YZ5HE*96YQ;JR6X)9]GHI+5[QU&
M&H@@#Z0.]3#1.=_?VG&L$9[^MXQ4CV:9C)Y?)$FY+AVVN=C"F--BA1P<W $X
MD:%'Q\]QE+-K;B!SIC3FJHI>,ON55<F7E<K GXRW.WL+6K ;]N12+&0B[5-V
M"ZL(G&E3X<*]<I,SD(Y1%F'J'?>DB):?@>\Z%8H[1)ZMQ78'2+?1-5HC6'QP
MCW&_VIZ"ZQRF@2U\R-F5*$#3<[#0=(2H,3YO@D4JCB*Y,4E]^\UX-GU^<CJ"
M(L(A1W=*[]  @&2-)0Z0>]1 G"^0)$J3&),K64#>XA[_YZ*.C0[ZXTP, >@M
M?,]Z03W(ZD!%'SI\UB>66W0S/_6"'9Y-@QI@'*+NH%H/OQZ/G[6^'SNJ4\\P
M/6\],4*JV0SZ/I_< V196FK4(4[LV8US@TB"DR#![4I" J$]=KE,%.).14XI
M UQZKWC&]3X4D,<][;^FJ+VEA!$[/NU:[A.)U3:)(L/3&X&$56#YV)<.A^PR
MXM:/SJ6=C&6?8*<2@H,G6Z 42YP%X\0Q#+Z&8")U'9Z.ZE#;9LB?8:=NYQ!W
MZY F.X2*BYQX#WRI124->#\PLH)KJ@>MJO/C0MZ)J# J^": OLI%@P?>]RS/
M?3ZHGH>,B)@@%[(: O#F*XYH^0*<.)$%$;SM!1O?MI< $.59XK/1?(,-((%?
M$&K2YM.CLE!Y6_F!G]0<]/'TI,4KV_;\:UC*=9-%4*7'I6ZPB%9%VI]]3$@_
M?94:VC:5"V\%*$"%O17"#_*= ZH,&F7X=B+[VY"-75[3)B-[(-)?PC?^3+0?
M1,G6)=7K;EA$Y .&ON:V)&5 W77C&!$,.Z&V#XYO8B9BK:PYT1^< ASE.I].
M=E"NJ+X.$E)6YT@#A&O3;6D=-] S7^A2N>JV*F 4@H&;#QDC-5>D#B&T5"HE
MG5(][]L,F0)*F,&RJ V(F&#PS\-_#$,/"HO"CUHE@,F>L-G67@(:.263YF#.
MPV<UB<%E8Z;#&:QG,T= ,!;;K"?PKNN5-.X)5-D?PH!,FP)]WT53NR+AJYTL
MWL<N9AMQUZ9"@<JVB6I,BII=@B;#/9MU:?KA4/# V(]"?X]"1U"NH9P#K(#E
M)3T+XN^A]BA9QG'MHKK-*NJ WEU#_6[T+GT$O>O!!B)ZF0(WKCJ3[8&-%O*<
MJC;*=R#/T1J/>=A/[U]_^,2*K#08I'06N _ILGOP%5:BYC)*8/NJVY>I#CMH
MCQB+T4IST/9JS?67+6H2G7<TV<[7L*N!K\.V6T5;GC8(O7E'1$CLG;JAL555
MWI^O'315@&1$AZ-W8J1#$JZ76.9[@@3$&U=N$Z!X6-0-=\N1?$Z!G9GZG9CK
MDNL-1OETR-Z1H'+MZ(E$5&X$ C7HT6[&17EG9 <G>U2S'?M^73%*K)#3B/]7
M80^KPGH/!ER$.+_QW7=4;.]! -?2A.!NU%)1L[.C9*&CI3D6*LV83#@ "2#A
M;6AK/[I[$*6/3E)(>8 70,ON)!YU09@=CH?31B__<#*<]77Q^^!E>RLQ&,?1
M5]5L/Y;9IM[BCSROXO'$!<$##GEZNN-MF091;4P'H*X"IU2]%^X9/*V+ 6B?
M M*3RB0#\AJB1#5H(2Y@.+@<D#NI:&:GYPAQH_AGW/MCC;?Q:6>0'64%80P>
M(WE*WJC9B#%5&+[,*5/*JA"US6[O!81HQB9G@XZ2ID& *K-!].AF@J]/Q'?:
MB;P85#F7N4LV6R[<Z&U%!U"S^N-!,^W?0/1R\&JLQ['/47IO[,G+,&V1\1S7
MGRL\V#>FI#Y(+[/J[#U\/<$"U.T%XHK(-K3@5/O[D2L/X;ODN'\Q//*+5C'R
MSJ^!7T"%#$/F//_"/E!3)V6?4&=/?)WT]O,GE,171T_#MK=M'=>O'4HA6A%5
MWI0N".J]52L;@G.?0AEO72C%];QO T3U( 6WG\<OP]TEC/H.09XZ[)L+=%ZP
M[6].#\!9P2'PMM81WJY!!4DZO A*%'<%@ @(=N-];0$1>X25"\ODHD-@)U^?
M:K944,&.P!L=[%< 7^NJE@#)%>FB/6[5T7[:& VW9-_21UR ==9?0_8)LSOZ
MW;MPLP*WQ\90FWFWN!1SU^WSCS2N(@VJ6AK7 I4CXKE[@R#[D%V&,XW)GP)B
MO!?&VBCV:+CBW8#U=\&KGGY(VRX/ZFG4G8C)^-[3NI/)KL.Z\_9QWFA;X 9+
M(.EW$0POK*<8[?[VE<C<%:E4&M>")3_S]V&<A#R%P,:OW4F@#]T'M+WKCI33
M62/@@ZXZ6JH/[N)LF?)K>KGQ 1X 2_<A7G1Y1D:79W!KO<UPC$JH1*PZHE<6
M*R/BFWA+: %L"GESDF#H4V/44;UP&;!NB#O>Z>YNM>OJ'85J7*-N\^<&OE#^
MK<Z,@F:W*M6>=D=]]0GG*03/&T7LKC)F5X'BBOA:<N=8TB74Z-R[69TT:'"3
MQCM?J2>\UY(ADE()+RV4*5N,_:\)L'LW^(#@ZVL<-W3..SLQK4*IKV_6:(%$
MM^-Z#D7J!DM7'[6[$@Q-%R\<C^LY"KQ@+[K!&?7'VW@3;COM<RE"FJ0TF(3X
M7.'MD>N6WER9B_3)73>.*ML1"9YC^Z//R2.GK"[[B@@V2'^7(JEHZ8Y>M!':
M7[/=UF'C *GSZ(B8Y"3J?39O3K;TZZ])PLS=U_RV-5613-],]%@4*M^-N_Q<
M-R<KS;;Z=TZKP?UW:K WAAZ+$1%.!R^/.4)T6>8/NR;30HRJ81.9;<OY'W%#
M""T7 N%]S;-A;TOP-C3:=CLEO@Q M-7E 5<"N2IH 6P/DM%W[+6[?,"NZ,=!
MK9S2>#MF[W"57ZI5B#5>$FO$/.^\>X]'GH#IO)G,4W:!!X[LI\#$V^]C-K'#
M\=B;KM;5$]]M><H^:E%PF88$4>?88^<*,)4N8?+,KXZ1?<BF(_QS#G_&@]/I
M&?Q_@O_PQ;/)K&=1-&Y8V,T>?>2/68_CA<@O)L_9=,9F9^?L;,+.)VPRF,VF
MV*S;72P]:2W7M9GI."R#=4+U^HR=C4[8->'4(9N-X<_9*?Z9X:9/9@TC[($
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MTN:4I0%X/C> +U[0 MV78$__!U!+ P04    " #J0:E4G)YO.I$&   9$
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ML_CCDCO3TP#\/B^*VOY!"U#F(V_OE_\'4$L#!!0    ( .I!J51V_/,H' T
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M >N+$CX-7XA!^TNK%_\#4$L#!!0    ( .I!J500L++7( 0  "D*   9
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M$_-#[BBT"U8Z*N*5XCF .=RANV\:R@78X@=Y)_ZFJ]_<NA]OKCEHU^1]N!M
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MHWW(@ D&ZO!A)6D..6V.L[LRVI!Q;=<0@\;)782/>-!V8@@7_!$UU+0/L,$
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M";C_$8;,NZXMEWVGHYT:24X'$8(W%6W\-H'SFSV</6X ('4-,/<1)Z'A!..
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MJ.3)=O,"!@,0L!V#3(3L+M FR9HB-5*5J;"L\^S5&FD*'4XP*S^%$*896U*
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M#CX OZ\;V)9\P FPW18M[_O_ 5!+ P04    " #J0:E4BC 9=6 #   7"
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MO9UBMIGA&1H63G>A]6^UP](,TP9?;FZ\ )[OM':O"W_!^"^P_ =02P,$%
M  @ ZD&I5)FU>169!   A P  !D   !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&ULU5=9;QLW$/XK ]4H;$"6]M#J<&4!/I+&:((8/MJ'H@_4[JR6")?<D%S)
M_O<=[J&L8EM14?2A+Q*/F6_N3]1\H_07DR%:>,J%-.>]S-KB;#@T<88Y,P-5
MH*2;5.F<6=KJU= 4&EE2*>5B&'C>>)@S+GN+>75VJQ=S55K!)=YJ,&6>,_U\
MB4)MSGM^KSVXXZO,NH/A8EZP%=ZC?2QN->V&6Y2$YR@-5Q(TIN>]"__L<N3D
M*X'?.6Y,9PTNDJ527]SF)CGO><XA%!A;A\#H:XU7*(0#(C>^-IB]K4FGV%VW
MZ.^KV"F6)3-XI<0?/+'9>6_:@P135@I[IS8?L(DG<GBQ$J;ZA$TM&T4]B$MC
M5=XHDP<YE_4W>VKRT%&8>F\H!(U"4/E=&ZJ\O&:6+>9:;4 [:4)SBRK42IN<
MX](5Y=YJNN6D9Q<?4"1 M85[)A".']A2H#F9#RUA.XEAW.!<UCC!&SA^ )^4
MM)F!=S+!9!=@2$YM/0M:SRZ#O8B?F!Y Z/<A\()@#UZXC32L\,(W\*ZYB<E#
M+DM,X'.!FKFV,,!D G17*,,$_*I561CX\V)IK*:.^6N/X='6\*@R/'K#\(4Q
M:&L['SE;<L$M1P,[F7\MX7M1W;">F8+%>-ZC:32HU]A;/&0(5ED*A'TS*CI&
M50J69-X-'@>0M$&O7-!TSBQD;(V0$Q<XJ5@0"D]Y7&7*Z6:MS\9U"Y>5V)7*
M"R:??_YI&OB37PSMI5&")\Q2HB^98#)&N*\8AFDDSPA!$!F8,SB^D=340KA"
MG !5/,ZV)8<F;U>EUBAM&]$=QLC759OV01+F$?C]D,1OY)K$E.;MQ=2;P:W&
M@O$$\(E8S&"=$$5>:Y@$=$ODINUS'PKRTO:K6_Q:\H)HQ]8HH3=JNT6N0" Q
M &@WZJ<J/2T-MGX%P8A<L$RN./G6G-80P7@"GRN;4LG3>#>>,)A23#GAEAJ=
M69?GYHY6R])0X8US?3?Y5D'*N(8U$R627\9 K PIT061GH!C_P2.0R\X@8=N
M1^RB'$'8]\CS;F.V">_VS;5F:=-.+(Y5*6E3L&=7AJH TV"\U2N4;OM%*+DZ
MM:AS(LJEA=%K,NJ[Y';-AF&3.#*JW=QV+T>3$#[N&O#]G9,4R5H"ECWM*$91
M1VJ?>7_JO5*X'8EPVJ2W>_I]CH/^)/"J@KQ[BD69D$B<,;VB;XVBFA.JFILE
M3J/$==L&7"9\S9-R6[T^;#).,^+FJ-"<?D:Y>*:ZY[0QA.):!XY\/VRGZ@4@
MQ2R9(*4$U_2+7)"24:G=.$2-L=)$WL0,M+0DQ%;TLVYJ-B"6H!ZKVZVAD::E
MG(V8@AC H?SS./CM_\H_5\QD55BQ6SBRH)2@FX<CB$+_)3_-Z/ %-T7C<!\W
M1=Y!W#3S#Z.FB?<6-?G^'FJ:_F?,U/>CV0]XR>^/IL&_YJ5H%OY3SHF\/9P3
MS0XA&']\(,$$X^ '!',@OWC^%%Y[J@P[+\,<B7'<^]?5@S)5/Q*WI]LG]D7]
MLOPF7K_/:3I61 8414JJWF!"+UI=OWGKC55%]<Y<*DNOUFJ9T=\$U$Z [E.E
M;+MQ!K9_/!9_ U!+ P04    " #J0:E4NJZ:6OT&  "T%P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970S-2YX;6S%6&EOXS80_2N$:Q0.X+4MR?*1"TC<731H
MMPV2;(NBZ =:HBUV)5%+4G&\O[XS)"W?=I(]BD".#L[)>8\<GL^$_*@2QC1Y
MRM)<7=02K8O3=EM%"<NH:HF"Y?!E(F1&-3S*:5L5DM'8"&5IV^]T>NV,\KQV
M>6[>W<K+<U'JE.?L5A)59AF5\VN6BME%S:LM7MSQ::+Q1?ORO*!3=L_TA^)6
MPE.[TA+SC.6*BYQ(-KFH77FGUR&.-P/^X&RF5NX)1C(6XB,^W,07M0XZQ%(6
M:=1 X=\C&[$T147@QB>GLU:91,'5^X7V=R9VB&5,%1N)]$\>Z^2B-JB1F$UH
MF>H[,?N9N7B,@Y%(E?DE,SLV[-5(5"HM,B<,'F0\M__ID\O#BL"@LT? =P*^
M\=L:,E[^1#6]/)=B1B2.!FUX8T(UTN <SW%2[K6$KQSD].4=4UJ6D2XESZ=-
M<I,5E$M(NFX2FL?DCJ54LYB,$BJG3)'& QVG3)V<MS481Q7MR!FZMH;\/88\
MG[P7N4X4>9O'+%Y7T :O*]?]A>O7_D&-[ZELD<!K$K_C^P?T!54J J,O>$XJ
MUJ*_PM+AFD,"_KX:PRBHI7\.6.Q6%KO&8G>/Q7N+!"(F4$B:\E01@!F)7+(E
MBX3<RI5-S6'%&[/*-V95NKB<H2;) ?UH62>,S!F5A.$<$<APE%0I)I$ +"H4
M!(=QZ$2D &HP<4K^0JFWNZ0:-SD4;IH"!M4)^="Z;Y%;L)O1B)6:1S0EMY*I
M2/+"P/2!14DN4C&=DWN1EOA.D?<LQI%O[DLY-2++3S>Y9C*G^ #O1T(60D)P
MY$%H',<>F:1YQ$S<+"M2,6?L394 H;0+OTX&<'EP-;P3]]3HX]V0O'WBVB@0
M$+5<ES;#AZ1+0A($I-LCPSZY4@HT+K.NC#"-(B C:41C!A0:<>,V:?@GQ!M
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M'QUTP-;_ _7$FV6X@V?&TXT>7JDV<[2\@=;GAB1J)NR@_2F;_ =02P,$%
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M^GZFPTP01$TDSAFQ:%RP=OIT%.EH##F#7RD2 V1*6E7^['G!'=3WWXU9RGZ
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MTJW$6-7*S65B[0,E;#-0@!(:>Y5S;;+E$**)-EK;'%#X1@G+.GK"[K:9QF#
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MGR*&)4D!SBR)[K>\"+13>!J!T-N8C;&)8VB8=BT!CDRA-IH@$E$.S2ELB/-
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MEBX0_G5%-S;43H"^+Q11.BS< ;L[X.5_4$L#!!0    ( .I!J52#?-@,8 H
M +,C   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;,U:>V\;-Q+_*H3N
M>I  1](^M)(<VX#L.FUP;<ZPDQ:'P_U![5(2VQ6IDEPKSJ>_&7)?DG;72M##
M'1+ODQS.>W[#U=5>JM_UAC%#/F]3H:][&V-VEZ.1CC=L2_50[IB -RNIMM3
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M_4+$W1BYL[_*6$ICY-9>;AA-F,(!\'XEI2EN<('R=SHW_P%02P,$%     @
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MP?,8K7?@\]P8VAJ>H)GPTW]02P,$%     @ ZD&I5(/JG A  P  0P<  !D
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MPK347#A=^N]&<^V<SOW/I> 8F.@ GB\T?%I?D(#V0^+I_P!02P,$%     @
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M-X/8(M$^C@]X6=Z9U$8!H:,U"TG<E7OINI"RVSK;A@D$B%'_&GX>,F8_ANO
MB[2,L<RJ( BS7UJT(UO9DG9N"X=HM+>@J/1?,=16P#.HAIRP#*?1_D#CK[4?
M"O!7?&&@R48R"Q98.5$QZ<49)F.GHPU9P M8L&^<*;^6B;D7:/_D+DLC%LC
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MG&M#RX-'*W 3552[W54195NF=MI=1YTM:M >>#0'&H!S,/&F3?1I$X/,YW2
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MP^"=RN W#/ZI)@4-0W J0]@P5,D<UL&J(CV-97Q]R=D6\9):22LOJG15W"K
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M&>2V1CL<]B(/&A(QO-:Y4XNR?$7+I;]J]8D4%V6E7!8I2NG2M&B96@2ZU:2
M;-/HB&%T; */_D$W!4T7KSTZS50;^U*'#-*CP1"/^Y 43V.I!R])'MMM>K=+
MMR3((MRUPY:G0=:#(5"GZ"%.UNK'<M.BLZ!@<DV@ >%ID/1P+Q*UMZ$'M]T_
MF2A8N&?/DX9;#X;;PZD$B=70Z 6]2(C&5P_N)N_+LHY4RY\9 PXS6Z'+T[#J
MP2BHXWW[.AP@N1H2O5$O JZQTX,;24O 869KP'T-F3Z,:@_Q=TN1]C6H^6X?
M@NQKW//AYO#\(FT1B'TKMO@:!/WWVWNPF0UK<AV[V7NG'Q9(K$?,&[L+7V.D
MWPN,]#5&^C#,_5S1L@CW3DB11E'?@J*[%+V]N_ UMOJ]P%9?8ZL/P^-/)LJ"
MO?8V,-#H&YR$OJ>U%X$&XJ 70!QH( Y@W(2KG87YE(AKT U@*-01/Z7!"#0J
M!GXO0KYWJ NOOBTAAYE/B+B&S0!&MM8YT6_-.1$D6<-<T(MMR4 C80 OO,\\
M$@L.MRC=@_WC6Q.5<[#+;*-J>Z2A-+ <9S:[Y&C"\O(@FM?'6T]4?%-3J-Y6
M?R(O)"]4D_*52/5P\N<<"&:HL3'LQ<9HJ%$UA-?LC[NS^/)X3S+5NZG<YH*E
M=%$="O$Z$&)W;&_<'+5HP:[E$#W4J!M:SN_.3]Z_28[NJ\U$B2;F$Y*V,1IX
MPU[LI(8:L4.XCWVO=,): FQ+IT;T$ 9E.)U-T,J,)H2^5"\E62?CWILUO=A_
M#37VAW"+^U[9@[5@VQLMH:X-(5P;WI*]LV>CQO6P%UNWD4;[R+)U^S[YM&CQ
M#6\VM0W6U2"R5 /.%D4BS\#6*2T/+9^+^BUKU2$\5:_;JM9?*-D"2FRD,3_J
MQ59OI'$_LFSUOE-B82WC8Z^ZW;Z5<?8&QG:(="6*+)7H[*$T)_R%)NKY*6-'
M%YBH%SLND:XZD67'Y9W&#JS%4*&;H?,VOMGY?'5\AGNO]BND7U4?80A41;I^
M57WW=/>AQY?J\X;.\ZG[>59_KJ'%U%^//*AJ0G.!4K)4(IU/Y8C@]0<9]8UD
MF^H#@F<F5;FI+M<D7A!>$JC?EXS)UYM2P>ZSF.O_ U!+ P04    " #J0:E4
MKBF:P) "  #P!@  &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6R-E5M/
MVS 4Q[^*%?$ $I#$N8+22*5HVAY@%1W;P[0'-SUM+!R[L]V6??O93HA*22M>
M$E_._YS?.;X5.R%?5 V@T6O#N!IYM=;K6]]750T-4==B#=S,+(5LB#9=N?+5
M6@)9.%'#?!P$J=\0RKVR<&-3619BHQGE,)5(;9J&R']WP,1NY(7>V\ 37=7:
M#OAEL28KF(%^7D^EZ?F]EP5M@"LJ.)*P''GC\':267MG\)/"3NVUD<UD+L2+
M[7Q;C+S  @&#2EL/Q/RV, '&K".#\;?SZ?4AK7"__>;]B\O=Y#(G"B:"_:(+
M78^\W$,+6)(-TT]B]Q6Z?!+KKQ),N2_:=;:!AZJ-TJ+IQ(:@H;S]D]>N#GN"
M,#XBP)T ?U80=8+()=J2N;3NB29E(<4.26MMO-F&JXU3FVPHMZLXT]+,4J/3
MY8RN.%W2BG"-QE4E-EQ3OD)3P6A%0:$K] 05T"V9,U"7Z-'LJ_-[T(0R=6$F
MGV?WZ/SL ITARM$#9<PLC2I\;<BL?[_J*.Y:"GR$XH'(:Q2%EP@'& _()Y^7
MA^_EOJE'7Q3<%P4[?]$1?X<I7Z+)1DHP)?H]GBLMS=[[<R),U(>)7)CX2)B)
M6UZ09B^[P@\6KG61.1?V2&[+,(VCO/"W^_49L,K"(.VMWO'%/5]\DN^[KD$.
M,;6R="\:QOG- =* 48238:*D)TI.$OT0FC!S>?3+,T27? @<YAG.#O &K&[B
M*!SF2WN^]"3?F)E;D?!J&"S]$/(JC.,#K@$CG 3#6%F/E9W$>K>?.>@AN.SC
M#LJ3/#J@&["Z"?/#JOE[]Y%]"\SY7%&N$(.ET077F2F^;._7MJ/%VEU1<Z'-
MB7#-VCQ)(*V!F5\*H=\Z]M;K'[GR/U!+ P04    " #J0:E4S$^Q./X"  "@
M"   &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6R-EFUOVC 0Q[^*%?5%
M*]'F$4@J0&KIIDU:)U36[<6T%R8QQ*ICI[8#[3[]SDF:43!1WT#LW/_N=^>'
MRV0GY)/*"='HI6!<39U<Z_+:=56:DP*K*U$2#F_60A98PU!N7%5*@K-:5# W
M\+R16V#*G=FDGEO(V414FE%.%A*IJBBP?+TE3.RFCN^\33S03:[-A#N;E'A#
MED0_E@L)([?SDM&"<$4%1Y*LI\Z-?SU/C'UM\).2G=I[1B:3E1!/9O UFSJ>
M 2*,I-IXP/"W)7/"F'$$&,^M3Z<+:83[SV_>/]>Y0RXKK,A<L%\TT_G4B1V4
MD36NF'X0NR^DS6=H_*6"J?H7[5I;ST%II;0H6C$0%)0W__BEK<.>P(]."()6
M$'Q4$+:"L$ZT(:O3NL,:SR92[) TUN#-/-2UJ=60#>5F%9=:PEL*.CU;T@VG
M:YIBKM%-FHJ*:\HW:"$832E1Z!(M)&P9J5\':,&,%>89^O1<T1+64@_0=]AI
MYW=$8\K4!9@_+N_0^=D%.D.4HWO*&"R6FK@:6$U$-VVY;ANNX 37/997*/0'
M*/""P"*??USNOY>[4*&N3$%7IJ#V%Y[P]X$B_+Y9*2UA6_[IB1=V\<(Z7G0B
MWC<(8"M:HQK7*G- MS/?BR;N=K\R%IOAJ+-YAQ-U.%$OSFU%66;VA<F;%J44
M6V(RMRYLXVJT'S\,_0-(B]$X&MHIAQWEL)?R'J<Y3$E8)?)_;0RRT#F1-M;A
M$480AO$!J\5HZ =VUE''.NIEG<.IT+)J[C(X*5#2C23*6M#14?S0#P\8+3;Q
M"<1QASCN1?PA-&8&K-WYI=GY33V[\MIPQT<HD1>/#G@M1N/DQ/K''7#<"PSW
M5U54#&N2P4T.32VEN.D5@(P+(37]6T_8J.,CH$L_20[/EL4J"/S(SIUTW$DO
M]Z*WQ /$B;7.R=$Y#[PD. "V& UC_X#7W>L?IG?#[;FA7"%&UB#SKL9P F33
M#YN!%F7=4E9"0X.J'W/XA"#2&,#[M1#Z;6"Z5/=1,OL'4$L#!!0    ( .I!
MJ50]/WPC$ <  !\F   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;+5:
M6W.;.!3^*QIO=R>=:6-TP9=LDIDD=M-<VF::2?NL8"5F%Y KA-/.[(_? \86
M&)!)&EX2(Y_SZ=STG0/F\$FJ?^.Y$!K]#(,H/NK-M5X<]/NQ-Q<AC_?E0D3P
MS8-4(==PJ1[[\4()/LN4PJ!/'&?0#[D?]8X/L[4;=7PH$QWXD;A1*$["D*M?
MIR*03T<]W%LO?/4?YSI=Z!\?+OBCN!7Z;G&CX*J_09GYH8AB7T9(B8>CW@D^
MN';=5"&3^.:+I[CP&:6NW$OY;WIQ,3OJ.:E%(A">3B$X_%N*,Q$$*1+8\2,'
M[6WV3!6+G]?H'S+GP9E['HLS&7SW9WI^U!OUT$P\\"307^731Y$[E!GHR2#.
M_J*G7-;I(2^)M0QS9; @]*/5?_XS#T1!@> &!9(KD+8*-%>@;158KL#:*KBY
M@MM689 K#-HJ#'.%85N%4:XP:JLPSA7&;16PL\Z<TUIED^S6V<;K=.,LW_U5
M8655.>&:'Q\J^814*@]XZ8>LM#-]*$8_2D_AK5;PK0]Z^OBC"&8(#C.ZY8%
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ME5L.15A['@Q$;>C$_WPQX/\(?M@?"U< 2"HYC@NM(1&> -2F3G)!E@,*2*N
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M2:&^)^C4Q6Y@U06QV2<;TQ\8]&P(#MSTPII>Z*7WG4F2N"H.K:%0KV]4[,!
MLR,V!N[1:M0\K&L>>FO^8Y/?^?S)G--5V9/_P./%_ +<*^U,242W,HY,6HVA
M1O50HR,( 0RTAP2_3@JJW/OW>FATS &!@=$Q%P:Y.P;WS!%^JAQ4Z08>77-
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M?]%+@QWV4+HMM5PWC0V#=5;L_B??FX'8:X!'@0:D:4#<!BS0@#8-:-<&K&G
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M :<]WHX9 K'0%%@?H7$?.2YDOK;WB;OCA$"A'2>S#L".G/B$E(P!DDY<VX5
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MUQ]7(ED(50',]T]2ZK>+Z@'M.V#7_P%02P,$%     @ ZD&I5%70*O),!P
MQB0  !D   !X;"]W;W)K<VAE971S+W-H965T-C N>&ULM5IM4]LX$/XKFMS+
MT)E"+%EY:X$9"C1 H64([7WHW ?A*,17VW(E&=J;_OA;.29*L**8@_1#\8MV
MI5WM/L^NXMU[(;^I*><:_4B33.VUIEKG;]IM%4UYRM2.R'D&;R9"IDS#K;QM
MJUQR-BZ%TJ1-@J#;3EF<M?9WRV>7<G]7%#J),WXID2K2E,F?[W@B[O=:N/7P
MX"J^G6KSH+V_F[-;/N+Z<WXIX:X]US*.4YZI6&1(\LE>ZP"_.>\$1J <\27F
M]VKA&AE3;H3X9FY.QWNMP*R()SS21@6#/W?\D">)T03K^%XI;<WG-(*+UP_:
MWY?&@S$W3/%#D?P5C_5TK]5OH3&?L"+15^+^A%<&=8R^2"2J_!_=5V.#%HH*
MI45:"<,*TCB;_64_*D<L"&"Z0H!4 N2Q0&>%0%@)A$T%:"5 FPIT*H%.4X%N
M)=!M*M"K!'I-O=2O!/I-!0:5P*"I  X>=BYH:@6>;W;CW<8/VXW+_6[/ JN,
MRB.FV?ZN%/=(FO&@SUR4H5W*0S#&F<G"D9;P-@8YO?^N4/!$*700?2]B%9O4
M4(AE8W0$V:%TK O)%=HZXIK%B7J%MM'GT1':^OW5;EO#_$9+.ZKF>C>;BZR8
MZX+)'10,7B,2D, A?MA /,0KQ8_\XB.>@WA@Q/' (7[<?';B$'_?7!P[Q(?/
ML_VD@3@.5HJ?^L7/B@0V#J]TW9E?_""77O$/C6UWBI\W%^\MB[<A6>890^89
M0TI]X1,R!GT]AV?H5/-4_>V9(YS/$99ST!5S'(HT!:V0_]&WURAG$MVQI.!H
M*\[06"0)DPKE',ATRB1W9>+Q3'^_U&^8^&X_V D@\.X60W;-H*6ET_G2J7_I
M15HDS% KXI,)<"UBXW\ R8"YM2OG9]IZ"VOHA,$@*/\M+_>X/G0;]P;$-?9]
M?2SN=5PCA\T7\*$^M$_ZO4=#E[S6F7NMX_7:,822_HDXDUF<W<X .(+-O07L
MG4B1HC@S:&R<")?H<,JR6XY..$OT-((80&<BAE=?X#W@M2L@9O-W%YU'0Z?K
M.G4WT[[3=0Z=8=?GCN[<'5VO.Z[9#W3%(Q[?L9N$HX-;R7EI^]:?O_4)"=Y>
M7QV45_CM*T^Z]>;3]3:6TOWY''VO29=<1F !5+9(3% &]77$U!1IL%2QNW+3
MH8I.XG_Y& D)A208/+:/BFP,^0YFHZU\ILF5]N_]:^AW=H+@#X\Q@[DQ@Q?;
M'_3+$:Z_T"<]!8-&_-;(*?3U@J<W7/H\C0-;TP0;VT^\4#EAKQ,^BBPJI#1F
M)S&[B1/(8&==@6MI\CCEJB$]YY#EY5F:PL2[O"M3L640.L<5J/B,ML2$P\VY
MUG((?ED2J=0MNAB'4*<Y:03787P05%!8VQ@7Y =.O<.G+.*#:S"A-=Y9]I]E
M$^RGDT_0I,.6 WQ4,6")9>Y']09N1%YN8(E(]] 21Z+(M)%4&BB(R;$W:BR<
MX^[FHL:B..Z];-3TZOR%G9PX;#[T@V,HQMYMM12"_?C]@ML*"/PD@+#,@ <;
MVVIB$9X$+[K5E;HF6]U\Z%DU=!$=NN[*T3'2'Q3$TA#QTQ#TM4RRA_UV5(9?
M?!Y?Z'HVU_802R_$W_B,3$.CT#A66L8WA8;HA')7Y<"MVV(R*1N@LNE1SO.'
M2OM2[O6\%2FQG$3\G%0M#7P<+71GB/^(2I>/UZ[-@?@=ZEN:A7OBA_N/A:F=
MS-)F\\,*H5V0,^]I85O%A1=;JY=Z0NJ%_8JND%@*(/Z2_MDM[4DU 0Z7^]55
M#2NQO$'6\,;CG/&%L@5KTM]<PEBX)?Y*O(I*R?-"0B"J!G$X>&(<AA:50S\J
M#X%/9NVJ8DG9Y_!97YMR/17CA2;6M;"PCI$44Q><'H9UC*X/73;"XFGHQ]-#
M(7,!@.KMJ9=U6Q --WAVM'!XY ?13_<9EVH:YR;[.<1!>6:P9(VWBSQ?H[\7
MK&DC0PNJH1]4RXC9.A=*O4+@BJ-8Y:)R"T3/J$18&#$J;E0\CIG\:7KCZK#D
M8A94IV50<=>AQU%8+]\)]?)!:$$W](/NBCB!PNI:LJPR8L3E71Q!@LY;9&5[
MY%&3,XS0(FRXN2([M& 9^L'R6FB6H DW+%,>4#V<34 _C\ DU]EV6"^):VW1
M\G(LRH;^DGCU+CP%U4.+M^'FREMJ@93Z@?2Y&7RZ1G^GO]/Q9C"U<$G]<+G9
M#![2^N')F@RF%HVI_X3D4O)M<_XFS%'4MH9XV88M-.$$JXS3G,5R!5<=59J7
MZODJHNL'S,31ZM?&+MM@L9[ZL?A9E'M8*6] N4-:+ZVWUW N7?C-P$\#&S_^
M'E+'#P+8>]I"+1/0_\L$SH//%VWB#T:?S0];=#L8/+&EIY98Z.:(A5IBH2]Z
M>G-6J5LZFO,GE245^F*D\AK0*]KQ.<!2"]T<M70LM70V2RWG:_2'*XO#]L)7
M"N8+GPO([SA3*.$3T!3L]"#+Y.RCF=F-%GGYX<*-T%JDY>64,Z@US !X/Q%"
M/]R8;R'FGR[M_P=02P,$%     @ ZD&I5"2KT7?2 P  OPL  !D   !X;"]W
M;W)K<VAE971S+W-H965T-C$N>&ULM5;;;N,V$/T50LA# L36S=? -K"QL]WL
M;HH@;M*'H@^T/+;84**6I.SLWW<HR;*VH56WP+Y((L4S<V;F<,C)7LA7%0-H
M\I;P5$V=6.OLQG55%$-"55=DD.*?C9 )U3B46U=E$NBZ "7<#3QOX":4I<YL
M4LP]RME$Y)JS%!XE47F24/G]%KC83QW?.4P\L6VLS80[FV1T"TO0S]FCQ)%;
M6UFS!%+%1$HD;*;.!__FS@\-H%CQPF"O&M_$A+(2XM4,[M=3QS.,@$.DC0F*
MKQW,@7-C"7E\JXPZM4\#;'X?K'\L@L=@5E3!7/#?V5K'4V?DD#5L:,[UD]A_
M@BJ@OK$7":Z*)]E7:SV'1+G2(JG R"!A:?FF;U4B&@"_=P(05(#@7$!8 <)S
M ;T*T#L7T*\ 1>AN&7N1N 75=#:18D^D68W6S$>1_0*-^6*I$<I22_S+$*=G
MM[G"&:7(A^A;SA0SU5.$IFNRP (JS70N09$.^15%^PL*CV!UEQEGNB,V&R(V
M9![3= OD$U"NXXA*()]?R.4"-&5<72'R_8(.>5XNR.7%%;D@+E$Q-2[0]'/*
MM+IN3#PPS@VA:US8&$Y<C:&; -RH"O.V##,X$>8#E5WBC:])X 6>!3X_ Q[Z
M!=RWP!?GPVW>[_XWW,5RUS4/ZIH'A;WP/]2<_/$5Y\B]AD3]V>(CK'V$A8_>
M"1\?*9-D1WD.1B,/T1?TAUXBD23X0EE'K]@D(L@TK,FEW^_V4-U%=0_EIYI<
M^*'?'0])!K*<->+#;$0QJ4IY99-"R6Q8,#.-<C<+O' P<7>6>'IU/+W6>.Y3
MLQNP0VHC1!V#7?=(&MZB\L^::K#1*QT-&O0Z@3<^P:]?\^NW\GN"'4A%N<DV
M]DF0$O.JZ1OAC*X8;M?O-BK]=U3Z1M\V(H.:R.!?B'# QFUX8'WS).?4E%A@
MRJ0I/QYGL3EG=D"X4*;,6K)5KNF* ]&B2.U?@F&>=YAL;#XVW@-+"GMVWL.:
M]["5]U<4Z WY3=)4T?(,BX32I@M%N4FFC<;00B.TTQC5-$:M-$R;W59M5C7;
M["G)V7B-WFV GG],3]FQVM?\P'U<<Q^W<E^6&U="EN,611'@SF:'_6S=J:4]
MWVNP,*W 3L/WCF>:UTID+F0F).J.?"Z4]&)3TH^V&^>E_].:IW_LT'[PTV6P
MJ'RTZN#.LJAS4@G^L?W[[?U_CIO'\%5V3>1J?>SJ-FG,*_NCIC2*T^ ?S-S&
MW<=<;?%XV#*\PG#8(-#K#K''R?*V6 ZTR(KKT$IHO%P5GS'>L$&:!?A_(X0^
M#,P-J[ZSS_X&4$L#!!0    ( .I!J51V;_KJO@0  /85   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8R+GAM;,U875/C-A3]*YK,=@9FNMB2\P$,9 8([6ZG
M[&1(V3YT^J#82JS!MK*2G$"G/[Z2;"Q#S$W:[D-X(+:L>W3ND70LWXN-D(\J
M94RCISPKU&4OU7IU'@0J3EE.U8E8L<(\60B94VUNY3)0*\EHXH+R+"!A. QR
MRHO>^,*U3>7X0I0ZXP6;2J3*/*?R^9IE8G/9P[V7AGN^3+5M",87*[ID,Z8?
M5E-I[H(&)>$Y*Q07!9)L<=F[PN>W460#7(^OG&U4ZQK95.9"/-J;S\EE+[2,
M6,9B;2&H^5FS&Y9E%LGP^%:#]IHQ;6#[^@7])Y>\269.%;L1V>\\T>EE[[2'
M$K:@9:;OQ>83JQ,:6+Q89,K]1YNJ[^BLA^)2:9'7P89!SHOJES[50K0"\/"=
M %('D+<!_7<"HCH@VC>@7P?T]PT8U $N]:#*W0DWH9J.+Z38(&E[&S1[X=1W
MT48O7MB%,M/2/.4F3H]G*97LX[61.D$W(C?K3U$W@Q_1%RHEM=.(CB9,4YZI
M8]/Z,)N@HP_'Z /B!;KC668ZJXM &RX6,8CK<:^K<<D[XV*"[D2A4X5NBX0E
MKP$"DT23"7G)Y)J B'=4GJ (_XA(2$@'H9O]PW%'^&3_\+ C_!8._Z7,7L)Q
M!(@1-=,:.;P(G-;Y]K1>F3DMELQL=8WFSZC=;TJ?7?/5ALH$_?&K@42?-<O5
MGP"A?D.H[PCUWR'T&WU"[,GR,,MIS@JVX/K8.$U&M1E:"T03L7(,Q0)1P\,L
M"N,BL2@+S8LE6I8\H47,NE9:-?+(C6R-<3W&9@K6[;G?[D)>]YA /5YE/&@R
M'H 9_VR$MKD=F7VBK,SJN(M\!3)LC?N6^\X>$ZC'*^[#AOL0Y'X_>U#H;S3A
MTOBYD I8 *,&<G08*_*T(70*YOB5*3L]+M4=<W2ZI>]@%(;O:'S6C'^VC\9W
MO.!YF0,)X=![>7@8&N/6ZP6#6<ZTB!\1=>!KH[C=RRLFN4@ZWQDP6(2>&057
M(R:>&-E+?OJT2W[ON?A 3!=[U\6P[?Y+^6&P_F[YO3EBV!VG1GX(R#L5'AZ(
MZ-[I\.A[B@Z#[;'FO>-AV/+NV;>2*ZX94DRN><P@6C#4'K2\$6+8"2N]JM<_
MA$B\$9(#,4+BC9!\3R/< ;9[)Q)OA 0VPC:QV!S)I?EV*VF&-)-Y)S48;K2;
MFC=4$H%8M[/I% +R-DCZ![(>O $2V "_E/F<27O:K0X>B)8Z%9+_98^,P%F$
M;!_V" [=7_=YA'@K)?"I;YO2VGSUT7G&T$)(M+0'6IC;<)L;2,U;*H%=<.IV
M"A)KPV^3\CA%*_HL198AKI#Y5"CC^C-B5<HX-?-7I]#)<I?AYN[#%)IE[[@$
MMDG#.S:+B"Z9E36G\I%IM)+6>JVDCF3#N9,LC'\Z. G#'R"JWH4)[,( U4I@
MNU^V27=+# ^%=[&.O--'(0AEOY=196'3C!80IK?J"!^&6T3>I"/85?^C6]S6
ML.T=&870EHQ:%0;8G/^W6]3X;6[XK)-;T*IOY4PN76%1(5<<J I$36M3O+QR
M);LW[=?X?%*5(#U,51&]HW+)"X4RMC"0X<G(V*RLBHS5C18K5T6;"ZU%[BY3
M1A,F;0?S?"&$?KFQ S2EWO$_4$L#!!0    ( .I!J51^A'RF7 ,  /@,   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;,U776^;,!3]*Q;:PR:M!0/Y
MZ)1$:I).F[1*5;N/AVD/#MP$JV SVVG2?S_;4$*)@ZIM#WU);'/NY1P?S+U,
M=ES<RPQ H7V1,SGU,J7*#[XODPP*(L]Y"4Q?67-1$*6G8N/+4@!);5"1^V$0
M#/V"4.;-)G;M1LPF?*MRRN!&(+DM"B(>YY#SW=3#WM/"+=UDRBSXLTE)-G '
MZEMY(_3,;[*DM  F*6=(P'KJ7>(/2SPP 1;QG<).ML;(2%EQ?F\FG].I%QA&
MD$.B3 JB_QY@ 7EN,FD>O^ND7G-/$]@>/V7_:,5K,2LB8<'S'S15V=0;>RB%
M-=GFZI;O/D$MR!),>"[M+]K5V,!#R58J7M3!FD%!6?5/]O5&M +P\$1 6 >$
MW8#X1$!4!T0O#8CK@-CN3"7%[L.2*#*;"+Y#PJ!U-C.PFVFCM7S*C.]W2NBK
M5,>IV5U&!)S-]<ZE:,$+_3A)8@TYLU/.@"F)^!J=!%[MS1C0VR4H0G/Y3H=^
MNUNBMV_>H3>(,G1-\UP#Y<17FK"YK9_4Y.85N? $.1RB:\Y4)M$52R%]GL#7
M2ANYX9/<>=B;\9J(<Q3A]R@,PM!!:/'R<.P(7[X\/.A1$S7F139?U&O>ZMB3
M2R$(VX ^GPJM'E$;=T,>[?+ECH@4_?RB4Z+/"@KYJX=0W!"*+:'X!822-B&H
M'A+7(U!E'-F,YBWU,,-#O;</;5<<F$$'LW1@\$6#>29GT,@9],KY2O9H!0S6
M5"']BD7R+^15=QBV:)U%@XX\!R:,.O(<&#QVRQLV\H;_Y-9[Q'3AT6=?D;U+
MVO"($@Z''6DNS+@CS8$)L%O:J)$VZI5V"U()FBBM3+]"DWNT953)GB=\W"0>
MOXXC=]$0NOCO1^[B>,/CCBD+!R8:=8QS8(+8;1P.#@4IZ!=D_>*E.JX9SS.V
M2AQ^'9[A\$ I_.^NU2G;VQUV3'- XHYG#LCHA&6',H2C7C5719GS1X#ZK)5;
MD61:&BISPOJVZU!6</Q*'#R4!MQ?&_[*P8&C1G4M=&""KH?'F&XI\%LM80%B
M8UMKJ9ENF:K:I6:U:=\O;=/:69^;MMZVFH<TU3>![F8VE$F4PUJG#,Y'FI6H
MVNQJHGAI&\\55[J-M<-,?YJ , !]?<VY>IJ8&S0?.[,_4$L#!!0    ( .I!
MJ51.2JET!P,  (D)   9    >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;)V6
M86_:,!"&_\HITJ166DE(*-TJ0(+2:I-6"8':?ICVP20'6'7BS#:E_/N=G32#
M-@34+V [?E[?O;[$[FVD>M8K1 .OJ<ATWUL9DU_[OHY7F#+=DCEF]&0A5<H,
M==72U[E"EC@H%7X8!%T_93SS!CTW-E&#GEP;P3.<*-#K-&5J.T(A-WVO[;T-
M3/ER9>R /^CE;(DS- _Y1%'/KU02GF*FN<Q X:+O#=O7XRL[WTUXY+C1.VVP
MF<RE?+:=GTG?"VQ *# V5H'1WPO>H!!6B,+X6VIZU9(6W&V_J=^YW"F7.=-X
M(\433\RJ[WWS(,$%6PLSE9L?6.9S:?5B*;3[A4TY-_ @7FLCTQ*F"%*>%?_L
MM?1A!VAW#P!A"83O@<X!("J!Z%2@4P(=YTR1BO-AS P;])3<@+*S2<TVG)F.
MIO1Y9K=]9A0]Y<29P6S%%%Z,R+D$;F1*U:29VY +F%&))6N!(!?PY/S#Y&+X
M@HK* 8::"B6W,S4\6-A(N-6&TTX@W#&NX)&)M6.GLP<-+$M@8AMG8S2,"WU.
M*^P]Z?F&\K%1^7$9^ZB(/3P0>SN$>YF9E8;;+,%D7\ G(RHWPC<W1F&CXCU3
M+8C:7R$,PK FH)O3\78-/CX=#QJRB:J]C9Q>U+BW\X][.U2*94NDM]? ? N[
M\R9LZX:'&Z82^/V+).&GP53_:0BH4P74<0%U#@1T^YK3ZTZK4%G'SY K'B.\
M2$%1"6ZV<):CBFGU\[I::):.+EM!\*5NRXYPW0/<^ @7?.3V/+FL/+D\S9.$
MO_ $Z678<A1)LQ?-DD'K>[T5S5B[U:YWXA@6-1K1K8SH-NI,N7Z^6"A$X)E!
MA=J LA^31B.:)8./H15&',/">B.:L? CMF?$567$U6D5(?B"TN<9;)$I79M_
MLU)4D'4.?!8<?P(L7/!W#JD4U=(=]AIBN<Y,\86N1JO[Q- =H^_&1W3/**X%
M_V6*2PI]0)><#B2!"Y(,6E=4N:HX^(N.D;D["N?2T,'JFBNZ*Z&R$^CY0DKS
MUK$+5+>OP3]02P,$%     @ ZD&I5#+441P2 P  *PH  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C4N>&ULG9;;;AHQ$(9?9;3J12(5]L Q$2 !:=I>1$)!
M2:X==@ K7IO:!A*I#]^Q%Q928$6X8>U=S^]OAIFQ.VNEW\P<T<)[)J3I!G-K
M%[=A:"9SS)BIJ@5*^C)5.F.6IGH6FH5&EGJC3(1)%#7#C'$9]#K^W4CW.FII
M!9<XTF"66<;TQP"%6G>#.-B^>.2SN74OPEYGP68X1ONT&&F:A85*RC.4ABL)
M&J?=H!_?#N*Z,_ KGCFNS=X8G"NO2KVYR>^T&T2." 5.K)-@]%CA$(5P2L3Q
M9R,:%'LZP_WQ5OW>.T_.O#*#0R5>>&KGW: =0(I3MA3V4:U_X<:AAM.;*&'\
M+ZPW:Z, )DMC5;8Q)H*,R_S)WC>!V#.HG3)(-@:)Y\XW\I1WS+)>1ZLU:+>:
MU-S N^JM"8Y+]Z^,K::OG.QL;SQG&BL#\BN%H<KHSS;,AZL"8\J ="D0U!0>
MQT\&F$QAY ;]-=,I]%U N?V JSNTC MS34:?%QJG;H!+>.!"D*SIA):HW=[A
M9$,XR F3$X1Q @]*VKF!'S+%]+- 2.X6/B=;GP=)J>(#TU6HQ=\AB9+D&X0;
MS/RW1+]6Q+3F]6ME,2T3JA="=2]4/R$TP!F7DLL9)9Y@<H)P1:',.:_A+QPC
MS@.0ZS:]KBO,5:_6"5='4!H%2J,4Y:=FTE*.G O0. "(CP,T"X!F*<#0^2_$
M%Q":!PC1<816@= J17A&\Y40M [VKYR(0;L :)<"4 %<D@SM<Y/AIN"X*4WP
M%]_K,*U ?X6:FC?X] #J0 CWC&MX9F*),$(-OAA*:B&.=ITJNJ :4B4$TP86
MM-<N&+NJ/MIP\HW:^]E93ZKQB;#$>\TT/KM*#L#.X,K5;_:XZ'2M-NLGN)(=
M5_*%XKF$+#D@<Q$[!;;KE''MW)*ZA*IVA"JNQLT36+N^&Y<WWB.%=E&>U0_S
MK!E5ZZW_^,*]\SM#/?.W% ,3M90V/\J+M\5-J)^?_[OE^36*SC:J$@,"IV0:
M55O4B'5^,\DG5BW\;>!56;I;^.&<;G.HW0+Z/E7*;B=N@^)^V/L'4$L#!!0
M   ( .I!J51\74IA.@,  *\(   9    >&PO=V]R:W-H965T<R]S:&5E=#8V
M+GAM;)U648_B-A#^*Z/H'NZD90,A0'L")%A:]:1;"2W=WD/5!Y,,Q%K'IO8
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M%OQ%@=8[\/.-,?2R\0<TWRC3?P%02P,$%     @ ZD&I5(+2P-K# P  6A
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M3\! "SN-?@YGRN;\'U?@<\K O0J!W^:&V8%A,WV-^U([+O([[FMSQB%NQG%
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M5/7T+-]<<NV>9%O%1@&9;[21905&!243_DW?JW-H .+L!""I ,DA(#T!Z%:
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MC#HW:(/RW=]/C%R[?CB3!KNK&Z[PP@1E W!_(:7936R"^@H>_ -02P,$%
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MKIJ:M>D86;DJ;B4-UH2NN<4Z'Y05X/Q:2K/OV 6Z_QQF_P%02P,$%     @
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M9A"*9Y3+HA F)L!H\IOQ)XWT(T\@PRE,16M_6*BGW+O2ZR8"'.ZBH5'I!+R
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MTO.J!>3QU E;T( R=*/R^683JJVTG))N2;AY*R>D!4E#02)7W1A8A,%)"]1
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M?HW^:V%>F5EB0:Y8_#>-Y.9\,!F B*QP%LM[MON-5(9&>;R0Q:+X"W:5UAV
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M%7$-4-]3QN2AHR>HJM[I?U!+ P04    " #J0:E4(0O8AA@#  ! "@  &0
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M?<:WCUM],\3"&.CW&\[5Z\ L4-TUY[\ 4$L#!!0    ( .I!J53.RG_PB04
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MX'[V.?"8=$IRF')$N[R^R"DN!:YNM;CC4?PSUF*+A_+/V/3/D#9E"9O^&;+
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M^!NBK=MHZZ*")G('\^BQJ-1B/TH500>8;L7XE9@2WK]?F*9G5/^=C;[ON@I
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M&DLIIXHQ%&8,W+!94@-A<'\"&D0V7PHQ%$;,J^HX-3!%J^,&46 YR5&%'>K
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M=?G#7 /4_)(QN1_HVT)YG9S\!5!+ P04    " #J0:E4%Q+GKM<"  #6"
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M^'FIXA(M)D8NW3WT+ W>:FZ8XH\'*&N ^W,IS69BK[;J5V;T!U!+ P04
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M3+-G&Y C3=$IPE?KAG&%4KH&RG[O#EX-631?Q4"+K6U'7H6&YL8^)M"P4FD
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M(;.JH'Q_F:;%TY/JQP%V/Q]Q_C]02P,$%     @ ZD&I5&)J_XR? @  WP8
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MI_4*4#4-<7>P85H*MU>$V_.&>PG=DD)[L5"*0=V<29$@#AU8Q)^8TM#S:+2
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M%XQ"O3(&\/M, /?YC7E!<>)\_#]02P,$%     @ ZD&I5/:\,%?C!   HAP
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MMMFJLBKG)$-,DQ-ML/&0F2P65.";?1%5OI(&S[B3[(UH5S-*^FT!)75 26M
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MUT%IVNMLKUQ:"T__47.E[VFNUT%;FBO>N/#\SX;/\UQJ!PIG#&L<I=P*MKS
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M(&)Q^9=\KR0A#3!5 \QJ@'DZ "L&6-4 ZV2 92H&V-4 N^\,3C7 .1F ;<4
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M)0MHV[;XVH.A:F%>EBSS>Y)"FE#HO2GR"_!5!X=E'AR664QA*::X3;),>*F
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M?WR5%L?P)Q?VLR3<ECD$C&JCI).G $QWL/M[Z0*_;U3YT,SMD]L,)Q4'5*X
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MXK"B+J&)X4L%5_8?'6K;./906BDM"@>&" I6UD_RY(0X H1!!R!T@/ <,.X
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MSCGW'E]R[V CU8O. 9"\%ESHH9<CEG>^K],<"JH[L@1AWBRE*BB:K5KYNE1
M,T<JN!\%0=<O*!/>:.#.9FHTD!5R)F"FB*Z*@JJW,7"Y&7JAMSV8LU6.]L ?
M#4JZ@@7@4SE39N>W*ADK0&@F!5&P''KWX=VD;_$.\)W!1N^LB77R+.6+W4RS
MH1?8A(!#BE:!FL<:'H!S*V32^-UH>FU(2]Q=;]4_.^_&RS/5\"#Y#Y9A/O3Z
M'LE@22N.<[GY HV?6ZN72J[=+]DTV, C::51%@W99% P43_I:W,/.X2P>X(0
M-83HD)"<(,0-(;Z4D#2$Q-U,;<7=PX0B'0V4W!!ET4;-+MQE.K:QSX0M^P*5
M><L,#T=SX!0A(S.J\(V,*:<B!4VHR,@W186FKCR:7$\ *>/ZAGPD4[$&C0!F
M^;28D.NK&W)%F""/C',+'OAH,K/Z?MID,:ZSB$YD$4;D40K,-?DD,LCV!7QC
MJ?45;7V-H[.*CU1U2!Q^(%$014<2>KB<'AZA3RZG!V?<Q&V58J>7G-";"@0E
MJ"T%Y6?TDE8O<7KQ157?*33Y^=5 R12AT+_.!+IM ]V>37P.:Q 5D*62A>D2
M==321&5P]&]2J_6<FNU8ZU$8]P;^>K=R1S"]_CYF<@23A"UFSTJWM=(]:^6I
ML^B064Y-LTFA0I92[CZ310DIH]S<XT+R"M]_ 'O1>FVTWO^M4+\-U/^G%>J_
MO]D@.*C0$4P8'E3H/:8;'!3(WVEK!:B5&P^:I+(26'>"]K2=0/>N\1Z<C\UD
MJ@?)7YEZK)D/=<5,>^.P-))!IV?^.*H>%?4&9>F:Y[-$TXK=,C?3%90%F/=+
M*7&[L0':>3WZ U!+ P04    " #J0:E46955TV4+  #A00  &@   'AL+W=O
M<FMS:&5E=',O<VAE970Q,38N>&ULQ5Q;;]LX%OXK1#"+[0!QK/NE2 ,T22^)
MFS:HVRD6@WU0)-H6*HL>BHX;H#]^#R79E"6*DAW'^Y+8$7G(<_O.A53.5X3^
MS&88,_1KGJ39FY,98XO7PV$6SO \R,[( J?P9$+H/&#PE4Z'V8+B(,HGS9.A
MH6G.<![$Z<G%>?ZW>WIQ3I8LB5-\3U&VG,\#^G2)$[)Z<Z*?K/_P-9[.&/_#
M\.)\$4SQ&+/OBWL*WX8;*E$\QVD6DQ11/'ES\E9_/=(UB\_(A_P5XU56^8PX
M+P^$_.1?;J(W)QK?$DYPR#B- 'X]XBN<))P4;.2?DNK)9E$^L?IY3?U]SCUP
M\Q!D^(HD/^*(S=Z<>"<HPI-@F;"O9/41EQS9G%Y(DBS_B5;E6.T$A<N,D7DY
M&78PC]/B=_"KE$1E@J&W3##*"4;?"68YP>P[P2HG6'TGV.4$N^\$IYS@])W@
MEA/<OA.\<H)7FV 9+1/\<H+?=P5=6VM.ZSUEH^S"Z HKR4WL.F#!Q3DE*T3Y
M>*#'/^1VFL\'RXI3[E-C1N%I#//8Q1A/P4-8AL@$72XS>)IE:( ^!Y0&W-C1
MJVO,@CC)_D0+2J)ER%"<HF\SLLR"-,I.T1_\^UV<). @V?F0P9XXY6%8KG]9
MK&^TK'^[3,Z089XB0S/T[^-K].J//R54KM14[@)ZAC0_IZ*U4[GN0<74NZB\
M4U,9XP50T3@5W6^G\KY++FD?*A]Z[\70LT+5$BH?^\M%0>6F/Q6CY"@DRY31
MI]*RVDG?[K#!=F&-GJO^(3C7QL.,C8<9.5E3[6'H*UX0RN)TBF[2(A;RD/+W
M)QB.;AB>9_]5+&9N%C/SQ:R6Q3XOYP^8<F>F^7+!0X)1MO;QWZA=Q!\*PDY.
MF$?BQPOK?/A8M9+.$3>J$5O\6!M^+"4_5Q1',>P\R#(2Q@'#$2 DFZ$DR-@@
M3D_1)*;P"9(%@*%'X(S0)S3';$8BF846B[F5_0T,<YN'6\D8T]L>,Y+1L0TY
MJ_:&55MI)U=DO@C2IW]G8!\,TS2WCR!!:_OYLL <DL%^/A' Z+_?/F2,0D:B
M,AMGL[:C%O,LH%.,P"S!;N8XR);\%RS*")H$,46/0;+$,HDZ#8WKMN;71-H<
MI-4$JAJQQ9&[X<A5<O2!D&@%40G%(-68YLR$.9<R+MRN#=XV1S@U+D?-(2T6
MX6UX\)0\O/MG&;,GA .:@MK!"=*HY"%#$TKFN<EG+.<-@C H,04E?L1!PF9A
M0#&Z)3$\^@N>@SYE?'N-+0^LNC_(QM3]03+&=.3,^QOF_0YWH !@X/$(_X("
M(L.0:Z108_2R>UT3Z8^F!DP@.872HPDQN)"^D+$LN[DIR6^Q[M?$<RL;I)NF
M7$!Z)773U5XK%Y%TF[ID!YI;U[5LF.=8=DW=LF&^V\:/")2ZH>3G4\SB:1$6
M,\Q8@BM>*Q>^T70YUZKSU!SD^A7K+%EJCO):W%<7P5A71^,<J(&;"#\PT!$'
M[V6<S5KSIV;XU'V]SDYS4!U,E4.V61%Q6%<'XF\XC2"Q^#*9P,_/A&&>37PB
M 3C.(GCB:8;*'44,U+N"X'.\7H0[71WO=E/,94G-52GF1C)H4!VUO541Q_2.
M0(8A54S1CQE)<!9 -K>NTE2"$!%&]XZ>=.@"XG5?#;XD#0D4  2J1U@BYEL
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M8,Q?#<;<P)@_'\8<6"B[U'XW-H=D/'#M91@D\RGK>V?:>FDZ3..C0#\5P-P
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M_(PWO^%TFYUZ/E/.:91=;@CV"4L!XOF*4OYVD[Z@/&D?_@]02P,$%     @
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MH'H.;CV/O-5SRFO_X1[^ 5!+ P04    " #J0:E4EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( .I!J50*,K2M_ <
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M%6X/D-LKW1Y@MU>\/4#OH'H'@-Y!]0X O8/YL@W0.ZC> :!W4+T#0.^@>@>
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M5?6N +VKZET!>C?5NP'T;JIW ^C=5.\&T+NIW@V@=U.]&T#OIGHW@-Y-]6X
MO9OJW0!Z-W.S-T#OIGHW@-Y=]>X O;OJW0%Z=]6[ _3NJG<'Z-U5[P[0NZO>
M':!W5[T[0.^N>G> WEWU[@"]NXEU 'I[9W,=@-_>F6#' 03WSB0[#F"X=R;:
M<0#%O3/9C@,X[IT)=QQ <N],NN, EGMGXAT'T-P[D^\X@.?>F8#'$42W 2:C
MP+0))D%T&V$B*DR;82(Z3!MB(DI,FV(B6DP;8R)J3)MC(GI,&V0BBDR;9'YK
MDSG-;]MQ^EST<:T#OK7 G,_O'3\___WRXTG#]4=T.7R=,=W\!5!+ P04
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M2P$"% ,4    " #J0:E4^\D33.\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #J0:E4F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( .I!J50AY#P+*0<  -$A   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #J0:E4/N0*"!\"  !N!0
M&               @(%M#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ ZD&I5-G4G\/R!@  K1T  !@              ("!PA$  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .I!J50<Z+3WV@,
M $D,   8              " @>H8  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " #J0:E4UBZGT^ &  #Y'   &               @('Z
M'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ ZD&I5/PB
M+SW@ @  NPD  !@              ("!$"0  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( .I!J53#V3.E[@D  -DV   8
M  " @28G  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #J
M0:E4-)4YELP"  "?!P  &               @(%*,0  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ ZD&I5,.$,+LU"@  ]2T  !@
M         ("!3#0  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( .I!J53E@4/3:BD  ,F'   9              " @;<^  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ZD&I5!; 6+?."P  [B8
M !D              ("!6&@  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " #J0:E454//=DL-  !.+P  &0              @(%==
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( .I!J50*M[&Q
MI T  ! J   9              " @=^!  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ ZD&I5% Y[:UF#0  ;28  !D
M ("!NH\  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #J
M0:E4Q_!]_48$  "="0  &0              @(%7G0  >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( .I!J51@3SY$0Q   !<O   9
M          " @=2A  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#
M%     @ ZD&I5/GC)JN8"0  Z1T  !D              ("!3K(  'AL+W=O
M<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #J0:E4GBTY8_D$  #;
M#   &0              @($=O   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM
M;%!+ 0(4 Q0    ( .I!J53C">T;-PL  .M.   9              " @4W!
M  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ ZD&I5&UC
MD\\L"P  >1P  !D              ("!N\P  'AL+W=O<FMS:&5E=',O<VAE
M970R,"YX;6Q02P$"% ,4    " #J0:E4+G"A[U .  #X)P  &0
M    @($>V   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M .I!J52!"!SCQ@8  !P1   9              " @:7F  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ ZD&I5&F%Y^Y=&@  _ED  !D
M             ("!HNT  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " #J0:E4PG+2TT4.  "O.   &0              @($V" $ >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .I!J50)'TCLC@L
M !4F   9              " @;(6 0!X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ ZD&I5)R>;SJ1!@  &1   !D              ("!
M=R(! 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #J0:E4
MQ6LYPJDH  !,A@  &0              @($_*0$ >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( .I!J51V_/,H' T  '4E   9
M      " @1]2 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ ZD&I5!"PLM<@!   *0H  !D              ("!<E\! 'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #J0:E4^&GZ>+T0  #7,P
M&0              @(')8P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( .I!J51&-14Y^ ,  (,)   9              " @;UT 0!X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ ZD&I5$UG<X#>
M+0  .J$  !D              ("!['@! 'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " #J0:E4BC 9=6 #   7"   &0
M@($!IP$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( .I!
MJ529M7D5F00  (0,   9              " @9BJ 0!X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ ZD&I5+JNFEK]!@  M!<  !D
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M=#,Y+GAM;%!+ 0(4 Q0    ( .I!J531%KI5:P,  'L)   9
M  " @5K- 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
MZD&I5&--&H#+ P  W@@  !D              ("!_- ! 'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " #J0:E4,VSP<0$(  !5&   &0
M            @('^U $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( .I!J535Z>W-304  $4,   9              " @3;= 0!X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ ZD&I5,ZQ*&28!
M#PH  !D              ("!NN(! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    " #J0:E4@WS8#& *  "S(P  &0              @(&)
MYP$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( .I!J51V
MR-5$= ,  &T(   9              " @2#R 0!X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @ ZD&I5 ]Z0A^Z @  [04  !D
M     ("!R_4! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .I!J52N*9K D (  / &   9              "
M@6L; @!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ ZD&I
M5,Q/L3C^ @  H @  !D              ("!,AX" 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    " #J0:E4/3]\(Q '   ?)@  &0
M        @(%G(0( >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   ( .I!J53:NNJ9800  ($/   9              " @:XH @!X;"]W;W)K
M<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ ZD&I5&Q X#[I P    T
M !D              ("!1BT" 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q0
M2P$"% ,4    " #J0:E4;#A1&YX$   ?$P  &0              @(%F,0(
M>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( .I!J527YY+*
M>04  ,(<   9              " @3LV @!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&UL4$L! A0#%     @ ZD&I5+-CUCO.!@  #R8  !D
M ("!ZSL" 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #J
M0:E45= J\DP'  #&)   &0              @('P0@( >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( .I!J50DJ]%WT@,  +\+   9
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M970V-2YX;6Q02P$"% ,4    " #J0:E4?%U*83H#  "O"   &0
M    @(&+70( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    (
M .I!J52"TL#:PP,  %H0   9              " @?Q@ @!X;"]W;W)K<VAE
M971S+W-H965T-C<N>&UL4$L! A0#%     @ ZD&I5*8Z50NG!   \1,  !D
M             ("!]F0" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"
M% ,4    " #J0:E4B_^;:N(#   2#   &0              @('4:0( >&PO
M=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( .I!J53N^M-=& 0
M ((.   9              " @>UM @!X;"]W;W)K<VAE971S+W-H965T-S N
M>&UL4$L! A0#%     @ ZD&I5'' +T:? P  ^PL  !D              ("!
M/'(" 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " #J0:E4
M2NX$6JT"  ".!P  &0              @($2=@( >&PO=V]R:W-H965T<R]S
M:&5E=#<R+GAM;%!+ 0(4 Q0    ( .I!J51:RT" ;P,  .T+   9
M      " @?9X @!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%
M  @ ZD&I5$4+D'6?!   6!   !D              ("!G'P" 'AL+W=O<FMS
M:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #J0:E4I.7>XIP$   >$0
M&0              @(%R@0( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+
M 0(4 Q0    ( .I!J52P&X?\L0,  $4,   9              " @46& @!X
M;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ ZD&I5$@I4NH'
M!P  .2$  !D              ("!+8H" 'AL+W=O<FMS:&5E=',O<VAE970W
M-RYX;6Q02P$"% ,4    " #J0:E49XF5D@T&   D'@  &0
M@(%KD0( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( .I!
MJ52 )ZOH404  +P:   9              " @:^7 @!X;"]W;W)K<VAE971S
M+W-H965T-SDN>&UL4$L! A0#%     @ ZD&I5&QG>?C\!   010  !D
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M=#@T+GAM;%!+ 0(4 Q0    ( .I!J50A"]B&& ,  $ *   9
M  " @=2Q @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @
MZD&I5-[R6L/E P  'Q(  !D              ("!([4" 'AL+W=O<FMS:&5E
M=',O<VAE970X-BYX;6Q02P$"% ,4    " #J0:E4DX4#GZH%  !"'@  &0
M            @($_N0( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4
M Q0    ( .I!J50Z@HX+OP,  '<.   9              " @2"_ @!X;"]W
M;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @ ZD&I5,[*?_")!0
MKAL  !D              ("!%L," 'AL+W=O<FMS:&5E=',O<VAE970X.2YX
M;6Q02P$"% ,4    " #J0:E4\L418^@"  !K"0  &0              @('6
MR ( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( .I!J50W
M;/&8[@8  !<J   9              " @?7+ @!X;"]W;W)K<VAE971S+W-H
M965T.3$N>&UL4$L! A0#%     @ ZD&I5([!4<\$"0  ,3<  !D
M     ("!&M," 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .I!J53Z/86@$P0  %@0   9              "
M@6[Q @!X;"]W;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ ZD&I
M5 0O  *;!P  4BL  !D              ("!N/4" 'AL+W=O<FMS:&5E=',O
M<VAE970Y."YX;6Q02P$"% ,4    " #J0:E4(RRMN@,#  !:"@  &0
M        @(&*_0( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0
M   ( .I!J507$N>NUP(  -8(   :              " @<0  P!X;"]W;W)K
M<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( .I!J51_J2GRZ ,   X/
M   :              " @=,# P!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM
M;%!+ 0(4 Q0    ( .I!J50::EMHHP,  -<.   :              " @?,'
M P!X;"]W;W)K<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( .I!J50Y
MD*U'NP<  $I"   :              " @<X+ P!X;"]W;W)K<VAE971S+W-H
M965T,3 S+GAM;%!+ 0(4 Q0    ( .I!J51B:O^,GP(  -\&   :
M      " @<$3 P!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0
M   ( .I!J514&HM[;P8  'T>   :              " @9@6 P!X;"]W;W)K
M<VAE971S+W-H965T,3 U+GAM;%!+ 0(4 Q0    ( .I!J53VO#!7XP0  *(<
M   :              " @3\= P!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM
M;%!+ 0(4 Q0    ( .I!J52HS@S:"@,  +4(   :              " @5HB
M P!X;"]W;W)K<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    ( .I!J50^
M)23YM@(  %$'   :              " @9PE P!X;"]W;W)K<VAE971S+W-H
M965T,3 X+GAM;%!+ 0(4 Q0    ( .I!J52[A?Y(N ,  &(1   :
M      " @8HH P!X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0
M   ( .I!J50VE+;+$P\  (A6   :              " @7HL P!X;"]W;W)K
M<VAE971S+W-H965T,3$P+GAM;%!+ 0(4 Q0    ( .I!J53HME!&;@(  "(&
M   :              " @<4[ P!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM
M;%!+ 0(4 Q0    ( .I!J53\.9%DG0,  $P-   :              " @6L^
M P!X;"]W;W)K<VAE971S+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( .I!J509
MI434&P4  /47   :              " @4!" P!X;"]W;W)K<VAE971S+W-H
M965T,3$S+GAM;%!+ 0(4 Q0    ( .I!J53^H3Y5_ @  #(W   :
M      " @9-' P!X;"]W;W)K<VAE971S+W-H965T,3$T+GAM;%!+ 0(4 Q0
M   ( .I!J52 !34CM (  +L'   :              " @<=0 P!X;"]W;W)K
M<VAE971S+W-H965T,3$U+GAM;%!+ 0(4 Q0    ( .I!J519E57390L  .%!
M   :              " @;-3 P!X;"]W;W)K<VAE971S+W-H965T,3$V+GAM
M;%!+ 0(4 Q0    ( .I!J53YU@[ P@8  /\F   :              " @5!?
M P!X;"]W;W)K<VAE971S+W-H965T,3$W+GAM;%!+ 0(4 Q0    ( .I!J53J
M 6;0IP,  -@.   :              " @4IF P!X;"]W;W)K<VAE971S+W-H
M965T,3$X+GAM;%!+ 0(4 Q0    ( .I!J50=/S"+! 4  '47   :
M      " @2EJ P!X;"]W;W)K<VAE971S+W-H965T,3$Y+GAM;%!+ 0(4 Q0
M   ( .I!J51$%S6E<P,  .X6   -              "  65O P!X;"]S='EL
M97,N>&UL4$L! A0#%     @ ZD&I5)>*NQS     $P(   L
M ( ! W,# %]R96QS+RYR96QS4$L! A0#%     @ ZD&I5 HRM*W\!P  5$X
M  \              ( ![',# 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M .I!J51)[13V1@,  -9%   :              "  15\ P!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .I!J531D>\:E0(   %#   3
M              "  9-_ P!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !_
- '\ !",  %F" P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>653</ContextCount>
  <ElementCount>749</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>222</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>25</UnitCount>
  <MyReports>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100040006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100050007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100070009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210071002 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210121003 - Disclosure - Restructuring, Impairment, and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment, and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210171004 - Disclosure - Business Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</Role>
      <ShortName>Business Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210211005 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210321006 - Disclosure - Other Income, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNet</Role>
      <ShortName>Other Income, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210361007 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210441008 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210481009 - Disclosure - Earnings per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShare</Role>
      <ShortName>Earnings per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210521010 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210591011 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210651012 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210711013 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210731014 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210841015 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210881016 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210921017 - Disclosure - Financial Guarantees and Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FinancialGuaranteesandWarranties</Role>
      <ShortName>Financial Guarantees and Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210941018 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210981019 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>211031020 - Disclosure - Related Party Balances and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RelatedPartyBalancesandTransactions</Role>
      <ShortName>Related Party Balances and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>211051021 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>211101022 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230083002 - Disclosure - Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleTables</Role>
      <ShortName>Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HeldforSale</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230133003 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230183004 - Disclosure - Business Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables</Role>
      <ShortName>Business Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230223005 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/ShareBasedCompensation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230333006 - Disclosure - Other Income, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetTables</Role>
      <ShortName>Other Income, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/OtherIncomeNet</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230373007 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230453008 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230493009 - Disclosure - Earnings per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShareTables</Role>
      <ShortName>Earnings per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsperCommonShare</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230533010 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/Leases</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230603011 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230663012 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230743013 - Disclosure - Pension Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsTables</Role>
      <ShortName>Pension Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/PensionBenefits</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230853014 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230893015 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230953016 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230993017 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquity</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>231063018 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240094004 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240104005 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (E.U. Disposal Group) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (E.U. Disposal Group) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240114006 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (U.K. Disposal Group) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails</Role>
      <ShortName>Held for Sale - Assets and Liabilities Held for Sale (U.K. Disposal Group) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240144007 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240154008 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240164009 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240194010 - Disclosure - Business Acquisitions and Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails</Role>
      <ShortName>Business Acquisitions and Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240204011 - Disclosure - Business Acquisitions and Divestitures - Net Gain on Split-off of Change Healthcare JV (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Net Gain on Split-off of Change Healthcare JV (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240234012 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240244013 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240254014 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240264015 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240274016 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240294018 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240304019 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240314020 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240344021 - Disclosure - Other Income, Net - Schedule of Other Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails</Role>
      <ShortName>Other Income, Net - Schedule of Other Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240354022 - Disclosure - Other Income, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetNarrativeDetails</Role>
      <ShortName>Other Income, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240384023 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240394024 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240404025 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240414026 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails</Role>
      <ShortName>Income Taxes - Components Of Deferred Tax Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240424027 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Gross Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240434028 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240464029 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240474030 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240504031 - Disclosure - Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails</Role>
      <ShortName>Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240514032 - Disclosure - Earnings per Common Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails</Role>
      <ShortName>Earnings per Common Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240544033 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240554034 - Disclosure - Leases - Supplemental balance sheet information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails</Role>
      <ShortName>Leases - Supplemental balance sheet information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240564035 - Disclosure - Leases - Components of lease costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesComponentsofleasecostsDetails</Role>
      <ShortName>Leases - Components of lease costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240574036 - Disclosure - Leases - Supplemental cash flow information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails</Role>
      <ShortName>Leases - Supplemental cash flow information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240584037 - Disclosure - Leases - Maturities of lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails</Role>
      <ShortName>Leases - Maturities of lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240614038 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240624039 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240634040 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240644041 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240674042 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240684043 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240694044 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240704045 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240724046 - Disclosure - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/VariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/VariableInterestEntities</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240754047 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240764048 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails</Role>
      <ShortName>Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240774049 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240784050 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails</Role>
      <ShortName>Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240794051 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240804052 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240814053 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails</Role>
      <ShortName>Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240824054 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails</Role>
      <ShortName>Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240834055 - Disclosure - Pension Benefits - Schedule of Investments Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails</Role>
      <ShortName>Pension Benefits - Schedule of Investments Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240864056 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240874057 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails</Role>
      <ShortName>Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240904058 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240914059 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240934060 - Disclosure - Financial Guarantees and Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails</Role>
      <ShortName>Financial Guarantees and Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FinancialGuaranteesandWarranties</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240964061 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240974062 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>241004063 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241014064 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241024065 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241044066 - Disclosure - Related Party Balances and Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails</Role>
      <ShortName>Related Party Balances and Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RelatedPartyBalancesandTransactions</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241074067 - Disclosure - Segments of Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails</Role>
      <ShortName>Segments of Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241084068 - Disclosure - Segments of Business - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails</Role>
      <ShortName>Segments of Business - Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241094069 - Disclosure - Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails</Role>
      <ShortName>Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="mck-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241114070 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>119</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="mck-20220331.htm">mck-20220331.htm</File>
    <File>mck-20220331.xsd</File>
    <File>mck-20220331_cal.xml</File>
    <File>mck-20220331_def.xml</File>
    <File>mck-20220331_lab.xml</File>
    <File>mck-20220331_pre.xml</File>
    <File>mck_ex1013x3312022xstockpl.htm</File>
    <File>mck_ex106xseverancepolicyf.htm</File>
    <File>mck_ex109xmanagementincent.htm</File>
    <File>mck_exhibit21x3312022.htm</File>
    <File>mck_exhibit23x3312022.htm</File>
    <File>mck_exhibit311x3312022.htm</File>
    <File>mck_exhibit312x3312022.htm</File>
    <File>mck_exhibit32x3312022.htm</File>
    <File>mck_exhibit415x3312022.htm</File>
    <File>mck_exx108xmanagementincen.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20220331_g1.jpg</File>
    <File>mck-20220331_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="2202">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>145
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20220331.htm": {
   "axisCustom": 1,
   "axisStandard": 56,
   "contextCount": 653,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 1221,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 11,
    "http://mckesson123.com/20220331": 2,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 19
   },
   "keyCustom": 154,
   "keyStandard": 595,
   "memberCustom": 122,
   "memberStandard": 91,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://mckesson123.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i60c1e60e920e4d629a84b4eff86bead7_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794051 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i60c1e60e920e4d629a84b4eff86bead7_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804052 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814053 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
     "shortName": "Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "iad63af957fc64549aee083f9cdee9453_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824054 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
     "shortName": "Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i9a603bd1125146b48426fed799546156_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834055 - Disclosure - Pension Benefits - Schedule of Investments Measured at Fair Value (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
     "shortName": "Pension Benefits - Schedule of Investments Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864056 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "if18ad6684a8e4fe68e7401d8d6aaf930_D20190401-20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ibbe2788b715640b4b52cee7ba7637f83_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874057 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
     "shortName": "Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ibbe2788b715640b4b52cee7ba7637f83_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904058 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914059 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
     "shortName": "Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i407dcd9fcbb146db960f9ded6cee8015_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:GuaranteeObligationsExposureExpiringinYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934060 - Disclosure - Financial Guarantees and Warranties (Details)",
     "role": "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
     "shortName": "Financial Guarantees and Warranties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:GuaranteeObligationsExposureExpiringinYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210071002 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActNewYorkAnnualSurcharge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964061 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:OpioidStewardshipActNewYorkAnnualSurcharge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i272671062b484a64b905316d40d3ac81_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974062 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
     "shortName": "Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004063 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014064 - Disclosure - Stockholders' Equity - Schedule of Share Repurchases (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails",
     "shortName": "Stockholders' Equity - Schedule of Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024065 - Disclosure - Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
     "shortName": "Stockholders' Equity - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i1f5d39fcc93f468db79dbc8f03cfc331_I20190331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "icbf8232e206747f2be913302ec5dbaaf_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044066 - Disclosure - Related Party Balances and Transactions (Details)",
     "role": "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
     "shortName": "Related Party Balances and Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "icbf8232e206747f2be913302ec5dbaaf_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074067 - Disclosure - Segments of Business - Narrative (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
     "shortName": "Segments of Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084068 - Disclosure - Segments of Business - Schedule of Segment Information (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
     "shortName": "Segments of Business - Schedule of Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:GrossProfitNetofExpensesIncludingOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241094069 - Disclosure - Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
     "shortName": "Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114070 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i3028b894dc5241e6bdae80eea3de8d1f_I20190331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210121003 - Disclosure - Restructuring, Impairment, and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment, and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210171004 - Disclosure - Business Acquisitions and Divestitures",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures",
     "shortName": "Business Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210211005 - Disclosure - Share-Based Compensation",
     "role": "http://mckesson123.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210321006 - Disclosure - Other Income, Net",
     "role": "http://mckesson123.com/role/OtherIncomeNet",
     "shortName": "Other Income, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210361007 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210441008 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210481009 - Disclosure - Earnings per Common Share",
     "role": "http://mckesson123.com/role/EarningsperCommonShare",
     "shortName": "Earnings per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorDirectFinancingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210521010 - Disclosure - Leases",
     "role": "http://mckesson123.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorDirectFinancingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://mckesson123.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210591011 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210651012 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210711013 - Disclosure - Variable Interest Entities",
     "role": "http://mckesson123.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210731014 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210841015 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210881016 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:FinancialGuaranteesAndWarrantiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210921017 - Disclosure - Financial Guarantees and Warranties",
     "role": "http://mckesson123.com/role/FinancialGuaranteesandWarranties",
     "shortName": "Financial Guarantees and Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:FinancialGuaranteesAndWarrantiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210941018 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981019 - Disclosure - Stockholders' Equity",
     "role": "http://mckesson123.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211031020 - Disclosure - Related Party Balances and Transactions",
     "role": "http://mckesson123.com/role/RelatedPartyBalancesandTransactions",
     "shortName": "Related Party Balances and Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211051021 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211101022 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230083002 - Disclosure - Held for Sale (Tables)",
     "role": "http://mckesson123.com/role/HeldforSaleTables",
     "shortName": "Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230133003 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment, and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230183004 - Disclosure - Business Acquisitions and Divestitures (Tables)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables",
     "shortName": "Business Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230223005 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230333006 - Disclosure - Other Income, Net (Tables)",
     "role": "http://mckesson123.com/role/OtherIncomeNetTables",
     "shortName": "Other Income, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230373007 - Disclosure - Income Taxes (Tables)",
     "role": "http://mckesson123.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230453008 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230493009 - Disclosure - Earnings per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsperCommonShareTables",
     "shortName": "Earnings per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230533010 - Disclosure - Leases (Tables)",
     "role": "http://mckesson123.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230603011 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230663012 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230743013 - Disclosure - Pension Benefits (Tables)",
     "role": "http://mckesson123.com/role/PensionBenefitsTables",
     "shortName": "Pension Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230853014 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230893015 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230953016 - Disclosure - Commitment and Contingencies (Tables)",
     "role": "http://mckesson123.com/role/CommitmentandContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993017 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231063018 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:AccountsReceivableCustomerAccountsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails",
     "shortName": "Significant Accounting Policies - Receivables, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:AccountsReceivableCustomerAccountsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails",
     "shortName": "Significant Accounting Policies - Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094004 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i5bb3e221693840dbb9ad1863bc6749ce_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i148d988b662042b2a7deeb2a40ab602b_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104005 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (E.U. Disposal Group) (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (E.U. Disposal Group) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i148d988b662042b2a7deeb2a40ab602b_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i72fd68575bf94328b58c74040ee351f4_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114006 - Disclosure - Held for Sale - Assets and Liabilities Held for Sale (U.K. Disposal Group) (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
     "shortName": "Held for Sale - Assets and Liabilities Held for Sale (U.K. Disposal Group) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i72fd68575bf94328b58c74040ee351f4_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144007 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i69ad3377d9084d09824adc34ca4401cc_D20190401-20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154008 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Details for Charges Recorded (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164009 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Activity Related to Restructuring Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveSettledWithoutCash2",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194010 - Disclosure - Business Acquisitions and Divestitures (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
     "shortName": "Business Acquisitions and Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i372b78f92945468a8ee64d9a3cfcac2a_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mck:TaxAgreementReceivablePercentofNetCashTaxSavingsRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i644b2169690443038315b62f32a3e6f6_D20200309-20200309",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:EquityMethodInvestmentFairValueofStockAccepted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204011 - Disclosure - Business Acquisitions and Divestitures - Net Gain on Split-off of Change Healthcare JV (Details)",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
     "shortName": "Business Acquisitions and Divestitures - Net Gain on Split-off of Change Healthcare JV (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i644b2169690443038315b62f32a3e6f6_D20200309-20200309",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:EquityMethodInvestmentFairValueofStockAccepted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234012 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244013 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Components of Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254014 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
     "shortName": "Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i0de78c2495d84cb2bf86aad5fed6c64a_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264015 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i0de78c2495d84cb2bf86aad5fed6c64a_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:DataRelatedtoRSUActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274016 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
     "shortName": "Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:DataRelatedtoRSUActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i032208a75b2c4b1285439d5cbd80c60d_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294018 - Disclosure - Share-Based Compensation - Summary of Options Outstanding (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails",
     "shortName": "Share-Based Compensation - Summary of Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304019 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314020 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ibcd330dd57be4c7b9eb07caed3329296_D20210401-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ia3deea6c14b24c35a88fb4f3b5239602_I20190331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ia3deea6c14b24c35a88fb4f3b5239602_I20190331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344021 - Disclosure - Other Income, Net - Schedule of Other Income, Net (Details)",
     "role": "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
     "shortName": "Other Income, Net - Schedule of Other Income, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354022 - Disclosure - Other Income, Net - Narrative (Details)",
     "role": "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
     "shortName": "Other Income, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i63827a6bb93940659eeb1ad9423601f5_I20220331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384023 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394024 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
     "shortName": "Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404025 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414026 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
     "shortName": "Income Taxes - Components Of Deferred Tax Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424027 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Gross Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434028 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "id55a461c58734092bdfe4dbc17c833c2_I20180919",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464029 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "id55a461c58734092bdfe4dbc17c833c2_I20180919",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474030 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ie0fc3a8b5a574f52a1306089076f6180_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "icb6786f86e4c4e6d8af02b607fd8f48b_D20210701-20210731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (Parentheticals)",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504031 - Disclosure - Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
     "shortName": "Earnings per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514032 - Disclosure - Earnings per Common Share - Narrative (Details)",
     "role": "http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails",
     "shortName": "Earnings per Common Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i046e3ecb45094e2c874a7c2bf57a0a82_I20190401",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544033 - Disclosure - Leases - Narrative (Details)",
     "role": "http://mckesson123.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554034 - Disclosure - Leases - Supplemental balance sheet information (Details)",
     "role": "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
     "shortName": "Leases - Supplemental balance sheet information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564035 - Disclosure - Leases - Components of lease costs (Details)",
     "role": "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails",
     "shortName": "Leases - Components of lease costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574036 - Disclosure - Leases - Supplemental cash flow information (Details)",
     "role": "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails",
     "shortName": "Leases - Supplemental cash flow information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584037 - Disclosure - Leases - Maturities of lease liabilities (Details)",
     "role": "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails",
     "shortName": "Leases - Maturities of lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "ied4fb100eb7e4d488f31db285fa7c8ca_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614038 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "if4e15a6a6f7a4c1c8421d5e8e9fcacba_D20210401-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624039 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i65c2a80c51924ffea392e70a7d81af35_I20220331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634040 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644041 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674042 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "idd7a390cba074697a32fefbb6fab99ca_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684043 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i9f981237ad304136b3c2ae388a494f17_I20190930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694044 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i1ae704fbe3b04d318f47ec250c37e298_D20190901-20190930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704045 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724046 - Disclosure - Variable Interest Entities (Details)",
     "role": "http://mckesson123.com/role/VariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i6ddb54fd3967467a87bab9dd990e6cad_I20220331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754047 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764048 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
     "shortName": "Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i4bb09b036d0a4a9a9418fbeb029408e2_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774049 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
     "shortName": "Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i68c9c1cd290f4f4d93c6f66a958047ca_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i60c1e60e920e4d629a84b4eff86bead7_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784050 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
     "shortName": "Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20220331.htm",
      "contextRef": "i60c1e60e920e4d629a84b4eff86bead7_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 222,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "U.K."
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S. Plans",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r1037",
      "r1038",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r1037",
      "r1038",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r1037",
      "r1038",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r1037",
      "r1038",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r1040"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1035"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1034"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r1037",
      "r1038",
      "r1039"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1036"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A063EuroNotesDueAugust172021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.63% Euro Notes Due August 17, 2021",
        "label": "0.63% Euro Notes Due August 17, 2021 [Member]",
        "terseLabel": "0.63% Euro Notes due August 17, 2021"
       }
      }
     },
     "localname": "A063EuroNotesDueAugust172021Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1.500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025 [Member]",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes due 2025"
       }
      }
     },
     "localname": "A1.500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1.625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026 [Member]",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes due 2026"
       }
      }
     },
     "localname": "A1.625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A130NotesDueAugust152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Notes Due August 15, 2026",
        "label": "1.30% Notes Due August 15, 2026 [Member]",
        "terseLabel": "1.30% Notes due August 15, 2026"
       }
      }
     },
     "localname": "A130NotesDueAugust152026Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2013StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2013 Stock Plan [Member]",
        "label": "2013 Stock Plan [Member]",
        "terseLabel": "2013 Stock Plan"
       }
      }
     },
     "localname": "A2013StockPlanMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3.125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029 [Member]",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes due 2029"
       }
      }
     },
     "localname": "A3.125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMarch12021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due March 1, 2021",
        "label": "4.75% Notes Due March 1, 2021 [Member]",
        "terseLabel": "4.75% Notes Due March 1, 2021"
       }
      }
     },
     "localname": "A475NotesDueMarch12021Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest",
        "label": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseFebruary2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, February 2022",
        "label": "Accelerated Share Repurchase, February 2022 [Member]",
        "terseLabel": "Accelerated Share Repurchase, February 2022"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseFebruary2022Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMay2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, May 2019",
        "label": "Accelerated Share Repurchase, May 2019 [Member]",
        "terseLabel": "Accelerated Share Repurchase, May 2019"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMay2019Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, May 2021",
        "label": "Accelerated Share Repurchase, May 2021 [Member]",
        "terseLabel": "Accelerated Share Repurchase, May 2021"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMay2021Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccountsReceivableCustomerAccountsGross": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Customer Accounts, Gross",
        "label": "Accounts Receivable, Customer Accounts, Gross",
        "terseLabel": "Customer accounts"
       }
      }
     },
     "localname": "AccountsReceivableCustomerAccountsGross",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AccruedShareRepurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Share Repurchases",
        "label": "Accrued Share Repurchases",
        "terseLabel": "Accrued shares repurchased"
       }
      }
     },
     "localname": "AccruedShareRepurchases",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AmortizationOfLossOnDerivativeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Loss On Derivative, Term",
        "label": "Amortization of Loss On Derivative, Term",
        "terseLabel": "Amortization of loss on derivative, term (in years)"
       }
      }
     },
     "localname": "AmortizationOfLossOnDerivativeTerm",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring compensation (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation (2)"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental balance sheet information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets for Plan Benefits, Defined Benefit Plan, Current",
        "label": "Assets for Plan Benefits, Defined Benefit Plan, Current",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsForPlanBenefitsDefinedBenefitPlanCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets for Plan Benefits, Defined Benefit Plan, Noncurrent",
        "label": "Assets for Plan Benefits, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information [Abstract]",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://mckesson123.com/20220331",
     "xbrltype": "stringItemType"
    },
    "mck_AustrianBusinessOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Austrian Business Operations",
        "label": "Austrian Business Operations [Member]",
        "terseLabel": "Austrian Business Operations"
       }
      }
     },
     "localname": "AustrianBusinessOperationsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Health Benefit Claims Management and Plan Administrative Services Business",
        "label": "Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]",
        "terseLabel": "Canadian Health Benefit Claims Management and Plan Administrative Services Business"
       }
      }
     },
     "localname": "CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CapitalizedSoftwareHeldforInternalUseUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized Software Held for Internal Use, Useful Life",
        "label": "Capitalized Software Held for Internal Use, Useful Life",
        "terseLabel": "Capitalized software held for internal use, useful life"
       }
      }
     },
     "localname": "CapitalizedSoftwareHeldforInternalUseUsefulLife",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "label": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "terseLabel": "Cash, cash equivalents, and restricted cash classified within Assets held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ChangeHealthcareInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare, Inc. [Member]",
        "label": "Change Healthcare, Inc. [Member]",
        "terseLabel": "Change Healthcare, Inc."
       }
      }
     },
     "localname": "ChangeHealthcareInc.Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ChangeHealthcareLLCChangeHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "label": "Change Healthcare, LLC (\u201cChange Healthcare\u201d) [Member]",
        "terseLabel": "Change Healthcare"
       }
      }
     },
     "localname": "ChangeHealthcareLLCChangeHealthcareMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cherokee Nation",
        "label": "Cherokee Nation [Member]",
        "terseLabel": "Cherokee Nation"
       }
      }
     },
     "localname": "CherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York [Member]",
        "label": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York [Member]",
        "terseLabel": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York"
       }
      }
     },
     "localname": "CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted",
        "label": "Common Stock, Conversion Basis, Number of Shares Issued For Each Share Converted",
        "terseLabel": "Number of shares converted into per share converted (shares)"
       }
      }
     },
     "localname": "CommonStockConversionBasisNumberofSharesIssuedForEachShareConverted",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_ConsolidatedActionsvSureScriptsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Actions v SureScripts, LLC [Member]",
        "label": "Consolidated Actions v SureScripts, LLC [Member]",
        "terseLabel": "Consolidated Actions v SureScripts, LLC"
       }
      }
     },
     "localname": "ConsolidatedActionsvSureScriptsLLCMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate expenses, net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DataRelatedtoRSUActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Data Related to RSU Activity [Table Text Block]",
        "label": "Data Related to RSU Activity [Table Text Block]",
        "terseLabel": "Schedule of data related to restricted stock unit award activity"
       }
      }
     },
     "localname": "DataRelatedtoRSUActivityTableTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_DeferredTaxAssetLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Lease Obligations",
        "label": "Deferred Tax Asset, Lease Obligations",
        "terseLabel": "Lease obligations"
       }
      }
     },
     "localname": "DeferredTaxAssetLeaseObligations",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DeferredTaxAssetLitigationAndClaims": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Litigation and Claims",
        "label": "Deferred Tax Asset, Litigation and Claims",
        "terseLabel": "Opioid-related litigation and claims"
       }
      }
     },
     "localname": "DeferredTaxAssetLitigationAndClaims",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DeferredTaxLiabilitiesLeaseRightofuseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Lease Right-of-use Assets",
        "label": "Deferred Tax Liabilities, Lease Right-of-use Assets",
        "negatedTerseLabel": "Lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeaseRightofuseAssets",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.",
        "label": "Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets",
        "terseLabel": "Unexpected actuarial losses (as a percent) (exceeding)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)",
        "label": "Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)",
        "terseLabel": "Amortization of unrecognized actuarial loss and prior service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanAnnuityContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Annuity Contracts",
        "label": "Defined Benefit Plan, Annuity Contracts [Member]",
        "terseLabel": "Annuity contracts"
       }
      }
     },
     "localname": "DefinedBenefitPlanAnnuityContractsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points",
        "terseLabel": "Increase (decrease) in basis points"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes",
        "terseLabel": "Actuarial gain (loss), demographic and assumption changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate",
        "terseLabel": "Actuarial loss resulting from discount rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement",
        "negatedTerseLabel": "Curtailment/settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationsExpensesPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligations, Expenses Paid",
        "label": "Defined Benefit Plan, Benefit Obligations, Expenses Paid",
        "negatedTerseLabel": "Expenses paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationsExpensesPaid",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Contributions by Employer and Plan Participants",
        "label": "Defined Benefit Plan, Contributions by Employer and Plan Participants",
        "terseLabel": "Employer and participant contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsbyEmployerandPlanParticipants",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset",
        "label": "Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset",
        "terseLabel": "Percentage of total plan contribution - exceeding (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanOtherFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Other Funds [Member]",
        "label": "Defined Benefit Plan, Other Funds [Member]",
        "terseLabel": "Real estate funds and Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherFundsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DefinedBenefitPlanPlanAssetsExpensesPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Expenses Paid",
        "label": "Defined Benefit Plan, Plan Assets, Expenses Paid",
        "negatedTerseLabel": "Expenses paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsExpensesPaid",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "label": "Defined Benefit Plan, Plan Assets, Payment For Annuity Contract",
        "terseLabel": "Annuity contracts purchased"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsPaymentForAnnuityContract",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanSettlementPlanParticipants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Settlement, Plan Participants",
        "label": "Defined Benefit Plan, Settlement, Plan Participants",
        "terseLabel": "Number of plan participants elected to receive settlement payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementPlanParticipants",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_DefinedContributionPlanMatchingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan Matching [Axis]",
        "label": "Defined Contribution Plan Matching [Axis]",
        "terseLabel": "Defined Contribution Plan Matching [Axis]"
       }
      }
     },
     "localname": "DefinedContributionPlanMatchingAxis",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_DefinedContributionPlanMatchingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Defined Contribution Plan Matching [Axis]",
        "label": "Defined Contribution Plan Matching [Domain]",
        "terseLabel": "Defined Contribution Plan Matching [Domain]"
       }
      }
     },
     "localname": "DefinedContributionPlanMatchingDomain",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value",
        "label": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value",
        "terseLabel": "Accumulated other comprehensive loss in charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "terseLabel": "Gross purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationExpected",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "terseLabel": "Consideration receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "label": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "label": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized",
        "verboseLabel": "Pension liabilities derecognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "label": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "negatedLabel": "Accumulated other comprehensive loss derecognized"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of businesses held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DistributionandRetailBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution and Retail Business [Member]",
        "label": "Distribution and Retail Business [Member]",
        "terseLabel": "Distribution and Retail Business"
       }
      }
     },
     "localname": "DistributionandRetailBusinessMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributors",
        "label": "Distributors [Member]",
        "terseLabel": "Distributors"
       }
      }
     },
     "localname": "DistributorsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EUBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E.U. Businesses (Disposal Group)",
        "label": "E.U. Businesses (Disposal Group) [Member]",
        "terseLabel": "E.U. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EUBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationCapitalLossCarryback": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Capital Loss Carryback",
        "label": "Effective Income Tax Rate Reconciliation, Capital Loss Carryback",
        "terseLabel": "Capital loss carryback"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCapitalLossCarryback",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit",
        "label": "Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit",
        "negatedTerseLabel": "Net tax benefit on intellectual property transfer"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Litigation and Claims",
        "label": "Effective Income Tax Rate Reconciliation, Litigation and Claims",
        "terseLabel": "Opioid-related litigation and claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLitigationAndClaims",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EmployeeContributions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.",
        "label": "Employee Contributions",
        "terseLabel": "Employee contributions (as a percent)"
       }
      }
     },
     "localname": "EmployeeContributions",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "label": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "terseLabel": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation"
       }
      }
     },
     "localname": "EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee service share based compensation period to purchase shares through payroll deductions",
        "label": "Employee Service Share Based Compensation Period To Purchase Shares Through Payroll Deductions",
        "terseLabel": "Period over which payroll is deducted to purchase shares"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]",
        "label": "Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]",
        "terseLabel": "Employee Severance, Accelerated Depreciation and Project Consulting Fees"
       }
      }
     },
     "localname": "EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]",
        "label": "Employee Severance, Exit-related Costs and Asset Impairment Charges [Member]",
        "terseLabel": "Employee Severance, Exit-related Costs and Asset Impairment Charges"
       }
      }
     },
     "localname": "EmployeeSeveranceExitrelatedCostsandAssetImpairmentChargesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EnvironmentalLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental Litigation [Member]",
        "label": "Environmental Litigation [Member]",
        "terseLabel": "Environmental Litigation"
       }
      }
     },
     "localname": "EnvironmentalLitigationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EquityMethodInvestmentCarryingAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Carrying Amount",
        "label": "Equity Method Investment, Carrying Amount",
        "negatedLabel": "Investment in the Change Healthcare JV at exchange date"
       }
      }
     },
     "localname": "EquityMethodInvestmentCarryingAmount",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentFairValueofStockAccepted": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Fair Value of Stock Accepted",
        "label": "Equity Method Investment, Fair Value of Stock Accepted",
        "terseLabel": "Fair value of McKesson common stock accepted (15.4 million shares at $131.97 per share on March 9, 2020)"
       }
      }
     },
     "localname": "EquityMethodInvestmentFairValueofStockAccepted",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)",
        "label": "Equity Method Investment, Release of Accumulated Other Comprehensive income (Loss)",
        "terseLabel": "Release of accumulated other comprehensive loss attributable to the joint venture"
       }
      }
     },
     "localname": "EquityMethodInvestmentReleaseofAccumulatedOtherComprehensiveincomeLoss",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentStockAccepted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Stock Accepted",
        "label": "Equity Method Investment, Stock Accepted",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentStockAccepted",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_EquityMethodInvestmentStockAcceptedAverageCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Stock Accepted, Average Cost",
        "label": "Equity Method Investment, Stock Accepted, Average Cost",
        "terseLabel": "Cost of shares repurchased (in usd per share)"
       }
      }
     },
     "localname": "EquityMethodInvestmentStockAcceptedAverageCost",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_EquityMethodInvestmentTransactionCostsIncurred": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Transaction Costs Incurred",
        "label": "Equity Method Investment, Transaction Costs Incurred",
        "negatedTerseLabel": "Less: Transaction costs incurred"
       }
      }
     },
     "localname": "EquityMethodInvestmentTransactionCostsIncurred",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EquityMethodInvestmentsReversalOfDeferredTaxLiability": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Reversal of Deferred Tax Liability",
        "label": "Equity Method Investments, Reversal of Deferred Tax Liability",
        "terseLabel": "Reversal of deferred tax liability"
       }
      }
     },
     "localname": "EquityMethodInvestmentsReversalOfDeferredTaxLiability",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EstimatedEnvironmentalAssessmentAndCleanupCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Environmental Assessment And Cleanup Costs",
        "label": "Estimated Environmental Assessment And Cleanup Costs",
        "terseLabel": "Estimated environmental assessment and cleanup costs"
       }
      }
     },
     "localname": "EstimatedEnvironmentalAssessmentAndCleanupCosts",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanAssetsHeldForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Assets Held for Sale",
        "label": "European Assets Held for Sale [Member]",
        "terseLabel": "European Assets Held for Sale"
       }
      }
     },
     "localname": "EuropeanAssetsHeldForSaleMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Businesses (Disposal Group)",
        "label": "European Businesses (Disposal Group) [Member]",
        "terseLabel": "European Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EuropeanBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EvanstonPolicePensionFundv.McKessonCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evanston Police Pension Fund v. McKesson Corporation [Member]",
        "label": "Evanston Police Pension Fund v. McKesson Corporation [Member]",
        "terseLabel": "Evanston Police Pension Fund v. McKesson Corporation"
       }
      }
     },
     "localname": "EvanstonPolicePensionFundv.McKessonCorporationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ExchangeOfferSharesDistributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Offer, Shares Distributed",
        "label": "Exchange Offer, Shares Distributed",
        "terseLabel": "Shares distributed in split-off (in shares)",
        "verboseLabel": "Shares distributed to stockholders (in shares)"
       }
      }
     },
     "localname": "ExchangeOfferSharesDistributed",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_ExchangeOfferSharesExchanged": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Offer, Shares Exchanged",
        "label": "Exchange Offer, Shares Exchanged",
        "terseLabel": "Shares of common stock exchanged (in shares)"
       }
      }
     },
     "localname": "ExchangeOfferSharesExchanged",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_FinancialGuaranteesAndWarrantiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Guarantees And Warranties [Abstract]",
        "label": "Financial Guarantees And Warranties [Abstract]",
        "terseLabel": "Financial Guarantees And Warranties [Abstract]"
       }
      }
     },
     "localname": "FinancialGuaranteesAndWarrantiesAbstract",
     "nsuri": "http://mckesson123.com/20220331",
     "xbrltype": "stringItemType"
    },
    "mck_FinancialGuaranteesAndWarrantiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial guarantees And warranties.",
        "label": "Financial Guarantees And Warranties [Text Block]",
        "terseLabel": "Financial Guarantees And Warranties"
       }
      }
     },
     "localname": "FinancialGuaranteesAndWarrantiesTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_FirstPartOfPayContributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Part Of Pay Contribution [Member]",
        "label": "First Part Of Pay Contribution [Member]",
        "terseLabel": "First Part Of Pay Contribution"
       }
      }
     },
     "localname": "FirstPartOfPayContributionMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]",
        "label": "Floating Rate Euro Notes Due February Twelve Two Thousand and Twenty [Member]",
        "terseLabel": "Floating Rate Euro Notes due February 12, 2020"
       }
      }
     },
     "localname": "FloatingRateEuroNotesDueFebruaryTwelveTwoThousandandTwentyMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For Two Counties In re: National Prescription Opiate Litigation [Member]",
        "label": "For Two Counties In re: National Prescription Opiate Litigation [Member]",
        "terseLabel": "For Two Counties In re: National Prescription Opiate Litigation"
       }
      }
     },
     "localname": "ForTwoCountiesInreNationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "label": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "terseLabel": "Forward Contracts to Hedge Euro Against British Pound Cash Flows"
       }
      }
     },
     "localname": "ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]",
        "label": "Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges [Member]",
        "terseLabel": "Forward Contracts to Offset Impact of Ineffectiveness of Net investment Hedges"
       }
      }
     },
     "localname": "ForwardContractstoOffsetImpactofIneffectivenessofNetinvestmentHedgesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanPharmaceuticalWholesaleJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Joint Venture [Member]",
        "label": "German Pharmaceutical Wholesale Joint Venture [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Joint Venture"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleJointVentureMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanWholesaleBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Business [Member]",
        "label": "German Wholesale Business [Member]",
        "terseLabel": "German Wholesale Business"
       }
      }
     },
     "localname": "GermanWholesaleBusinessMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GlobalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Facility [Member]",
        "label": "Global Facility [Member]",
        "terseLabel": "Global Facility"
       }
      }
     },
     "localname": "GlobalFacilityMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Governmental Entities",
        "label": "Governmental Entities [Member]",
        "terseLabel": "Governmental Entities"
       }
      }
     },
     "localname": "GovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GrossProfitNetofExpensesIncludingOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Profit, Net of Expenses, Including Other Income",
        "label": "Gross Profit, Net of Expenses, Including Other Income",
        "terseLabel": "Operating income"
       }
      }
     },
     "localname": "GrossProfitNetofExpensesIncludingOtherIncome",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsCustomersDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Customers Debt [Member]",
        "label": "Guarantee Obligations Customers Debt [Member]",
        "terseLabel": "Guarantee Obligations Customers Debt"
       }
      }
     },
     "localname": "GuaranteeObligationsCustomersDebtMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Five",
        "label": "Guarantee Obligations Exposure Expiring in Year Five",
        "terseLabel": "Guarantee obligations, expiring in 2027"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFive",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Five Thereafter",
        "label": "Guarantee Obligations Exposure Expiring in Year Five Thereafter",
        "terseLabel": "Guarantee obligations, expiring after 2027"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFiveThereafter",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Four",
        "label": "Guarantee Obligations Exposure Expiring in Year Four",
        "terseLabel": "Guarantee obligations, expiring in 2026"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFour",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year One",
        "label": "Guarantee Obligations Exposure Expiring in Year One",
        "terseLabel": "Guarantee obligations, expiring in 2023"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearOne",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Three",
        "label": "Guarantee Obligations Exposure Expiring in Year Three",
        "terseLabel": "Guarantee obligations, expiring in 2025"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearThree",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Two",
        "label": "Guarantee Obligations Exposure Expiring in Year Two",
        "terseLabel": "Guarantee obligations, expiring in 2024"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearTwo",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GuaranteeObligationsInventoryRepurchaseGuaranteesMember",
        "label": "Guarantee Obligations Inventory Repurchase Guarantees [Member]",
        "terseLabel": "Guarantee Obligations Inventory Repurchase Guarantees"
       }
      }
     },
     "localname": "GuaranteeObligationsInventoryRepurchaseGuaranteesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GuarantorObligationsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Period",
        "label": "Guarantor Obligations, Period",
        "terseLabel": "Debt guarantee period"
       }
      }
     },
     "localname": "GuarantorObligationsPeriod",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_HazardousSubstanceSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of sites that hazardous substances were allegedly disposed at.",
        "label": "Hazardous substance sites",
        "terseLabel": "Hazardous substance sites, number"
       }
      }
     },
     "localname": "HazardousSubstanceSites",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "positiveIntegerItemType"
    },
    "mck_HeldforSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale [Policy Text Block]",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldforSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment",
        "label": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment",
        "negatedTerseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairment",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs",
        "label": "Income (Loss) from Equity Method Investments, Including Other Than Temporary Impairment and Transaction Costs",
        "terseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture"
       }
      }
     },
     "localname": "IncomeLossfromEquityMethodInvestmentsIncludingOtherThanTemporaryImpairmentandTransactionCosts",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncomeTaxExpenseBenefitDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Discrete Items",
        "label": "Income Tax Expense (Benefit) Discrete Items",
        "negatedLabel": "Net discrete tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDiscreteItems",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IndividualClaimantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Claimant",
        "label": "Individual Claimant [Member]",
        "terseLabel": "Individual Claimant"
       }
      }
     },
     "localname": "IndividualClaimantMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InsuranceCoverageLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Coverage Litigation",
        "label": "Insurance Coverage Litigation [Member]",
        "terseLabel": "Insurance Coverage Litigation"
       }
      }
     },
     "localname": "InsuranceCoverageLitigationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InsuranceProgramsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]",
        "label": "Insurance Programs [Policy Text Block]",
        "terseLabel": "Insurance Programs"
       }
      }
     },
     "localname": "InsuranceProgramsPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_InternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software",
        "label": "Internally developed software [Member]",
        "terseLabel": "Internally developed software"
       }
      }
     },
     "localname": "InternallyDevelopedSoftwareMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "International Segment [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]",
        "label": "Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640 [Member]",
        "terseLabel": "Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640"
       }
      }
     },
     "localname": "KennebunkVillagePharmacyInc.v.SureScriptsLLCetal.119cv7445Whitmanv.SureScriptsLLCetal.No.119cv7448BBKGlobalCorp.v.SureScriptsLLCetal.119cv7640Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Largest Customer [Member]",
        "label": "Largest Customer [Member]",
        "terseLabel": "CVS"
       }
      }
     },
     "localname": "LargestCustomerMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities Payments Due [Abstract]",
        "label": "Lease Liabilities Payments Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due",
        "label": "Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDue",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 6.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due After Year Five",
        "label": "Lease, Liability, Payments, Due After Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Next Twelve Months",
        "label": "Lease, Liability, Payments, Due Next Twelve Months",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 5.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Five",
        "label": "Lease, Liability, Payments, Due Year Five",
        "totalLabel": "2027"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 4.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Four",
        "label": "Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Three",
        "label": "Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Two",
        "label": "Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseandOtherObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease and Other Obligations [Member]",
        "label": "Lease and Other Obligations [Member]",
        "terseLabel": "Lease and Other Obligations"
       }
      }
     },
     "localname": "LeaseandOtherObligationsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments",
        "terseLabel": "Future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LessorLeasePaymentstobeReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Lease, Payments to be Received",
        "label": "Lessor, Lease, Payments to be Received",
        "terseLabel": "Minimum sublease income"
       }
      }
     },
     "localname": "LessorLeasePaymentstobeReceived",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term",
        "label": "Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "terseLabel": "Litigation settlement, amount awarded to other party, percentage of total settlement award"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "terseLabel": "Percentage of total settlement to be used to remediate damages (in percent)"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "label": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "terseLabel": "Litigation settlement, award amount to be used by state and local government"
       }
      }
     },
     "localname": "LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "label": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "terseLabel": "Loss contingency accrual, period increase (decrease), net of tax"
       }
      }
     },
     "localname": "LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyAccrualProvisionAfterTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Provision, After Tax",
        "label": "Loss Contingency Accrual, Provision, After Tax",
        "terseLabel": "After-tax charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvisionAfterTax",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Received",
        "label": "Loss Contingency, Class Action, Number of Faxes Received",
        "terseLabel": "Number of faxes received"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesReceived",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesRemainingintheClass": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "label": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "terseLabel": "Number of faxes remaining in class"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesRemainingintheClass",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyDamagesSoughtPerViolationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Sought Per Violation, Value",
        "label": "Loss Contingency, Damages Sought Per Violation, Value",
        "terseLabel": "Damages sought per violation"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtPerViolationValue",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberOfAdditionalDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional Defendants",
        "label": "Loss Contingency, Number of Additional Defendants",
        "terseLabel": "Number of additional defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfAdditionalDefendants",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfEligibleStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Eligible States",
        "label": "Loss Contingency, Number of Eligible States",
        "terseLabel": "Number of eligible states"
       }
      }
     },
     "localname": "LossContingencyNumberOfEligibleStates",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Eligible Subdivisions, Participation Percentage",
        "label": "Loss Contingency, Number of Eligible Subdivisions, Participation Percentage",
        "terseLabel": "Number of eligible political subdivisions, participation percentage (in percent)"
       }
      }
     },
     "localname": "LossContingencyNumberOfEligibleSubdivisionsParticipationPercentage",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyNumberOfOtherDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Other Defendants",
        "label": "Loss Contingency, Number of Other Defendants",
        "terseLabel": "Number of other defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfOtherDefendants",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfRelators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Relators",
        "label": "Loss Contingency, Number of Relators",
        "terseLabel": "Number of relators"
       }
      }
     },
     "localname": "LossContingencyNumberOfRelators",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCitiesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cities Filed On Behalf Of",
        "label": "Loss Contingency, Number of Cities Filed On Behalf Of",
        "terseLabel": "Number of cities filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberofCitiesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofFormerOfficers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Former Officers",
        "label": "Loss Contingency, Number of Former Officers",
        "terseLabel": "Number of former officers"
       }
      }
     },
     "localname": "LossContingencyNumberofFormerOfficers",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofRelators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of Relators",
        "label": "Loss Contingency Number of Relators",
        "terseLabel": "Number of relators alleging violations"
       }
      }
     },
     "localname": "LossContingencyNumberofRelators",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStatesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of States Filed On Behalf Of",
        "label": "Loss Contingency Number of States Filed On Behalf Of",
        "terseLabel": "Number of states filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Party Substitution Period to Prevent Case Dismissal",
        "label": "Loss Contingency, Party Substitution Period to Prevent Case Dismissal",
        "terseLabel": "Period within which party can be substituted"
       }
      }
     },
     "localname": "LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Expected payment period"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementInstallmentPaymentsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Installment Payments, Term",
        "label": "Loss Contingency, Settlement, Installment Payments, Term",
        "terseLabel": "Loss contingency, settlement, installment payments, term (in years)"
       }
      }
     },
     "localname": "LossContingencySettlementInstallmentPaymentsTerm",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementNumberOfInstallmentPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Number of Installment Payments",
        "label": "Loss Contingency, Settlement, Number of Installment Payments",
        "terseLabel": "Settlement, payment terms"
       }
      }
     },
     "localname": "LossContingencySettlementNumberOfInstallmentPayments",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_MachineryEquipmentAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery, Equipment, and Other",
        "label": "Machinery, Equipment, and Other [Member]",
        "terseLabel": "Machinery, equipment, and other"
       }
      }
     },
     "localname": "MachineryEquipmentAndOtherMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MultiemployerPlanFundedStatusPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multiemployer Plan, Funded Status, Percentage",
        "label": "Multiemployer Plan, Funded Status, Percentage",
        "terseLabel": "Funded status (as a percent)"
       }
      }
     },
     "localname": "MultiemployerPlanFundedStatusPercentage",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opiate Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NativeAmericanTribesOtherThanCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Native American Tribes Other Than Cherokee Nation",
        "label": "Native American Tribes Other Than Cherokee Nation [Member]",
        "terseLabel": "Native American Tribes Other Than Cherokee Nation"
       }
      }
     },
     "localname": "NativeAmericanTribesOtherThanCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NewYorkOpioidTaxSurchargeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York Opioid Tax Surcharge",
        "label": "New York Opioid Tax Surcharge [Member]",
        "terseLabel": "New York Opioid Tax Surcharge"
       }
      }
     },
     "localname": "NewYorkOpioidTaxSurchargeMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "label": "Non-Derivatives Used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Gains recorded in earnings for ineffectiveness of Company's non-derivative hedges"
       }
      }
     },
     "localname": "NonDerivativesUsedinNetInvestmentHedgeIncreaseDecreaseGrossofTax",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedTerseLabel": "Exercises of Put Right"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseFromReclassificationToLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "label": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromReclassificationToLiability",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right (in euro per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePriceIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price, Increase",
        "label": "Noncontrolling Interests, Put Right, Exercise Price, Increase",
        "terseLabel": "Put Right increase (euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePriceIncrease",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NorwegianPublicServicePensionFundSPKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norwegian Public Service Pension Fund (SPK) [Member]",
        "label": "Norwegian Public Service Pension Fund (SPK) [Member]",
        "terseLabel": "Norwegian Public Service Pension Fund (SPK)"
       }
      }
     },
     "localname": "NorwegianPublicServicePensionFundSPKMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NotesDueNovember302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due November 30, 2020 [Member]",
        "label": "Notes Due November 30, 2020 [Member]",
        "terseLabel": "Notes Due November 30, 2020"
       }
      }
     },
     "localname": "NotesDueNovember302020Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_November2018CrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2018 Cross Currency Swaps [Member]",
        "label": "November 2018 Cross Currency Swaps [Member]",
        "terseLabel": "November 2018 Cross Currency Swaps"
       }
      }
     },
     "localname": "November2018CrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical Surgical Products",
        "label": "Number of National Brand Medical Surgical Products",
        "terseLabel": "Number of national brand medical surgical products"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberofSitesSelectedforPreferredRemedy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Sites Selected for Preferred Remedy",
        "label": "Number of Sites Selected for Preferred Remedy",
        "terseLabel": "Number of sites selected for preferred remediation"
       }
      }
     },
     "localname": "NumberofSitesSelectedforPreferredRemedy",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberofSoftwareProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Software Products",
        "label": "Number of Software Products",
        "terseLabel": "Number of software products"
       }
      }
     },
     "localname": "NumberofSoftwareProducts",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpenMarketTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Transactions [Member]",
        "label": "Open Market Transactions [Member]",
        "terseLabel": "Open Market Transactions"
       }
      }
     },
     "localname": "OpenMarketTransactionsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OperatingLeaseImpairmentLossNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Impairment Loss, Net of Tax",
        "label": "Operating Lease, Impairment Loss, Net of Tax",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLossNetOfTax",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OpioidStewardshipActNewYorkAnnualSurcharge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, New York, Annual Surcharge",
        "label": "Opioid Stewardship Act, New York, Annual Surcharge",
        "terseLabel": "Annual surcharge"
       }
      }
     },
     "localname": "OpioidStewardshipActNewYorkAnnualSurcharge",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Allowances [Member]",
        "label": "Other Allowances [Member]",
        "terseLabel": "Other allowances"
       }
      }
     },
     "localname": "OtherAllowancesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax",
        "label": "Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax",
        "negatedTerseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherNoncurrentAssetsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Noncurrent Assets / Liabilities [Member]",
        "label": "Other Noncurrent Assets / Liabilities [Member]",
        "terseLabel": "Other non-current assets/liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value",
        "label": "Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value",
        "terseLabel": "Amount of plan asset value"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PerformancebasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-based Stock Units [Member]",
        "label": "Performance-based Stock Units [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformancebasedStockUnitsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PharmacyLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy licenses [Member]",
        "label": "Pharmacy Licenses [Member]",
        "terseLabel": "Pharmacy licenses"
       }
      }
     },
     "localname": "PharmacyLicensesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]",
        "label": "Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC [Member]",
        "terseLabel": "Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC"
       }
      }
     },
     "localname": "PowellPrescriptionCenteretal.v.SurescriptsLLCetal.andIntergratedPharmaceuticalSolutionsLLCv.SurescriptsLLCMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]",
        "label": "Prepaid Expenses and Other Assets / Other Accrued Liabilities [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "PrepaidExpensesandOtherAssetsOtherAccruedLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "Prescription Technology Solutions [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prescription Technology Solutions Segment",
        "label": "Prescription Technology Solutions Segment [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant and Equipment, Including Net Capitalized Software",
        "label": "Property, Plant and Equipment, Including Net Capitalized Software",
        "verboseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Annual increase in interest (percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range One [Member]",
        "label": "Range One [Member]",
        "terseLabel": "Range One"
       }
      }
     },
     "localname": "RangeOneMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range Two [Member]",
        "label": "Range Two [Member]",
        "terseLabel": "Range Two"
       }
      }
     },
     "localname": "RangeTwoMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RealPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Property [Member]",
        "label": "Real Property [Member]",
        "terseLabel": "Real Property"
       }
      }
     },
     "localname": "RealPropertyMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "label": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "negatedTerseLabel": "Reclassification of McKesson Europe redeemable noncontrolling interests"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityToNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "label": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "terseLabel": "Maximum redemption value"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMaximumRedemptionValue",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance-based Stock Units [Member]",
        "label": "Restricted Stock Units and Performance-based Stock Units [Member]",
        "terseLabel": "RSUs and PSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsandPerformancebasedStockUnitsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RestructuringImpairmentandOtherRelatedCharges": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Impairment and Other Related Charges",
        "label": "Restructuring, Impairment and Other Related Charges",
        "negatedTerseLabel": "Restructuring, impairment, and related charges, net"
       }
      }
     },
     "localname": "RestructuringImpairmentandOtherRelatedCharges",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RestructuringPlanRemoteWorkTransitioningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan, Remote Work Transitioning",
        "label": "Restructuring Plan, Remote Work Transitioning [Member]",
        "terseLabel": "Restructuring Plan, Remote Work Transitioning"
       }
      }
     },
     "localname": "RestructuringPlanRemoteWorkTransitioningMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RetailPharmacyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Pharmacy Reporting Unit [Member]",
        "label": "Retail Pharmacy Reporting Unit [Member]",
        "terseLabel": "Retail Pharmacy Reporting Unit [Member]"
       }
      }
     },
     "localname": "RetailPharmacyReportingUnitMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Derived revenues (percent)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns",
        "terseLabel": "Sales returns from customers"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RexallHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rexall Health [Member]",
        "label": "Rexall Health [Member]",
        "terseLabel": "Rexall Health"
       }
      }
     },
     "localname": "RexallHealthMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount",
        "terseLabel": "Current allowances"
       }
      }
     },
     "localname": "SECSchedule1209ValuationAllowancesandReservesCurrentAmount",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award Data Related To Stock Option Activity [Table Text Block]",
        "terseLabel": "Summary of data related to stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]",
        "label": "Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used to estimate fair value of PSUs"
       }
      }
     },
     "localname": "ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_SecondPartOfPayContributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Part Of Pay Contribution [Member]",
        "label": "Second Part Of Pay Contribution [Member]",
        "terseLabel": "Second Part Of Pay Contribution"
       }
      }
     },
     "localname": "SecondPartOfPayContributionMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2020 Credit Facility)"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeparationofChangeHealthcareJVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separation of Change Healthcare JV [Member]",
        "label": "Separation of Change Healthcare JV [Member]",
        "terseLabel": "Separation of Change Healthcare JV"
       }
      }
     },
     "localname": "SeparationofChangeHealthcareJVMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services Business [Member]",
        "label": "Services Business [Member]",
        "terseLabel": "Services Business"
       }
      }
     },
     "localname": "ServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlementofExecutiveRetirementBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement of Executive Retirement Benefits [Member]",
        "label": "Settlement of Executive Retirement Benefits [Member]",
        "terseLabel": "Settlement of Executive Retirement Benefits"
       }
      }
     },
     "localname": "SettlementofExecutiveRetirementBenefitsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlingGovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling Governmental Entities",
        "label": "Settling Governmental Entities [Member]",
        "terseLabel": "Settling Governmental Entities"
       }
      }
     },
     "localname": "SettlingGovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]",
        "label": "Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]",
        "terseLabel": "Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs"
       }
      }
     },
     "localname": "ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period",
        "negatedTerseLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested",
        "verboseLabel": "Vested RSUs (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_ShareholderDerivativeActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Derivative Action",
        "label": "Shareholder Derivative Action [Member]",
        "terseLabel": "Shareholder Derivative Action"
       }
      }
     },
     "localname": "ShareholderDerivativeActionMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SiteContingencyNumberofSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of sites requiring environmental conditions to be addressed.",
        "label": "Site Contingency Number of Sites",
        "terseLabel": "Number of sites"
       }
      }
     },
     "localname": "SiteContingencyNumberofSites",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_StateOfAlabamaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Alabama",
        "label": "State of Alabama [Member]",
        "terseLabel": "Alabama"
       }
      }
     },
     "localname": "StateOfAlabamaMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfWashingtonAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Washington and Subdivisions",
        "label": "State of Washington and Subdivisions [Member]",
        "terseLabel": "State of Washington and Subdivisions"
       }
      }
     },
     "localname": "StateOfWashingtonAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockExchangedDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchanged During Period, Shares",
        "label": "Stock Exchanged During Period, Shares",
        "negatedLabel": "Change Healthcare share exchange (in shares)"
       }
      }
     },
     "localname": "StockExchangedDuringPeriodShares",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_StockExchangedDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchanged During Period, Value",
        "label": "Stock Exchanged During Period, Value",
        "negatedLabel": "Change Healthcare share exchange"
       }
      }
     },
     "localname": "StockExchangedDuringPeriodValue",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]",
        "label": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]",
        "label": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SupplierIncentivesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Incentives, Policy [Policy Text Block]",
        "label": "Supplier Incentives, Policy [Policy Text Block]",
        "terseLabel": "Supplier Incentives"
       }
      }
     },
     "localname": "SupplierIncentivesPolicyPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_SupplierReservesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]",
        "label": "Supplier Reserves [Policy Text Block]",
        "terseLabel": "Supplier Reserves"
       }
      }
     },
     "localname": "SupplierReservesPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_TaxAgreementReceivablePercentofNetCashTaxSavingsRealized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized",
        "label": "Tax Agreement Receivable, Percent of Net Cash Tax Savings Realized",
        "terseLabel": "Percentage of net cash tax savings realized or deemed realized under TRA (percent)"
       }
      }
     },
     "localname": "TaxAgreementReceivablePercentofNetCashTaxSavingsRealized",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_TaxReceivableAgreementTRAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "label": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "terseLabel": "Tax Receivable Agreement (\u201cTRA\u201d)"
       }
      }
     },
     "localname": "TaxReceivableAgreementTRAMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TenLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ten Largest Customers",
        "label": "Ten Largest Customers [Member]",
        "terseLabel": "Ten Largest Customers"
       }
      }
     },
     "localname": "TenLargestCustomersMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TenderOfferNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Notes",
        "label": "Tender Offer Notes [Member]",
        "terseLabel": "Tender Offer Notes"
       }
      }
     },
     "localname": "TenderOfferNotesMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TerminationofU.SDefinedBenefitPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of U.S Defined Benefit Pension Plan [Member]",
        "label": "Termination of U.S Defined Benefit Pension Plan [Member]",
        "terseLabel": "Termination of U.S Defined Benefit Pension Plan"
       }
      }
     },
     "localname": "TerminationofU.SDefinedBenefitPensionPlanMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]",
        "label": "Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits [Member]",
        "terseLabel": "Termination of U.S Defined Benefit Pension Plan and Settlement of Retirement Benefits"
       }
      }
     },
     "localname": "TerminationofU.SDefinedBenefitPensionPlanandSettlementofRetirementBenefitsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeNationalPharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three National Pharmaceutical Distributors",
        "label": "Three National Pharmaceutical Distributors [Member]",
        "terseLabel": "Three National Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeNationalPharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TransitionServicesAgreementsTSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Services Agreements (\u201cTSA\u201d) [Member]",
        "label": "Transition Services Agreements (\u201cTSA\u201d) [Member]",
        "terseLabel": "Transition Services Agreements (\u201cTSA\u201d)"
       }
      }
     },
     "localname": "TransitionServicesAgreementsTSAMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TreasuryStockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock",
        "label": "Treasury Stock [Policy Text Block]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "label": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "terseLabel": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al"
       }
      }
     },
     "localname": "TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_U.S.PharmaceuticalandSpecialtySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical and Specialty Solutions [Member]",
        "label": "U.S. Pharmaceutical and Specialty Solutions [Member]",
        "terseLabel": "U.S. Pharmaceutical and Specialty Solutions"
       }
      }
     },
     "localname": "U.S.PharmaceuticalandSpecialtySolutionsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupAndAustrianBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. and Austrian Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) and Austrian Business [Member]",
        "terseLabel": "U.K. Businesses (Disposal Group) and Austrian Business"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupAndAustrianBusinessMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) [Member]",
        "terseLabel": "U.K. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitValueOfCashAndCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unit value of cash and cash equivalents",
        "label": "Unit Value Of Cash And Cash Equivalents",
        "terseLabel": "Unit value of cash and cash equivalents (in dollars per share)"
       }
      }
     },
     "localname": "UnitValueOfCashAndCashEquivalents",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA",
        "label": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]",
        "terseLabel": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA"
       }
      }
     },
     "localname": "UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Piacentile v. Amgen Inc., et al.",
        "label": "United States ex rel. Piacentile v. Amgen Inc., et al. [Member]",
        "terseLabel": "United States ex rel. Piacentile v. Amgen Inc., et al."
       }
      }
     },
     "localname": "UnitedStatesExRelPiacentileVAmgenIncEtAlMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]",
        "label": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]",
        "terseLabel": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al"
       }
      }
     },
     "localname": "UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]",
        "label": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]",
        "terseLabel": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al."
       }
      }
     },
     "localname": "UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]",
        "label": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]",
        "terseLabel": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931"
       }
      }
     },
     "localname": "UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation",
        "terseLabel": "Exchange rate fluctuations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves, deductions credited to other accounts [Member]",
        "label": "Valuation Allowances And Reserves Deductions Credited To Other Accounts [Member]",
        "terseLabel": "Credited to other accounts and other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves, deductions written off [Member]",
        "label": "Valuation Allowances And Reserves Deductions Written Off [Member]",
        "terseLabel": "Written-off"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductionsWrittenOffMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WalgreensBootsAllianceJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walgreens Boots Alliance Joint Venture",
        "label": "Walgreens Boots Alliance Joint Venture [Member]",
        "terseLabel": "Walgreens Boots Alliance Joint Venture"
       }
      }
     },
     "localname": "WalgreensBootsAllianceJointVentureMember",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "label": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "terseLabel": "Write-off of Deferred Debt Issuance Cost and Transaction Costs"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts",
     "nsuri": "http://mckesson123.com/20220331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r190",
      "r411",
      "r416",
      "r424",
      "r740",
      "r741",
      "r751",
      "r752",
      "r886",
      "r1026",
      "r1044",
      "r1055",
      "r1064",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r190",
      "r411",
      "r416",
      "r424",
      "r740",
      "r741",
      "r751",
      "r752",
      "r886",
      "r1026",
      "r1044",
      "r1055",
      "r1064",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r190",
      "r259",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r279",
      "r283",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r421",
      "r423",
      "r424",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r190",
      "r259",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r279",
      "r283",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r421",
      "r423",
      "r424",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r90",
      "r92",
      "r187",
      "r188",
      "r431",
      "r470",
      "r1066"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r203",
      "r211",
      "r314",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r797",
      "r802",
      "r803",
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount after cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r203",
      "r211",
      "r217",
      "r314",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r797",
      "r800",
      "r802",
      "r803",
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustments: adoption of new accounting standards"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r203",
      "r211",
      "r217",
      "r314",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r797",
      "r800",
      "r802",
      "r803",
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r203",
      "r211",
      "r217",
      "r314",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r797",
      "r800",
      "r802",
      "r803",
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of executive officer.",
        "label": "Executive Officer [Member]",
        "terseLabel": "Retired executive"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r290",
      "r501",
      "r504",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r430",
      "r469",
      "r600",
      "r610",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r983",
      "r987",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r430",
      "r469",
      "r600",
      "r610",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r983",
      "r987",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r290",
      "r501",
      "r504",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r286",
      "r501",
      "r502",
      "r906",
      "r982",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r286",
      "r501",
      "r502",
      "r906",
      "r982",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r430",
      "r469",
      "r536",
      "r600",
      "r610",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r983",
      "r987",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r430",
      "r469",
      "r536",
      "r600",
      "r610",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r983",
      "r987",
      "r1027",
      "r1028"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r91",
      "r92",
      "r187",
      "r188",
      "r431",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r198",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r287",
      "r288",
      "r501",
      "r503",
      "r985",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1043",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r287",
      "r288",
      "r501",
      "r503",
      "r985",
      "r1010",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1043",
      "r1045"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r292",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.",
        "label": "Accelerated Share Repurchases [Table Text Block]",
        "terseLabel": "Schedule of shares repurchased over last three years"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "ASU 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r69",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "totalLabel": "Total receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r364",
      "r387",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Estimated loss"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingenciesGross": {
     "auth_ref": [
      "r364",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount of the accrual for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies, Gross",
        "terseLabel": "Remediation costs"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingenciesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "verboseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r98",
      "r104",
      "r114",
      "r115",
      "r116",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r97",
      "r104",
      "r114",
      "r115",
      "r116",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r67",
      "r355"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r95",
      "r104",
      "r114",
      "r115",
      "r116",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax",
        "verboseLabel": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r96",
      "r104",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "verboseLabel": "Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r55",
      "r101",
      "r103",
      "r104",
      "r961",
      "r995",
      "r999"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r100",
      "r104",
      "r114",
      "r115",
      "r116",
      "r200",
      "r201",
      "r202",
      "r747",
      "r990",
      "r991",
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Total Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Less: Restricted cash at end of period included in Other Noncurrent Assets"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r53",
      "r656",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r653",
      "r654",
      "r655",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r165",
      "r343"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r204",
      "r205",
      "r206",
      "r207",
      "r217",
      "r301",
      "r302",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r410",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r702",
      "r703",
      "r704",
      "r705",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r876",
      "r908",
      "r909",
      "r910",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r612",
      "r614",
      "r659",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r254",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other Segments [Member]"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r614",
      "r645",
      "r658"
     ],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Share-based compensation expense, net of tax"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowances for credit losses"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r296",
      "r317",
      "r318",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r59",
      "r296",
      "r317"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r165",
      "r338",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Potentially dilutive securities excluded from diluted earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r165",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Long-lived asset impairment charges, before tax"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r182",
      "r267",
      "r274",
      "r281",
      "r309",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r740",
      "r751",
      "r822",
      "r887",
      "r889",
      "r927",
      "r958"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets",
        "verboseLabel": "VIE consolidated assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "netLabel": "Assets",
        "terseLabel": "ASSETS",
        "verboseLabel": "Segment assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r31",
      "r32",
      "r88",
      "r182",
      "r309",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r740",
      "r751",
      "r822",
      "r887",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r28",
      "r1004",
      "r1005",
      "r1008",
      "r1009"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "terseLabel": "Net Assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r22",
      "r26",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r22",
      "r26",
      "r352",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "verboseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r615",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r775",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r34",
      "r354"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.",
        "label": "Capital Loss Carryforward [Member]",
        "terseLabel": "Capital Loss Carryforward"
       }
      }
     },
     "localname": "CapitalLossCarryforwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r1031"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "terseLabel": "Capitalized software held for internal use, accumulated amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r1030",
      "r1032"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized software held for internal use, amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r1029"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "terseLabel": "Capitalized software held for internal use, net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29",
      "r63",
      "r167"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r39",
      "r168",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r158",
      "r167",
      "r173"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year",
        "totalLabel": "Cash, cash equivalents, and restricted cash at end of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r158",
      "r832"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r179",
      "r182",
      "r220",
      "r224",
      "r225",
      "r227",
      "r229",
      "r239",
      "r240",
      "r241",
      "r309",
      "r411",
      "r416",
      "r417",
      "r418",
      "r424",
      "r425",
      "r467",
      "r468",
      "r472",
      "r476",
      "r822",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r77",
      "r388",
      "r935",
      "r967"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "#REF!"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r384",
      "r385",
      "r386",
      "r398",
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r405",
      "r1014"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParentheticals",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common stock, $0.01 par value"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r51",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized, 275 and 273 shares issued at March 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r109",
      "r111",
      "r112",
      "r127",
      "r945",
      "r976"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r109",
      "r111",
      "r126",
      "r738",
      "r739",
      "r762",
      "r944",
      "r975"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r109",
      "r111",
      "r125",
      "r737",
      "r762",
      "r943",
      "r974"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r249",
      "r250",
      "r290",
      "r820",
      "r821",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r249",
      "r250",
      "r290",
      "r820",
      "r821",
      "r1002",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r249",
      "r250",
      "r290",
      "r820",
      "r821",
      "r1002",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r244",
      "r955"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and Receivables"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r249",
      "r250",
      "r290",
      "r820",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of total consolidated revenues (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r249",
      "r250",
      "r290",
      "r820",
      "r821",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r748",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Schedule of Changes in Noncontrolling Interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r174",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "auth_ref": [
      "r170",
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by description of stock conversions.",
        "label": "Stock Conversion Description [Axis]",
        "terseLabel": "Stock Conversion Description [Axis]"
       }
      }
     },
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "auth_ref": [
      "r170",
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The unique name of a noncash or part noncash stock conversion.",
        "label": "Conversion of Stock, Name [Domain]",
        "terseLabel": "Conversion of Stock, Name [Domain]"
       }
      }
     },
     "localname": "ConversionOfStockNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r537",
      "r586",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.",
        "label": "Corporate Joint Venture [Member]",
        "terseLabel": "Corporate Joint Venture"
       }
      }
     },
     "localname": "CorporateJointVentureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r283",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r135",
      "r906"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r374",
      "r375",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap",
        "verboseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r698",
      "r708"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r698"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r698",
      "r708",
      "r710"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r698",
      "r708"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r247",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r934",
      "r968"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in earnings from investment in debt and equity securities measured at fair value with change in fair value recognized in net income, and recognized from transfer of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity) to investment in debt security measured at fair value with change in fair value recognized in net income (trading). Excludes other-than-temporary impairment (OTTI).",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment",
        "terseLabel": "Net gains associated with equity investments"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r178",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r444",
      "r451",
      "r452",
      "r454",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r181",
      "r190",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r456",
      "r457",
      "r458",
      "r459",
      "r847",
      "r928",
      "r930",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r427",
      "r456",
      "r457",
      "r845",
      "r847",
      "r848"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r818"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value of liabilities",
        "verboseLabel": "Long-term debt, including current maturities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r74",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r75",
      "r181",
      "r190",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r456",
      "r457",
      "r458",
      "r459",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Debt instrument, repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt Instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r75",
      "r181",
      "r190",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r456",
      "r457",
      "r458",
      "r459",
      "r483",
      "r484",
      "r485",
      "r486",
      "r844",
      "r845",
      "r847",
      "r848",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of facility"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r440",
      "r844",
      "r848"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r676"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Amount of decrease in unrecognized tax benefits that is reasonably possible in the next twelve months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r699",
      "r708"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r699",
      "r708"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r669",
      "r670"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Long-term deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r165",
      "r183",
      "r699",
      "r708",
      "r709",
      "r710"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "negatedLabel": "Deferred tax benefit",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r47",
      "r48",
      "r688",
      "r929",
      "r956"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r669",
      "r670"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Long-term deferred tax liability",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r699",
      "r708"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r691"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r694",
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Net operating loss and credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Compensation and benefit related accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Receivable allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r670",
      "r691"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "totalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedTerseLabel": "Inventory valuation and other assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r696",
      "r697"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Fixed assets and systems development costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r99",
      "r104",
      "r557"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r104",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r104",
      "r557"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r104",
      "r557"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "verboseLabel": "Prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r526",
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets",
        "verboseLabel": "Return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial loss (gain)",
        "terseLabel": "Actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit": {
     "auth_ref": [
      "r512",
      "r552",
      "r580"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of ten percent of greater of fair value of plan assets or benefit obligation.",
        "label": "Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit",
        "negatedTerseLabel": "Actuarial losses from pension plans",
        "terseLabel": "Actuarial gains (losses) from pension plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r510",
      "r534"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rates",
        "verboseLabel": "Discount rates (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of increase in compensation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "verboseLabel": "Discount rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r561",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of increase in compensation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r514"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of period",
        "periodStartLabel": "Benefit obligation at beginning of period",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r521",
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r564",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r528",
      "r537",
      "r539",
      "r584",
      "r586",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Amounts of plan exceeding total plan contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "negatedTerseLabel": "Divestiture"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "verboseLabel": "Expected benefit payments in 2028 through 2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "verboseLabel": "Expected benefit payments in 2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "verboseLabel": "Expected benefit payments in 2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "verboseLabel": "Expected benefit payments in 2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Expected benefit payments in 2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "verboseLabel": "Expected benefit payments in 2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r547",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "verboseLabel": "Expected contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r512",
      "r551",
      "r579",
      "r586",
      "r587"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r525",
      "r537",
      "r539",
      "r540",
      "r586"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of period",
        "periodStartLabel": "Fair value of plan assets at beginning of period",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r510",
      "r534",
      "r586"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of period"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r512",
      "r517",
      "r550",
      "r578",
      "r586",
      "r587"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost on projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r548",
      "r576",
      "r586",
      "r587"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic pension expense",
        "totalLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r530",
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase in plan asset of defined benefit plan from purchase.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r513",
      "r555",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedLabel": "Pre-tax pension settlement charges",
        "negatedTerseLabel": "Pre-tax pension settlement charges"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r513",
      "r555",
      "r583"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedTerseLabel": "Curtailment/settlement loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r515",
      "r549",
      "r577",
      "r586",
      "r587"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost - benefits earned during the year"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlements",
        "terseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Contribution expenses"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Company match employee contributions (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Percentage of eligible compensation (up to percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r165",
      "r353"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r165",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Total depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization [Abstract]",
        "terseLabel": "Segment depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r165",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation expense for property, plant, and equipment, and amortization of finance leases"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r767",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative asset, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r89",
      "r92",
      "r93",
      "r777",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of derivative asset, gross fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r89",
      "r92",
      "r93",
      "r777",
      "r900"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of derivative liability, gross fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r92",
      "r776",
      "r778",
      "r782",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r793",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r773",
      "r776",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r781",
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gains (losses) from contracts not designated as hedges"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r767",
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative liability, notional amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r768",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amounts of derivative"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r766",
      "r769",
      "r770",
      "r773",
      "r774",
      "r780",
      "r782",
      "r788",
      "r790",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r189",
      "r766",
      "r769",
      "r773",
      "r774",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting",
        "verboseLabel": "Derivatives Designated for Hedge Accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r351",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r22",
      "r349",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration agreed upon for sale of business"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r352",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r352",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r352",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r165",
      "r351",
      "r358"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "terseLabel": "European businesses held for sale",
        "verboseLabel": "Charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r27",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r593",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r592",
      "r596",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r128",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r218",
      "r220",
      "r227",
      "r228",
      "r229",
      "r233",
      "r234",
      "r803",
      "r804",
      "r946",
      "r977"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r128",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r220",
      "r227",
      "r228",
      "r229",
      "r233",
      "r234",
      "r803",
      "r804",
      "r946",
      "r977"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r832"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r185",
      "r672",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory federal income tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r661",
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "verboseLabel": "Tax expense (benefit) related to adoption of amended accounting guidance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r646"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax",
        "verboseLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period in years over which restricted stock unit award cost is expected to be recognized",
        "verboseLabel": "Weighted-average period in years over which stock option compensation cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r645"
     ],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "negatedTerseLabel": "Tax benefit for share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefits realized related to exercise"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock purchase plan",
        "verboseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r114",
      "r115",
      "r116",
      "r200",
      "r201",
      "r202",
      "r205",
      "r214",
      "r216",
      "r238",
      "r314",
      "r482",
      "r487",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r802",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r839",
      "r990",
      "r991",
      "r992",
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Pre-tax other-than-temporary impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest in Joint Venture (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r129",
      "r130",
      "r165"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Gain from sale of equity method investment",
        "totalLabel": "Net gain on split-off of the Change Healthcare JV",
        "verboseLabel": "Gain from sale of equity method investment (in dollars per share)"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r64",
      "r268",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Carrying value of investment in joint venture"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r64",
      "r157",
      "r308",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Net Gain on Split-off of Change Healthcare JV"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r816"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Investments in equity securities of growth stage companies"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Net gains on investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r303",
      "r979"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r933",
      "r1013"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Escrow Deposit",
        "terseLabel": "Escrow deposit"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Investment Assets at Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r806",
      "r807",
      "r808",
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r806",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of information regarding fair value of derivatives on a gross basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r586",
      "r807",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r806",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r806",
      "r807",
      "r809",
      "r810",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r442",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r442",
      "r537",
      "r539",
      "r544",
      "r586",
      "r807",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r537",
      "r539",
      "r544",
      "r586",
      "r807",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r586",
      "r807",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r442",
      "r456",
      "r457",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r586",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r806",
      "r807",
      "r809",
      "r810",
      "r811",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Measurements, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r812",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r775",
      "r780",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r852",
      "r861",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 2.0,
       "parentTag": "mck_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r855",
      "r866"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "negatedTerseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r850",
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r871"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r854",
      "r866"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r849"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r852",
      "r861",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 1.0,
       "parentTag": "mck_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r869",
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - Finance leases (percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r868",
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (Years) - Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r342"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Estimated annual amortization expense, after 2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization expense, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r339",
      "r340",
      "r342",
      "r345",
      "r907",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r342",
      "r911"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r339",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r342",
      "r907"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FixedIncomeFundsMember": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments.",
        "label": "Fixed Income Funds [Member]",
        "terseLabel": "Fixed income commingled funds"
       }
      }
     },
     "localname": "FixedIncomeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r92",
      "r537",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r592",
      "r596",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Non-U.S. Plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r165",
      "r750"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Pre-tax gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "auth_ref": [
      "r165",
      "r947"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.",
        "label": "Gain (Loss) on Sale of Derivatives",
        "terseLabel": "Settlement gain recorded in earnings"
       }
      }
     },
     "localname": "GainLossOnSaleOfDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "Loss (gain) from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r129",
      "r130",
      "r165",
      "r938",
      "r978"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "negatedLabel": "Pre-tax dilution loss",
        "negatedTerseLabel": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Litigation settlement charges",
        "terseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r165",
      "r460",
      "r461"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt extinguishment",
        "terseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r325",
      "r327",
      "r889",
      "r926"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r329"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r328",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r165",
      "r326",
      "r330",
      "r336"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairment charges",
        "negatedTerseLabel": "Goodwill impairment charges",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "terseLabel": "Other changes/disposals"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r332",
      "r721"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "verboseLabel": "Acquisition accounting, transfers, and other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r132",
      "r182",
      "r267",
      "r273",
      "r277",
      "r280",
      "r283",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Guarantor Obligations [Line Items]",
        "terseLabel": "Guarantor Obligations [Line Items]"
       }
      }
     },
     "localname": "GuaranteeObligationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor obligations, maximum exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r773",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r133",
      "r166",
      "r209",
      "r210",
      "r211",
      "r212",
      "r226",
      "r229",
      "r736"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to McKesson"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r184",
      "r711"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r120",
      "r267",
      "r273",
      "r277",
      "r280",
      "r283",
      "r924",
      "r939",
      "r949",
      "r980"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r184",
      "r711"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r182",
      "r204",
      "r267",
      "r273",
      "r277",
      "r280",
      "r283",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r737",
      "r804",
      "r822"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations",
        "verboseLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r118",
      "r128",
      "r204",
      "r209",
      "r210",
      "r211",
      "r212",
      "r220",
      "r227",
      "r228",
      "r804",
      "r936",
      "r940",
      "r946",
      "r970"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r118",
      "r128",
      "r204",
      "r209",
      "r210",
      "r211",
      "r212",
      "r220",
      "r227",
      "r228",
      "r229",
      "r804",
      "r946",
      "r970",
      "r973",
      "r977"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r23",
      "r26",
      "r715",
      "r971"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r122",
      "r128",
      "r224",
      "r227",
      "r228",
      "r946",
      "r971",
      "r973",
      "r977"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r224",
      "r227",
      "r228",
      "r764"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r121",
      "r165",
      "r264",
      "r306",
      "r937",
      "r969"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity earnings and charges from investment in Change Healthcare Joint Venture",
        "verboseLabel": "Equity in earnings, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r593",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Discontinued Operations Disclosures"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r7",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r21",
      "r24",
      "r25",
      "r26",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r678",
      "r685",
      "r687",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r185",
      "r673",
      "r686",
      "r693",
      "r706",
      "r713",
      "r716",
      "r717",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r674"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax expense (benefit), before any tax effect, related to accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r186",
      "r215",
      "r216",
      "r265",
      "r671",
      "r707",
      "r714",
      "r981"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "totalLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r667",
      "r668",
      "r686",
      "r687",
      "r692",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "terseLabel": "Tax-free gain on investment exit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Tax effect of foreign operations"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax expense (benefit) at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Unrecognized tax benefits and settlements"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "Research and development credit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r164",
      "r866"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r229"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "verboseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r175",
      "r341",
      "r903",
      "r904",
      "r905",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r119",
      "r261",
      "r843",
      "r846",
      "r948"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpensePolicyTextBlock": {
     "auth_ref": [
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.",
        "label": "Interest Expense, Policy [Policy Text Block]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpensePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Accrued and unpaid interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r154",
      "r160",
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest, net"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Software Held for Internal Use"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "LIFO reserve"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r323"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "negatedLabel": "Credits associated with last-in, first-out inventory method",
        "terseLabel": "Credits associated with last-in, first-out inventory method"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r30",
      "r82",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "verboseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r35",
      "r83",
      "r176",
      "r236",
      "r320",
      "r322",
      "r324",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvesteeMember": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A corporation that issued voting stock held by an investor.",
        "label": "Investee [Member]",
        "terseLabel": "Investee"
       }
      }
     },
     "localname": "InvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r137",
      "r260"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r33",
      "r66"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r870",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of lease costs and supplemental cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Leases, Operating [Abstract]"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Noncancelable lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r871"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_2": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal option increments for leases (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorDirectFinancingLeasesTextBlock": {
     "auth_ref": [
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's direct financing leases.",
        "label": "Lessor, Direct Financing Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorDirectFinancingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r71",
      "r182",
      "r275",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r741",
      "r751",
      "r752",
      "r822",
      "r887",
      "r888"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "VIE consolidated liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r58",
      "r182",
      "r309",
      "r822",
      "r889",
      "r932",
      "r964"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r73",
      "r182",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r741",
      "r751",
      "r752",
      "r822",
      "r887",
      "r888",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r806"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value on a nonrecurring basis"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r44",
      "r45",
      "r182",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r741",
      "r751",
      "r752",
      "r822",
      "r887",
      "r888"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Noncurrent liability"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r22",
      "r26",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleEUDisposalGroupDetails",
      "http://mckesson123.com/role/HeldforSaleAssetsandLiabilitiesHeldforSaleUKDisposalGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r20",
      "r22",
      "r26",
      "r352",
      "r359"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale",
        "verboseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r44",
      "r930",
      "r957"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "verboseLabel": "Credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility borrowing capacity",
        "verboseLabel": "Credit facility borrowing capacity (up to)"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r70",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r77",
      "r388"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Aggregate amount expected to be paid"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation settlement payments"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r44",
      "r441",
      "r455",
      "r456",
      "r457",
      "r930",
      "r959"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Total debt outstanding",
        "verboseLabel": "Total debt outstanding"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r190",
      "r408",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Scheduled principal payments of long-term debt, thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r190",
      "r408",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Scheduled principal payments of long-term debt in 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r190",
      "r408",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Scheduled principal payments of long-term debt in 2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r190",
      "r408",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Scheduled principal payments of long-term debt in 2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r190",
      "r408",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Scheduled principal payments of long-term debt in 2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r190",
      "r408",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Scheduled principal payments of long-term debt in 2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r75",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "terseLabel": "Loss contingency, accrual, current"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "terseLabel": "Loss contingency, accrual, noncurrent"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Loss contingency accrual, period increase (decrease)"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Loss contingency accrual, payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r388",
      "r391",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Loss contingency, statutory damages"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of complaints served"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r27",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Business Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r81",
      "r182",
      "r309",
      "r411",
      "r416",
      "r417",
      "r418",
      "r424",
      "r425",
      "r822",
      "r931",
      "r963"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests",
        "verboseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest (percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "verboseLabel": "Percentage of outstanding common shares"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r81",
      "r134",
      "r735",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interests [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlansWithdrawalObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.",
        "label": "Multiemployer Plans, Withdrawal Obligation",
        "terseLabel": "Amounts accrued for liability"
       }
      }
     },
     "localname": "MultiemployerPlansWithdrawalObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Equity commingled funds"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r158",
      "r162",
      "r166"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r26",
      "r107",
      "r110",
      "r116",
      "r123",
      "r166",
      "r182",
      "r204",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r226",
      "r267",
      "r273",
      "r277",
      "r280",
      "r283",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r804",
      "r822",
      "r941",
      "r972"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r107",
      "r110",
      "r116",
      "r215",
      "r216",
      "r744",
      "r761"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r217",
      "r233",
      "r301",
      "r302",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r410",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r702",
      "r703",
      "r704",
      "r705",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r876",
      "r908",
      "r909",
      "r910",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r487",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "netLabel": "Noncontrolling Interests",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated for hedge accounting",
        "verboseLabel": "Derivatives Not Designated for Hedge Accounting"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r267",
      "r273",
      "r277",
      "r280",
      "r283"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r862",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r853"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofleaseliabilitiesDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r850"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r856",
      "r866"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "negatedTerseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r849"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease, right-of-use asset, transition adjustment"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails",
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r869",
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - Operating leases (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r868",
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (Years) - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r694"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Federal, state and foreign net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAdditionalCapitalMember": {
     "auth_ref": [
      "r140",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a category to capture additional Paid-in Capital other than attributable to capital contributed by shareholders in excess of the par or stated value of the common or preferred stock issued by an entity. Certain entities report two components of additional Paid-in Capital consisting of (i) capital in excess of par or stated value and (ii) other additional capital. This member is only to be used if the entity distinguishes between additional Paid-in Capital and other additional capital in its financial statements. If using this element, the preparer would be expected to elevate the Other Additional Capital [Member] to the same level as the Additional Paid-in Capital [Member].",
        "label": "Other Additional Capital [Member]",
        "terseLabel": "Other Capital"
       }
      }
     },
     "localname": "OtherAdditionalCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r165",
      "r357"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Goodwill and long-lived asset impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r101",
      "r105",
      "r106",
      "r556"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Prior service credit (cost)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r104",
      "r114",
      "r115",
      "r117",
      "r833",
      "r835",
      "r839"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r102",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedTerseLabel": "Unrealized gain (loss) on net investment hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r96",
      "r101"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gains (losses) on cash flow hedges",
        "verboseLabel": "Gains (losses) recorded in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r108",
      "r111",
      "r114",
      "r115",
      "r117",
      "r124",
      "r482",
      "r833",
      "r838",
      "r839",
      "r942",
      "r973"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r111",
      "r737",
      "r738",
      "r746"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other comprehensive income",
        "verboseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r108",
      "r111",
      "r737",
      "r738",
      "r746"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r99",
      "r101",
      "r556",
      "r586"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in other comprehensive loss (income)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r99",
      "r101"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r556"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net actuarial loss (gain)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r101",
      "r105",
      "r106",
      "r556"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Actuarial loss",
        "terseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]",
        "terseLabel": "Amortization of:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r507",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r509",
      "r510",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Gross, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReceivablesGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for legal settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r143",
      "r146"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "terseLabel": "Payments to purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r155",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Payments for debt extinguishments",
        "terseLabel": "Payments for debt extinguishments"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r145",
      "r728",
      "r729",
      "r730"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Total expenditures for long-lived assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Productive Assets [Abstract]",
        "terseLabel": "Segment expenditures for long-lived assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r536",
      "r538",
      "r544",
      "r563",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r586",
      "r588",
      "r589",
      "r591",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r43",
      "r510",
      "r511",
      "r534",
      "r586"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities (3)",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46",
      "r510",
      "r511",
      "r534",
      "r586"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability, Defined Benefit Plan [Abstract]",
        "terseLabel": "Amounts recognized on the balance sheet"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r508",
      "r510",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r591",
      "r592",
      "r606",
      "r607",
      "r608",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans, Defined Benefit"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "terseLabel": "LIFO inventory (percentage)"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r564",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r615",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not measured at fair value.",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "terseLabel": "Assets held at NAV practical expedient"
       }
      }
     },
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r50",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r50",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r50",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r31",
      "r61",
      "r62"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from collection of notes receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from issuance, net"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r143",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Proceeds from termination of swaps"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Commercial paper issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r147",
      "r648"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Net cash proceeds from settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r148",
      "r181"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "verboseLabel": "Amount borrowed under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r149",
      "r153"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Repurchase of) Equity [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "verboseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r147",
      "r648"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received upon exercise"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r26",
      "r107",
      "r110",
      "r116",
      "r156",
      "r182",
      "r204",
      "r215",
      "r216",
      "r267",
      "r273",
      "r277",
      "r280",
      "r283",
      "r309",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r420",
      "r422",
      "r424",
      "r425",
      "r737",
      "r743",
      "r745",
      "r761",
      "r762",
      "r804",
      "r822",
      "r949"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r67",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r66",
      "r354"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Total property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r40",
      "r41",
      "r356",
      "r889",
      "r951",
      "r966"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net",
        "totalLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Property, Plant and Equipment, Net [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Other, Gross",
        "terseLabel": "Machinery, equipment, and other"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r65",
      "r356",
      "r1015",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r40",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r40",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r52",
      "r60",
      "r889",
      "r965",
      "r1006"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "totalLabel": "Receivables, net",
        "verboseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Net, Current [Abstract]",
        "terseLabel": "Receivables, Net, Current [Abstract]"
       }
      }
     },
     "localname": "ReceivablesNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r295",
      "r298",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables, Net and Allowances for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r104",
      "r114",
      "r115",
      "r117",
      "r833",
      "r837",
      "r839"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amount reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r102",
      "r106",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedTerseLabel": "Reclassification from AOCI, Current Period, Tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of segment assets and long-lived assets by net by geographic areas"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r463",
      "r464",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Redeemable Noncontrolling Interest, Ending balance",
        "periodStartLabel": "Redeemable Noncontrolling Interest, Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests",
        "verboseLabel": "Carrying amount of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r564",
      "r879",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r879",
      "r883"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Total fees charged under the TSA"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r564",
      "r879",
      "r880",
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r564",
      "r879",
      "r883",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r877",
      "r878",
      "r880",
      "r884",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Balances and Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Commercial paper repaid"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt",
        "verboseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r173",
      "r925",
      "r960"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r29",
      "r39",
      "r173"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of year included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units",
        "verboseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r366",
      "r368",
      "r371",
      "r381",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r165",
      "r365",
      "r374",
      "r378"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r367",
      "r368",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r368",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Cost Alignment Plan"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r368",
      "r379"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r368",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r54",
      "r487",
      "r656",
      "r889",
      "r962",
      "r994",
      "r999"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r200",
      "r201",
      "r202",
      "r205",
      "r214",
      "r216",
      "r314",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r802",
      "r990",
      "r992"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanFundingStatusAxis": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r572",
      "r573",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Axis]",
        "terseLabel": "Retirement Plan Funding Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanFundingStatusDomain": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r572",
      "r573",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Domain]",
        "terseLabel": "Retirement Plan Funding Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r572",
      "r573",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r572",
      "r573",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r592",
      "r596",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r592",
      "r596",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r606",
      "r607",
      "r608",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r606",
      "r607",
      "r608",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r258",
      "r259",
      "r272",
      "r278",
      "r279",
      "r286",
      "r287",
      "r290",
      "r500",
      "r501",
      "r906"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r131",
      "r414",
      "r416",
      "r417",
      "r423",
      "r424",
      "r425",
      "r1007"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r867",
      "r872"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r867",
      "r872"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalcashflowinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r249",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
     "auth_ref": [
      "r874"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received",
        "terseLabel": "Total lease receivable"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r572",
      "r573",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r104",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Summary of pension plan assets using fair value hierarchy by asset class"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresNetGainonSplitoffofChangeHealthcareJVDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "verboseLabel": "Schedule of components of share-based compensation expense and related tax benefits"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax balances"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.",
        "label": "Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of defined benefit plan amounts recognized in other comprehensive loss"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r570",
      "r571",
      "r574",
      "r575",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r570",
      "r571",
      "r574",
      "r575",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of changes in benefit obligations and plan assets for pension plans"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r21",
      "r24",
      "r25",
      "r26",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r220",
      "r224",
      "r227",
      "r229",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.",
        "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r339",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r334",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r334",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGuaranteeObligationsTable": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.",
        "label": "Schedule of Guarantor Obligations [Table]",
        "terseLabel": "Schedule of Guarantor Obligations [Table]"
       }
      }
     },
     "localname": "ScheduleOfGuaranteeObligationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r396",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Estimated Accrual Liability"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of net periodic expense for pension plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the detailed components of other nonoperating income. May include methodology, assumptions and amounts for: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.",
        "label": "Schedule of Other Nonoperating Income, by Component [Table Text Block]",
        "terseLabel": "Schedule of other income, net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r881",
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r370",
      "r378",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r372",
      "r373",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of details for charges recorded"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r368",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r267",
      "r270",
      "r276",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r267",
      "r270",
      "r276",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Schedule of segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r615",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of restricted stock unit award activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Schedule of Share-based Compensation Data by Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of options outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r622",
      "r632",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r740",
      "r741",
      "r751",
      "r752",
      "r753",
      "r755",
      "r756",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r254",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r290",
      "r370",
      "r380",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r256",
      "r257",
      "r267",
      "r271",
      "r277",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r289",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationAdditionalInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Additional Information [Abstract]",
        "verboseLabel": "Corporate expenses, net [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationAdditionalInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Company's International Segment Operating Loss [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses",
        "terseLabel": "Shipping and handling costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Percentage of market price deduction for share purchases"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per shares)",
        "periodStartLabel": "Beginning balance (in dollars per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Stock options vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Stock options vested and exercisable, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value on exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per stock option (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r647"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Stock options outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r624",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Stock options vested and exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Stock options vested and expected to vest, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Stock options vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Stock options vested and expected to vest, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r613",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r615",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices lower limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number of Options Exercisable at Year End (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number of Options Outstanding at Year End (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices upper limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Stock award contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r639",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofAssumptionsforStockOptionsFairValuesDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options outstanding, remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options vested and exercisable, weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options vested and expected to vest, weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of market price for share purchase"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Life (Years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofOptionsOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance common stock (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r863",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r399",
      "r406",
      "r732",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r13",
      "r254",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r290",
      "r334",
      "r360",
      "r370",
      "r380",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r49",
      "r50",
      "r51",
      "r179",
      "r182",
      "r220",
      "r224",
      "r225",
      "r227",
      "r229",
      "r239",
      "r240",
      "r241",
      "r309",
      "r411",
      "r416",
      "r417",
      "r418",
      "r424",
      "r425",
      "r467",
      "r468",
      "r472",
      "r476",
      "r482",
      "r822",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r79",
      "r114",
      "r115",
      "r116",
      "r200",
      "r201",
      "r202",
      "r205",
      "r214",
      "r216",
      "r238",
      "r314",
      "r482",
      "r487",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r802",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r839",
      "r990",
      "r991",
      "r992",
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r238",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r50",
      "r51",
      "r482",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r51",
      "r482",
      "r487",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r50",
      "r51",
      "r482",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Shares repurchase authorization increase in 2021"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r50",
      "r51",
      "r482",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r50",
      "r51",
      "r482",
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r51",
      "r56",
      "r57",
      "r182",
      "r297",
      "r309",
      "r822",
      "r889"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r115",
      "r182",
      "r200",
      "r201",
      "r202",
      "r205",
      "r214",
      "r309",
      "r314",
      "r487",
      "r653",
      "r654",
      "r655",
      "r704",
      "r705",
      "r734",
      "r735",
      "r760",
      "r802",
      "r822",
      "r833",
      "r834",
      "r839",
      "r991",
      "r992",
      "r1072"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Cumulative effect adjustment",
        "totalLabel": "Total equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r180",
      "r468",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r487",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r865",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r840",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r840",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r840",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r675",
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of gross unrecognized tax benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r831",
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "verboseLabel": "Gains (losses) from net investment hedges"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price paid per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r78",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r78",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance, treasury common stock (shares)",
        "negatedPeriodStartLabel": "Beginning balance, treasury common stock (shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r51",
      "r482",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "verboseLabel": "Total Number of Shares Purchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r78",
      "r489",
      "r490"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury shares, at cost, 130 and 115 shares at March 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r482",
      "r487",
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r204",
      "r205",
      "r206",
      "r207",
      "r217",
      "r301",
      "r302",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r410",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r702",
      "r703",
      "r704",
      "r705",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r876",
      "r908",
      "r909",
      "r910",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r367",
      "r368",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r537",
      "r950",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r665",
      "r718",
      "r954",
      "r1000"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign operations"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnfundedPlanMember": {
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r564",
      "r567",
      "r571",
      "r572",
      "r573",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan in which retirement benefits are payable directly from general assets of employer sponsoring plan.",
        "label": "Defined Benefit Plan, Unfunded Plan [Member]",
        "terseLabel": "Unfunded plan"
       }
      }
     },
     "localname": "UnfundedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r666",
      "r679"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of period",
        "periodStartLabel": "Unrecognized tax benefits at beginning of period",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r680"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r682"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Reductions based on settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r681"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r680"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r674"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "verboseLabel": "Accrued interest and penalties on unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions based on the lapse of the applicable statutes of limitations",
        "terseLabel": "Unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would Impact income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r242",
      "r243",
      "r245",
      "r246",
      "r251",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "verboseLabel": "Increase (decrease) in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r191",
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Charged to Other Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions From Allowance Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r754",
      "r757"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Unconsolidated VIE maximum exposure to loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r740",
      "r741",
      "r751",
      "r752",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Consolidated Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r864",
      "r872"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r219",
      "r229"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding:",
        "verboseLabel": "Weighted-average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r218",
      "r229"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsperCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 25
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r1033": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1034": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1035": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1036": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1037": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r1038": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r1039": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r1040": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1041": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r1042": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r1043": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1044": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1045": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r1046": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1047": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1048": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1049": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r1050": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1051": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1052": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1053": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1054": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r1055": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r1056": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r1057": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r1058": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r1059": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r1060": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r1061": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r1062": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r1063": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r1064": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r1065": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r1066": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r1067": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.T)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868742-224227"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e639-108305"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32006-111567"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4815-112606"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5291-111683"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=28365394&loc=d3e23770-108382"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>146
<FILENAME>0000927653-22-000051-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-22-000051-xbrl.zip
M4$L#!!0    ( .I!J53:WF2!QHX& "HO2  0    ;6-K+3(P,C(P,S,Q+FAT
M;>R]6WL32=(M?/_^BO[ZN]V:SD/D(7AF>C^ :89YL4V#Z1ZXF2<R,](6R))'
MD@'SZW>D?,#FT&T:V:H2F@/6H50JU5H9N2(R,N+O__?=X>B'-SR=#2?C?_RH
M_Z9^_.'__OSW_V\P^/>]IX]_V)KDXT,>SW^X/V6:<_GA[7!^\,/OA6>O?ZC3
MR>$/OT^FKX=O:#!8?.;^Y.AD.MP_F/]@E#$?O3F]PUQR4 X&Q208 -8T2$Z9
M0<V1@G$)*-/_V;]3BJX$B@<Q>3V :/4 -<(@.U=U,%B@QO]3[D "MLE8+J@
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MM9VM##NO[HVV?XOO'^\]FF\_4^\>[[VP.WL/3O[# ""6E 8I5!I 03>@I-5
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M2U6^$<O:''.'XTCK9(;Z&N02WZYJ2@6MN'M%V*,0T7BN'BC8#COEZT2>]8G
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M3Z;1_&!#H*43*#K5>(.5DP'(.L7B0 %F0A]27602ZM!MWBPJ-CZ1NW6R:%A
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MB:D\..=M#](0_@RA7R93'NZ/^S5P5$W!!.V]U[:5'$J6BX=LM;*>J@[=AT4
MN3]EF:KNTW1Z(E-G6W3]2-W1T7!.HX4O<.F@Y4ZC:T:,FHS)'&5\J@BFUNA5
M"@355R@QQ[*H?P/:=(\87^R_O)U?B_"8C$^ER+/C-!N6(=TL(AH&VOQE1(['
MPU,X^'CZA*>+=-*+V[TH/<"7#]TY/FS":W)QTPZ9FFK[>3B;@-'ASH/G3\^_
MZ?RM\^>?_7Q[<8O'D\4J\:>G/;LQBR37/SKOE5/\=/7J+QWV^<4"D?XYF>AJ
M90@&R&69Y!G$437:YSZDAG]AU>#VZ+CZ\$)DTI5ELBE! T6+K8&6:]4EP8NE
MZ4-AT&ZAN))%@@)8T:68(A0(UI)UXH_[$JPSG'P?HKV=0G$UT5V488@!T9F@
M@(F3LJU[BR*("B)R=V?VE8.WK'G]:DRA4'8)17SK*,J[Y1ZY*(8RMCIKJ=3;
MPV-5=R" T\%'QV@-Z%(C@W*J%!^UV)JS(NYM<:EU>CU]T(%;<64DQ]:67%^G
M0^K'AWZ+/7:.P.OL8K @/T;(PE!2UB%':T]3^SMSNRXQYZ,[\"V]8S0X9U.P
MD1ELS2C3$2L?$QE/9/-9)KV,GD[=@5,1ILTRK$>J,908+6D1Q6(\DB+%)".I
MU.*,O;T[\+76O%-^VA(1"4JS)BT^<W40O"*=1.F*=2\A)T]]JFWV[(_[Q9Y6
MB2C,AZVOS\YDW.[#=#(:#<?[B[5RGMWP^OB*MJN&T+;OM#HLXI-&'V,PU54L
M(43MSOI4=-N;Z0_"*_%TK$<NMCAK6I\G;Y,85E8LFKG(\P#=W:'5(8V\Q.U9
MADPQZ-EDE\&$BB%%)\/.NTI6A]C=,'67\%CB=J"2H52CL@H&%%74M=0<O/B6
MH5JD'LQQ7P#F-[DCM,\T+O='-#V>[8[YV>1XFEM3[;-&LX\?WU_'6<V1JS*K
M%1VS E8AE9A!<XU59\;37+Z.SVI=QG0E\QB00%BU,JYJ"&!3"L5BM8*KL5Q"
M?R-V7<!T-?&[6)-A,$J\?_%YBR)";2GIMF"7,BTRHP33#D+9:=%Y*3Z!RUM%
M%9>\9G$5O-C4Z%J)&UT\)[!!D,(^M2?L)&BK'XTB>TK6!&#9 :9"C*V"N<\
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M*>ES(!_R9']*1P=MQKK46VBQDW3M6',C01Q5?"04WR"(IR!XBYK6H3C#;6]
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MD0D*/Q&-5GZ,6S,N+'%OI?'HG.C%$!%*A:2-=0':3IE*(?4@,>5[Y\+R[ (
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MD3*MOE[BZBCX&K2IP2#TV"!\#T18HD)0B G!I*(3N!IB+<PU6XPVD,U]SE:
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MTEND-P[I=0%71)Z""T;PDIKFO-,B)6-D4CHK+53])VY:<+7@6MW0>'&38"#
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M!(HE&W/CT!>OY')&WIG0%Y:"]RTH[ X'Z1P-#?''0('P@@<RAPID!!\CRQY
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MOY5\VP;D&BQP-C<E2!85(D.PVGJ&#@PZ;R.RI!HP$=$J:HT5=7&,:BTP'[-
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M0'*:0U396\F 1\>E1S#N#(F*R>[9A[HAL;6 =;* ,^)YX<='A,G)<+ Q2#2
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MYGK@)L&3>#X5]&[$"JWO/A56?5?K/A%/LBJQ:H$6L4R56Z>#$2K2/7*,O/+
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M1L/C33\^>M0?OK\BUM4#L+>QU$X3F>@?HHQ69<.99<!5,'96YF_59/T0<V^
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MBDV?X1A'[W#\N<T_/XW\R\T14@A;2F<U1%P\IA!C,H L02 K0IX^TYZK$#R
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M/?K;EW8"-_;1FKL+J!I^-5VW>=;*JO.X=$\O*QKM(L;JH*\-69=KI]KV (U
MBER[?V&<2OMT'(S;V;O5$C"7JURLHOY4V!:*;012]-K]^0[ET\[>^P$YZ4>]
MDZJU(;UZWQMT'N  R7LO>2^SXY4?>;'#9;Y5Y>L;_UM*705%:2EUN93:%J!M
M!%+<VOTS\JQXL:QN$*F./V'*@Q$-T\_71&;YB+.)D\XVW90<TH1M:+Y**L&!
MM>2Y1/)L:]<V "F"59T+>H/8.R&'\U(&]B/$^586'+WKQ3;=<(4$OMK4V*X6
M-WBU6#!UMEK\=[M8W Q+WU:6; 3QVS()?]0+O?D>U6LVKW;VXQ&F:;^-@U9'
MYAS:O?S+9,>V>EX3D,+-VOU'P]%QA[/NGYW]Z?&Q'YVV++@RLN6PRHD:;0./
M^FNA8&OW]^G5^DF[>7.EA,KAJZMT_YKXT,>SO]]@!N'^O\/H7U<N=^EK\V<
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M^?[NU^>+\@R=^6]H8Q=-538D%*_J'C> ;%R,K#4U;HCB P,X 9T"\"MI<#(
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M(_5M0$L(QMH=0L[>W.,R3793=,3K?!>[91FQX[;F/N-;4>L2(ZSIZ$3?%J0
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M9K'0*8K#NT7",DF:8NQKN<FW&N9EZRH$TKPFK(&0D7*->R\*/NV"2;$P ":
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M9N#?P)8)Q MK/G0+9YY^7J48T%V &IK9'6,WOBAGV65SM-+&?T;267?=&,L
M,PS\!NP!OQ7J/\(=28*C-D.*6[]Q^_ "YM(W+\ HP)W@>PY=^V3<PX-U[:JS
MYH!1M@6-R2T7W9^-_1<<*W2@EX#2A5>)%RZ;>5$E"B'F8_;=DG9K'#W>MTO>
MB;'LVR7O Z'X1\8Q?HS>P6F^*/K-[28F6$MWQ6P-3 [<11@40SN1 A5-+TK2
M;):$8$?M0J!!D?? Y ^XM<@0-SCI$,WPD0KS5[0(QLRYX@(H-!Q7!YA; :BH
MB)'=EMW[3OFQ0A+N',Z06%%SD"&5M691!%/K0LT*UO<!PIQO 9*A\^""B97
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MO;(22(O"D0;OQS".4+@]9SBN"OW7EU O4OR@Y>TN0(L#FC8SR-OT ^@\5\K
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M-(1QG1WO7$A@C&/PRV0[IG'FEH9:ZB*+&;YYH)U8HA<%W[ )0+9&(T 7IW"
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M(M&10<J A++;.8F[MD[;$*.GCH29F@ ;97ZA?1)D/Y,1FU!=G-%!P&'&C2,
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MMA3ZLWKC1Z?J+%S8S8U5&Z.@60G_/, '[C.PMYN!_6J?@;T38]EG8.]]!G8
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M9'R^1>VA-.N-% <RKXU@;@D5>;J_\=)^'N![+9_'M&;<%-+;N+&1"'(Y\(?
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M3$,[6:!$R16L0S 2G1;0T:DT!@BK[#(OP9.Y4)"M1DV["AI<VS09J&'=EUO
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M>TN]+Z9C-? &_C%(Z:#@+EB;D[9-(];!&-:?L>RGX[1Z]:B8'-^H$E;GU L
M;Z*KBQFVCLXWP_/$;&AJ$3"D?\%O<1K_0:0$.F_OO>Z/HO.\/_WG[+U)\^8N
MZM0M!08A4+VKR2")D 3D^5]/?FG+\ZN0P.JLIK^_1E3Q,Z>V/RXI'.=U(#@$
M0@'_V6WM]_<]R<'' T.L1DYVJE+)UE[>=^$%FD/#[-5CGI-7QGS"W1? %(([
MXRD2*D?J$^@F&4;/.^U=LK#P'P>(]FG.#(LKB,/K'V,CJR#R4X8MPQ:UJ$DS
M%#<6_A. BJ[OD)2"/Y3]$2,P2P,].RB0RO-N^[#?PO_9/V!Q@/_LT73L/'!L
M!BCCGE%5LN2%XZ_13T5E'%-N,1E=;0[Q7=L[-,Y#9,NY0))>HOD:1=2()HP9
MEGCJ7SF'7]EO 3I@*-.V]W-RB14M+2F3NIIH!Z$_0<Q2/![=GL,,D:J)'W*2
MM8R&X!*I<H%F..F14+MQ>M+]HYAJ0%$>$XX3H79*V,4&PJYEH.?<KM 5H#^L
M']J<TUV1M5C5QSMFY-O_"G@WZDN4U\/24U0E]%^H.!/W2 1S>6R>Y!;Y19S!
M2I A"!:$NG68<5-0O-"\%/3J@%ERVO(8.A4%3E('&;*UATX<[ZO2#0O7X2!9
MCTO-G#(-<S[!SE"F7R 8>3L$ 8U 44")6G5T6CHRSN:%3ZWX8G6>(&"4&E8>
M$0!.ZH(>"7HG2P([!Z--'I]]-<HD$--YZD^X'G! H%,#TZD6:P916DT4W*4A
M<1(JBV2U%E>$**735.WX:>I33UZMDB(6J=/J9T@E@@SM1\":!.GE]JZ'8;\6
M$6)6#O9VNB^"EYHQ.G?:Z,7' 3':[E%_5PHNPXD4.>(4W7W7&-78GPGN0ER0
M/U-70V;.LV7.2TBCV"A*,7*AL,XJ>'85<8\5?#@Q1!8+3%A<.E/JC@IE_IPB
M9I?NGFRU^^K00S6 50\B<>>6&+O0#?5$T'VP;&N)MN> PT58V@OTHD0[D+YB
M%6+)6%_55$;@:$QBP";&<XF59@#T9>A*^XK#=+B#T'!7CN#"GEYA7C3=E2IN
MW:.FN]):S*7QT-9Y:&OA(1ZV#!NHM]UA"EZU#GMWM]TYV+M1$?+B[_;Z=U_=
MW=UO[^[VF\G>TV2/[K)H?&X,NWMXTSP&IOG'%E)U-<6S2G=V/TXWEEG73:=&
M+\#HR4Z_7<-.!C!;%C4ONB\KO.[N<U',&=[IMARM;BK1J;TXC34R(^A]B-8X
MS5E9=7Q'0S_W7RZ1O2%LGG"#8!C"L_3THE9([5AJG"VX,M\2=,VLLTK 6>?:
M0EK[F9ZQ!;?V\_QB#,P-Y)&]EUX-DUQ/CE"?!'<_+'C)LS_&1B'GF 2&3)82
MF+[XL)HO<,6(?C> T:[CMB*._0_N$$B;^@YMC-3[W8\*LL+H0V$0Y(7ZU;_B
M#_^C<N^M\IQ+B9_^9MPN?$;BOJA+S)V[O7[P_3Q-P'[<D6T( J7 =+T7 ?<8
MNRX=)%JE4%+W:!D2OM7>+$/;S0L>]@5W1O0=;[U(OUYS?EXE\KM;O[ON%%^Y
M5@OOMW;WC\H95'>^!?CMBEMQ,X8\HO^WICRW?O_/9L,4.PAOH]WO-V*^E7V8
MRSQZJ^UE[55>/Y(^:O=6).AZNKD1S=[1$=WZ6-:.T)?GL'5+7&^*Z^[NMO</
M-Y[HMIPOO.BV^OW=&=?70QS034V+C9=D:):A#8%!X]O8$;<BV9K-W!"2W6T?
MW$PW>TBN<LT1W?I8UH[25S86-DF4]0Y6%V7K1W1;SA=>['<ZRPNR.SR>[3+)
M5G"#]98I>+ZYQM6,L;(&.M?]L(D7NMO:Z^_=S(!8;A\>67/E4V@?[*W-W5]2
MB?5\233GK&W31I=[MBZ#V')SV=6,\11D>:\%XS^>PO70$MT)X)?J$3O$'-;E
MVE>\L \5V:^;W4TC^_VZ[*?&4W0_9O?Z.?,:#_)&F=W[G7:_O_%$M^5\X<7!
MW@IF=^,_O@.SN]&PUTS#OEWBQ_K=Z5[KX'!5R[M)@'B0L%&O>^.PT=.64WM-
M!L0:4OI6ZZ]'_79O\XENR_G"BR[ZFAH-=I-R^9ZV<W2WO;_QL>@F 6*3)%FO
M>] ^6-43LWY$M^5\@23909,"L1YAT&6ZAFU^3L*ZC+&=NNGN#<*@&ZR?;DX8
M](,:I+J?5(_ GS8P&+I[FV#HTQ:UN^W-3P=M5/"-4L'W]]I[FV_W;3E? !5\
M;\.RD"5@(UADO>TKUK^=)K[L]MQ&NVW><?_ON.VX3[:V_\[W9[TY>+_5.[AA
MU>J=;=&M1,"27<?ZT\5==Q#N^MI6&/>!B7UTW3'U6-"^O!>+:YFWES?JH+W7
MPUWXANCCC DZ3.!-<9(+;K(BC)T+#=.C&(?=O_338>9E19IBKX*4@:(1EST;
M7<% /PA&&-MFA(CR;#&0$;5ZE*0C%7+[S>J0;>\T]_PH2Q#L#E^?6=QG[K #
M[R'\XVD4YCO):*1AIT\8:?IGY4?Y.$!<O'__[OF(PIP%:3C WBVQ]\%@&7]*
M<N5UCUJZ XO3N"?[/QIN_L4[-0J#,'\I\-L,U*X0J9DN $W(XB-G.7S Z-BR
M>4/N1G!3:/?^IA%V;_T(6\U"B%MG2*I&D0K@O(@E(JWZ0]Q3.L2M/:7^NIW2
M9[[".0$N#AD9C%A.RWM^J $PJ;>+'P1I0<COU)I#+N]GPE37WT6A/P@C0J#7
M]S;DIAPG[KT5?=L[&R.^O4^\J)RI2(TH9H'6I2T)=O>@QJ%\RY$[R>\14SU3
M>1[Q-\K'+B7'TS2,5NKIL%$TM;MN-'4:EQV=K5(#5$+(H^,!E@[S=2#P&0'?
MOQX#'Z6!$U!YWFU+VN% "%9+IDI?@%+3*.J&X OHH""[(MZ@A7>EA@AT,Q8P
M,MV%@-N-T#+PMPHFBYA[F3>@QQ+N9A/&<#M08-$+S KX]?@^_<!012',[<IY
M)[])MLP_3Y4R'76PP<0P'(VP<0UUS+C3I:G2(5&CG1 X-QY-)->-9@(W3K(-
M>\M>M_W'[J!R;;.Z$3#%Y!(%%&MITE,&%0W;@49:#\URK*'M)C&")X"\I7L2
M;CANU*NY&U6'R;HQX/&]H_;![L'=@Y'OM@_[]X%)?]B[&1[[]DQVO[UW=#/T
M^$>8[%Y[M[?[()CTO>Z3P*1_I!90-)E-#((V>/@U>/AW!H6_!3=LTR#LO8V#
MB-\8K/5-(]TR$/L7;3BPS-A(7/Z-(94UQ(]G1C;#)RPHO)]Q8TWX[DLQ &F"
M+I<X3HHX@&]KX>&;S;\!>'\5M[\*V3^#UF^!^I\Z1G^]2O-O/R8?E83[O1U/
M?W)M!L 3+.XE)UKO]9J6]]X'#3<X_O=TR&L>RV\HO>%S3_GT&S[W-/C<;NM@
MY9RE!J[C[O;?!$FM FKCIH>WT$ WN')IY0*)!OA@$RH*FE-J+E)S1'>6,KR)
M59J/L<6<%&;%ZY+U'=M99'0KPZ:I!6N.J3FFYI@V[9AN(F0WK[J2S^)HS:4Q
M11)O8]#>;['=^A'OC97X1R\IVZ(*T =]1W,)FDNP=@2Z5'UH4PVZ7=6@U]5O
MX'EO7/G=6A9)-B5(CUN"1!5_%:J>I6&AV#?_'*3_>#-W9#GP74Q(G,U6-%4U
M?RLG?LI$.O8G_@#X<I'/_\G#YXK67ZE^IY);Z?QWG-K,]W.U,TB5_WW''\%D
M7_G1I7^5/?M'^5C@ &3P \X(K:Y^[AI'H_M)PL.+2UL]5$&2$NM\123)J:7_
M]-=F+MXX5:-_/?N?<'>PJ_J#7E\-CSJ[NT>'@U&_?[0_&G7VCOK!H+/WOP?
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MU*ZW8ZI<X9\?Y#<?Y3=GI1?Q^<QAQ4A&J*3C:<*G(S_(DU3$*P[%\C5355'
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M4:^I?Z736@LZW"K1= ]+>]6DY]GTO'Z3GM>DYS5)7$UZ7G.R37I>DY[WZ);
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M*"OK.D@D'<)T9UMX#^@5H#YBD!'5R;+^;7]GI(Q4&N \*0'%[7O;71G?=).
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M,"T0. O?A1SJ6H05*D_N[O^-F[GR+U/I,J(S>4QU.B'P(QIX#'+XRL#IN^5
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MN-5\JARUH?0G0NG]PU:O=_B$*?U>=8?>'4K,VINT?A35[3XA8MH$WO:W&ZJ
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M4'2 01%,?4[ZS).S:';;O<8D?VR3_*D0VT&[=\/0>T-LC?]G#7;U1;_3;1Q
MC0-H739VX38R"!6WB"=8K<;AL\GV=V_O:.,#V0W%;13%]?H;3W&-RV?U-*I5
MJPH>_]0W@5-LC-MG?E3+11?;07BQM=K@CYC=@Y"D:H#(J^@#*L)LC A3VV=Y
M7^.J/]HH,^5&2:R;>SS4<JCW>N,\(6LC6YNCW[JCOT9VW1U=-4\^Y)-/P<]R
MBG7UV.M) DZW*;G90);VHGNP'4D!6WH\O>[!5AQ/8\ O?R.WXT*NHUW<.[S.
M+CY:,[/XE ( W@M$(W_)P.,"N\UX[!H VANH$0,JT_.Y_^-VZ1%;5UW8.MH6
M%(*[L+NW[7A?[+4Z_=V5O28;=[2-K;Y\N?@-K_LV'_L#&72/!ZQU:L0?",18
M8:GH"S'LYB,[;JD>N=_?WPI%<CN/9_]H;^,"=6LCEC;WV%]T-[OJY_%%TJIA
MSW633=>:<HW9YIIMO:->8[9MZ_&^V&WU^T>-V=:8;=9LV[R"EO63D1L8AZ/\
M'Q**L .ZL^#0$8N4!$VM]OP?3\V4VZ@JSB=FR+U8(5EKC0^G,>&6/7#XM+'<
MGZX9]TGE.LK&IEQCKY7LM<,;(M)MG%+_!(\7[;7=3F.O-?9:8Z\]<7O-$8-^
MGJ?AH.#.CGGBP5:@ 9<F482>S5 R+&_FV-Q</?%%]V %O,$UUA&W]7B.5O \
MKO'Q-);;\D>^'1=R'8VVS4NMG#'D9@39K\$O*LN2V#M)TJFT(6]:MMW7^M>;
M=W1;W>[N=ENV#2D_#5(&*WZOB;HV5KS#W'JK)J,]OA6_"2SFP5 C]"/Z[7N+
M&F+?@=XY=PR'2?2!'H9)@;K439I//YE9WD<U[[WNWD;:)QL(B?(NC(I<#3WE
MIS$L)]-FRE2EL!V3"1@FV=A/9QUPR]@M]R1IMVF,A[F8F[BVA^[ \7C1WI-E
M,G1O[2I;.\5EFX'Q#MJ]S<-(:[ 8-YGD7O0.@>@:W_.3BC9T-Y#-; *CV (H
MQK51;][5YUH_-<3%3KNS4:T!&\C%S3ZFQC/='/T:F>#]@W664=09:E4=ZLG&
M*E=>_WK??S#6;PACOS;AREM:\@TE;P<EW] 'L"EDW#@(&@?!FNSKAD3=[S#P
M<X_Q[&V=91/<NVO+0HZ7KSXPBF6$%=WH5;.&'\\4^8/^4,,='Z:$S6B'$J)W
MP_&9EQ1YEOLQKO8V-2^K;.BFB+R]W?:J341O05[W+!27G=)M*FNVD0CV.^T;
M:C[;2 2/I# OFO<F4M6+%>!_5]V"-2.E1@DW>LH_*.D-_G<87KSY)_Q'_V+B
MI^=A3,KF?GFK_BRR/!Q=W?6^'%VW+3WNCNOM> ,_"S-OFH1QGGEFGQ:LH+]&
M*SB.(LQ #$ [0PTH&/OQ.0PN)P2ZD#](+I1W.0Z#L8?9B7&2>Q/E8PKCJ(CH
M(^?AS/NO2A,]8GON;L@<=L'&>CU-LA#CE*]2%?EY>*%>7X;#?"R4Y_Y*KE+'
M_L0?P)T"G6WN3YQ]QAFI].$O4(]A9LI[X?YW;$S/*9S!SB!5_O<=?P23?>5'
ME_Y5]NP?95(".I+!#_;;N(75U</%H^Q1LV_$B6"MD3_-U"O]C]?Z(H8QS9A^
M]%HH539[KT9CQSWEK^7-1T?M@\X!OEPL#7FQS*M-\ZKP<?YN][!]U)G_=:?=
MG?O='0U[C8%T4RY-IS"'TD:C.Z&T@QI6S?,;JD 2A5^!7%(I/@5S\M=F+MXX
M5:-_/?N?<'>PJ_J#7E\-CSJ[NT>'@U&_?[0_&G7VCOK!H+/WOP?/WGPC6DY&
M'J9OPB7._OD/_TWE.LT7-K<XP!HF0FK"?![2G.SR)[N[_^S-K^_^[D^FKX^]
M4QC@QYQS7:P:/#R'G]D1XO"_!K^\/SO[_,D[^?SUR^>OQ]]./W]:1AO8*]/D
MHZ[AP^FGXT\GI\<?O:_O?S]]_X?WXD3G$[VLDU^S*Q*I4:^DE7Q!6*!Q?\ND
M$5^%.;P_6&+A7]6%@E5FUQV8+*_;>^SU+50V]&JP(!Z4B0PTLU&2>OE8>5?*
M3S-/P12'WJ]^"DI=O]OR>IU>S_/C(?ZCB^ZO*>AU0RP^P=^D*INJ #4S;YJ&
M,! / O^&78'9>\.""E7@K^\J]\ 8NLS'+7QY5"#KQ69\/KUQ4&0PV2SS+L-\
M#!^'&78&]@+8OF2B4OX\C+VD2+W?VF=M[\O83R=^H IBT5ZFSK&%<!NG;E\E
M;X+UXM\XX# MSCWX313^E_A3"R<;*+,?68M6&ZM+F'WD%W$PAME-TV18!#E\
M"<O/0S^"+Y/1*(,7#:YDA*$:130DZ+I9$H0^^@MI-8.4UP@;<:YB.+B IQ$D
M,8B8#'[2OM8ZV-#;\U.*<*]?TF04YMMQ@WA%4UK1G%M4?XFJ=\=>&.>^"(7_
MJH:D>)P5L#-(WF=HRU#_+R%TH""X=3&27SB!V5PH_!3O-9!H'N(3 5I@%R'8
M0YD>EU]TQ5_I*]>BZ1"2$Q:7(043/N_W,*<[B/<!S '[+>A;?AR$8"G 4%DQ
MG48A["_NP,GGWT_?[72/O L_"'#P^@N#[ROBD7\!2@(J<+ "/\CYK5^^O*<W
M)O!0ZI'AYUQ N)+IN;*,)80;%.<)+FF,WV1MKW1 EV!WZO=<R7N0VUQI!@%K
M018&,\SA(I=X2D;SJ-\;W$Q98WEOX+WGJ3\Q.[Z05\U,%5Z:N"=KR.L"SG^B
MF)T ;Z*9U3!)>>G7']_.S%NV\-JM(+*TL($G/IY^^.P2#-Q%O!I  <]U[A%,
M/"(.#K]^KAM+R8<M1]I%5VWO&TP@2BZ!2&E@/1P<P<QU)]D9ULC%,:P0!B !
M ;\T @1O'%#^%<U.BP^X/SMPM_%J5R6)""J@_J]J! ,*B]%'_]"RH/X(,<6S
MUWE]DH9\#8Z#("EBHN O"0R!3 17_AX(;P+KS.@'W=?WO(J%<X9;%-"1&"J"
M\P5%)/,^A#$R05@'Z%0AO V)<E2DQ+;@*!.X\3F)]IN2+G,#\V)$10_\;(PC
M!4H-,Z#'0 $Q#HF$=_=K2+A[V%U P_C7%#Y0? C(.;C.F!A\'N8I\  O4N?$
ML_(\8AFS+$?9-%V%\D^]SUP< ?OQGON);8GF?PR2>D+"G[E+%J3A5(MS%G*3
M:1*3$@&?(#'DM"&)V1!IL):M1,1P55 &)Q'PRNS5"J0CWID==,6\ZB]!3#N/
MN+O$JO8?D565MZN[VS;.@WJ_T)DBT,Y627MIL53Q(S:"_.$DC/%K\KW;XW\A
MG/SLW4_LHQ%&_?+5H[)J,QW4US*8-Q$R4&^6Q+&*X-,,+3A83IQ-DS1G62N?
M#I$3HM&F>:<_@4>,D1BA&J:?158.>C-\ ==CI.S.M.9M&7+:"0Q1I,1"M;*J
MY32K$3!9T,O3*[QJ%WX$&@)*%#],Y:\(S6.: OXN@P-L.9JRG)S1@YN;MB8W
M[23RPPEK-A%H/N="=GQ,U.SD<:\-Z+&9,A0IZ@80,AX\VY3([I4H962*#3B$
M9%4"8Z<!8:+DT+# \$E6##!'*E#>)(E#T+RU20FZ!]XPY$%$Q=,P"8<[>J"
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MY(Z7!UHX/D+1\. 7$&*),6@JS.-ZH^9RK A\0=%!X%S,SM1Q,*"],9 OJ?]
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M?3\'[K#I;BEA*-BN''EC?LUJY=_*.7N1(34M&TX=(6AVT8F6 1%+%9=M_2R
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M[30 6Q+SN!3Q&VH%<8JENV:!,%\<>#P-$)&1 =1M,H":#* F3Z3) &I.MLD
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M'(K'[-9P0G#(45>,&SZR;^+6'-?,WX5=\BD,@A$18;1@QP;)Y*F4OC-C.*/
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M1[ @FK(*?9SKU!P*0Y8]1"M7/2[S>$0FK'56R"U'F0LT@^%.ID-JZ?X"*.+
MTC[!O<T6I=[%Z4X8L+$9+JR,*C)H(0^C@903JTY^#M:9CN>NHM0E%0H9%7B.
M!**,P*G>>K'(K4HENL0E8M=05;(.H)LV5SL7C#YBNGZ7Z@4*0ER6,&-M 5U+
M4OJA-^\V#\92$Y%P9N1#P@'Y]HV,$--VR. =)JK+N)W._=SGBL\%!+&/!0VG
MW\-*8$N+<5.#,$+TNK/46D&,J%-/DZQ$G,TZWTE]S5%JB_*[*['',_)%ZR1?
MPJ20!5<KWTBL4Q%\O/AP6)FDQE<HYRKK7&99_9+3B!C%38ICZFAC8):@QE2/
M4S'!\G-;3TF(\B94^HXN_J&,')!F)7JFM,3@E_GMU$Y,L^<('I0TR%N;3.>6
M&8Z6UWG9G#A#5"!$/G6RH)I_U;;9K*"0B](_S!%<T?> )+)DF+HDX3N@Q=Y%
M/2>9#)Y3P#6C<U(C7K[WFA0!0^V8E-%-:?-<<E[(ZM#PP:F"!-Y*4*?<W_;Y
MT5OSMIKR4BF;(=-R^!.^PXW^0D <LD]7RX+C=+FXTJA3D\W%97XNL:AK+^TK
M-J4(J%#U8#(;?677H2D@-2,O*6V0-6C6+36Z8H#&A)^)QWDN TEZ$6V=&9;O
M$3;3P$VZ<O)6<@1\0<H@W\,X@J<4:"7JM1)(;T1^R7!D9.LFS2/X_K;UM_ &
MU3V^>7SOF_"]12A1<7F*M.$2XXV<8;)&$2&D"%F6:8DPE\,Y=@9'51&_3R1
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M%.N6Y$92HLK<B8@*C#P2VC-5. 72@0._&N]'^:>DZ<&G@@ZUJTCH5$#V:Q%
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M '>6^H[IJ=:G'><=**";\?*@<,V!&M%I>+DRO-S=BY=A37?@Y8P'7_<F(ST
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MVAH&JA4A-=7!,<'&=JD_UYF6VQ3]I,C)_987YW(X"B]7W1NE0PZ;[\!C(%6
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M=AS@;^ TX'_)"FMASUS8=R?R9DI+%8_=Q99&W+\KLM3 OT8@FUG"_PXV0I2
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M6'XAP*6K#.YD<.S<\%+6"$<Z&&DP-$K5+V&Q+_QC?72 I+_-Q H(_NV7E1&
M\ 3X!_SH/]FOT\CGUC(3V/"QR#-7??F@E?C5]]VQ[\D'.RNK*; O.GY250L^
M-F7[.EZ1.%]<==&J8I%J<)P4G=XW>%"(#RM85QWF& )ZN^0B!"+*BJ7@:\N>
M37R4QBYLHC61JO'ZN[VAF\K:P!P[.X*+N^,C.W;\Q(#VB1HF ?TQ3UYX5;2*
MN70NX%F%Z_LPT+#GCV[F8%?%?,:GO)D H4,L9XG:ZXW=M*9QWL<9U4WJL&YR
M15SWKK=PY8+7&]9-7HS%\N##P91;;A=>?2 LV^N&.'.O0OW6Y8'0.1G2P-\)
MX,7 .T4*5?8[@ 3 IJK324Y5X.!.R!H!$1PL/G1LF2\$0G\$:E-@&(PZ%8"5
M_J\)B(5W^%]-X>C6: 3O 9&&IP##7"3??$K)3 SYK'*#^#24SZX+Z^@ V,#K
M[FP&FSYV VR$VS.L>OL4OM&HS60;L"5\Q1(%QD<RSJMQ]JKCG8;](P[]$(<>
M$H9FTDL\=-PH(6,F?!&^K3&*_>]J4%:"-E8=;Z#3S>RJ42K>X8I+?B9;9T5.
M'(CM8#5T5CK1;(K<3PALA7_^01[AKI%H=H,GS^>X+.BRS9+X_0D-)F19RE]9
M0H6#'Q@F#\%@F\D!@/Z$B7RGEPO/5G"[NG-_L_KK;'PIU+;8)?P5.&/IS;?0
M42>W@+^7@MH[J'3A/OQW22K5;++5MW'FY;OJK>/;;'OZ$4^2@3^.VGI^,7=+
M_C+1L-Z]VC[X?6KV^(WVO0H QD>MBV@WE_,5OKN^&OW+L[>IOT%A"7T;[+')
M*C]N?MA,"F?]_9T,G!GU0]>=I*.^30T/=78&6PD^PW[(._4OP)Y'G7EU\</T
M\_X=DX35&>UQ_,BPM^O> 4T&2V"-:1KLE&<N.V_@W*X%HD_.K#J(Y/"X-YA]
MM:9RE0SY#12UCJH.#S0VKY%5=*F^"BC=TQY>X5,*3.M *$#)43]\-RBL(WC&
ML8./]"_7<3UO%?W*+ICH69YLX[>T)L^P(Q=DM=\'2(;_%WU82072X[?\C%KF
MLSBG2M^E.M]3X)J#*:/4?'!U F9-]4KO[AEG1W :E47O+\/*-B@'7P:74N^J
M[[D692]=0H7CM@(<S\5A(9O)!Y_'/O/6R6;<.1QI-]R^'A&2H9\AH[TF!>K\
M5Q]L-A[F/H,@^&\+G'[JP;."%5L.3*<WJ)]YZ::J2Z8^Y.#)F"[@J^J,U'#R
M\)5&S6@0\MIM E#=+0O /SA$6&EY&FR94V6=UV6GBE%(WO_F_+#&P>)7>)[W
MS%R;C7/9^#]8_(WTF>D>*T2H:Q)"/"& B__%32L2/(>--^)I6X&2FO+9-Z>^
M!-7+G<,U.*C-57]6=8G$PFE8Y\\TO%);L+-ZX:5*W%Q!0+4L^-FOZ I:S[!M
M**SH!3Z?8<M M. I!,[S]VK7&7BRZE^,N<N4?3,Z]<<'+P1E0+M.Z;ZZ::IZ
M_=7P6,^_<#8S2*PG-L*,J7L%BCV_V#^_//8?P_@QC!_CO3&,_VS(&L/X5WK_
M&A76]_W]NN4D@OFV/"V'4XOXYV/$C\^>V4[,3WM<?.56I9 -!K5J6'DWQMK4
M2JMVWCX ]:AN&7SACWZET[_V/( *?J;Z$PU\I=T5(B?G]0;.1GW0J=Q*DWY%
MY&.E-;&9W.J$*F5V4-M79[U.:<9.EEE;S&NC+_ O7N<-[H#:!11L:M<-JX8=
M]SU V>KM(;(R<[[6P0<[+;^)D0\A^(UYUVN(<ODP6">XEGPP::8=V]@L&ZN>
M$Z-6A3'UXY_J _@M>4%^N9JX82?SWQ \7W[A_H@',TJZ9Q3G0U37HNPM:#B.
MPBE?8VA<>5;;H^[<^]_*8:#!_%;#LK7SSPGV8J_;6>F)4R.@;'\V^CKC;Z\.
M=R:[9NXL_:LOZ _.<RHL<$9@855'U$_ F/4D!JH[,SZV47>\FG 0_QF5%5%;
MWB)N^4_-4'IA.1/>K@D?#@N.LF/K-(*IS5B9>Y/RS%4V\!/ Q=^=47!LXWAM
MV07CT].T,[TJ6C< @E-UX7-"QE0,Q BTFW/U#,;15>")$V<F/.49<FR)5Z2;
MM[E!DHJ19^,Z+%Q)W6"D3V;\R5,'0+W:05B5=B%I!M8\;G^@IUNOW,"#.J!L
MRWK?(7"DAK5+X'/M>_2L!& ^YS6=(%YOSG3W7^SW#XOU8/6S(<4'XIC5.L4K
M[T 'K3O9#LZ??36$_3V5J*(9;Z[R;)U6F_,D/QUUX860,N8ZO6^!\\8O*^"Y
M$&KI]RJ_-]Q-7HI0G;TP<9-=ZD>MO>A]-_]5O?YB-&7NY9KCJ\>;2=[,Y!;P
M5VV5J14\L=6=,:@1<N*BK)QEU78JZ*N?>VDXRU^/9?=KK_/5^RJ]T[L,UQ.(
M4:?CNI^#6ZX62Y#=($A!:MQY<C*RGVL,.#R>W4\M\9=0P/9@I1Y95 =^#E<4
M@(7/_)GQ65T%UJUDJ+XXWP4$0/[;<:_CZGA %3F#1[>\MW1F/;7F=LF" A>T
MZELM..^JN]U-'&CCU5SR .]NFT9T5Q*F!PLM34"8BYJ0CP5"+HT<7P(JO56C
M-1+DLQ9ZI4U>=51Y"H?>[XU\6!((-9^X\\*'"7])WOB+J>OI[:M?ZZ'OH6MO
MX2-+O:0:K!((7_U37,7LCP/4;ABD7XG?R8X; )^>K<R#;N2NKYL@,LD[4T4!
M;!6XQ0N\!9;H@H9;J=RG_IU&#5RE&5;*C*F8;ISK"HP"TCGLEWHT :M*P^BX
M*CNX<L"/4S9")".P;XUUDT@W()DZK<P$-5U(XBLY/U<Z11T$.%;]4V7<J")8
M0*V!\E;0>!V@<+<6WP9[&15@E@"&],>1<&\TC=\7<+KLUHLZZWCCJRR*<:QJ
MX &I4LEJLZZ2B 08I=?ONHM).IW/2P;<JHXXH&8H.OP\$4)8&]B#9YXU/?["
MBN'E[EBK/': Y<<U"'>*$-X==6W(2"S[%IV%%MMGZJ)7;Z,$S0S =@1/NR*?
MLS%,>-!-7CO='WD;D/!Q$M]P@36'WWHUM><1;8&H<YQ7&3,A#7TVD[J5;.S,
M,,;&+Y7N>1J"U6-%%DZY]"V\?#UHZ?'V0T7<*L'='W!(@YAORU7Y.HP;IX_X
M4+]7AX/Y]V+C@QL..^$'^$YX[R#\#+Q="\4PQ'K5"=ALE?NC$@LTEBR?RS'R
M,@H2ZL7BLV?/2NV>W5" ?9\.$OC1\XGKPQ-[_;&KH=,S<_SGK;CQ);!X4F'-
M7D17WAD;OU32,=U9,!=.9U*Y_.V]#<9W)R'C)C][14@(F)H0X\MEYC'!8H%3
M'12ESQM=VN.W8(P"UT\_>.DJD]%94.S.@#CG(>P+2MB_L-SD"5RAG0!2WE*#
M6RXDU;8JZJW\5+[))A^J5,TS5<XF90>.':>X4;&)_[\D6'V^D=8V"+*_F1<W
M6W&?&B?F7Y,=*EX(/@OO%IOAAGH9+<]:I_ZHNZ-3#1N$9\PP;T"R&0;VREDE
M5,'&[YW5E0N!K2=O<^-HZG3]8X=*R'P)B^H[[ZL:KVT>UDW084:5XE:Y>NKD
MPZ!43]!UO+%:$:R^I [8UMIX6;4< U,82! NB(&;,%-]+2V>3UDO%SX;O&DV
M?.!K^;D'2M,@.%'\13-YOS^^$'"NGU<6M7NI"C[.$W$P5I+A/<=^H?8I.#_^
M/O8&0>+K:#PHSH38031TY:(*UV?ML;JHTRNT-QYFQ6+LL81G3;R\XW3-D!@R
M]J^,TS/&2:G)J%/_PB]BGI_Z[FOI?)(;$"HLT8R5Y,JW.DPZL+!A\A^X88!&
MG>!IG"#^7#Y5I_P"_'7<ZX5*N/"PT-(NN#VJ)))IJL[X@W,Y I.%UU9L>(8W
M3T/^W/BA!FBH77 ESN\EI#S4F0Z#Y6:,*[;W+5Q54^+,$.$,?N4S>P/@EL-+
M7ATG@80'>$=,$'[MG&]#%PQT.W&Y_]C75SL)]=1*GN> VFYS5:830)[W4LV>
MU71W%^.4T,4SG:Q\]>'V/$FFZ5)A>T& 9Q\%%/!26A,AX'W-B%6IUA76SJ;O
M+1=>]9?%)247,V[?><BJ#SJX0"H\GP +7-R@X5Q'IL+!!-<S'%4GU*\E_Q*;
M='(S3<7+\V\@YL3IOI#K%)374"_G%?5E^]$K$BM5A59M=0."5\E0@Y49N]HG
MA<V2L'9-AF.8L1GJP_ 6[>>@3<7$FFEB3183:V)B3<S B(DUD:PQL:;!A;A_
M@W7H*UA*;[77*O7430W*;,^4X<*OO'=S^L^,TA'TH*MM^KDD[<N5%.\,G-AD
ME:=LR=?@_7,S=?9UT<[J;ZVK>"J7Y,J(Q6R\-!CS,UGGXZ!.B,OXSU3V[5(U
MV&Q9TJ0JK[:#ZWS\R:,Z=35S4->]NA@2\X>UQ0 :>Z\_G'6U!AW751^J@U-)
M'9KR.=_P>/^#7W G:)97+7.I@.]4P6:'WA<ZUNDGBNC8AAA;7I-(UHP!5CG=
MU$JM=T'+AQ-TYV:F$W5M0,+1]4>ATG@P$UJK=>D0(ARL)LEG'SVO*?:]^D =
MBYOSOJS@UI6<<@.[OS$AC__K?:M4^)6AC[^!Y[>M[5?9^K6U%-[Q"'S,DR*,
MF:R#&>-C#J5FH]0W(_JT6F$XVZJ\Y9G31SD\BP]>_KQ':*X[N>]>_Z,.]^@!
M6]P'J,Q^>[CZU(7C8INA>RQ<4;ZBY;*F]HLY/'?!)K4![QW+7^'78P";@OX0
M ' XR1D;+V FYGWM/AV1B>Z*B<ING7#RHTD(56IA_4/'?0Z\->H.7&>^T&S<
MKK6*T52QKE/G_?8+B80MSXK32K#P[=/:I%5KJ69RA(#5K!-JV?MR;9P;7-=-
M-?;3EU5:RM3KV)LZA=3-[O9+1D?L^9$]MDYQ_.8)%,I,?6595:!>N?4JNET
M):K\DM#]Q4=RO,YY#:+Y;P_3*3IJQE%8.?]]?&6B5@XJ)7>U=C#IRA3<C]6:
MRBKM=/[;YM.CO1=R%-[EP6 T&$RR=JM/U=%'>/M5WSZG%-<Y6-XCO%H]CECS
MX%A3)WLZNU(+!Q:]\-+O>6==%]2\O7 *&GK/PAE\OJC*:>=\R//QE"HUWV/#
M)(L_>-^#9%=:]3P8W0LXC,5M>I+7V]=D&>'MO<&PBA%=5&L9=VZHPR0+06!5
MF3*^T5.]UD%M:H'M,4^1*&,/+V.AF!VHN*(3YJESE0U<=D?#>?& >P!XJNM#
M3!I-<TN7/G'L.G8&YZOTD$DY %P;_:\A$:H[S@"8/JPU,495?VRWK[JFZBMC
M @S??/?[$/F9N?ZJ>5QS5V!DO@=FOG%VO +XJY+CQD/V9APSXW*3&;_0<C@X
M*#[S&.=3W&;[,4QF R[HB&-E<*49$KYM/7?++1(B(K.M69NH"DF"KNISCMQ_
M1O6UM]"_,-S3IZ'340E<X\M4KG1:3A@G$ONAB5VU#_$>]\EM,-N[I,Y$6# ^
M9YP@E14R;^-&JCXT52?*RM3VG#'FKVF#1BH^-!7G+NJJX,Y<7.906N$&#/=R
M2,<;#$/&5!56 \6A;MKS1,M@/H(B4U5&'ZKSY-VXAO6*,I@;5[SDL>!EL>#E
M$=02S.92^LRW2=*;.08Z3!H>UD@)O*-=UQ5EI> NI%=7^NQ"@ER5Y/Q#'=<[
M(T/:U$Q!X327=<R]/BJZ$!*?RW4%+:I3UY)/6C_/K/DR]^VJG-MJM/?DF\-S
M)K7?7A_H?_6IJ-.GUXK!ZD],R_@_=T-Y^3>?(5PY<DY[?3=VDH#>V*TRR,?E
MP9/O_%9V.MYY,@!^J124$1BI]<6F*B?NK)4=,O5F"Z G]HJ?#]P):9_3W,%Q
M&PIO$<UU&QLZ<]RMRG^ P\;5E5TW'+N19C8U[PSR6W/*PZX=M]_O!)X:SN0N
MSY*G<FX-DL]>&0[Q;3@,GOKT7E.5CH<S@D]5C04J:CL[GQ$\&EP6L/:.L/EV
M;-/-^754&ZQB6J&F>SA+W; ZN&\Z(*R!,^N-+Y[\RI#]C-MMO,N59%_:6_BF
MN5:EH:!F6)453%8Y[M014T"G*:!Y3 &-*: Q5S"F@$:R/OL4T,;HV\OYGHM6
MZZ4JY]ISKZZ?DCGNOU&W KLBPW&Q]&BF2FU)IYI5J<K:-I]1JA83*Z<UQJN4
MNU5VP7*ZY64*7U7N-.,'6M3HQL<?''UGONY]K-I-6\2W0"W^UKE KJO,V%R:
M=).?:1J_61F,XT??'\$G+5]4<@P\.=-Z*) 4CG]ZG%4EV<]GR :?"NQG-E/V
M27H!GF\.Z QZ_;]+<6M1+F/BZ'-RV/YTXNBJF_$J.)^QW;VM/L.!BT!UQ5/5
M)#MM>FTM.B=6>VM"6LO$9@^.F9E"]SIW 585ZNJK)H/#B^J9WNM6C#J=Y$NW
M]ZWC;)6YXVNS)YD291A%5M5XQM2#IJ8>+-QV:\@LF%&9)CEK:TPLF)4,WS'S
M]*SR%ZY.[*I]>7/:T(SOS^]EU)WYQ:SS+$;.'AJ(UY!\O88DZKJORV*MTVUU
M@6_C%@J@#XS@CJEG3TR=V(M-1UJ3]K5!4;<],SH=!_@G8&Y<Z=L0A@5=ID^/
M4XV/00F<^9+0;BJX_+TL1<Q^</9?E4QX?3&8P>'9_+(%=>42!3AF@CTA/IKD
ME$[OQO\WF+NG%W14KS%6EN E2NTT9="K$:&&91* ''-''8H=3K.Q*Z_,3![#
M); ^:8IZ/6:-#/;0#!93#9\1L6.JX5.DZC35\*HTP[NLCX^$O8?LPW5D&U9N
M=E]F-7 >U>M\C^ 04[;TA2X74W>!]CD\*M@;<U_B0>+,N?ZT?6MK4K!8]<>;
MK5-<:ANVAHS71Y8-^:;7LR&=ZJH&WCCF,UX_G[%1V[[QB/?YT2"?Q]P1>M+"
M.\M^G3X6(EN#V@B8M/%7_7X8F3[U&3M5=?FK9Y>,NF50W$*.(#S-MU\=N6E3
MR/Y@F%@UT>%#DVKX]<"3HN[!Z9/U?,J@^^KF?"W37HG>N>(C=%5'6.L'#?1"
M_]J9'53QO[#6RH]=]&NU<L9L\?[HGJD*-%=DUBF_?;V0VE8;0*%=M^I_\<F!
MOE<#'$-MM@PF"9ISAS(]C<WD8]?6>UMX1&OVT,IIB-G68Q5F:*%'8%K7 UT&
M)7"/ZD]^YZJY*Y]'@*:>+6::77\+.:K^<  F9T:!!P ==SGRB%R%\.I1Z-4R
M![,K'Y_#9.7#Y>/ST.T9Q2?,JL%Q4OBA'^/!YSNO7D_&GI_V8*%UN]+).[T.
M..XK;.MQ.7.3:UK)66<T"+.%0P9BISZX.IW4-^H-1/,_@UPE8=Z1CY*$WO73
MM57@5_;'@WOKQXP&U;55[?&L[R-[DX\E_<HTK2(EOAS3=0=AFM;4XQ*FZ$RF
M <VT$9UGC8KSPD>#.[KJD5]]2]4%>691DREA(6-W< &WK8^6F.K+X+VGY>AT
MW'VS'-1MC.LV4%5P=B['>,%6GE_9!#7J<Y\2<6;H4+7\"9)HU:G&^H!L_6NV
MB_:JVNM6U>/)K_5?>.:]_L.JXUN1SZQMW_P;5@^OO@*CSZJ5ISB+.>/(TNR[
M!J$^W-7!U+(_GC?N,[@7T&U0K[BJ!0\!@0 :MF[U7F=I '+Z;(C>+/A\J[/+
MJ_! 3%2=)JJ*F*@:$U5C1F-,5(UD??:)JH_'D%K.9*T5\QF[8%[S^+&^,M'U
MYN(<7FL :9SICS-1K'XJA762O[HJD;1.?RC'@>/.=#ZHFE=T%Q.++M4\0W%;
M-0]D!!9):_%H)M91&9IK>?WEJYL&:BYYZDS*QHQJJT*6564;30W"<9LO/U+3
M/V)^,F4P4CPY2C]E86Q"S22M!B]4]VO9[W7'4S:O2 &NSJSVA$W-@OM./ITY
MX)B#>DD.ZE-PZ-P@2W6!17\LUBOK^*ZP,,>9,%>C7"LFKSX*?_]/)Z^N ,7)
MC35C$4_=CO-XYIU1"PQ\%<-68[(7.?4J5T@,)3TT:UW=G[!6=*I*^/$T>N]3
M,7XL4^_,]:L2YJI5WN":L#/O+O5S',.$[>H1J[GV&*[,7C_<*..O#UFCTU+]
M\6BK6E$;CW6::!"S/3JNTA4BKS:35[<'07,=YS@OI^!?Y6]=#)DN\(>ONQIZ
M[OX,'SWKP,JG*9EUHTC?3MY_F]<F1Q,W_T04ZC'82W& ";/"<RZ_1^<V3+,Q
M?T1FN)09YC$#Z#<#$ NDC*>^KE/?FZH:,R/-%R![4DNPW(PS FA#"T966ZC7
MPLW09.2GG!%A&+UU7UW'CY/_/-LMV!/1#_\,NFGMDPC#< >36E7XU7'U4.]5
M",K)-/D4?F?J&M?9#JSAL[WE)4\O_[E:D[NPT+?^1_=_W;IN,DLZ_^3P<W,?
M[9\3..V> SLDHYND_N+5D9WPVLH@"\GP^+.7Q6^F+]91F(7XH$\YVOB1;S_U
MGOTU/.>:,8+J?'X0Y+DK! HQK5\'OR;)_Y3G+[N];GODBR)-L%!AW>^]![YD
M6J=2IS2SJ6)**LFP*+33*9$L%8[\LT-2@E.68N1CT2FE>",,E?_?#>O*E]N5
MJZX-O]A(2@L/M/2O"[W3^_J6O/]Z1/=']F3WZZ<W\N3@Y'W9?O/Q^]')WO=/
M?__)]W?^3 \.C\M/)_O?#PX_G7XZV<8'A^V3(_C[+6UWCK[WTJ.3]YU]LG>Q
M3_[Z<G"XG;9WOK"CTZ/O^]^_D$^G1]_:AU^^'Y&];^V_!#MX)4_-Z>ONP8GY
MWC[\^*W]]QX_^GY\ M]S_NE-^[B]<WS\:6?[ IYY\NEPG^T?_IF^I>^/CT[/
M.P<G'_'1R9=O^_"T3V]>'Q_XM>W\7L)GRD]_ORX/_OX3[^^\[QR1/T[&GX'O
M&GTB'[/VX5\EK.U[^^33EZ._=UE[YT^V_V8O/7CS1^<(UO!I!];RYJ^3H]-V
ML?\A_?;V<'<(?Y_#]W_;W_GXU;[YB]G_^Z/SB72^ZI,>;1\>G>^_^?,;G-'W
M_9.CM/WF]0FLY4M[Y^C\T\X^:Q^V3]O?_SC]U!'G^SM?>/MP][Q]LD</=O;H
M/Y@X*5-G$3=.(J:)0B+/") NHUC+7 HC-[9V .M]?G'RW^KT[+?DL#<R@,5O
MW[[[GU_G..720,L3%YJ[EY>WO4IIBS+S8YDI9V7FZ!P^MR@S>/_[\9>C0\,^
MO?GC>/_P2_KI\(_.P=^?RO9)Y[2]\YG#YS#\38Z69&:;_&-!.%+E&+)%GB%F
MM$$RDQ(I*FB685(08D%F%%R7H/P<NG,U:):</(2([*N+1%;I29/-7QZ'O5)]
M>;!H91C3'?HV3OH1+O4"J"-1@]*KZ5AF(N8I3?.4Y.5Y2GZY =I^&."7>&,-
MR4TLIC;%U*:GF@,34YN>)%F?>VI34Y;^ZJ#]X>#MWL[VX>Y.\N$0_MK?;1]^
M2 Y>)P?O=JNM?+BF0R>;EZX'W=>+O6YR6N6*^R8SY\:=A0A),C@.A0Q5 O<O
M/UG2]1 N)A"]S;2ZT&YZP_)\4V9L[3<L3C>YY#_UV*M>(YLYH<]^L=EZ=9<Y
MY]_L6S&_SDU9R?(#66&K+J&-K2.G^H-D-Y2N3&M&E@VRM>EU=[-;<2V3\[__
M"V?I;W.;6[TGK<R7SWT -XOJI17A?[_5^!0<[0"%8&:5-AFO^W%1?LGPON0H
MKK/C2^7BAL]Y-">'X\G]Y,FE-\&693DTQCF0PT: SC4=7>]]RY61&RRRS(_V
M>&VZI\EC.(9_W=W^?UNT+ANU\3H6\+JOJG1+GS@7(@&C@=U80V@ ;,CR5'4&
M_[N!LG&@8#1 GY4Z>UGSWNM^[]2;_7X)/GO@U6@ Y^'ZN^=U@'\[)&$Y>ZC.
M-Y*J,R@LYWSXLCLZ1;87#%7_)2"9<*KP!=G#QAWX_H<Z[G"Z=]$^V;]HO]G_
MUM[9(T>'\(PWKX_;I^WC3W^__[+_-ZR*O.\<G?Z)IW&'W8OV]R_GGW;VONU_
MW_MV )_YY-=[N$O:L(;VR4?<WC&L3?;/%^,.^X=[].#P]9?]D^WO\!]OO_GK
MM/UF#^\?'A'8+VD??DS;WS_3H^^O?=SAO(X[D/;WC^?[G__1@:9&(*&S%+$B
MLT@KJE#AN,M,)@HN4X#)C+9DEHUC!&/.N41_69L<^5=O*$\WTJ$6L'OQZHMX
M&/%P 0]34P@F03)DGC%'N29.6BV(IC;#5A4!#],Q'N*(ATW'P^\+>&A3YXC3
M&6(9$XCI-$4BQQ:E5%*1"] BN0 \I*)%B(AX&/'P>>-A@86R62:8$HX5+A,N
M!^RSPF9*%9*F'@^Q'.-A&O&PZ7B(%_#0Y%E&;9JA+"\P8IAE2%M,$5>828F%
ML81[/,2ME./'@H<W-O)K9]MC,O)?]0:A?F4 W+]DZ4\V36ZVZ97 W3P >_&0
M%JX_^(/"M]\;;'?M!]?_6AHW^-#KV A4:P.JBR5#EEA9*"XH8B3/$1,83-J"
M%$B20F=&",VS H"*IRU!EPW97ZZ-4:NAX$[5LH6OO-1#&X5Y[>99%.9[$>8E
M*PQ;#-JD1'E*+&(RQR#,3B,0Z"++L-/.41!FDK52D49A?IK"O';;(@KSO0CS
MH@F1\MQ*H!/B. 5A+@J'A"P,HH1Q4/@%UEJ",&/92E>X5!Y$F-<4!:QD4C;<
M4GC3[PT&OK%,,3.P\29PM!;W3_.PZB&-B$"3=X$D$9O6A4WM5TM60R8Y,<0I
MI"AV8#48,!@DXRC-"JQX85*L\XTM3%N8+NL9#?5NK,G;&T7_84R.*/IW(_J+
M-H8KJ #$Q@AG&0,;@Z1($F91+HDTBKLL%0I$G[0P>VZ!GBCZ#V.@1-&_&]%?
MM$@8S8C)I$+:J11$GVJD4S!+TLS ?8]!)> XB'Y*Z&,1_><0T_C@.IW00]*6
M@V&_U*.J#<MGUW5]U6G5S=A.RVX9&C7Y#K.^V59W$",@]VF\U&1Z4Y%ENVNW
MYVBR6Y$D(MS:$&XYK0\43X:=(H@H,&F8M@9)C'/$6.K P)'8L@(0+FUQFC?#
MY1+]IXT/AD2YOG>Y7C1:*/$9:"9%(LL< M*!7!.*D<ZE #M&<$[-QI9H >&C
M6#]-L5Z[U1'%^M[%>M$@R3E6Q(D,&5EPQ')FD;*I0;HPVI("S!&?A2];6)!F
MB/5S*)-Z5<VL]4;%S"#1>E!Y*^FZ6T5+GCA*K<&H\)-+X%]+3A)5=M_V!H/W
M5??XP][;"7$^3&8/1T"Z"2 M9U/AHK"8IP7"6!($IH1&PF48665S5V"2LLR7
M!>7L%G!T1<ST$?@]G[C\KL%XN)W\1FUC;<*]:$00I1D5G"&7$8.8(3F26!:(
M%DX8T"P%UG9C*V_)6R5*1O%NL'BOP8B(U_/]2?"BO0#7L)&J2)&5!0,)=A@!
M3G/$4]"T*"NRG.N-K5L9"VL4W^<0FGBS8O91;2H\L]##@Z9-U538FQ#!0]&\
M,E&4Y\ZB[Z[?BRAT Q0Z6$Z>,C*UA/$4,9$[7W?A.W.#N: $<1DU&'XHJID5
MF/QVVSAJ]$DV6)U8?Q+4)8(<!?8F KND^(M< 3>F2!3,1P\H1@+,>H33@B@J
M+,L*7O5 ;H*/,8II [7^**;K%]-%[5YA(=*4@USF2OGJ)X8TYAAN6$(+S@M)
MN-O8BI& >VR8-ACV1V88IO.U9E3\5CU!NIIC&D,#]ZOUGYHO+^=(,X4A(,N!
MGS!<>R%>592)P'038/JPI/"KE$N5&8T$-A8QFU(D>.J0<!:SHI Y<0: 22PW
M@HANPR<ANFO3\Z/HWK'H+JK^N1'*9&"K6R*=]_DKI+C,499F.>;4Y;A0&UN4
MQH#>$Q7=M>G^473O6'27DH.T 8IXT976=S:Q#BE%*0)CG4O,, ;J^1:=MZF=
M;IZW_W'43A_VAJHS,ZU^'>4&EY:*/'6(6GLXX&!,ESJ'<1#3"M;6Y^%P+XPO
M]%C5/C'PGKU_<";A0E$2X4)CQ')%D++&(:H*2Y7T'33=QA;&K52NP7EQ/3%Y
M1,['9ROW:X\>1+F_6[F_F)=[0I@4.&>(6\:1#R(@813U<T<+FL./A?'EE'D+
MBS7T=XER_U3D?NWAB"CW=RKW[87[OLA<:G/G4$Y2AIC2!@F;9XA+E0NP4[+,
M65^UP&_E5;@7L7]6#9\F8I*47=,[=<F+3F\P6*+(6KI /$8,:X3)LA=(LYR^
M%$'L-B"VOV2T@&6B.',9HAD%E<5JB62N.'($2T5D*K@',=)*Z9UW@7FLGM,G
M)?S-*)*(,'#7,+!HPV2$NM!L-I498L2WCW:2(2<SC#.'-2W<QA9O 3%O[V:-
M"-!D!&B$!1/E_F[D?M&&L=SD6M$46,D5B#'*D;)"H@RN?RD5!Y9@_OIG8CDK
MLHG7_W.HM0@QQMIV^?EDJ\>;\OF0]DF[U^W-8]2D/T1$HAL@T9]+AHB1+BTX
MUHB#%NF3JQ1269XBHAG\E:>,%;Y--K\U#L44[>;*Z]I#(5%>UR:O%XN: Q!"
M<8(8]?)*4HVDP :EE,!OK<F4]).Q;M]!,LIK<^5U[09 E-=UR>NBIJ]5RGSK
M0U3DA4-,@[JO"R51FCL 7)T:XKL>X.7,A(<3USN/2H2?RZYUW>%+A,59L^1P
M]S^C<GB1.-7OPFZJ3DQUC452]'NG8 )\=8-AJ+4NN\FK8]7][)+_<ZHS/#:J
M[Y(_>B6\]!>\/NJ[9U:1\5 %&5/'A2=11<)]-SSNV;T)M0;PIFJ,9S#E#H%P
MA^[TK-=7_8NY;-+#/IQ M0$_O"=6<J\''#\N&1\9%51+DB.>BI#"(9%*G4':
MF52YC ,OK*^4.^:)-Q<+UEKA$;'@46#!@F%#L738,@7J$?55XH *FAN+M+6@
M)Q'*,LXB%CQ6+'C8+E'WC HQ6G([:%B*EF#'228$TCC-$,MSC:0V&F$JB<'&
M%Z;[<5DMG#ZM8I1&AT.\)"4@R-;I80+KA'6/RL&Q%Y!G%AAI3H/:@2>*&QQT
M=^?H<5#L )$B#-T(AHZ6K!5G%$G]1%&XE(1/ULB0"'\P10EG'.XH/]U"WJ8.
M/7I=GX&1<@.1C<;&>D1YP=A0F5:*^<[2@G*??IDA:1E%U I2R-3FC,C80^X9
MR/3Z>U-%F;XGF5Z*M&0J2Y56"!MK$>.914ICAXP \Z# 6. U.A.;%VYIM+&P
M!R+7!R-[7*G^S*(B#UJ./C[[&-']&9PQ2V: IAIGTG$$VI]"+%4.2:I25#!-
M" <44D3XNM.&^"*B?[*!]1=10M<JH0O:O<!.4D8$XKZDBKG4($&%0\10E7.>
M*JOTQA;!MYE!&26TP1*Z=JT^2NCM)'115X=#STR!?9,6ZT!7]Y,D#$M17M#4
MI$5!F?'U#[<:)]D\?_[CJ-/>FZW.KC*>O'"5W9&OW:[3!'O=0:(=6+)N7,T]
M5.=WU(#JZ1=TW8'./PYVO@;ZO9J0[V!"O=\#\:KW'7K2[9X/^PI(4'9]L'/H
M3@?M7M>OLM\+@SK'$!A#G>L#QL_+Y1A%RJG+0#8X]A,NP*X0H, @FPJ=<LVI
M];UN<4N26]>%WU3L'I'/\JE!23.JPR.H/!90N5CT6 AI?'\LI64.VA;32$JL
M49I30 QK<X9MJ#*_TXXY$4\:@R</:TI%%'D4*+)DLPD.JH@4B!0,(\8803++
M"$HUO"(%Z"VT"%E8;!E%&JJ:/(_0R]@\ X.MZXIRF+RHHS"WZKWU"&'O@<,P
M-9[5/J3?*V)$6+H1+'U9LIB*7'.@58%,3B1B&64>ED"Y887E.*=*8+*QE<6A
MPH])4AMD[T2)O;7$+E9Z:.-$D67(B(* (H$ITKEAB ' FEQ0HPKJYP'R6.7Q
MR,3V@6,T45S7(:Z+>C\FJ;0V+Y#@Q"'F"A!7$$.4%8717&AG# >]OR'I#C%4
MLR)4$\,RCR4L,RE >]?K^U]L#X?]4H^&2G?<82^Z/>X8_DZVESOU<EL(H37B
M*="9^8$#6@,&8DREH33EU">3X!99,5VDH6Z/Z$%]-A&9B"</CB<+UH\# G.7
M420S"7@B4U"LF&8(*\ZPLL1R;C>V6(O2-0Q$CU#2?"AY>)LI DB3 631'I,B
MPSRG!$GJ&&(&:Z2494@:@JD6VBI.0AR&++L\&ZJ0/(<X3*B7#R::+0>UE>;L
MC)$6>@HGO<*':F)@Y@$JZ.?!<&>&2E,X;+OA07&HSB.*W0C%=I?,*BY38:4T
MB"M+$6,YX)E3#@DCF,4Y&%U<;FPMNX!CT.9)2/%]V411BM<KQ0O&3*X)9\1F
MB*8J]77T"JG"691RJ4BF?2:KG\$8I?AI2O'Z.W5%*;X'*5ZT*++"*&U9CK I
M_$1%7B#E-$68"<MS[(0F/H6B&5+\K (\P.)KF)88'2=KC^2\Z_>*<A@'):T7
MFI:'NQ-J#,6^7WK!%6+<*J1Y1A!SG%!K\TS+T/J/B.5BWH8Z.Z++](E8&A$#
M[@@#%HR,E*I"X8RC(BW\I$3&D"*B0 2+U$AA),<L1$QN-20QBO^C$?^'C)A$
MH;\;H5^:\NZ8L]KFB&4F YL$_J5=QI#%FDE"G>6BJC8ART+?T(O_64U[G[%<
MU$S(,!GVDNY<T!#>544-?RY+[7DX6M8_4-$-IRZ6Z\5T(Z#= -"6)[Y3G;)<
M:E!;N 3[)4\SI-.B0-PHGNO4Y:E6OFW8\N"VZ"Q]$C*\_B&+48;O6H87&XL9
MG1-M'5)42\0*()7@2H%AHH@F+&<X]</<9$/:%D49;F# (\KP_<KP4K C3XG(
M"H*X8B##SBFD698AFPM!%%4Y4-8/4+V-+Z&AX0Z:_\PP1C"('MZ&J$M<%DV)
M??-O-QB S+[J]?V8'D^GM=E]/P:SQEE=_[JCS3<;P1MC2$67T/J0>WE4O7*@
M,S/.$<^D'\*2%[X0$2PH9BP&VTHH4B6^XCMO0-(D3W#$MZ>.;\T(=T6DNSND
M6[0S,\Z5+@PJB.]I@DF.5%[DR%+%"J)EJG/A(U[\3FN$(LA%D&ND$G>W5GA$
MKQNBU]*X3E$8X62&,LLT8I8XI#.K4%9H1DQ>2,S2C2V9WGG@;IT&^'@58YYE
M 9[6[6&[QC-F=DMA2[8W\K;P8ISR-M\05WG%*N\\_?2'_I@'1>E=U>_"-@9C
MA\R9Z\,QG)X"8 ^.57\YV'L=#\U:\V'B,YY9IL%.V1D-G?TIIEHCECSY9]RY
M)[I)3#4MA;^BC=)-=OY$38\G8F"\<_T/_OI:K[>8W+S= BRDQK-Z/;4MDD9;
MY!JVR/(\#:R!A*+ 2+B4(B99CL (<<@ 49DV1F":;VSEFVOKE?"(?"81GIJT
MMRN=O)?@TRV=O>06C:4B4-T2J!9<OMA0K',A$-,$_LA5CB0N#)+$IMQBQ0')
M-K:(6(54-W;Y1I"*('5?.M0MG;51A[IW:%KTYY*4&9=*B9S+-&(BPT@65")-
M':4\9Z!/ 32QS15ICX]^JOKCL%9W5G>4B@45]V#AK:&!102LVP#6\D@08QC6
MOKMFBHDO%:<9TAPK!->+H@X73#&WL95NIK'6XA&)]X/81VL4ZMF$F:(\=Q9]
M=_U>%/:;"OO%8CZWTDPJAQ@I?",Y;)#0EB(A9:Z-+BC(_ 8H(H)@\EN<*/+(
MA/YG[O3;6QSQ3G]P,5\R0BPM,I47R"J0<&:)@#M=$F0T3S,0>)9E)-SIMQEA
MVM"ZC0QOYKSA)LAA;Z@Z=U9R_T0]/]???[-1N@&AM7%BROCK:O"-N'L3W/V^
M8OR)):8H3(ZD2R6"*Y4B90T0A0MLK92ZR$0(H"W;4@UMP_'0&<D1VQX5MC4J
M+A=1;DTHMV!$&B!5D?N6IX7VT3>BD,2Y!9M2BL*F)N66KRWZ%A$N(ER3-MZ
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M]D6Y:Q>9!W8&1?",X-E813B"YQV YZ+F2V26Y92@W/B1WS8E2'%F4<$%:,&
MG]2F )Z\E>);5T@W!CQ7*L[XA@;LI!M+N@+3PL]EUX+E]A+)Y:F-IZ6U'?=
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M-S%JH4U, 4II#1M"5N!%J7]PC J93*JU\98D>"1X#U3P=! \AJPY%TI9Q;S
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MK*Y:H:SMFN!90)M8ULAR0=?M]O=NC86"=OM_4R!VIM.35KC9MO&?K0]4C:A
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MS[9\>I9U%7OO?WFW^_IWZ:0K(B*XK ,HK2Q4OR,A.XVF_A!,;FN4]MK3&4D
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M\?<R>[X_<7#95:NG@5N60>G(($@60;N0;&0!19*5V9P1KQ\LKQ=]P/>3FGS
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M0DDQ@]*F@&/%0A%::R>C"*6M)-G%5CI4"7X_Z+WR!62B]]W1>Z$!CN%&:6]
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ML=ZZ2NI8[P(O5:6N9^Y>[=(GVMY8?H-H>Q.TG??]NI10"@N0,;?BX1( E53
MI<C,RE)TJT:4EZ0F[X2V#R;)\;C>Y\/9M%4RC=NNG&K]_QK.W@P.<3J#X6AS
M4(:3^M/X9-:E.T:S\>1T<-0%U@\KH[&,1MUD>'".P=.=G_:?YWHJ?^9G]7S&
MZ2PE2SJUE$YM_W4^'Z=JU4NY=[!]^GMQT;692!"UK$+EG(00,X=8HBH\)RYD
M%2HAKS\>AQ8G>TC=FVOD1=1=.75W/Z<NC]RIY".@;J$!K]2M6"8P2OL:Z'L3
MG*H>XSJ1 5&WO]1=?6*!J'MCU/WE<^I&4856*P\YF@C*1 XH,@*KDBLX3\KF
M4)^Z>@53Z2@?L$QWY?$(NMY6'_M9';8@>9#?'>?1]/NJFM9VG>).-SI< /"T
M7?_ML\M/PK.<\+Q;L/LFAF!T,L!]M-7N!P.(]0\O,<GV*(E%MY+I/G50H#7%
MGE8B$5=7R]4Y?R]CRB%X :K(ZN^UM^!X\:"KK\NQ>?Q6.R I;7>/N;KZ[0W$
MU95P=<[0&\EYR"R#52C;]@8-04L..@E=@E)H;#7T\OK=!VC1?WF^M3*YP=]>
MXW#TWV<[&:;U9I^VN:SA9%K?/9WFL^T.'W<X?%\MT(-8=UBYU?^Y M,@VA^]
MJ+CLEX\[L"@/N:0PG2X8?B&JOY->5L/?3$1V'H)D 4+A,6B5G,VY;;GJR4H#
MK1+V;X&?V'IS;)VS_,PD[KF)P$-IW? Q0D!5@&?!=5%8'8;9V%K<'DE<[2M7
M>[&@3YQ=)6?GK#_R"D2T$:PW')1I9;8V)M#.5MA\<2B;]5_,H%-]_\WO:3Z9
MC(]S_=I/C/Z;?)C:GI<N"J %_5L;)C"<'H_K)?^Y7LKCO?&L_KU]X7!TDM/Y
MHL2X$ZDF5ONCWR;#67XR_FM$^Y-6J%[O/\8'KU5[_7<3$K*8:U20?8T/G+?@
MF1:@E:^@JA*C;/'!IF9]:LI RXR?L?WRL<9W.IA@)6RG[<C7(/KN1Z(_>:E^
MCVB-;=T'<@H"5$H24')=_ZI#%MYR_;4^!!<DOX.'%JE,3U2F#P$.J4S/5.8B
M&'I=CVGW]/=HM3+6:^"!E3:AH8"S*8,3L:I/\<'[U74[H5S(\G3M0O_!Z*+.
MJ1+BZ('E.GJQL:&#86\\:B"<[;NB5.QU(YKS]1@5A!<9#20G/*@<!3AM.1AF
M*UC*!QGYQI;N56=I6DKM78D3$??6(I1SXMJ4E!$Y0_350"CI.03G,A3#BO*)
M2>'\QA9WBQL:B+CWA;@WEP,AXJ[>])\3MT*EHB\:1(QM+%MKG%Y<!"M59C$[
MDPIN;!E^[<;I_4N!]-;GG[5GG;9.K=W4AK,"I\,AAN%A-YU[LQOD/2X#C/\Y
M&4Z'#8_O'-E]U?4/^HP'%&@^SS$/_\1P^)U]M=;V:7>GM72+W3T^P8%2:2M\
M#/+%K?1<&FT1(2060#EN6M.> D%QC247IGSSKYM.T6[Z]:%S+Z).HO4MTGHN
M+!6(LF(5023/H.*KP,DLP,:JWHZCU4HU6G/5)W]+W.[?=GOB])UQ>G[_/1-%
MMQGB'+4'E3('AR& 1Q6\R-:@+QM;8E/YQ<UUM /_)BEYT7MB^-#:\?8L;/@$
M!]*B%6J16 @;HHBJ8B8@>15!%<Q5AEP$;5VQZ(1CB)V_,->I^Z>RF/[2^19:
M\Q*=;XS.<^%"12]4TY^A0NE;Q_\$:#(#M+PZ12EC3*VAWJ:PBWN!B<[W@<ZW
M$"E\1F=B[)*,G0L&F(WU">QU>^):4$)+<"9;D"74> "YK93>V))]X>N#R2 \
MF6 YSUMAC/6,ZE^.\;3%QP\KH]"OR.#1.1;/SJ @.[%"<9(+T4%0%I-/"8KP
MU4ZTUO_U(1*@8NET*(XKWJU4.';M*<>T^MA;6M]"A$"TOE%:ST4)F$JPHJT]
M8M*@@JX!0N0*A//.H=-)8VA!OS"6:'UO:7T+D0+1^D9I/1=*"&9JR% 9[213
MH#(S$(05H'B("J51-<*HH<2FOZ2S[]K7PO4_HMB?Z^K[23D<)1OZ,/SO\^Z$
M3\_A.25A6DZ8U$(8D8NO@816S6^P-BO U@@B,W#<&2&KVV"HJS#IGJQQT)ID
M_U(,1.);)_%<T."*<SPQ"]*TJ0$!*W^]#E <]_5OSJ+CK<EH3X:*$8G[EU@@
M$M\ZB>="!,^2L$E(*$%;4!K;#GE;(-<(P2LI."]=MF$Q[J=LPTT2\>"[)X _
MA)6*V\DK3$YRZG#XL%I!:K.,VNC%>1\BR>*LKAK#!2@G#(1<'-B0A/)%1&=8
MF_?1I^Z$M,JXQN:?6+P*%N_.3Q>PPC(C(:(N-7K'6 -W[D ([]%DYVVT&UO\
MDND"M*_H/A#X-HT_$7@5!)XS_4IH8ZUQX+5J;;':>!#&+8AJ^KFTREAI-K9Z
M,JGSP:0#G@YGP]==C[B'FPFXBQC@*+Z]1'@^HG$^<I1D9RG9V;EDN#?W$K4V
M8)E5H)A4-0Z(")A"T#)5-X&E^@9/K7WO+VM75CIT9=92A<$J*3U?.&19014D
M%-&&?KOZAT>60 HCC%+.&!FKD]ADUR\<(E+WEM0K*QSZ+E)3P]QK\'DN,M!<
M::&B )-EC0R$<E!-501M='!.1!&2H(:Y=]TPE_("?2@.:DA\R$L^QN/A# _W
M\HQ$:#D16IP*CBZ("DJ HG5JTTLC..\C>&]1%R]X:".,!+OV]%):9.PMDV^U
M0HB8O"HFS_?058[SP"*4B Z4:CW(8@T/&#K!<L3,E-[8TIR:7Z\9DWNV 9D8
MO#(&SX\3#":@MQ:8T0B*2P2,-D.1)6OG*GX*[V6J0-H>1P'UUAYT S..)^,_
MARFG03@=C#]L)V@8_'GM[$$83U*>0#W)']M%F8X/AVG03FT-]>HN:XLJ6(\K
M5L_.H?K'Z2_3G#XI:7ST 2U:K%RAEBT.'X]9A1*L@VQU!*49@A,I0N@>1R9Y
MS#6N4)M*+K99^[ZEC:M1:(V6,1^H)JQ\PS-IPEUIPER$4HH5.B95-4&:UFTE
M0ZB( LLAA>*%KM:U:8)6U]XB29IPKS1AY6$-:<)=:<)\>51$FTT08#.+;=MT
M F^" 11>2IU$"-(W39!V/7S">5AT<107-_P9XU>]W$&?L9K/N#\382X?![VS
M]^OVBX.=O9\'CQX?[/RZ<["S_8+&O=SP9ZPH3=J#F^KRQ_<S/#W*K3%;?3ZV
MM9'ZZ)R=;@Z.#W$TV^Q:M^7_G R/VWL>5@[U3MLY7Z!R,'[4ACM-\K-S9)XU
M7!Z-TO8%*.1=EO,NBU-?<L4L^QPA%LY!,:4AJ"1!>Q\Q624"UGA&7C*UD/9F
MW ?RKGRE@LA[@^2=6XQ0G*L<%(*7J9+76 OHF8,<@F92R"K*H@8>>C%=2N2]
M#^1=^9("D?<&R3O?;*T$AC)8D E;)P45P)N8(*&+5D>O1;QV.Y3^Y4I[&PJ<
M%P'47ZC7<UQF?^$D#W*;L9N&LY/)0]M8U:\ X,4Y(*0ZRZG.)>-:8F!<E@+9
M:P:J> ;.1 6^L*@\8F;<;6QQU9/^+;3S8NW\/G'UN[FZT#"MFCO/$:0NU=YK
M5R!PD<#:% V7077=3ZK!(Z[>2Z[>O+TGKGXW5^?=O% !2S0@5#:@+ ^  @L8
M99SAQ6/&[KEZG8&,_=O_U%LWW]W?TV&[P-/-P2C/!N/254!NGM5!MF7]/^L=
M7\EPMLY?#?YL,HRSZOZ[-^ 901(M^]^=Z__'R;0>X72:IWMYME]:L</Y*XD$
M:SG!6IS,DB0J)U4 YEI?9>=B*UK($%*()3%>5"M:H)9,]Y.\-Q\&$'E72=ZY
MR$"B3UZ5-N0M(B@5'""BKPQ.-A61=138^J$3>^\E>V\^,"#VKI*]<[&"B2QG
M# 9<)2TH%ABXS"N9I8XQMA _RAHKR,6NIK3R?Q-%0)-QO5AI.BB3\=%@6N_M
M:8L6P@<*= '"</1G#1&.SB*&&E \K'3 G<8%Y_C\5.%Y,FPH= F9_?)1I!Z-
MTDX]A!;$37=&CTH9'@YQ1M-EE]6JQ<DK)L9D)(]@C><U3(@!,,;6[]TK'3E:
M9\/&EK:+]4'4KNF^,'KUP0(Q^A89/=^-63AN5? 0M:F,%C* UUP"XRX7M-H'
MGS:VZDU#C+ZWC%Y] $&,OD5&S\4347(3A#9@%#.@I!/@0E+@?2A95N&N,MUF
MLO2(T/<]__  VZ[U(G?PTWCRJ11U,.QTD=O<ADC2G&4T9W$RB\W,BR DI-8(
M7@7'P EK@!G.G2A9B: VMKB@!,+]9/"-)1"(P3?%X+DX(&K/#8\:BFO=3501
M$)SBX&).UB64)?FV"KG879T8W%<&]V(H"S'YIID\GT_@R$.V%K)TNC*9,<#L
M+6#2FI7,G72M_VF?AJ0]O,YK)]/<D@CG>03JNM:#$.(+^O6%OBHD7=>5KMW%
M$2]*8LS")"A6)E!6>,!B5(5,F7KMZW^LW=ARU_$@U$;I?A'_YCH]$_%OD/AS
MT0=7&$LQ$;PJU;,P$R!$X4"F@A*EJI(>-[84OTX)$S'_?C'_YD(68OX-,G\N
M6N&6<XY60919@=+:0IL4 PF]XS;G7,U:JRCH_3.?VJ2MX6?<GV*VR]ND_;2S
M]VCO,;5)HS9I-U<A^68\F<$L3XX&56 GX[_J*7S?$L9#6&>]T7+(%PV*@XK$
MDQQFU.5UA;[E_6+GA"1L2=)!D*%-HRT)T$@)*E;SZ5QT3O.-+<XWN;]VZV?*
MF_26SS=:#$E\OD$^S^^A2E%QDRN?=<F@T&3 @ 5X,<()SXI/>F/+;,I>)4Z(
MSKU+@Q*=[X3.\T60NCZ'K:UT]ER#XD*"YX%#E62&23/CB]C8$GQ37;\0LG^)
MT-Z&#L_S\46/Y7%98>BPME7:=UHF^1&-_4+B=%/BQ!9B!V&\MB8%8,A#]1I9
M@P\J5^L1N3+>!L;#%V,':N9T'[B\\KB!N'Q+7)Z+&T)V6HO$(>I40%DOP9DV
M"THJJ[5D:#/[4MQ 5+X/5%YYS$!4OB4JS\4,O@;\@AD!LJ "Y6.$D+0#DTKV
M0;KZQ(Y?C!FH;]N-9QJ&T^D)CN)9/X;#\>CU6>B0*C,HWW 7^8:=<T#VR].*
MQD>5(B%:1H@6I[ DI;QTS()UZ,\\1<!@(1L4DC%G0FA[LOVUNRS02F1OB7NC
MB04B[HJ(NSO?1=&B=#8#JA)!I> !O7#U)Y.X3173ULI)7[^9 A&WM\2]T13"
MEXC[:5Q0AN]R@O=Y,B9"+TWH^32"EX$S@: -:QL26D(AM3C?B!BYXKX&_QN5
MO$YP\?<>D?IAY1%6$ L\B)6*&TT@?%F0:*'B6JJT.+4E95<]H9(@@ZY:A(I!
M,.VGD).R.I:*WL86WS3J.G,::<VQOTR^T?0!,?GFF#S??:TD'K)DD+5!4#E;
M\"XYT"D(BRHZ76QC<D62F'POF7RCV0.*[J]%UKE@H'!6I-$:0FP)/I8$.,T%
M^,R++\FGPMC&EKAD68Z2 S<]K;T9_T$]T'K@)\/IF^Z%AY44Z$7#M?W2I&;[
M,QP>CZ<SVBBYI/HL3FCQ'D5;BP#3MD=6\Q<@2,T!4U28-!J)K4&3N\Y(*5I6
M[.VRXHUU6/L*96E5<454GG/]K1.31FO >I$JE4WKT,ICY;.3,D0GG?%]7%4D
M3O<]54"<OC5.S_<Q2#4ZJ/\'7Z2JD7P-YRN+$62I@AUS$"['/G+ZOF<*'H^/
MCL;M2\?Q[6 VJ1]T=LFG/](^^/78!W^F^K[']]A%5O:!19S]*T-[\08G>?K+
M*+76HK$^](9_YD>CU/WS/W":4U6#XUPEH!WOL\-ZZO5MAR?MNK]H K%_W$D#
M/0V7>QHN]@-7''W#%EK'T;;]KD! GH%I+J+.S(:@-[8JT#UZ$I*[[7O$2ISO
M%>?GHMHL+1:+'+*QU0%')<'EXL!$*1CZH!D+&UO4#>,>4_Z6:M^(\G=%^;F@
MER&R4B6\S?EHE)<>4,4$SF;M>9 E^]PVLO:I9<8J>XWW.BKIZ#"8Y..327Q3
M64$[Z^]D -'S#P#LE[/%B$Z#J+!F=<KT[\5.XD)[B<GK&H#X5ECC$"JH 8J2
MT64IBFE;:.2FYM<9242%-?WE]$V.)/HBIXFV2])V+H;0-L08M :CVBHZ)@?U
M)E60O).BY<6TPXTMJZ@MQOTD[8UEQ.A!?%N,G@\1&+HBW?_/WILVMXUDB:)_
M!>%W)UYUA%*#!!) PGU#$6HOU;I3DJIL5_>M^:+(58)-D1R M"S_^GM.9@($
M%VTV92W&Q'2W3!*)S#S[SHCD,?;'8#F1,5<$M*DR%DJ)+,->-SME^CV)*T/:
MW*W)\76%3>W'NHFFHM(_5\3B4=@$Q[8#P: [?#.G^;*F\N>QR O+"I))70"G
M$8:4,LF)M;F),QO'6<%?["7%]_3N&'R/CY=@[S-#;B#8;1#L:L! E)GF"2>@
MQV6$Y:#G"RX2(G5<E*Q0N4+5("F&H<'/DV#O,_UM(-AM$.R*+L]4E@BA"E(
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M6?;N#/;PY>@<S+BJC/_[_Y[%ZOQ?8_'O<G[\465_?7SS]2\PKXX_J*]'7_\
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M0IC@*I!Z<JIF0"C."0LOA4W;:A1$;^]]0&>PN], P77$N]DAN/;]<R^#N;Z
M)+NZ@&0H!1E*08::@:$4Y*<!ZU *\C3.L5+[$?WRJC5B_K9)FFU4_V_,IEZQ
MC#(E>5Y*G<M<L4(5@N>QQC]S+JQ.]):RKQ_"7EX;QKW1GOX9S>B/?R8G3"4
M<YN2+-64L(Q1(E);$B$LUSSF8$?;1^I-[4V'1I ^<.P"+4V?L-"@>?71>38G
M8/B>^@1MMU5G$( Y#+^9C\5G 3:-LQS@HY <UDL? %,;-&[CLI5Z$0_1=,MU
M<['1BFB6#.C@,KQZ+':;N80?A!_[1%<@4-+&4##%Y/HDIW_X;*7H_9DQ:)UO
M&-G=1EYW,,DVZ9FW+GVF\>E1_^L.320$+S(A@#TI4["TS'A.N4A3^&>6 9\K
MOVUN]5.9A_&0^>F']/##GR<4^'&62DMDK!+"REB2LC""Z+C,,RZHI%:]V /
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M>%6UEV?8&#^O:B?8,0L82SM=[O1G_ 1K#7R\&6-"5:WFY\W,9\=/%"BI(9$
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M:3\XCK5S?[64A3 67H2;"_A^,O52_9?9Y11%],@WO;\.,W*;ZK+0A<3A<]0
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MYP[+;G?"3#>F?IA&OX5I],6+O0\.D4%ZH _(]VO>.)%^N]#;P#Z<:G$U]QC
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MP$ZL(L+$)4A06DJE>,QI^6(OVS"6*^J:EO0;3?A.22C!>FW=5YLF_0"NP>^
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M#<BQ9>2@)ZFU0N2&@>F;"[2"!"FUQ2:.6<ZT83))T*F2E#^L3=\3\\NCD^_
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M!>?(VH(@3S570M.H!%A09%%3\,:">D1XBJ&?V+(NS-?&E'J&D+55+5#9O//
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MJ$@+9'CTB&OCD:::($EH08UE%O.XMBE84QG_9%0O=?"^H<Y[=JA4]YO-QRP
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M.:QE6[Q\9(IZ$8&L9L$LI3 ),.KD^%6.)XYMA[#UE9<F52BCANLUET?H)*B
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MU)YZC#26$6QC$9".%)Q<9VC!$F45-VN;M,'3V?$V8-J Z8L[WFO =(5@.GV
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M<H]U+BI;IYH1'3?HSXB/>V$Y^@]/EKZR\'=#EOY(T/5N)CQNHW?.ZH"P! >
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M!J15(,"S3#DC/.C$LE%^7RZG+MV?W7#JDCAUVH'-$C51^X0"PR!3A3=@IJ:
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MM]_.1_]KZ1'>_AK_F;NS(U:^/;V#MA_S!0!9R"6E3,R,7B2J>8]!$*N'M0M
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MJ[*8/MSX-]MO]_>*_[F;*L;<Z??/8WC3[;V&ARHOO1JN?8)50;#ZS*[?NKT
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MG>Y<[-'78N_'$?UT\/9B[W27[YY^_+[WXR/_2'>S-^5B?WOKV[PZCI0GU[)
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M/7?<1VNUB!*L;$S6Q;B5O3KJ^X5AQ/*9]).RE<6DGXWC/9K%)()9V L&,6=
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M@[__N_G?']N#3.!5J0@S-FA,*/*)!,23#\A09U%2%'ZQR3N,US;HLC36F <
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M5BU:=Z<%3F:C'=YWVMV5/\[^1*"V,Q;_XIYZRFA"AD:%.(L):<$MDI(K:T3
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M&3O$XT,@45J&K+ 8\4 =TI8HQ PL1W1$<69FV(IM&DQ\BCYM#])_!? *X(T
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MN[?U]8L%2T!HQ1#W).7.< ;!.F 4P9+!T8+_YOD8=7"ARETR]MFE&FRARGT
M56YARGT1K*6%*;<PY3[US+U8IMS),S*PQ*L.<H/^<0-+&-Z@-BA5 W"JN<H
M'3K*O;[E?O<>G"FK6WG ,S_@J3LL/D=U:,X0/Z9!RHH6!Z]F?>^<2:S>7D+I
MWB62CGCRL3OTY9<DC?1 U[Y?'MPF?Y]LD[VM0W#A=T6=@EM_W#S9^^L#^?O]
MA^\YPKRW_V?S[^/?C@\:(^7!QW^>'.Q_YN#F8W@F^WO_P\7>7P?B[ZT_O_Z]
M]0[>;EO4__KS9/=]O3&)]XH+3Z@P!&EA'.*46&2T%,@0:XT(C+.0^]F^,IRO
M7L>T@E_+A%_3-(";P;&O6ZJ/"I(M"I*-'!\SB3@IM<S'QP#)/*9(*V90\$GY
M%!-1@:]MR%>8C!_+?9;6;P7$7B"(+0ZGV9305=!I*G0:/885F:'&$8.,SUU@
M0 6AW/P%*>.LC-9[K^/:!IU0O_MRJ,Z>0QX':<);8S:KV6YJ&E-J!K[@[$RI
MP7(5.)H*CL:YPI()Q%D<D&4F<X5YC*P7'#D&?Z:$TN# 6)J 1O>WE$H/N<4U
M+>;,=%Q$>9ZB/.+WP"I9GHQ"5B2,.&88&:PTHI'ZA(7&RIA,^_=H$HPBT(LK
MT(O@*Q2!?IA CU&,"3"C!%6(FI0K#4&JC7<2218=Y;"-5= @T'21B#Q+Q\@Y
M)8]+\Y[2O&<%DWO;WWL="U/?:-G.Q4XOGG1O'B 9GC4I(?/9:9IQ]C1B*:.)
M!T0<I9G,DB+-I$<^4ID"4RH84B7_'J]K%J4]T(SUTX.*40JF%TQ?Z81G0?=G
M0?>+472/4CA'D!-<(*ZI1%;8@)B521-N8R*9&_,59N.E'5,G1%<-V MV%^Q^
M0;&;@MC/@=BCD1\9M/49I\$;RWT@9$).Q5R19ZE@/NI@:+;'R<R*\9X=MF^V
MZ[RSG<[8Z=>!T/%\R'"<V^_R;.$_UFY<-7A??'6)=?!N9[W;+YETIO8YNFH8
M,=*"Z-K/H\[5Z:_#B%PGVJ_()ACL:]L\MQ?=M7_=/#K<: UOKOK\B:-O_]3'
M0(U95U@]Y!0HU^L&W_[Q0\\J3G';V1[( Y&[@ZXSI;D=@.D/+N2NKI7@O0;D
MB)T^%^:O=F'&4COJ9 WZ/W?WAU!K&]5)\-Q8)2O$W!CSUW_9D5/U/S$D'[IZ
M$^"C0L7;T:,LZ_V758,ZS-9*3==VX/+OMRSIO7I"W]5 X3D:@.SZ_VQ_^K17
MK[W=^_C'WL?-_9V]^F,;03S'>[S;J6_6W^YL_EZK[^UO?ZK]\G;85F*45[?Z
M.;%7Q9V])T9Z502.D^78!D<53UR!#6099HI818PUX@E[55PVGNP.^U: T3UH
M<#_H.ECZ5&SM?#&YO9:, FGI/>(R&F1RQ(*D1'CP0=# QOI4_+3=SQW-?9ZD
MM\]D.V[G,NE7B_V=4/MET-WRG]<[8D[.',)?NXUNO[ES;A26P!!KGV<%=6=#
M];OPH?3]6+)6&DLUV-+W8\Y]/Q;[L/&3-02Y(^"Q(ET;[M4IY%%3\:"#]"LY
MU_?J+5+FNG0CF?V,O#WK=&"=2F.1E_: I=;U]SV!%6%2IF?8?@&YTM5,=\Z\
M_'" CH-]-!9969VLY-8!WMTZA.L\W'L'[[VO-ZM,Y/[F^>[)CJ@?-X__WO<_
MZI_&LI)?Z\<?X/Z_'==_P*B./_ #^CEG(IN[6YL7!\=?Z=Y?=7CN+IG4(D2Q
M9 TA*5,&.L1Q("@O%J+2*QIPH$XXT-IL5KRLY6Q] :$EKI<K<#1C.!HI:Y-2
M"JDT1M$8CGAB!EFF!9+$PC8PR6,GUS;(^'&WTN1CD81UE8'H.8N_"OS,%GY&
M:[1\8CIJYY%6%JPA6"UD>1((#%IBF!.69ZX>HL9Y/$HCCWG*W*>>[<47UL9C
M ;RN:MHW6^'WMB]H\UBT&>_3 =K 6.P=<B$(Q(ETR&(9D<KE#-@PEID;-@@=
M;VE6#O>OC.S.O%M'D=VYR.Z(HY*$\8QPCA@/9L".R@BLD4^12JZL$'YM@ZLB
MNJLKNO,R[XOHSE1T1XU\BDW$&GODC):("Y!:%T"224H<>Y4"-5ET5Z$#QS+9
M^(]IUG??0,E2P\W<<BM#,K4"-(\!FO$.#);BZ%FDR BG$.<A(.MP B/?:68"
M@% ,:QN4+U(T848AS2*U\[;OB]3.2FI'+'M% %>Q](B&W*&+48&<2@09Y@!D
MK:4\8/#*-2E2N[I2.[?(?9':V4CMJ%&OO#'448MDI 'QW/?($>90<(X2+:D/
M)"<..5T@J9U1Y'XY^N;MMWNV6?-W%#O>(Z;PN"8;2XU*\_( ;CFV5D!I*E Z
M&', !!4F64F1UT$C[K! )F"&B PTL.!A ?W:AL2/!J4'U$0O2PCQ!8O[O%R'
M(NXS$O<1SR%HAI.7"05E,@V(L,A205$DR@GIO.289QJ01]=2%G%?17&?E\]1
MQ'TVXC[J<H .SXV;%%+$.]#N3B#+)4'1.*&D<<QX<#F8?'1X[ZG$?>"/C'1?
M(J(2YEF'&!;A7%T9Y.P.)RUT5=GDDW=;,45 R/"8HW>S.#JV\O=X$>G+R2?=
M2DAU;L&+H?@.9KZ8.;,P<[Z.!3&H")I2H9%2G"".HT9:6([ 2J7!)((%(6L;
M>E9-Y$LZY&6=J"I2/!\I'HE-:,\<L]RC!-X)XIY+I)TRB),$<HQEHMZM;0@Y
M'HI<YI-518)G&5TH$OR4$CP:;F"P?LPF@F!M0 ][BY'%P2-L1"314H49SOU5
M9M#O?X&2FPMM\[_$8TF+P2X\Q)P;I=(%>6:!/-OG&77Z7L !J^]O7WRQ3"I!
MC$#*)HZXP#PG-AABU%FE*%<8AT(HO+IR/'_KO\CQ7.1X]Z8<4\)=\LXC O8?
MXDH'9).C*&@CL3#"N]PY^7$F1!'D!1;D^3L!19#G(LB?;PIR2)0+(RU*43/$
MC?5("Y^0EX8DGF!UL0>%C!_3)Z4<7RK'EY;,&QBL08&=F<#.]S$_P& 6C \!
MB>2J9G&9O2IZI(+R8%=@FG*!$QM/!908XDI(\!-D 8H$SU:"1ST V* F88V,
MS1X QP+9H,&.("$0J;Q+2DT^)E%$>"5$^ G2 $6$9RO"GT>5,&>.$XPD2QYQ
M$0/2%IQX)Z@QD5"N%08E/%YDO,QI@&4ZXQ3N*BLK9=#/4B=4$&DFB'0QYA80
MT!U8*(UTX#)7%%"DD]:(<)6(I)PF;0"1'DUK6XX]+(V\+Y97421_5I(_XDY8
M+95T+J# B$#<188LY1AY2[!SU/I@Z=J&P8^)"!2I7TFIG[\C4J1^5E(_XH%(
MITFN)T0A$(8XEQ09S3"BD<2@HX=5C5G?/R:(\,1GGAYZHF; ADGO-3:F%MQ_
M^1EMZ;3.XUT3]#CL6[BIF[KC_>SF9[%UPG-Z?D4#S$0#_!CS^**@/$:A493*
M@L='(G(L$21PC-@I;*S7:QN2C5>$/>Q0R,R$Y8D"T??5#M,R@110+:"Z..YU
M@==9P>N(6QV5LV!0!T0H 7A5AB(M0D3<9@T90!]F&A)I9D"#5)"U(&M!UL7H
MUU+P=%9X.A*P4(81[@! 0>L!B@ICD6;!(NHH,<X+HDBN>IC5$>9GQ]0JJ/&O
MGG7-"/\-C6\;PS>KGYV 7/B-7^&/P_<XL9W#1FLX7 +C?3/X4S5">A/*CL^Z
MO4:ZZ/^IT0JQ!:*C*ZQ]8GFE5<KU*-;>MD_@R1>U3CQM=WHQU& 8C9^$,FH=
MVXNU=JK=*NRMLQ,7.[-U3]FHN&^G%.&YW^*EW'^$<;V%1S9:9[ %]DXC#!3&
MU;U$ $27% +^_N\1]B=_MNQ?YFSOI YW_^UX;_\#K>]_QKO['X]@/'SO_8&
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M,C6O:JU8E>4,(PLY]#"(.+RP/L8+Z$U/[J0>NP6]ID*OW7%_.1 F!*7(&A4
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M2;NU#36#5$^1Z$64Z"?W'8I$SUBB1WT(D.-H,'$H8D:S#V&0%=(@YS%)CBA
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M($H J*=.H9 (N$W&2*1M  ,9<ZI\2%YD9GBY?EL1M!N#E5$+^482+9UUJB+
M\60:T9?6)1A:)XV*2;!O*U^N?J_V^Y79/#G-MJP&YJ @HU]_<KWNHMMNAEL(
MX5WLG<?8JBS_Y@4"3Q!FN!D/X3OP-GW?8F#][_K_Q&XW)SZ/;*^6:X!S0Z@J
MJ3DLM^RST!_#.+JA42UQ=[V6[=XA[WR[T[]MOQ;DL 5O%\ C&?(_5L7'MGG=
MT3D_:OBCVCGL@%:[5^N>N6-XA>Q87+.8X>)<O=EL9Q_F^M/?P 5P=;[]H)8T
M-ALGL&FR-7QV"D\$S*F*Y/N.1C56FXNIJYF\G(%!%?3D*>S?-W^UV7>Y+#@P
M/7BSZIK3LP[8Z-V8O3P?AW<:O%PVV_,+P)? :X?]".X4/#]7R<"^[OM=M<U/
MGV%-B41$7FYO\+HZ%FWWIW+(*EN-<[-_YZH-!;P.[,*=5G;CVIV+2R<K-$"6
M8J\_>8-3^%.[!;,__)>1^I:#*EN#$0^Z:11;[TXW@.6 E@_*1TD3(EX ,A/O
M$2A2BUA,$JP_:@ACDTFO+VV]+'G79'7@E@+ 5'O3PI[H9*QN]WW/QD"95F(
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MM*=5*]<?,5PNV]MVMU?B]K-4;C_&#%MF7,+2<Y1XS'4$SB$;,$,Q6B:USHR
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M_%4JN/?]Q4P$J<Y]L2>(H W=PTP#7O#TV/\0N8*PD+A:VL:?_CU9)0': ($
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MY.!1>R_7<G +.3C8O4>/Y0LY &C)"ES*0U[!]0QG9]%G^&R=KY>OGW5AYKL
MZT7I,BK1-.^,N28_+%W[J/R4K[H!%:U."<_-MA^4.-:\Q+8I\"IWL&H?;7?*
MMUULQ]3L%]]A)\SP>-0NX;;(^ 8BT"U+F>9+S<:[C,*+B#5W#AN'F0S8<FNL
M >J<7'28&HYUI(=;I5AS3-#M<&Y:G"<E_AWL*$=QI[U9\LQ:V&\G[-\.??*:
M < AQB)#7&=A#TXCBSUPN0 ;E<QM>]DUC&XH-Z5@MOO%>;3=H4CWK@@Y2/>(
MS_E*O$"HQK9E9UO5YGI[LG=7:K<^I';%F>WVX<,PODY*($:%.R\?9EP1)Y4O
M*^;8T$_!J,G<I+<DO7QY!/,8GC#% #/:6H=Q@'!4* A3 E]ISYAP@+YN]QS>
M_VZ[H;<H!'ELO13286P4CY[:;+?3&##6V&HJ;\NP]D=C^@.&].[JB&J,N17&
MG'P[-#J1%*1 .FJ.."P'LCD/,_I@M;1"2HS7-AB>;D0PPICUQ9P%7&KK-(O*
M>!XL<R$ZJJQQ)JHH2)JS]GK9:V]>^]K_W#DTE(A@@T=>*%C[F BR+DFDDDC!
M!"LP!U+-&M,]]0HW6OM%6772)H!!);2F#LA:LAA3ZY3&D@LA&:W7_['6_W-N
M0N*D(!PIFEN#VT"0 [U$5A%C!=6.TAQ1;DP?"1FM_RR'SE4VW2A^J_:5JC]@
MWEIF;]^Y6441?YPUL^G>O[#]0TE42D<E7)S!]M_M#(Z.X0].&\6G@8-+MH<D
M 7X4S7[OFEUKY(G(NV]J@HQFGP<0ED:Q T\20AGQ72\YQMC6.+S@5;I_OPT0
M)Z>H(E)*PL!DH8[%(+EG8$U*FXBJ-\!'40*Q>_+YD.@0I54!A2  !,'$1UH!
M'$J3!.B'=U&SM0TUXUS4!<G^WNP?SQ"J<:(XEKRP!)-L7!(^#4Z!?I[OIXO4
M]RJ2<A2!<,?> =SKUU;'?WMU"^Y_[AU\.)1!Q$0C!H+#P9+" '*P!PE$%1>,
MR>A5BFM%!+4XRS'9[N#:*)!<>6:?.MD6S[@W3-,HQ0,N,G0B9WAN]D?>C9 -
MP"NHEPTPHM[VBJ-NAKI!^]+\N6H95393_A[8COV,S3&6%F;OS7UCD8^;7$(P
M;N JF6/1[!+!&]KPI6>7$-*0Q-SILM>]1QN*LGJPE"XS;V?NN2XB;I,E4LG\
M$Z64SDK 6-OXDG6XV&[G.,TENQM+(5QN3M/#/*T9/6QYP3=EXW9_FXQ:8(/#
MK;TWE3@Y*_5[@5S(%5_Y3"^6]<2W*?+SHF:.U#-WQYG#BV#+4HK)KLA9A]DS
M\GDNX0+3V$6@-^U,[<#H!/NOV0D/5G7WI1T-6?CY5_OHQQ,$LZ^*)AB9OPX%
M\V6[&ZJC'QW^]???3K[\^1^P-N';8'GN'_QV_.4 KKWU!>]N?3[?._W,=__<
M8;O-B:,?)\??OORY=_SUS]^:8+O^ (M4[/[YV_'N"8SWY .,<8=^/3CZ\>7$
MG__WY\[PV,=V?^_$D]V#G<-@ PZ<>I2H-(B'0/(1:XR$#I3R:$7,B5UD78GI
ML/>"Q5M6M"[_G;;-&@9K&)R 08J)X3@J)AGE0FE-@Q6"^22YI$I6D4=\#QBL
MD6XQI#L?1SJ"C0C*.T2#EH@K$Y!302$;N/)4<.^46=LP8CKCH<:Y&N=JG!OA
M',-4.VUX\()R$J4+-FH<HV4AZE!%V8FIZ=Y*@.#>!-TC1D5FG461DYS'SR0R
M5 $2$N85UP"0MCSHBP5]+C#X&BHP;PX#R+W"V5Z5X9YM]]%)XM[58,L9F.W=
M*E;RRGK//F6FZAPTVVE72;:]C^6Q!IC0W[J=T_=YB=Z7_A7X[/O1*M;HMA"Z
M[4X9LY)Q*F20R/J4SR81B;3Q(-DL.,8"T;*L0WIO2W;URA_7FGV1_^*3YB9*
M;Y3DD0E'8TYLIHX%28)-I6;CD6;?W2U5:_:#:O:$\:8]!=WV&CDPW!"G4B(7
MK47:&FU%X GCM+8AIC-):\U^,9J=B+9!2LVMCCQ%J:,"+0XZ2&N383AK-A@>
M0\V^NZ>EUNR'U.Q)BT2:G"CJ#0J"90<T-4A[PU$@L+I6 !TK>\+B%=+LUU Z
M_&,, _]8)L?KJ$3\6#;'5JSQZZ'PZ\.4S9&XUUXJCAR)"N4C1\A0SY'51F#L
MF,62Y8-T*U*7N"XPOFRU?BR#HU;K!U7K"8.#14-" CVFL)"("XN!EL2  JQS
MT#@%(3 8'+52OTRE?BQ;HU;JAU3J25M#1Z8\-QYIC07BU ODL*0(DT28RP6^
M2/8/RA5I!E)'-L;-C*N5!NK0QE.;&;/=).^J-:K!ZY[@]7G*T." 6=RZA**W
M^30]94@[[I"W#H"+6^65KX,;+UNWGS:X4>OVTG1[TMIPBDHE(F+6&-!M9Y%+
MP0 [R84+I,&,Q+4-)5:I@6*MW"\JOE$K][*4>RKGBC.A$I.(2!L0#SPAJZU%
M6/%D722Y>^K:AKYWPE4=X;AWA*,7^_U65=&K#F0\N84QVSGRZ7*-_FSVC^'S
M\,;FH'_<Z0Z+.M=XM0!>?9DR-**G6B:C4 @!(R[ Y- Q<I22<-H[Y;%1,R.R
MM>_S1:CWTP8T:O5>MGJ?3ZJW)LP&C2B/0$<D5LAP0Y'RC!/CO><^TY%:NU^F
M=C]M9*/6[B5K]Y2Q(90QEF 4638V.&/(,F.0S!4P <A]LGAEM/LU!#AF)E*5
M=:W.>K%J<U!V%&C!@*O"5+8_R)4)X:U6\[39+XLFO[:C'*MHCERNY!BD_9$7
M<C]M7BSAIVH%]],?E\M7X]I"N.:GZQ2H4!U<,RY7V2,DY%Z5 DEI54[4""KF
MT"V>]J(LW)^R=HZNHI8_EE52:_EC:OF$;<*IY8#9#!E&'>(*]%US'Q"SD;M(
MDP09!RVOE?R%*OEC&2>UDC^BDD^:*"[:B$'!D0PNGT%W FD9#7).RN0D 7#7
M.6-Z-93\-81"MG_XLHU.T<U%U%,+=&-P#[/C=3A2EF!V]."!X;<1:)WZ;S?%
M;$=>E0O8RO7K?ZN*R%<17']^T(49:)7K5V/50EAU-'VZ(Q?-9YJ@% U'G!*-
M#/<>$2"CRE!OO4]K&].=X6IGZ<KJ^%/8'+5F/[UF3Y@:7CN-C;=(4>)S[7Z-
M'$X2:1HCYHHDDO!,%G*W,CBU?J_B'KX$>Z/>PU=-TZ?SKP++I PQZQUHNM)(
M>P)&1R I!=C&3<Z_4JNQA]\U)#(LLS5L34%?;HWJV YWJ$Y]RUEZM>4,ESX_
MJ[U'/$'+[KK<X8-#_[<I\\T*S8#C)4148(@GQ9!UU.;4%^T8P1JV]%SN4-!E
M50Y:F@8]DE/ZMOO&K0O#UDA;(VW=1^#E(^V$.6VM FLZ1:18+KT8<$)&4HXP
M]L$312.79$E]!&JDK9&V1MJZ5<'+ =-)CT4 N8V!LMRE(&7:FHO/4(TDQ88%
M8BG-48<EM"I8%2@MO1Z_E$TV1XT]?QEK:KM H\\5:YFZ669R3C:R'N\#O5B;
M\SM:I%-MSN_%DUYYCW.QMW5TJ*-F-%J.M L!<:P#TB&S'T,P39HDZ]T-/<Y!
M-.:VP%W/[WX_;H+@K)!X'!S;_I^=02OL@/3Z_C8@5=F0'3[RT?9C+3VWDIX#
M?R@,T<P M"LM">)6*F0H=4@0YV60G,+*9>F9]DQ<2,_WO Y%-R<SY<[SN3MW
M*4'QQUEL]V)AVZ%$FCA:I/+=G.2Q7C13<;F^C2)W=@[#P 1<ZIK&S/!F%B 0
M.A" ;E69)QMF1;.7"X'F7M"M\\+V^]VF&U3-EN$3P[3V\:SV/-!FM\HTR=?]
M"[[;&?3R_7(3PI-!M]D+S6'V_.AA8%PMV^LU$^PF_:$.+:(?W'F6]U<*E@F'
MK52#IEINM/*6AL#]:J2+OV1;]>Y:M$UA/%F#\-X!O+_E#V44@8#EB3C5''$9
M. )3U")J!-4Z:*FE7=N8Z]X[O04.%[97'$=0M-R2O <S7_ZR/>AVSB+P"2 F
M$1A'?]"- -GPV=#L^4$O'_4 D?ZMV;9MW[2M8J\#X@];?^Z 3O';?XZN^ FN
MV"A?)&]+-6RV;Z^&9%(-\?5J.&A[X&&VV>Z?YRN 8K1CI3'?F_WC4K]");>
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MZ%S"\6PQ?2[1S$<781CW43X"2G8//O\$43Z407-C"$=888VX$!A93B/2SKH
MEBJ-W"\OJTM'2Q+0'1<4X58SXSB1PEGIN 1HXPMG==4R\M R<K![*!.+R:N
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M]Q%Q8 AD$A?(@T%#\AD E6ZCBF!HG&0J[H_BG2_>7%]?6;3S1=O[H!F7.MJ
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M>LLJ(9-R7/1:Y@<Q*VX+_ &Z?RY*_L5V1G%NY;,;FFA73E/)-+VL^5EMLG\
M#>T*TZHX@9;'_KM?,_./;:QW;/]P]_0#D8Y$[S1B-@+]:Z.1588@S847"?Y,
M/%]0V93RUM$PRX;0_6;L_ZGDN&'2_D*UA6I7PA@N7+HPE[8N<ZERD7A/&3 H
ML9E+ ](I2!2Q%U;DHKMUEM[;I]8N3%J8M##I:IU;%CUUN=SZIJ&G)J:%"!&E
M% APJW/()1Q!;>6".$8LHZJ.2%)KHZ?6KHY?ZVKBV]^+DD_[?;F^.('^34N.
MYQ[E<NV3/J!,8'5Q]O-7ZH<_:W@WYI5T1W=1T]W\#,QU2?<+ 9GW_O3+4Z>V
M!,VS,#?2U?9CU>T-JWX,(Q]#Y4ZKXW:W?3PZK@8C-_YPN^M[QW&\"WNI^L>]
M\]1@T.O7;#4-KACV7'P5?6Q_B6&]B>O]WT?8'__5M6_-Z.#39W*P\^=9:Z?S
MZ?W;=[AU^.?I_G&+[Y_]]^?]'>CC3J=]L /]^+3?R21T</B9M YW:>OL#87G
M?& ^>A,81YPY^&&=1-I0#/H=MU8%JK3,65LQF6&@:7GOZNM1VQ_5FR:,(BP\
M,$B51L-1O8NZ/FOEG4Y&_/GN&6PUXI+'3>^/CF%C^]F_?TP1/\'[7<#]Y\*[
MQON+079@MFP?YH>1S2KOZ\UJ>!2KE[UCZ,]I51>Q'@<]]*H,T#RU4T0.JI,^
M;-@^="SOYRI9/W&!0AMV6!W9+V.@GL8A0.P88)#A^K4]/)HN0 /9#X34F1B#
M_&._-X1^OYQV^[>ZPY<075!\'10?[+S[X)@047@)JH-GB'N!D;64(DX\EBD1
M#K\ BO5L9/,YBNL=]9WY4R?Z<31.O5]KB5U9U_L2MZK#HPB;JC==TNEF_0HM
MG6_#RL7AUQB[><^SRG9#_H6/]V:#%<9[%'!P7&_02T@%Y'G4_H:.V@' _.RI
M+C)K?7KS03A))%$,#/!,U4R NDBM0UQPR[U+3E"SL9U _DW8M0).^=<E*KT,
M;RN3"XPE167DRCHKN"$V"M!*DS7$7(3W-0*')J!^=P'4A["H!^DE/#3O-W()
MT'EIGX51_S3:_M.&,(/G?9".!:.E0(%A, 92!$&<"$.*:"ZEQ,[7695$4SA6
M>?Z: O5*@2D?6E[6+3YK@];9]M>0H&,][YJ#6W%MX/""W)]0I@=;R0+%]KYV
M@6OC_X[:)UGR;5:^8P>#=FK#JW90A78?V+A*M8LS,RXH P,0?@,T/#V9$.A@
M,\/]Y.ATT/9M&-Q)S? >=*UJGAHRI60RUD>&%^R ?JU$U]3\%1Z^B,(0 T^.
M8!R=BCQPK1,CP=',)\IK;VM&(3]WYK[.@SN$L;WHAIUZ\+]-QU[3S*#^^>J\
MHU.-X;#W[V(#+$0]^T ]N=@:CI8C'$P$<>(ITLY2%(0F*I(4K/4/XM,OV^ ^
MMT'2(CC-#*B.$K0*)SVR21&DL:,F"1(TS@E_S6P:T2NURDT@D\$)K!NL1.=T
M<ZS^V6I,DS$@,&#Z]F.FG&.@P7-=LE8&,V?9DY-^[QNLU!"^_D-=ACN'C<-,
M!FRY-=9P FI2=)@:CG6D'W9JYN$@6YM*S7=_0KW?,J7:*_;;VTG'7XS[_6K:
M[?K=K.S,U7"^]OIA$+M/?(O![Q\(K _+!9V$P3;7C(8M0"1%E#G)>+ZN%=,Y
MT\Q=9^R3Y@98Q"C)(^C -!K8M12T)TF"3?4ZX^DZD[+.#[+.+E)8$1F0UA'6
M61H.+)(B"H8K;F7TEN"-[4'\ @9BK;_^S 6T5>U-KH5,/(]5ZO>.L^HRB.?V
M)R@KV7C-;-%O@SJ3?299N:F?4$50 ,.,,V:L DV4(3S'+Y5W7[L[LM^)[F>O
M9/VTW@'<P0YUE,5@,.=&N\1 (J:$A6'>8?&!<+IQ4ZWVSI58-5>))61K[/2=
M_7E']#Q5!G[O]4)V,8 N 'O!=C^V0>*_ #MT.-AI#WRG-QCU 9O?AO_N]/SG
M!P;A_L[>%(3PC*.CUN^M;_O'?[*#W]]@>"Y^=PC/V7GW%0!S=O#[_N?WAWMG
M!R^;(-QO'_R^^_7=V2Y]O^/Y^\,_\?O#5T>M,P#BIQ=G^X<M_HY"GSZU^-]G
MGK3._OP@LTFON4,BX8!XR%D^:3ZX%U())K#@6HZ5-=BOP&^9P 2CB5@NF N@
MM(GH!$X)A+T(1#D182$B:$DGL!3#_BAN;$\7HD;-]Z6HQFNQ"3MM6,WB^2*N
M&I 9+]7/N]'H-I54LPBC2P N+BSF5F&C2126>6PV%C:#'PA2T_F<F:,[!--K
M?Q3#J!,/TO3I3QLY;SX00;3#7"$B0@+5Q$407M3"DA.#,>5.:-%$P@K[67[H
MB7AY!)B%YB;.76_[_=.L?-OZ^D%6O#].,?X5A&YV0:1>I]/[.GAV0U>,KP\Z
M8+AC1_+TG'I\W S#[MB307PV_>5Y: ]..O;T6;M;=[[^TO/+3YB3^:9^WOCM
MYU_;87B48RBV\#B.8A)?/WGRY.VM^JW&Z?GX/2JWF!97OHVWR)7O_:A9PK8$
M,3=J]L>/).1..BNE?"R=Q5O"W*S9!^@LO,GX8^DLW0(1<ZUF?W*5924NI9O%
M?='CRV)[W:E?8S!S3VBQP8[I\($"S6:TD'IT;[9>;U5_'%FP:GT<U=U:8(Q7
MWAM\K-.1KR'Y?ONDUD\/HS_JPH,_GE:O>YU1?FWF%M)3FIQ6#'577H] (L,O
M95;RK-0>BJX=1W \Y8FH@\HN3< M;SC.QB.N:'J3^?/Q;]O)X0Z;EYU/>&FI
M9IY0O/?/!K\VP=Q8T\B9=B9*L#VEUD%0&1)68.[+9&-]A(9_?H0V->\?QS'8
M38W_22@W??_VK^-]^-[^V4?X_4]XO84/=O98-OCWW_[5WJ=[_-VA)_NOFZ'<
M[SOOW[ZC![_OLH,=^'WGU=&[LS]Y*U\H/_M(WK_=8^_J=M^0O\]V9U.Z$.*8
M(!9)%C#B,1%D9,0($TD=I9Q[03>VV:996GV=:S/C/5Z"^7'8^ UOP!2Z>PIT
M%[R7(GF"K4Q<1J<54PP[SCSE(J50Z.Y!Z:Z1"L<1*8F-'B6I'.(^Y9A$2A!S
M4E@EM:$A%QO8%'S)UP(+W16Z6P>Z2]9)&R(!P&"N$G5>*,X$]5)C1H0M=/>0
M=-=,)X2%UEPXBI@T)L?4.Z2#]$@PBV, U4[GTT:ZR<62[^D5NBMTMPYTQV/D
M@C"F*/<\\F"B\5Y'L&HQ9]BF0G</2G<-[0[SI)(/!!&9<OU)&Y')/Y3TH-NQ
M8)6OKR5S7NBNT%VANQFZHY@8CJ-BDH'UJK2FP0K!?))<4B5EH;N'I+N#AG:G
M&).@B@M$K(I =P2T.\?A-U@?;!0E*O&-;;/)Y.,P9N\I83ST_H&0^#W^T/_O
MJ-V/X8EEBE^ B90SB1%K,!.)*ZL,BX+FVQPR,B^=FALM?QU*>C&9^IU1'V;O
M#QA(KW'3)K6_Q8#.8K]7&&HAAMJ;.5VPR0@)&C,"J@+[4UF!#..T_DV#H&$B
M@$+V?_]+4T*?KU"]P)*#>LEP9D9')Y7BD7&>M#+Y7IU6RE!O0F"ZP'DEX=PL
MU2M,XHR 566Y0MRSB+04$ED#Y&R(B(&D N<G &?NK0@)C&PPMKG0TN(()@)E
M@0>0SK; >27AW/0.FYA K;<,V2ASI2F"D1,YY3 SS('AIQ,M<'X:< 8KDG!L
MF>+9T#<4AY H=I@&2B5;,IP+;!>#;;-(I#.>6:]0<LXA+IE%UEN*6$P$C'X>
ML' ;V[<N!5L N[J O=%=\@+8>P)LTT^'C?8@:@/26.9LJ8D@38U!RJ2\9L;!
MFJT68&\:]3RW;@N>XY*[E-;4S+D0]V ^NAH!XYKUE?5UC2,8T68U[$.C*?8'
MXSOWO>%1[%<VY/N1=>:6&[GRYDS;^I'5G;GR_ACU_9$=Q!?GR_3B^WH4JV$I
M;-::\>DY;<%LH $E,!$0-U+E$#J#O".>4><U=WAI5L,/>.41E*)>;US?F4_O
M)[@N^%T,OPWS04JNF0T>.:T56/V"(4,I0Y%RJR6C2M0UY@MRUQ>Y=^:^*Q+Y
M/A#=].,EIGCVV*#D4T0<"XJL,PSAO*"1,!J3*1+Y2>#ZCOQX!=?W@NN&I/:@
M3DFC):(J:<09Z-S.Y@K.+ G+;:!8ZH+K)X#K.W/W%4U[F?AM^OVHX]$E24 0
MBUR!+F>D)<8@X9-0@1!'G%XM3?N>(O >%'<'M>?.CQ.)_9KS=?4& ),G%HJW
M2/WX)3CP!C!@^.TJ'JK79*_K^SD?ZDX<_UOX9R'^^7/&4Z>9C$%9BAQ8"(AS
MKI".+"'#N7<*"P]:XL;V;'VD!RDE7\X('XM[[@JP%B-@.2!N& $<!V:,Q"CA
M7#LG"H^LUQP1#(8>221R+4J0SA/ \YTY[0J>[Q+/36>=,(DDZA.2TGC$ <O(
M:JH1& ;*2)=<]+[@^4G@^8Z<=07/=XKGAGQFSCMNF4 DYA0++FJDC4B($NF)
MC4X)*0N>'RN>%S&3E^"E*V;R/2"XZ:8S)NE<J1 EHQ.8R0DCJ[A#WA"E@_94
M,[,R9O*2(O-6VD.W=WQBV_WL@\YNNO['6(+K[C^X[OLB_*<W*&=\RR&?-[/1
M= 84B!024B92,.]A7K7" C%#0K Q6,Y".>-[ D"^,W== ?+= +F9>PC(-TH<
M$ T&@*Q]0+!^$;ED/1$B!:MC ?(3 /*=^>D*D.\$R$T'74[N%F2P*$12G]I'
MI '3R 9'D\;$@BI?@/Q8@;R(07]G'KHFD@MB%T-L,Z+=<<.D-OETVX$!CQ-R
MA@9$0/3FJJW$*K:Q+<TM+/B"TQ7&Z9V%QQ6<W@JG34<;4=8SE22*(FK$P;!!
M %/ J?=,4"65%&EU<+JD6+C'> ?VMUX?_NQ6?M3OQZX_'5]^[8Q+WEZX\[I9
M=>/PB07.K8)O;K(^+R?+<_A]=7ZW[6[AJH6YZMV,7XYZ182I@^US[&[4 IEH
M,?P(0GI/G<ZQ<[>O$E%.]%87OW?FDKL.?HMUOQQ<-VP%FDC"P264<C@LIQ(@
M[:E%GB5016"Q"6'EN/X)@/O.W'0%W/<&[J;KSEK#+ &+0A@!X :3$#DA',)$
M!TQ5X)PL+S5% ?<J@_N./'=%\UX^B)L!=5XPCQ-#AFA0OPFG2.,<(.NB$]PY
MAKW;V"9"%@"O+X#OS*57 +QT #?=?%9)QIE*R 0,IC-G &4I-$K4.9.XIBKE
M&HMFE0"\7F%UBQ3S)K>)K;M%<:!'34]":,N3(9:#EJ$9U5&9%(TG6 B*HZKK
MY"S 2J5.SO((R<_X\CSFBH88D8TT(FYQ0M:[B )/\%]2(%ED7>-:KF59L&6<
M(#Y5H ?'B%1>6\I!]TQ>!R$X)4*+P(+1H@#]08'>,!V,2QISR1 H&6D<"&#!
M7D!6&D6Q@I4*85S=>5E)-PK0UP3H1#@A+%@97"?N*+?,":J\L%Y11K L0'](
MH#<=?3*80!1)2&H-:,?!(R.D1D$D!2OG/+RTQG6-"]!O4>)2&RV)BA8+D.G$
M.N*(E)%(&[!+B12@/RC0FQ6G:%(TI5S"EQH$<+;(&B:08M8;K%ETG-82G=TZ
M?7X!^GH!/8)MY^!;T:G( ]<Z,1(<U2)94.B]+4!_2* WG88A2,D9%HB3+-$5
M=DAK3Q LD.*,,JJPS;5LN7D<$KW4LBV'&>>V!8O"$H8C=X$[+D'GT-;$J!AF
M.CE3'V:0Z6$&+=7R5H"A/LYX$8.GEFIID='6(AX"1H9A"3\DCX$I)<+R+OB5
ML\D5AK-2.N%\XR0 G$,T 9/(G(_>>QPB+W!>23@WPPQ,3,YIAZ3F!. L*;(X
M&908:!M<>T[#\B[>%SBO+IRU)H8GFTE<<$>]XREJIXC27$:,4X'S*L*YZ1&D
MFG/,A$94BH2XC@(9SS1R%C//HM',N@+G)P!GA7GT0.$V*L*CC(9R@+;3/J3$
ML5)+AG.![6*P;6:W5=GM*C#R(8+93YA!1GB+0H[==& PT51JV:XW8+ESV#C,
M9,"66V,-)V 41X>IX5A'6@#[D(!M^NDDBU82"AJS4"!G5;X_@P&P2@4=O7&2
MR14#[$\\<;D 1,>>YL[&'V.\?/+N/UD6ZQ%]LBS6(_KD$R[I???I#)Y&GI4E
MG&/\),%QN9VQ9 5N]S0K;^.CC'?0]N[I!S"T?!24(IL(!PV..>08"4AZ;HF6
M(@@Y/[-!R9:TLBA>A=.+<N_Y'C'=NHQIP:,@@FD$:YOC(0'3FC".HK$YK9+F
M7M*2L_ )H/O.#C,*NN\1W6\NH]M2J0PW!FEL)0*]2R!KC$5:..:)<=+A4M_[
MT:)[H4J<MS_<*!KX_>/97\:SD@QL)J-0DC*"M,8,F90L<EX+:0,1@9*-;544
M\/4$\1(./ J([Q_$GQLJM^"<)9(0YE0@SK1$1F&*6$XDIKSSEEDPHU<$Q3<-
M1YX$28\;@Q[\*$[Z$28_H(L>2/UP/FYQTV+E:C#]XR%F9K4Y?I&[)]I%SVE,
M7E,NI-8R,:I#LE9$[I6N[YXL8'V5NR=+Y/*S&9>H!XU:1<H1H3X@GAQ%+EB%
M)-:6:.Q52+Q.$$%O??ED>6BYIP"6'_7T8I>:"E]ATL*DR\BTHQQ)#-@S)0\6
MK[<*_I4B96Y-UOC"I _+I U'M$LTN80UBCKG_F*>(QN41HH%*Y+2DN4,G$O)
MP%&8])KM%C*]_>2L#9]J(S&UE%H+/.HIUUS2X)4 I51%$ESATX?ETX;KG^,D
M& U I3YI!*9$0"97.HHR$N,]_"?<DA*=+!4P:TRIA4^+<CHA4RD\M6 ?"F(H
M3RE:9FA4V*J@B4U,%#)]6#)MG+OX@ G!WB#AK0<R)0%IQAF*V#JB8,&X).-D
M,L7,+TQ:F/0^F30$)W@*S$C%I;(ZE]HQ(1B#L]$?"I,^+),V#K^"-%[*1)#4
M1"#.+0,F51:Q&$#VA<@,$W6V'D$>/Y/69V>_#JWK1/@WM+]L3\>T/SH&9/CQ
MWWD_M[NC^IAU^U_PL>F8)IC@ D!STANT\P>>]6,^D/T2GW]MA^'1%# 7OC49
M*?[^%>M@8*/AU5^Y,"P? 5S]^\<]S7TBF)\O[WBZ+OP\ZD^[<V(_1N3ZT7Y&
M-D%OG]G.5WLZV/CUTJ".V]UIZTINY3EL#A_V3UZ;[Q-7;P88;,>>#.*SZ2_/
MI[<BVMVZR_67GA_;_D=XPF2VQ9QK"WE2QV]/GFS,EL(J/WQRH#IY\*1?6W6_
M&OMZ_![76P9?_3;>(E>^MZ1F?W(.?*/L4_427+'/4KJS,]UQYX#2>_T:<\^
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M1D;+]OU1Q<AFE??Q5G71^,CO0R.#<R3Y:/-01R?PGN_ B^T$E%A_U#;Z,>W
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M8=IJ2Z(&8I W$T.AI;,H+Y0,V1AK&;P!^&=P$3.^ :"\V=@!G7I>8 ?;[8X
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M6',.<P8*Q^&,1!1+C;C #%DJ/6+&1&><4PE[8$U-GQ!KUF[.Y6Y.;(PSG+I
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M.^-.G].=CZ@2R02>]-N/?&K\J9W:SF??&05XA*\",5GZS7I,LL2S%Q?]WF?
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M:V:I9I$:(G45C%=$U2&4-0<E_57KR]NCY&,R1EJ$<9['1G,#H:0I IA-B$X
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M^_OVJ@G,3Y2(P9F$DO)@RL/9(1?@1PL 7"N5 )#3Y5WC9_5/NULELCQY6CD
ME+5_V:M)Y XD\J6UWSQR%/")(A$TM8ZYT(DBEQ38:D0E*37F+->_&7E+:[2*
M1/B#D(CX=A(YZ<=8$\D=>E6SUO[!D5%&:J<H4F!. (C 683DAJ.2&9>2E5K'
M%R_98@2\,4L>X@>1(*]Z.:^[CCG=082<[APQ+ B-QB 1+%C&>2:%L6 ML^BM
M=H$Y$62..=UDY;@9&I$_"HVT/]U1@OQ\-#(K0?:VWQX%R540C*) &08DHB28
M(=XB&G._*I%8\NSN-*(V5IYF\PATLI5;4=:DLIHX.3OR2B8NA4+%P$H>>$).
M6H,"3L8KJI2U>5;EIKJ%5+*!%XMVH,_5AGT7/_4ZG[+WYH]^#.UAXY7UU4#+
MYV'-5LV]!C'WWVG\W\CVAT56RY("KJ(G3MF5K->PXPW9.N[G^K'N<*-1SA\J
M!W:^CQ?#LDR5%B,LB)EO>X[GMO1JG'*S47;Z*;K<A*+_W."J&XI>0ZL))$<3
MCD+BD)UHVEIKO+%2!D$-2"JGLD B!IO9,L?%S)F_8-?V4KG:\6*;]G/[?'3^
M^WC Y!_V OXRO*J%T)V$T)>W1X)BGV).^)0T#^T+(4]PC$@QP177',00S^E>
M-U4^CH70OV>FO\Z5"A+A(QA8,8%FLLI8C%F,FCOOG9=J7"JHBE+!,2E\S56?
M]=+,$0/?^5_#J'_9ZX=![/YTYSKCD?_2!$N&<F&"C1(%1SCBPBID3>+(YY:K
M0@A*O7CQ,H'"1CE@,S^]%T11-Y>]7[=Q]*682!7G58TB5Y($F$=LB7+!$,*5
M<U83I3'8WB1:IH.I)<%C28)</&I]3#P0B9B08-U(CY%))J D.6><&!*-*.K>
M;Y$$UPF7@SQ[Y;Q=!(SM)]ONE&.H<[RY\8?MVM#.,[.+(<*#C<;O&6$.3AH7
MO5$WM^,NN@8?EP XUZ%N-B:'.YB:=;U,AS5<+!J#5GD5+J?5E278^0I M@&^
M+;(=G.V>E1%V^$11\OK+>&CV[N][[ZZ5X62]VQ$HIC][3=&ZLUP"$'OL%EWA
M&M,=<):^<=%W\KQHJ1F+?G>V TOJ%DWN&T7GTPP1RK:C\^WXRF22K/5#HX0Z
M@S*/8.E^%+7>13AL&A)@RHO=/;'AY@RV)7T+@HHA6NE<-)P;IGV2C!"BHXK8
M4UY.@!A7?B\,SER2OC8] B(S]V#,W;/<6[1C15]BO_<3.ZVF&?> MK:;1QP+
MR^#_$>QU#KX*CHQ)$GF>ZS>5I7 L+UZN<,!*2VF$9UYKRJD@3O$@%"<L4>L8
MPZLW-*T/^%L.6 2.X3 $<CQWIZ \(AV"!%,$U"@#3"6]>O&RVUL0S#=)ZFLY
M"I@IFU4S@]B+;U:1!](%+P(V)FN* +#.&*68Q!IT^77ASNU4,JW7:\+X>LR;
M-_<_' FG T]1($!1/B?!:^0HRX&-W!@=Y#++,XU6X7Q/F4G*.^,L3X08)Y*T
MUG,7N?(R+7<>U4?Y[4=I5;"8.(QLB J$. W XY$A:P,<"N$XY>J[N_!XE8H\
MTUB]<@?,YF--&/[Y]*^=>4'R%<?)%IB1H4AF; &PI.,FR<O TSAM;3"ZB'T
MDG"+V:O)K,_ENDG*>&S73;!LHP!UYT6NW,:XY_"@\<GVVSU =]?-AQ>:L'M
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M[Y7+^0G&Y?=W*L%U<=9Z_>?9WO;O'3!1/S?W#S!<0?>V=^#ZUFGK=(<??OP
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M['5#MNVWHG7://(\L2@H0Y(Z@+""8V0]%X@ZF4@*8&-$^^(EOZD]WQC&YBJ
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M"XI +ARR6B8D'-=.1$&Q67@_CD)WA>Z6X*GGH+NZ0Z>N.QDFSB/5ADBCO5>
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MYH=)$(/DQ5Z^[&RZP5@UJ'_/6U=^%)MUBY&\3&JLX\?>'9X ?/Q/U ASLY)
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ML[ B?7B7PN'VL]RYPE%S<=3;"=^;-$E*R0C2F&#$8?& K5A"$J=D(\?*\K@
MW]MT(GB(MC5WZJ#]))![?XZC@MQ%(K>A76 :/,,"(ZHH(!?G@F 28^0(Y88;
M197T"_ A%>0N+W+OSP%2D+M Y#9](9BR*(PE2*2,W&1R(R0P$V AK:&:<)GT
MQI:<<K2P8'=ML'M_AGS![B*QV]AUO;!4^TA0T#@@;D) CB<P\9,P*L):2NY
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MA=;*S$V;.5Q*U!5 %D NS\SA>3;[IUC<K_KER+8ZLV?JSCLCZQWZF>'YUR;
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MJ=RP#V+=[V]6(V$F"Q%F2@'R@BOCE.?2)1-T"(%:X9)/A)C5[554H# -"A_
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MKN2G-P3%.6P<9C+ UF^--9SHY*+#U'"L(YV:3'551M[[XQB&[;B77OP U ?
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MG[28S# E=Q672]4'YCA:N^3SEDV9&01GIB=^<C-'RLS=<N;P(LAJ72>G +(
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M)62#920&JT.0C0Q^TBQK-),F49ZT==S3Z$1BT5@5/7%$RR8KX)Y9=CZ3)Z6
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M^ZK@\P]?]XZ/I(T&$-8CE^O>N5(*&2DQ\H&31(5STBNP>2EM^/;I\BV)<,Y
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MJ!,S[7$_QM,ZTFB'<%6NQ0)YT>NB?JRCD$!3]7,N@Y ?MM^7A V*B7J14RI
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MX4VVB"WLS+VJE<NWXO=^/+. +>-:D,L*N;]7R9&@^O1'H QU:OVS/57P.1O
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M*#[<#=+UP/>/!<5[[FZ8AA_UV+M?&7\!!/\7&JR_&_O!]S+8+[:RD;OQ@ 9
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MA5)2MRWO='G28R2STB_T>J^FLJST909]E*Y 2LIOPO/T4[EHTXB27W&JYK_
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MH[[F8#OM!V_Q3!93H]EG,",X1WEN7%ET*JVOKX%^]K23NP)J'MXZ5;<-/H=
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MO$6-WXD:][>H\2UJ? LOWJ+&M]NZ18U_)_/X'*CQ>]%=2V@PIE@<AUGBN5[
M$&'HRH0G61K&F<L@Y/B.T6!GO7B!P 57RH $J(?>=+0WJXK)R-?I(<+G+*6T
M#/ZH\QC>SW'U&Q01&GFF4UM8@?D>W-",BM;5>\0,F2L&?4%44X\T)2JED3W@
M'5P5M8ZW;+IG(&6ELVH(Z6E&MC:@&BUFA%+#L=S0K>GD]D%D#8E2B>\F412F
M'E/2S_+4]WT9I7$LO,37_-.^RUS?L3_T6!N2%=:&YF:R75-]H[QWS?&J^:RD
MQ#.&3+>;43BD/W+P=/ 'TCB<^WD81SEGCF ,FU1$W.%^FCEY& 6216G&I0MN
M<;J[KKUZ9HD<.K'T(#[YHR1B;=3<$0(;/I$<O-*UM(^=4_G;;CR\ZUP$BH>A
ME X3,G98'$9.ED>9$\:QF^1>F @F$8L^S*D\ULGJ3]42+(\%\Q)7Q!*,B)!<
MIKZ7R<@/N<J]5&RUQ&,0%G$N,S>.69 Y:<Y<U!+*22.>.3[/ VQE(\,(#'Z\
MNTKTTE<2NF/MC!?2M@^S]YBV'.EAV;@\Q/?SD(>^SUB8\,QS_2S-5!!'S!>^
MR<8MB4W0TRL/D9@V!7>2GY5@,#O?P4]O$W.-U+P%VY+!R?9BY8C 2U#%I$[B
M1;FCN"\8Q!<9T;8'R:XWD)JCEIW8K_5UDRAK%WN, .%B2IP/=]U$# J-I_+0
MEVDN80P,3!^7*@;M$P1YS',IW&&A\>\5&A0 +3EGY:_J=:WDK[=T(;$WE;_C
MY5GK:6WEI)63B_,4%COS0^$$F4"BM=AUN!?&3AI$N>LFF1\IOO,L6?5 _K?%
MG'2RH@V9ANV/LZ@?</]K,*U*%A:);.Z3U:R0ZJH0NZ.CLFXZ9FKX*WK1LT8S
M&'07/:I%1UGJI@;_U#1-:ICYR]JV[V[:],!D=%H%G2L^JB]+A,9JTI$9N3CK
MSL>J]T\(S1JC]**^)*@J&'(8^F5)_"PE118&3VGSR0W>QFGP-GW$&GR8-ZQ<
MID=XB[2V/9QMJ-&Y8,:_X7MY35ENLZ %0E_GA8-L*A5=ED/4!7,V8+-.--5@
M7QM,:O]ZOM0L1_*JF/>QS]=5.;V0I:U3,1^\YAC8:7QO3D1>3P0]]*O*2U.F
MV@:PLH-[7A8::Y IGT&(-T(=P";AEX9P'75;J&OV%AZ-PW]35N_&HY/+HAR/
M_KPLI1H=UA-8]/'H3-UP(^LO8!T* X6KFR<@8=94KKT%Z0B"A2PC] *+0J@]
M_=A>5O8IP=JV'R@TU)"[U0I4#+WV8K/!I%#5,)[%=@@&8TRC,2N!@CQ!/;-T
MU].'RW2FD5=@7*YIP=H;U#'A#;'M. %)QVVOD+NUR.[HN+QN3T;G-0B3SQ1U
M,F_$86P6ZIY--E!(^FY[9.$5655RG%_SV2=R=(BE>_D6?#S: ]W&KT#KG;R;
M\,L2?](-%^M+$)HY B\E& S4*D.WST]C;?Y&.3=LN%;-F]M'HU?,,C6BVN)]
M5UCN.GBR+OB)F/J*J:#6WMW>@-T'D-'!G-:#.I7(+ BX)Q/AYBSVW13D%P('
M/XD"E<A(W1=VKE**?OZP\]OSBWYUQQ!"S7>WQV^%=_3V#_?H[9OS1/'$S7S/
MX1Q[EV29ZV2AR!T>)>"NQU$B V1S9JOQ@PX[+<DH2-):Z<!;>U#5VBO_G%)R
M-W*IE1.+_SAL!V*26%OH[)HZ_/#H["@X.GC-0$@^'+U]=WN>I(H'G',G2;GK
M,"]G#L\2YGB>"(,D]H3K0P@!)GH YO2?!5&53!>F@Z?9!-,WK*T,QT]]=*;K
MJZB<YS=("_O=T,5_6P4#(S]G<1[E$0=A80&(C2MB)V%Q@"0.7NBE;IZ'8N=9
M$-RO7QHSU_?$=#Q)I9&=:++!#O5-IO9%X1^-[31N:=<1)83R$1B\8"TVN05N
M]^QIXZ4OFV1\9>N^=%#&JU:]&6+G\\.CM&$IGW<!3O=\K1OY@@^ET\L/NG8*
MPB3(,B;3R&,BS'D2N,P3J1=PA8U#S#$+W<"Q/VPM^U>M==A#\I1S[G.>1X([
MN$\.XP&V296^DZ>Y\%T>B""'@Q=ZJZ"]WLD;[D;6T"Z;'&(K50]+%"IL\PE^
M!G.3G*G(X[Y*1>BY@7*]B/F>210NR= VN_S%14AW..2I],!T.FGB)F#R,]])
MPM1S\BCT0A5@2C%=FUW^J:P^Y=H*'B]YDK! "A8(L.5! *8BY$&0>3*.MUKF
MVXO(R<'1N:]\Q=W4=11CN<,2M.P\AI_ +?2\(.$"NXEYZ6H3S)Z6^7F\DN)I
M[5BC;#;(]PPF>=JD3L?/O"^_<[9BF6TV8M6Z$RV.9:^9]E'Y^]2@ ![Q:W4+
MSL(^E>*VJ8W13_O80_:XW!WM_X:R[()_-!XEH<YY)-'/)M-&3"W(<"0NE5Q,
M=.(NPQ)1?.5O?*KKJ5P_Z/$8-(NW5)%_J_GIX;1TF._FE(]9*4;H^0^5RB>4
MDABB&^\DLWJYA;+"%+;2:5+J+#&:EFL2$>/FL4B3\QZ.VI02(-<ZV0;_Z6<4
M![R;MJ;8B RL5BLQC8RL)FB?2.ZH6UC?*1K3/J=<2B:3KZGJ^>BO J=8V&Q;
M]U=K%MN2$[95)H.YY'4IV5W+?@ CP#)K&.72:Y<DCYA0.@<-=J.;7^Y7B\,Q
MT&?&#()K]II]GJ%6V&]+XO=-7=^_%W0XT',N19^"C*Y5EHZTI? Y+1<HU-->
M(<[JZL'1,V7ZI2TW3G2YL3ZO\!1*_-J<;W/@S7R7-9+5:;HP]8YE&U!.=J&.
MD";'L47_R]0467NQH=?XB(,*Z7SH%9^J"45+IVHV5^C?C0*W6T,]^ W;5X;;
M3C!&I=&%47N5Y)139*BA93 M:)8*ZP=68TV)R=J:3-Q$VHS0 @T_2G?>M_Y&
M:;8"U6%*Z='2K(]@.<VSWQOJB:BKNU/=QU0*,]HC<!2?$C$%WA*47;&S9VFY
M='^YOKJ_^Q5>4*T-XO?A8)7OP" >MW7$_/93G-HH\GG@AT' &.-1G,0^3_P4
M(C(OB0)F^4-3/W'L#UNG]JOFK.!];P_/8S>/W9AS6!RF' A!/"?C7#K"#QG$
MIFZ4(_@Z7H?7O-H4KYEE7@8Q>>!G(F2^+V&_N5#*"],PCIB0@_*P0;Y[(,]]
MIJJK+59SS99_>'XN!(M#F62.[_O8*3OE#O>RT.&^\*,L2B,OBG>>12U&MP_6
M["8A!]7WETVC!!E7.01@09;F+'*#%)&=F? @;A9A&&BND15]LDVC?''9NCDZ
M>'?NYQ*AOM)1G@392MT0U(GP'9F &8@X%ZYB=Z51QI]@<CY*Q6Q-SM>5D0^'
MYU@&%/I9[@@/ >,NDPZ//.&XN9^K,/!C%0<[S_Q5#H%^&J5/87A)-%)UV>>3
M(3#)$B_FL,MIR[&SVS5.6!<:UQ#3=.XB+']^K8-QS6*L&F3R1"&JI;XL9H8/
M>JZ4+L!93&N($RJ%[/F*+!Q]P;I^]Q3># _61$K4?FS(O?OX0^;&89#X01:&
MJ4"NCU2&*N&NXFGDYLK</&X/V;<\9-[1P?/S+(^%B$/E0/B;X2%+'1['N2-S
ME<K$5;&?(A<+<S_5L4LS7WIN(I+ YRSSPHSY*H]8F LN4N&%6\?NZ^SYV=YY
M(#,E9)PYRD?JBBC!N@H9.(GR60Y66 0,';MU-3A?TFL3(42#"+)Q1<02Q3)0
M%V&4YW[H!ZXREU];K^T;" [\[9R%L"N2"X?%/''@ ,=.RG/X*4%"OU3(*)9?
MRFO[*/VQ-2A?5T8^7)R'V-###X031L@GJ+S8R1@/'"'RD*F4>W",=YY!Z+B!
MVU;4JYY9T<DZSILD:(_<[DZFOCN<H7M)=VS:<4WFM./Z]>Y]/JENZ.,TXOUU
M0Q^A$6V!T5GYIRU6.="TL3^TFNQ< !\&"""5><:2S%5.Z&58Z>HK)_'#P%$)
M;%W .$0RV:=7%MTER/>6$ZW+Z#MW9O37O*YS_5FW%Z"$8_QJ>?XMH52?4"K8
M$DIM":6VS$-;0JGMMFX)I;Z3>7P.0JE[":*6^R+&*E.A<F,>I2R38>;S*%>Q
MS\(X"<*<?\>$4GN3^25U7%VJQFQZ+YDNM'=2>B\1CC;-]@:)1T?U%1)2Z3@&
MG]$#?133Y4K7>=O3I)SA2Q XM0E>JO6/>RT8:(B=#/WRZ\'7=@:'T(=1]6\,
MK+SHTOH*RU65]E<[4*JZQ1,U+?4(+C0IU'L;6A:Z$O8]2(ML*KZ7P!W+"UR8
M&6)[)*I.IB^L] AL/H_K3_W!S/.0]EX(-3,.6E\*-!"'2M;%)0Y4?CQ.\DO@
M>Y;QKP1W;#*+&^$8ZZ>,8[PD'@,0I@?=S##A13R+@YCGS%59(L(T=D.5>_ [
MP<+!CKV=1%JXG$BS:?<79?4[-KYL54V]39MM0"?M'G]X=RXBS_.YKQPW$<QA
M>1X[6>YS)T&_)G C(=P4XKKPGK295K(F8S#7C./8":H4^JJS 7)U*0*I!?N=
M5?AKKT.QB>. 0ATOT[/#*]9<EZZT#/Z"G:9/#4[\).]?)Q6J_O6V<[NT;3;]
M[N;D0-P<(U5?""OM1ZX3,I&!8,;*23,E'<E<&4A72<G2Y>;1C[@YW::ZM;%]
MG8Z(IAW]IM8+SL8PVT]!&:V\!/MU7?]KK5E:7:>=KYUH@1!LU]6)C8=F6B)_
M-PW"SYYI\<)=YG]< N>NO_F[L1]\F<'ZFSYV()]@]Q%THGH<G_R\Z2LM;)_[
MM*</[T1),O[3X71D[&C=1IP?E>W1<?37F>Y&B92=9_WT^0.FY^+D[I:4[W@E
MO U6XKL[AAD7[RX@0)Q*QRPJQ( JSW\Q%F->SOX%^S0BYK41KO@O'WMR[\H]
M?REC3;NXC]5(TWFW4ZZUS&AD[;9^UJ'IZX_[QC9PQX0+[@2[ T87VVKJW.I/
MWL^CG_SE5%??<'SBQKJC;ZJ8-]S9_[5\)#_3Y']93J\_JED_A-8E]J/8<R,_
M8PGC$<M2-PR\B%QR+A)ON!W4  2F#ZK;TUF=?5Y5M_"KO_ADH<PI>]J!_)N_
M?ZO_.2N]HZL_/AQ=_?GN^. -Q#]'[IL/\*ZWS\/CM[^^/7[YQ_4QCOOLW>VQ
M_<[__':97<G)R=O7M_\<'-W^\Q()7IZSHP]_OL5YP1C\HY='[C\'>_[1V^/)
MR=FA!\'__.C4O?G]#/[O&3[[M7O.DR#(W3QSN$BEPQ(1.ID;I8[G^DH$81YR
M-X/H?^P.-,73\?^7.3+XIP<>G3L,V2<,9MD'V:K#K3IL,YI*\4Q$0D5>S&0D
M4X]E.<M"YH6@$9/40*2^F#K,BQLEG0^J*K>:\*&:\-9JPB-,@X;G?I!+QG/7
M297/'!9C;U#/#1WIJ3 4<9Y%OK_SC+(S_B_?L2Y\ B%%3O_ST8'#MU JOY?3
M"P=OOM9$#6MC0?]AZS!H6+YK'?L57<[C<BJV7N?GUK6'':_S\ ;6X.;<39.$
MY7'DN(%,L;\&,A)RX?! @0'U6,12MO,L'L.^?JJF'=857]2W7'KEVBS6#W^T
MOZ+[M#W:7^AH+[M1B<L"7ZK82>*,.XQEB<.S('9@7X/(=3-?)/G.LV3LKJW#
M>#Q'^[MSE1[?@+^73WYB6MM<;?KW._%>NBDZ]ULH;ZJ[V=!%_:2EV:9)/G%E
MGHP3\&7]^[UYSPW8&O_/9_S_6,HF@U_OI3Q*(YX[;IZ \4]8ZB1)[CDIRU06
M2S_G&=:?C?WH,V>3/^4H?=U4\]V6XB.SS5L=N]6QWR[0VNK8+ZECEP.L%.F'
M.,L=+MS08:&G'!Y[$FG!8U2_H>^ZGRG >JPZ]I&&#_=5<.$:(0S5+(R#2I9
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MN\Q0$!=$"]/-VA8=IV4(UC6DD<NV+Y%GB9\.-I U4^*T]#A+]GB'Q+6$C^$
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M#'2U9BY0U=^2RL_4B/Q_3#Y@O;.88RNURMZAC;M6P](.GMJ*YR:UQV4YL^B
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M>'T-*['X?2JQ7K;1OE@,4!//1+0<[A=SYX-QFBN*@TR<!<%]B0$^'1]?7,8
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M#R9&:G=!F-I 7>TN//?A><53\-&)1*Y%:(QJ+Z/"1.I@.>'>8>MY-%YR1G3
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M2<O%3&N53Y"#*^UXGF4F-1\:^2>#:P1IJ_4AQM:O8Z=\KS>,+;XYBA_]<CX
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MT\X@T819[!,*SGC$20(T4X"T2)J*?&AN%=W8UM?U="N(?@:(IA&D(*F$&5>
M:&5EGK:6F3QJT-BB('J%$3T;[O8>%+26R"0J<XLR^)=-$0656\0(ST/,'6CO
M/:RJ('J%$:V-Q)0G'0+EWDBG(LDUPCI9HHRC!=&KC.AI'4U%X-QBC63"N>^4
M-,B%*)'33DII;20V;6RS>Y_J%T2O+J)S"U#PM3QVPG$:I4Z&>9%PHL%0+%A!
M] HC>B:H&*CE5I&(E(^ :",B,LHH)$7R\!*8WI0M(T]GB8A^,;/'Z[[@@XF(
M7ST?)=I^GMU4-TN[MJ!J.M#Y1,Q2]TU8P_GH[*92JN<YB/1QPZI7-<$TS__:
M[YW>HAE,7?2:9PVW>^%2-4P>1J7V-Z"W[['?*RIC(97Q^VS851LB"3,>168L
MXB !"+PZAS"AT8@@<QO*C>VJB0K]N0PB?K[X7WK\M>!_%?$_D[7#&'5:,@0>
M7W8"/4<.<XEH(M%H*4VDON#_!>!_Z=':@O\5Q/],6-=2QA0.!JFH/>)12:2I
M9H@9&:U+V'M1\/\B\'__V.XU:17+)8("^,4 /ZWP<<+.6JF1(3X!X*-%%@>/
MLK<G:1"*)'"8S;W/<0K65Q?K2XCZ%JRO'M9GXL':14Z3C\@RC!$7+,&_!$6>
MN#S%PV%OPXIA?:T[Y"TK._3:7CBW.*^Z1_' ZG':ZN>%%K*Z$UE]G), *BDU
MV B4. V(!YO $\DC\5S$Q%&.:;)+2@!=C?JA)1Y2/RO0KVK2:('Z7:$^DQW*
M'-7,YU,&'G+0 2,K'44D\B!BE#C9N,3LT +W9P+W1\TH+7"_(]QG8HR1,"^3
MMHB8F$=9!(E,\ 1A&V"+:#1&^26FCJX7W._3@OA'7L]Z _TQ$TT+T.\*]&F]
MSH*R-E*"A%("<0-_.,,8<MHR*U+0D8!>)W2VI/5!N[\6C;H:^9\%:'<$VDQ@
M+P5"E2 2V604:%1BD9-@1?L8HB(J2"$X &U.[?@JJM0EY8#6X#0K'OS[=QP,
M7K5LDPUJ)SHQY&S0[I5>#%5.:!_V-)Y6;YAZM=VT:KA^RLJ+/^E8>E;C;?BM
MM!UZ*"H\G)/ *(1F5@9$,/>(@SY#SB9P,ZQU/IE@.69 A2MTQ%&.,Y]#%/#.
MK71*]M+=P3^3S. E%4$Q%"QVB$<3D&,F(AN3#<I)P8@LV4LO@ *>)#)8*.#Q
M*6 FN"A)E-)I4/B!8,2E(,@JBL$SHM%3YE6@HE# 2Z" IX@9%E/_ :$^4[ >
M'=.PS4AQG-O0,YU3%QVRS(FDI,)"XHUM6D#^?$'^)/'* O*' _E,:)-%X0,E
M%@E7]8'S O0YV/4D*AJ8X33E_.1EC9I8QY3%9]'_<CKPN>O_-PX&O>[]VU\^
MJZ.<]4F G$N2O]F<UEU(<2%2]+-!3HQI9"0H!/:/0!QL':2MAG\!4WIK-!?,
MY-S(6=NGY$8^*SY8RZAH88&[L<"T_Y/G!1E/$K" 8< "S"+-M40V<B; 9$I)
ML9(V69A@=8.CA0GNQ 0S0<]$C>0N@I-D8D*<4HL<@^T+1!K%F=:\2J N&94E
MHW+EHJ.% ^[& 3/6 '8&1RN0=CXB[BE#5FN/%'4L, STX'+B YV=MU22+5]Z
M\+)@\$X8G U6DD0)&%:(Q*I[DC+(.0"B=TS%/"S>")KS,-=#$3]V+\Z'A:N:
M"]=?;,=V?6S986O7]OU)BY'-5D;;?7(HGQ6A+32[S"8LP)+@5GINA30I.7 T
M"+/@8$1%\^RRA2*-97;9JK'>SC@:N??9D]V#G2,O7$B)4Z058X@3L#F,=F!]
M8,^QM" "+$_JV50:K_KHLB<XGWU67+&( V*\3-**!+XKE]290+572N7!V($J
M?CU5E'&OJT "%U,D #C'3$=$K,P1B)QT&9A'@D:2@B#,X]RM@>DE'=06'G@F
M/*!LX-91;0..7&'F-)C0WGDIM3'<VL(#*\T#>U/&@.%>RR@YPE2"!Z2E1,:#
M12 5P80*)JW4&]OW+T0K-+ &-+#0''BKL? T4N\4CS0YT!4&"QMID#8Z\62N
M0R&$.\V!'Q$"!O1+3$'.A;>(<\Z0258AA?/)L\?15W,\2?$-"AE<1D99PM8:
M16GB7$EOA>9*1<PLD\ZD'S@')8ZP-DRQ/V4ZN,B$P)8A< PCX@0XPV))@#A8
M])Q9'!*NX@AX-MMSQ;BBI("6$>B/YT(Q3I(71##M*3=4.AN%YTI3IA43,>5S
M)&#+YAR)E*%MJ\."NS/15"U%=(E)))SGB-- D;$D(:.IL5I:K*M\=W+OLI8E
M#FTK8QB7;0 9F7C2WA(;%=>86R^H])P2JL!'LNP6D+Y#[G;!]L.,01]A6X K
M1'A2R$5I$&<2?"$1$F(J!TB5<#@/UR!J-F-SX;3M NM5A#637&MBE%8I\.B5
M]D%+<&J(UHX[+PJLUP'6TS%/K+F+1& 4$U6(>V60Y9$B8I5+1*CD+0.5/9OT
M45#]+%#MO(J&B$"YYCSOMC;:46N,#UXS=AO[NZ#ZZ5$]I:RY"X9031&V,2(>
M%$% VPY)YWWF<4(IF5==7D"]LJ!>) ))L0O.DZ"YY<Y0@VEPQECIDP>GVA:?
M>H6A/!U9Q#@ZR1D%[.:AMCH$Y*@"@4Y@@Q,1N0AB8]LLJSOF.N9>ECGH+W(.
M.B]ST!\^N%IFHZV:BOA])NQJL'01AXBLC01E7QPY@S%RPFOK8&.)I!O;?+9X
MIC03>C907T+0M8P\7GWD3_EY)LDH=& (K'V>_3R)=(H<,6\%\4P)3W5I&/@"
MX+^$X&R!_\K#?SIX&WU4,FB+&(DJ-]%P ']GD#$2$Q\$HTX5^+\ ^#]<%+<8
M^BLP\'R$=Z9%I(YC1%F4B&NBD6$"(X,5<#PCP2NYL4UY@?KSA?H2@KL%ZJL'
M]>FPKS"<X QU9SQ#7$J.-!ARB"IN!=6$FMP?6*W2+) R[KR,.U_]'-#"4/<<
M<CYB**H9(<E%)(B)B%,?D,;9#;$B*9^LQMD886(]YK:5UD'//4&T /^>(\]'
MP =7T[,4&/)@@"*N,'@A$2C TR"!$H*,W"XI$[1@_KE@_FFR1POF[SGW?(1Y
M2[!@CAH$=IE'7#N+M ?='Q,A&K:/,(*7DR9:(+_*D'_<F&0!^J/-/1];]48;
M3O*<<R$PXC$9I/,4=&TM-=P$8H3:V*;+JN J:'\F:'_4G-."]GL.7Q\GET;F
M8J+@N1MO$ ]2Y:(NAY)2T4DK)5$DF_*S#2Y6$>YE]GJ9O?Y@_LN#I5*6J6VK
M,85]Q(F$)1JEP2@EXQ#G@B.GX5_4TZA$(#BYL+$ME]#SIYROKB+2GS8Z69#^
M\"/71T@/P6D!MBFR4BG$4V+(,"(04=0EIQ57'I ^>\1:@+ZR0'_*E,DR9GTU
M83\=RP0NE]%@CP0F!''I)3*:@_MC%.$LB!C5BTB:OE]%WEIC_TEBDT6U/_Q\
M]?$9)3718IF0U?F,DH$1;YS&*,>DI(L<]AM4^VQ#[SN-$WK9*G>AWI@/EKQ8
M +@:L\_'K>"X59':A"C3'O$@*+(<3&V1@H_.!="TH&3%$KIAKF/JXK/H>5G&
MGC^+1,@R5&WYP\[';8$]=M)$@AA5"<P0H$(GE44A.!E]I(+@/%& E!S)E\ $
M:QZ%+)QPK]'G8T[ ACDK,2(I:,0YMDB[G$.9(DN<1<&5R&>NLU5<)9?JQ=+!
MTZ9/%CI8_OSS$1T STMFK$'!"W"4% $3(>:J"K !C1$,/&/[$C,KR^3SE8Y;
M%O3?:_+Y.-U2F*"JTBG/(^)6THQ^CD#B'&=8>JQX'KI<YIZO" *?),^Q('#Y
M<\_'/53 KI(8P!>Y5HCK))$1+B%PMRPU4082<JM<.ANI7$47_26//2=E[/E=
MCF2$#S0EHX)@7/"D3<36*&F\=-FLJ,:5+>)0E'%EJT9ZQS-QR>AEI(1JE$3.
M^XZ>@]D1@ ,E!R\DQ6!DRN/*F%Q"]M-J^!UEM.']N4)8HKV2*0G'>++!.,,3
M\(3'+$;KU)-Q1:&#Q>A@>ER 5(I$!5X(\U5(4J(\RAYA21A-43!FR3UC$(4+
MUH +%J""Z 78"9X8G3Q7G%NOC02W2 E0'2&)ZZF@,, *,,!T%))CJK15$BD7
M<A32!60#RZG0)E%L%5:"@4%P;R>HT, :T, B)H$/%N#OA/0L<FN)I1RL1T6\
M44 021>38$T(8=HD )^0"Z91IGG$/0_(A) 0ICR RVA=\GICVQ23H'#!Y>D$
M3IAIKXD5ECL-MD'@P ,NFLA\LD_G'I10PO*(8B9^:D22U$2D*%8YQ<D@31A&
MV!BBL+;>N9A#"5POH6)RQ8*G)0NT3#Z_.UV&@)66T@)\'."&&6JI,BPPA8.
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M/6S]%+^=Q>X@+J[['K6EWR^56_M^VJLM)#:61;S[_?C(!L%"BAA)JS.)*8;
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MMDG"&G9AH=8R99-7;Y,C83@XIQ%.1",PDBT 73BD!,OM$9T$U.?6N;/U(#]
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M@!%WEB!XM +<>9K@_X%A&:;/9@P15"FJ8O"4Z^1UE,XH;VABRLXY56J>?D6
M8_S>X0SIYNM>7:<'4< IP'_"\,"M$TFKA+&,5EEBTAJ?(8%.@T?J,Y&-CFG
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MSLAEB<.#M.2M8XTW1@AF [KY*2.V-<<0S">6=2#C)S+M4_Y H.^UJ[=!3+G
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M!J2)@"GDG$1&18\H#S%R*T&,<Q>Y64^F8/A98#A1C;%.F -9<Z>"8Y;AY #
M-%BB]"V\F(+AQ\;PQZL8)A9+&SU%7N>VU-B!#C;4(FVC4A1V5J<\=53.UIP^
M"8A?S(E,)>3KY\"T?I+W\F!>1/2'1^ZP8)IB1W-_"ZU#,EC1; ;1*&[?7_=^
M*:^I_2T&]#WV>X5&[^S/-%$AGD<&)F815@%H-'&+##4XC_5(+G=2]5YN;/^_
M_]&4T)]7*#)4(KO+SA#-,Z;@?_DTE4MF+6R^4(8H%1A7U#Q2\4W!]A+<G ;;
MAJ5 (U&(4V'SB2M'EB>+B/&1V&"LC[9@>UVQ_?_9>]>F-I)E7?BO*#C[G)B)
MH%AUO]CK)<)CX]G,'L!CXYF%OSCJ:H2%Q-;%&'[]F]7=$D(26 (!0NYUSO8
M4G=7=64^E9F5^>0B#@])S@BL TG&<:J5P4;RI+$-41NIPV,X/'71RD-X0Z,D
M-<ES:TA$2&;+!M,+:1;!);)6\!B-)E&!-[1)R'2)W?S^T.J=[#P#]MP/ ]?/
M!+KW*4ZYD?!HDO/HF6#74S#*UHCUA(A%IAT/(3@/1J.,4(C;1) VL(A66&V,
M32*QG%:[R=2R"EOF5J)G%*C]B8%A:12K-3 \+3!,>"V.8N4L84C1"*Y+,@89
M[0ABP7*GM0\,TPP,^N%I56M@>([ L#3.T1H8GA88)GP<3832"7R<2+E!G#N.
M=/ .P>HJJ3QXM 7C\B9[>-[Y90'#(YT*/1K)Y&S=?=WIGG6ZMA\;L=*>S48[
M]I]CFIOZ.2MT%HDU+=5A&XG.P9"@M )@VPYCR O07(/O$L&73KEK0BN%F26(
M*VKA'^R1HP%$VU"FO(N!!Y\#3%BM2("I#B(O6[&7ZG#5BOU4BCU)SF9II#AJ
M1&00B N/<]-GAZCQRB3!=20T-WV6,^B.:L5>"\5>JL.TB&+7NKN@[DYX1%(+
M&:-7R#$%FS+V'IF@.+*>" T+F4+*);6KLB6O&Z7^;,W[L]/K-4#A0G1]<'BR
M!@R:O>."9O\9>CSZ/A[/SY%.O 2/9^)T?=CMYG?;;/>R0,7>07OGFBP=I#<@
M8#6&+H:A;+R@9__DU??/B6*5M(V($ W>C3,4N90,L@;6*C@%2PKV#S$KDD=<
M%P.LZC'2 CI;)[PM29?WKNNR9YX1SA+2UFO$P9!%SAF"L ]<"Z(E(//2$MYJ
MI5Y=I5YZV[E:J1]/J3^.*?7'R\]>@!%%%$.AZ'6!0;,UXP$I'I*0VFFLPBHJ
M]:.>[3P99T'L]8>G.G=*</LY(BQ+;XL^?/=5;*5&F3N[ 4-V(TL4K(9$.L;<
MH\(J9+WG2.@@-%748Y+/-]1]ZOKK(.@*J^C2_8!:19=EW0^CG1Q,-RH(@L4!
MZ]Y*BZPE'D7FC U6)25 12FY3]E^K:(KK*)+M^IK%5V6K3[LG:(T(TP99*S.
MMCH7R"G*$:P<LTF8* 0&%>73'&//^4#B&12AE(=NPZZ^J=LY+52KV1[DGK]5
M]]_,FNPB^+&QT2R_W[??XU17E8=-/5VYKC/SM[M:>/ZK#<U/Z]]D^<L!E[<@
MJZ]'HGHPDM3?"D$MOW>8Q73G>[]KX=4WV[9[L=N/I[W]3CN/LMMIP>2^#,&^
MSB=9XA; IQ/%(O7$: #^9/(6H EL 0J#J8:%5$9$8UE.%#,_7?I^C9L_!VX^
MLM=YP]%QC:#/!D$G_%QLP*/QBB'JL$7<>86,\P$ESER2$G95!T:TV,2,W_],
MN@;/&CQ7:>)/&PZH(?.90.9$W('$O/)1(4VL0%PR@8RT#G%FK3#&NJ!%07_!
MIR%S18W.*C8Q',A0242!BLN.+<YQC[$),YA2Z Q<*T[-^#Y/J$=YRRC7+7=6
MS>9*B5^*/-D0S[J C07H-FP[-.QI!\9Y6?[AD;)H9PWQKEFTYH?DDLO(^ZGO
M\?A$JT]A)'W<^K#5>'=LP:+P<5 ,ZS[A\W4SB6=-<6VL7DJE,S@P0*?$#?'.
M1*RC%BX%:S"=OP/>T.I],X:UK]KAU1C2UH;I0H;I[G3S;L]M-$13Q#,W-1BF
M'#D6 J(1<^*M(ER9C6UZ_UCHZAU<UPBTI@@D4N[<IW$RRG)OA.8^DA2=P#0H
M$^;O15XCT$,@T&1];X*=04;PA9/ X!#3W+Z8*&2TB99JGD(F@:5DNKZE1J :
M@583@30U!F-%?2*2)T6<CI'8Z"1U481@%X[\U0BT3 2:",XYSBS.=76 - )Q
MSCVR$2ND6?!26"F]<8! >)5LH,=N//@4"O>N&WN^VSPKM.TP^N,V//C+Q54+
M]?LPUC[#5,1%R/)Y2%YA;6DTW NOF6("["%/L.=<R=H)>SH FNX\KJG5AJJ(
M%/,><94)$S1)2$;!N4W2:ITI3N@*%0_5%8'+#IN E:# "1<4W!<2F6'4^F@,
MTXHD[6NGY6DU=L)IT9$Z Q"+<- 6/!<5D!:&(1Z$\$D[QXP"C;UWJ_%:8U=7
M8WEP4E!03:PI)T:: !NML\0P&XB6BQ_OUQJ[3(V=;$!!(V%8)T1(Q(A;)I"S
MC"!L;>*8Q\2( 8V=YA!;^P+=)]6WO1B*H7P8=+_D'ZZ,^\9/5JZ[ /*HB(TP
M*O(D!/=1&K 8<ELL#_+--*^/6)X0>2ZGCU@BMBX$A43!3(IQ0%;PS!>O95(L
MQ.##QC:ATS5'SS[ 6:OL4&5ACLX1EWB4-)].6,69UT8*I8B2C-?F_9.J[(1Y
M'XEQBA&&A* .C 6?NU4)CBPH;R)@^1N+0679O3N_U"J[NBJ+J4H),X.CXMQ3
M[GRPGH#1C\%@U*ZV[Y]692>I1JV(L 01&6PBXMI%I*7C2.)@HC),$V.RRMZ[
M]4(=Q%^<A*=="/G]6LRM-]A$(6P$%*&<$<ZC<$+HE'R@7 8J*:M-^J<#&S+.
MR;EWN$L_,T*3)F#2QPPQW!*!K)$$$>9$<,$EXDD^,5Q6,G\=_UM!E=5@%II
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MI+$-41NI0VW./ZG*3D3HK26<!1G ^<[-+US"R/I@4/ VGZE1"2NTIA'Z9T#
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MM+/+\3N Q$%[0=@V/QULCR64PCA@++!M.V-<KA;+YSV<4(X<5Q()@WTNN"4
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M[@4GN !3EZKIQA1SYF46VT33%2?!13X+6+0GQ0:3?YL'WH96[?".U^&N2%,
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MG],JJP3@&I/\E,'L+AI?8CY7.SL&Z;0Y%1'<HX)_OBKGZMU<S#4]]XW'MLT
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MK:LPVHTCG7<L/QC\JT%H]G,HY+39[\>X6<40\H/R0R>"FG[XO5&X=.+ZL6C
MSO=\G \*<9>7<;LXW/A2P*ML_-:!37SS:DAE1+"2EM[F>$1A^""Z\(,FIUV&
M-X;O>ETUO8R:A>&Y<!CX<8LANZ[@M#;BZ5FK<P$O'MS6:Z@81B#A838N9L>Y
M781U\[L_CZ[7[(,$/MU^<]M!_OGY^=:I_QI[X*]O@1X\Y:XX'LGSMNSL.(*%
M;[%7O&,TOO<,I?YP1MQSUF;5^'W0# 612*D^KX^+V$9OA,2% A1:=A;;O>)M
ME8L\=H\Q%<P+;EN]SDVK/C:AGCT=S6I-]LRQMUY$<=JAEY7EK-,KXJK-?!1?
MO8=1E*HYIGW=D6.2[P#OIQT*>.IWBCC2N6T6D2" TLV9.EHX+H6BQN+!G9O/
MP39O/@"K I"M_'-QR +RD-TB^&\>:AY>KPEOS\)0!NW*9\J1.(#9'")KN$&O
M61QO!7L!8I73?(H)%:'TJUF-9K35N''Y?\+D*[64Y"O#ZN2K.OFJ3KY:IHM,
M:A=Y8DQ7V\JX@; FN_FX75P<-'5C$0K,.VOANC6S5-S1#Y[ED\Y\F4.+KCHT
MF_!<[A/^7M]8%JT5=6),'T"TNLW^1>/@O WFW''SK-AVP'&W(%B_Q78$XZ^P
M HO/2U=ZE"I0_/J^2E[XT._XKV40!K[2S]["+0;<L]7XTA/N#=];9_R]^>J]
MN:OWUKEZ;U<98$L$AW==N%'S++?H'0N"+0P.,U=%KO2B9*<J@3O2.2^"587)
M5%1XP%H!*(_[3V7ZVI[M@I_!R&891IR&[EA4GO2JEWU^W/3',Q.%<A2LD^<+
M I^7T@[ZQYUN49"2BF/]WB#[OR\6LMBJ"0P=E:(."EYERY[UXHOA#R^'#9F:
M[>*%%!>]O+YJ,TA!B^>5'U<VNS%;0I)LME=,!]6#*XM^J[#H)ZJZRL^8WC):
MW_@QWB(W?G;;;0EX%/3F2V^[[>V/5/@!!JNV-*?/9;!ZBS,VUVU_0'VQ$MQ8
MH^JSXH8OBE(P?SM<%/YIKCUMO 8$_-+I7OS;=?^U_<MNNP%/;N4XQ6:N'HMG
M_1S,:/2.BY*RLHKLBD3WYCKN6UY,J=^/_&INY3;>'^20?@;$:A-KQE[Q/OI%
M="ZC%P#9X*S3+OX:O\>N;_:R.UK\#KM?KP_;67'T4@3I>IO%!^>VVRV*2/)>
M5Y1BWMPL?OK5S4$.? \6Z4=SE>=;@G^*7V) %L8,-L'3N?;SC7<D V?=IB\D
M8<4'/%-(5WS,,_3G88Y"Q):>I!V?!9DWTXZ3I?&.+T?[GP?&@JUY"LY!$<7_
M9INMPM[+]F(:]'/VT=!LK,S/? X _H4?<_DK\_27LM"YB+>/WSVUBM32,OD[
MYJSP7C^_R<%I^_HF=E=NS$6J\^^"SM<B"B-FK&'TP#R%IU&LYLZ-2V'/SKJ=
M;Z4#=R.^3$[KB68Q<EDK'_'^S0$>6AXFJ1V>Z,6Q+?Q8[1\6P^';89@NH?W#
M7"M<=XB:DP1ES3I$$26V*%O1GD"/(>@U5D[)!,5;_#F")9L%EC^RDQ8C_%RE
MKD>+VCGM,C5\76V=.3I#+[+8SX2%N8AGTY</P^3U$Y$FKK/)<I=74$O]<Y#Z
M&OQ66PP682ID-5'A<HD*\]GR^420OC$1!>_%_NBHN<S[*6-M^408%M4/RK2(
MJV#=>%"Z&WM]N$O^0GF,G!E8&[\,R1(^?!R5JMASVPV]S4:OF6.#W>B;9\V"
MO"N?466[;)0QG#.*[44#7N#$2.$#N"[F#*(BP3H?;V4""W=R=?0-7RZ?-&]R
MP(3,L><F<W359.Y]/(-E*9:V/+(HLVL^?*P6YIK\7.6#7*5 %*;ZB\8OS5\;
MQ!C5V.^TT4Y5BW%5S%1E,30J8W\\I:QDB,MY*%W;:N0#TY=P-[A=67J%19GC
M4WV2OPR?CCXF;.SCA5+]GK,8L146([)EROVM.N4>:O[UXX>S0=<?@R<\)E.P
MUK@Q$IUJ58=?*P[2"R(;O27FN/^7?*IU[>9WEY3GDHV4L3G$GN\VR\/'?!)4
M'>B4#G7%#9*IK6)L7_.M9V4<]:YRZWI;11%/=?Z0\Q3":;,]9-$9NWZDU5=5
M:E457U$A=ZW"<93^,"SO*9A$1O1:DVM6+/\$((Q(C& _:0/R#*O KJJ^-JN4
MJIPQ-6/,TZ,J.%) CF>5%#T?L9D_3X66$;1KK_K%@\#+G$)=2-KDVF?.'AM@
MB[I]Z=J-/3!&*-TL;U 0."T@Y?D&?PQ:%U6^'F%;,P=S%KNG643R[4J@@5%4
M^^7P'+33/2U.8HNKAMD U:]Y2&!25656Q:'[YK1Q=F67#<VR&5_*%EQOW(3K
M77VY*I'*(HQ*+KL?7/XNWGB#"F7+&JR2>K#X2W7CRHHKWE;[ZABZ1.:\,W2_
M3>0IWHS-&;-LJWR[O4'Q%K-UP? 6;ES'_,TK0^'FA[I!W@>&"4;CN\TU(!DC
M&QP1 (9<GC@;C#8G+)&IYQ=8ZZ+OG,:)K:D;!Y/[WK61C*67SCN:K<P=4E2U
M==K54A69P==31HLW,(.R"I[Y_L-F-OIF+'E1ZU<N>!JT6JA*4SLORIW[Q]UA
M57;68ML:31_^TVKES*X0<S%@7OQA@O',_;I*1RBT">3H0_F=R3EDSZ.:!UR3
M2T5+%L@,#GG%!ZW^\ UEXO:Q++*&O::*XQ7GS?8H(7?(,6DORIK =*W0V'XO
MJHN[5R(VM&*&+)%P=]A782_X"D\OWFW!"1D!%T;3'Q]4A0O5V\JS<]G;@E?1
M+O>TDJ>OD.0QV;K^ZGZL4:/WF8=44-'#K?,^W4L7>5J-CH-MRI9C*8\PLO25
MC\^5O17C@9T2@:MU?H!1UW685W68^N8ZS+JBLJZH7+V*RM5UFCZ,FV2%,U/L
M.GD;Z6=>R%8N%H?M&W9BV^P.T3Q3.L:*.[63T;NZ?GCMS>;,E]B.W8)7L7"]
M;,FD:'T_\\D47*Y%QMXWV#DNHLVNUL'PWJ,K*T.BVCL*L1K6MQ?6$@RLH*=I
MMGM@\K=*HGT785&*U+]L%>1[5^7O5W9KMBE*JVT,YM]_R)M<-@5+EMD\QH)H
M]G8_SY94'7U8JWR7X@%;C=]&@RAMC=)*'KZU/(EF[JA4#B\W=<J&R# (-?X*
M\@!+\LG2ZJC>5?FMJ44H3-F\^\)'I^6U8Y=-VEC7Z*5']D])-;TUD[XBCLHC
MAVPC8Y;Q&']-+[:;G>YX%5;9.":O%DQJ./#QQU:O"%Y*:^*3F3;[-8N]]'4K
M.2LFC(H7.SVM$;DM&#M#>>I=60FYW"Q;Q2$46R4LT%! JK?R;#SA'Y$VSH@9
MP')EE;O"A79E[516WM 2CS932)2:=WI%#%48N>->9;9W!F?9,A*;.<B5978S
M&ZW3NC7MU(+QEIDJ9D8WJF&!EF;#K-21.#7,D;H_GT5;.'QQS85:A?#%=9]N
ML?"%V"QO<.?P!57E';9F#F8J?%');2FBG&Z)"3_[!T&-RGF$G\H PET"!T_D
MOYYWGHW#VGLH%^YY.+371'BK<=V(.X\+6W&WV6_7U65A^^W9H.RM./9V=AAJ
MO%/(5$P,WGO*K.1Q)%+%RIS:$,=/?DNYNVUU'S&&]U#QNEM?U'FS!)OK3ZHL
MOS4XM5IP_U[6R?%3[OLOBKUV63,I+88['5W@S6(4+QO'G7- I>[F^/>J>V:.
MB#13FB=-" "]\5Y!Q66%S5KM,,N<<]G=Y+@$\#8L2Z40YYT!;'AC!OF5ABSK
MV6NK6C\^51^GKMWY\.[=T)M\\82<F.71=AY-R5J2V0M+ R)'.^"%%Q;4B']R
MY!B5)M,HN2"?5P]922I.P))?UK:')+Z5(<DI&VK$J/?)^[RG#TIBPRWX<\7E
M 6^4;HZ9\ 6'8-50JQAQR4C:.2\3':[U[:H&D,>5E7I$6CK.XW)#&ZZJ$4?E
MC8]9TP/7:X:F[38CV*&O<Y^0=K]U =I+MLC,3(G9&0!3'NL,,RQ/[_EHROSR
M!<M0!&>*5>QV!E^.*S.OV1YT!@"T,;_=<F5R3 4,_&P*C\2L"(F,Q61&^E5^
M,$JKJ]JWE%&:PHQL@FE3V*$5.6UA*O4[A8%42,KP5I.>Q=6BG!4FTTZ.18!_
M\:69K8F10N1(1FP-[:XA94SF]AQDRLPS>Y')-2NGIQA(-<;2)?G>SZ"<#?[\
MMXEYE4I0,E;D\973RD_,AG_.[8BY\=3_+?V.D2*,-7L:+_K8:KSJCT?CBN#*
MS">F0:8R'3E"68_R=\<>,+*O!KTJ17%XG][(3_L1QTZ5\3):XXJ$H'S6R$6=
MAZE'EZ^@&/J4+S)QQQ(?6K:78[,7P\O&3B$GWDB!2Y6'4KZ=4_N]>3HXG3Z1
MGI2@8J.M(EU7?A^\S6MK54!!,<+<][X=0&B*B.)49!B H%E(R7_1,LI5&2TS
MIWRSFS_T.\':*.2PB%"O#>3DWH-#A*YR:8<I6C/R+8L5NN;;7JO2'TOJ*KZ4
MM0YV@R(<7R9;C(R]>3*\ZN/6J^-6LQS:6U/3WM:'M"M\2/L,V319S:8YV;:Q
M\AL*2LQLPATWSWK72#(/8??HV<J^*QNR5^='5VTQU[)5S"3;XM#%ZH^_D.)+
M5V=_=R+-G+N%QW!)<M^5B^L+\ZX#-MY%\?S#J?&-KBOI[V?V5[DB[!^M;W-L
M?9<]E=E"-!S8JZN3X]E-!89K,<S@/BO>B+.M['.6RW!MF<K1CW6:C=>:P'YK
M@OCTKOKH3'>B+6YY=<E^IY^C7YNS5^:W\7&,+\=P?M59!CAQ115><>E55\S>
M\/5-#GIR4'>F3*:8KB]E,J]!?K);W(AQ=[Q7\;#/T(?8_0;NZ;H</<T&M;/1
M*ZBZ4!?>Z? 5]*I7D''BJDCR9ARVN86O'[5S?W5VUFFV^\.TWS>QU<EN5./_
MV=.SEXW#SL##/?[\\UV..\[RI!;J+UWX9F_+O*>C*N^)W<Z>7.8"M%IEC'P<
M42=1?:'^U#^?:\?Q,EP[BD7MVM6NW0J[=JLRF[+-Z=]W-W-F]D6&T7@$,\QI
M&"]Z@U-X 1<OU\/V$;7M,]77Y;CIFA5'[94!?[4W?H#-.0QF=@^^KB"YV%O<
MH!R/2X4/8+^%2\!?E M?ZRU-[L8#?^MMYV;8GY.P_?G0Z_Y8#O'M&^2[<3KM
MY\)I/R=GS2_VUU_(KXU&WD2O7-T9:GAGXO7J94W8I*0$XJ7)V*Q'/@#I^T/;
M;C/Y!^>RW:[MF;'$U)=//L#Y#3JM"YZ)',FYS4/;7,@7*RS"M7I%I^-&[E,
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ME4/<.X$,!_!)7JO(A?.T""/=GZA\A8K;G@.:+(5L:E[>OF<-.%Q'1YUS4<G
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MTNNB.T(,C7ZGT2E9FJKTT(9MA_)/#QI=6L\RU44@D7"GP<.@6*? M5*:>B'
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MJOI) #FFS>J=6PH CD^WY-3Q#AP[WK07?GYY&ZX%C['G*!1=\;RQOZ28I96
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M81+5@JC&F41LB?&,L8K58%@R!"S5'I:JA+$F_5V5.Q,5!P&7'&Y/*>;TD2_
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M1F=ZCRJ6-^2.9;II<-3$AZGJ)8BJ"U$-0@=-H$,-T$&;1H>C),[*FF@TBFY
MTX/!GQP,F(?SNG"CT$,'GI<4,3.W3\.TWT+')$K"/"=E-M#;I/!Z-++A6L"'
M($H0)>!C/>HT11+F10T 1%-F[ M:)68<>LUJ:X8D0"=/Q"M8ULPJ2GNR%/1-
M$1&D:+BMZ'OX,R_AR2X9?GFIM$HFDER>/'D\7.[ 8WBE.)K.LW3R0J#<1X[]
M9$!WL0<37^O2A.70.4U61^WBU,4QR=I73Q$95DVJLJP*^!)$":($?*T-7ZJ
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MM+WX%'3'3?PA_-?+^]'7_P=02P,$%     @ ZD&I5'X_>IW +P  A! " !
M  !M8VLM,C R,C S,S$N>'-D[7UK=^,XCNCW^16Z=<_9NWM.)Q7'>=9V]1['
M<:K2G<3>V*G:_C1'D6A;4[+HIJ0DGE]_ 5(O6P]2LEWAK#USTI78!/@ "((
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MU^JUFBF.C]"ZTY I#KCK"8=B4,_@@SF T> )+<9CI ,R?O^VDTPT!/V%7)D
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M3%P [!X141N23C2Q,OHI@6Z<D.(30(\23#H]. CGU#==CBZ1@W@\<M*$< ;
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MM62[Y&6D1-:V%L!*S3R)14*@G0*T=.A-3%9@'V;M=M)UK&UU2/S94TK-6/+
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M@&<I0Q".\YA*8KY;Z;Y'/>J!^7R[<N)1PN\N@GZ$KUU9UC-]Z6&.-&V\"I.
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M'8VC^?'[$N31N_G[2>,H#GP%922ZJ)4!9UBM0Z (%!,.+-(+*6>6L4^YCT>
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M2?7)2NR29W6\5BY#8]S.PCP)YU:^' HNA F!&&%K*2@D(SQ8!8G<N*AU%'X
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M4O/^\W0'("="?CUCW_4%T]\7WOE/+Q*N*\,\O#SZ7,Y!5G)/M<<YR#&-<Y#
M8)%+12B/%$ *IZI-Y1L@G C_-0Q\EWG;G_DG*4UA-EO^48;+!C90(0WZ'YA<
MSOY-QF"":F(\34%3ES(-E5A?\_@38;RO8>^R[:JQ_12_?#5]-_ES/% V^I \
M)3[10*3@AGC+,U$Z!ZHPS. \UN7ZR\-/B^D]C;KF%*77*=D-3(N5YM7T]73R
M<3B.,+ )<25K21(9IQN!>P4<.R."^Z@#+D/.V+ILWT)P6I3W,>\:WGL=G]T
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MQ6"3*Q4"TD@,7IP%XGD"HA">R#'2V&A2OP?8MZ!Q<]!8D].*)Q4=X"U?LRX
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M2(Q2HJ3%J5<I1X+FDD1&&<>%F07:Y@S_P&YQ7W+20;UB%Z.W]X95N@QHT%X
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M+XK?N,P3YXPGWD>J;19:T$YUFIWVPQMAG.K&J9[M*\IQ+$!=7D1<A[1\1;J
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M0[><-U"JI_WH57X&&:;_E[UO[6XCR;'\19B-]^.C78\>SU;;/BY7]]E///%
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MP:,).^&AFOUYNEP/MON5C/7/L/AO7&T766CGSS[\'%8X24YY%R16]TJ"2K*
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M-00T%+(R6C@K7D?1B&[V+I&>,)2&-5>#R.$[P6YB79.L$\I"$=K4P)FDB5*
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M9,C!T@7#LA)WEK3V%N+D!#C!)9.-K>P"F6*I$!($DSP4IH*5*O(P:H7EHR#
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M0A/07ABQ7B\DW$NLU\<BCX62K,N:GHGU.I6R'0&6,;C)#K'T8T$QA;1&Z5C
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MK^>K%U?U/Z35WA1?=9"QJ?O01<K3.!1'F_2'Y%<C>S3P)3K)ZH(R-D8&3/@
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M)M?SVX^!_B?A]6J:PM77B^2_YJ2E?]')1+[.]C(1)M'Q)#1$Z^ETRIJ!MQC
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M**!U]G1"IY)<&^["$\'F 7Z $Z.FAS%:H^4_\2J7^:*VL;V>K_:WM6][VLC
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M! 2KL\S6.2Q=4JN/@]JGZ5G66ON#DVE\?_2^V3UZ[[R?LTV<.1DAJTI>E5P
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M*E""8LH8*&I0!I*R)6F;4F!MZN;[2GI9Z&EJISW .OH9^S;<.XCKR'/3B6=
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M^.P9J!)IJYABP$>O(/"L=.2Q"-T&CN.L[QP[#7JA<>^<I+-"18,JF%X"W^(
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M:M<>&8VS&D)&@B1BHE(MQKR51?W(=XZ!YS%%>9=FMQ?-QM\P!K]JP;#B5:E
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M1N:@>R7MGU3HT^<FY[>+TTPW#[5J@\HI0HR9P,1<( KA&:M(#)5ET>M=<CN
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MS1*]4 ]43-SSM3$?)G__EL\AA?).R@2BULBW0:R0K'#@V><L3L0B99\!?O<
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MU!?>X6VG_34Y.90::AM9O<%ZHPS/!E^T5$9-!&>(=S80:F4.0>E,0Z\+X=?
ME4<,M"-191?I5XYFG9W#=/*O5>QEE>F<C#<EM5F(5%K"0L85LTRB\)"!4254
MG\9^FS[[P,=]&Q5,*LJO<GSJ0U<=O>Q9.?XZ'0:8=0,<OI[[\4:P0?*,J]?$
M".]+1R=&;#""6"DD-1HHVC4];P1W>O"I,:&MY"N_]K^65I3+F^PN\(?VTJK#
M5XP!%\W1*[6YC*M4I>B%$RL"."\@BEX1Z^U/.#7%5Y)EY<:>OXW3\/LP7?G1
MV<@/+_QXOL1$O0)/:2*9E;G%F6GBP";B971H$QN@ZV.CMW1MW?SYIZ;=*G*L
MW'>SJU!"/^<1YE'* D5D)'&E\ C2&4GG.&%&11I!""G[I&X]_:13TW=EV59N
MD=F5/'S,__2S<\0X1S&/TY>K4"A:C-L50J:8%LXS$GA ;BH5B O1$JHC^KM.
M9<[Z[.']GG9R#*@OX\J=,)<(W^"W_85?M=(JATTL-1*E.E4F&8CELL02-0TQ
M6XB^3X.039]]HAI^OOPJWFW=5)VNBIG>7LV&8YC-EB4QB[)VSSFW@5)"9>D0
MGBD:$M)J MDF#LQZNWYHURKT?0S6"83ZZHN_8INZVXKD#LN*]3W -"WZN ?G
M.&4>%=7UH/I[7UDWJ.6X#\I$K]#XU"0D*%-34B+61D.8D"HD/'Y\OQ#_2U3\
M$_4:A]+[+B*N/</HRUH'XP6P56A)66L8,))#<D1R//R<%)EXBQN<E2Q'VR=;
M_]&''#YE>P_A3UI(KO)=ZVU/3)1B-X"QHVLN):T @B  -%\BE#;JWA"3HXY6
MX7=SO;R'S1A.X 2O)."*+48W(UJ2NP^FZK=SV] <XS)N?TT]JO@]Q%S]>GX+
MM@C4)B\C<2RZ,L [DV"<)48G!8R# _586<9+5OVC=VN'T?PNTFU@JGW$7="7
M?6UEF:S"!8![%_JDN+4EANZEX'CR9$8T1ZS*!(ZK;F*T;0%T6)^^CK8F]47=
MHEG759C!OZ\0T+OO93(Z_MHBY\\X%36-!'Q61'H.:-8P3H(M;;"3R-XW,MLW
M SJ!L[^FR&MV>'X$UZJM20]D;9WX;=".Y-#7T.#3K-A#^BW<^JT  \OHK28@
M4;C2P$B4>@F'.QIU,5!NN6"]3(273HNGW/V#LF(7H;=GPRI7WW'P )((7LKE
M6.E_9(P@@6K%RSTRZ%Z9N?LRX6BA@3KJ>IP$SY#U5L/A__VO-=F\Q[]V_]!]
MOZS],^3_5?[\^^??;N1T$?_5C4QA7/P4)Q?_U<GH;')Q,9QWMHT?IYM#<_Y^
MZ,-PU-U)OIO-AQ>+81MQ>E7Z$BS^Z?IGF/OA:'8?[VQX<3EZ:IAPC:?^U^V*
M[TMB^>A['#G,VN'/.8P3H#<Q3/_?_S.D221.;5#,)9FH\%I;)!$+PE*EM!G4
M %"Y>Q@*$#KK>0 AH8GD/#&QVP%5(CY%1IPSN*20)5L?>]BJ6]@-ILH-BY8B
M/?/3Z35^ZQ]^= 5G5],I:F @&!5,\$1$SF(Q\]0'!03_1J/C7&31JYQOW_Y%
MCV \=M^+9[/EB=Y%M=32O-G>1J0?)N.X!!NS#$%QE(F1")8G3WQ$]Y-FX[V2
M'N3ZN)[#<>@6YH]$HV<JIWWOM"78-_-[< ?!I"BH,D31C 8(-5#HC@:(#-Y:
MT-;$-B&=7O!.G#G[**/%Z([-00WM2QE]3H2QG(D,N&Y'T5KU2;L4:=)1M;'>
M-^.IR D_&AV9"<\2\J;-XG^51:;Y_XZCR0S0-)Q/K^#VF_@\M!S?C;IK9[2@
M%['& S:&31H2VJ8"3]48B30^$QLM$*X$FJH2O.!M<G]>;6/8G0CQ_,:PNRCF
MP T^^T#[JS%L#;WNT.GS.4HY,&\H\UPQL$3G6$I2K"%6)$8T<])(P[/SAW K
M7U5CV%9TV447QVLH*:Q+-E-*''Y%I)"1>"<B42R6>S9KI5TS@D^JH>1.2GI>
M0\E=)'R0J.27^23^ZWPRPL^?O?OWU;#D9$^GR[&LSPTZ]OC0_6.*NR)?"QF6
MPCQIC-%44*FT#Y%+;BRU2@DP"@8]/G^_O?OG4HN$D&:?_'4Q=6[MZI0Y\B$!
M8;8,/DOH,3OC I'*R*AL-)&U:>F]%=)^P[DO+LI()Q3G/R;EQ?L\_'8^GWVX
M*F_$)./W8/8)ILL?._=3&!C!M<H !*37^)J$3!Q'?U#[Z)7QPK*L>VQ$NS_Y
M\!M2'1;<G]K=5-X-@GUW$-^* Z8=MI\ACO"/-# <'!-!D0BV--W&331H;4@(
M(ELNA16\382F#[K7SIMFFJALS+S[,YZ7MC\?<UZBFMVT*41D 8 E)10!5_H3
M,CS!?0B2"(E'NA76I-BG_OWQI[QV75>68^5:Y\51^SO,SR=I,26^A&@Z1KZ)
M$2X+O(RPG%6^M.7&M2;JB:4ID:R!&1V-">L=KC:K^>E'G82N*TNT<@'T!BJN
MOI4&41DEK%>HO!()#LJ14-JK,2\\5=Y0D/EY+_3-,TY"Q;5D6+G$^<YQ@D[7
M=[2D4;!O_6QX8XTLP/XVFUU!^F4R?>?C>?>MQ8\7:@IP,:+?3:+,!O<B9XEE
M/A!A?-#*)9I4G^KW"E!.@2F'UDC%:ND--LHG/_TX[>K(4G=SM#)5!CXALY'T
MQ"9 /YOF0+SRJ51U<Z: T@>1C/K&XC9PKYU&K?30H!![?>&+*P4!B5++')YN
M'!=M(",\80F%'$0,@/MBFXR3C7 .=8_7A@3[2_BEW.+=;H<?<T?JM]=_'P__
M?85^STU4;S&6/MFH\"PEGH-%9QF/4FN=0^-8N4 I.LZ-AK7W17BL&[P*7'BP
MQ33028-KF <X[S2VZ .MZ?7=(^".<WW71JM/46=/E1R8-91[EY-,1-M<)BUP
M--HYE!QF/$1ESC;R-@5&!V?+$Y=W1R?++IJH'.WZ I=^VET?3?)9Y\W]#?QH
M?A[1M/H__UAU'J1<H(L.!*@'(JTR)"1GB./,6.X9B[97KZ >SSJ\Y5I-,9.&
M4FT0$?\9IL/OW5W3;^,96C]=YOJON.IR?_GV^F^0OI7 /HRZ=<S.AY?=.Z %
MO@34:Q)=>0=HX,2CH4V"\(K9Q&DT;7:-Y^$]'4/E /IJD.BX =;RW>H#K*G1
MLA7:<4R60^AWTE(Y#<R7[0!9ZBKW%$E:92*9PJ/80R+"QB2%!,5DFRS' [/F
M"=/E19%F%YTT(,L'F-_>/2Q1KIKU"1-U<(F IF5PBG7$"N%*L;CVCIM /6O"
MENV8#F_H5%+<I(G46S166#7_6MQ.G4TN+B?CF^9?R'EF:+0DIUQ> 5]&U@6-
M=AA3$27 K:!-*/$HK-,Q5^I)O^)EX K<&J:5M=\#5%.+9".L(W=,W%]]DU:R
M;W"&; 9GK JFS&NRJ:3LJJS0 [2JC%]CQH 1*;5)<SX@(?IV4CP0'W81>0,>
MO(GQZN)J5&Z;?IE,8?AMO"A:C==OTO^]6AQVOXWCZ"KA<?=I,NWD/U\DMW3[
MYZ14)T[&<Q0S/N/;;Z4?,1Z2*]>_I+XQ@VN*&@]<9='T8KA8(X)W,2NF:9M^
M'6W7=7B;I@)Y)B]6\Y5GO;SY>/;;G=6MO(0'!AS,;M;WZ%)4-C)&K0C+I6\6
MC4!\,?18"$QFD26C:[OBQJA@95BOF8/'UE*#C?2M'_EQA"_G //WY:=7L725
M\8<#]T3'X(E,Y97P41#FF*,V)"]EFRO.;8A.Q_2N(O.*:5J/X5J^+7V0-36]
MMV,[COU=1X<]B+&' @ZT7:QN5(-!Z](#T;84$/A2.I4A$J84CPHX=5R>!#6>
ML,0/S8Q=Y-ZB06J9B;;L&'.GE=+*G!)4)]9U^BA3E30NU^5$2^].R)HYD5RO
M6=([D^)16(>W06KI;[UE:C7A5VZ1_B6>0[H:P<>\.?7\X7?+,+WEA$[CC*#4
M)))TQA<E>T]<E()$KP4- $Z$7JU\>C54W@?IZS=)#JJKBHG !?<V7"L#OP>R
MZIW9'\=T^/[LA]/MI*EB*O=R?P*A Y\$L-(X4N&;9)U'GXQ'!,PDJ*""$+U\
MGQ=+F4?ZNK]$QNRBC^H#E>]G![U_?[;^K=5M6O*)2\&)8:S,E8Z.!,J!&">H
M-U*IZ/I-6>[YP,-V?*^IH4EK\1ZI;<+JU5D6T-P.OIO5[*/P]%-:-%;8<6UK
MG18@..HY)*YYD.CO^"!#S%)QQ=#ZS71#IX6G'[CW#0*,RL !2.L/>']3%D$=
M**JU( *0:A+W,.*]UH1Y9APSR$+9[![@273[>FY?I^!G5]/K3O:+DJ\W$65?
MZKLEQ=<J.R!1670=G,2-/./+YY"8( 6^:[9-^XE'0!W>:ZO.D77_K98*&F1G
MW(.V O7F.TKC&YQ-9O/;^BYCC0;FB2E%7C+02-"]Y$2J  G_Q4:7VU/E$82G
MSIM:RFG1 [_@NUW]I^GDV]1?O+E"*V(Z_ ]"OBB38-D 5$)N2TJ"]Y)(/.=)
M4&@^L "(5+I@:)LP44^ )TBA%JJIW =B?>%O+B^GDS^[#NT_3T8C/^T*35?E
MRO-S/__=7_\/S-_"I^6OI+^C$3*=GZ^6-_N,O_?+9/J'GZ:!558FM+2(=[J\
M$1E7%A6R)'L=6!)"F%Y5$TU1GA#S7IA*&Z2M;7ZG/D.1^W#\[?;ENC,3>_F:
M,:O1@RK9!I:7*FDNB3?H18EL//?*4JOA@#M@'\R'H^9+8TZOK;2ZVAN<S_?L
MB$Z *V.B6!$+;W^ 'AN* R*)#.')S#0)+J!=RJ064C,><IM,@#[H_B)A*U4V
M*#;:XT41F>8H(1"T10Q!*3GB+?I%U@:5@T_:JS:WR[7VQQUSP4I7_(<'\"!2
M]/NXY02-$(WV?)EZG 2"5LXI9Z.UZP&)S3E=FS_^AW^9:HF^07+.(V;9XOI/
M1B&"5'B :(9OB$J!!!XIL<*!TYFKQ-L,0'D*V:&ZFS1WF:JJX*7T/%E;R<H/
M[&YS8FD+@P<%[<J.3!*DU#VCK:(D![#!F38'_W9,Q[IQKZOZ=?NQC@I:Q&\V
M(EO=X_; UG;FZ2/HCE254TF3O0BRAQH.3A4KO=)X EOC\"SF61:[4Q)&N9;&
M9>%,FQCQX2GR5)W.,1BR@_0K7Y]_O(3Q[W[Z+YA_G?KQS,>NLG4UGU,"31R]
MD0#EAL,P29PWB3C)@XO:T+A>];O1F'WL&4<8<%I-$Y,&8JQ=LK+U6$13G5/F
M5C,/:#*<IC+]NUA=3 *Q&O\3++7@;8YV?3C?-K>ES^-.1.DMA%OY]7X"(F=+
MB"P:,#Q$H@SNT=*53-2 /$TTI9@0IDM\?_VO'O=CZ/]9PJU\0[,=XB\0IE=^
M6G#RU3ZEHM:9<>*$5Z7TM/#4^3*.&;)A"I39CP0/GWGR3-A3S WN0+:6/S!J
MM0%<K5,:<26%'I(TGB3)E3#1J 1M9B>^M(*RIKYD%?$W"/T^4@#1!]E?M64[
MZ[!_!=%S%'#8VC+&8]!"9I)%&5!0BJBLYX8 !>7PQ#/4I).@QG-KRUHQ8P>Y
M'[RV#!Q54>1 P(AR=QHU<3DF0KVR*=%(G6O3]>/UU);MI+^=:LMV$?[1T[$7
M*>6SX?A.X?YB>9.+RRF<E[>O=&C##X-PIU- DZSM/<&T3>ZN*:FU'/#,M/><
M*T^Y+!/@O8J&<9X4+^.CO'LT!WQ/7!5"FV_+?6/Y8'S48M^=3@NF<@?S]OKV
M1S[YZ_*M-^4.\LZU$YKANICZ7@I*9-;HGOL@B&<\16HSMZ%-@[O]L>]]<5D:
M9MQKP/+)ESWE \P_YJ_^S[MWMBE:$S,XDI,K11ZL)!MJ34KE@#!4"YK:9$'M
M /)(/N7A^/?@VK.1 INT%%S?0I[3"FC 64R(&@C"E>A"TXQV5<##3>=HLC;:
M\#;30>K@/T+.:"N*;,JT.ZQ^FYFU#P^NKB<LY$D)"<21G\V&>;@PYV8K00Y8
MSHDR2"1;8XC4J23T R<*F#2!1V8;M>79 _3I\O%0FFP0D%D']@L*L8=QM70(
M/L%T.$DW:]$V1N\=)SDK5?R,0)S%_RAG;88R5#FUV3!KKN)T:7HT73>(+S_V
MRMU@%%R"< "DNQ>5L9@[^#V2K$ GS?K(19ORQ3[H3I=GU773((^R#\9=; DI
ML]664F1"-X(D,A)TH,2A70W>9^=4&\^N\D)^;%:VTGB#V9?/7LY"N@/%J4XF
M!A*IP_T;HB!6,GP3N16&":&U:7-6[PG\+X+6T&C%"9O=S?1-S]W9U\F;E#J-
M^-$G/TR_C<_\Y7#N1^_^A&D<SN!C_G0U_SS\=HZ(1; E1$QLL YQQDQ\HH)H
M%X$;[ZEG3X58G__TTR/2@33QD#OFA01LC* FX;Y,?"XWYD%;XA5/:%. 3TP&
M(T2;:3,M C:[2[%+"EQ,#;FE 1+J85-B1%?JQ.!G6/SYZQ3WF(5=)A,U7J9
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M@W52YO7*PXT:W^69KU7QS>3:()B^0\=BPV6P"12AQHDR1-@3/%\T8D[)9"M
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MT-J0W0&^EHY:KQT)TEDB$2?Q-')B@PO&1NL5',"4.#9_GW"13IB^N^B_<H+
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MIK"'4P$YX5;( 2>2+#9*\"K48;II_VKV].);/"!X@"()$"DF"M'0#1%:-KZ
M^TYANSFM/D"W*&DPA5RT*2GZZEC#JO_CK7W[TW+1KOKSKT5O%](7%3!9,(9&
M;<-R(7AS/U24Y9"OOMBZYJ6Z\M[.M!U-5;:E>:DUQ-V-K@&[6,34#)U%*S+^
MZIUAG^Z0@':F@D2/(Y>:=5GW7\N/#F1I>VN%2+CK%SB4\"!K7E+Z%A<%K=TO
M[AX5U8V^IP854VK-\8YN" X+C17+=T2+>SZ9&2!;D^NPBY-PT_TX*F#(3GJ!
M&9Z94)VW?4<(.#C32#!_U=P2SJE,6)8_PQCA?/'0EA'!@-,XBG%\RNG&SI]4
MIXY]OF98(LV?T@O!0$JI "E[.Q*ZGM%%R3"]]I]U^$4E\GQ!(:E_L!2Z54'F
M2Z99)CT52/<90ZZO3?X[.AHSQ@.>%B:]\2VG(8WMS/$YNT5R>.>5OR#8!_X%
M09EM*I (XT'.T=8V,APTLHY5.6R"5,:2V9/02O[&1@-*OE3@&3NH9#8B/Q0H
M?F<]:-S?1[%7G)O5[21JA)T< C+,$9&"B&Y]L<&2 5-OY =Q3[XZP4?=1HO>
M.Z8="*D:?%;\OI/0JLF4YZ'5'?T0!5<^=#O=T7"W4D!W)<O@-_4BG0(QD>?[
M"20.9UU"3BZ!HV.BX'FE(1?RL\F#++_+CYA92NF;5L@1""DJX$IB)_0GELA(
M+]@;%\\^@.RTBORZ'^Z$IAP)'I$]O>7VIX0&2HX^^8NI%IX'>'H2R-EXOXAY
MT(^H-QD2I,$^IBWS\:W+:]T/CNC'[4-]A8H7[AIH.U%8BR*C,,Z!R\59\_V=
MIACP^ WY@/( :T!+4EG(G=/@ @7K0X/[.S0:Q)'"+?Z#!O,6T/_2X*#/G67H
MENIBP")T1PW5<XQ:@+7JR2SX/?,CJ1<RB/5HMCQY+US]\G&)?MR>/%96_QR)
MC>#7HA<:QL/K^2W1\M1MC=,O*AO6TRL*@V1YZIZNPRK$<HH]/XPWCN[WV&:N
M'^:_COQ\G.Y8]64!0^]M^]C!2[L*%>Y]<@(_92SQO&T@*C4!=)0/XRQQS) O
M.M9TW9-H.T49=<0G_G&RJ@7?W?WJM'J+K:ADN2*K!)2][WM)(@%;%/(31J!G
M'-DO-B +N*AT_/RN_TH>:[6/B: "Y8A&]1^!N>!C!83%KRVSSR1&\QJ2HA//
M+'9C>>XH[8X93]O9U62L]RM'5(G<@S^-!1VUUI4^L%'DZUWOZ  MXI=Z.$TW
MP1M0@@DR'L;PI*/A['%LRLSX\/5FTMJSAP\/CQYI[6%RH+.?83MJ(3*41E_H
MGARF$:XNCY)/YSD0'F=^BU6^]_UTDFOI9 =<D&;:M.5(S6J![&_2Z#Q7Y?&2
M3>[S'AE;=.M6Z.L.L5?PXJ'/VW*N\^^$AG0V'[2..1[=<C02]YG=? #,'L_B
M/B &(0P:D A];1_%1[N>FIX'R=J$./YK4_SD)046O-YZ!!Y+2JHS(B.NTGHO
M1C12!F#T%=LH&/ND8<T_*)O(\_KO0HQZ.5M"EHE%^E9Z/*68DB[7I@+G=Q3A
M6L*E(*?]#3T[2+Q#UY)="S9Q8J8%*F$?@OKGU59RI.-$V:FS=Q7^)#>B_ SH
M,+\LHJF P 58(H5MF&26V_]G8@K3+PK55>/T3>ZZQT8Q:D0HAJ#:JBG\.+\]
M']O?Q1KBHMEL<_Z1106,X4HXI!ML@L:&LSS)&9^>*N";WO^4RGO IO.T^;71
MX4N$JT9_]A*A\Y;-9Q+L]6CZ@[1FFP/!)F$04@KI_F\J%?\O*F6P&ZWCKG>=
M]Q'KMQD^Z]I06A_O'AGRYG'=N>\G<=TPO!45.)()A9)C^*G %2]PJE(CZ1,Z
M8%O=\XR+HL8O4A^FB0JXPWX%S,UT0*/TQ0CFY6=+ZS+S.'Z<JZJW1DD;658\
MU)HS0CJ )[ F6#?LQ)LYY#,* VAA@(/;^Q2L505ME4]6J*5%=V\P&_ -I,0V
M36KG2 OD;:B&[4'UOM^-??<T_,%8]2UOBF0U/H\2MDX%0 DTR3>=(EGYO]?K
MMT$?BTB:?^HY(&=U:2'2%_6?#4W0R0=.2R Z8!^>5V%Q \\3^9=LI;B'&C3R
M1=^8#Y_DO>P+"=B$3&N)0F.>.'DG@GZ$J%:(L(K?65VYXFM%;0_6)38%?'-%
M8R\?O0R2+&0Y> $VS# B^->:%&).91^?2'6XJA_T0^D<P,NJU6DA%=LP:IYO
M\C8YK.<@O%C1.OP#8M[(:($*1%-XP?P",JI#FRFGC%?$-@<ZK5!7<Y2%EVYR
M)AR2^#5;0XO2+.;T$#2%!_T0JG9Q,N!Q$9EK/LXL[H^!X2TMZ$.JID_KVDDT
M"8S4Z6B_]HE?D#VW&+BE-+TWDP+E"7SCKU&07,&6[KN!]&@7X;'BN(_06.E8
M*%7-<$(8I<ME_K'\$X1\??2%H'G 0V.MK:&P]3!3Y E/?'*O?&;[=Q8K^#?-
M1WKJ,&VUC'LBO$9,%BRK">0(,)GH E<!D9_Z97,4RL=\(],E<S(4IRKB2KO3
M\F@;=3GX78QJ@NZ=XG5C;\DT+[MAI^(*6- IV20B2^EO5&O3SS,=]_S/$$-6
MIT#E99;H5A.H[;OM@>-^"ELY09$*F(+)7T UXVPS5<M*[YIYWW\>=UZ6#;>F
M1&*-0S ]/* \%8CQW?=+QF4/G57>Z]6^ED$@69UCQ^9J'/AMWB4:F!+U0"7S
M464?%^S(MFJ:R*8O&SLAJ2).)K>3!=GX5NPH:0)5V4745MQ$WTV[IY?BM*D$
M#91$MZ,C$,Q@M==@2%Y;9G;2J]:IV2YM9+WTB[9=3);N4RK V#6PU3#> )E/
M;+STHWMB[;D\*J=E1(ENGQ'W@73^[X^7< U"Q;F.HJD?<V;7GG$)[F0F^B\L
MI89TC; ?A,&2D3S;/F;M^A?QI!>?I_K)!=S"Z[O^($[6RQ6OMF1G]'!UZ77T
M4[02=AKA!'<@)^O+DF3*:D8P%U;VDZ4Y7ZM>Z%)CM"3=^.C+,",XYYJ>3;X'
MCA,?P-7QL)A]'6^S![CVXX\#NI:W5WOD#1]8,2]#3DOL]B)N3ID=),8_^%6V
M_9AH]_Y''W#0&]YDE]!^SV5:^F+9T99_=.N<EUQL!A6X2DO\H#RL_><Z$7("
ME-H)RIEHE\]U*0I84CIO?S/T[&:<5-%TY1($;Z7";::YL%],N+7H):9[0LDU
MN7M'AO-XSIH*-,<$P_ W>%@=C4M"?G:HB-ZY_C[1+.7J6YUR-DE:M+FOZ$XF
M.+^AQ6YAT B:U"3^*P1C\>QGV-RJZ"?V2T3=5SQ'O 6[&):)X;8_6Y/J*XW)
MCK:&Z:/%B.ND>7P*+:6RXA(JG%R9L.7;+G43C>8_! G@//9QA9,Y5X!AV8B*
MF_WFUGOC^51NFXR7O%=H>Q$2!%.)O.\W&=DU-Q.G A==R+LTM*EO*FFEL<MY
M?EE:P;G>[BW?6T[.1TH#_>=NM;=JG%&J>-J@]^I6JW6&8E^WT4J_"8%G4J>3
M-P1Z$$ (^RG]<2*F^N )>VC]C2!>Z*Q<_YS9"-;'(JK.-]NW*\FG)/;W3ZX&
MJPO),W1!>$0-YAG6&S*1N7X0C?,I?G@JW0)?E=,S-K:3VN2N*^H8.OM(ASX,
MU[LT'A@Z.K\D+MM?U!O@J"=Q(8]-01Z%CC,A*]!LZO[*XU\D)0)W@?2+K(E<
M/O3-U*]H&A]V?%K%:7?F>]]UYW!T=C(IO<KIDAE\3]":Q^HZ9IP*C._.)<!/
M@:;O0[PY#MZ$:/ZFP9Q [^XE4A^4_?@&I>+N%:NFHB-GL;;ND"R'"5FX#6U)
M]*E 6N(L%2 R0RG)7D?BS51@1SL$26D5HJ&VAO<Z^M_WLC 6*O#OBUEON^_3
MM.^IPVU4X(#W+^X4.CWU(R7FK?1#-6CM'QOM5A =I'#PJBNA? Y1,/>STO(1
MX6@L0*K,_/U+O_ZH#3/$A?5CKNW8P)]D!<N8XNV-3Q[R\1%,]N:LI [$MNIQ
MV1ZF'PV>QC7#2M>$9D[L>?N4.?I4C0Z=;T:D]AC5'%D,6@3 =%(7PI.-#,),
M_6ZMU<2I'HQDRHMW(:\N40$6N$L#_K 5+0R>F&V8L"V5R6%:.U5CRYBZT8R(
M;%@8B[@6/G6F\TUZPBCZ;5_1VNDO.K_((60:I"_BX'Q4P+$$NO?5X?1_-BCM
MW+ C=EC8':&K79"_/8]E( =4P-9OO-Z>G8T*F%3-(G%78"^=_WE+V<1NI\,:
M@K/#J_)]7>JJ$_XP_$BYSUV UWA'LV-8W#'RGB?-X3@@H!TFZ\^,Y<?5G>GE
MF->+J'-%7W<GKT:2,Z[ QI>;WR<AVVMUPK))5(",;9*LCM;7_;UFBR^MP/D,
M[=L;(D/T[2".)4@^V-=SDVUN[%<9C1E/7_SH_]G&<@58M0F4Y#$??<VU'U,Y
M9[GS>MZN,UQ-*9T-%?+0M"1C.YR;%'2[+.3VW%31@H_%#YY?N+F?) /R>]U+
M?LJ<!PYA%_,#:A%.J:X 45@1FXSX%C*(G$_&G8,N=2+)0J/N%GC*ZX\]0^.>
M8U5II1/.K#9L5J$G6,RA)@/W[644F]5*6UAR>T4VGI159A@6O7"K]6J^F:'T
MNQSONR:J/PK=FME&SQUJ'//0XFIC<GJKOA9G?D"8WX@K*-;4X<>T(KEGIH4^
MWK? %V8'I;I^S"M.SFC,+OO)*F/-2)P-< *G%M:M]>+DJG1[L-(ARB:83=4=
M+9Z),\%PE9%FT:-T*F @2,C*G)F"9B 2INYT!(JF>(Q9Z]ET7J-!3'38C>]4
MX'(5%<":4@1!-"_^[6Z/2;MB0Y7M+W*ZW+S<RX$G3OK>]5N(L",?<MO1K1M^
M7=TSJ9B!?M"H8N8(_S\?%$"VZGQ"]L=@R<<P/(860)\'W*)$0GE A0$J4+).
M@2.@>!X=\ALZ6,S8Y4AHF (E!B:';+DI$T10B+Q8>%'%5YN3"IS K4@V-MB6
ML<XFW[ORW5I$\([EP-ZF_8N9VW><!8F?YN7@[L/26-_ON ,][9N(0^GJ+T="
MP19$V,3D[^5@*!?\/"<:G[8*E:$"75-ZJ,,Q[!,:R8!_IUCB38IY@(EZ(N#R
M\\/J;-2+:U_=CVR_.Y_3$MQZ8(_"3<%4BD+&S6UW1I6Z#_65_J8O1*][AX,I
M_!I^_U-@&&NKUZ-6M$8[Q]"-X/N0[(A5V%O*#?1N+U8&UJAF^,UP\'ON:"Q[
MZHOPY/O(5N'W@93V82Q>"(HOZ>$.5%91==/:#=)2YX;$JE571=?ZU1X-$KD1
M(U8DC=%9/#1^2R3$^=C1?LKL\.$GUX&<[^UDNDM;WE,TC,TW<0,U\P286D9Y
M20U4@,%N!(N/61$/(,<5(&<5D3'.#4,/*Y6>Q&X-<7RVRTCQ:/O<)4&OE!*R
MHFOM?S,F9>VIS^W9_.@O5JL;1$@4Y1_:A*G =KI1JNJA..5(@YCWK^]1@166
M MI@M/X@^!@027D6BJ30%X!V]90R*C",;3_:WK>%[1[BH1P-\=!E6L*:D4=)
M6QS]H0*'/S"_(: !"4HS(#W:B>X6Z33-HE1I47"/89@*X 6AK5G'[=CEF7G(
M6A%V>7L6[O^OB6>U4K2FBK"KI:XRD)W>0MKPD5$D33""H-[F+%&!STF^6/;Q
M=J_*[[V+)9]<Y0?*4J4>-S,H<*3O/L$4[FU*M5VWNR.N$Z81D,G[SV>VP^;"
M-][+^2G(.\<CKAC7U;E,S.<B@:5=*$N@#X_5@*ILQ>@%8K'VFGI<[)90/.Y7
M(8#4SN] K(-1K6*0A/>\Z]IZ*87"]QNJC"]3@::(CD?!R&^XUK#5GO(08>.S
MR'KNP2-ZIG!9K00NQ$Y.0;?U7&@\9:U@&J$6>)+;>QC!1^E#Z("#GSN$HCXX
MGLWIC=<P_=P35):T$YRZRT<>_8$9_<US$ )ZSXT+F?(PKI1^+U#L]_C&M\7!
MX!S!R3?9FMHAUB4&?$VH 9X /":=U;S5XI8QC69XDJJG@G,^F4>#C*8PKLP
M)!ZAN$_\ 4_/G)B!G6MS-$WBWV"YK&/WDZ;FF^@8)!_E))AN/'(!RN/DK2\V
MK,)*6Q/RQ@=;OU>OXOI"&#)8(F#!EETW[/IN=EKGP=9Y[)^B;9[_7+5K"[<)
M*]N!,FTK^SZ9C(O<FO"V7]!QOI1WNMOHYA5)+S%R/T&8QG(+C QW!I[\MF,
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M(P@7R'1 #Q;XB>8Y3VQ?[7:21#S""+VIQER8@-ZJ?/*]V86W>6*?VU7>JJR
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M7A8,L?8C L/S% <2JB^+SO_C=LZXYZ6AU3B]7Q?\4O6KVD301**\A?V\E05
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MZ7(=[31=L^'PV:;US[7(-]/@5JXB^"WVGSH#C7H53:;K*W=)XUI2J':BC@?
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MWQ4<PML?"MU':36<%\-\$ %<Y_BIQ3=VKB;1EZ27UO\^C+!@%DQU4:$JKL5
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M[P:XO;/O>#N?4>8T_B4G)UN([PWNK6LS]-PJ%Q*/*(<N5="_G^-">'#<(TD
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MG,:213_AZ XZ/RW_(7+A0^'ZY7/8(+V?O."1PF,[OPZY<"%$*Q>+OY<$3!0
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MPK>_G?_&A?\#I$KE\"&YD)KU=J+ !*K""IPEBWA2J^J[C=XTTCYI.@@)RRA
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M7N>S\<==T_ PW8H>]0SMAEWJQ][NRK54JI7042MH_,?'MA"'@>8S+ 4X=;"
MYULMFF6MV5D4RV)-COXBH_L!S[[$E.;O^*1U\,CHI:./#R2].S4L6;WUC/*&
M(24_@2[;BMBA5R)(AB8NP;0HR.Z39WG\T#M3:'!??^EN5P_D:9@B9C)'-$Z(
M[X2<( D1C:6=@X/JFT5S1)S!*V0B2[9NK%EO[[DIFX'E:7;:/<.778NCX_=J
M='J,5CMU2R+J_Z@>.&/6\OI(1""6=@TO8D8&0'4<2S+N3'_*<(M#R&.6??[U
MTZ)AOE3-A$<IXZT0LN7X[M-<R/FO)Z_A0<WPID)>S&TV 4C9QO*TE@IO'-/$
M"ETD2V2*U8S<:H %5II8^HTL(LZS/#8ANA=\#_X63\7P?"Q?.LZ^%GQ (USO
M:[A UGHB:QNOGR,;YX/M/EG\5(>:<N*'5\.X,UDT4->[LTK.%U1E'*#'Q -(
M0)PSCJC"M_J*M+EHTK2B2W]9Q\@;/&(9ZF?EH4+]@^.9I!I9 XGNT#MOD_TU
M8_<<[-K^Q<$60H.")ZPXYS/(P^P_0B+QOZH6Y_#@$<027) E%<BCOK',/5@I
MB]?.8,WYB'GYAF_IB4.<H06%KMM/M50.ZNXJFE)UT]]RO-2-(_QF\[P_R/O)
MOP=T)..B7"38;W2M8S8\8EC(/#!GMA$$-*ON!H:Z*J6<>9!QN>KJXPI-<M7+
MZ>.NV<:/4Z!Q^BZ0E?T#E6)6;8<A4&_DX:5[O]TGND)=?%;,<P)7?B=:0E%\
M'P6G55G2^"D+EA2&P-D^Z,[<R>&%]?+A:!_.0=:9 981;<IRL-+_\=T%<<K$
M6>=3E"GK\C@B:O7R8.9IPY8#VJ+^G^/8OB _;1)X"&QMD*9%+UZ2#0#M6AS\
MDI1[OZH@D==)6CVP9SW&53^,M[$?V3FP\WS@/KBQ>HH4?"=F'^I^.Q(*&1N;
MFR&8T-P;/@J-6U>$Y@>&'-WBWI!IESQH\NH1/ 1QNO<?:KY+"-.*A7Y(DB70
MWWE.*F2T8C2&?L(KT(*D\1,F3LB-BC>ZM@O6N]JW5E9<Q)S=EVB/$(YNE&C:
M"?*T=QL/44;FHF89)719ZFE:!T=$]@UX;$W-MA]]XA5N:;1@H0P,LUPUB+<*
M]0]2O=&GW;[Z.4>,T"%W0^:0VQ.^3SP@F(LH$\ SH4!S#7&O\4[/L<^+V?I#
MZM,\2\?MNG[J4UU364CQ&-%[_5!!6I2Y4L*6:5-AO\YM6#-V115.9(RGU>5C
MG$(O=8OS6(9-?[^U:T*NU9OQW-T;%?EPX?6D44>&&CA+PD?S7#=L+Q.#&0F!
M5]KFT(6A2Q/G9FUH1KB82F:XY-*R."/ BY'28'HW^T?N\YTKL;L<V9=39U0Y
M0JI3^%V8KOOB+,F7%#NJAG\)IL<%.J AY4D@2)A1C!S/5-19O=007K:1O0VM
M:/_6)MDM76>E?C37K4MY^HZX"6]^;BU6XS=SO#PE;D5?H-<C'IZII"U_!,2=
MD34;Q9,.UQT[\D[-=M]FUA_\N.^76AR.N9O3T[2?[D%5H_.8NCT]IJ7FI$&L
ML9*7OK$B334FZ)!H2+8B+3Q5-YW^/6?&L*@K5JDA4_++_E=19$KJB<W=C1%5
MQF=V,=J-]#)IM)\CS/>&M9>&C52.WNAOL2!5X1Z[-0Y05#_5_O&=:"$:*[#K
M5<RG<:FW*ETGS]P$EFJ8DCQ/V 1EA?5CU#"C4)JM O$)9N\W=4U\.4P\G[6W
M'WW83T_(;<7V)P6I%JLX?UGV#W6)K0^F+;>([?XD& $T%VY@<G)X"V/(NDO&
M2ZAIXO,XO<:'*^G:YXX=0!2,HC^RU]UN!W8;<L32:@8U,5*8 6/U6/M[&AZ,
M)GIX^T-VY\%13_DS2U=91<F3VH9VWX+Q[PW:B _PLL9'6*?9CYL,YQ0%^C&Z
M"VX.].!8BI: Y;O\5(K 8].[Q?--SC_JBBO:W_:9GOR4H.NE8O(SENW(T&4G
M<R0P+5Q(14@T<!L:&9QAE0/ZC0Y3,Y^T.#::+]C+.\9WQ4(49C(]0G='"#@*
M2YN\A:S]W_6O_VY[0P$DP<!F%X4!F-N4V/T>J[Y[18?]]8RL+WVX?J.R)D&D
M4SVQ]<B!M^K7GT*V938BU(!F"_Q-\7%Q1N\ 3+D O8W=6-D3Y:) F_AU/SLG
MQXFU_V$K=OS^D\NRD5:I@>%2UMN4#N;5FWQ6.:VFHWWF( 0Q"B<%%]'C&7AZ
M"$M:D@)$_[Q7A-N),AEO1@CI&IT;S:GO;U 6(TPT_OCBPV=V%[@W<U<20AOO
M\$N4,3VB^A5+\[F8]=83RH_WXD)$467V,"M7YDVPR0AS(EI9(C[\A*7/:N2B
M*D6^<9@1L!FI<YO$P;57Z/-L')Q4NHZ5:5 FTV%T-+R/(SR?+1.YLI:#>IU)
MF?E*GLXZL"K7*BHL)V% >M5C"E]2I9N2UJER=%5&-#N.<PP,:>YCW8SK Q0]
M%=5HZ+&J%*0,O?+8HCY2[$=98G!L=;=(NN78<6+ 45\25(^G-HW!&WE<2(?_
M>%=[NG<'82R#&D.Y_JO0CNV4VG%7[6+7>%KZ=^Q;7!@X0>OCH1A5ICU*A%"T
M]3M:E8V%H9H.#U>=OZVU$]77=V)_67_).$AY[Y6?_:/]"E71[$-7VYVR"X(L
M2;MV/#^<A-7FM"+>UU"M@FAXIX%2/TW8:;K'5=K[H:HPYLN.T""1WL) [S(7
MZX/TXS?WGZ[6Y7=#L>);X+1S1%#-XU&#>"YK;P7/OA?R7Y#"C;<7W^YM.,@\
MYGG_S.Q%1+I56-B'TB_IB9T?A/K7'W>@E-8@&W8<81X_/-3&?@,L/03QO/!<
M$\3#<=M\N9!G%S'=7 C##&; A>3/(1O8Y9OIJ.0QF^$D)@'NSH7P/)C$/9P
M+J%A/T NHB*OTK[4X4=]_#64JIZU";LX8GXIO;#U<-\64'(-N($;+>H RHA+
M.:2DT;!V+D2Z$B>G%<$ZX9$S?W+F!=E>]Z%>7J6:E/EUEY4YW9=7W=/2+.=>
M1QC%_</M:K6O !(:C5 T/L82',;(<;J)E<KXEAYII P/O%;1!YJD.*,9YV,_
M))-J#/075-2>IN@\C?HYTBH*00%44]H0;[&TF*:@ 4FZ6"V05D^:3=* V=$-
M[/B.>8^Q4S+Z&XR$YO<E6LK\I*WLM/ 7U%"/U-I*_XE]R]-86K#!@S5_20&F
MXAOF 6=3<NT>=+3G&C(_4P\^*7SKIN#QNXN.D\*;%_R!9D03%*W_GO<8'*@%
M<X!&^_@V?:G.%%^JRAEW^JUN^:RDLR%4)D3]Y_"VRGP+;1T=">L^>&7/DG0N
MVH5NUP(D8(5@/C!EN@XI8:"$!)=<T+<N-#5*:*L9];_7;7)0-\!I_+MIQ/5S
MY;EQ*6JWM#\(?D94Z?T%7_4A*OAK8JX]GR-N@5F%4\2U0!]W^2>[9#MH[%>O
MY*;TUD)84GQMDWIT' %)'"&0Q+Y?H!^DE,8&Y3M.E/O'MVSH$I;6Z]9Z!7^<
M/9B<+@7K"?AVQABA-^7_<7DDWIEF016?PHXC*<36"VJM^-T-;N27@-A\755!
M3&Y-'UKOM6.%U0XLTF=82_?QL*B?:L@?NE\%O@E'O)FU%MO,@@.0WKN(T)/B
M86&D95"S_67!0I/N8 *G]C[@[JNX8'M$F+#5,O#MIT7_K1)EIA]R;Y3Q!=8?
M%1S'5^ ^^L=@RWD1:SOF*U;HUVP5;3:RP0CY9HY^KCGW:+/\J]#=6^K,FT-\
MT%^^A WWQ/-6F@&RZV"RS(M.)A5H=7#KQFN4P*J<M33JW3Q_R5".#"I,;??E
MLP>>W=7XTJ^=E3ZWXL$ZOWDH&O-]TH#]Z#4[[1<"/++W1T9B5:/#S#+%HGVO
M*3DJQ""3I?VI8RE]R(9(V/%"_-F!B&*SYL0#LJXAJL]HO/CLR!$NRE_(WDWK
M:.5"0(WG@TU[YH:'K(I!\1:@ A-/)A3.!_^,FB^;='"6\WF-ZO\\L9W?YO'6
M"&/Z?_0!YC_;G^W?W/!9T']A18-5SOZ9("X$?IB]PH5,BW<#E,-WN!#61A$7
M$D'@0E+AKQ?4?G_[>UWQO'](2H7OY:AA^N$T:R($[0=.4'!4O!02&,./W<>.
MW*A>;<BR79F$3XR_-O\0=VCXATU6[0FEU.E9F-KS6ZAK+@VO^C.TZL9#O)K*
M'#S#7@C*_4";/4E7$!,J/%0;]OFPO6Z=Y>*[N7!9,RF[+U@G*9NKZ MOD2=M
M'P2]!<,(U'>3A%U(WQ.:*9)WB-]W<"%'L(%M$)?73><VB[WP?#]'@ >T."KH
MRR"4K!6#4:%9)S3M6H2.<@[1.N(=>K].6^LUI+0,]9]+R0W\2*\5C+Q241+.
MQS1GA8%A3 V6 !V@RM(1EY#^.T MPOK)ZG=TR"T4^4E-AGR*P>?I;68]7WZ^
M.Z&[9<P&<1)HUH63<NK@+*EQ1E@%^VV3(GHG'1K%@K[[/N$XEV&LVEB!C)^I
MR7J5%F7;UUFV+?9 9*O$)?H3R5_.$"F[3H0B0'JGC=[.;D1OX6$ !IZ=BG8M
M1M50'E51B9%5OCH._0)904C/5*N[ZCCU125CITNP)WE"[5N75:4'.,/P&D81
M4Y/E!-ZE:1%XWCF>HXPJHMSXP.GX!I-\.S]#Z?9M>1D?GQP$.Z!PG?6)X%2Q
MG7#VW5GETY -[;@WY!)3N\%[(D96B%[HN<9L_K 2?:MG+TK^2'33C"K:U7_D
M[*^B@;\^<G*=1Z":]J.@9(,'04 L7A)FYYJ#"CO5GX<?JLJZ_,.UIKPZUHH'
M>K\?>1=IB<O&\+2O^92Q!J:?(UD#$IB:G%9%]6',7F]A]UZT(P6W<V1. HP>
MSJH)EKE2<;'W[%&WL!QDX]D;^D];^>87>.'M5L]X3 M059!H?!!]LJ])$M75
M7$=L83MTG:>;)TR%&RL@/Y26^C;U2MO*N2>>;9%6TPV !0A\?](9[>_[M[C%
M>+4M6_X]W2PI$A?4Y5D5?O'KS+)U?_8EE0^1$SGVTV8+U^0ID(ZR-",SB*>-
MBS.27C!UCUBMT?-1B MQG[BH%?,>Y _Z@#F:A>'STG_K%Z5Z5L85W4M1[YY)
M;Q?0%XTV?O,_.<VQN<%3D\22,2>0DN)Q33LPW1LRV%)DG4^) (XB=K9BU/[+
M#OG=;\ROZ,8%R,7SV^XFK$:(-QS"M4T8<$34F.B11=.K=>#+O,E3>R3SOX,W
MOYB8W[]]?.@\\'%U&8$"FHWQI$)%,?9[?SC9'K5ZIH9&3'Q3XW6S,O*FK]Y5
MFPQDP&Q W9-429G]YJ0O?+Z0C<__SYQ0\)X]8Y)D@Z4W- ->M*STZ(!+J220
MX=N]K-\B'1ZV.^4B(Z1WA8;N_?QZWX^L00LENZ]X*8#T%KZ;LQ4M@&<7&1_G
M+; ^YI 75%R]TF[03[.RT>/L@%Z"=K_'\Y0%>9^0_=0,/]'L*U]=O][:+OTY
M(APP\P"M$$EM&.E^V!6Q"I/,=*Q8GTEW2N19PB/5)ITXD#',$3E!\@TDEY8P
M;5%PQGVZ9B$3/F>L8ZPP:*QI\6XTG^$X_3[U<G5__.]U>72(]C:O\G+RWB'9
M:]V0\#PSBU#E5OV4;B_?V7/)97%[R>AVOD>=I%OT3/ - 4J[CI5%K3(JP)=,
M6=:)S30<Z,MT: )F5YN708+&+YP$RN_0S>@%Y<RQLXJKER.L9]H7/K\1U8D6
M1KT2KY[#;6%' :1<? 4/OZF=HU]%"! 1WQHND#2\*K%0%%][IO6(7L\.%X&@
M7<ZG]@ZXOWXJF# AE# <_..&T<^%A;'V,:OQ\<?DZ-U=7>JETC:G.F]:0[9T
MJD1 S="J-( C<K>4A0*7<]"'0![2W89CO]6$Z5 0.RT\7K/LFL [C&RY#_VY
MJ3POYI,6&:\:(UFTYCD:7'A;&!/)SH'[:HFA]X ]9*W1D(_9 GAZ3YN6PG5G
M;P?XPU]%'WR'>JRJ]UD7$IV^F(PY%)6WEL2$NM](;I\^<4G<^W5#$L.._1XM
MQKST'=71/-0$'8#I3"5%;X#?,/M1"HZHS%7S.L^H7N.Y%RE(Y&/[VY'W#&^9
M?G-VENW4LP;5$!$_P- IZ)C=1^A6UA4*$ D7KZHO,6@#I.^]?'E%4L025L1D
M*FASPM<2WD1+.JGTG='9??G.BWU0QV]781J4I!TH(D$^) $&+1E;N&^.<Q7[
MF5%H?UXI^N?850DS=;\&;6WM]Z[-V^1_QW.$!;D0?@L>(XI$L\Z =TEP.<P7
MEZ/T6X TR]67["_@[;)[X!<I=:&_$BG=4!@(NR SD[J%9K>]-;G]E''QZT)4
M,--NH-(*R0XS/>D^72;PX;V!FL%3XL1D@\' M3'(H>(>N<7,CN@&M?!2,*RY
M9G)_4U6-%O*U5^IXF]$4(T%QYOKKR^'. UN(52A_E@23L;XI2CKF4QV"ZE:
M/E)+NR5?6OONNMFKR86B4%TKCU"-]R');D\$_J_VWC.JJ>Y[%XVB(B @'6E1
M0%$0HP*"@D1%FHBH2!<BTFM$1(*&!$%ZB> K* A1JDJ)=*FAHR "(BV4-$41
M(HDE;DVR<S?O^=\/]]YSSSCC_N_'WX<%8P1V]MYKSOG,YUEE+CPBXL36BS>_
MA8;OA)\:_Y\NYML4=]@>R@:#Y(91OOPPN!V?JHB3!7:'^%6Z+ANW3*\M_2GI
M'+#PZ.DM)OSY:I KLN-\=*P.VXZ)OF-N#LA2!SLW?L"^]OUSH-IWIWW P1V!
MI1?&DS]:;=7>'O+Q>OA1^F.>"2GW2N5SIY+6Y0/?I%E[.]2;<,X!XTM8':+?
M#C\UG&YZYK$"\\JZ')Y^M9,0=ERJ,VTOJ<;\VG^M6?$:0]**%PV 609>J6(U
MDK<+(#"2$[$2#--JD<N<#'.="<.",.M+C;O"63<:VA[8+R>.YKY_?>7.X\.E
M-?*-L%@+2PQU]0(O &/'I0)X!B(%MQT(88R*6=-)*EZ S_EQ;%A%67G99E;I
M-=7$_$W1,O_D.A,VS, 1UTR\+T\/.,QQL 8\1^+,?>YM8/=S[!D@SX_&81!E
MEMDASA0OXM/EL(-)BBUM1"3YT3NM>,.;NA(MF0?[1+[DZXW@??&4A&YXDTY7
MIAZ3'-<0YF#7W-G6^?*#H6>XMMT(XGQ=6_Z[[^^\55N5TAABCM<-M#9O*ZT4
M\=+G1>.['0=7=W,&Z<2N#CSW'*<B@P0>#&$58S:N]% &_LE>I)+N;9,5U"U)
MUS]^]S# =.NF;\K]L-@ 2VPE>P44?\.^?UY0;4B8\>%F GK,T7@A3(YO6UY
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MD]IM<ND^SP1EU9/B\3U( VV&0<8]2?@L@ALO*%L_ ;)3 DC@G>%O%937@$J
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M94N+4>O)_5M6S5A6%)]J6WB;;<]-RC)Y_,@\RO<S)*^H<WE<2+_'W\!W6[!
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M*-0Q4A=QF<!*^] EJ.J8Y('6L[@=$_T9A[J#JKJX]2/1^GVXLY'[MY]X_?Y
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M46S\6<%CQ"^4Y-=6;+24?A7"2.>]YU++JSL;;E?>!G9FV1YYP3K%6O,R$D
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M?%114A4+8($4)V[$C-N62"+SE^0/B40B\U__UX^'%?C&\R+-UO_V)_<GYT^
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MRX$ZY5;O#U92&V25'T?Y>&#1+G:C[ZWN.YE9YV!7$@^HT*>!HD$ZO54TI\J
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MI4E>%L5&\=.UD,,^\)RF>/49/ZI]!H>),)1S!!%^ A%S'1B[PH=!Y/(X9%%
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MJ<Y<BDE)<#!(+^EQ^(.&$6>G*H1*3B[E$^^SE;R_N/C')BV?MB<!(AIAZN(
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M-S,19@T@2)XBK:!(D( H9PH2)LU_%"(BHKGFF7(YD74;;FKGKN9;E;DG=3C
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MTS',"4+4"EOD&?+:>G0<>&I$<ZC>4POQ; Z3/];F&>+-F;[G_J3K3#AN5PZ
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MY,K*(V>0QCR%J<#8YLLKI,V"PB:,NS'?\1!>Q+8;:+AG[EN5_?Z[^+N!?[D
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MFR,(S?,<<9U"F2(*$4ZM5 >6,!,<HS3!*M7.3>I"&#2UL+7V"=1.F6@56+>
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M D24QZE7H_E@<([!TGMC:V%BL+'FAH37C9>#@38P+Q_@51D**DO!*_NE_&6
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ME"ZP96HD5+OBV4C@@JEP(Z*1 !XZV&FL!Y7Y5V#G #CT .Q<N *UWX,H8@6
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MFC(U>JGMML>*#U8(CE7V7GJZZ#PO?<\7AT#[14X8]_!;5RJAIRI(K53Y:G?
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M;3_]?G%=+V"^V>.4S^RQZB,1QR+"*4V@0%S;KI<YI#)*822E6>)Q'.722]7
M:=2ID5IEFQ]/N:'KQE#!,1N8F[;V@E=;BW^Q!1^-T:"R&C1FAV,E+Y2"\I';
MR*,RD1<8SSG([V)_ ?S]9M6-N7OUJDXTBW+!8ZB)-C2CD((L3QG$BA&D<D$2
M[BQV?WS[J?')P?ZI-=$K$#H#8#N37 [+P)3AB8B7M/QYQR^6D3]QZ]$DX\^[
M=2@/W_*IGNNBI9G%=2%L4-*<C- TRSG.<Z@I,P]OIC'D4E,8,8EE(A$AD=/#
M>WZ(J3W 6PNK@-MS 7.,G^,ZY2)4AEZ.' +RO\E[U^7&<2Q=]%40)\[$J8H0
MJGD!2'#O7\Y;=4YG93K26=DQIWXH<+4Y+4MN2G*E^^DWP(M$RQ(%4"#-GAW3
MD^5,D\1:'\@/"POK,D#N_FGE_>XL7@XS[@;BI)HO]@FGK[RTQU^9A/!YM5PU
M@;G:'M"CO=FG++6:0Y,X#$24PI &#*)42OWIZY_B1*68JDPB$?7K^.<@Q=38
MH=VC;F74T-:OD7T&ELXU/WK-BAVA#([UP)S3AKG4 +15 !]KS-FS/,>RJYS?
M=LA>\!RH8:"+)*_4/K '6*>;"?9YF'M,U*^K1UDLRV",1=.NL%[+TU H@IF$
M4A$!D0H5S&*]D4DD3\*8!8HB*U=P]S!38[RVI+LFG/91.!UX=E.9/Y0&YJJC
M /6(5^I RCX^R0]B(\4CN;U:3M%&YW'HB"[JN'FT:*+S"K2CARRN[I%0)=?K
M55&F;C496YL5D[NL$BD#@7$J8:J9$2(B$L@DIAI/%D<)0SQ45DFE%F--C11_
MRY?Y_?8>K+?:Y#!.C<H*=,C@.8/M>6[TB-C0#J!2TEF3!MI(6R>!]LA^.H.=
M0[:3/PS'RFZZ#$NW7"8[=+IRE\X\8;Q<)3M5GN4F6=[2,Y._#B(TYWU-!U+,
M8HY2I: I[PM1QA2DC'-(4DQ(*%E*B).O[<@84^/1EHB.:?A'\+/;&E^(RN#.
M\IUT@[21[M#>;];[D7'&36@_K>B+7/6.2R]UN%TMRCDQP=QJ=]:_+CT5>Y].
MDD;&G28AD6D$44)C$V/$8) &) A)I$3D%&OM-OS4..%F>W]/BR?C^C&EV<RY
MT8/Q/--2=K!=&P]0JT[E72X+/4-W3\8=5%YDVK*N'0G%<<I<W7"^)V)$_]M>
M=/.W5AC22!XW%^@&<K59B?!*/C87>$X[UYR><BDIMHLNOEVM-Q]6Q<MRB_MB
MC.NV<,=+-YJGK*MHJH,/E<11&J0X@T+%&40!#B$-B81)&C".]2XU1=%<;Y[9
MRIU=1]3#A1O:VHQ#$;SQP*[-W]:M6K&\75-6_C _R[*'7=-0>T-_Z)U+&1'7
MF[''?)]<B7^B[\C0Z\>Q<L%[+4WKT'595[@Z4QYE'7F%F1AH.1I3DU=:U5YA
MLDXOCJ\AC+N[]O=?;GZYUJ/=ZT]RN\DYU0\7-P^2YW2Q>;I9+;9EY8#Z2 '%
M&#$182A2DTIE6@R1+!20L9#&5 8D":U;##F-/+7MAA$>/)>^7*!V\H.= O8N
M2K>Y.._L'0SA@=<!!W![G)BYH6SO%AX,[9&<Q%Y1=W(9]T*NPX'L]KS1W,F]
MU&P[E_L]X.)]%RV*IWQY6Q:E7YM6NNM-?F_,\%VI^O47]4ZRS<>E:;-9+F8'
M]F^ $Q'2+(8!(P%$<9) &D0<AB)3098%64*<6G)[E6YJ:TM[C]2H5_6\6%>-
MO!L-6]TPRBV4T1*TU.R],_(PX\X[GG'G<41/V$53.-8NQQ_Z0^U>/$CX6KL2
M?^!V[#8\#N*>P/-5/NA/Y\XD%-P6LMS/O#4U4&3Q0(O-4ZOZ7IC(3"9) '$6
M*Q/^P6$6<@D3$5$D:1K&J54Q!J=1I\;P;2G[E$!T@[R;B@<#<F"*[8&A4Y*0
M,R87YP[9CSA:2I$S".U,(_>;^T2;Z<?K%;4,\]U7E&EV;[$B*J,LA2F-F6:;
M5$+]_P'4W,,4BC$GS#KXMGNHJ5%,*6UI:U21\"V!76*F.M$][X'PA]G0$12G
MX>KA8CB#FTNHF2_\1HLTNP!'QS@S&V@ZP\PZ'S!BE)F-(L^#S*SN&+9;C&G
M\4&_-W-MT DL4P69XA0B1!7,LCB )&(A%8+@@#K5NG$58&K,JU^T9)CN,#O(
M[3;70P(Y.!WWZ 9C=!B_'<PA>J_2!F8GQ"3;OQQ"U+?MRXOGN-N+S\IE?UYM
MCM;)-@T&?M5VZ6KY]R+7.^C5G\MP'K.$2LH)C)(P@ AS#%G9L)XJ%692)*%"
M#HWS+A+&ZDL=OZW>5VWCT_6VJ/K_KE03?*=_8B8 STSS&MS)154256LNS5?<
MBLI;Z$L -\><YA=KN5C8&UW]I_:\'3OL3+U&/X 9T&J MAY@IXBF6=,.Y2>C
MS,]@M02E/K!4:(SYL+>/1YF7D4SG@>?'R;B^&-<.N[O_LT<SR2]6OVVM7_ZP
M?H;\AWQ)M:;/5].WVZ+0K_)<B)0PD620<*$@2F,.B8@E9)R3#$D>D"QT,=J[
M!IN:@5Z+!1Y611.?O%@M;Z$>^QX(R1PK,G3B;&>I^T)OX!6D%O.(+5[+ZL_Z
MMD'$JZ7=.>"H5K6-ZH<6M-4]O:M"KNZEX:</6M2J[]966^G[KC)OI+;F9'5=
M61#N_8]-0?486JCBJ2R]^UFKKN_4,"S*$@Q5?=XY5@*3T(19AQF"*,EBJ$E)
M04$"%@5A'$LLYIO5AB[L6&A 69U(;"?Q<-]BI0+X::&5_1F8MPCPG;Y@M5-8
M[Y&-QG6JL0F<[E&X<K 7P(X>)S*M [-K,Z.?]C.Z5W5O_.UFM+Z^5-=8BVWU
M=H7*O5;3''H2?-?@'$S>L2MW#@W\D7J?@P_9TZAM@AD^+A^VF_4G^2@747VL
MH@B/*<$82I6DYK OA)E$$419@K$4B;9LG1(B.\::FDE;R@8B1\.U TM+N]4/
M0D.;K;L0JQFH!#65$$K !BA,:(&)7\.U8[QQ[=;SBK\P6RUNZ<<3W_1M7]25
M6#WL6V#-D8ACG')M;O(80\2-"S<. QC3# 4L2#*JG CBV"!38P8C8YF/6TO9
ML]GJ43SM2.)2E 9FARO.35"*,9IN-G0I:"'6X/<'8=K:^6^7V@6&5UHX.M"H
M?-"EZB$1=%Y[R;Y5VR9?I1%8[XA+RT7_P]M"BGRS_BK7TE0 F&=!@K2!H!DA
M"JC>A2(%"24I9)%(490%:<"MDIJ<1YX:5S1RE?$;PI#QZJ$\RN&EW'VVC3;X
MNVP"/:,Z,+>\5TKR3?[8WJR!KX99GBLQ*W]1Z3$#C2(S4#42]+V'<\!P@!V9
MS>BOL+]R .7X;LGE 6Z,)F0^O]KJ!ZV*3W6&Z#P2299Q',,TB@.]UZ$1)"(J
M"Z[S- U$0)+$AK../'MJK%2+!QKY[&CH&&C=1',A%$.;*;8H6)-"A[Y'/ONU
MY+_<KA[_HN\JO_A_(O,CK'XL/_-CSQOE0^Y0I/E4NR[IF1\G;\W2^%66ITC+
MVUT]L8PAIB0E4*J80X3CQ$3"":C_%@NN<)1QJR_SW$!3^TQK.<%.4)M*9&[0
MVAD*/@ ;^&/NA95[>M<9(/QF:IT:;-RDJS,JO\B?.G?])=X'O>QOBBW?; O]
MY#H71X2(R]BX()AQ06"L8!9BS1,"BQ1+RHATVFN<'&EJ]-#X(9Z)>I$SXAB\
M+AZ)"T$;F")ZXM73(=&!Q0!>B6.CO8)KHD/IX_Z)KAMZQ^CD&_G)E(;]N-SH
M^<_90I95U'Y?2[5=?,J5G*L8D3A#"<RR1-OZ011#*I2"F(8)C3(9!2ISC-4Y
M.^C4Z&,O:!U4.@/;4EBPT-(Z!^R<!]WR ,0SE$.?A)3BPE)>T(*TE'@&*IG!
MIRY$^T3R6$/D.Z+G_,!C1_980W$DPL?^WMX-KF51E$T=FT*./YI_>U\5X6M7
MH[I:-DUIU_-(<D$SP2'CA&EC)E"02![ D')"",]4'!+'?M<]19D:<;7%+/VJ
M==G"72E#:CIITH5C4,X%<V7';./,P,!\UPA<NE>;+MCFY]TO:E5FX,4\O3E7
M7K)/E^P+(?7=-+NO.&/WT+X0MB,MM2]]XN4AV4U 3#W@7$8RE0%*(0Y"O1\,
MJ(0,(PZCA"=Q0)B(I55?%(NQIL:1C7@FE:%JC++H6^&_"V%KD\X';L-;<NU0
M[!V"M:3#!&*?@&.P..S#\5XM#/N$XEU1V*=N<4]9_$ZUO7=K\KW?+FBQ77]9
MRAOS'ND]Z(TL'G,NUY\^O:U#,I)(9%2E"8Q$&)NS[!1F)LTC#6,>Q*%2$56V
M!2]<!IX:I=2REROY3GK0B \:^8%6P#ZCS6DFNMEF2'P'IAX':'N4SG#"V#Y1
M<"BL1\H-](JY4R9@'^ ZDO^<'C=:OE\?)=LI?KWN[V="ZMW^%]74=EO/,X)%
MB$(&%:*:[TD00,)B#@/.0B$TX0?4*:3Q^>.GQNI:.N,3W\GG9AL>0&=G#O8'
M9& :/L1B!JY7BYP_@3_J_PY2,O(X'%XMP(,A1C7ZCJMW:.>=N.K20KOO:;'4
MC+&^EKM"\3G7F\]W^6)K*C@<M"A)$Q1PRF&8<@E1A$*8T93!!.E=8Z9DB&.G
M_6)/.:9&$>W*J\P(7@4S5J(#6:L&'F1ANHS<ZQUGV7BD;ZE<MSFSHYP19F)@
M;FI/0J,#T$J 4HL9>+.;F%J3D<K<]L)SH(*V;K*\4NG:7H"=+E+;[W']>+4L
MCF;<>(6\,PWA'N4^J^VSW'Q1W^B/ZZH"P-5F4^1LNRF'7UW3,G,_9!%'BG.8
M!J9O.^(44D4)Y&G*9( #%3'APJ\7RC,UGJW*^_&V/D[MC'U-$PLS0B.&8)#P
MN*KP205)( UIDJ8)#G$6N*20CSE-(Z2)GYXF0%OBFVI+O_&_F>:UEO&UON;/
M;DD<<58&7AJK"7FF"GB6^3T#6B&S<&J5C$U?U2BY.IBL2B]_:Z0G@+VNE9?*
M-.J:Z0G P[73UV/]E1#*Y;I5DF\7FTOC2/(X%9"+C$ 42[U<BH! HF*9QGJ?
M$E!Y:4&AXT-/;65\=C1SP?'5&<#=3[/\P3CNX5:KSE M]PQHP0>)F7;':_ J
M1">&?_6:1-VPV%0H.O,$]Z.RJS")WV^+U>?51II'?N&;%9-%')B:O/69@>14
MA3+6MB(5^@\>F5 EF<"(825315-%K"J?68XW-78*?TGB_P!&:%!*#83^DFJY
M01S,@'WY8EO$SY^$><9Q8'IZ >&[(Q#V./JRP=+^Q,LSIB,==%EAZ^=DRP&@
MC@,MFZ>,=H[EH%+[^,KE-O?4U1O)MX5>O<.(?<LW"SGG*DD42O6676 ,49(@
MTY1#02E%(L,DB#-I=69U[.%3H]M2*+.;"Z.?V,^@$=<^A_4%>MUL>BDF U.G
M*QQ.R:RG].Z=S?KB@:.ELYY2I9W/>O(:=[NI3&S)^4:*F\V*_^/W9;Y9TZ6X
MEH5:%??&;BN;<N]_6:]& 4XR;%)11!H*6'I+21QQ*(@04E!$8SL?Z04R3.V#
M_WKS>]7B[UK_8+_V]YV!\[;5"+@.3!I[#4 I)2C%K$#>:U'WC6]?X6Z"]9T&
M>[-LA.D8R50;;EJ<S+@+ >TP[?H^>31S[T+5VR;@I8_JF7'4+HW^<<D76V$R
M*X\52+\NY /-Q57=]:B*VV^J;"<A#:-(<LB0R9"D(88T8A2&E$6"J#@4Q"D6
MPI-<4UN;:EF!K&*2JV]U9<1V3#[R-&UV+LQ7F(R!%[3#3@\[I4[V>VAF;M]8
MK<EF\EYYW3/<?E.6/,DV;OZ27T!?)#-Y?KQ[\]_W_]SJ;<AO<G.W$A^7CWHE
MD;+5?C:504@%DA!CG$(4I0FD2C 8A7KG$A"!T]"JY,7YH:;&MY6$U8%%SRZ_
M9[#M9E"_B U,BNY@.;7SM</AXAZ^9X89K7&OG;KM;KV6=_0S]+[3(C?GTKNL
M*$U-FZ?/J\UUD=_3XJG*K^2Y_M$PUV)ENHBM]X?+"<D2_7]0(*$I1%MUID(G
MAK$,0Q*E*0XSIYI:EXDS-9IIM&EE 9;Z5"VD:I5 2Z<9:&G5NTS7A7-J9_R-
M-U,#T]OPD^1LZ?G!UJN!=Z%(H]IU?N [-.<\/;4?3;\M(^++37X9G[N^VNKE
MH,C_)<4\R"0EDE"(D;;@4!9FD)& 0SV1(1*(9(%;/&S'6%,CV+=UHH"1=5;E
M"^B]\TY<\%->9Q&L?W:CT"Z\[?C1$XH#DU\-X$T%8"4HV$OJC](LX/#*5UWC
MC4I&%HH?,HW-+3U3FLSC2G_ALS(:1:'?B;(W[)NG_25U!-#5G[30.]6RN<QW
M8WR:;:I)GC<^R6^K[V4JO2QXOC;L^'>9W]Z9:Q[UUO96?I7&1M7;7M.JQO#@
MEBZ^R>(^G$L99I*D'(9<$<U:"D.*$86!"G@8!H'* J<^A]-1;6HD67GXJP+^
M:U#N'RI_E=SK-@-_UMH!6JD'BD:_LGU9K2 PK1@=4[(F,S&V65Z3$7A""T6I
M<7UD]*PB4PL7P)Y ^[H:&U""8UK&E_#,P/?]*]A 9"+GS3_/P/OV2]D !6JD
MP XJT,(*?.MZ*=VSTB8W_WX3W::CWKBY<]/1^\2Z/T$)W7W.9<3+%_5Q*?+'
M7.@'7OW(UW.:13%7@>F*(!A$#%.8)5Q"*9B0*DL"R9"MJ_GH"%-;='?Q5'LQ
MP1]&4 <7\W$HSWN6+P9HX+6D!S9.'N5._2]V)!]_^FC^XT[EVF[C[@O=HT7?
MU<$KIN+R7*51(%-MO9.,,I.#BR'A200CH2)!@SBDU.I[/GSPU#[C1C9@A+./
M#7V&5?<'>PD"0Y^&6RGO% EZ3-/>4:#/'C9:!.@Q%=K1GT=_WR-C!A'2A'W_
M9GH4A3@*$*K#VC*L&(DD@8+JKP[%/((DC&.8L)!G:<Q1*JR2^LZ.-+4/$OU"
MR'^T$F1*@4&(3?X!0@XI'9WP=G^R7D$;^!MNX_7N!5Y]<F$Z@7/(@O$%X$A!
ME=U >DI\L<&D*^6E\_[QDEULU'B6YF)U@SN'GMU0L1,;JNK(_>/2=)4HLR#+
ML)S-'5T^VVK-F2GREF44\B33-)R:HIX9$C!&L3D0CR(1AG.]UV(K&R(>6ER7
MKZHM](!GKY4GJ S-=SZK&66&SZ\$4YJUZ3L!*Z5!2^LZ;-+H?>@BG-![8+^P
M3>E]&&EMG,Q[X;3:CC51'0OVX"*,MN:/!6;;;!AM3'<OZ'6Q$EN^65\M15-G
MM@X,Q2$A01(J&$=9"I$B(<PB(6%&*$]B3K%(K79NG:-,;==6"UH>^=22]@BY
M/0WJ>9^H%Z@&7EY[H>3D&3V+PL7>T=,CC.8A/:MDVTMZ_N*^+9O89D\P3<R8
MZ3!^LS'=A:ZE?FG*VM3S,),,<QY"F<54,X**8(9D""F/6:($DW'FEB-E/?34
M:,)(#O(F#+,P[=A_>JBD=8S?<H#?+BA@&%"'=N ://=2M[J1&,%GH!(=[&7W
MV5+)%2_/+92LAQ^Y99(K+"];)#D_P=UQXI"Z5)I.GU?+.ENI54&J229$QN01
M*(,B"E,3GZH@B<( 1BEB/,OT#$JK' '?@DV-_:K]SG*UA+P2T+W9DO>Y.^_^
M>*T9&9HZG3-!J^G[W)J^EH+GTT&'G4=[]\5KS>=(KHK1Y]7))3$$^!WN!Z_#
MC>9J& *DMEMAD.?WVT5\DNNUE/5PR]NR1N-7N91_5G%:<\I2@5)"H4QC 5&0
M8DA$@&&:<AXC)FF<,I>MPYGQIK9BUJ+5L<VF?'8A*]^A6A55P\+J7.%)TL(U
M!>0<]G;[!H^(#KSB59+.P$[6ILIK@[+?*%M+8+SN"LZ-.>I6P!* 0_O?]K9^
MA/-9;O9EK)_7K=8T5R8"K!;Z_MMFXS$7,=%+"N908F;R. 2!61 AB&(B& ]Y
M+)2<+^6MV9M\LV<B9T&LOJ2L^I)>B#/<5V5*QI\HZ[]\IL?.[^%8F-I]QD@@
MI H0@9PI#E&8"4B(WI2%* FR+$Y23IU:@@\S52,N(Q.<(YD%!+%$P 1'F8FO
M#& FE?YK$&/*0X0(PLU7-9T/ZO^^>;(S @;]0@8V"PSHS]I@O.AX\5R%G8_1
MGZG0&SZOQH.[%*.:$[U!.C0P^C^HYQY'#_.VW%G=RB5_NN*\V-+%6UH43_J?
MOM/%5NX\B4+$2:@H)+'0%D:($60T2*!*5$#CB-$8.?74M!]Z:DN6D1SPO>@S
M0"OA9X"[.)IZ3(+EOF<0:(?> AE4W[91O6I0]5[-S1T@OULA^^''W14YP_)B
M@^3^A'[$]5N^7!5E'$G%@_NJ'_N^DE',,,8*PT#Q1.^)E+;C5$8@"6@6DIBS
M4%IU?7<8<VI4]54**>]+8^&$I5"5NSSU2S<BLYD4.P;S#/709MIQ]%JEBL ?
M@_3P=(#)*X'9C#LJ<SD <4A9+K=>4/CCS?G4XC>'H7*?\J7\N)'WZSG+(J((
M,AX#4^H-F7Z.E)BZD5*R,,$B(4Y]Q"X7:6I,=W$8+/C#Z 9*Y1QKOGF88#M:
M''?:!F;-D6:L7PD*+R#[+QUQF5CCEWSP N/14@U^GMPK.J?:E:^*ILU!'(<D
MXFD,I=!_H"B+(,-Z9QRE21!2'A"16I7R/?[XJ1%M6T*G@(I#V*S"6RX 8_@@
ME9UP/5(YCP#B%"=R 3#C17N<?U%<(S1.J-T=9W%XTYC1$B<$/HAY.'55/X/S
MJWQ<+1Y-:9E"BGSS@?*R46CSFG%E.A )&*<),XX\ 9D@!(8A11'7^V)I5S["
M:K2IL==.6%!)"QIQW2R^;H3MC#EON U,="<A\]BRQ@D3KV95]XBC6DQ6RA\:
M0W8WN=LY!YZ\=_2>WLKUS6I[>[>YEL7W?+4HUX_2IS>7DDN2J @&C G-*?H/
MDC(**<]BB<-0!7%D:P(YC3PU?JFE!>M27/ @"_#8"&QO'+B!?]Z0&@S2T<\$
M&GPKV4WV!-A)/P.E_$/!;&^>#0;W2):;7]B=3+Q>T'58?V[/&\TP[*5FVV;L
M]X!^YN0'FA?E<][H984:SZAY!S\4\I_;\I#'%,8C+.9$A %,M0D)$3+]PY,0
MPX0F(F,)YC2B+D:EQ9A3H_Z6G& GJ%/=01? [6Q,SS .3/>]$'2V,1TP\6II
MVHP[JKWI ,2AU>ERZZ 9<)]6RUL3>FLR\^J3Y=_HQG0 SN5ZCHF*")$1%#BA
M$+$X@BS4.]\D#!&.@Q3'D57,BD^AID9;M8#@8564WO>5 @LM/S3%QH'0&@R2
M-=4];U:NP=%G8WB'HF-VU*?=/!G==G$R8*_>*\S=(-ENWN9PLIEN%\SE4%EN
M5J#[R7#K'FJ*V6U6X/3,;+-[=H^RIN*_MU4SP?6WU940N1F,+JYI+CXNW]*'
M?$,7=<%R^45=;S=?3<7R><8CBD6401KQ "(9!)!E:0@SQ5&&)<]"9%_OM)<(
M4ULS&PG-8OFPW8#""&G.J@]"X<N2>G>KA9Z>M;GV-_XWN5[K1?;]ME@]2'#U
MJT/MSWZ3=WXI'7Y*!EXX6PJ8D/B]"L#H /(EJ+78-;@H)TYK DI5!I\#A\*L
M@\_%2 O@8'/B5M/U(CB[BKWV>_!X56 O4OQ9>=C+GM3/XW2U6)39W3?RMARY
M/E=3F 0"F;,%'G*(4"R@?@\1E%DBHHA$#,69BY/I^#!36VRJ&@B-C(ZA!F<0
MM?,B78[3P"N *T3./J-N!+RZB4X,-:IGJ%O=0V?0F:M[!LWR.RFVIHG&\7"O
MP^9\OR_UL\MN:U49R6O]@JS?/#74=%WD7'XU 6+?3#3\/(XT:2#$(#<EWY"D
MU.1X9C!*D BC.%,H<PNH'53<J5%2HZU9LD^&<;ZC&VILXMWZ7BH%2JW 'Z5>
MKG&VP[X3=F0XG9D>F%2/QMWN@RR;GG*S?A/L'I8["NY^0W:'%7G<<-Y1X'\1
MZCO.J'W+C!;YHQ;C43:UATQ'ZM(\OKI?;9>;>1"C"*680Q$P!E& )*2<Z/=$
M1FF2H) AY50BZ.R(4ULH]@+OZND]S<"REAG04FC7ZJ+G4+?C<:]8#GTTL(?Q
MTQ[&1EQPU0UCC_JAEM!X+AMZ;M21JX5:@O"R2*CMC3T\N"$.C.^P:=CR>?58
M&MMAJD'%]:8N0$HI&1#($E.8+,XRF"F9P3!,,$J"E"?2BG5L!YP:Z82_X. _
M2A=KJU=5(S@(4],U*,(.7C\;T"W\K)ZA')AS7J#X[AB*?9I8V<#IX#+U#.M(
M#E([>#VY01T@ZG)ZVCQF/!>G@U+/')HN]_6M'*GMU+>K]::T,O>Y[P+1B,4X
MAIJ<%41<I9 %*(%Q@%6FL)11[%9"Y?@X4^-C8["OEJ5GS@27&*$!7S6E!];;
MAX=%N:/4E@RGZSN@%JL_0;Y4J^+>(6[Z'/AV5J$'2 ?FY;HPI)&QWF2#06H+
MG$'"<VW(XV.-7!.R4^&7M2"[+W?O6U/6D#<?PJ]R=5O0A[N<UVVG59SA2" &
M<1A+O8]D&%*B,!2"R91&@LO,JFI@YRA3HXVV?,[MNT]CV<T#WA :F 5<P''J
M4G-6^8N[U)P>8;0N-6>5;'>I.7_QA6'UZ_V.<?V&ZFGF\N9.RLTG,U%Z_7OS
MM+_ Q/P7E)<-CM\\_56*6Q-$)-?Y[;*\MO)D"RQ#K >%@INXUR!+(45)!!.:
MA7$:F*K55ET?AA=U:J1C-*WR6;1%OM=U!FIM0:DN:/2=F0..EG>FT;GLVMWO
MD&/ U\+.!)K&9 _,GZ/.<_\4A<&F8)C,!O_BODY"Q&"PG\RC&&[$GL?O9M&[
M6@HS_N(_MT6^%CDW#Z_],QF-)"-80B*Y\3$*!C,4*OV'PD3O9F6<.>5[G1EO
M:LM$*:[CX?491"U/G_WA-/3QL9&TW.&7LH*VL -$Z%@"X_=\]\R8XQ[0V@'P
MXH35\K8+6AIH2BL#"&NFJM]WSG B@BB":6PB<"*>0(*(9I!8IAG"E-#,R1EV
M>JBID4=5U;L1%=2R]JB6?AQ8.R+Q ]? ''(<J0'8XSP:_LN9'Q]N_+KEG6H?
M+5#>?<>EP12MUM"_TGQI,MUW5LY76:6UK^_RA]*;$R0XPCP2D%$60H01@R31
M?\62",1"'N+0L7]K'S&FQC#-A]*6LU<F>L]9L:.@X;$>F)[ZP'Q!,$8?E :*
MT' 2Y97"-OK =3J6H]?3>J2^2Y4OI7@CE_J'C0E?JW_\PA;Y;3G*1]-IC:[E
M.UG]]\.J>+LM-C1?E(4N32_MS:8Z49MC&40H1!&,9!) )!2!!&LCBY$P$FD2
M9RB-'1I$^9?0ZFL>OW-42]R_K'?".F13^YW&;CY]I5D9*_2M5 S4Z@"CVFSW
MM[UV,_!3H^#/H%&Q;$784K+<CMZ\_GPZY,B_VKR.E2G_&O/KEC$_R!1TY<W[
M'7"\[/E!@'J60S_,"#U;D,CB5B]%5_R?VWQ=ID6N]>.K-/_JK_M6 NM]'$J
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MA_$GK\/*&%&8T<R1\0%NVRVO,'H/5\"/*FW]BVG$617ZUK94)9L4<TYB25!
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MHW[6)Q0\_)9/7=8W"?A1+K=RO6L,3JD0241"B#!'$"&E%WP4<T@5CD.9LBQ
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M&E 8$"182N(X9DX62$\YIL811G*H18=&=D>"Z#D3EBPR/+Y#4\U!6,DSJ&=
M*W(BOL1G]+8G./VR5T]9QJ6XRP![P8,7/JX?6?ZV>BR=6A^7O^7+LIYRTQBM
M[:=.1!0%FAZAV8M!A'@$F0PBB!6E^M\SR8+,A1JM1IT:$=ZTNFG]?^4^8O-D
MVR+1UA5]P1S9D:9WY(<^&A@!=&>J= +1*S':C3PJ#3J!<4AZ;C=[=CY]EILY
MD511(DQ9KPA#Q!F!62(D3#*"5$@0%9G3GJ]KL*D1VO5S)]-L."]3B7241CQ
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ML7R'44QD2D0 $T("B*3^B4@I(,I$I+)0T81:Q3>Y#3LUMMA)#=2J +R0(M\
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M[KVDF!KU_+[4K\!ZM<A%>4SZ_>-[<%_);JRD*F5JLP(+ZW;.E\V1'3D-COS
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M01Z97JRAIJN,HL2X:RCG0B#,TOE2WIJ1OCE4T/<DG]6WF%7?X@LI![6"&O6
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M&F32Y>0Y%0]7>6>O&UKQ6!&&GA_JK584^8G/,8)<"E_7-_,AP0HJS$+D1RC
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M[3XNJ7W<W>/B'2X:D%7%"V[E[X6X49]&N8S\2 ;<]V J.-?'>#!,**$PCE!
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M!IXFR?3.QJ_9=]U)H%1OA6[66FWC%S>,;1^W*^VUWCQN\K*I [54S@H+?1%
M$A-=(SD.%-,0!FD<<1$S%!*,[+J*V MA]/5,VFBD(RCH2FIYG,3>'&9<-!+$
M$QTLJ82'E?1@+WZ=!U14IX/ML+<_:S(8/K<'3NS%F/;4R6"8CHZ>#'^2'1$6
M>;G\JC>:VGR&)"%AA)3C%"(*L9_ZD# _@@A%21*1,.&I9^)''3QW;AZ3WLK.
MBC)C9 4ZIWLL3\$=@M?/15= ,C+!#$;#F$C.Z-['#NJ6#C.H_SIDA<-G3O*I
MGU&D_7[/_7GT:BGO-NLBX\U_+.,X9MA' C(_ECH!7, TBF.8I@'#41"QU.,C
M%49Y(<C</OL7P@%RGPLU96Z?U,_Z?$F[P4NWA5K&%I8[$H.-91BFF< $8P=P
MK.N>O-#D56J;G,3RM<J8O!1FKA5+3D)V17&2T\^S8U0NLN4']>"RJF:U2U>K
M,MK>Z=(G^?.[#1=+&1(NO)C!B JUN,/:_<%80A0BM=+#V L\HS"2X7ASX\=:
M9/!"YD6=X:EW_AK)@1;=C!Q-<>_GP!'0')GJ7 !I3&N6\)Q@KT*PO]]OOO]?
MZDD5<?T7UC_"^L>*K4S'F(24+!5NN<?V-OL#'+I(WBY:=:/="^U'W^VRQ16K
M^"C%&/K$0Q C%D#BZ=65ATB8(AZ&9BDB!F/-C5JJTI/[\ZD[@<&;__4_DB#P
M_D-)7OWD_X=%S_A+@/?SBF,81^84&P0''(2X!*7Y20>'D$YTE,$MM%:G%@S!
MZCF6<.D)DYT[,%2E>[# ]):A6X:=?!*]!7FSYNIW(O\N;GYFQ3+QDY@R%L,D
M1C'$:8)AXOD"AI'4H7R68F19;J%WO+E1\LLTO#OU?/"GEM-ZK[ ?9=/=0F?8
MC;Y?: O;@$U"(S <;Q/VCSGQ1J$1 ,=;A6:WV7MVOVQ)3M:E$+>['*A"IR>O
M=87D?4N,W65MW47,/2\6-(4X4FX?]D,*"?4BF*#(#P67?H*,2A1?(</<:&<G
M'^CH 7:*=)O$[%4Q]V.&6NJRJS@!_B-3UR#H!_B20VU@[F-.8(N)?,^!FKCQ
M/J^$L<<K'?KDR;S5*U7O>K'7/FI@#:#R0>3UGO!GI6Z=%[,D//8P2CB,@U3Y
MM )12)4O"QE'"4I21K"?6-:C.36.S8<T41T:+298;]:P$7%8L9^3H)JYL%<#
M-3+[UPBU62-[$1V6DNE#P&T)F9,C35LZID_9HY(QO1?;^Z/'J;;JX=O'NMWP
M[[I1,5DQG26B'.'/HOPB\FS#,]9<KUUCW<WC5G;[&=<GCC^M]5_>DB(KOFRR
M=:F6R01'J2]T6BUB$#/==RUF J(X1G[" Y;X1ILB$\L]-[_W4]M \@T7]4]_
MT[TDJ988/%4BFWM84]K_LF<\4ZN.O9]]\D!"1W.@50<=W:O*EJWVN_NT_G4O
MIUL)NA LVB( G]9-VZ8*"/!EQB^+N0L_TY=FJL;/,WUYK)8/KV#"GB7'E-),
MMDQY!8B[2YO7&-[5 <\//Y^J\XM?1;G-U[?K1GKE@BTIP;&7T!0F#(40)W$
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MS8V@VMV=KLSU%DXKM54TVA1UXY0<5UA.M$DV,8S6R2JNX)PXR60XK$/204Q
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MJP;/NL?;'?EIGDKJVL3]Q/;*AAM[AU1I]K)EK5:NJ7^S.&>U_?+YI9J@U7-
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MMU[4!+M9\P\_GP331Q\V^E>WV[(HR5J?/#FH!O)B^W/)N!?1A$H8LD1 C$0
MTYCJ\X4,)4E &/,<I)5,I<[<F/;%EFA3][+JX"L:[4"YJ7Z] #_:"DBDJ8 D
MVN2(IRHYXE6K=+EYUPSW=/\R;]#($XJ#>ER'93/UJ_>A\^K]4;UZ'6A.5.)Z
MF:0S@Q)<3NT\C[I;;E2:0;;/U.9S5F'+K50# \WZR;?R]T)4\>M;6A)]2NG3
M^L-/]J 5^+C)/V9K?0:U:B*^.P&W3'U/^E$HH: H@3BA!!(9^3#U(\']%,5Q
M@JTBT$,EF=L$W @)5EI*RT7-<',8!J>G 'GLJ+76 6XD5%K4]9] JX<.IK6:
M5.6?6EM4RH"=-@YCVM<"ZC;8/5B:::/@UX)V%!Z_^H%#"[(H0LD>ZPJ([S9%
M=7#H9J5?&[H23<H1#F-)$2.0^CHI,Q(,4AFE,!9AX.$H#KE=<VR30>?&B8W,
MN]JKE=C5R;R=X .SO(Q,8$:.KH$=F0>=8#J@6(DY2(Y+C1@,/'&A$',HCLM\
M6-P[JRC/;CL\3''L1=2'$=>9J<2/8"))#$-$ Q:'! 42S2",,]<,AHF6VH/3
M(<9^?5XU,C/#9(P9O0]SB:N,FA@RMLS_'2(CE])2IAK6OFFIDN=QLZYBX7]L
MRFQ]7RT1BL];?4YC(]7O1*$FW^8R+>-2!('G(\9AP#C1+0Z5G^Y%,40,)T@F
M8<BHT7PV;/BY34^UJ#I?Y;L6UKP)Z@#D^Z>"\?$<F=EKJ4 EO>+F2GY0*[
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MS!ZK!36IRQ62C@) U!JTRR[URB=V7'F-U<Q8<R);C,R?M1:P4@/L]:@+6BR
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M# \2D44BBRE!@55IL)ZYYF9\M!<8S;5%1USP70ML6>2A#V:;VZ"+P9OHXF<
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M2%(OA"&C61"'61@0JW+^?9/-S29L9 6-L*HP;RVNI<W7AZ^AB><(M;$MNE.
MC7"Y8@*)6UNM;\)I33,#U0\L,9-G[/BC*C?+/_-U_K!]:+[,*4:9[S$D*4*:
M48AG"&*<Q9!BCT2"^X@D1@5X#D:>&S,TPIGQP"%._2_]1=J/_(8W<CE\GT]J
MV_?RRH<Z+Z[\V^N7]G#42=[0D\JTK^/I#PPNAO7";_UIK9W6.V_%._R8;_#J
M"]\LXY3@-"0>9,)/5:T]"E,:<QB$":4D2'&,PS:%V6PO-Y_<Z!O\,H=Y/I>.
M [ VV]4=XS=9[:R#:RUY'JSC*_9>LB;0117N_IQCDJ_R3<XK7;K;:7TM2P!=
M%]PRG7[J"ER6L!PIR64[PC#^^J,LJJIV!4GK 2/D90RFC".(1!)#@A!3[I@P
MX4$6H#2U24_LC&UE/TR0=JA% X]:-CL2Z@)FQC(#81B91FH$OO8C8$T(1W1U
M^L9WQY_TE3ZBV.MW]MA'AKV4G_,U;T\(2R8D%!&51CPB$41>$$/L9P+BA. D
M%$C:]*&=?[0[_/R\GLV!56"J]JQG4&PWE3H[2=:S>U-?H&CVJ@Y%9N1W]7.Q
MOH/R6/4 E( &;A#K]_:8XDY?W!<33/KF'E/M]:M[]#,#WUTN#2^^VZ@_J]V[
M-<">6[_A^RW?77\(^7\98]!/B=QTDS2%Q),[;X!CA&C$>!!9Y<-:SC^W@[W]
MM88MX(9,,!Z,8Y.%EGS1O3!7PB]VQX#GA0J!(QQ\Q3D;XP9C('9N^<92AFDI
M:1A !ZPU<!C[$.L_Z;_D7,7ZPU9U%KK9DBIG.2Z?&W<:]VG&41Q R@/5BRP1
MD(B,PXS@V \"GOB145FD\U/-C:[^I/];2PMJ<<UC>L\@VD]2;G$:VV/9"-I
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M-P+0L6'25CE2(<G."#F/-:)") @12((LA"B)&<Q"+/^:<L(\SE 4TP$EP=Q
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M^(G*5 PI3+.(0<(#RG&$288\FRW(9-*Y[2(=F6N: 1VIP7<E-]""6X9+&2V
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M4EQ%6%Y BEZP"C-9IO!N_=,O)G7QYR%UD;::N?&E\^384>64@$_,DF>R06_
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M"3PAZ[FLZG4RS5QHU0N +TNO^GFLN^_^PQ_O]N5ZJ\U\69X,W+@L>1"F2*@
MAA&-M%6N#7*:Q,8Q$PB1I5+_8;4"6HRUM-7MPZ]__ J.$H,WIU^S0W&5(9"'
M/? >H9N8\H90&^%E'X+/WJWN$<:9_.BC7T(GU[DE+CV^\J$GS.8<MU2EZPVW
MO65LO&_QF&NZEK^;PMKWYIUI\[1)FE"E8AA@ADR>MMY=)$I $B.E I.K;==P
M?'"DI3'K05#7D-Y+2-K9E5[PF9@^#S+> "TE;,2<(&M[$ S/D;R71ILYCG=
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M"O=GSI9F,5K=;N+%^(>,VR3_EF_ETV]52<Z/^ZTHW^YN:5$\K;?W)O-<KGA
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M](QE$L8BE9"8]L\HC0+(F%*0IUQF89J9-K[C$M)?#K8T$N@F06_R[3W4@SX
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MZ2]Z5ZSSHM-GNBXE3K?B>T&W956 _ O;K.]K >LJDJM$!5R;NP%,44H@PB*
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MRZ]'W3-%]_JN'I5&455F.JW)]-G4M/VZOO^QR]6^E,T)6I2F6/(X@Z%2L7$
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M4'&0U)[Y+,$>7GC\0SCQ$E,E*'<DO@%'/.NDVO?3X6F_9OC'=:;5P0N^3HN
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M^GV#/,L"B/1?S;K!82*B2*\<*,XH<DA*MAITA+4^1RIR1T+GSAL]"-NQT/6
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M/U9\<?FIL]#!H%+MUSY\X;7G!J<YQ]IF???424$^>JF3(*(DQ10FE,40)4Q
M&F(,91SPC! 5T]2JKMYH"99&!B?M*,O=^J'9QU4E7@]EVRVY8?R\N)X>3(#V
MQ-S2!?I9F0*S769/W;H%,YTF.*(XT7F"K12O=*+@"-+E,P77![GOLK_*GW*[
ME^]EL?XIQ4>M5.N)O)/Z-=9F^;U<18A&L5(49HPJB.)(4V":*:B8"%B@0L15
M9KNGMAEP:8S7" N*6O82O'FL9778*5L!/;PO]@W?Y'Z_2ES0(F@$/IP\W("C
MS)Z!M-_@^@9TINWL]< Z[5U=4.K9J5H]9K9]J8M2W5VHTWWNE/SA'WMM/OTF
M=S]R82)-RYUYG[X7=%M2;MZJZDA9;WI-XJE8"=/]CHH48A1J<@ZC%!)&$X@R
M&@NL"$Y3YM@!RTV"$:?!\S3!*LO_ !VA :^B+M:-V/:,XS@APR0^ ;XS[78K
MP4$M.3B*?G."<QW=\FEJG.TY?CJ\9V)[K[@[$?\XZ'J6 ,<'SK88C%.TNRR,
M?,(X/T;5><L\<,5XA+*0Q##,M(6.5)I K&@&>1RRD*4AT?_L4J?L\&0G*WR&
M$F1U[F/5::2B<C<'PQ$P.\?!*!@FIM]*IIOJ._>WMW^AJ-<]^_'IL^[%7RCU
M?(_]\H))"VPU/VSOJW$//K*V$R\)*9(A"J&@2D+$P@#2 ,60I1S'"6%Q2,4$
MA;7ZI5K:+KPMRO-H>JW4[8?R5H&&%C;'UH23%&8:F,9AR^]5)F=B5G(OO'10
MK>GK>5!NN'7SA+,W23DM?[.XV#):5\SF5,6S[%#W4S1K8*PE%LNR@V=DD2S+
MAX_.N\\?Y#?]$53E4-_1C6D_]^V'E#O3ADN(==W Q$BVR<M]85SF)\*7_=*7
MG]=;^4D_O5QQQI*0QBE4*-:+<B8S2#"A4/]?L2!!' GE<O WH^Q+6[K/4T<)
M.JHZ5P>8[3VPVR\L='8G7OMKK<%![1O0* XJS>N.A@?=N_-MCB]/UYIR>+$I
MP9\&!5#!X/%\\Q4FSW>)A=GDG[M@P]P3<Z;\P^PB7!O;\H$66SV<.8^HLF[?
MKS?[G13F]-@D[MYN:%E6X0*K, LRF@41I#(3$.$J^X,IF#(52D$"0K'3(C="
MAJ4M5B?Q+8T2YD"M3EJ_ 8TB-W4 1I4(7RG3I:^J<Y[Y9>NSK:,S'#-'QDRH
M:UC,)-,T8V#,;#-T1=",,\83A<W8R_%*@3/.0%T.G7%_U$C2/5O%ORY_\':O
MWZQB_2\I_MCJ)U;U$KY4315-'ZKRPU^RX.M2WA5K+K^:6I=_/.I%H?KI\_IA
MO5M1*D0043VK IL>)!F')&)ZAA&F8412P1%U8N<)A5T:C5>2&8:0C>3@L:CR
M7?=&;K Q,H,WZRT0^69#B_)8#,@RJF>6-\"2SA<RKU/S_E!SE%HO4\F]F?)*
M*U I<P,JQ>J_@$HUCUP_PP3X712F%'C>U6,&Z%\L,W.,.6X]^F-KBK?<;XT
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MJ6-@R_T)%HII' J40YS2&*(H36&.0@:ES,,T9RS,N1&SV0PZ-[9KQ+.SK(W
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M_"BJ5Z2\_;Q9?R^XX"\??B^UA^']ZKLHJ\>]ODF>A"3C.:0AY1#E2!GS21[
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M$@<A\=(<\?B(S](4<5#Y4\T0AV]ZKL, [8]2-F6ON'77WFR1$YH0FJ>04))
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M'*?[YC[K&V%(I/.;9]^,K'6#5*N\Z^9^O=EH^9OB=XW(5Z#3#]0*@EK#*]!
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MNG%:MGO+A&*9Y%D,>1"HE3'31;0S%L,TBB4-,D$8-T[F'"/ W):T3H?&4R9
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M#I>;UBZ7$G&&.1G0@PAD?94I!F@!1'!%%Y53Y ';U!4]1-% ;8A;(J<7X8_
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M^?.U8.'<7V-%QFQX!C*,FY:^&KQS%@0W0@;!O<=&>]-]Y(S!-^YG3]I;V*/
MS):#"1?*<$>NO%"6XCZ)Q(&@;V.*2MKDT;F6J:%A1V?W?E#V)'&.($9Z.PUQ
M.INNI[@B-_W#>I'^^+28D=!7VYF45\4M)3)T,0#/M0B%U;%#@F(_&Z1#;272
M%TU@TI7"T5Q%;'-DWT11H[!#USB[G;I(,13'"T)V5I# -#EUBA>(1BNA*8KT
MIDW9^\,T#7L(VP8%#T-M'X6, EQ'*2W.YNO5N_"MG@]>G@UZVINE$8#UEHCB
M@0R]M@5D"IEKJXB6-LGG^^D9#:CVTO?M#7%_T8\@4'N[F)]\Q.5IG7N[*5;X
M/*U[;\U&',?9]&3;CN^"N22\%Y9B!C1NTS^M#N<3Y$"4E)$[%I&WN;WY)#*'
MW2H;P:V=HD9AR&XFPBYD^.V"'V55RI;5[LY8YXJ*")Y)!*-8B8YK'56;C-+C
M= V;AVR$M!Y5,08#=R6DG0ZGF=&!0AT.W&5B5P4&014/65M4/GH6;)N6BGL2
M/FP*M)41/* R1X!=<C&6Q,9=84Z""47+S" Z3:&6+@Y\,8;<859R*@69;A.N
M/DC2L+G3=CY>#PH8Q09[#P]$:/!&1E)SB!1$R5!3>@BU#0EZ9TO@;<J!=T1/
ML^1I>VNUB\C'D#[KY'1.M-8I:,[(!^ 65!$"G)06M/<V6\PAL#:)^&[TC28>
M:)C3Z%]1(]C_7IZ_]G)6_#59UG.LB,8J48<7%%?/QTVN8^(+>.E,\-DX9MK<
MZ?P.8:,)"]H!KD_5C !I#\0\U\Z_DHPZ!T-&6Q0%*CH*>U!RP"B5*Q(%%XVZ
M&'Z/M-%X^NW0UJ]Z1H"WMR2PK5%^3^I:?L%KK$@933!.@W$Y@4*?B)4@H0A4
M-AJ6E6G3E_41HD;CW;<\%NA')2- U^8$_[I!ON)$V9 0*5#1(AE05I)=3BZ
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MEB<<%CY%&:-(C-T\MZ*E?+S<R"]OHN1WN/SPB80^06:-*XC %1=D@QU)RE
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M R/K3(X$P=410S$49;-RV.@TZ0&"1GL*V2N.=A#^"#!TXR!^R\@D^A"<C13
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M -3YK9\[+/V*IQ&7$R-4"8EKX%(13]9S<#)ET$QGGS071C<JEGJ<L)$!:U<
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MS:'(XW0->\.H';)ZU,;NV%I0/'+ VVP7S#D4$37QE52NYI@)B#5[Z103-NN
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MY)2!+(54?#;(),:Y4GMP21._:@ZA\*=!M(/T^X/1U9,L.7*H"5R,I8VWXD-
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M*U99_'LN3SPY&ZPEP%PS&.D<8+NZ=0D%F[!)R8AM0;S- J9M*I\<JJ/I:GM
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M$L<<R=8"IIH J"U[?E]K3-;K*L8A)]YTA;VTL1W@2G(4I?4(QAN6FZTP5+$
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MWGZMTQ)+'-IU#J6TB:_/7OZ55_<VKRI_]-L/V&AE9V?GRUFZ8.B?R&BJ-<6
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M=(G\EU?@1P9W=IR@6-$8,[4C!G\T4+"FE"T:*VD4=W!K&;TPH4QYQNRNEPY
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MA6W$-UEX:0Q:"FJC0J&-V(^O/[879K0I<N+=Y3\QC_9JT6NTZV25LRF#*KF
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MY5H>'V?G)^Q" JWZQDIL5!E20C Q@[2QED2D,AVR"'.873VC,&-'U(YJ2'M
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M,B!0N%13]>3[K!C>=(?''1$."NO#F-Q^&-O9]C@:38M.K.]&+_1:!%Y5G91
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M(+%:%VUR0'&)I,^]Q/444)T-AV/ =H)N.H ;48VK]33=2;=[S9PI10-G2#>
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MY!\XYQ1Z9K'-+.^.YF+U-2[CC'NW0\QT<)).G95CR4[8R"+(4'/76'=WE6A
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M&B+Q62<C[[%9DD$>N8:<?2(V9:RKZ!!TJ>?2,NVQM6=P%,'C%MRW1VH[[?4
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MT<<!Q/67CQ[VPAQ*+QU [4<.]IG<]LC\.M\.T)_DI$JN(\,"KX%^<@B.(G_
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M%O2Z,!\L%&.)7V8=^(0)$EEYE5W(C+7I,6U<A=3NSFR.R0MILQOT'O_,4HI
MK>I&G5+'NAD*90*6!"[:A-H*;O1S>A=K]Q+;'*MM==?!U7Q6<Z1 [K5B8"0G
M5J/WX&V(P)WG&K/QZ!K-,&_<X-KN'7=,P ZJSPZ@^W;]&9<U5;#$SSA?3?_
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M3[C #R9@Y':XB][F;;32!P+O9^2Z+^'ZO/U\A>O%QK>>H),9%3$F8HHD5*O
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MP&NKL0Y N0TX\2#68M E"8=04U:@,KF,T5MR\U)2(JK(@FO3F'($D>-V);<
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MT',@@6,7U T&J18*Z0QGU^-/7_WU%><KG&"44;DD(9E@R$ESEFPKQ0P"A</
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MD-E 5^PV\<N3'^DH0S"6BA=CR'MBX/SRUS7MM/I.B!M6,$538DU0 _]B5.&
MC_\5+/M+2#Y6&[<)8Y[YS+1%CL<&SY RGQ@^+RY7[&GC_)JA>TDRGZFZ5%HA
M<6US9J*&%(L#[=G]%EJDG,46^'GN.]/VE!P;0(-*O0=/[9Y_?.,M_/YM\95C
MJ>C M[]8[\I.60%'_039BNB5<6QRQ^D2V(J\K1 83S_6&%Y7?3P!WV+H9M!&
M^UU[59CEV6><7ZS.A'5>^-!*7A)+3K)#BB(4*$YH=E!UJ5N9LUV^.;%C-;RZ
M[S\+#R_[+HW:#6^KFY&09U+)J )+S+GF+!9K(.D0P/NLM2ZN>!JG,GM+ B?V
MS4;#WYAZZA)^-S/,7]/%K^Q_M('E/U_2^\4MAN59(NE,1 \>50:C8^%(.V>H
M48F*E?\ 1WK^V)/BB7V_"0 Z@B9W1VR\0NR</K1-*>]'NHMO#N!;_-KX>K58
MOIC/+V<75Z_\;98EH:4L:JN$: ,>!!I DRK[-#9D;PN**/>ZE+?X^+0-4\>^
MG8?61I=V\M;^G\=6/6R.W:J=.UJ]J$S.>_S[+%BO?&49*TKV:CM;\M:!-XZL
M+\+G>JRK?&\FINUWF,*:'D??4T<YMY\HGGZAN-4A?F__U<^T_';WG)EH<VUE
M:(XH<1BI"Z0<!3@1JL\^UA#+-G9W>-*FK2(>V2I/K,F]@?R%EFDQ-)0?*]*_
M=:B_.4BW.;:JN3#>@#.Y@D&E(-A6U^2]32($3W:K0'X 6J8M&SPB6(^AJT/]
MV!%<V!?YXA*7,SR_NCW>TC(W!7^@MDF0VN']=4G\[>6;^G:Y^"_*#RT>?+/\
M Y?_31>;C8.;F)1/JK&6;QRA1%N<K73;82U!!DK24$%]]TET2\]W/)JGK<DX
MML/<B>ZGSA*M*>98X=9-M+HOK)>7RZ;#,R*#PE0'"D-@\4<-B'PY)9LI&)16
MB&W&4._VU6G?[\?%Y8CR[R""VW@Y+^;E@<$R#Z1#-FS^/L,T.Y]=S&AUUA:Q
M9F,E&*,,QZRN39CT"!83A[+.\UD:9R#0X;1OEQX0IP?<B=3; :"?N$:N_:.S
MI*(5RM@V3((EZ@M";*W82E8OV2%R:([U2GN/N.T@>8(IJ[$4-/7;P#UV[KD@
M]_A;._*7\XL_V7DY(YU$]L2NB ]\OJAF"-A*5[*PA0+%4G?HC]F;CNUP=X*I
MJJ,KJ4\C^/V6TY=XGEO0R#[T_<>-VXQ7):HJLH");=-T4&W552H@E<S%JB)R
M&:?(?3 6M@/V#Y7B.H:R3]'LTJ?%AR5^_CC+K;KZFY VNR;/D(PNE!)D'9H,
MJH2(K(1B,*9@4G&[-+L.2=IV&/YA,F7'564']OJIK>A_4OY^CE#YK\O5Q3I_
MR(IZ\>;E;T\Z^;>]>PYB;^6\?Z*Z6%)+Q9"46<J265]ME$+)NDU#\Z"%=&2E
M]6.MZ)N6[^U.U0FGZTX(5I,^/3^ND7N6Z$S65)*-"I1W;4>814@N^,:C<+IF
M+4T]DD-TC[CM 'V"J;NQ%-2!Z;_/4MO8V)ZR7UVV#8[7?W%5,K)Z37]?O/\'
MG7^A/Q;SBX_MI@M:)U.8/^O!*)T 2R)PI;1JY)*B/=9;QDZ$;X?5$\S<3:'8
M2=/*>S+\GX3+]_]8G-GDDK0A (5L6<8^M4([;+,(,HO7VK&64^]'[W:X/<$<
MW!'5>+)P9?S1F9?66%/5>EAP&Y[A(21A6=;HHT9K4!VKE68[BK>#[ FFYXZJ
MRM/S%1J?KQ:7R[.JE?*Y"B I')C*(7'4F8!L$:92R5A<+XAM!&_7-7'":;EC
M*/)4C>PK#E//O$"L2O%)K"&!012 )A<0'#N67$U*X5C%P%L1O!UB?ZBLW?"*
M/$7$-B9?L:SQO+&\>O^1EH2MQ/FL)LHV"0VA39PT(K(O)'R '$I1M3U_A&-E
M3O;C8#M,GV!&<%)5GP3(?_GT^7SQM;T=WLP"6T>H-_R?R:*R<@*97V*'7XL"
MH7K?O'YG/-7HRD@[)PXG?CMH_U YP7$5W"FJ]TV$%DNDL4K(0D<PIM7OA62!
M(]PH @>X+)<?(.NM3C!C.*VRI^_?V('MUW3QEI:S19GES?_^Y6*UYOE-;5DA
MFJ_P)FGZV[S]S4^XFJW>+F9M9H#W/G!$P<Z::!U:3E; 4A$\9F2!Q2SRG;!Q
MVP+YL4C>#O4GF-'K6?435X+\-9]=%_>_Q-7'%_/2_O'+_[F<?<'SYK>=J2HU
M&6K4&P_&I@C12PE65EU+8F9<V@+'SWYH._2=8/IM>#%/C)E=RZ*_M6ZO)7"F
M<Q96% _>.0-&6?;\D=U_,C92RBYHM\W$X<.HV YM)YA .[*"NGS7_<XO_^GK
MM;M^1J)(DM:!+JZ"*;Y"*")"=EFBUP;5T<9X/4+B=K#\H?)C0RBKNW+*!R/$
M30O>5?_=MS-WAH0UMYT&V46V_*U9)):VS]ICQ!RH%KO-!7L0$=OA[@237,=5
MS\0X_./R_&)&&]X:!Z_6FUNO5L'>-(">52&M0FJ"O%K^%"!YE. ,&?8U:I)U
MFP[T+3^WW9"D$\Q'C27R#N[4>VRM_F-V\;$L\1]X?JM:##$)P^$^1.<YT/'1
M 7I#;+)-T<EZRG*<"W4[^K9#W@GGE4904P?@>W1AQ]^S3Y>?VM G/+]KN3<6
MG39'[DQ@%<KG DIZO%JZ@<X2AU,D:LZ8HQHU:7\(\=O!]O131T=3<+^8OG9$
MKI?1?/?W&TYMTK$61EK1-O'I=008^/ZH.ODVEKNZNX-?QX7R%C1OA^#3SQ"-
MK<ZI)_1OSMQW9_$L^F*S=P&T:-,_2'-@IAA TOE@L+05Q'D+[_'!'[X=<$XP
M\3*,./LU9.L'\EMSDYQ,A#)"4B&RNUL\6V<= 8V. 4VHLHS3$[45>=NA[ 03
M'>,IJ1_DW1+;PWF:,R,HY;:K)RM56YT?1^P^.(ZUJL-8:C(QCPF^9RG<#G\G
MF.H8556#0?#_^]=[<F>V_WO]5^N_:?_5GU3_G_;/O_[\[=O/9R-.J]5B+I7^
ME[SX=/73-X_MU[.-KM<A+.HMEEOYR'S56OMNS45<_4P7.#M??<_?:L:WQ',C
M*P[_YK_><'M7#IM/?P>Y8W!.?U]0>SOY?P\S$[<3M"_FY6:=]0W(7Z35U<!@
M2R'8G!U0M'SW)M=:]I%C"I,9A@EU*>.XUCL0>:C9W&T_1[:RIJK;J<_LG3I1
M(?+/Y+ J*70FH31R%(GL1.:TBRG&0MA=*SJ>YCJXS;]?,_^>_ZNK+<\Y&E^#
M!AMT>VTO!6+-! ISUBB#\#F-@K^'Z9D6:","8#&X-KK$U&;;E=3)">8$M.5P
MVPC3MN+5"%7)*"-%]*2.A*H>%F<.H>UG ;2'Z#N T/=>RNU#M]EO%CDP"H06
MK%<.3&#3GE(-(*NH5;8-BW:<QH3G*.L-4OOH_^'YB\,HHP-P?2^D=Y\7\]5B
M^?MB,T*D'4$?;'(E%TC6:):6T)"J2!"5+105)4KC)-2>)6W:74Q3W82'ZJAW
MT&T.*3FMJ\<$P4@^1XK#\.#8\L=4=%!962?'B8.V(*XGNW8P''8!VQZZF1!N
MZXZ Y=>SO]Z=%9\BULA!3FE#'D41$"CP;ZGJBIIL]D\9L17E?_FP^/*OFY]X
M!:;-;]8X6B/HYGL= V0?%2X.DF<'!N?58DFS#U<9W:MKNDJK5:P.1*( )A.?
MCES6,Y%%R21*',F\W"-EVEML+*P,(_D.H+/=RS1?X]%(CD[:^D,PGBUN3-5#
M0NW(&N^*[GT;[VBI[^,Y2L/KJDL OJ/EEUFF=;;"F=:-;Q1$VTJ2#14(0A5P
M(54,46<]TC/"DV2=PI;>G6"PQ9;4_732:9_M;W,&,*VN,F+51ZE,<N!U*S?V
M3O%E;QLHDC%.!B'SL8S;;;I.817OL"#;6RN=HNRZA9V=D,OE_,VMA9IGDMBM
M*(Y *E)@JL^-NPS>"BDRN:KTL1+FCU-Y"KMVAT7@0!KK=;_NBT^+Y<7L?]8J
M7-1;2R[?+F>+Y2T;_Y()GEW@O+Q?LA,S6^^E^E;<O-I(A,EVQ0B"$-&"L>Q!
M)TD6R"G=VFX%.]5[==$,2N8I[.S=!\2]:;A+5W*KW=FM-?ARV<HC-JNT72&9
M<K6036@3>5,$%,J#+,T(A%J5.]8PK[T8.(6MOL/:[?'U/+U)W[G2*PL3.:JL
M8 5%,-1F2AO7A&U$I(R$.$YAR:!%>1/7Y V+TP$TM;^=75S@^?%K\C8;+F;W
M)Y^O^/:Y<;!&*,W;]=.C5N@=)(<I"O6$L38+OO%%8N/H/ )F%=A"QIRMTH'*
M.&.NNRW4DZ&*4E4;TH!MVY EB)4(;,E"!T,JX3@2^5$+]79 V&&%>KMHK@,_
M]I%BH6@*Q5@<4,J%W96,?$LD"2I'OHDJ.NG&&6!X^H5Z.P%@NT*]7;31):8V
MV2\G@_$8'%3T$HPV;?]O5!SCF:R3Q%J$/A*J^JL^V$_;VQ;J[2+Z#B#T;&U8
M:8ER4PE"SFS0*1(D$H)_*T,I-7@U4L!QHH5Z.^E_UT*]7931 ;BN%GVU(1Y7
MZ[J0&<OT[B/115N85\KZB0K/;YGVG[[R;SXO5GC^ZW)Q^7G%/^+\LLSF'];3
M,N<7L_DEE3>?:;EYTVKGF*P.T;:DJS+(%X&Q$*HJT/XXINQ0C]2H=AS^3JED
M\) [N4.T='"&=F+P-7ZZMD,B1..,MY"M8SM$R4),+H&F7'S0*$08*<F^'\'3
MFO,>L7?WX>D(0)AX4,*OM/R$\__XR#^1&:6?+E=L<%:KS>5G N5*K@";%K8M
MTF1H[W7@F8W@)$FJVVS&??(C$Q>!'$/%BS'D/?6$C;^N::?5=T+<L**$\25X
M VA]:*R4-EU;0U66+!E7C)1;0.>9STQ<W'%D\ PI\ZGA<[E<?":</\U0,5FD
M2,VI+ZI5^2&DZ@F<*2%Y$[2)<1L0;?.QB:LTC@VEP>7?@>/V?,M#-K+*&F.3
M3VL4-!%BB!6J]S)*+,G(<::[#-.EU$GQ[7#/@(?JJ'?079]2'QW68L!GSP*K
M6D)T-H%/PI L,7D?CP^['J* @>&P1Y?2+KKIHTM)5F;9D@),K?;=UPJ)A0/H
M@W JJ2+S4X\O/UZ7TDXJO-^EM(L\.S X]WME/$>TWK(]+J9M8(C50A)5@+4A
MIC:Q-]ZM(/SG[5+:!RO#2+X#Z&Q7JR,X4G"1#-BHD)E*'H)$!UXDK1&-(GFL
MM;'[=BF-5HAZ/$=I>%UU"<#K343WRGG^7)R?\X'[!R[+68T<N1HVSCG%T+:)
M>DC95\!<D*K07JACM2]M0^\I]#7M!)SG5V$,K<4NL7J/N[-"2AL5"U@5V770
MQ"Q1-E"2Y,"["&?EL8!YC[C>4#@\1IZ%Y6$*VQN#G]>UJ>\N<'EQA-Y.TRB7
M&OEJ0<,B,PK:9'P00?B:(OLA=Q_)NNGM/&+;W03HVU=)7=J^[YH*+?H<36*O
M65<%AB\2"-XZR-K'(I+(5AZK[6[G5L\C-MI-@+F]U=0EZ%[DBTM<SO#\NA?E
MS*=8M3>2><#2EB=(/D=M_#,'\:ZD*(Z'O'O$]=8B-P'\#E-8S\U!]X1XW9KP
M%F?E3)H2JM$%)$GF,ND,,?,O*HH8$GI9TS@O,#L2VEM+6P\^X=Z*G!ZN#S>O
MWN/PMWE>$J[H9[KZ)POV5@??BWFYZ>X["U$9/J %L$@"4Z4#C'QHI2*38W%D
MY#8[3H>EJK<.M]%@.[%"3P;1J\UT]JM#:Y0UT6D%0:L,1K09%PXC.#3.:E64
MJP-A]KOO;H7*(R[BG1J5^RME>MP]]7CVA?WIV<6Z /'>>P)'<I$O# )IHV,N
MO046*0$F76KU-6=[+'_T24*WPNH1M_-.</$/I\B>X;K)4?%UP(K)7W_Y.Z\E
M_2=_=],Z>Y]W+<AJ&3VH'%)S>@1@VVI2BZ_5$5DTY4@@WH/\K:!]Q 7 $T![
M;*5W^3APGR6A@[6D#1@=)!BO)82V)4HIZ4QLPX7LL1*7>[[&'W&7< ^AUTX:
M._ Y_I=Y&3F%^0IGRW_'\TMZ4V_F$-R6)N6 63H'+M$Z'5P@%#YWY*0-ROBJ
M[#B=[_O3W-LS_O%2F8-JLTL#^B"'9[EM<U39@<Y1@;&%@(U  %6D0YV<*_I8
M*<T'">PUK3DL7IZ_\@]67L?IS?4S\OD#TP--B%X'']OS'-]'4;'3DE.%E&0Q
ME)37\5COK(_1V)O%G B?@ZAPXB:5!X1Y>P%N^GJ]-7DS>>@MGXA9GGW&.?.I
M@W!HO(.24O.O0P1TL0!JE"@LBN3NC,/=\E%J>QIZS8>. L6C*JS+^_Q&EM^E
M-'1!FV-$0._;JB%=(>;(1JZT/=[*5"..-;_N80I[S9L>V6(.H+[I'Z8>/H4W
MK'WW1(S:MB'H!0C;B<O8%LKKR/)#&WQRA:K:RT0^_+U>DY]'-(<#*&)ZC#U5
M<?5M2NEMC\,)%ZW(H%2VK8/( HJ:0%945B2.$,4X [^V)+#7[.:1[=_ARNL9
MFC<LW7FL70^./E^K^Z9H1J8DC!%@?*L6;(YRD(X#.I6-:2E;?;22SEWH[C4A
M.ME%/K"JN_0Z'WZ(,$YKHQT?6UN8-Q0.$HH"'@,BI8*A'&L9R/ZO2!/D0[MX
M1=I%>=V^RK^Z;)-^VWRAR]45=V<<P9&U2H,.%<%8$2!EK<!%=BA=B2K3.-W_
MVU#76[ ^_DO[@1H:;(+WP:,<7\S+FXN/M'R[6%TL;T;UWF-X]7HQS^N[X.+W
M&:;9^>QB1JMO@WRK<L'PZ6Y]R'SLA"*(3B;P!4FKI*5QX]SZ@[+16S0_-(ZG
MT_G$KZ'?7)I;J=S5 S?9%;-G2AH9#&I(+E1V9[3A?RL2<DK.HJH1Q9UDYX/!
M_6Y?G38Y-"$T%D?1TVD@\$:L9TK[6)LG4ZEMFW*:#[HI'$=&EV0LOO _A@/A
MS8>G30*=% [WU%8'L="N8GYY3\9G,?AL-54@18D/GR- U $JEA*%DQI'VB]\
M..W3^JO30WPB%/3SQK4KX[<XOG7F0PDAD4I@UR,R9(XMGB40%670-ELK^W!Z
M'R1_6F?W= _!X5CHYQP\N#WP<GZQNMFF]MO\]GCC,PHF$JH /FK7=F ZON=,
M^Z7&[%02I:9C5;$\3>JT*;-^\#VNCD]M%]G;Y>*_UOM=[Q7TOLCY\M/E.3[T
M=S@OWYX;%[>>&RM[B-]M81A\@=E1Z!UUZ]GQ)3[!JK3@C,_:5_ <!X#1,D.P
MID+6FK0(+D@:IU"EVU5I?.<)*T5;9=)JY3@2AR!U@JA]XO^OQ98ZBD1^T%5I
MNR#LL%5INVBN@U#V^3&LI"R68!"0(W$PIA2('@MX,M7*@BZ%8^RWVG=R<B<+
MU':"Q<Z3DW?14>^@VXSKK)5O=\&AL<]MP&;1""G'P"?6"!>\S#F.DT?^ 28G
M[P2'/28G[Z*;/B8G"RVR+-F (JG!V)HAJJP 3532H[=4GVH?^/$F)^^DPON3
MDW>19P<&Y_[\7NF$L3$$$-HJ,+ZM3:U9LB2,I*2BD7>+]/]Y)R?O@Y5A)-\!
M=![99TE%^I(LW^+5)([R2VMFB0YTB@4IHO+U&-?33KMD.]E;-YPKM)<VNL34
MYJ09+6QT47)PDMOV>F$@RE:$)6+24@=I:9RLT$GMDMU)V]ONDMU%]!U Z-GU
MI4FTML\<@.VS!2."A60B0DC.\3%S2OEQ2MY.=)?L3OK?=9?L+LKH %S;U5(E
MF]&6[-GI,P2F=<P%6PEL3B'+5&P5XQBKX;8%=+)6Z9 ;<7A==0G ^Q-$;-7&
M9.LANK91O+0#RW\$Q3M263);_E@S-?:<^3)M*>1.D-ACPLLN^ND2<D\E6,Z:
M@)RM%J02L66L-42K-3@5E9<2)1TOD_L$G;W-)!@?B(-IK4M,/MRVH47T0@0$
M39Z/6E[/7O2&Q>BB%B:JD,=YHA^RYV;B#H=A47BXGO:&WQ=:IL5W #Q2<<"]
MPHC9[<.X+N1H*;LE?6P_X0NU+K@1<OZ'D#%J*G\P^4R0H9<E2FE" IF4!Z,L
MA]PF,8:K\#88K9(89\!>MQGZC$Z0#1%J0+Y*#/LXT6 &%;QSA9Q78IR!1#]H
MAGX7A!V6H=]%<QTX <^G^[36%=$R0]AF*3IVLF.*#I*-U9,N&.PX@]M^J S]
M3K#8.4._BXYZ!]WFQ2QK;TV5&K*NAKV96B#5'"%I+$$2V23'J=KZ 3+T.\%A
MCPS]+KKI(T-O*QK4I>D;V?[G+""T_6S.B&JMM]:&IV:U_'@9^IU4>#]#OXL\
M.S X#^2)E1268W+0B*&U)U:.DUJW(E8J1L8HU3@NYPEFZ/?!RC"2[P ZCV0)
MV]*>X!*+HVWU,0D3L,$-8"VB"D(1X3BS[4\_0S^<*[27-KK$U'4MC Q1J-@R
MA*&))O&Q4'SP7"#MR0>#.$YA]DEEZ'?2]K89^EU$WP&$GD\**^%D-+:]/LM6
MQI @J!*!8I(FB6Q*'<= G6B&?B?][YRAWT$9'8!KNS=M4[//VA4H56 ;&840
M@LS@M5(VE.H='FL [(EGZ ^Y$8?759< ?/(M^[=Y7GRBUW31QM^MVLMVVTQ3
MV?5\CW_S=2%B#25 $%BOZM5;O4WK!A9&D**BS)%PNC\7IY#SWPEDNZ1:Q]1X
MUPW?6XG@[7*V6-Y:"OZ2.9A=W$BCE! IN]J6,3G^Q0N(6J0V@-QZLC&6<JPY
MM8,P= I5!U,<A2%Q,&!^^,@'XH9?4U(JEMIJ2)W :*$@.4?@6"6EY*J"'B>8
M.HSN4RAG.#J\]]/JJ0U N.+^:K/>,^G[*[&,4."P-PVC5C<,(YD)2AN\\K9*
M62'5R' U*"%%(2!XI5Q2(9N1-@MU6]H07,Q2AN:2M5FL)<@V>3T 50ZS21>A
M1C++/VAIPRX(.ZRT81?-=1!$;M');)+DNP-!Q< ,&=OZ,T2$&',--A*Y,L[A
M_*%*&W:"Q>[#!W;04>^@NWYJ]%Y)$1WXHBP8GRM$3.R-YTH)6U6[&&<VW0]0
MVK 3'/89/K"#;OHH;<A)D*4JH&HOP1"?/)1>@T;2OB1&0G[J/OWQ2AMV4N']
MTH9=Y-F!P;F?8'>5E&#3"]9&#O9;!P*F-I!.*;+)1X-AG'?Y$RQMV <KPTB^
M ^@\DEXM)A<G:YM@:#T861Q$B2P3I:-RU2@3CS&2Z11+&X9SA?;21I>8VIPT
M:]%:E2JH8%N3LO1\R K;5J?1I9*QQO\M;=A-V]N6-NPB^@X@]&PVO5C4[/FU
MX0PJ\BE#-MI:&^#S)8MR,427_[>T84_][UK:L(LR.@#7=N_;60N%F>]P*4P;
MZ*@0HB,)5M7J$VHK[;'Z;T^\M.&0&W%X774 P,<>K%L.^\G!U-]-I*:+O^;X
M:;&\:)U^UTO_7BQGJ]G\P\^72_[U[7H/VDW>I!JI:L@%1!)M3+7W;?F:@A)]
M<$*40&6<J& BAD^A8&(GZ"Y.#T?]U%8\):T_*9_C:C6KL\T[4_FOR]5%$]4K
MUNN+-R]_VT6>;RI+Z=OCO&"1).\MY#87WIC0!E:("J)JK"4[S'F<YKF)&#Z%
MVHRQ3ETO..K\DAM03*\6RTT)6/O!-S8*5?+)2 /*:]DF(?BV[I&%%Z6N/J"M
MX:1/W2-\3WOEG<31F.8X#X'3SD_UBRLG8AA)/5?)EH/7N1H'WJK,%CRRW'0J
M_%L72\I)Y3).16\O$ICVFOW13GJWV#W4?SYX,^;CU57WER31Q0-[Z)\,)62)
MQ6KGP5/@4$)S*!&+)"A>EV)*-:3NM"@]N$5S5")/H1IS'X>V+^V>1J"XM26X
M,2(WXD@R.I5-!54L@E%M8&$N&:HLK"5131RI6VHLCDYA(??D#RR'(N'4*IC_
M@V8?/O*!?/&%EOB!7JQ6EY\^MX^M_EI1N5C\LKJ8?>(3VR[*M;V8Y<W/^N7O
M5O%(."\O\L4E+F=X_O:*V,V>L7OS%L<8[S8)_:-63D^OD0FJKG6HUCG3NG<-
M.UF)VN9;K(!24M0QN/K/5G6M5':^! MJO:4R6 F890&,7E7RE!6-4]3Q@U9=
M[X*PPZJN=]%<!X\$6TRGLKHRZ14XTBE@)/_"D9N#FL@6(X6/<ISDZ@]5=;T3
M+'8?*+>#CGH'W?44HS;$B'P$29K M**_1"E <$GJZ#S:-,Y$]Q^@ZGHG..PS
M4&X'W?11=4U6BJ"1*7:!)<*'$9*G5O29A*TN5%^?ND]_O*KKG51XO^IZ%WEV
M8'#NU_X&U#4J+*"3;>O&1(24%%MFAT0QH!0X3E/'"59=[X.5823? 70>J?S,
M40O4*D'P*;),VE@\9@"437P"BDO:'\,K.L6JZ^%<H;VTT26F-B>-?$77MD)E
M%3E,B25"0!L@B21#RL:0/\84W<ZKKG?2]K95U[N(O@,(/5OHBZDZ<E4R%T+S
M*5,*@I0*A,,LC-541VJ6/=&JZYWTOVO5]2[*Z !<V[W6DQ5."N> [W,^AC5X
M2#$B6*NSJ!1$HG%F\OYP5=>'W(C#ZZI+ #[]+O[;_"6>YS9B9#;_<.MI?/,#
M6F+_VU.@82?3$')P3&W1L/:A#7<4K9%0^1+12'>L386#,74*U=,[0?!9D$^#
MARZ/QAW>G^6\*:=%\G_B!9TY&20Z:R :,AS(1[[Q7,E )K-:DB6TQYH*>@@?
MO1V B>#Y_.RN8V&EUXET._+?^'Y3;V>:?IOG)>&*SHJ2N0T7 "R)V)[9#+$:
M ]:@]U[&HG&<G<IC<M5;0\"/<HX&PM$/<?^T0H7<RAT7\P_O:?F)0[++Y?S-
M]5Y$Y9/(Q%(@+!PK63X K"@"%\F@53IE-4[@.C9GO=4F_BAG:T \=7F^=M#3
MO1*?;RJ*I$74QH'(K:G<H85(04$1R51I8R1YK*VP0_#3VSW55< S# JZ/ N/
MVX9[3'_GNI98?2XHP*SGD*7B(0HAP.6@3-L_[IV?_%)YDH43CG &PN,!%\=P
MX#CU4_&$(TK:4&E+OJH.MHWACVW3EVB=+]6K)%(=:87C2 SU=D><]HD9"#B#
MG9]Q*^0O/WW"Y==%O979N7(G_VH=--\6NO_;C%6YS!^_IJ_KOW[9FNF&JW,?
M@HHQJM4'E\X$-><N2'**-,28 EM^EQBT[*)A5B9:22&Z<9YONJTYSS(%$V.%
M&D4%(U,!E.3!8-:UUF!-&*>DY0>M.=\%80<N,=]!<QTX,(^4=>B$J#*'2GR+
MM%9;5]D-X]^&'"P'3\)B[&Y'9R?5Y3L!8+N2JEVTT26F-G4=297@443 V+8%
M*I9*"I$ K:A81#%5C3-]\*1*JG;2]K8E5;N(O@,(/3\[T7A1G6[UJOR+L<2^
MMZH65!#D4,F,3Q:1_].55.VD_YT'6>Z@C [ ]7S3AJMLPZEFH*14*P*R$+SS
M0*Z68B3;<!QG[]LP?5:=%!</=Q,>JJ/>0;<YI-+J:%NGO49DRT_86$KLI982
MHW'&QWP,K^LD^ZQV@L,>?5:[Z*8#N-WO]: <+?FJP!/ZMOTM0XIM\9PW01@M
M2T@]==E,VI&UD[*?[;+91?(=0.>^:?_IZ[=GI9=X01\6RQFMUJ<NVAR=( 1J
M.PP-*@/\+PID*,($TEJ;8RV*?)3(4ZH^/N3*'$MO'4#R 3:N6P6L%Z0L09'6
ML>M9)6"P&JKST:$KF<_J.'' 8R3UEAP<" 1W8X)!--(!M.X+["6N/KZ8E_:/
M7_[/Y>P+GK/<5]>ACJ"4%!7(LAB^&9R!6%T!*6+R)<IBW;$,WE-T3@O"@<#Q
MK'T;3%,=X/"/RXM+/']U.2\;^@T[#<3N 11/JHUL%"PJ84%XU-4D:\5(BQ3N
M4C)MR#D.E@Z2=@=H^>O=^Y;OO5Q^9?S_NOA"RWGS:*^7:96:F'H6BHG,3(X>
M KNN$*K,R0I4=J2%04^2-:T?-@Z.AM-#!Z!ZN5A^7BQ9/#]3NGA'^7(YNV Q
M;9@1VF'(TH$EUYA1%:*7 91'Y7/AB+N.TV+X)%G3CE(<!U3#Z:$#4+V:_=T*
M:MKXQV9NOW$1%$57!>0VB]BT\27K;5U25;2(M>HRSOO]P_1L!2-[6C :0/(3
MXJ=-V7V@2&H^OYQ=?'VYF*_S^M<\44S)!;*@J8V4*YEMK"D6%,90 OI8[3;C
MD+?]WE9H<:>!EM'DW!UVUO-F;Y^$4FH+@7,+>)D;DR2$0(D-:XK.LC,HHMH+
M-7>_M!5>_"GCY2#9]G!+7=?)_?3U?LG<[_2%SM<O)K[4+%464"6:EF2H@)0(
MM&Z#E**RDD;:#[P5?=,Z0\=[Z1Q!6SUA\(]U1+%.4:SN\W>=HJC2"L("')C6
MMFL[0:3<=B.T5A?+-WH>YWE@)S*G?8<: R>/07%PI?6$R-_FGR\O5FN)R8V!
MCY%LDM(#T_]_V7NWY;9R)%WX57;L>]3@?(CX;V25J[IVNVR'[>Z)N5+@D)"X
M2R+=).4JS=/_B4521TI:)!>XH)[=T>&R9(G(PX=$)C*1Z<N+JHC[EP8"S J>
M*)>)U7G%\P)1C:!M>"@\![H#]=(HQ/CF^L2EZ&-RA,>((L(HA?@R'U>"MV"9
MT,+5*1=\@:AQ+T/'A=@^>FD48F+-2I#).NXY09\>W52J.'%16?P#3#91 ] Z
M+P]>(&K<>])Q(;:/7EJ"V+N;>V)[YQ>35:85N 7D2)1154!DL*67G;2$&<JM
MA$BUJ'Q8;B=LW&NO40*&@_73$MSNA%2>N9]<E6>TF^!>8M M%<5HWN=2E(N2
M\P8B"=HQD!*= E8G"=2'ND8\M2'@\!S4AM)- WC[7(;\H6J6M\QMX7)MN16@
MD\F-(Z6I0FFA(X@M.0K#9!2448GG0IV"G/Y$-H*^P1#RN#:GDKH:0.)FY-*G
MW(,W3X/4N(4)<[)XIXZ24"HPG?;2"*6Y<W6N2':ALI& HA86JRFL 3#>[K/N
M]OO;A9_VX%&C]YK0CR%9!8X;SC#B,)@BX(3'Z#Q'F>H\+=F'VD9"D>J&LI8"
M&P!IS_Y(T@F>E2*,&4^D-*4]ME3$^.05#RY+46<L]'#]HZOE6\>LX#Y45TT"
M\'9O?<IW[2K.O.<:W0V#GDBY51+4$\]#)"S$%()DZ'H?J[)V*X&MU74?#(U7
MP7>XG@;L/'ND*:R_37_ :NKL8AT:)G_G1U<8F]IOP:IS3O?@>: F,67Z+Z#T
M9C?WIO\N[AHL!:J5UHY$6IJ!L51R&3J1D%Q6F7K\P#KO(5^FZ[BM8"R4R?8B
M$"M$N6(5B5C0Z.70[+PS*9M8YX7+&VH%,R".#NO^LHNR&CB;>R;(/?=)A3)L
MVTIT>;EU))AL2?( -M@@;:SC'0Y8]M)(=YB= +)?V<LNVFH)@[T23KAOG0DN
MD<P4,J>4(8%R0[2./)>&W=97JAO^MRM[V0DG!Y6][**TEA"Y)3')%.Y?%S)1
M625D)65B@])$9VX4@Q1]I:EPAR:,&RE[V0D*.R2,=]%+ Q#K%\[YZ)1R):=.
M8YD=' 4)R Q)#L,LD-%S>ZQ.R?O>RC32BN:08W=X734)P.W1/B@E,@T.8WPK
MB/2XPUP4EBCK< -GQV@ZUH2N-WLKLQ,T]KR5V45/>\/O>S?PX>O2SY>50'C'
MT<JZ?X$XF\;)Y>1!E^-?9O//UWBHE(;'C!MO!8J4"8_"%2B"4-XT66]$]D&'
M6&DV_0#$M]85NSYXZ^JW2;MZ$LM3\\T@E'M;-CEN$P3TOR/#+4LU)2$%3D)@
M@67KK M'Z_'^#(VMC<FI#]!!M-7HP+7M)X>.06@H8TY-2: R&TB()A"90J8V
M,EFK6<"0)WRU1TWMG/"[Z.G $_[]-%7+O/P-TOED>H[[;/*C>]:^1S+EZ6<,
MD1]YA;*!4AX_HX1_('$_,(I=+.?77;A\,DU/5M_2Q3P%D;1UFC :2A-7Q\O0
M1T.<%R&@CV=]KE,[<@#1AYNQG9?^AJIZAY_QQYE7U."6Y(2ETO76EQ:U-FN2
M=:08\P7G*]7 'D+UV"'-<?#YU P>2<^-3CUYPF=W<3&(=5Q_4A4;N8W*!BRE
M#E)X&O"(U)X1Z2 3CVX:,1@=9V8$Y[*6;SV:I;QW[?_.H]\0X>L%P/+7^>SZ
M^Z2,8]SLEHB^@W,J$_#1$*FU)I[+1*B#%+P"&U6=J9Y]*7R[%G 7W+V0WAM.
M?V_%VGWT\WDG\_U+;%[_S"H6\&7*&["%5&B!L%/$I(#!B2\CP8($PEU ?&HN
M:U4<-^$UKN__5=96Z4"4EI1(PX%X@$2<U$8KC)],J#5R]0$A;]>R[8*BYWV[
MW;71Q)U>6-X)K,N=9RJD,:5))"V=<QC:8:NL)! "LXY"2*S.TY*GM+0"J3U4
M^P0F!\FY.:1\]%>;\2O9"UYZC!"K2R=(IF3A*)/,6?!29/0.:F4IME,T-FH.
MT_2+P-E3["/W*WM_/9_]#-/9U63JEY ^SI:W'1^9UT(;BJ:7YTQD1JMK8XFM
MP6B6>3#4N5=\HY=7: D,^VIO-K@H1P;$N]+U<W'Q>78]35_Q(_%GSI_A*G.
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M+96&&8/2R8.@]"[O**.V*4H2:%1$>MQ4KO3=5SE1E(%')S3W..F&HZ@5-WS
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MS&\7E32 LFT59]1J(97.).5BOIDM"<XDB>%,>:%#M+3.,?EVBOP.0=&A(F\
M-=O<A,YP"ZVDU4:5RX92Y)H2\<%:PIUC2I2GDK3.E?ES%(V+GT9]K$'4UR@,
MUQL4A2!%S(:XB$QT3Y@LPV!*6\.TC-)* T<#8@N>UC Z[P&D/10P\OWTYSE\
M]Y/T_J_O,%W PD]3EV9:#4%<_37&^372-/%A<MF%[IN^73(Y+7,B.99;>$B>
M^&0",2FF4AY4)BCVN+?>GX+V0+6/_F='5T8#UNL1IR=K3E>=+98KAF\[HL1,
MN4]$X-8DDG-T*J-#V\^$U91R&VB=&\_^-(Y[T X,Q,HJ:@!\]_EXNI,T"TK@
M_PB 0><"9"3>!$2'-<[3J)*F=?K7O$C6N#6HE2 VG")&/D4[1C"VB?<WQU..
M$OH4@D=#6*09(R?GB371DQB90R:-MUGW.#'[K39N16F%T[&"D%LQ1G=<;>%'
M9VE<F?)JLL=MH#5Q,C'\PPL12X%:I:X@KU$V;FEI39,TE#J:*)S:NFTV34^B
M35XC,]EB#%V>EQ.KDD!Q&9TM!!<K]=A^@:AQZTN/ ZN]E=" P7JQE:8W%B6$
M)S7DTN 7A4*LDYIHX"KZX+SPQYL OE,+VVJ^4Z/W8(.IL2E(;FGHDPQWH!UN
M6U[Z(\9D,3(60$Q *"6)WJ2H73'SIKKA[J3[7;KA[J*(!D"UI<MFH(I&027Q
ML@QE-<$1FXPG22JFT&13R^K<\._9VG2<_K@[Z?GUUJ:["+T!V#S37JYL*8%1
M'#&9X2&?A2>AE"Q'*@WW(J88ZLQF.J"WWSB=<0^!SP#";P!"+S=DA2"T2"!(
M H7,!!J)MPJ9\31RS16+J4X5S5OMC7L(H(9310.XNN=_WCJE'VYK\0T>]S'0
M1*(MFP2$(0%"2>L+R2CUQN7:,]NWD#7N+5;SOONABFP*E;>\W'^&V87*9UJ!
MS3XJ(ESI>^$M)U9D(%P#HXDR_'^=2[ ^U+7BBQT,AF=A-I!FVD?;YK[O!L.@
M()-#3# :PZHJR5,I"+5  7<G<%^GVUM?"EMQX8Z,NOTTU!3RNHWSJ#$&^B$A
M,<.),]R62A24&)= LE *F%0BR=I-XK:0U8I75P]CA^JB*6#=[HU'#,5,E4Z.
MH?-;VN,#_BW(X@M;PT.TDF96IT/)JZ2UTO:F'L"&T$FC[U-O9?8[^/*0JWOK
M]9#F7F]+MW_.$.]">U XT)O.VY7NWK4M;A^V820H#=>,:%5\)"8#L1E4^3(R
M<%'R2B5,+U$UV*O,>Y_]#:7Y#G_HC[-$73)4:Y*<0GCG5"8]XN',9>1,^*QD
MK#3!YR6R&GEU=BA&GGW\>+ JWI*EZ>+HP>S-^M.J69UMU![#]D1CK>#.$9U8
M+"V9 _'.9F*\#A8/F>Q$I>O"BK9G\[S_4S[U\_G-9'J^NJ4YF:;WB^7DJKPN
MN;N[*>%#6-Y[C]SIXFZ#>!VM#2$1+\KP#8GG,8J&$J_1T3.!2E6I"F)0-AJV
M;;M@\+%M&T_5;\D6?D39=.[F_AT^^GUN-?OX,@='L90"P OEB0W.E#R!("'D
M3)SV&826#&2=!Z5'\=)6)4>X:QZ4M'7R3Y^F7Z!4)I4&#=/T<3:=;[[L>J&L
M+JR%XU%Y$,1!*F%*B!@.&4N"8=YBI&2<KG,%.Q@++5O(';#WK/=W5!4W</%Q
MR_B[FWN6Y)<Y_.NZU!!TU2PY*\."HNA,*R!2H$?M- <2O1,J!86?6B>KU8.X
M1O!X7-@\!]Z!=-@2++<QM,Y)Y^BSQ["..-S?Z!$Y3[ID8)+:4F.%,+9.=J$'
M<8W <BA / >X@;33*. 6]_?JYHT@3T8R 0@+RHG4Y8:[U"Q8A3YQC)DI5J<&
MJ2>!C0!O*&#T -ZA6FH)? <<(W=W[MHP0Y5E)'D/I?A4DB"H(=$E!QYB]JER
M/[8AV&BD\4(;!_O1<=' IOA]-H6;W_W\#UC^<CU-BY/E@\L+9(>&4!KE)(V>
MODSE:2/*FECM)0TZ60MU8/X*88U8X.-#9E9/?PW \?V_KB?+FZ]%4)TL?_GQ
M<7*F@3J9J20@72!2>H7[&KDQ&KCTW)BLZW0ZVD;-V[>8PP#O8$TUBK9_H+3\
MY>2_(6WZ>)])9S4%90FR%HE401.G')"RM:QE"J*ODQ3M1U\CC\::1.2!VFP
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MI!12<J")OL&S]N?)CTE"\2T^^YMN%W17U *!3RUS).ORD,9 )C8)2RCD(&(
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M]<[A+$B&0H1(8JE3D)GI<J&/'CR36DC->,AUJH3Z4#>.4]LXC =7Z^Z =2O
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MAUA;8>^CC:S,G:,90RXJR[!,C(@ HW0,NR X7\?=ZD%<:\#:!P5/O/MA5=(
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M(^-6)[6$Z%K:;Z*R:6\!K/1QICC5R<1 (G5XX$ 4Q,I2K,ZM,$P(K4T=1^-
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M/9W!JMO&1"AA8M 4=^% B52)$IN!D41=:90A$@MUHJP^U/4#U=^F]?K@"FL
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MI\]^.B_O392)+C#)21(,B!2&(G,9&=9*<H=_-+I.N_[=:6WV5/HHKN=@6FP
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M@U:M[OWT2K6LPTBC=H4KFE"K(AB"QE0CSA4C/D9'P$B R+4-X3B#B,:L< V
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M*ZAM=F0&$1/SQ%"4D[0,>7%:$# Q..6I9J%."YK'J&H99OM@X.XQ]U *&?E
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M\>D)1K_:[JB,/D6;;8ZWMA[]4FVCU*5+:)QJG6R)UK[U#JQ]IK,AH67D1R"
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MO#Y6:I9+\KM?/ L;<F?55LT.*$)0]E52]_8-)YE>$6PWTY#X<[R:/\]V*5[
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M=B&37:ZP7('[ =XJ-P3$,@H;%'*+']^[R^.R5(0]%]89TJ%FEW#)N2&#:54
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MC#Z4*0R]U^?:$L#;W'*U3K?G9*U<GA_!X_D104@OGD!(?2)BFSB$UJ[Y^9+
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M526M:.MO:3-^Z"XCXSB/R/J<<5'DENS^=^NT^U^1J38@G2^&2$I^K3$H,(H
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MS=00R#W!A4IB'6T="1ZZ]6SBSB#A@B4CK59I?RWH6R!04)[$,+,9X8BD>5I
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M)5@F\[HTV@*;>3Y9^MGPECNK/S5UF\&:;MG<_L+081S(OM&._.T_/7:YC+"
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M1>,D@_*Q!=2'BG440C"&5D?"IP;"XBP"ZK\[#'>"!Q-EL'_TL(G0&'G<D O
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MQ']4X6W-IT"(*L9&Z4>K!K)D8,@'./ _":R31@-V548KF\/D%@;7[O=A$X
M(PC [,2:#\0%ZAL-0-?)P48J:+4:>X((O$]%F0 7Z#%P=4$"Y:4;M.?!-$)T
MZ77KF"<\YEB.F1Q-&W9RP]&W20WH$XTS@7J.Y!:YQKAX?"52'!-S&HU!%.4
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MS4GK84<C?=-*'%UGGD=^B:'#"D*ON.^ 3S%4>599HY6#IY?I_J+)V(:-3!C
MR-D?([,6!E?U')\E&>;G11C$,NO.3=4KR%*3*UDR&(*@-+IM0(@PR!PP_@ML
MCS1-JPHL"J:=XB9_$ML,M']%7F/^#&K>7LG/([XZ&/Y/-7FJ;Z2R%R#:(@8,
MP$CYQ,>^,P;:N*2'C8_T(4%#@0/]*J)!L6!NAF>6?J@.5B@DA!*I;M*9%V>@
M\<$3ES?@E]ZM,-:*;1NS4ZI_R<"MFQ[VP:'D.AJB;9RA,GL#+!40DP"G-U=M
M4&3[#)UT$J(P)I8]W&ZH"H:&B(LA[>1?_=O)M&WC&-XOKK$2.^\)&Q6WFLXS
MX9PJ.M'H-^8%?3ZD_3KISWZ]V=E%'C#*8R(NR(+L-0,/ &D!Y%4ZY;Z$)L3"
MLET@.TMM[62%(K;:1=-(Z.5)DLI0J*'*D<F2DLY<B/@+W7!5UMO?SK'(%8&$
MT:QT2]I<W#+^[B::5P6A_:AU'[5UPOY97 !O3"<%)FUHUC@IZES27AC]>* O
M,#6,M/FE,%#/'IM5W:')4QW'3_5E+APNC166*-(5RN3J;RL+UGI+62:W!< X
M"%A.75::*^DL(5N_C.,C85&<,B@%#F$H\80VL5)&VM>A$76>+I:#UGO53DZH
M7' HU#P$&EXOG&"X0?'MI?E@F)BY2/+)=Q'2'S3! \Z!00AT8LR$%F8HO3K_
M;W\TW>N=0^R=!*=;(@!M4M<5CHUCJZK*?E2<L-\Z9J[Y@L>>LC)B!T<'"I ]
MX%)% ?1:5IT\/=9GV%!JK,$:5BJ/G&*ZIFXKK2):PN>BEIM(&AE3W7K4W>JZ
M#<]J?_0;*>\ZI[G#E.[@-A)N-["O9 NMC'"0XOT>HIUN4+V_#V"[8#6"[1PP
MQ[@!D BGN?R3RT-FQ6>5U!G4U)%F]Q[+8D#33T+4(6,=#7XC)CNF.@]5+*)Y
MR?!R3'Y& ,UIGYBF3);!@3OLC<>6'V(CW!2$/0 9]E /8@0&2&^2!^(FNI7]
MN:R(@G?X/9)"4N\\7-D!6\F!JM65=K!3JX,A2-<@L@P?KI^0+-Z]5$*/(XJT
MDO,60!I>PKZ,!9(ERL:=BN?H?HO2=H58/<I:FG^"!23NZ.;-49"W"CJ(FICA
MP:G (LX2:F"'4H\OO!)F2YQL#ZJO]S_Z8RN8\0A+P5,25>\2IL"!^('H+J'T
M69S,'!DC@.XQQOZ[)?S0?19S@I*C =7N"<@YGGK-'=!!8-G1IA<J_2@=@[K1
MPKVJ8-I I.9S?Z3&S!PX"@4N%]!NP !*AQV./@"KVS#&=SD30469*6$8!;5$
M#$&+6F+NA]"^2B982J]ED3E57&H2* -9-["8GX=];_>IT6+XQ/](YV+Z\=(!
M-61H&7@QFD?!US*]C>)%8'* ,KMO]?2LX?>:'\+,UD;7W'-J3P\=^Q59DL /
M%)GC(LNX2@$DY1NR0C:K+&00R*H7B>FW(:'V*[+@H!"#H^E:4YG,K]$5\*L[
MJFUI K/M4LLQ?7H#N55%<0IC3;)D=@,6*%74A3:I9JC(3Z[2<G[C87.2/YM%
M5256P>!K IX:@T%4?E%<IQ%0?LINPNE<_.-_BJL XSJAR2)=R$:O0D7?I+.*
MBOO21O5Z""8IUIXPO/=,-EASFP2U=#03W[3Z^W#!(U'8X;]>?<!J:@GO8?>*
M*=GLD)0L1H2O B@PAF=F\%_2/1E3[3K\O^Y8+):MGJO0'4^2Q2A1VSB);J%^
MG;TYD$Q-0N54.N)JJ!H0%!B;JI'[$D;7)F_C#HHT79974956(;MVLN+)> ])
M,_<UPE.2-HBJU,ACTJV/>0OV2Y<].?3Q,709R3S:+D<V(;ILE_25PCAEY=%N
MXKMY-1&?T6X+8?^40@'9?!$8#[Z0KM?GS\>,F05N8O9?": 1Y4C2#PA=L9<(
MFH4UDU )'@-S&/!A@).*QY9JI"G5(21N \LRS;/##2RK-SI!W(EII=(A;L\U
MPCM)!2U;M]NG4NEH5;YB*VJWPK-*,B(Q':?( NH[5,C9JTJ1W8\KV2E&Z'P\
MY3A4@R%=/0=_27=5I"*(U.AVI\$>R*#YJ/I!7A&&]K"9'[5M,SLLCN&UQNW"
M3=\D"26&I9Q1A\8P5=10O!#O.=UM0U57,Q5=D]#U*;RU?MU33PZM?HQ[Z@14
MJ#0120XOY>738G9CZJ IS&72<8LT:2X->P5:R2"BR0IT@R!C=%2?,)97\BDQ
M0LXENO.$FU8B#XWG[<X\-%GB*O:7O(T-ZVO)SDXFSRIJ09\$K1%7^GTLTR?'
MX?_:B:=8,4KP.8(-J&;8/>.$:0*>!>D^PX;BSXH<2'PKU4,B;:N$-UT@XVZ]
M/S<#N8"5Q0-A=2*2\>PRN08\,? !&;P')L,/YZB Y ,NWB2ND><#] A5&%(9
MZGQ.O'@>HD%\ KJ.I'F6DH_Z]$R+6]>V,F0:8%82$S'0U<AF.5?$551"JY9"
MTOVRJUK5J9?%3[S;X#44 TV9/%E2_5,N03C-*&LZH^SOC,N_"2E9B .8"#-A
M7$R11DPFLLP1Z"Q6CCP8G4LA04^\9,2QU<Z49&Y9TS84@EXF4V3IFA,8""^W
M1?785!C]TE-/7L7P&);)=UDNE,L8&D:-@?<YII@+1Y&#CTF>DA( EKIQ&=U%
M66=32*,8:>&'DU5&[@P^Y*NKDO0)F.844H=ME-6C\'R#+FE2MNC"1GJ2I'-R
MOT>P%:!G8DJEV^)'N]I4#VO[ @4!2;0+?Z=+%4$U4]W4HR$9Z^0UJOY8[P#I
MC4E-^HOZ5,+2JQA7^W I>N7A -+@"Q@"L\03LI/A)1YB4JLS"E' IMAPPFA^
M/>"S_.3%%H\6V;_@>J1SO!@\Q/?*XC=IY_@:H<N[Z0 TV?F4M-D<?4)+0/2+
M6]FTHFC0A>&^Z?QJ&)9)E*)0,%OIMOB >%DEC(*0:$*V?Z14E40!/$?0P;JJ
M_(D'?,)-<<<E\FPD)&.K>2(V;D<F&.P@5LQ2THC>E\E'B-MQ*Q5#E@\@O5:6
MG&U!7-W,#)*H)_H'BD<XA2V(H!D7=JW%JC+Q#&I2(7[UJIB\&K/+G^'"\<6M
M@N<&]-ZVBG"X8KS%%9YFA.F5B!=2 S,M!VF&-J+S'2]0JZM)7*4>R[5RU=^"
M9WLM),(%\R@!+2;T19=55^!1H)1*H; :LFT?HH&S#(=(_6;X_4"14.2O7"O0
MI,%%0]/L.PK+>*MWO>2\#%F'N3>YD*N$697.:TG/ZCTRDR3)*K2:C >14 #_
MKCBK*!=;Q@@@>^7T0&ZU]M0UX;8?B-!<S3!L "DQ^H?&:3=9ZK8HCJTN8GFD
M4:< S>AMPMA0X>J#IZ%8$3FMF%# ;#LTEL)>/=0:,C^C)$K>>AU(&!.*ER-E
M0AR5)3#0P<$#0$8M;B<,ZB,7'2PHGHS_P72GL6%Q6L;U% S>&,WAHBV#U";*
M^&CQ[*P07@WY&W"?<DA0X]1-@L@5E7!HLB?"6U 92<+,3%S@VBJ!-"H[6=QY
M4;=M*M!W13'G)GU*^<&MHF&JL3!^=&+4ZG12)8:#8B(:S<^:[D0<<3\K<8\!
M]%;\^$:!_6YJ<9_" 2OJ$DQ4L_7*[1IQ&-W3!/G@+4=@7C-L&8HME_D4W*:-
M&\H A,%C4*\IWKWF'B#?-6ZMI*F]P=NF G<00M)&^+H]PJTH'*5)C^5XTLSG
M<Q,K,$)H/D7&1>19:N,M]\4.%=NT$MTI16(D8;09LC"^!2(VIRM -=\.I$I#
MA28."C2) ?BMI-[.$J$6D8E7Q4BYYB48U=#U-,JQ#PHE'.!J^;9SL;.MEDW^
M!A#5@)W@*($G!:Z7$R>Q/L+>G>3;ZP]CUU+$U066T-/%V@.Z.*/?GBQ46-[K
M';((1 4@*V13)E"F?AC84,=X,GS?J'7@0H],105U_42=,ST=]1"!QL(W!;6-
M &"0T"\A'TSP'TE7J-<05CN'@8GO8&6&0>-H<-_!PX<B^_MK)/N?H_RZCJY?
MNHNKZ]'Z \3-2!-P;&)@A-%(^352TF8\*_0"P.IE,*XL$D=5C\A:$&:DEZ\G
M_"RRAI<^6,ANR+TSQ7)#H8<;,;7[9JH8&EUPJQQJ?T#L!H/ZW'UY1>U@H<'&
MA3!T5:V;#0&F:Y=;&.;8_UQ.V6Q8(9>#]0S\&LQK(R)O/$><_8JQ]3HCJ?*-
M\E'\K=#W1XJP82U1D0U%2QRLD988@3%7%GD: [,HMA;O@<)PH"5A:WD>D**-
M$ZH,(C)Q;%_(Y\!JTRF;WD+VA7@J.K#UBR#1"X/^I4>5<66 :2%+-XN*]]0P
M[.>I'N[HRY%YWHX&"50+)XBQOX(UHZZ'ZGF4G+'()BF_F,HNP_ZF".!UI,(M
M@1<ONALN;7KS62?\]:"!;L/ONK=WN$8J^H(]SL/=]T<OS3D\";:.MGT66Q1<
M"$\826D5<EPR3P+1;%=8\X)@>,H39Q OA?>W/FP+M3]-5%EQ49IT(K*-S2Q:
MM/10-@JNL?>Y6;=Y31D*Q2;%*$/F-K.X4BFNP%!"XR'CA&.C%G\*Y68J8^?D
M@!E=E@7G0(91@Y8=X^KLO7_WAIK&$:6O0MJ;^R\1]X37L-GLL!=[='T-03V*
M[D'G!A[*98EUQ0MHQ2U;N\GA[>W HU_M;<7;6P?;'(7<DJM#=IM$_<O96JWC
M/O BJ=%1UI+[C_!=EDZEHL>HI4:! OR$!FG.%':MK?$B75^P:_SL*OTI_.!<
M[")7'JM^D/AQJX#-$7MA]?+!F]L1LNY9\SR-THG.J=+::"]<4^Q*&6Y,;Y*6
MT*!(3K):=7HIEY6GN3 0HK%L4&R\1S]=]D+77?8*2&&I2':%W"TWO,PK#0#C
M:+B>G)'BS2&4E E?BFZ+=/P0*=G>"8Z@]YQN?^W?*V.$<MN:1+ER7=*<W3\;
M5"0;Q%>QL+#J+'%:MR-WAFHBKS3'O9P:ZV: ^]&Z,%^]8.GER7\_TXVY4@K]
MX#VFT$>?3DY/+D_.3B^&898@%"R.9IAG^)=!9[(T#D!*VCB5^!V'3T$Z\E6"
M3:*$6%\EXON/W0_@)>VZ_IAUV$WB;__)]^8+#JO#LG18<E[2N)2$,-17# T9
M74DQOTL\9!\RGV1ZM0GDNO/8:HG!-!^R#VNC"I,II-K^WJS.!.W>4I_I=/T=
M2$2K1V'O=3A6Q]#:MC^'Z1=(&-V 46XP[&*GKK:'Y<FU$&2VA,"^FM19D.37
MLIA,7&S3M(+:J!K8?,&W4E@A"O(EGF$?WZ3))!C]3.(:D=EG$-G7K5CM%N9E
MUT_40"GJE23;(4%T )Q1U)4'+1-B!%(2"5$A-OPE%F=56-58&S2,X]ZC^/4Z
M'/<1L(%!^0C#R_IS\J,.OK$M(^D#?8<QA!X!S\)G8(8'(S/XF%8*E58BP %5
MVS8'0]A!5"W#3XD0_]Q@CJ^EL\[T9S?,9H9X4WA&FP*!M-06$_RQ(2S)VQ9)
MQ)6B$E@Y9K]X.YAEM:[$6TF- 2PDJX(WKW>"3PXWF-1!8$TDXJ"FO!:P$.ZF
MDP$.WY>A$AZ%W!&[NZ!O#I1\9P]?\^\-Q(;H4<1U'93*)WQ=\"4!T'>/- H1
M.P+KJ.18(:I"<:9X/=/I-!GCT:+QZ <@?EV<Y',(GNR]V8JVX;/=]W_L;0F=
MPI?XZ&<L5)(X_4< XXPJ"B#A3V0=-\='"8P*L66XK,7_BPOXM)N&&*%X%N4@
M/%-EOLP8,$YRJQ)#W'NS^X>DRUYLI8E0,]A>F>=+L^3I[?!LAW%F7^_0['W_
MV^.S\V=1C(5J!F[<?IT<%G$=IB'&-@I%SJ,?"6'M964!7W_!79G.YXF!FO88
M\4-JZ=@F=$=B"0&970+0F;6$G\JWS:J8U+E<\7$]3]F*AUI/2.C@]9YJ?A=^
M!07LXTB6_7J+=670VFMS( 8/0^]BZQ J-Q8KC^Q3UKL!Z##%6@#L^@/1\[B8
M)1IVKUZ#R('YO$R%A25Q5!AV2+P)$Z63$0+%YAJY1SA%L63'!6)P;')W8.VZ
M(_I\*N?0U.WT0SD&,_?F@S'KJA3-BP%,/%RR/*NOLC0&#O8R&E,N;0H)*HS#
M,-*0"P6%$A93#HPSKGO,Z&%SMYF05P;;),7WE@Z?<*![2BT\;]-R7OOX<^4D
M8\YP$!ICG*C648"]*J\E?]?"H686RL!0$<T]:FPO-"!.\_8J82DV"C3'RT^0
M4OVIVU@0J%P(Z$:E4+K5#B=?:8(EK3(6 <AA^(3@"BHCA?1OK[:E ]%G'SKU
M&5@>6(^!V[B"D,H$+U&+"-'*@8&;BUHQ) J2A;4\(%Q .CP#E5*3OHDPH4=<
MX_=5"P/9D./5+IA)E&: $O/<, [A@G&UV\A012YMY"?Q6+6HW:(<R!)_;%WB
MRQ;=0-E@3Z4T ]BI=(P[%V/A1ZIB"'1!J[9$;2>'.""0\_S5'5)C3J>@=\0&
M(X8>0R'[KP.Q(+(/"M5SMIR7)$Z4C]'8T) [_%)92!E!T0FU:^"&+'PUR!ZZ
M1I*A(T;K7D:;UJ"-#.";04/S?DD-#*BAXE>S^U!#95P+X:YD+P)/W:OL</(3
M"!*,(V=8( 9O&P-Q#G:#L9 1^=U4W*=P3:SX$%^R4E%JB'G(IU.<%&'$L\YR
M:3T["$".%^WO=OHUL6GL7;EED+Q@*L2 XKYR64Q4DG13[KDV:=. 5B7)/#GR
M.=0O5,>;2H]3UHD[;1G@J\9K=P:2HWFSGJ&9T<]9ROOU4=RC_0G/J,P$.8P2
M+@ QF!0IE2L#-L.7-G_E3P09G-)YC"H3+NE,=UC1P;?K*8*T7;V5/C= C1 6
M^@;Z$@-)![U;9^&AL]XO\6%[P/0Z472\ 4$9X10JK6*=)MDR5)I54T4-1.3>
MKZ?(03J>\V1.4KX_ A@%LYM%E<9488YL29EIX.4JJB@$2R?^(TO3=?0APV;U
MF%P?:T@"UCM --.L=F\I**;T?9:8-7I(S 35[>)!L=WI7H9C0A\?'7>2PMJ!
M2%?MZ9+B>\T@7+9X:DJ/L%IJI2H.FB VN(1\:MEL>7K?50O%XYH/P=*&)(?B
M HIW4(7%.G8E:@DY[*ZG8FG =?JC3YX(MA3--10) $9O=H.MUV\U25E$!#;>
M0_TE_D=2@=]JNJE[[]\=&N!"+BTQ$5!0P;O-8>(Y= $4_O/>+N-_S":;*V"5
M[H=0:FQOV(E,@H5O@)$:P]S:VZ<T-,^8<5=#.<E[ZWF2V1']BN55/3K%-ZH3
M*#5)C)EJ$D-!R@VS\/G$OL&Q<SBOJD[.[/'+)6"T-2<G.Z_%3Q21):&(;,=[
M(/*YOY[RV1)-[)&D=K3E;=7+D=;+1YU-YF5C>;".HM;0:M/2U)3%RR\)-1@J
MK03:,ZJLS&6*N%31+;"' ?4*GR/E8<5=(L3*2+M2];"5QF&(!,] 0P4<.>-:
MY>K:DF+08^4^UYR>P18;WHV.NMY8OO/CB34C8QC,8 N?J5+4[<%@]O<.UE4U
M@$CEPU$&Q%H QXNPL=APVB6:(7HTJW6?(AK0?<.])J=:,*$I%E8_X65?+[(T
M9O"ZLEA'NIS%*EP+VXJ@=:>DV""AFFBGKG*U(;063)DGVFI!(PFZP)F^_WK!
MXYPUTV.0Q.TY,!A(;KIYF2"[C21JE*TK38/:(#"5_19]3 L6RD/6HW\_$9;(
M>U*@J]7L1EK8B'6'$ +T4+EO-CV!,4!7,-U;P'@T$F@K1E!R_:$ROII0WM#8
M2UP=XP1,$ /7'!:4=LB5G #W*UXM:@M@ -0:Q2Z2E_+F0\TU;C)/WR(4&I*6
MA5]6<!Q#"B\<MFKVH-^J_:8HYZY'WA\U7^'PW# 9AA,G&$OLB.;Y?XM"-Q1[
M8DVQ_TT6HOY(W/Q&7#.&"C0J:'QTR94XW@>'?S1G5.'?2?L9=Q<2"9GD*$-1
M@&N*=2 6@;.[/,$6TFR ]4D<_<K-/VZ+FJI1>J5*)H \$9RP.D>B?V&3GB9S
MX64Y-B&0#_H\7;+H8@290VE6E%5&>P]HZZ&@MOYAPDF">AGT06UO$0\'0.4!
M*#WWFLMA\.;UZ]<0.A7VU%]BY0 GNO=F+PQ.L-]H* RYGV(=WK[>/7C?/%ZK
MP.Q^2U#FVW90)@PW'?^?OZ6[R>NW[Y+QV[?[^]'A.(ZCMX=O)F\/XC>[!_%>
M=/7N_^T=_.VW07(N?]/]G_-XN[Z_$F74Z,O7SV?_'(W:R9G:Y+-[QD\OU:O-
M3RB0T<7%V6EP?';^]>S\"(BH>C_HB\NCR]&7T>EE</8IN!R=?[D(CDX_BBF<
M?B0FK>#HZ]?/)\=''SZ/@LNSWL_G["N..@S.1Q>7YR?'EZ./P<7EV?$_FG\)
MOIV>7-Y?&)][1K =7T?GG\[.OQR='H_,L0=_GA^=PGPNSX+EIZM;,[SH'+]^
M.[_X)J8"$[G\:Q3L[^X=\$2_?CYJ/T4]GM((2T0@IH:(8T+M?4C$<#$[^T48
M$ON'H9CI_OY & '[0PCX?N?-'G;N/KT\/_OX[;A3$Z^5[W/I8?5S@J^4;8(P
MVX(3/C;Z3\>359,";"EBAS3;XKKR=TA_OE)'@I1:WN;<<VR:) 1?,ANPN>XJ
M>7-(^XKCRQ=,7CL3CD:=71.'._"MXVQT;V(D)95=L ":E%=4<K P:.-6:[,B
M>YXB)DLM%ZWN=7&;E+ &QP8Y(RT9-@)626HK=K32>Y=R-!I4\$/A$NV1ZGB]
M0U5,;$<,0VOTC09S!>Q*+T@H(4ZA@"@M^E,E]YEJDH)W&K^B)@)'&,,0=(R7
M*5E)3ZD[G<G^J4:I28I$.R>JM)MC(#.5/@E.H9X^FM?8]=WZ6"HXW4>6V2R=
MFX"^+I9B!(3&OAH7166E BN8NL+^+S&UJ+IR+IC5\F%Z[@A!@, GH!1\J\9:
M\6B&'6Q_JE24O\<R-(=;!%M$^"SIRZ#@ME*4#"OG['*#.%ZH [/-!RV,06E@
M;)V2"VXD8NPHQ+CN>QT/0U'UC5BTNW2-VV%^+5\8N\029 _(8;F%>C65.+#K
MU90DAH8R,_! UY@G+P/5R.E3E);"@2E_")OD>Y1IRA-6($XW8:F.7)S?0&2V
M;^R8:P$,M6Y6+74DP=R,0/@O!JS,P U8LR -S%]$N('U,6,E^+E61V7W[8[*
MO4VJN=/C4(,[%-+T$$[6M!A;:3OR52R3G7]7:8@JCOO[B:W^>=!J3.!-:#(*
M[+G (#I57#VX ]4W9LBN _6=A41(QCD\!(1'Z6':T^I%S]DPZ!VVCK9[(Q/[
M.WNX$!=:7;0>[M!P!+Q:SE!PM@9H@=M)I>2U!\V&;TU4/>+66DP TYP?BLA\
MZ)/(O'D'"P%\4K"# #+4'86TB("VEUW6J>DV QDII!<+OP)Z-2F7RI0DID*B
MWEHY-9R9T,W1*'\(W;ONGA?6:2%'S!2L>M VW/JUPH_/"ZAB;/B:5#1Y&Z49
M3H)H[UA]&B!.Y8.>P")QE(]6Q87)7"56)Z&TJFH@3"1F33$$>O'+]B]\9)%\
MOT0BWQ^":X4I%0P 8-SBXO(XV)((HFU?<OHW2:VSWAI>4\/7:V1'?0;L-2"$
MG6L05,Y1'"=9HJF:V.;J@<=MCQ5T88**N5WO8AOE7)$KQ&DI='J%_*Z5=<&K
MIF+6!2$9K^6*0%? 5;#HI,2_GVQC(( 22-6P2()[(^O2/CR9V)@VL>E119U]
M80N#*W$=!1.HA) (T!8,O/@KG U5]ENU6XT:G%^93;Q5R;._*CKTU08W&QIH
MK+\.@=L"["G)#,!RV/JTO96FVT@WR]79S;'3=9[DRG85;FZ6DK6PE3*!Y'N+
M%DW1Y'3PHK57[V WT50^N>NX8A27-L\3-VA$+>P*#2JQFP=WXN0Y!AL:1MP,
M%>V<UL%2K]7(Y9T0%@:\ F,!=T7Y8[46%U<)D5<W5^WO5>!%Z9,YZ:6\IL(.
M+-28P?Z+W<\2R%Z"XH+A<5]-3T4DF+NZ*M(0:BX2YC0NKHQZE,6S;'XD=JG(
MX5U<76F4N]RWE9$L-ZX\_$N@@G5^ERG9(50EJ30V_M.3^4]N-P>C/8.\]72F
MW= _U-IS69<KNT1*Z<Q6;;N2$I/JJ?MXJV2<I5L(X#!CQ]#1- CM6$@E<R>4
M3%6 @AZ*^!WW3_Q>XD:WB@#]EW>;V=AV([KWEV%-AKX+#OE])G66+>S[RQ;9
MU6YQJP[\,2_QIV9Y>%GV[!X=A9<S;JVCT#1/MTQ+[@EMM%*3^30MR*8Y3N6G
M=O]P_I;J,T0=DSJP&IVG*EIVJKS#OAKTD1GUY\@<[.P?]N+(-)P\# #<JSZU
M!4/83QE(^R,#;W9>OV49P,/8[(SH]D[$,OJTA"JW/$^%75<9?59LKB03+68F
MP-L2VWZV O33/VZ3TU/4UXU6C,&=L$8U!:"OZ>%#NE:LETCU2*8.=MZM)%*%
MTV]S1:DRL$/8F(]NN$>[RZ Y4)H38=\M%G.VRAW0),FO2Q9W5I'>0ND"6WJT
MJTE<+H7N,$ DXD[LNLF)R^*Q;_*!7L"?^G10WO;#?5,!5!2WX2K)_FR]O'<O
M&RJE@E9U$7,$.\4H7K9,UJ/6!;W,51UC$!ESW*M<S,UW=ES5H^W-;?O\MZU/
MD" X]VS"!#1+!E7S?=_;;-*B#8/FRYY:2^WM[U'KY9>1KZ@WXK6WMW.X)^7K
M'F:_ 8JE(C\ICVC[E80#<P7M%S24:_#;<7?'E7#UT],NLK^TK-V[_1UY-_8W
M,)^'PGS63;==]4>W[>Z\.WPLW?8 O;;U<_LQ@["]=%P7VRU@D&?Q67\#0[1'
MENC>SNY!+TQ1D#PR1>&USV".TG&.MA\SXXG'E^.BWF."JL.PN!F_W8+/+\2%
ME@+,N#&\9U 3JUOU*OV3Z)-L3YMU2"NBZVC;))IP6DI2.LW;*0>+6SN#R&[2
MS9V$E?]EH?BEJ7RTIC*4 -R?_=%8K4GCZ@;/U3A-$!MP=Y-FBN67]KB=%EBC
MM10$H!NH\V@*PP?5:4-)W!OHN#29B_C)KA1NJ*E+/#/[X! JJFH+'$@.AS"H
M<UW/X2A%/&UFAISK.&(@1"%U9?J16[A7"TFR'TVA\IZ#[.*T1]2IQH%*X0R'
M<@S_6H-C"!3:#XV%6R<QK8S.]MC5_ ;K<"SCHJFG;0"JS#HIQ=YJ?I,$(:&\
M1 0*\4HS'^Z(\'=PI3"JT])#YJ 5!K!:&6<4!-]F+,3>=AWJ\4LN,G':*J*1
MEM]1QU/VS8FR&$O D*:^JF'T2RDB'#2D5FNR+P@;&;HZ"S'6FC!I.4!+=GA>
MCG"T-[L4 @LJ9ZS<"'E-A\%-<0<)D] R)Z1(67D<EHEJ->/)$EFP0%0C+C"K
M0._JXFIWM&JPAGS"I@5=FR:Y2-Q;Q>A3Z#$G90&>LK?$O8#VH[C:J9C3!%%'
M8]!\9,\*SRXNTRN3=LJT=_X:2GNN-VM4X/0E$=8_0MIE>?A+TR]81\@R!72]
M$0JB;-4)B.,L"_A*USPYB<\@V)09/=-M_F$17*>WTNZUN*O%3H&'&-5"]$JD
MJ"L3*%> CJ)(%V6$@$A'"57!#/(ALF;/D]QH)(QWJ)(2JB57+"^-TEYRK'5S
M5TUP!!Z@-#"%)%[ 8W.32HHL[F(J1#-5?%ID/&IF&KJ(+<J;:9W-TUF6^JXT
M'I5ZL>KR"+1/LM0$_>H2NM-=&;<8?8M)%U&<3<[Y.*INB&L+JOJHNEZX&/&/
M,+B*\A_!N!1&?(BW!'5TY9H1<-43J*R!6JI9M)"H?@HCC!-?2U<8<Q;="3=#
M_IJ^8K5$ 7,DQQILDX=0736\,G95BW@NB$H%31[':06TZ-((:^@),5;/XN-Z
M4I=(>AXH""S70>['TD/ SO=QMXS2ODD^>0S!8 ?9XLZ8C#E$ZT8W0B+*"*VB
M=,R#(E])/!2K28()$!M-B=CH%HB-PL!N)]PT*,(N@0QY*81$UG*KQDD&L6_<
MNBB>UZHD7;7"E4-SEPKY[V.J3,HAU 9\#U3SWE@%ZM=$L@W+R?: WR#JW  V
MO]Q5%LL/ANT$?$DP[W@.8E(EW']CGGE$=@T<7)C>O 3VSSRB1@%FQR%WX:C+
M$E1W&?/$+DZZ8BSBI3*.M]L# U7:5-V]\O1S_>Z]!-%8?G$")"D<9BI(,T'[
MV5KZ 4I-VK$H5^=XC6EA-E;(58!J1(SU*[]/=4"X@N&,D6=/R=.69LL3?_YT
M]-^!.-MY-4TKR,]*9-L#3B"! 1/L$08V95DFMX7%Q*0FB_-2;'AH/9A?3W,A
M 36;M=R,4!8-ELDU,+66:+5"K(9:29?%CX1.;9*9)T5?"(80BJ_YE5,PR^H*
M-;R15;J,?KXZ3\B9.IDGPGG:LKO]6(V\WFPSU1\MZX3#,F+T<9*,=<^S*M)J
MW%CFER6<Z%LB^F"3B+9LVO>[L^Z7KZ>YW,,2TI.)IH?QW>97RIRFVTE<T9 /
MC:JJIMIWL'*HGTP8@/7L-4+:*IZOT]M& ?7?*^/IZJ[MXF)%ONZK!+/ =1G?
M1))XQU"<H*L@-$"= (/;5*PI/V0,5E]Z57-Z2ZC<8N)+X-#UJX;F=K$5!K+5
MRD_57V'-=J0#[#P5&1JVS<EQTMU9$B])NAOXOJH4)RL&G55B'%ZIS<0*Z9/F
M!5)QH,&XQ<7;\'<*JU\E/.))FG%@G^/XB2+OUU0'WW8N=N!*J&'WQ7R.8C0
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MCB6YM5(O7O>T*;@?5%73\H)[SY4 <4"9>!6[7R9QDMX*I:[-8\0F6RALH[+
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M:L-T4T%]N8!KKB8, #T9L4N2W,+6-4:24?5SZ%;[J!3=XW9F=IV [D&$.TD
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MA/K5JWSX:L#QH!$N'%MU.GYME4:X)C-.5\TWOT%5CTBY B$[>F*V62D^2BU
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M9]L"S!>JM]PZSTLZSQ7;JV^TPLU<B)/4WS\L+F)L5:VFAV<9>:$%%BU,D,F
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M]N 7]!0&J.=RC+ZB_X [+'+Z)52IQ!IT)N4JXU1)>E?$N46%K(^*\P>EFA_
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MB-I(M8D^N,<6Z>FZS9HVTT4YG&V!TA+@%C._<2.H :UN;N3+CX9IV76N&A8
M7%]P!7';9 0N%$K()RGI)_+@*S+.'B)XW,A%",$W$\*#>%(6YP7\%7\?,OG.
M0+G(\@WY^_VNW6@3FU[4 T;JB^I[$#>T6AO)!VK@43ZX3>CVA'/#WJK!7'&Y
M^Q3>:<G%#FW>(O40>DM$4$38@]PH'XB9DG(7+G=#V)NC-:(4N_IQJM8TF^I5
M!>$QL(Q8Z3BSA [C96F:M!75[G#ZLSHX+(Z8RUCM D!-H+6*QEG<S=2Q@97/
M9T6,?H>AX+S?H$+3%37-+UYD'5>?8Q,"[/;"*OX^K8F^A0J 83 .K.D1ZGN
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M\\G?WS0(XA3+;?6-4"@_X!4P?4:3,OF[_,?/@[2<C*+YW],,IXP_^ME](#P
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MG%XDY]CC2^H8]O]-:>77T&:-1V%]DFE" UR+"F)2#01_#H-TR,L3ZN6:1.E
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M%P%L&N7 6&2DS"U#KU4_$ (;BD(6QC*!-NNX1TG@=YO'J"50F^,(.R]S#O=
M,@Y+@[PGNHFD$SJ]P&P ^\NX)H5!0SFT(-OJ=BM-0U[]]]^]>/6V;GMWGKJ'
M;8P2KY1L$5V-X ]7F$,=@*@SLTG6&-B:-=QOGI*O1+#P<WEIJZ[ [>"7>9[5
MK.1QP=B"G*HV,/N &@-95B:QQ?8P\C+9PHCM]5R =S"?C<J+R8>P.FT+"=28
M-3>4D%G;?:T7,*P+?[F+?#WL!/)HB%V+CC$&A^6F'H'K0O<@^F **UV-ER/A
M5M(9V.S<0DVP7AV^-&'@%0UV$6KO!>Q:-RUH&MZ&5I7O7IX>=(J/D"GKLD@B
M21FJ5<:Q)RB76&1G "]*O'PCN*5 0&':5@3V5R"[FJ?,K_"+#+PQ"95:$JOS
MJI"IP8CGI>]#.ZCYT!IBB#FM=9P9!.C[.\^(K8G#T(*'$"./#(KPRCHLWZ65
MQCZ2.U@#.O&PVVLKV=WK6HJ5VI_AR^MVW;EKV>*J._!==8)$W4,_G6S+FMR>
MTX9.5END\;EXE:\MRN'#3U_@WCH.E^_BAMY<<8PX@]ZZ2.BH'NP?099.#I(V
M7TUIH;OK)$O145>=(S[R ;_B+L6C3:\8W$^Q&'0K1#75HDTA6EF9*=PE']!-
MGH+ I<SK%5]+/AZKE8)I>YU6U1CK.I&T/;[5;K8<@F[X9UHF2*E_MG/8JL_F
MCC>+TR:[E[]F72[O=>WF?L)_6K_9[I:B?C"X+R*B%WZ"WV(47X ^P]MD5LVL
MM.'>?.3#1 "YA:T/6.,00-] >9[].)3J:0,[.%/8966;@!RH(@R3&T%VEL*;
M&(#\+H15=_8F1"1Z#M(%XSOXSE5R+CC=N0G.4'M52_Z&[U4?.$<%6_JFZ:PG
MG+3GP^@>*Y*Q'H+,8*5?][#Q)C/KU6EZ?@X[X\YK2D43!FW!$UD/F0A58]SS
MA)LA/QLN_N:>YG]?K8][^K%*%=#4\,+&W#RT(Q.AIJY9/H(*VYWWR5/L[.W)
MLR]6UGN5QWK8LSS6_QJ>#2\Y>_77TZO3\[-O'0[Z$>!_APA>W(%-F@R)(Y/R
M0UB2/W*27)K>1\D@7'4/]HYMAN9353:N*.V>>_[)J,U>F6:X/$N7+E%F H\7
MB#JCM>+B>/>NLQQ]%!-3(^#<:LT)N&1\;/J"R+%!652Z-/'VCPB$;HQ9OQ6,
M5Q]""6[FYPA-;_'T6;2"\CU-YO#K<J%$Z19P3(FJ>Z4F;6EL;H'>3^L-)WBW
M,C3CX Z&)CL.-]>?N78><ZZ#<-UII%LB6K/H7IU,+0H]&.DYIL4A=M@TSS6J
MH4=N6LSR[63D$1P28QVDD<4WI.S@;*@+HG6;<CS$.Q>!K J$*@A?\5OKBT=G
M6I^* H-5,K0==_L A6,9P">O_83MYJ4/X42N+%=\/T/'B S$%[5Q%ZF8B'K7
M)7$B'1K@EY3J8NJ ,'[HQOW$[['.S70A&,!D9WE)SBA0JL!('V,E4 ';,\88
M)O 8@_+>0.=S';9J7UD/C&N27&O,%6:Q[4K(_J^!7'*>>\(,FL!\&9!KC:_A
MTTH.S' ;E4O/,FGYCWT7_1[59,YVZPUP"_ZPLH]S\3DJ[U8V"'2(41%W!QAU
ME^77/%4QWAJ51=5LQ!T;43[+93(2%_/U9W-Z#THX\_J;/%EG<GY2N44,@$B%
MZ45%_H_';[?1)-<)(J=FHL#:CC;M?JQU5UGZYD6]B[:.I[F!V0P7/< M;])5
MQ%0OA*4P(A/A'T12DA,Q5C$90(C=(]7.U(&85.LY]H>=>WD5B/]K6YN7TH?R
M! R415B@"5.Z5K:@U=/38H=P,W*S7^L="7A2V.77X2VQ1^J8_.C5<\X&=+6B
M50@"F!K%%J !8PMC]OEA1^?(F[DQJ<4*];J^M72*(Q%>+S_%:T/I%I2%A&V8
M!WB+L!^&=)XC]3:\5=R?.>1J!*Q3K2?A(*R)H+(:DQFQ'7VMQ&6NRP4<2. 9
MYX6Z.)<<8*-PNJCX4E11@H7"0*F6J^:EXL&JBYRBO#'+N6\8[CU10:YLM[;#
MH\=6HNM]C1VV1"=:1+/)G>V&)PD,+&%J5>3=P2G< 6>VQI*4Z;<%A'G,JA0K
M.\GG)"X\IW'+;!&_AU)+K+9$%CC?!NP5B T0.1<J=[ <[/6COM&Y%"JN-41E
M?RZ)P;MMTU(<2;5HP'!0E%L +P;U!)41(A/IDMU.5;8S93Z;I\N[*= DT%#6
M6-G!KY$.RYS JL2?7D\OH>02<2YSDR1L%BX*DRXQSF65)B#0<NM:%3-0F\#L
M1-7K0@K*#/0*0VBA!U-JFS7]"#TQG%=1L/\%._RV^S5;VIUKZ7?.04WI>KZ[
M,=K<.-S\Q,HHR!:*2M@R%]UQEIB919 .2]EBU"Y- #K)7 :2=NW/08H98..'
MK8&[+=1/DS..S,K 0L<%2/DLY<+,*.FXUEKS<UZ[<81;>%U[=VC5D)8=Y<Q&
M(>AV8OX6?N=_7S_!\'O?H *MM*645D.7+69B_?I0$8?D<U%2"W*7+JP55P[+
M#7#)&SU.;N$#'8&DKG@0&SIZP%7;!TFVL?L%?4:>@*CND:PVR.;#D HA0%E,
M4R(80SCV#)F/UW0_-(F$G;ON]?R[!XNL-EK80[:[!VQWS<FA/_1@P<4_PWC(
M\H84;'/6$T?QBA+:U"8-AA6:&[5&9:[J&A^ACQ(_>^C*J14B8J4M#L)1?(%U
MW*NDH-V=_F0%[>(NG S?GYZ=7C\X':@WXO*W*1@!V,JLTF*01.$\ 2Y(;A;A
M7#C;-F!%CR8)3I*IW**Q&X;G5$[JH45%J.OKK>E;[A1JFR29:M#@1C[A&6D?
M,*05Z>/5&GO7>I<V8@_L'9; 784I6(WUXZJY<FURP@Q>-DV75.N#\5XJ=Z%4
M<S4F1)-DACGQ('O2I<MB<KFH4OG6-G2'<%ECJNA;%H,C"FPYO7I[;2?J$P%(
MKZ?WK>]!]2X^;T_J&%/U!N:HJ)<DYQ>Y""-F,ZE,\\V"/ZATA"Q. C\8AZ""
M#LREMWULFFU!P3[H8 F%&E>:4YM@K+0JE$$XRHL9)6%F:@+GJJ2UA,@!*F:C
M+!#38[QE[+@BX/E6-'H">VQ[=106F.Q5&7@E6RN8AHMQE;IB7Z)B3\DF^J9X
M%9GU5!U,Q<PPT8R5:4F.Q'8PQ:S6J%J"6?F8 K4V:PQF"AMX^):;H[;OH,HF
MX83K\AAX&N--DM:/3KT;0ND:<?TLO,!ELM;S2N\QEZ^ZGL]9$-DW"X2UBP@N
MPAX/X6APM3#[34C%\]"?1,!0 1TESTIKKP&[MY4NA2;F56E3K1ZPG)NNU61Y
MMD6>[\0Y9^RX<U15A1Q;H;(<,@(E'DJJ%"[ @SF)230>\T;)A#KG<Y/DJ5T@
M+LH6)A'*>!B5E&G82AI^R>_JO$01%[#]KDOYSO14.\)48VR%*AWT@J,)IC<8
M<!G[4K.@3GI!@(I$&WMW7(057$,U&ZE__"-5G#\&DQF7 P<+$B<:>W4 *UY)
MSK[/-<"OQF-@):"5" 7 1P2QWSG'#-01L^UXVJD*\3\S$ .T\Q@2(PXTX'QS
ML$,DB=3:]5&!L3*^U-1<QZT"GIOE&+PHJP*,HRI>9\VG;SE)3I["55Q5?$Z1
MP62$7LXM6,R-W3U\?4"A40F(KO&1]2X%QSLS2M>N'YME C:SU%QWED,+ U;D
M8<^$W/ W0J4!;G]BNC_/X492]<3]O:J[&Y-U;N/=NVP12PS#D'"^]7V,6=)I
MJ4L>.:(\4QB8>Z5992LQ0;D,1GD&GYB2HW&B,:&H[B%]J&4K;M,5A=/ !AAL
M48JI:@D.>R 2[DUK3&F]:QCO*$V*PQJ45N_'/LTI@I.Y4C+GMD>M!U1+S!.E
M$  :URL6G"LGXPQ0C5@Q6(6"&3K8_ A!5PP4A953WV+=_._A$XQU]ZO4W&@\
MPK/J.#%;9;XEG8U(SN[M;'&W$3 B!+I'LBI==N:D2BC(O<8\JS^A1ILF5N=9
MQ2=T)3FTS].8$"!#7O, [<GJ3=/-C?W-+VATW7OJ^*.WU/$AAV\XDR[1(3G:
M5H("\^E24_-+M%<1II02[!C]'&64L<,)O=R"I=9Z''MN&<M.4GPUY\#95W.=
M\;0N$BT^A9]HCD!B<-B)X):;IH*@2N4S)$T8**HW%S0F_P!+J%N&PV0R^#BC
MK#/OF^P!4Q]\:KL<)-H7[(_=&RTWE/QF!3LCXI6U/7"?$-AG=1!"XU$99L=S
M#(_S K^H_V+O[^W'_MS;AB;J4TL+5Z^A*(>VN @(T7Z^QL>6]N?8&NRV82JZ
MDV.[%)-9!=&*VV@738<VAQ2LO+8F1J.,/598ADL% &'#%+X[1K3&5#'K#578
M;KR&*BQ:KJ=RKV11^("Z8#P65 V8-T&AZF?-K8,D]$9&Z32OB*B,$F?<&SX.
MBN+<-']L^(4'I%SKQ3'VX0OJ< 7;0? .C2R*09DW;JCMR?:@;55<6M(Y=B.K
MH%!3A/_UR!E>O&ES[ 4"D^M_6WTT*]L.TSVCP$^FS37D9[3WD)>G/YD4U#]M
MG7W 66]N35,$_AV=>.,E4NJUHQES=0C'<&P A_S"@34^K+RWAW6%R8 42S5%
M,JOR+ZUF\RU=S= IZI6<;+CPI?T,CC1-5(77$G./4-MVG@>CR&X.Q)V+V?AP
M4C.2A])K(;@)TXKX"#.A)&J\EIUV<X2PS"N=+G&(T%3,D6MXX+4P'SA?;>0)
M5B]Z:1BLW[I<#R2F/D;D70\<RJL!]Z#JD9OQM,Q@\/&D"+GC-A7U<@B^V=4I
MSY0$&U4P*?)JKAUK59(A$!L+)?>9I8 G4Z@<^6*5DM@9XZ\V?"CI9#:J"DTO
MQ(@^<%"]Z2_#R\F@'Y.<D0<93!.^Q30'902%5^<@G-_**$8[=)=^((5CA84U
MJ4L%[G;O"\8Y3+;RL)\EG]J<%F4K,&YO32 UAJW+IY9,MQJ<C[<;*ST!O>97
MP?$4SQ$/Y9@=;0.LMY*=_A7($.'BCZ*HD,K,HSELU+P@MXW!F5EC)C?O,9.3
MF@T_Y&/X'!Q4_;%F;*BA]'6J09:CV'NR8=INA*3B#:U1P+X.CQ>$E-EB'MCT
M6@:)^VY@\"L,RM:-4':LPG)*F+@KY?YU&"_R1: '(>P,@JWZ7ZQ.9I3$E8EQ
MLX2XBO@MF"1$8;R@\/%0U9\5]\""39*>J_#DWLY_N!H(V3/C+1D0PBD*)P+X
MJFP+A'I6JX+W\C>(2V_[>'9/%[L]P3J9A7&V.C]J>@F;!]TTO;$'S$GP.Q1"
M)*'N4%S^8B&>W9WUB?'TAZ_^V5^^:FL'.@*P-9XD =C5K-A:H8(%N#3EX?8=
MJO&.!U92K['D+?I#(8U\H'MJ1<VXO8<M\U %\E[*86=Z2 ?@XV=KB Y>  TI
M>#ZC3K&\&YYM4M-O38-R4K^]&:W(2)1,!$3KNU^ZA+NO67]5,VD3%1D0I]8(
MJF6N?JU7@?X#+(*V60"2Z&#D+/WC#E>2S;T<#<\?VY*(7W+W9.K:9D*K+AN7
M-)%499-RZNL8SL"M=VYJF9N8E<R8K$7K=RPP?:>$#5I+BQN,>$:? _. 3T 1
M@9^!LN ;9PVR%[N9CZW3/FWXJ[^:N0H:ZGOQ:(:(("GE!D&<5R,@B7OR"0\8
MV732\1@%,XAV"W*-N;_N#_??E^IZX?Z_8T[>7=[SK)J-.)9BBY^I;<+]7<,!
MY7<QM>\?O%R7NN?=GM4]#]^_'QY?G_XZ#$Z.KH=/LO*96NX="5@6,LU+1:!T
M<>#Y0-G;A'+7]; 96OY&#3CBG# CL<0"N%,:[!T,P) %U?B;%2@*]VZW%?A\
ME,=+^)]I.4M__']02P,$%     @ ZD&I5!1M,Y:+$P   8   !X   !M8VM?
M97@Q,#EX;6%N86=E;65N=&EN8V5N="YH=&WM75MSVSBR?C^_ NNIG76JY&N<
MFYU-E6)[9G,VOI2MV=0^G8)(4,2$(C@ :$7SZT]W ^!%U"6W263%\Y"Q)!)H
M-+J_;C0:C9=_.[LZ'?SW^IRE=IRQZ]]>OWUSRK9V]O;>/3[=VSL;G+%_#2[>
MLJ/=_0,VT#PWTDJ5\VQO[_QRBVVEUA;'>WN3R61W\GA7Z='>X&8/FSK:RY0R
M8C>V\=:KE_@-_"MX_.I_7OYM9X>=J:@<B]RR2 MN1<Q*(_,1>Q<+\Y[M[/BG
M3E4QU7*46G:X?WC(WBG]7MYQ][N5-A.O0CLO]]SGEWO4R<NABJ>O7L;RCLGX
MGUMR_X4X>G'$GT9'A\^/AON<OSC83Z+H,(X.$GXT3/[O (C<@\?=.\9.,_'/
MK;',=U*!_1\_.RSLR43&-CT^V-__^U;K.2L^V!V>R5%^3-3"KXF"L?F?(Y4I
M??S3/OUW@K_L)'PLL^GQ/P9R+ R[%!-VH\8\_T?/ (=WC- R<0\:^:<X/L#.
MZ>/$4P/M9#(7@3I'TOF'5 ZE90?[NR]>[N'S84R=D34HCH![0G\GDG^YNKE@
M5[^TJ5U#.B^B?Y_?WEY=LM.KF^NKF_[@S=7EVA-].^@/SB_.+P? 838XO[FX
M9?W+,QC"Y=D;',#MVH^@?WT-<-1__?:<#:Y8_UW_YFPQT6.N1Z"P0V6M&KL>
MUF4<U[_=W/[6AXF 40S^=<XN^I?]7]W4O+D\A?^]^<\YNW[;7RQ3:SRX\R01
MD95W@O4++3-V^+1'</V98_F]-%8F4_>5S&,8VO'CI\5?#ZI'<T<W2 5+5):I
M"=HGX/+8,)['+%)Y3*;0,)/R+&.\*+(ILXKQ"=>Q86,>"U8"_9I9: ,01!BC
M<K!INE":XZOL@N=\),@.OLEQ$I&+UQG/V3:^\_-/SP\/]T_P"_KSX.01=9 S
M\4%$)3[=@WZP#2UYQI1FA58)]$,FFHEQD:FI$$PE1,.I&A<\G[))JI@$N@L1
MR41&0/V4@>$%[I,IYC!"5G!M923A><MD3J\C';N,G?)"6IBK/^%1QX_2P)^I
MT (>Y%I 6PGP,6Z^A[3!QUN4% 6C.7BZ?P)VBL&XZ1EQATR OXR8SV3X,\ED
M9-E$VI1><8_YH5$?L7<&>MVO_"1!*U:K;/=39+/@<0QSOY.)Q$EB2S1WOHEL
MSM>\@VH<W[[W-EL.GP6VQ"+RTGU,PH_O 0#6TO3]2-YZ]4GSOKZ8=)6#PH)P
M<P>[*]3<_TSJ^-'0$?&"1]).X9DI&XH./#0FM %R#JF>O#C!QNYD+.(>2]4$
ME%NC3G);M8/HUVE(DII;D"K4V+)0'AL<Q?@&8$(L,B!>$]0V1PN#1Y:,M! .
M Q H<,BL@"&JN('BA0:8R2WA C9)3R5*CQV-"(U H4F OZK348]I,0*$QX80
ME"1* [ 0F-6#EJS(,@"Y$G@(/("N+4Y5_/-/1\].@,D*6M+0@K%:NMF+%$ ?
MC-[TD"$3@:8$^0"S)CD8!0=XIHS2>G".QTAZS>>DU-BVY[,G>"RM!<%PX!<+
MA$R0)ARPM#!*E<',2@-K,&+O)!5$'DUE8U[2BB"8_@I_J6M#X$R\G\X0"3.0
M2O@B=.LFW9$RQ''G40:K/F !#F0(:H4LQ5F&!Y"1R"7H$'@(=M. K=@,[1W,
MF1HM[B2T;E-8,E?Z;$B#T:""R(_D$"8+1+$RS%:T#"PR40/XCH'W(!!L./7Z
M78EY/?]N8@@N9CJ4-#G0BF^U(08X VW:$1O "B!5(-J@F()H@HF1,2B 88E6
M8Z(PD\9B?PT8:;;,N"4!LL!G(M6]B)]0^>#_/7QDCLQV:$)914I&U GVS4L8
MI48L0]^I0+&=,[A*RU,I$G8>0))=)> A@4ZTL75CA+%B 2EG4Y[B4I/'BY^%
M1G0D-+IV8!HKH"%7EHU*KH%_P/F"3TG4'!#W'0;VT1F>L1 (M0O:!;ZNI$CE
M'T]1LRG_.@>8&AKQ1XFTSJ%@,US#PWOC&KZI\((-@,/".IEY<!._BJ%9P%WT
M<<B&"XW+3K 2J+9#;A!^<WS:\(R#[^/7B.CV.:=B*( !.>EAL@@<MD&_6\^U
M%!&\I(1E ,_Z$2%!RP?\?/5[=KA&ZM=?'_4[VGU\M%P#H5=83YP''^,\> /W
M1@47P/!:*F6?Y<3N5&I0JN!Y]="!PL596,KYM1LX*V-E:>WFG"R+6S")T/@R
M.4D<;63E'Q;*[<^$,%'G^\H(=M6V-V^MUUH'D.L/S2X"%6?7^=<UJVNEUZ_7
M1Z^?+%?J@1<46%9>DQ#10@U]ZS/A/SWH]U^BWRV- 34>PWK#K'"G2971L9VO
MR8@9<WYR^@A0,L)5^R*MQ#4=1B;82.1"<_@[Y;"P04K:2W,PU"E@#B@Q-M=R
MX &'- '"4-B)$,XIMQ.UJ%.S>'Z;&ZIA),=:@$, RZV%6ZQ>'/;K5_@0EH*E
M[;[R?>;=A;2[_Q[,VXEU_Z8Z$%F  [8SU(*_W^$)3,DQSR9\:K8^:3?:C?O5
MRZ%^M6+W=^-4;+ER28P(.#/:-:*KU2M3DQ7:]24*!7I9AVEPE^?@V8EI!CA^
M'*#\Z%ET:#G?&5KD"LUSDA[F[C/G[E)95 YCN0O:6MHDU6*DX%./0GF.2<C)
M,=".;B6N+F/F8_H\2J6X$R%@U)SO7Q6%#I?%B#8C1O-X?9S)5=MWC4FX$-R4
M6CA?DN;JWOB1ZZM0YZ /+3QTVP*$3>@6@C*,0;^:5FC>G-!^^M(GPAKOCQ)Z
MD9:[C4#XE/D/V!7P+/6!]:YB;C=V]_M(<":<I_-+<R_^D?M. $0,,VE2X5:'
M L=IQ"CH?7,##S<ZM&B891>B>HV9@<(8=@N2*2( 8""M93PJY%TU=I3864RA
M0?68Y>^%WY$$4Y2)GC,.]98)@=98E37=\RAHVHD-$<VNG8Y2GH^@@]_5T/&4
M-C=1<)0>\5S^R=UB<[D]1T$D^8YE I.. M&=:D-I-3+B?O.+Y ?ZK;JL^PL"
MVR 6NNBM--)?=3DT9P0;LJ%P=&^,U2(44#$&LO6#M?IR2&CH0K5GS'B,9&(J
MPFJ5 U4&J,=$B8506N\CNZPM.2R#.]_5,LRH*#/;@/A/-P\;HJA/[HVB7MF9
ML-6-^*.4FJ3FP:G\^JLTORQS23NMQ$F?^T!ZQC48S5P%9Z?*URGXE*PP145
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MKTSTA?==8:T><^ZZKQN*1]K(,KO#TV"O\;PB]!(88JR*WKL]>K#;5FF3RL(
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M#J<D$ME#WO!6PL)G^DY,\G9.\U]02P,$%     @ ZD&I5"!DZ,+U P  S0L
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MX-J&4-OH[8:5Q24(ZKDQ&]8^;Q0V'AT*^RLA>_GBJ!8<'NL<9SG?L.E$1I'
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M(H/8A+:,V$4RL<A[0+W>X&5WIE%P,R.5OBN1K@$JQV-A#.?W)NJ!1/FU/4S
M,C=\#[A&7M0V[^*OY8;S#<C_R@0,=ULN2T)WT-UWU/[9)L+MQ+X3@VS 9 $
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MW.G6-SO](_SU'LY=>RI.M8$!N2O9?#.\XNR#^-WT.D2?*SLMT!>(_AQKN2-
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MPT>ON=>$]_;([MLP&O2-]EZMX58?O=Z]$?0.AJ?!X&#5W4LC6NXN# \A>#.
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M_-*XMWNK@(KI\-RS5L(L.W-2UTW748&C%M+]&J:TKM]P+L+#5>I8@_X0 5#
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M$I.&%U4[WIPMZ0#B#A[,R;6OQUNVX#&+HFR;QKUP)N=V[3CLX F"IVE.^'9
M^=!3HT-)4)S=Z4J:^->Q$SOZDQSXQIF<-!\?;$AWCR6'; @2X9H>-OA"J<70
MQ@,#QJ@2GTG(Y,L \XC<\13?1X,1"?QQ %F);73JDL%Y7 ,^XCYV&B.OY96
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M]?&;<>K.'0\^_<Q3>E3$\G9SB.49 J&^.<YC)HME"O@=:\K0V(R$$3K"NQ6
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MBKDZ+.(B"_9CE(MID2<58LXU94A;3[WQU)\\>D_]QK0XX*)G*X_!(+B-SIQ
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M3;515N0KNV.A[CWL$#9+?9WP2>\#8\KSO>TLN 5Q"FJ1P?U>Z.X%W\=8(B;
M86U;,0N8S&A,&R4S;":4GT9L+]*? FV/1TG-5HH<2GF4C*N!HU=MP*,;<GC
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M4$L! A0#%     @ ZD&I5-K>9('&C@8 *B]( !               ( !
M &UC:RTR,#(R,#,S,2YH=&U02P$"% ,4    " #J0:E4?C]ZG< O  "$$ (
M$               @ 'TC@8 ;6-K+3(P,C(P,S,Q+GAS9%!+ 0(4 Q0    (
M .I!J52%\?SU[$8  #CF @ 4              "  >*^!@!M8VLM,C R,C S
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( .I!J51 F>.$?$T! *8%#P 4
M      "  0 &!P!M8VLM,C R,C S,S%?9&5F+GAM;%!+ 0(4 Q0    ( .I!
MJ50PW3UL\2H  '0L   3              "  :Y3" !M8VLM,C R,C S,S%?
M9S$N:G!G4$L! A0#%     @ ZD&I5,ER*<P"_0  =V8! !,
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M;V-K<&PN:'1M4$L! A0#%     @ ZD&I5"JCRV,R+@  ^B@! !X
M     ( !=-P. &UC:U]E>#$P-GAS979E<F%N8V5P;VQI8WEF+FAT;5!+ 0(4
M Q0    ( .I!J504;3.6BQ,   &    >              "  >(*#P!M8VM?
M97@Q,#EX;6%N86=E;65N=&EN8V5N="YH=&U02P$"% ,4    " #J0:E4LI07
M;P$%  #X,P  &0              @ &I'@\ ;6-K7V5X:&EB:70R,7@S,S$R
M,#(R+FAT;5!+ 0(4 Q0    ( .I!J50@9.C"]0,  ,T+   9
M  "  >$C#P!M8VM?97AH:6)I=#(S>#,S,3(P,C(N:'1M4$L! A0#%     @
MZD&I5!Y=^@EI"   A"@  !H              ( !#2@/ &UC:U]E>&AI8FET
M,S$Q>#,S,3(P,C(N:'1M4$L! A0#%     @ ZD&I5!(:9E=W"   DB@  !H
M             ( !KC / &UC:U]E>&AI8FET,S$R>#,S,3(P,C(N:'1M4$L!
M A0#%     @ ZD&I5'ONH=LP!@  2R0  !D              ( !73D/ &UC
M:U]E>&AI8FET,S)X,S,Q,C R,BYH=&U02P$"% ,4    " #J0:E4Z;*.&9DQ
M   ?J $ &@              @ '$/P\ ;6-K7V5X:&EB:70T,35X,S,Q,C R
M,BYH=&U02P$"% ,4    " #J0:E4_Z/;__4A  "5#0$ '@
M@ &5<0\ ;6-K7V5X>#$P.'AM86YA9V5M96YT:6YC96XN:'1M4$L%!@     2
- !( XP0  ,:3#P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
